SampleID	day-relative-to-fmt	PatientID	Timepoint	Consistency	Accession	BioProject	DayRelativeToNearestHCT	AccessionShotgun	patient-sample-counts	TimepointOfTransplant	HCTSource	Disease	wbcPatientId	autoFmtPatientId	nejmPatientId	autoFmtGroup	categorical-time-relative-to-hct	week-relative-to-hct	RandomizationArm	RandomizationDayRelativeToNearestHCT	FMTDayRelativeToNearestHCT	DonorSampleID	LastSampleBeforeFMT	FirstSampleAfterFMT	week-relative-to-fmt	categorical-time-relative-to-fmt
#q2:types	numeric	categorical	numeric	categorical	categorical	categorical	numeric	categorical	numeric	numeric	categorical	categorical	categorical	categorical	numeric	categorical	categorical	numeric	categorical	numeric	numeric	categorical	categorical	categorical	numeric	categorical
1000A		1000	0	formed	SRR11414397	PRJNA545312	-9		5	9	TCD	Multiple Myeloma	2401c48f5007ed31ce8203		1		pre	-2								
1000B		1000	5	liquid	SRR11414992	PRJNA545312	-4		5	9	TCD	Multiple Myeloma	2401c48f5007ed31ce8203		1		pre	-1								
1000C		1000	15	liquid	SRR11414991	PRJNA545312	6		5	9	TCD	Multiple Myeloma	2401c48f5007ed31ce8203		1		post	0								
1000D		1000	18	semi-formed	SRR11414990	PRJNA545312	9		5	9	TCD	Multiple Myeloma	2401c48f5007ed31ce8203		1		post	1								
1000E		1000	22	formed	SRR11414989	PRJNA545312	13		5	9	TCD	Multiple Myeloma	2401c48f5007ed31ce8203		1		post	1								
1001		pt_with_samples_1001_1002_1003_1004_1005_1006_1007_1008_1048_1121_152	15	formed	SRR11414988	PRJNA545312	-6		10	21	cord	Leukemia	c8848e19e1175e744f8987	36	1		pre	-1								
1001A		1001	0	semi-formed	SRR11414987	PRJNA545312	-3		5	3	cord	Leukemia	3b6772ed982d10c47cd58d	686	1		pre	-1								
1001B		1001	3	liquid	SRR11414986	PRJNA545312	0		5	3	cord	Leukemia	3b6772ed982d10c47cd58d	686	1		peri	-1								
1001D		1001	16	semi-formed	SRR11414984	PRJNA545312	13		5	3	cord	Leukemia	3b6772ed982d10c47cd58d	686	1		post	1								
1001E		1001	19	semi-formed	SRR11414983	PRJNA545312	16		5	3	cord	Leukemia	3b6772ed982d10c47cd58d	686	1		post	2								
1001F		1001	34	semi-formed	SRR11414982	PRJNA545312	31		5	3	cord	Leukemia	3b6772ed982d10c47cd58d	686	1		post	4								
1002		pt_with_samples_1001_1002_1003_1004_1005_1006_1007_1008_1048_1121_152	21	liquid	SRR11414981	PRJNA545312	0		10	21	cord	Leukemia	c8848e19e1175e744f8987	36	1		peri	-1								
1002A		1002	0	formed	SRR11414980	PRJNA545312	-34		4	34	TCD	Leukemia	6d6f45d2e607fcd8a455b0	691	1		pre	-3								
1002B		1002	33	formed	SRR11414979	PRJNA545312	-1		4	34	TCD	Leukemia	6d6f45d2e607fcd8a455b0	691	1		pre	-1								
1002C		1002	37	liquid	SRR11414978	PRJNA545312	3		4	34	TCD	Leukemia	6d6f45d2e607fcd8a455b0	691	1		peri	0								
1002D		1002	41	liquid	SRR11414977	PRJNA545312	7		4	34	TCD	Leukemia	6d6f45d2e607fcd8a455b0	691	1		post	0								
1003A		1003	0	semi-formed	SRR11414976	PRJNA545312	3		1	-3	PBSC_unmodified	Leukemia	dc043119b5b9e11ad8070d	695	1		peri	0								
1004A		FMT.0002	1	formed	SRR11414975	PRJNA545312	-10		6	11	TCD	Leukemia	444ae43d61a3ec1b7de52f		1		pre	-2								
1004B		FMT.0002	8	semi-formed	SRR11414972	PRJNA545312	-3		6	11	TCD	Leukemia	444ae43d61a3ec1b7de52f		1		pre	-1								
1005		pt_with_samples_1001_1002_1003_1004_1005_1006_1007_1008_1048_1121_152	63	formed	SRR11414971	PRJNA545312	42		10	21	cord	Leukemia	c8848e19e1175e744f8987	36	1		post	5								
1006		pt_with_samples_1001_1002_1003_1004_1005_1006_1007_1008_1048_1121_152	72	semi-formed	SRR11414970	PRJNA545312	51		10	21	cord	Leukemia	c8848e19e1175e744f8987	36	1		post	6								
1006A		pt_with_samples_1006_2024	0	semi-formed	SRR11395486	PRJNA607574			4																	
1007		pt_with_samples_1001_1002_1003_1004_1005_1006_1007_1008_1048_1121_152	151	liquid	SRR11414969	PRJNA545312	130		10	21	cord	Leukemia	c8848e19e1175e744f8987	36	1		post	6								
1007A		1007	0	semi-formed	SRR11414345	PRJNA545312	-5		4	5	PBSC_unmodified	Leukemia	59a820c9214c46e85c51be	534	1		pre	-1								
1007B		1007	3	semi-formed	SRR11414344	PRJNA545312	-2		4	5	PBSC_unmodified	Leukemia	59a820c9214c46e85c51be	534	1		pre	-1								
1007C		1007	10	semi-formed	SRR11414343	PRJNA545312	5		4	5	PBSC_unmodified	Leukemia	59a820c9214c46e85c51be	534	1		peri	0								
1007D		1007	22	semi-formed	SRR11414342	PRJNA545312	17		4	5	PBSC_unmodified	Leukemia	59a820c9214c46e85c51be	534	1		post	2								
1008		pt_with_samples_1001_1002_1003_1004_1005_1006_1007_1008_1048_1121_152	176	liquid	SRR11414341	PRJNA545312	155		10	21	cord	Leukemia	c8848e19e1175e744f8987	36	1		post	6								
1008A		1008	0	formed	SRR11414340	PRJNA545312	-8		3	8	TCD	Multiple Myeloma	7069ef4770ee131ce832f3	684	1		pre	-2								
1008B		1008	5	liquid	SRR11414338	PRJNA545312	-3		3	8	TCD	Multiple Myeloma	7069ef4770ee131ce832f3	684	1		pre	-1								
1008C		1008	12	liquid	SRR11414337	PRJNA545312	4		3	8	TCD	Multiple Myeloma	7069ef4770ee131ce832f3	684	1		peri	0								
1009		pt_with_samples_1009_1010_1011_1049_1125_145	0	formed	SRR11414336	PRJNA545312	-6		8	6	cord	Myelodysplastic Syndromes	2cb8f755953c8e7e729fe3	176	1		pre	-1								
1009A		1009	0	formed	SRR11414335	PRJNA545312	-5		3	5	PBSC_unmodified	Leukemia	935f743643de70772034de	685	1		pre	-1								
1009B		1009	3	formed	SRR11414334	PRJNA545312	-2		3	5	PBSC_unmodified	Leukemia	935f743643de70772034de	685	1		pre	-1								
1009C		1009	21	semi-formed	SRR11414333	PRJNA545312	16		3	5	PBSC_unmodified	Leukemia	935f743643de70772034de	685	1		post	2								
1010A		1010	0	formed	SRR11414332	PRJNA545312	-3		4	3	PBSC_unmodified	Leukemia	734b5113f52574553c1707	690	1		pre	-1								
1010B		1010	4	semi-formed	SRR11414331	PRJNA545312	1		4	3	PBSC_unmodified	Leukemia	734b5113f52574553c1707	690	1		peri	0								
1010C		1010	9	formed	SRR11414330	PRJNA545312	6		4	3	PBSC_unmodified	Leukemia	734b5113f52574553c1707	690	1		post	0								
1010D		1010	18	formed	SRR11414329	PRJNA545312	15		4	3	PBSC_unmodified	Leukemia	734b5113f52574553c1707	690	1		post	2								
1011		pt_with_samples_1009_1010_1011_1049_1125_145	41	semi-formed	SRR11414327	PRJNA545312	35		8	6	cord	Myelodysplastic Syndromes	2cb8f755953c8e7e729fe3	176	1		post	4								
1011A		1011	0	liquid	SRR11140284	PRJNA606262			1																	
1012		pt_with_samples_1012_1013_1014_1015_1016_1017_1018	0	formed	SRR11414326	PRJNA545312	-8		5	8	cord	Non-Hodgkin's Lymphoma	4c5e3185aac6836a74a8c5	168	1		pre	-2								
1012A		1012	0	formed	SRR11414325	PRJNA545312	-5		4	5	cord	Leukemia	f1f90aeb79b29632c98c94	667	1		pre	-1								
1012B		1012	5	liquid	SRR11414324	PRJNA545312	0		4	5	cord	Leukemia	f1f90aeb79b29632c98c94	667	1		peri	-1								
1012C		1012	10	liquid	SRR11414323	PRJNA545312	5		4	5	cord	Leukemia	f1f90aeb79b29632c98c94	667	1		peri	0								
1012D		1012	17	semi-formed	SRR11414322	PRJNA545312	12		4	5	cord	Leukemia	f1f90aeb79b29632c98c94	667	1		post	1								
1013		pt_with_samples_1012_1013_1014_1015_1016_1017_1018	8	semi-formed	SRR11414321	PRJNA545312	0		5	8	cord	Non-Hodgkin's Lymphoma	4c5e3185aac6836a74a8c5	168	1		peri	-1								
1013A		1013	0	formed	SRR11139605	PRJNA606262			1																	
1014A		1014	0	formed	SRR11140289	PRJNA606262			3																	
1014B		1014	9	semi-formed	SRR11140288	PRJNA606262			3																	
1014C		1014	10	liquid	SRR11140287	PRJNA606262			3																	
1015A		1015	0	liquid	SRR11414320	PRJNA545312	-3		14	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	6907b65762365ffa98be58	636	1		pre	-1								
1015D		1015	21	liquid	SRR11414319	PRJNA545312	18		14	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	6907b65762365ffa98be58	636	1		post	2								
1015G		1015	51	liquid	SRR11414318	PRJNA545312	48		14	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	6907b65762365ffa98be58	636	1		post	6								
1015H		1015	64	liquid	SRR11415173	PRJNA545312	61		14	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	6907b65762365ffa98be58	636	1		post	6								
1015J		1015	112	liquid	SRR11115508	PRJNA607574	109		14	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	6907b65762365ffa98be58	636	1		post	6								
1015P		1015	322	liquid	SRR11415172	PRJNA545312	319		14	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	6907b65762365ffa98be58	636	1		post	6								
1015Q		1015	364	liquid	SRR11415171	PRJNA545312	361		14	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	6907b65762365ffa98be58	636	1		post	6								
1015R		1015	385	liquid	SRR11415170	PRJNA545312	382		14	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	6907b65762365ffa98be58	636	1		post	6								
1015S		1015	414	liquid	SRR11415169	PRJNA545312	411		14	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	6907b65762365ffa98be58	636	1		post	6								
1015T		1015	485	liquid	SRR11415168	PRJNA545312	482		14	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	6907b65762365ffa98be58	636	1		post	6								
1015U		1015	518	liquid	SRR11415167	PRJNA545312	515		14	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	6907b65762365ffa98be58	636	1		post	6								
1015V		1015	532	liquid	SRR11415166	PRJNA545312	529		14	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	6907b65762365ffa98be58	636	1		post	6								
1015W		1015	546	liquid	SRR11415165	PRJNA545312	543		14	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	6907b65762365ffa98be58	636	1		post	6								
1015X		1015	588	liquid	SRR11415164	PRJNA545312	585		14	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	6907b65762365ffa98be58	636	1		post	6								
1016		pt_with_samples_1012_1013_1014_1015_1016_1017_1018	42	semi-formed	SRR11415162	PRJNA545312	34		5	8	cord	Non-Hodgkin's Lymphoma	4c5e3185aac6836a74a8c5	168	1		post	4								
1016A		1016	0	semi-formed	SRR11415161	PRJNA545312	3		1	-3	TCD	Leukemia	9abcd635e2963abdeaf654	701	1		peri	0								
1017		pt_with_samples_1012_1013_1014_1015_1016_1017_1018	50	semi-formed	SRR11415160	PRJNA545312	42		5	8	cord	Non-Hodgkin's Lymphoma	4c5e3185aac6836a74a8c5	168	1		post	5								
1017A		1017	0	semi-formed	SRR11415159	PRJNA545312	1		1	-1	PBSC_unmodified	Myelodysplastic Syndromes	e3a309c1146abfe508afd8	104	1		peri	0								
1018		pt_with_samples_1012_1013_1014_1015_1016_1017_1018	99	liquid	SRR11415158	PRJNA545312	91		5	8	cord	Non-Hodgkin's Lymphoma	4c5e3185aac6836a74a8c5	168	1		post	6								
1019		pt_with_samples_1019_1020_1021_1022_1023_1024	0	formed	SRR11415157	PRJNA545312	-7		5	7	cord	Leukemia	fee41993ccb6ca25689f7d	193	1		pre	-2								
101A		101	0	formed	SRR11415156	PRJNA545312	-20		3	20	TCD	Multiple Myeloma	8d3e8f53554499dbdafc16	105	1		pre	-3								
101B		101	21	liquid	SRR11415155	PRJNA545312	1		3	20	TCD	Multiple Myeloma	8d3e8f53554499dbdafc16	105	1		peri	0								
101C		101	26	liquid	SRR11415154	PRJNA545312	6		3	20	TCD	Multiple Myeloma	8d3e8f53554499dbdafc16	105	1		post	0								
1020		pt_with_samples_1019_1020_1021_1022_1023_1024	7	semi-formed	SRR11415153	PRJNA545312	0		5	7	cord	Leukemia	fee41993ccb6ca25689f7d	193	1		peri	-1								
1020A		1020	0	semi-formed	SRR11395410	PRJNA607574			1																	
1021		pt_with_samples_1019_1020_1021_1022_1023_1024	15	semi-formed	SRR11415151	PRJNA545312	8		5	7	cord	Leukemia	fee41993ccb6ca25689f7d	193	1		post	1								
1021A		1021	0	formed	SRR11415150	PRJNA545312	-3		2	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	40c35b75c25a06526992d6	692	1		pre	-1								
1021C		1021	14	formed	SRR10668238	PRJNA545312	11		2	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	40c35b75c25a06526992d6	692	1		post	1								
1022A		1022	0	formed	SRR11415149	PRJNA545312	-4		2	4	cord	Leukemia	bd872b06dbc027871de889	699	1		pre	-1								
1022C		1022	683	formed	SRR11415148	PRJNA545312	679		2	4	cord	Leukemia	bd872b06dbc027871de889	699	1		post	6								
1023		pt_with_samples_1019_1020_1021_1022_1023_1024	35	semi-formed	SRR11415147	PRJNA545312	28		5	7	cord	Leukemia	fee41993ccb6ca25689f7d	193	1		post	3								
1023A		1023	0	semi-formed	SRR11140268	PRJNA606262			1																	
1024		pt_with_samples_1019_1020_1021_1022_1023_1024	49	formed	SRR11414968	PRJNA545312	42		5	7	cord	Leukemia	fee41993ccb6ca25689f7d	193	1		post	5								
1024A		1024	0	formed	SRR11414967	PRJNA545312	-5		2	5	PBSC_unmodified	Hodgkin's Disease	aadb3d1e42176ab8f24c3b	643	1		pre	-1								
1024G		1024	291	semi-formed	SRR11414966	PRJNA545312	286		2	5	PBSC_unmodified	Hodgkin's Disease	aadb3d1e42176ab8f24c3b	643	1		post	6								
1025		pt_with_samples_1025_1026_1027_1028_1029	0	liquid	SRR11414965	PRJNA545312	0		4	0	cord	Leukemia	a4d5a2fa2376c303f282fb	196	1		peri	-1								
1025A		1025	0	formed	SRR11395284	PRJNA607574			2																	
1025B		1025	14	liquid	SRR11395745	PRJNA607574			2																	
1026A		1026	0	formed	SRR11395484	PRJNA607574			3																	
1026B		1026	6	semi-formed	SRR11395217	PRJNA607574			3																	
1026C		1026	142	liquid	SRR11395206	PRJNA607574			3																	
1027		pt_with_samples_1025_1026_1027_1028_1029	16	semi-formed	SRR11414964	PRJNA545312	16		4	0	cord	Leukemia	a4d5a2fa2376c303f282fb	196	1		post	2								
1028		pt_with_samples_1025_1026_1027_1028_1029	22	liquid	SRR11414962	PRJNA545312	22		4	0	cord	Leukemia	a4d5a2fa2376c303f282fb	196	1		post	3								
1028B		1028	0	semi-formed	SRR11414960	PRJNA545312	-2		1	2	cord	Leukemia	b9a031f0dc4ac913c0b295	700	1		pre	-1								
1029		pt_with_samples_1025_1026_1027_1028_1029	29	semi-formed	SRR11414959	PRJNA545312	29		4	0	cord	Leukemia	a4d5a2fa2376c303f282fb	196	1		post	4								
1029B		1029	56	formed	SRR11414958	PRJNA545312	-3		2	59	PBSC_unmodified	Leukemia	3736d04f20304c84612794	32	1		pre	-1								
1029E		1029	73	liquid	SRR10668227	PRJNA545312	14		2	59	PBSC_unmodified	Leukemia	3736d04f20304c84612794	32	1		post	1								
1030		pt_with_samples_1030_1031_1032_1033_1034_1035_1036	0	formed	SRR11414957	PRJNA545312	-8		6	8	cord	Non-Malignant Hemat Disorders	647a951c8f0005ecdd4657	78	1		pre	-2								
1031		pt_with_samples_1030_1031_1032_1033_1034_1035_1036	8	semi-formed	SRR11414956	PRJNA545312	0		6	8	cord	Non-Malignant Hemat Disorders	647a951c8f0005ecdd4657	78	1		peri	-1								
1031A		1031	0	formed	SRR5926098	PRJNA394877			8																	
1031C		1031	9	semi-formed	SRR11140279	PRJNA606262			8																	
1031D		1031	13	liquid	SRR5926100	PRJNA394877			8																	
1031F		1031	14	liquid	SRR11140278	PRJNA606262			8																	
1031G		1031	16	semi-formed	SRR5925953	PRJNA394877			8																	
1031H		1031	17	semi-formed	SRR5926119	PRJNA394877			8																	
1031I		1031	18	semi-formed	SRR5926121	PRJNA394877			8																	
1031J		1031	19	formed	SRR5926123	PRJNA394877			8																	
1032A		1032	0	formed	SRR11414955	PRJNA545312	-2		1	2	PBSC_unmodified	Leukemia	74ead7cabf286a9d1a9695	411	1		pre	-1								
1033		pt_with_samples_1030_1031_1032_1033_1034_1035_1036	26	liquid	SRR11414954	PRJNA545312	18		6	8	cord	Non-Malignant Hemat Disorders	647a951c8f0005ecdd4657	78	1		post	2								
1034		pt_with_samples_1030_1031_1032_1033_1034_1035_1036	33	liquid	SRR11414953	PRJNA545312	25		6	8	cord	Non-Malignant Hemat Disorders	647a951c8f0005ecdd4657	78	1		post	3								
1034B		1034	6	liquid	SRR5925877	PRJNA394877			9																	
1034C		1034	9	formed	SRR5925916	PRJNA394877			9																	
1034E		1034	17	liquid	SRR5925911	PRJNA394877			9																	
1034F		1034	18	semi-formed	SRR5925912	PRJNA394877			9																	
1034I		1034	21	liquid	SRR5925913	PRJNA394877			9																	
1034J		1034	25	liquid	SRR5925914	PRJNA394877			9																	
1034K		1034	26	semi-formed	SRR5925907	PRJNA394877			9																	
1034L		1034	51	formed	SRR5925908	PRJNA394877			9																	
1034M		1034	176	formed	SRR5925909	PRJNA394877			9																	
1035		pt_with_samples_1030_1031_1032_1033_1034_1035_1036	36	liquid	SRR11414951	PRJNA545312	28		6	8	cord	Non-Malignant Hemat Disorders	647a951c8f0005ecdd4657	78	1		post	3								
1035A		1035	0	liquid	SRR11140290	PRJNA606262			1																	
1036		pt_with_samples_1030_1031_1032_1033_1034_1035_1036	43	formed	SRR11414950	PRJNA545312	35		6	8	cord	Non-Malignant Hemat Disorders	647a951c8f0005ecdd4657	78	1		post	4								
1036A		1036	0	formed	SRR11414949	PRJNA545312	-63		6	63	cord	Leukemia	118064b219e4f2ccb8a6df	706	1		pre	-3								
1036B		1036	62	formed	SRR11414948	PRJNA545312	-1		6	63	cord	Leukemia	118064b219e4f2ccb8a6df	706	1		pre	-1								
1036C		1036	70	liquid	SRR11414947	PRJNA545312	7		6	63	cord	Leukemia	118064b219e4f2ccb8a6df	706	1		post	0								
1036D		1036	74	liquid	SRR11414946	PRJNA545312	11		6	63	cord	Leukemia	118064b219e4f2ccb8a6df	706	1		post	1								
1036E		1036	93	semi-formed	SRR11414945	PRJNA545312	30		6	63	cord	Leukemia	118064b219e4f2ccb8a6df	706	1		post	4								
1036F		1036	287	formed	SRR11414944	PRJNA545312	224		6	63	cord	Leukemia	118064b219e4f2ccb8a6df	706	1		post	6								
1037		pt_with_samples_1037_1038_1039_1040_1041_1042_1043_1124	0	liquid	SRR11414943	PRJNA545312	-1		7	1	cord	Leukemia	2482c3f51ee6837262cb78	182	1		pre	-1								
1037E		1037	388	semi-formed	SRR11414942	PRJNA545312	411		3	-23	cord	Leukemia	d598722c905fe957f5b64a		1		post	6								
1037F		1037	389	semi-formed	SRR11414541	PRJNA545312	412		3	-23	cord	Leukemia	d598722c905fe957f5b64a		1		post	6								
1037G		1037	390	formed	SRR11414540	PRJNA545312	413		3	-23	cord	Leukemia	d598722c905fe957f5b64a		1		post	6								
1038A		1038	0	formed	SRR11115507	PRJNA607574	-3		1	3	PBSC_unmodified	Leukemia	9c26bff3cba9264c5770da		0		pre	-1								
1039		pt_with_samples_1037_1038_1039_1040_1041_1042_1043_1124	16	semi-formed	SRR11414539	PRJNA545312	15		7	1	cord	Leukemia	2482c3f51ee6837262cb78	182	1		post	2								
103A		103	0	formed	SRR11414538	PRJNA545312	-13		6	13	TCD	Leukemia	a6a77bde4e7dd8e2f89ac4	232	1		pre	-2								
103B		103	12	formed	SRR11414537	PRJNA545312	-1		6	13	TCD	Leukemia	a6a77bde4e7dd8e2f89ac4	232	1		pre	-1								
103C		103	22	liquid	SRR11414536	PRJNA545312	9		6	13	TCD	Leukemia	a6a77bde4e7dd8e2f89ac4	232	1		post	1								
103D		103	27	liquid	SRR11414535	PRJNA545312	14		6	13	TCD	Leukemia	a6a77bde4e7dd8e2f89ac4	232	1		post	1								
103E		103	90	formed	SRR11414534	PRJNA545312	77		6	13	TCD	Leukemia	a6a77bde4e7dd8e2f89ac4	232	1		post	6								
103F		103	563	formed	SRR11414533	PRJNA545312	550		6	13	TCD	Leukemia	a6a77bde4e7dd8e2f89ac4	232	1		post	6								
1040		pt_with_samples_1037_1038_1039_1040_1041_1042_1043_1124	23	semi-formed	SRR11414532	PRJNA545312	22		7	1	cord	Leukemia	2482c3f51ee6837262cb78	182	1		post	3								
1040A		1040	0	liquid	SRR11140122	PRJNA606262			2																	
1040B		1040	14	semi-formed	SRR11140121	PRJNA606262			2																	
1041		pt_with_samples_1037_1038_1039_1040_1041_1042_1043_1124	29	semi-formed	SRR11414530	PRJNA545312	28		7	1	cord	Leukemia	2482c3f51ee6837262cb78	182	1		post	3								
1041A		1041	0	formed	SRR5925910	PRJNA394877			23																	
1041B		1041	1	formed	SRR5925905	PRJNA394877			23																	
1041C		1041	3	formed	SRR5925906	PRJNA394877			23																	
1041D		1041	4	formed	SRR5925943	PRJNA394877			23																	
1041E		1041	5	formed	SRR5925942	PRJNA394877			23																	
1041F		1041	7	semi-formed	SRR5925945	PRJNA394877			23																	
1041G		1041	8	semi-formed	SRR5925944	PRJNA394877			23																	
1041H		1041	9	liquid	SRR5925947	PRJNA394877			23																	
1041I		1041	11	liquid	SRR5925946	PRJNA394877			23																	
1041J		1041	12	liquid	SRR5925949	PRJNA394877			23																	
1041K		1041	15	semi-formed	SRR5925948	PRJNA394877			23																	
1041L		1041	16	liquid	SRR5925938	PRJNA394877			23																	
1041M		1041	17	semi-formed	SRR5925937	PRJNA394877			23																	
1041N		1041	19	liquid	SRR5925991	PRJNA394877			23																	
1041O		1041	20	liquid	SRR5925992	PRJNA394877			23																	
1041P		1041	21	semi-formed	SRR5926155	PRJNA394877			23																	
1041Q		1041	22	semi-formed	SRR5925990	PRJNA394877			23																	
1041R		1041	23	semi-formed	SRR5925995	PRJNA394877			23																	
1041S		1041	24	semi-formed	SRR5925996	PRJNA394877			23																	
1041T		1041	27	semi-formed	SRR5925993	PRJNA394877			23																	
1041U		1041	29	semi-formed	SRR5925994	PRJNA394877			23																	
1041V		1041	30	semi-formed	SRR5925986	PRJNA394877			23																	
1041W		1041	38	formed	SRR5925987	PRJNA394877			23																	
1042		pt_with_samples_1037_1038_1039_1040_1041_1042_1043_1124	36	formed	SRR11414529	PRJNA545312	35		7	1	cord	Leukemia	2482c3f51ee6837262cb78	182	1		post	4								
1042A		1042	0	formed	SRR11414528	PRJNA545312	-9	SRR14092348	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		pre	-2								
1042AA		1042	49	semi-formed	SRR11414527	PRJNA545312	40	SRR14092347	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	5								
1042B		1042	1	formed	SRR11414526	PRJNA545312	-8	SRR14092272	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		pre	-2								
1042BB		1042	335	formed	SRR11414525	PRJNA545312	326	SRR13697068	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	6								
1042C		1042	2	formed	SRR11414524	PRJNA545312	-7	SRR14092261	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		pre	-2								
1042CC		1042	343	formed	SRR11414523	PRJNA545312	334		34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	6								
1042D		1042	3	formed	SRR11414522	PRJNA545312	-6	SRR14092250	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		pre	-1								
1042DD		1042	344	formed	SRR11414521	PRJNA545312	335		34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	6								
1042E		1042	4	formed	SRR11414518	PRJNA545312	-5	SRR14092239	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		pre	-1								
1042F		1042	5	semi-formed	SRR11414517	PRJNA545312	-4	SRR14092228	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		pre	-1								
1042G		1042	6	formed	SRR11414516	PRJNA545312	-3	SRR14092217	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		pre	-1								
1042H		1042	7	liquid	SRR11414515	PRJNA545312	-2	SRR14092206	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		pre	-1								
1042HH		1042	352	liquid	SRR11414514	PRJNA545312	343	SRR13697067	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	6								
1042I		1042	8	liquid	SRR11414755	PRJNA545312	-1	SRR13697113	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		pre	-1								
1042II		1042	353	liquid	SRR11414754	PRJNA545312	344	SRR14092195	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	6								
1042J		1042	9	semi-formed	SRR11414753	PRJNA545312	0	SRR13697102	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		peri	-1								
1042JJ		1042	359	liquid	SRR11414752	PRJNA545312	350	SRR13697155	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	6								
1042K		1042	10	formed	SRR11414751	PRJNA545312	1	SRR14092346	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		peri	0								
1042KK		1042	364	liquid	SRR11414749	PRJNA545312	355	SRR14092335	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	6								
1042L		1042	11	liquid	SRR11414748	PRJNA545312	2	SRR13697144	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		peri	0								
1042M		1042	12	liquid	SRR11414747	PRJNA545312	3	SRR14092324	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		peri	0								
1042N		1042	13	liquid	SRR11414746	PRJNA545312	4	SRR14092313	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		peri	0								
1042O		1042	14	liquid	SRR11414745	PRJNA545312	5	SRR14092174	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		peri	0								
1042P		1042	15	liquid	SRR11414744	PRJNA545312	6	SRR14092163	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	0								
1042Q		1042	16	liquid	SRR11414743	PRJNA545312	7	SRR14092312	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	0								
1042R		1042	19	liquid	SRR11414742	PRJNA545312	10	SRR14092301	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	1								
1042S		1042	20	liquid	SRR11414741	PRJNA545312	11	SRR14092290	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	1								
1042T		1042	24	liquid	SRR11414740	PRJNA545312	15	SRR14092279	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	2								
1042U		1042	25	liquid	SRR11414738	PRJNA545312	16	SRR13697133	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	2								
1042V		1042	26	liquid	SRR11414737	PRJNA545312	17	SRR14092271	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	2								
1042W		1042	27	liquid	SRR11414736	PRJNA545312	18	SRR14092270	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	2								
1042X		1042	34	semi-formed	SRR11414735	PRJNA545312	25	SRR13697186	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	3								
1042Y		1042	39	semi-formed	SRR11414734	PRJNA545312	30	SRR14092269	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	4								
1042Z		1042	45	semi-formed	SRR11414733	PRJNA545312	36	SRR14092268	34	9	TCD	Leukemia	2c4054d1faef9bf2348b68	704	1		post	5								
1043		pt_with_samples_1037_1038_1039_1040_1041_1042_1043_1124	43	formed	SRR11414732	PRJNA545312	42		7	1	cord	Leukemia	2482c3f51ee6837262cb78	182	1		post	5								
1044		pt_with_samples_1044_1045_1046_1047	0	formed	SRR11414731	PRJNA545312	-5		3	5	cord	Leukemia	577f3bec0f4b2895366128	201	1		pre	-1								
1044A		1044	0	formed	SRR11414730	PRJNA545312	-7	SRR14092267	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		pre	-2								
1044B		1044	1	liquid	SRR11414729	PRJNA545312	-6	SRR14092266	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		pre	-1								
1044C		1044	3	liquid	SRR11414681	PRJNA545312	-4	SRR14092265	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		pre	-1								
1044D		1044	4	liquid	SRR11414680	PRJNA545312	-3	SRR14092264	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		pre	-1								
1044E		1044	5	liquid	SRR11414679	PRJNA545312	-2	SRR14092263	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		pre	-1								
1044F		1044	6	liquid	SRR11414678	PRJNA545312	-1	SRR14092262	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		pre	-1								
1044G		1044	7	liquid	SRR11414677	PRJNA545312	0	SRR14092260	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		peri	-1								
1044H		1044	8	liquid	SRR11414676	PRJNA545312	1	SRR14092259	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		peri	0								
1044I		1044	11	liquid	SRR11414675	PRJNA545312	4	SRR14092258	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		peri	0								
1044J		1044	12	liquid	SRR11414674	PRJNA545312	5	SRR14092257	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		peri	0								
1044K		1044	13	liquid	SRR11414673	PRJNA545312	6	SRR13697175	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		post	0								
1044L		1044	14	liquid	SRR11414672	PRJNA545312	7	SRR13697207	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		post	0								
1044M		1044	17	semi-formed	SRR11414670	PRJNA545312	10	SRR14092256	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		post	1								
1044N		1044	18	liquid	SRR11414669	PRJNA545312	11	SRR14143427	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		post	1								
1044O		1044	19	semi-formed	SRR11414668	PRJNA545312	12	SRR13697066	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		post	1								
1044P		1044	20	liquid	SRR11414667	PRJNA545312	13	SRR14092255	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		post	1								
1044Q		1044	22	liquid	SRR11414666	PRJNA545312	15	SRR13697230	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		post	2								
1044R		1044	24	liquid	SRR11414665	PRJNA545312	17	SRR13697219	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		post	2								
1044S		1044	25	semi-formed	SRR11414664	PRJNA545312	18	SRR13697208	19	7	PBSC_unmodified	Leukemia	dd9e2e0709a2beaa745376	698	1		post	2								
1045		pt_with_samples_1044_1045_1046_1047	7	liquid	SRR11414663	PRJNA545312	2		3	5	cord	Leukemia	577f3bec0f4b2895366128	201	1		peri	0								
1045D		1045	267	semi-formed	SRR11414662	PRJNA545312	-4		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		pre	-1								
1045E		1045	269	formed	SRR11414661	PRJNA545312	-2		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		pre	-1								
1045F		1045	271	semi-formed	SRR11414659	PRJNA545312	0		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		peri	-1								
1045G		1045	272	liquid	SRR11414658	PRJNA545312	1		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		peri	0								
1045H		1045	273	liquid	SRR11414657	PRJNA545312	2		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		peri	0								
1045I		1045	276	liquid	SRR11414656	PRJNA545312	5		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		peri	0								
1045J		1045	277	liquid	SRR11414655	PRJNA545312	6		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		post	0								
1045K		1045	274	liquid	SRR11414654	PRJNA545312	3		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		peri	0								
1045L		1045	282	liquid	SRR11414856	PRJNA545312	11		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		post	1								
1045M		1045	284	liquid	SRR11414855	PRJNA545312	13		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		post	1								
1045N		1045	286	liquid	SRR11414854	PRJNA545312	15		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		post	2								
1045O		1045	289	liquid	SRR11414853	PRJNA545312	18		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		post	2								
1045P		1045	292	liquid	SRR11414851	PRJNA545312	21		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		post	2								
1045Q		1045	294	liquid	SRR11414850	PRJNA545312	23		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		post	3								
1045R		1045	295	liquid	SRR11414849	PRJNA545312	24		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		post	3								
1045S		1045	296	liquid	SRR11414848	PRJNA545312	25		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		post	3								
1045T		1045	297	liquid	SRR11414847	PRJNA545312	26		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		post	3								
1045U		1045	298	semi-formed	SRR11414846	PRJNA545312	27		18	271	PBSC_unmodified	Leukemia	4b7d68eb8e17e839014581		0		post	3								
1046A		1046	0	formed	SRR11414845	PRJNA545312	-9		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		pre	-2								
1046B		1046	1	formed	SRR11414844	PRJNA545312	-8		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		pre	-2								
1046C		1046	2	formed	SRR11414843	PRJNA545312	-7		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		pre	-2								
1046D		1046	3	semi-formed	SRR11414842	PRJNA545312	-6		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		pre	-1								
1046E		1046	4	semi-formed	SRR11414840	PRJNA545312	-5		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		pre	-1								
1046F		1046	5	formed	SRR11414839	PRJNA545312	-4		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		pre	-1								
1046G		1046	6	semi-formed	SRR11414838	PRJNA545312	-3		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		pre	-1								
1046H		1046	7	semi-formed	SRR11414837	PRJNA545312	-2		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		pre	-1								
1046I		1046	8	semi-formed	SRR11414836	PRJNA545312	-1		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		pre	-1								
1046J		1046	10	liquid	SRR11414835	PRJNA545312	1		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		peri	0								
1046L		1046	12	liquid	SRR11414834	PRJNA545312	3		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		peri	0								
1046M		1046	13	liquid	SRR11414833	PRJNA545312	4		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		peri	0								
1046N		1046	14	liquid	SRR11414832	PRJNA545312	5		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		peri	0								
1046O		1046	15	liquid	SRR11414831	PRJNA545312	6		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		post	0								
1046P		1046	16	liquid	SRR11414829	PRJNA545312	7		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		post	0								
1046Q		1046	17	liquid	SRR11415062	PRJNA545312	8		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		post	1								
1046R		1046	18	liquid	SRR11415061	PRJNA545312	9		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		post	1								
1046S		1046	19	liquid	SRR11415060	PRJNA545312	10		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		post	1								
1046T		1046	20	liquid	SRR11415059	PRJNA545312	11		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		post	1								
1046U		1046	21	liquid	SRR11415058	PRJNA545312	12		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		post	1								
1046V		1046	22	liquid	SRR11415057	PRJNA545312	13		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		post	1								
1046W		1046	24	semi-formed	SRR11415056	PRJNA545312	15		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		post	2								
1046Y		1046	340	semi-formed	SRR11415055	PRJNA545312	331		23	9	TCD	Leukemia	fb60a8dfaaeedb22efd8cb	708	1		post	6								
1047		pt_with_samples_1044_1045_1046_1047	23	liquid	SRR11415054	PRJNA545312	18		3	5	cord	Leukemia	577f3bec0f4b2895366128	201	1		post	2								
1048		pt_with_samples_1001_1002_1003_1004_1005_1006_1007_1008_1048_1121_152	28	semi-formed	SRR11415052	PRJNA545312	7		10	21	cord	Leukemia	c8848e19e1175e744f8987	36	1		post	0								
1049		pt_with_samples_1009_1010_1011_1049_1125_145	13	formed	SRR11415051	PRJNA545312	7		8	6	cord	Myelodysplastic Syndromes	2cb8f755953c8e7e729fe3	176	1		post	0								
1049A		1049	0	formed	SRR11415050	PRJNA545312	-4		6	4	PBSC_unmodified	Leukemia	0bbcb0d5eb1e3630cdfcfe	705	1		pre	-1								
1049B		1049	3	liquid	SRR11415049	PRJNA545312	-1		6	4	PBSC_unmodified	Leukemia	0bbcb0d5eb1e3630cdfcfe	705	1		pre	-1								
1049C		1049	4	liquid	SRR11415048	PRJNA545312	0		6	4	PBSC_unmodified	Leukemia	0bbcb0d5eb1e3630cdfcfe	705	1		peri	-1								
1049F		1049	181	semi-formed	SRR11415047	PRJNA545312	177		6	4	PBSC_unmodified	Leukemia	0bbcb0d5eb1e3630cdfcfe	705	1		post	6								
1049G		1049	306	formed	SRR11415046	PRJNA545312	302		6	4	PBSC_unmodified	Leukemia	0bbcb0d5eb1e3630cdfcfe	705	1		post	6								
1049H		1049	378	semi-formed	SRR11415045	PRJNA545312	374		6	4	PBSC_unmodified	Leukemia	0bbcb0d5eb1e3630cdfcfe	705	1		post	6								
104A		104	0	formed	SRR11415044	PRJNA545312	-10		3	10	TCD	Leukemia	04b496e444980082ce2111	227	1		pre	-2								
104B		104	8	formed	SRR11415043	PRJNA545312	-2		3	10	TCD	Leukemia	04b496e444980082ce2111	227	1		pre	-1								
104C		104	126	formed	SRR11415040	PRJNA545312	116		3	10	TCD	Leukemia	04b496e444980082ce2111	227	1		post	6								
1050		pt_with_samples_1050_1051_1052_1053_1054_1055_1123	0	formed	SRR11415039	PRJNA545312	-7		6	7	cord	Non-Hodgkin's Lymphoma	6b2a6198cfe3980b13a40b	61	1		pre	-2								
1050A		1050	0	formed	SRR11415038	PRJNA545312	-5		2	5	PBSC_unmodified	Myelodysplastic Syndromes	fca7f81b698878e8a9750f	153	1		pre	-1								
1050E		1050	355	formed	SRR11415037	PRJNA545312	350		2	5	PBSC_unmodified	Myelodysplastic Syndromes	fca7f81b698878e8a9750f	153	1		post	6								
1051		pt_with_samples_1050_1051_1052_1053_1054_1055_1123	7	formed	SRR11415036	PRJNA545312	0		6	7	cord	Non-Hodgkin's Lymphoma	6b2a6198cfe3980b13a40b	61	1		peri	-1								
1052		pt_with_samples_1050_1051_1052_1053_1054_1055_1123	14	formed	SRR11415035	PRJNA545312	7		6	7	cord	Non-Hodgkin's Lymphoma	6b2a6198cfe3980b13a40b	61	1		post	0								
1053		pt_with_samples_1050_1051_1052_1053_1054_1055_1123	22	formed	SRR11415034	PRJNA545312	15		6	7	cord	Non-Hodgkin's Lymphoma	6b2a6198cfe3980b13a40b	61	1		post	2								
1053D		1053	597	formed	SRR11415033	PRJNA545312	-3		13	600	PBSC_unmodified	Myeloproliferative Disorder	44bd3b5210c7bb84228b0f		0		pre	-1								
1053E		1053	598	formed	SRR11415032	PRJNA545312	-2		13	600	PBSC_unmodified	Myeloproliferative Disorder	44bd3b5210c7bb84228b0f		0		pre	-1								
1053F		1053	603	liquid	SRR11415031	PRJNA545312	3		13	600	PBSC_unmodified	Myeloproliferative Disorder	44bd3b5210c7bb84228b0f		0		peri	0								
1053G		1053	604	liquid	SRR11415029	PRJNA545312	4		13	600	PBSC_unmodified	Myeloproliferative Disorder	44bd3b5210c7bb84228b0f		0		peri	0								
1053H		1053	605	semi-formed	SRR11415028	PRJNA545312	5		13	600	PBSC_unmodified	Myeloproliferative Disorder	44bd3b5210c7bb84228b0f		0		peri	0								
1053I		1053	606	liquid	SRR11415027	PRJNA545312	6		13	600	PBSC_unmodified	Myeloproliferative Disorder	44bd3b5210c7bb84228b0f		0		post	0								
1053J		1053	607	liquid	SRR11415026	PRJNA545312	7		13	600	PBSC_unmodified	Myeloproliferative Disorder	44bd3b5210c7bb84228b0f		0		post	0								
1053K		1053	608	liquid	SRR11415025	PRJNA545312	8		13	600	PBSC_unmodified	Myeloproliferative Disorder	44bd3b5210c7bb84228b0f		0		post	1								
1053L		1053	611	liquid	SRR11415024	PRJNA545312	11		13	600	PBSC_unmodified	Myeloproliferative Disorder	44bd3b5210c7bb84228b0f		0		post	1								
1053M		1053	612	liquid	SRR11415023	PRJNA545312	12		13	600	PBSC_unmodified	Myeloproliferative Disorder	44bd3b5210c7bb84228b0f		0		post	1								
1053N		1053	613	liquid	SRR11415022	PRJNA545312	13		13	600	PBSC_unmodified	Myeloproliferative Disorder	44bd3b5210c7bb84228b0f		0		post	1								
1053O		1053	617	liquid	SRR11415021	PRJNA545312	17		13	600	PBSC_unmodified	Myeloproliferative Disorder	44bd3b5210c7bb84228b0f		0		post	2								
1053P		1053	621	semi-formed	SRR11415020	PRJNA545312	21		13	600	PBSC_unmodified	Myeloproliferative Disorder	44bd3b5210c7bb84228b0f		0		post	2								
1054		pt_with_samples_1050_1051_1052_1053_1054_1055_1123	28	formed	SRR11415018	PRJNA545312	21		6	7	cord	Non-Hodgkin's Lymphoma	6b2a6198cfe3980b13a40b	61	1		post	2								
1054E		1054	358	formed	SRR11415017	PRJNA545312	355		1	3	TCD	Leukemia	dd9c242423c29375bdd321		1		post	6								
1056		pt_with_samples_1056_1057_1058_1120	0	formed	SRR11415016	PRJNA545312	-4		4	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	230c4a4e1e42454a3733bf	158	1		pre	-1								
1057		pt_with_samples_1056_1057_1058_1120	13	formed	SRR11415015	PRJNA545312	9		4	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	230c4a4e1e42454a3733bf	158	1		post	1								
1058		pt_with_samples_1056_1057_1058_1120	19	formed	SRR11415014	PRJNA545312	15		4	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	230c4a4e1e42454a3733bf	158	1		post	2								
1058A		1058	0	formed	SRR11415013	PRJNA545312	-4		1	807	PBSC_unmodified	Leukemia	2516fbd7d1edba244f76ed	707	1		pre	-1								
1059		pt_with_samples_1059_1060_1061_1062_1063_1064	0	formed	SRR11415012	PRJNA545312	-1		5	1	cord	Non-Hodgkin's Lymphoma	943b1a4473e9a1056fe5d7	165	0		pre	-1								
1059A		1059	0	semi-formed	SRR11139981	PRJNA606262			1																	
105C		105	131	semi-formed	SRR11415011	PRJNA545312	117		1	14	TCD	Leukemia	5c4638118adb941d44bfb9		1		post	6								
1060		pt_with_samples_1059_1060_1061_1062_1063_1064	8	formed	SRR11415010	PRJNA545312	7		5	1	cord	Non-Hodgkin's Lymphoma	943b1a4473e9a1056fe5d7	165	0		post	0								
1061		pt_with_samples_1059_1060_1061_1062_1063_1064	19	formed	SRR11415009	PRJNA545312	18		5	1	cord	Non-Hodgkin's Lymphoma	943b1a4473e9a1056fe5d7	165	0		post	2								
1062		pt_with_samples_1059_1060_1061_1062_1063_1064	22	liquid	SRR11415007	PRJNA545312	21		5	1	cord	Non-Hodgkin's Lymphoma	943b1a4473e9a1056fe5d7	165	0		post	2								
1063A		1063	0	formed	SRR11414884	PRJNA545312	-5		4	5	PBSC_unmodified	Leukemia	b85bb475cfaa3b4fa9711f	72	1		pre	-1								
1063B		1063	4	formed	SRR11414883	PRJNA545312	-1		4	5	PBSC_unmodified	Leukemia	b85bb475cfaa3b4fa9711f	72	1		pre	-1								
1063C		1063	17	liquid	SRR9270384	PRJNA548153	12		4	5	PBSC_unmodified	Leukemia	b85bb475cfaa3b4fa9711f	72	1		post	1								
1063E		1063	136	formed	SRR11115396	PRJNA607574	131		4	5	PBSC_unmodified	Leukemia	b85bb475cfaa3b4fa9711f	72	1		post	6								
1064		pt_with_samples_1059_1060_1061_1062_1063_1064	58	liquid	SRR11414882	PRJNA545312	57		5	1	cord	Non-Hodgkin's Lymphoma	943b1a4473e9a1056fe5d7	165	0		post	6								
1064A		1064	0	formed	SRR11414881	PRJNA545312	-4		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		pre	-1								
1064C		1064	2	formed	SRR11414880	PRJNA545312	-2		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		pre	-1								
1064D		1064	3	formed	SRR11414879	PRJNA545312	-1		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		pre	-1								
1064E		1064	4	liquid	SRR11414878	PRJNA545312	0		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		peri	-1								
1064F		1064	8	semi-formed	SRR11414877	PRJNA545312	4		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		peri	0								
1064G		1064	9	formed	SRR11414876	PRJNA545312	5		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		peri	0								
1064H		1064	10	semi-formed	SRR11414874	PRJNA545312	6		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		post	0								
1064I		1064	12	formed	SRR11414873	PRJNA545312	8		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		post	1								
1064J		1064	13	formed	SRR11414872	PRJNA545312	9		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		post	1								
1064K		1064	14	formed	SRR11414871	PRJNA545312	10		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		post	1								
1064L		1064	15	formed	SRR11414870	PRJNA545312	11		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		post	1								
1064M		1064	17	semi-formed	SRR11414869	PRJNA545312	13		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		post	1								
1064N		1064	18	semi-formed	SRR11414868	PRJNA545312	14		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		post	1								
1064O		1064	19	semi-formed	SRR11414867	PRJNA545312	15		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		post	2								
1064P		1064	20	formed	SRR11414866	PRJNA545312	16		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		post	2								
1064Q		1064	22	semi-formed	SRR11414865	PRJNA545312	18		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		post	2								
1064R		1064	23	formed	SRR11414863	PRJNA545312	19		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		post	2								
1064S		1064	24	liquid	SRR11414862	PRJNA545312	20		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		post	2								
1064T		1064	25	liquid	SRR11414861	PRJNA545312	21		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		post	2								
1064V		1064	27	semi-formed	SRR11414860	PRJNA545312	23		20	4	BM_unmodified	Non-Malignant Hemat Disorders	d7ccd1f642b15b75c4c6df	697	1		post	3								
1065		pt_with_samples_1065_1066_1067_1068_1069	0	formed	SRR11414858	PRJNA545312	-6		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	aa2ec2948075700a641fd4	21	1		pre	-1								
1066A		1066	0	formed	SRR11414857	PRJNA545312	-5		12	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e45122e96a5e75c756317	710	1		pre	-1								
1066B		1066	1	semi-formed	SRR11415146	PRJNA545312	-4		12	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e45122e96a5e75c756317	710	1		pre	-1								
1066C		1066	2	formed	SRR11415145	PRJNA545312	-3		12	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e45122e96a5e75c756317	710	1		pre	-1								
1066D		1066	3	formed	SRR11415144	PRJNA545312	-2		12	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e45122e96a5e75c756317	710	1		pre	-1								
1066E		1066	4	formed	SRR11415142	PRJNA545312	-1		12	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e45122e96a5e75c756317	710	1		pre	-1								
1066F		1066	5	semi-formed	SRR11415141	PRJNA545312	0		12	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e45122e96a5e75c756317	710	1		peri	-1								
1066G		1066	6	semi-formed	SRR11415140	PRJNA545312	1		12	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e45122e96a5e75c756317	710	1		peri	0								
1066I		1066	9	semi-formed	SRR11415139	PRJNA545312	4		12	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e45122e96a5e75c756317	710	1		peri	0								
1066J		1066	10	semi-formed	SRR11415138	PRJNA545312	5		12	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e45122e96a5e75c756317	710	1		peri	0								
1066L		1066	13	semi-formed	SRR11415137	PRJNA545312	8		12	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e45122e96a5e75c756317	710	1		post	1								
1066N		1066	16	semi-formed	SRR11415136	PRJNA545312	11		12	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e45122e96a5e75c756317	710	1		post	1								
1066S		1066	34	formed	SRR11415135	PRJNA545312	29		12	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e45122e96a5e75c756317	710	1		post	4								
1067		pt_with_samples_1065_1066_1067_1068_1069	385	formed	SRR11415134	PRJNA545312	379		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	aa2ec2948075700a641fd4	21	1		post	6								
1067A		1067	0	formed	SRR11415133	PRJNA545312	-5		1	5	PBSC_unmodified	Hodgkin's Disease	ab7baf661425182ae3fda2	278	1		pre	-1								
1068		pt_with_samples_1065_1066_1067_1068_1069	27	formed	SRR11415131	PRJNA545312	21		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	aa2ec2948075700a641fd4	21	1		post	2								
1069		pt_with_samples_1065_1066_1067_1068_1069	62	formed	SRR11415130	PRJNA545312	56		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	aa2ec2948075700a641fd4	21	1		post	6								
1070		pt_with_samples_1070_1071_1072_1073	0	formed	SRR11415129	PRJNA545312	-6		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	e9e54fc03868d74a3df07f	123	1		pre	-1								
1070A		1070	0	formed	SRR11415128	PRJNA545312	-102		3	102	PBSC_unmodified	Leukemia	789b5ea2c429d103b54207		1		pre	-3								
1070B		1070	6	semi-formed	SRR11415127	PRJNA545312	-96		3	102	PBSC_unmodified	Leukemia	789b5ea2c429d103b54207		1		pre	-3								
1070C		1070	13	formed	SRR11415126	PRJNA545312	-89		3	102	PBSC_unmodified	Leukemia	789b5ea2c429d103b54207		1		pre	-3								
1071		pt_with_samples_1070_1071_1072_1073	6	formed	SRR11415125	PRJNA545312	0		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	e9e54fc03868d74a3df07f	123	1		peri	-1								
1071A		1071	0	formed	SRR11415124	PRJNA545312	-5		1	5	cord	Leukemia	152133ddb68c88c6a337e4	668	1		pre	-1								
1072		pt_with_samples_1070_1071_1072_1073	13	formed	SRR11415123	PRJNA545312	7		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	e9e54fc03868d74a3df07f	123	1		post	0								
1072A		1072	0	formed	SRR11415122	PRJNA545312	135		1	-135	PBSC_unmodified	Leukemia	448990c7aef09bc607efb7		1		post	6								
1073		pt_with_samples_1070_1071_1072_1073	58	formed	SRR11415120	PRJNA545312	52		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	e9e54fc03868d74a3df07f	123	1		post	6								
1073A		1073	0	liquid	SRR11140242	PRJNA606262			1																	
1074		pt_with_samples_1074_1075_1076	0	formed	SRR11415119	PRJNA545312	-1		3	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	f4b9e514198ad27ee7c38e	156	1		pre	-1								
1075		pt_with_samples_1074_1075_1076	3	liquid	SRR11415118	PRJNA545312	2		3	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	f4b9e514198ad27ee7c38e	156	1		peri	0								
1075A		1075	0	formed	SRR11415117	PRJNA545312	-6		12	6	PBSC_unmodified	Leukemia	dd6cc9f888aa7638f3ff88	429	1		pre	-1								
1075B		1075	5	formed	SRR11115590	PRJNA607574	-1		12	6	PBSC_unmodified	Leukemia	dd6cc9f888aa7638f3ff88	429	1		pre	-1								
1075C		1075	9	semi-formed	SRR11415116	PRJNA545312	3		12	6	PBSC_unmodified	Leukemia	dd6cc9f888aa7638f3ff88	429	1		peri	0								
1075D		1075	10	formed	SRR11415115	PRJNA545312	4		12	6	PBSC_unmodified	Leukemia	dd6cc9f888aa7638f3ff88	429	1		peri	0								
1075E		1075	11	semi-formed	SRR11415114	PRJNA545312	5		12	6	PBSC_unmodified	Leukemia	dd6cc9f888aa7638f3ff88	429	1		peri	0								
1075F		1075	12	semi-formed	SRR11415113	PRJNA545312	6		12	6	PBSC_unmodified	Leukemia	dd6cc9f888aa7638f3ff88	429	1		post	0								
1075G		1075	13	semi-formed	SRR11415112	PRJNA545312	7		12	6	PBSC_unmodified	Leukemia	dd6cc9f888aa7638f3ff88	429	1		post	0								
1075H		1075	16	semi-formed	SRR11415111	PRJNA545312	10		12	6	PBSC_unmodified	Leukemia	dd6cc9f888aa7638f3ff88	429	1		post	1								
1075I		1075	17	formed	SRR11415109	PRJNA545312	11		12	6	PBSC_unmodified	Leukemia	dd6cc9f888aa7638f3ff88	429	1		post	1								
1075J		1075	18	semi-formed	SRR11415108	PRJNA545312	12		12	6	PBSC_unmodified	Leukemia	dd6cc9f888aa7638f3ff88	429	1		post	1								
1075K		1075	20	formed	SRR11415107	PRJNA545312	14		12	6	PBSC_unmodified	Leukemia	dd6cc9f888aa7638f3ff88	429	1		post	1								
1075L		1075	39	semi-formed	SRR11415106	PRJNA545312	33		12	6	PBSC_unmodified	Leukemia	dd6cc9f888aa7638f3ff88	429	1		post	4								
1076		pt_with_samples_1074_1075_1076	8	formed	SRR11415105	PRJNA545312	7		3	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	f4b9e514198ad27ee7c38e	156	1		post	0								
1076A		1076	0	liquid	SRR11140351	PRJNA606262			1																	
1077		pt_with_samples_1077_1078_1079_1080	0	formed	SRR11415104	PRJNA545312	-6		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	432b44421061719fd0c7c6	142	1		pre	-1								
1078		pt_with_samples_1077_1078_1079_1080	8	formed	SRR11415103	PRJNA545312	2		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	432b44421061719fd0c7c6	142	1		peri	0								
1078A		1078	0	semi-formed	SRR11140343	PRJNA606262			2																	
1078B		1078	5	semi-formed	SRR11140342	PRJNA606262			2																	
1079		pt_with_samples_1077_1078_1079_1080	13	formed	SRR11415102	PRJNA545312	7		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	432b44421061719fd0c7c6	142	1		post	0								
1079A		1079	0	formed	SRR11140134	PRJNA606262			1																	
107C		107	96	semi-formed	SRR11415101	PRJNA545312	110		3	-14	TCD	Myelodysplastic Syndromes	1fa86d101c43965b0995cc		1		post	6								
107D		107	97	semi-formed	SRR11415100	PRJNA545312	111		3	-14	TCD	Myelodysplastic Syndromes	1fa86d101c43965b0995cc		1		post	6								
107E		107	618	formed	SRR11415097	PRJNA545312	632		3	-14	TCD	Myelodysplastic Syndromes	1fa86d101c43965b0995cc		1		post	6								
1080		pt_with_samples_1077_1078_1079_1080	55	semi-formed	SRR11415096	PRJNA545312	49		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	432b44421061719fd0c7c6	142	1		post	6								
1080A		1080	0	formed	SRR11415095	PRJNA545312	-8		10	8	TCD	Leukemia	32921d5737d4bd665589c8	715	1		pre	-2								
1080C		1080	1	formed	SRR11415093	PRJNA545312	-7		10	8	TCD	Leukemia	32921d5737d4bd665589c8	715	1		pre	-2								
1080E		1080	5	semi-formed	SRR11415091	PRJNA545312	-3		10	8	TCD	Leukemia	32921d5737d4bd665589c8	715	1		pre	-1								
1080F		1080	7	liquid	SRR11414940	PRJNA545312	-1		10	8	TCD	Leukemia	32921d5737d4bd665589c8	715	1		pre	-1								
1080G		1080	8	liquid	SRR11414939	PRJNA545312	0		10	8	TCD	Leukemia	32921d5737d4bd665589c8	715	1		peri	-1								
1080I		1080	12	liquid	SRR11414938	PRJNA545312	4		10	8	TCD	Leukemia	32921d5737d4bd665589c8	715	1		peri	0								
1080K		1080	13	liquid	SRR11414935	PRJNA545312	5		10	8	TCD	Leukemia	32921d5737d4bd665589c8	715	1		peri	0								
1080R		1080	22	liquid	SRR11414934	PRJNA545312	14		10	8	TCD	Leukemia	32921d5737d4bd665589c8	715	1		post	1								
1080V		1080	28	semi-formed	SRR11414933	PRJNA545312	20		10	8	TCD	Leukemia	32921d5737d4bd665589c8	715	1		post	2								
1080W		1080	29	liquid	SRR11414932	PRJNA545312	21		10	8	TCD	Leukemia	32921d5737d4bd665589c8	715	1		post	2								
1081		pt_with_samples_1081_1082_1083_1084_1085	0	formed	SRR11414931	PRJNA545312	-7		2	7	PBSC_unmodified	Leukemia	e6a99472131da62be4d301	37	1		pre	-2								
1081A		1081	0	semi-formed	SRR11140233	PRJNA606262			1																	
1082		pt_with_samples_1081_1082_1083_1084_1085	7	liquid	SRR11414930	PRJNA545312	0		2	7	PBSC_unmodified	Leukemia	e6a99472131da62be4d301	37	1		peri	-1								
1082A		1082	0	liquid	SRR11140276	PRJNA606262			3																	
1082B		1082	315	semi-formed	SRR11395655	PRJNA607574			3																	
1082C		1082	366	liquid	SRR11395644	PRJNA607574			3																	
1083A		FMT.0023	1	semi-formed	SRR11414929	PRJNA545312	-4		15	5	PBSC_unmodified	Myelodysplastic Syndromes	43eeb2b61262448bead22b		1		pre	-1								
1083B		FMT.0023	2	semi-formed	SRR11414928	PRJNA545312	-3		15	5	PBSC_unmodified	Myelodysplastic Syndromes	43eeb2b61262448bead22b		1		pre	-1								
1085A		1085	0	semi-formed	SRR11395633	PRJNA607574			1																	
1086		pt_with_samples_1086_1087_1088_1089_1090_1091_1092_1093	0	liquid	SRR11414927	PRJNA545312	0		6	0	cord	Non-Hodgkin's Lymphoma	a1585ecba55fe6894d26db	81	1		peri	-1								
1086A		1086	0	formed	SRR11414925	PRJNA545312	-1		2	1	PBSC_unmodified	Leukemia	422f86ef60c996b1cf73b7	676	1		pre	-1								
1086C		1086	16	semi-formed	SRR11414924	PRJNA545312	15		2	1	PBSC_unmodified	Leukemia	422f86ef60c996b1cf73b7	676	1		post	2								
1087		pt_with_samples_1086_1087_1088_1089_1090_1091_1092_1093	7	formed	SRR11414923	PRJNA545312	7		6	0	cord	Non-Hodgkin's Lymphoma	a1585ecba55fe6894d26db	81	1		post	0								
1087A		1087	0	formed	SRR11140476	PRJNA606262			1																	
1088		pt_with_samples_1086_1087_1088_1089_1090_1091_1092_1093	14	semi-formed	SRR11414922	PRJNA545312	14		6	0	cord	Non-Hodgkin's Lymphoma	a1585ecba55fe6894d26db	81	1		post	1								
1088M		1088	277	semi-formed	SRR11414921	PRJNA545312	270		2	7	PBSC_unmodified	Leukemia	d0b676f1c0595360364efa		1		post	6								
1088N		1088	379	formed	SRR11414920	PRJNA545312	372		2	7	PBSC_unmodified	Leukemia	d0b676f1c0595360364efa		1		post	6								
1089E		1089	281	formed	SRR11414919	PRJNA545312	273		1	8	TCD	Myelodysplastic Syndromes	361395f203cc5820a77d0a		1		post	6								
108A		108	0	formed	SRR11414918	PRJNA545312	-10		3	10	TCD	Leukemia	193077e739a2d11195aad9	185	1		pre	-2								
108B		108	44	formed	SRR11414917	PRJNA545312	34		3	10	TCD	Leukemia	193077e739a2d11195aad9	185	1		post	4								
108C		108	71	liquid	SRR11414916	PRJNA545312	61		3	10	TCD	Leukemia	193077e739a2d11195aad9	185	1		post	6								
1091		pt_with_samples_1086_1087_1088_1089_1090_1091_1092_1093	35	semi-formed	SRR11414914	PRJNA545312	35		6	0	cord	Non-Hodgkin's Lymphoma	a1585ecba55fe6894d26db	81	1		post	4								
1091A		1091	0	liquid	SRR11140260	PRJNA606262			1																	
1092		pt_with_samples_1086_1087_1088_1089_1090_1091_1092_1093	42	semi-formed	SRR11414913	PRJNA545312	42		6	0	cord	Non-Hodgkin's Lymphoma	a1585ecba55fe6894d26db	81	1		post	5								
1092A		1092	0	formed	SRR11414513	PRJNA545312	-92		16	92	cord	Leukemia	49b563d9c1431d19da341f	731	1		pre	-3								
1092B		1092	7	semi-formed	SRR11414512	PRJNA545312	-85		16	92	cord	Leukemia	49b563d9c1431d19da341f	731	1		pre	-3								
1092C		1092	10	semi-formed	SRR11414511	PRJNA545312	-82		16	92	cord	Leukemia	49b563d9c1431d19da341f	731	1		pre	-3								
1092D		1092	11	semi-formed	SRR11414510	PRJNA545312	-81		16	92	cord	Leukemia	49b563d9c1431d19da341f	731	1		pre	-3								
1092E		1092	13	semi-formed	SRR11414509	PRJNA545312	-79		16	92	cord	Leukemia	49b563d9c1431d19da341f	731	1		pre	-3								
1092F		1092	20	formed	SRR11414508	PRJNA545312	-72		16	92	cord	Leukemia	49b563d9c1431d19da341f	731	1		pre	-3								
1092G		1092	23	formed	SRR11414507	PRJNA545312	-69		16	92	cord	Leukemia	49b563d9c1431d19da341f	731	1		pre	-3								
1092H		1092	26	formed	SRR11414506	PRJNA545312	-66		16	92	cord	Leukemia	49b563d9c1431d19da341f	731	1		pre	-3								
1092I		1092	31	formed	SRR11414504	PRJNA545312	-61		16	92	cord	Leukemia	49b563d9c1431d19da341f	731	1		pre	-3								
1092J		1092	47	semi-formed	SRR11414503	PRJNA545312	-45		16	92	cord	Leukemia	49b563d9c1431d19da341f	731	1		pre	-3								
1092K		1092	48	semi-formed	SRR11414502	PRJNA545312	-44		16	92	cord	Leukemia	49b563d9c1431d19da341f	731	1		pre	-3								
1092L		1092	125	formed	SRR11414501	PRJNA545312	33		16	92	cord	Leukemia	49b563d9c1431d19da341f	731	1		post	4								
1092M		1092	130	semi-formed	SRR11414500	PRJNA545312	38		16	92	cord	Leukemia	49b563d9c1431d19da341f	731	1		post	5								
1092N		1092	132	liquid	SRR11414499	PRJNA545312	40		16	92	cord	Leukemia	49b563d9c1431d19da341f	731	1		post	5								
1092O		1092	152	semi-formed	SRR11414498	PRJNA545312	60		16	92	cord	Leukemia	49b563d9c1431d19da341f	731	1		post	6								
1092P		1092	497	formed	SRR11414497	PRJNA545312	405		16	92	cord	Leukemia	49b563d9c1431d19da341f	731	1		post	6								
1093		pt_with_samples_1086_1087_1088_1089_1090_1091_1092_1093	47	semi-formed	SRR11414496	PRJNA545312	47		6	0	cord	Non-Hodgkin's Lymphoma	a1585ecba55fe6894d26db	81	1		post	6								
1094		pt_with_samples_1094_1095_1096_1097_1098	0	formed	SRR11414495	PRJNA545312	-6		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	b4476976cd291663dca076	6	1		pre	-1								
1094B		1094	420	liquid	SRR11414493	PRJNA545312	614		1	-194	PBSC_unmodified	Leukemia	6a81bf96e3aff46980a0e4		1		post	6								
1095		pt_with_samples_1094_1095_1096_1097_1098	9	formed	SRR11414492	PRJNA545312	3		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	b4476976cd291663dca076	6	1		peri	0								
1095A		1095	0	liquid	SRR11140482	PRJNA606262			1																	
1096		pt_with_samples_1094_1095_1096_1097_1098	13	formed	SRR11414491	PRJNA545312	7		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	b4476976cd291663dca076	6	1		post	0								
1096C		1096	266	semi-formed	SRR11414490	PRJNA545312	274		2	-8	PBSC_unmodified	Non-Hodgkin's Lymphoma	77db09d038c6d8f06dd705		1		post	6								
1096D		1096	360	formed	SRR11414489	PRJNA545312	368		2	-8	PBSC_unmodified	Non-Hodgkin's Lymphoma	77db09d038c6d8f06dd705		1		post	6								
1097A		1097	0	formed	SRR11414488	PRJNA545312	-5		2	5	PBSC_unmodified	Myelodysplastic Syndromes	2694d7615a7d7827c92106	713	1		pre	-1								
1097B		1097	2	formed	SRR11414487	PRJNA545312	-3		2	5	PBSC_unmodified	Myelodysplastic Syndromes	2694d7615a7d7827c92106	713	1		pre	-1								
1098		pt_with_samples_1094_1095_1096_1097_1098	48	formed	SRR11414486	PRJNA545312	42		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	b4476976cd291663dca076	6	1		post	5								
1098F		1098	283	semi-formed	SRR11414727	PRJNA545312	275		1	8	cord	Leukemia	21d194c7e4747c390c64ed		1		post	6								
1099		pt_with_samples_1099_1100_1101_1102	0	formed	SRR11414726	PRJNA545312	-2		4	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	c78dd0c4fe1a56bb271f9c	151	1		pre	-1								
1099A		1099	0	formed	SRR11414724	PRJNA545312	-5		4	5	PBSC_unmodified	Leukemia	ec6042c6490bb30ef76cd4	228	1		pre	-1								
1099B		1099	1	semi-formed	SRR11414723	PRJNA545312	-4		4	5	PBSC_unmodified	Leukemia	ec6042c6490bb30ef76cd4	228	1		pre	-1								
1099C		1099	3	formed	SRR11414722	PRJNA545312	-2		4	5	PBSC_unmodified	Leukemia	ec6042c6490bb30ef76cd4	228	1		pre	-1								
1099D		1099	16	formed	SRR11414721	PRJNA545312	11		4	5	PBSC_unmodified	Leukemia	ec6042c6490bb30ef76cd4	228	1		post	1								
1100		pt_with_samples_1099_1100_1101_1102	2	formed	SRR11414720	PRJNA545312	0		4	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	c78dd0c4fe1a56bb271f9c	151	1		peri	-1								
1100A		1100	0	formed	SRR11140332	PRJNA606262			1																	
1101		pt_with_samples_1099_1100_1101_1102	10	liquid	SRR11414719	PRJNA545312	8		4	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	c78dd0c4fe1a56bb271f9c	151	1		post	1								
1101A		1101	0	formed	SRR11414718	PRJNA545312	-6		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		pre	-1								
1101B		1101	4	formed	SRR11414717	PRJNA545312	-2		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		pre	-1								
1101C		1101	7	semi-formed	SRR11414716	PRJNA545312	1		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		peri	0								
1101D		1101	8	liquid	SRR11414715	PRJNA545312	2		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		peri	0								
1101E		1101	9	liquid	SRR11414713	PRJNA545312	3		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		peri	0								
1101F		1101	10	liquid	SRR11414712	PRJNA545312	4		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		peri	0								
1101G		1101	11	liquid	SRR11414711	PRJNA545312	5		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		peri	0								
1101H		1101	12	liquid	SRR11414710	PRJNA545312	6		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		post	0								
1101J		1101	14	liquid	SRR11414709	PRJNA545312	8		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		post	1								
1101K		1101	15	liquid	SRR11414708	PRJNA545312	9		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		post	1								
1101M		1101	16	liquid	SRR11414706	PRJNA545312	10		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		post	1								
1101N		1101	18	liquid	SRR11414705	PRJNA545312	12		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		post	1								
1101O		1101	19	liquid	SRR11414704	PRJNA545312	13		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		post	1								
1101P		1101	20	liquid	SRR11414702	PRJNA545312	14		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		post	1								
1101Q		1101	21	liquid	SRR11414701	PRJNA545312	15		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		post	2								
1101R		1101	22	liquid	SRR11414700	PRJNA545312	16		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		post	2								
1101S		1101	28	semi-formed	SRR11414485	PRJNA545312	22		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		post	3								
1101T		1101	129	liquid	SRR11414484	PRJNA545312	123		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		post	6								
1101U		1101	158	liquid	SRR11414483	PRJNA545312	152		19	6	PBSC_unmodified	Hodgkin's Disease	5526aaba7a5c802b48699b	97	1		post	6								
1102		pt_with_samples_1099_1100_1101_1102	16	liquid	SRR11414482	PRJNA545312	14		4	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	c78dd0c4fe1a56bb271f9c	151	1		post	1								
1102A		1102	0	formed	SRR11140259	PRJNA606262			11																	
1102B		1102	2	formed	SRR11140258	PRJNA606262			11																	
1102C		1102	3	formed	SRR11140257	PRJNA606262			11																	
1102D		1102	5	formed	SRR11140256	PRJNA606262			11																	
1102E		1102	6	formed	SRR11140255	PRJNA606262			11																	
1102F		1102	7	semi-formed	SRR11140254	PRJNA606262			11																	
1102G		1102	8	semi-formed	SRR11140253	PRJNA606262			11																	
1102H		1102	9	liquid	SRR11140251	PRJNA606262			11																	
1102I		1102	10	liquid	SRR11140250	PRJNA606262			11																	
1102J		1102	11	liquid	SRR11140249	PRJNA606262			11																	
1102O		1102	17	semi-formed	SRR11140248	PRJNA606262			11																	
1103		pt_with_samples_1103_1104	0	formed	SRR11414481	PRJNA545312	0		2	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	5fba5eb1c9194a547dea29	117	1		peri	-1								
1103A		1103	0	formed	SRR11395519	PRJNA607574			9																	
1103B		1103	5	semi-formed	SRR11395508	PRJNA607574			9																	
1103D		1103	9	semi-formed	SRR11395497	PRJNA607574			9																	
1103E		1103	14	semi-formed	SRR11395180	PRJNA607574			9																	
1103F		1103	19	semi-formed	SRR11395137	PRJNA607574			9																	
1103G		1103	22	liquid	SRR11395126	PRJNA607574			9																	
1103H		1103	68	formed	SRR11395114	PRJNA607574			9																	
1103I		1103	112	formed	SRR11395007	PRJNA607574			9																	
1103J		1103	159	formed	SRR11394996	PRJNA607574			9																	
1104		pt_with_samples_1103_1104	42	formed	SRR11414480	PRJNA545312	42		2	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	5fba5eb1c9194a547dea29	117	1		post	5								
1105		pt_with_samples_1105_1106_1107_1108	0	formed	SRR11414479	PRJNA545312	-6		4	6	cord	Leukemia	ff493eac17bd83d1a2c57c		1		pre	-1								
1105A		1105	0	formed	SRR11414477	PRJNA545312	-4	SRR14092254	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		pre	-1								
1105B		1105	1	formed	SRR11414476	PRJNA545312	-3	SRR14092253	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		pre	-1								
1105C		1105	2	semi-formed	SRR11414475	PRJNA545312	-2	SRR13697090	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		pre	-1								
1105D		1105	3	semi-formed	SRR11414474	PRJNA545312	-1	SRR14092252	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		pre	-1								
1105E		1105	4	semi-formed	SRR11414473	PRJNA545312	0	SRR13697079	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		peri	-1								
1105F		1105	5	formed	SRR11414472	PRJNA545312	1	SRR14092251	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		peri	0								
1105G		1105	6	semi-formed	SRR11414471	PRJNA545312	2	SRR14092249	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		peri	0								
1105H		1105	7	liquid	SRR11414470	PRJNA545312	3	SRR14092248	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		peri	0								
1105I		1105	8	semi-formed	SRR11414469	PRJNA545312	4	SRR14092247	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		peri	0								
1105J		1105	9	semi-formed	SRR11414468	PRJNA545312	5	SRR14092246	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		peri	0								
1105K		1105	10	semi-formed	SRR11414465	PRJNA545312	6	SRR14092245	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		post	0								
1105L		1105	11	semi-formed	SRR11414464	PRJNA545312	7	SRR14092244	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		post	0								
1105M		1105	12	semi-formed	SRR11414463	PRJNA545312	8	SRR13697132	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		post	1								
1105N		1105	13	liquid	SRR11414462	PRJNA545312	9	SRR13697121	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		post	1								
1105O		1105	14	liquid	SRR11414461	PRJNA545312	10	SRR14092243	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		post	1								
1105P		1105	15	liquid	SRR11414460	PRJNA545312	11	SRR13697115	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		post	1								
1105Q		1105	17	semi-formed	SRR11414459	PRJNA545312	13	SRR13697114	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		post	1								
1105R		1105	20	semi-formed	SRR11414458	PRJNA545312	16	SRR14092242	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		post	2								
1105S		1105	24	formed	SRR11414699	PRJNA545312	20	SRR14092241	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		post	2								
1105T		1105	25	formed	SRR11414698	PRJNA545312	21	SRR14092240	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		post	2								
1105U		1105	30	formed	SRR11414696	PRJNA545312	26	SRR14092238	21	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	6c96523eea5938e1404e62	551	1		post	3								
1106		pt_with_samples_1105_1106_1107_1108	7	formed	SRR11414695	PRJNA545312	1		4	6	cord	Leukemia	ff493eac17bd83d1a2c57c		1		peri	0								
1106D		1106	201	formed	SRR11414396	PRJNA545312	202		3	-1	PBSC_unmodified	Non-Hodgkin's Lymphoma	5a6cb969d61658b429fcfa		1		post	6								
1106E		1106	263	formed	SRR11414395	PRJNA545312	264		3	-1	PBSC_unmodified	Non-Hodgkin's Lymphoma	5a6cb969d61658b429fcfa		1		post	6								
1106F		1106	396		SRR11414394	PRJNA545312	397		3	-1	PBSC_unmodified	Non-Hodgkin's Lymphoma	5a6cb969d61658b429fcfa		1		post	6								
1107		pt_with_samples_1105_1106_1107_1108	14	liquid	SRR11414393	PRJNA545312	8		4	6	cord	Leukemia	ff493eac17bd83d1a2c57c		1		post	1								
1107B		1107	0	formed	SRR11414391	PRJNA545312	-5		18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		pre	-1								
1107C		1107	1	formed	SRR11414390	PRJNA545312	-4		18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		pre	-1								
1107D		1107	2	formed	SRR11414389	PRJNA545312	-3		18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		pre	-1								
1107E		1107	3	formed	SRR11414387	PRJNA545312	-2	SRR13697112	18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		pre	-1								
1107G		1107	8	liquid	SRR11414386	PRJNA545312	3		18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		peri	0								
1107H		1107	12	liquid	SRR11414385	PRJNA545312	7		18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		post	0								
1107I		1107	14	semi-formed	SRR11414384	PRJNA545312	9		18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		post	1								
1107J		1107	15	liquid	SRR11414383	PRJNA545312	10		18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		post	1								
1107K		1107	17	liquid	SRR11414382	PRJNA545312	12		18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		post	1								
1107L		1107	21	liquid	SRR11414381	PRJNA545312	16		18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		post	2								
1107M		1107	26	liquid	SRR11414380	PRJNA545312	21		18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		post	2								
1107N		1107	27	semi-formed	SRR11414379	PRJNA545312	22		18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		post	3								
1107O		1107	30	liquid	SRR11414378	PRJNA545312	25		18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		post	3								
1107P		1107	35	semi-formed	SRR11414376	PRJNA545312	30		18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		post	4								
1107Q		1107	49	semi-formed	SRR11414375	PRJNA545312	44		18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		post	6								
1107R		1107	181	formed	SRR11414374	PRJNA545312	176		18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		post	6								
1107S		1107	185	liquid	SRR11414317	PRJNA545312	180		18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		post	6								
1107T		1107	196	formed	SRR11416385	PRJNA545312	191		18	5	PBSC_unmodified	Leukemia	7f5985c7704a9622214cad	725	1		post	6								
1108		pt_with_samples_1105_1106_1107_1108	20	formed	SRR11416384	PRJNA545312	14		4	6	cord	Leukemia	ff493eac17bd83d1a2c57c		1		post	1								
1108G		1108	52	semi-formed	SRR11414316	PRJNA545312	46		4	6	BM_unmodified	Leukemia	d90a6e6f5dd26ff1bafb5b	569	1		post	6								
1108H		1108	54	liquid	SRR11416865	PRJNA545312	48		4	6	BM_unmodified	Leukemia	d90a6e6f5dd26ff1bafb5b	569	1		post	6								
1108I		1108	75	semi-formed	SRR11416695	PRJNA545312	69		4	6	BM_unmodified	Leukemia	d90a6e6f5dd26ff1bafb5b	569	1		post	6								
1108J		1108	229	semi-formed	SRR11416895	PRJNA545312	223		4	6	BM_unmodified	Leukemia	d90a6e6f5dd26ff1bafb5b	569	1		post	6								
1109		pt_with_samples_1109	0	liquid	SRR11394985	PRJNA607574			1																	
1109A		1109	0	formed	SRR11139700	PRJNA606262			9																	
1109B		1109	3	liquid	SRR11140033	PRJNA606262			9																	
1109C		1109	4	semi-formed	SRR11139606	PRJNA606262			9																	
1109D		1109	5	semi-formed	SRR11139871	PRJNA606262			9																	
1109E		1109	8	semi-formed	SRR11140518	PRJNA606262			9																	
1109F		1109	10	semi-formed	SRR11140507	PRJNA606262			9																	
1109G		1109	11	liquid	SRR11140496	PRJNA606262			9																	
1109H		1109	12	liquid	SRR11140025	PRJNA606262			9																	
1109I		1109	15	liquid	SRR11140014	PRJNA606262			9																	
110A		110	0	formed	SRR11417008	PRJNA545312	-8		1	8	TCD	Multiple Myeloma	2f624aadf8ed8fc8317107	187	1		pre	-2								
1110		pt_with_samples_1110_1111	0	formed	SRR11416757	PRJNA545312	-2		2	2	PBSC_unmodified	Hodgkin's Disease	c1659fb193a53211fda5cb	144	1		pre	-1								
1110A		1110	0	formed	SRR11416982	PRJNA545312	-7		14	7	TCD	Non-Malignant Hemat Disorders	a79bffe2eca6ae66fb619a	718	1		pre	-2								
1110G		1110	8	semi-formed	SRR11416955	PRJNA545312	1		14	7	TCD	Non-Malignant Hemat Disorders	a79bffe2eca6ae66fb619a	718	1		peri	0								
1110H		1110	9	semi-formed	SRR11416448	PRJNA545312	2	SRR14092237	14	7	TCD	Non-Malignant Hemat Disorders	a79bffe2eca6ae66fb619a	718	1		peri	0								
1110I		1110	10	formed	SRR11416383	PRJNA545312	3		14	7	TCD	Non-Malignant Hemat Disorders	a79bffe2eca6ae66fb619a	718	1		peri	0								
1110J		1110	11	formed	SRR11416372	PRJNA545312	4		14	7	TCD	Non-Malignant Hemat Disorders	a79bffe2eca6ae66fb619a	718	1		peri	0								
1110K		1110	13	formed	SRR11416361	PRJNA545312	6	SRR13697111	14	7	TCD	Non-Malignant Hemat Disorders	a79bffe2eca6ae66fb619a	718	1		post	0								
1110L		1110	16	formed	SRR11416802	PRJNA545312	9		14	7	TCD	Non-Malignant Hemat Disorders	a79bffe2eca6ae66fb619a	718	1		post	1								
1110M		1110	17	formed	SRR11416791	PRJNA545312	10	SRR14092236	14	7	TCD	Non-Malignant Hemat Disorders	a79bffe2eca6ae66fb619a	718	1		post	1								
1110N		1110	18	formed	SRR11417066	PRJNA545312	11		14	7	TCD	Non-Malignant Hemat Disorders	a79bffe2eca6ae66fb619a	718	1		post	1								
1110O		1110	20	semi-formed	SRR11417055	PRJNA545312	13		14	7	TCD	Non-Malignant Hemat Disorders	a79bffe2eca6ae66fb619a	718	1		post	1								
1110P		1110	21	semi-formed	SRR11417044	PRJNA545312	14		14	7	TCD	Non-Malignant Hemat Disorders	a79bffe2eca6ae66fb619a	718	1		post	1								
1110Q		1110	23	liquid	SRR11416435	PRJNA545312	16		14	7	TCD	Non-Malignant Hemat Disorders	a79bffe2eca6ae66fb619a	718	1		post	2								
1110R		1110	24	liquid	SRR11414315	PRJNA545312	17		14	7	TCD	Non-Malignant Hemat Disorders	a79bffe2eca6ae66fb619a	718	1		post	2								
1110S		1110	26	semi-formed	SRR11414314	PRJNA545312	19		14	7	TCD	Non-Malignant Hemat Disorders	a79bffe2eca6ae66fb619a	718	1		post	2								
1111		pt_with_samples_1110_1111	7	formed	SRR11416424	PRJNA545312	5		2	2	PBSC_unmodified	Hodgkin's Disease	c1659fb193a53211fda5cb	144	1		peri	0								
1111A		1111	0	semi-formed	SRR11139641	PRJNA606262			1																	
1112		pt_with_samples_1112	0	formed	SRR11416864	PRJNA545312	36		1	-36	cord	Leukemia	514c03aa473056b1a2eabc	188	1		post	5								
1112D		1112	221	semi-formed	SRR11416853	PRJNA545312	225		3	-4	cord	Non-Hodgkin's Lymphoma	a84b8e7e81080dbd6549e8		1		post	6								
1112E		1112	275	semi-formed	SRR11416842	PRJNA545312	279		3	-4	cord	Non-Hodgkin's Lymphoma	a84b8e7e81080dbd6549e8		1		post	6								
1112F		1112	326	semi-formed	SRR11417145	PRJNA545312	330		3	-4	cord	Non-Hodgkin's Lymphoma	a84b8e7e81080dbd6549e8		1		post	6								
1113A		1113	0	formed	SRR11140478	PRJNA606262			2																	
1113B		1113	7	semi-formed	SRR11140477	PRJNA606262			2																	
1114A		1114	0	formed	SRR11140471	PRJNA606262			2																	
1114B		1114	5	semi-formed	SRR11140470	PRJNA606262			2																	
1116A		1116	0	formed	SRR11417134	PRJNA545312	-5		4	5	cord	Leukemia	8b69da0fc723e82b1d7a27	716	1		pre	-1								
1116B		1116	9	formed	SRR11416525	PRJNA545312	4		4	5	cord	Leukemia	8b69da0fc723e82b1d7a27	716	1		peri	0								
1116C		1116	19	semi-formed	SRR11416514	PRJNA545312	14		4	5	cord	Leukemia	8b69da0fc723e82b1d7a27	716	1		post	1								
1116D		1116	29	formed	SRR11416503	PRJNA545312	24		4	5	cord	Leukemia	8b69da0fc723e82b1d7a27	716	1		post	3								
1117B		1117	3	semi-formed	SRR11416717	PRJNA545312	22		4	-19	cord	Leukemia	6b4f34624fa73e93275f83	714	1		post	3								
1117C		1117	169	semi-formed	SRR11416706	PRJNA545312	188		4	-19	cord	Leukemia	6b4f34624fa73e93275f83	714	1		post	6								
1117D		1117	357	formed	SRR11416949	PRJNA545312	376		4	-19	cord	Leukemia	6b4f34624fa73e93275f83	714	1		post	6								
1117E		1117	454	formed	SRR11416938	PRJNA545312	473		4	-19	cord	Leukemia	6b4f34624fa73e93275f83	714	1		post	6								
1118A		1118	0	liquid	SRR11416927	PRJNA545312	-17		1	17	PBSC_unmodified	Myelodysplastic Syndromes	4178e85423375e904c0a8b		1		pre	-3								
1119A		1119	0	formed	SRR11417174	PRJNA545312	-5		7	5	TCD	Myeloproliferative Disorder	c10dbacb321e4db27b2a94	164	1		pre	-1								
1119B		1119	2	formed	SRR11417163	PRJNA545312	-3		7	5	TCD	Myeloproliferative Disorder	c10dbacb321e4db27b2a94	164	1		pre	-1								
1119C		1119	12	liquid	SRR11417152	PRJNA545312	7		7	5	TCD	Myeloproliferative Disorder	c10dbacb321e4db27b2a94	164	1		post	0								
1119D		1119	21	formed	SRR11416487	PRJNA545312	16		7	5	TCD	Myeloproliferative Disorder	c10dbacb321e4db27b2a94	164	1		post	2								
1119E		1119	28	formed	SRR11416476	PRJNA545312	23		7	5	TCD	Myeloproliferative Disorder	c10dbacb321e4db27b2a94	164	1		post	3								
1119F		1119	32	formed	SRR11416917	PRJNA545312	27		7	5	TCD	Myeloproliferative Disorder	c10dbacb321e4db27b2a94	164	1		post	3								
1119G		1119	38	semi-formed	SRR11416906	PRJNA545312	33		7	5	TCD	Myeloproliferative Disorder	c10dbacb321e4db27b2a94	164	1		post	4								
1120		pt_with_samples_1056_1057_1058_1120	153	semi-formed	SRR11416894	PRJNA545312	149		4	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	230c4a4e1e42454a3733bf	158	1		post	6								
1120A		1120	0	formed	SRR11394956	PRJNA607574			4																	
1120B		1120	9	liquid	SRR11394945	PRJNA607574			4																	
1120C		1120	16	liquid	SRR11394934	PRJNA607574			4																	
1120D		1120	34	semi-formed	SRR11394923	PRJNA607574			4																	
1121		pt_with_samples_1001_1002_1003_1004_1005_1006_1007_1008_1048_1121_152	0	formed	SRR11417253	PRJNA545312	-21		10	21	cord	Leukemia	c8848e19e1175e744f8987	36	1		pre	-3								
1121A		1121	0	formed	SRR11414313	PRJNA545312	-3		4	3	TCD	Multiple Myeloma	1e17e51d3f8ab12bb5138e	192	1		pre	-1								
1121B		1121	6	liquid	SRR11414312	PRJNA545312	3		4	3	TCD	Multiple Myeloma	1e17e51d3f8ab12bb5138e	192	1		peri	0								
1121C		1121	15	formed	SRR11414311	PRJNA545312	12		4	3	TCD	Multiple Myeloma	1e17e51d3f8ab12bb5138e	192	1		post	1								
1121D		1121	195	liquid	SRR11417242	PRJNA545312	192		4	3	TCD	Multiple Myeloma	1e17e51d3f8ab12bb5138e	192	1		post	6								
1122A		1122	0	formed	SRR11140483	PRJNA606262			1																	
1123		pt_with_samples_1050_1051_1052_1053_1054_1055_1123	43	liquid	SRR11416605	PRJNA545312	36		6	7	cord	Non-Hodgkin's Lymphoma	6b2a6198cfe3980b13a40b	61	1		post	5								
1123B		1123	6	semi-formed	SRR11416594	PRJNA545312			22																	
1123C		1123	13	liquid	SRR11416583	PRJNA545312			22																	
1123D		1123	20	liquid	SRR11416685	PRJNA545312			22																	
1123E		1123	27	liquid	SRR11416674	PRJNA545312			22																	
1123F		1123	34	semi-formed	SRR11416326	PRJNA545312			22																	
1123G		1123	364	formed	SRR11416315	PRJNA545312			22																	
1123H		1123	365	liquid	SRR11417007	PRJNA545312			22																	
1123I		1123	366	liquid	SRR11416744	PRJNA545312			22																	
1123J		1123	367	liquid	SRR11416733	PRJNA545312			22																	
1123K		1123	369	liquid	SRR11416663	PRJNA545312			22																	
1123L		1123	370	liquid	SRR11416652	PRJNA545312			22																	
1123M		1123	371	liquid	SRR11416641	PRJNA545312			22																	
1123N		1123	372	liquid	SRR11416349	PRJNA545312			22																	
1123O		1123	376	liquid	SRR11416338	PRJNA545312			22																	
1123P		1123	378	liquid	SRR11416779	PRJNA545312			22																	
1123Q		1123	379	liquid	SRR11416768	PRJNA545312			22																	
1123R		1123	380	liquid	SRR11416756	PRJNA545312			22																	
1123S		1123	383	semi-formed	SRR11417283	PRJNA545312			22																	
1123T		1123	384	liquid	SRR11417272	PRJNA545312			22																	
1123U		1123	385	liquid	SRR11416636	PRJNA545312			22																	
1123V		1123	397	liquid	SRR11416625	PRJNA545312			22																	
1123W		1123	514	semi-formed	SRR11395493	PRJNA607574			22																	
1124		pt_with_samples_1037_1038_1039_1040_1041_1042_1043_1124	105	liquid	SRR11414309	PRJNA545312	104		7	1	cord	Leukemia	2482c3f51ee6837262cb78	182	1		post	6								
1124A		1124	0	semi-formed	SRR11416614	PRJNA545312	-3		8	3	cord	Myelodysplastic Syndromes	5ebcd69565e0bd9d3fb7b1	91	1		pre	-1								
1124B		1124	11	liquid	SRR11416574	PRJNA545312	8		8	3	cord	Myelodysplastic Syndromes	5ebcd69565e0bd9d3fb7b1	91	1		post	1								
1124C		1124	14	liquid	SRR11416563	PRJNA545312	11		8	3	cord	Myelodysplastic Syndromes	5ebcd69565e0bd9d3fb7b1	91	1		post	1								
1124D		1124	21	liquid	SRR11417004	PRJNA545312	18		8	3	cord	Myelodysplastic Syndromes	5ebcd69565e0bd9d3fb7b1	91	1		post	2								
1124E		1124	29	semi-formed	SRR11416993	PRJNA545312	26		8	3	cord	Myelodysplastic Syndromes	5ebcd69565e0bd9d3fb7b1	91	1		post	3								
1124F		1124	206	formed	SRR11416981	PRJNA545312	203		8	3	cord	Myelodysplastic Syndromes	5ebcd69565e0bd9d3fb7b1	91	1		post	6								
1124G		1124	217	semi-formed	SRR11417312	PRJNA545312	214		8	3	cord	Myelodysplastic Syndromes	5ebcd69565e0bd9d3fb7b1	91	1		post	6								
1124H		1124	318	formed	SRR11417301	PRJNA545312	315		8	3	cord	Myelodysplastic Syndromes	5ebcd69565e0bd9d3fb7b1	91	1		post	6								
1125		pt_with_samples_1009_1010_1011_1049_1125_145	178	liquid	SRR11417234	PRJNA545312	172		8	6	cord	Myelodysplastic Syndromes	2cb8f755953c8e7e729fe3	176	1		post	6								
1125A		1125	0	semi-formed	SRR11417223	PRJNA545312	7		1	-7	PBSC_unmodified	Leukemia	5731792c0c9695981fa6ed	215	1		post	0								
1126A		1126	0	formed	SRR11139788	PRJNA606262			1																	
1127A		1127	0	formed	SRR11417212	PRJNA545312	-2		4	2	PBSC_unmodified	Hodgkin's Disease	ed7700f07627e33d53ddf4	288	1		pre	-1								
1127B		1127	12	formed	SRR11416547	PRJNA545312	10		4	2	PBSC_unmodified	Hodgkin's Disease	ed7700f07627e33d53ddf4	288	1		post	1								
1127D		1127	169	liquid	SRR11416536	PRJNA545312	167		4	2	PBSC_unmodified	Hodgkin's Disease	ed7700f07627e33d53ddf4	288	1		post	6								
1127E		1127	183	liquid	SRR11416977	PRJNA545312	181		4	2	PBSC_unmodified	Hodgkin's Disease	ed7700f07627e33d53ddf4	288	1		post	6								
1128A		1128	0	formed	SRR11416966	PRJNA545312	-5		6	5	cord	Leukemia	0f435796ae49defea65c92	738	1		pre	-1								
1128B		1128	2	formed	SRR11416954	PRJNA545312	-3		6	5	cord	Leukemia	0f435796ae49defea65c92	738	1		pre	-1								
1128C		1128	9	liquid	SRR11416887	PRJNA545312	4		6	5	cord	Leukemia	0f435796ae49defea65c92	738	1		peri	0								
1128D		1128	24	semi-formed	SRR11416876	PRJNA545312	19		6	5	cord	Leukemia	0f435796ae49defea65c92	738	1		post	2								
1128E		1128	30	formed	SRR11417207	PRJNA545312	25		6	5	cord	Leukemia	0f435796ae49defea65c92	738	1		post	3								
1128F		1128	37	formed	SRR11417196	PRJNA545312	32		6	5	cord	Leukemia	0f435796ae49defea65c92	738	1		post	4								
1129A		1129	0	semi-formed	SRR11140240	PRJNA606262			1																	
112A		112	0	formed	SRR11417185	PRJNA545312	-155		6	155	TCD	Multiple Myeloma	fafbdaa3227f32b6a670c9	236	1		pre	-3								
112B		112	147	semi-formed	SRR11417118	PRJNA545312	-8		6	155	TCD	Multiple Myeloma	fafbdaa3227f32b6a670c9	236	1		pre	-2								
112D		112	160	liquid	SRR11417107	PRJNA545312	5		6	155	TCD	Multiple Myeloma	fafbdaa3227f32b6a670c9	236	1		peri	0								
112E		112	162	liquid	SRR11417096	PRJNA545312	7		6	155	TCD	Multiple Myeloma	fafbdaa3227f32b6a670c9	236	1		post	0								
112F		112	167	liquid	SRR11416459	PRJNA545312	12		6	155	TCD	Multiple Myeloma	fafbdaa3227f32b6a670c9	236	1		post	1								
112G		112	174	semi-formed	SRR11416447	PRJNA545312	19		6	155	TCD	Multiple Myeloma	fafbdaa3227f32b6a670c9	236	1		post	2								
1130A		1130	0	formed	SRR11416408	PRJNA545312	-7		2	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	481ec14fb36025e1dfab0f		1		pre	-2								
1130B		1130	3	liquid	SRR11416397	PRJNA545312	-4		2	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	481ec14fb36025e1dfab0f		1		pre	-1								
1131A		1131	0	semi-formed	SRR11139822	PRJNA606262			1																	
1132A		1132	0	formed	SRR11140212	PRJNA606262			2																	
1132B		1132	8	semi-formed	SRR11140211	PRJNA606262			2																	
1133A		FMT.0059	0	semi-formed	SRR11416386	PRJNA545312	-63		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		pre	-3								
1133B		FMT.0059	5	formed	SRR11416827	PRJNA545312	-58		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		pre	-3								
1133D		FMT.0059	15	formed	SRR11416816	PRJNA545312	-48		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		pre	-3								
1133E		FMT.0059	19	formed	SRR11417091	PRJNA545312	-44		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		pre	-3								
1134A		1134	0	liquid	SRR11417080	PRJNA545312	4		1	-4	TCD	Multiple Myeloma	2719b6adc6fb058702abd2	712	1		peri	0								
1135A		1135	0	liquid	SRR11140197	PRJNA606262			7																	
1135B		1135	871	formed	SRR11395250	PRJNA607574			7																	
1135C		1135	876	semi-formed	SRR11395239	PRJNA607574			7																	
1135D		1135	878	semi-formed	SRR11395228	PRJNA607574			7																	
1135E		1135	881	semi-formed	SRR11395697	PRJNA607574			7																	
1135F		1135	883	semi-formed	SRR11395686	PRJNA607574			7																	
1135G		1135	885	semi-formed	SRR11395675	PRJNA607574			7																	
1136A		1136	0	formed	SRR11417069	PRJNA545312	-6		7	6	PBSC_unmodified	Leukemia	8abfccade4991e7d4e683a	711	1		pre	-1								
1136B		1136	10	formed	SRR11417030	PRJNA545312	4		7	6	PBSC_unmodified	Leukemia	8abfccade4991e7d4e683a	711	1		peri	0								
1136D		1136	40	formed	SRR11416382	PRJNA545312	34		7	6	PBSC_unmodified	Leukemia	8abfccade4991e7d4e683a	711	1		post	4								
1136E		1136	41	semi-formed	SRR11416381	PRJNA545312	35		7	6	PBSC_unmodified	Leukemia	8abfccade4991e7d4e683a	711	1		post	4								
1136F		1136	202	formed	SRR11423464	PRJNA545312	196		7	6	PBSC_unmodified	Leukemia	8abfccade4991e7d4e683a	711	1		post	6								
1136G		1136	341	formed	SRR11423013	PRJNA545312	335		7	6	PBSC_unmodified	Leukemia	8abfccade4991e7d4e683a	711	1		post	6								
1136H		1136	404	formed	SRR11423368	PRJNA545312	398		7	6	PBSC_unmodified	Leukemia	8abfccade4991e7d4e683a	711	1		post	6								
1137A		1137	0	semi-formed	SRR11140480	PRJNA606262			1																	
1138A		1138	0	formed	SRR11395744	PRJNA607574			3																	
1138B		1138	5	semi-formed	SRR11395743	PRJNA607574			3																	
1138C		1138	19	semi-formed	SRR11395742	PRJNA607574			3																	
1139A		1139	0	semi-formed	SRR11416380	PRJNA545312	-3		1	3	PBSC_unmodified	Leukemia	1ea926378fdb452837869d	724	1		pre	-1								
1140A		1140	0	formed	SRR11140495	PRJNA606262			7																	
1140B		1140	9	liquid	SRR11140494	PRJNA606262			7																	
1140C		1140	438	formed	SRR11395739	PRJNA607574			7																	
1140D		1140	464	formed	SRR11395674	PRJNA607574			7																	
1140E		1140	520	formed	SRR11395673	PRJNA607574			7																	
1140F		1140	697	formed	SRR11395672	PRJNA607574			7																	
1140G		1140	774	liquid	SRR11395671	PRJNA607574			7																	
1141A		1141	0	formed	SRR11416379	PRJNA545312	-5		6	5	PBSC_unmodified	Leukemia	da27258bea35b862439d00	644	1		pre	-1								
1141B		1141	9	semi-formed	SRR11416378	PRJNA545312	4		6	5	PBSC_unmodified	Leukemia	da27258bea35b862439d00	644	1		peri	0								
1141C		1141	17	formed	SRR11416377	PRJNA545312	12		6	5	PBSC_unmodified	Leukemia	da27258bea35b862439d00	644	1		post	1								
1141D		1141	23	liquid	SRR11416376	PRJNA545312	18		6	5	PBSC_unmodified	Leukemia	da27258bea35b862439d00	644	1		post	2								
1141E		1141	46	formed	SRR11416375	PRJNA545312	41		6	5	PBSC_unmodified	Leukemia	da27258bea35b862439d00	644	1		post	5								
1141F		1141	60	formed	SRR11416374	PRJNA545312	55		6	5	PBSC_unmodified	Leukemia	da27258bea35b862439d00	644	1		post	6								
1142A		1142	0	formed	SRR11140201	PRJNA606262			4																	
1142B		1142	3	liquid	SRR11140200	PRJNA606262			4																	
1142C		1142	12	formed	SRR11140199	PRJNA606262			4																	
1142D		1142	18	semi-formed	SRR11140198	PRJNA606262			4																	
1143A		1143	0	formed	SRR11416373	PRJNA545312	-30		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		pre	-3								
1143AA		1143	60	semi-formed	SRR11416371	PRJNA545312	30		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	4								
1143B		1143	25	semi-formed	SRR11416370	PRJNA545312	-5		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		pre	-1								
1143BB		1143	62	semi-formed	SRR11416369	PRJNA545312	32		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	4								
1143C		1143	27	semi-formed	SRR11416368	PRJNA545312	-3		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		pre	-1								
1143CC		1143	63	formed	SRR11416367	PRJNA545312	33		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	4								
1143D		1143	35	liquid	SRR11416366	PRJNA545312	5		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		peri	0								
1143DD		1143	64	formed	SRR11416365	PRJNA545312	34		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	4								
1143E		1143	36	liquid	SRR11416364	PRJNA545312	6		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	0								
1143EE		1143	66	formed	SRR11416363	PRJNA545312	36		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	5								
1143FF		1143	67	formed	SRR11416362	PRJNA545312	37		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	5								
1143G		1143	38	liquid	SRR11416360	PRJNA545312	8		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	1								
1143H		1143	39	liquid	SRR11423145	PRJNA545312	9		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	1								
1143I		1143	42	liquid	SRR11416359	PRJNA545312	12		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	1								
1143J		1143	44	liquid	SRR11416358	PRJNA545312	14		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	1								
1143K		1143	46	liquid	SRR11416809	PRJNA545312	16		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	2								
1143L		1143	47	liquid	SRR11416808	PRJNA545312	17		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	2								
1143M		1143	48	liquid	SRR11416807	PRJNA545312	18		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	2								
1143N		1143	49	liquid	SRR11416806	PRJNA545312	19		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	2								
1143O		1143	50	liquid	SRR11416805	PRJNA545312	20		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	2								
1143P		1143	51	semi-formed	SRR11416804	PRJNA545312	21		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	2								
1143Q		1143	52	semi-formed	SRR11416803	PRJNA545312	22		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	3								
1143R		1143	53	semi-formed	SRR11416801	PRJNA545312	23		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	3								
1143S		1143	54	semi-formed	SRR11416800	PRJNA545312	24		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	3								
1143T		1143	55	semi-formed	SRR11416799	PRJNA545312	25		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	3								
1143V		1143	56	semi-formed	SRR11416797	PRJNA545312	26		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	3								
1143W		1143	57	semi-formed	SRR11416796	PRJNA545312	27		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	3								
1143X		1143	58	semi-formed	SRR11416795	PRJNA545312	28		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	3								
1143Y		1143	59	semi-formed	SRR11416794	PRJNA545312	29		29	30	cord	Myelodysplastic Syndromes	85c6b894edb17153189265	26	1		post	4								
1144A		1144	0	formed	SRR11416792	PRJNA545312	-10		3	10	TCD	Leukemia	ad8dd57fc75395cf0c5b9a	737	1		pre	-2								
1144B		1144	7	liquid	SRR11416790	PRJNA545312	-3		3	10	TCD	Leukemia	ad8dd57fc75395cf0c5b9a	737	1		pre	-1								
1144E		1144	22	liquid	SRR11416789	PRJNA545312	12		3	10	TCD	Leukemia	ad8dd57fc75395cf0c5b9a	737	1		post	1								
1145A		1145	0	formed	SRR11140247	PRJNA606262			5																	
1145B		1145	4	semi-formed	SRR11140246	PRJNA606262			5																	
1145C		1145	12	liquid	SRR11140245	PRJNA606262			5																	
1145D		1145	22	semi-formed	SRR11140244	PRJNA606262			5																	
1145E		1145	25	semi-formed	SRR11140243	PRJNA606262			5																	
1146A		1146	0	formed	SRR11140213	PRJNA606262			1																	
1147A		1147	0	semi-formed	SRR11416788	PRJNA545312	12		3	-12	PBSC_unmodified	Myelodysplastic Syndromes	fdd8626c17ef25852bbe89	630	1		post	1								
1147B		1147	7	semi-formed	SRR11416787	PRJNA545312	19		3	-12	PBSC_unmodified	Myelodysplastic Syndromes	fdd8626c17ef25852bbe89	630	1		post	2								
1147C		1147	342	formed	SRR11416786	PRJNA545312	354		3	-12	PBSC_unmodified	Myelodysplastic Syndromes	fdd8626c17ef25852bbe89	630	1		post	6								
1148A		1148	0	semi-formed	SRR11139811	PRJNA606262			3																	
1148B		1148	43	formed	SRR11139810	PRJNA606262			3																	
1148C		1148	206	formed	SRR11395214	PRJNA607574			3																	
1149A		1149	0	semi-formed	SRR11140032	PRJNA606262			1																	
114A		114	0	formed	SRR11416785	PRJNA545312	-8		3	8	TCD	Multiple Myeloma	8235cfcdeed401bd74b3ba	77	1		pre	-2								
114B		114	14	semi-formed	SRR11416784	PRJNA545312	6		3	8	TCD	Multiple Myeloma	8235cfcdeed401bd74b3ba	77	1		post	0								
114C		114	20	semi-formed	SRR11416783	PRJNA545312	12		3	8	TCD	Multiple Myeloma	8235cfcdeed401bd74b3ba	77	1		post	1								
1150A		1150	0	formed	SRR11416782	PRJNA545312	-4		4	4	PBSC_unmodified	Myelodysplastic Syndromes	b905a56eb130359ccd2152	661	1		pre	-1								
1150B		1150	4	formed	SRR11417067	PRJNA545312	0		4	4	PBSC_unmodified	Myelodysplastic Syndromes	b905a56eb130359ccd2152	661	1		peri	-1								
1150C		1150	15	liquid	SRR11417065	PRJNA545312	11		4	4	PBSC_unmodified	Myelodysplastic Syndromes	b905a56eb130359ccd2152	661	1		post	1								
1150D		1150	25	formed	SRR11417064	PRJNA545312	21		4	4	PBSC_unmodified	Myelodysplastic Syndromes	b905a56eb130359ccd2152	661	1		post	2								
1151A		1151	0	semi-formed	SRR11417063	PRJNA545312	1		8	-1	PBSC_unmodified	Myelodysplastic Syndromes	8e712756c1549d1bc3264b	739	1		peri	0								
1151B		1151	6	liquid	SRR11417062	PRJNA545312	7		8	-1	PBSC_unmodified	Myelodysplastic Syndromes	8e712756c1549d1bc3264b	739	1		post	0								
1151C		1151	7	semi-formed	SRR11417061	PRJNA545312	8		8	-1	PBSC_unmodified	Myelodysplastic Syndromes	8e712756c1549d1bc3264b	739	1		post	1								
1151D		1151	9	liquid	SRR11417060	PRJNA545312	10		8	-1	PBSC_unmodified	Myelodysplastic Syndromes	8e712756c1549d1bc3264b	739	1		post	1								
1151E		1151	10	liquid	SRR11417059	PRJNA545312	11		8	-1	PBSC_unmodified	Myelodysplastic Syndromes	8e712756c1549d1bc3264b	739	1		post	1								
1151F		1151	18	formed	SRR11417058	PRJNA545312	19		8	-1	PBSC_unmodified	Myelodysplastic Syndromes	8e712756c1549d1bc3264b	739	1		post	2								
1151G		1151	82	liquid	SRR11417057	PRJNA545312	83		8	-1	PBSC_unmodified	Myelodysplastic Syndromes	8e712756c1549d1bc3264b	739	1		post	6								
1151H		1151	206	semi-formed	SRR11417056	PRJNA545312	207		8	-1	PBSC_unmodified	Myelodysplastic Syndromes	8e712756c1549d1bc3264b	739	1		post	6								
1152A		1152	0	formed	SRR11139826	PRJNA606262			2																	
1152C		1152	14	semi-formed	SRR11139824	PRJNA606262			2																	
1153A		1153	0	formed	SRR11140281	PRJNA606262			1																	
1154A		1154	0	semi-formed	SRR11417054	PRJNA545312	-1		11	1	cord	Leukemia	9177245ba3a9bab1a6fc4c	752	1		pre	-1								
1154B		1154	7	liquid	SRR11417053	PRJNA545312	6		11	1	cord	Leukemia	9177245ba3a9bab1a6fc4c	752	1		post	0								
1154C		1154	25	liquid	SRR11417052	PRJNA545312	24		11	1	cord	Leukemia	9177245ba3a9bab1a6fc4c	752	1		post	3								
1154D		1154	27	liquid	SRR11417051	PRJNA545312	26		11	1	cord	Leukemia	9177245ba3a9bab1a6fc4c	752	1		post	3								
1154E		1154	34	semi-formed	SRR11417050	PRJNA545312	33		11	1	cord	Leukemia	9177245ba3a9bab1a6fc4c	752	1		post	4								
1154G		1154	39	semi-formed	SRR11417049	PRJNA545312	38		11	1	cord	Leukemia	9177245ba3a9bab1a6fc4c	752	1		post	5								
1154H		1154	41	semi-formed	SRR11417048	PRJNA545312	40		11	1	cord	Leukemia	9177245ba3a9bab1a6fc4c	752	1		post	5								
1154I		1154	49	semi-formed	SRR11417047	PRJNA545312	48		11	1	cord	Leukemia	9177245ba3a9bab1a6fc4c	752	1		post	6								
1154J		1154	52	formed	SRR11417046	PRJNA545312	51		11	1	cord	Leukemia	9177245ba3a9bab1a6fc4c	752	1		post	6								
1154K		1154	53	formed	SRR11417045	PRJNA545312	52		11	1	cord	Leukemia	9177245ba3a9bab1a6fc4c	752	1		post	6								
1154L		1154	69	formed	SRR11417043	PRJNA545312	68		11	1	cord	Leukemia	9177245ba3a9bab1a6fc4c	752	1		post	6								
1155A		FMT.0082	0	liquid	SRR11417042	PRJNA545312	-92		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		pre	-3								
1155B		FMT.0082	15	semi-formed	SRR11417041	PRJNA545312	-77		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		pre	-3								
1156A		1156	0	liquid	SRR11417040	PRJNA545312	0		3	0	TCD	Multiple Myeloma	a31678e5b4dbcfed3b5433		1		peri	-1								
1156B		1156	2	liquid	SRR11416441	PRJNA545312	2		3	0	TCD	Multiple Myeloma	a31678e5b4dbcfed3b5433		1		peri	0								
1156E		1156	31	liquid	SRR11416440	PRJNA545312	31		3	0	TCD	Multiple Myeloma	a31678e5b4dbcfed3b5433		1		post	4								
1157A		1157	0	formed	SRR11416439	PRJNA545312	-5		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		pre	-1								
1157B		1157	2	liquid	SRR11416438	PRJNA545312	-3		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		pre	-1								
1157C		1157	4	liquid	SRR11416437	PRJNA545312	-1		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		pre	-1								
1157D		1157	5	liquid	SRR11416436	PRJNA545312	0		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		peri	-1								
1157DD		1157	37	formed	SRR11416434	PRJNA545312	32		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		post	4								
1157E		1157	6	semi-formed	SRR11416433	PRJNA545312	1		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		peri	0								
1157F		1157	7	liquid	SRR11416432	PRJNA545312	2		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		peri	0								
1157K		1157	14	semi-formed	SRR11416431	PRJNA545312	9		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		post	1								
1157L		1157	16	liquid	SRR11416430	PRJNA545312	11		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		post	1								
1157M		1157	18	semi-formed	SRR11416429	PRJNA545312	13		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		post	1								
1157S		1157	24	semi-formed	SRR11416428	PRJNA545312	19		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		post	2								
1157T		1157	25	semi-formed	SRR11414308	PRJNA545312	20		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		post	2								
1157U		1157	26	semi-formed	SRR11414307	PRJNA545312	21		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		post	2								
1157V		1157	28	semi-formed	SRR11414306	PRJNA545312	23		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		post	3								
1157W		1157	29	semi-formed	SRR11414305	PRJNA545312	24		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		post	3								
1157X		1157	30	semi-formed	SRR11414304	PRJNA545312	25		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		post	3								
1157Y		1157	31	semi-formed	SRR11414303	PRJNA545312	26		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		post	3								
1157Z		1157	33	semi-formed	SRR11414302	PRJNA545312	28		18	5	cord	Leukemia	e65b3dec1314cdb5bb2e77	753	1		post	3								
1158A		1158	0	formed	SRR11414301	PRJNA545312	-75		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		pre	-3								
1158B		1158	69	formed	SRR11414300	PRJNA545312	-6		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		pre	-1								
1158C		1158	70	semi-formed	SRR11414298	PRJNA545312	-5		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		pre	-1								
1158D		1158	71	formed	SRR11414297	PRJNA545312	-4		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		pre	-1								
1158E		1158	75	semi-formed	SRR11414296	PRJNA545312	0		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		peri	-1								
1158F		1158	78	liquid	SRR11414295	PRJNA545312	3		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		peri	0								
1158G		1158	79	liquid	SRR11414294	PRJNA545312	4		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		peri	0								
1158H		1158	80	semi-formed	SRR11414293	PRJNA545312	5		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		peri	0								
1158I		1158	83	liquid	SRR11414292	PRJNA545312	8		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		post	1								
1158J		1158	86	liquid	SRR11414291	PRJNA545312	11		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		post	1								
1158K		1158	87	liquid	SRR11414290	PRJNA545312	12		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		post	1								
1158L		1158	88	liquid	SRR11414653	PRJNA545312	13		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		post	1								
1158M		1158	90	liquid	SRR11416427	PRJNA545312	15		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		post	2								
1158N		1158	91	liquid	SRR11416426	PRJNA545312	16		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		post	2								
1158R		1158	103	liquid	SRR11416425	PRJNA545312	28		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		post	3								
1158S		1158	109	formed	SRR11416423	PRJNA545312	34		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		post	4								
1158T		1158	110	semi-formed	SRR11416422	PRJNA545312	35		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		post	4								
1158U		1158	114	formed	SRR11416421	PRJNA545312	39		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		post	5								
1158V		1158	117	semi-formed	SRR11416420	PRJNA545312	42		19	75	cord	Leukemia	a3c2ab3e5102cdad6b44d9	756	1		post	5								
1159A		1159	0	formed	SRR11139808	PRJNA606262			1																	
115B		115	23	formed	SRR11416419	PRJNA545312	53		1	-30	PBSC_unmodified	Leukemia	43a8f7dbf21d96c112429c	219	1		post	6								
1160A		1160	0	formed	SRR11416417	PRJNA545312	-6		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		pre	-1								
1160C		1160	3	formed	SRR11416415	PRJNA545312	-3		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		pre	-1								
1160D		1160	4	formed	SRR11416414	PRJNA545312	-2		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		pre	-1								
1160E		1160	5	formed	SRR11416863	PRJNA545312	-1		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		pre	-1								
1160F		1160	6	formed	SRR11416862	PRJNA545312	0		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		peri	-1								
1160G		1160	7	formed	SRR11416861	PRJNA545312	1		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		peri	0								
1160H		1160	8	formed	SRR11416860	PRJNA545312	2		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		peri	0								
1160I		1160	9	formed	SRR11416859	PRJNA545312	3		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		peri	0								
1160J		1160	10	semi-formed	SRR11416858	PRJNA545312	4		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		peri	0								
1160K		1160	11	semi-formed	SRR11416857	PRJNA545312	5		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		peri	0								
1160L		1160	12	semi-formed	SRR11416856	PRJNA545312	6		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		post	0								
1160M		1160	13	semi-formed	SRR11416855	PRJNA545312	7		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		post	0								
1160N		1160	15	formed	SRR11416854	PRJNA545312	9		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		post	1								
1160O		1160	16	formed	SRR11416852	PRJNA545312	10		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		post	1								
1160P		1160	17	formed	SRR11416851	PRJNA545312	11		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		post	1								
1160Q		1160	18	semi-formed	SRR11416850	PRJNA545312	12		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		post	1								
1160R		1160	19	formed	SRR11416849	PRJNA545312	13		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		post	1								
1160S		1160	20	formed	SRR11416848	PRJNA545312	14		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		post	1								
1160T		1160	21	semi-formed	SRR11416847	PRJNA545312	15		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		post	2								
1160U		1160	22	formed	SRR11416846	PRJNA545312	16		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		post	2								
1160V		1160	23	formed	SRR11416845	PRJNA545312	17		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		post	2								
1160W		1160	29	formed	SRR11416844	PRJNA545312	23		22	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe92a6e334f3ec8a2062e8	694	1		post	3								
1161A		1161	0	formed	SRR11416843	PRJNA545312	-556		16	556	BM_unmodified	Non-Hodgkin's Lymphoma	a86a28c772b8f4f17c1e4e		1		pre	-3								
1161B		1161	2	formed	SRR11416841	PRJNA545312	-554		16	556	BM_unmodified	Non-Hodgkin's Lymphoma	a86a28c772b8f4f17c1e4e		1		pre	-3								
1161C		1161	10	liquid	SRR11416840	PRJNA545312	-546		16	556	BM_unmodified	Non-Hodgkin's Lymphoma	a86a28c772b8f4f17c1e4e		1		pre	-3								
1161D		1161	16	liquid	SRR11416839	PRJNA545312	-540		16	556	BM_unmodified	Non-Hodgkin's Lymphoma	a86a28c772b8f4f17c1e4e		1		pre	-3								
1161E		1161	563	liquid	SRR11416838	PRJNA545312	7		16	556	BM_unmodified	Non-Hodgkin's Lymphoma	a86a28c772b8f4f17c1e4e		1		post	0								
1161F		1161	564	liquid	SRR11417151	PRJNA545312	8		16	556	BM_unmodified	Non-Hodgkin's Lymphoma	a86a28c772b8f4f17c1e4e		1		post	1								
1161G		1161	565	liquid	SRR11417150	PRJNA545312	9		16	556	BM_unmodified	Non-Hodgkin's Lymphoma	a86a28c772b8f4f17c1e4e		1		post	1								
1161I		1161	569	liquid	SRR11417149	PRJNA545312	13		16	556	BM_unmodified	Non-Hodgkin's Lymphoma	a86a28c772b8f4f17c1e4e		1		post	1								
1161J		1161	571	semi-formed	SRR11417148	PRJNA545312	15		16	556	BM_unmodified	Non-Hodgkin's Lymphoma	a86a28c772b8f4f17c1e4e		1		post	2								
1161K		1161	572	semi-formed	SRR11417147	PRJNA545312	16		16	556	BM_unmodified	Non-Hodgkin's Lymphoma	a86a28c772b8f4f17c1e4e		1		post	2								
1161L		1161	577	liquid	SRR11417146	PRJNA545312	21		16	556	BM_unmodified	Non-Hodgkin's Lymphoma	a86a28c772b8f4f17c1e4e		1		post	2								
1161M		1161	584	semi-formed	SRR11417144	PRJNA545312	28		16	556	BM_unmodified	Non-Hodgkin's Lymphoma	a86a28c772b8f4f17c1e4e		1		post	3								
1161N		1161	586	formed	SRR11417143	PRJNA545312	30		16	556	BM_unmodified	Non-Hodgkin's Lymphoma	a86a28c772b8f4f17c1e4e		1		post	4								
1161O		1161	589	semi-formed	SRR11417142	PRJNA545312	33		16	556	BM_unmodified	Non-Hodgkin's Lymphoma	a86a28c772b8f4f17c1e4e		1		post	4								
1161P		1161	591	formed	SRR11417141	PRJNA545312	35		16	556	BM_unmodified	Non-Hodgkin's Lymphoma	a86a28c772b8f4f17c1e4e		1		post	4								
1161Q		1161	660	semi-formed	SRR11115769	PRJNA607574	104		16	556	BM_unmodified	Non-Hodgkin's Lymphoma	a86a28c772b8f4f17c1e4e		1		post	6								
1162A		1162	0	liquid	SRR11140239	PRJNA606262			3																	
1162B		1162	6	semi-formed	SRR11140238	PRJNA606262			3																	
1162C		1162	9	semi-formed	SRR11140237	PRJNA606262			3																	
1163A		1163	0	formed	SRR11417140	PRJNA545312	-3		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		pre	-1								
1163B		1163	3	formed	SRR11417139	PRJNA545312	0		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		peri	-1								
1163C		1163	4	semi-formed	SRR11417138	PRJNA545312	1		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		peri	0								
1163D		1163	5	semi-formed	SRR11417137	PRJNA545312	2		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		peri	0								
1163E		1163	6	formed	SRR11417136	PRJNA545312	3		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		peri	0								
1163F		1163	7	formed	SRR11417135	PRJNA545312	4		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		peri	0								
1163G		1163	8	formed	SRR11417133	PRJNA545312	5		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		peri	0								
1163H		1163	9	semi-formed	SRR11417132	PRJNA545312	6		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		post	0								
1163I		1163	10	formed	SRR11417131	PRJNA545312	7		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		post	0								
1163J		1163	11	formed	SRR11417130	PRJNA545312	8		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		post	1								
1163K		1163	12	formed	SRR11417129	PRJNA545312	9		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		post	1								
1163L		1163	13	formed	SRR11417128	PRJNA545312	10		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		post	1								
1163M		1163	14	formed	SRR11417127	PRJNA545312	11		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		post	1								
1163N		1163	15	formed	SRR11417126	PRJNA545312	12		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		post	1								
1163O		1163	16	formed	SRR11417125	PRJNA545312	13		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		post	1								
1163P		1163	17	formed	SRR11417124	PRJNA545312	14		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		post	1								
1163Q		1163	19	semi-formed	SRR11416524	PRJNA545312	16		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		post	2								
1163R		1163	21	formed	SRR11416523	PRJNA545312	18		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		post	2								
1163S		1163	23	formed	SRR11416522	PRJNA545312	20		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		post	2								
1163T		1163	24	semi-formed	SRR11416521	PRJNA545312	21		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		post	2								
1163U		1163	162	formed	SRR11416520	PRJNA545312	159		21	3	BM_unmodified	Myelodysplastic Syndromes	291c32e2e8110ee2e4a1a6	730	1		post	6								
1164A		1164	0	liquid	SRR11140190	PRJNA606262			1																	
1165A		1165	0	formed	SRR11139855	PRJNA606262			5																	
1165B		1165	7	formed	SRR11139854	PRJNA606262			5																	
1165C		1165	14	semi-formed	SRR11139853	PRJNA606262			5																	
1165D		1165	44	semi-formed	SRR11139852	PRJNA606262			5																	
1165E		1165	43	semi-formed	SRR11139851	PRJNA606262			5																	
1166A		1166	0	semi-formed	SRR11139927	PRJNA606262			2																	
1166B		1166	7	semi-formed	SRR11139916	PRJNA606262			2																	
1167A		1167	0	semi-formed	SRR11416519	PRJNA545312	-7		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		pre	-2								
1167AA		1167	62	formed	SRR11416518	PRJNA545312	55		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167B		1167	1	semi-formed	SRR11416517	PRJNA545312	-6		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		pre	-1								
1167BB		1167	63	formed	SRR11416516	PRJNA545312	56		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167C		1167	3	liquid	SRR11416515	PRJNA545312	-4		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		pre	-1								
1167CC		1167	64	formed	SRR11416513	PRJNA545312	57		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167D		1167	5	liquid	SRR11416512	PRJNA545312	-2		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		pre	-1								
1167DD		1167	65	formed	SRR11416511	PRJNA545312	58		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167EE		1167	67	formed	SRR11416509	PRJNA545312	60		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167F		1167	6	liquid	SRR11416508	PRJNA545312	-1		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		pre	-1								
1167FF		1167	68	semi-formed	SRR11416507	PRJNA545312	61		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167G		1167	7	liquid	SRR11416506	PRJNA545312	0		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		peri	-1								
1167GG		1167	69	liquid	SRR11416505	PRJNA545312	62		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167H		1167	8	liquid	SRR11416504	PRJNA545312	1		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		peri	0								
1167HH		1167	70	liquid	SRR11416502	PRJNA545312	63		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167I		1167	10	liquid	SRR11416501	PRJNA545312	3		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		peri	0								
1167II		1167	71	liquid	SRR11416500	PRJNA545312	64		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167J		1167	9	liquid	SRR11416499	PRJNA545312	2		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		peri	0								
1167JJ		1167	72	liquid	SRR11416498	PRJNA545312	65		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167KK		1167	73	liquid	SRR11417019	PRJNA545312	66		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167LL		1167	74	liquid	SRR11417018	PRJNA545312	67		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167MM		1167	76	liquid	SRR11417017	PRJNA545312	69		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167NN		1167	78	liquid	SRR11417016	PRJNA545312	71		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167OO		1167	79	liquid	SRR11416611	PRJNA545312	72		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167PP		1167	80	semi-formed	SRR11416716	PRJNA545312	73		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167QQ		1167	103	semi-formed	SRR11416715	PRJNA545312	96		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167RR		1167	136	semi-formed	SRR11416714	PRJNA545312	-74		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		pre	-3								
1167SS		1167	137	formed	SRR11416713	PRJNA545312	-73		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		pre	-3								
1167TT		1167	138	formed	SRR11416712	PRJNA545312	-72		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		pre	-3								
1167U		1167	25	formed	SRR11416711	PRJNA545312	18		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	2								
1167UU		1167	149	formed	SRR11416710	PRJNA545312	-61		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		pre	-3								
1167V		1167	26	semi-formed	SRR11416709	PRJNA545312	19		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	2								
1167VV		1167	163	semi-formed	SRR11416708	PRJNA545312	-47		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		pre	-3								
1167W		1167	32	liquid	SRR11416707	PRJNA545312	25		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	3								
1167WW		1167	164	formed	SRR11416705	PRJNA545312	-46		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		pre	-3								
1167X		1167	59	formed	SRR11416704	PRJNA545312	52		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167XX		1167	196	formed	SRR11416703	PRJNA545312	-14		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		pre	-3								
1167Y		1167	60	formed	SRR11416702	PRJNA545312	53		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167YY		1167	275	semi-formed	SRR11416701	PRJNA545312	65		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1167Z		1167	61	formed	SRR11416700	PRJNA545312	54		40	210	PBSC_unmodified		4cf339e246e99debe59cb1	696	1		post	6								
1168A		1168	0	formed	SRR11416699	PRJNA545312	10		1	-10	PBSC_unmodified	Myeloproliferative Disorder	c01292e1d5f7c991dce86a		1		post	1								
1169A		1169	0	formed	SRR11140322	PRJNA606262			3																	
1169B		1169	3	formed	SRR11140321	PRJNA606262			3																	
1169C		1169	10	liquid	SRR11140320	PRJNA606262			3																	
116A		116	0	formed	SRR11416698	PRJNA545312	-6		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	d92f3ef72e077278ecd638	181	1		pre	-1								
116B		116	1	formed	SRR11416697	PRJNA545312	-5		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	d92f3ef72e077278ecd638	181	1		pre	-1								
116C		116	2	formed	SRR11416696	PRJNA545312	-4		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	d92f3ef72e077278ecd638	181	1		pre	-1								
116D		116	3	formed	SRR11416948	PRJNA545312	-3		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	d92f3ef72e077278ecd638	181	1		pre	-1								
116E		116	18	formed	SRR11416947	PRJNA545312	12		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	d92f3ef72e077278ecd638	181	1		post	1								
1170A		1170	0	formed	SRR11416946	PRJNA545312	-3		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		pre	-1								
1170B		1170	2	formed	SRR11416945	PRJNA545312	-1		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		pre	-1								
1170C		1170	3	formed	SRR11416944	PRJNA545312	0		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		peri	-1								
1170D		1170	4	formed	SRR11416943	PRJNA545312	1		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		peri	0								
1170E		1170	5	formed	SRR11416942	PRJNA545312	2		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		peri	0								
1170F		1170	6	formed	SRR11416941	PRJNA545312	3		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		peri	0								
1170G		1170	7	semi-formed	SRR11416940	PRJNA545312	4		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		peri	0								
1170H		1170	9	formed	SRR11416939	PRJNA545312	6		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		post	0								
1170I		1170	10	formed	SRR11416937	PRJNA545312	7		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		post	0								
1170J		1170	13	semi-formed	SRR11416936	PRJNA545312	10		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		post	1								
1170K		1170	14	semi-formed	SRR11416935	PRJNA545312	11		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		post	1								
1170L		1170	15	formed	SRR11416934	PRJNA545312	12		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		post	1								
1170M		1170	17	formed	SRR11416933	PRJNA545312	14		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		post	1								
1170O		1170	19	formed	SRR11416931	PRJNA545312	16		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		post	2								
1170P		1170	38	formed	SRR11416930	PRJNA545312	35		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		post	4								
1170Q		1170	69	formed	SRR11416929	PRJNA545312	66		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		post	6								
1170R		1170	91		SRR11416928	PRJNA545312	88		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		post	6								
1170S		1170	198	formed	SRR11416926	PRJNA545312	195		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		post	6								
1170T		1170	365	formed	SRR11416925	PRJNA545312	362		19	3	PBSC_unmodified	Myelodysplastic Syndromes	c904444941336cb8964b0f	736	1		post	6								
1171A		1171	0	formed	SRR11416924	PRJNA545312	-5		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		pre	-1								
1171AA		1171	39	formed	SRR11416923	PRJNA545312	34		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	4								
1171B		1171	6	semi-formed	SRR11416922	PRJNA545312	1		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		peri	0								
1171BB		1171	51	formed	SRR11417179	PRJNA545312	46		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	6								
1171C		1171	8	semi-formed	SRR11417178	PRJNA545312	3		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		peri	0								
1171CC		1171	67	formed	SRR11417177	PRJNA545312	62		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	6								
1171D		1171	9	liquid	SRR11417176	PRJNA545312	4		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		peri	0								
1171DD		1171	109	semi-formed	SRR11417175	PRJNA545312	104		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	6								
1171E		1171	11	semi-formed	SRR11417173	PRJNA545312	6		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	0								
1171EE		1171	200	formed	SRR11417172	PRJNA545312	195		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	6								
1171F		1171	12	liquid	SRR11417171	PRJNA545312	7		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	0								
1171FF		1171	443	semi-formed	SRR11417170	PRJNA545312	438		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	6								
1171I		1171	14	semi-formed	SRR11417169	PRJNA545312	9		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	1								
1171J		1171	15	liquid	SRR11417168	PRJNA545312	10		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	1								
1171K		1171	16	semi-formed	SRR11417167	PRJNA545312	11		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	1								
1171L		1171	17	liquid	SRR11417166	PRJNA545312	12		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	1								
1171M		1171	19	formed	SRR11417165	PRJNA545312	14		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	1								
1171N		1171	20	liquid	SRR11417164	PRJNA545312	15		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	2								
1171P		1171	22	semi-formed	SRR11417162	PRJNA545312	17		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	2								
1171Q		1171	24	semi-formed	SRR11417161	PRJNA545312	19		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	2								
1171R		1171	25	semi-formed	SRR11417160	PRJNA545312	20		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	2								
1171S		1171	26	liquid	SRR11417159	PRJNA545312	21		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	2								
1171T		1171	27	semi-formed	SRR11417158	PRJNA545312	22		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	3								
1171U		1171	28	liquid	SRR11417157	PRJNA545312	23		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	3								
1171V		1171	29	semi-formed	SRR11417156	PRJNA545312	24		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	3								
1171W		1171	31	semi-formed	SRR11417155	PRJNA545312	26		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	3								
1171X		1171	35	semi-formed	SRR11417154	PRJNA545312	30		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	4								
1171Y		1171	36	semi-formed	SRR11417153	PRJNA545312	31		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	4								
1171Z		1171	38	formed	SRR11416497	PRJNA545312	33		29	5	cord	Leukemia	b85f30525ee6a36419bcb3	670	1		post	4								
1172A		1172	0	formed	SRR11140189	PRJNA606262			5																	
1172B		1172	6	semi-formed	SRR11140188	PRJNA606262			5																	
1172C		1172	75		SRR11140187	PRJNA606262			5																	
1172D		1172	96	liquid	SRR11140186	PRJNA606262			5																	
1172E		1172	202	formed	SRR11395166	PRJNA607574			5																	
1173A		1173	0	formed	SRR11416496	PRJNA545312	-4		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		pre	-1								
1173B		1173	1	formed	SRR11416495	PRJNA545312	-3		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		pre	-1								
1173C		1173	2	semi-formed	SRR11416494	PRJNA545312	-2		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		pre	-1								
1173D		1173	3	formed	SRR11416493	PRJNA545312	-1		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		pre	-1								
1173E		1173	4	formed	SRR11416492	PRJNA545312	0		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		peri	-1								
1173F		1173	6	formed	SRR11416491	PRJNA545312	2		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		peri	0								
1173G		1173	5	formed	SRR11416490	PRJNA545312	1		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		peri	0								
1173H		1173	7	semi-formed	SRR11416489	PRJNA545312	3		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		peri	0								
1173I		1173	10	formed	SRR11416488	PRJNA545312	6		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		post	0								
1173J		1173	11	formed	SRR11416486	PRJNA545312	7		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		post	0								
1173K		1173	12	formed	SRR11416485	PRJNA545312	8		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		post	1								
1173L		1173	13	formed	SRR11416484	PRJNA545312	9		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		post	1								
1173M		1173	14	formed	SRR11416483	PRJNA545312	10		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		post	1								
1173N		1173	17	formed	SRR11416482	PRJNA545312	13		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		post	1								
1173O		1173	18	formed	SRR11416481	PRJNA545312	14		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		post	1								
1173P		1173	19	formed	SRR11416480	PRJNA545312	15		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		post	2								
1173Q		1173	20	formed	SRR11416479	PRJNA545312	16		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		post	2								
1173R		1173	106	semi-formed	SRR11416478	PRJNA545312	102		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		post	6								
1173S		1173	229	formed	SRR11416477	PRJNA545312	225		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		post	6								
1173T		1173	423	semi-formed	SRR11416475	PRJNA545312	419		20	4	PBSC_unmodified	Myelodysplastic Syndromes	198d5974caf5981344274e		1		post	6								
1174A		1174	0	formed	SRR11416474	PRJNA545312	-6		13	6	cord	Non-Hodgkin's Lymphoma	fd1885d3dcaadfb55cde1c		1		pre	-1								
1174B		1174	2	semi-formed	SRR11416473	PRJNA545312	-4		13	6	cord	Non-Hodgkin's Lymphoma	fd1885d3dcaadfb55cde1c		1		pre	-1								
1174C		1174	3	formed	SRR11416472	PRJNA545312	-3		13	6	cord	Non-Hodgkin's Lymphoma	fd1885d3dcaadfb55cde1c		1		pre	-1								
1174D		1174	6	liquid	SRR11416471	PRJNA545312	0		13	6	cord	Non-Hodgkin's Lymphoma	fd1885d3dcaadfb55cde1c		1		peri	-1								
1174E		1174	7	liquid	SRR11416470	PRJNA545312	1		13	6	cord	Non-Hodgkin's Lymphoma	fd1885d3dcaadfb55cde1c		1		peri	0								
1174F		1174	8	semi-formed	SRR11416921	PRJNA545312	2		13	6	cord	Non-Hodgkin's Lymphoma	fd1885d3dcaadfb55cde1c		1		peri	0								
1174G		1174	12	semi-formed	SRR11416920	PRJNA545312	6		13	6	cord	Non-Hodgkin's Lymphoma	fd1885d3dcaadfb55cde1c		1		post	0								
1174H		1174	15	semi-formed	SRR11416919	PRJNA545312	9		13	6	cord	Non-Hodgkin's Lymphoma	fd1885d3dcaadfb55cde1c		1		post	1								
1174I		1174	19	formed	SRR11416918	PRJNA545312	13		13	6	cord	Non-Hodgkin's Lymphoma	fd1885d3dcaadfb55cde1c		1		post	1								
1174J		1174	20	semi-formed	SRR11416916	PRJNA545312	14		13	6	cord	Non-Hodgkin's Lymphoma	fd1885d3dcaadfb55cde1c		1		post	1								
1174K		1174	21	semi-formed	SRR11416915	PRJNA545312	15		13	6	cord	Non-Hodgkin's Lymphoma	fd1885d3dcaadfb55cde1c		1		post	2								
1174L		1174	23	semi-formed	SRR11416914	PRJNA545312	17		13	6	cord	Non-Hodgkin's Lymphoma	fd1885d3dcaadfb55cde1c		1		post	2								
1174M		1174	84	liquid	SRR11416913	PRJNA545312	78		13	6	cord	Non-Hodgkin's Lymphoma	fd1885d3dcaadfb55cde1c		1		post	6								
1175A		1175	0	semi-formed	SRR11139816	PRJNA606262			4																	
1175B		1175	8	liquid	SRR11139815	PRJNA606262			4																	
1175C		1175	10	liquid	SRR11139814	PRJNA606262			4																	
1175D		1175	25	formed	SRR11139813	PRJNA606262			4																	
1176A		1176	0	formed	SRR11416912	PRJNA545312	-2		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		pre	-1								
1176AA		1176	46	semi-formed	SRR11416911	PRJNA545312	44		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	6								
1176B		1176	1	liquid	SRR11416910	PRJNA545312	-1		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		pre	-1								
1176BB		1176	47	semi-formed	SRR11416909	PRJNA545312	45		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	6								
1176C		1176	2	liquid	SRR11416908	PRJNA545312	0		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		peri	-1								
1176D		1176	6	liquid	SRR11416907	PRJNA545312	4		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		peri	0								
1176E		1176	7	liquid	SRR11416905	PRJNA545312	5		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		peri	0								
1176F		1176	8	liquid	SRR11416904	PRJNA545312	6		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	0								
1176G		1176	4	liquid	SRR11416903	PRJNA545312	2		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		peri	0								
1176H		1176	9	liquid	SRR11416902	PRJNA545312	7		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	0								
1176I		1176	10	liquid	SRR11416901	PRJNA545312	8		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	1								
1176J		1176	11	liquid	SRR11416900	PRJNA545312	9		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	1								
1176K		1176	12	liquid	SRR11416899	PRJNA545312	10		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	1								
1176L		1176	13	liquid	SRR11416898	PRJNA545312	11		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	1								
1176M		1176	14	liquid	SRR11416897	PRJNA545312	12		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	1								
1176N		1176	15	semi-formed	SRR11416896	PRJNA545312	13		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	1								
1176O		1176	16	semi-formed	SRR11417263	PRJNA545312	14		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	1								
1176P		1176	17	semi-formed	SRR11417262	PRJNA545312	15		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	2								
1176Q		1176	18	formed	SRR11417261	PRJNA545312	16		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	2								
1176R		1176	20	formed	SRR11417260	PRJNA545312	18		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	2								
1176S		1176	21	formed	SRR11417259	PRJNA545312	19		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	2								
1176T		1176	22	semi-formed	SRR11417258	PRJNA545312	20		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	2								
1176U		1176	23	formed	SRR11417257	PRJNA545312	21		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	2								
1176V		1176	24	semi-formed	SRR11417256	PRJNA545312	22		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	3								
1176W		1176	25	semi-formed	SRR11417255	PRJNA545312	23		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	3								
1176X		1176	26	semi-formed	SRR11423416	PRJNA545312	24		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	3								
1176Y		1176	28	formed	SRR11417254	PRJNA545312	26		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	3								
1176Z		1176	45	liquid	SRR11417252	PRJNA545312	43		28	2	cord	Leukemia	143be57df0b039ef4b3c74	747	1		post	6								
1177A		1177	0	semi-formed	SRR11395160	PRJNA607574			3																	
1177B		1177	2	liquid	SRR11395159	PRJNA607574			3																	
1177C		1177	1	liquid	SRR11395158	PRJNA607574			3																	
1178A		1178	0	formed	SRR11139809	PRJNA606262			4																	
1178B		1178	85	semi-formed	SRR11140092	PRJNA606262			4																	
1178C		1178	187	semi-formed	SRR11395155	PRJNA607574			4																	
1178D		1178	279	formed	SRR11395154	PRJNA607574			4																	
1179A		1179	0	formed	SRR11417251	PRJNA545312	-1	SRR14143426	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		pre	-1								
1179B		1179	4	liquid	SRR11417250	PRJNA545312	3	SRR14092235	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		peri	0								
1179C		1179	5	liquid	SRR11417249	PRJNA545312	4	SRR14092234	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		peri	0								
1179D		1179	6	semi-formed	SRR11417248	PRJNA545312	5	SRR14092233	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		peri	0								
1179E		1179	9	semi-formed	SRR11417247	PRJNA545312	8	SRR14092232	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	1								
1179F		1179	11	liquid	SRR11417246	PRJNA545312	10	SRR13697110	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	1								
1179G		1179	12	semi-formed	SRR11414651	PRJNA545312	11	SRR13697109	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	1								
1179H		1179	13	liquid	SRR11414650	PRJNA545312	12	SRR13697108	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	1								
1179I		1179	19	liquid	SRR11414649	PRJNA545312	18	SRR14092231	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	2								
1179J		1179	20	liquid	SRR11414648	PRJNA545312	19	SRR13697107	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	2								
1179K		1179	21	liquid	SRR11414647	PRJNA545312	20	SRR13697106	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	2								
1179L		1179	23	liquid	SRR11414646	PRJNA545312	22	SRR14092230	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	3								
1179M		1179	26	liquid	SRR11414645	PRJNA545312	25	SRR13697105	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	3								
1179N		1179	29	semi-formed	SRR11414644	PRJNA545312	28	SRR13697104	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	3								
1179O		1179	30	semi-formed	SRR11414643	PRJNA545312	29	SRR14092229	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	4								
1179P		1179	31	semi-formed	SRR11414642	PRJNA545312	30	SRR14143419	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	4								
1179Q		1179	34	liquid	SRR11414640	PRJNA545312	33	SRR14092227	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	4								
1179R		1179	35	liquid	SRR11414639	PRJNA545312	34	SRR13697103	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	4								
1179S		1179	36	semi-formed	SRR11414638	PRJNA545312	35	SRR13697101	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	4								
1179T		1179	38	liquid	SRR11414637	PRJNA545312	37	SRR13697164	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	5								
1179U		1179	39	liquid	SRR11414636	PRJNA545312	38	SRR13697163	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	5								
1179V		1179	40	semi-formed	SRR11414635	PRJNA545312	39	SRR13697162	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	5								
1179W		1179	41	semi-formed	SRR11414634	PRJNA545312	40	SRR13697161	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	5								
1179X		1179	42	semi-formed	SRR11414633	PRJNA545312	41	SRR13697160	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	5								
1179Y		1179	43	semi-formed	SRR11414632	PRJNA545312	42	SRR14092226	25	1	cord	Leukemia	0113b6b5aa14468331fd4b	750	1		post	5								
117A		117	0	formed	SRR11414631	PRJNA545312	-7		5	7	TCD	Leukemia	059e211d1a6d3eef4de274	99	1		pre	-2								
117B		117	4	formed	SRR11414629	PRJNA545312	-3		5	7	TCD	Leukemia	059e211d1a6d3eef4de274	99	1		pre	-1								
117C		117	10	semi-formed	SRR11414628	PRJNA545312	3		5	7	TCD	Leukemia	059e211d1a6d3eef4de274	99	1		peri	0								
117D		117	22	formed	SRR11414627	PRJNA545312	15		5	7	TCD	Leukemia	059e211d1a6d3eef4de274	99	1		post	2								
117E		117	26	formed	SRR11414626	PRJNA545312	19		5	7	TCD	Leukemia	059e211d1a6d3eef4de274	99	1		post	2								
1180A		1180	0	liquid	SRR11139821	PRJNA606262			2																	
1180C		1180	14	liquid	SRR11139819	PRJNA606262			2																	
1181A		1181	0	formed	SRR11140193	PRJNA606262			3																	
1181B		1181	12	semi-formed	SRR11140192	PRJNA606262			3																	
1181C		1181	13	semi-formed	SRR11140191	PRJNA606262			3																	
1182A		1182	0	formed	SRR11140072	PRJNA606262			4																	
1182B		1182	4	formed	SRR11140071	PRJNA606262			4																	
1182C		1182	5	formed	SRR11140070	PRJNA606262			4																	
1182D		1182	12	semi-formed	SRR11140069	PRJNA606262			4																	
1183A		1183	0	formed	SRR11395142	PRJNA607574			3																	
1183B		1183	4	formed	SRR11395141	PRJNA607574			3																	
1183C		1183	31	formed	SRR11395043	PRJNA607574			3																	
1184A		1184	0	formed	SRR11139843	PRJNA606262			12																	
1184B		1184	1	formed	SRR11139842	PRJNA606262			12																	
1184C		1184	3	formed	SRR11139841	PRJNA606262			12																	
1184D		1184	4	formed	SRR11139840	PRJNA606262			12																	
1184E		1184	7	semi-formed	SRR11139839	PRJNA606262			12																	
1184F		1184	8	liquid	SRR11139838	PRJNA606262			12																	
1184G		1184	9	liquid	SRR11139837	PRJNA606262			12																	
1184H		1184	10	liquid	SRR11139836	PRJNA606262			12																	
1184J		1184	11	liquid	SRR11139833	PRJNA606262			12																	
1184K		1184	16	liquid	SRR11139832	PRJNA606262			12																	
1184L		1184	23	semi-formed	SRR11139831	PRJNA606262			12																	
1184M		1184	25	semi-formed	SRR11139830	PRJNA606262			12																	
1185A		1185	0	formed	SRR11140219	PRJNA606262			2																	
1185B		1185	1	semi-formed	SRR11140216	PRJNA606262			2																	
1186A		1186	0	formed	SRR11414828	PRJNA545312	-5		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		pre	-1								
1186B		1186	3	liquid	SRR11414827	PRJNA545312	-2		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		pre	-1								
1186C		1186	4	liquid	SRR11414826	PRJNA545312	-1		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		pre	-1								
1186D		1186	9	semi-formed	SRR11414825	PRJNA545312	4		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		peri	0								
1186E		1186	10	liquid	SRR11414824	PRJNA545312	5		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		peri	0								
1186F		1186	12	semi-formed	SRR11417245	PRJNA545312	7		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		post	0								
1186G		1186	13	liquid	SRR11417244	PRJNA545312	8		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		post	1								
1186H		1186	15	semi-formed	SRR11417243	PRJNA545312	10		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		post	1								
1186I		1186	17	semi-formed	SRR11417241	PRJNA545312	12		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		post	1								
1186J		1186	18	semi-formed	SRR11417240	PRJNA545312	13		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		post	1								
1186K		1186	19	liquid	SRR11417239	PRJNA545312	14		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		post	1								
1186M		1186	21	formed	SRR11417237	PRJNA545312	16		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		post	2								
1186N		1186	22	semi-formed	SRR11417236	PRJNA545312	17		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		post	2								
1186P		1186	23	semi-formed	SRR11416608	PRJNA545312	18		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		post	2								
1186R		1186	24	semi-formed	SRR11416606	PRJNA545312	19		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		post	2								
1186S		1186	25	liquid	SRR11416604	PRJNA545312	20		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		post	2								
1186U		1186	95	semi-formed	SRR11416602	PRJNA545312	90		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		post	6								
1186V		1186	221	formed	SRR11416601	PRJNA545312	216		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		post	6								
1186W		1186	382	formed	SRR11416600	PRJNA545312	377		19	5	BM_unmodified	Non-Malignant Hemat Disorders	fdd6a16e1797be664b59b5	759	1		post	6								
1187A		1187	0	formed	SRR11140236	PRJNA606262			3																	
1187B		1187	11	liquid	SRR11140235	PRJNA606262			3																	
1187C		1187	86	semi-formed	SRR11140234	PRJNA606262			3																	
1188A		1188	0	formed	SRR11140109	PRJNA606262			4																	
1188B		1188	9	formed	SRR11140108	PRJNA606262			4																	
1188C		1188	15	liquid	SRR11140107	PRJNA606262			4																	
1188E		1188	30	formed	SRR11140104	PRJNA606262			4																	
1189A		FMT.0137	0	semi-formed	SRR11416599	PRJNA545312	-170		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		pre	-3								
1189B		FMT.0137	8	formed	SRR11416598	PRJNA545312	-162		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		pre	-3								
1189C		FMT.0137	9	semi-formed	SRR11416597	PRJNA545312	-161		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		pre	-3								
1189D		FMT.0137	10	semi-formed	SRR11416596	PRJNA545312	-160		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		pre	-3								
1189E		FMT.0137	11	liquid	SRR11416595	PRJNA545312	-159		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		pre	-3								
118A		118	0	formed	SRR11416593	PRJNA545312	13		3	-13	TCD	Multiple Myeloma	d316292eb9e249dd8969f2	130	1		post	1								
118B		118	7	formed	SRR11416592	PRJNA545312	20		3	-13	TCD	Multiple Myeloma	d316292eb9e249dd8969f2	130	1		post	2								
118C		118	230	liquid	SRR11416591	PRJNA545312	243		3	-13	TCD	Multiple Myeloma	d316292eb9e249dd8969f2	130	1		post	6								
1190A		1190	0	semi-formed	SRR11140457	PRJNA606262			2																	
1190B		1190	132	formed	SRR11395018	PRJNA607574			2																	
1191A		1191	0	semi-formed	SRR11416590	PRJNA545312	-5		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		pre	-1								
1191B		1191	1	semi-formed	SRR11416589	PRJNA545312	-4		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		pre	-1								
1191C		1191	2	liquid	SRR11416588	PRJNA545312	-3		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		pre	-1								
1191D		1191	3	semi-formed	SRR11416587	PRJNA545312	-2		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		pre	-1								
1191E		1191	4	liquid	SRR11416586	PRJNA545312	-1		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		pre	-1								
1191F		1191	6	formed	SRR11416585	PRJNA545312	1		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		peri	0								
1191G		1191	7	formed	SRR11416584	PRJNA545312	2		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		peri	0								
1191H		1191	8	formed	SRR11416582	PRJNA545312	3		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		peri	0								
1191J		1191	12	formed	SRR11416694	PRJNA545312	7		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		post	0								
1191K		1191	13	semi-formed	SRR11416693	PRJNA545312	8		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		post	1								
1191L		1191	14	formed	SRR11416692	PRJNA545312	9		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		post	1								
1191M		1191	15	semi-formed	SRR11416691	PRJNA545312	10		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		post	1								
1191N		1191	16	semi-formed	SRR11416690	PRJNA545312	11		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		post	1								
1191O		1191	18	semi-formed	SRR11416689	PRJNA545312	13		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		post	1								
1191P		1191	20	liquid	SRR11416688	PRJNA545312	15		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		post	2								
1191Q		1191	21	liquid	SRR11416687	PRJNA545312	16		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		post	2								
1191R		1191	26	semi-formed	SRR11416686	PRJNA545312	21		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		post	2								
1191S		1191	47	formed	SRR11416684	PRJNA545312	42		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		post	5								
1191T		1191	61		SRR11416683	PRJNA545312	56		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		post	6								
1191U		1191	103	semi-formed	SRR11416682	PRJNA545312	98		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		post	6								
1191V		1191	265	formed	SRR11416681	PRJNA545312	260		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		post	6								
1191W		1191	270	formed	SRR11416680	PRJNA545312	265		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		post	6								
1191X		1191	274	formed	SRR11416679	PRJNA545312	269		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		post	6								
1191Y		1191	278	formed	SRR11416678	PRJNA545312	273		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		post	6								
1191Z		1191	327	semi-formed	SRR11416677	PRJNA545312	322		25	5	BM_unmodified	Leukemia	ee3b2b943a6fff993e1ee2	751	1		post	6								
1192A		1192	0	formed	SRR11416676	PRJNA545312	-2		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		pre	-1								
1192B		1192	1	liquid	SRR11416675	PRJNA545312	-1		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		pre	-1								
1192C		1192	2	liquid	SRR11416673	PRJNA545312	0		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		peri	-1								
1192D		1192	3	liquid	SRR11416672	PRJNA545312	1		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		peri	0								
1192E		1192	4	liquid	SRR11416671	PRJNA545312	2		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		peri	0								
1192F		1192	5	liquid	SRR11416670	PRJNA545312	3		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		peri	0								
1192G		1192	6	liquid	SRR11416669	PRJNA545312	4		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		peri	0								
1192H		1192	7	liquid	SRR11416668	PRJNA545312	5		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		peri	0								
1192K		1192	10	liquid	SRR11416667	PRJNA545312	8		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	1								
1192L		1192	13	semi-formed	SRR11416329	PRJNA545312	11		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	1								
1192M		1192	15	liquid	SRR11416328	PRJNA545312	13		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	1								
1192MM		1192	747	liquid	SRR11115962	PRJNA607574	28		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	3								
1192N		1192	16	liquid	SRR11416327	PRJNA545312	14		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	1								
1192NN		1192	748	liquid	SRR11115676	PRJNA607574	29		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	4								
1192O		1192	18	semi-formed	SRR11416325	PRJNA545312	16		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	2								
1192OO		1192	749	liquid	SRR11115506	PRJNA607574	30		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	4								
1192P		1192	19	semi-formed	SRR11416324	PRJNA545312	17		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	2								
1192PP		1192	750	liquid	SRR11115495	PRJNA607574	31		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	4								
1192Q		1192	22	semi-formed	SRR11416323	PRJNA545312	20		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	2								
1192QQ		1192	751	liquid	SRR11115484	PRJNA607574	32		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	4								
1192R		1192	55	semi-formed	SRR11416322	PRJNA545312	53		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	6								
1192RR		1192	754	liquid	SRR11115473	PRJNA607574	35		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	4								
1192S		1192	135	semi-formed	SRR11416321	PRJNA545312	133		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	6								
1192SS		1192	755	liquid	SRR11115462	PRJNA607574	36		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	5								
1192T		1192	306	semi-formed	SRR11416320	PRJNA545312	304		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	6								
1192TT		1192	757	liquid	SRR11115451	PRJNA607574	38		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		post	5								
1192U		1192	715	semi-formed	SRR9270170	PRJNA548153	-4		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		pre	-1								
1192V		1192	721	liquid	SRR9270171	PRJNA548153	2		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		peri	0								
1192W		1192	722	liquid	SRR9270176	PRJNA548153	3		29	719	cord	Leukemia	b23587b68b33a798501063	735	1		peri	0								
1193A		1193	0	formed	SRR11416319	PRJNA545312	-9	SRR14092225	13	9	TCD	Leukemia	a818a99df90a3d23ec2752	146	1		pre	-2								
1193B		1193	4	formed	SRR11416318	PRJNA545312	-5	SRR14092224	13	9	TCD	Leukemia	a818a99df90a3d23ec2752	146	1		pre	-1								
1193C		1193	5	formed	SRR11416317	PRJNA545312	-4	SRR14092223	13	9	TCD	Leukemia	a818a99df90a3d23ec2752	146	1		pre	-1								
1193D		1193	6	semi-formed	SRR11416316	PRJNA545312	-3	SRR14092222	13	9	TCD	Leukemia	a818a99df90a3d23ec2752	146	1		pre	-1								
1193E		1193	7	formed	SRR11416314	PRJNA545312	-2	SRR14092221	13	9	TCD	Leukemia	a818a99df90a3d23ec2752	146	1		pre	-1								
1193F		1193	8	formed	SRR11416313	PRJNA545312	-1	SRR14092220	13	9	TCD	Leukemia	a818a99df90a3d23ec2752	146	1		pre	-1								
1193G		1193	9	liquid	SRR11416719	PRJNA545312	0	SRR14092219	13	9	TCD	Leukemia	a818a99df90a3d23ec2752	146	1		peri	-1								
1193H		1193	10	liquid	SRR11417015	PRJNA545312	1	SRR14092218	13	9	TCD	Leukemia	a818a99df90a3d23ec2752	146	1		peri	0								
1193J		1193	11	liquid	SRR11417013	PRJNA545312	2		13	9	TCD	Leukemia	a818a99df90a3d23ec2752	146	1		peri	0								
1193K		1193	12	liquid	SRR11417012	PRJNA545312	3		13	9	TCD	Leukemia	a818a99df90a3d23ec2752	146	1		peri	0								
1193M		1193	13	liquid	SRR11417010	PRJNA545312	4	SRR13697159	13	9	TCD	Leukemia	a818a99df90a3d23ec2752	146	1		peri	0								
1193N		1193	15	liquid	SRR11417009	PRJNA545312	6	SRR13697158	13	9	TCD	Leukemia	a818a99df90a3d23ec2752	146	1		post	0								
1193O		1193	43	liquid	SRR11417006	PRJNA545312	34		13	9	TCD	Leukemia	a818a99df90a3d23ec2752	146	1		post	4								
1194A		1194	0	liquid	SRR11140395	PRJNA606262			1																	
1195B		1195	0	formed	SRR11416752	PRJNA545312	-6		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		pre	-1								
1195C		1195	2	formed	SRR11416751	PRJNA545312	-4		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		pre	-1								
1195CC		1195	49	formed	SRR11416750	PRJNA545312	43		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	6								
1195D		1195	3	formed	SRR11416749	PRJNA545312	-3		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		pre	-1								
1195DD		1195	51	semi-formed	SRR11416748	PRJNA545312	45		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	6								
1195E		1195	4	formed	SRR11416747	PRJNA545312	-2		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		pre	-1								
1195EE		1195	76	liquid	SRR11416746	PRJNA545312	70		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	6								
1195F		1195	6	semi-formed	SRR11416745	PRJNA545312	0		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		peri	-1								
1195FF		1195	201	semi-formed	SRR11416743	PRJNA545312	195		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	6								
1195G		1195	7	semi-formed	SRR11416742	PRJNA545312	1		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		peri	0								
1195GG		1195	285	formed	SRR11416741	PRJNA545312	279		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	6								
1195H		1195	8	liquid	SRR11416740	PRJNA545312	2		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		peri	0								
1195HH		1195	403	semi-formed	SRR11416739	PRJNA545312	397		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	6								
1195I		1195	9	liquid	SRR11416738	PRJNA545312	3		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		peri	0								
1195II		1195	416	formed	SRR11416737	PRJNA545312	410		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	6								
1195J		1195	10	liquid	SRR11416736	PRJNA545312	4		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		peri	0								
1195K		1195	11	liquid	SRR11416735	PRJNA545312	5		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		peri	0								
1195L		1195	12	liquid	SRR11416734	PRJNA545312	6		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	0								
1195M		1195	15	liquid	SRR11416732	PRJNA545312	9		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	1								
1195N		1195	16	liquid	SRR11416731	PRJNA545312	10		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	1								
1195O		1195	17	liquid	SRR11416730	PRJNA545312	11		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	1								
1195P		1195	18	liquid	SRR11416729	PRJNA545312	12		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	1								
1195Q		1195	21	liquid	SRR11416728	PRJNA545312	15		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	2								
1195R		1195	23	semi-formed	SRR11416727	PRJNA545312	17		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	2								
1195S		1195	24	liquid	SRR11416726	PRJNA545312	18		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	2								
1195T		1195	25	liquid	SRR11416666	PRJNA545312	19		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	2								
1195U		1195	26	liquid	SRR11416665	PRJNA545312	20		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	2								
1195V		1195	29	liquid	SRR11416664	PRJNA545312	23		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	3								
1195W		1195	30	semi-formed	SRR11416662	PRJNA545312	24		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	3								
1195X		1195	31	liquid	SRR11416661	PRJNA545312	25		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	3								
1195Y		1195	32	liquid	SRR11416660	PRJNA545312	26		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	3								
1195Z		1195	43	semi-formed	SRR11416659	PRJNA545312	37		32	6	cord	Leukemia	f14a2050cc330c868ca5aa		1		post	5								
1196A		1196	0	liquid	SRR11416658	PRJNA545312	-9		10	9	PBSC_unmodified	Leukemia	2a47363c52a9b6324b5524		1		pre	-2								
1196B		1196	1	liquid	SRR11416657	PRJNA545312	-8		10	9	PBSC_unmodified	Leukemia	2a47363c52a9b6324b5524		1		pre	-2								
1196C		1196	2	liquid	SRR11416656	PRJNA545312	-7		10	9	PBSC_unmodified	Leukemia	2a47363c52a9b6324b5524		1		pre	-2								
1196E		1196	5	liquid	SRR11416655	PRJNA545312	-4		10	9	PBSC_unmodified	Leukemia	2a47363c52a9b6324b5524		1		pre	-1								
1196F		1196	6	liquid	SRR11416654	PRJNA545312	-3		10	9	PBSC_unmodified	Leukemia	2a47363c52a9b6324b5524		1		pre	-1								
1196H		1196	8	liquid	SRR11416651	PRJNA545312	-1		10	9	PBSC_unmodified	Leukemia	2a47363c52a9b6324b5524		1		pre	-1								
1196I		1196	9	semi-formed	SRR11416650	PRJNA545312	0		10	9	PBSC_unmodified	Leukemia	2a47363c52a9b6324b5524		1		peri	-1								
1196J		1196	11	semi-formed	SRR11416649	PRJNA545312	2		10	9	PBSC_unmodified	Leukemia	2a47363c52a9b6324b5524		1		peri	0								
1196L		1196	16	semi-formed	SRR11416648	PRJNA545312	7		10	9	PBSC_unmodified	Leukemia	2a47363c52a9b6324b5524		1		post	0								
1196R		1196	25	semi-formed	SRR11416647	PRJNA545312	16		10	9	PBSC_unmodified	Leukemia	2a47363c52a9b6324b5524		1		post	2								
1197A		1197	0	formed	SRR11423051	PRJNA545312	-4		10	4	BM_unmodified	Leukemia	9a95480cbe96ce57d2eb3d		1		pre	-1								
1197B		1197	5	formed	SRR11416646	PRJNA545312	1		10	4	BM_unmodified	Leukemia	9a95480cbe96ce57d2eb3d		1		peri	0								
1197C		1197	6	formed	SRR11416645	PRJNA545312	2		10	4	BM_unmodified	Leukemia	9a95480cbe96ce57d2eb3d		1		peri	0								
1197D		1197	8	formed	SRR11416644	PRJNA545312	4		10	4	BM_unmodified	Leukemia	9a95480cbe96ce57d2eb3d		1		peri	0								
1197E		1197	9	formed	SRR11416643	PRJNA545312	5		10	4	BM_unmodified	Leukemia	9a95480cbe96ce57d2eb3d		1		peri	0								
1197F		1197	11	semi-formed	SRR11423040	PRJNA545312	7		10	4	BM_unmodified	Leukemia	9a95480cbe96ce57d2eb3d		1		post	0								
1197G		1197	16	formed	SRR11416642	PRJNA545312	12		10	4	BM_unmodified	Leukemia	9a95480cbe96ce57d2eb3d		1		post	1								
1197H		1197	18	semi-formed	SRR11416640	PRJNA545312	14		10	4	BM_unmodified	Leukemia	9a95480cbe96ce57d2eb3d		1		post	1								
1197I		1197	19	liquid	SRR11416639	PRJNA545312	15		10	4	BM_unmodified	Leukemia	9a95480cbe96ce57d2eb3d		1		post	2								
1197J		1197	25	semi-formed	SRR11416357	PRJNA545312	21		10	4	BM_unmodified	Leukemia	9a95480cbe96ce57d2eb3d		1		post	2								
1198A		1198	0	formed	SRR11139867	PRJNA606262			6																	
1198B		1198	12	liquid	SRR11140517	PRJNA606262			6																	
1198C		1198	13	semi-formed	SRR11140516	PRJNA606262			6																	
1198D		1198	14	liquid	SRR11140515	PRJNA606262			6																	
1198E		1198	15	semi-formed	SRR11140514	PRJNA606262			6																	
1198F		1198	16	semi-formed	SRR11140513	PRJNA606262			6																	
1199A		1199	0	liquid	SRR11140474	PRJNA606262			4																	
1199B		1199	3	semi-formed	SRR11140473	PRJNA606262			4																	
1199C		1199	10	liquid	SRR11140472	PRJNA606262			4																	
1199D		1199	52	semi-formed	SRR11395347	PRJNA607574			4																	
119A		119	0	formed	SRR11416356	PRJNA545312	-1		5	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	d5de566e6f67112f5b3ef1	73	1		pre	-1								
119B		119	7	formed	SRR11416355	PRJNA545312	6		5	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	d5de566e6f67112f5b3ef1	73	1		post	0								
119C		119	20	semi-formed	SRR11416354	PRJNA545312	19		5	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	d5de566e6f67112f5b3ef1	73	1		post	2								
119D		119	798	formed	SRR11416353	PRJNA545312	797		5	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	d5de566e6f67112f5b3ef1	73	1		post	6								
119E		119	902	formed	SRR11416352	PRJNA545312	901		5	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	d5de566e6f67112f5b3ef1	73	1		post	6								
1200A		1200	0	formed	SRR11395346	PRJNA607574			7																	
1200B		1200	1	formed	SRR11395345	PRJNA607574			7																	
1200C		1200	5	formed	SRR11395344	PRJNA607574			7																	
1200D		1200	7	formed	SRR11395343	PRJNA607574			7																	
1200E		1200	8	formed	SRR11395340	PRJNA607574			7																	
1200F		1200	9	formed	SRR11395339	PRJNA607574			7																	
1200G		1200	10	formed	SRR11395338	PRJNA607574			7																	
1201A		1201	0	semi-formed	SRR11416351	PRJNA545312	-123		3	123	PBSC_unmodified	Leukemia	855f0ab373e7311b4e9d4f	767	1		pre	-3								
1201B		1201	129	liquid	SRR11416350	PRJNA545312	6		3	123	PBSC_unmodified	Leukemia	855f0ab373e7311b4e9d4f	767	1		post	0								
1201C		1201	130	semi-formed	SRR11416348	PRJNA545312	7		3	123	PBSC_unmodified	Leukemia	855f0ab373e7311b4e9d4f	767	1		post	0								
1202A		1202	0	formed	SRR11416347	PRJNA545312	-5		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		pre	-1								
1202B		1202	1	formed	SRR11423001	PRJNA545312	-4		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		pre	-1								
1202C		1202	2	formed	SRR11416346	PRJNA545312	-3		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		pre	-1								
1202D		1202	3	formed	SRR11416345	PRJNA545312	-2		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		pre	-1								
1202E		1202	4	formed	SRR11416344	PRJNA545312	-1		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		pre	-1								
1202F		1202	5	semi-formed	SRR11416343	PRJNA545312	0		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		peri	-1								
1202G		1202	7	semi-formed	SRR11416342	PRJNA545312	2		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		peri	0								
1202H		1202	8	semi-formed	SRR11416341	PRJNA545312	3		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		peri	0								
1202I		1202	9	semi-formed	SRR11416340	PRJNA545312	4		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		peri	0								
1202J		1202	10	semi-formed	SRR11416339	PRJNA545312	5		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		peri	0								
1202K		1202	11	formed	SRR11416337	PRJNA545312	6		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		post	0								
1202L		1202	13	liquid	SRR11416336	PRJNA545312	8		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		post	1								
1202O		1202	14	semi-formed	SRR11416334	PRJNA545312	9		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		post	1								
1202P		1202	17	formed	SRR11416333	PRJNA545312	12		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		post	1								
1202Q		1202	18	formed	SRR11416332	PRJNA545312	13		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		post	1								
1202R		1202	19	formed	SRR11416331	PRJNA545312	14		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		post	1								
1202S		1202	20	formed	SRR11422990	PRJNA545312	15		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		post	2								
1202T		1202	21	semi-formed	SRR11416330	PRJNA545312	16		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		post	2								
1202U		1202	48		SRR11416781	PRJNA545312	43		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		post	6								
1202V		1202	75	semi-formed	SRR11416780	PRJNA545312	70		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		post	6								
1202W		1202	95	semi-formed	SRR11416778	PRJNA545312	90		21	5	PBSC_unmodified	Leukemia	173df91e6bdf79c08a928a	743	1		post	6								
1203A		1203	0	formed	SRR11416777	PRJNA545312	-18	SRR13697157	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		pre	-3								
1203B		1203	14	formed	SRR11416776	PRJNA545312	-4	SRR14143418	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		pre	-1								
1203C		1203	15	formed	SRR11416775	PRJNA545312	-3	SRR14143417	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		pre	-1								
1203D		1203	16	formed	SRR11416774	PRJNA545312	-2	SRR13697156	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		pre	-1								
1203E		1203	17	formed	SRR11416773	PRJNA545312	-1	SRR13697154	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		pre	-1								
1203F		1203	19	formed	SRR11416772	PRJNA545312	1	SRR13697153	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		peri	0								
1203G		1203	21	formed	SRR11416771	PRJNA545312	3	SRR14092216	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		peri	0								
1203H		1203	23	semi-formed	SRR11416770	PRJNA545312	5	SRR14092215	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		peri	0								
1203I		1203	25	formed	SRR11416769	PRJNA545312	7	SRR14092214	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		post	0								
1203J		1203	26	semi-formed	SRR11416767	PRJNA545312	8	SRR13697152	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		post	1								
1203K		1203	27	semi-formed	SRR11416766	PRJNA545312	9	SRR13697151	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		post	1								
1203L		1203	29	semi-formed	SRR11416765	PRJNA545312	11	SRR13697150	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		post	1								
1203M		1203	30	formed	SRR11416764	PRJNA545312	12	SRR13697149	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		post	1								
1203N		1203	31	formed	SRR11416763	PRJNA545312	13	SRR13697148	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		post	1								
1203O		1203	32	semi-formed	SRR11416762	PRJNA545312	14	SRR13697147	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		post	1								
1203P		1203	35	semi-formed	SRR11416761	PRJNA545312	17	SRR13697146	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		post	2								
1203Q		1203	36	semi-formed	SRR11416760	PRJNA545312	18	SRR14092213	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		post	2								
1203R		1203	37	formed	SRR11416759	PRJNA545312	19	SRR14092212	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		post	2								
1203S		1203	38	semi-formed	SRR11416758	PRJNA545312	20	SRR14092211	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		post	2								
1203T		1203	39	semi-formed	SRR11416755	PRJNA545312	21	SRR14092210	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		post	2								
1203V		1203	45	formed	SRR11416754	PRJNA545312	27	SRR14092209	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		post	3								
1203W		1203	46	formed	SRR11417291	PRJNA545312	28	SRR13697145	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		post	3								
1203X		1203	49	formed	SRR11417290	PRJNA545312	31	SRR13697143	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		post	4								
1203Y		1203	53	formed	SRR11417289	PRJNA545312	35	SRR13697142	24	18	cord	Myelodysplastic Syndromes	7e77acf7897d37ba98bfcb		1		post	4								
1204A		1204	0	formed	SRR11139630	PRJNA606262			5																	
1204B		1204	1	formed	SRR11139619	PRJNA606262			5																	
1204C		1204	2	formed	SRR11140448	PRJNA606262			5																	
1204D		1204	3	formed	SRR11140437	PRJNA606262			5																	
1204E		1204	4	formed	SRR11140426	PRJNA606262			5																	
1205A		1205	0	liquid	SRR11140091	PRJNA606262			7																	
1205B		1205	3	formed	SRR11140090	PRJNA606262			7																	
1205C		1205	7	liquid	SRR11140089	PRJNA606262			7																	
1205D		1205	16	liquid	SRR11140088	PRJNA606262			7																	
1205E		1205	21	semi-formed	SRR11140087	PRJNA606262			7																	
1205F		1205	116	formed	SRR11395326	PRJNA607574			7																	
1205G		1205	183	formed	SRR11395325	PRJNA607574			7																	
1206A		1206	0	formed	SRR11395324	PRJNA607574			6																	
1206B		1206	7	liquid	SRR11395323	PRJNA607574			6																	
1206C		1206	863	formed	SRR11395738	PRJNA607574			6																	
1206D		1206	877	formed	SRR11395737	PRJNA607574			6																	
1206E		1206	962	semi-formed	SRR11395736	PRJNA607574			6																	
1206F		1206	972	formed	SRR11395734	PRJNA607574			6																	
1207A		1207	0	formed	SRR11417288	PRJNA545312	-10		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		pre	-2								
1207AA		1207	42	semi-formed	SRR11417287	PRJNA545312	32		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		post	4								
1207B		1207	1	formed	SRR11417286	PRJNA545312	-9		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		pre	-2								
1207BB		1207	43	liquid	SRR11417285	PRJNA545312	33		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		post	4								
1207C		1207	3	formed	SRR11417284	PRJNA545312	-7		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		pre	-2								
1207CC		1207	44	liquid	SRR11417282	PRJNA545312	34		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		post	4								
1207D		1207	4	formed	SRR11417281	PRJNA545312	-6		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		pre	-1								
1207E		1207	5	formed	SRR11417280	PRJNA545312	-5		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		pre	-1								
1207F		1207	6	formed	SRR11417279	PRJNA545312	-4		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		pre	-1								
1207G		1207	7	semi-formed	SRR11417278	PRJNA545312	-3		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		pre	-1								
1207H		1207	8	formed	SRR11417277	PRJNA545312	-2		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		pre	-1								
1207J		1207	9	semi-formed	SRR11417275	PRJNA545312	-1		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		pre	-1								
1207L		1207	10	liquid	SRR11417273	PRJNA545312	0		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		peri	-1								
1207M		1207	11	liquid	SRR11417271	PRJNA545312	1		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		peri	0								
1207N		1207	12	liquid	SRR11417270	PRJNA545312	2		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		peri	0								
1207P		1207	13	semi-formed	SRR11417268	PRJNA545312	3		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		peri	0								
1207Q		1207	14	liquid	SRR11417267	PRJNA545312	4		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		peri	0								
1207R		1207	15	liquid	SRR11417266	PRJNA545312	5		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		peri	0								
1207S		1207	20	liquid	SRR11417265	PRJNA545312	10		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		post	1								
1207V		1207	26	semi-formed	SRR11417264	PRJNA545312	16		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		post	2								
1207W		1207	33	liquid	SRR11416638	PRJNA545312	23		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		post	3								
1207X		1207	37	liquid	SRR11416637	PRJNA545312	27		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		post	3								
1207Y		1207	39	liquid	SRR11416635	PRJNA545312	29		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		post	4								
1207Z		1207	41	semi-formed	SRR11416634	PRJNA545312	31		24	10	TCD	Leukemia	c3d0f76ef97b2b5beee154	593	1		post	4								
1208A		1208	0	formed	SRR11416633	PRJNA545312	-1		4	1	PBSC_unmodified	Leukemia	04901fa9efc9cb005f0c1e		1		pre	-1								
1208B		1208	1	formed	SRR11416632	PRJNA545312	0		4	1	PBSC_unmodified	Leukemia	04901fa9efc9cb005f0c1e		1		peri	-1								
1208C		1208	7	formed	SRR11416631	PRJNA545312	6		4	1	PBSC_unmodified	Leukemia	04901fa9efc9cb005f0c1e		1		post	0								
1208D		1208	15	formed	SRR11416630	PRJNA545312	14		4	1	PBSC_unmodified	Leukemia	04901fa9efc9cb005f0c1e		1		post	1								
1209A		1209	0	formed	SRR11416629	PRJNA545312	-5		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	bcb9e083674f694251d616		1		pre	-1								
1209B		1209	2	formed	SRR11416628	PRJNA545312	-3		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	bcb9e083674f694251d616		1		pre	-1								
1209C		1209	3	formed	SRR11416627	PRJNA545312	-2		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	bcb9e083674f694251d616		1		pre	-1								
1209D		1209	4	formed	SRR11416626	PRJNA545312	-1		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	bcb9e083674f694251d616		1		pre	-1								
1209E		1209	6	semi-formed	SRR11416624	PRJNA545312	1		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	bcb9e083674f694251d616		1		peri	0								
1209F		1209	7	formed	SRR11416623	PRJNA545312	2		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	bcb9e083674f694251d616		1		peri	0								
1209G		1209	8	liquid	SRR11416622	PRJNA545312	3		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	bcb9e083674f694251d616		1		peri	0								
1209H		1209	10	semi-formed	SRR11416621	PRJNA545312	5		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	bcb9e083674f694251d616		1		peri	0								
1209I		1209	13	formed	SRR11416620	PRJNA545312	8		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	bcb9e083674f694251d616		1		post	1								
1209J		1209	15	formed	SRR11416619	PRJNA545312	10		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	bcb9e083674f694251d616		1		post	1								
1209K		1209	18	formed	SRR11416618	PRJNA545312	13		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	bcb9e083674f694251d616		1		post	1								
120A		120	0	semi-formed	SRR11414823	PRJNA545312	-3		9	3	TCD	Myeloproliferative Disorder	8509756313caec9dfc8e97	167	1		pre	-1								
120B		120	2	liquid	SRR11414821	PRJNA545312	-1		9	3	TCD	Myeloproliferative Disorder	8509756313caec9dfc8e97	167	1		pre	-1								
120C		120	7	liquid	SRR11414820	PRJNA545312	4		9	3	TCD	Myeloproliferative Disorder	8509756313caec9dfc8e97	167	1		peri	0								
120D		120	17	liquid	SRR11414819	PRJNA545312	14		9	3	TCD	Myeloproliferative Disorder	8509756313caec9dfc8e97	167	1		post	1								
120E		120	20	liquid	SRR11414818	PRJNA545312	17		9	3	TCD	Myeloproliferative Disorder	8509756313caec9dfc8e97	167	1		post	2								
120F		120	43	formed	SRR11414817	PRJNA545312	40		9	3	TCD	Myeloproliferative Disorder	8509756313caec9dfc8e97	167	1		post	5								
120G		120	56	formed	SRR11414816	PRJNA545312	53		9	3	TCD	Myeloproliferative Disorder	8509756313caec9dfc8e97	167	1		post	6								
120H		120	62	formed	SRR11414815	PRJNA545312	59		9	3	TCD	Myeloproliferative Disorder	8509756313caec9dfc8e97	167	1		post	6								
120I		120	63	formed	SRR11414814	PRJNA545312	60		9	3	TCD	Myeloproliferative Disorder	8509756313caec9dfc8e97	167	1		post	6								
1210A		1210	0	formed	SRR11414813	PRJNA545312	-6		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		pre	-1								
1210AA		1210	30	semi-formed	SRR11414811	PRJNA545312	24		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	3								
1210B		1210	2	formed	SRR11416617	PRJNA545312	-4		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		pre	-1								
1210BB		1210	62	semi-formed	SRR11416616	PRJNA545312	56		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	6								
1210C		1210	4	semi-formed	SRR11416615	PRJNA545312	-2		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		pre	-1								
1210CC		1210	94	semi-formed	SRR11416613	PRJNA545312	88		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	6								
1210D		1210	5	formed	SRR11416612	PRJNA545312	-1		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		pre	-1								
1210DD		1210	109	semi-formed	SRR11416610	PRJNA545312	103		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	6								
1210EE		1210	110	liquid	SRR11416581	PRJNA545312	104		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	6								
1210F		1210	7	formed	SRR11416580	PRJNA545312	1		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		peri	0								
1210G		1210	8	semi-formed	SRR11416578	PRJNA545312	2		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		peri	0								
1210GG		1210	111	semi-formed	SRR11416577	PRJNA545312	105		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	6								
1210H		1210	9	formed	SRR11416576	PRJNA545312	3		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		peri	0								
1210HH		1210	221	semi-formed	SRR11416575	PRJNA545312	215		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	6								
1210I		1210	10	semi-formed	SRR11416573	PRJNA545312	4		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		peri	0								
1210II		1210	338	semi-formed	SRR11416572	PRJNA545312	332		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	6								
1210J		1210	12	semi-formed	SRR11416571	PRJNA545312	6		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	0								
1210K		1210	13	semi-formed	SRR11416570	PRJNA545312	7		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	0								
1210L		1210	14	liquid	SRR11416569	PRJNA545312	8		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	1								
1210M		1210	15	liquid	SRR11416568	PRJNA545312	9		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	1								
1210N		1210	16	semi-formed	SRR11416567	PRJNA545312	10		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	1								
1210O		1210	17	formed	SRR11416566	PRJNA545312	11		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	1								
1210P		1210	18	formed	SRR11416565	PRJNA545312	12		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	1								
1210Q		1210	19	semi-formed	SRR11416564	PRJNA545312	13		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	1								
1210R		1210	21	semi-formed	SRR11416562	PRJNA545312	15		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	2								
1210S		1210	22	semi-formed	SRR11416561	PRJNA545312	16		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	2								
1210T		1210	23	formed	SRR11416560	PRJNA545312	17		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	2								
1210U		1210	24	formed	SRR11416559	PRJNA545312	18		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	2								
1210V		1210	25	formed	SRR11416558	PRJNA545312	19		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	2								
1210W		1210	26	semi-formed	SRR11416557	PRJNA545312	20		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	2								
1210X		1210	27	liquid	SRR11416556	PRJNA545312	21		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	2								
1210Y		1210	28	semi-formed	SRR11416555	PRJNA545312	22		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	3								
1210Z		1210	29	semi-formed	SRR11416554	PRJNA545312	23		33	6	BM_unmodified	Non-Hodgkin's Lymphoma	97ff7c9bcbfed63cb99602	145	1		post	3								
1211A		1211	0	semi-formed	SRR11139844	PRJNA606262			1																	
1212A		1212	0	liquid	SRR11139850	PRJNA606262			2																	
1212B		1212	7	liquid	SRR11139849	PRJNA606262			2																	
1213A		1213	0	formed	SRR11140003	PRJNA606262			2																	
1213B		1213	102	semi-formed	SRR11395729	PRJNA607574			2																	
1215A		1215	0	formed	SRR11140373	PRJNA606262			8																	
1215B		1215	1	semi-formed	SRR11140372	PRJNA606262			8																	
1215C		1215	2	semi-formed	SRR11140371	PRJNA606262			8																	
1215D		1215	5	formed	SRR11140370	PRJNA606262			8																	
1215E		1215	7	semi-formed	SRR11140369	PRJNA606262			8																	
1215F		1215	8	semi-formed	SRR11140368	PRJNA606262			8																	
1215G		1215	9	semi-formed	SRR11140367	PRJNA606262			8																	
1215H		1215	14	semi-formed	SRR11140366	PRJNA606262			8																	
1216A		1216	0	formed	SRR11140503	PRJNA606262			2																	
1216B		1216	6	formed	SRR11140502	PRJNA606262			2																	
1217A		1217	0	semi-formed	SRR11417005	PRJNA545312	-5		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		pre	-1								
1217AA		1217	31	formed	SRR11417003	PRJNA545312	26		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		post	3								
1217B		1217	1	formed	SRR11417002	PRJNA545312	-4		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		pre	-1								
1217BB		1217	52	semi-formed	SRR11417001	PRJNA545312	47		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		post	6								
1217C		1217	3	liquid	SRR11417000	PRJNA545312	-2		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		pre	-1								
1217CC		1217	55	semi-formed	SRR11416999	PRJNA545312	50		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		post	6								
1217D		1217	4	liquid	SRR11416998	PRJNA545312	-1		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		pre	-1								
1217DD		1217	74	semi-formed	SRR11416997	PRJNA545312	69		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		post	6								
1217F		1217	5	liquid	SRR11416995	PRJNA545312	0		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		peri	-1								
1217G		1217	6	liquid	SRR11416994	PRJNA545312	1		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		peri	0								
1217L		1217	7	semi-formed	SRR11416991	PRJNA545312	2		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		peri	0								
1217M		1217	8	semi-formed	SRR11416990	PRJNA545312	3		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		peri	0								
1217N		1217	10	liquid	SRR11416989	PRJNA545312	5		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		peri	0								
1217O		1217	11	liquid	SRR11416988	PRJNA545312	6		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		post	0								
1217P		1217	12	liquid	SRR11416987	PRJNA545312	7		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		post	0								
1217Q		1217	13	semi-formed	SRR11416986	PRJNA545312	8		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		post	1								
1217R		1217	14	liquid	SRR11416985	PRJNA545312	9		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		post	1								
1217S		1217	15	liquid	SRR11416984	PRJNA545312	10		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		post	1								
1217T		1217	16	liquid	SRR11416983	PRJNA545312	11		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		post	1								
1217U		1217	20	liquid	SRR11416980	PRJNA545312	15		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		post	2								
1217V		1217	22	semi-formed	SRR11416979	PRJNA545312	17		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		post	2								
1217W		1217	26	liquid	SRR11416978	PRJNA545312	21		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		post	2								
1217X		1217	27		SRR11416725	PRJNA545312	22		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		post	3								
1217Y		1217	28	semi-formed	SRR11416724	PRJNA545312	23		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		post	3								
1217Z		1217	29	semi-formed	SRR11416723	PRJNA545312	24		25	5	TCD	Leukemia	298378cef00bd2431ceed4	754	1		post	3								
1218A		1218	0	formed	SRR11140275	PRJNA606262			2																	
1218C		1218	6	semi-formed	SRR11140272	PRJNA606262			2																	
1219A		1219	0	semi-formed	SRR11139802	PRJNA606262			2																	
1219B		1219	7	formed	SRR11139801	PRJNA606262			2																	
121A		121	0	formed	SRR11416722	PRJNA545312	-32		6	32	TCD	Leukemia	234bb1e8e81414292c7397	238	1		pre	-3								
121B		121	25	formed	SRR11416721	PRJNA545312	-7		6	32	TCD	Leukemia	234bb1e8e81414292c7397	238	1		pre	-2								
121D		121	31	semi-formed	SRR11416720	PRJNA545312	-1		6	32	TCD	Leukemia	234bb1e8e81414292c7397	238	1		pre	-1								
121E		121	38	liquid	SRR11416718	PRJNA545312	6		6	32	TCD	Leukemia	234bb1e8e81414292c7397	238	1		post	0								
121F		121	42	liquid	SRR11417311	PRJNA545312	10		6	32	TCD	Leukemia	234bb1e8e81414292c7397	238	1		post	1								
121G		121	350	formed	SRR11417310	PRJNA545312	318		6	32	TCD	Leukemia	234bb1e8e81414292c7397	238	1		post	6								
1220A		1220	0	formed	SRR11417309	PRJNA545312	-7		9	7	BM_unmodified	Myelodysplastic Syndromes	0e8aef9186244bbdeb9bb6		1		pre	-2								
1220B		1220	11	semi-formed	SRR11417308	PRJNA545312	4		9	7	BM_unmodified	Myelodysplastic Syndromes	0e8aef9186244bbdeb9bb6		1		peri	0								
1220C		1220	12	semi-formed	SRR11417307	PRJNA545312	5		9	7	BM_unmodified	Myelodysplastic Syndromes	0e8aef9186244bbdeb9bb6		1		peri	0								
1220D		1220	13	liquid	SRR11417306	PRJNA545312	6		9	7	BM_unmodified	Myelodysplastic Syndromes	0e8aef9186244bbdeb9bb6		1		post	0								
1220E		1220	15	liquid	SRR11417305	PRJNA545312	8		9	7	BM_unmodified	Myelodysplastic Syndromes	0e8aef9186244bbdeb9bb6		1		post	1								
1220F		1220	65	liquid	SRR11417304	PRJNA545312	58		9	7	BM_unmodified	Myelodysplastic Syndromes	0e8aef9186244bbdeb9bb6		1		post	6								
1220G		1220	66	semi-formed	SRR11417303	PRJNA545312	59		9	7	BM_unmodified	Myelodysplastic Syndromes	0e8aef9186244bbdeb9bb6		1		post	6								
1220H		1220	68	liquid	SRR11417302	PRJNA545312	61		9	7	BM_unmodified	Myelodysplastic Syndromes	0e8aef9186244bbdeb9bb6		1		post	6								
1220I		1220	73	semi-formed	SRR11417300	PRJNA545312	66		9	7	BM_unmodified	Myelodysplastic Syndromes	0e8aef9186244bbdeb9bb6		1		post	6								
1221A		1221	0	formed	SRR11417299	PRJNA545312	-6		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		pre	-1								
1221B		1221	7	semi-formed	SRR11417298	PRJNA545312	1		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		peri	0								
1221C		1221	8	formed	SRR11417297	PRJNA545312	2		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		peri	0								
1221D		1221	9	semi-formed	SRR11417296	PRJNA545312	3		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		peri	0								
1221E		1221	10	semi-formed	SRR11417295	PRJNA545312	4		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		peri	0								
1221F		1221	11	formed	SRR11417294	PRJNA545312	5		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		peri	0								
1221G		1221	12	formed	SRR11417293	PRJNA545312	6		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		post	0								
1221H		1221	13	formed	SRR11417292	PRJNA545312	7		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		post	0								
1221I		1221	14	formed	SRR11417235	PRJNA545312	8		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		post	1								
1221J		1221	15	formed	SRR11417233	PRJNA545312	9		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		post	1								
1221K		1221	16	semi-formed	SRR11417232	PRJNA545312	10		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		post	1								
1221L		1221	17	formed	SRR11417231	PRJNA545312	11		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		post	1								
1221P		1221	21	semi-formed	SRR11417230	PRJNA545312	15		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		post	2								
1221Q		1221	23	formed	SRR11417229	PRJNA545312	17		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		post	2								
1221R		1221	24	formed	SRR11417228	PRJNA545312	18		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		post	2								
1221S		1221	25	formed	SRR11417227	PRJNA545312	19		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		post	2								
1221T		1221	67	semi-formed	SRR11422979	PRJNA545312	61		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		post	6								
1221U		1221	87	semi-formed	SRR11417226	PRJNA545312	81		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		post	6								
1221V		1221	277	semi-formed	SRR11417225	PRJNA545312	271		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		post	6								
1221W		1221	451	semi-formed	SRR11417224	PRJNA545312	445		20	6	BM_unmodified	Leukemia	7aff3de4f710e8057e2698	729	1		post	6								
1222A		1222	0	formed	SRR11417222	PRJNA545312	-5		8	5	BM_unmodified	Non-Hodgkin's Lymphoma	6e23552cdee82596844c2c		1		pre	-1								
1222B		1222	1	formed	SRR11417221	PRJNA545312	-4		8	5	BM_unmodified	Non-Hodgkin's Lymphoma	6e23552cdee82596844c2c		1		pre	-1								
1222C		1222	2	formed	SRR11417220	PRJNA545312	-3		8	5	BM_unmodified	Non-Hodgkin's Lymphoma	6e23552cdee82596844c2c		1		pre	-1								
1222D		1222	3	formed	SRR11417219	PRJNA545312	-2		8	5	BM_unmodified	Non-Hodgkin's Lymphoma	6e23552cdee82596844c2c		1		pre	-1								
1222E		1222	5	liquid	SRR11417218	PRJNA545312	0		8	5	BM_unmodified	Non-Hodgkin's Lymphoma	6e23552cdee82596844c2c		1		peri	-1								
1222F		1222	6	liquid	SRR11417217	PRJNA545312	1		8	5	BM_unmodified	Non-Hodgkin's Lymphoma	6e23552cdee82596844c2c		1		peri	0								
1222G		1222	7	semi-formed	SRR11417216	PRJNA545312	2		8	5	BM_unmodified	Non-Hodgkin's Lymphoma	6e23552cdee82596844c2c		1		peri	0								
1222J		1222	14	liquid	SRR11417215	PRJNA545312	9		8	5	BM_unmodified	Non-Hodgkin's Lymphoma	6e23552cdee82596844c2c		1		post	1								
1223A		1223	0	formed	SRR11139829	PRJNA606262			3																	
1223B		1223	6	liquid	SRR11139828	PRJNA606262			3																	
1223C		1223	14	liquid	SRR11139827	PRJNA606262			3																	
1224B		1224	9	semi-formed	SRR11395707	PRJNA607574			1																	
1225A		1225	0	formed	SRR11140066	PRJNA606262			8																	
1225B		1225	6	semi-formed	SRR11140065	PRJNA606262			8																	
1225C		1225	225	formed	SRR11395668	PRJNA607574			8																	
1225D		1225	253	semi-formed	SRR11395667	PRJNA607574			8																	
1225E		1225	316	formed	SRR11395665	PRJNA607574			8																	
1225F		1225	379	semi-formed	SRR11395664	PRJNA607574			8																	
1225G		1225	484	semi-formed	SRR11395663	PRJNA607574			8																	
1225H		1225	556	formed	SRR11395662	PRJNA607574			8																	
1226A		1226	0	formed	SRR11139905	PRJNA606262			6																	
1226B		1226	4	liquid	SRR11139582	PRJNA606262			6																	
1226D		1226	6	liquid	SRR11139560	PRJNA606262			6																	
1226F		1226	17	formed	SRR11139893	PRJNA606262			6																	
1226G		1226	18	semi-formed	SRR11139882	PRJNA606262			6																	
1226H		1226	20	formed	SRR11139870	PRJNA606262			6																	
1227A		1227	0	semi-formed	SRR11139792	PRJNA606262			1																	
1228A		1228	0	liquid	SRR11139848	PRJNA606262			3																	
1228B		1228	49	semi-formed	SRR11139847	PRJNA606262			3																	
1228C		1228	182	semi-formed	SRR11395651	PRJNA607574			3																	
1229B		1229	1	formed	SRR11417214	PRJNA545312	-5		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		pre	-1								
1229C		1229	5	formed	SRR11417213	PRJNA545312	-1		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		pre	-1								
1229D		1229	6	formed	SRR11417211	PRJNA545312	0		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		peri	-1								
1229E		1229	7	formed	SRR11417210	PRJNA545312	1		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		peri	0								
1229F		1229	8	formed	SRR11417209	PRJNA545312	2		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		peri	0								
1229G		1229	9	formed	SRR11417208	PRJNA545312	3		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		peri	0								
1229H		1229	10	formed	SRR11416553	PRJNA545312	4		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		peri	0								
1229I		1229	12	formed	SRR11416552	PRJNA545312	6		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		post	0								
1229K		1229	16	formed	SRR11416551	PRJNA545312	10		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		post	1								
1229L		1229	17	formed	SRR11416550	PRJNA545312	11		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		post	1								
1229M		1229	18	formed	SRR11416549	PRJNA545312	12		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		post	1								
1229N		1229	21	formed	SRR11416548	PRJNA545312	15		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		post	2								
1229O		1229	20	formed	SRR11416546	PRJNA545312	14		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		post	1								
1229Q		1229	23	formed	SRR11416545	PRJNA545312	17		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		post	2								
1229R		1229	24	formed	SRR11416544	PRJNA545312	18		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		post	2								
1229S		1229	25	formed	SRR11416543	PRJNA545312	19		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		post	2								
1229T		1229	28	formed	SRR11416542	PRJNA545312	22		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		post	3								
1229U		1229	31	semi-formed	SRR11416541	PRJNA545312	25		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		post	3								
1229V		1229	34	formed	SRR11416540	PRJNA545312	28		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		post	3								
1229W		1229	36	formed	SRR11416539	PRJNA545312	30		20	6	cord	Leukemia	3449b56b0b9ff4dcac6c79		1		post	4								
122A		122	0	liquid	SRR11416538	PRJNA545312	10		1	-10	TCD	Leukemia	bc50a17d8ae54659808f03	202	1		post	1								
1230A		1230	0	formed	SRR11416537	PRJNA545312	-13	SRR14092208	32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		pre	-2								
1230AA		1230	402	semi-formed	SRR11416535	PRJNA545312	389		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	6								
1230B		1230	7	formed	SRR11416534	PRJNA545312	-6		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		pre	-1								
1230BB		1230	403	formed	SRR11416533	PRJNA545312	390		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	6								
1230C		1230	17	formed	SRR11416532	PRJNA545312	4		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		peri	0								
1230CC		1230	404	formed	SRR11416531	PRJNA545312	391		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	6								
1230D		1230	14	formed	SRR11416530	PRJNA545312	1		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		peri	0								
1230DD		1230	409	formed	SRR11416529	PRJNA545312	396		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	6								
1230E		1230	18	formed	SRR11416528	PRJNA545312	5		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		peri	0								
1230EE		1230	432	formed	SRR11416527	PRJNA545312	419		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	6								
1230F		1230	20	formed	SRR11416526	PRJNA545312	7		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	0								
1230FF		1230	459	semi-formed	SRR11416976	PRJNA545312	446		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	6								
1230G		1230	21	formed	SRR11416975	PRJNA545312	8		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	1								
1230GG		1230	460	semi-formed	SRR11416974	PRJNA545312	447		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	6								
1230H		1230	22	formed	SRR11416973	PRJNA545312	9	SRR14092207	32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	1								
1230I		1230	24	formed	SRR11416972	PRJNA545312	11		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	1								
1230J		1230	26	formed	SRR11416971	PRJNA545312	13		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	1								
1230K		1230	27	formed	SRR11416970	PRJNA545312	14		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	1								
1230L		1230	28	formed	SRR11416969	PRJNA545312	15		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	2								
1230M		1230	31	formed	SRR11416968	PRJNA545312	18		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	2								
1230N		1230	33	formed	SRR11416967	PRJNA545312	20		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	2								
1230O		1230	34	formed	SRR11416965	PRJNA545312	21		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	2								
1230P		1230	35	formed	SRR11416964	PRJNA545312	22		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	3								
1230Q		1230	37	formed	SRR11416963	PRJNA545312	24		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	3								
1230R		1230	39	formed	SRR11416962	PRJNA545312	26		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	3								
1230S		1230	40	formed	SRR11416961	PRJNA545312	27		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	3								
1230U		1230	42	formed	SRR11416960	PRJNA545312	29		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	4								
1230V		1230	46	semi-formed	SRR11416959	PRJNA545312	33		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	4								
1230W		1230	271	formed	SRR11416958	PRJNA545312	258		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	6								
1230X		1230	298	formed	SRR11416957	PRJNA545312	285		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	6								
1230Y		1230	304	semi-formed	SRR11416956	PRJNA545312	291		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	6								
1230Z		1230	395	formed	SRR11416953	PRJNA545312	382		32	13	cord	Leukemia	248a03139d31f1674db68f	768	1		post	6								
1231A		1231	0	formed	SRR11140316	PRJNA606262			7																	
1231B		1231	4	formed	SRR11140315	PRJNA606262			7																	
1231C		1231	6	semi-formed	SRR11140314	PRJNA606262			7																	
1231D		1231	14	semi-formed	SRR11140313	PRJNA606262			7																	
1231E		1231	53	semi-formed	SRR11140312	PRJNA606262			7																	
1231F		1231	67	formed	SRR11140311	PRJNA606262			7																	
1231G		1231	106	formed	SRR11140310	PRJNA606262			7																	
1232A		1232	0	formed	SRR11140185	PRJNA606262			2																	
1232B		1232	192	formed	SRR11395641	PRJNA607574			2																	
1233A		1233	0	formed	SRR11416952	PRJNA545312	-2		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		pre	-1								
1233AA		1233	66	liquid	SRR11416951	PRJNA545312	64		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	6								
1233B		1233	1	liquid	SRR11416950	PRJNA545312	-1		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		pre	-1								
1233BB		1233	69	liquid	SRR11416893	PRJNA545312	67		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	6								
1233CC		1233	71	liquid	SRR11416892	PRJNA545312	69		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	6								
1233DD		1233	73	liquid	SRR11416890	PRJNA545312	71		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	6								
1233E		1233	3	liquid	SRR11416889	PRJNA545312	1		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		peri	0								
1233EE		1233	78	liquid	SRR11416888	PRJNA545312	76		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	6								
1233FF		1233	79	liquid	SRR11416886	PRJNA545312	77		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	6								
1233H		1233	8	liquid	SRR11416885	PRJNA545312	6		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	0								
1233I		1233	9	liquid	SRR11416884	PRJNA545312	7		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	0								
1233J		1233	14	liquid	SRR11416883	PRJNA545312	12		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	1								
1233K		1233	15	liquid	SRR11416882	PRJNA545312	13		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	1								
1233L		1233	20	liquid	SRR11416881	PRJNA545312	18		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	2								
1233M		1233	22	semi-formed	SRR11416880	PRJNA545312	20		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	2								
1233S		1233	46	liquid	SRR11416879	PRJNA545312	44		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	6								
1233T		1233	47	liquid	SRR11416878	PRJNA545312	45		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	6								
1233U		1233	10	liquid	SRR11416877	PRJNA545312	8		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	1								
1233W		1233	48	liquid	SRR11416875	PRJNA545312	46		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	6								
1233X		1233	53		SRR11416874	PRJNA545312	51		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	6								
1233Y		1233	63	liquid	SRR11416873	PRJNA545312	61		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	6								
1233Z		1233	64	liquid	SRR11416872	PRJNA545312	62		22	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	91ab664636a9d71093b7a4		1		post	6								
1234A		1234	0	formed	SRR10668205	PRJNA545312	2		14	-2	BM_unmodified	Myelodysplastic Syndromes	052375a2e0a63a1b2683f5		1		peri	0								
1234B		1234	5	formed	SRR10668434	PRJNA545312	7		14	-2	BM_unmodified	Myelodysplastic Syndromes	052375a2e0a63a1b2683f5		1		post	0								
1234C		1234	8	liquid	SRR11416871	PRJNA545312	10		14	-2	BM_unmodified	Myelodysplastic Syndromes	052375a2e0a63a1b2683f5		1		post	1								
1234D		1234	9	liquid	SRR11416870	PRJNA545312	11		14	-2	BM_unmodified	Myelodysplastic Syndromes	052375a2e0a63a1b2683f5		1		post	1								
1234E		1234	10	liquid	SRR11416869	PRJNA545312	12		14	-2	BM_unmodified	Myelodysplastic Syndromes	052375a2e0a63a1b2683f5		1		post	1								
1234F		1234	11	liquid	SRR11416868	PRJNA545312	13		14	-2	BM_unmodified	Myelodysplastic Syndromes	052375a2e0a63a1b2683f5		1		post	1								
1234G		1234	12	liquid	SRR11416867	PRJNA545312	14		14	-2	BM_unmodified	Myelodysplastic Syndromes	052375a2e0a63a1b2683f5		1		post	1								
1234H		1234	13	liquid	SRR11416866	PRJNA545312	15		14	-2	BM_unmodified	Myelodysplastic Syndromes	052375a2e0a63a1b2683f5		1		post	2								
1234I		1234	22	semi-formed	SRR11417206	PRJNA545312	24		14	-2	BM_unmodified	Myelodysplastic Syndromes	052375a2e0a63a1b2683f5		1		post	3								
1234J		1234	23	semi-formed	SRR11417205	PRJNA545312	25		14	-2	BM_unmodified	Myelodysplastic Syndromes	052375a2e0a63a1b2683f5		1		post	3								
1234K		1234	28	semi-formed	SRR11417204	PRJNA545312	30		14	-2	BM_unmodified	Myelodysplastic Syndromes	052375a2e0a63a1b2683f5		1		post	4								
1234L		1234	29	semi-formed	SRR11417203	PRJNA545312	31		14	-2	BM_unmodified	Myelodysplastic Syndromes	052375a2e0a63a1b2683f5		1		post	4								
1234M		1234	40	liquid	SRR11417202	PRJNA545312	42		14	-2	BM_unmodified	Myelodysplastic Syndromes	052375a2e0a63a1b2683f5		1		post	5								
1234N		1234	53	semi-formed	SRR11417201	PRJNA545312	55		14	-2	BM_unmodified	Myelodysplastic Syndromes	052375a2e0a63a1b2683f5		1		post	6								
1235A		1235	0	formed	SRR11139772	PRJNA606262			8																	
1235B		1235	1	formed	SRR11139771	PRJNA606262			8																	
1235C		1235	4	formed	SRR11139770	PRJNA606262			8																	
1235D		1235	5	semi-formed	SRR11139769	PRJNA606262			8																	
1235E		1235	6	semi-formed	SRR11139768	PRJNA606262			8																	
1235F		1235	9	liquid	SRR11139767	PRJNA606262			8																	
1235G		1235	13	liquid	SRR11139765	PRJNA606262			8																	
1235H		1235	266	formed	SRR11395632	PRJNA607574			8																	
1236A		1236	0	formed	SRR11140024	PRJNA606262			4																	
1236B		1236	7	semi-formed	SRR11140023	PRJNA606262			4																	
1236C		1236	11	liquid	SRR11140022	PRJNA606262			4																	
1236D		1236	13	liquid	SRR11140021	PRJNA606262			4																	
1237A		1237	0	formed	SRR11140215	PRJNA606262			3																	
1237B		1237	48	semi-formed	SRR11395626	PRJNA607574			3																	
1237C		1237	224	formed	SRR11395625	PRJNA607574			3																	
1238A		1238	0	liquid	SRR11140353	PRJNA606262			1																	
1239A		1239	0	formed	SRR11140225	PRJNA606262			6																	
1239B		1239	2	formed	SRR11140224	PRJNA606262			6																	
1239C		1239	3	formed	SRR11140223	PRJNA606262			6																	
1239F		1239	10	liquid	SRR11140222	PRJNA606262			6																	
1239H		1239	88	formed	SRR11140220	PRJNA606262			6																	
1239I		1239	263	semi-formed	SRR11395617	PRJNA607574			6																	
123A		123	0	formed	SRR11417200	PRJNA545312	-8		6	8	PBSC_unmodified	Leukemia	ff1747f896ef4e6f987a14	206	1		pre	-2								
123B		123	27	liquid	SRR11417199	PRJNA545312	19		6	8	PBSC_unmodified	Leukemia	ff1747f896ef4e6f987a14	206	1		post	2								
123C		123	54	semi-formed	SRR11417198	PRJNA545312	46		6	8	PBSC_unmodified	Leukemia	ff1747f896ef4e6f987a14	206	1		post	6								
123D		123	65	semi-formed	SRR11417197	PRJNA545312	57		6	8	PBSC_unmodified	Leukemia	ff1747f896ef4e6f987a14	206	1		post	6								
123E		123	85	semi-formed	SRR11417195	PRJNA545312	77		6	8	PBSC_unmodified	Leukemia	ff1747f896ef4e6f987a14	206	1		post	6								
123F		123	129	formed	SRR11417194	PRJNA545312	121		6	8	PBSC_unmodified	Leukemia	ff1747f896ef4e6f987a14	206	1		post	6								
1240A		1240	0	liquid	SRR11140387	PRJNA606262			2																	
1240B		1240	161	semi-formed	SRR11395615	PRJNA607574			2																	
1241A		1241	0	formed	SRR11395614	PRJNA607574			1																	
1242A		1242	0	formed	SRR11395613	PRJNA607574			1																	
1243C		1243	0	formed	SRR11417193	PRJNA545312	-4		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		pre	-1								
1243CC		1243	381	formed	SRR11115440	PRJNA607574	377		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	6								
1243D		1243	2	liquid	SRR11417192	PRJNA545312	-2		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		pre	-1								
1243DD		1243	704	semi-formed	SRR11115429	PRJNA607574	700		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	6								
1243E		1243	4	semi-formed	SRR11417191	PRJNA545312	0		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		peri	-1								
1243EE		1243	740	formed	SRR11115418	PRJNA607574	736		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	6								
1243F		1243	7	liquid	SRR11417190	PRJNA545312	3		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		peri	0								
1243FF		1243	741	semi-formed	SRR11115407	PRJNA607574	737		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	6								
1243G		1243	8	liquid	SRR11417189	PRJNA545312	4		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		peri	0								
1243GG		1243	744	formed	SRR11115395	PRJNA607574	740		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	6								
1243H		1243	9	liquid	SRR11417188	PRJNA545312	5		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		peri	0								
1243HH		1243	745	formed	SRR11115384	PRJNA607574	741		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	6								
1243I		1243	11	semi-formed	SRR11417187	PRJNA545312	7		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	0								
1243J		1243	12	liquid	SRR11417186	PRJNA545312	8		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	1								
1243K		1243	13	liquid	SRR11417184	PRJNA545312	9		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	1								
1243L		1243	14	liquid	SRR11417183	PRJNA545312	10		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	1								
1243M		1243	15	liquid	SRR11417182	PRJNA545312	11		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	1								
1243N		1243	16	liquid	SRR11417181	PRJNA545312	12		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	1								
1243O		1243	19	liquid	SRR11417180	PRJNA545312	15		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	2								
1243P		1243	22	semi-formed	SRR11417123	PRJNA545312	18		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	2								
1243Q		1243	23	semi-formed	SRR11417122	PRJNA545312	19		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	2								
1243S		1243	33	semi-formed	SRR11417121	PRJNA545312	29		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	4								
1243T		1243	35	formed	SRR11417120	PRJNA545312	31		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	4								
1243U		1243	41	formed	SRR11417119	PRJNA545312	37		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	5								
1243V		1243	42	semi-formed	SRR11417117	PRJNA545312	38		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	5								
1243W		1243	62	formed	SRR11417116	PRJNA545312	58		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	6								
1243X		1243	96	formed	SRR11417115	PRJNA545312	92		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	6								
1243Y		1243	102	semi-formed	SRR11417114	PRJNA545312	98		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	6								
1243Z		1243	136	semi-formed	SRR11417113	PRJNA545312	132		29	4	BM_unmodified	Non-Hodgkin's Lymphoma	ef4a461874d3ff6c881700	760	1		post	6								
1244B		1244	0	liquid	SRR11417112	PRJNA545312	-5		15	5	TCD	Leukemia	0f0a521872c3061670bf37		1		pre	-1								
1244C		1244	1	liquid	SRR11417111	PRJNA545312	-4		15	5	TCD	Leukemia	0f0a521872c3061670bf37		1		pre	-1								
1244D		1244	2	liquid	SRR11417110	PRJNA545312	-3		15	5	TCD	Leukemia	0f0a521872c3061670bf37		1		pre	-1								
1244E		1244	3	semi-formed	SRR11417109	PRJNA545312	-2		15	5	TCD	Leukemia	0f0a521872c3061670bf37		1		pre	-1								
1244F		1244	4	semi-formed	SRR11417108	PRJNA545312	-1		15	5	TCD	Leukemia	0f0a521872c3061670bf37		1		pre	-1								
1244G		1244	5	liquid	SRR11417106	PRJNA545312	0		15	5	TCD	Leukemia	0f0a521872c3061670bf37		1		peri	-1								
1244H		1244	7	liquid	SRR11417105	PRJNA545312	2		15	5	TCD	Leukemia	0f0a521872c3061670bf37		1		peri	0								
1244I		1244	8	liquid	SRR11417104	PRJNA545312	3		15	5	TCD	Leukemia	0f0a521872c3061670bf37		1		peri	0								
1244J		1244	9	liquid	SRR11417103	PRJNA545312	4		15	5	TCD	Leukemia	0f0a521872c3061670bf37		1		peri	0								
1244K		1244	10	liquid	SRR11417102	PRJNA545312	5		15	5	TCD	Leukemia	0f0a521872c3061670bf37		1		peri	0								
1244L		1244	13	liquid	SRR11417101	PRJNA545312	8		15	5	TCD	Leukemia	0f0a521872c3061670bf37		1		post	1								
1244M		1244	14	liquid	SRR11417100	PRJNA545312	9		15	5	TCD	Leukemia	0f0a521872c3061670bf37		1		post	1								
1244N		1244	16	liquid	SRR11417099	PRJNA545312	11		15	5	TCD	Leukemia	0f0a521872c3061670bf37		1		post	1								
1244O		1244	17	liquid	SRR11417098	PRJNA545312	12		15	5	TCD	Leukemia	0f0a521872c3061670bf37		1		post	1								
1244P		1244	18	liquid	SRR11417097	PRJNA545312	13		15	5	TCD	Leukemia	0f0a521872c3061670bf37		1		post	1								
1245A		1245	0		SRR11416469	PRJNA545312	-7		14	7	BM_unmodified	Hodgkin's Disease	0f6546c2559a003894613a		1		pre	-2								
1245D		1245	11	liquid	SRR11416468	PRJNA545312	4		14	7	BM_unmodified	Hodgkin's Disease	0f6546c2559a003894613a		1		peri	0								
1245E		1245	12	semi-formed	SRR11416467	PRJNA545312	5		14	7	BM_unmodified	Hodgkin's Disease	0f6546c2559a003894613a		1		peri	0								
1245F		1245	14	formed	SRR11416466	PRJNA545312	7		14	7	BM_unmodified	Hodgkin's Disease	0f6546c2559a003894613a		1		post	0								
1245G		1245	16	liquid	SRR11416465	PRJNA545312	9		14	7	BM_unmodified	Hodgkin's Disease	0f6546c2559a003894613a		1		post	1								
1245H		1245	17	liquid	SRR11416464	PRJNA545312	10		14	7	BM_unmodified	Hodgkin's Disease	0f6546c2559a003894613a		1		post	1								
1245I		1245	18	semi-formed	SRR11416463	PRJNA545312	11		14	7	BM_unmodified	Hodgkin's Disease	0f6546c2559a003894613a		1		post	1								
1245J		1245	20	semi-formed	SRR11416462	PRJNA545312	13		14	7	BM_unmodified	Hodgkin's Disease	0f6546c2559a003894613a		1		post	1								
1245K		1245	21	formed	SRR11416461	PRJNA545312	14		14	7	BM_unmodified	Hodgkin's Disease	0f6546c2559a003894613a		1		post	1								
1245L		1245	22	formed	SRR11416460	PRJNA545312	15		14	7	BM_unmodified	Hodgkin's Disease	0f6546c2559a003894613a		1		post	2								
1245M		1245	23	semi-formed	SRR11416458	PRJNA545312	16		14	7	BM_unmodified	Hodgkin's Disease	0f6546c2559a003894613a		1		post	2								
1245N		1245	24	formed	SRR11416457	PRJNA545312	17		14	7	BM_unmodified	Hodgkin's Disease	0f6546c2559a003894613a		1		post	2								
1245O		1245	25	semi-formed	SRR11416456	PRJNA545312	18		14	7	BM_unmodified	Hodgkin's Disease	0f6546c2559a003894613a		1		post	2								
1245P		1245	28	formed	SRR11416455	PRJNA545312	21		14	7	BM_unmodified	Hodgkin's Disease	0f6546c2559a003894613a		1		post	2								
1246A		1246	0	formed	SRR11416454	PRJNA545312	-7		13	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	f9744839960d111e1c9d1f		1		pre	-2								
1246B		1246	6	semi-formed	SRR11416453	PRJNA545312	-1		13	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	f9744839960d111e1c9d1f		1		pre	-1								
1246C		1246	8	liquid	SRR11416452	PRJNA545312	1		13	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	f9744839960d111e1c9d1f		1		peri	0								
1246D		1246	9	liquid	SRR11416451	PRJNA545312	2		13	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	f9744839960d111e1c9d1f		1		peri	0								
1246E		1246	10	liquid	SRR11416450	PRJNA545312	3		13	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	f9744839960d111e1c9d1f		1		peri	0								
1246F		1246	11	liquid	SRR11416449	PRJNA545312	4		13	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	f9744839960d111e1c9d1f		1		peri	0								
1246G		1246	23	liquid	SRR11416446	PRJNA545312	16		13	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	f9744839960d111e1c9d1f		1		post	2								
1246H		1246	43	liquid	SRR11416445	PRJNA545312	36		13	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	f9744839960d111e1c9d1f		1		post	5								
1246I		1246	44	liquid	SRR11416444	PRJNA545312	37		13	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	f9744839960d111e1c9d1f		1		post	5								
1246J		1246	52	liquid	SRR11416443	PRJNA545312	45		13	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	f9744839960d111e1c9d1f		1		post	6								
1246K		1246	101	semi-formed	SRR11416442	PRJNA545312	94		13	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	f9744839960d111e1c9d1f		1		post	6								
1246L		1246	102	semi-formed	SRR11416413	PRJNA545312	95		13	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	f9744839960d111e1c9d1f		1		post	6								
1246M		1246	109	semi-formed	SRR11416412	PRJNA545312	102		13	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	f9744839960d111e1c9d1f		1		post	6								
1247A		1247	0		SRR11416411	PRJNA545312	-5		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		pre	-1								
1247AA		1247	32	semi-formed	SRR11416410	PRJNA545312	27		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	3								
1247B		1247	2	formed	SRR11416409	PRJNA545312	-3		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		pre	-1								
1247BB		1247	33	semi-formed	SRR11416407	PRJNA545312	28		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	3								
1247C		1247	3	formed	SRR11416406	PRJNA545312	-2		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		pre	-1								
1247CC		1247	34	formed	SRR11416405	PRJNA545312	29		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	4								
1247D		1247	4	formed	SRR11416404	PRJNA545312	-1		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		pre	-1								
1247DD		1247	35	formed	SRR11416403	PRJNA545312	30		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	4								
1247G		1247	7	liquid	SRR11416402	PRJNA545312	2		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		peri	0								
1247H		1247	8	liquid	SRR11416401	PRJNA545312	3		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		peri	0								
1247J		1247	11	semi-formed	SRR11416400	PRJNA545312	6		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	0								
1247K		1247	12	semi-formed	SRR11416399	PRJNA545312	7		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	0								
1247L		1247	13	semi-formed	SRR11416398	PRJNA545312	8		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	1								
1247M		1247	15	liquid	SRR11416396	PRJNA545312	10		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	1								
1247N		1247	16	liquid	SRR11416395	PRJNA545312	11		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	1								
1247O		1247	17	liquid	SRR11416394	PRJNA545312	12		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	1								
1247P		1247	18	liquid	SRR11416393	PRJNA545312	13		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	1								
1247Q		1247	19	liquid	SRR11416392	PRJNA545312	14		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	1								
1247R		1247	20	liquid	SRR11416391	PRJNA545312	15		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	2								
1247S		1247	22	liquid	SRR11416390	PRJNA545312	17		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	2								
1247T		1247	23	liquid	SRR11416389	PRJNA545312	18		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	2								
1247U		1247	25	liquid	SRR11418312	PRJNA545312	20		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	2								
1247V		1247	26	liquid	SRR11418311	PRJNA545312	21		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	2								
1247Z		1247	31	semi-formed	SRR11418060	PRJNA545312	26		24	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	dd5886623f7863ec6288ba	251	1		post	3								
1248A		1248	0	semi-formed	SRR11140214	PRJNA606262			1																	
1249A		1249	0	formed	SRR11417967	PRJNA545312	-8		16	8	TCD	Leukemia	739ff0ec46f9fa1f5b33ab	746	1		pre	-2								
1249B		1249	7	liquid	SRR11417345	PRJNA545312	-1		16	8	TCD	Leukemia	739ff0ec46f9fa1f5b33ab	746	1		pre	-1								
1249C		1249	8	liquid	SRR11417514	PRJNA545312	0		16	8	TCD	Leukemia	739ff0ec46f9fa1f5b33ab	746	1		peri	-1								
1249D		1249	9	liquid	SRR11417319	PRJNA545312	1		16	8	TCD	Leukemia	739ff0ec46f9fa1f5b33ab	746	1		peri	0								
1249E		1249	10	liquid	SRR11417432	PRJNA545312	2		16	8	TCD	Leukemia	739ff0ec46f9fa1f5b33ab	746	1		peri	0								
1249F		1249	11	liquid	SRR11417377	PRJNA545312	3		16	8	TCD	Leukemia	739ff0ec46f9fa1f5b33ab	746	1		peri	0								
1249G		1249	12	liquid	SRR11417630	PRJNA545312	4		16	8	TCD	Leukemia	739ff0ec46f9fa1f5b33ab	746	1		peri	0								
1249H		1249	13	liquid	SRR11418310	PRJNA545312	5		16	8	TCD	Leukemia	739ff0ec46f9fa1f5b33ab	746	1		peri	0								
1249I		1249	15	liquid	SRR11418299	PRJNA545312	7		16	8	TCD	Leukemia	739ff0ec46f9fa1f5b33ab	746	1		post	0								
1249J		1249	17	liquid	SRR11418288	PRJNA545312	9		16	8	TCD	Leukemia	739ff0ec46f9fa1f5b33ab	746	1		post	1								
1249K		1249	18	liquid	SRR11418249	PRJNA545312	10		16	8	TCD	Leukemia	739ff0ec46f9fa1f5b33ab	746	1		post	1								
1249L		1249	19	liquid	SRR11418238	PRJNA545312	11		16	8	TCD	Leukemia	739ff0ec46f9fa1f5b33ab	746	1		post	1								
1249N		1249	23	liquid	SRR11418227	PRJNA545312	15		16	8	TCD	Leukemia	739ff0ec46f9fa1f5b33ab	746	1		post	2								
1249O		1249	26	semi-formed	SRR11418132	PRJNA545312	18		16	8	TCD	Leukemia	739ff0ec46f9fa1f5b33ab	746	1		post	2								
1249P		1249	27	semi-formed	SRR11418121	PRJNA545312	19		16	8	TCD	Leukemia	739ff0ec46f9fa1f5b33ab	746	1		post	2								
1249Q		1249	30	semi-formed	SRR11418082	PRJNA545312	22		16	8	TCD	Leukemia	739ff0ec46f9fa1f5b33ab	746	1		post	3								
124A		124	0	formed	SRR11418071	PRJNA545312	93		3	-93	PBSC_unmodified	Non-Hodgkin's Lymphoma	86f47776ac64cb54953bf0	112	1		post	6								
124B		124	262	liquid	SRR11418059	PRJNA545312	355		3	-93	PBSC_unmodified	Non-Hodgkin's Lymphoma	86f47776ac64cb54953bf0	112	1		post	6								
124C		124	263	liquid	SRR11418020	PRJNA545312	356		3	-93	PBSC_unmodified	Non-Hodgkin's Lymphoma	86f47776ac64cb54953bf0	112	1		post	6								
1250B		1250	3	semi-formed	SRR11417712	PRJNA545312	3		9	0	BM_unmodified	Non-Malignant Hemat Disorders	9a4e6940caad3c9f875239	740	1		peri	0								
1250C		1250	1	semi-formed	SRR11417561	PRJNA545312	1		9	0	BM_unmodified	Non-Malignant Hemat Disorders	9a4e6940caad3c9f875239	740	1		peri	0								
1250D		1250	6	semi-formed	SRR11417550	PRJNA545312	6		9	0	BM_unmodified	Non-Malignant Hemat Disorders	9a4e6940caad3c9f875239	740	1		post	0								
1250E		1250	9	semi-formed	SRR11417539	PRJNA545312	9		9	0	BM_unmodified	Non-Malignant Hemat Disorders	9a4e6940caad3c9f875239	740	1		post	1								
1250F		1250	10	formed	SRR11417472	PRJNA545312	10		9	0	BM_unmodified	Non-Malignant Hemat Disorders	9a4e6940caad3c9f875239	740	1		post	1								
1250G		1250	46	semi-formed	SRR11417461	PRJNA545312	46		9	0	BM_unmodified	Non-Malignant Hemat Disorders	9a4e6940caad3c9f875239	740	1		post	6								
1250H		1250	53	semi-formed	SRR11417989	PRJNA545312	53		9	0	BM_unmodified	Non-Malignant Hemat Disorders	9a4e6940caad3c9f875239	740	1		post	6								
1250I		1250	202	liquid	SRR11417978	PRJNA545312	202		9	0	BM_unmodified	Non-Malignant Hemat Disorders	9a4e6940caad3c9f875239	740	1		post	6								
1250J		1250	336	semi-formed	SRR11417966	PRJNA545312	336		9	0	BM_unmodified	Non-Malignant Hemat Disorders	9a4e6940caad3c9f875239	740	1		post	6								
1251A		1251	0	formed	SRR11417899	PRJNA545312	-3		10	3	PBSC_unmodified	Leukemia	c0127109b68485668fc517		1		pre	-1								
1251B		1251	1	formed	SRR11417888	PRJNA545312	-2		10	3	PBSC_unmodified	Leukemia	c0127109b68485668fc517		1		pre	-1								
1251C		1251	2	formed	SRR11417804	PRJNA545312	-1		10	3	PBSC_unmodified	Leukemia	c0127109b68485668fc517		1		pre	-1								
1251D		1251	3	formed	SRR11417793	PRJNA545312	0		10	3	PBSC_unmodified	Leukemia	c0127109b68485668fc517		1		peri	-1								
1251E		1251	4	formed	SRR11417782	PRJNA545312	1		10	3	PBSC_unmodified	Leukemia	c0127109b68485668fc517		1		peri	0								
1251F		1251	5	formed	SRR11417417	PRJNA545312	2		10	3	PBSC_unmodified	Leukemia	c0127109b68485668fc517		1		peri	0								
1251G		1251	7	semi-formed	SRR11417406	PRJNA545312	4		10	3	PBSC_unmodified	Leukemia	c0127109b68485668fc517		1		peri	0								
1251H		1251	8	liquid	SRR11417367	PRJNA545312	5		10	3	PBSC_unmodified	Leukemia	c0127109b68485668fc517		1		peri	0								
1251I		1251	28	semi-formed	SRR11417356	PRJNA545312	25		10	3	PBSC_unmodified	Leukemia	c0127109b68485668fc517		1		post	3								
1251K		1251	45	liquid	SRR11417344	PRJNA545312	42		10	3	PBSC_unmodified	Leukemia	c0127109b68485668fc517		1		post	5								
1252A		1252	0	formed	SRR11418190	PRJNA545312	-6	SRR14092205	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		pre	-1								
1252AA		1252	37	liquid	SRR11418179	PRJNA545312	31	SRR13697141	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	4								
1252AAA		1252	109	liquid	SRR11418056	PRJNA545312	103	SRR14092204	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	6								
1252B		1252	1	formed	SRR11418045	PRJNA545312	-5	SRR14092203	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		pre	-1								
1252BB		1252	38	liquid	SRR11418034	PRJNA545312	32	SRR13697140	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	4								
1252BBB		1252	200	formed	SRR11416388	PRJNA545312	194	SRR14092202	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	6								
1252C		1252	3	formed	SRR11416387	PRJNA545312	-3	SRR13697139	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		pre	-1								
1252CC		1252	39	liquid	SRR11417698	PRJNA545312	33	SRR13697138	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	4								
1252CCC		1252	208	semi-formed	SRR11417687	PRJNA545312	202	SRR14143416	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	6								
1252D		1252	6	formed	SRR11417536	PRJNA545312	0		51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		peri	-1								
1252DD		1252	40	liquid	SRR11417525	PRJNA545312	34	SRR14092201	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	4								
1252E		1252	7	formed	SRR11417513	PRJNA545312	1	SRR14092200	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		peri	0								
1252EE		1252	41	liquid	SRR11418013	PRJNA545312	35	SRR14092199	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	4								
1252F		1252	8	semi-formed	SRR11418002	PRJNA545312	2	SRR14092198	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		peri	0								
1252FF		1252	42	liquid	SRR11417879	PRJNA545312	36	SRR14092197	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	5								
1252G		1252	9	semi-formed	SRR11417868	PRJNA545312	3		51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		peri	0								
1252GG		1252	43	liquid	SRR11417857	PRJNA545312	37	SRR14092196	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	5								
1252H		1252	10	semi-formed	SRR11417773	PRJNA545312	4		51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		peri	0								
1252HH		1252	44	semi-formed	SRR11417762	PRJNA545312	38	SRR13697137	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	5								
1252I		1252	11	liquid	SRR11417751	PRJNA545312	5		51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		peri	0								
1252II		1252	45	semi-formed	SRR11417330	PRJNA545312	39	SRR14092194	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	5								
1252JJ		1252	46	semi-formed	SRR11418164	PRJNA545312	40	SRR13697136	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	5								
1252K		1252	12	liquid	SRR11418153	PRJNA545312	6	SRR14092192	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	0								
1252KK		1252	47	semi-formed	SRR11416837	PRJNA545312	41	SRR13697135	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	5								
1252L		1252	13	semi-formed	SRR11416836	PRJNA545312	7	SRR14143415	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	0								
1252LL		1252	48	semi-formed	SRR11416835	PRJNA545312	42	SRR14092191	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	5								
1252M		1252	14	liquid	SRR11418142	PRJNA545312	8	SRR14143414	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	1								
1252MM		1252	49	semi-formed	SRR11417666	PRJNA545312	43	SRR14092190	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	6								
1252N		1252	16	liquid	SRR11417655	PRJNA545312	10		51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	1								
1252NN		1252	62	semi-formed	SRR11417616	PRJNA545312	56	SRR13697134	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	6								
1252O		1252	15	liquid	SRR11417605	PRJNA545312	9		51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	1								
1252OO		1252	76	semi-formed	SRR11417594	PRJNA545312	70	SRR14092189	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	6								
1252P		1252	17	liquid	SRR11417443	PRJNA545312	11		51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	1								
1252PP		1252	86	liquid	SRR11417431	PRJNA545312	80	SRR13697196	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	6								
1252Q		1252	19	semi-formed	SRR11417959	PRJNA545312	13	SRR13697195	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	1								
1252QQ		1252	87	liquid	SRR11417948	PRJNA545312	81	SRR13697194	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	6								
1252RR		1252	88	formed	SRR11417937	PRJNA545312	82	SRR13697193	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	6								
1252T		1252	25	semi-formed	SRR11417842	PRJNA545312	19	SRR13697192	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	2								
1252TT		1252	89	liquid	SRR11417831	PRJNA545312	83	SRR14092188	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	6								
1252U		1252	27	liquid	SRR11417747	PRJNA545312	21	SRR13697191	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	2								
1252UU		1252	90	liquid	SRR11417736	PRJNA545312	84	SRR14092187	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	6								
1252V		1252	28	semi-formed	SRR11416834	PRJNA545312	22	SRR13697190	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	3								
1252VV		1252	91	semi-formed	SRR11417725	PRJNA545312	85	SRR14092186	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	6								
1252W		1252	29	semi-formed	SRR11417388	PRJNA545312	23	SRR14092185	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	3								
1252WW		1252	93	liquid	SRR11417376	PRJNA545312	87	SRR14092345	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	6								
1252X		1252	30	liquid	SRR11418278	PRJNA545312	24	SRR13697189	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	3								
1252XX		1252	94	liquid	SRR11418267	PRJNA545312	88	SRR14092344	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	6								
1252Y		1252	31	semi-formed	SRR11418256	PRJNA545312	25	SRR13697188	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	3								
1252YY		1252	95	liquid	SRR11418217	PRJNA545312	89	SRR14143413	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	6								
1252Z		1252	35	liquid	SRR11418206	PRJNA545312	29	SRR13697187	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	4								
1252ZZ		1252	100	liquid	SRR11418111	PRJNA545312	94	SRR14092343	51	6	cord	Leukemia	29f5d1e6cb5030c5b016f2	31	1		post	6								
1253A		1253	0	formed	SRR11140082	PRJNA606262			6																	
1253B		1253	2	formed	SRR11140081	PRJNA606262			6																	
1253C		1253	3	formed	SRR11140080	PRJNA606262			6																	
1253D		1253	4	semi-formed	SRR11140079	PRJNA606262			6																	
1253E		1253	5	semi-formed	SRR11140078	PRJNA606262			6																	
1253F		1253	6	liquid	SRR11140077	PRJNA606262			6																	
1254A		1254	0	semi-formed	SRR11140086	PRJNA606262			1																	
1255A		1255	0	liquid	SRR11140064	PRJNA606262			1																	
1256A		1256	0	formed	SRR11395601	PRJNA607574			4																	
1256B		1256	4	semi-formed	SRR11395600	PRJNA607574			4																	
1256C		1256	7	semi-formed	SRR11395598	PRJNA607574			4																	
1256D		1256	13	liquid	SRR11395597	PRJNA607574			4																	
1257A		1257	0	semi-formed	SRR11139727	PRJNA606262			4																	
1257B		1257	13	semi-formed	SRR11139726	PRJNA606262			4																	
1257C		1257	71	formed	SRR11139725	PRJNA606262			4																	
1257D		1257	154	formed	SRR11395593	PRJNA607574			4																	
1258A		1258	0	formed	SRR11395592	PRJNA607574			1																	
1259C		1259	0	formed	SRR11422940	PRJNA545312	-10		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		pre	-2								
1259D		1259	1	formed	SRR11417641	PRJNA545312	-9		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		pre	-2								
1259E		1259	3	formed	SRR11417629	PRJNA545312	-7		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		pre	-2								
1259F		1259	6	semi-formed	SRR11417590	PRJNA545312	-4		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		pre	-1								
1259G		1259	4	semi-formed	SRR11417579	PRJNA545312	-6		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		pre	-1								
1259H		1259	5	semi-formed	SRR11417568	PRJNA545312	-5		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		pre	-1								
1259I		1259	8	liquid	SRR11417501	PRJNA545312	-2		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		pre	-1								
1259J		1259	7	semi-formed	SRR11417490	PRJNA545312	-3		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		pre	-1								
1259K		1259	9	liquid	SRR11417934	PRJNA545312	-1		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		pre	-1								
1259L		1259	10	liquid	SRR11417923	PRJNA545312	0		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		peri	-1								
1259O		1259	13	liquid	SRR11417912	PRJNA545312	3		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		peri	0								
1259P		1259	14	semi-formed	SRR11417817	PRJNA545312	4		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		peri	0								
1259R		1259	17	semi-formed	SRR11418309	PRJNA545312	7		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		post	0								
1259S		1259	18	semi-formed	SRR11418308	PRJNA545312	8		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		post	1								
1259T		1259	19	semi-formed	SRR11418307	PRJNA545312	9		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		post	1								
1259U		1259	20	semi-formed	SRR11418306	PRJNA545312	10		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		post	1								
1259V		1259	21	liquid	SRR11418305	PRJNA545312	11		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		post	1								
1259W		1259	22	liquid	SRR11418304	PRJNA545312	12		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		post	1								
1259X		1259	23	liquid	SRR11418303	PRJNA545312	13		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		post	1								
1259Y		1259	24	semi-formed	SRR11418302	PRJNA545312	14		20	10	TCD	Leukemia	0d3deb1aa146420ea4377b	765	1		post	1								
125A		125	6	semi-formed	SRR11418301	PRJNA545312	4		2	2	PBSC_unmodified	Leukemia	af1dde9b3a68e69460d204		1		peri	0								
125B		125	0	liquid	SRR11418300	PRJNA545312	-2		2	2	PBSC_unmodified	Leukemia	af1dde9b3a68e69460d204		1		pre	-1								
1260A		1260	0	formed	SRR11395591	PRJNA607574			1																	
1261A		1261	0	formed	SRR11418298	PRJNA545312	-10		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		pre	-2								
1261B		1261	4	formed	SRR11422929	PRJNA545312	-6		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		pre	-1								
1261C		1261	7	formed	SRR11418297	PRJNA545312	-3		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		pre	-1								
1261D		1261	8	liquid	SRR11418296	PRJNA545312	-2		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		pre	-1								
1261E		1261	9	liquid	SRR11418295	PRJNA545312	-1		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		pre	-1								
1261F		1261	10	semi-formed	SRR11418294	PRJNA545312	0		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		peri	-1								
1261G		1261	11	liquid	SRR11418293	PRJNA545312	1		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		peri	0								
1261J		1261	16	semi-formed	SRR11418292	PRJNA545312	6		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		post	0								
1261K		1261	17	liquid	SRR11418291	PRJNA545312	7		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		post	0								
1261L		1261	18	semi-formed	SRR11418290	PRJNA545312	8		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		post	1								
1261M		1261	19	semi-formed	SRR11418289	PRJNA545312	9		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		post	1								
1261N		1261	20	liquid	SRR11418287	PRJNA545312	10		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		post	1								
1261O		1261	21	semi-formed	SRR11418286	PRJNA545312	11		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		post	1								
1261P		1261	22	liquid	SRR11418285	PRJNA545312	12		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		post	1								
1261Q		1261	23	liquid	SRR11418284	PRJNA545312	13		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		post	1								
1261R		1261	24	liquid	SRR11418283	PRJNA545312	14		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		post	1								
1261S		1261	25	semi-formed	SRR11418282	PRJNA545312	15		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		post	2								
1261T		1261	26	semi-formed	SRR11418253	PRJNA545312	16		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		post	2								
1261U		1261	27	semi-formed	SRR11418252	PRJNA545312	17		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		post	2								
1261V		1261	28	semi-formed	SRR11418251	PRJNA545312	18		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		post	2								
1261W		1261	29	liquid	SRR11422918	PRJNA545312	19		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		post	2								
1261X		1261	64	semi-formed	SRR11418250	PRJNA545312	54		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		post	6								
1261Y		1261	65	semi-formed	SRR11418248	PRJNA545312	55		23	10	TCD	Leukemia	36715726acc0d496bb2346	769	1		post	6								
1262D		1262	5	semi-formed	SRR11418247	PRJNA545312	14		8	-9	PBSC_unmodified	Leukemia	30d9fc8f92071d4d673aed	727	1		post	1								
1262E		1262	6	semi-formed	SRR11418246	PRJNA545312	15		8	-9	PBSC_unmodified	Leukemia	30d9fc8f92071d4d673aed	727	1		post	2								
1262I		1262	10	formed	SRR11418245	PRJNA545312	19		8	-9	PBSC_unmodified	Leukemia	30d9fc8f92071d4d673aed	727	1		post	2								
1262J		1262	12	liquid	SRR11418244	PRJNA545312	21		8	-9	PBSC_unmodified	Leukemia	30d9fc8f92071d4d673aed	727	1		post	2								
1262K		1262	13	liquid	SRR11418243	PRJNA545312	22		8	-9	PBSC_unmodified	Leukemia	30d9fc8f92071d4d673aed	727	1		post	3								
1262L		1262	28	semi-formed	SRR11418242	PRJNA545312	37		8	-9	PBSC_unmodified	Leukemia	30d9fc8f92071d4d673aed	727	1		post	5								
1262M		1262	60	semi-formed	SRR11418241	PRJNA545312	69		8	-9	PBSC_unmodified	Leukemia	30d9fc8f92071d4d673aed	727	1		post	6								
1262N		1262	88	semi-formed	SRR11418240	PRJNA545312	97		8	-9	PBSC_unmodified	Leukemia	30d9fc8f92071d4d673aed	727	1		post	6								
1263B		1263	75	formed	SRR11139764	PRJNA606262			2																	
1263C		1263	138	formed	SRR11395589	PRJNA607574			2																	
1264A		1264	0	formed	SRR11140075	PRJNA606262			2																	
1264B		1264	8	formed	SRR11140073	PRJNA606262			2																	
1265A		1265	0	semi-formed	SRR11139785	PRJNA606262			2																	
1265B		1265	122	formed	SRR11395584	PRJNA607574			2																	
1266A		1266	0	semi-formed	SRR11139717	PRJNA606262			6																	
1266C		1266	10	semi-formed	SRR11139715	PRJNA606262			6																	
1266D		1266	14	liquid	SRR11139714	PRJNA606262			6																	
1266E		1266	30	formed	SRR11139713	PRJNA606262			6																	
1266F		1266	63	semi-formed	SRR11139712	PRJNA606262			6																	
1266G		1266	118	semi-formed	SRR11395576	PRJNA607574			6																	
1267A		1267	0	formed	SRR11139796	PRJNA606262			1																	
1268A		1268	0	liquid	SRR11140391	PRJNA606262			1																	
1269A		1269	0	formed	SRR11395107	PRJNA607574			1																	
126A		126	0	semi-formed	SRR11418239	PRJNA545312	34		2	-34	PBSC_unmodified	Leukemia	7acfdbb2753b14c1bb6b5a	222	1		post	4								
126B		126	5	semi-formed	SRR11418237	PRJNA545312	39		2	-34	PBSC_unmodified	Leukemia	7acfdbb2753b14c1bb6b5a	222	1		post	5								
1270A		1270	0	liquid	SRR11418235	PRJNA545312	78		7	-78	cord	Leukemia	5ec8063f0e7d0b9746de4f		1		post	6								
1270B		1270	18	formed	SRR11418234	PRJNA545312	96		7	-78	cord	Leukemia	5ec8063f0e7d0b9746de4f		1		post	6								
1270C		1270	25	semi-formed	SRR11418233	PRJNA545312	103		7	-78	cord	Leukemia	5ec8063f0e7d0b9746de4f		1		post	6								
1270D		1270	28	semi-formed	SRR11418232	PRJNA545312	106		7	-78	cord	Leukemia	5ec8063f0e7d0b9746de4f		1		post	6								
1270E		1270	504	semi-formed	SRR11115351	PRJNA607574	582		7	-78	cord	Leukemia	5ec8063f0e7d0b9746de4f		1		post	6								
1270F		1270	542	formed	SRR11115340	PRJNA607574	620		7	-78	cord	Leukemia	5ec8063f0e7d0b9746de4f		1		post	6								
1270G		1270	630	liquid	SRR11115329	PRJNA607574	708		7	-78	cord	Leukemia	5ec8063f0e7d0b9746de4f		1		post	6								
1271A		1271	0	formed	SRR11418231	PRJNA545312	-5		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		pre	-1								
1271D		1271	5	semi-formed	SRR11418230	PRJNA545312	0		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		peri	-1								
1271E		1271	8	semi-formed	SRR11418229	PRJNA545312	3		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		peri	0								
1271F		1271	9	semi-formed	SRR11418228	PRJNA545312	4		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		peri	0								
1271G		1271	10	semi-formed	SRR11418226	PRJNA545312	5		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		peri	0								
1271H		1271	12	liquid	SRR11418141	PRJNA545312	7		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		post	0								
1271I		1271	13	semi-formed	SRR11418140	PRJNA545312	8		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		post	1								
1271J		1271	14	liquid	SRR11418139	PRJNA545312	9		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		post	1								
1271K		1271	15	semi-formed	SRR11418138	PRJNA545312	10		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		post	1								
1271L		1271	16	semi-formed	SRR11418137	PRJNA545312	11		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		post	1								
1271M		1271	17		SRR11418136	PRJNA545312	12		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		post	1								
1271N		1271	18	semi-formed	SRR11418135	PRJNA545312	13		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		post	1								
1271O		1271	20	formed	SRR11418134	PRJNA545312	15		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		post	2								
1271P		1271	25	formed	SRR11418133	PRJNA545312	20		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		post	2								
1271Q		1271	49	formed	SRR11418131	PRJNA545312	44		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		post	6								
1271R		1271	60	formed	SRR11418130	PRJNA545312	55		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		post	6								
1271S		1271	91	formed	SRR11418129	PRJNA545312	86		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		post	6								
1271T		1271	196	formed	SRR11418128	PRJNA545312	191		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		post	6								
1271U		1271	291	formed	SRR11418127	PRJNA545312	286		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		post	6								
1271V		1271	441	formed	SRR11115318	PRJNA607574	436		20	5	PBSC_unmodified	Myeloproliferative Disorder	e7c04f5c7abf2b3860530a	720	1		post	6								
1272A		1272	0	semi-formed	SRR11140326	PRJNA606262			2																	
1272B		1272	4	semi-formed	SRR11140325	PRJNA606262			2																	
1273C		1273	0	formed	SRR11418126	PRJNA545312	0		5	0	PBSC_unmodified	Leukemia	678b82df0e223bec47dbc4		1		peri	-1								
1273D		1273	6	formed	SRR11418125	PRJNA545312	6		5	0	PBSC_unmodified	Leukemia	678b82df0e223bec47dbc4		1		post	0								
1273E		1273	8	semi-formed	SRR11418124	PRJNA545312	8		5	0	PBSC_unmodified	Leukemia	678b82df0e223bec47dbc4		1		post	1								
1273F		1273	20	formed	SRR11418123	PRJNA545312	20		5	0	PBSC_unmodified	Leukemia	678b82df0e223bec47dbc4		1		post	2								
1273G		1273	27	formed	SRR11418122	PRJNA545312	27		5	0	PBSC_unmodified	Leukemia	678b82df0e223bec47dbc4		1		post	3								
1274B		1274	0	formed	SRR11140026	PRJNA606262			8																	
1274C		1274	209		SRR11395103	PRJNA607574			8																	
1274D		1274	237	formed	SRR11395102	PRJNA607574			8																	
1274E		1274	296		SRR11395101	PRJNA607574			8																	
1274F		1274	392	formed	SRR11395099	PRJNA607574			8																	
1274G		1274	470	semi-formed	SRR11395098	PRJNA607574			8																	
1274H		1274	560	formed	SRR11395097	PRJNA607574			8																	
1274I		1274	729	formed	SRR11395096	PRJNA607574			8																	
1275A		1275	0	formed	SRR11140210	PRJNA606262			3																	
1275B		1275	5	semi-formed	SRR11140209	PRJNA606262			3																	
1275C		1275	12	semi-formed	SRR11140208	PRJNA606262			3																	
1276A		1276	0	liquid	SRR11418120	PRJNA545312	-6		9	6	PBSC_unmodified	Leukemia	a7f1d21a47639d96354460		1		pre	-1								
1276B		1276	2	semi-formed	SRR11418119	PRJNA545312	-4		9	6	PBSC_unmodified	Leukemia	a7f1d21a47639d96354460		1		pre	-1								
1276C		1276	6	semi-formed	SRR11418118	PRJNA545312	0		9	6	PBSC_unmodified	Leukemia	a7f1d21a47639d96354460		1		peri	-1								
1276D		1276	7	semi-formed	SRR11418117	PRJNA545312	1		9	6	PBSC_unmodified	Leukemia	a7f1d21a47639d96354460		1		peri	0								
1276E		1276	9	semi-formed	SRR11418116	PRJNA545312	3		9	6	PBSC_unmodified	Leukemia	a7f1d21a47639d96354460		1		peri	0								
1276F		1276	25	semi-formed	SRR11418115	PRJNA545312	19		9	6	PBSC_unmodified	Leukemia	a7f1d21a47639d96354460		1		post	2								
1276G		1276	26	formed	SRR11418114	PRJNA545312	20		9	6	PBSC_unmodified	Leukemia	a7f1d21a47639d96354460		1		post	2								
1276H		1276	30	semi-formed	SRR11418085	PRJNA545312	24		9	6	PBSC_unmodified	Leukemia	a7f1d21a47639d96354460		1		post	3								
1276I		1276	61	formed	SRR11418084	PRJNA545312	55		9	6	PBSC_unmodified	Leukemia	a7f1d21a47639d96354460		1		post	6								
1277A		1277	0	semi-formed	SRR11418083	PRJNA545312	-5		17	5	PBSC_unmodified	Leukemia	0079d6c0a49b8b6c3daf83	748	1		pre	-1								
1277B		1277	1	formed	SRR11418081	PRJNA545312	-4		17	5	PBSC_unmodified	Leukemia	0079d6c0a49b8b6c3daf83	748	1		pre	-1								
1277C		1277	2	formed	SRR11418080	PRJNA545312	-3		17	5	PBSC_unmodified	Leukemia	0079d6c0a49b8b6c3daf83	748	1		pre	-1								
1277D		1277	4	formed	SRR11418079	PRJNA545312	-1		17	5	PBSC_unmodified	Leukemia	0079d6c0a49b8b6c3daf83	748	1		pre	-1								
1277E		1277	7	formed	SRR11418078	PRJNA545312	2		17	5	PBSC_unmodified	Leukemia	0079d6c0a49b8b6c3daf83	748	1		peri	0								
1277F		1277	9	formed	SRR11418077	PRJNA545312	4		17	5	PBSC_unmodified	Leukemia	0079d6c0a49b8b6c3daf83	748	1		peri	0								
1277G		1277	10	semi-formed	SRR11418076	PRJNA545312	5		17	5	PBSC_unmodified	Leukemia	0079d6c0a49b8b6c3daf83	748	1		peri	0								
1277H		1277	11	semi-formed	SRR11418075	PRJNA545312	6		17	5	PBSC_unmodified	Leukemia	0079d6c0a49b8b6c3daf83	748	1		post	0								
1277I		1277	12	formed	SRR11418074	PRJNA545312	7		17	5	PBSC_unmodified	Leukemia	0079d6c0a49b8b6c3daf83	748	1		post	0								
1277J		1277	13	formed	SRR11418073	PRJNA545312	8		17	5	PBSC_unmodified	Leukemia	0079d6c0a49b8b6c3daf83	748	1		post	1								
1277K		1277	14	formed	SRR11418072	PRJNA545312	9		17	5	PBSC_unmodified	Leukemia	0079d6c0a49b8b6c3daf83	748	1		post	1								
1277L		1277	18	semi-formed	SRR11418070	PRJNA545312	13		17	5	PBSC_unmodified	Leukemia	0079d6c0a49b8b6c3daf83	748	1		post	1								
1277M		1277	19	formed	SRR11418069	PRJNA545312	14		17	5	PBSC_unmodified	Leukemia	0079d6c0a49b8b6c3daf83	748	1		post	1								
1277N		1277	31	formed	SRR11418068	PRJNA545312	26		17	5	PBSC_unmodified	Leukemia	0079d6c0a49b8b6c3daf83	748	1		post	3								
1277O		1277	73	formed	SRR11418067	PRJNA545312	68		17	5	PBSC_unmodified	Leukemia	0079d6c0a49b8b6c3daf83	748	1		post	6								
1277P		1277	122	semi-formed	SRR11418066	PRJNA545312	117		17	5	PBSC_unmodified	Leukemia	0079d6c0a49b8b6c3daf83	748	1		post	6								
1277Q		1277	251	formed	SRR11418065	PRJNA545312	246		17	5	PBSC_unmodified	Leukemia	0079d6c0a49b8b6c3daf83	748	1		post	6								
1278A		1278	0	formed	SRR11139675	PRJNA606262			2																	
1278B		1278	3	formed	SRR11139674	PRJNA606262			2																	
1279A		1279	0	semi-formed	SRR11418064	PRJNA545312	2		3	-2	PBSC_unmodified	Non-Hodgkin's Lymphoma	9a99f73f2141b3f18160e7		1		peri	0								
1279B		1279	156	liquid	SRR11418063	PRJNA545312	158		3	-2	PBSC_unmodified	Non-Hodgkin's Lymphoma	9a99f73f2141b3f18160e7		1		post	6								
1279C		1279	158	liquid	SRR11418062	PRJNA545312	160		3	-2	PBSC_unmodified	Non-Hodgkin's Lymphoma	9a99f73f2141b3f18160e7		1		post	6								
127A		127	0	liquid	SRR11418061	PRJNA545312	82		1	-82	PBSC_unmodified	Non-Hodgkin's Lymphoma	333621549115f41dce4cf4	87	1		post	6								
1280A		1280	0	semi-formed	SRR11395090	PRJNA607574			1																	
1281A		1281	0	formed	SRR11139760	PRJNA606262			16																	
1281B		1281	9	semi-formed	SRR11139759	PRJNA606262			16																	
1281C		1281	10	semi-formed	SRR11139758	PRJNA606262			16																	
1281D		1281	11	semi-formed	SRR11139757	PRJNA606262			16																	
1281E		1281	14	semi-formed	SRR11139756	PRJNA606262			16																	
1281F		1281	15	semi-formed	SRR11139754	PRJNA606262			16																	
1281G		1281	16	liquid	SRR11139753	PRJNA606262			16																	
1281H		1281	18	liquid	SRR11139752	PRJNA606262			16																	
1281I		1281	20	semi-formed	SRR11139751	PRJNA606262			16																	
1281J		1281	21	semi-formed	SRR11139750	PRJNA606262			16																	
1281K		1281	22	semi-formed	SRR11139749	PRJNA606262			16																	
1281L		1281	23	semi-formed	SRR11139748	PRJNA606262			16																	
1281M		1281	25	formed	SRR11139747	PRJNA606262			16																	
1281N		1281	28	formed	SRR11139746	PRJNA606262			16																	
1281O		1281	64	semi-formed	SRR11139745	PRJNA606262			16																	
1281P		1281	116	semi-formed	SRR11395190	PRJNA607574			16																	
1282A		1282	0	formed	SRR11139779	PRJNA606262			3																	
1282B		1282	3	formed	SRR11139778	PRJNA606262			3																	
1282C		1282	10	formed	SRR11139776	PRJNA606262			3																	
1283A		1283	0	formed	SRR11140505	PRJNA606262			1																	
1284A		1284	0	formed	SRR11139696	PRJNA606262			5																	
1284B		1284	3	formed	SRR11139695	PRJNA606262			5																	
1284C		1284	4	formed	SRR11139694	PRJNA606262			5																	
1284D		1284	10	semi-formed	SRR11139693	PRJNA606262			5																	
1284E		1284	11	liquid	SRR11139692	PRJNA606262			5																	
1285A		1285	0	semi-formed	SRR11139685	PRJNA606262	-878		14	878	PBSC_unmodified	Multiple Myeloma	679e535dcd4db4a7a1427e		0		pre	-3								
1285B		1285	50	formed	SRR11139684	PRJNA606262	-828		14	878	PBSC_unmodified	Multiple Myeloma	679e535dcd4db4a7a1427e		0		pre	-3								
1285C		1285	875	formed	SRR11115659	PRJNA607574	-3		14	878	PBSC_unmodified	Multiple Myeloma	679e535dcd4db4a7a1427e		0		pre	-1								
1285D		1285	877	liquid	SRR11115648	PRJNA607574	-1		14	878	PBSC_unmodified	Multiple Myeloma	679e535dcd4db4a7a1427e		0		pre	-1								
1285G		1285	883	liquid	SRR11115908	PRJNA607574	5		14	878	PBSC_unmodified	Multiple Myeloma	679e535dcd4db4a7a1427e		0		peri	0								
1285Q		1285	905	semi-formed	SRR11115897	PRJNA607574	27		14	878	PBSC_unmodified	Multiple Myeloma	679e535dcd4db4a7a1427e		0		post	3								
1285R		1285	906	semi-formed	SRR11115886	PRJNA607574	28		14	878	PBSC_unmodified	Multiple Myeloma	679e535dcd4db4a7a1427e		0		post	3								
1285S		1285	907	semi-formed	SRR11115315	PRJNA607574	29		14	878	PBSC_unmodified	Multiple Myeloma	679e535dcd4db4a7a1427e		0		post	4								
1285T		1285	913	formed	SRR11115304	PRJNA607574	35		14	878	PBSC_unmodified	Multiple Myeloma	679e535dcd4db4a7a1427e		0		post	4								
1285U		1285	915	formed	SRR11115293	PRJNA607574	37		14	878	PBSC_unmodified	Multiple Myeloma	679e535dcd4db4a7a1427e		0		post	5								
1285V		1285	924	semi-formed	SRR11115634	PRJNA607574	46		14	878	PBSC_unmodified	Multiple Myeloma	679e535dcd4db4a7a1427e		0		post	6								
1285W		1285	925	semi-formed	SRR11115623	PRJNA607574	47		14	878	PBSC_unmodified	Multiple Myeloma	679e535dcd4db4a7a1427e		0		post	6								
1285X		1285	936	formed	SRR11115612	PRJNA607574	58		14	878	PBSC_unmodified	Multiple Myeloma	679e535dcd4db4a7a1427e		0		post	6								
1285Y		1285	949	formed	SRR11115601	PRJNA607574	71		14	878	PBSC_unmodified	Multiple Myeloma	679e535dcd4db4a7a1427e		0		post	6								
1286A		1286	0	semi-formed	SRR11139784	PRJNA606262			2																	
1286B		1286	7	formed	SRR11139783	PRJNA606262			2																	
1287A		1287	0		SRR11139777	PRJNA606262			5																	
1287B		1287	2	semi-formed	SRR11139766	PRJNA606262			5																	
1287C		1287	3	semi-formed	SRR11139755	PRJNA606262			5																	
1287D		1287	4	semi-formed	SRR11139744	PRJNA606262			5																	
1287E		1287	7	semi-formed	SRR11139733	PRJNA606262			5																	
1288A		1288	0	semi-formed	SRR11140252	PRJNA606262			3																	
1288B		1288	8	semi-formed	SRR11140241	PRJNA606262			3																	
1288C		1288	10	semi-formed	SRR11140486	PRJNA606262			3																	
1289A		1289	0	semi-formed	SRR11395772	PRJNA607574			5																	
1289B		1289	72	semi-formed	SRR11395771	PRJNA607574			5																	
1289C		1289	139	liquid	SRR11395770	PRJNA607574			5																	
1289D		1289	149	semi-formed	SRR11395769	PRJNA607574			5																	
1289E		1289	300	semi-formed	SRR11395768	PRJNA607574			5																	
128A		128	0	liquid	SRR11418058	PRJNA545312	5		3	-5	TCD	Multiple Myeloma	82e627cb778d4df73392d5	102	1		peri	0								
128C		128	21	semi-formed	SRR11418028	PRJNA545312	26		3	-5	TCD	Multiple Myeloma	82e627cb778d4df73392d5	102	1		post	3								
128D		128	96	semi-formed	SRR11418027	PRJNA545312	101		3	-5	TCD	Multiple Myeloma	82e627cb778d4df73392d5	102	1		post	6								
1290A		1290	0	semi-formed	SRR11418026	PRJNA545312	-1		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		pre	-1								
1290B		1290	3	formed	SRR11418025	PRJNA545312	2		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		peri	0								
1290C		1290	6	liquid	SRR11418024	PRJNA545312	5		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		peri	0								
1290D		1290	7	liquid	SRR11418023	PRJNA545312	6		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	0								
1290E		1290	10	semi-formed	SRR11418022	PRJNA545312	9		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	1								
1290F		1290	12	liquid	SRR11418021	PRJNA545312	11		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	1								
1290G		1290	20	liquid	SRR11418019	PRJNA545312	19		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	2								
1290H		1290	22	semi-formed	SRR11418018	PRJNA545312	21		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	2								
1290J		1290	82	formed	SRR11418017	PRJNA545312	81		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	6								
1290K		1290	446	semi-formed	SRR11115589	PRJNA607574	445		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	6								
1290L		1290	522	semi-formed	SRR11115578	PRJNA607574	521		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	6								
1290M		1290	530	semi-formed	SRR11115279	PRJNA607574	529		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	6								
1290N		1290	536	semi-formed	SRR11115268	PRJNA607574	535		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	6								
1290O		1290	543	semi-formed	SRR11115257	PRJNA607574	542		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	6								
1290P		1290	549	formed	SRR11115246	PRJNA607574	548		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	6								
1290Q		1290	557	formed	SRR11115235	PRJNA607574	556		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	6								
1290R		1290	558	formed	SRR11115224	PRJNA607574	557		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	6								
1290S		1290	559	formed	SRR11115213	PRJNA607574	558		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	6								
1290T		1290	560	formed	SRR11115202	PRJNA607574	559		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	6								
1290U		1290	563	semi-formed	SRR11115190	PRJNA607574	562		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	6								
1290V		1290	564	formed	SRR11115563	PRJNA607574	563		21	1	TCD	Myeloproliferative Disorder	b49294dd503d3c1943a207		1		post	6								
1291A		1291	0	formed	SRR11140487	PRJNA606262			3																	
1291B		1291	4	formed	SRR11140485	PRJNA606262			3																	
1291C		1291	10	semi-formed	SRR11140484	PRJNA606262			3																	
1292A		1292	0	formed	SRR11140479	PRJNA606262			1																	
1293A		1293	0	formed	SRR11418016	PRJNA545312	-2		8	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	45fd77831708f8bdca2d98	169	1		pre	-1								
1293B		1293	1	semi-formed	SRR11417421	PRJNA545312	-1		8	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	45fd77831708f8bdca2d98	169	1		pre	-1								
1293C		1293	4	semi-formed	SRR11417717	PRJNA545312	2		8	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	45fd77831708f8bdca2d98	169	1		peri	0								
1293D		1293	6	semi-formed	SRR11417716	PRJNA545312	4		8	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	45fd77831708f8bdca2d98	169	1		peri	0								
1293E		1293	8	formed	SRR11417715	PRJNA545312	6		8	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	45fd77831708f8bdca2d98	169	1		post	0								
1293F		1293	10	formed	SRR11417714	PRJNA545312	8		8	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	45fd77831708f8bdca2d98	169	1		post	1								
1293G		1293	11	semi-formed	SRR11417713	PRJNA545312	9		8	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	45fd77831708f8bdca2d98	169	1		post	1								
1293H		1293	13	formed	SRR11417711	PRJNA545312	11		8	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	45fd77831708f8bdca2d98	169	1		post	1								
1294A		1294	0	semi-formed	SRR11417710	PRJNA545312	4		7	-4	TCD	Myeloproliferative Disorder	a0cf89fc87a862b55a842b	619	1		peri	0								
1294B		1294	1	semi-formed	SRR11417709	PRJNA545312	5		7	-4	TCD	Myeloproliferative Disorder	a0cf89fc87a862b55a842b	619	1		peri	0								
1294C		1294	6	liquid	SRR11417708	PRJNA545312	10		7	-4	TCD	Myeloproliferative Disorder	a0cf89fc87a862b55a842b	619	1		post	1								
1294D		1294	25	formed	SRR11417707	PRJNA545312	29		7	-4	TCD	Myeloproliferative Disorder	a0cf89fc87a862b55a842b	619	1		post	4								
1294E		1294	59	formed	SRR11417706	PRJNA545312	63		7	-4	TCD	Myeloproliferative Disorder	a0cf89fc87a862b55a842b	619	1		post	6								
1294F		1294	98	semi-formed	SRR11417705	PRJNA545312	102		7	-4	TCD	Myeloproliferative Disorder	a0cf89fc87a862b55a842b	619	1		post	6								
1294G		1294	206	formed	SRR11417564	PRJNA545312	210		7	-4	TCD	Myeloproliferative Disorder	a0cf89fc87a862b55a842b	619	1		post	6								
1295A		1295	0	formed	SRR11139669	PRJNA606262			2																	
1295C		1295	6	liquid	SRR11139667	PRJNA606262			2																	
1296A		1296	0	semi-formed	SRR11395567	PRJNA607574			1																	
1297A		1297	0	formed	SRR11417563	PRJNA545312	-5		8	5	PBSC_unmodified	Leukemia	14cb6aa0a4b90cb2d48dce		1		pre	-1								
1297B		1297	1	formed	SRR11417562	PRJNA545312	-4		8	5	PBSC_unmodified	Leukemia	14cb6aa0a4b90cb2d48dce		1		pre	-1								
1297C		1297	9	liquid	SRR11417560	PRJNA545312	4		8	5	PBSC_unmodified	Leukemia	14cb6aa0a4b90cb2d48dce		1		peri	0								
1297E		1297	17	liquid	SRR11417558	PRJNA545312	12		8	5	PBSC_unmodified	Leukemia	14cb6aa0a4b90cb2d48dce		1		post	1								
1297F		1297	21	liquid	SRR11417557	PRJNA545312	16		8	5	PBSC_unmodified	Leukemia	14cb6aa0a4b90cb2d48dce		1		post	2								
1297G		1297	22	liquid	SRR11417556	PRJNA545312	17		8	5	PBSC_unmodified	Leukemia	14cb6aa0a4b90cb2d48dce		1		post	2								
1297H		1297	29	semi-formed	SRR11417555	PRJNA545312	24		8	5	PBSC_unmodified	Leukemia	14cb6aa0a4b90cb2d48dce		1		post	3								
1297J		1297	32	liquid	SRR11417554	PRJNA545312	27		8	5	PBSC_unmodified	Leukemia	14cb6aa0a4b90cb2d48dce		1		post	3								
1298A		1298	0	liquid	SRR11139653	PRJNA606262			5																	
1298B		1298	30	semi-formed	SRR11139652	PRJNA606262			5																	
1298C		1298	45	formed	SRR11139651	PRJNA606262			5																	
1298D		1298	87	formed	SRR11139650	PRJNA606262			5																	
1298E		1298	205	semi-formed	SRR11395560	PRJNA607574			5																	
1299A		1299	0	liquid	SRR11417553	PRJNA545312	6		5	-6	cord	Non-Hodgkin's Lymphoma	c2c522d7ee77d9220feb55		1		post	0								
1299B		1299	41	semi-formed	SRR11417552	PRJNA545312	47		5	-6	cord	Non-Hodgkin's Lymphoma	c2c522d7ee77d9220feb55		1		post	6								
1299C		1299	50	liquid	SRR11417551	PRJNA545312	56		5	-6	cord	Non-Hodgkin's Lymphoma	c2c522d7ee77d9220feb55		1		post	6								
1299D		1299	51	liquid	SRR11417549	PRJNA545312	57		5	-6	cord	Non-Hodgkin's Lymphoma	c2c522d7ee77d9220feb55		1		post	6								
1299E		1299	198	formed	SRR11417548	PRJNA545312	204		5	-6	cord	Non-Hodgkin's Lymphoma	c2c522d7ee77d9220feb55		1		post	6								
129A		129	0	liquid	SRR11417547	PRJNA545312	18		9	1450	cord	Leukemia	523e069e2984feb981efea	240	1		post	2								
129B		129	8	semi-formed	SRR11417546	PRJNA545312	26		9	1450	cord	Leukemia	523e069e2984feb981efea	240	1		post	3								
129C		129	20	semi-formed	SRR11417545	PRJNA545312	38		9	1450	cord	Leukemia	523e069e2984feb981efea	240	1		post	5								
129D		129	1445	formed	SRR11417544	PRJNA545312	-5		9	1450	cord	Leukemia	523e069e2984feb981efea	240	1		pre	-1								
129E		129	1449	semi-formed	SRR11417543	PRJNA545312	-1		9	1450	cord	Leukemia	523e069e2984feb981efea	240	1		pre	-1								
129F		129	1456	liquid	SRR11417542	PRJNA545312	6		9	1450	cord	Leukemia	523e069e2984feb981efea	240	1		post	0								
129G		129	1473	liquid	SRR11417541	PRJNA545312	23		9	1450	cord	Leukemia	523e069e2984feb981efea	240	1		post	3								
129H		129	1496	semi-formed	SRR11417540	PRJNA545312	46		9	1450	cord	Leukemia	523e069e2984feb981efea	240	1		post	6								
129I		129	1512	semi-formed	SRR11417538	PRJNA545312	62		9	1450	cord	Leukemia	523e069e2984feb981efea	240	1		post	6								
1300A		1300	0	formed	SRR11140324	PRJNA606262			2																	
1300B		1300	3	formed	SRR11140323	PRJNA606262			2																	
1301A		1301	0	formed	SRR11140068	PRJNA606262			2																	
1301B		1301	86	semi-formed	SRR11140067	PRJNA606262			2																	
1302A		1302	0	semi-formed	SRR11417464	PRJNA545312	4		4	-4	PBSC_unmodified	Myelodysplastic Syndromes	5160a6c4735353e056b1bf		1		peri	0								
1302B		1302	1	liquid	SRR11417463	PRJNA545312	5		4	-4	PBSC_unmodified	Myelodysplastic Syndromes	5160a6c4735353e056b1bf		1		peri	0								
1302C		1302	6	liquid	SRR11417462	PRJNA545312	10		4	-4	PBSC_unmodified	Myelodysplastic Syndromes	5160a6c4735353e056b1bf		1		post	1								
1302D		1302	7	semi-formed	SRR11417460	PRJNA545312	11		4	-4	PBSC_unmodified	Myelodysplastic Syndromes	5160a6c4735353e056b1bf		1		post	1								
1303A		1303	0	semi-formed	SRR11422907	PRJNA545312	-1		11	1	PBSC_unmodified	Leukemia	ede88811ca90e7f051464a	742	1		pre	-1								
1303B		1303	2	formed	SRR11417459	PRJNA545312	1		11	1	PBSC_unmodified	Leukemia	ede88811ca90e7f051464a	742	1		peri	0								
1303C		1303	4	formed	SRR11417458	PRJNA545312	3		11	1	PBSC_unmodified	Leukemia	ede88811ca90e7f051464a	742	1		peri	0								
1303D		1303	6	semi-formed	SRR11417457	PRJNA545312	5		11	1	PBSC_unmodified	Leukemia	ede88811ca90e7f051464a	742	1		peri	0								
1303E		1303	7	formed	SRR11417456	PRJNA545312	6		11	1	PBSC_unmodified	Leukemia	ede88811ca90e7f051464a	742	1		post	0								
1303F		1303	8	semi-formed	SRR11417455	PRJNA545312	7		11	1	PBSC_unmodified	Leukemia	ede88811ca90e7f051464a	742	1		post	0								
1303G		1303	9	formed	SRR11417454	PRJNA545312	8		11	1	PBSC_unmodified	Leukemia	ede88811ca90e7f051464a	742	1		post	1								
1303H		1303	10	semi-formed	SRR11417453	PRJNA545312	9		11	1	PBSC_unmodified	Leukemia	ede88811ca90e7f051464a	742	1		post	1								
1303I		1303	15	liquid	SRR11422895	PRJNA545312	14		11	1	PBSC_unmodified	Leukemia	ede88811ca90e7f051464a	742	1		post	1								
1303J		1303	55	formed	SRR11417991	PRJNA545312	54		11	1	PBSC_unmodified	Leukemia	ede88811ca90e7f051464a	742	1		post	6								
1303K		1303	202	semi-formed	SRR11417990	PRJNA545312	201		11	1	PBSC_unmodified	Leukemia	ede88811ca90e7f051464a	742	1		post	6								
1304A		1304	0	formed	SRR11140061	PRJNA606262			4																	
1304B		1304	159		SRR11395554	PRJNA607574			4																	
1304C		1304	198	formed	SRR11395553	PRJNA607574			4																	
1304D		1304	273	semi-formed	SRR11395551	PRJNA607574			4																	
1305A		1305	0	formed	SRR11417988	PRJNA545312	-13		13	13	PBSC_unmodified	Myeloproliferative Disorder	041211fb144ed2c3fa1e50		1		pre	-2								
1305B		1305	1	formed	SRR11417987	PRJNA545312	-12		13	13	PBSC_unmodified	Myeloproliferative Disorder	041211fb144ed2c3fa1e50		1		pre	-2								
1305C		1305	4	formed	SRR11417986	PRJNA545312	-9		13	13	PBSC_unmodified	Myeloproliferative Disorder	041211fb144ed2c3fa1e50		1		pre	-2								
1305D		1305	5	formed	SRR11417985	PRJNA545312	-8		13	13	PBSC_unmodified	Myeloproliferative Disorder	041211fb144ed2c3fa1e50		1		pre	-2								
1305E		1305	6	formed	SRR11417984	PRJNA545312	-7		13	13	PBSC_unmodified	Myeloproliferative Disorder	041211fb144ed2c3fa1e50		1		pre	-2								
1305G		1305	12	formed	SRR11417983	PRJNA545312	-1		13	13	PBSC_unmodified	Myeloproliferative Disorder	041211fb144ed2c3fa1e50		1		pre	-1								
1305H		1305	15	formed	SRR11417982	PRJNA545312	2		13	13	PBSC_unmodified	Myeloproliferative Disorder	041211fb144ed2c3fa1e50		1		peri	0								
1305I		1305	18	formed	SRR11417981	PRJNA545312	5		13	13	PBSC_unmodified	Myeloproliferative Disorder	041211fb144ed2c3fa1e50		1		peri	0								
1305J		1305	19	formed	SRR11417980	PRJNA545312	6		13	13	PBSC_unmodified	Myeloproliferative Disorder	041211fb144ed2c3fa1e50		1		post	0								
1305K		1305	21	formed	SRR11417979	PRJNA545312	8		13	13	PBSC_unmodified	Myeloproliferative Disorder	041211fb144ed2c3fa1e50		1		post	1								
1305M		1305	27	formed	SRR11417977	PRJNA545312	14		13	13	PBSC_unmodified	Myeloproliferative Disorder	041211fb144ed2c3fa1e50		1		post	1								
1305N		1305	74	formed	SRR11417976	PRJNA545312	61		13	13	PBSC_unmodified	Myeloproliferative Disorder	041211fb144ed2c3fa1e50		1		post	6								
1305O		1305	410	formed	SRR11115552	PRJNA607574	397		13	13	PBSC_unmodified	Myeloproliferative Disorder	041211fb144ed2c3fa1e50		1		post	6								
1306A		1306	0	formed	SRR11395548	PRJNA607574			1																	
1307A		1307	0	formed	SRR11140318	PRJNA606262			1																	
1308A		1308	0	formed	SRR11140493	PRJNA606262			5																	
1308B		1308	4	formed	SRR11140492	PRJNA606262			5																	
1308C		1308	5	semi-formed	SRR11140491	PRJNA606262			5																	
1308D		1308	6	formed	SRR11140490	PRJNA606262			5																	
1308E		1308	11	formed	SRR11140489	PRJNA606262			5																	
1309A		1309	0	formed	SRR11139795	PRJNA606262			3																	
1309B		1309	3	formed	SRR11139794	PRJNA606262			3																	
1309C		1309	4	semi-formed	SRR11139793	PRJNA606262			3																	
130A		130	0	formed	SRR11417975	PRJNA545312	-3		5	3	TCD	Multiple Myeloma	7ba9cee3b96222791ea23c	253	1		pre	-1								
130B		130	5	liquid	SRR11417974	PRJNA545312	2		5	3	TCD	Multiple Myeloma	7ba9cee3b96222791ea23c	253	1		peri	0								
130C		130	10	liquid	SRR11417973	PRJNA545312	7		5	3	TCD	Multiple Myeloma	7ba9cee3b96222791ea23c	253	1		post	0								
130D		130	14	liquid	SRR11417972	PRJNA545312	11		5	3	TCD	Multiple Myeloma	7ba9cee3b96222791ea23c	253	1		post	1								
130E		130	133	semi-formed	SRR11417971	PRJNA545312	130		5	3	TCD	Multiple Myeloma	7ba9cee3b96222791ea23c	253	1		post	6								
1310A		1310	0	semi-formed	SRR11140461	PRJNA606262			1																	
1311A		1311	0	semi-formed	SRR11395536	PRJNA607574			1																	
1312A		1312	0	formed	SRR11417970	PRJNA545312	-2		8	2	BM_unmodified	Leukemia	3be8fe1a1f43a1ab30c6e7		1		pre	-1								
1312B		1312	4	formed	SRR11417969	PRJNA545312	2		8	2	BM_unmodified	Leukemia	3be8fe1a1f43a1ab30c6e7		1		peri	0								
1312C		1312	6	formed	SRR11417968	PRJNA545312	4		8	2	BM_unmodified	Leukemia	3be8fe1a1f43a1ab30c6e7		1		peri	0								
1312G		1312	17	formed	SRR11417965	PRJNA545312	15		8	2	BM_unmodified	Leukemia	3be8fe1a1f43a1ab30c6e7		1		post	2								
1312H		1312	18	formed	SRR11417964	PRJNA545312	16		8	2	BM_unmodified	Leukemia	3be8fe1a1f43a1ab30c6e7		1		post	2								
1312I		1312	20	formed	SRR11417907	PRJNA545312	18		8	2	BM_unmodified	Leukemia	3be8fe1a1f43a1ab30c6e7		1		post	2								
1312J		1312	22	semi-formed	SRR11417906	PRJNA545312	20		8	2	BM_unmodified	Leukemia	3be8fe1a1f43a1ab30c6e7		1		post	2								
1312K		1312	28	formed	SRR11417905	PRJNA545312	26		8	2	BM_unmodified	Leukemia	3be8fe1a1f43a1ab30c6e7		1		post	3								
1313A		1313	0	formed	SRR11139782	PRJNA606262			1																	
1314A		1314	0	semi-formed	SRR11417904	PRJNA545312	0		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		peri	-1								
1314B		1314	1	semi-formed	SRR11417903	PRJNA545312	1		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		peri	0								
1314C		1314	2	semi-formed	SRR11417902	PRJNA545312	2		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		peri	0								
1314D		1314	3	liquid	SRR11417901	PRJNA545312	3		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		peri	0								
1314E		1314	4	liquid	SRR11417900	PRJNA545312	4		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		peri	0								
1314F		1314	6	formed	SRR11417898	PRJNA545312	6		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		post	0								
1314G		1314	7	formed	SRR11417897	PRJNA545312	7		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		post	0								
1314H		1314	8	formed	SRR11417896	PRJNA545312	8		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		post	1								
1314I		1314	9	semi-formed	SRR11417895	PRJNA545312	9		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		post	1								
1314J		1314	10	semi-formed	SRR11417894	PRJNA545312	10		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		post	1								
1314K		1314	11	semi-formed	SRR11417893	PRJNA545312	11		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		post	1								
1314L		1314	13	liquid	SRR11417892	PRJNA545312	13		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		post	1								
1314M		1314	14	semi-formed	SRR11417891	PRJNA545312	14		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		post	1								
1314N		1314	15	semi-formed	SRR11417890	PRJNA545312	15		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		post	2								
1314O		1314	16	liquid	SRR11417889	PRJNA545312	16		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		post	2								
1314P		1314	17	liquid	SRR11417887	PRJNA545312	17		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		post	2								
1314Q		1314	18	semi-formed	SRR11417886	PRJNA545312	18		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		post	2								
1314R		1314	23	semi-formed	SRR11417885	PRJNA545312	23		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		post	3								
1314S		1314	25	semi-formed	SRR11417884	PRJNA545312	25		19	0	PBSC_unmodified	Leukemia	18aea456f6e212ea6c90ba		1		post	3								
1315A		1315	0	liquid	SRR11139762	PRJNA606262			1																	
1316A		1316	0	liquid	SRR11417883	PRJNA545312	36		6	-36	cord	Leukemia	6346456ad5edbde34b0b15		1		post	5								
1316B		1316	1	semi-formed	SRR11417882	PRJNA545312	37		6	-36	cord	Leukemia	6346456ad5edbde34b0b15		1		post	5								
1316C		1316	4	formed	SRR11417881	PRJNA545312	40		6	-36	cord	Leukemia	6346456ad5edbde34b0b15		1		post	5								
1316D		1316	7	liquid	SRR11417880	PRJNA545312	43		6	-36	cord	Leukemia	6346456ad5edbde34b0b15		1		post	6								
1316E		1316	11	liquid	SRR11417807	PRJNA545312	47		6	-36	cord	Leukemia	6346456ad5edbde34b0b15		1		post	6								
1316F		1316	13	liquid	SRR11417805	PRJNA545312	49		6	-36	cord	Leukemia	6346456ad5edbde34b0b15		1		post	6								
1317A		1317	0	formed	SRR11139738	PRJNA606262			1																	
1318A		1318	0	semi-formed	SRR11139807	PRJNA606262			1																	
1319A		1319	0	formed	SRR11140488	PRJNA606262			1																	
131A		131	0	semi-formed	SRR11417803	PRJNA545312	259		1	-259	PBSC_unmodified	Leukemia	2bbc2d4764ededfce148f7		1		post	6								
1320A		1320	0	formed	SRR11417802	PRJNA545312	-3		16	3	PBSC_unmodified	Leukemia	6915baf26c798b32ad8c98		1		pre	-1								
1320B		1320	1	semi-formed	SRR11417801	PRJNA545312	-2		16	3	PBSC_unmodified	Leukemia	6915baf26c798b32ad8c98		1		pre	-1								
1320C		1320	4	semi-formed	SRR11417800	PRJNA545312	1		16	3	PBSC_unmodified	Leukemia	6915baf26c798b32ad8c98		1		peri	0								
1320D		1320	8	liquid	SRR11417799	PRJNA545312	5		16	3	PBSC_unmodified	Leukemia	6915baf26c798b32ad8c98		1		peri	0								
1320E		1320	14	liquid	SRR11417798	PRJNA545312	11		16	3	PBSC_unmodified	Leukemia	6915baf26c798b32ad8c98		1		post	1								
1320F		1320	15	liquid	SRR11417797	PRJNA545312	12		16	3	PBSC_unmodified	Leukemia	6915baf26c798b32ad8c98		1		post	1								
1320G		1320	16	liquid	SRR11417796	PRJNA545312	13		16	3	PBSC_unmodified	Leukemia	6915baf26c798b32ad8c98		1		post	1								
1320H		1320	21	liquid	SRR11417795	PRJNA545312	18		16	3	PBSC_unmodified	Leukemia	6915baf26c798b32ad8c98		1		post	2								
1320M		1320	36	semi-formed	SRR11417794	PRJNA545312	33		16	3	PBSC_unmodified	Leukemia	6915baf26c798b32ad8c98		1		post	4								
1320N		1320	37	semi-formed	SRR11417792	PRJNA545312	34		16	3	PBSC_unmodified	Leukemia	6915baf26c798b32ad8c98		1		post	4								
1320O		1320	41	formed	SRR11417791	PRJNA545312	38		16	3	PBSC_unmodified	Leukemia	6915baf26c798b32ad8c98		1		post	5								
1320P		1320	42	liquid	SRR11417790	PRJNA545312	39		16	3	PBSC_unmodified	Leukemia	6915baf26c798b32ad8c98		1		post	5								
1320Q		1320	44	semi-formed	SRR11417789	PRJNA545312	41		16	3	PBSC_unmodified	Leukemia	6915baf26c798b32ad8c98		1		post	5								
1320R		1320	46	formed	SRR11417788	PRJNA545312	43		16	3	PBSC_unmodified	Leukemia	6915baf26c798b32ad8c98		1		post	6								
1320S		1320	79	formed	SRR11417787	PRJNA545312	76		16	3	PBSC_unmodified	Leukemia	6915baf26c798b32ad8c98		1		post	6								
1320T		1320	120	formed	SRR11417786	PRJNA545312	117		16	3	PBSC_unmodified	Leukemia	6915baf26c798b32ad8c98		1		post	6								
1321A		1321	0	liquid	SRR11140468	PRJNA606262			9																	
1321B		1321	1	liquid	SRR11140467	PRJNA606262			9																	
1321C		1321	2	liquid	SRR11140466	PRJNA606262			9																	
1321D		1321	5	liquid	SRR11140465	PRJNA606262			9																	
1321E		1321	7	semi-formed	SRR11140463	PRJNA606262			9																	
1321G		1321	194	semi-formed	SRR11395523	PRJNA607574			9																	
1321H		1321	230	semi-formed	SRR11395522	PRJNA607574			9																	
1321I		1321	293	formed	SRR11395521	PRJNA607574			9																	
1321J		1321	320	formed	SRR11395520	PRJNA607574			9																	
1322A		1322	0	formed	SRR11140301	PRJNA606262			2																	
1322B		1322	65	formed	SRR11140300	PRJNA606262			2																	
1323A		1323	0	liquid	SRR11140469	PRJNA606262			1																	
1324A		1324	0	semi-formed	SRR11140207	PRJNA606262			5																	
1324B		1324	1	semi-formed	SRR11140205	PRJNA606262			5																	
1324C		1324	2	liquid	SRR11140204	PRJNA606262			5																	
1324D		1324	6	liquid	SRR11140203	PRJNA606262			5																	
1324E		1324	7	liquid	SRR11140202	PRJNA606262			5																	
1325A		1325	0	formed	SRR11139703	PRJNA606262			9																	
1325B		1325	4	semi-formed	SRR11139702	PRJNA606262			9																	
1325C		1325	10	semi-formed	SRR11139701	PRJNA606262			9																	
1325D		1325	82	semi-formed	SRR11139698	PRJNA606262			9																	
1325E		1325	94	formed	SRR11139697	PRJNA606262			9																	
1325F		1325	122	formed	SRR11395504	PRJNA607574			9																	
1325G		1325	164	semi-formed	SRR11395503	PRJNA607574			9																	
1325H		1325	192	semi-formed	SRR11395502	PRJNA607574			9																	
1325I		1325	437	formed	SRR11395501	PRJNA607574			9																	
1326A		1326	0	formed	SRR11417785	PRJNA545312	-5		15	5	BM_unmodified	Leukemia	902cf0888b4857d5ad703f		1		pre	-1								
1326B		1326	1	formed	SRR11417784	PRJNA545312	-4		15	5	BM_unmodified	Leukemia	902cf0888b4857d5ad703f		1		pre	-1								
1326C		1326	2	formed	SRR11417783	PRJNA545312	-3		15	5	BM_unmodified	Leukemia	902cf0888b4857d5ad703f		1		pre	-1								
1326D		1326	5	formed	SRR11417781	PRJNA545312	0		15	5	BM_unmodified	Leukemia	902cf0888b4857d5ad703f		1		peri	-1								
1326E		1326	8	formed	SRR11417780	PRJNA545312	3		15	5	BM_unmodified	Leukemia	902cf0888b4857d5ad703f		1		peri	0								
1326F		1326	9	liquid	SRR11417779	PRJNA545312	4		15	5	BM_unmodified	Leukemia	902cf0888b4857d5ad703f		1		peri	0								
1326G		1326	17	liquid	SRR11417722	PRJNA545312	12		15	5	BM_unmodified	Leukemia	902cf0888b4857d5ad703f		1		post	1								
1326H		1326	18	liquid	SRR11417721	PRJNA545312	13		15	5	BM_unmodified	Leukemia	902cf0888b4857d5ad703f		1		post	1								
1326I		1326	23	liquid	SRR11417720	PRJNA545312	18		15	5	BM_unmodified	Leukemia	902cf0888b4857d5ad703f		1		post	2								
1326J		1326	25	liquid	SRR11417719	PRJNA545312	20		15	5	BM_unmodified	Leukemia	902cf0888b4857d5ad703f		1		post	2								
1326K		1326	26	liquid	SRR11417718	PRJNA545312	21		15	5	BM_unmodified	Leukemia	902cf0888b4857d5ad703f		1		post	2								
1326L		1326	31	liquid	SRR11417419	PRJNA545312	26		15	5	BM_unmodified	Leukemia	902cf0888b4857d5ad703f		1		post	3								
1326N		1326	35	semi-formed	SRR11422856	PRJNA545312	30		15	5	BM_unmodified	Leukemia	902cf0888b4857d5ad703f		1		post	4								
1326O		1326	36	liquid	SRR11417418	PRJNA545312	31		15	5	BM_unmodified	Leukemia	902cf0888b4857d5ad703f		1		post	4								
1326P		1326	39	liquid	SRR11417416	PRJNA545312	34		15	5	BM_unmodified	Leukemia	902cf0888b4857d5ad703f		1		post	4								
1327A		1327	0	semi-formed	SRR11139791	PRJNA606262			3																	
1327B		1327	6	liquid	SRR11139790	PRJNA606262			3																	
1327C		1327	13	liquid	SRR11139789	PRJNA606262			3																	
1328A		1328	0	formed	SRR11139691	PRJNA606262			2																	
1328B		1328	2	formed	SRR11139690	PRJNA606262			2																	
1329A		1329	0	semi-formed	SRR11417415	PRJNA545312	-3		15	3	PBSC_unmodified	Myelodysplastic Syndromes	826b069534134fecb6036b		1		pre	-1								
1329B		1329	2	semi-formed	SRR11417414	PRJNA545312	-1		15	3	PBSC_unmodified	Myelodysplastic Syndromes	826b069534134fecb6036b		1		pre	-1								
1329C		1329	7	formed	SRR11417413	PRJNA545312	4		15	3	PBSC_unmodified	Myelodysplastic Syndromes	826b069534134fecb6036b		1		peri	0								
1329D		1329	8	formed	SRR11417412	PRJNA545312	5		15	3	PBSC_unmodified	Myelodysplastic Syndromes	826b069534134fecb6036b		1		peri	0								
1329E		1329	9	formed	SRR11417411	PRJNA545312	6		15	3	PBSC_unmodified	Myelodysplastic Syndromes	826b069534134fecb6036b		1		post	0								
1329F		1329	10	formed	SRR11417410	PRJNA545312	7		15	3	PBSC_unmodified	Myelodysplastic Syndromes	826b069534134fecb6036b		1		post	0								
1329G		1329	11	formed	SRR11417409	PRJNA545312	8		15	3	PBSC_unmodified	Myelodysplastic Syndromes	826b069534134fecb6036b		1		post	1								
1329H		1329	12	formed	SRR11417408	PRJNA545312	9		15	3	PBSC_unmodified	Myelodysplastic Syndromes	826b069534134fecb6036b		1		post	1								
1329I		1329	14	formed	SRR11417407	PRJNA545312	11		15	3	PBSC_unmodified	Myelodysplastic Syndromes	826b069534134fecb6036b		1		post	1								
1329J		1329	15	formed	SRR11417405	PRJNA545312	12		15	3	PBSC_unmodified	Myelodysplastic Syndromes	826b069534134fecb6036b		1		post	1								
1329K		1329	16	formed	SRR11417404	PRJNA545312	13		15	3	PBSC_unmodified	Myelodysplastic Syndromes	826b069534134fecb6036b		1		post	1								
1329L		1329	17	semi-formed	SRR11417403	PRJNA545312	14		15	3	PBSC_unmodified	Myelodysplastic Syndromes	826b069534134fecb6036b		1		post	1								
1329M		1329	18	semi-formed	SRR11417402	PRJNA545312	15		15	3	PBSC_unmodified	Myelodysplastic Syndromes	826b069534134fecb6036b		1		post	2								
1329N		1329	19	semi-formed	SRR11417401	PRJNA545312	16		15	3	PBSC_unmodified	Myelodysplastic Syndromes	826b069534134fecb6036b		1		post	2								
1329O		1329	54	semi-formed	SRR11417400	PRJNA545312	51		15	3	PBSC_unmodified	Myelodysplastic Syndromes	826b069534134fecb6036b		1		post	6								
132A		132	0	formed	SRR11417399	PRJNA545312	-8		7	8	TCD	Leukemia	556b35fc470067b7a8a200	195	1		pre	-2								
132C		132	13	liquid	SRR11417398	PRJNA545312	5		7	8	TCD	Leukemia	556b35fc470067b7a8a200	195	1		peri	0								
132D		132	21	liquid	SRR11417397	PRJNA545312	13		7	8	TCD	Leukemia	556b35fc470067b7a8a200	195	1		post	1								
132E		132	27	liquid	SRR11417368	PRJNA545312	19		7	8	TCD	Leukemia	556b35fc470067b7a8a200	195	1		post	2								
132F		132	71	formed	SRR11417366	PRJNA545312	63		7	8	TCD	Leukemia	556b35fc470067b7a8a200	195	1		post	6								
132G		132	76	formed	SRR11417365	PRJNA545312	68		7	8	TCD	Leukemia	556b35fc470067b7a8a200	195	1		post	6								
132H		132	85	formed	SRR11417364	PRJNA545312	77		7	8	TCD	Leukemia	556b35fc470067b7a8a200	195	1		post	6								
1330A		1330	0	semi-formed	SRR11139743	PRJNA606262			1																	
1331A		1331	0	formed	SRR11417363	PRJNA545312	-4		16	4	PBSC_unmodified	Leukemia	f1610b7f6f986abb88f0e2		1		pre	-1								
1331B		1331	2	formed	SRR11417362	PRJNA545312	-2		16	4	PBSC_unmodified	Leukemia	f1610b7f6f986abb88f0e2		1		pre	-1								
1331C		1331	6	formed	SRR11417361	PRJNA545312	2		16	4	PBSC_unmodified	Leukemia	f1610b7f6f986abb88f0e2		1		peri	0								
1331D		1331	7	formed	SRR11417360	PRJNA545312	3		16	4	PBSC_unmodified	Leukemia	f1610b7f6f986abb88f0e2		1		peri	0								
1331E		1331	8	formed	SRR11417359	PRJNA545312	4		16	4	PBSC_unmodified	Leukemia	f1610b7f6f986abb88f0e2		1		peri	0								
1331F		1331	9	formed	SRR11417358	PRJNA545312	5		16	4	PBSC_unmodified	Leukemia	f1610b7f6f986abb88f0e2		1		peri	0								
1331G		1331	10	formed	SRR11417357	PRJNA545312	6		16	4	PBSC_unmodified	Leukemia	f1610b7f6f986abb88f0e2		1		post	0								
1331H		1331	13	formed	SRR11417355	PRJNA545312	9		16	4	PBSC_unmodified	Leukemia	f1610b7f6f986abb88f0e2		1		post	1								
1331I		1331	18	formed	SRR11417354	PRJNA545312	14		16	4	PBSC_unmodified	Leukemia	f1610b7f6f986abb88f0e2		1		post	1								
1331J		1331	20	formed	SRR11417353	PRJNA545312	16		16	4	PBSC_unmodified	Leukemia	f1610b7f6f986abb88f0e2		1		post	2								
1331K		1331	21	formed	SRR11417352	PRJNA545312	17		16	4	PBSC_unmodified	Leukemia	f1610b7f6f986abb88f0e2		1		post	2								
1331L		1331	23	formed	SRR11417351	PRJNA545312	19		16	4	PBSC_unmodified	Leukemia	f1610b7f6f986abb88f0e2		1		post	2								
1331M		1331	27	formed	SRR11417350	PRJNA545312	23		16	4	PBSC_unmodified	Leukemia	f1610b7f6f986abb88f0e2		1		post	3								
1331N		1331	28	semi-formed	SRR11417349	PRJNA545312	24		16	4	PBSC_unmodified	Leukemia	f1610b7f6f986abb88f0e2		1		post	3								
1331O		1331	55	semi-formed	SRR11417348	PRJNA545312	51		16	4	PBSC_unmodified	Leukemia	f1610b7f6f986abb88f0e2		1		post	6								
1331P		1331	83	semi-formed	SRR11417347	PRJNA545312	79		16	4	PBSC_unmodified	Leukemia	f1610b7f6f986abb88f0e2		1		post	6								
1332A		1332	0	formed	SRR11139797	PRJNA606262			4																	
1332B		1332	99	formed	SRR11395186	PRJNA607574			4																	
1332C		1332	100	formed	SRR11395185	PRJNA607574			4																	
1332D		1332	106	semi-formed	SRR11395184	PRJNA607574			4																	
1333A		1333	0	semi-formed	SRR11417346	PRJNA545312	-8		2	8	TCD	Leukemia	303582cf4a4e270742e928		1		pre	-2								
1333B		1333	295	formed	SRR11417343	PRJNA545312	287		2	8	TCD	Leukemia	303582cf4a4e270742e928		1		post	6								
1334A		1334	0	formed	SRR11417342	PRJNA545312	0		8	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	d88d2e3f1808df1d9e9c5f		1		peri	-1								
1334B		1334	1	semi-formed	SRR11417341	PRJNA545312	1		8	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	d88d2e3f1808df1d9e9c5f		1		peri	0								
1334C		1334	5	semi-formed	SRR11418197	PRJNA545312	5		8	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	d88d2e3f1808df1d9e9c5f		1		peri	0								
1334D		1334	6	semi-formed	SRR11418196	PRJNA545312	6		8	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	d88d2e3f1808df1d9e9c5f		1		post	0								
1334E		1334	7	semi-formed	SRR11418195	PRJNA545312	7		8	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	d88d2e3f1808df1d9e9c5f		1		post	0								
1334F		1334	8	semi-formed	SRR11418194	PRJNA545312	8		8	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	d88d2e3f1808df1d9e9c5f		1		post	1								
1334G		1334	13	semi-formed	SRR11418193	PRJNA545312	13		8	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	d88d2e3f1808df1d9e9c5f		1		post	1								
1334H		1334	184	semi-formed	SRR11418192	PRJNA545312	184		8	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	d88d2e3f1808df1d9e9c5f		1		post	6								
1335A		1335	0	formed	SRR11139730	PRJNA606262			3																	
1335B		1335	1	formed	SRR11139729	PRJNA606262			3																	
1335C		1335	2	semi-formed	SRR11139728	PRJNA606262			3																	
1336A		1336	0	formed	SRR11139689	PRJNA606262			1																	
1337A		1337	0	semi-formed	SRR11418191	PRJNA545312	-3		13	3	BM_unmodified	Leukemia	5413311fc07b93d67a3f5d		1		pre	-1								
1337B		1337	2	formed	SRR11418189	PRJNA545312	-1		13	3	BM_unmodified	Leukemia	5413311fc07b93d67a3f5d		1		pre	-1								
1337C		1337	3	semi-formed	SRR11418188	PRJNA545312	0		13	3	BM_unmodified	Leukemia	5413311fc07b93d67a3f5d		1		peri	-1								
1337D		1337	5	semi-formed	SRR11418187	PRJNA545312	2		13	3	BM_unmodified	Leukemia	5413311fc07b93d67a3f5d		1		peri	0								
1337E		1337	7	semi-formed	SRR11418186	PRJNA545312	4		13	3	BM_unmodified	Leukemia	5413311fc07b93d67a3f5d		1		peri	0								
1337F		1337	8	formed	SRR11418185	PRJNA545312	5		13	3	BM_unmodified	Leukemia	5413311fc07b93d67a3f5d		1		peri	0								
1337G		1337	9	formed	SRR11418184	PRJNA545312	6		13	3	BM_unmodified	Leukemia	5413311fc07b93d67a3f5d		1		post	0								
1337H		1337	11	formed	SRR11418183	PRJNA545312	8		13	3	BM_unmodified	Leukemia	5413311fc07b93d67a3f5d		1		post	1								
1337I		1337	12	semi-formed	SRR11418182	PRJNA545312	9		13	3	BM_unmodified	Leukemia	5413311fc07b93d67a3f5d		1		post	1								
1337J		1337	21	liquid	SRR11418181	PRJNA545312	18		13	3	BM_unmodified	Leukemia	5413311fc07b93d67a3f5d		1		post	2								
1337K		1337	22	liquid	SRR11418180	PRJNA545312	19		13	3	BM_unmodified	Leukemia	5413311fc07b93d67a3f5d		1		post	2								
1337L		1337	26	semi-formed	SRR11418178	PRJNA545312	23		13	3	BM_unmodified	Leukemia	5413311fc07b93d67a3f5d		1		post	3								
1337M		1337	19	semi-formed	SRR11418177	PRJNA545312	16		13	3	BM_unmodified	Leukemia	5413311fc07b93d67a3f5d		1		post	2								
1338A		1338	0	semi-formed	SRR11418176	PRJNA545312	-5		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		pre	-1								
1338B		1338	2	formed	SRR11418175	PRJNA545312	-3		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		pre	-1								
1338C		1338	3	liquid	SRR11418174	PRJNA545312	-2		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		pre	-1								
1338D		1338	4	liquid	SRR11418173	PRJNA545312	-1		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		pre	-1								
1338E		1338	5	semi-formed	SRR11418172	PRJNA545312	0		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		peri	-1								
1338F		1338	7	semi-formed	SRR11418171	PRJNA545312	2		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		peri	0								
1338G		1338	9	semi-formed	SRR11418170	PRJNA545312	4		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		peri	0								
1338H		1338	10	liquid	SRR11418057	PRJNA545312	5		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		peri	0								
1338I		1338	11	semi-formed	SRR11418055	PRJNA545312	6		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		post	0								
1338J		1338	15	semi-formed	SRR11418054	PRJNA545312	10		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		post	1								
1338K		1338	18	liquid	SRR11418053	PRJNA545312	13		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		post	1								
1338L		1338	19	liquid	SRR11418052	PRJNA545312	14		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		post	1								
1338M		1338	21	semi-formed	SRR11418051	PRJNA545312	16		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		post	2								
1338N		1338	22	semi-formed	SRR11418050	PRJNA545312	17		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		post	2								
1338O		1338	47	formed	SRR11418049	PRJNA545312	42		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		post	5								
1338P		1338	53		SRR11418048	PRJNA545312	48		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		post	6								
1338Q		1338	85	formed	SRR11418047	PRJNA545312	80		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		post	6								
1338R		1338	173	semi-formed	SRR11418046	PRJNA545312	-36		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		pre	-3								
1338S		1338	213	semi-formed	SRR11418044	PRJNA545312	4		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		peri	0								
1338T		1338	219	semi-formed	SRR11418043	PRJNA545312	10		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		post	1								
1338U		1338	220	semi-formed	SRR11416833	PRJNA545312	11		21	209	PBSC_unmodified		9fed691e0c8591854eabdb		1		post	1								
1339A		1339	0	semi-formed	SRR11416832	PRJNA545312	-3		11	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	599913ac2fc6db4863ce90		1		pre	-1								
1339B		1339	1	liquid	SRR11416831	PRJNA545312	-2		11	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	599913ac2fc6db4863ce90		1		pre	-1								
1339C		1339	4	semi-formed	SRR11416830	PRJNA545312	1		11	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	599913ac2fc6db4863ce90		1		peri	0								
1339D		1339	8	liquid	SRR11416829	PRJNA545312	5		11	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	599913ac2fc6db4863ce90		1		peri	0								
1339E		1339	11	semi-formed	SRR11416828	PRJNA545312	8		11	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	599913ac2fc6db4863ce90		1		post	1								
1339F		1339	12	semi-formed	SRR11416826	PRJNA545312	9		11	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	599913ac2fc6db4863ce90		1		post	1								
1339G		1339	15	liquid	SRR11416825	PRJNA545312	12		11	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	599913ac2fc6db4863ce90		1		post	1								
1339H		1339	16	semi-formed	SRR11416824	PRJNA545312	13		11	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	599913ac2fc6db4863ce90		1		post	1								
1339I		1339	17	formed	SRR11416823	PRJNA545312	14		11	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	599913ac2fc6db4863ce90		1		post	1								
1339J		1339	113	semi-formed	SRR11416822	PRJNA545312	110		11	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	599913ac2fc6db4863ce90		1		post	6								
1339K		1339	275	semi-formed	SRR11115541	PRJNA607574	272		11	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	599913ac2fc6db4863ce90		1		post	6								
133A		133	0	formed	SRR11416821	PRJNA545312	-6		5	6	TCD	Multiple Myeloma	c8f9da7645e669f9714b47	138	1		pre	-1								
133B		133	5	formed	SRR11416820	PRJNA545312	-1		5	6	TCD	Multiple Myeloma	c8f9da7645e669f9714b47	138	1		pre	-1								
133C		133	9	liquid	SRR11416819	PRJNA545312	3		5	6	TCD	Multiple Myeloma	c8f9da7645e669f9714b47	138	1		peri	0								
133D		133	19	liquid	SRR11416818	PRJNA545312	13		5	6	TCD	Multiple Myeloma	c8f9da7645e669f9714b47	138	1		post	1								
133E		133	164	liquid	SRR11416817	PRJNA545312	158		5	6	TCD	Multiple Myeloma	c8f9da7645e669f9714b47	138	1		post	6								
1340A		1340	0	formed	SRR11139974	PRJNA606262			2																	
1340B		1340	7	semi-formed	SRR11139973	PRJNA606262			2																	
1341C		1341	8	formed	SRR11416815	PRJNA545312	40		5	-32	BM_unmodified	Leukemia	60f16c653baee1527cd4ff	774	1		post	5								
1341D		1341	17	semi-formed	SRR11416814	PRJNA545312	49		5	-32	BM_unmodified	Leukemia	60f16c653baee1527cd4ff	774	1		post	6								
1341E		1341	22	semi-formed	SRR11416813	PRJNA545312	54		5	-32	BM_unmodified	Leukemia	60f16c653baee1527cd4ff	774	1		post	6								
1341F		1341	21	semi-formed	SRR11416812	PRJNA545312	53		5	-32	BM_unmodified	Leukemia	60f16c653baee1527cd4ff	774	1		post	6								
1341G		1341	24	semi-formed	SRR11416811	PRJNA545312	56		5	-32	BM_unmodified	Leukemia	60f16c653baee1527cd4ff	774	1		post	6								
1342A		1342	0	liquid	SRR11395176	PRJNA607574			1																	
1343A		FMT.0155	0	formed	SRR11416810	PRJNA545312	-25		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		pre	-3								
1343B		FMT.0155	1	formed	SRR11417095	PRJNA545312	-24		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		pre	-3								
1344A		1344	0	semi-formed	SRR11140012	PRJNA606262			4																	
1344B		1344	1	semi-formed	SRR11140011	PRJNA606262			4																	
1344E		1344	13	liquid	SRR11140008	PRJNA606262			4																	
1344F		1344	70	semi-formed	SRR11140007	PRJNA606262			4																	
1345A		1345	0	semi-formed	SRR11417094	PRJNA545312	-6		8	6	BM_unmodified	Leukemia	1f47f9e5337f772d835a9c		1		pre	-1								
1345B		1345	3	liquid	SRR11417093	PRJNA545312	-3		8	6	BM_unmodified	Leukemia	1f47f9e5337f772d835a9c		1		pre	-1								
1345C		1345	7	liquid	SRR11417092	PRJNA545312	1		8	6	BM_unmodified	Leukemia	1f47f9e5337f772d835a9c		1		peri	0								
1345D		1345	9	liquid	SRR11417090	PRJNA545312	3		8	6	BM_unmodified	Leukemia	1f47f9e5337f772d835a9c		1		peri	0								
1345E		1345	10	liquid	SRR11418042	PRJNA545312	4		8	6	BM_unmodified	Leukemia	1f47f9e5337f772d835a9c		1		peri	0								
1345I		1345	31	liquid	SRR11418041	PRJNA545312	25		8	6	BM_unmodified	Leukemia	1f47f9e5337f772d835a9c		1		post	3								
1345J		1345	30	liquid	SRR11418040	PRJNA545312	24		8	6	BM_unmodified	Leukemia	1f47f9e5337f772d835a9c		1		post	3								
1345K		1345	33	semi-formed	SRR11418039	PRJNA545312	27		8	6	BM_unmodified	Leukemia	1f47f9e5337f772d835a9c		1		post	3								
1346A		1346	0	liquid	SRR11139724	PRJNA606262			4																	
1346B		1346	2	liquid	SRR11139723	PRJNA606262			4																	
1346C		1346	7	liquid	SRR11139721	PRJNA606262			4																	
1346D		1346	21	liquid	SRR11139720	PRJNA606262			4																	
1347A		1347	0	semi-formed	SRR11418038	PRJNA545312	-2		4	2	TCD	Leukemia	28bcb3ddef3f8058ebc7c1		1		pre	-1								
1347B		1347	1	liquid	SRR11418037	PRJNA545312	-1		4	2	TCD	Leukemia	28bcb3ddef3f8058ebc7c1		1		pre	-1								
1347C		1347	9	liquid	SRR11418036	PRJNA545312	7		4	2	TCD	Leukemia	28bcb3ddef3f8058ebc7c1		1		post	0								
1347D		1347	15	semi-formed	SRR11418035	PRJNA545312	13		4	2	TCD	Leukemia	28bcb3ddef3f8058ebc7c1		1		post	1								
1348A		1348	0	semi-formed	SRR11139980	PRJNA606262			1																	
1349A		1349	0	formed	SRR11140048	PRJNA606262			4																	
1349B		1349	4	formed	SRR11140047	PRJNA606262			4																	
1349C		1349	27	semi-formed	SRR11140046	PRJNA606262			4																	
1349D		1349	81	semi-formed	SRR11140045	PRJNA606262			4																	
134A		134	0	semi-formed	SRR11418033	PRJNA545312	-5		8	379	PBSC_unmodified	Leukemia	f8f43d9f6acb3109d99842	205	1		pre	-1								
134B		134	9	liquid	SRR11418032	PRJNA545312	4		8	379	PBSC_unmodified	Leukemia	f8f43d9f6acb3109d99842	205	1		peri	0								
134C		134	17	liquid	SRR11418031	PRJNA545312	12		8	379	PBSC_unmodified	Leukemia	f8f43d9f6acb3109d99842	205	1		post	1								
134D		134	24	liquid	SRR11418030	PRJNA545312	19		8	379	PBSC_unmodified	Leukemia	f8f43d9f6acb3109d99842	205	1		post	2								
134E		134	374	formed	SRR11417704	PRJNA545312	-5		8	379	PBSC_unmodified	Leukemia	f8f43d9f6acb3109d99842	205	1		pre	-1								
134F		134	379	liquid	SRR11417703	PRJNA545312	0		8	379	PBSC_unmodified	Leukemia	f8f43d9f6acb3109d99842	205	1		peri	-1								
134G		134	386	liquid	SRR11417702	PRJNA545312	7		8	379	PBSC_unmodified	Leukemia	f8f43d9f6acb3109d99842	205	1		post	0								
134H		134	393	semi-formed	SRR11417701	PRJNA545312	14		8	379	PBSC_unmodified	Leukemia	f8f43d9f6acb3109d99842	205	1		post	1								
1350A		1350	0	formed	SRR11139991	PRJNA606262			5																	
1350C		1350	61	semi-formed	SRR11139990	PRJNA606262			5																	
1350D		1350	102	semi-formed	SRR11395127	PRJNA607574			5																	
1350E		1350	158		SRR11395125	PRJNA607574			5																	
1350F		1350	215	semi-formed	SRR11395124	PRJNA607574			5																	
1351A		1351	0	semi-formed	SRR11140232	PRJNA606262	-892		12	892	BM_unmodified		837be98c00092e24c768e0		0		pre	-3								
1351B		1351	9	liquid	SRR11140231	PRJNA606262	-883		12	892	BM_unmodified		837be98c00092e24c768e0		0		pre	-3								
1351C		1351	31	semi-formed	SRR11140230	PRJNA606262	-861		12	892	BM_unmodified		837be98c00092e24c768e0		0		pre	-3								
1351D		1351	891	semi-formed	SRR11115178	PRJNA607574	-1		12	892	BM_unmodified		837be98c00092e24c768e0		0		pre	-1								
1351E		1351	896	liquid	SRR11115839	PRJNA607574	4		12	892	BM_unmodified		837be98c00092e24c768e0		0		peri	0								
1351F		1351	898	semi-formed	SRR11115540	PRJNA607574	6		12	892	BM_unmodified		837be98c00092e24c768e0		0		post	0								
1351G		1351	901	semi-formed	SRR11115529	PRJNA607574	9		12	892	BM_unmodified		837be98c00092e24c768e0		0		post	1								
1351H		1351	902	semi-formed	SRR11115518	PRJNA607574	10		12	892	BM_unmodified		837be98c00092e24c768e0		0		post	1								
1351I		1351	903	liquid	SRR11115875	PRJNA607574	11		12	892	BM_unmodified		837be98c00092e24c768e0		0		post	1								
1351J		1351	904	liquid	SRR11115863	PRJNA607574	12		12	892	BM_unmodified		837be98c00092e24c768e0		0		post	1								
1351K		1351	905	liquid	SRR11115852	PRJNA607574	13		12	892	BM_unmodified		837be98c00092e24c768e0		0		post	1								
1351L		1351	908	liquid	SRR11115825	PRJNA607574	16		12	892	BM_unmodified		837be98c00092e24c768e0		0		post	2								
1352A		1352	0	liquid	SRR11417700	PRJNA545312	10		3	-10	PBSC_unmodified	Leukemia	77a689fb85d64ed63b8ed4		1		post	1								
1352B		1352	5	semi-formed	SRR11417699	PRJNA545312	15		3	-10	PBSC_unmodified	Leukemia	77a689fb85d64ed63b8ed4		1		post	2								
1352C		1352	41	semi-formed	SRR11417697	PRJNA545312	51		3	-10	PBSC_unmodified	Leukemia	77a689fb85d64ed63b8ed4		1		post	6								
1353A		1353	0	formed	SRR11417696	PRJNA545312	-4		16	4	PBSC_unmodified	Leukemia	f4ce890d3b3a2c6d8a3972		1		pre	-1								
1353B		1353	1	semi-formed	SRR11417695	PRJNA545312	-3		16	4	PBSC_unmodified	Leukemia	f4ce890d3b3a2c6d8a3972		1		pre	-1								
1353C		1353	5	formed	SRR11417694	PRJNA545312	1		16	4	PBSC_unmodified	Leukemia	f4ce890d3b3a2c6d8a3972		1		peri	0								
1353D		1353	16	semi-formed	SRR11417693	PRJNA545312	12		16	4	PBSC_unmodified	Leukemia	f4ce890d3b3a2c6d8a3972		1		post	1								
1353E		1353	21	semi-formed	SRR11417692	PRJNA545312	17		16	4	PBSC_unmodified	Leukemia	f4ce890d3b3a2c6d8a3972		1		post	2								
1353F		1353	22	liquid	SRR11417691	PRJNA545312	18		16	4	PBSC_unmodified	Leukemia	f4ce890d3b3a2c6d8a3972		1		post	2								
1353G		1353	23	semi-formed	SRR11417690	PRJNA545312	19		16	4	PBSC_unmodified	Leukemia	f4ce890d3b3a2c6d8a3972		1		post	2								
1353H		1353	24	liquid	SRR11417689	PRJNA545312	20		16	4	PBSC_unmodified	Leukemia	f4ce890d3b3a2c6d8a3972		1		post	2								
1353I		1353	28	semi-formed	SRR11417688	PRJNA545312	24		16	4	PBSC_unmodified	Leukemia	f4ce890d3b3a2c6d8a3972		1		post	3								
1353J		1353	29	semi-formed	SRR11417686	PRJNA545312	25		16	4	PBSC_unmodified	Leukemia	f4ce890d3b3a2c6d8a3972		1		post	3								
1353K		1353	30	semi-formed	SRR11417685	PRJNA545312	26		16	4	PBSC_unmodified	Leukemia	f4ce890d3b3a2c6d8a3972		1		post	3								
1353L		1353	31	semi-formed	SRR11417684	PRJNA545312	27		16	4	PBSC_unmodified	Leukemia	f4ce890d3b3a2c6d8a3972		1		post	3								
1353M		1353	32	formed	SRR11417683	PRJNA545312	28		16	4	PBSC_unmodified	Leukemia	f4ce890d3b3a2c6d8a3972		1		post	3								
1353N		1353	33	formed	SRR11417682	PRJNA545312	29		16	4	PBSC_unmodified	Leukemia	f4ce890d3b3a2c6d8a3972		1		post	4								
1353O		1353	61	formed	SRR11417681	PRJNA545312	57		16	4	PBSC_unmodified	Leukemia	f4ce890d3b3a2c6d8a3972		1		post	6								
1353P		1353	94	semi-formed	SRR11417680	PRJNA545312	90		16	4	PBSC_unmodified	Leukemia	f4ce890d3b3a2c6d8a3972		1		post	6								
1354A		1354	0	liquid	SRR11417679	PRJNA545312	-7		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		pre	-2								
1354B		1354	6	liquid	SRR11417678	PRJNA545312	-1		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		pre	-1								
1354E		1354	15	liquid	SRR11417677	PRJNA545312	8		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		post	1								
1354G		1354	18	liquid	SRR11417535	PRJNA545312	11		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		post	1								
1354H		1354	20	liquid	SRR11417534	PRJNA545312	13		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		post	1								
1354I		1354	21	liquid	SRR11417533	PRJNA545312	14		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		post	1								
1354J		1354	22	liquid	SRR11417532	PRJNA545312	15		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		post	2								
1354K		1354	23	liquid	SRR11417531	PRJNA545312	16		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		post	2								
1354L		1354	26	liquid	SRR11417530	PRJNA545312	19		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		post	2								
1354M		1354	27	liquid	SRR11417529	PRJNA545312	20		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		post	2								
1354N		1354	28	liquid	SRR11417528	PRJNA545312	21		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		post	2								
1354O		1354	30	semi-formed	SRR11417527	PRJNA545312	23		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		post	3								
1354P		1354	33	semi-formed	SRR11417526	PRJNA545312	26		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		post	3								
1354Q		1354	34	liquid	SRR11417524	PRJNA545312	27		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		post	3								
1354R		1354	37	liquid	SRR11417523	PRJNA545312	30		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		post	4								
1354S		1354	147	semi-formed	SRR11417522	PRJNA545312	140		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		post	6								
1354T		1354	179	liquid	SRR11417521	PRJNA545312	172		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		post	6								
1354U		1354	180	liquid	SRR11417520	PRJNA545312	173		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		post	6								
1354V		1354	181	liquid	SRR11417519	PRJNA545312	174		19	7	TCD	Leukemia	15b50f659d5066438d99ef		1		post	6								
1355A		1355	0	formed	SRR11139798	PRJNA606262			1																	
1356A		1356	0	semi-formed	SRR11139656	PRJNA606262			2																	
1356B		1356	5	semi-formed	SRR11139654	PRJNA606262			2																	
1357A		1357	0	liquid	SRR11395120	PRJNA607574			1																	
1358A		1358	0	formed	SRR11139687	PRJNA606262			2																	
1358B		1358	1	formed	SRR11139686	PRJNA606262			2																	
1359A		1359	0	liquid	SRR11140261	PRJNA606262			1																	
1360A		1360	0	formed	SRR11139818	PRJNA606262			2																	
1360B		1360	3	liquid	SRR11139817	PRJNA606262			2																	
1361A		1361	0	semi-formed	SRR11417518	PRJNA545312	-9		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		pre	-2								
1361B		1361	1	semi-formed	SRR11417517	PRJNA545312	-8		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		pre	-2								
1361C		1361	5	semi-formed	SRR11422845	PRJNA545312	-4		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		pre	-1								
1361D		1361	6	liquid	SRR11417516	PRJNA545312	-3		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		pre	-1								
1361E		1361	7	liquid	SRR11417515	PRJNA545312	-2		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		pre	-1								
1361F		1361	8	liquid	SRR11417512	PRJNA545312	-1		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		pre	-1								
1361G		1361	9	liquid	SRR11417511	PRJNA545312	0		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		peri	-1								
1361H		1361	12	liquid	SRR11417510	PRJNA545312	3		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		peri	0								
1361I		1361	13	liquid	SRR11417509	PRJNA545312	4		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		peri	0								
1361J		1361	14	liquid	SRR11417424	PRJNA545312	5		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		peri	0								
1361K		1361	16	liquid	SRR11417423	PRJNA545312	7		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		post	0								
1361L		1361	15	liquid	SRR11423412	PRJNA545312	6		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		post	0								
1361M		1361	19	liquid	SRR11417422	PRJNA545312	10		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		post	1								
1361N		1361	20	liquid	SRR11417420	PRJNA545312	11		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		post	1								
1361Q		1361	25	semi-formed	SRR11418015	PRJNA545312	16		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		post	2								
1361R		1361	26	liquid	SRR11418014	PRJNA545312	17		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		post	2								
1361S		1361	27	liquid	SRR11418012	PRJNA545312	18		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		post	2								
1361T		1361	28	semi-formed	SRR11418011	PRJNA545312	19		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		post	2								
1361U		1361	29	liquid	SRR11418010	PRJNA545312	20		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		post	2								
1361V		1361	30	liquid	SRR11418009	PRJNA545312	21		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		post	2								
1361W		1361	32	liquid	SRR11418008	PRJNA545312	23		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		post	3								
1361X		1361	33	liquid	SRR11418007	PRJNA545312	24		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		post	3								
1361Y		1361	40	liquid	SRR11418006	PRJNA545312	31		23	9	TCD	Leukemia	4b0c6ed67d037f35939190		1		post	4								
1362A		1362	0	formed	SRR11418005	PRJNA545312	-5		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		pre	-1								
1362AA		1362	253	liquid	SRR11418004	PRJNA545312	248		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362B		1362	1	formed	SRR11418003	PRJNA545312	-4	SRR14092342	28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		pre	-1								
1362BB		1362	254	liquid	SRR11418001	PRJNA545312	249		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362C		1362	3	formed	SRR11418000	PRJNA545312	-2		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		pre	-1								
1362D		1362	15	formed	SRR11417999	PRJNA545312	10		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	1								
1362E		1362	16	semi-formed	SRR11417998	PRJNA545312	11		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	1								
1362F		1362	19	formed	SRR11417997	PRJNA545312	14		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	1								
1362G		1362	36	liquid	SRR11417996	PRJNA545312	31		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	4								
1362H		1362	52	liquid	SRR11417995	PRJNA545312	47		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362I		1362	51	liquid	SRR11417994	PRJNA545312	46		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362J		1362	53	liquid	SRR11417993	PRJNA545312	48		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362K		1362	54	liquid	SRR11417992	PRJNA545312	49	SRR14092341	28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362L		1362	57	liquid	SRR11417878	PRJNA545312	52		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362M		1362	58	liquid	SRR11417877	PRJNA545312	53		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362N		1362	60	liquid	SRR11417876	PRJNA545312	55		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362O		1362	63	liquid	SRR11417875	PRJNA545312	58		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362P		1362	66	liquid	SRR11417874	PRJNA545312	61		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362Q		1362	67	semi-formed	SRR11417873	PRJNA545312	62		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362R		1362	70	formed	SRR11417872	PRJNA545312	65		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362S		1362	85	liquid	SRR11417871	PRJNA545312	80		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362T		1362	88	liquid	SRR11417870	PRJNA545312	83		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362U		1362	95	liquid	SRR11417869	PRJNA545312	90		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362V		1362	100	liquid	SRR11417867	PRJNA545312	95		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362W		1362	131	liquid	SRR11417866	PRJNA545312	126		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362X		1362	148	liquid	SRR11417865	PRJNA545312	143		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362Y		1362	219	liquid	SRR11417864	PRJNA545312	214		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1362Z		1362	242	liquid	SRR11417863	PRJNA545312	237		28	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e54fe2e45f4dfbf6a175d	683	1		post	6								
1363A		1363	0	formed	SRR11139731	PRJNA606262			1																	
1364A		1364	0	formed	SRR11417862	PRJNA545312	-5		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		pre	-1								
1364AA		1364	312	formed	SRR11115814	PRJNA607574	307		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		post	6								
1364B		1364	1	formed	SRR11417861	PRJNA545312	-4		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		pre	-1								
1364C		1364	2	formed	SRR9298328	PRJNA548153	-3		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		pre	-1								
1364E		1364	4	semi-formed	SRR11417860	PRJNA545312	-1		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		pre	-1								
1364F		1364	5	semi-formed	SRR11417859	PRJNA545312	0		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		peri	-1								
1364G		1364	8	semi-formed	SRR11417858	PRJNA545312	3		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		peri	0								
1364H		1364	9	formed	SRR11417856	PRJNA545312	4		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		peri	0								
1364I		1364	10	semi-formed	SRR11417855	PRJNA545312	5		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		peri	0								
1364J		1364	11	formed	SRR11417854	PRJNA545312	6		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		post	0								
1364K		1364	12	formed	SRR11417853	PRJNA545312	7		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		post	0								
1364L		1364	15	formed	SRR11417852	PRJNA545312	10		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		post	1								
1364M		1364	16	formed	SRR11417778	PRJNA545312	11		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		post	1								
1364N		1364	17	formed	SRR11417777	PRJNA545312	12		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		post	1								
1364O		1364	18	semi-formed	SRR11417776	PRJNA545312	13		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		post	1								
1364P		1364	19	semi-formed	SRR11417775	PRJNA545312	14		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		post	1								
1364Q		1364	21	formed	SRR11417774	PRJNA545312	16		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		post	2								
1364R		1364	22	formed	SRR11417772	PRJNA545312	17		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		post	2								
1364S		1364	23	formed	SRR11417771	PRJNA545312	18		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		post	2								
1364T		1364	24	semi-formed	SRR11115803	PRJNA607574	19		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		post	2								
1364U		1364	25	formed	SRR11417770	PRJNA545312	20		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		post	2								
1364V		1364	26	formed	SRR11417769	PRJNA545312	21		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		post	2								
1364W		1364	37	semi-formed	SRR11417768	PRJNA545312	32		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		post	4								
1364X		1364	67	formed	SRR11417767	PRJNA545312	62		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		post	6								
1364Y		1364	137	formed	SRR11417766	PRJNA545312	132		25	5	BM_unmodified	Leukemia	8a25110c831e982ce15747	763	1		post	6								
1365A		1365	0	formed	SRR11139722	PRJNA606262			3																	
1365B		1365	6	liquid	SRR11139711	PRJNA606262			3																	
1365C		1365	7	liquid	SRR11139699	PRJNA606262			3																	
1366A		1366	0	formed	SRR11417765	PRJNA545312	-6		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		pre	-1								
1366B		1366	1	formed	SRR11417764	PRJNA545312	-5		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		pre	-1								
1366C		1366	3	formed	SRR11417763	PRJNA545312	-3		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		pre	-1								
1366D		1366	4	formed	SRR11417761	PRJNA545312	-2		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		pre	-1								
1366E		1366	5	semi-formed	SRR11423401	PRJNA545312	-1		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		pre	-1								
1366F		1366	6	formed	SRR11423390	PRJNA545312	0		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		peri	-1								
1366G		1366	7	formed	SRR11417760	PRJNA545312	1		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		peri	0								
1366H		1366	8	formed	SRR11417759	PRJNA545312	2		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		peri	0								
1366I		1366	10	semi-formed	SRR11417758	PRJNA545312	4		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		peri	0								
1366J		1366	11	semi-formed	SRR11417757	PRJNA545312	5		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		peri	0								
1366K		1366	12	formed	SRR11417756	PRJNA545312	6		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		post	0								
1366L		1366	13	liquid	SRR11417755	PRJNA545312	7		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		post	0								
1366M		1366	14	formed	SRR11417754	PRJNA545312	8		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		post	1								
1366N		1366	18	formed	SRR11417753	PRJNA545312	12		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		post	1								
1366O		1366	26		SRR11417752	PRJNA545312	20		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		post	2								
1366P		1366	31	semi-formed	SRR11417340	PRJNA545312	25		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		post	3								
1366Q		1366	32	semi-formed	SRR11417339	PRJNA545312	26		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		post	3								
1366R		1366	35	semi-formed	SRR11417338	PRJNA545312	29		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		post	4								
1366S		1366	34	semi-formed	SRR11417337	PRJNA545312	28		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		post	3								
1366T		1366	38	semi-formed	SRR11417336	PRJNA545312	32		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		post	4								
1366U		1366	40	semi-formed	SRR11417335	PRJNA545312	34		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		post	4								
1366V		1366	42	formed	SRR11417334	PRJNA545312	36		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		post	5								
1366W		1366	41	formed	SRR11417333	PRJNA545312	35		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		post	4								
1366X		1366	105	semi-formed	SRR11417332	PRJNA545312	99		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		post	6								
1366Y		1366	210	semi-formed	SRR11417331	PRJNA545312	204		25	6	PBSC_unmodified	Leukemia	7a7e6f063a3cee8d4b38c7		1		post	6								
1367A		1367	0	formed	SRR11140347	PRJNA606262			2																	
1367B		1367	12	semi-formed	SRR11140346	PRJNA606262			2																	
1368A		1368	0	formed	SRR11139763	PRJNA606262			1																	
1369A		1369	0	semi-formed	SRR11139781	PRJNA606262			2																	
1369B		1369	12	semi-formed	SRR11139780	PRJNA606262			2																	
136A		136	0	formed	SRR11417329	PRJNA545312	-10		3	10	TCD	Leukemia	6c5668d88af5ff65c243af	106	1		pre	-2								
136B		136	7	formed	SRR11417328	PRJNA545312	-3		3	10	TCD	Leukemia	6c5668d88af5ff65c243af	106	1		pre	-1								
136C		136	14	liquid	SRR11417327	PRJNA545312	4		3	10	TCD	Leukemia	6c5668d88af5ff65c243af	106	1		peri	0								
1370A		1370	0	semi-formed	SRR11139734	PRJNA606262			4																	
1370B		1370	56	formed	SRR11139732	PRJNA606262			4																	
1370C		1370	168	formed	SRR11395004	PRJNA607574			4																	
1370D		1370	406	semi-formed	SRR11395003	PRJNA607574			4																	
1371A		1371	0	formed	SRR11417326	PRJNA545312	-7		5	7	TCD	Myelodysplastic Syndromes	3bd13c67ec273a3ca14a55		1		pre	-2								
1371B		1371	6	semi-formed	SRR11417325	PRJNA545312	-1		5	7	TCD	Myelodysplastic Syndromes	3bd13c67ec273a3ca14a55		1		pre	-1								
1371C		1371	7	semi-formed	SRR11417324	PRJNA545312	0		5	7	TCD	Myelodysplastic Syndromes	3bd13c67ec273a3ca14a55		1		peri	-1								
1371D		1371	9	liquid	SRR11417323	PRJNA545312	2		5	7	TCD	Myelodysplastic Syndromes	3bd13c67ec273a3ca14a55		1		peri	0								
1371H		1371	13	liquid	SRR11417322	PRJNA545312	6		5	7	TCD	Myelodysplastic Syndromes	3bd13c67ec273a3ca14a55		1		post	0								
1372A		1372	0	semi-formed	SRR11417321	PRJNA545312	-3		17	3	PBSC_unmodified	Myelodysplastic Syndromes	aa778346c1ef8dc2ea5d93		1		pre	-1								
1372B		1372	2	liquid	SRR11417320	PRJNA545312	-1		17	3	PBSC_unmodified	Myelodysplastic Syndromes	aa778346c1ef8dc2ea5d93		1		pre	-1								
1372D		1372	4	liquid	SRR11417317	PRJNA545312	1		17	3	PBSC_unmodified	Myelodysplastic Syndromes	aa778346c1ef8dc2ea5d93		1		peri	0								
1372E		1372	5	liquid	SRR11417316	PRJNA545312	2		17	3	PBSC_unmodified	Myelodysplastic Syndromes	aa778346c1ef8dc2ea5d93		1		peri	0								
1372H		1372	10	liquid	SRR11417315	PRJNA545312	7		17	3	PBSC_unmodified	Myelodysplastic Syndromes	aa778346c1ef8dc2ea5d93		1		post	0								
1372I		1372	11	liquid	SRR11417314	PRJNA545312	8		17	3	PBSC_unmodified	Myelodysplastic Syndromes	aa778346c1ef8dc2ea5d93		1		post	1								
1372J		1372	12	liquid	SRR11417313	PRJNA545312	9		17	3	PBSC_unmodified	Myelodysplastic Syndromes	aa778346c1ef8dc2ea5d93		1		post	1								
1372K		1372	14	liquid	SRR11418169	PRJNA545312	11		17	3	PBSC_unmodified	Myelodysplastic Syndromes	aa778346c1ef8dc2ea5d93		1		post	1								
1372L		1372	15	liquid	SRR11418168	PRJNA545312	12		17	3	PBSC_unmodified	Myelodysplastic Syndromes	aa778346c1ef8dc2ea5d93		1		post	1								
1372M		1372	16	liquid	SRR11423351	PRJNA545312	13		17	3	PBSC_unmodified	Myelodysplastic Syndromes	aa778346c1ef8dc2ea5d93		1		post	1								
1372N		1372	18	liquid	SRR11418167	PRJNA545312	15		17	3	PBSC_unmodified	Myelodysplastic Syndromes	aa778346c1ef8dc2ea5d93		1		post	2								
1372O		1372	21	liquid	SRR11418166	PRJNA545312	18		17	3	PBSC_unmodified	Myelodysplastic Syndromes	aa778346c1ef8dc2ea5d93		1		post	2								
1372P		1372	22	liquid	SRR11418165	PRJNA545312	19		17	3	PBSC_unmodified	Myelodysplastic Syndromes	aa778346c1ef8dc2ea5d93		1		post	2								
1372Q		1372	23	liquid	SRR11418163	PRJNA545312	20		17	3	PBSC_unmodified	Myelodysplastic Syndromes	aa778346c1ef8dc2ea5d93		1		post	2								
1372R		1372	25	formed	SRR11418162	PRJNA545312	22		17	3	PBSC_unmodified	Myelodysplastic Syndromes	aa778346c1ef8dc2ea5d93		1		post	3								
1372S		1372	26	formed	SRR11417089	PRJNA545312	23		17	3	PBSC_unmodified	Myelodysplastic Syndromes	aa778346c1ef8dc2ea5d93		1		post	3								
1372T		1372	59	semi-formed	SRR11417088	PRJNA545312	56		17	3	PBSC_unmodified	Myelodysplastic Syndromes	aa778346c1ef8dc2ea5d93		1		post	6								
1373A		1373	0	formed	SRR11395002	PRJNA607574			4																	
1373B		1373	31	formed	SRR11395001	PRJNA607574			4																	
1373C		1373	88	semi-formed	SRR11395000	PRJNA607574			4																	
1373D		1373	327	formed	SRR11394999	PRJNA607574			4																	
1374A		1374	0	formed	SRR11139710	PRJNA606262			2																	
1374B		1374	1	semi-formed	SRR11139709	PRJNA606262			2																	
1375A		1375	0	liquid	SRR11139806	PRJNA606262			4																	
1375B		1375	3	semi-formed	SRR11139805	PRJNA606262			4																	
1375C		1375	8	semi-formed	SRR11139804	PRJNA606262			4																	
1375D		1375	89	semi-formed	SRR11139803	PRJNA606262			4																	
1376A		FMT.0216	0	liquid	SRR11417087	PRJNA545312	-185		15	185	PBSC_unmodified	Non-Hodgkin's Lymphoma	0108dfb76b3943dc8934a8		1		pre	-3								
1376B		FMT.0216	1	semi-formed	SRR11417086	PRJNA545312	-184		15	185	PBSC_unmodified	Non-Hodgkin's Lymphoma	0108dfb76b3943dc8934a8		1		pre	-3								
1376C		FMT.0216	9	semi-formed	SRR11417085	PRJNA545312	-176		15	185	PBSC_unmodified	Non-Hodgkin's Lymphoma	0108dfb76b3943dc8934a8		1		pre	-3								
1376D		FMT.0216	12	semi-formed	SRR11417084	PRJNA545312	-173		15	185	PBSC_unmodified	Non-Hodgkin's Lymphoma	0108dfb76b3943dc8934a8		1		pre	-3								
1376E		FMT.0216	53	formed	SRR11417083	PRJNA545312	-132		15	185	PBSC_unmodified	Non-Hodgkin's Lymphoma	0108dfb76b3943dc8934a8		1		pre	-3								
1376F		FMT.0216	110	semi-formed	SRR11417082	PRJNA545312	-75		15	185	PBSC_unmodified	Non-Hodgkin's Lymphoma	0108dfb76b3943dc8934a8		1		pre	-3								
1377A		1377	0	liquid	SRR11139787	PRJNA606262			1																	
1378A		1378	0	formed	SRR11139707	PRJNA606262	-879		3	879	PBSC_unmodified		3f44ced59578538761273e		0		pre	-3								
1378B		1378	7	semi-formed	SRR11139706	PRJNA606262	-872		3	879	PBSC_unmodified		3f44ced59578538761273e		0		pre	-3								
1378D		1378	91	formed	SRR11139704	PRJNA606262	-788		3	879	PBSC_unmodified		3f44ced59578538761273e		0		pre	-3								
1379A		1379	0	liquid	SRR11417081	PRJNA545312	-3		15	3	BM_unmodified	Myelodysplastic Syndromes	e07fceea54405f5fe89c74		1		pre	-1								
1379B		1379	1	liquid	SRR11417079	PRJNA545312	-2		15	3	BM_unmodified	Myelodysplastic Syndromes	e07fceea54405f5fe89c74		1		pre	-1								
1379C		1379	2	semi-formed	SRR11417078	PRJNA545312	-1		15	3	BM_unmodified	Myelodysplastic Syndromes	e07fceea54405f5fe89c74		1		pre	-1								
1379D		1379	7	liquid	SRR11417077	PRJNA545312	4		15	3	BM_unmodified	Myelodysplastic Syndromes	e07fceea54405f5fe89c74		1		peri	0								
1379E		1379	9	semi-formed	SRR11417076	PRJNA545312	6		15	3	BM_unmodified	Myelodysplastic Syndromes	e07fceea54405f5fe89c74		1		post	0								
1379F		1379	10	semi-formed	SRR11417075	PRJNA545312	7		15	3	BM_unmodified	Myelodysplastic Syndromes	e07fceea54405f5fe89c74		1		post	0								
1379G		1379	11	liquid	SRR11417074	PRJNA545312	8		15	3	BM_unmodified	Myelodysplastic Syndromes	e07fceea54405f5fe89c74		1		post	1								
1379H		1379	13	liquid	SRR11417073	PRJNA545312	10		15	3	BM_unmodified	Myelodysplastic Syndromes	e07fceea54405f5fe89c74		1		post	1								
1379I		1379	14	formed	SRR11417072	PRJNA545312	11		15	3	BM_unmodified	Myelodysplastic Syndromes	e07fceea54405f5fe89c74		1		post	1								
1379J		1379	15	semi-formed	SRR11417071	PRJNA545312	12		15	3	BM_unmodified	Myelodysplastic Syndromes	e07fceea54405f5fe89c74		1		post	1								
1379K		1379	22	liquid	SRR11423340	PRJNA545312	19		15	3	BM_unmodified	Myelodysplastic Syndromes	e07fceea54405f5fe89c74		1		post	2								
1379L		1379	25	liquid	SRR11417070	PRJNA545312	22		15	3	BM_unmodified	Myelodysplastic Syndromes	e07fceea54405f5fe89c74		1		post	3								
1379M		1379	27	semi-formed	SRR11417068	PRJNA545312	24		15	3	BM_unmodified	Myelodysplastic Syndromes	e07fceea54405f5fe89c74		1		post	3								
1379N		1379	28	semi-formed	SRR11417039	PRJNA545312	25		15	3	BM_unmodified	Myelodysplastic Syndromes	e07fceea54405f5fe89c74		1		post	3								
1379O		1379	29	formed	SRR11417038	PRJNA545312	26		15	3	BM_unmodified	Myelodysplastic Syndromes	e07fceea54405f5fe89c74		1		post	3								
137C		137	19	liquid	SRR11417037	PRJNA545312	129		2	-110	TCD	Multiple Myeloma	5d20262cb6f1d6a5227d02		1		post	6								
137D		137	33	liquid	SRR11417036	PRJNA545312	143		2	-110	TCD	Multiple Myeloma	5d20262cb6f1d6a5227d02		1		post	6								
1380A		1380	0	formed	SRR11417035	PRJNA545312	-8		13	8	TCD	Leukemia	91e8d88e6fd88cbce88f09		1		pre	-2								
1380B		1380	1	formed	SRR11417034	PRJNA545312	-7		13	8	TCD	Leukemia	91e8d88e6fd88cbce88f09		1		pre	-2								
1380C		1380	5	liquid	SRR11417033	PRJNA545312	-3		13	8	TCD	Leukemia	91e8d88e6fd88cbce88f09		1		pre	-1								
1380D		1380	7		SRR11417032	PRJNA545312	-1		13	8	TCD	Leukemia	91e8d88e6fd88cbce88f09		1		pre	-1								
1380E		1380	10	liquid	SRR11418161	PRJNA545312	2		13	8	TCD	Leukemia	91e8d88e6fd88cbce88f09		1		peri	0								
1380F		1380	12	liquid	SRR11418160	PRJNA545312	4		13	8	TCD	Leukemia	91e8d88e6fd88cbce88f09		1		peri	0								
1380G		1380	14	semi-formed	SRR11418159	PRJNA545312	6		13	8	TCD	Leukemia	91e8d88e6fd88cbce88f09		1		post	0								
1380H		1380	16	liquid	SRR11418158	PRJNA545312	8		13	8	TCD	Leukemia	91e8d88e6fd88cbce88f09		1		post	1								
1380I		1380	19	liquid	SRR11418157	PRJNA545312	11		13	8	TCD	Leukemia	91e8d88e6fd88cbce88f09		1		post	1								
1380J		1380	20	liquid	SRR11418156	PRJNA545312	12		13	8	TCD	Leukemia	91e8d88e6fd88cbce88f09		1		post	1								
1380K		1380	37	formed	SRR11418155	PRJNA545312	29		13	8	TCD	Leukemia	91e8d88e6fd88cbce88f09		1		post	4								
1380L		1380	121	semi-formed	SRR11116067	PRJNA607574	113		13	8	TCD	Leukemia	91e8d88e6fd88cbce88f09		1		post	6								
1380N		1380	146	formed	SRR11116056	PRJNA607574	138		13	8	TCD	Leukemia	91e8d88e6fd88cbce88f09		1		post	6								
1381A		1381	0	liquid	SRR11418154	PRJNA545312	8		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	1								
1381AA		1381	162	semi-formed	SRR11418152	PRJNA545312	170		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	6								
1381B		1381	3	liquid	SRR11418151	PRJNA545312	11		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	1								
1381C		1381	6	liquid	SRR11418150	PRJNA545312	14		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	1								
1381D		1381	18	liquid	SRR11418149	PRJNA545312	26		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	3								
1381E		1381	21	semi-formed	SRR11418148	PRJNA545312	29		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	4								
1381F		1381	22	semi-formed	SRR11418147	PRJNA545312	30		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	4								
1381G		1381	32	semi-formed	SRR11418146	PRJNA545312	40		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	5								
1381H		1381	34	formed	SRR11418145	PRJNA545312	42		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	5								
1381I		1381	119	semi-formed	SRR11418144	PRJNA545312	127		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	6								
1381J		1381	136	liquid	SRR11418143	PRJNA545312	144		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	6								
1381K		1381	137	liquid	SRR11417676	PRJNA545312	145		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	6								
1381L		1381	138	liquid	SRR11417675	PRJNA545312	146		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	6								
1381M		1381	139	semi-formed	SRR11417674	PRJNA545312	147		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	6								
1381N		1381	140	formed	SRR11417673	PRJNA545312	148		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	6								
1381O		1381	143	formed	SRR11417672	PRJNA545312	151		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	6								
1381P		1381	144	formed	SRR11417671	PRJNA545312	152		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	6								
1381Q		1381	145	formed	SRR11417670	PRJNA545312	153		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	6								
1381S		1381	148	semi-formed	SRR11417668	PRJNA545312	156		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	6								
1381T		1381	152	formed	SRR11417667	PRJNA545312	160		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	6								
1381U		1381	153	formed	SRR11417665	PRJNA545312	161		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	6								
1381V		1381	154	semi-formed	SRR11417664	PRJNA545312	162		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	6								
1381W		1381	157	formed	SRR11417663	PRJNA545312	165		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	6								
1381X		1381	160	semi-formed	SRR11417662	PRJNA545312	168		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	6								
1381Z		1381	161	semi-formed	SRR11417660	PRJNA545312	169		25	-8	PBSC_unmodified	Leukemia	c24546c67a2ccfbaada8fd		1		post	6								
1382A		1382	0	formed	SRR11139683	PRJNA606262			1																	
1383A		1383	0	semi-formed	SRR11394989	PRJNA607574			2																	
1383B		1383	46	semi-formed	SRR11394988	PRJNA607574			2																	
1384A		1384	0	formed	SRR11140309	PRJNA606262			2																	
1384B		1384	8	formed	SRR11140307	PRJNA606262			2																	
1385A		1385	0	semi-formed	SRR11140285	PRJNA606262			4																	
1385B		1385	80	formed	SRR11140274	PRJNA606262			4																	
1385C		1385	128	formed	SRR11394982	PRJNA607574			4																	
1385D		1385	198	formed	SRR11394981	PRJNA607574			4																	
1387A		1387	0		SRR11395482	PRJNA607574			4																	
1387B		1387	38	formed	SRR11395481	PRJNA607574			4																	
1387C		1387	92	semi-formed	SRR11395480	PRJNA607574			4																	
1387D		1387	352	semi-formed	SRR11395479	PRJNA607574			4																	
1388A		1388	0	formed	SRR11395478	PRJNA607574			19																	
1388B		1388	1	formed	SRR11395477	PRJNA607574			19																	
1388C		1388	2	semi-formed	SRR11395475	PRJNA607574			19																	
1388D		1388	4	formed	SRR11395474	PRJNA607574			19																	
1388E		1388	5	semi-formed	SRR11395473	PRJNA607574			19																	
1388F		1388	6	formed	SRR11395472	PRJNA607574			19																	
1388G		1388	7	formed	SRR11395471	PRJNA607574			19																	
1388H		1388	8	semi-formed	SRR11395470	PRJNA607574			19																	
1388I		1388	11	semi-formed	SRR11395469	PRJNA607574			19																	
1388J		1388	12	liquid	SRR11395468	PRJNA607574			19																	
1388K		1388	13	semi-formed	SRR11395467	PRJNA607574			19																	
1388N		1388	18	semi-formed	SRR11395466	PRJNA607574			19																	
1388O		1388	19	formed	SRR11395464	PRJNA607574			19																	
1388P		1388	21	formed	SRR11395463	PRJNA607574			19																	
1388Q		1388	20	semi-formed	SRR11395462	PRJNA607574			19																	
1388R		1388	76	formed	SRR11395461	PRJNA607574			19																	
1388S		1388	387	formed	SRR11395460	PRJNA607574			19																	
1388T		1388	389	semi-formed	SRR11395459	PRJNA607574			19																	
1388U		1388	399	semi-formed	SRR11395458	PRJNA607574			19																	
1389A		1389	0	formed	SRR11139655	PRJNA606262			2																	
1389B		1389	28	semi-formed	SRR11139992	PRJNA606262			2																	
138A		138	0	formed	SRR11417659	PRJNA545312	-7		5	7	TCD	Leukemia	c95dbe8922fe4d39e7a6f8	248	1		pre	-2								
138B		138	9	liquid	SRR11417658	PRJNA545312	2		5	7	TCD	Leukemia	c95dbe8922fe4d39e7a6f8	248	1		peri	0								
138C		138	11	liquid	SRR11417657	PRJNA545312	4		5	7	TCD	Leukemia	c95dbe8922fe4d39e7a6f8	248	1		peri	0								
138D		138	12	liquid	SRR11417656	PRJNA545312	5		5	7	TCD	Leukemia	c95dbe8922fe4d39e7a6f8	248	1		peri	0								
138E		138	19	liquid	SRR11417654	PRJNA545312	12		5	7	TCD	Leukemia	c95dbe8922fe4d39e7a6f8	248	1		post	1								
1390A		1390	0	liquid	SRR11417653	PRJNA545312	-119		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		pre	-3								
1390B		1390	5	liquid	SRR11417652	PRJNA545312	-114		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		pre	-3								
1390C		1390	118	semi-formed	SRR11417651	PRJNA545312	-1		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		pre	-1								
1390D		1390	123	semi-formed	SRR11417650	PRJNA545312	4		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		peri	0								
1390E		1390	124	semi-formed	SRR11417649	PRJNA545312	5		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		peri	0								
1390F		1390	125	semi-formed	SRR11417620	PRJNA545312	6		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		post	0								
1390G		1390	128	semi-formed	SRR11417619	PRJNA545312	9		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		post	1								
1390H		1390	130	semi-formed	SRR11417618	PRJNA545312	11		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		post	1								
1390I		1390	132	liquid	SRR11417617	PRJNA545312	13		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		post	1								
1390J		1390	133	liquid	SRR11417615	PRJNA545312	14		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		post	1								
1390K		1390	134	liquid	SRR11417614	PRJNA545312	15		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		post	2								
1390L		1390	135	liquid	SRR11417613	PRJNA545312	16		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		post	2								
1390M		1390	137	liquid	SRR11417612	PRJNA545312	18		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		post	2								
1390N		1390	138	liquid	SRR11417611	PRJNA545312	19		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		post	2								
1390O		1390	139	liquid	SRR11417610	PRJNA545312	20		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		post	2								
1390P		1390	140	liquid	SRR11417609	PRJNA545312	21		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		post	2								
1390Q		1390	141	liquid	SRR11417608	PRJNA545312	22		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		post	3								
1390R		1390	146	liquid	SRR11417607	PRJNA545312	27		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		post	3								
1390S		1390	149	liquid	SRR11417606	PRJNA545312	30		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		post	4								
1390T		1390	151	semi-formed	SRR11417604	PRJNA545312	32		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		post	4								
1390U		1390	162	semi-formed	SRR11417603	PRJNA545312	43		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		post	6								
1390V		1390	211		SRR11417602	PRJNA545312	92		22	119	BM_unmodified	Leukemia	86f5c1b1606e937c286695		1		post	6								
1391A		1391	0	formed	SRR11395455	PRJNA607574			1																	
1392A		1392	0	formed	SRR11417601	PRJNA545312	-240		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		pre	-3								
1392B		1392	1	formed	SRR11417600	PRJNA545312	-239		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		pre	-3								
1392C		1392	232	formed	SRR11417599	PRJNA545312	-8		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		pre	-2								
1392D		1392	237	formed	SRR11417598	PRJNA545312	-3		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		pre	-1								
1392E		1392	239	liquid	SRR11417597	PRJNA545312	-1		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		pre	-1								
1392F		1392	240	semi-formed	SRR11417596	PRJNA545312	0		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		peri	-1								
1392G		1392	251	liquid	SRR11417595	PRJNA545312	11		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		post	1								
1392H		1392	252	liquid	SRR11417593	PRJNA545312	12		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		post	1								
1392I		1392	253	semi-formed	SRR11417452	PRJNA545312	13		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		post	1								
1392J		1392	254	semi-formed	SRR11417451	PRJNA545312	14		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		post	1								
1392K		1392	257	semi-formed	SRR11417450	PRJNA545312	17		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		post	2								
1392L		1392	260	semi-formed	SRR11417449	PRJNA545312	20		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		post	2								
1392M		1392	261	semi-formed	SRR11417448	PRJNA545312	21		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		post	2								
1392N		1392	264	liquid	SRR11417447	PRJNA545312	24		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		post	3								
1392O		1392	265	semi-formed	SRR11417446	PRJNA545312	25		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		post	3								
1392P		1392	266	formed	SRR11417445	PRJNA545312	26		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		post	3								
1392Q		1392	267	semi-formed	SRR11417444	PRJNA545312	27		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		post	3								
1392R		1392	268	formed	SRR11417442	PRJNA545312	28		18	240	BM_unmodified	Leukemia	d7ca93f803bcf1e74d37b6		1		post	3								
1393A		1393	0	formed	SRR11417441	PRJNA545312	-8		13	8	BM_unmodified	Aplastic Anemia	7ca2a4bf666200e787770c		1		pre	-2								
1393B		1393	3	formed	SRR11417440	PRJNA545312	-5		13	8	BM_unmodified	Aplastic Anemia	7ca2a4bf666200e787770c		1		pre	-1								
1393C		1393	4	formed	SRR11417439	PRJNA545312	-4		13	8	BM_unmodified	Aplastic Anemia	7ca2a4bf666200e787770c		1		pre	-1								
1393D		1393	5	formed	SRR11417438	PRJNA545312	-3		13	8	BM_unmodified	Aplastic Anemia	7ca2a4bf666200e787770c		1		pre	-1								
1393E		1393	7	formed	SRR11417437	PRJNA545312	-1		13	8	BM_unmodified	Aplastic Anemia	7ca2a4bf666200e787770c		1		pre	-1								
1393F		1393	8	formed	SRR11417436	PRJNA545312	0		13	8	BM_unmodified	Aplastic Anemia	7ca2a4bf666200e787770c		1		peri	-1								
1393G		1393	11	semi-formed	SRR11417435	PRJNA545312	3		13	8	BM_unmodified	Aplastic Anemia	7ca2a4bf666200e787770c		1		peri	0								
1393H		1393	13	semi-formed	SRR11417434	PRJNA545312	5		13	8	BM_unmodified	Aplastic Anemia	7ca2a4bf666200e787770c		1		peri	0								
1393I		1393	14	semi-formed	SRR11417433	PRJNA545312	6		13	8	BM_unmodified	Aplastic Anemia	7ca2a4bf666200e787770c		1		post	0								
1393J		1393	15	formed	SRR11417430	PRJNA545312	7		13	8	BM_unmodified	Aplastic Anemia	7ca2a4bf666200e787770c		1		post	0								
1393K		1393	17	formed	SRR11417429	PRJNA545312	9		13	8	BM_unmodified	Aplastic Anemia	7ca2a4bf666200e787770c		1		post	1								
1393L		1393	21	semi-formed	SRR11417428	PRJNA545312	13		13	8	BM_unmodified	Aplastic Anemia	7ca2a4bf666200e787770c		1		post	1								
1393M		1393	24	semi-formed	SRR11417427	PRJNA545312	16		13	8	BM_unmodified	Aplastic Anemia	7ca2a4bf666200e787770c		1		post	2								
1394A		1394	0	formed	SRR11417426	PRJNA545312	-4		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		pre	-1								
1394B		1394	1	formed	SRR11417425	PRJNA545312	-3		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		pre	-1								
1394C		1394	2	formed	SRR11417963	PRJNA545312	-2		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		pre	-1								
1394D		1394	4	liquid	SRR11417962	PRJNA545312	0		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		peri	-1								
1394E		1394	8	semi-formed	SRR11417961	PRJNA545312	4		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		peri	0								
1394F		1394	9	semi-formed	SRR11417960	PRJNA545312	5		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		peri	0								
1394G		1394	11	semi-formed	SRR11417958	PRJNA545312	7		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		post	0								
1394H		1394	10	liquid	SRR11417957	PRJNA545312	6		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		post	0								
1394I		1394	12	liquid	SRR11417956	PRJNA545312	8		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		post	1								
1394J		1394	14	liquid	SRR11417955	PRJNA545312	10		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		post	1								
1394P		1394	36	liquid	SRR11417954	PRJNA545312	32		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		post	4								
1394Q		1394	37	liquid	SRR11417953	PRJNA545312	33		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		post	4								
1394R		1394	42	formed	SRR11417952	PRJNA545312	38		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		post	5								
1394S		1394	144	semi-formed	SRR11116045	PRJNA607574	140		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		post	6								
1394T		1394	150	formed	SRR11115791	PRJNA607574	146		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		post	6								
1394U		1394	155	semi-formed	SRR11115780	PRJNA607574	151		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		post	6								
1394V		1394	162	semi-formed	SRR11115768	PRJNA607574	158		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		post	6								
1394W		1394	191	semi-formed	SRR11116032	PRJNA607574	187		18	4	PBSC_unmodified	Myelodysplastic Syndromes	2114911c40a09a1244abde		1		post	6								
1395A		1395	0	formed	SRR11139993	PRJNA606262			1																	
1396A		1396	0	liquid	SRR11139786	PRJNA606262			1																	
1397A		1397	0		SRR11395451	PRJNA607574			4																	
1397B		1397	34	semi-formed	SRR11395450	PRJNA607574			4																	
1397C		1397	205	semi-formed	SRR11395449	PRJNA607574			4																	
1397D		1397	387	formed	SRR11395448	PRJNA607574			4																	
1398A		1398	0	formed	SRR11139979	PRJNA606262	-429		13	429	PBSC_unmodified	Multiple Myeloma	ca775ebe4da302611f9478		0		pre	-3								
1398B		1398	18	semi-formed	SRR11139978	PRJNA606262	-411		13	429	PBSC_unmodified	Multiple Myeloma	ca775ebe4da302611f9478		0		pre	-3								
1398C		1398	72		SRR11116021	PRJNA607574	-357		13	429	PBSC_unmodified	Multiple Myeloma	ca775ebe4da302611f9478		0		pre	-3								
1398D		1398	106	semi-formed	SRR11116010	PRJNA607574	-323		13	429	PBSC_unmodified	Multiple Myeloma	ca775ebe4da302611f9478		0		pre	-3								
1398E		1398	244	formed	SRR11115932	PRJNA607574	-185		13	429	PBSC_unmodified	Multiple Myeloma	ca775ebe4da302611f9478		0		pre	-3								
1398F		1398	426	semi-formed	SRR9270369	PRJNA548153	-3		13	429	PBSC_unmodified	Multiple Myeloma	ca775ebe4da302611f9478		0		pre	-1								
1398G		1398	428	semi-formed	SRR9270370	PRJNA548153	-1		13	429	PBSC_unmodified	Multiple Myeloma	ca775ebe4da302611f9478		0		pre	-1								
1398H		1398	429	formed	SRR9270367	PRJNA548153	0		13	429	PBSC_unmodified	Multiple Myeloma	ca775ebe4da302611f9478		0		peri	-1								
1398I		1398	433	formed	SRR9270368	PRJNA548153	4		13	429	PBSC_unmodified	Multiple Myeloma	ca775ebe4da302611f9478		0		peri	0								
1398J		1398	435	formed	SRR9270404	PRJNA548153	6		13	429	PBSC_unmodified	Multiple Myeloma	ca775ebe4da302611f9478		0		post	0								
1398K		1398	436	formed	SRR9270403	PRJNA548153	7		13	429	PBSC_unmodified	Multiple Myeloma	ca775ebe4da302611f9478		0		post	0								
1398L		1398	510	formed	SRR11115921	PRJNA607574	81		13	429	PBSC_unmodified	Multiple Myeloma	ca775ebe4da302611f9478		0		post	6								
1398M		1398	511	formed	SRR11115910	PRJNA607574	82		13	429	PBSC_unmodified	Multiple Myeloma	ca775ebe4da302611f9478		0		post	6								
1399A		1399	0	formed	SRR11395447	PRJNA607574			2																	
1399B		1399	35	liquid	SRR11395446	PRJNA607574			2																	
139A		139	0	formed	SRR11417951	PRJNA545312	-8		3	8	TCD	Leukemia	ad3744deb80643f21c8448	241	1		pre	-2								
139C		139	13	liquid	SRR11417950	PRJNA545312	5		3	8	TCD	Leukemia	ad3744deb80643f21c8448	241	1		peri	0								
139D		139	19	liquid	SRR11417949	PRJNA545312	11		3	8	TCD	Leukemia	ad3744deb80643f21c8448	241	1		post	1								
1400A		1400	0	semi-formed	SRR11417947	PRJNA545312	-5		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		pre	-1								
1400B		1400	3	formed	SRR11417946	PRJNA545312	-2		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		pre	-1								
1400C		1400	4	formed	SRR11417945	PRJNA545312	-1		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		pre	-1								
1400D		1400	6	formed	SRR11417944	PRJNA545312	1		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		peri	0								
1400E		1400	5	formed	SRR11417943	PRJNA545312	0		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		peri	-1								
1400F		1400	7	semi-formed	SRR11417942	PRJNA545312	2		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		peri	0								
1400G		1400	8	semi-formed	SRR11417941	PRJNA545312	3		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		peri	0								
1400H		1400	10	formed	SRR11417940	PRJNA545312	5		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		peri	0								
1400I		1400	11	semi-formed	SRR11417939	PRJNA545312	6		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		post	0								
1400J		1400	12	liquid	SRR11417938	PRJNA545312	7		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		post	0								
1400K		1400	13	liquid	SRR11417936	PRJNA545312	8		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		post	1								
1400M		1400	14	semi-formed	SRR11417850	PRJNA545312	9		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		post	1								
1400N		1400	17	semi-formed	SRR11417849	PRJNA545312	12		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		post	1								
1400O		1400	18	formed	SRR11417848	PRJNA545312	13		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		post	1								
1400P		1400	19	formed	SRR11417847	PRJNA545312	14		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		post	1								
1400Q		1400	20	formed	SRR11417846	PRJNA545312	15		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		post	2								
1400R		1400	22	semi-formed	SRR11417845	PRJNA545312	17		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		post	2								
1400S		1400	24	formed	SRR11417844	PRJNA545312	19		18	5	PBSC_unmodified	Leukemia	ea42dedafcda4a9f91e613		1		post	2								
1401A		1401	0	liquid	SRR11139625	PRJNA606262			1																	
1402A		1402	0	formed	SRR11140196	PRJNA606262			2																	
1402B		1402	6	liquid	SRR11140194	PRJNA606262			2																	
1403A		1403	0	semi-formed	SRR11417843	PRJNA545312	5	SRR14092340	12	-5	PBSC_unmodified	Myelodysplastic Syndromes	20a3b8a02f623b1be28e09		1		peri	0								
1403B		1403	3	semi-formed	SRR11417841	PRJNA545312	8	SRR14092339	12	-5	PBSC_unmodified	Myelodysplastic Syndromes	20a3b8a02f623b1be28e09		1		post	1								
1403C		1403	2	liquid	SRR11417840	PRJNA545312	7	SRR13697185	12	-5	PBSC_unmodified	Myelodysplastic Syndromes	20a3b8a02f623b1be28e09		1		post	0								
1403D		1403	5	semi-formed	SRR11417839	PRJNA545312	10		12	-5	PBSC_unmodified	Myelodysplastic Syndromes	20a3b8a02f623b1be28e09		1		post	1								
1403E		1403	7	liquid	SRR11417838	PRJNA545312	12		12	-5	PBSC_unmodified	Myelodysplastic Syndromes	20a3b8a02f623b1be28e09		1		post	1								
1403F		1403	9	liquid	SRR11417837	PRJNA545312	14		12	-5	PBSC_unmodified	Myelodysplastic Syndromes	20a3b8a02f623b1be28e09		1		post	1								
1403G		1403	10	liquid	SRR11417836	PRJNA545312	15		12	-5	PBSC_unmodified	Myelodysplastic Syndromes	20a3b8a02f623b1be28e09		1		post	2								
1403H		1403	11	liquid	SRR11417835	PRJNA545312	16	SRR14092338	12	-5	PBSC_unmodified	Myelodysplastic Syndromes	20a3b8a02f623b1be28e09		1		post	2								
1403I		1403	12	liquid	SRR11417834	PRJNA545312	17		12	-5	PBSC_unmodified	Myelodysplastic Syndromes	20a3b8a02f623b1be28e09		1		post	2								
1403J		1403	14	liquid	SRR11417833	PRJNA545312	19		12	-5	PBSC_unmodified	Myelodysplastic Syndromes	20a3b8a02f623b1be28e09		1		post	2								
1403K		1403	15	liquid	SRR11417832	PRJNA545312	20		12	-5	PBSC_unmodified	Myelodysplastic Syndromes	20a3b8a02f623b1be28e09		1		post	2								
1403L		1403	16	semi-formed	SRR11417830	PRJNA545312	21		12	-5	PBSC_unmodified	Myelodysplastic Syndromes	20a3b8a02f623b1be28e09		1		post	2								
1404A		1404	0	semi-formed	SRR11417829	PRJNA545312	-3		5	3	TCD	Multiple Myeloma	c658ed3532040a8ec42393		1		pre	-1								
1404D		1404	12	formed	SRR11417828	PRJNA545312	9		5	3	TCD	Multiple Myeloma	c658ed3532040a8ec42393		1		post	1								
1404E		1404	13	formed	SRR11417827	PRJNA545312	10		5	3	TCD	Multiple Myeloma	c658ed3532040a8ec42393		1		post	1								
1404F		1404	14	semi-formed	SRR11417826	PRJNA545312	11		5	3	TCD	Multiple Myeloma	c658ed3532040a8ec42393		1		post	1								
1404G		1404	15	semi-formed	SRR11417031	PRJNA545312	12		5	3	TCD	Multiple Myeloma	c658ed3532040a8ec42393		1		post	1								
1405A		1405	0	formed	SRR11139682	PRJNA606262			1																	
1406A		1406	0	formed	SRR11417029	PRJNA545312	-8		13	8	TCD	Leukemia	8896c73e545046793fc111		1		pre	-2								
1406B		1406	1	formed	SRR11417028	PRJNA545312	-7		13	8	TCD	Leukemia	8896c73e545046793fc111		1		pre	-2								
1406C		1406	2	semi-formed	SRR11417027	PRJNA545312	-6		13	8	TCD	Leukemia	8896c73e545046793fc111		1		pre	-1								
1406D		1406	4	formed	SRR11417026	PRJNA545312	-4		13	8	TCD	Leukemia	8896c73e545046793fc111		1		pre	-1								
1406E		1406	6	liquid	SRR11417025	PRJNA545312	-2		13	8	TCD	Leukemia	8896c73e545046793fc111		1		pre	-1								
1406G		1406	11	liquid	SRR11417024	PRJNA545312	3		13	8	TCD	Leukemia	8896c73e545046793fc111		1		peri	0								
1406H		1406	12	liquid	SRR11417023	PRJNA545312	4		13	8	TCD	Leukemia	8896c73e545046793fc111		1		peri	0								
1406I		1406	14	semi-formed	SRR11417022	PRJNA545312	6		13	8	TCD	Leukemia	8896c73e545046793fc111		1		post	0								
1406J		1406	15	semi-formed	SRR11417021	PRJNA545312	7		13	8	TCD	Leukemia	8896c73e545046793fc111		1		post	0								
1406K		1406	16	semi-formed	SRR11417020	PRJNA545312	8		13	8	TCD	Leukemia	8896c73e545046793fc111		1		post	1								
1406L		1406	18	liquid	SRR11417825	PRJNA545312	10		13	8	TCD	Leukemia	8896c73e545046793fc111		1		post	1								
1406N		1406	20	semi-formed	SRR11417824	PRJNA545312	12		13	8	TCD	Leukemia	8896c73e545046793fc111		1		post	1								
1406O		1406	22	liquid	SRR11417750	PRJNA545312	14		13	8	TCD	Leukemia	8896c73e545046793fc111		1		post	1								
1407B		1407	1	semi-formed	SRR11395440	PRJNA607574			25																	
1407C		1407	3	semi-formed	SRR11395439	PRJNA607574			25																	
1407D		1407	9	formed	SRR11395438	PRJNA607574			25																	
1407E		1407	15	semi-formed	SRR11395437	PRJNA607574			25																	
1407F		1407	19	liquid	SRR11395436	PRJNA607574			25																	
1407G		1407	21	semi-formed	SRR11395435	PRJNA607574			25																	
1407H		1407	37	semi-formed	SRR11395434	PRJNA607574			25																	
1407I		1407	43	liquid	SRR11395433	PRJNA607574			25																	
1407J		1407	48	semi-formed	SRR11395431	PRJNA607574			25																	
1407K		1407	49	semi-formed	SRR11395430	PRJNA607574			25																	
1407L		1407	64	semi-formed	SRR11395429	PRJNA607574			25																	
1407M		1407	72	liquid	SRR11395428	PRJNA607574			25																	
1407MA		1407	0	formed	SRR11395427	PRJNA607574			25																	
1407N		1407	75	liquid	SRR11395426	PRJNA607574			25																	
1407O		1407	77	semi-formed	SRR11395425	PRJNA607574			25																	
1407P		1407	100	liquid	SRR11395424	PRJNA607574			25																	
1407Q		1407	101	liquid	SRR11395423	PRJNA607574			25																	
1407R		1407	107	liquid	SRR11395422	PRJNA607574			25																	
1407S		1407	115	semi-formed	SRR11395420	PRJNA607574			25																	
1407T		1407	128	liquid	SRR11395419	PRJNA607574			25																	
1407U		1407	177	semi-formed	SRR11395418	PRJNA607574			25																	
1407V		1407	183	semi-formed	SRR11395417	PRJNA607574			25																	
1407W		1407	185	semi-formed	SRR11395416	PRJNA607574			25																	
1407X		1407	240	formed	SRR11395415	PRJNA607574			25																	
1407Y		1407	336	semi-formed	SRR11395414	PRJNA607574			25																	
1408A		1408	0	semi-formed	SRR11395413	PRJNA607574			1																	
1409A		1409	1	formed	SRR11395412	PRJNA607574			14																	
1409B		1409	0	formed	SRR11395411	PRJNA607574			14																	
1409C		1409	2	semi-formed	SRR11395408	PRJNA607574			14																	
1409D		1409	4	liquid	SRR11395407	PRJNA607574			14																	
1409E		1409	5	liquid	SRR11395406	PRJNA607574			14																	
1409F		1409	7	semi-formed	SRR11395405	PRJNA607574			14																	
1409G		1409	8	semi-formed	SRR11395404	PRJNA607574			14																	
1409H		1409	9	formed	SRR11395403	PRJNA607574			14																	
1409J		1409	11	semi-formed	SRR11395402	PRJNA607574			14																	
1409K		1409	14	semi-formed	SRR11395401	PRJNA607574			14																	
1409L		1409	15	semi-formed	SRR11395400	PRJNA607574			14																	
1409M		1409	16	semi-formed	SRR11395399	PRJNA607574			14																	
1409N		1409	17	semi-formed	SRR11395397	PRJNA607574			14																	
1409O		1409	30	semi-formed	SRR11395396	PRJNA607574			14																	
140A		140	0	semi-formed	SRR11417749	PRJNA545312	236		1	-236	PBSC_unmodified	Hodgkin's Disease	ffe9adf3d8b0ab843ff29e		1		post	6								
1410A		1410	0		SRR11395395	PRJNA607574			4																	
1410B		1410	43	formed	SRR11395394	PRJNA607574			4																	
1410C		1410	106	formed	SRR11395393	PRJNA607574			4																	
1410D		1410	365	formed	SRR11395392	PRJNA607574			4																	
1411A		1411	0		SRR11395391	PRJNA607574			4																	
1411B		1411	71	formed	SRR11395390	PRJNA607574			4																	
1411C		1411	98	semi-formed	SRR11395389	PRJNA607574			4																	
1411D		1411	352	semi-formed	SRR11395388	PRJNA607574			4																	
1412A		1412	0	liquid	SRR11139662	PRJNA606262			3																	
1412B		1412	1	semi-formed	SRR11139661	PRJNA606262			3																	
1412C		1412	2	semi-formed	SRR11139660	PRJNA606262			3																	
1413A		1413	0	formed	SRR11139649	PRJNA606262			4																	
1413B		1413	5	formed	SRR11139996	PRJNA606262			4																	
1413C		1413	6	liquid	SRR11139995	PRJNA606262			4																	
1413D		1413	11	semi-formed	SRR11139994	PRJNA606262			4																	
1414A		1414	0	semi-formed	SRR11417748	PRJNA545312	4		10	-4	PBSC_unmodified	Leukemia	ca1951f22b6048fc586dd6		1		peri	0								
1414B		1414	1	formed	SRR11417746	PRJNA545312	5	SRR13697184	10	-4	PBSC_unmodified	Leukemia	ca1951f22b6048fc586dd6		1		peri	0								
1414C		1414	3	formed	SRR11417745	PRJNA545312	7		10	-4	PBSC_unmodified	Leukemia	ca1951f22b6048fc586dd6		1		post	0								
1414D		1414	4	formed	SRR11417744	PRJNA545312	8		10	-4	PBSC_unmodified	Leukemia	ca1951f22b6048fc586dd6		1		post	1								
1414E		1414	5	formed	SRR11417743	PRJNA545312	9		10	-4	PBSC_unmodified	Leukemia	ca1951f22b6048fc586dd6		1		post	1								
1414F		1414	7	formed	SRR11417742	PRJNA545312	11		10	-4	PBSC_unmodified	Leukemia	ca1951f22b6048fc586dd6		1		post	1								
1414G		1414	8	semi-formed	SRR11417741	PRJNA545312	12		10	-4	PBSC_unmodified	Leukemia	ca1951f22b6048fc586dd6		1		post	1								
1414H		1414	9	semi-formed	SRR11417740	PRJNA545312	13	SRR14092337	10	-4	PBSC_unmodified	Leukemia	ca1951f22b6048fc586dd6		1		post	1								
1414I		1414	10	semi-formed	SRR11417739	PRJNA545312	14		10	-4	PBSC_unmodified	Leukemia	ca1951f22b6048fc586dd6		1		post	1								
1414J		1414	11	formed	SRR11417738	PRJNA545312	15		10	-4	PBSC_unmodified	Leukemia	ca1951f22b6048fc586dd6		1		post	2								
1415A		1415	0	formed	SRR11139681	PRJNA606262			8																	
1415B		1415	8	semi-formed	SRR11139680	PRJNA606262			8																	
1415C		1415	14	semi-formed	SRR11139679	PRJNA606262			8																	
1415D		1415	31	semi-formed	SRR11139678	PRJNA606262			8																	
1415E		1415	45	semi-formed	SRR11139676	PRJNA606262			8																	
1415F		1415	109	semi-formed	SRR11395309	PRJNA607574			8																	
1415G		1415	136	semi-formed	SRR11395308	PRJNA607574			8																	
1415H		1415	193	semi-formed	SRR11395307	PRJNA607574			8																	
1416A		1416	0	liquid	SRR11395306	PRJNA607574			1																	
1417A		1417	0	semi-formed	SRR11395305	PRJNA607574			2																	
1417B		1417	111	formed	SRR11395304	PRJNA607574			2																	
1418A		1418	0	semi-formed	SRR11395303	PRJNA607574			4																	
1418B		1418	39	formed	SRR11395302	PRJNA607574			4																	
1418C		1418	94	semi-formed	SRR11395300	PRJNA607574			4																	
1418D		1418	382	formed	SRR11395299	PRJNA607574			4																	
1419A		1419	0	semi-formed	SRR11417737	PRJNA545312	48		3	-48	PBSC_unmodified	Non-Hodgkin's Lymphoma	933c5e3ce23f4663b87ed8		1		post	6								
1419B		1419	17	semi-formed	SRR11417735	PRJNA545312	65		3	-48	PBSC_unmodified	Non-Hodgkin's Lymphoma	933c5e3ce23f4663b87ed8		1		post	6								
1419C		1419	70	semi-formed	SRR11417734	PRJNA545312	118		3	-48	PBSC_unmodified	Non-Hodgkin's Lymphoma	933c5e3ce23f4663b87ed8		1		post	6								
1420A		1420	0	semi-formed	SRR11395298	PRJNA607574			4																	
1420B		1420	29	semi-formed	SRR11395297	PRJNA607574			4																	
1420C		1420	85	formed	SRR11395296	PRJNA607574			4																	
1420D		1420	343	formed	SRR11395295	PRJNA607574			4																	
1421A		1421	0	semi-formed	SRR11395294	PRJNA607574			5																	
1421B		1421	7	semi-formed	SRR11395293	PRJNA607574			5																	
1421C		1421	56	semi-formed	SRR11395292	PRJNA607574			5																	
1421D		1421	122	semi-formed	SRR11395291	PRJNA607574			5																	
1421E		1421	356	semi-formed	SRR11395075	PRJNA607574			5																	
1422A		1422	0	semi-formed	SRR11395074	PRJNA607574			1																	
1423A		1423	0	formed	SRR11140053	PRJNA606262			3																	
1423B		1423	12	semi-formed	SRR11140052	PRJNA606262			3																	
1423C		1423	14	liquid	SRR11140051	PRJNA606262			3																	
1424A		1424	0	formed	SRR11140228	PRJNA606262			3																	
1424B		1424	8	liquid	SRR11140227	PRJNA606262			3																	
1424C		1424	11	formed	SRR11140226	PRJNA606262			3																	
1425A		1425	0	liquid	SRR11417733	PRJNA545312	10		6	-10	cord	Leukemia	bd38471ffb7633a962b455		1		post	1								
1425B		1425	1	semi-formed	SRR11417732	PRJNA545312	11		6	-10	cord	Leukemia	bd38471ffb7633a962b455		1		post	1								
1425C		1425	3	semi-formed	SRR11417731	PRJNA545312	13		6	-10	cord	Leukemia	bd38471ffb7633a962b455		1		post	1								
1425D		1425	4	liquid	SRR11417730	PRJNA545312	14		6	-10	cord	Leukemia	bd38471ffb7633a962b455		1		post	1								
1425E		1425	8	liquid	SRR11417729	PRJNA545312	18		6	-10	cord	Leukemia	bd38471ffb7633a962b455		1		post	2								
1425F		1425	10	semi-formed	SRR11417728	PRJNA545312	20		6	-10	cord	Leukemia	bd38471ffb7633a962b455		1		post	2								
1426A		1426	0	semi-formed	SRR11417727	PRJNA545312	-4		4	4	BM_unmodified	Myelodysplastic Syndromes	c97e360e325748953e486c		1		pre	-1								
1426B		1426	1	liquid	SRR11417726	PRJNA545312	-3		4	4	BM_unmodified	Myelodysplastic Syndromes	c97e360e325748953e486c		1		pre	-1								
1426C		1426	2	liquid	SRR11417724	PRJNA545312	-2		4	4	BM_unmodified	Myelodysplastic Syndromes	c97e360e325748953e486c		1		pre	-1								
1426D		1426	3	semi-formed	SRR11417723	PRJNA545312	-1		4	4	BM_unmodified	Myelodysplastic Syndromes	c97e360e325748953e486c		1		pre	-1								
1427A		1427	0	formed	SRR11140057	PRJNA606262			3																	
1427B		1427	8	formed	SRR11140056	PRJNA606262			3																	
1427C		1427	30	formed	SRR11140054	PRJNA606262			3																	
1428A		1428	0	semi-formed	SRR11417396	PRJNA545312	-17		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		pre	-3								
1428AA		1428	39	liquid	SRR11417395	PRJNA545312	22		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	3								
1428B		1428	8	semi-formed	SRR11417394	PRJNA545312	-9		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		pre	-2								
1428BB		1428	41	liquid	SRR11417393	PRJNA545312	24		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	3								
1428C		1428	9	liquid	SRR11417392	PRJNA545312	-8		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		pre	-2								
1428CC		1428	42	semi-formed	SRR11417391	PRJNA545312	25		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	3								
1428D		1428	11	semi-formed	SRR11417390	PRJNA545312	-6		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		pre	-1								
1428DD		1428	43	liquid	SRR11417389	PRJNA545312	26		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	3								
1428E		1428	10	liquid	SRR11417387	PRJNA545312	-7		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		pre	-2								
1428EE		1428	44	liquid	SRR11417386	PRJNA545312	27		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	3								
1428F		1428	13	liquid	SRR11417385	PRJNA545312	-4		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		pre	-1								
1428G		1428	14	liquid	SRR11417383	PRJNA545312	-3		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		pre	-1								
1428GG		1428	45	liquid	SRR11417382	PRJNA545312	28		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	3								
1428H		1428	15	liquid	SRR11417381	PRJNA545312	-2		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		pre	-1								
1428HH		1428	46	liquid	SRR11417380	PRJNA545312	29		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	4								
1428I		1428	16	liquid	SRR11417379	PRJNA545312	-1		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		pre	-1								
1428II		1428	48	liquid	SRR11417378	PRJNA545312	31		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	4								
1428JJ		1428	49	semi-formed	SRR11417375	PRJNA545312	32		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	4								
1428K		1428	18	semi-formed	SRR11417374	PRJNA545312	1		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		peri	0								
1428KK		1428	50	semi-formed	SRR11417373	PRJNA545312	33		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	4								
1428L		1428	20	liquid	SRR11417372	PRJNA545312	3		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		peri	0								
1428LL		1428	52	semi-formed	SRR11417371	PRJNA545312	35		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	4								
1428M		1428	21	liquid	SRR11417370	PRJNA545312	4		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		peri	0								
1428MM		1428	56	semi-formed	SRR11417369	PRJNA545312	39		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	5								
1428N		1428	22	liquid	SRR11418281	PRJNA545312	5		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		peri	0								
1428NN		1428	71	semi-formed	SRR11418280	PRJNA545312	54		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	6								
1428O		1428	23	semi-formed	SRR11418279	PRJNA545312	6		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	0								
1428OO		1428	116	semi-formed	SRR11418277	PRJNA545312	99		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	6								
1428P		1428	24	semi-formed	SRR11418276	PRJNA545312	7		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	0								
1428Q		1428	25	formed	SRR11418275	PRJNA545312	8		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	1								
1428R		1428	27	liquid	SRR11418274	PRJNA545312	10		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	1								
1428S		1428	28	semi-formed	SRR11418273	PRJNA545312	11		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	1								
1428T		1428	29	liquid	SRR11418272	PRJNA545312	12		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	1								
1428U		1428	30	liquid	SRR11418271	PRJNA545312	13		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	1								
1428V		1428	31	liquid	SRR11418270	PRJNA545312	14		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	1								
1428W		1428	32	liquid	SRR11418269	PRJNA545312	15		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	2								
1428X		1428	34	liquid	SRR11418268	PRJNA545312	17		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	2								
1428Y		1428	35	liquid	SRR11418266	PRJNA545312	18		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	2								
1428Z		1428	37	liquid	SRR11418265	PRJNA545312	20		39	17	TCD	Leukemia	8dc3170c78f80dd01a3895		1		post	2								
1429A		1429	0	formed	SRR11395063	PRJNA607574			4																	
1429B		1429	40	formed	SRR11395062	PRJNA607574			4																	
1429C		1429	111	formed	SRR11395061	PRJNA607574			4																	
1429D		1429	370	formed	SRR11395060	PRJNA607574			4																	
142A		142	0	formed	SRR11418264	PRJNA545312	-4		9	4	TCD	Leukemia	d6700d853c73e54471d95c	233	1		pre	-1								
142B		142	2	liquid	SRR11418263	PRJNA545312	-2		9	4	TCD	Leukemia	d6700d853c73e54471d95c	233	1		pre	-1								
142D		142	16	liquid	SRR11418262	PRJNA545312	12		9	4	TCD	Leukemia	d6700d853c73e54471d95c	233	1		post	1								
142E		142	22	liquid	SRR11418261	PRJNA545312	18		9	4	TCD	Leukemia	d6700d853c73e54471d95c	233	1		post	2								
142F		142	72	liquid	SRR11418260	PRJNA545312	68		9	4	TCD	Leukemia	d6700d853c73e54471d95c	233	1		post	6								
142G		142	82	liquid	SRR11418259	PRJNA545312	78		9	4	TCD	Leukemia	d6700d853c73e54471d95c	233	1		post	6								
142H		142	93	liquid	SRR11418258	PRJNA545312	89		9	4	TCD	Leukemia	d6700d853c73e54471d95c	233	1		post	6								
142I		142	142	liquid	SRR11418257	PRJNA545312	138		9	4	TCD	Leukemia	d6700d853c73e54471d95c	233	1		post	6								
142J		142	149	liquid	SRR11418255	PRJNA545312	145		9	4	TCD	Leukemia	d6700d853c73e54471d95c	233	1		post	6								
1430A		1430	0	semi-formed	SRR11395059	PRJNA607574			4																	
1430B		1430	27	formed	SRR11395058	PRJNA607574			4																	
1430C		1430	76	semi-formed	SRR11395057	PRJNA607574			4																	
1430D		1430	426	formed	SRR11395056	PRJNA607574			4																	
1431A		1431	0	liquid	SRR11418254	PRJNA545312	-2		7	2	TCD	Leukemia	ebe72582da5c7f8a5803bc		1		pre	-1								
1431B		1431	1	liquid	SRR11418225	PRJNA545312	-1		7	2	TCD	Leukemia	ebe72582da5c7f8a5803bc		1		pre	-1								
1431C		1431	4	liquid	SRR11418224	PRJNA545312	2		7	2	TCD	Leukemia	ebe72582da5c7f8a5803bc		1		peri	0								
1431D		1431	6	liquid	SRR11418223	PRJNA545312	4		7	2	TCD	Leukemia	ebe72582da5c7f8a5803bc		1		peri	0								
1431E		1431	12	semi-formed	SRR11418222	PRJNA545312	10		7	2	TCD	Leukemia	ebe72582da5c7f8a5803bc		1		post	1								
1431F		1431	13	liquid	SRR11418221	PRJNA545312	11		7	2	TCD	Leukemia	ebe72582da5c7f8a5803bc		1		post	1								
1431G		1431	14	liquid	SRR11418220	PRJNA545312	12		7	2	TCD	Leukemia	ebe72582da5c7f8a5803bc		1		post	1								
1432A		1432	0	formed	SRR11418219	PRJNA545312	-7		14	7	TCD	Leukemia	edf072fa8d18450bfa5b93		1		pre	-2								
1432B		1432	3	formed	SRR11418218	PRJNA545312	-4		14	7	TCD	Leukemia	edf072fa8d18450bfa5b93		1		pre	-1								
1432C		1432	4	semi-formed	SRR11418216	PRJNA545312	-3		14	7	TCD	Leukemia	edf072fa8d18450bfa5b93		1		pre	-1								
1432D		1432	6	liquid	SRR11418215	PRJNA545312	-1		14	7	TCD	Leukemia	edf072fa8d18450bfa5b93		1		pre	-1								
1432F		1432	7	liquid	SRR11418213	PRJNA545312	0		14	7	TCD	Leukemia	edf072fa8d18450bfa5b93		1		peri	-1								
1432G		1432	8	liquid	SRR11418212	PRJNA545312	1		14	7	TCD	Leukemia	edf072fa8d18450bfa5b93		1		peri	0								
1432H		1432	11	semi-formed	SRR11418211	PRJNA545312	4		14	7	TCD	Leukemia	edf072fa8d18450bfa5b93		1		peri	0								
1432I		1432	12	semi-formed	SRR11418210	PRJNA545312	5		14	7	TCD	Leukemia	edf072fa8d18450bfa5b93		1		peri	0								
1432J		1432	13	semi-formed	SRR11418209	PRJNA545312	6		14	7	TCD	Leukemia	edf072fa8d18450bfa5b93		1		post	0								
1432K		1432	14	semi-formed	SRR11418208	PRJNA545312	7		14	7	TCD	Leukemia	edf072fa8d18450bfa5b93		1		post	0								
1432L		1432	15	semi-formed	SRR11418207	PRJNA545312	8		14	7	TCD	Leukemia	edf072fa8d18450bfa5b93		1		post	1								
1432M		1432	18	semi-formed	SRR11418205	PRJNA545312	11		14	7	TCD	Leukemia	edf072fa8d18450bfa5b93		1		post	1								
1432N		1432	19	liquid	SRR11418204	PRJNA545312	12		14	7	TCD	Leukemia	edf072fa8d18450bfa5b93		1		post	1								
1432O		1432	20	semi-formed	SRR11418203	PRJNA545312	13		14	7	TCD	Leukemia	edf072fa8d18450bfa5b93		1		post	1								
1433A		1433	0	liquid	SRR11395055	PRJNA607574			3																	
1433B		1433	7	semi-formed	SRR11395053	PRJNA607574			3																	
1433C		1433	49	formed	SRR11395052	PRJNA607574			3																	
1434A		1434	0	semi-formed	SRR11395051	PRJNA607574			5																	
1434B		1434	4	semi-formed	SRR11395050	PRJNA607574			5																	
1434C		1434	5	semi-formed	SRR11395049	PRJNA607574			5																	
1434D		1434	6	semi-formed	SRR11395048	PRJNA607574			5																	
1434E		1434	7	semi-formed	SRR11395047	PRJNA607574			5																	
1435A		1435	0	semi-formed	SRR11395046	PRJNA607574			7																	
1435B		1435	6	liquid	SRR11395045	PRJNA607574			7																	
1435C		1435	13	formed	SRR11394980	PRJNA607574			7																	
1435D		1435	48	formed	SRR11394978	PRJNA607574			7																	
1435E		1435	139	formed	SRR11394977	PRJNA607574			7																	
1435F		1435	221	formed	SRR11394976	PRJNA607574			7																	
1435G		1435	606	semi-formed	SRR11394975	PRJNA607574			7																	
1436A		1436	0	formed	SRR11140037	PRJNA606262			5																	
1436B		1436	5	formed	SRR11140036	PRJNA606262			5																	
1436C		1436	11	liquid	SRR11140035	PRJNA606262			5																	
1436D		1436	16	semi-formed	SRR11140034	PRJNA606262			5																	
1436E		1436	24	semi-formed	SRR11140031	PRJNA606262			5																	
1437A		1437	0	semi-formed	SRR11394969	PRJNA607574			26																	
1437AA		1437	604	liquid	SRR11394967	PRJNA607574			26																	
1437B		1437	8	semi-formed	SRR11394966	PRJNA607574			26																	
1437BB		1437	651	semi-formed	SRR11394965	PRJNA607574			26																	
1437C		1437	9	semi-formed	SRR11394964	PRJNA607574			26																	
1437D		1437	10	semi-formed	SRR11394963	PRJNA607574			26																	
1437E		1437	12	semi-formed	SRR11394962	PRJNA607574			26																	
1437G		1437	13	semi-formed	SRR11394961	PRJNA607574			26																	
1437H		1437	14	liquid	SRR11394960	PRJNA607574			26																	
1437I		1437	54	liquid	SRR11394959	PRJNA607574			26																	
1437K		1437	55	semi-formed	SRR11394958	PRJNA607574			26																	
1437L		1437	56	semi-formed	SRR11394955	PRJNA607574			26																	
1437M		1437	57	semi-formed	SRR11394954	PRJNA607574			26																	
1437N		1437	89	semi-formed	SRR11394953	PRJNA607574			26																	
1437O		1437	98	semi-formed	SRR11394952	PRJNA607574			26																	
1437P		1437	126	semi-formed	SRR11394951	PRJNA607574			26																	
1437Q		1437	127	semi-formed	SRR11394950	PRJNA607574			26																	
1437R		1437	134	semi-formed	SRR11394949	PRJNA607574			26																	
1437S		1437	135	semi-formed	SRR11394948	PRJNA607574			26																	
1437T		1437	136	semi-formed	SRR11394947	PRJNA607574			26																	
1437U		1437	177	semi-formed	SRR11394946	PRJNA607574			26																	
1437V		1437	192	liquid	SRR11394944	PRJNA607574			26																	
1437W		1437	225	semi-formed	SRR11394943	PRJNA607574			26																	
1437X		1437	267	semi-formed	SRR11394942	PRJNA607574			26																	
1437Y		1437	517	liquid	SRR11394941	PRJNA607574			26																	
1437Z		1437	597	semi-formed	SRR11394940	PRJNA607574			26																	
1438A		1438	0	semi-formed	SRR11394939	PRJNA607574			7																	
1438B		1438	12	formed	SRR11394938	PRJNA607574			7																	
1438C		1438	162	liquid	SRR11394937	PRJNA607574			7																	
1438D		1438	196	semi-formed	SRR11394936	PRJNA607574			7																	
1438E		1438	265	semi-formed	SRR11394935	PRJNA607574			7																	
1438F		1438	520	semi-formed	SRR11394933	PRJNA607574			7																	
1438G		1438	603	semi-formed	SRR11394932	PRJNA607574			7																	
1439A		1439	0	liquid	SRR11139775	PRJNA606262			3																	
1439B		1439	5	semi-formed	SRR11139774	PRJNA606262			3																	
1439C		1439	19	formed	SRR11139773	PRJNA606262			3																	
143A		143	0	formed	SRR11418202	PRJNA545312	-5		4	5	PBSC_unmodified	Hodgkin's Disease	2c2d0264cb2787b9788779	252	1		pre	-1								
143B		143	8	formed	SRR11418201	PRJNA545312	3		4	5	PBSC_unmodified	Hodgkin's Disease	2c2d0264cb2787b9788779	252	1		peri	0								
143C		143	18	formed	SRR11418200	PRJNA545312	13		4	5	PBSC_unmodified	Hodgkin's Disease	2c2d0264cb2787b9788779	252	1		post	1								
143D		143	65	formed	SRR11418199	PRJNA545312	60		4	5	PBSC_unmodified	Hodgkin's Disease	2c2d0264cb2787b9788779	252	1		post	6								
1440A		1440	0	formed	SRR11139665	PRJNA606262			2																	
1440C		1440	11	semi-formed	SRR11139664	PRJNA606262			2																	
1441A		1441	0	formed	SRR11140058	PRJNA606262			1																	
1442A		1442	0	formed	SRR11418198	PRJNA545312	-5		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		pre	-1								
1442AA		1442	285	liquid	SRR9271387	PRJNA548153	13		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	1								
1442B		1442	4	semi-formed	SRR11418113	PRJNA545312	-1		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		pre	-1								
1442BB		1442	286	liquid	SRR9271388	PRJNA548153	14		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	1								
1442C		1442	5	semi-formed	SRR11418112	PRJNA545312	0		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		peri	-1								
1442CC		1442	290	liquid	SRR11115998	PRJNA607574	18		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	2								
1442D		1442	7	formed	SRR11418110	PRJNA545312	2		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		peri	0								
1442DD		1442	291	liquid	SRR11115987	PRJNA607574	19		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	2								
1442E		1442	8	semi-formed	SRR11418109	PRJNA545312	3		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		peri	0								
1442EE		1442	292	liquid	SRR11115976	PRJNA607574	20		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	2								
1442F		1442	10	formed	SRR11418108	PRJNA545312	5		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		peri	0								
1442FF		1442	293	liquid	SRR11115961	PRJNA607574	21		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	2								
1442G		1442	11	liquid	SRR11418107	PRJNA545312	6		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	0								
1442GG		1442	294	liquid	SRR11115950	PRJNA607574	22		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	3								
1442H		1442	13	semi-formed	SRR11418106	PRJNA545312	8		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	1								
1442HH		1442	295	liquid	SRR11115763	PRJNA607574	23		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	3								
1442I		1442	17	liquid	SRR11418105	PRJNA545312	12		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	1								
1442II		1442	297	liquid	SRR11115752	PRJNA607574	25		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	3								
1442J		1442	18	liquid	SRR11418104	PRJNA545312	13		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	1								
1442JJ		1442	298	liquid	SRR11115741	PRJNA607574	26		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	3								
1442K		1442	19	semi-formed	SRR11418103	PRJNA545312	14		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	1								
1442KK		1442	301	formed	SRR11115730	PRJNA607574	29		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	4								
1442L		1442	21	liquid	SRR11418102	PRJNA545312	16		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	2								
1442M		1442	24	formed	SRR11418101	PRJNA545312	19		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	2								
1442N		1442	25	formed	SRR11418099	PRJNA545312	20		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	2								
1442O		1442	265	formed	SRR11418098	PRJNA545312	-7		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		pre	-2								
1442P		1442	266	formed	SRR11423301	PRJNA545312	-6		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		pre	-1								
1442Q		1442	270	semi-formed	SRR11418097	PRJNA545312	-2		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		pre	-1								
1442R		1442	271	formed	SRR11418096	PRJNA545312	-1		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		pre	-1								
1442S		1442	272	formed	SRR11418095	PRJNA545312	0		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		peri	-1								
1442T		1442	273	semi-formed	SRR11418094	PRJNA545312	1		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		peri	0								
1442U		1442	277	liquid	SRR11418093	PRJNA545312	5		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		peri	0								
1442W		1442	278	liquid	SRR11418091	PRJNA545312	6		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	0								
1442X		1442	280	liquid	SRR11418090	PRJNA545312	8		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	1								
1442Y		1442	283	liquid	SRR11418088	PRJNA545312	11		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	1								
1442Z		1442	284	liquid	SRR9271385	PRJNA548153	12		36	272	PBSC_unmodified	Leukemia	bd1ad86cf0226b12066f99		1		post	1								
1443A		1443	0	formed	SRR11418087	PRJNA545312	-8		10	8	TCD	Leukemia	9cbe8bf31dec8288983fb1		1		pre	-2								
1443B		1443	1	formed	SRR11423290	PRJNA545312	-7		10	8	TCD	Leukemia	9cbe8bf31dec8288983fb1		1		pre	-2								
1443C		1443	6	formed	SRR11418086	PRJNA545312	-2		10	8	TCD	Leukemia	9cbe8bf31dec8288983fb1		1		pre	-1								
1443D		1443	7	formed	SRR11417648	PRJNA545312	-1		10	8	TCD	Leukemia	9cbe8bf31dec8288983fb1		1		pre	-1								
1443E		1443	12	liquid	SRR11417647	PRJNA545312	4		10	8	TCD	Leukemia	9cbe8bf31dec8288983fb1		1		peri	0								
1443F		1443	14	liquid	SRR11423278	PRJNA545312	6		10	8	TCD	Leukemia	9cbe8bf31dec8288983fb1		1		post	0								
1443G		1443	15	liquid	SRR11417646	PRJNA545312	7		10	8	TCD	Leukemia	9cbe8bf31dec8288983fb1		1		post	0								
1443H		1443	20	liquid	SRR11417645	PRJNA545312	12		10	8	TCD	Leukemia	9cbe8bf31dec8288983fb1		1		post	1								
1443I		1443	42	formed	SRR11417644	PRJNA545312	34		10	8	TCD	Leukemia	9cbe8bf31dec8288983fb1		1		post	4								
1443K		1443	179	formed	SRR11115719	PRJNA607574	171		10	8	TCD	Leukemia	9cbe8bf31dec8288983fb1		1		post	6								
1444A		1444	0	formed	SRR11139639	PRJNA606262			3																	
1444B		1444	9	semi-formed	SRR11139638	PRJNA606262			3																	
1444C		1444	16	liquid	SRR11139637	PRJNA606262			3																	
1445A		1445	0	semi-formed	SRR11417643	PRJNA545312	12		1	-12	PBSC_unmodified	Non-Hodgkin's Lymphoma	ef9040125dd3c4f6883eb8		1		post	1								
1446A		1446	0	formed	SRR11394921	PRJNA607574			4																	
1446B		1446	37	formed	SRR11394920	PRJNA607574			4																	
1446C		1446	93	formed	SRR11394919	PRJNA607574			4																	
1446D		1446	345	formed	SRR11394918	PRJNA607574			4																	
1447A		1447	0	semi-formed	SRR11394917	PRJNA607574			2																	
1447B		1447	188	formed	SRR11394916	PRJNA607574			2																	
1448A		1448	0	formed	SRR11140271	PRJNA606262			3																	
1448B		1448	11	semi-formed	SRR11140270	PRJNA606262			3																	
1448C		1448	17	semi-formed	SRR11140269	PRJNA606262			3																	
1449A		1449	0	semi-formed	SRR11394911	PRJNA607574			6																	
1449B		1449	7	semi-formed	SRR11394910	PRJNA607574			6																	
1449D		1449	8	semi-formed	SRR11394909	PRJNA607574			6																	
1449E		1449	9	semi-formed	SRR11394908	PRJNA607574			6																	
1449F		1449	13	semi-formed	SRR11394907	PRJNA607574			6																	
1449G		1449	586	formed	SRR11394906	PRJNA607574			6																	
144A		144	0	formed	SRR11417642	PRJNA545312	-5		3	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	fb4aed38182c2607936a23	175	1		pre	-1								
144B		144	6	semi-formed	SRR11417640	PRJNA545312	1		3	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	fb4aed38182c2607936a23	175	1		peri	0								
144C		144	13	formed	SRR11417639	PRJNA545312	8		3	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	fb4aed38182c2607936a23	175	1		post	1								
1450A		1450	0	semi-formed	SRR11394905	PRJNA607574			8																	
1450B		1450	4	semi-formed	SRR11394904	PRJNA607574			8																	
1450C		1450	5	semi-formed	SRR11394903	PRJNA607574			8																	
1450D		1450	7	semi-formed	SRR11394902	PRJNA607574			8																	
1450E		1450	8	semi-formed	SRR11394900	PRJNA607574			8																	
1450F		1450	14	formed	SRR11394899	PRJNA607574			8																	
1450G		1450	26	formed	SRR11394898	PRJNA607574			8																	
1450H		1450	84	semi-formed	SRR11394897	PRJNA607574			8																	
1451A		1451	0	semi-formed	SRR11394896	PRJNA607574			4																	
1451B		1451	35		SRR11394895	PRJNA607574			4																	
1451C		1451	78	semi-formed	SRR11394894	PRJNA607574			4																	
1451D		1451	91	formed	SRR11394893	PRJNA607574			4																	
1452A		1452	0	liquid	SRR11417638	PRJNA545312	-6		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		pre	-1								
1452B		1452	4	liquid	SRR11417637	PRJNA545312	-2		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		pre	-1								
1452C		1452	5	semi-formed	SRR11417636	PRJNA545312	-1		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		pre	-1								
1452D		1452	6	liquid	SRR11417635	PRJNA545312	0		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		peri	-1								
1452E		1452	7	liquid	SRR11417634	PRJNA545312	1		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		peri	0								
1452F		1452	9	liquid	SRR11417633	PRJNA545312	3		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		peri	0								
1452G		1452	10	liquid	SRR11417632	PRJNA545312	4		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		peri	0								
1452H		1452	11	liquid	SRR11417631	PRJNA545312	5		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		peri	0								
1452I		1452	12	liquid	SRR11417628	PRJNA545312	6		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		post	0								
1452J		1452	13	liquid	SRR9271298	PRJNA548153	7		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		post	0								
1452K		1452	14	liquid	SRR9271299	PRJNA548153	8		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		post	1								
1452L		1452	16	liquid	SRR9271308	PRJNA548153	10		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		post	1								
1452M		1452	17	liquid	SRR10668387	PRJNA545312	11		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		post	1								
1452N		1452	19	liquid	SRR10668386	PRJNA545312	13		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		post	1								
1452O		1452	20	liquid	SRR10668385	PRJNA545312	14		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		post	1								
1452P		1452	21	liquid	SRR10668384	PRJNA545312	15		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		post	2								
1452Q		1452	23	liquid	SRR10668383	PRJNA545312	17		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		post	2								
1452R		1452	24	semi-formed	SRR10668382	PRJNA545312	18		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		post	2								
1452S		1452	26	liquid	SRR10668381	PRJNA545312	20		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		post	2								
1452U		1452	27	semi-formed	SRR10668378	PRJNA545312	21		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		post	2								
1452V		1452	32	liquid	SRR11115708	PRJNA607574	26		21	6	cord	Leukemia	636015deb7278b1f9a83a1		1		post	3								
1453A		1453	0	semi-formed	SRR11395488	PRJNA607574			3																	
1453B		1453	180	formed	SRR11395494	PRJNA607574			3																	
1453C		1453	326	formed	SRR11395492	PRJNA607574			3																	
1454A		1454	0	formed	SRR11139672	PRJNA606262			3																	
1454B		1454	6	liquid	SRR11139671	PRJNA606262			3																	
1454C		1454	12	liquid	SRR11139670	PRJNA606262			3																	
1455A		1455	0	formed	SRR11139989	PRJNA606262			7																	
1455B		1455	2	formed	SRR11139988	PRJNA606262			7																	
1455C		1455	5	semi-formed	SRR11139987	PRJNA606262			7																	
1455D		1455	9	liquid	SRR11139986	PRJNA606262			7																	
1455E		1455	10	semi-formed	SRR11139985	PRJNA606262			7																	
1455F		1455	11	semi-formed	SRR11139984	PRJNA606262			7																	
1455G		1455	87	formed	SRR11139983	PRJNA606262			7																	
1456A		1456	0	semi-formed	SRR11140060	PRJNA606262	-583		1	583	PBSC_unmodified	Non-Hodgkin's Lymphoma	894e87be77763d5c4b8351		0		pre	-3								
1457A		1457	0	formed	SRR11139761	PRJNA606262			1																	
1458A		1458	0	liquid	SRR11140340	PRJNA606262			1																	
1459A		1459	0	formed	SRR11395377	PRJNA607574			5																	
1459B		1459	34	semi-formed	SRR11395376	PRJNA607574			5																	
1459C		1459	90	formed	SRR11395375	PRJNA607574			5																	
1459D		1459	174	formed	SRR11395374	PRJNA607574			5																	
1459E		1459	342	formed	SRR11395373	PRJNA607574			5																	
145G		pt_with_samples_1009_1010_1011_1049_1125_145	332	liquid	SRR11417627	PRJNA545312	326		8	6	cord	Myelodysplastic Syndromes	2cb8f755953c8e7e729fe3	176	1		post	6								
145I		pt_with_samples_1009_1010_1011_1049_1125_145	378	semi-formed	SRR11417626	PRJNA545312	372		8	6	cord	Myelodysplastic Syndromes	2cb8f755953c8e7e729fe3	176	1		post	6								
145J		pt_with_samples_1009_1010_1011_1049_1125_145	408	semi-formed	SRR11417625	PRJNA545312	402		8	6	cord	Myelodysplastic Syndromes	2cb8f755953c8e7e729fe3	176	1		post	6								
145L		pt_with_samples_1009_1010_1011_1049_1125_145	1139	semi-formed	SRR11417623	PRJNA545312	1133		8	6	cord	Myelodysplastic Syndromes	2cb8f755953c8e7e729fe3	176	1											
1460A		1460	0	semi-formed	SRR11417622	PRJNA545312	-7		16	7	BM_unmodified	Non-Hodgkin's Lymphoma	275549cf1c35c269f17869		1		pre	-2								
1460B		1460	2	semi-formed	SRR11417621	PRJNA545312	-5		16	7	BM_unmodified	Non-Hodgkin's Lymphoma	275549cf1c35c269f17869		1		pre	-1								
1460C		1460	3	semi-formed	SRR11417592	PRJNA545312	-4		16	7	BM_unmodified	Non-Hodgkin's Lymphoma	275549cf1c35c269f17869		1		pre	-1								
1460D		1460	4	semi-formed	SRR11417591	PRJNA545312	-3		16	7	BM_unmodified	Non-Hodgkin's Lymphoma	275549cf1c35c269f17869		1		pre	-1								
1460E		1460	12	liquid	SRR11417589	PRJNA545312	5		16	7	BM_unmodified	Non-Hodgkin's Lymphoma	275549cf1c35c269f17869		1		peri	0								
1460F		1460	13	liquid	SRR11417588	PRJNA545312	6		16	7	BM_unmodified	Non-Hodgkin's Lymphoma	275549cf1c35c269f17869		1		post	0								
1460G		1460	16	semi-formed	SRR11417587	PRJNA545312	9		16	7	BM_unmodified	Non-Hodgkin's Lymphoma	275549cf1c35c269f17869		1		post	1								
1460H		1460	17	semi-formed	SRR11417586	PRJNA545312	10		16	7	BM_unmodified	Non-Hodgkin's Lymphoma	275549cf1c35c269f17869		1		post	1								
1460I		1460	18	liquid	SRR11417585	PRJNA545312	11		16	7	BM_unmodified	Non-Hodgkin's Lymphoma	275549cf1c35c269f17869		1		post	1								
1460J		1460	24	semi-formed	SRR11417584	PRJNA545312	17		16	7	BM_unmodified	Non-Hodgkin's Lymphoma	275549cf1c35c269f17869		1		post	2								
1460K		1460	25	semi-formed	SRR11417583	PRJNA545312	18		16	7	BM_unmodified	Non-Hodgkin's Lymphoma	275549cf1c35c269f17869		1		post	2								
1460L		1460	30	liquid	SRR11417582	PRJNA545312	23		16	7	BM_unmodified	Non-Hodgkin's Lymphoma	275549cf1c35c269f17869		1		post	3								
1460M		1460	31	liquid	SRR11417581	PRJNA545312	24		16	7	BM_unmodified	Non-Hodgkin's Lymphoma	275549cf1c35c269f17869		1		post	3								
1460N		1460	34	semi-formed	SRR11417580	PRJNA545312	27		16	7	BM_unmodified	Non-Hodgkin's Lymphoma	275549cf1c35c269f17869		1		post	3								
1460O		1460	38	formed	SRR11417578	PRJNA545312	31		16	7	BM_unmodified	Non-Hodgkin's Lymphoma	275549cf1c35c269f17869		1		post	4								
1460P		1460	74	semi-formed	SRR11420961	PRJNA545312	67		16	7	BM_unmodified	Non-Hodgkin's Lymphoma	275549cf1c35c269f17869		1		post	6								
1461A		1461	0	formed	SRR11420960	PRJNA545312	-5		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		pre	-1								
1461AA		1461	42	semi-formed	SRR11421531	PRJNA545312	37		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	5								
1461B		1461	1	formed	SRR11420934	PRJNA545312	-4		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		pre	-1								
1461BB		1461	43	formed	SRR11420823	PRJNA545312	38		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	5								
1461C		1461	2	semi-formed	SRR11420712	PRJNA545312	-3		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		pre	-1								
1461CC		1461	45	formed	SRR11421221	PRJNA545312	40		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	5								
1461D		1461	5	liquid	SRR11421452	PRJNA545312	0		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		peri	-1								
1461DD		1461	46	semi-formed	SRR11420354	PRJNA545312	41		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	5								
1461E		1461	7	liquid	SRR11421307	PRJNA545312	2		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		peri	0								
1461EE		1461	71	semi-formed	SRR11421566	PRJNA545312	66		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	6								
1461F		1461	8	liquid	SRR11420959	PRJNA545312	3		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		peri	0								
1461G		1461	10	liquid	SRR11421176	PRJNA545312	5		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		peri	0								
1461H		1461	11	liquid	SRR11421165	PRJNA545312	6		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	0								
1461I		1461	12	liquid	SRR11421126	PRJNA545312	7		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	0								
1461J		1461	14	liquid	SRR11421115	PRJNA545312	9		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	1								
1461K		1461	15	semi-formed	SRR11421104	PRJNA545312	10		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	1								
1461L		1461	18	formed	SRR11421631	PRJNA545312	13		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	1								
1461M		1461	19	semi-formed	SRR11421620	PRJNA545312	14		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	1								
1461N		1461	22	formed	SRR11421553	PRJNA545312	17		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	2								
1461O		1461	23	formed	SRR11421542	PRJNA545312	18		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	2								
1461P		1461	24	semi-formed	SRR11421530	PRJNA545312	19		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	2								
1461Q		1461	25	semi-formed	SRR11421491	PRJNA545312	20		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	2								
1461R		1461	26	liquid	SRR11421480	PRJNA545312	21		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	2								
1461S		1461	28	formed	SRR11421413	PRJNA545312	23		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	3								
1461T		1461	29	formed	SRR11421402	PRJNA545312	24		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	3								
1461U		1461	31	semi-formed	SRR11420353	PRJNA545312	26		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	3								
1461V		1461	32	formed	SRR11420326	PRJNA545312	27		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	3								
1461W		1461	33	semi-formed	SRR11421391	PRJNA545312	28		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	3								
1461X		1461	35	formed	SRR11421027	PRJNA545312	30		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	4								
1461Y		1461	36	semi-formed	SRR11421016	PRJNA545312	31		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	4								
1461Z		1461	40	semi-formed	SRR11420956	PRJNA545312	35		31	5	cord	Leukemia	781db535d2bd2517b8d550		1		post	4								
1462A		1462	0	semi-formed	SRR11420945	PRJNA545312	-2		11	2	PBSC_unmodified	Leukemia	f34b05dbda393a17370eb8		1		pre	-1								
1462B		1462	15	semi-formed	SRR11420933	PRJNA545312	13		11	2	PBSC_unmodified	Leukemia	f34b05dbda393a17370eb8		1		post	1								
1462C		1462	17	semi-formed	SRR11420922	PRJNA545312	15		11	2	PBSC_unmodified	Leukemia	f34b05dbda393a17370eb8		1		post	2								
1462D		1462	23	semi-formed	SRR11420911	PRJNA545312	21		11	2	PBSC_unmodified	Leukemia	f34b05dbda393a17370eb8		1		post	2								
1462E		1462	24	liquid	SRR11420900	PRJNA545312	22		11	2	PBSC_unmodified	Leukemia	f34b05dbda393a17370eb8		1		post	3								
1462F		1462	28	liquid	SRR11420889	PRJNA545312	26		11	2	PBSC_unmodified	Leukemia	f34b05dbda393a17370eb8		1		post	3								
1462G		1462	30	semi-formed	SRR11420878	PRJNA545312	28		11	2	PBSC_unmodified	Leukemia	f34b05dbda393a17370eb8		1		post	3								
1462H		1462	31	semi-formed	SRR11420867	PRJNA545312	29		11	2	PBSC_unmodified	Leukemia	f34b05dbda393a17370eb8		1		post	4								
1462I		1462	52	semi-formed	SRR11420856	PRJNA545312	50		11	2	PBSC_unmodified	Leukemia	f34b05dbda393a17370eb8		1		post	6								
1462J		1462	98	liquid	SRR11420845	PRJNA545312	96		11	2	PBSC_unmodified	Leukemia	f34b05dbda393a17370eb8		1		post	6								
1462K		1462	101	semi-formed	SRR11420834	PRJNA545312	99		11	2	PBSC_unmodified	Leukemia	f34b05dbda393a17370eb8		1		post	6								
1463A		1463	0	semi-formed	SRR11140038	PRJNA606262			1																	
1464A		1464	0	formed	SRR11139741	PRJNA606262			3																	
1464B		1464	7	semi-formed	SRR11139740	PRJNA606262			3																	
1464C		1464	23	formed	SRR11139739	PRJNA606262			3																	
1465A		1465	0	formed	SRR11395367	PRJNA607574			3																	
1465B		1465	14	formed	SRR11395366	PRJNA607574			3																	
1465C		1465	28	formed	SRR11395365	PRJNA607574			3																	
1466A		1466	0	formed	SRR11139624	PRJNA606262			2																	
1466B		1466	7	liquid	SRR11139623	PRJNA606262			2																	
1467A		1467	0	formed	SRR11395362	PRJNA607574			4																	
1467B		1467	30	formed	SRR11395361	PRJNA607574			4																	
1467C		1467	86	formed	SRR11395360	PRJNA607574			4																	
1467D		1467	429	formed	SRR11395358	PRJNA607574			4																	
1468A		1468	0	liquid	SRR11420822	PRJNA545312	-2		3	2	TCD	Myelodysplastic Syndromes	bf22d5a58ea6b3427edd69		1		pre	-1								
1468B		1468	1	liquid	SRR11420811	PRJNA545312	-1		3	2	TCD	Myelodysplastic Syndromes	bf22d5a58ea6b3427edd69		1		pre	-1								
1468C		1468	2	liquid	SRR11420800	PRJNA545312	0		3	2	TCD	Myelodysplastic Syndromes	bf22d5a58ea6b3427edd69		1		peri	-1								
1469A		1469	0	semi-formed	SRR11395357	PRJNA607574			10																	
1469B		1469	14	semi-formed	SRR11395356	PRJNA607574			10																	
1469C		1469	23	formed	SRR11395355	PRJNA607574			10																	
1469D		1469	62	formed	SRR11395290	PRJNA607574			10																	
1469E		1469	63	semi-formed	SRR11395289	PRJNA607574			10																	
1469F		1469	125	formed	SRR11395288	PRJNA607574			10																	
1469G		1469	180	semi-formed	SRR11395287	PRJNA607574			10																	
1469H		1469	209	semi-formed	SRR11395286	PRJNA607574			10																	
1469I		1469	572	formed	SRR11395285	PRJNA607574			10																	
1469J		1469	611	semi-formed	SRR11395282	PRJNA607574			10																	
146A		146	0	formed	SRR11420789	PRJNA545312	215		4	-215	TCD	Leukemia	ed78f5eb4d1eeac1162649		1		post	6								
146B		146	182	formed	SRR11420778	PRJNA545312	397		4	-215	TCD	Leukemia	ed78f5eb4d1eeac1162649		1		post	6								
146C		146	196	semi-formed	SRR11420767	PRJNA545312	411		4	-215	TCD	Leukemia	ed78f5eb4d1eeac1162649		1		post	6								
146D		146	217	semi-formed	SRR11420756	PRJNA545312	432		4	-215	TCD	Leukemia	ed78f5eb4d1eeac1162649		1		post	6								
1470A		1470	0	semi-formed	SRR11395281	PRJNA607574			4																	
1470B		1470	40	semi-formed	SRR11395280	PRJNA607574			4																	
1470C		1470	96	formed	SRR11395279	PRJNA607574			4																	
1470D		1470	348	formed	SRR11395278	PRJNA607574			4																	
1471A		1471	0	semi-formed	SRR11395277	PRJNA607574			11																	
1471B		1471	6	semi-formed	SRR11395276	PRJNA607574			11																	
1471C		1471	7	semi-formed	SRR11395275	PRJNA607574			11																	
1471D		1471	8	liquid	SRR11395274	PRJNA607574			11																	
1471E		1471	9	semi-formed	SRR11395273	PRJNA607574			11																	
1471F		1471	10	liquid	SRR11395271	PRJNA607574			11																	
1471G		1471	66	semi-formed	SRR11395270	PRJNA607574			11																	
1471H		1471	126	semi-formed	SRR11395269	PRJNA607574			11																	
1471I		1471	151	semi-formed	SRR11395268	PRJNA607574			11																	
1471J		1471	274	semi-formed	SRR11395267	PRJNA607574			11																	
1471K		1471	653	semi-formed	SRR11395266	PRJNA607574			11																	
1472A		1472	0	semi-formed	SRR11395265	PRJNA607574			11																	
1472B		1472	1	semi-formed	SRR11395264	PRJNA607574			11																	
1472C		1472	2	semi-formed	SRR11395263	PRJNA607574			11																	
1472D		1472	31	semi-formed	SRR11395262	PRJNA607574			11																	
1472E		1472	35	semi-formed	SRR11395260	PRJNA607574			11																	
1472F		1472	36	semi-formed	SRR11395259	PRJNA607574			11																	
1472G		1472	64	semi-formed	SRR11395258	PRJNA607574			11																	
1472H		1472	91	semi-formed	SRR11395257	PRJNA607574			11																	
1472I		1472	122	semi-formed	SRR11395256	PRJNA607574			11																	
1472J		1472	155	semi-formed	SRR11395255	PRJNA607574			11																	
1472K		1472	658	semi-formed	SRR11395254	PRJNA607574			11																	
1473A		1473	0	semi-formed	SRR11139673	PRJNA606262			6																	
1473B		1473	153	formed	SRR11395252	PRJNA607574			6																	
1473C		1473	160	liquid	SRR11395251	PRJNA607574			6																	
1473D		1473	175	semi-formed	SRR11395249	PRJNA607574			6																	
1473E		1473	184	semi-formed	SRR11395248	PRJNA607574			6																	
1473F		1473	226	semi-formed	SRR11395247	PRJNA607574			6																	
1474A		1474	0	formed	SRR11395246	PRJNA607574			4																	
1474B		1474	35	formed	SRR11395245	PRJNA607574			4																	
1474C		1474	91	semi-formed	SRR11395244	PRJNA607574			4																	
1474D		1474	350	formed	SRR11395243	PRJNA607574			4																	
1475A		1475	0	semi-formed	SRR11395242	PRJNA607574			2																	
1475B		1475	8	liquid	SRR11395241	PRJNA607574			2																	
1476A		1476	0	formed	SRR11140277	PRJNA606262			1																	
1477A		1477	0	semi-formed	SRR11139742	PRJNA606262			1																	
1479A		1479	0	formed	SRR11420745	PRJNA545312	-4		15	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	3faee65a0a44b72f9018a5		1		pre	-1								
1479B		1479	3	formed	SRR11420734	PRJNA545312	-1		15	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	3faee65a0a44b72f9018a5		1		pre	-1								
1479C		1479	10	semi-formed	SRR11420723	PRJNA545312	6		15	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	3faee65a0a44b72f9018a5		1		post	0								
1479D		1479	23	semi-formed	SRR11420711	PRJNA545312	19		15	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	3faee65a0a44b72f9018a5		1		post	2								
1479E		1479	24	semi-formed	SRR11420700	PRJNA545312	20		15	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	3faee65a0a44b72f9018a5		1		post	2								
1479G		1479	30	formed	SRR11420689	PRJNA545312	26		15	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	3faee65a0a44b72f9018a5		1		post	3								
1479H		1479	35	formed	SRR11419526	PRJNA545312	31		15	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	3faee65a0a44b72f9018a5		1		post	4								
1479I		1479	36	formed	SRR11419695	PRJNA545312	32		15	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	3faee65a0a44b72f9018a5		1		post	4								
1479J		1479	38	formed	SRR11420301	PRJNA545312	34		15	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	3faee65a0a44b72f9018a5		1		post	4								
1479K		1479	50	liquid	SRR11421354	PRJNA545312	46		15	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	3faee65a0a44b72f9018a5		1		post	6								
1479L		1479	55	semi-formed	SRR11421343	PRJNA545312	51		15	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	3faee65a0a44b72f9018a5		1		post	6								
1479M		1479	57	semi-formed	SRR11421332	PRJNA545312	53		15	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	3faee65a0a44b72f9018a5		1		post	6								
1479N		1479	59	semi-formed	SRR11421293	PRJNA545312	55		15	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	3faee65a0a44b72f9018a5		1		post	6								
1479O		1479	60	semi-formed	SRR11421282	PRJNA545312	56		15	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	3faee65a0a44b72f9018a5		1		post	6								
1479P		1479	130	semi-formed	SRR11115697	PRJNA607574	126		15	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	3faee65a0a44b72f9018a5		1		post	6								
147A		147	0	semi-formed	SRR11421271	PRJNA545312	136		1	-136	TCD	Multiple Myeloma	14093a1ab00ff9bb64d401		1		post	6								
1480A		1480	0	formed	SRR11139628	PRJNA606262			3																	
1480B		1480	1	formed	SRR11139627	PRJNA606262			3																	
1480C		1480	2	formed	SRR11139626	PRJNA606262			3																	
1481A		1481	0	semi-formed	SRR11395234	PRJNA607574			34																	
1481AA		1481	63	liquid	SRR11395233	PRJNA607574			34																	
1481B		1481	7	semi-formed	SRR11395232	PRJNA607574			34																	
1481BB		1481	64	semi-formed	SRR11395231	PRJNA607574			34																	
1481CC		1481	70	semi-formed	SRR11395230	PRJNA607574			34																	
1481D		1481	11	liquid	SRR11395229	PRJNA607574			34																	
1481DD		1481	81	semi-formed	SRR11395227	PRJNA607574			34																	
1481EE		1481	84	semi-formed	SRR11395706	PRJNA607574			34																	
1481F		1481	13	semi-formed	SRR11395705	PRJNA607574			34																	
1481FF		1481	105	semi-formed	SRR11395704	PRJNA607574			34																	
1481G		1481	14	semi-formed	SRR11395703	PRJNA607574			34																	
1481GG		1481	111	semi-formed	SRR11395702	PRJNA607574			34																	
1481H		1481	16	semi-formed	SRR11395701	PRJNA607574			34																	
1481HH		1481	113	liquid	SRR11395700	PRJNA607574			34																	
1481I		1481	18	semi-formed	SRR11395699	PRJNA607574			34																	
1481II		1481	116	semi-formed	SRR11395698	PRJNA607574			34																	
1481J		1481	20	semi-formed	SRR11395696	PRJNA607574			34																	
1481JJ		1481	118	liquid	SRR11395695	PRJNA607574			34																	
1481KK		1481	119	liquid	SRR11395694	PRJNA607574			34																	
1481L		1481	21	semi-formed	SRR11395693	PRJNA607574			34																	
1481M		1481	23	semi-formed	SRR11395692	PRJNA607574			34																	
1481N		1481	26	semi-formed	SRR11395691	PRJNA607574			34																	
1481O		1481	29	semi-formed	SRR11395690	PRJNA607574			34																	
1481P		1481	30	semi-formed	SRR11395689	PRJNA607574			34																	
1481Q		1481	32	formed	SRR11395688	PRJNA607574			34																	
1481R		1481	33	semi-formed	SRR11395687	PRJNA607574			34																	
1481S		1481	34	semi-formed	SRR11395685	PRJNA607574			34																	
1481T		1481	36	semi-formed	SRR11395684	PRJNA607574			34																	
1481U		1481	37	semi-formed	SRR11395683	PRJNA607574			34																	
1481V		1481	43	semi-formed	SRR11395682	PRJNA607574			34																	
1481W		1481	47	semi-formed	SRR11395681	PRJNA607574			34																	
1481X		1481	53	semi-formed	SRR11395680	PRJNA607574			34																	
1481Y		1481	56	semi-formed	SRR11395679	PRJNA607574			34																	
1481Z		1481	62	liquid	SRR11395678	PRJNA607574			34																	
1482A		1482	0	formed	SRR11139648	PRJNA606262			7																	
1482B		1482	6	semi-formed	SRR11139647	PRJNA606262			7																	
1482C		1482	79	formed	SRR11139646	PRJNA606262			7																	
1482D		1482	154	formed	SRR11395765	PRJNA607574			7																	
1482E		1482	198	semi-formed	SRR11395764	PRJNA607574			7																	
1482F		1482	260	semi-formed	SRR11395763	PRJNA607574			7																	
1482G		1482	505	formed	SRR11395762	PRJNA607574			7																	
1483A		1483	0	formed	SRR11139634	PRJNA606262			1																	
1484A		1484	0	semi-formed	SRR11140429	PRJNA606262			2																	
1484B		1484	5	liquid	SRR11140428	PRJNA606262			2																	
1485A		1485	0	formed	SRR11140084	PRJNA606262			2																	
1485B		1485	8	liquid	SRR11140083	PRJNA606262			2																	
1486A		1486	0		SRR11395755	PRJNA607574			4																	
1486B		1486	50	semi-formed	SRR11395754	PRJNA607574			4																	
1486C		1486	113		SRR11395753	PRJNA607574			4																	
1486D		1486	369	semi-formed	SRR11395752	PRJNA607574			4																	
1487A		1487	0	formed	SRR11395751	PRJNA607574			4																	
1487B		1487	12	liquid	SRR11395750	PRJNA607574			4																	
1487C		1487	24	formed	SRR11395749	PRJNA607574			4																	
1487D		1487	39	semi-formed	SRR11395748	PRJNA607574			4																	
1488A		1488	0	liquid	SRR11140498	PRJNA606262			2																	
1488B		1488	6	liquid	SRR11140497	PRJNA606262			2																	
1489A		1489	0	formed	SRR11397015	PRJNA607574			1																	
148A		148	0	liquid	SRR11421232	PRJNA545312	43		3	-43	PBSC_unmodified	Leukemia	ea9a9506a4187579b20006	220	1		post	6								
148B		148	18	semi-formed	SRR11421220	PRJNA545312	61		3	-43	PBSC_unmodified	Leukemia	ea9a9506a4187579b20006	220	1		post	6								
148C		148	454	formed	SRR11421153	PRJNA545312	497		3	-43	PBSC_unmodified	Leukemia	ea9a9506a4187579b20006	220	1		post	6								
1491A		1491	0	semi-formed	SRR9271204	PRJNA548153	-4		10	4	cord	Leukemia	811543a08e04700b8ce264		0		pre	-1								
1491B		1491	1	semi-formed	SRR9271257	PRJNA548153	-3		10	4	cord	Leukemia	811543a08e04700b8ce264		0		pre	-1								
1491C		1491	3	liquid	SRR9271256	PRJNA548153	-1		10	4	cord	Leukemia	811543a08e04700b8ce264		0		pre	-1								
1491D		1491	6	semi-formed	SRR9271259	PRJNA548153	2		10	4	cord	Leukemia	811543a08e04700b8ce264		0		peri	0								
1491E		1491	9	liquid	SRR9271258	PRJNA548153	5		10	4	cord	Leukemia	811543a08e04700b8ce264		0		peri	0								
1491F		1491	10	liquid	SRR9271261	PRJNA548153	6		10	4	cord	Leukemia	811543a08e04700b8ce264		0		post	0								
1491G		1491	11	semi-formed	SRR9271260	PRJNA548153	7		10	4	cord	Leukemia	811543a08e04700b8ce264		0		post	0								
1491H		1491	13	semi-formed	SRR9271263	PRJNA548153	9		10	4	cord	Leukemia	811543a08e04700b8ce264		0		post	1								
1491I		1491	24	semi-formed	SRR11115686	PRJNA607574	20		10	4	cord	Leukemia	811543a08e04700b8ce264		0		post	2								
1491J		1491	93	formed	SRR11115675	PRJNA607574	89		10	4	cord	Leukemia	811543a08e04700b8ce264		0		post	6								
1492A		1492	0	formed	SRR11397014	PRJNA607574			3																	
1492B		1492	139	formed	SRR11397273	PRJNA607574			3																	
1492C		1492	344	semi-formed	SRR11396747	PRJNA607574			3																	
1493A		1493	0	formed	SRR11421142	PRJNA545312	-8		15	8	TCD	Leukemia	db9c35508f936bb451eec1		1		pre	-2								
1493B		1493	1	formed	SRR11421131	PRJNA545312	-7		15	8	TCD	Leukemia	db9c35508f936bb451eec1		1		pre	-2								
1493C		1493	5	formed	SRR11421092	PRJNA545312	-3		15	8	TCD	Leukemia	db9c35508f936bb451eec1		1		pre	-1								
1493D		1493	6	semi-formed	SRR11421081	PRJNA545312	-2		15	8	TCD	Leukemia	db9c35508f936bb451eec1		1		pre	-1								
1493E		1493	8	semi-formed	SRR11421608	PRJNA545312	0		15	8	TCD	Leukemia	db9c35508f936bb451eec1		1		peri	-1								
1493F		1493	9	liquid	SRR11421597	PRJNA545312	1		15	8	TCD	Leukemia	db9c35508f936bb451eec1		1		peri	0								
1493G		1493	11	liquid	SRR11421586	PRJNA545312	3		15	8	TCD	Leukemia	db9c35508f936bb451eec1		1		peri	0								
1493H		1493	12	liquid	SRR11421463	PRJNA545312	4		15	8	TCD	Leukemia	db9c35508f936bb451eec1		1		peri	0								
1493I		1493	15	liquid	SRR11421451	PRJNA545312	7		15	8	TCD	Leukemia	db9c35508f936bb451eec1		1		post	0								
1493J		1493	16	liquid	SRR11421384	PRJNA545312	8		15	8	TCD	Leukemia	db9c35508f936bb451eec1		1		post	1								
1493K		1493	22	liquid	SRR11421373	PRJNA545312	14		15	8	TCD	Leukemia	db9c35508f936bb451eec1		1		post	1								
1493L		1493	26	semi-formed	SRR11421065	PRJNA545312	18		15	8	TCD	Leukemia	db9c35508f936bb451eec1		1		post	2								
1493M		1493	27	semi-formed	SRR11420040	PRJNA545312	19		15	8	TCD	Leukemia	db9c35508f936bb451eec1		1		post	2								
1493N		1493	33	liquid	SRR11420219	PRJNA545312	25		15	8	TCD	Leukemia	db9c35508f936bb451eec1		1		post	3								
1493O		1493	47	formed	SRR11420998	PRJNA545312	39		15	8	TCD	Leukemia	db9c35508f936bb451eec1		1		post	5								
1494A		1494	0	liquid	SRR11420987	PRJNA545312	-3		1	3	cord	Non-Hodgkin's Lymphoma	ac4f8196a273f551dcedae		1		pre	-1								
1495A		1495	0	liquid	SRR11396611	PRJNA607574			1																	
1496A		1496	0	semi-formed	SRR11396500	PRJNA607574			7																	
1496B		1496	55	semi-formed	SRR11397039	PRJNA607574			7																	
1496C		1496	57	semi-formed	SRR11396924	PRJNA607574			7																	
1496D		1496	118	semi-formed	SRR11396781	PRJNA607574			7																	
1496E		1496	121	semi-formed	SRR11397232	PRJNA607574			7																	
1496F		1496	139	semi-formed	SRR11397013	PRJNA607574			7																	
1496H		1496	335	semi-formed	SRR11396842	PRJNA607574			7																	
1497A		1497	0	formed	SRR11396831	PRJNA607574			4																	
1497B		1497	36	formed	SRR11396820	PRJNA607574			4																	
1497C		1497	91	semi-formed	SRR11397403	PRJNA607574			4																	
1497D		1497	350	formed	SRR11397392	PRJNA607574			4																	
1498A		1498	0	semi-formed	SRR11420675	PRJNA545312	-7		9	7	BM_unmodified	Myelodysplastic Syndromes	b88c02d1f416f34e05ba4d		1		pre	-2								
1498B		1498	2	formed	SRR11421071	PRJNA545312	-5		9	7	BM_unmodified	Myelodysplastic Syndromes	b88c02d1f416f34e05ba4d		1		pre	-1								
1498C		1498	8	formed	SRR11421357	PRJNA545312	1		9	7	BM_unmodified	Myelodysplastic Syndromes	b88c02d1f416f34e05ba4d		1		peri	0								
1498D		1498	9	semi-formed	SRR11421318	PRJNA545312	2		9	7	BM_unmodified	Myelodysplastic Syndromes	b88c02d1f416f34e05ba4d		1		peri	0								
1498E		1498	13	liquid	SRR11421306	PRJNA545312	6		9	7	BM_unmodified	Myelodysplastic Syndromes	b88c02d1f416f34e05ba4d		1		post	0								
1498F		1498	23	semi-formed	SRR11421267	PRJNA545312	16		9	7	BM_unmodified	Myelodysplastic Syndromes	b88c02d1f416f34e05ba4d		1		post	2								
1498G		1498	25	liquid	SRR11421256	PRJNA545312	18		9	7	BM_unmodified	Myelodysplastic Syndromes	b88c02d1f416f34e05ba4d		1		post	2								
1498H		1498	26	liquid	SRR11421245	PRJNA545312	19		9	7	BM_unmodified	Myelodysplastic Syndromes	b88c02d1f416f34e05ba4d		1		post	2								
1498I		1498	28	liquid	SRR11421206	PRJNA545312	21		9	7	BM_unmodified	Myelodysplastic Syndromes	b88c02d1f416f34e05ba4d		1		post	2								
149A		149	0	formed	SRR11421195	PRJNA545312	-2		4	2	TCD	Leukemia	dd81a2036c594c42e0488d	194	1		pre	-1								
149B		149	6	liquid	SRR11421072	PRJNA545312	4		4	2	TCD	Leukemia	dd81a2036c594c42e0488d	194	1		peri	0								
149C		149	14	formed	SRR11421655	PRJNA545312	12		4	2	TCD	Leukemia	dd81a2036c594c42e0488d	194	1		post	1								
149D		149	20	liquid	SRR11421644	PRJNA545312	18		4	2	TCD	Leukemia	dd81a2036c594c42e0488d	194	1		post	2								
1502A		1502	0	formed	SRR11140062	PRJNA606262			2																	
1502B		1502	8	liquid	SRR11139799	PRJNA606262			2																	
1503A		1503	0	semi-formed	SRR11139982	PRJNA606262			1																	
1504A		1504	0	semi-formed	SRR11397284	PRJNA607574			4																	
1504B		1504	29	formed	SRR11397272	PRJNA607574			4																	
1504C		1504	92		SRR11397261	PRJNA607574			4																	
1504D		1504	336	formed	SRR11397218	PRJNA607574			4																	
1506A		1506	0	liquid	SRR11139663	PRJNA606262			1																	
1507A		1507	0	liquid	SRR11139635	PRJNA606262			1																	
1508A		1508	0	semi-formed	SRR11397185	PRJNA607574			3																	
1508B		1508	40	semi-formed	SRR11397174	PRJNA607574			3																	
1508C		1508	107	formed	SRR11397163	PRJNA607574			3																	
1509A		1509	0	formed	SRR11140217	PRJNA606262			5																	
1509B		1509	1	formed	SRR11140206	PRJNA606262			5																	
1509C		1509	13	liquid	SRR11140195	PRJNA606262			5																	
1509D		1509	21	liquid	SRR11139856	PRJNA606262			5																	
1509E		1509	22	liquid	SRR11139845	PRJNA606262			5																	
1510A		1510	0	formed	SRR11139620	PRJNA606262			14																	
1510B		1510	1	semi-formed	SRR11139618	PRJNA606262			14																	
1510C		1510	2	semi-formed	SRR11139617	PRJNA606262			14																	
1510D		1510	4	semi-formed	SRR11140456	PRJNA606262			14																	
1510E		1510	5	liquid	SRR11140455	PRJNA606262			14																	
1510F		1510	7	liquid	SRR11140454	PRJNA606262			14																	
1510G		1510	8	liquid	SRR11140453	PRJNA606262			14																	
1510H		1510	9	liquid	SRR11140452	PRJNA606262			14																	
1510I		1510	10	liquid	SRR11140451	PRJNA606262			14																	
1510J		1510	12	liquid	SRR11140450	PRJNA606262			14																	
1510K		1510	14	liquid	SRR11140449	PRJNA606262			14																	
1510L		1510	15	liquid	SRR11140447	PRJNA606262			14																	
1510M		1510	17	liquid	SRR11140446	PRJNA606262			14																	
1510N		1510	18	semi-formed	SRR11140445	PRJNA606262			14																	
1511A		1511	0	semi-formed	SRR11421577	PRJNA545312	-4		16	4	BM_unmodified	Non-Hodgkin's Lymphoma	5ed3b4d1fd82a354e6b9d0		1		pre	-1								
1511B		1511	1	formed	SRR11421565	PRJNA545312	-3		16	4	BM_unmodified	Non-Hodgkin's Lymphoma	5ed3b4d1fd82a354e6b9d0		1		pre	-1								
1511C		1511	4	semi-formed	SRR11421526	PRJNA545312	0		16	4	BM_unmodified	Non-Hodgkin's Lymphoma	5ed3b4d1fd82a354e6b9d0		1		peri	-1								
1511D		1511	6	semi-formed	SRR11421515	PRJNA545312	2		16	4	BM_unmodified	Non-Hodgkin's Lymphoma	5ed3b4d1fd82a354e6b9d0		1		peri	0								
1511E		1511	8	semi-formed	SRR11421504	PRJNA545312	4		16	4	BM_unmodified	Non-Hodgkin's Lymphoma	5ed3b4d1fd82a354e6b9d0		1		peri	0								
1511F		1511	9	liquid	SRR11421437	PRJNA545312	5		16	4	BM_unmodified	Non-Hodgkin's Lymphoma	5ed3b4d1fd82a354e6b9d0		1		peri	0								
1511G		1511	10	semi-formed	SRR11421426	PRJNA545312	6		16	4	BM_unmodified	Non-Hodgkin's Lymphoma	5ed3b4d1fd82a354e6b9d0		1		post	0								
1511H		1511	15	semi-formed	SRR11421062	PRJNA545312	11		16	4	BM_unmodified	Non-Hodgkin's Lymphoma	5ed3b4d1fd82a354e6b9d0		1		post	1								
1511I		1511	16	semi-formed	SRR11421051	PRJNA545312	12		16	4	BM_unmodified	Non-Hodgkin's Lymphoma	5ed3b4d1fd82a354e6b9d0		1		post	1								
1511J		1511	17	formed	SRR11421040	PRJNA545312	13		16	4	BM_unmodified	Non-Hodgkin's Lymphoma	5ed3b4d1fd82a354e6b9d0		1		post	1								
1511K		1511	18	semi-formed	SRR11420973	PRJNA545312	14		16	4	BM_unmodified	Non-Hodgkin's Lymphoma	5ed3b4d1fd82a354e6b9d0		1		post	1								
1511L		1511	22	semi-formed	SRR11421186	PRJNA545312	18		16	4	BM_unmodified	Non-Hodgkin's Lymphoma	5ed3b4d1fd82a354e6b9d0		1		post	2								
1511M		1511	24	semi-formed	SRR11421185	PRJNA545312	20		16	4	BM_unmodified	Non-Hodgkin's Lymphoma	5ed3b4d1fd82a354e6b9d0		1		post	2								
1511N		1511	270	formed	SRR11115674	PRJNA607574	266		16	4	BM_unmodified	Non-Hodgkin's Lymphoma	5ed3b4d1fd82a354e6b9d0		1		post	6								
1511O		1511	274	semi-formed	SRR11115673	PRJNA607574	270		16	4	BM_unmodified	Non-Hodgkin's Lymphoma	5ed3b4d1fd82a354e6b9d0		1		post	6								
1511P		1511	316	formed	SRR11115672	PRJNA607574	312		16	4	BM_unmodified	Non-Hodgkin's Lymphoma	5ed3b4d1fd82a354e6b9d0		1		post	6								
1512A		1512	0	formed	SRR11140415	PRJNA606262			1																	
1513A		1513	0	semi-formed	SRR9271309	PRJNA548153	-7		15	7	TCD	Multiple Myeloma	6b1c4fbd2a8a777dd27db7		0		pre	-2								
1513B		1513	3	liquid	SRR9271275	PRJNA548153	-4		15	7	TCD	Multiple Myeloma	6b1c4fbd2a8a777dd27db7		0		pre	-1								
1513C		1513	4	liquid	SRR9271274	PRJNA548153	-3		15	7	TCD	Multiple Myeloma	6b1c4fbd2a8a777dd27db7		0		pre	-1								
1513D		1513	6	liquid	SRR9271273	PRJNA548153	-1		15	7	TCD	Multiple Myeloma	6b1c4fbd2a8a777dd27db7		0		pre	-1								
1513E		1513	7	liquid	SRR9271272	PRJNA548153	0		15	7	TCD	Multiple Myeloma	6b1c4fbd2a8a777dd27db7		0		peri	-1								
1513F		1513	8	liquid	SRR9271279	PRJNA548153	1		15	7	TCD	Multiple Myeloma	6b1c4fbd2a8a777dd27db7		0		peri	0								
1513G		1513	10	liquid	SRR9271278	PRJNA548153	3		15	7	TCD	Multiple Myeloma	6b1c4fbd2a8a777dd27db7		0		peri	0								
1513I		1513	12	semi-formed	SRR9271277	PRJNA548153	5		15	7	TCD	Multiple Myeloma	6b1c4fbd2a8a777dd27db7		0		peri	0								
1513K		1513	15	liquid	SRR9271276	PRJNA548153	8		15	7	TCD	Multiple Myeloma	6b1c4fbd2a8a777dd27db7		0		post	1								
1513L		1513	18	liquid	SRR9271267	PRJNA548153	11		15	7	TCD	Multiple Myeloma	6b1c4fbd2a8a777dd27db7		0		post	1								
1513M		1513	19	liquid	SRR9271266	PRJNA548153	12		15	7	TCD	Multiple Myeloma	6b1c4fbd2a8a777dd27db7		0		post	1								
1513N		1513	21	liquid	SRR11115671	PRJNA607574	14		15	7	TCD	Multiple Myeloma	6b1c4fbd2a8a777dd27db7		0		post	1								
1513O		1513	25	liquid	SRR11115670	PRJNA607574	18		15	7	TCD	Multiple Myeloma	6b1c4fbd2a8a777dd27db7		0		post	2								
1513P		1513	31	liquid	SRR11115669	PRJNA607574	24		15	7	TCD	Multiple Myeloma	6b1c4fbd2a8a777dd27db7		0		post	3								
1513Q		1513	32	semi-formed	SRR11115975	PRJNA607574	25		15	7	TCD	Multiple Myeloma	6b1c4fbd2a8a777dd27db7		0		post	3								
1514A		1514	0	semi-formed	SRR11396522	PRJNA607574			5																	
1514B		1514	25	formed	SRR11396511	PRJNA607574			5																	
1514C		1514	29	semi-formed	SRR11396499	PRJNA607574			5																	
1514D		1514	68	semi-formed	SRR11396488	PRJNA607574			5																	
1514E		1514	180	formed	SRR11396477	PRJNA607574			5																	
1517A		1517	0	formed	SRR11139643	PRJNA606262			2																	
1517B		1517	87	semi-formed	SRR11139642	PRJNA606262			2																	
1518A		1518	0	semi-formed	SRR11140095	PRJNA606262			7																	
1518B		1518	4	formed	SRR11140352	PRJNA606262			7																	
1518C		1518	6	semi-formed	SRR11140341	PRJNA606262			7																	
1518D		1518	10	liquid	SRR11140330	PRJNA606262			7																	
1518E		1518	140	semi-formed	SRR11397050	PRJNA607574			7																	
1518F		1518	167	formed	SRR11397038	PRJNA607574			7																	
1518G		1518	223	formed	SRR11397027	PRJNA607574			7																	
1519B		1519	4	semi-formed	SRR11139633	PRJNA606262			1																	
151A		151	0	liquid	SRR11421184	PRJNA545312	167		2	-167	cord	Hodgkin's Disease	a2b2210cbd7f6672b3c329		1		post	6								
151B		151	13	liquid	SRR11421183	PRJNA545312	180		2	-167	cord	Hodgkin's Disease	a2b2210cbd7f6672b3c329		1		post	6								
1520B		1520	10	formed	SRR11115973	PRJNA607574	-583		2	593	PBSC_unmodified		e6fa747726be7cf0df22aa		0		pre	-3								
1520C		1520	93	formed	SRR11115505	PRJNA607574	-500		2	593	PBSC_unmodified		e6fa747726be7cf0df22aa		0		pre	-3								
1521A		1521	0	formed	SRR11421182	PRJNA545312	-4		13	4	BM_unmodified	Leukemia	4fe6afede723a74e7251ec		1		pre	-1								
1521B		1521	1	formed	SRR11421181	PRJNA545312	-3		13	4	BM_unmodified	Leukemia	4fe6afede723a74e7251ec		1		pre	-1								
1521C		1521	2	semi-formed	SRR11421180	PRJNA545312	-2		13	4	BM_unmodified	Leukemia	4fe6afede723a74e7251ec		1		pre	-1								
1521D		1521	3	liquid	SRR11421179	PRJNA545312	-1		13	4	BM_unmodified	Leukemia	4fe6afede723a74e7251ec		1		pre	-1								
1521E		1521	6	semi-formed	SRR11421178	PRJNA545312	2		13	4	BM_unmodified	Leukemia	4fe6afede723a74e7251ec		1		peri	0								
1521F		1521	7	formed	SRR11421177	PRJNA545312	3		13	4	BM_unmodified	Leukemia	4fe6afede723a74e7251ec		1		peri	0								
1521G		1521	8	semi-formed	SRR11421175	PRJNA545312	4		13	4	BM_unmodified	Leukemia	4fe6afede723a74e7251ec		1		peri	0								
1521H		1521	9	semi-formed	SRR11421174	PRJNA545312	5		13	4	BM_unmodified	Leukemia	4fe6afede723a74e7251ec		1		peri	0								
1521J		1521	14	liquid	SRR11421172	PRJNA545312	10		13	4	BM_unmodified	Leukemia	4fe6afede723a74e7251ec		1		post	1								
1521K		1521	17	semi-formed	SRR11421171	PRJNA545312	13		13	4	BM_unmodified	Leukemia	4fe6afede723a74e7251ec		1		post	1								
1521L		1521	20	liquid	SRR11421170	PRJNA545312	16		13	4	BM_unmodified	Leukemia	4fe6afede723a74e7251ec		1		post	2								
1521M		1521	23	liquid	SRR11421169	PRJNA545312	19		13	4	BM_unmodified	Leukemia	4fe6afede723a74e7251ec		1		post	2								
1521N		1521	27	formed	SRR11421168	PRJNA545312	23		13	4	BM_unmodified	Leukemia	4fe6afede723a74e7251ec		1		post	3								
1522A		1522	0	liquid	SRR11140005	PRJNA606262			1																	
1523A		1523	0	semi-formed	SRR11140443	PRJNA606262			3																	
1523B		1523	1	liquid	SRR11140442	PRJNA606262			3																	
1523C		1523	6	liquid	SRR11140441	PRJNA606262			3																	
1524A		1524	0	semi-formed	SRR11396957	PRJNA607574			1																	
1525A		1525	0	formed	SRR11140434	PRJNA606262			4																	
1525B		1525	7	semi-formed	SRR11140433	PRJNA606262			4																	
1525C		1525	15	semi-formed	SRR11140432	PRJNA606262			4																	
1525D		1525	26	formed	SRR11140431	PRJNA606262			4																	
1526A		1526	0	liquid	SRR11139657	PRJNA606262			1																	
1527A		1527	0	semi-formed	SRR11396890	PRJNA607574			4																	
1527B		1527	1	liquid	SRR11396879	PRJNA607574			4																	
1527C		1527	2	semi-formed	SRR11396868	PRJNA607574			4																	
1527D		1527	3	semi-formed	SRR11396857	PRJNA607574			4																	
1528A		1528	0	formed	SRR11421167	PRJNA545312	-5		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		pre	-1								
1528AA		1528	116	semi-formed	SRR11115504	PRJNA607574	111		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	6								
1528B		1528	3	liquid	SRR11421166	PRJNA545312	-2		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		pre	-1								
1528BB		1528	361	formed	SRR11115503	PRJNA607574	356		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	6								
1528C		1528	4	semi-formed	SRR11421164	PRJNA545312	-1		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		pre	-1								
1528CC		1528	368	semi-formed	SRR11115502	PRJNA607574	363		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	6								
1528D		1528	5	formed	SRR11421163	PRJNA545312	0		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		peri	-1								
1528DD		1528	369	semi-formed	SRR11115501	PRJNA607574	364		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	6								
1528E		1528	6	formed	SRR11421162	PRJNA545312	1		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		peri	0								
1528EE		1528	385	formed	SRR11115500	PRJNA607574	380		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	6								
1528F		1528	7	liquid	SRR11421161	PRJNA545312	2		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		peri	0								
1528G		1528	12	semi-formed	SRR11421160	PRJNA545312	7		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	0								
1528H		1528	13	formed	SRR11421159	PRJNA545312	8		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	1								
1528I		1528	14	formed	SRR11421130	PRJNA545312	9		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	1								
1528J		1528	17	liquid	SRR11421129	PRJNA545312	12		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	1								
1528K		1528	18	liquid	SRR11421128	PRJNA545312	13		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	1								
1528L		1528	20	liquid	SRR11421127	PRJNA545312	15		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	2								
1528M		1528	21	formed	SRR11421125	PRJNA545312	16		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	2								
1528N		1528	22	semi-formed	SRR11421124	PRJNA545312	17		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	2								
1528O		1528	24	formed	SRR11421123	PRJNA545312	19		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	2								
1528P		1528	25	formed	SRR11421122	PRJNA545312	20		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	2								
1528Q		1528	26	formed	SRR11421121	PRJNA545312	21		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	2								
1528R		1528	27	formed	SRR11421120	PRJNA545312	22		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	3								
1528S		1528	28	formed	SRR11421119	PRJNA545312	23		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	3								
1528T		1528	32	formed	SRR11421118	PRJNA545312	27		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	3								
1528U		1528	33	semi-formed	SRR11421117	PRJNA545312	28		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	3								
1528V		1528	39	semi-formed	SRR11421116	PRJNA545312	34		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	4								
1528W		1528	40	semi-formed	SRR11421114	PRJNA545312	35		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	4								
1528X		1528	74	semi-formed	SRR11115499	PRJNA607574	69		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	6								
1528Y		1528	102	semi-formed	SRR11115498	PRJNA607574	97		30	5	PBSC_unmodified	Leukemia	6ec39bd29017e52b232ca0		1		post	6								
1529B		1529	5	formed	SRR11139966	PRJNA606262			2																	
1529C		1529	15	semi-formed	SRR11139965	PRJNA606262			2																	
152L		pt_with_samples_1001_1002_1003_1004_1005_1006_1007_1008_1048_1121_152	362	semi-formed	SRR11421113	PRJNA545312	341		10	21	cord	Leukemia	c8848e19e1175e744f8987	36	1		post	6								
152M		pt_with_samples_1001_1002_1003_1004_1005_1006_1007_1008_1048_1121_152	364	semi-formed	SRR11421112	PRJNA545312	343		10	21	cord	Leukemia	c8848e19e1175e744f8987	36	1		post	6								
1530A		1530	0	semi-formed	SRR11421111	PRJNA545312	-8		16	8	BM_unmodified	Leukemia	e45518ce28c1f70e4f8eb0		1		pre	-2								
1530B		1530	5	semi-formed	SRR11421110	PRJNA545312	-3		16	8	BM_unmodified	Leukemia	e45518ce28c1f70e4f8eb0		1		pre	-1								
1530C		1530	7	liquid	SRR11421109	PRJNA545312	-1		16	8	BM_unmodified	Leukemia	e45518ce28c1f70e4f8eb0		1		pre	-1								
1530D		1530	8	liquid	SRR11421108	PRJNA545312	0		16	8	BM_unmodified	Leukemia	e45518ce28c1f70e4f8eb0		1		peri	-1								
1530E		1530	9	liquid	SRR11421107	PRJNA545312	1		16	8	BM_unmodified	Leukemia	e45518ce28c1f70e4f8eb0		1		peri	0								
1530F		1530	14	liquid	SRR11421106	PRJNA545312	6		16	8	BM_unmodified	Leukemia	e45518ce28c1f70e4f8eb0		1		post	0								
1530G		1530	16	liquid	SRR11421105	PRJNA545312	8		16	8	BM_unmodified	Leukemia	e45518ce28c1f70e4f8eb0		1		post	1								
1530H		1530	17	semi-formed	SRR11421103	PRJNA545312	9		16	8	BM_unmodified	Leukemia	e45518ce28c1f70e4f8eb0		1		post	1								
1530J		1530	21	liquid	SRR11421639	PRJNA545312	13		16	8	BM_unmodified	Leukemia	e45518ce28c1f70e4f8eb0		1		post	1								
1530K		1530	24	liquid	SRR11421638	PRJNA545312	16		16	8	BM_unmodified	Leukemia	e45518ce28c1f70e4f8eb0		1		post	2								
1530L		1530	27	liquid	SRR11421637	PRJNA545312	19		16	8	BM_unmodified	Leukemia	e45518ce28c1f70e4f8eb0		1		post	2								
1530M		1530	29	liquid	SRR11421636	PRJNA545312	21		16	8	BM_unmodified	Leukemia	e45518ce28c1f70e4f8eb0		1		post	2								
1530N		1530	62	semi-formed	SRR11115497	PRJNA607574	54		16	8	BM_unmodified	Leukemia	e45518ce28c1f70e4f8eb0		1		post	6								
1530O		1530	64	liquid	SRR11115496	PRJNA607574	56		16	8	BM_unmodified	Leukemia	e45518ce28c1f70e4f8eb0		1		post	6								
1530P		1530	65	liquid	SRR11115494	PRJNA607574	57		16	8	BM_unmodified	Leukemia	e45518ce28c1f70e4f8eb0		1		post	6								
1530Q		1530	75	semi-formed	SRR11115493	PRJNA607574	67		16	8	BM_unmodified	Leukemia	e45518ce28c1f70e4f8eb0		1		post	6								
1531A		1531	0	formed	SRR11421635	PRJNA545312	-2		6	2	TCD	Leukemia	9e77a65eedd436e110d256		1		pre	-1								
1531B		1531	1	liquid	SRR11421634	PRJNA545312	-1		6	2	TCD	Leukemia	9e77a65eedd436e110d256		1		pre	-1								
1531D		1531	2	semi-formed	SRR11421633	PRJNA545312	0		6	2	TCD	Leukemia	9e77a65eedd436e110d256		1		peri	-1								
1531E		1531	5	semi-formed	SRR11421632	PRJNA545312	3		6	2	TCD	Leukemia	9e77a65eedd436e110d256		1		peri	0								
1531F		1531	8	liquid	SRR11421630	PRJNA545312	6		6	2	TCD	Leukemia	9e77a65eedd436e110d256		1		post	0								
1531G		1531	14	semi-formed	SRR11421629	PRJNA545312	12		6	2	TCD	Leukemia	9e77a65eedd436e110d256		1		post	1								
1532A		1532	0	semi-formed	SRR11421628	PRJNA545312	0		10	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	4b03ac81576ca6d09847f3		1		peri	-1								
1532B		1532	8	formed	SRR11421627	PRJNA545312	8		10	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	4b03ac81576ca6d09847f3		1		post	1								
1532C		1532	9	semi-formed	SRR11421626	PRJNA545312	9		10	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	4b03ac81576ca6d09847f3		1		post	1								
1532D		1532	17	liquid	SRR11421625	PRJNA545312	17		10	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	4b03ac81576ca6d09847f3		1		post	2								
1532E		1532	19	semi-formed	SRR11421624	PRJNA545312	19		10	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	4b03ac81576ca6d09847f3		1		post	2								
1532F		1532	22	formed	SRR11421623	PRJNA545312	22		10	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	4b03ac81576ca6d09847f3		1		post	3								
1532G		1532	42	semi-formed	SRR11115492	PRJNA607574	42		10	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	4b03ac81576ca6d09847f3		1		post	5								
1532I		1532	315	liquid	SRR11115491	PRJNA607574	315		10	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	4b03ac81576ca6d09847f3		1		post	6								
1532J		1532	356	semi-formed	SRR11115490	PRJNA607574	356		10	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	4b03ac81576ca6d09847f3		1		post	6								
1532K		1532	422	semi-formed	SRR11115489	PRJNA607574	422		10	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	4b03ac81576ca6d09847f3		1		post	6								
1533A		1533	0	formed	SRR11115488	PRJNA607574	-299		8	299	PBSC_unmodified	Multiple Myeloma	02d62c17053e673065fc58		0		pre	-3								
1533B		1533	300	liquid	SRR11115487	PRJNA607574	1		8	299	PBSC_unmodified	Multiple Myeloma	02d62c17053e673065fc58		0		peri	0								
1533C		1533	471	formed	SRR11115486	PRJNA607574	172		8	299	PBSC_unmodified	Multiple Myeloma	02d62c17053e673065fc58		0		post	6								
1533D		1533	473	liquid	SRR11115485	PRJNA607574	174		8	299	PBSC_unmodified	Multiple Myeloma	02d62c17053e673065fc58		0		post	6								
1533E		1533	486	liquid	SRR11115483	PRJNA607574	187		8	299	PBSC_unmodified	Multiple Myeloma	02d62c17053e673065fc58		0		post	6								
1533F		1533	494	formed	SRR11115482	PRJNA607574	195		8	299	PBSC_unmodified	Multiple Myeloma	02d62c17053e673065fc58		0		post	6								
1533G		1533	495	semi-formed	SRR11115481	PRJNA607574	196		8	299	PBSC_unmodified	Multiple Myeloma	02d62c17053e673065fc58		0		post	6								
1533H		1533	549	semi-formed	SRR11115480	PRJNA607574	250		8	299	PBSC_unmodified	Multiple Myeloma	02d62c17053e673065fc58		0		post	6								
1534A		1534	0	formed	SRR11140039	PRJNA606262			1																	
1535A		1535	0	liquid	SRR11139622	PRJNA606262			2																	
1535B		1535	7	formed	SRR11139621	PRJNA606262			2																	
1536A		1536	0	liquid	SRR11139846	PRJNA606262			1																	
1537A		1537	0	semi-formed	SRR11397362	PRJNA607574			2																	
1537C		1537	10	semi-formed	SRR11397351	PRJNA607574			2																	
1538A		1538	0	formed	SRR11139936	PRJNA606262			1																	
1539A		1539	0	formed	SRR11421622	PRJNA545312	-6		7	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	940ab59b2138d714c47a99		1		pre	-1								
1539B		1539	3	formed	SRR11421621	PRJNA545312	-3		7	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	940ab59b2138d714c47a99		1		pre	-1								
1539C		1539	5	liquid	SRR11421619	PRJNA545312	-1		7	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	940ab59b2138d714c47a99		1		pre	-1								
1539D		1539	7	liquid	SRR11421618	PRJNA545312	1		7	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	940ab59b2138d714c47a99		1		peri	0								
1539E		1539	10	formed	SRR11421617	PRJNA545312	4		7	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	940ab59b2138d714c47a99		1		peri	0								
1539F		1539	12	formed	SRR11421616	PRJNA545312	6		7	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	940ab59b2138d714c47a99		1		post	0								
1539G		1539	14	formed	SRR11421615	PRJNA545312	8		7	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	940ab59b2138d714c47a99		1		post	1								
153A		153	0	formed	SRR11421614	PRJNA545312	-17		6	17	TCD	Leukemia	276779be01fcfbd98d7672	246	1		pre	-3								
153B		153	8	formed	SRR11421613	PRJNA545312	-9		6	17	TCD	Leukemia	276779be01fcfbd98d7672	246	1		pre	-2								
153C		153	16	semi-formed	SRR11421556	PRJNA545312	-1		6	17	TCD	Leukemia	276779be01fcfbd98d7672	246	1		pre	-1								
153D		153	23	liquid	SRR11421555	PRJNA545312	6		6	17	TCD	Leukemia	276779be01fcfbd98d7672	246	1		post	0								
153G		153	42	semi-formed	SRR11421554	PRJNA545312	25		6	17	TCD	Leukemia	276779be01fcfbd98d7672	246	1		post	3								
153H		153	385	formed	SRR11421552	PRJNA545312	368		6	17	TCD	Leukemia	276779be01fcfbd98d7672	246	1		post	6								
1540A		1540	0	formed	SRR11397297	PRJNA607574			4																	
1540B		1540	37		SRR11397286	PRJNA607574			4																	
1540C		1540	93	semi-formed	SRR11397243	PRJNA607574			4																	
1540D		1540	350	formed	SRR11397231	PRJNA607574			4																	
1541A		1541	0	formed	SRR11140414	PRJNA606262			7																	
1541B		1541	1	formed	SRR11140413	PRJNA606262			7																	
1541C		1541	6	liquid	SRR11140412	PRJNA606262			7																	
1541D		1541	8	semi-formed	SRR11140411	PRJNA606262			7																	
1541E		1541	12	liquid	SRR11140410	PRJNA606262			7																	
1541F		1541	18	liquid	SRR11140408	PRJNA606262			7																	
1541G		1541	20	formed	SRR11140407	PRJNA606262			7																	
1542A		1542	0	formed	SRR11139945	PRJNA606262			2																	
1542B		1542	13	liquid	SRR11139943	PRJNA606262			2																	
1543A		1543	0	formed	SRR11397012	PRJNA607574			3																	
1543B		1543	40		SRR11396851	PRJNA607574			3																	
1543C		1543	97	formed	SRR11396850	PRJNA607574			3																	
1544A		1544	0	liquid	SRR11140438	PRJNA606262			1																	
1546A		1546	0	semi-formed	SRR11421551	PRJNA545312	5		12	-5	BM_unmodified	Myelodysplastic Syndromes	3d25fe1fe7f3b9b675549e		1		peri	0								
1546B		1546	1	formed	SRR11421550	PRJNA545312	6		12	-5	BM_unmodified	Myelodysplastic Syndromes	3d25fe1fe7f3b9b675549e		1		post	0								
1546C		1546	2	semi-formed	SRR11421549	PRJNA545312	7		12	-5	BM_unmodified	Myelodysplastic Syndromes	3d25fe1fe7f3b9b675549e		1		post	0								
1546D		1546	3	formed	SRR11421548	PRJNA545312	8		12	-5	BM_unmodified	Myelodysplastic Syndromes	3d25fe1fe7f3b9b675549e		1		post	1								
1546E		1546	9	formed	SRR11421547	PRJNA545312	14		12	-5	BM_unmodified	Myelodysplastic Syndromes	3d25fe1fe7f3b9b675549e		1		post	1								
1546F		1546	14	formed	SRR11421546	PRJNA545312	19		12	-5	BM_unmodified	Myelodysplastic Syndromes	3d25fe1fe7f3b9b675549e		1		post	2								
1546G		1546	15	formed	SRR11421545	PRJNA545312	20		12	-5	BM_unmodified	Myelodysplastic Syndromes	3d25fe1fe7f3b9b675549e		1		post	2								
1546H		1546	16	formed	SRR11421544	PRJNA545312	21		12	-5	BM_unmodified	Myelodysplastic Syndromes	3d25fe1fe7f3b9b675549e		1		post	2								
1546I		1546	20	formed	SRR11421543	PRJNA545312	25		12	-5	BM_unmodified	Myelodysplastic Syndromes	3d25fe1fe7f3b9b675549e		1		post	3								
1546J		1546	21	formed	SRR11421541	PRJNA545312	26		12	-5	BM_unmodified	Myelodysplastic Syndromes	3d25fe1fe7f3b9b675549e		1		post	3								
1546K		1546	38	semi-formed	SRR11115479	PRJNA607574	43		12	-5	BM_unmodified	Myelodysplastic Syndromes	3d25fe1fe7f3b9b675549e		1		post	6								
1546L		1546	52	semi-formed	SRR11115478	PRJNA607574	57		12	-5	BM_unmodified	Myelodysplastic Syndromes	3d25fe1fe7f3b9b675549e		1		post	6								
1547A		1547	0	semi-formed	SRR11140335	PRJNA606262			1																	
1548A		1548	0	formed	SRR11139939	PRJNA606262			2																	
1548B		1548	6	formed	SRR11139938	PRJNA606262			2																	
1549A		1549	0	formed	SRR11140436	PRJNA606262			2																	
1549B		1549	12		SRR11140435	PRJNA606262			2																	
154A		154	0	formed	SRR11421539	PRJNA545312	-3		5	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	e90bae5b301dce57e97f53	48	1		pre	-1								
154B		154	7	semi-formed	SRR11421538	PRJNA545312	4		5	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	e90bae5b301dce57e97f53	48	1		peri	0								
154C		154	8	semi-formed	SRR11421537	PRJNA545312	5		5	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	e90bae5b301dce57e97f53	48	1		peri	0								
154D		154	15	formed	SRR11421536	PRJNA545312	12		5	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	e90bae5b301dce57e97f53	48	1		post	1								
154E		154	99	semi-formed	SRR11421535	PRJNA545312	96		5	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	e90bae5b301dce57e97f53	48	1		post	6								
1550A		1550	0	liquid	SRR11140178	PRJNA606262			3																	
1550B		1550	40	formed	SRR11140167	PRJNA606262			3																	
1550C		1550	60	formed	SRR11140156	PRJNA606262			3																	
1551A		1551	0	liquid	SRR11139944	PRJNA606262			2																	
1551B		1551	6	semi-formed	SRR11139933	PRJNA606262			2																	
1552A		1552	0	formed	SRR11115477	PRJNA607574	-9		3	9	TCD	Myelodysplastic Syndromes	e176edf8e4317d9aa39a4e		0		pre	-2								
1552C		1552	3	formed	SRR11115476	PRJNA607574	-6		3	9	TCD	Myelodysplastic Syndromes	e176edf8e4317d9aa39a4e		0		pre	-1								
1552D		1552	13	semi-formed	SRR11115475	PRJNA607574	4		3	9	TCD	Myelodysplastic Syndromes	e176edf8e4317d9aa39a4e		0		peri	0								
1553A		1553	0	formed	SRR11421534	PRJNA545312	-2		16	2	PBSC_unmodified	Myelodysplastic Syndromes	8b407686349a80041bd4ab		1		pre	-1								
1553B		1553	2	semi-formed	SRR11421533	PRJNA545312	0		16	2	PBSC_unmodified	Myelodysplastic Syndromes	8b407686349a80041bd4ab		1		peri	-1								
1553C		1553	3	liquid	SRR11421532	PRJNA545312	1		16	2	PBSC_unmodified	Myelodysplastic Syndromes	8b407686349a80041bd4ab		1		peri	0								
1553D		1553	34	liquid	SRR11421529	PRJNA545312	32		16	2	PBSC_unmodified	Myelodysplastic Syndromes	8b407686349a80041bd4ab		1		post	4								
1553F		1553	35	liquid	SRR11421499	PRJNA545312	33		16	2	PBSC_unmodified	Myelodysplastic Syndromes	8b407686349a80041bd4ab		1		post	4								
1553G		1553	36	liquid	SRR11421498	PRJNA545312	34		16	2	PBSC_unmodified	Myelodysplastic Syndromes	8b407686349a80041bd4ab		1		post	4								
1553H		1553	41	liquid	SRR11421497	PRJNA545312	39		16	2	PBSC_unmodified	Myelodysplastic Syndromes	8b407686349a80041bd4ab		1		post	5								
1553I		1553	43	liquid	SRR11421496	PRJNA545312	41		16	2	PBSC_unmodified	Myelodysplastic Syndromes	8b407686349a80041bd4ab		1		post	5								
1553J		1553	44	liquid	SRR11421495	PRJNA545312	42		16	2	PBSC_unmodified	Myelodysplastic Syndromes	8b407686349a80041bd4ab		1		post	5								
1553K		1553	45	liquid	SRR11421494	PRJNA545312	43		16	2	PBSC_unmodified	Myelodysplastic Syndromes	8b407686349a80041bd4ab		1		post	6								
1553L		1553	47	semi-formed	SRR11421493	PRJNA545312	45		16	2	PBSC_unmodified	Myelodysplastic Syndromes	8b407686349a80041bd4ab		1		post	6								
1553M		1553	48	liquid	SRR11421492	PRJNA545312	46		16	2	PBSC_unmodified	Myelodysplastic Syndromes	8b407686349a80041bd4ab		1		post	6								
1553N		1553	52	liquid	SRR11421490	PRJNA545312	50		16	2	PBSC_unmodified	Myelodysplastic Syndromes	8b407686349a80041bd4ab		1		post	6								
1553O		1553	76	semi-formed	SRR11421489	PRJNA545312	74		16	2	PBSC_unmodified	Myelodysplastic Syndromes	8b407686349a80041bd4ab		1		post	6								
1553P		1553	111	semi-formed	SRR11115474	PRJNA607574	109		16	2	PBSC_unmodified	Myelodysplastic Syndromes	8b407686349a80041bd4ab		1		post	6								
1553Q		1553	112	liquid	SRR11115472	PRJNA607574	110		16	2	PBSC_unmodified	Myelodysplastic Syndromes	8b407686349a80041bd4ab		1		post	6								
1554A		1554	0	formed	SRR11139640	PRJNA606262			1																	
1555A		1555	0	semi-formed	SRR11396836	PRJNA607574			5																	
1555B		1555	21	semi-formed	SRR11396835	PRJNA607574			5																	
1555C		1555	27		SRR11396834	PRJNA607574			5																	
1555D		1555	46	semi-formed	SRR11396833	PRJNA607574			5																	
1555E		1555	119	semi-formed	SRR11396832	PRJNA607574			5																	
1556A		1556	0	semi-formed	SRR11140030	PRJNA606262			1																	
1557A		1557	0	semi-formed	SRR11396829	PRJNA607574			33																	
1557AA		1557	79	semi-formed	SRR11396828	PRJNA607574			33																	
1557B		1557	1	semi-formed	SRR11396827	PRJNA607574			33																	
1557BB		1557	101	semi-formed	SRR11396826	PRJNA607574			33																	
1557C		1557	2	semi-formed	SRR11396825	PRJNA607574			33																	
1557CC		1557	117	semi-formed	SRR11396824	PRJNA607574			33																	
1557D		1557	4	semi-formed	SRR11396823	PRJNA607574			33																	
1557DD		1557	164	semi-formed	SRR11396822	PRJNA607574			33																	
1557E		1557	5	semi-formed	SRR11396821	PRJNA607574			33																	
1557EE		1557	193	semi-formed	SRR11396755	PRJNA607574			33																	
1557F		1557	6	semi-formed	SRR11396754	PRJNA607574			33																	
1557FF		1557	373	semi-formed	SRR11396753	PRJNA607574			33																	
1557G		1557	16	semi-formed	SRR11396752	PRJNA607574			33																	
1557GG		1557	445	formed	SRR11396751	PRJNA607574			33																	
1557H		1557	17	semi-formed	SRR11396750	PRJNA607574			33																	
1557HH		1557	499	semi-formed	SRR11396749	PRJNA607574			33																	
1557I		1557	19	liquid	SRR11397101	PRJNA607574			33																	
1557J		1557	23	semi-formed	SRR11397405	PRJNA607574			33																	
1557K		1557	24	semi-formed	SRR11397404	PRJNA607574			33																	
1557L		1557	25	semi-formed	SRR11397402	PRJNA607574			33																	
1557M		1557	26	semi-formed	SRR11397401	PRJNA607574			33																	
1557N		1557	29	semi-formed	SRR11397400	PRJNA607574			33																	
1557O		1557	30		SRR11397399	PRJNA607574			33																	
1557Q		1557	31	semi-formed	SRR11397398	PRJNA607574			33																	
1557R		1557	32	semi-formed	SRR11397397	PRJNA607574			33																	
1557S		1557	34	semi-formed	SRR11397396	PRJNA607574			33																	
1557T		1557	36	semi-formed	SRR11397395	PRJNA607574			33																	
1557U		1557	37	semi-formed	SRR11397394	PRJNA607574			33																	
1557V		1557	39	semi-formed	SRR11397393	PRJNA607574			33																	
1557W		1557	40	semi-formed	SRR11397391	PRJNA607574			33																	
1557X		1557	64	semi-formed	SRR11397390	PRJNA607574			33																	
1557Y		1557	65	semi-formed	SRR11397389	PRJNA607574			33																	
1557Z		1557	66	semi-formed	SRR11397388	PRJNA607574			33																	
1558A		1558	0	semi-formed	SRR11397387	PRJNA607574			2																	
1558B		1558	213	semi-formed	SRR11397386	PRJNA607574			2																	
1559A		1559	0	formed	SRR11397385	PRJNA607574			2																	
1559B		1559	7	liquid	SRR11397384	PRJNA607574			2																	
155A		155	0	formed	SRR11421488	PRJNA545312	-28		8	28	TCD	Non-Hodgkin's Lymphoma	df0ed1f76ea41f6e993a10	262	1		pre	-3								
155B		155	26	liquid	SRR11421487	PRJNA545312	-2		8	28	TCD	Non-Hodgkin's Lymphoma	df0ed1f76ea41f6e993a10	262	1		pre	-1								
155C		155	35	semi-formed	SRR11421486	PRJNA545312	7		8	28	TCD	Non-Hodgkin's Lymphoma	df0ed1f76ea41f6e993a10	262	1		post	0								
155D		155	39	semi-formed	SRR11421485	PRJNA545312	11		8	28	TCD	Non-Hodgkin's Lymphoma	df0ed1f76ea41f6e993a10	262	1		post	1								
155E		155	46	semi-formed	SRR11421484	PRJNA545312	18		8	28	TCD	Non-Hodgkin's Lymphoma	df0ed1f76ea41f6e993a10	262	1		post	2								
155F		155	66	semi-formed	SRR11421483	PRJNA545312	38		8	28	TCD	Non-Hodgkin's Lymphoma	df0ed1f76ea41f6e993a10	262	1		post	5								
155G		155	67	liquid	SRR11421482	PRJNA545312	39		8	28	TCD	Non-Hodgkin's Lymphoma	df0ed1f76ea41f6e993a10	262	1		post	5								
155H		155	78	formed	SRR11421481	PRJNA545312	50		8	28	TCD	Non-Hodgkin's Lymphoma	df0ed1f76ea41f6e993a10	262	1		post	6								
1560A		1560	0	formed	SRR11421479	PRJNA545312	-4		7	4	PBSC_unmodified	Multiple Myeloma	f19a97265e1fea7d5a4287		1		pre	-1								
1560B		1560	2	semi-formed	SRR11421478	PRJNA545312	-2		7	4	PBSC_unmodified	Multiple Myeloma	f19a97265e1fea7d5a4287		1		pre	-1								
1560C		1560	4	liquid	SRR11421477	PRJNA545312	0		7	4	PBSC_unmodified	Multiple Myeloma	f19a97265e1fea7d5a4287		1		peri	-1								
1560D		1560	6	semi-formed	SRR11421476	PRJNA545312	2		7	4	PBSC_unmodified	Multiple Myeloma	f19a97265e1fea7d5a4287		1		peri	0								
1560E		1560	9	liquid	SRR11421475	PRJNA545312	5		7	4	PBSC_unmodified	Multiple Myeloma	f19a97265e1fea7d5a4287		1		peri	0								
1560F		1560	13	semi-formed	SRR11421474	PRJNA545312	9		7	4	PBSC_unmodified	Multiple Myeloma	f19a97265e1fea7d5a4287		1		post	1								
1560G		1560	14	semi-formed	SRR11421473	PRJNA545312	10		7	4	PBSC_unmodified	Multiple Myeloma	f19a97265e1fea7d5a4287		1		post	1								
1561A		1561	0	formed	SRR11421416	PRJNA545312	-6		11	6	PBSC_unmodified	Leukemia	1f89653890ac964f7497c9		1		pre	-1								
1561B		1561	1	formed	SRR11421415	PRJNA545312	-5		11	6	PBSC_unmodified	Leukemia	1f89653890ac964f7497c9		1		pre	-1								
1561C		1561	6	semi-formed	SRR11421414	PRJNA545312	0		11	6	PBSC_unmodified	Leukemia	1f89653890ac964f7497c9		1		peri	-1								
1561D		1561	7	formed	SRR11421412	PRJNA545312	1		11	6	PBSC_unmodified	Leukemia	1f89653890ac964f7497c9		1		peri	0								
1561E		1561	10	formed	SRR11421411	PRJNA545312	4		11	6	PBSC_unmodified	Leukemia	1f89653890ac964f7497c9		1		peri	0								
1561F		1561	19	semi-formed	SRR11421410	PRJNA545312	13		11	6	PBSC_unmodified	Leukemia	1f89653890ac964f7497c9		1		post	1								
1561G		1561	21	semi-formed	SRR11421409	PRJNA545312	15		11	6	PBSC_unmodified	Leukemia	1f89653890ac964f7497c9		1		post	2								
1561H		1561	22	liquid	SRR11421408	PRJNA545312	16		11	6	PBSC_unmodified	Leukemia	1f89653890ac964f7497c9		1		post	2								
1561I		1561	23	liquid	SRR11421407	PRJNA545312	17		11	6	PBSC_unmodified	Leukemia	1f89653890ac964f7497c9		1		post	2								
1561J		1561	26	semi-formed	SRR11421406	PRJNA545312	20		11	6	PBSC_unmodified	Leukemia	1f89653890ac964f7497c9		1		post	2								
1561K		1561	27	liquid	SRR11421405	PRJNA545312	21		11	6	PBSC_unmodified	Leukemia	1f89653890ac964f7497c9		1		post	2								
1562A		1562	0	formed	SRR11421404	PRJNA545312	-1		16	1	BM_unmodified	Leukemia	23a8869806888678720618		1		pre	-1								
1562B		1562	1	formed	SRR11421403	PRJNA545312	0		16	1	BM_unmodified	Leukemia	23a8869806888678720618		1		peri	-1								
1562C		1562	2	formed	SRR11421401	PRJNA545312	1		16	1	BM_unmodified	Leukemia	23a8869806888678720618		1		peri	0								
1562D		1562	4	semi-formed	SRR11421400	PRJNA545312	3		16	1	BM_unmodified	Leukemia	23a8869806888678720618		1		peri	0								
1562E		1562	5	semi-formed	SRR11421399	PRJNA545312	4		16	1	BM_unmodified	Leukemia	23a8869806888678720618		1		peri	0								
1562F		1562	6	semi-formed	SRR11421398	PRJNA545312	5		16	1	BM_unmodified	Leukemia	23a8869806888678720618		1		peri	0								
1562G		1562	7	semi-formed	SRR11421397	PRJNA545312	6		16	1	BM_unmodified	Leukemia	23a8869806888678720618		1		post	0								
1562H		1562	9	semi-formed	SRR11419902	PRJNA545312	8		16	1	BM_unmodified	Leukemia	23a8869806888678720618		1		post	1								
1562I		1562	12	semi-formed	SRR11420081	PRJNA545312	11		16	1	BM_unmodified	Leukemia	23a8869806888678720618		1		post	1								
1562J		1562	13	formed	SRR11420352	PRJNA545312	12		16	1	BM_unmodified	Leukemia	23a8869806888678720618		1		post	1								
1562K		1562	14	formed	SRR11419568	PRJNA545312	13		16	1	BM_unmodified	Leukemia	23a8869806888678720618		1		post	1								
1562L		1562	15	formed	SRR11419557	PRJNA545312	14		16	1	BM_unmodified	Leukemia	23a8869806888678720618		1		post	1								
1562M		1562	16	formed	SRR11419760	PRJNA545312	15		16	1	BM_unmodified	Leukemia	23a8869806888678720618		1		post	2								
1562N		1562	18	formed	SRR11419451	PRJNA545312	17		16	1	BM_unmodified	Leukemia	23a8869806888678720618		1		post	2								
1562O		1562	19	formed	SRR11419440	PRJNA545312	18		16	1	BM_unmodified	Leukemia	23a8869806888678720618		1		post	2								
1562P		1562	20	formed	SRR11419401	PRJNA545312	19		16	1	BM_unmodified	Leukemia	23a8869806888678720618		1		post	2								
1563A		1563	0	semi-formed	SRR11397383	PRJNA607574			3																	
1563B		1563	38	semi-formed	SRR11397382	PRJNA607574			3																	
1563C		1563	120	semi-formed	SRR11397348	PRJNA607574			3																	
1564A		1564	0	formed	SRR11419390	PRJNA545312	-7		13	7	PBSC_unmodified	Leukemia	6575bada9410d3c086657d		1		pre	-2								
1564B		1564	1	formed	SRR11420348	PRJNA545312	-6		13	7	PBSC_unmodified	Leukemia	6575bada9410d3c086657d		1		pre	-1								
1564C		1564	3	formed	SRR11420337	PRJNA545312	-4		13	7	PBSC_unmodified	Leukemia	6575bada9410d3c086657d		1		pre	-1								
1564D		1564	6	formed	SRR11420325	PRJNA545312	-1		13	7	PBSC_unmodified	Leukemia	6575bada9410d3c086657d		1		pre	-1								
1564E		1564	7	formed	SRR11419681	PRJNA545312	0		13	7	PBSC_unmodified	Leukemia	6575bada9410d3c086657d		1		peri	-1								
1564F		1564	10	semi-formed	SRR11419670	PRJNA545312	3		13	7	PBSC_unmodified	Leukemia	6575bada9410d3c086657d		1		peri	0								
1564G		1564	11	semi-formed	SRR11419631	PRJNA545312	4		13	7	PBSC_unmodified	Leukemia	6575bada9410d3c086657d		1		peri	0								
1564H		1564	20	liquid	SRR11419620	PRJNA545312	13		13	7	PBSC_unmodified	Leukemia	6575bada9410d3c086657d		1		post	1								
1564I		1564	21	semi-formed	SRR11419609	PRJNA545312	14		13	7	PBSC_unmodified	Leukemia	6575bada9410d3c086657d		1		post	1								
1564J		1564	26	semi-formed	SRR11421396	PRJNA545312	19		13	7	PBSC_unmodified	Leukemia	6575bada9410d3c086657d		1		post	2								
1564K		1564	27	semi-formed	SRR11421395	PRJNA545312	20		13	7	PBSC_unmodified	Leukemia	6575bada9410d3c086657d		1		post	2								
1564L		1564	28	semi-formed	SRR11421394	PRJNA545312	21		13	7	PBSC_unmodified	Leukemia	6575bada9410d3c086657d		1		post	2								
1564M		1564	60	formed	SRR11421393	PRJNA545312	53		13	7	PBSC_unmodified	Leukemia	6575bada9410d3c086657d		1		post	6								
1565A		1565	0	semi-formed	SRR11139961	PRJNA606262			1																	
1566A		1566	0	formed	SRR11140028	PRJNA606262			5																	
1566B		1566	2	formed	SRR11140027	PRJNA606262			5																	
1566C		1566	109	formed	SRR11397344	PRJNA607574			5																	
1566D		1566	137	formed	SRR11397343	PRJNA607574			5																	
1566E		1566	192	formed	SRR11397342	PRJNA607574			5																	
1567A		1567	0	formed	SRR11421392	PRJNA545312	-3		10	3	PBSC_unmodified	Leukemia	53d97e36f76cba33be5cd2		1		pre	-1								
1567B		1567	1	formed	SRR11421390	PRJNA545312	-2		10	3	PBSC_unmodified	Leukemia	53d97e36f76cba33be5cd2		1		pre	-1								
1567C		1567	2	formed	SRR11421389	PRJNA545312	-1		10	3	PBSC_unmodified	Leukemia	53d97e36f76cba33be5cd2		1		pre	-1								
1567D		1567	4	semi-formed	SRR11421035	PRJNA545312	1		10	3	PBSC_unmodified	Leukemia	53d97e36f76cba33be5cd2		1		peri	0								
1567E		1567	7	semi-formed	SRR11421034	PRJNA545312	4		10	3	PBSC_unmodified	Leukemia	53d97e36f76cba33be5cd2		1		peri	0								
1567F		1567	8	formed	SRR11421033	PRJNA545312	5		10	3	PBSC_unmodified	Leukemia	53d97e36f76cba33be5cd2		1		peri	0								
1567G		1567	9	formed	SRR11421032	PRJNA545312	6		10	3	PBSC_unmodified	Leukemia	53d97e36f76cba33be5cd2		1		post	0								
1567H		1567	10	formed	SRR11421031	PRJNA545312	7		10	3	PBSC_unmodified	Leukemia	53d97e36f76cba33be5cd2		1		post	0								
1567I		1567	12	semi-formed	SRR11421030	PRJNA545312	9		10	3	PBSC_unmodified	Leukemia	53d97e36f76cba33be5cd2		1		post	1								
1567J		1567	17	formed	SRR11421029	PRJNA545312	14		10	3	PBSC_unmodified	Leukemia	53d97e36f76cba33be5cd2		1		post	1								
1568A		1568	0	formed	SRR11139636	PRJNA606262			1																	
1569A		1569	0	liquid	SRR11421028	PRJNA545312	-8		10	8	BM_unmodified	Non-Malignant Hemat Disorders	812c95c092aed9c8cf6a52		1		pre	-2								
1569B		1569	12	semi-formed	SRR11421026	PRJNA545312	4		10	8	BM_unmodified	Non-Malignant Hemat Disorders	812c95c092aed9c8cf6a52		1		peri	0								
1569C		1569	19	semi-formed	SRR11421025	PRJNA545312	11		10	8	BM_unmodified	Non-Malignant Hemat Disorders	812c95c092aed9c8cf6a52		1		post	1								
1569D		1569	21	semi-formed	SRR11421024	PRJNA545312	13		10	8	BM_unmodified	Non-Malignant Hemat Disorders	812c95c092aed9c8cf6a52		1		post	1								
1569E		1569	23	semi-formed	SRR11421023	PRJNA545312	15		10	8	BM_unmodified	Non-Malignant Hemat Disorders	812c95c092aed9c8cf6a52		1		post	2								
1569F		1569	25	semi-formed	SRR11421022	PRJNA545312	17		10	8	BM_unmodified	Non-Malignant Hemat Disorders	812c95c092aed9c8cf6a52		1		post	2								
1569G		1569	29	semi-formed	SRR11423239	PRJNA545312	21		10	8	BM_unmodified	Non-Malignant Hemat Disorders	812c95c092aed9c8cf6a52		1		post	2								
1569H		1569	33	semi-formed	SRR11421021	PRJNA545312	25		10	8	BM_unmodified	Non-Malignant Hemat Disorders	812c95c092aed9c8cf6a52		1		post	3								
1569I		1569	35	formed	SRR11421020	PRJNA545312	27		10	8	BM_unmodified	Non-Malignant Hemat Disorders	812c95c092aed9c8cf6a52		1		post	3								
1569J		1569	39	semi-formed	SRR11421019	PRJNA545312	31		10	8	BM_unmodified	Non-Malignant Hemat Disorders	812c95c092aed9c8cf6a52		1		post	4								
156A		156	0	formed	SRR11421018	PRJNA545312	-46		7	46	TCD	Leukemia	1d3cb2853e5070d0e69cce	247	1		pre	-3								
156B		156	42	liquid	SRR11421017	PRJNA545312	-4		7	46	TCD	Leukemia	1d3cb2853e5070d0e69cce	247	1		pre	-1								
156C		156	50	semi-formed	SRR11421015	PRJNA545312	4		7	46	TCD	Leukemia	1d3cb2853e5070d0e69cce	247	1		peri	0								
156D		156	56	liquid	SRR11421014	PRJNA545312	10		7	46	TCD	Leukemia	1d3cb2853e5070d0e69cce	247	1		post	1								
156E		156	86	liquid	SRR11421013	PRJNA545312	40		7	46	TCD	Leukemia	1d3cb2853e5070d0e69cce	247	1		post	5								
156F		156	119	semi-formed	SRR11421012	PRJNA545312	73		7	46	TCD	Leukemia	1d3cb2853e5070d0e69cce	247	1		post	6								
156G		156	284	semi-formed	SRR11421011	PRJNA545312	238		7	46	TCD	Leukemia	1d3cb2853e5070d0e69cce	247	1		post	6								
1570A		1570	0	formed	SRR9271239	PRJNA548153	-5		14	5	BM_unmodified	Myeloproliferative Disorder	e3f13770f50a5d89745c66		0		pre	-1								
1570B		1570	4	formed	SRR9271240	PRJNA548153	-1		14	5	BM_unmodified	Myeloproliferative Disorder	e3f13770f50a5d89745c66		0		pre	-1								
1570C		1570	7	semi-formed	SRR9271241	PRJNA548153	2		14	5	BM_unmodified	Myeloproliferative Disorder	e3f13770f50a5d89745c66		0		peri	0								
1570D		1570	8	semi-formed	SRR9271242	PRJNA548153	3		14	5	BM_unmodified	Myeloproliferative Disorder	e3f13770f50a5d89745c66		0		peri	0								
1570E		1570	11	formed	SRR9271207	PRJNA548153	6		14	5	BM_unmodified	Myeloproliferative Disorder	e3f13770f50a5d89745c66		0		post	0								
1570F		1570	13	formed	SRR9271208	PRJNA548153	8		14	5	BM_unmodified	Myeloproliferative Disorder	e3f13770f50a5d89745c66		0		post	1								
1570G		1570	14	semi-formed	SRR9271209	PRJNA548153	9		14	5	BM_unmodified	Myeloproliferative Disorder	e3f13770f50a5d89745c66		0		post	1								
1570H		1570	19	semi-formed	SRR9271238	PRJNA548153	14		14	5	BM_unmodified	Myeloproliferative Disorder	e3f13770f50a5d89745c66		0		post	1								
1570I		1570	21	formed	SRR9271203	PRJNA548153	16		14	5	BM_unmodified	Myeloproliferative Disorder	e3f13770f50a5d89745c66		0		post	2								
1570J		1570	24	semi-formed	SRR11115471	PRJNA607574	19		14	5	BM_unmodified	Myeloproliferative Disorder	e3f13770f50a5d89745c66		0		post	2								
1570K		1570	31	liquid	SRR11115470	PRJNA607574	26		14	5	BM_unmodified	Myeloproliferative Disorder	e3f13770f50a5d89745c66		0		post	3								
1570L		1570	32	semi-formed	SRR11115469	PRJNA607574	27		14	5	BM_unmodified	Myeloproliferative Disorder	e3f13770f50a5d89745c66		0		post	3								
1570M		1570	35	formed	SRR11115468	PRJNA607574	30		14	5	BM_unmodified	Myeloproliferative Disorder	e3f13770f50a5d89745c66		0		post	4								
1570N		1570	36	formed	SRR11115467	PRJNA607574	31		14	5	BM_unmodified	Myeloproliferative Disorder	e3f13770f50a5d89745c66		0		post	4								
1571A		1571	0	formed	SRR11397340	PRJNA607574			3																	
1571B		1571	8	liquid	SRR11397339	PRJNA607574			3																	
1571C		1571	9	liquid	SRR11397337	PRJNA607574			3																	
1572A		1572	0	formed	SRR11115466	PRJNA607574	4		5	-4	cord	Leukemia	1f0f40d6b825f560a0331d		0		peri	0								
1572B		1572	2	semi-formed	SRR11115465	PRJNA607574	6		5	-4	cord	Leukemia	1f0f40d6b825f560a0331d		0		post	0								
1572C		1572	7	liquid	SRR11115464	PRJNA607574	11		5	-4	cord	Leukemia	1f0f40d6b825f560a0331d		0		post	1								
1572D		1572	9	liquid	SRR11115463	PRJNA607574	13		5	-4	cord	Leukemia	1f0f40d6b825f560a0331d		0		post	1								
1572E		1572	190	formed	SRR11115461	PRJNA607574	194		5	-4	cord	Leukemia	1f0f40d6b825f560a0331d		0		post	6								
1573A		1573	0	formed	SRR11139960	PRJNA606262			1																	
1574A		1574	0	formed	SRR11421010	PRJNA545312	-8		11	8	TCD	Leukemia	da875ef8e3b611bbf98448		1		pre	-2								
1574B		1574	1	formed	SRR11421009	PRJNA545312	-7		11	8	TCD	Leukemia	da875ef8e3b611bbf98448		1		pre	-2								
1574C		1574	6	formed	SRR11421008	PRJNA545312	-2		11	8	TCD	Leukemia	da875ef8e3b611bbf98448		1		pre	-1								
1574D		1574	7	liquid	SRR11420958	PRJNA545312	-1		11	8	TCD	Leukemia	da875ef8e3b611bbf98448		1		pre	-1								
1574E		1574	16	formed	SRR11420957	PRJNA545312	8		11	8	TCD	Leukemia	da875ef8e3b611bbf98448		1		post	1								
1574F		1574	21	semi-formed	SRR11420955	PRJNA545312	13		11	8	TCD	Leukemia	da875ef8e3b611bbf98448		1		post	1								
1574G		1574	22	formed	SRR11420954	PRJNA545312	14		11	8	TCD	Leukemia	da875ef8e3b611bbf98448		1		post	1								
1574H		1574	23	formed	SRR11420953	PRJNA545312	15		11	8	TCD	Leukemia	da875ef8e3b611bbf98448		1		post	2								
1574I		1574	25	formed	SRR11420952	PRJNA545312	17		11	8	TCD	Leukemia	da875ef8e3b611bbf98448		1		post	2								
1574J		1574	26	semi-formed	SRR11420951	PRJNA545312	18		11	8	TCD	Leukemia	da875ef8e3b611bbf98448		1		post	2								
1574K		1574	28	formed	SRR11420950	PRJNA545312	20		11	8	TCD	Leukemia	da875ef8e3b611bbf98448		1		post	2								
1575A		1575	0	semi-formed	SRR11139645	PRJNA606262			2																	
1575B		1575	3	semi-formed	SRR11139644	PRJNA606262			2																	
1576A		1576	0	formed	SRR11139615	PRJNA606262			3																	
1576B		1576	8	semi-formed	SRR11139614	PRJNA606262			3																	
1576C		1576	12	formed	SRR11139613	PRJNA606262			3																	
1577A		1577	0		SRR11420949	PRJNA545312	-6		10	6	PBSC_unmodified	Myelodysplastic Syndromes	0383a01053282d0a1da91a		1		pre	-1								
1577B		1577	3	formed	SRR11420948	PRJNA545312	-3		10	6	PBSC_unmodified	Myelodysplastic Syndromes	0383a01053282d0a1da91a		1		pre	-1								
1577C		1577	4	formed	SRR11420947	PRJNA545312	-2		10	6	PBSC_unmodified	Myelodysplastic Syndromes	0383a01053282d0a1da91a		1		pre	-1								
1577E		1577	10	semi-formed	SRR11420946	PRJNA545312	4		10	6	PBSC_unmodified	Myelodysplastic Syndromes	0383a01053282d0a1da91a		1		peri	0								
1577F		1577	13	semi-formed	SRR11420944	PRJNA545312	7		10	6	PBSC_unmodified	Myelodysplastic Syndromes	0383a01053282d0a1da91a		1		post	0								
1577G		1577	15	semi-formed	SRR11420943	PRJNA545312	9		10	6	PBSC_unmodified	Myelodysplastic Syndromes	0383a01053282d0a1da91a		1		post	1								
1577H		1577	17	semi-formed	SRR11420942	PRJNA545312	11		10	6	PBSC_unmodified	Myelodysplastic Syndromes	0383a01053282d0a1da91a		1		post	1								
1577I		1577	20	semi-formed	SRR11420941	PRJNA545312	14		10	6	PBSC_unmodified	Myelodysplastic Syndromes	0383a01053282d0a1da91a		1		post	1								
1577J		1577	21	liquid	SRR11420940	PRJNA545312	15		10	6	PBSC_unmodified	Myelodysplastic Syndromes	0383a01053282d0a1da91a		1		post	2								
1577K		1577	26	semi-formed	SRR11420939	PRJNA545312	20		10	6	PBSC_unmodified	Myelodysplastic Syndromes	0383a01053282d0a1da91a		1		post	2								
1578A		1578	0	formed	SRR11139937	PRJNA606262			1																	
1579A		1579	0	semi-formed	SRR11397329	PRJNA607574			4																	
1579B		1579	39	semi-formed	SRR11397328	PRJNA607574			4																	
1579C		1579	266	semi-formed	SRR11397326	PRJNA607574			4																	
1579D		1579	279	semi-formed	SRR11397325	PRJNA607574			4																	
157A		157	0	formed	SRR11420938	PRJNA545312	-11		7	11	TCD	Leukemia	f0cb03f0db0f192f10563a	245	1		pre	-2								
157B		157	8	formed	SRR11420937	PRJNA545312	-3		7	11	TCD	Leukemia	f0cb03f0db0f192f10563a	245	1		pre	-1								
157D		157	23	liquid	SRR11420935	PRJNA545312	12		7	11	TCD	Leukemia	f0cb03f0db0f192f10563a	245	1		post	1								
157E		157	35	semi-formed	SRR11420932	PRJNA545312	24		7	11	TCD	Leukemia	f0cb03f0db0f192f10563a	245	1		post	3								
157F		157	36	semi-formed	SRR11420931	PRJNA545312	25		7	11	TCD	Leukemia	f0cb03f0db0f192f10563a	245	1		post	3								
157G		157	61	formed	SRR11420930	PRJNA545312	50		7	11	TCD	Leukemia	f0cb03f0db0f192f10563a	245	1		post	6								
157H		157	62	formed	SRR11420929	PRJNA545312	51		7	11	TCD	Leukemia	f0cb03f0db0f192f10563a	245	1		post	6								
1580A		1580	0	formed	SRR11420927	PRJNA545312	-6		12	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	15ba9f1b5201b70b64cf0e		1		pre	-1								
1580B		1580	3	formed	SRR11420926	PRJNA545312	-3		12	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	15ba9f1b5201b70b64cf0e		1		pre	-1								
1580C		1580	5	formed	SRR11420925	PRJNA545312	-1		12	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	15ba9f1b5201b70b64cf0e		1		pre	-1								
1580D		1580	6	semi-formed	SRR11420924	PRJNA545312	0		12	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	15ba9f1b5201b70b64cf0e		1		peri	-1								
1580E		1580	8	semi-formed	SRR11420923	PRJNA545312	2		12	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	15ba9f1b5201b70b64cf0e		1		peri	0								
1580F		1580	10	liquid	SRR11420921	PRJNA545312	4		12	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	15ba9f1b5201b70b64cf0e		1		peri	0								
1580H		1580	11	semi-formed	SRR11420919	PRJNA545312	5		12	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	15ba9f1b5201b70b64cf0e		1		peri	0								
1580I		1580	12	semi-formed	SRR11420918	PRJNA545312	6		12	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	15ba9f1b5201b70b64cf0e		1		post	0								
1580J		1580	15	semi-formed	SRR11420917	PRJNA545312	9		12	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	15ba9f1b5201b70b64cf0e		1		post	1								
1580K		1580	17	semi-formed	SRR11420916	PRJNA545312	11		12	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	15ba9f1b5201b70b64cf0e		1		post	1								
1580L		1580	18	semi-formed	SRR11420915	PRJNA545312	12		12	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	15ba9f1b5201b70b64cf0e		1		post	1								
1580M		1580	19	formed	SRR11420914	PRJNA545312	13		12	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	15ba9f1b5201b70b64cf0e		1		post	1								
1581A		1581	0	liquid	SRR11115460	PRJNA607574	3		4	-3	TCD	Leukemia	a015391bd9d8ceb0b0e47f		0		peri	0								
1581B		1581	2	liquid	SRR11115459	PRJNA607574	5		4	-3	TCD	Leukemia	a015391bd9d8ceb0b0e47f		0		peri	0								
1581C		1581	3	liquid	SRR11115458	PRJNA607574	6		4	-3	TCD	Leukemia	a015391bd9d8ceb0b0e47f		0		post	0								
1581D		1581	4	semi-formed	SRR11115457	PRJNA607574	7		4	-3	TCD	Leukemia	a015391bd9d8ceb0b0e47f		0		post	0								
1583A		1583	0	liquid	SRR11420913	PRJNA545312	-2		3	2	TCD	Leukemia	5b4df7e3b8a41056daccae		1		pre	-1								
1583B		1583	2	liquid	SRR11420912	PRJNA545312	0		3	2	TCD	Leukemia	5b4df7e3b8a41056daccae		1		peri	-1								
1583C		1583	3	liquid	SRR11420910	PRJNA545312	1		3	2	TCD	Leukemia	5b4df7e3b8a41056daccae		1		peri	0								
1584A		1584	0	liquid	SRR11140430	PRJNA606262			1																	
1585B		1585	2	semi-formed	SRR11397323	PRJNA607574			4																	
1585E		1585	56	semi-formed	SRR11397322	PRJNA607574			4																	
1585F		1585	75	semi-formed	SRR11397321	PRJNA607574			4																	
1585H		1585	95	semi-formed	SRR11397320	PRJNA607574			4																	
1586A		1586	0	formed	SRR11139632	PRJNA606262			2																	
1586B		1586	6	liquid	SRR11139631	PRJNA606262			2																	
1587A		1587	0	semi-formed	SRR11397285	PRJNA607574			2																	
1587B		1587	1	semi-formed	SRR11397283	PRJNA607574			2																	
1588A		1588	0	formed	SRR11420909	PRJNA545312	-1		6	1	BM_unmodified	Myelodysplastic Syndromes	4bb76bd006730fe48dcf9e		1		pre	-1								
1588B		1588	2	formed	SRR11420908	PRJNA545312	1		6	1	BM_unmodified	Myelodysplastic Syndromes	4bb76bd006730fe48dcf9e		1		peri	0								
1588C		1588	6	semi-formed	SRR11420907	PRJNA545312	5		6	1	BM_unmodified	Myelodysplastic Syndromes	4bb76bd006730fe48dcf9e		1		peri	0								
1588D		1588	14	formed	SRR11420906	PRJNA545312	13		6	1	BM_unmodified	Myelodysplastic Syndromes	4bb76bd006730fe48dcf9e		1		post	1								
1588E		1588	15	formed	SRR11420905	PRJNA545312	14		6	1	BM_unmodified	Myelodysplastic Syndromes	4bb76bd006730fe48dcf9e		1		post	1								
1588F		1588	16	formed	SRR11420904	PRJNA545312	15		6	1	BM_unmodified	Myelodysplastic Syndromes	4bb76bd006730fe48dcf9e		1		post	2								
1589A		1589	0	formed	SRR11397282	PRJNA607574			5																	
1589B		1589	44	semi-formed	SRR11397281	PRJNA607574			5																	
1589C		1589	97	formed	SRR11397280	PRJNA607574			5																	
1589D		1589	210	formed	SRR11397279	PRJNA607574			5																	
1589E		1589	343	semi-formed	SRR11397278	PRJNA607574			5																	
158A		158	0	liquid	SRR11420903	PRJNA545312	-2		2	2	TCD	Non-Hodgkin's Lymphoma	634e4a2af7e5b20e5b9692	131	1		pre	-1								
158C		158	20	semi-formed	SRR11420901	PRJNA545312	18		2	2	TCD	Non-Hodgkin's Lymphoma	634e4a2af7e5b20e5b9692	131	1		post	2								
1591A		1591	0	liquid	SRR11140475	PRJNA606262			2																	
1591B		1591	30	formed	SRR11140464	PRJNA606262			2																	
1592A		1592	0	semi-formed	SRR11397275	PRJNA607574			1																	
1593A		1593	0	formed	SRR11397274	PRJNA607574			4																	
1593B		1593	35	formed	SRR11397271	PRJNA607574			4																	
1593C		1593	96	semi-formed	SRR11397270	PRJNA607574			4																	
1593D		1593	365	semi-formed	SRR11397269	PRJNA607574			4																	
1594A		1594	0	semi-formed	SRR11397268	PRJNA607574			4																	
1594B		1594	32	formed	SRR11397267	PRJNA607574			4																	
1594C		1594	99	formed	SRR11397266	PRJNA607574			4																	
1594D		1594	344	semi-formed	SRR11397265	PRJNA607574			4																	
1595A		1595	0	semi-formed	SRR11139956	PRJNA606262			1																	
1597A		1597	0		SRR11397263	PRJNA607574			4																	
1597B		1597	15	semi-formed	SRR11397262	PRJNA607574			4																	
1597C		1597	23	formed	SRR11397260	PRJNA607574			4																	
1597D		1597	37	semi-formed	SRR11397259	PRJNA607574			4																	
1598A		1598	0	semi-formed	SRR11115456	PRJNA607574	41		3	-41	BM_unmodified	Non-Malignant Hemat Disorders	25c8872eb54a0d06ac6b34		0		post	5								
1598C		1598	224	semi-formed	SRR11115455	PRJNA607574	265		3	-41	BM_unmodified	Non-Malignant Hemat Disorders	25c8872eb54a0d06ac6b34		0		post	6								
1598D		1598	287	formed	SRR11115454	PRJNA607574	328		3	-41	BM_unmodified	Non-Malignant Hemat Disorders	25c8872eb54a0d06ac6b34		0		post	6								
1600A		1600	0	semi-formed	SRR11140029	PRJNA606262			4																	
1600B		1600	67	formed	SRR11397257	PRJNA607574			4																	
1600C		1600	99	semi-formed	SRR11397256	PRJNA607574			4																	
1600D		1600	168	formed	SRR11397255	PRJNA607574			4																	
1601A		1601	0	formed	SRR11397254	PRJNA607574			4																	
1601B		1601	53	formed	SRR11397221	PRJNA607574			4																	
1601C		1601	115	formed	SRR11397220	PRJNA607574			4																	
1601D		1601	144	formed	SRR11397219	PRJNA607574			4																	
1603A		1603	0	formed	SRR11139603	PRJNA606262			5																	
1603B		1603	36	formed	SRR11139602	PRJNA606262			5																	
1603C		1603	50	semi-formed	SRR11139601	PRJNA606262			5																	
1603D		1603	53	liquid	SRR11139600	PRJNA606262			5																	
1603E		1603	57	semi-formed	SRR11139599	PRJNA606262			5																	
1605A		1605	0	formed	SRR11420899	PRJNA545312	-2		7	2	TCD	Myeloproliferative Disorder	ebc876a2ac60807d1a8612		1		pre	-1								
1605B		1605	1	formed	SRR11420898	PRJNA545312	-1		7	2	TCD	Myeloproliferative Disorder	ebc876a2ac60807d1a8612		1		pre	-1								
1605C		1605	5	semi-formed	SRR11420897	PRJNA545312	3		7	2	TCD	Myeloproliferative Disorder	ebc876a2ac60807d1a8612		1		peri	0								
1605D		1605	10	liquid	SRR11420896	PRJNA545312	8		7	2	TCD	Myeloproliferative Disorder	ebc876a2ac60807d1a8612		1		post	1								
1605E		1605	17	liquid	SRR11420895	PRJNA545312	15		7	2	TCD	Myeloproliferative Disorder	ebc876a2ac60807d1a8612		1		post	2								
1605F		1605	22	semi-formed	SRR11420894	PRJNA545312	20		7	2	TCD	Myeloproliferative Disorder	ebc876a2ac60807d1a8612		1		post	2								
1605G		1605	23	semi-formed	SRR11420893	PRJNA545312	21		7	2	TCD	Myeloproliferative Disorder	ebc876a2ac60807d1a8612		1		post	2								
1606A		1606	0	formed	SRR9271165	PRJNA548153	-7		7	7	BM_unmodified	Leukemia	2b79fbd68db16178507447		0		pre	-2								
1606B		1606	1	formed	SRR9271164	PRJNA548153	-6		7	7	BM_unmodified	Leukemia	2b79fbd68db16178507447		0		pre	-1								
1606C		1606	6	liquid	SRR9271163	PRJNA548153	-1		7	7	BM_unmodified	Leukemia	2b79fbd68db16178507447		0		pre	-1								
1606D		1606	7	semi-formed	SRR9271162	PRJNA548153	0		7	7	BM_unmodified	Leukemia	2b79fbd68db16178507447		0		peri	-1								
1606E		1606	8	liquid	SRR9271161	PRJNA548153	1		7	7	BM_unmodified	Leukemia	2b79fbd68db16178507447		0		peri	0								
1606F		1606	19	liquid	SRR9271160	PRJNA548153	12		7	7	BM_unmodified	Leukemia	2b79fbd68db16178507447		0		post	1								
1606G		1606	21	liquid	SRR9271159	PRJNA548153	14		7	7	BM_unmodified	Leukemia	2b79fbd68db16178507447		0		post	1								
1607A		1607	0	formed	SRR11139591	PRJNA606262			5																	
1607B		1607	6	semi-formed	SRR11139590	PRJNA606262			5																	
1607C		1607	12	liquid	SRR11139589	PRJNA606262			5																	
1607D		1607	26	liquid	SRR11139932	PRJNA606262			5																	
1607E		1607	33	liquid	SRR11139931	PRJNA606262			5																	
1608A		1608	0	formed	SRR11139629	PRJNA606262			1																	
1609A		1609	0	liquid	SRR11397205	PRJNA607574			3																	
1609B		1609	36	formed	SRR11397204	PRJNA607574			3																	
1609C		1609	344	semi-formed	SRR11397203	PRJNA607574			3																	
160A		160	0	liquid	SRR11397202	PRJNA607574			1																	
1611A		1611	0	semi-formed	SRR11397201	PRJNA607574			4																	
1611B		1611	2	semi-formed	SRR11397200	PRJNA607574			4																	
1611C		1611	103	semi-formed	SRR11397199	PRJNA607574			4																	
1611E		1611	117	semi-formed	SRR11397198	PRJNA607574			4																	
1613A		1613	0	semi-formed	SRR11140357	PRJNA606262			2																	
1613B		1613	7	formed	SRR11140356	PRJNA606262			2																	
1614A		1614	0	formed	SRR11397194	PRJNA607574			3																	
1614B		1614	7	semi-formed	SRR11397193	PRJNA607574			3																	
1614C		1614	22	formed	SRR11397192	PRJNA607574			3																	
1615A		1615	0	semi-formed	SRR11397191	PRJNA607574			4																	
1615B		1615	23	semi-formed	SRR11397190	PRJNA607574			4																	
1615C		1615	29		SRR11397189	PRJNA607574			4																	
1615D		1615	56	semi-formed	SRR11397188	PRJNA607574			4																	
1616A		1616	0	formed	SRR11139972	PRJNA606262			4																	
1616B		1616	11	formed	SRR11139971	PRJNA606262			4																	
1616C		1616	19	semi-formed	SRR11139969	PRJNA606262			4																	
1616D		1616	24	semi-formed	SRR11139968	PRJNA606262			4																	
1617A		1617	0	semi-formed	SRR9271212	PRJNA548153	-2		11	2	BM_unmodified	Leukemia	fe064b7e5431f884d168df		0		pre	-1								
1617B		1617	2	semi-formed	SRR9271213	PRJNA548153	0		11	2	BM_unmodified	Leukemia	fe064b7e5431f884d168df		0		peri	-1								
1617C		1617	3	semi-formed	SRR9271214	PRJNA548153	1		11	2	BM_unmodified	Leukemia	fe064b7e5431f884d168df		0		peri	0								
1617D		1617	4	semi-formed	SRR9271215	PRJNA548153	2		11	2	BM_unmodified	Leukemia	fe064b7e5431f884d168df		0		peri	0								
1617E		1617	15	liquid	SRR9271216	PRJNA548153	13		11	2	BM_unmodified	Leukemia	fe064b7e5431f884d168df		0		post	1								
1617F		1617	16	semi-formed	SRR9271217	PRJNA548153	14		11	2	BM_unmodified	Leukemia	fe064b7e5431f884d168df		0		post	1								
1617G		1617	17	liquid	SRR9271218	PRJNA548153	15		11	2	BM_unmodified	Leukemia	fe064b7e5431f884d168df		0		post	2								
1617H		1617	19	semi-formed	SRR9271219	PRJNA548153	17		11	2	BM_unmodified	Leukemia	fe064b7e5431f884d168df		0		post	2								
1617N		1617	30	semi-formed	SRR11115453	PRJNA607574	28		11	2	BM_unmodified	Leukemia	fe064b7e5431f884d168df		0		post	3								
1617O		1617	31	semi-formed	SRR11115452	PRJNA607574	29		11	2	BM_unmodified	Leukemia	fe064b7e5431f884d168df		0		post	4								
1617P		1617	32	semi-formed	SRR11115450	PRJNA607574	30		11	2	BM_unmodified	Leukemia	fe064b7e5431f884d168df		0		post	4								
1618A		1618	0	formed	SRR11397182	PRJNA607574			1																	
161A		161	0	liquid	SRR11420892	PRJNA545312	-3		1	3	TCD	Myelodysplastic Syndromes	da3f090908e54b9a03cab2	237	1		pre	-1								
1622A		1622	0	formed	SRR11115449	PRJNA607574	0		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		peri	-1								
1622B		1622	1	liquid	SRR11115448	PRJNA607574	1		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		peri	0								
1622C		1622	5	liquid	SRR11115447	PRJNA607574	5		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		peri	0								
1622D		1622	6	liquid	SRR11115446	PRJNA607574	6		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		post	0								
1622E		1622	7	liquid	SRR11115445	PRJNA607574	7		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		post	0								
1622F		1622	9	liquid	SRR11115444	PRJNA607574	9		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		post	1								
1622G		1622	13	liquid	SRR11115443	PRJNA607574	13		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		post	1								
1622H		1622	15	semi-formed	SRR11115442	PRJNA607574	15		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		post	2								
1622I		1622	16	semi-formed	SRR11115441	PRJNA607574	16		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		post	2								
1622J		1622	18	semi-formed	SRR11115439	PRJNA607574	18		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		post	2								
1622K		1622	19	semi-formed	SRR11115438	PRJNA607574	19		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		post	2								
1622L		1622	20	liquid	SRR11115437	PRJNA607574	20		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		post	2								
1622M		1622	21	liquid	SRR11115436	PRJNA607574	21		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		post	2								
1622N		1622	22	semi-formed	SRR11115435	PRJNA607574	22		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		post	3								
1622O		1622	41	formed	SRR11115434	PRJNA607574	41		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		post	5								
1622P		1622	203	semi-formed	SRR11115433	PRJNA607574	203		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		post	6								
1622Q		1622	253	liquid	SRR11115432	PRJNA607574	253		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		post	6								
1622R		1622	259	semi-formed	SRR11115431	PRJNA607574	259		18	0	cord	Leukemia	641f43b6587923f941dd3c		0		post	6								
1624A		1624	0	semi-formed	SRR11397181	PRJNA607574			4																	
1624B		1624	6	semi-formed	SRR11397180	PRJNA607574			4																	
1624C		1624	7	semi-formed	SRR11397179	PRJNA607574			4																	
1624D		1624	8	semi-formed	SRR11397178	PRJNA607574			4																	
1628B		1628	3	semi-formed	SRR11115430	PRJNA607574	12		3	-9	PBSC_unmodified	Leukemia	8f06917be9571f51156e3d		0		post	1								
1628C		1628	5	liquid	SRR11115428	PRJNA607574	14		3	-9	PBSC_unmodified	Leukemia	8f06917be9571f51156e3d		0		post	1								
1628E		1628	7	semi-formed	SRR11115427	PRJNA607574	16		3	-9	PBSC_unmodified	Leukemia	8f06917be9571f51156e3d		0		post	2								
1629A		1629	0		SRR11115426	PRJNA607574	-10		5	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	02485fbf3ac37cd7201831		0		pre	-2								
1629B		1629	7	formed	SRR11115425	PRJNA607574	-3		5	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	02485fbf3ac37cd7201831		0		pre	-1								
1629C		1629	16	formed	SRR11115424	PRJNA607574	6		5	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	02485fbf3ac37cd7201831		0		post	0								
1629D		1629	36	semi-formed	SRR11115423	PRJNA607574	26		5	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	02485fbf3ac37cd7201831		0		post	3								
1629E		1629	137	formed	SRR11115422	PRJNA607574	127		5	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	02485fbf3ac37cd7201831		0		post	6								
162A		162	0	formed	SRR11420891	PRJNA545312	-9		6	9	PBSC_unmodified	Leukemia	4caac81dd8f9fd46929fec	163	0		pre	-2								
162B		162	7	formed	SRR11420890	PRJNA545312	-2		6	9	PBSC_unmodified	Leukemia	4caac81dd8f9fd46929fec	163	0		pre	-1								
162C		162	14	liquid	SRR11420888	PRJNA545312	5		6	9	PBSC_unmodified	Leukemia	4caac81dd8f9fd46929fec	163	0		peri	0								
162E		162	26	liquid	SRR11420887	PRJNA545312	17		6	9	PBSC_unmodified	Leukemia	4caac81dd8f9fd46929fec	163	0		post	2								
162F		162	36	semi-formed	SRR11420886	PRJNA545312	27		6	9	PBSC_unmodified	Leukemia	4caac81dd8f9fd46929fec	163	0		post	3								
162G		162	41	semi-formed	SRR11420885	PRJNA545312	32		6	9	PBSC_unmodified	Leukemia	4caac81dd8f9fd46929fec	163	0		post	4								
1630A		1630	0	liquid	SRR11420884	PRJNA545312	-2		14	2	PBSC_unmodified	Leukemia	92a5c867485f0f457cb6cb		1		pre	-1								
1630B		1630	1	semi-formed	SRR11420883	PRJNA545312	-1		14	2	PBSC_unmodified	Leukemia	92a5c867485f0f457cb6cb		1		pre	-1								
1630C		1630	3	semi-formed	SRR11420882	PRJNA545312	1		14	2	PBSC_unmodified	Leukemia	92a5c867485f0f457cb6cb		1		peri	0								
1630D		1630	6	semi-formed	SRR11420881	PRJNA545312	4		14	2	PBSC_unmodified	Leukemia	92a5c867485f0f457cb6cb		1		peri	0								
1630E		1630	7	semi-formed	SRR11420880	PRJNA545312	5		14	2	PBSC_unmodified	Leukemia	92a5c867485f0f457cb6cb		1		peri	0								
1630F		1630	8	formed	SRR11420879	PRJNA545312	6		14	2	PBSC_unmodified	Leukemia	92a5c867485f0f457cb6cb		1		post	0								
1630G		1630	15	formed	SRR11420877	PRJNA545312	13		14	2	PBSC_unmodified	Leukemia	92a5c867485f0f457cb6cb		1		post	1								
1630H		1630	16	formed	SRR11420876	PRJNA545312	14		14	2	PBSC_unmodified	Leukemia	92a5c867485f0f457cb6cb		1		post	1								
1630I		1630	17	formed	SRR11420875	PRJNA545312	15		14	2	PBSC_unmodified	Leukemia	92a5c867485f0f457cb6cb		1		post	2								
1630J		1630	28	formed	SRR11420874	PRJNA545312	26		14	2	PBSC_unmodified	Leukemia	92a5c867485f0f457cb6cb		1		post	3								
1630K		1630	30	semi-formed	SRR11420873	PRJNA545312	28		14	2	PBSC_unmodified	Leukemia	92a5c867485f0f457cb6cb		1		post	3								
1630L		1630	35	liquid	SRR11420872	PRJNA545312	33		14	2	PBSC_unmodified	Leukemia	92a5c867485f0f457cb6cb		1		post	4								
1630M		1630	36	semi-formed	SRR11420871	PRJNA545312	34		14	2	PBSC_unmodified	Leukemia	92a5c867485f0f457cb6cb		1		post	4								
1630N		1630	38	formed	SRR11420870	PRJNA545312	36		14	2	PBSC_unmodified	Leukemia	92a5c867485f0f457cb6cb		1		post	5								
1631A		1631	0	semi-formed	SRR11397177	PRJNA607574			2																	
1631B		1631	55	semi-formed	SRR11397176	PRJNA607574			2																	
1632A		1632	0	semi-formed	SRR11397175	PRJNA607574			5																	
1632D		1632	20	liquid	SRR11397173	PRJNA607574			5																	
1632E		1632	25	semi-formed	SRR11397172	PRJNA607574			5																	
1632F		1632	27	semi-formed	SRR11397171	PRJNA607574			5																	
1632G		1632	104	formed	SRR11397170	PRJNA607574			5																	
1635A		1635	0	semi-formed	SRR11397169	PRJNA607574			4																	
1635B		1635	1	semi-formed	SRR11397168	PRJNA607574			4																	
1635C		1635	2	formed	SRR11397167	PRJNA607574			4																	
1635D		1635	4	semi-formed	SRR11397166	PRJNA607574			4																	
1636A		1636	0		SRR11397165	PRJNA607574			5																	
1636B		1636	15	semi-formed	SRR11397164	PRJNA607574			5																	
1636C		1636	16	semi-formed	SRR11397162	PRJNA607574			5																	
1636E		1636	140	liquid	SRR11397161	PRJNA607574			5																	
1636F		1636	360	semi-formed	SRR11397160	PRJNA607574			5																	
1637A		1637	0	formed	SRR11397159	PRJNA607574			4																	
1637B		1637	26	formed	SRR11397158	PRJNA607574			4																	
1637C		1637	30	formed	SRR11397126	PRJNA607574			4																	
1637D		1637	40	formed	SRR11397125	PRJNA607574			4																	
1638A		1638	0	formed	SRR11397124	PRJNA607574			2																	
1638B		1638	8	semi-formed	SRR11397123	PRJNA607574			2																	
1639A		1639	0	semi-formed	SRR11397122	PRJNA607574			1																	
163A		163	0	formed	SRR11115421	PRJNA607574	873		1	-873	TCD	Leukemia	da03037e5b36f603bcefc4		0		post	6								
1640A		1640	0	formed	SRR11397120	PRJNA607574			3																	
1640B		1640	60	formed	SRR11397119	PRJNA607574			3																	
1640C		1640	137	formed	SRR11397118	PRJNA607574			3																	
1641A		1641	0	liquid	SRR11397117	PRJNA607574			3																	
1641B		1641	296	semi-formed	SRR11397116	PRJNA607574			3																	
1641C		1641	415		SRR11397115	PRJNA607574			3																	
1642A		1642	0		SRR11420869	PRJNA545312	-10		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		pre	-2								
1642AA		1642	293	semi-formed	SRR11115420	PRJNA607574	283		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		post	6								
1642B		1642	1	formed	SRR11420868	PRJNA545312	-9		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		pre	-2								
1642C		1642	2	formed	SRR11420866	PRJNA545312	-8		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		pre	-2								
1642D		1642	8	liquid	SRR11420865	PRJNA545312	-2		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		pre	-1								
1642E		1642	9	liquid	SRR11420864	PRJNA545312	-1		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		pre	-1								
1642H		1642	14	liquid	SRR11420863	PRJNA545312	4		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		peri	0								
1642I		1642	15	liquid	SRR11420862	PRJNA545312	5		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		peri	0								
1642N		1642	148	liquid	SRR11115419	PRJNA607574	138		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		post	6								
1642O		1642	160	liquid	SRR11115417	PRJNA607574	150		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		post	6								
1642P		1642	176	semi-formed	SRR11115416	PRJNA607574	166		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		post	6								
1642Q		1642	177	semi-formed	SRR11115415	PRJNA607574	167		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		post	6								
1642R		1642	181	formed	SRR11115414	PRJNA607574	171		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		post	6								
1642S		1642	180	formed	SRR11115413	PRJNA607574	170		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		post	6								
1642U		1642	182	semi-formed	SRR11397114	PRJNA607574	172		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		post	6								
1642V		1642	183	semi-formed	SRR11115411	PRJNA607574	173		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		post	6								
1642W		1642	184	semi-formed	SRR11115410	PRJNA607574	174		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		post	6								
1642X		1642	246	formed	SRR11115409	PRJNA607574	236		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		post	6								
1642Y		1642	285	liquid	SRR11115408	PRJNA607574	275		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		post	6								
1642Z		1642	286	liquid	SRR11115406	PRJNA607574	276		20	10	TCD	Leukemia	48ee5269cfe57dd768e4ed		1		post	6								
1643A		1643	0	formed	SRR11139954	PRJNA606262			4																	
1643B		1643	9	semi-formed	SRR11139953	PRJNA606262			4																	
1643C		1643	17	semi-formed	SRR11139952	PRJNA606262			4																	
1643D		1643	35	formed	SRR11139951	PRJNA606262			4																	
1644A		1644	0	liquid	SRR11115405	PRJNA607574	14		3	-14	PBSC_unmodified	Leukemia	333c120242dc7b768a0cac		0		post	1								
1644B		1644	3	liquid	SRR11115404	PRJNA607574	17		3	-14	PBSC_unmodified	Leukemia	333c120242dc7b768a0cac		0		post	2								
1644C		1644	6	semi-formed	SRR11115403	PRJNA607574	20		3	-14	PBSC_unmodified	Leukemia	333c120242dc7b768a0cac		0		post	2								
1645A		1645	0	semi-formed	SRR11420861	PRJNA545312	-2		12	2	BM_unmodified	Myelodysplastic Syndromes	7e7a8ee1cec8847f8c1aa5		1		pre	-1								
1645B		1645	3	semi-formed	SRR11420860	PRJNA545312	1		12	2	BM_unmodified	Myelodysplastic Syndromes	7e7a8ee1cec8847f8c1aa5		1		peri	0								
1645C		1645	6	liquid	SRR11420859	PRJNA545312	4		12	2	BM_unmodified	Myelodysplastic Syndromes	7e7a8ee1cec8847f8c1aa5		1		peri	0								
1645D		1645	7	liquid	SRR11420858	PRJNA545312	5		12	2	BM_unmodified	Myelodysplastic Syndromes	7e7a8ee1cec8847f8c1aa5		1		peri	0								
1645E		1645	8	liquid	SRR11420857	PRJNA545312	6		12	2	BM_unmodified	Myelodysplastic Syndromes	7e7a8ee1cec8847f8c1aa5		1		post	0								
1645F		1645	10	liquid	SRR11420855	PRJNA545312	8		12	2	BM_unmodified	Myelodysplastic Syndromes	7e7a8ee1cec8847f8c1aa5		1		post	1								
1645G		1645	11	liquid	SRR11420854	PRJNA545312	9		12	2	BM_unmodified	Myelodysplastic Syndromes	7e7a8ee1cec8847f8c1aa5		1		post	1								
1645H		1645	17	liquid	SRR9271455	PRJNA548153	15		12	2	BM_unmodified	Myelodysplastic Syndromes	7e7a8ee1cec8847f8c1aa5		1		post	2								
1645I		1645	23	semi-formed	SRR9271422	PRJNA548153	21		12	2	BM_unmodified	Myelodysplastic Syndromes	7e7a8ee1cec8847f8c1aa5		1		post	2								
1645J		1645	28	formed	SRR9271421	PRJNA548153	26		12	2	BM_unmodified	Myelodysplastic Syndromes	7e7a8ee1cec8847f8c1aa5		1		post	3								
1645K		1645	30	formed	SRR9271420	PRJNA548153	28		12	2	BM_unmodified	Myelodysplastic Syndromes	7e7a8ee1cec8847f8c1aa5		1		post	3								
1645L		1645	31	semi-formed	SRR9271419	PRJNA548153	29		12	2	BM_unmodified	Myelodysplastic Syndromes	7e7a8ee1cec8847f8c1aa5		1		post	4								
1646A		1646	0	formed	SRR11397108	PRJNA607574			3																	
1646B		1646	33	formed	SRR11397107	PRJNA607574			3																	
1646C		1646	90	formed	SRR11397106	PRJNA607574			3																	
1648A		1648	0	formed	SRR11420853	PRJNA545312	-3		5	3	BM_unmodified	Myelodysplastic Syndromes	b5f7b6ca34a1f6d6bd9137		1		pre	-1								
1648B		1648	1	semi-formed	SRR11420852	PRJNA545312	-2		5	3	BM_unmodified	Myelodysplastic Syndromes	b5f7b6ca34a1f6d6bd9137		1		pre	-1								
1648C		1648	2	semi-formed	SRR11420851	PRJNA545312	-1		5	3	BM_unmodified	Myelodysplastic Syndromes	b5f7b6ca34a1f6d6bd9137		1		pre	-1								
1648D		1648	3	semi-formed	SRR11420850	PRJNA545312	0		5	3	BM_unmodified	Myelodysplastic Syndromes	b5f7b6ca34a1f6d6bd9137		1		peri	-1								
1648E		1648	4	liquid	SRR11420849	PRJNA545312	1		5	3	BM_unmodified	Myelodysplastic Syndromes	b5f7b6ca34a1f6d6bd9137		1		peri	0								
1649A		1649	0	semi-formed	SRR11397105	PRJNA607574			1																	
164A		164	0	liquid	SRR11420848	PRJNA545312	-3		3	3	BM_unmodified	Leukemia	742c78241f87013764fae5	249	1		pre	-1								
164B		164	6	liquid	SRR11420847	PRJNA545312	3		3	3	BM_unmodified	Leukemia	742c78241f87013764fae5	249	1		peri	0								
164C		164	16	semi-formed	SRR11420846	PRJNA545312	13		3	3	BM_unmodified	Leukemia	742c78241f87013764fae5	249	1		post	1								
1651A		1651	0	formed	SRR11397104	PRJNA607574			3																	
1651B		1651	46	semi-formed	SRR11397103	PRJNA607574			3																	
1651C		1651	101	formed	SRR11397102	PRJNA607574			3																	
1652A		1652	0	formed	SRR11396451	PRJNA607574			3																	
1652B		1652	15	semi-formed	SRR11396748	PRJNA607574			3																	
1652C		1652	23	formed	SRR11396745	PRJNA607574			3																	
1653A		1653	0	semi-formed	SRR11396744	PRJNA607574			3																	
1653B		1653	204	semi-formed	SRR11396743	PRJNA607574			3																	
1653C		1653	344	formed	SRR11396742	PRJNA607574			3																	
1656A		1656	0	liquid	SRR9271386	PRJNA548153	-3		16	3	PBSC_unmodified	Myeloproliferative Disorder	e0844d613a13c80d5104aa		0		pre	-1								
1656B		1656	1	formed	SRR9271389	PRJNA548153	-2		16	3	PBSC_unmodified	Myeloproliferative Disorder	e0844d613a13c80d5104aa		0		pre	-1								
1656C		1656	2	liquid	SRR9271390	PRJNA548153	-1		16	3	PBSC_unmodified	Myeloproliferative Disorder	e0844d613a13c80d5104aa		0		pre	-1								
1656D		1656	3	liquid	SRR9271424	PRJNA548153	0		16	3	PBSC_unmodified	Myeloproliferative Disorder	e0844d613a13c80d5104aa		0		peri	-1								
1656E		1656	5	liquid	SRR9271423	PRJNA548153	2		16	3	PBSC_unmodified	Myeloproliferative Disorder	e0844d613a13c80d5104aa		0		peri	0								
1656F		1656	7	liquid	SRR9271426	PRJNA548153	4		16	3	PBSC_unmodified	Myeloproliferative Disorder	e0844d613a13c80d5104aa		0		peri	0								
1656G		1656	10	liquid	SRR9271425	PRJNA548153	7		16	3	PBSC_unmodified	Myeloproliferative Disorder	e0844d613a13c80d5104aa		0		post	0								
1656H		1656	11	liquid	SRR9271428	PRJNA548153	8		16	3	PBSC_unmodified	Myeloproliferative Disorder	e0844d613a13c80d5104aa		0		post	1								
1656I		1656	15	liquid	SRR9271427	PRJNA548153	12		16	3	PBSC_unmodified	Myeloproliferative Disorder	e0844d613a13c80d5104aa		0		post	1								
1656J		1656	16	semi-formed	SRR9271430	PRJNA548153	13		16	3	PBSC_unmodified	Myeloproliferative Disorder	e0844d613a13c80d5104aa		0		post	1								
1656K		1656	19	semi-formed	SRR9271429	PRJNA548153	16		16	3	PBSC_unmodified	Myeloproliferative Disorder	e0844d613a13c80d5104aa		0		post	2								
1656L		1656	21	semi-formed	SRR9271432	PRJNA548153	18		16	3	PBSC_unmodified	Myeloproliferative Disorder	e0844d613a13c80d5104aa		0		post	2								
1656M		1656	22	semi-formed	SRR11115402	PRJNA607574	19		16	3	PBSC_unmodified	Myeloproliferative Disorder	e0844d613a13c80d5104aa		0		post	2								
1656N		1656	23	semi-formed	SRR11115401	PRJNA607574	20		16	3	PBSC_unmodified	Myeloproliferative Disorder	e0844d613a13c80d5104aa		0		post	2								
1656O		1656	29	semi-formed	SRR11115400	PRJNA607574	26		16	3	PBSC_unmodified	Myeloproliferative Disorder	e0844d613a13c80d5104aa		0		post	3								
1656P		1656	30	semi-formed	SRR11115399	PRJNA607574	27		16	3	PBSC_unmodified	Myeloproliferative Disorder	e0844d613a13c80d5104aa		0		post	3								
1657A		1657	0	formed	SRR9271522	PRJNA548153	-3		10	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	854689d1e9a45e8d55ec55		0		pre	-1								
1657B		1657	1	formed	SRR9271523	PRJNA548153	-2		10	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	854689d1e9a45e8d55ec55		0		pre	-1								
1657C		1657	2	formed	SRR9271492	PRJNA548153	-1		10	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	854689d1e9a45e8d55ec55		0		pre	-1								
1657D		1657	3	formed	SRR9271491	PRJNA548153	0		10	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	854689d1e9a45e8d55ec55		0		peri	-1								
1657E		1657	5	formed	SRR9271494	PRJNA548153	2		10	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	854689d1e9a45e8d55ec55		0		peri	0								
1657F		1657	7	formed	SRR9271378	PRJNA548153	4		10	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	854689d1e9a45e8d55ec55		0		peri	0								
1657G		1657	8	formed	SRR9271488	PRJNA548153	5		10	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	854689d1e9a45e8d55ec55		0		peri	0								
1657H		1657	9	formed	SRR9271487	PRJNA548153	6		10	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	854689d1e9a45e8d55ec55		0		post	0								
1657I		1657	10	semi-formed	SRR9271490	PRJNA548153	7		10	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	854689d1e9a45e8d55ec55		0		post	0								
1657J		1657	11	formed	SRR9271489	PRJNA548153	8		10	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	854689d1e9a45e8d55ec55		0		post	1								
1658A		1658	0	formed	SRR9271431	PRJNA548153	-5		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	3fb9bdf321999946e8b519		0		pre	-1								
1658B		1658	1	formed	SRR9271548	PRJNA548153	-4		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	3fb9bdf321999946e8b519		0		pre	-1								
1658C		1658	2	formed	SRR9271549	PRJNA548153	-3		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	3fb9bdf321999946e8b519		0		pre	-1								
1658D		1658	3	semi-formed	SRR9271550	PRJNA548153	-2		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	3fb9bdf321999946e8b519		0		pre	-1								
1658E		1658	4	formed	SRR9271551	PRJNA548153	-1		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	3fb9bdf321999946e8b519		0		pre	-1								
1658F		1658	5	semi-formed	SRR9271552	PRJNA548153	0		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	3fb9bdf321999946e8b519		0		peri	-1								
1658G		1658	7	liquid	SRR9271553	PRJNA548153	2		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	3fb9bdf321999946e8b519		0		peri	0								
1658H		1658	21	semi-formed	SRR9271554	PRJNA548153	16		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	3fb9bdf321999946e8b519		0		post	2								
1658I		1658	22	semi-formed	SRR11115398	PRJNA607574	17		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	3fb9bdf321999946e8b519		0		post	2								
1658J		1658	25	semi-formed	SRR11115397	PRJNA607574	20		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	3fb9bdf321999946e8b519		0		post	2								
1658K		1658	31	semi-formed	SRR11115394	PRJNA607574	26		11	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	3fb9bdf321999946e8b519		0		post	3								
165A		165	0	liquid	SRR11420844	PRJNA545312	452		1	-452	TCD	Leukemia	7a063863ffcd089ca72616		1		post	6								
1660A		1660	0	semi-formed	SRR11115393	PRJNA607574	-22		5	22	PBSC_unmodified	Leukemia	a5f94face17321de8cb7de		0		pre	-3								
1660B		1660	56	liquid	SRR11115392	PRJNA607574	34		5	22	PBSC_unmodified	Leukemia	a5f94face17321de8cb7de		0		post	4								
1660C		1660	63	formed	SRR11115391	PRJNA607574	41		5	22	PBSC_unmodified	Leukemia	a5f94face17321de8cb7de		0		post	5								
1660D		1660	70	liquid	SRR11115390	PRJNA607574	48		5	22	PBSC_unmodified	Leukemia	a5f94face17321de8cb7de		0		post	6								
1660E		1660	102	formed	SRR11115389	PRJNA607574	80		5	22	PBSC_unmodified	Leukemia	a5f94face17321de8cb7de		0		post	6								
1661A		1661	0	formed	SRR11396741	PRJNA607574			2																	
1661B		1661	2	semi-formed	SRR11396740	PRJNA607574			2																	
1662A		1662	0	semi-formed	SRR11140267	PRJNA606262			5																	
1662B		1662	2	formed	SRR11140266	PRJNA606262			5																	
1662C		1662	16	liquid	SRR11140265	PRJNA606262			5																	
1662D		1662	26	semi-formed	SRR11140264	PRJNA606262			5																	
1662E		1662	35	semi-formed	SRR11140262	PRJNA606262			5																	
1663A		1663	0	liquid	SRR9270406	PRJNA548153	-1		7	1	TCD	Leukemia	39c9b3056007d720a5ba86		0		pre	-1								
1663B		1663	3	liquid	SRR9270405	PRJNA548153	2		7	1	TCD	Leukemia	39c9b3056007d720a5ba86		0		peri	0								
1663C		1663	5	semi-formed	SRR9270400	PRJNA548153	4		7	1	TCD	Leukemia	39c9b3056007d720a5ba86		0		peri	0								
1663D		1663	10	semi-formed	SRR9270399	PRJNA548153	9		7	1	TCD	Leukemia	39c9b3056007d720a5ba86		0		post	1								
1663E		1663	11	semi-formed	SRR9270402	PRJNA548153	10		7	1	TCD	Leukemia	39c9b3056007d720a5ba86		0		post	1								
1663F		1663	12	semi-formed	SRR9270401	PRJNA548153	11		7	1	TCD	Leukemia	39c9b3056007d720a5ba86		0		post	1								
1663G		1663	14	semi-formed	SRR11115388	PRJNA607574	13		7	1	TCD	Leukemia	39c9b3056007d720a5ba86		0		post	1								
1665A		1665	0	formed	SRR9271496	PRJNA548153	-5		13	5	PBSC_unmodified	Myeloproliferative Disorder	f4c7258b4a446998810956		0		pre	-1								
1665B		1665	2	formed	SRR9271495	PRJNA548153	-3		13	5	PBSC_unmodified	Myeloproliferative Disorder	f4c7258b4a446998810956		0		pre	-1								
1665C		1665	3	semi-formed	SRR9271374	PRJNA548153	-2		13	5	PBSC_unmodified	Myeloproliferative Disorder	f4c7258b4a446998810956		0		pre	-1								
1665D		1665	4	liquid	SRR9271375	PRJNA548153	-1		13	5	PBSC_unmodified	Myeloproliferative Disorder	f4c7258b4a446998810956		0		pre	-1								
1665E		1665	6	liquid	SRR9271376	PRJNA548153	1		13	5	PBSC_unmodified	Myeloproliferative Disorder	f4c7258b4a446998810956		0		peri	0								
1665F		1665	9	semi-formed	SRR9271377	PRJNA548153	4		13	5	PBSC_unmodified	Myeloproliferative Disorder	f4c7258b4a446998810956		0		peri	0								
1665G		1665	10	semi-formed	SRR9271370	PRJNA548153	5		13	5	PBSC_unmodified	Myeloproliferative Disorder	f4c7258b4a446998810956		0		peri	0								
1665H		1665	11	liquid	SRR9271371	PRJNA548153	6		13	5	PBSC_unmodified	Myeloproliferative Disorder	f4c7258b4a446998810956		0		post	0								
1665I		1665	13	liquid	SRR9271372	PRJNA548153	8		13	5	PBSC_unmodified	Myeloproliferative Disorder	f4c7258b4a446998810956		0		post	1								
1665J		1665	17	liquid	SRR9271373	PRJNA548153	12		13	5	PBSC_unmodified	Myeloproliferative Disorder	f4c7258b4a446998810956		0		post	1								
1665K		1665	18	liquid	SRR9271379	PRJNA548153	13		13	5	PBSC_unmodified	Myeloproliferative Disorder	f4c7258b4a446998810956		0		post	1								
1665L		1665	19	liquid	SRR9271380	PRJNA548153	14		13	5	PBSC_unmodified	Myeloproliferative Disorder	f4c7258b4a446998810956		0		post	1								
1665M		1665	24	liquid	SRR9271561	PRJNA548153	19		13	5	PBSC_unmodified	Myeloproliferative Disorder	f4c7258b4a446998810956		0		post	2								
1666A		1666	0	semi-formed	SRR11396733	PRJNA607574			2																	
1666B		1666	28	formed	SRR11396732	PRJNA607574			2																	
1669A		1669	0	formed	SRR11115387	PRJNA607574	-6		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	9da24c9ea69190d3d2c42e		0		pre	-1								
1669B		1669	5	liquid	SRR11115386	PRJNA607574	-1		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	9da24c9ea69190d3d2c42e		0		pre	-1								
1669C		1669	10	formed	SRR11115385	PRJNA607574	4		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	9da24c9ea69190d3d2c42e		0		peri	0								
166A		166	0	formed	SRR11420843	PRJNA545312	-24		6	24	PBSC_unmodified	Non-Hodgkin's Lymphoma	8f9af80346378d27d617cf	63	1		pre	-3								
166B		166	15	formed	SRR11420842	PRJNA545312	-9		6	24	PBSC_unmodified	Non-Hodgkin's Lymphoma	8f9af80346378d27d617cf	63	1		pre	-2								
166C		166	24	liquid	SRR11420841	PRJNA545312	0		6	24	PBSC_unmodified	Non-Hodgkin's Lymphoma	8f9af80346378d27d617cf	63	1		peri	-1								
166D		166	36	liquid	SRR11420840	PRJNA545312	12		6	24	PBSC_unmodified	Non-Hodgkin's Lymphoma	8f9af80346378d27d617cf	63	1		post	1								
166E		166	42	liquid	SRR11420839	PRJNA545312	18		6	24	PBSC_unmodified	Non-Hodgkin's Lymphoma	8f9af80346378d27d617cf	63	1		post	2								
166F		166	93	formed	SRR11420838	PRJNA545312	69		6	24	PBSC_unmodified	Non-Hodgkin's Lymphoma	8f9af80346378d27d617cf	63	1		post	6								
1671A		1671	0	semi-formed	SRR9271555	PRJNA548153	-7		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		pre	-2								
1671B		1671	10	liquid	SRR9271544	PRJNA548153	3		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		peri	0								
1671E		1671	19	liquid	SRR9271545	PRJNA548153	12		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		post	1								
1671F		1671	21	liquid	SRR9271361	PRJNA548153	14		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		post	1								
1671G		1671	24	liquid	SRR9271360	PRJNA548153	17		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		post	2								
1671H		1671	28	liquid	SRR9271359	PRJNA548153	21		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		post	2								
1671I		1671	31	liquid	SRR11115383	PRJNA607574	24		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		post	3								
1671J		1671	40	liquid	SRR11115382	PRJNA607574	33		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		post	4								
1671K		1671	61	formed	SRR11115381	PRJNA607574	54		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		post	6								
1671L		1671	118	liquid	SRR11115380	PRJNA607574	111		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		post	6								
1671M		1671	445	semi-formed	SRR11115379	PRJNA607574	438		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		post	6								
1671N		1671	446	liquid	SRR11115378	PRJNA607574	439		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		post	6								
1671O		1671	448	liquid	SRR11115377	PRJNA607574	441		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		post	6								
1671P		1671	451	semi-formed	SRR11115376	PRJNA607574	444		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		post	6								
1671Q		1671	453	liquid	SRR11115375	PRJNA607574	446		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		post	6								
1671R		1671	454	liquid	SRR11115374	PRJNA607574	447		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		post	6								
1671S		1671	461	semi-formed	SRR11115372	PRJNA607574	454		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		post	6								
1671T		1671	487	semi-formed	SRR11115371	PRJNA607574	480		18	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	1753ba2e9be09ed03806cc		0		post	6								
1677A		1677	0	liquid	SRR11396731	PRJNA607574			13																	
1677B		1677	15	semi-formed	SRR11396730	PRJNA607574			13																	
1677C		1677	16	liquid	SRR11396729	PRJNA607574			13																	
1677D		1677	28	semi-formed	SRR11396728	PRJNA607574			13																	
1677E		1677	38	semi-formed	SRR11396727	PRJNA607574			13																	
1677F		1677	45	semi-formed	SRR11396726	PRJNA607574			13																	
1677G		1677	52	semi-formed	SRR11396725	PRJNA607574			13																	
1677H		1677	59	semi-formed	SRR11396723	PRJNA607574			13																	
1677I		1677	63	semi-formed	SRR11396722	PRJNA607574			13																	
1677J		1677	66	semi-formed	SRR11396721	PRJNA607574			13																	
1677K		1677	101	semi-formed	SRR11396720	PRJNA607574			13																	
1677L		1677	183	semi-formed	SRR11396719	PRJNA607574			13																	
1677M		1677	190	semi-formed	SRR11396718	PRJNA607574			13																	
167A		167	0	formed	SRR11420837	PRJNA545312	-9		8	9	TCD	Leukemia	9ae0553f25c3998fabad18	47	1		pre	-2								
167B		167	13	liquid	SRR11420836	PRJNA545312	4		8	9	TCD	Leukemia	9ae0553f25c3998fabad18	47	1		peri	0								
167D		167	31	liquid	SRR11420835	PRJNA545312	22		8	9	TCD	Leukemia	9ae0553f25c3998fabad18	47	1		post	3								
167E		167	37	semi-formed	SRR11420833	PRJNA545312	28		8	9	TCD	Leukemia	9ae0553f25c3998fabad18	47	1		post	3								
167F		167	63	semi-formed	SRR11420832	PRJNA545312	54		8	9	TCD	Leukemia	9ae0553f25c3998fabad18	47	1		post	6								
167G		167	64	semi-formed	SRR11420831	PRJNA545312	55		8	9	TCD	Leukemia	9ae0553f25c3998fabad18	47	1		post	6								
167H		167	65	semi-formed	SRR11420830	PRJNA545312	56		8	9	TCD	Leukemia	9ae0553f25c3998fabad18	47	1		post	6								
167I		167	438	liquid	SRR11420829	PRJNA545312	429		8	9	TCD	Leukemia	9ae0553f25c3998fabad18	47	1		post	6								
1680A		1680	0	formed	SRR11139912	PRJNA606262			4																	
1680B		1680	7	semi-formed	SRR11139911	PRJNA606262			4																	
1680C		1680	21	semi-formed	SRR11139910	PRJNA606262			4																	
1680D		1680	27	semi-formed	SRR11139909	PRJNA606262			4																	
1681A		1681	0	semi-formed	SRR11396712	PRJNA607574			5																	
1681B		1681	11	semi-formed	SRR11396710	PRJNA607574			5																	
1681C		1681	12	semi-formed	SRR11396685	PRJNA607574			5																	
1681D		1681	17	liquid	SRR11396684	PRJNA607574			5																	
1681E		1681	19	liquid	SRR11396683	PRJNA607574			5																	
1683A		1683	0	liquid	SRR11139977	PRJNA606262			1																	
1684A		1684	0	semi-formed	SRR11115370	PRJNA607574	11		7	-11	PBSC_unmodified	Leukemia	655d4da3162cdbb82488f0		0		post	1								
1684B		1684	10	liquid	SRR11115369	PRJNA607574	21		7	-11	PBSC_unmodified	Leukemia	655d4da3162cdbb82488f0		0		post	2								
1684C		1684	14	liquid	SRR11115368	PRJNA607574	25		7	-11	PBSC_unmodified	Leukemia	655d4da3162cdbb82488f0		0		post	3								
1684D		1684	15	semi-formed	SRR11115367	PRJNA607574	26		7	-11	PBSC_unmodified	Leukemia	655d4da3162cdbb82488f0		0		post	3								
1684E		1684	17	semi-formed	SRR11115366	PRJNA607574	28		7	-11	PBSC_unmodified	Leukemia	655d4da3162cdbb82488f0		0		post	3								
1684F		1684	18	semi-formed	SRR11115365	PRJNA607574	29		7	-11	PBSC_unmodified	Leukemia	655d4da3162cdbb82488f0		0		post	4								
1684G		1684	22	semi-formed	SRR11115364	PRJNA607574	33		7	-11	PBSC_unmodified	Leukemia	655d4da3162cdbb82488f0		0		post	4								
1686A		1686	0	formed	SRR9271358	PRJNA548153	-9		12	9	TCD	Leukemia	491aeab22390d8810c6604		0		pre	-2								
1686B		1686	1	formed	SRR9271357	PRJNA548153	-8		12	9	TCD	Leukemia	491aeab22390d8810c6604		0		pre	-2								
1686C		1686	2	formed	SRR9271356	PRJNA548153	-7		12	9	TCD	Leukemia	491aeab22390d8810c6604		0		pre	-2								
1686D		1686	8	semi-formed	SRR9271355	PRJNA548153	-1		12	9	TCD	Leukemia	491aeab22390d8810c6604		0		pre	-1								
1686E		1686	9	semi-formed	SRR9271354	PRJNA548153	0		12	9	TCD	Leukemia	491aeab22390d8810c6604		0		peri	-1								
1686F		1686	11	liquid	SRR9271369	PRJNA548153	2		12	9	TCD	Leukemia	491aeab22390d8810c6604		0		peri	0								
1686G		1686	13	liquid	SRR9271368	PRJNA548153	4		12	9	TCD	Leukemia	491aeab22390d8810c6604		0		peri	0								
1686H		1686	14	liquid	SRR9271532	PRJNA548153	5		12	9	TCD	Leukemia	491aeab22390d8810c6604		0		peri	0								
1686I		1686	15	semi-formed	SRR9271533	PRJNA548153	6		12	9	TCD	Leukemia	491aeab22390d8810c6604		0		post	0								
1686J		1686	17	semi-formed	SRR9271530	PRJNA548153	8		12	9	TCD	Leukemia	491aeab22390d8810c6604		0		post	1								
1686K		1686	21	semi-formed	SRR11115363	PRJNA607574	12		12	9	TCD	Leukemia	491aeab22390d8810c6604		0		post	1								
1686L		1686	29	semi-formed	SRR11115361	PRJNA607574	20		12	9	TCD	Leukemia	491aeab22390d8810c6604		0		post	2								
1687A		1687	0	formed	SRR9271531	PRJNA548153	-8		15	8	TCD	Myelodysplastic Syndromes	336d8655fbad75498735ca		0		pre	-2								
1687B		1687	1	formed	SRR9271528	PRJNA548153	-7		15	8	TCD	Myelodysplastic Syndromes	336d8655fbad75498735ca		0		pre	-2								
1687C		1687	4	semi-formed	SRR9271529	PRJNA548153	-4		15	8	TCD	Myelodysplastic Syndromes	336d8655fbad75498735ca		0		pre	-1								
1687D		1687	6	formed	SRR9271526	PRJNA548153	-2		15	8	TCD	Myelodysplastic Syndromes	336d8655fbad75498735ca		0		pre	-1								
1687E		1687	7	liquid	SRR9271527	PRJNA548153	-1		15	8	TCD	Myelodysplastic Syndromes	336d8655fbad75498735ca		0		pre	-1								
1687F		1687	11	liquid	SRR9271524	PRJNA548153	3		15	8	TCD	Myelodysplastic Syndromes	336d8655fbad75498735ca		0		peri	0								
1687G		1687	12	liquid	SRR9271525	PRJNA548153	4		15	8	TCD	Myelodysplastic Syndromes	336d8655fbad75498735ca		0		peri	0								
1687H		1687	18	semi-formed	SRR11115360	PRJNA607574	10		15	8	TCD	Myelodysplastic Syndromes	336d8655fbad75498735ca		0		post	1								
1687I		1687	19	semi-formed	SRR11115359	PRJNA607574	11		15	8	TCD	Myelodysplastic Syndromes	336d8655fbad75498735ca		0		post	1								
1687J		1687	20	formed	SRR11115358	PRJNA607574	12		15	8	TCD	Myelodysplastic Syndromes	336d8655fbad75498735ca		0		post	1								
1687K		1687	21	formed	SRR11115357	PRJNA607574	13		15	8	TCD	Myelodysplastic Syndromes	336d8655fbad75498735ca		0		post	1								
1687L		1687	22	semi-formed	SRR11115356	PRJNA607574	14		15	8	TCD	Myelodysplastic Syndromes	336d8655fbad75498735ca		0		post	1								
1687M		1687	25	semi-formed	SRR11115355	PRJNA607574	17		15	8	TCD	Myelodysplastic Syndromes	336d8655fbad75498735ca		0		post	2								
1687N		1687	27	semi-formed	SRR11115354	PRJNA607574	19		15	8	TCD	Myelodysplastic Syndromes	336d8655fbad75498735ca		0		post	2								
1687O		1687	28	semi-formed	SRR11115353	PRJNA607574	20		15	8	TCD	Myelodysplastic Syndromes	336d8655fbad75498735ca		0		post	2								
168A		168	0	formed	SRR11420828	PRJNA545312	-9		3	9	TCD	Myelodysplastic Syndromes	45d1f975bd89f385f13869	42	1		pre	-2								
168B		168	7	semi-formed	SRR11420827	PRJNA545312	-2		3	9	TCD	Myelodysplastic Syndromes	45d1f975bd89f385f13869	42	1		pre	-1								
168C		168	17	semi-formed	SRR11420826	PRJNA545312	8		3	9	TCD	Myelodysplastic Syndromes	45d1f975bd89f385f13869	42	1		post	1								
1690A		1690	0	formed	SRR9271351	PRJNA548153	-6		11	6	PBSC_unmodified	Leukemia	6d72f1ec69278085bc6999		0		pre	-1								
1690B		1690	3	semi-formed	SRR9271350	PRJNA548153	-3		11	6	PBSC_unmodified	Leukemia	6d72f1ec69278085bc6999		0		pre	-1								
1690C		1690	4	formed	SRR9271353	PRJNA548153	-2		11	6	PBSC_unmodified	Leukemia	6d72f1ec69278085bc6999		0		pre	-1								
1690D		1690	5	formed	SRR9271352	PRJNA548153	-1		11	6	PBSC_unmodified	Leukemia	6d72f1ec69278085bc6999		0		pre	-1								
1690E		1690	6	semi-formed	SRR9271347	PRJNA548153	0		11	6	PBSC_unmodified	Leukemia	6d72f1ec69278085bc6999		0		peri	-1								
1690F		1690	7	formed	SRR9271346	PRJNA548153	1		11	6	PBSC_unmodified	Leukemia	6d72f1ec69278085bc6999		0		peri	0								
1690H		1690	11	liquid	SRR9271349	PRJNA548153	5		11	6	PBSC_unmodified	Leukemia	6d72f1ec69278085bc6999		0		peri	0								
1690I		1690	17	semi-formed	SRR9271348	PRJNA548153	11		11	6	PBSC_unmodified	Leukemia	6d72f1ec69278085bc6999		0		post	1								
1690J		1690	18	semi-formed	SRR9271343	PRJNA548153	12		11	6	PBSC_unmodified	Leukemia	6d72f1ec69278085bc6999		0		post	1								
1690K		1690	21	formed	SRR9271342	PRJNA548153	15		11	6	PBSC_unmodified	Leukemia	6d72f1ec69278085bc6999		0		post	2								
1690L		1690	24	semi-formed	SRR11115352	PRJNA607574	18		11	6	PBSC_unmodified	Leukemia	6d72f1ec69278085bc6999		0		post	2								
1691A		1691	1	liquid	SRR9271396	PRJNA548153	-1		8	2	BM_unmodified	Leukemia	e6a5b51953e559fcfcc39f		0		pre	-1								
1691B		1691	0	semi-formed	SRR9271397	PRJNA548153	-2		8	2	BM_unmodified	Leukemia	e6a5b51953e559fcfcc39f		0		pre	-1								
1691C		1691	3	semi-formed	SRR9271394	PRJNA548153	1		8	2	BM_unmodified	Leukemia	e6a5b51953e559fcfcc39f		0		peri	0								
1691D		1691	10	formed	SRR9271395	PRJNA548153	8		8	2	BM_unmodified	Leukemia	e6a5b51953e559fcfcc39f		0		post	1								
1691E		1691	15	liquid	SRR11115350	PRJNA607574	13		8	2	BM_unmodified	Leukemia	e6a5b51953e559fcfcc39f		0		post	1								
1691F		1691	17	liquid	SRR11115349	PRJNA607574	15		8	2	BM_unmodified	Leukemia	e6a5b51953e559fcfcc39f		0		post	2								
1691G		1691	18	semi-formed	SRR11115348	PRJNA607574	16		8	2	BM_unmodified	Leukemia	e6a5b51953e559fcfcc39f		0		post	2								
1691H		1691	25	semi-formed	SRR11115347	PRJNA607574	23		8	2	BM_unmodified	Leukemia	e6a5b51953e559fcfcc39f		0		post	3								
1694A		1694	0	formed	SRR9271480	PRJNA548153	-9		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		pre	-2								
1694B		1694	5	formed	SRR9271481	PRJNA548153	-4		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		pre	-1								
1694C		1694	7	formed	SRR9271482	PRJNA548153	-2		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		pre	-1								
1694D		1694	8	formed	SRR9271483	PRJNA548153	-1		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		pre	-1								
1694E		1694	14	liquid	SRR9271476	PRJNA548153	5		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		peri	0								
1694F		1694	18	liquid	SRR9271477	PRJNA548153	9		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		post	1								
1694G		1694	19	liquid	SRR9271478	PRJNA548153	10		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		post	1								
1694H		1694	20	liquid	SRR9271479	PRJNA548153	11		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		post	1								
1694I		1694	22	liquid	SRR9271484	PRJNA548153	13		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		post	1								
1694J		1694	25	liquid	SRR9271485	PRJNA548153	16		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		post	2								
1694K		1694	26	liquid	SRR11115346	PRJNA607574	17		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		post	2								
1694L		1694	28	liquid	SRR11115345	PRJNA607574	19		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		post	2								
1694M		1694	30	liquid	SRR11115344	PRJNA607574	21		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		post	2								
1694N		1694	32	semi-formed	SRR11115343	PRJNA607574	23		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		post	3								
1694R		1694	47	semi-formed	SRR11115342	PRJNA607574	38		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		post	5								
1694S		1694	58	liquid	SRR11115341	PRJNA607574	49		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		post	6								
1694T		1694	82	semi-formed	SRR11115339	PRJNA607574	73		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		post	6								
1694U		1694	84	formed	SRR11115338	PRJNA607574	75		18	9	PBSC_unmodified	Leukemia	22bb8cf0302df760ff2ca2		0		post	6								
1695A		1695	0	liquid	SRR11115337	PRJNA607574	5		10	-5	BM_unmodified	Hodgkin's Disease	a6a9ea740920f4cb7e3179		0		peri	0								
1695B		1695	4	liquid	SRR11115336	PRJNA607574	9		10	-5	BM_unmodified	Hodgkin's Disease	a6a9ea740920f4cb7e3179		0		post	1								
1695G		1695	53	semi-formed	SRR11115335	PRJNA607574	58		10	-5	BM_unmodified	Hodgkin's Disease	a6a9ea740920f4cb7e3179		0		post	6								
1695H		1695	68	liquid	SRR11115334	PRJNA607574	73		10	-5	BM_unmodified	Hodgkin's Disease	a6a9ea740920f4cb7e3179		0		post	6								
1695I		1695	69	liquid	SRR11115333	PRJNA607574	74		10	-5	BM_unmodified	Hodgkin's Disease	a6a9ea740920f4cb7e3179		0		post	6								
1695J		1695	70	liquid	SRR11115332	PRJNA607574	75		10	-5	BM_unmodified	Hodgkin's Disease	a6a9ea740920f4cb7e3179		0		post	6								
1695K		1695	75	semi-formed	SRR11115331	PRJNA607574	80		10	-5	BM_unmodified	Hodgkin's Disease	a6a9ea740920f4cb7e3179		0		post	6								
1695L		1695	76	semi-formed	SRR11115330	PRJNA607574	81		10	-5	BM_unmodified	Hodgkin's Disease	a6a9ea740920f4cb7e3179		0		post	6								
1695M		1695	91	semi-formed	SRR11115328	PRJNA607574	96		10	-5	BM_unmodified	Hodgkin's Disease	a6a9ea740920f4cb7e3179		0		post	6								
1695O		1695	102	liquid	SRR11115327	PRJNA607574	107		10	-5	BM_unmodified	Hodgkin's Disease	a6a9ea740920f4cb7e3179		0		post	6								
1697A		1697	0	semi-formed	SRR11396680	PRJNA607574			1																	
1698A		1698	0	liquid	SRR11140510	PRJNA606262			6																	
1698B		1698	8	liquid	SRR11140509	PRJNA606262			6																	
1698C		1698	10	liquid	SRR11140508	PRJNA606262			6																	
1698D		1698	15	semi-formed	SRR11140506	PRJNA606262			6																	
1698E		1698	120	liquid	SRR11396674	PRJNA607574			6																	
1698F		1698	122	semi-formed	SRR11396673	PRJNA607574			6																	
169A		169	0	formed	SRR11420825	PRJNA545312	-5		1	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	d7820e265393d5c300d261	24	1		pre	-1								
1700A		1700	0	semi-formed	SRR9271400	PRJNA548153	-4		9	4	PBSC_unmodified	Myelodysplastic Syndromes	8923ca4bdf2fefd435322f		0		pre	-1								
1700B		1700	1	semi-formed	SRR9271401	PRJNA548153	-3		9	4	PBSC_unmodified	Myelodysplastic Syndromes	8923ca4bdf2fefd435322f		0		pre	-1								
1700C		1700	2	liquid	SRR9271398	PRJNA548153	-2		9	4	PBSC_unmodified	Myelodysplastic Syndromes	8923ca4bdf2fefd435322f		0		pre	-1								
1700D		1700	7	semi-formed	SRR9271399	PRJNA548153	3		9	4	PBSC_unmodified	Myelodysplastic Syndromes	8923ca4bdf2fefd435322f		0		peri	0								
1700E		1700	9	semi-formed	SRR9271391	PRJNA548153	5		9	4	PBSC_unmodified	Myelodysplastic Syndromes	8923ca4bdf2fefd435322f		0		peri	0								
1700F		1700	16	liquid	SRR11115326	PRJNA607574	12		9	4	PBSC_unmodified	Myelodysplastic Syndromes	8923ca4bdf2fefd435322f		0		post	1								
1700G		1700	18	liquid	SRR11115325	PRJNA607574	14		9	4	PBSC_unmodified	Myelodysplastic Syndromes	8923ca4bdf2fefd435322f		0		post	1								
1700H		1700	23	semi-formed	SRR11115324	PRJNA607574	19		9	4	PBSC_unmodified	Myelodysplastic Syndromes	8923ca4bdf2fefd435322f		0		post	2								
1700I		1700	30	formed	SRR11115323	PRJNA607574	26		9	4	PBSC_unmodified	Myelodysplastic Syndromes	8923ca4bdf2fefd435322f		0		post	3								
1701A		1701	0	semi-formed	SRR11396672	PRJNA607574			4																	
1701B		1701	135	formed	SRR11396671	PRJNA607574			4																	
1701C		1701	161	formed	SRR11396670	PRJNA607574			4																	
1701D		1701	224	formed	SRR11396669	PRJNA607574			4																	
1703A		1703	0	semi-formed	SRR11396668	PRJNA607574			6																	
1703B		1703	12	liquid	SRR11396667	PRJNA607574			6																	
1703C		1703	15	liquid	SRR11396665	PRJNA607574			6																	
1703D		1703	19	liquid	SRR11396664	PRJNA607574			6																	
1703E		1703	21	liquid	SRR11396663	PRJNA607574			6																	
1703F		1703	22	liquid	SRR11396662	PRJNA607574			6																	
1704A		1704	0	semi-formed	SRR11396661	PRJNA607574			2																	
1704B		1704	357	semi-formed	SRR11396660	PRJNA607574			2																	
1705B		1705	3	formed	SRR11115322	PRJNA607574	2		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		peri	0								
1705C		1705	4	semi-formed	SRR11115321	PRJNA607574	3		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		peri	0								
1705D		1705	5	semi-formed	SRR11115320	PRJNA607574	4		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		peri	0								
1705E		1705	6	liquid	SRR11115319	PRJNA607574	5		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		peri	0								
1705F		1705	7	semi-formed	SRR11115317	PRJNA607574	6		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		post	0								
1705G		1705	8	semi-formed	SRR11115668	PRJNA607574	7		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		post	0								
1705I		1705	11	formed	SRR11115667	PRJNA607574	10		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		post	1								
1705J		1705	12	semi-formed	SRR11115666	PRJNA607574	11		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		post	1								
1705K		1705	13	liquid	SRR11115665	PRJNA607574	12		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		post	1								
1705L		1705	14	formed	SRR11115664	PRJNA607574	13		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		post	1								
1705M		1705	15	formed	SRR11115663	PRJNA607574	14		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		post	1								
1705N		1705	17	formed	SRR11115662	PRJNA607574	16		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		post	2								
1705O		1705	18	semi-formed	SRR11115661	PRJNA607574	17		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		post	2								
1705P		1705	19	semi-formed	SRR11115660	PRJNA607574	18		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		post	2								
1705Q		1705	20	semi-formed	SRR11115658	PRJNA607574	19		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		post	2								
1705R		1705	21	semi-formed	SRR11115657	PRJNA607574	20		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		post	2								
1705S		1705	22	semi-formed	SRR11115656	PRJNA607574	21		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		post	2								
1705T		1705	24	semi-formed	SRR11115655	PRJNA607574	23		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		post	3								
1705U		1705	25	semi-formed	SRR11115654	PRJNA607574	24		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		post	3								
1705V		1705	27	semi-formed	SRR11115653	PRJNA607574	26		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		post	3								
1705W		1705	40	semi-formed	SRR11115652	PRJNA607574	39		21	1	BM_unmodified	Myelodysplastic Syndromes	6f02efe9c1b5bae36acdcc		0		post	5								
1706A		1706	0	formed	SRR9270398	PRJNA548153	-1		8	1	PBSC_unmodified	Leukemia	f16f2e2198dd30e00de807		0		pre	-1								
1706B		1706	3	formed	SRR9270397	PRJNA548153	2		8	1	PBSC_unmodified	Leukemia	f16f2e2198dd30e00de807		0		peri	0								
1706C		1706	4	semi-formed	SRR9270183	PRJNA548153	3		8	1	PBSC_unmodified	Leukemia	f16f2e2198dd30e00de807		0		peri	0								
1706D		1706	5	semi-formed	SRR9270184	PRJNA548153	4		8	1	PBSC_unmodified	Leukemia	f16f2e2198dd30e00de807		0		peri	0								
1706E		1706	12	semi-formed	SRR9270185	PRJNA548153	11		8	1	PBSC_unmodified	Leukemia	f16f2e2198dd30e00de807		0		post	1								
1706F		1706	13	semi-formed	SRR11115651	PRJNA607574	12		8	1	PBSC_unmodified	Leukemia	f16f2e2198dd30e00de807		0		post	1								
1706G		1706	17	semi-formed	SRR11115650	PRJNA607574	16		8	1	PBSC_unmodified	Leukemia	f16f2e2198dd30e00de807		0		post	2								
1706H		1706	29	formed	SRR11115649	PRJNA607574	28		8	1	PBSC_unmodified	Leukemia	f16f2e2198dd30e00de807		0		post	3								
1708A		1708	0	semi-formed	SRR9271392	PRJNA548153	-5		6	5	TCD	Multiple Myeloma	289fb8cb93b8a5142e5e57		0		pre	-1								
1708B		1708	1	semi-formed	SRR9271436	PRJNA548153	-4		6	5	TCD	Multiple Myeloma	289fb8cb93b8a5142e5e57		0		pre	-1								
1708C		1708	3	liquid	SRR9271435	PRJNA548153	-2		6	5	TCD	Multiple Myeloma	289fb8cb93b8a5142e5e57		0		pre	-1								
1708D		1708	4	liquid	SRR9271438	PRJNA548153	-1		6	5	TCD	Multiple Myeloma	289fb8cb93b8a5142e5e57		0		pre	-1								
1708E		1708	8	liquid	SRR9271437	PRJNA548153	3		6	5	TCD	Multiple Myeloma	289fb8cb93b8a5142e5e57		0		peri	0								
1708F		1708	14	liquid	SRR9271440	PRJNA548153	9		6	5	TCD	Multiple Myeloma	289fb8cb93b8a5142e5e57		0		post	1								
1709A		1709	0	formed	SRR9271439	PRJNA548153	-4		11	4	PBSC_unmodified	Leukemia	c4e99ddee3643413af6074		0		pre	-1								
1709B		1709	1	formed	SRR9271442	PRJNA548153	-3		11	4	PBSC_unmodified	Leukemia	c4e99ddee3643413af6074		0		pre	-1								
1709C		1709	3	semi-formed	SRR9271441	PRJNA548153	-1		11	4	PBSC_unmodified	Leukemia	c4e99ddee3643413af6074		0		pre	-1								
1709D		1709	8	semi-formed	SRR9271434	PRJNA548153	4		11	4	PBSC_unmodified	Leukemia	c4e99ddee3643413af6074		0		peri	0								
1709E		1709	11	semi-formed	SRR9271433	PRJNA548153	7		11	4	PBSC_unmodified	Leukemia	c4e99ddee3643413af6074		0		post	0								
1709F		1709	10	semi-formed	SRR9271363	PRJNA548153	6		11	4	PBSC_unmodified	Leukemia	c4e99ddee3643413af6074		0		post	0								
1709G		1709	14	formed	SRR9271362	PRJNA548153	10		11	4	PBSC_unmodified	Leukemia	c4e99ddee3643413af6074		0		post	1								
1709H		1709	16	formed	SRR9271365	PRJNA548153	12		11	4	PBSC_unmodified	Leukemia	c4e99ddee3643413af6074		0		post	1								
1709I		1709	23	formed	SRR11115647	PRJNA607574	19		11	4	PBSC_unmodified	Leukemia	c4e99ddee3643413af6074		0		post	2								
1709J		1709	29	formed	SRR11115646	PRJNA607574	25		11	4	PBSC_unmodified	Leukemia	c4e99ddee3643413af6074		0		post	3								
1709K		1709	45	formed	SRR11115645	PRJNA607574	41		11	4	PBSC_unmodified	Leukemia	c4e99ddee3643413af6074		0		post	5								
1710A		1710	0	semi-formed	SRR9271364	PRJNA548153	-3		10	3	cord	Leukemia	dd03d010abd3c5f867f9a4		0		pre	-1								
1710C		1710	1	liquid	SRR11115644	PRJNA607574	-2		10	3	cord	Leukemia	dd03d010abd3c5f867f9a4		0		pre	-1								
1710D		1710	3	semi-formed	SRR9271366	PRJNA548153	0		10	3	cord	Leukemia	dd03d010abd3c5f867f9a4		0		peri	-1								
1710E		1710	9	liquid	SRR9271452	PRJNA548153	6		10	3	cord	Leukemia	dd03d010abd3c5f867f9a4		0		post	0								
1710F		1710	17	semi-formed	SRR9271446	PRJNA548153	14		10	3	cord	Leukemia	dd03d010abd3c5f867f9a4		0		post	1								
1710G		1710	22	liquid	SRR9271493	PRJNA548153	19		10	3	cord	Leukemia	dd03d010abd3c5f867f9a4		0		post	2								
1710H		1710	23	liquid	SRR9271393	PRJNA548153	20		10	3	cord	Leukemia	dd03d010abd3c5f867f9a4		0		post	2								
1710I		1710	28	formed	SRR11115643	PRJNA607574	25		10	3	cord	Leukemia	dd03d010abd3c5f867f9a4		0		post	3								
1710J		1710	41	semi-formed	SRR11115642	PRJNA607574	38		10	3	cord	Leukemia	dd03d010abd3c5f867f9a4		0		post	5								
1710K		1710	42	semi-formed	SRR11115641	PRJNA607574	39		10	3	cord	Leukemia	dd03d010abd3c5f867f9a4		0		post	5								
1711A		1711	0	formed	SRR9271412	PRJNA548153	-3		12	3	PBSC_unmodified	Myelodysplastic Syndromes	9b93aa7135378c00243acf		0		pre	-1								
1711B		1711	1	formed	SRR9271512	PRJNA548153	-2		12	3	PBSC_unmodified	Myelodysplastic Syndromes	9b93aa7135378c00243acf		0		pre	-1								
1711C		1711	5	liquid	SRR9271497	PRJNA548153	2		12	3	PBSC_unmodified	Myelodysplastic Syndromes	9b93aa7135378c00243acf		0		peri	0								
1711D		1711	6	semi-formed	SRR9271498	PRJNA548153	3		12	3	PBSC_unmodified	Myelodysplastic Syndromes	9b93aa7135378c00243acf		0		peri	0								
1711E		1711	7	semi-formed	SRR9271511	PRJNA548153	4		12	3	PBSC_unmodified	Myelodysplastic Syndromes	9b93aa7135378c00243acf		0		peri	0								
1711F		1711	17	liquid	SRR9271513	PRJNA548153	14		12	3	PBSC_unmodified	Myelodysplastic Syndromes	9b93aa7135378c00243acf		0		post	1								
1711G		1711	16	semi-formed	SRR9271509	PRJNA548153	13		12	3	PBSC_unmodified	Myelodysplastic Syndromes	9b93aa7135378c00243acf		0		post	1								
1711H		1711	19	semi-formed	SRR9271510	PRJNA548153	16		12	3	PBSC_unmodified	Myelodysplastic Syndromes	9b93aa7135378c00243acf		0		post	2								
1711K		1711	26	semi-formed	SRR11115640	PRJNA607574	23		12	3	PBSC_unmodified	Myelodysplastic Syndromes	9b93aa7135378c00243acf		0		post	3								
1711L		1711	27	formed	SRR11115639	PRJNA607574	24		12	3	PBSC_unmodified	Myelodysplastic Syndromes	9b93aa7135378c00243acf		0		post	3								
1711M		1711	28	semi-formed	SRR11115638	PRJNA607574	25		12	3	PBSC_unmodified	Myelodysplastic Syndromes	9b93aa7135378c00243acf		0		post	3								
1711N		1711	30	formed	SRR11115907	PRJNA607574	27		12	3	PBSC_unmodified	Myelodysplastic Syndromes	9b93aa7135378c00243acf		0		post	3								
1712A		1712	0	semi-formed	SRR11396658	PRJNA607574			5																	
1712B		1712	1	semi-formed	SRR11396657	PRJNA607574			5																	
1712C		1712	2	semi-formed	SRR11396656	PRJNA607574			5																	
1712E		1712	5	semi-formed	SRR11396654	PRJNA607574			5																	
1712F		1712	7	semi-formed	SRR11396653	PRJNA607574			5																	
1713A		1713	0	formed	SRR9271502	PRJNA548153	-9		17	9	TCD	Leukemia	81b792039d15cbd1c3569b		0		pre	-2								
1713B		1713	1	formed	SRR9271501	PRJNA548153	-8		17	9	TCD	Leukemia	81b792039d15cbd1c3569b		0		pre	-2								
1713C		1713	2	formed	SRR9271500	PRJNA548153	-7		17	9	TCD	Leukemia	81b792039d15cbd1c3569b		0		pre	-2								
1713D		1713	5	formed	SRR9271499	PRJNA548153	-4		17	9	TCD	Leukemia	81b792039d15cbd1c3569b		0		pre	-1								
1713E		1713	6	formed	SRR9271506	PRJNA548153	-3		17	9	TCD	Leukemia	81b792039d15cbd1c3569b		0		pre	-1								
1713F		1713	7	formed	SRR9271505	PRJNA548153	-2		17	9	TCD	Leukemia	81b792039d15cbd1c3569b		0		pre	-1								
1713G		1713	8	liquid	SRR9271504	PRJNA548153	-1		17	9	TCD	Leukemia	81b792039d15cbd1c3569b		0		pre	-1								
1713H		1713	10	liquid	SRR9271503	PRJNA548153	1		17	9	TCD	Leukemia	81b792039d15cbd1c3569b		0		peri	0								
1713I		1713	9	liquid	SRR9271508	PRJNA548153	0		17	9	TCD	Leukemia	81b792039d15cbd1c3569b		0		peri	-1								
1713J		1713	15	liquid	SRR9271507	PRJNA548153	6		17	9	TCD	Leukemia	81b792039d15cbd1c3569b		0		post	0								
1713K		1713	16	liquid	SRR9271345	PRJNA548153	7		17	9	TCD	Leukemia	81b792039d15cbd1c3569b		0		post	0								
1713L		1713	17	liquid	SRR9271344	PRJNA548153	8		17	9	TCD	Leukemia	81b792039d15cbd1c3569b		0		post	1								
1713M		1713	19	liquid	SRR9271534	PRJNA548153	10		17	9	TCD	Leukemia	81b792039d15cbd1c3569b		0		post	1								
1713N		1713	22	liquid	SRR11115906	PRJNA607574	13		17	9	TCD	Leukemia	81b792039d15cbd1c3569b		0		post	1								
1713O		1713	27	liquid	SRR11115905	PRJNA607574	18		17	9	TCD	Leukemia	81b792039d15cbd1c3569b		0		post	2								
1713P		1713	28	semi-formed	SRR11115904	PRJNA607574	19		17	9	TCD	Leukemia	81b792039d15cbd1c3569b		0		post	2								
1713Q		1713	29	semi-formed	SRR11115903	PRJNA607574	20		17	9	TCD	Leukemia	81b792039d15cbd1c3569b		0		post	2								
1715A		1715	0	formed	SRR11396652	PRJNA607574			1																	
1716A		1716	0	semi-formed	SRR11115902	PRJNA607574	-3		4	3	BM_unmodified	Multiple Myeloma	1ccd99ad1560a2da3d9247		0		pre	-1								
1716B		1716	2	semi-formed	SRR11115901	PRJNA607574	-1		4	3	BM_unmodified	Multiple Myeloma	1ccd99ad1560a2da3d9247		0		pre	-1								
1716C		1716	5	semi-formed	SRR11115900	PRJNA607574	2		4	3	BM_unmodified	Multiple Myeloma	1ccd99ad1560a2da3d9247		0		peri	0								
1716D		1716	43	semi-formed	SRR11115899	PRJNA607574	40		4	3	BM_unmodified	Multiple Myeloma	1ccd99ad1560a2da3d9247		0		post	5								
1717A		1717	0	formed	SRR11140481	PRJNA606262			1																	
1718A		1718	0	semi-formed	SRR11396650	PRJNA607574			3																	
1718B		1718	205	semi-formed	SRR11396649	PRJNA607574			3																	
1718C		1718	345	formed	SRR11396648	PRJNA607574			3																	
1719A		1719	0	liquid	SRR11139584	PRJNA606262			5																	
1719B		1719	5	liquid	SRR11139583	PRJNA606262			5																	
1719C		1719	21	liquid	SRR11139581	PRJNA606262			5																	
1719D		1719	25	liquid	SRR11139580	PRJNA606262			5																	
1719E		1719	32	liquid	SRR11139579	PRJNA606262			5																	
171A		171	0	formed	SRR11396641	PRJNA607574			1																	
1720A		1720	0	formed	SRR9271546	PRJNA548153	-2		14	2	BM_unmodified	Myelodysplastic Syndromes	fdd97af364815b4eb7e182		0		pre	-1								
1720B		1720	1	formed	SRR9271547	PRJNA548153	-1		14	2	BM_unmodified	Myelodysplastic Syndromes	fdd97af364815b4eb7e182		0		pre	-1								
1720C		1720	2	semi-formed	SRR9271543	PRJNA548153	0		14	2	BM_unmodified	Myelodysplastic Syndromes	fdd97af364815b4eb7e182		0		peri	-1								
1720D		1720	3	semi-formed	SRR9271542	PRJNA548153	1		14	2	BM_unmodified	Myelodysplastic Syndromes	fdd97af364815b4eb7e182		0		peri	0								
1720F		1720	7	formed	SRR9271541	PRJNA548153	5		14	2	BM_unmodified	Myelodysplastic Syndromes	fdd97af364815b4eb7e182		0		peri	0								
1720G		1720	8	semi-formed	SRR9271540	PRJNA548153	6		14	2	BM_unmodified	Myelodysplastic Syndromes	fdd97af364815b4eb7e182		0		post	0								
1720H		1720	9	formed	SRR9271535	PRJNA548153	7		14	2	BM_unmodified	Myelodysplastic Syndromes	fdd97af364815b4eb7e182		0		post	0								
1720I		1720	10	formed	SRR9271536	PRJNA548153	8		14	2	BM_unmodified	Myelodysplastic Syndromes	fdd97af364815b4eb7e182		0		post	1								
1720J		1720	14	formed	SRR9271537	PRJNA548153	12		14	2	BM_unmodified	Myelodysplastic Syndromes	fdd97af364815b4eb7e182		0		post	1								
1720K		1720	16	semi-formed	SRR11115898	PRJNA607574	14		14	2	BM_unmodified	Myelodysplastic Syndromes	fdd97af364815b4eb7e182		0		post	1								
1720L		1720	15	semi-formed	SRR11115896	PRJNA607574	13		14	2	BM_unmodified	Myelodysplastic Syndromes	fdd97af364815b4eb7e182		0		post	1								
1720M		1720	17	formed	SRR11115895	PRJNA607574	15		14	2	BM_unmodified	Myelodysplastic Syndromes	fdd97af364815b4eb7e182		0		post	2								
1720O		1720	23	formed	SRR11115894	PRJNA607574	21		14	2	BM_unmodified	Myelodysplastic Syndromes	fdd97af364815b4eb7e182		0		post	2								
1720Q		1720	24	formed	SRR11396640	PRJNA607574	22		14	2	BM_unmodified	Myelodysplastic Syndromes	fdd97af364815b4eb7e182		0		post	3								
1721A		1721	0	semi-formed	SRR9271539	PRJNA548153	-4		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	c404e7a8b8b1304841370f		0		pre	-1								
1721B		1721	1	semi-formed	SRR9271538	PRJNA548153	-3		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	c404e7a8b8b1304841370f		0		pre	-1								
1721C		1721	6	liquid	SRR9271466	PRJNA548153	2		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	c404e7a8b8b1304841370f		0		peri	0								
1721E		1721	8	semi-formed	SRR9271445	PRJNA548153	4		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	c404e7a8b8b1304841370f		0		peri	0								
1721F		1721	9	formed	SRR9271326	PRJNA548153	5		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	c404e7a8b8b1304841370f		0		peri	0								
1721G		1721	10	semi-formed	SRR9271327	PRJNA548153	6		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	c404e7a8b8b1304841370f		0		post	0								
1721H		1721	13	formed	SRR9271328	PRJNA548153	9		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	c404e7a8b8b1304841370f		0		post	1								
1721I		1721	14	formed	SRR9271329	PRJNA548153	10		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	c404e7a8b8b1304841370f		0		post	1								
1721J		1721	17	semi-formed	SRR11115892	PRJNA607574	13		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	c404e7a8b8b1304841370f		0		post	1								
1722A		1722	0	formed	SRR11396639	PRJNA607574			2																	
1722B		1722	7	formed	SRR11396638	PRJNA607574			2																	
1725A		1725	0	semi-formed	SRR11139568	PRJNA606262			5																	
1725B		1725	13	formed	SRR11139567	PRJNA606262			5																	
1725C		1725	19	liquid	SRR11139566	PRJNA606262			5																	
1725D		1725	70	formed	SRR11139565	PRJNA606262			5																	
1725E		1725	106	semi-formed	SRR11139564	PRJNA606262			5																	
1726A		1726	0	formed	SRR11115891	PRJNA607574	-1		4	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	1ecbea411ea09ee0f19730		0		pre	-1								
1726B		1726	4	formed	SRR11115890	PRJNA607574	3		4	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	1ecbea411ea09ee0f19730		0		peri	0								
1726C		1726	5	formed	SRR11115889	PRJNA607574	4		4	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	1ecbea411ea09ee0f19730		0		peri	0								
1726D		1726	7	formed	SRR11115888	PRJNA607574	6		4	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	1ecbea411ea09ee0f19730		0		post	0								
1727A		1727	0	formed	SRR11139922	PRJNA606262			5																	
1727B		1727	2	semi-formed	SRR11139921	PRJNA606262			5																	
1727C		1727	4	semi-formed	SRR11139920	PRJNA606262			5																	
1727D		1727	5	semi-formed	SRR11139919	PRJNA606262			5																	
1727E		1727	6	formed	SRR11139918	PRJNA606262			5																	
1728B		1728	5	semi-formed	SRR9271330	PRJNA548153	-1		4	6	BM_unmodified	Aplastic Anemia	dfabe1fb0f178db83412e2		0		pre	-1								
1728C		1728	10	liquid	SRR9271331	PRJNA548153	4		4	6	BM_unmodified	Aplastic Anemia	dfabe1fb0f178db83412e2		0		peri	0								
1728F		1728	18	semi-formed	SRR9270245	PRJNA548153	12		4	6	BM_unmodified	Aplastic Anemia	dfabe1fb0f178db83412e2		0		post	1								
1728G		1728	20	formed	SRR9270244	PRJNA548153	14		4	6	BM_unmodified	Aplastic Anemia	dfabe1fb0f178db83412e2		0		post	1								
1729A		1729	0	formed	SRR11139598	PRJNA606262			3																	
1729B		1729	4	semi-formed	SRR11139597	PRJNA606262			3																	
1729D		1729	12	liquid	SRR11139596	PRJNA606262			3																	
172B		172	15	liquid	SRR11420824	PRJNA545312	1		10	14	cord	Non-Hodgkin's Lymphoma	d20ed7326a74302298f359	139	1		peri	0								
172C		172	26	liquid	SRR11420821	PRJNA545312	12		10	14	cord	Non-Hodgkin's Lymphoma	d20ed7326a74302298f359	139	1		post	1								
172D		172	32	semi-formed	SRR11420820	PRJNA545312	18		10	14	cord	Non-Hodgkin's Lymphoma	d20ed7326a74302298f359	139	1		post	2								
172E		172	39	formed	SRR11420819	PRJNA545312	25		10	14	cord	Non-Hodgkin's Lymphoma	d20ed7326a74302298f359	139	1		post	3								
172F		172	41	semi-formed	SRR11420818	PRJNA545312	27		10	14	cord	Non-Hodgkin's Lymphoma	d20ed7326a74302298f359	139	1		post	3								
172G		172	43	formed	SRR11420817	PRJNA545312	29		10	14	cord	Non-Hodgkin's Lymphoma	d20ed7326a74302298f359	139	1		post	4								
172H		172	46	semi-formed	SRR11420816	PRJNA545312	32		10	14	cord	Non-Hodgkin's Lymphoma	d20ed7326a74302298f359	139	1		post	4								
172I		172	55	formed	SRR11420815	PRJNA545312	41		10	14	cord	Non-Hodgkin's Lymphoma	d20ed7326a74302298f359	139	1		post	5								
172J		172	62	liquid	SRR11420814	PRJNA545312	48		10	14	cord	Non-Hodgkin's Lymphoma	d20ed7326a74302298f359	139	1		post	6								
172K		172	67	formed	SRR11420813	PRJNA545312	53		10	14	cord	Non-Hodgkin's Lymphoma	d20ed7326a74302298f359	139	1		post	6								
1730A		1730	0	liquid	SRR9270243	PRJNA548153	-4		5	4	PBSC_unmodified	Leukemia	43dba793374dd789c1776c		0		pre	-1								
1730B		1730	8	liquid	SRR9270242	PRJNA548153	4		5	4	PBSC_unmodified	Leukemia	43dba793374dd789c1776c		0		peri	0								
1730C		1730	10	semi-formed	SRR9270327	PRJNA548153	6		5	4	PBSC_unmodified	Leukemia	43dba793374dd789c1776c		0		post	0								
1730D		1730	18	formed	SRR9270195	PRJNA548153	14		5	4	PBSC_unmodified	Leukemia	43dba793374dd789c1776c		0		post	1								
1730E		1730	24	liquid	SRR11115887	PRJNA607574	20		5	4	PBSC_unmodified	Leukemia	43dba793374dd789c1776c		0		post	2								
1731A		1731	0	liquid	SRR9270239	PRJNA548153	-4		12	4	TCD	Leukemia	d51b9711c26f54df210d85		0		pre	-1								
1731B		1731	1	semi-formed	SRR9270238	PRJNA548153	-3		12	4	TCD	Leukemia	d51b9711c26f54df210d85		0		pre	-1								
1731C		1731	3	semi-formed	SRR9270194	PRJNA548153	-1		12	4	TCD	Leukemia	d51b9711c26f54df210d85		0		pre	-1								
1731E		1731	8	semi-formed	SRR9270193	PRJNA548153	4		12	4	TCD	Leukemia	d51b9711c26f54df210d85		0		peri	0								
1731F		1731	9	liquid	SRR9270279	PRJNA548153	5		12	4	TCD	Leukemia	d51b9711c26f54df210d85		0		peri	0								
1731G		1731	10	liquid	SRR9270278	PRJNA548153	6		12	4	TCD	Leukemia	d51b9711c26f54df210d85		0		post	0								
1731H		1731	11	liquid	SRR9270281	PRJNA548153	7		12	4	TCD	Leukemia	d51b9711c26f54df210d85		0		post	0								
1731I		1731	15	semi-formed	SRR9270280	PRJNA548153	11		12	4	TCD	Leukemia	d51b9711c26f54df210d85		0		post	1								
1731J		1731	16	liquid	SRR11115885	PRJNA607574	12		12	4	TCD	Leukemia	d51b9711c26f54df210d85		0		post	1								
1731K		1731	18	liquid	SRR11115884	PRJNA607574	14		12	4	TCD	Leukemia	d51b9711c26f54df210d85		0		post	1								
1731L		1731	46	liquid	SRR11115883	PRJNA607574	42		12	4	TCD	Leukemia	d51b9711c26f54df210d85		0		post	5								
1731M		1731	102	semi-formed	SRR11115882	PRJNA607574	98		12	4	TCD	Leukemia	d51b9711c26f54df210d85		0		post	6								
1734A		1734	0	liquid	SRR9270275	PRJNA548153	-3		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		pre	-1								
1734AA		1734	47	liquid	SRR11115881	PRJNA607574	44		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	6								
1734B		1734	5	semi-formed	SRR9270274	PRJNA548153	2		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		peri	0								
1734BB		1734	49	semi-formed	SRR11115880	PRJNA607574	46		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	6								
1734C		1734	6	liquid	SRR9270277	PRJNA548153	3		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		peri	0								
1734D		1734	7	liquid	SRR9270276	PRJNA548153	4		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		peri	0								
1734E		1734	9	liquid	SRR9270284	PRJNA548153	6		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	0								
1734F		1734	12	liquid	SRR9270283	PRJNA548153	9		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	1								
1734G		1734	13	liquid	SRR9270222	PRJNA548153	10		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	1								
1734H		1734	14	liquid	SRR9270223	PRJNA548153	11		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	1								
1734J		1734	16	liquid	SRR11396623	PRJNA607574	13		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	1								
1734K		1734	19	liquid	SRR9270225	PRJNA548153	16		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	2								
1734L		1734	20	liquid	SRR9270226	PRJNA548153	17		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	2								
1734N		1734	23	liquid	SRR9270227	PRJNA548153	20		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	2								
1734O		1734	26	liquid	SRR11115879	PRJNA607574	23		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	3								
1734P		1734	27	liquid	SRR11115878	PRJNA607574	24		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	3								
1734Q		1734	28	semi-formed	SRR11115877	PRJNA607574	25		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	3								
1734S		1734	34	semi-formed	SRR11115316	PRJNA607574	31		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	4								
1734T		1734	36	semi-formed	SRR11115314	PRJNA607574	33		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	4								
1734U		1734	35	liquid	SRR11115313	PRJNA607574	32		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	4								
1734V		1734	37	formed	SRR11115312	PRJNA607574	34		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	4								
1734W		1734	40	semi-formed	SRR11115311	PRJNA607574	37		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	5								
1734X		1734	42	formed	SRR11115310	PRJNA607574	39		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	5								
1734Y		1734	43	semi-formed	SRR11115309	PRJNA607574	40		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	5								
1734Z		1734	44	formed	SRR11115308	PRJNA607574	41		25	3	cord	Leukemia	9d3dc44674fe5ddc51d508		0		post	5								
1736A		1736	0	formed	SRR11115307	PRJNA607574	9		5	-9	BM_unmodified	Myeloproliferative Disorder	d4f8c90e6066bd2dbd638a		0		post	1								
1736B		1736	1	formed	SRR11115306	PRJNA607574	10		5	-9	BM_unmodified	Myeloproliferative Disorder	d4f8c90e6066bd2dbd638a		0		post	1								
1736C		1736	7	formed	SRR11115305	PRJNA607574	16		5	-9	BM_unmodified	Myeloproliferative Disorder	d4f8c90e6066bd2dbd638a		0		post	2								
1736D		1736	8	semi-formed	SRR11115303	PRJNA607574	17		5	-9	BM_unmodified	Myeloproliferative Disorder	d4f8c90e6066bd2dbd638a		0		post	2								
1736E		1736	9	liquid	SRR11115302	PRJNA607574	18		5	-9	BM_unmodified	Myeloproliferative Disorder	d4f8c90e6066bd2dbd638a		0		post	2								
173A		173	0	semi-formed	SRR11420812	PRJNA545312	-5		6	5	PBSC_unmodified	Myelodysplastic Syndromes	a534b45e73b9332fe1c2a5	174	1		pre	-1								
173B		173	3	semi-formed	SRR11420810	PRJNA545312	-2		6	5	PBSC_unmodified	Myelodysplastic Syndromes	a534b45e73b9332fe1c2a5	174	1		pre	-1								
173C		173	11	liquid	SRR11420809	PRJNA545312	6		6	5	PBSC_unmodified	Myelodysplastic Syndromes	a534b45e73b9332fe1c2a5	174	1		post	0								
173D		173	17	liquid	SRR11420808	PRJNA545312	12		6	5	PBSC_unmodified	Myelodysplastic Syndromes	a534b45e73b9332fe1c2a5	174	1		post	1								
173E		173	29	liquid	SRR11420807	PRJNA545312	24		6	5	PBSC_unmodified	Myelodysplastic Syndromes	a534b45e73b9332fe1c2a5	174	1		post	3								
173F		173	31	formed	SRR11420806	PRJNA545312	26		6	5	PBSC_unmodified	Myelodysplastic Syndromes	a534b45e73b9332fe1c2a5	174	1		post	3								
1742A		1742	0	semi-formed	SRR11396621	PRJNA607574			5																	
1742B		1742	6	formed	SRR11396620	PRJNA607574			5																	
1742C		1742	14	formed	SRR11396619	PRJNA607574			5																	
1742D		1742	18	formed	SRR11396618	PRJNA607574			5																	
1742E		1742	54	formed	SRR11396617	PRJNA607574			5																	
1744A		1744	0	formed	SRR11140375	PRJNA606262			4																	
1744B		1744	7	liquid	SRR11140364	PRJNA606262			4																	
1744C		1744	13	formed	SRR11140117	PRJNA606262			4																	
1744D		1744	31	formed	SRR11140106	PRJNA606262			4																	
1745A		1745	0	formed	SRR11115301	PRJNA607574	41		4	-41	PBSC_unmodified	Hodgkin's Disease	d75ab4d87df69c8b77399d		0		post	5								
1745B		1745	9	semi-formed	SRR11115300	PRJNA607574	50		4	-41	PBSC_unmodified	Hodgkin's Disease	d75ab4d87df69c8b77399d		0		post	6								
1745C		1745	49	semi-formed	SRR11115299	PRJNA607574	90		4	-41	PBSC_unmodified	Hodgkin's Disease	d75ab4d87df69c8b77399d		0		post	6								
1745D		1745	154	semi-formed	SRR11115298	PRJNA607574	195		4	-41	PBSC_unmodified	Hodgkin's Disease	d75ab4d87df69c8b77399d		0		post	6								
1748A		1748	0	semi-formed	SRR11396612	PRJNA607574			3																	
1748B		1748	15	semi-formed	SRR11396609	PRJNA607574			3																	
1748C		1748	22	semi-formed	SRR11396608	PRJNA607574			3																	
174A		174	0	semi-formed	SRR11420805	PRJNA545312	12		1	-12	PBSC_unmodified	Non-Hodgkin's Lymphoma	cfe5cbbe92166dcdf30075	134	1		post	1								
1750A		1750	0	semi-formed	SRR11396607	PRJNA607574			1																	
1751A		1751	0	formed	SRR9270228	PRJNA548153	-3		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		pre	-1								
1751AA		1751	66	formed	SRR11115297	PRJNA607574	63		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	6								
1751BB		1751	72	semi-formed	SRR11115296	PRJNA607574	69		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	6								
1751C		1751	1	liquid	SRR9270229	PRJNA548153	-2		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		pre	-1								
1751CC		1751	92	liquid	SRR11115295	PRJNA607574	89		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	6								
1751D		1751	2	liquid	SRR9270219	PRJNA548153	-1		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		pre	-1								
1751DD		1751	93	semi-formed	SRR11115294	PRJNA607574	90		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	6								
1751E		1751	3	liquid	SRR9270220	PRJNA548153	0		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		peri	-1								
1751EE		1751	94	semi-formed	SRR11115292	PRJNA607574	91		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	6								
1751FF		1751	95	semi-formed	SRR11115291	PRJNA607574	92		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	6								
1751GG		1751	105	semi-formed	SRR11115290	PRJNA607574	102		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	6								
1751HH		1751	108	semi-formed	SRR11115289	PRJNA607574	105		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	6								
1751II		1751	109	semi-formed	SRR11115288	PRJNA607574	106		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	6								
1751Q		1751	24	liquid	SRR11115287	PRJNA607574	21		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	2								
1751R		1751	25	liquid	SRR11115286	PRJNA607574	22		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	3								
1751S		1751	26	semi-formed	SRR11115285	PRJNA607574	23		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	3								
1751T		1751	28	liquid	SRR11115636	PRJNA607574	25		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	3								
1751U		1751	29	liquid	SRR11115635	PRJNA607574	26		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	3								
1751W		1751	32	semi-formed	SRR11115633	PRJNA607574	29		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	4								
1751X		1751	37	semi-formed	SRR11115632	PRJNA607574	34		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	4								
1751Y		1751	57	liquid	SRR11115631	PRJNA607574	54		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	6								
1751Z		1751	64	liquid	SRR11115630	PRJNA607574	61		22	270	PBSC_unmodified		2b3f03a8b7d55a2de3e745		0		post	6								
1755A		1755	0	formed	SRR9270205	PRJNA548153	-3		14	3	BM_unmodified	Hodgkin's Disease	cdf3e2828d4098a08886da		0		pre	-1								
1755B		1755	1	semi-formed	SRR9270204	PRJNA548153	-2		14	3	BM_unmodified	Hodgkin's Disease	cdf3e2828d4098a08886da		0		pre	-1								
1755C		1755	3	semi-formed	SRR9270203	PRJNA548153	0		14	3	BM_unmodified	Hodgkin's Disease	cdf3e2828d4098a08886da		0		peri	-1								
1755D		1755	6	semi-formed	SRR9270202	PRJNA548153	3		14	3	BM_unmodified	Hodgkin's Disease	cdf3e2828d4098a08886da		0		peri	0								
1755E		1755	7	semi-formed	SRR9270201	PRJNA548153	4		14	3	BM_unmodified	Hodgkin's Disease	cdf3e2828d4098a08886da		0		peri	0								
1755F		1755	8	semi-formed	SRR9270200	PRJNA548153	5		14	3	BM_unmodified	Hodgkin's Disease	cdf3e2828d4098a08886da		0		peri	0								
1755G		1755	9	formed	SRR9270199	PRJNA548153	6		14	3	BM_unmodified	Hodgkin's Disease	cdf3e2828d4098a08886da		0		post	0								
1755H		1755	13	formed	SRR9270186	PRJNA548153	10		14	3	BM_unmodified	Hodgkin's Disease	cdf3e2828d4098a08886da		0		post	1								
1755I		1755	14	semi-formed	SRR9270187	PRJNA548153	11		14	3	BM_unmodified	Hodgkin's Disease	cdf3e2828d4098a08886da		0		post	1								
1755J		1755	15	liquid	SRR9270188	PRJNA548153	12		14	3	BM_unmodified	Hodgkin's Disease	cdf3e2828d4098a08886da		0		post	1								
1755K		1755	20	formed	SRR9270189	PRJNA548153	17		14	3	BM_unmodified	Hodgkin's Disease	cdf3e2828d4098a08886da		0		post	2								
1755L		1755	21	semi-formed	SRR9270190	PRJNA548153	18		14	3	BM_unmodified	Hodgkin's Disease	cdf3e2828d4098a08886da		0		post	2								
1755M		1755	22	liquid	SRR11115629	PRJNA607574	19		14	3	BM_unmodified	Hodgkin's Disease	cdf3e2828d4098a08886da		0		post	2								
1755N		1755	23	liquid	SRR11115628	PRJNA607574	20		14	3	BM_unmodified	Hodgkin's Disease	cdf3e2828d4098a08886da		0		post	2								
1757A		1757	0	formed	SRR9270198	PRJNA548153	-6		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		pre	-1								
1757B		1757	1	formed	SRR9270197	PRJNA548153	-5		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		pre	-1								
1757C		1757	4	formed	SRR9270196	PRJNA548153	-2		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		pre	-1								
1757D		1757	5	semi-formed	SRR9270172	PRJNA548153	-1		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		pre	-1								
1757E		1757	6	semi-formed	SRR9270173	PRJNA548153	0		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		peri	-1								
1757F		1757	7	semi-formed	SRR9270177	PRJNA548153	1		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		peri	0								
1757G		1757	8	semi-formed	SRR9270174	PRJNA548153	2		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		peri	0								
1757H		1757	12	semi-formed	SRR9270175	PRJNA548153	6		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		post	0								
1757I		1757	13	semi-formed	SRR9270168	PRJNA548153	7		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		post	0								
1757J		1757	15	formed	SRR9270169	PRJNA548153	9		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		post	1								
1757K		1757	18	semi-formed	SRR9270390	PRJNA548153	12		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		post	1								
1757L		1757	19	formed	SRR9270389	PRJNA548153	13		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		post	1								
1757M		1757	20	semi-formed	SRR9270392	PRJNA548153	14		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		post	1								
1757N		1757	21	semi-formed	SRR9270391	PRJNA548153	15		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		post	2								
1757O		1757	25	formed	SRR9270394	PRJNA548153	19		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		post	2								
1757P		1757	26	formed	SRR9270393	PRJNA548153	20		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		post	2								
1757Q		1757	27	semi-formed	SRR9270396	PRJNA548153	21		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		post	2								
1757R		1757	32	formed	SRR9270395	PRJNA548153	26		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		post	3								
1757S		1757	33	formed	SRR11115627	PRJNA607574	27		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		post	3								
1757T		1757	34	semi-formed	SRR11115626	PRJNA607574	28		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		post	3								
1757U		1757	35	semi-formed	SRR11115625	PRJNA607574	29		21	6	BM_unmodified	Myeloproliferative Disorder	0f0e735fb05b8dfd877424		0		post	4								
1758A		1758	0	liquid	SRR9270181	PRJNA548153	-7		6	7	TCD	Leukemia	36ddf866431173abbc0fd0		0		pre	-2								
1758B		1758	5	formed	SRR9270182	PRJNA548153	-2		6	7	TCD	Leukemia	36ddf866431173abbc0fd0		0		pre	-1								
1758C		1758	6	formed	SRR9270213	PRJNA548153	-1		6	7	TCD	Leukemia	36ddf866431173abbc0fd0		0		pre	-1								
1758D		1758	10	liquid	SRR9270212	PRJNA548153	3		6	7	TCD	Leukemia	36ddf866431173abbc0fd0		0		peri	0								
1758E		1758	11	liquid	SRR9270211	PRJNA548153	4		6	7	TCD	Leukemia	36ddf866431173abbc0fd0		0		peri	0								
1758H		1758	19	semi-formed	SRR11115624	PRJNA607574	12		6	7	TCD	Leukemia	36ddf866431173abbc0fd0		0		post	1								
1759A		1759	0	formed	SRR11115622	PRJNA607574	-8		2	8	cord	Leukemia	ff650b2e1faab2a3fbcfc9		0		pre	-2								
1759D		1759	14	liquid	SRR11115621	PRJNA607574	6		2	8	cord	Leukemia	ff650b2e1faab2a3fbcfc9		0		post	0								
175A		175	0	semi-formed	SRR11420804	PRJNA545312	-7		4	7	BM_unmodified	Myelodysplastic Syndromes	b2a7323c3c106fd61315cf	258	1		pre	-2								
175B		175	7	semi-formed	SRR11420803	PRJNA545312	0		4	7	BM_unmodified	Myelodysplastic Syndromes	b2a7323c3c106fd61315cf	258	1		peri	-1								
175C		175	28	semi-formed	SRR11420802	PRJNA545312	21		4	7	BM_unmodified	Myelodysplastic Syndromes	b2a7323c3c106fd61315cf	258	1		post	2								
175D		175	34	semi-formed	SRR11420801	PRJNA545312	27		4	7	BM_unmodified	Myelodysplastic Syndromes	b2a7323c3c106fd61315cf	258	1		post	3								
1760A		1760	0	formed	SRR9270210	PRJNA548153	-3		14	3	PBSC_unmodified	Myelodysplastic Syndromes	f1a0f4e258f101d28afb8e		0		pre	-1								
1760B		1760	1	formed	SRR9270209	PRJNA548153	-2		14	3	PBSC_unmodified	Myelodysplastic Syndromes	f1a0f4e258f101d28afb8e		0		pre	-1								
1760C		1760	2	formed	SRR9270208	PRJNA548153	-1		14	3	PBSC_unmodified	Myelodysplastic Syndromes	f1a0f4e258f101d28afb8e		0		pre	-1								
1760D		1760	3	formed	SRR9270207	PRJNA548153	0		14	3	PBSC_unmodified	Myelodysplastic Syndromes	f1a0f4e258f101d28afb8e		0		peri	-1								
1760E		1760	4	formed	SRR9270206	PRJNA548153	1		14	3	PBSC_unmodified	Myelodysplastic Syndromes	f1a0f4e258f101d28afb8e		0		peri	0								
1760F		1760	5	formed	SRR9270215	PRJNA548153	2		14	3	PBSC_unmodified	Myelodysplastic Syndromes	f1a0f4e258f101d28afb8e		0		peri	0								
1760G		1760	7	formed	SRR9270214	PRJNA548153	4		14	3	PBSC_unmodified	Myelodysplastic Syndromes	f1a0f4e258f101d28afb8e		0		peri	0								
1760H		1760	8	formed	SRR9270232	PRJNA548153	5		14	3	PBSC_unmodified	Myelodysplastic Syndromes	f1a0f4e258f101d28afb8e		0		peri	0								
1760I		1760	9	formed	SRR9270233	PRJNA548153	6		14	3	PBSC_unmodified	Myelodysplastic Syndromes	f1a0f4e258f101d28afb8e		0		post	0								
1760J		1760	11	formed	SRR9270230	PRJNA548153	8		14	3	PBSC_unmodified	Myelodysplastic Syndromes	f1a0f4e258f101d28afb8e		0		post	1								
1760K		1760	16	formed	SRR11115620	PRJNA607574	13		14	3	PBSC_unmodified	Myelodysplastic Syndromes	f1a0f4e258f101d28afb8e		0		post	1								
1760L		1760	17	formed	SRR11115619	PRJNA607574	14		14	3	PBSC_unmodified	Myelodysplastic Syndromes	f1a0f4e258f101d28afb8e		0		post	1								
1760M		1760	19	semi-formed	SRR11115618	PRJNA607574	16		14	3	PBSC_unmodified	Myelodysplastic Syndromes	f1a0f4e258f101d28afb8e		0		post	2								
1760N		1760	58	semi-formed	SRR11115617	PRJNA607574	55		14	3	PBSC_unmodified	Myelodysplastic Syndromes	f1a0f4e258f101d28afb8e		0		post	6								
1761A		1761	0	formed	SRR11396606	PRJNA607574			1																	
1765A		1765	0	formed	SRR11396605	PRJNA607574			2																	
1765B		1765	27		SRR11396604	PRJNA607574			2																	
1766A		1766	0	formed	SRR9270388	PRJNA548153	-6		14	6	PBSC_unmodified	Leukemia	785d3fb132ff357fe637e7		0		pre	-1								
1766B		1766	5	semi-formed	SRR9270387	PRJNA548153	-1		14	6	PBSC_unmodified	Leukemia	785d3fb132ff357fe637e7		0		pre	-1								
1766C		1766	7	semi-formed	SRR9270363	PRJNA548153	1		14	6	PBSC_unmodified	Leukemia	785d3fb132ff357fe637e7		0		peri	0								
1766D		1766	10	liquid	SRR9270364	PRJNA548153	4		14	6	PBSC_unmodified	Leukemia	785d3fb132ff357fe637e7		0		peri	0								
1766F		1766	12	liquid	SRR9270365	PRJNA548153	6		14	6	PBSC_unmodified	Leukemia	785d3fb132ff357fe637e7		0		post	0								
1766G		1766	13	semi-formed	SRR9270366	PRJNA548153	7		14	6	PBSC_unmodified	Leukemia	785d3fb132ff357fe637e7		0		post	0								
1766H		1766	14	liquid	SRR9270359	PRJNA548153	8		14	6	PBSC_unmodified	Leukemia	785d3fb132ff357fe637e7		0		post	1								
1766I		1766	17	liquid	SRR9270360	PRJNA548153	11		14	6	PBSC_unmodified	Leukemia	785d3fb132ff357fe637e7		0		post	1								
1766J		1766	18	liquid	SRR9270361	PRJNA548153	12		14	6	PBSC_unmodified	Leukemia	785d3fb132ff357fe637e7		0		post	1								
1766K		1766	20	semi-formed	SRR9270362	PRJNA548153	14		14	6	PBSC_unmodified	Leukemia	785d3fb132ff357fe637e7		0		post	1								
1766L		1766	21	liquid	SRR9270357	PRJNA548153	15		14	6	PBSC_unmodified	Leukemia	785d3fb132ff357fe637e7		0		post	2								
1766M		1766	24	semi-formed	SRR11115616	PRJNA607574	18		14	6	PBSC_unmodified	Leukemia	785d3fb132ff357fe637e7		0		post	2								
1766N		1766	25	semi-formed	SRR11115615	PRJNA607574	19		14	6	PBSC_unmodified	Leukemia	785d3fb132ff357fe637e7		0		post	2								
1766O		1766	26	liquid	SRR11115614	PRJNA607574	20		14	6	PBSC_unmodified	Leukemia	785d3fb132ff357fe637e7		0		post	2								
1767A		1767	0	formed	SRR11396603	PRJNA607574			1																	
1772A		1772	0	formed	SRR9270358	PRJNA548153	-8		13	8	TCD	Leukemia	08ae57fd0788c6c0a7608c		0		pre	-2								
1772B		1772	3	semi-formed	SRR9270341	PRJNA548153	-5		13	8	TCD	Leukemia	08ae57fd0788c6c0a7608c		0		pre	-1								
1772D		1772	6	liquid	SRR9270340	PRJNA548153	-2		13	8	TCD	Leukemia	08ae57fd0788c6c0a7608c		0		pre	-1								
1772E		1772	8	semi-formed	SRR9270339	PRJNA548153	0		13	8	TCD	Leukemia	08ae57fd0788c6c0a7608c		0		peri	-1								
1772F		1772	10	liquid	SRR9270338	PRJNA548153	2		13	8	TCD	Leukemia	08ae57fd0788c6c0a7608c		0		peri	0								
1772G		1772	11	liquid	SRR9270345	PRJNA548153	3		13	8	TCD	Leukemia	08ae57fd0788c6c0a7608c		0		peri	0								
1772H		1772	13	liquid	SRR9270344	PRJNA548153	5		13	8	TCD	Leukemia	08ae57fd0788c6c0a7608c		0		peri	0								
1772I		1772	14	liquid	SRR9270343	PRJNA548153	6		13	8	TCD	Leukemia	08ae57fd0788c6c0a7608c		0		post	0								
1772J		1772	19	liquid	SRR9270342	PRJNA548153	11		13	8	TCD	Leukemia	08ae57fd0788c6c0a7608c		0		post	1								
1772K		1772	20	liquid	SRR11115613	PRJNA607574	12		13	8	TCD	Leukemia	08ae57fd0788c6c0a7608c		0		post	1								
1772L		1772	21	liquid	SRR11115611	PRJNA607574	13		13	8	TCD	Leukemia	08ae57fd0788c6c0a7608c		0		post	1								
1772M		1772	25	semi-formed	SRR11115610	PRJNA607574	17		13	8	TCD	Leukemia	08ae57fd0788c6c0a7608c		0		post	2								
1772N		1772	26	liquid	SRR11115609	PRJNA607574	18		13	8	TCD	Leukemia	08ae57fd0788c6c0a7608c		0		post	2								
1773B		1773	3	liquid	SRR9270347	PRJNA548153	-3		15	6	PBSC_unmodified	Myelodysplastic Syndromes	df7d92498290fbd95e0c59		0		pre	-1								
1773C		1773	4	formed	SRR9270346	PRJNA548153	-2		15	6	PBSC_unmodified	Myelodysplastic Syndromes	df7d92498290fbd95e0c59		0		pre	-1								
1773D		1773	5	semi-formed	SRR9270309	PRJNA548153	-1		15	6	PBSC_unmodified	Myelodysplastic Syndromes	df7d92498290fbd95e0c59		0		pre	-1								
1773E		1773	6	semi-formed	SRR9270310	PRJNA548153	0		15	6	PBSC_unmodified	Myelodysplastic Syndromes	df7d92498290fbd95e0c59		0		peri	-1								
1773F		1773	7	formed	SRR9270307	PRJNA548153	1		15	6	PBSC_unmodified	Myelodysplastic Syndromes	df7d92498290fbd95e0c59		0		peri	0								
1773G		1773	10	semi-formed	SRR9270308	PRJNA548153	4		15	6	PBSC_unmodified	Myelodysplastic Syndromes	df7d92498290fbd95e0c59		0		peri	0								
1773H		1773	11	semi-formed	SRR9270191	PRJNA548153	5		15	6	PBSC_unmodified	Myelodysplastic Syndromes	df7d92498290fbd95e0c59		0		peri	0								
1773I		1773	12	semi-formed	SRR9270192	PRJNA548153	6		15	6	PBSC_unmodified	Myelodysplastic Syndromes	df7d92498290fbd95e0c59		0		post	0								
1773J		1773	13	semi-formed	SRR9270303	PRJNA548153	7		15	6	PBSC_unmodified	Myelodysplastic Syndromes	df7d92498290fbd95e0c59		0		post	0								
1773K		1773	15	semi-formed	SRR9270304	PRJNA548153	9		15	6	PBSC_unmodified	Myelodysplastic Syndromes	df7d92498290fbd95e0c59		0		post	1								
1773L		1773	17	semi-formed	SRR9270179	PRJNA548153	11		15	6	PBSC_unmodified	Myelodysplastic Syndromes	df7d92498290fbd95e0c59		0		post	1								
1773M		1773	19	semi-formed	SRR11115608	PRJNA607574	13		15	6	PBSC_unmodified	Myelodysplastic Syndromes	df7d92498290fbd95e0c59		0		post	1								
1773N		1773	20	semi-formed	SRR11115607	PRJNA607574	14		15	6	PBSC_unmodified	Myelodysplastic Syndromes	df7d92498290fbd95e0c59		0		post	1								
1773O		1773	18	semi-formed	SRR9270180	PRJNA548153	12		15	6	PBSC_unmodified	Myelodysplastic Syndromes	df7d92498290fbd95e0c59		0		post	1								
1773P		1773	21	semi-formed	SRR11115606	PRJNA607574	15		15	6	PBSC_unmodified	Myelodysplastic Syndromes	df7d92498290fbd95e0c59		0		post	2								
1774A		1774	0	semi-formed	SRR11396601	PRJNA607574			2																	
1774B		1774	32	formed	SRR11396600	PRJNA607574			2																	
1776A		1776	0	formed	SRR9270231	PRJNA548153	-5		12	5	TCD	Leukemia	5f29698d48fcc1e7915d1e		0		pre	-1								
1776B		1776	1	semi-formed	SRR9270236	PRJNA548153	-4		12	5	TCD	Leukemia	5f29698d48fcc1e7915d1e		0		pre	-1								
1776C		1776	4	semi-formed	SRR9270237	PRJNA548153	-1		12	5	TCD	Leukemia	5f29698d48fcc1e7915d1e		0		pre	-1								
1776D		1776	14	liquid	SRR11115605	PRJNA607574	9		12	5	TCD	Leukemia	5f29698d48fcc1e7915d1e		0		post	1								
1776E		1776	15	liquid	SRR11115604	PRJNA607574	10		12	5	TCD	Leukemia	5f29698d48fcc1e7915d1e		0		post	1								
1776F		1776	35	semi-formed	SRR11115603	PRJNA607574	30		12	5	TCD	Leukemia	5f29698d48fcc1e7915d1e		0		post	4								
1776G		1776	36	formed	SRR11115602	PRJNA607574	31		12	5	TCD	Leukemia	5f29698d48fcc1e7915d1e		0		post	4								
1776H		1776	44	semi-formed	SRR11115600	PRJNA607574	39		12	5	TCD	Leukemia	5f29698d48fcc1e7915d1e		0		post	5								
1776I		1776	46	semi-formed	SRR11115599	PRJNA607574	41		12	5	TCD	Leukemia	5f29698d48fcc1e7915d1e		0		post	5								
1776J		1776	51	semi-formed	SRR11115598	PRJNA607574	46		12	5	TCD	Leukemia	5f29698d48fcc1e7915d1e		0		post	6								
1776K		1776	52	formed	SRR11115597	PRJNA607574	47		12	5	TCD	Leukemia	5f29698d48fcc1e7915d1e		0		post	6								
1776L		1776	59	formed	SRR11115596	PRJNA607574	54		12	5	TCD	Leukemia	5f29698d48fcc1e7915d1e		0		post	6								
1777A		1777	0	semi-formed	SRR11115595	PRJNA607574	4		14	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	724c859cafc47de8f0ed17		0		peri	0								
1777B		1777	1	formed	SRR11115594	PRJNA607574	5		14	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	724c859cafc47de8f0ed17		0		peri	0								
1777C		1777	2	semi-formed	SRR11115593	PRJNA607574	6		14	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	724c859cafc47de8f0ed17		0		post	0								
1777D		1777	3	formed	SRR11115592	PRJNA607574	7		14	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	724c859cafc47de8f0ed17		0		post	0								
1777E		1777	4	semi-formed	SRR11115591	PRJNA607574	8		14	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	724c859cafc47de8f0ed17		0		post	1								
1777F		1777	7	semi-formed	SRR11115588	PRJNA607574	11		14	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	724c859cafc47de8f0ed17		0		post	1								
1777G		1777	8	semi-formed	SRR11115587	PRJNA607574	12		14	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	724c859cafc47de8f0ed17		0		post	1								
1777H		1777	9	semi-formed	SRR11115586	PRJNA607574	13		14	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	724c859cafc47de8f0ed17		0		post	1								
1777I		1777	10	formed	SRR11115585	PRJNA607574	14		14	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	724c859cafc47de8f0ed17		0		post	1								
1777J		1777	184	liquid	SRR11115584	PRJNA607574	188		14	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	724c859cafc47de8f0ed17		0		post	6								
1777K		1777	186	semi-formed	SRR11115583	PRJNA607574	190		14	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	724c859cafc47de8f0ed17		0		post	6								
1777L		1777	192	semi-formed	SRR11115582	PRJNA607574	196		14	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	724c859cafc47de8f0ed17		0		post	6								
1777M		1777	193	semi-formed	SRR11115581	PRJNA607574	197		14	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	724c859cafc47de8f0ed17		0		post	6								
1777N		1777	197	formed	SRR11115580	PRJNA607574	201		14	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	724c859cafc47de8f0ed17		0		post	6								
1778A		1778	0		SRR11396598	PRJNA607574			3																	
1778B		1778	51	formed	SRR11396597	PRJNA607574			3																	
1778C		1778	107	semi-formed	SRR11396596	PRJNA607574			3																	
1779A		1779	0	formed	SRR11396595	PRJNA607574			2																	
1779B		1779	39	liquid	SRR11396594	PRJNA607574			2																	
177A		177	0	formed	SRR11420799	PRJNA545312	-2		4	2	TCD	Leukemia	0a1d271d7fb69dd015d73c	273	1		pre	-1								
177B		177	6	liquid	SRR11420798	PRJNA545312	4		4	2	TCD	Leukemia	0a1d271d7fb69dd015d73c	273	1		peri	0								
177C		177	13	semi-formed	SRR11420797	PRJNA545312	11		4	2	TCD	Leukemia	0a1d271d7fb69dd015d73c	273	1		post	1								
177D		177	136	semi-formed	SRR11420796	PRJNA545312	134		4	2	TCD	Leukemia	0a1d271d7fb69dd015d73c	273	1		post	6								
1781A		1781	0	semi-formed	SRR11396593	PRJNA607574			1																	
1783B		1783	2	formed	SRR11396592	PRJNA607574			2																	
1783C		1783	4	formed	SRR11396591	PRJNA607574			2																	
1784A		1784	0	formed	SRR11396590	PRJNA607574			2																	
1784B		1784	42	formed	SRR11396589	PRJNA607574			2																	
1785A		1785	0	formed	SRR9270263	PRJNA548153	-9		16	9	TCD	Leukemia	2a2d4355bd23ea1a241fae		0		pre	-2								
1785B		1785	1	formed	SRR9270262	PRJNA548153	-8		16	9	TCD	Leukemia	2a2d4355bd23ea1a241fae		0		pre	-2								
1785C		1785	2	formed	SRR9270261	PRJNA548153	-7		16	9	TCD	Leukemia	2a2d4355bd23ea1a241fae		0		pre	-2								
1785D		1785	5	formed	SRR9270260	PRJNA548153	-4		16	9	TCD	Leukemia	2a2d4355bd23ea1a241fae		0		pre	-1								
1785E		1785	7	formed	SRR9270255	PRJNA548153	-2		16	9	TCD	Leukemia	2a2d4355bd23ea1a241fae		0		pre	-1								
1785F		1785	8	liquid	SRR9270254	PRJNA548153	-1		16	9	TCD	Leukemia	2a2d4355bd23ea1a241fae		0		pre	-1								
1785G		1785	9	liquid	SRR9270257	PRJNA548153	0		16	9	TCD	Leukemia	2a2d4355bd23ea1a241fae		0		peri	-1								
1785H		1785	10	liquid	SRR9270256	PRJNA548153	1		16	9	TCD	Leukemia	2a2d4355bd23ea1a241fae		0		peri	0								
1785I		1785	13	liquid	SRR9270221	PRJNA548153	4		16	9	TCD	Leukemia	2a2d4355bd23ea1a241fae		0		peri	0								
1785J		1785	14	liquid	SRR9270218	PRJNA548153	5		16	9	TCD	Leukemia	2a2d4355bd23ea1a241fae		0		peri	0								
1785K		1785	15	liquid	SRR9270250	PRJNA548153	6		16	9	TCD	Leukemia	2a2d4355bd23ea1a241fae		0		post	0								
1785L		1785	16	liquid	SRR9270251	PRJNA548153	7		16	9	TCD	Leukemia	2a2d4355bd23ea1a241fae		0		post	0								
1785M		1785	19	semi-formed	SRR9270252	PRJNA548153	10		16	9	TCD	Leukemia	2a2d4355bd23ea1a241fae		0		post	1								
1785N		1785	21	semi-formed	SRR9270253	PRJNA548153	12		16	9	TCD	Leukemia	2a2d4355bd23ea1a241fae		0		post	1								
1785O		1785	22	semi-formed	SRR11115579	PRJNA607574	13		16	9	TCD	Leukemia	2a2d4355bd23ea1a241fae		0		post	1								
1785P		1785	23	semi-formed	SRR11115577	PRJNA607574	14		16	9	TCD	Leukemia	2a2d4355bd23ea1a241fae		0		post	1								
1786A		1786	0	formed	SRR9270234	PRJNA548153	-9		8	9	TCD	Myelodysplastic Syndromes	631ae9c4bd16d555cfe7da		0		pre	-2								
1786B		1786	8	semi-formed	SRR9270235	PRJNA548153	-1		8	9	TCD	Myelodysplastic Syndromes	631ae9c4bd16d555cfe7da		0		pre	-1								
1786C		1786	9	liquid	SRR9270240	PRJNA548153	0		8	9	TCD	Myelodysplastic Syndromes	631ae9c4bd16d555cfe7da		0		peri	-1								
1786D		1786	10	liquid	SRR9270241	PRJNA548153	1		8	9	TCD	Myelodysplastic Syndromes	631ae9c4bd16d555cfe7da		0		peri	0								
1786F		1786	16	liquid	SRR9270286	PRJNA548153	7		8	9	TCD	Myelodysplastic Syndromes	631ae9c4bd16d555cfe7da		0		post	0								
1786G		1786	20	liquid	SRR11115575	PRJNA607574	11		8	9	TCD	Myelodysplastic Syndromes	631ae9c4bd16d555cfe7da		0		post	1								
1786H		1786	22	formed	SRR11115574	PRJNA607574	13		8	9	TCD	Myelodysplastic Syndromes	631ae9c4bd16d555cfe7da		0		post	1								
1786I		1786	38	formed	SRR11115573	PRJNA607574	29		8	9	TCD	Myelodysplastic Syndromes	631ae9c4bd16d555cfe7da		0		post	4								
1787A		1787	0	formed	SRR11396587	PRJNA607574			1																	
1789A		1789	0	formed	SRR9270246	PRJNA548153	-6		16	6	PBSC_unmodified	Leukemia	8531a283bc1d7346ad4ba1		0		pre	-1								
1789B		1789	3	semi-formed	SRR9270247	PRJNA548153	-3		16	6	PBSC_unmodified	Leukemia	8531a283bc1d7346ad4ba1		0		pre	-1								
1789C		1789	4	semi-formed	SRR9270248	PRJNA548153	-2		16	6	PBSC_unmodified	Leukemia	8531a283bc1d7346ad4ba1		0		pre	-1								
1789D		1789	5	semi-formed	SRR9270249	PRJNA548153	-1		16	6	PBSC_unmodified	Leukemia	8531a283bc1d7346ad4ba1		0		pre	-1								
1789E		1789	13	formed	SRR9270258	PRJNA548153	7		16	6	PBSC_unmodified	Leukemia	8531a283bc1d7346ad4ba1		0		post	0								
1789F		1789	14	liquid	SRR9270259	PRJNA548153	8		16	6	PBSC_unmodified	Leukemia	8531a283bc1d7346ad4ba1		0		post	1								
1789G		1789	17	semi-formed	SRR9270298	PRJNA548153	11		16	6	PBSC_unmodified	Leukemia	8531a283bc1d7346ad4ba1		0		post	1								
1789H		1789	19	formed	SRR9270297	PRJNA548153	13		16	6	PBSC_unmodified	Leukemia	8531a283bc1d7346ad4ba1		0		post	1								
1789I		1789	20	formed	SRR9270296	PRJNA548153	14		16	6	PBSC_unmodified	Leukemia	8531a283bc1d7346ad4ba1		0		post	1								
1789J		1789	21	semi-formed	SRR9270295	PRJNA548153	15		16	6	PBSC_unmodified	Leukemia	8531a283bc1d7346ad4ba1		0		post	2								
1789K		1789	22	semi-formed	SRR9270302	PRJNA548153	16		16	6	PBSC_unmodified	Leukemia	8531a283bc1d7346ad4ba1		0		post	2								
1789L		1789	24	formed	SRR11115284	PRJNA607574	18		16	6	PBSC_unmodified	Leukemia	8531a283bc1d7346ad4ba1		0		post	2								
1789M		1789	25	formed	SRR11115283	PRJNA607574	19		16	6	PBSC_unmodified	Leukemia	8531a283bc1d7346ad4ba1		0		post	2								
1789N		1789	26	semi-formed	SRR11115282	PRJNA607574	20		16	6	PBSC_unmodified	Leukemia	8531a283bc1d7346ad4ba1		0		post	2								
1789O		1789	32	formed	SRR11115281	PRJNA607574	26		16	6	PBSC_unmodified	Leukemia	8531a283bc1d7346ad4ba1		0		post	3								
1789P		1789	53	semi-formed	SRR11115280	PRJNA607574	47		16	6	PBSC_unmodified	Leukemia	8531a283bc1d7346ad4ba1		0		post	6								
178A		178	0	semi-formed	SRR11420795	PRJNA545312	-9		12	9	TCD	Myeloproliferative Disorder	567c452deb2a2fd64dbf06	239	1		pre	-2								
178B		178	6	semi-formed	SRR11420794	PRJNA545312	-3		12	9	TCD	Myeloproliferative Disorder	567c452deb2a2fd64dbf06	239	1		pre	-1								
178C		178	13	liquid	SRR11420793	PRJNA545312	4		12	9	TCD	Myeloproliferative Disorder	567c452deb2a2fd64dbf06	239	1		peri	0								
178D		178	20	liquid	SRR11420792	PRJNA545312	11		12	9	TCD	Myeloproliferative Disorder	567c452deb2a2fd64dbf06	239	1		post	1								
178E		178	27	semi-formed	SRR11420791	PRJNA545312	18		12	9	TCD	Myeloproliferative Disorder	567c452deb2a2fd64dbf06	239	1		post	2								
178F		178	30	liquid	SRR11420790	PRJNA545312	21		12	9	TCD	Myeloproliferative Disorder	567c452deb2a2fd64dbf06	239	1		post	2								
178G		178	34	formed	SRR11420788	PRJNA545312	25		12	9	TCD	Myeloproliferative Disorder	567c452deb2a2fd64dbf06	239	1		post	3								
178H		178	52	liquid	SRR11420787	PRJNA545312	43		12	9	TCD	Myeloproliferative Disorder	567c452deb2a2fd64dbf06	239	1		post	6								
178I		178	54	semi-formed	SRR11420786	PRJNA545312	45		12	9	TCD	Myeloproliferative Disorder	567c452deb2a2fd64dbf06	239	1		post	6								
178J		178	62	semi-formed	SRR11420785	PRJNA545312	53		12	9	TCD	Myeloproliferative Disorder	567c452deb2a2fd64dbf06	239	1		post	6								
178L		178	76	formed	SRR11420784	PRJNA545312	67		12	9	TCD	Myeloproliferative Disorder	567c452deb2a2fd64dbf06	239	1		post	6								
178M		178	84	formed	SRR11420783	PRJNA545312	75		12	9	TCD	Myeloproliferative Disorder	567c452deb2a2fd64dbf06	239	1		post	6								
1791A		1791	0	liquid	SRR11115278	PRJNA607574	11		6	-11	PBSC_unmodified	Non-Hodgkin's Lymphoma	b15ff567c31a7e367b96b2		0		post	1								
1791B		1791	2	semi-formed	SRR11115277	PRJNA607574	13		6	-11	PBSC_unmodified	Non-Hodgkin's Lymphoma	b15ff567c31a7e367b96b2		0		post	1								
1791C		1791	3	semi-formed	SRR11115276	PRJNA607574	14		6	-11	PBSC_unmodified	Non-Hodgkin's Lymphoma	b15ff567c31a7e367b96b2		0		post	1								
1791D		1791	4	semi-formed	SRR11115275	PRJNA607574	15		6	-11	PBSC_unmodified	Non-Hodgkin's Lymphoma	b15ff567c31a7e367b96b2		0		post	2								
1791E		1791	9	formed	SRR11115274	PRJNA607574	20		6	-11	PBSC_unmodified	Non-Hodgkin's Lymphoma	b15ff567c31a7e367b96b2		0		post	2								
1791F		1791	14	liquid	SRR11115273	PRJNA607574	25		6	-11	PBSC_unmodified	Non-Hodgkin's Lymphoma	b15ff567c31a7e367b96b2		0		post	3								
1794A		1794	0	semi-formed	SRR11396586	PRJNA607574			2																	
1794B		1794	9	liquid	SRR11396585	PRJNA607574			2																	
1795A		1795	0	semi-formed	SRR11396584	PRJNA607574			5																	
1795B		1795	191	semi-formed	SRR11396583	PRJNA607574			5																	
1795C		1795	204	semi-formed	SRR11396582	PRJNA607574			5																	
1795D		1795	239	semi-formed	SRR11396581	PRJNA607574			5																	
1795E		1795	324	semi-formed	SRR11396580	PRJNA607574			5																	
1796A		1796	0	formed	SRR9270285	PRJNA548153	-1		8	1	PBSC_unmodified	Hodgkin's Disease	6ce58ec714f262501dd310		0		pre	-1								
1796B		1796	1	formed	SRR9270288	PRJNA548153	0		8	1	PBSC_unmodified	Hodgkin's Disease	6ce58ec714f262501dd310		0		peri	-1								
1796C		1796	5	formed	SRR9270287	PRJNA548153	4		8	1	PBSC_unmodified	Hodgkin's Disease	6ce58ec714f262501dd310		0		peri	0								
1796D		1796	11	formed	SRR9270290	PRJNA548153	10		8	1	PBSC_unmodified	Hodgkin's Disease	6ce58ec714f262501dd310		0		post	1								
1796E		1796	12	formed	SRR9270289	PRJNA548153	11		8	1	PBSC_unmodified	Hodgkin's Disease	6ce58ec714f262501dd310		0		post	1								
1796F		1796	13	formed	SRR9270292	PRJNA548153	12		8	1	PBSC_unmodified	Hodgkin's Disease	6ce58ec714f262501dd310		0		post	1								
1796H		1796	67	semi-formed	SRR11115272	PRJNA607574	66		8	1	PBSC_unmodified	Hodgkin's Disease	6ce58ec714f262501dd310		0		post	6								
1796I		1796	98	formed	SRR11115271	PRJNA607574	97		8	1	PBSC_unmodified	Hodgkin's Disease	6ce58ec714f262501dd310		0		post	6								
1797A		1797	0	semi-formed	SRR11396579	PRJNA607574			1																	
1798A		1798	0	liquid	SRR9270291	PRJNA548153	-1		12	1	TCD	Leukemia	1425d6d6fc858b790ea9d0		0		pre	-1								
1798C		1798	5	liquid	SRR9270294	PRJNA548153	4		12	1	TCD	Leukemia	1425d6d6fc858b790ea9d0		0		peri	0								
1798D		1798	6	liquid	SRR9270293	PRJNA548153	5		12	1	TCD	Leukemia	1425d6d6fc858b790ea9d0		0		peri	0								
1798E		1798	7	liquid	SRR9270270	PRJNA548153	6		12	1	TCD	Leukemia	1425d6d6fc858b790ea9d0		0		post	0								
1798F		1798	10	liquid	SRR9270271	PRJNA548153	9		12	1	TCD	Leukemia	1425d6d6fc858b790ea9d0		0		post	1								
1798I		1798	14	semi-formed	SRR11115270	PRJNA607574	13		12	1	TCD	Leukemia	1425d6d6fc858b790ea9d0		0		post	1								
1798J		1798	18	semi-formed	SRR11115269	PRJNA607574	17		12	1	TCD	Leukemia	1425d6d6fc858b790ea9d0		0		post	2								
1798K		1798	24	semi-formed	SRR11115267	PRJNA607574	23		12	1	TCD	Leukemia	1425d6d6fc858b790ea9d0		0		post	3								
1798L		1798	25	formed	SRR11115266	PRJNA607574	24		12	1	TCD	Leukemia	1425d6d6fc858b790ea9d0		0		post	3								
1798M		1798	27	liquid	SRR11115265	PRJNA607574	26		12	1	TCD	Leukemia	1425d6d6fc858b790ea9d0		0		post	3								
1798N		1798	31	semi-formed	SRR11115264	PRJNA607574	30		12	1	TCD	Leukemia	1425d6d6fc858b790ea9d0		0		post	4								
1798Q		1798	34	liquid	SRR11115263	PRJNA607574	33		12	1	TCD	Leukemia	1425d6d6fc858b790ea9d0		0		post	4								
1799A		1799	0	semi-formed	SRR11396578	PRJNA607574			3																	
1799B		1799	140	semi-formed	SRR11396576	PRJNA607574			3																	
1799C		1799	231	semi-formed	SRR11396575	PRJNA607574			3																	
179A		179	0	formed	SRR11420782	PRJNA545312			14																	
179B		179	4	formed	SRR11420781	PRJNA545312			14																	
179C		179	12	formed	SRR11420780	PRJNA545312			14																	
179D		179	18	formed	SRR11420779	PRJNA545312			14																	
179E		179	25	formed	SRR11420777	PRJNA545312			14																	
179F		179	28	formed	SRR11420776	PRJNA545312			14																	
179H		179	39	semi-formed	SRR11420775	PRJNA545312			14																	
179I		179	48	semi-formed	SRR11420774	PRJNA545312			14																	
179J		179	1048	formed	SRR11420773	PRJNA545312			14																	
179K		179	1065	formed	SRR11420772	PRJNA545312			14																	
179L		179	1069	semi-formed	SRR11420771	PRJNA545312			14																	
179M		179	1083	semi-formed	SRR11420770	PRJNA545312			14																	
179N		179	1096	semi-formed	SRR11420769	PRJNA545312			14																	
179O		179	1114	semi-formed	SRR11420768	PRJNA545312			14																	
1801A		1801	0	liquid	SRR11115262	PRJNA607574	3		5	-3	TCD	Myelodysplastic Syndromes	95d2e8f5fcac7f4592290c		0		peri	0								
1801B		1801	7	semi-formed	SRR11115261	PRJNA607574	10		5	-3	TCD	Myelodysplastic Syndromes	95d2e8f5fcac7f4592290c		0		post	1								
1801C		1801	9	liquid	SRR11115260	PRJNA607574	12		5	-3	TCD	Myelodysplastic Syndromes	95d2e8f5fcac7f4592290c		0		post	1								
1801D		1801	21	formed	SRR11115259	PRJNA607574	24		5	-3	TCD	Myelodysplastic Syndromes	95d2e8f5fcac7f4592290c		0		post	3								
1801E		1801	22	formed	SRR11115258	PRJNA607574	25		5	-3	TCD	Myelodysplastic Syndromes	95d2e8f5fcac7f4592290c		0		post	3								
1802A		1802	0	formed	SRR9270272	PRJNA548153	-3		15	3	cord	Leukemia	ab5ebf7b09bc8dce9cd0c9		0		pre	-1								
1802B		1802	1	formed	SRR9270273	PRJNA548153	-2		15	3	cord	Leukemia	ab5ebf7b09bc8dce9cd0c9		0		pre	-1								
1802C		1802	7	semi-formed	SRR9270266	PRJNA548153	4		15	3	cord	Leukemia	ab5ebf7b09bc8dce9cd0c9		0		peri	0								
1802D		1802	13	formed	SRR9270267	PRJNA548153	10		15	3	cord	Leukemia	ab5ebf7b09bc8dce9cd0c9		0		post	1								
1802E		1802	15	semi-formed	SRR9270268	PRJNA548153	12		15	3	cord	Leukemia	ab5ebf7b09bc8dce9cd0c9		0		post	1								
1802F		1802	16	liquid	SRR9270269	PRJNA548153	13		15	3	cord	Leukemia	ab5ebf7b09bc8dce9cd0c9		0		post	1								
1802G		1802	17	liquid	SRR9270264	PRJNA548153	14		15	3	cord	Leukemia	ab5ebf7b09bc8dce9cd0c9		0		post	1								
1802H		1802	19	liquid	SRR9270265	PRJNA548153	16		15	3	cord	Leukemia	ab5ebf7b09bc8dce9cd0c9		0		post	2								
1802I		1802	20	formed	SRR9270322	PRJNA548153	17		15	3	cord	Leukemia	ab5ebf7b09bc8dce9cd0c9		0		post	2								
1802J		1802	23	formed	SRR9270321	PRJNA548153	20		15	3	cord	Leukemia	ab5ebf7b09bc8dce9cd0c9		0		post	2								
1802K		1802	28	semi-formed	SRR11115256	PRJNA607574	25		15	3	cord	Leukemia	ab5ebf7b09bc8dce9cd0c9		0		post	3								
1802M		1802	29	semi-formed	SRR11115255	PRJNA607574	26		15	3	cord	Leukemia	ab5ebf7b09bc8dce9cd0c9		0		post	3								
1802N		1802	30	semi-formed	SRR11115254	PRJNA607574	27		15	3	cord	Leukemia	ab5ebf7b09bc8dce9cd0c9		0		post	3								
1802O		1802	33	formed	SRR11115253	PRJNA607574	30		15	3	cord	Leukemia	ab5ebf7b09bc8dce9cd0c9		0		post	4								
1802P		1802	34	semi-formed	SRR11115252	PRJNA607574	31		15	3	cord	Leukemia	ab5ebf7b09bc8dce9cd0c9		0		post	4								
1804A		1804	0	semi-formed	SRR11396574	PRJNA607574			3																	
1804B		1804	12	liquid	SRR11396573	PRJNA607574			3																	
1804C		1804	19	liquid	SRR11396572	PRJNA607574			3																	
1805C		1805	161	semi-formed	SRR11115251	PRJNA607574	-119		6	280	PBSC_unmodified		4dfdaa0a816f832cd4681f		0		pre	-3								
1805D		1805	278	formed	SRR11115250	PRJNA607574	-2		6	280	PBSC_unmodified		4dfdaa0a816f832cd4681f		0		pre	-1								
1805E		1805	279	formed	SRR11115249	PRJNA607574	-1		6	280	PBSC_unmodified		4dfdaa0a816f832cd4681f		0		pre	-1								
1805F		1805	280	formed	SRR11115248	PRJNA607574	0		6	280	PBSC_unmodified		4dfdaa0a816f832cd4681f		0		peri	-1								
1805G		1805	285	formed	SRR11115247	PRJNA607574	5		6	280	PBSC_unmodified		4dfdaa0a816f832cd4681f		0		peri	0								
1805H		1805	292	semi-formed	SRR11115245	PRJNA607574	12		6	280	PBSC_unmodified		4dfdaa0a816f832cd4681f		0		post	1								
1806A		1806	0	semi-formed	SRR9270320	PRJNA548153	-8		5	8	TCD	Myeloproliferative Disorder	34a9722ff1669911b0c117		0		pre	-2								
1806B		1806	3	liquid	SRR9270319	PRJNA548153	-5		5	8	TCD	Myeloproliferative Disorder	34a9722ff1669911b0c117		0		pre	-1								
1806C		1806	6	semi-formed	SRR9270326	PRJNA548153	-2		5	8	TCD	Myeloproliferative Disorder	34a9722ff1669911b0c117		0		pre	-1								
1806D		1806	7	liquid	SRR9270325	PRJNA548153	-1		5	8	TCD	Myeloproliferative Disorder	34a9722ff1669911b0c117		0		pre	-1								
1806E		1806	12	liquid	SRR9270324	PRJNA548153	4		5	8	TCD	Myeloproliferative Disorder	34a9722ff1669911b0c117		0		peri	0								
1809A		1809	0	liquid	SRR9270323	PRJNA548153	-3		12	3	TCD	Non-Malignant Hemat Disorders	e8fd4faf423ddcc9cd836f		0		pre	-1								
1809B		1809	1	liquid	SRR9270314	PRJNA548153	-2		12	3	TCD	Non-Malignant Hemat Disorders	e8fd4faf423ddcc9cd836f		0		pre	-1								
1809C		1809	2	liquid	SRR9270313	PRJNA548153	-1		12	3	TCD	Non-Malignant Hemat Disorders	e8fd4faf423ddcc9cd836f		0		pre	-1								
1809D		1809	5	liquid	SRR9270337	PRJNA548153	2		12	3	TCD	Non-Malignant Hemat Disorders	e8fd4faf423ddcc9cd836f		0		peri	0								
1809E		1809	6	liquid	SRR9270336	PRJNA548153	3		12	3	TCD	Non-Malignant Hemat Disorders	e8fd4faf423ddcc9cd836f		0		peri	0								
1809F		1809	9	liquid	SRR9270335	PRJNA548153	6		12	3	TCD	Non-Malignant Hemat Disorders	e8fd4faf423ddcc9cd836f		0		post	0								
1809G		1809	10	liquid	SRR9270334	PRJNA548153	7		12	3	TCD	Non-Malignant Hemat Disorders	e8fd4faf423ddcc9cd836f		0		post	0								
1809I		1809	12	liquid	SRR9270386	PRJNA548153	9		12	3	TCD	Non-Malignant Hemat Disorders	e8fd4faf423ddcc9cd836f		0		post	1								
1809K		1809	16	liquid	SRR11115244	PRJNA607574	13		12	3	TCD	Non-Malignant Hemat Disorders	e8fd4faf423ddcc9cd836f		0		post	1								
1809L		1809	19	semi-formed	SRR11115243	PRJNA607574	16		12	3	TCD	Non-Malignant Hemat Disorders	e8fd4faf423ddcc9cd836f		0		post	2								
1809M		1809	21	semi-formed	SRR11115242	PRJNA607574	18		12	3	TCD	Non-Malignant Hemat Disorders	e8fd4faf423ddcc9cd836f		0		post	2								
1809N		1809	24	semi-formed	SRR11115241	PRJNA607574	21		12	3	TCD	Non-Malignant Hemat Disorders	e8fd4faf423ddcc9cd836f		0		post	2								
180A		180	0	formed	SRR11420766	PRJNA545312	-6		3	6	PBSC_unmodified	Leukemia	e4d2e4847b371b021fdebd	226	1		pre	-1								
180B		180	4	liquid	SRR11420765	PRJNA545312	-2		3	6	PBSC_unmodified	Leukemia	e4d2e4847b371b021fdebd	226	1		pre	-1								
180C		180	12	liquid	SRR11420764	PRJNA545312	6		3	6	PBSC_unmodified	Leukemia	e4d2e4847b371b021fdebd	226	1		post	0								
1810A		1810	0	liquid	SRR11115240	PRJNA607574	-2		3	2	cord	Leukemia	d03f6c09c69e5cbfd49f43		0		pre	-1								
1810B		1810	6	liquid	SRR11115239	PRJNA607574	4		3	2	cord	Leukemia	d03f6c09c69e5cbfd49f43		0		peri	0								
1810C		1810	14	semi-formed	SRR11115238	PRJNA607574	12		3	2	cord	Leukemia	d03f6c09c69e5cbfd49f43		0		post	1								
1812A		1812	0	liquid	SRR11396571	PRJNA607574			4																	
1812B		1812	35	semi-formed	SRR11396570	PRJNA607574			4																	
1812C		1812	39	semi-formed	SRR11396569	PRJNA607574			4																	
1812D		1812	56	semi-formed	SRR11396568	PRJNA607574			4																	
1814A		1814	0	formed	SRR9270333	PRJNA548153	-2		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		pre	-1								
1814B		1814	1	formed	SRR9270332	PRJNA548153	-1		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		pre	-1								
1814C		1814	2	formed	SRR9270331	PRJNA548153	0		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		peri	-1								
1814D		1814	3	semi-formed	SRR9270330	PRJNA548153	1		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		peri	0								
1814E		1814	4	semi-formed	SRR9270329	PRJNA548153	2		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		peri	0								
1814G		1814	6	liquid	SRR9270378	PRJNA548153	4		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		peri	0								
1814L		1814	14	liquid	SRR9270377	PRJNA548153	12		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		post	1								
1814M		1814	17	liquid	SRR9270351	PRJNA548153	15		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		post	2								
1814N		1814	21	semi-formed	SRR9270352	PRJNA548153	19		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		post	2								
1814O		1814	23	semi-formed	SRR9270349	PRJNA548153	21		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		post	2								
1814P		1814	28	semi-formed	SRR11115237	PRJNA607574	26		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		post	3								
1814R		1814	35	semi-formed	SRR11115236	PRJNA607574	33		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		post	4								
1814S		1814	38	semi-formed	SRR11115234	PRJNA607574	36		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		post	5								
1814T		1814	42	semi-formed	SRR11115233	PRJNA607574	40		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		post	5								
1814U		1814	45	semi-formed	SRR11115232	PRJNA607574	43		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		post	6								
1814V		1814	49	semi-formed	SRR11115231	PRJNA607574	47		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		post	6								
1814W		1814	52	liquid	SRR11115230	PRJNA607574	50		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		post	6								
1814X		1814	53	semi-formed	SRR11115229	PRJNA607574	51		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		post	6								
1814Y		1814	56	semi-formed	SRR11115228	PRJNA607574	54		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		post	6								
1814Z		1814	57	semi-formed	SRR11115227	PRJNA607574	55		20	2	PBSC_unmodified	Leukemia	d58cf35125159af640abc6		0		post	6								
1815A		1815	0	formed	SRR11139948	PRJNA606262			3																	
1815B		1815	2	formed	SRR11139947	PRJNA606262			3																	
1815C		1815	6	liquid	SRR11139946	PRJNA606262			3																	
1816A		1816	0	liquid	SRR11115226	PRJNA607574	6		17	-6	PBSC_unmodified	Leukemia	ca9512587998e63dcd50b2		0		post	0								
1816B		1816	1	semi-formed	SRR11115225	PRJNA607574	7		17	-6	PBSC_unmodified	Leukemia	ca9512587998e63dcd50b2		0		post	0								
1816C		1816	2	liquid	SRR11115223	PRJNA607574	8		17	-6	PBSC_unmodified	Leukemia	ca9512587998e63dcd50b2		0		post	1								
1816D		1816	3	liquid	SRR11115222	PRJNA607574	9		17	-6	PBSC_unmodified	Leukemia	ca9512587998e63dcd50b2		0		post	1								
1816E		1816	5	liquid	SRR11115221	PRJNA607574	11		17	-6	PBSC_unmodified	Leukemia	ca9512587998e63dcd50b2		0		post	1								
1816F		1816	6	liquid	SRR11115220	PRJNA607574	12		17	-6	PBSC_unmodified	Leukemia	ca9512587998e63dcd50b2		0		post	1								
1816G		1816	19	liquid	SRR11115219	PRJNA607574	25		17	-6	PBSC_unmodified	Leukemia	ca9512587998e63dcd50b2		0		post	3								
1816H		1816	20	liquid	SRR11115218	PRJNA607574	26		17	-6	PBSC_unmodified	Leukemia	ca9512587998e63dcd50b2		0		post	3								
1816I		1816	21	liquid	SRR11115217	PRJNA607574	27		17	-6	PBSC_unmodified	Leukemia	ca9512587998e63dcd50b2		0		post	3								
1816J		1816	22	liquid	SRR11115216	PRJNA607574	28		17	-6	PBSC_unmodified	Leukemia	ca9512587998e63dcd50b2		0		post	3								
1816K		1816	28	semi-formed	SRR11115215	PRJNA607574	34		17	-6	PBSC_unmodified	Leukemia	ca9512587998e63dcd50b2		0		post	4								
1816L		1816	29	liquid	SRR11115214	PRJNA607574	35		17	-6	PBSC_unmodified	Leukemia	ca9512587998e63dcd50b2		0		post	4								
1816M		1816	33	liquid	SRR11115212	PRJNA607574	39		17	-6	PBSC_unmodified	Leukemia	ca9512587998e63dcd50b2		0		post	5								
1816N		1816	35	semi-formed	SRR11115211	PRJNA607574	41		17	-6	PBSC_unmodified	Leukemia	ca9512587998e63dcd50b2		0		post	5								
1816O		1816	37	semi-formed	SRR11115210	PRJNA607574	43		17	-6	PBSC_unmodified	Leukemia	ca9512587998e63dcd50b2		0		post	6								
1816P		1816	42	liquid	SRR11115209	PRJNA607574	48		17	-6	PBSC_unmodified	Leukemia	ca9512587998e63dcd50b2		0		post	6								
1816Q		1816	69	semi-formed	SRR11115208	PRJNA607574	75		17	-6	PBSC_unmodified	Leukemia	ca9512587998e63dcd50b2		0		post	6								
1817A		1817	0	semi-formed	SRR11396563	PRJNA607574			2																	
1817B		1817	22	semi-formed	SRR11396562	PRJNA607574			2																	
1818A		1818	0	formed	SRR9270350	PRJNA548153	-10		11	10	TCD	Myeloproliferative Disorder	9a1cff6e08efea74050396		0		pre	-2								
1818B		1818	1	formed	SRR9270355	PRJNA548153	-9		11	10	TCD	Myeloproliferative Disorder	9a1cff6e08efea74050396		0		pre	-2								
1818D		1818	6	liquid	SRR9270356	PRJNA548153	-4		11	10	TCD	Myeloproliferative Disorder	9a1cff6e08efea74050396		0		pre	-1								
1818E		1818	9	formed	SRR9270353	PRJNA548153	-1		11	10	TCD	Myeloproliferative Disorder	9a1cff6e08efea74050396		0		pre	-1								
1818F		1818	12	liquid	SRR9270354	PRJNA548153	2		11	10	TCD	Myeloproliferative Disorder	9a1cff6e08efea74050396		0		peri	0								
1818G		1818	13	semi-formed	SRR9270348	PRJNA548153	3		11	10	TCD	Myeloproliferative Disorder	9a1cff6e08efea74050396		0		peri	0								
1818H		1818	14	semi-formed	SRR11115207	PRJNA607574	4		11	10	TCD	Myeloproliferative Disorder	9a1cff6e08efea74050396		0		peri	0								
1818N		1818	26	semi-formed	SRR11115206	PRJNA607574	16		11	10	TCD	Myeloproliferative Disorder	9a1cff6e08efea74050396		0		post	2								
1818O		1818	27	semi-formed	SRR11115205	PRJNA607574	17		11	10	TCD	Myeloproliferative Disorder	9a1cff6e08efea74050396		0		post	2								
1818P		1818	28	semi-formed	SRR11115204	PRJNA607574	18		11	10	TCD	Myeloproliferative Disorder	9a1cff6e08efea74050396		0		post	2								
1818Q		1818	29	formed	SRR11115203	PRJNA607574	19		11	10	TCD	Myeloproliferative Disorder	9a1cff6e08efea74050396		0		post	2								
1819A		1819	0	formed	SRR11140018	PRJNA606262			5																	
1819B		1819	5	formed	SRR11140017	PRJNA606262			5																	
1819C		1819	12	semi-formed	SRR11140016	PRJNA606262			5																	
1819D		1819	14	liquid	SRR11140015	PRJNA606262			5																	
1819E		1819	18	formed	SRR11140013	PRJNA606262			5																	
181A		181	0	semi-formed	SRR11396556	PRJNA607574			1																	
1822A		1822	0	formed	SRR9270541	PRJNA548153	-8		5	8	TCD	Leukemia	2261097008502f700ef4b3		0		pre	-2								
1822B		1822	4	formed	SRR9270542	PRJNA548153	-4		5	8	TCD	Leukemia	2261097008502f700ef4b3		0		pre	-1								
1822C		1822	11	semi-formed	SRR9270543	PRJNA548153	3		5	8	TCD	Leukemia	2261097008502f700ef4b3		0		peri	0								
1822D		1822	18	formed	SRR9270544	PRJNA548153	10		5	8	TCD	Leukemia	2261097008502f700ef4b3		0		post	1								
1822E		1822	19	formed	SRR9270537	PRJNA548153	11		5	8	TCD	Leukemia	2261097008502f700ef4b3		0		post	1								
1823B		1823	1	semi-formed	SRR9270538	PRJNA548153	-1		17	2	BM_unmodified	Leukemia	a1c1eab079279fe8575c75		0		pre	-1								
1823C		1823	3	semi-formed	SRR9270539	PRJNA548153	1		17	2	BM_unmodified	Leukemia	a1c1eab079279fe8575c75		0		peri	0								
1823D		1823	4	semi-formed	SRR9270540	PRJNA548153	2		17	2	BM_unmodified	Leukemia	a1c1eab079279fe8575c75		0		peri	0								
1823E		1823	10	liquid	SRR9270545	PRJNA548153	8		17	2	BM_unmodified	Leukemia	a1c1eab079279fe8575c75		0		post	1								
1823F		1823	11	liquid	SRR9270546	PRJNA548153	9		17	2	BM_unmodified	Leukemia	a1c1eab079279fe8575c75		0		post	1								
1823G		1823	14	liquid	SRR9270463	PRJNA548153	12		17	2	BM_unmodified	Leukemia	a1c1eab079279fe8575c75		0		post	1								
1823H		1823	17	liquid	SRR9270464	PRJNA548153	15		17	2	BM_unmodified	Leukemia	a1c1eab079279fe8575c75		0		post	2								
1823J		1823	18	liquid	SRR9270427	PRJNA548153	16		17	2	BM_unmodified	Leukemia	a1c1eab079279fe8575c75		0		post	2								
1823K		1823	21	semi-formed	SRR9270428	PRJNA548153	19		17	2	BM_unmodified	Leukemia	a1c1eab079279fe8575c75		0		post	2								
1823L		1823	22	liquid	SRR9270433	PRJNA548153	20		17	2	BM_unmodified	Leukemia	a1c1eab079279fe8575c75		0		post	2								
1823M		1823	24	semi-formed	SRR9270434	PRJNA548153	22		17	2	BM_unmodified	Leukemia	a1c1eab079279fe8575c75		0		post	3								
1823N		1823	29	semi-formed	SRR11115201	PRJNA607574	27		17	2	BM_unmodified	Leukemia	a1c1eab079279fe8575c75		0		post	3								
1823O		1823	31	semi-formed	SRR11115200	PRJNA607574	29		17	2	BM_unmodified	Leukemia	a1c1eab079279fe8575c75		0		post	4								
1823P		1823	35	semi-formed	SRR11115199	PRJNA607574	33		17	2	BM_unmodified	Leukemia	a1c1eab079279fe8575c75		0		post	4								
1823Q		1823	37	semi-formed	SRR11115198	PRJNA607574	35		17	2	BM_unmodified	Leukemia	a1c1eab079279fe8575c75		0		post	4								
1823R		1823	38	semi-formed	SRR11115197	PRJNA607574	36		17	2	BM_unmodified	Leukemia	a1c1eab079279fe8575c75		0		post	5								
1823S		1823	39	semi-formed	SRR11115196	PRJNA607574	37		17	2	BM_unmodified	Leukemia	a1c1eab079279fe8575c75		0		post	5								
1824A		1824	0	formed	SRR9270465	PRJNA548153	-3		18	3	cord	Leukemia	774274268060692ae85e25		0		pre	-1								
1824B		1824	1	liquid	SRR9270466	PRJNA548153	-2		18	3	cord	Leukemia	774274268060692ae85e25		0		pre	-1								
1824C		1824	2	liquid	SRR9270467	PRJNA548153	-1		18	3	cord	Leukemia	774274268060692ae85e25		0		pre	-1								
1824D		1824	4	liquid	SRR9270468	PRJNA548153	1		18	3	cord	Leukemia	774274268060692ae85e25		0		peri	0								
1824E		1824	7	liquid	SRR9270469	PRJNA548153	4		18	3	cord	Leukemia	774274268060692ae85e25		0		peri	0								
1824G		1824	23	liquid	SRR9270532	PRJNA548153	20		18	3	cord	Leukemia	774274268060692ae85e25		0		post	2								
1824H		1824	24	liquid	SRR9270496	PRJNA548153	21		18	3	cord	Leukemia	774274268060692ae85e25		0		post	2								
1824I		1824	25	liquid	SRR9270495	PRJNA548153	22		18	3	cord	Leukemia	774274268060692ae85e25		0		post	3								
1824J		1824	36	liquid	SRR11115195	PRJNA607574	33		18	3	cord	Leukemia	774274268060692ae85e25		0		post	4								
1824K		1824	39	liquid	SRR11115194	PRJNA607574	36		18	3	cord	Leukemia	774274268060692ae85e25		0		post	5								
1824L		1824	113	semi-formed	SRR11115193	PRJNA607574	110		18	3	cord	Leukemia	774274268060692ae85e25		0		post	6								
1824M		1824	128	formed	SRR11115192	PRJNA607574	125		18	3	cord	Leukemia	774274268060692ae85e25		0		post	6								
1824N		1824	144	semi-formed	SRR11115189	PRJNA607574	141		18	3	cord	Leukemia	774274268060692ae85e25		0		post	6								
1824O		1824	177	semi-formed	SRR11115572	PRJNA607574	174		18	3	cord	Leukemia	774274268060692ae85e25		0		post	6								
1824P		1824	178	liquid	SRR11115571	PRJNA607574	175		18	3	cord	Leukemia	774274268060692ae85e25		0		post	6								
1824R		1824	192	semi-formed	SRR11115570	PRJNA607574	189		18	3	cord	Leukemia	774274268060692ae85e25		0		post	6								
1824S		1824	193	semi-formed	SRR11115569	PRJNA607574	190		18	3	cord	Leukemia	774274268060692ae85e25		0		post	6								
1824T		1824	198	semi-formed	SRR11115568	PRJNA607574	195		18	3	cord	Leukemia	774274268060692ae85e25		0		post	6								
1825A		1825	0	formed	SRR11139964	PRJNA606262			3																	
1825C		1825	10	liquid	SRR11139963	PRJNA606262			3																	
1825D		1825	46	semi-formed	SRR11139962	PRJNA606262			3																	
1826A		1826	0	semi-formed	SRR11115567	PRJNA607574	4		5	-4	PBSC_unmodified	Leukemia	58257ad367036c53641d4b		0		peri	0								
1826B		1826	5	formed	SRR11115566	PRJNA607574	9		5	-4	PBSC_unmodified	Leukemia	58257ad367036c53641d4b		0		post	1								
1826C		1826	8	formed	SRR11115565	PRJNA607574	12		5	-4	PBSC_unmodified	Leukemia	58257ad367036c53641d4b		0		post	1								
1826D		1826	43	semi-formed	SRR11115564	PRJNA607574	47		5	-4	PBSC_unmodified	Leukemia	58257ad367036c53641d4b		0		post	6								
1826E		1826	47	semi-formed	SRR11115562	PRJNA607574	51		5	-4	PBSC_unmodified	Leukemia	58257ad367036c53641d4b		0		post	6								
182A		182	0	semi-formed	SRR11420763	PRJNA545312	-4		4	4	TCD	Leukemia	732e5fab73e647b1c51bed	260	1		pre	-1								
182B		182	7	liquid	SRR11420762	PRJNA545312	3		4	4	TCD	Leukemia	732e5fab73e647b1c51bed	260	1		peri	0								
182C		182	15	semi-formed	SRR11420761	PRJNA545312	11		4	4	TCD	Leukemia	732e5fab73e647b1c51bed	260	1		post	1								
182D		182	21	semi-formed	SRR11420760	PRJNA545312	17		4	4	TCD	Leukemia	732e5fab73e647b1c51bed	260	1		post	2								
1830A		1830	0	formed	SRR11396551	PRJNA607574			4																	
1830B		1830	6	liquid	SRR11396550	PRJNA607574			4																	
1830C		1830	7	liquid	SRR11396549	PRJNA607574			4																	
1830D		1830	11	formed	SRR11396548	PRJNA607574			4																	
1833A		1833	0	formed	SRR9270470	PRJNA548153	-4		9	4	PBSC_unmodified	Leukemia	3977be0e4b70575974c904		0		pre	-1								
1833B		1833	1	semi-formed	SRR9270471	PRJNA548153	-3		9	4	PBSC_unmodified	Leukemia	3977be0e4b70575974c904		0		pre	-1								
1833C		1833	2	semi-formed	SRR9270472	PRJNA548153	-2		9	4	PBSC_unmodified	Leukemia	3977be0e4b70575974c904		0		pre	-1								
1833E		1833	8	liquid	SRR9270510	PRJNA548153	4		9	4	PBSC_unmodified	Leukemia	3977be0e4b70575974c904		0		peri	0								
1833F		1833	18	liquid	SRR9270552	PRJNA548153	14		9	4	PBSC_unmodified	Leukemia	3977be0e4b70575974c904		0		post	1								
1833G		1833	21	liquid	SRR9270555	PRJNA548153	17		9	4	PBSC_unmodified	Leukemia	3977be0e4b70575974c904		0		post	2								
1833H		1833	22	liquid	SRR9270556	PRJNA548153	18		9	4	PBSC_unmodified	Leukemia	3977be0e4b70575974c904		0		post	2								
1833I		1833	44	formed	SRR11115561	PRJNA607574	40		9	4	PBSC_unmodified	Leukemia	3977be0e4b70575974c904		0		post	5								
1833J		1833	75	semi-formed	SRR11115560	PRJNA607574	71		9	4	PBSC_unmodified	Leukemia	3977be0e4b70575974c904		0		post	6								
1835A		1835	0	formed	SRR11396547	PRJNA607574			2																	
1835B		1835	48	formed	SRR11396546	PRJNA607574			2																	
1836A		1836	0	liquid	SRR11396545	PRJNA607574			9																	
1836B		1836	1	liquid	SRR11396543	PRJNA607574			9																	
1836C		1836	2	liquid	SRR11396542	PRJNA607574			9																	
1836D		1836	4	liquid	SRR11396541	PRJNA607574			9																	
1836E		1836	5	liquid	SRR11396540	PRJNA607574			9																	
1836F		1836	8	liquid	SRR11396539	PRJNA607574			9																	
1836G		1836	12	formed	SRR11396538	PRJNA607574			9																	
1836H		1836	14	formed	SRR11396537	PRJNA607574			9																	
1836I		1836	18	semi-formed	SRR11396536	PRJNA607574			9																	
1837A		1837	0	liquid	SRR9270436	PRJNA548153	-1		9	1	TCD	Leukemia	792b72e468717285ad7eb6		0		pre	-1								
1837B		1837	4	semi-formed	SRR9270435	PRJNA548153	3		9	1	TCD	Leukemia	792b72e468717285ad7eb6		0		peri	0								
1837C		1837	7	semi-formed	SRR9270444	PRJNA548153	6		9	1	TCD	Leukemia	792b72e468717285ad7eb6		0		post	0								
1837D		1837	10	liquid	SRR9270443	PRJNA548153	9		9	1	TCD	Leukemia	792b72e468717285ad7eb6		0		post	1								
1837E		1837	11	formed	SRR9270417	PRJNA548153	10		9	1	TCD	Leukemia	792b72e468717285ad7eb6		0		post	1								
1837F		1837	12	semi-formed	SRR9270418	PRJNA548153	11		9	1	TCD	Leukemia	792b72e468717285ad7eb6		0		post	1								
1837G		1837	13	formed	SRR9270419	PRJNA548153	12		9	1	TCD	Leukemia	792b72e468717285ad7eb6		0		post	1								
1837H		1837	14	formed	SRR11115559	PRJNA607574	13		9	1	TCD	Leukemia	792b72e468717285ad7eb6		0		post	1								
1837I		1837	17	formed	SRR11115558	PRJNA607574	16		9	1	TCD	Leukemia	792b72e468717285ad7eb6		0		post	2								
1838A		1838	0	semi-formed	SRR9270509	PRJNA548153	-2		8	2	TCD	Leukemia	fb96ba7c073015acfebf81		0		pre	-1								
1838B		1838	1	semi-formed	SRR9270512	PRJNA548153	-1		8	2	TCD	Leukemia	fb96ba7c073015acfebf81		0		pre	-1								
1838C		1838	3	formed	SRR9270511	PRJNA548153	1		8	2	TCD	Leukemia	fb96ba7c073015acfebf81		0		peri	0								
1838D		1838	4	liquid	SRR9270506	PRJNA548153	2		8	2	TCD	Leukemia	fb96ba7c073015acfebf81		0		peri	0								
1838E		1838	5	semi-formed	SRR9270505	PRJNA548153	3		8	2	TCD	Leukemia	fb96ba7c073015acfebf81		0		peri	0								
1838F		1838	6	semi-formed	SRR9270508	PRJNA548153	4		8	2	TCD	Leukemia	fb96ba7c073015acfebf81		0		peri	0								
1838H		1838	12	liquid	SRR11115557	PRJNA607574	10		8	2	TCD	Leukemia	fb96ba7c073015acfebf81		0		post	1								
1838I		1838	13	liquid	SRR11115556	PRJNA607574	11		8	2	TCD	Leukemia	fb96ba7c073015acfebf81		0		post	1								
1839A		1839	0	liquid	SRR11115555	PRJNA607574	2		11	-2	PBSC_unmodified	Non-Hodgkin's Lymphoma	8dd2eb7ed61ed70f90dbc0		0		peri	0								
1839B		1839	1	formed	SRR11115554	PRJNA607574	3		11	-2	PBSC_unmodified	Non-Hodgkin's Lymphoma	8dd2eb7ed61ed70f90dbc0		0		peri	0								
1839C		1839	4	semi-formed	SRR11115553	PRJNA607574	6		11	-2	PBSC_unmodified	Non-Hodgkin's Lymphoma	8dd2eb7ed61ed70f90dbc0		0		post	0								
1839D		1839	7	semi-formed	SRR11115551	PRJNA607574	9		11	-2	PBSC_unmodified	Non-Hodgkin's Lymphoma	8dd2eb7ed61ed70f90dbc0		0		post	1								
1839E		1839	9	semi-formed	SRR11115550	PRJNA607574	11		11	-2	PBSC_unmodified	Non-Hodgkin's Lymphoma	8dd2eb7ed61ed70f90dbc0		0		post	1								
1839F		1839	10	semi-formed	SRR11115549	PRJNA607574	12		11	-2	PBSC_unmodified	Non-Hodgkin's Lymphoma	8dd2eb7ed61ed70f90dbc0		0		post	1								
1839G		1839	14	formed	SRR11115548	PRJNA607574	16		11	-2	PBSC_unmodified	Non-Hodgkin's Lymphoma	8dd2eb7ed61ed70f90dbc0		0		post	2								
1839H		1839	15	semi-formed	SRR11115547	PRJNA607574	17		11	-2	PBSC_unmodified	Non-Hodgkin's Lymphoma	8dd2eb7ed61ed70f90dbc0		0		post	2								
1839I		1839	17	formed	SRR11115546	PRJNA607574	19		11	-2	PBSC_unmodified	Non-Hodgkin's Lymphoma	8dd2eb7ed61ed70f90dbc0		0		post	2								
1839J		1839	18	formed	SRR11115545	PRJNA607574	20		11	-2	PBSC_unmodified	Non-Hodgkin's Lymphoma	8dd2eb7ed61ed70f90dbc0		0		post	2								
1839K		1839	52	liquid	SRR11115544	PRJNA607574	54		11	-2	PBSC_unmodified	Non-Hodgkin's Lymphoma	8dd2eb7ed61ed70f90dbc0		0		post	6								
183A		183	0	formed	SRR11420759	PRJNA545312	-9		3	9	TCD	Leukemia	f2adc900101e032635a08c	287	1		pre	-2								
183B		183	6	liquid	SRR11420758	PRJNA545312	-3		3	9	TCD	Leukemia	f2adc900101e032635a08c	287	1		pre	-1								
183E		183	28	formed	SRR11420757	PRJNA545312	19		3	9	TCD	Leukemia	f2adc900101e032635a08c	287	1		post	2								
1840A		1840	0	formed	SRR11396535	PRJNA607574			2																	
1840C		1840	8	liquid	SRR11396534	PRJNA607574			2																	
1841A		1841	0	formed	SRR11396532	PRJNA607574			5																	
1841B		1841	6	liquid	SRR11396531	PRJNA607574			5																	
1841C		1841	8	liquid	SRR11396530	PRJNA607574			5																	
1841E		1841	52	formed	SRR11396529	PRJNA607574			5																	
1841F		1841	158	formed	SRR11396528	PRJNA607574			5																	
1842A		1842	0	semi-formed	SRR9270507	PRJNA548153	-7		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		pre	-2								
1842AA		1842	57	formed	SRR11115543	PRJNA607574	50		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	6								
1842B		1842	4	semi-formed	SRR9270504	PRJNA548153	-3		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		pre	-1								
1842BB		1842	81	liquid	SRR11115542	PRJNA607574	74		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	6								
1842C		1842	5	semi-formed	SRR9270503	PRJNA548153	-2		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		pre	-1								
1842CC		1842	82	liquid	SRR11115188	PRJNA607574	75		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	6								
1842D		1842	6	formed	SRR9270521	PRJNA548153	-1		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		pre	-1								
1842DD		1842	90	liquid	SRR11115187	PRJNA607574	83		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	6								
1842E		1842	7	formed	SRR9270522	PRJNA548153	0		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		peri	-1								
1842EE		1842	91	liquid	SRR11115186	PRJNA607574	84		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	6								
1842F		1842	11	semi-formed	SRR9270519	PRJNA548153	4		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		peri	0								
1842G		1842	14	semi-formed	SRR9270520	PRJNA548153	7		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	0								
1842GG		1842	92	liquid	SRR11115185	PRJNA607574	85		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	6								
1842H		1842	20	liquid	SRR9270517	PRJNA548153	13		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	1								
1842HH		1842	96	liquid	SRR11115184	PRJNA607574	89		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	6								
1842I		1842	21	liquid	SRR9270518	PRJNA548153	14		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	1								
1842II		1842	97	liquid	SRR11115183	PRJNA607574	90		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	6								
1842JJ		1842	98	liquid	SRR11115182	PRJNA607574	91		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	6								
1842KK		1842	103	liquid	SRR11115181	PRJNA607574	96		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	6								
1842LL		1842	104	liquid	SRR11115180	PRJNA607574	97		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	6								
1842MM		1842	105	liquid	SRR11115179	PRJNA607574	98		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	6								
1842N		1842	29	liquid	SRR9270515	PRJNA548153	22		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	3								
1842NN		1842	106	liquid	SRR11115177	PRJNA607574	99		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	6								
1842O		1842	32	liquid	SRR9270516	PRJNA548153	25		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	3								
1842P		1842	35	liquid	SRR11115176	PRJNA607574	28		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	3								
1842Q		1842	36	formed	SRR11115175	PRJNA607574	29		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	4								
1842R		1842	39	liquid	SRR11115174	PRJNA607574	32		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	4								
1842S		1842	40	liquid	SRR11115173	PRJNA607574	33		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	4								
1842T		1842	41	liquid	SRR11115844	PRJNA607574	34		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	4								
1842U		1842	42	semi-formed	SRR11115843	PRJNA607574	35		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	4								
1842V		1842	43	semi-formed	SRR11115842	PRJNA607574	36		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	5								
1842W		1842	44	semi-formed	SRR11115841	PRJNA607574	37		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	5								
1842X		1842	48	semi-formed	SRR11115840	PRJNA607574	41		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	5								
1842Y		1842	49	liquid	SRR11115838	PRJNA607574	42		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	5								
1842Z		1842	50	semi-formed	SRR11115837	PRJNA607574	43		35	7	BM_unmodified	Leukemia	fc0103da11bcae7b355b7e		0		post	6								
1843A		1843	0	formed	SRR9270523	PRJNA548153	-6		15	6	cord	Leukemia	df7d3f71ada64958b54d8f		0		pre	-1								
1843B		1843	4	formed	SRR9270491	PRJNA548153	-2		15	6	cord	Leukemia	df7d3f71ada64958b54d8f		0		pre	-1								
1843C		1843	6	formed	SRR9270492	PRJNA548153	0		15	6	cord	Leukemia	df7d3f71ada64958b54d8f		0		peri	-1								
1843D		1843	7	liquid	SRR9270483	PRJNA548153	1		15	6	cord	Leukemia	df7d3f71ada64958b54d8f		0		peri	0								
1843E		1843	12	semi-formed	SRR9270484	PRJNA548153	6		15	6	cord	Leukemia	df7d3f71ada64958b54d8f		0		post	0								
1843F		1843	13	semi-formed	SRR9270485	PRJNA548153	7		15	6	cord	Leukemia	df7d3f71ada64958b54d8f		0		post	0								
1843G		1843	14	formed	SRR9270486	PRJNA548153	8		15	6	cord	Leukemia	df7d3f71ada64958b54d8f		0		post	1								
1843H		1843	18	formed	SRR9270487	PRJNA548153	12		15	6	cord	Leukemia	df7d3f71ada64958b54d8f		0		post	1								
1843I		1843	20	semi-formed	SRR9270488	PRJNA548153	14		15	6	cord	Leukemia	df7d3f71ada64958b54d8f		0		post	1								
1843J		1843	21	semi-formed	SRR9270489	PRJNA548153	15		15	6	cord	Leukemia	df7d3f71ada64958b54d8f		0		post	2								
1843K		1843	25	liquid	SRR9270490	PRJNA548153	19		15	6	cord	Leukemia	df7d3f71ada64958b54d8f		0		post	2								
1843L		1843	26	semi-formed	SRR11115836	PRJNA607574	20		15	6	cord	Leukemia	df7d3f71ada64958b54d8f		0		post	2								
1843M		1843	27	formed	SRR11115835	PRJNA607574	21		15	6	cord	Leukemia	df7d3f71ada64958b54d8f		0		post	2								
1843N		1843	28	semi-formed	SRR11115834	PRJNA607574	22		15	6	cord	Leukemia	df7d3f71ada64958b54d8f		0		post	3								
1843O		1843	29	semi-formed	SRR11115833	PRJNA607574	23		15	6	cord	Leukemia	df7d3f71ada64958b54d8f		0		post	3								
1844A		1844	0	formed	SRR9270494	PRJNA548153	-13		8	13	TCD	Leukemia	9cc3cf4619b4b6182678ec		0		pre	-2								
1844B		1844	11	formed	SRR9270493	PRJNA548153	-2		8	13	TCD	Leukemia	9cc3cf4619b4b6182678ec		0		pre	-1								
1844C		1844	12	formed	SRR9270500	PRJNA548153	-1		8	13	TCD	Leukemia	9cc3cf4619b4b6182678ec		0		pre	-1								
1844D		1844	13	formed	SRR9270499	PRJNA548153	0		8	13	TCD	Leukemia	9cc3cf4619b4b6182678ec		0		peri	-1								
1844E		1844	15	liquid	SRR9270498	PRJNA548153	2		8	13	TCD	Leukemia	9cc3cf4619b4b6182678ec		0		peri	0								
1844F		1844	17	liquid	SRR9270497	PRJNA548153	4		8	13	TCD	Leukemia	9cc3cf4619b4b6182678ec		0		peri	0								
1844G		1844	18	liquid	SRR9270502	PRJNA548153	5		8	13	TCD	Leukemia	9cc3cf4619b4b6182678ec		0		peri	0								
1844H		1844	19	semi-formed	SRR9270501	PRJNA548153	6		8	13	TCD	Leukemia	9cc3cf4619b4b6182678ec		0		post	0								
1845A		1845	0	liquid	SRR9270420	PRJNA548153	-4		6	4	TCD	Myelodysplastic Syndromes	6e224d6979c4c4ab869dfd		0		pre	-1								
1845B		1845	1	semi-formed	SRR9270421	PRJNA548153	-3		6	4	TCD	Myelodysplastic Syndromes	6e224d6979c4c4ab869dfd		0		pre	-1								
1845C		1845	4	semi-formed	SRR9270422	PRJNA548153	0		6	4	TCD	Myelodysplastic Syndromes	6e224d6979c4c4ab869dfd		0		peri	-1								
1845E		1845	9	semi-formed	SRR9270423	PRJNA548153	5		6	4	TCD	Myelodysplastic Syndromes	6e224d6979c4c4ab869dfd		0		peri	0								
1845F		1845	10	semi-formed	SRR9270424	PRJNA548153	6		6	4	TCD	Myelodysplastic Syndromes	6e224d6979c4c4ab869dfd		0		post	0								
1845G		1845	60	formed	SRR11115832	PRJNA607574	56		6	4	TCD	Myelodysplastic Syndromes	6e224d6979c4c4ab869dfd		0		post	6								
1846A		1846	0	formed	SRR9270442	PRJNA548153	-3		6	3	cord	Leukemia	65934c40eca28e16860bb2		0		pre	-1								
1846B		1846	5	semi-formed	SRR9270441	PRJNA548153	2		6	3	cord	Leukemia	65934c40eca28e16860bb2		0		peri	0								
1846C		1846	6	liquid	SRR9270440	PRJNA548153	3		6	3	cord	Leukemia	65934c40eca28e16860bb2		0		peri	0								
1846D		1846	13	formed	SRR9270439	PRJNA548153	10		6	3	cord	Leukemia	65934c40eca28e16860bb2		0		post	1								
1846E		1846	16	formed	SRR9270438	PRJNA548153	13		6	3	cord	Leukemia	65934c40eca28e16860bb2		0		post	1								
1846F		1846	23	formed	SRR9270437	PRJNA548153	20		6	3	cord	Leukemia	65934c40eca28e16860bb2		0		post	2								
1848A		1848	0	formed	SRR9270513	PRJNA548153	-1		11	1	PBSC_unmodified	Multiple Myeloma	d627eb58494b9776512be7		0		pre	-1								
1848B		1848	1	formed	SRR9270446	PRJNA548153	0		11	1	PBSC_unmodified	Multiple Myeloma	d627eb58494b9776512be7		0		peri	-1								
1848C		1848	2	formed	SRR9270445	PRJNA548153	1		11	1	PBSC_unmodified	Multiple Myeloma	d627eb58494b9776512be7		0		peri	0								
1848D		1848	4	semi-formed	SRR9270448	PRJNA548153	3		11	1	PBSC_unmodified	Multiple Myeloma	d627eb58494b9776512be7		0		peri	0								
1848E		1848	5	semi-formed	SRR9270447	PRJNA548153	4		11	1	PBSC_unmodified	Multiple Myeloma	d627eb58494b9776512be7		0		peri	0								
1848F		1848	6	liquid	SRR9270450	PRJNA548153	5		11	1	PBSC_unmodified	Multiple Myeloma	d627eb58494b9776512be7		0		peri	0								
1848G		1848	7	liquid	SRR9270449	PRJNA548153	6		11	1	PBSC_unmodified	Multiple Myeloma	d627eb58494b9776512be7		0		post	0								
1848H		1848	8	liquid	SRR9270452	PRJNA548153	7		11	1	PBSC_unmodified	Multiple Myeloma	d627eb58494b9776512be7		0		post	0								
1848I		1848	11	semi-formed	SRR9270451	PRJNA548153	10		11	1	PBSC_unmodified	Multiple Myeloma	d627eb58494b9776512be7		0		post	1								
1848J		1848	12	semi-formed	SRR9270454	PRJNA548153	11		11	1	PBSC_unmodified	Multiple Myeloma	d627eb58494b9776512be7		0		post	1								
1848K		1848	13	liquid	SRR9270453	PRJNA548153	12		11	1	PBSC_unmodified	Multiple Myeloma	d627eb58494b9776512be7		0		post	1								
184A		184	0	formed	SRR11420755	PRJNA545312	-2		8	363	PBSC_unmodified	Leukemia	0f837377422c0c9e1cd843	275	1		pre	-1								
184B		184	5	liquid	SRR11420754	PRJNA545312	3		8	363	PBSC_unmodified	Leukemia	0f837377422c0c9e1cd843	275	1		peri	0								
184C		184	15	semi-formed	SRR11420753	PRJNA545312	13		8	363	PBSC_unmodified	Leukemia	0f837377422c0c9e1cd843	275	1		post	1								
184D		184	362	liquid	SRR11420752	PRJNA545312	-1		8	363	PBSC_unmodified	Leukemia	0f837377422c0c9e1cd843	275	1		pre	-1								
184E		184	369	liquid	SRR11420751	PRJNA545312	6		8	363	PBSC_unmodified	Leukemia	0f837377422c0c9e1cd843	275	1		post	0								
184F		184	376	liquid	SRR11420750	PRJNA545312	13		8	363	PBSC_unmodified	Leukemia	0f837377422c0c9e1cd843	275	1		post	1								
184G		184	384	semi-formed	SRR11420749	PRJNA545312	21		8	363	PBSC_unmodified	Leukemia	0f837377422c0c9e1cd843	275	1		post	2								
184H		184	398	liquid	SRR11420748	PRJNA545312	35		8	363	PBSC_unmodified	Leukemia	0f837377422c0c9e1cd843	275	1		post	4								
1850A		1850	0	semi-formed	SRR11396527	PRJNA607574			4																	
1850B		1850	6	semi-formed	SRR11396526	PRJNA607574			4																	
1850C		1850	11	liquid	SRR11396525	PRJNA607574			4																	
1850D		1850	13	liquid	SRR11396524	PRJNA607574			4																	
1852A		1852	0	semi-formed	SRR11396523	PRJNA607574			5																	
1852B		1852	3	liquid	SRR11396521	PRJNA607574			5																	
1852E		1852	15	liquid	SRR11396520	PRJNA607574			5																	
1852F		1852	31	liquid	SRR11396519	PRJNA607574			5																	
1852G		1852	112	formed	SRR11396518	PRJNA607574			5																	
1855A		1855	0	formed	SRR9270415	PRJNA548153	-1		15	1	PBSC_unmodified	Leukemia	e6633834afcb8fe2e43c31		0		pre	-1								
1855B		1855	2	semi-formed	SRR9270416	PRJNA548153	1		15	1	PBSC_unmodified	Leukemia	e6633834afcb8fe2e43c31		0		peri	0								
1855C		1855	7	semi-formed	SRR9270474	PRJNA548153	6		15	1	PBSC_unmodified	Leukemia	e6633834afcb8fe2e43c31		0		post	0								
1855D		1855	8	semi-formed	SRR9270473	PRJNA548153	7		15	1	PBSC_unmodified	Leukemia	e6633834afcb8fe2e43c31		0		post	0								
1855E		1855	13	liquid	SRR11115831	PRJNA607574	12		15	1	PBSC_unmodified	Leukemia	e6633834afcb8fe2e43c31		0		post	1								
1855F		1855	15	liquid	SRR11115830	PRJNA607574	14		15	1	PBSC_unmodified	Leukemia	e6633834afcb8fe2e43c31		0		post	1								
1855G		1855	16	liquid	SRR11115829	PRJNA607574	15		15	1	PBSC_unmodified	Leukemia	e6633834afcb8fe2e43c31		0		post	2								
1855H		1855	19	liquid	SRR11115539	PRJNA607574	18		15	1	PBSC_unmodified	Leukemia	e6633834afcb8fe2e43c31		0		post	2								
1855I		1855	23	semi-formed	SRR11115538	PRJNA607574	22		15	1	PBSC_unmodified	Leukemia	e6633834afcb8fe2e43c31		0		post	3								
1855J		1855	26	semi-formed	SRR11115537	PRJNA607574	25		15	1	PBSC_unmodified	Leukemia	e6633834afcb8fe2e43c31		0		post	3								
1855K		1855	27	liquid	SRR11115536	PRJNA607574	26		15	1	PBSC_unmodified	Leukemia	e6633834afcb8fe2e43c31		0		post	3								
1855L		1855	30	liquid	SRR11115535	PRJNA607574	29		15	1	PBSC_unmodified	Leukemia	e6633834afcb8fe2e43c31		0		post	4								
1855M		1855	34	semi-formed	SRR11115534	PRJNA607574	33		15	1	PBSC_unmodified	Leukemia	e6633834afcb8fe2e43c31		0		post	4								
1855N		1855	44	semi-formed	SRR11115533	PRJNA607574	43		15	1	PBSC_unmodified	Leukemia	e6633834afcb8fe2e43c31		0		post	6								
1855O		1855	51	semi-formed	SRR11115532	PRJNA607574	50		15	1	PBSC_unmodified	Leukemia	e6633834afcb8fe2e43c31		0		post	6								
1856A		1856	0	liquid	SRR11115531	PRJNA607574	4		4	-4	TCD	Myelodysplastic Syndromes	6f32f5f1ba74eda0e6de15		0		peri	0								
1856B		1856	1	liquid	SRR11115530	PRJNA607574	5		4	-4	TCD	Myelodysplastic Syndromes	6f32f5f1ba74eda0e6de15		0		peri	0								
1856C		1856	6	formed	SRR11115528	PRJNA607574	10		4	-4	TCD	Myelodysplastic Syndromes	6f32f5f1ba74eda0e6de15		0		post	1								
1856E		1856	23	liquid	SRR11115527	PRJNA607574	27		4	-4	TCD	Myelodysplastic Syndromes	6f32f5f1ba74eda0e6de15		0		post	3								
1858A		1858	0	formed	SRR9270476	PRJNA548153	-1		7	1	TCD	Leukemia	e6205fc0e2fcc52f6bfc88		0		pre	-1								
1858B		1858	3	liquid	SRR9270475	PRJNA548153	2		7	1	TCD	Leukemia	e6205fc0e2fcc52f6bfc88		0		peri	0								
1858C		1858	4	liquid	SRR9270478	PRJNA548153	3		7	1	TCD	Leukemia	e6205fc0e2fcc52f6bfc88		0		peri	0								
1858D		1858	5	liquid	SRR9270477	PRJNA548153	4		7	1	TCD	Leukemia	e6205fc0e2fcc52f6bfc88		0		peri	0								
1858E		1858	6	liquid	SRR9270480	PRJNA548153	5		7	1	TCD	Leukemia	e6205fc0e2fcc52f6bfc88		0		peri	0								
1858F		1858	11	liquid	SRR9270479	PRJNA548153	10		7	1	TCD	Leukemia	e6205fc0e2fcc52f6bfc88		0		post	1								
1858H		1858	14	semi-formed	SRR11115526	PRJNA607574	13		7	1	TCD	Leukemia	e6205fc0e2fcc52f6bfc88		0		post	1								
1859A		1859	0	formed	SRR11396517	PRJNA607574			6																	
1859B		1859	2	formed	SRR11396516	PRJNA607574			6																	
1859C		1859	4	formed	SRR11396515	PRJNA607574			6																	
1859D		1859	25	formed	SRR11396514	PRJNA607574			6																	
1859E		1859	30	formed	SRR11396513	PRJNA607574			6																	
1859F		1859	31	formed	SRR11396512	PRJNA607574			6																	
185A		pt_with_samples_185_91	0	semi-formed	SRR11420747	PRJNA545312	-577		9	577	cord	Non-Hodgkin's Lymphoma	528a13bfba5b2c8c3d0be8	250	1		pre	-3								
1860A		1860	0	semi-formed	SRR11396510	PRJNA607574			5																	
1860B		1860	6	liquid	SRR11396509	PRJNA607574			5																	
1860C		1860	11	liquid	SRR11396508	PRJNA607574			5																	
1860D		1860	20	semi-formed	SRR11396507	PRJNA607574			5																	
1860E		1860	27	liquid	SRR11396506	PRJNA607574			5																	
1861A		1861	0	liquid	SRR11115525	PRJNA607574	5		7	-5	PBSC_unmodified	Leukemia	d586cbd3ed35a526a63264		0		peri	0								
1861B		1861	2	liquid	SRR11115524	PRJNA607574	7		7	-5	PBSC_unmodified	Leukemia	d586cbd3ed35a526a63264		0		post	0								
1861C		1861	3	liquid	SRR11115523	PRJNA607574	8		7	-5	PBSC_unmodified	Leukemia	d586cbd3ed35a526a63264		0		post	1								
1861D		1861	9	semi-formed	SRR11115522	PRJNA607574	14		7	-5	PBSC_unmodified	Leukemia	d586cbd3ed35a526a63264		0		post	1								
1861E		1861	21	formed	SRR11115521	PRJNA607574	26		7	-5	PBSC_unmodified	Leukemia	d586cbd3ed35a526a63264		0		post	3								
1861F		1861	30	liquid	SRR11115520	PRJNA607574	35		7	-5	PBSC_unmodified	Leukemia	d586cbd3ed35a526a63264		0		post	4								
1861H		1861	31	liquid	SRR11115519	PRJNA607574	36		7	-5	PBSC_unmodified	Leukemia	d586cbd3ed35a526a63264		0		post	5								
1865B		1865	4	semi-formed	SRR9270536	PRJNA548153	-4		7	8	TCD	Myelodysplastic Syndromes	f77831b99da2b2e8059fa6		0		pre	-1								
1865C		1865	5	formed	SRR9270535	PRJNA548153	-3		7	8	TCD	Myelodysplastic Syndromes	f77831b99da2b2e8059fa6		0		pre	-1								
1865D		1865	6	semi-formed	SRR9270534	PRJNA548153	-2		7	8	TCD	Myelodysplastic Syndromes	f77831b99da2b2e8059fa6		0		pre	-1								
1865G		1865	13	liquid	SRR9270533	PRJNA548153	5		7	8	TCD	Myelodysplastic Syndromes	f77831b99da2b2e8059fa6		0		peri	0								
1865H		1865	18	liquid	SRR9270526	PRJNA548153	10		7	8	TCD	Myelodysplastic Syndromes	f77831b99da2b2e8059fa6		0		post	1								
1865I		1865	19	liquid	SRR9270525	PRJNA548153	11		7	8	TCD	Myelodysplastic Syndromes	f77831b99da2b2e8059fa6		0		post	1								
1865J		1865	27	formed	SRR11115517	PRJNA607574	19		7	8	TCD	Myelodysplastic Syndromes	f77831b99da2b2e8059fa6		0		post	2								
1866A		1866	0	semi-formed	SRR9270514	PRJNA548153	-4		13	4	cord	Leukemia	5b5d93d837477ba7a92a50		0		pre	-1								
1866B		1866	1	semi-formed	SRR9270410	PRJNA548153	-3		13	4	cord	Leukemia	5b5d93d837477ba7a92a50		0		pre	-1								
1866C		1866	3	liquid	SRR9270409	PRJNA548153	-1		13	4	cord	Leukemia	5b5d93d837477ba7a92a50		0		pre	-1								
1866D		1866	6	liquid	SRR9270408	PRJNA548153	2		13	4	cord	Leukemia	5b5d93d837477ba7a92a50		0		peri	0								
1866E		1866	7	liquid	SRR9270407	PRJNA548153	3		13	4	cord	Leukemia	5b5d93d837477ba7a92a50		0		peri	0								
1866F		1866	16	liquid	SRR9270414	PRJNA548153	12		13	4	cord	Leukemia	5b5d93d837477ba7a92a50		0		post	1								
1866G		1866	17	liquid	SRR9270413	PRJNA548153	13		13	4	cord	Leukemia	5b5d93d837477ba7a92a50		0		post	1								
1866H		1866	18	liquid	SRR9270412	PRJNA548153	14		13	4	cord	Leukemia	5b5d93d837477ba7a92a50		0		post	1								
1866I		1866	21	liquid	SRR9270411	PRJNA548153	17		13	4	cord	Leukemia	5b5d93d837477ba7a92a50		0		post	2								
1866J		1866	28	semi-formed	SRR9270528	PRJNA548153	24		13	4	cord	Leukemia	5b5d93d837477ba7a92a50		0		post	3								
1866K		1866	35	semi-formed	SRR11115516	PRJNA607574	31		13	4	cord	Leukemia	5b5d93d837477ba7a92a50		0		post	4								
1866L		1866	36	semi-formed	SRR11115515	PRJNA607574	32		13	4	cord	Leukemia	5b5d93d837477ba7a92a50		0		post	4								
1866M		1866	37	semi-formed	SRR11115514	PRJNA607574	33		13	4	cord	Leukemia	5b5d93d837477ba7a92a50		0		post	4								
1867A		1867	0	formed	SRR11396505	PRJNA607574			3																	
1867B		1867	35	formed	SRR11396504	PRJNA607574			3																	
1867C		1867	90	formed	SRR11396503	PRJNA607574			3																	
186A		186	0	formed	SRR11420746	PRJNA545312	-1		5	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	a1099e9b81037507e8c016	255	1		pre	-1								
186B		186	6	liquid	SRR11420744	PRJNA545312	5		5	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	a1099e9b81037507e8c016	255	1		peri	0								
186C		186	7	liquid	SRR11420743	PRJNA545312	6		5	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	a1099e9b81037507e8c016	255	1		post	0								
186D		186	8	liquid	SRR11420742	PRJNA545312	7		5	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	a1099e9b81037507e8c016	255	1		post	0								
186E		186	13	formed	SRR11420741	PRJNA545312	12		5	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	a1099e9b81037507e8c016	255	1		post	1								
1871A		1871	0	semi-formed	SRR11396502	PRJNA607574			4																	
1871B		1871	1	liquid	SRR11396501	PRJNA607574			4																	
1871C		1871	2	liquid	SRR11396498	PRJNA607574			4																	
1871D		1871	5	liquid	SRR11396497	PRJNA607574			4																	
1872A		1872	0	liquid	SRR11115513	PRJNA607574	-2		12	2	BM_unmodified	Non-Hodgkin's Lymphoma	f22286f1b160503eab74b9		0		pre	-1								
1872B		1872	8	liquid	SRR11115512	PRJNA607574	6		12	2	BM_unmodified	Non-Hodgkin's Lymphoma	f22286f1b160503eab74b9		0		post	0								
1872D		1872	56	liquid	SRR11115511	PRJNA607574	54		12	2	BM_unmodified	Non-Hodgkin's Lymphoma	f22286f1b160503eab74b9		0		post	6								
1872E		1872	58	liquid	SRR11115510	PRJNA607574	56		12	2	BM_unmodified	Non-Hodgkin's Lymphoma	f22286f1b160503eab74b9		0		post	6								
1872F		1872	62	liquid	SRR11115509	PRJNA607574	60		12	2	BM_unmodified	Non-Hodgkin's Lymphoma	f22286f1b160503eab74b9		0		post	6								
1872G		1872	63	liquid	SRR11115876	PRJNA607574	61		12	2	BM_unmodified	Non-Hodgkin's Lymphoma	f22286f1b160503eab74b9		0		post	6								
1872H		1872	64	liquid	SRR11115874	PRJNA607574	62		12	2	BM_unmodified	Non-Hodgkin's Lymphoma	f22286f1b160503eab74b9		0		post	6								
1872I		1872	65	liquid	SRR11115873	PRJNA607574	63		12	2	BM_unmodified	Non-Hodgkin's Lymphoma	f22286f1b160503eab74b9		0		post	6								
1872J		1872	96	liquid	SRR11115872	PRJNA607574	94		12	2	BM_unmodified	Non-Hodgkin's Lymphoma	f22286f1b160503eab74b9		0		post	6								
1872K		1872	97	liquid	SRR11115871	PRJNA607574	95		12	2	BM_unmodified	Non-Hodgkin's Lymphoma	f22286f1b160503eab74b9		0		post	6								
1872L		1872	121	liquid	SRR11115870	PRJNA607574	119		12	2	BM_unmodified	Non-Hodgkin's Lymphoma	f22286f1b160503eab74b9		0		post	6								
1872M		1872	128	liquid	SRR11115869	PRJNA607574	126		12	2	BM_unmodified	Non-Hodgkin's Lymphoma	f22286f1b160503eab74b9		0		post	6								
1873A		1873	0	semi-formed	SRR11115868	PRJNA607574	0		16	0	PBSC_unmodified	Myelodysplastic Syndromes	502dac27b4acafd0598604		0		peri	-1								
1873B		1873	1	liquid	SRR11115867	PRJNA607574	1		16	0	PBSC_unmodified	Myelodysplastic Syndromes	502dac27b4acafd0598604		0		peri	0								
1873C		1873	4	liquid	SRR11115866	PRJNA607574	4		16	0	PBSC_unmodified	Myelodysplastic Syndromes	502dac27b4acafd0598604		0		peri	0								
1873F		1873	11	liquid	SRR11115865	PRJNA607574	11		16	0	PBSC_unmodified	Myelodysplastic Syndromes	502dac27b4acafd0598604		0		post	1								
1873G		1873	14	liquid	SRR11115862	PRJNA607574	14		16	0	PBSC_unmodified	Myelodysplastic Syndromes	502dac27b4acafd0598604		0		post	1								
1873H		1873	15	liquid	SRR11115861	PRJNA607574	15		16	0	PBSC_unmodified	Myelodysplastic Syndromes	502dac27b4acafd0598604		0		post	2								
1873I		1873	16	liquid	SRR11115860	PRJNA607574	16		16	0	PBSC_unmodified	Myelodysplastic Syndromes	502dac27b4acafd0598604		0		post	2								
1873J		1873	20	liquid	SRR11115859	PRJNA607574	20		16	0	PBSC_unmodified	Myelodysplastic Syndromes	502dac27b4acafd0598604		0		post	2								
1873K		1873	21	liquid	SRR11115858	PRJNA607574	21		16	0	PBSC_unmodified	Myelodysplastic Syndromes	502dac27b4acafd0598604		0		post	2								
1873L		1873	22	liquid	SRR11115857	PRJNA607574	22		16	0	PBSC_unmodified	Myelodysplastic Syndromes	502dac27b4acafd0598604		0		post	3								
1873N		1873	26	liquid	SRR11115856	PRJNA607574	26		16	0	PBSC_unmodified	Myelodysplastic Syndromes	502dac27b4acafd0598604		0		post	3								
1873O		1873	27	liquid	SRR11115855	PRJNA607574	27		16	0	PBSC_unmodified	Myelodysplastic Syndromes	502dac27b4acafd0598604		0		post	3								
1873P		1873	28	semi-formed	SRR11115854	PRJNA607574	28		16	0	PBSC_unmodified	Myelodysplastic Syndromes	502dac27b4acafd0598604		0		post	3								
1873Q		1873	29	liquid	SRR11115853	PRJNA607574	29		16	0	PBSC_unmodified	Myelodysplastic Syndromes	502dac27b4acafd0598604		0		post	4								
1873R		1873	30	liquid	SRR11115851	PRJNA607574	30		16	0	PBSC_unmodified	Myelodysplastic Syndromes	502dac27b4acafd0598604		0		post	4								
1873S		1873	32	semi-formed	SRR11115850	PRJNA607574	32		16	0	PBSC_unmodified	Myelodysplastic Syndromes	502dac27b4acafd0598604		0		post	4								
1876A		1876	0	semi-formed	SRR11115849	PRJNA607574	5		3	-5	PBSC_unmodified	Leukemia	8c23db712b01e92e5a0b70		0		peri	0								
1876B		1876	1	liquid	SRR11115848	PRJNA607574	6		3	-5	PBSC_unmodified	Leukemia	8c23db712b01e92e5a0b70		0		post	0								
1876C		1876	6	semi-formed	SRR11115847	PRJNA607574	11		3	-5	PBSC_unmodified	Leukemia	8c23db712b01e92e5a0b70		0		post	1								
187A		187	0	formed	SRR11420740	PRJNA545312	-7		4	7	TCD	Multiple Myeloma	e9b08cbdf210788ac867d2	200	1		pre	-2								
187B		187	3	formed	SRR11420739	PRJNA545312	-4		4	7	TCD	Multiple Myeloma	e9b08cbdf210788ac867d2	200	1		pre	-1								
187C		187	10	semi-formed	SRR11420738	PRJNA545312	3		4	7	TCD	Multiple Myeloma	e9b08cbdf210788ac867d2	200	1		peri	0								
187D		187	19	formed	SRR11420737	PRJNA545312	12		4	7	TCD	Multiple Myeloma	e9b08cbdf210788ac867d2	200	1		post	1								
1881A		1881	0	formed	SRR11115846	PRJNA607574	3		8	-3	PBSC_unmodified	Leukemia	10eaddcdc4ff2942d3c76d		0		peri	0								
1881B		1881	2	formed	SRR11115845	PRJNA607574	5		8	-3	PBSC_unmodified	Leukemia	10eaddcdc4ff2942d3c76d		0		peri	0								
1881C		1881	4	semi-formed	SRR11115828	PRJNA607574	7		8	-3	PBSC_unmodified	Leukemia	10eaddcdc4ff2942d3c76d		0		post	0								
1881D		1881	5	formed	SRR11115827	PRJNA607574	8		8	-3	PBSC_unmodified	Leukemia	10eaddcdc4ff2942d3c76d		0		post	1								
1881E		1881	6	formed	SRR11115826	PRJNA607574	9		8	-3	PBSC_unmodified	Leukemia	10eaddcdc4ff2942d3c76d		0		post	1								
1881F		1881	12	formed	SRR11115824	PRJNA607574	15		8	-3	PBSC_unmodified	Leukemia	10eaddcdc4ff2942d3c76d		0		post	2								
1881G		1881	13	semi-formed	SRR11115823	PRJNA607574	16		8	-3	PBSC_unmodified	Leukemia	10eaddcdc4ff2942d3c76d		0		post	2								
1881H		1881	17	semi-formed	SRR11115822	PRJNA607574	20		8	-3	PBSC_unmodified	Leukemia	10eaddcdc4ff2942d3c76d		0		post	2								
1882A		1882	0	liquid	SRR9270530	PRJNA548153	-5		5	5	TCD	Myeloproliferative Disorder	ea4c1d7c08f12933707bdb		0		pre	-1								
1882B		1882	1	semi-formed	SRR9270529	PRJNA548153	-4		5	5	TCD	Myeloproliferative Disorder	ea4c1d7c08f12933707bdb		0		pre	-1								
1882C		1882	4	liquid	SRR9270524	PRJNA548153	-1		5	5	TCD	Myeloproliferative Disorder	ea4c1d7c08f12933707bdb		0		pre	-1								
1882D		1882	22	semi-formed	SRR11115821	PRJNA607574	17		5	5	TCD	Myeloproliferative Disorder	ea4c1d7c08f12933707bdb		0		post	2								
1882E		1882	23	semi-formed	SRR11115820	PRJNA607574	18		5	5	TCD	Myeloproliferative Disorder	ea4c1d7c08f12933707bdb		0		post	2								
1884B		1884	1	liquid	SRR11396496	PRJNA607574			3																	
1884C		1884	2	liquid	SRR11396495	PRJNA607574			3																	
1884D		1884	155	formed	SRR11396494	PRJNA607574			3																	
1885A		1885	0	liquid	SRR11115819	PRJNA607574	0		9	0	TCD	Leukemia	7fa13fb8c0510925463a5c		0		peri	-1								
1885B		1885	1	semi-formed	SRR11115818	PRJNA607574	1		9	0	TCD	Leukemia	7fa13fb8c0510925463a5c		0		peri	0								
1885C		1885	5	liquid	SRR11115817	PRJNA607574	5		9	0	TCD	Leukemia	7fa13fb8c0510925463a5c		0		peri	0								
1885E		1885	8	liquid	SRR11115816	PRJNA607574	8		9	0	TCD	Leukemia	7fa13fb8c0510925463a5c		0		post	1								
1885F		1885	12	liquid	SRR11115815	PRJNA607574	12		9	0	TCD	Leukemia	7fa13fb8c0510925463a5c		0		post	1								
1885G		1885	13	liquid	SRR11115813	PRJNA607574	13		9	0	TCD	Leukemia	7fa13fb8c0510925463a5c		0		post	1								
1885H		1885	14	semi-formed	SRR11115812	PRJNA607574	14		9	0	TCD	Leukemia	7fa13fb8c0510925463a5c		0		post	1								
1885I		1885	16	formed	SRR11115811	PRJNA607574	16		9	0	TCD	Leukemia	7fa13fb8c0510925463a5c		0		post	2								
1885J		1885	18	semi-formed	SRR11115810	PRJNA607574	18		9	0	TCD	Leukemia	7fa13fb8c0510925463a5c		0		post	2								
188A		188	0	semi-formed	SRR11420736	PRJNA545312	-6		9	6	cord	Leukemia	21798fbb15d6fdf6f99332	280	1		pre	-1								
188B		188	5	liquid	SRR11420735	PRJNA545312	-1		9	6	cord	Leukemia	21798fbb15d6fdf6f99332	280	1		pre	-1								
188C		188	11	semi-formed	SRR11420733	PRJNA545312	5		9	6	cord	Leukemia	21798fbb15d6fdf6f99332	280	1		peri	0								
188D		188	19	semi-formed	SRR11420732	PRJNA545312	13		9	6	cord	Leukemia	21798fbb15d6fdf6f99332	280	1		post	1								
188E		188	25	semi-formed	SRR11420731	PRJNA545312	19		9	6	cord	Leukemia	21798fbb15d6fdf6f99332	280	1		post	2								
188F		188	32	formed	SRR11420730	PRJNA545312	26		9	6	cord	Leukemia	21798fbb15d6fdf6f99332	280	1		post	3								
188G		188	44	formed	SRR11420729	PRJNA545312	38		9	6	cord	Leukemia	21798fbb15d6fdf6f99332	280	1		post	5								
188H		188	46	semi-formed	SRR11420728	PRJNA545312	40		9	6	cord	Leukemia	21798fbb15d6fdf6f99332	280	1		post	5								
188I		188	53	semi-formed	SRR11420727	PRJNA545312	47		9	6	cord	Leukemia	21798fbb15d6fdf6f99332	280	1		post	6								
1891A		1891	0	formed	SRR9270482	PRJNA548153	-2		12	2	cord	Non-Hodgkin's Lymphoma	06055ccf76ff461ccce7a1		0		pre	-1								
1891B		1891	1	semi-formed	SRR9270481	PRJNA548153	-1		12	2	cord	Non-Hodgkin's Lymphoma	06055ccf76ff461ccce7a1		0		pre	-1								
1891C		1891	5	semi-formed	SRR9270457	PRJNA548153	3		12	2	cord	Non-Hodgkin's Lymphoma	06055ccf76ff461ccce7a1		0		peri	0								
1891D		1891	6	liquid	SRR9270458	PRJNA548153	4		12	2	cord	Non-Hodgkin's Lymphoma	06055ccf76ff461ccce7a1		0		peri	0								
1891E		1891	7	semi-formed	SRR9270455	PRJNA548153	5		12	2	cord	Non-Hodgkin's Lymphoma	06055ccf76ff461ccce7a1		0		peri	0								
1891F		1891	14	liquid	SRR9270456	PRJNA548153	12		12	2	cord	Non-Hodgkin's Lymphoma	06055ccf76ff461ccce7a1		0		post	1								
1891H		1891	20	liquid	SRR11115809	PRJNA607574	18		12	2	cord	Non-Hodgkin's Lymphoma	06055ccf76ff461ccce7a1		0		post	2								
1891I		1891	22	liquid	SRR11115808	PRJNA607574	20		12	2	cord	Non-Hodgkin's Lymphoma	06055ccf76ff461ccce7a1		0		post	2								
1891J		1891	26	liquid	SRR11115807	PRJNA607574	24		12	2	cord	Non-Hodgkin's Lymphoma	06055ccf76ff461ccce7a1		0		post	3								
1891K		1891	28	semi-formed	SRR11115806	PRJNA607574	26		12	2	cord	Non-Hodgkin's Lymphoma	06055ccf76ff461ccce7a1		0		post	3								
1891L		1891	29	liquid	SRR11115805	PRJNA607574	27		12	2	cord	Non-Hodgkin's Lymphoma	06055ccf76ff461ccce7a1		0		post	3								
1891M		1891	37	liquid	SRR11115804	PRJNA607574	35		12	2	cord	Non-Hodgkin's Lymphoma	06055ccf76ff461ccce7a1		0		post	4								
1893A		1893	0	formed	SRR9270527	PRJNA548153	-2		7	2	BM_unmodified	Non-Hodgkin's Lymphoma	01df20d4de9592488b0825		0		pre	-1								
1893B		1893	1	formed	SRR9270429	PRJNA548153	-1		7	2	BM_unmodified	Non-Hodgkin's Lymphoma	01df20d4de9592488b0825		0		pre	-1								
1893C		1893	4	semi-formed	SRR9270430	PRJNA548153	2		7	2	BM_unmodified	Non-Hodgkin's Lymphoma	01df20d4de9592488b0825		0		peri	0								
1893D		1893	5	liquid	SRR9270431	PRJNA548153	3		7	2	BM_unmodified	Non-Hodgkin's Lymphoma	01df20d4de9592488b0825		0		peri	0								
1893E		1893	6	semi-formed	SRR9270432	PRJNA548153	4		7	2	BM_unmodified	Non-Hodgkin's Lymphoma	01df20d4de9592488b0825		0		peri	0								
1893F		1893	8	liquid	SRR9270425	PRJNA548153	6		7	2	BM_unmodified	Non-Hodgkin's Lymphoma	01df20d4de9592488b0825		0		post	0								
1893H		1893	14	liquid	SRR9270426	PRJNA548153	12		7	2	BM_unmodified	Non-Hodgkin's Lymphoma	01df20d4de9592488b0825		0		post	1								
1894A		1894	0	formed	SRR11396493	PRJNA607574			1																	
1896A		1896	0	formed	SRR9270461	PRJNA548153	-4		8	4	PBSC_unmodified	Leukemia	90384afd52a57db49f455b		0		pre	-1								
1896B		1896	2	formed	SRR9270462	PRJNA548153	-2		8	4	PBSC_unmodified	Leukemia	90384afd52a57db49f455b		0		pre	-1								
1896C		1896	3	semi-formed	SRR9270459	PRJNA548153	-1		8	4	PBSC_unmodified	Leukemia	90384afd52a57db49f455b		0		pre	-1								
1896D		1896	6	semi-formed	SRR9270460	PRJNA548153	2		8	4	PBSC_unmodified	Leukemia	90384afd52a57db49f455b		0		peri	0								
1896E		1896	7	semi-formed	SRR9270531	PRJNA548153	3		8	4	PBSC_unmodified	Leukemia	90384afd52a57db49f455b		0		peri	0								
1896F		1896	15	semi-formed	SRR11115802	PRJNA607574	11		8	4	PBSC_unmodified	Leukemia	90384afd52a57db49f455b		0		post	1								
1896G		1896	57	liquid	SRR11115801	PRJNA607574	53		8	4	PBSC_unmodified	Leukemia	90384afd52a57db49f455b		0		post	6								
1896H		1896	62	semi-formed	SRR11115800	PRJNA607574	58		8	4	PBSC_unmodified	Leukemia	90384afd52a57db49f455b		0		post	6								
1899A		1899	0	formed	SRR11115799	PRJNA607574	-3		9	3	BM_unmodified	Leukemia	de2395aadb80773088fecc		0		pre	-1								
1899B		1899	9	semi-formed	SRR11115798	PRJNA607574	6		9	3	BM_unmodified	Leukemia	de2395aadb80773088fecc		0		post	0								
1899C		1899	15	liquid	SRR11115797	PRJNA607574	12		9	3	BM_unmodified	Leukemia	de2395aadb80773088fecc		0		post	1								
1899D		1899	18	liquid	SRR11116071	PRJNA607574	15		9	3	BM_unmodified	Leukemia	de2395aadb80773088fecc		0		post	2								
1899E		1899	21	semi-formed	SRR11116070	PRJNA607574	18		9	3	BM_unmodified	Leukemia	de2395aadb80773088fecc		0		post	2								
1899F		1899	22	semi-formed	SRR11116069	PRJNA607574	19		9	3	BM_unmodified	Leukemia	de2395aadb80773088fecc		0		post	2								
1899G		1899	23	semi-formed	SRR11116068	PRJNA607574	20		9	3	BM_unmodified	Leukemia	de2395aadb80773088fecc		0		post	2								
1899I		1899	25	semi-formed	SRR11116066	PRJNA607574	22		9	3	BM_unmodified	Leukemia	de2395aadb80773088fecc		0		post	3								
1899J		1899	28	formed	SRR11116065	PRJNA607574	25		9	3	BM_unmodified	Leukemia	de2395aadb80773088fecc		0		post	3								
189A		189	0	formed	SRR11420726	PRJNA545312	-5		3	5	PBSC_unmodified	Leukemia	3c379493381951c94b2d3d	65	1		pre	-1								
189B		189	3	formed	SRR11420725	PRJNA545312	-2		3	5	PBSC_unmodified	Leukemia	3c379493381951c94b2d3d	65	1		pre	-1								
189C		189	10	formed	SRR11420724	PRJNA545312	5		3	5	PBSC_unmodified	Leukemia	3c379493381951c94b2d3d	65	1		peri	0								
1901A		1901	0	formed	SRR11116064	PRJNA607574	-9		7	9	TCD	Leukemia	94df67f2fb5a1546cd9d77		0		pre	-2								
1901B		1901	7	liquid	SRR11116063	PRJNA607574	-2		7	9	TCD	Leukemia	94df67f2fb5a1546cd9d77		0		pre	-1								
1901C		1901	14	liquid	SRR11116062	PRJNA607574	5		7	9	TCD	Leukemia	94df67f2fb5a1546cd9d77		0		peri	0								
1901D		1901	16	liquid	SRR11116061	PRJNA607574	7		7	9	TCD	Leukemia	94df67f2fb5a1546cd9d77		0		post	0								
1901E		1901	34	semi-formed	SRR11116060	PRJNA607574	25		7	9	TCD	Leukemia	94df67f2fb5a1546cd9d77		0		post	3								
1901F		1901	35	semi-formed	SRR11116059	PRJNA607574	26		7	9	TCD	Leukemia	94df67f2fb5a1546cd9d77		0		post	3								
1901G		1901	45	semi-formed	SRR11116058	PRJNA607574	36		7	9	TCD	Leukemia	94df67f2fb5a1546cd9d77		0		post	5								
1902A		1902	0	semi-formed	SRR11116057	PRJNA607574	-8		15	8	TCD	Leukemia	22e088c17ef6a6e06f10c4		0		pre	-2								
1902B		1902	6	formed	SRR11116055	PRJNA607574	-2		15	8	TCD	Leukemia	22e088c17ef6a6e06f10c4		0		pre	-1								
1902C		1902	9	formed	SRR11116054	PRJNA607574	1		15	8	TCD	Leukemia	22e088c17ef6a6e06f10c4		0		peri	0								
1902D		1902	13	liquid	SRR11116053	PRJNA607574	5		15	8	TCD	Leukemia	22e088c17ef6a6e06f10c4		0		peri	0								
1902E		1902	12	semi-formed	SRR11116052	PRJNA607574	4		15	8	TCD	Leukemia	22e088c17ef6a6e06f10c4		0		peri	0								
1902G		1902	16	semi-formed	SRR11396492	PRJNA607574	8		15	8	TCD	Leukemia	22e088c17ef6a6e06f10c4		0		post	1								
1902H		1902	17	semi-formed	SRR11116050	PRJNA607574	9		15	8	TCD	Leukemia	22e088c17ef6a6e06f10c4		0		post	1								
1902I		1902	19	formed	SRR11116049	PRJNA607574	11		15	8	TCD	Leukemia	22e088c17ef6a6e06f10c4		0		post	1								
1902J		1902	20	semi-formed	SRR11116048	PRJNA607574	12		15	8	TCD	Leukemia	22e088c17ef6a6e06f10c4		0		post	1								
1902K		1902	22	formed	SRR11116047	PRJNA607574	14		15	8	TCD	Leukemia	22e088c17ef6a6e06f10c4		0		post	1								
1902L		1902	23	semi-formed	SRR11116046	PRJNA607574	15		15	8	TCD	Leukemia	22e088c17ef6a6e06f10c4		0		post	2								
1902M		1902	68	semi-formed	SRR11116044	PRJNA607574	60		15	8	TCD	Leukemia	22e088c17ef6a6e06f10c4		0		post	6								
1902N		1902	89	formed	SRR11116043	PRJNA607574	81		15	8	TCD	Leukemia	22e088c17ef6a6e06f10c4		0		post	6								
1902O		1902	118	formed	SRR11116042	PRJNA607574	110		15	8	TCD	Leukemia	22e088c17ef6a6e06f10c4		0		post	6								
1902P		1902	139	formed	SRR11116041	PRJNA607574	131		15	8	TCD	Leukemia	22e088c17ef6a6e06f10c4		0		post	6								
1903A		1903	0	liquid	SRR11116040	PRJNA607574	4		10	-4	BM_unmodified	Non-Hodgkin's Lymphoma	cc4266e7f23a1b848888f9		0		peri	0								
1903B		1903	2	semi-formed	SRR11115796	PRJNA607574	6		10	-4	BM_unmodified	Non-Hodgkin's Lymphoma	cc4266e7f23a1b848888f9		0		post	0								
1903C		1903	9	semi-formed	SRR11115795	PRJNA607574	13		10	-4	BM_unmodified	Non-Hodgkin's Lymphoma	cc4266e7f23a1b848888f9		0		post	1								
1903D		1903	13	semi-formed	SRR11115794	PRJNA607574	17		10	-4	BM_unmodified	Non-Hodgkin's Lymphoma	cc4266e7f23a1b848888f9		0		post	2								
1903E		1903	14	semi-formed	SRR11115793	PRJNA607574	18		10	-4	BM_unmodified	Non-Hodgkin's Lymphoma	cc4266e7f23a1b848888f9		0		post	2								
1903F		1903	15	liquid	SRR11115792	PRJNA607574	19		10	-4	BM_unmodified	Non-Hodgkin's Lymphoma	cc4266e7f23a1b848888f9		0		post	2								
1903G		1903	17	semi-formed	SRR11115790	PRJNA607574	21		10	-4	BM_unmodified	Non-Hodgkin's Lymphoma	cc4266e7f23a1b848888f9		0		post	2								
1903H		1903	28	semi-formed	SRR11115789	PRJNA607574	32		10	-4	BM_unmodified	Non-Hodgkin's Lymphoma	cc4266e7f23a1b848888f9		0		post	4								
1903I		1903	29	formed	SRR11115788	PRJNA607574	33		10	-4	BM_unmodified	Non-Hodgkin's Lymphoma	cc4266e7f23a1b848888f9		0		post	4								
1903J		1903	30	formed	SRR11115787	PRJNA607574	34		10	-4	BM_unmodified	Non-Hodgkin's Lymphoma	cc4266e7f23a1b848888f9		0		post	4								
1905A		1905	0	formed	SRR11115786	PRJNA607574	-1		3	1	BM_unmodified	Hodgkin's Disease	d8aacb6c1246d900e40c67		0		pre	-1								
1905B		1905	2	formed	SRR11115785	PRJNA607574	1		3	1	BM_unmodified	Hodgkin's Disease	d8aacb6c1246d900e40c67		0		peri	0								
1905C		1905	3	formed	SRR11115784	PRJNA607574	2		3	1	BM_unmodified	Hodgkin's Disease	d8aacb6c1246d900e40c67		0		peri	0								
1906A		1906	0	semi-formed	SRR11396491	PRJNA607574			1																	
1908B		1908	0	formed	SRR11396490	PRJNA607574	-1		6	1	PBSC_unmodified	Leukemia	7983f47077c788b8d55c3a		0		pre	-1								
1908C		1908	6	semi-formed	SRR11115782	PRJNA607574	5		6	1	PBSC_unmodified	Leukemia	7983f47077c788b8d55c3a		0		peri	0								
1908D		1908	12	liquid	SRR11115781	PRJNA607574	11		6	1	PBSC_unmodified	Leukemia	7983f47077c788b8d55c3a		0		post	1								
1908E		1908	15	liquid	SRR11115779	PRJNA607574	14		6	1	PBSC_unmodified	Leukemia	7983f47077c788b8d55c3a		0		post	1								
1908F		1908	57	semi-formed	SRR11115778	PRJNA607574	56		6	1	PBSC_unmodified	Leukemia	7983f47077c788b8d55c3a		0		post	6								
1908G		1908	81	semi-formed	SRR11115777	PRJNA607574	80		6	1	PBSC_unmodified	Leukemia	7983f47077c788b8d55c3a		0		post	6								
1909A		1909	0	formed	SRR11115776	PRJNA607574	-3		13	3	BM_unmodified	Multiple Myeloma	6fafe8f9dbd494a8801289		0		pre	-1								
1909B		1909	1	formed	SRR11115775	PRJNA607574	-2		13	3	BM_unmodified	Multiple Myeloma	6fafe8f9dbd494a8801289		0		pre	-1								
1909C		1909	2	formed	SRR11115774	PRJNA607574	-1		13	3	BM_unmodified	Multiple Myeloma	6fafe8f9dbd494a8801289		0		pre	-1								
1909D		1909	7	formed	SRR11115773	PRJNA607574	4		13	3	BM_unmodified	Multiple Myeloma	6fafe8f9dbd494a8801289		0		peri	0								
1909E		1909	8	formed	SRR11115772	PRJNA607574	5		13	3	BM_unmodified	Multiple Myeloma	6fafe8f9dbd494a8801289		0		peri	0								
1909F		1909	9	semi-formed	SRR11115771	PRJNA607574	6		13	3	BM_unmodified	Multiple Myeloma	6fafe8f9dbd494a8801289		0		post	0								
1909G		1909	10	semi-formed	SRR11115770	PRJNA607574	7		13	3	BM_unmodified	Multiple Myeloma	6fafe8f9dbd494a8801289		0		post	0								
1909H		1909	11	semi-formed	SRR11115767	PRJNA607574	8		13	3	BM_unmodified	Multiple Myeloma	6fafe8f9dbd494a8801289		0		post	1								
1909I		1909	14	formed	SRR11115766	PRJNA607574	11		13	3	BM_unmodified	Multiple Myeloma	6fafe8f9dbd494a8801289		0		post	1								
1909J		1909	15	formed	SRR11115765	PRJNA607574	12		13	3	BM_unmodified	Multiple Myeloma	6fafe8f9dbd494a8801289		0		post	1								
1909K		1909	16	formed	SRR11116039	PRJNA607574	13		13	3	BM_unmodified	Multiple Myeloma	6fafe8f9dbd494a8801289		0		post	1								
1909L		1909	17	semi-formed	SRR11116038	PRJNA607574	14		13	3	BM_unmodified	Multiple Myeloma	6fafe8f9dbd494a8801289		0		post	1								
1909M		1909	18	semi-formed	SRR11116037	PRJNA607574	15		13	3	BM_unmodified	Multiple Myeloma	6fafe8f9dbd494a8801289		0		post	2								
190A		190	0	formed	SRR11420722	PRJNA545312	-10		4	10	TCD	Myelodysplastic Syndromes	ad0c33ba953c6aa8a68b6c	150	1		pre	-2								
190B		190	8	formed	SRR11420721	PRJNA545312	-2		4	10	TCD	Myelodysplastic Syndromes	ad0c33ba953c6aa8a68b6c	150	1		pre	-1								
190C		190	15	liquid	SRR11420720	PRJNA545312	5		4	10	TCD	Myelodysplastic Syndromes	ad0c33ba953c6aa8a68b6c	150	1		peri	0								
190D		190	22	liquid	SRR11420719	PRJNA545312	12		4	10	TCD	Myelodysplastic Syndromes	ad0c33ba953c6aa8a68b6c	150	1		post	1								
1911A		1911	0	formed	SRR11116036	PRJNA607574	-3		10	3	PBSC_unmodified	Leukemia	f6ae3c2e5a6c8ed2c9962b		0		pre	-1								
1911B		1911	1	formed	SRR11116035	PRJNA607574	-2		10	3	PBSC_unmodified	Leukemia	f6ae3c2e5a6c8ed2c9962b		0		pre	-1								
1911C		1911	7	semi-formed	SRR11116034	PRJNA607574	4		10	3	PBSC_unmodified	Leukemia	f6ae3c2e5a6c8ed2c9962b		0		peri	0								
1911D		1911	8	liquid	SRR11116033	PRJNA607574	5		10	3	PBSC_unmodified	Leukemia	f6ae3c2e5a6c8ed2c9962b		0		peri	0								
1911F		1911	10	liquid	SRR11396489	PRJNA607574	7		10	3	PBSC_unmodified	Leukemia	f6ae3c2e5a6c8ed2c9962b		0		post	0								
1911H		1911	14	liquid	SRR11116030	PRJNA607574	11		10	3	PBSC_unmodified	Leukemia	f6ae3c2e5a6c8ed2c9962b		0		post	1								
1911I		1911	15	semi-formed	SRR11116029	PRJNA607574	12		10	3	PBSC_unmodified	Leukemia	f6ae3c2e5a6c8ed2c9962b		0		post	1								
1911J		1911	17	semi-formed	SRR11116028	PRJNA607574	14		10	3	PBSC_unmodified	Leukemia	f6ae3c2e5a6c8ed2c9962b		0		post	1								
1911K		1911	57	liquid	SRR11116027	PRJNA607574	54		10	3	PBSC_unmodified	Leukemia	f6ae3c2e5a6c8ed2c9962b		0		post	6								
1911L		1911	95	formed	SRR11116026	PRJNA607574	92		10	3	PBSC_unmodified	Leukemia	f6ae3c2e5a6c8ed2c9962b		0		post	6								
1912A		1912	0	semi-formed	SRR11396487	PRJNA607574			3																	
1912B		1912	35	semi-formed	SRR11396486	PRJNA607574			3																	
1912C		1912	155	semi-formed	SRR11396485	PRJNA607574			3																	
1913A		1913	0	liquid	SRR11396484	PRJNA607574			1																	
1915A		1915	0	liquid	SRR11116025	PRJNA607574	-1		3	1	TCD	Myeloproliferative Disorder	db5a18d3fa0cad732a7610		0		pre	-1								
1915B		1915	1	liquid	SRR11116024	PRJNA607574	0		3	1	TCD	Myeloproliferative Disorder	db5a18d3fa0cad732a7610		0		peri	-1								
1915H		1915	61	semi-formed	SRR11116023	PRJNA607574	60		3	1	TCD	Myeloproliferative Disorder	db5a18d3fa0cad732a7610		0		post	6								
1916A		1916	0	semi-formed	SRR11396483	PRJNA607574			1																	
1917A		1917	0	formed	SRR11116022	PRJNA607574	-3		6	3	PBSC_unmodified	Myelodysplastic Syndromes	d4139dc78c2a060ceb08d5		0		pre	-1								
1917B		1917	1	formed	SRR11116020	PRJNA607574	-2		6	3	PBSC_unmodified	Myelodysplastic Syndromes	d4139dc78c2a060ceb08d5		0		pre	-1								
1917C		1917	4	semi-formed	SRR11116019	PRJNA607574	1		6	3	PBSC_unmodified	Myelodysplastic Syndromes	d4139dc78c2a060ceb08d5		0		peri	0								
1917D		1917	14	semi-formed	SRR11116018	PRJNA607574	11		6	3	PBSC_unmodified	Myelodysplastic Syndromes	d4139dc78c2a060ceb08d5		0		post	1								
1917E		1917	22	formed	SRR11116017	PRJNA607574	19		6	3	PBSC_unmodified	Myelodysplastic Syndromes	d4139dc78c2a060ceb08d5		0		post	2								
1917F		1917	23	formed	SRR11116016	PRJNA607574	20		6	3	PBSC_unmodified	Myelodysplastic Syndromes	d4139dc78c2a060ceb08d5		0		post	2								
1919A		1919	0	liquid	SRR11116015	PRJNA607574	2		17	-2	BM_unmodified	Myelodysplastic Syndromes	2aaa7e47502291d8fec386		0		peri	0								
1919B		1919	2	liquid	SRR11116014	PRJNA607574	4		17	-2	BM_unmodified	Myelodysplastic Syndromes	2aaa7e47502291d8fec386		0		peri	0								
1919C		1919	4	semi-formed	SRR11116013	PRJNA607574	6		17	-2	BM_unmodified	Myelodysplastic Syndromes	2aaa7e47502291d8fec386		0		post	0								
1919D		1919	9	semi-formed	SRR11116012	PRJNA607574	11		17	-2	BM_unmodified	Myelodysplastic Syndromes	2aaa7e47502291d8fec386		0		post	1								
1919E		1919	10	liquid	SRR11116011	PRJNA607574	12		17	-2	BM_unmodified	Myelodysplastic Syndromes	2aaa7e47502291d8fec386		0		post	1								
1919H		1919	22	semi-formed	SRR11116009	PRJNA607574	24		17	-2	BM_unmodified	Myelodysplastic Syndromes	2aaa7e47502291d8fec386		0		post	3								
1919I		1919	28	semi-formed	SRR11116008	PRJNA607574	30		17	-2	BM_unmodified	Myelodysplastic Syndromes	2aaa7e47502291d8fec386		0		post	4								
1919J		1919	32	semi-formed	SRR11115940	PRJNA607574	34		17	-2	BM_unmodified	Myelodysplastic Syndromes	2aaa7e47502291d8fec386		0		post	4								
1919K		1919	33	semi-formed	SRR11115939	PRJNA607574	35		17	-2	BM_unmodified	Myelodysplastic Syndromes	2aaa7e47502291d8fec386		0		post	4								
1919L		1919	37	formed	SRR11115938	PRJNA607574	39		17	-2	BM_unmodified	Myelodysplastic Syndromes	2aaa7e47502291d8fec386		0		post	5								
1919M		1919	42	liquid	SRR11115937	PRJNA607574	44		17	-2	BM_unmodified	Myelodysplastic Syndromes	2aaa7e47502291d8fec386		0		post	6								
1919N		1919	46	semi-formed	SRR11115936	PRJNA607574	48		17	-2	BM_unmodified	Myelodysplastic Syndromes	2aaa7e47502291d8fec386		0		post	6								
1919O		1919	59	formed	SRR11115935	PRJNA607574	61		17	-2	BM_unmodified	Myelodysplastic Syndromes	2aaa7e47502291d8fec386		0		post	6								
1919P		1919	60	semi-formed	SRR11115934	PRJNA607574	62		17	-2	BM_unmodified	Myelodysplastic Syndromes	2aaa7e47502291d8fec386		0		post	6								
1919Q		1919	65	semi-formed	SRR11115933	PRJNA607574	67		17	-2	BM_unmodified	Myelodysplastic Syndromes	2aaa7e47502291d8fec386		0		post	6								
1919R		1919	68	semi-formed	SRR11115931	PRJNA607574	70		17	-2	BM_unmodified	Myelodysplastic Syndromes	2aaa7e47502291d8fec386		0		post	6								
1919S		1919	81	formed	SRR11115930	PRJNA607574	83		17	-2	BM_unmodified	Myelodysplastic Syndromes	2aaa7e47502291d8fec386		0		post	6								
191A		191	0	formed	SRR11420718	PRJNA545312	-5		8	5	cord	Leukemia	94546d0037708ea519d775	16	1		pre	-1								
191B		191	3	formed	SRR11420717	PRJNA545312	-2		8	5	cord	Leukemia	94546d0037708ea519d775	16	1		pre	-1								
191F		191	31	liquid	SRR11420716	PRJNA545312	26		8	5	cord	Leukemia	94546d0037708ea519d775	16	1		post	3								
191G		191	38	semi-formed	SRR11420715	PRJNA545312	33		8	5	cord	Leukemia	94546d0037708ea519d775	16	1		post	4								
191H		191	46	liquid	SRR11420714	PRJNA545312	41		8	5	cord	Leukemia	94546d0037708ea519d775	16	1		post	5								
191I		191	47	liquid	SRR11420713	PRJNA545312	42		8	5	cord	Leukemia	94546d0037708ea519d775	16	1		post	5								
191J		191	53	liquid	SRR11420710	PRJNA545312	48		8	5	cord	Leukemia	94546d0037708ea519d775	16	1		post	6								
191K		191	91	semi-formed	SRR11420709	PRJNA545312	86		8	5	cord	Leukemia	94546d0037708ea519d775	16	1		post	6								
1920B		1920	6	formed	SRR11396480	PRJNA607574			3																	
1920C		1920	7	semi-formed	SRR11396479	PRJNA607574			3																	
1920D		1920	9	semi-formed	SRR11396478	PRJNA607574			3																	
1921A		1921	0	liquid	SRR11115929	PRJNA607574	-1		16	1	PBSC_unmodified	Leukemia	c6d4f5faefc84ec180ad24		0		pre	-1								
1921B		1921	1	liquid	SRR11115928	PRJNA607574	0		16	1	PBSC_unmodified	Leukemia	c6d4f5faefc84ec180ad24		0		peri	-1								
1921C		1921	3	semi-formed	SRR11115927	PRJNA607574	2		16	1	PBSC_unmodified	Leukemia	c6d4f5faefc84ec180ad24		0		peri	0								
1921D		1921	6	semi-formed	SRR11115926	PRJNA607574	5		16	1	PBSC_unmodified	Leukemia	c6d4f5faefc84ec180ad24		0		peri	0								
1921E		1921	7	semi-formed	SRR11115925	PRJNA607574	6		16	1	PBSC_unmodified	Leukemia	c6d4f5faefc84ec180ad24		0		post	0								
1921F		1921	10	semi-formed	SRR11115924	PRJNA607574	9		16	1	PBSC_unmodified	Leukemia	c6d4f5faefc84ec180ad24		0		post	1								
1921G		1921	13	liquid	SRR11115923	PRJNA607574	12		16	1	PBSC_unmodified	Leukemia	c6d4f5faefc84ec180ad24		0		post	1								
1921H		1921	14	semi-formed	SRR11115922	PRJNA607574	13		16	1	PBSC_unmodified	Leukemia	c6d4f5faefc84ec180ad24		0		post	1								
1921I		1921	15	semi-formed	SRR11115920	PRJNA607574	14		16	1	PBSC_unmodified	Leukemia	c6d4f5faefc84ec180ad24		0		post	1								
1921J		1921	16	liquid	SRR11115919	PRJNA607574	15		16	1	PBSC_unmodified	Leukemia	c6d4f5faefc84ec180ad24		0		post	2								
1921K		1921	17	semi-formed	SRR11115918	PRJNA607574	16		16	1	PBSC_unmodified	Leukemia	c6d4f5faefc84ec180ad24		0		post	2								
1921L		1921	21	formed	SRR11115917	PRJNA607574	20		16	1	PBSC_unmodified	Leukemia	c6d4f5faefc84ec180ad24		0		post	2								
1921M		1921	43	semi-formed	SRR11115916	PRJNA607574	42		16	1	PBSC_unmodified	Leukemia	c6d4f5faefc84ec180ad24		0		post	5								
1921N		1921	78	formed	SRR11115915	PRJNA607574	77		16	1	PBSC_unmodified	Leukemia	c6d4f5faefc84ec180ad24		0		post	6								
1921O		1921	183	formed	SRR11115914	PRJNA607574	182		16	1	PBSC_unmodified	Leukemia	c6d4f5faefc84ec180ad24		0		post	6								
1921P		1921	211	formed	SRR11115913	PRJNA607574	210		16	1	PBSC_unmodified	Leukemia	c6d4f5faefc84ec180ad24		0		post	6								
1927A		1927	0	semi-formed	SRR11396476	PRJNA607574			1																	
1928A		1928	0	formed	SRR11115912	PRJNA607574	-3		12	3	PBSC_unmodified	Leukemia	a920fe9ca2510447c02156		0		pre	-1								
1928B		1928	2	formed	SRR11115911	PRJNA607574	-1		12	3	PBSC_unmodified	Leukemia	a920fe9ca2510447c02156		0		pre	-1								
1928C		1928	3	semi-formed	SRR11115909	PRJNA607574	0		12	3	PBSC_unmodified	Leukemia	a920fe9ca2510447c02156		0		peri	-1								
1928D		1928	7	semi-formed	SRR11116007	PRJNA607574	4		12	3	PBSC_unmodified	Leukemia	a920fe9ca2510447c02156		0		peri	0								
1928E		1928	8	formed	SRR11116006	PRJNA607574	5		12	3	PBSC_unmodified	Leukemia	a920fe9ca2510447c02156		0		peri	0								
1928F		1928	9	formed	SRR11116005	PRJNA607574	6		12	3	PBSC_unmodified	Leukemia	a920fe9ca2510447c02156		0		post	0								
1928G		1928	10	liquid	SRR11116004	PRJNA607574	7		12	3	PBSC_unmodified	Leukemia	a920fe9ca2510447c02156		0		post	0								
1928H		1928	16	semi-formed	SRR11116003	PRJNA607574	13		12	3	PBSC_unmodified	Leukemia	a920fe9ca2510447c02156		0		post	1								
1928I		1928	17	semi-formed	SRR11116002	PRJNA607574	14		12	3	PBSC_unmodified	Leukemia	a920fe9ca2510447c02156		0		post	1								
1928J		1928	18	semi-formed	SRR11116001	PRJNA607574	15		12	3	PBSC_unmodified	Leukemia	a920fe9ca2510447c02156		0		post	2								
1928K		1928	21	formed	SRR11116000	PRJNA607574	18		12	3	PBSC_unmodified	Leukemia	a920fe9ca2510447c02156		0		post	2								
1928L		1928	22	semi-formed	SRR11115999	PRJNA607574	19		12	3	PBSC_unmodified	Leukemia	a920fe9ca2510447c02156		0		post	2								
1929A		1929	0	formed	SRR11396475	PRJNA607574			9																	
1929B		1929	2	formed	SRR11396474	PRJNA607574			9																	
1929C		1929	5	liquid	SRR11396473	PRJNA607574			9																	
1929D		1929	6	liquid	SRR11396472	PRJNA607574			9																	
1929E		1929	7	liquid	SRR11396471	PRJNA607574			9																	
1929F		1929	9	liquid	SRR11396470	PRJNA607574			9																	
1929G		1929	13	liquid	SRR11396469	PRJNA607574			9																	
1929H		1929	16	liquid	SRR11396468	PRJNA607574			9																	
1929I		1929	37	semi-formed	SRR11396467	PRJNA607574			9																	
192A		192	0	formed	SRR11420708	PRJNA545312	-3		12	3	cord	Leukemia	80407f9ad1f8cc1f9dd2a0	254	1		pre	-1								
192B		192	4	formed	SRR11420707	PRJNA545312	1		12	3	cord	Leukemia	80407f9ad1f8cc1f9dd2a0	254	1		peri	0								
192C		192	10	liquid	SRR11420706	PRJNA545312	7		12	3	cord	Leukemia	80407f9ad1f8cc1f9dd2a0	254	1		post	0								
192D		192	19	liquid	SRR11420705	PRJNA545312	16		12	3	cord	Leukemia	80407f9ad1f8cc1f9dd2a0	254	1		post	2								
192E		192	24	liquid	SRR11420704	PRJNA545312	21		12	3	cord	Leukemia	80407f9ad1f8cc1f9dd2a0	254	1		post	2								
192F		192	31	liquid	SRR11420703	PRJNA545312	28		12	3	cord	Leukemia	80407f9ad1f8cc1f9dd2a0	254	1		post	3								
192G		192	39	liquid	SRR11420702	PRJNA545312	36		12	3	cord	Leukemia	80407f9ad1f8cc1f9dd2a0	254	1		post	5								
192H		192	45	liquid	SRR11420701	PRJNA545312	42		12	3	cord	Leukemia	80407f9ad1f8cc1f9dd2a0	254	1		post	5								
192I		192	52	semi-formed	SRR11420699	PRJNA545312	49		12	3	cord	Leukemia	80407f9ad1f8cc1f9dd2a0	254	1		post	6								
192J		192	70	liquid	SRR11420698	PRJNA545312	67		12	3	cord	Leukemia	80407f9ad1f8cc1f9dd2a0	254	1		post	6								
192K		192	73	semi-formed	SRR11420697	PRJNA545312	70		12	3	cord	Leukemia	80407f9ad1f8cc1f9dd2a0	254	1		post	6								
192L		192	95	semi-formed	SRR11420696	PRJNA545312	92		12	3	cord	Leukemia	80407f9ad1f8cc1f9dd2a0	254	1		post	6								
1930A		1930	275	semi-formed	SRR11396465	PRJNA607574			6																	
1930B		1930	315	semi-formed	SRR11396464	PRJNA607574			6																	
1930C		1930	324	semi-formed	SRR11396463	PRJNA607574			6																	
1930D		1930	0	semi-formed	SRR11396462	PRJNA607574			6																	
1930E		1930	368	semi-formed	SRR11396461	PRJNA607574			6																	
1930F		1930	450	semi-formed	SRR11396460	PRJNA607574			6																	
1931A		1931	0	formed	SRR11396459	PRJNA607574			3																	
1931B		1931	1	liquid	SRR11396458	PRJNA607574			3																	
1931E		1931	97	semi-formed	SRR11396457	PRJNA607574			3																	
1934A		1934	0	formed	SRR11115997	PRJNA607574	-2		12	2	BM_unmodified	Myelodysplastic Syndromes	367100a0d03bda18e3de43		0		pre	-1								
1934B		1934	1	formed	SRR11115996	PRJNA607574	-1		12	2	BM_unmodified	Myelodysplastic Syndromes	367100a0d03bda18e3de43		0		pre	-1								
1934C		1934	2	formed	SRR11115995	PRJNA607574	0		12	2	BM_unmodified	Myelodysplastic Syndromes	367100a0d03bda18e3de43		0		peri	-1								
1934D		1934	3	formed	SRR11115994	PRJNA607574	1		12	2	BM_unmodified	Myelodysplastic Syndromes	367100a0d03bda18e3de43		0		peri	0								
1934E		1934	4	semi-formed	SRR11115993	PRJNA607574	2		12	2	BM_unmodified	Myelodysplastic Syndromes	367100a0d03bda18e3de43		0		peri	0								
1934F		1934	5	liquid	SRR11115992	PRJNA607574	3		12	2	BM_unmodified	Myelodysplastic Syndromes	367100a0d03bda18e3de43		0		peri	0								
1934G		1934	10	semi-formed	SRR11115991	PRJNA607574	8		12	2	BM_unmodified	Myelodysplastic Syndromes	367100a0d03bda18e3de43		0		post	1								
1934H		1934	14	semi-formed	SRR11115990	PRJNA607574	12		12	2	BM_unmodified	Myelodysplastic Syndromes	367100a0d03bda18e3de43		0		post	1								
1934I		1934	17	liquid	SRR11115989	PRJNA607574	15		12	2	BM_unmodified	Myelodysplastic Syndromes	367100a0d03bda18e3de43		0		post	2								
1934J		1934	21	formed	SRR11115988	PRJNA607574	19		12	2	BM_unmodified	Myelodysplastic Syndromes	367100a0d03bda18e3de43		0		post	2								
1934K		1934	22	formed	SRR11115986	PRJNA607574	20		12	2	BM_unmodified	Myelodysplastic Syndromes	367100a0d03bda18e3de43		0		post	2								
1934L		1934	24	semi-formed	SRR11115985	PRJNA607574	22		12	2	BM_unmodified	Myelodysplastic Syndromes	367100a0d03bda18e3de43		0		post	3								
1935A		1935	0	formed	SRR11396456	PRJNA607574			7																	
1935B		1935	3	formed	SRR11396454	PRJNA607574			7																	
1935C		1935	9	semi-formed	SRR11396453	PRJNA607574			7																	
1935D		1935	10	liquid	SRR11396452	PRJNA607574			7																	
1935E		1935	11	liquid	SRR11396450	PRJNA607574			7																	
1935G		1935	16	liquid	SRR11397100	PRJNA607574			7																	
1935I		1935	65	formed	SRR11397099	PRJNA607574			7																	
1937B		1937	3	formed	SRR11115984	PRJNA607574	1		7	2	PBSC_unmodified	Myelodysplastic Syndromes	09c0282988adf4e712f0b8		0		peri	0								
1937C		1937	7	semi-formed	SRR11115983	PRJNA607574	5		7	2	PBSC_unmodified	Myelodysplastic Syndromes	09c0282988adf4e712f0b8		0		peri	0								
1937D		1937	8	semi-formed	SRR11115982	PRJNA607574	6		7	2	PBSC_unmodified	Myelodysplastic Syndromes	09c0282988adf4e712f0b8		0		post	0								
1937E		1937	9	semi-formed	SRR11115981	PRJNA607574	7		7	2	PBSC_unmodified	Myelodysplastic Syndromes	09c0282988adf4e712f0b8		0		post	0								
1937F		1937	13	semi-formed	SRR11115980	PRJNA607574	11		7	2	PBSC_unmodified	Myelodysplastic Syndromes	09c0282988adf4e712f0b8		0		post	1								
1937G		1937	14	semi-formed	SRR11115979	PRJNA607574	12		7	2	PBSC_unmodified	Myelodysplastic Syndromes	09c0282988adf4e712f0b8		0		post	1								
1937H		1937	16	semi-formed	SRR11115978	PRJNA607574	14		7	2	PBSC_unmodified	Myelodysplastic Syndromes	09c0282988adf4e712f0b8		0		post	1								
1939A		1939	0	semi-formed	SRR11397097	PRJNA607574			13																	
1939B		1939	6	semi-formed	SRR11397096	PRJNA607574			13																	
1939C		1939	8	semi-formed	SRR11397095	PRJNA607574			13																	
1939D		1939	11	liquid	SRR11397093	PRJNA607574			13																	
1939E		1939	12	liquid	SRR11397092	PRJNA607574			13																	
1939F		1939	13	liquid	SRR11397091	PRJNA607574			13																	
1939G		1939	14	semi-formed	SRR11397090	PRJNA607574			13																	
1939H		1939	15	liquid	SRR11397089	PRJNA607574			13																	
1939I		1939	16	liquid	SRR11397088	PRJNA607574			13																	
1939J		1939	19	liquid	SRR11397087	PRJNA607574			13																	
1939K		1939	20	liquid	SRR11397086	PRJNA607574			13																	
1939L		1939	21	liquid	SRR11397085	PRJNA607574			13																	
1939M		1939	22	liquid	SRR11397084	PRJNA607574			13																	
193A		193	0	formed	SRR11420695	PRJNA545312	-10		8	10	TCD	Multiple Myeloma	4ac5043d4517f59cd5b7a2	95	1		pre	-2								
193B		193	7	semi-formed	SRR11420694	PRJNA545312	-3		8	10	TCD	Multiple Myeloma	4ac5043d4517f59cd5b7a2	95	1		pre	-1								
193C		193	14	liquid	SRR11420693	PRJNA545312	4		8	10	TCD	Multiple Myeloma	4ac5043d4517f59cd5b7a2	95	1		peri	0								
193D		193	21	liquid	SRR11420692	PRJNA545312	11		8	10	TCD	Multiple Myeloma	4ac5043d4517f59cd5b7a2	95	1		post	1								
193E		193	56	semi-formed	SRR11420691	PRJNA545312	46		8	10	TCD	Multiple Myeloma	4ac5043d4517f59cd5b7a2	95	1		post	6								
193F		193	57	semi-formed	SRR11420690	PRJNA545312	47		8	10	TCD	Multiple Myeloma	4ac5043d4517f59cd5b7a2	95	1		post	6								
193G		193	59	semi-formed	SRR11420688	PRJNA545312	49		8	10	TCD	Multiple Myeloma	4ac5043d4517f59cd5b7a2	95	1		post	6								
193H		193	70	semi-formed	SRR11420687	PRJNA545312	60		8	10	TCD	Multiple Myeloma	4ac5043d4517f59cd5b7a2	95	1		post	6								
1943B		1943	1	formed	SRR11397081	PRJNA607574			4																	
1943C		1943	3	formed	SRR11397080	PRJNA607574			4																	
1943D		1943	4	formed	SRR11397079	PRJNA607574			4																	
1943E		1943	10	semi-formed	SRR11397078	PRJNA607574			4																	
1944C		1944	72	liquid	SRR11397077	PRJNA607574			1																	
1945A		1945	0	semi-formed	SRR11115977	PRJNA607574	6		9	-6	PBSC_unmodified	Leukemia	ce71dd61255e04c46bc349		0		post	0								
1945B		1945	3	formed	SRR11115972	PRJNA607574	9		9	-6	PBSC_unmodified	Leukemia	ce71dd61255e04c46bc349		0		post	1								
1945C		1945	8	formed	SRR11115971	PRJNA607574	14		9	-6	PBSC_unmodified	Leukemia	ce71dd61255e04c46bc349		0		post	1								
1945E		1945	14	semi-formed	SRR11115970	PRJNA607574	20		9	-6	PBSC_unmodified	Leukemia	ce71dd61255e04c46bc349		0		post	2								
1945F		1945	15	semi-formed	SRR11115969	PRJNA607574	21		9	-6	PBSC_unmodified	Leukemia	ce71dd61255e04c46bc349		0		post	2								
1945G		1945	16	semi-formed	SRR11115968	PRJNA607574	22		9	-6	PBSC_unmodified	Leukemia	ce71dd61255e04c46bc349		0		post	3								
1945I		1945	20	formed	SRR11115967	PRJNA607574	26		9	-6	PBSC_unmodified	Leukemia	ce71dd61255e04c46bc349		0		post	3								
1945J		1945	34	liquid	SRR11115966	PRJNA607574	40		9	-6	PBSC_unmodified	Leukemia	ce71dd61255e04c46bc349		0		post	5								
1945K		1945	45	semi-formed	SRR11115965	PRJNA607574	51		9	-6	PBSC_unmodified	Leukemia	ce71dd61255e04c46bc349		0		post	6								
1946A		1946	0	liquid	SRR11397075	PRJNA607574			5																	
1946B		1946	5	liquid	SRR11397074	PRJNA607574			5																	
1946C		1946	7	liquid	SRR11397073	PRJNA607574			5																	
1946D		1946	49	formed	SRR11397071	PRJNA607574			5																	
1946E		1946	97	formed	SRR11397070	PRJNA607574			5																	
1949A		1949	0	formed	SRR11115964	PRJNA607574	-6		11	6	TCD	Myelodysplastic Syndromes	d030c9790bf5f3616990c8		0		pre	-1								
1949B		1949	3	formed	SRR11115963	PRJNA607574	-3		11	6	TCD	Myelodysplastic Syndromes	d030c9790bf5f3616990c8		0		pre	-1								
1949C		1949	5	liquid	SRR11115960	PRJNA607574	-1		11	6	TCD	Myelodysplastic Syndromes	d030c9790bf5f3616990c8		0		pre	-1								
1949D		1949	6	liquid	SRR11115959	PRJNA607574	0		11	6	TCD	Myelodysplastic Syndromes	d030c9790bf5f3616990c8		0		peri	-1								
1949E		1949	8	liquid	SRR11115958	PRJNA607574	2		11	6	TCD	Myelodysplastic Syndromes	d030c9790bf5f3616990c8		0		peri	0								
1949H		1949	35	formed	SRR11115957	PRJNA607574	29		11	6	TCD	Myelodysplastic Syndromes	d030c9790bf5f3616990c8		0		post	4								
1949I		1949	39	formed	SRR11115956	PRJNA607574	33		11	6	TCD	Myelodysplastic Syndromes	d030c9790bf5f3616990c8		0		post	4								
1949J		1949	40	formed	SRR11115955	PRJNA607574	34		11	6	TCD	Myelodysplastic Syndromes	d030c9790bf5f3616990c8		0		post	4								
1949K		1949	41	semi-formed	SRR11115954	PRJNA607574	35		11	6	TCD	Myelodysplastic Syndromes	d030c9790bf5f3616990c8		0		post	4								
1949L		1949	42	formed	SRR11115953	PRJNA607574	36		11	6	TCD	Myelodysplastic Syndromes	d030c9790bf5f3616990c8		0		post	5								
1949M		1949	45	formed	SRR11115952	PRJNA607574	39		11	6	TCD	Myelodysplastic Syndromes	d030c9790bf5f3616990c8		0		post	5								
194A		194	0	semi-formed	SRR11420686	PRJNA545312	-9		7	9	TCD	Leukemia	f954b631deb524009ce371	230	1		pre	-2								
194B		194	5	liquid	SRR11420685	PRJNA545312	-4		7	9	TCD	Leukemia	f954b631deb524009ce371	230	1		pre	-1								
194C		194	13	liquid	SRR11420684	PRJNA545312	4		7	9	TCD	Leukemia	f954b631deb524009ce371	230	1		peri	0								
194F		194	36	semi-formed	SRR11420683	PRJNA545312	27		7	9	TCD	Leukemia	f954b631deb524009ce371	230	1		post	3								
194G		194	94	formed	SRR11420682	PRJNA545312	85		7	9	TCD	Leukemia	f954b631deb524009ce371	230	1		post	6								
194H		194	96	formed	SRR11420681	PRJNA545312	87		7	9	TCD	Leukemia	f954b631deb524009ce371	230	1		post	6								
194I		194	582	semi-formed	SRR11420680	PRJNA545312	573		7	9	TCD	Leukemia	f954b631deb524009ce371	230	1		post	6								
1950A		1950	0	semi-formed	SRR11397068	PRJNA607574			3																	
1950B		1950	41	semi-formed	SRR11397067	PRJNA607574			3																	
1950C		1950	118	semi-formed	SRR11397066	PRJNA607574			3																	
1951A		1951	0	formed	SRR11115951	PRJNA607574	-3		7	3	TCD	Leukemia	d7b364fd8b7d9cd9626c9e		0		pre	-1								
1951B		1951	3	liquid	SRR11115949	PRJNA607574	0		7	3	TCD	Leukemia	d7b364fd8b7d9cd9626c9e		0		peri	-1								
1951C		1951	4	liquid	SRR11115948	PRJNA607574	1		7	3	TCD	Leukemia	d7b364fd8b7d9cd9626c9e		0		peri	0								
1951D		1951	8	liquid	SRR11115947	PRJNA607574	5		7	3	TCD	Leukemia	d7b364fd8b7d9cd9626c9e		0		peri	0								
1951E		1951	11	liquid	SRR11115946	PRJNA607574	8		7	3	TCD	Leukemia	d7b364fd8b7d9cd9626c9e		0		post	1								
1951G		1951	17	semi-formed	SRR11115945	PRJNA607574	14		7	3	TCD	Leukemia	d7b364fd8b7d9cd9626c9e		0		post	1								
1951H		1951	81	semi-formed	SRR11115944	PRJNA607574	78		7	3	TCD	Leukemia	d7b364fd8b7d9cd9626c9e		0		post	6								
1953A		1953	0	liquid	SRR11115943	PRJNA607574	-4		6	4	PBSC_unmodified	Hodgkin's Disease	64c2cf418c5ba6114eb440		0		pre	-1								
1953B		1953	6	semi-formed	SRR11115942	PRJNA607574	2		6	4	PBSC_unmodified	Hodgkin's Disease	64c2cf418c5ba6114eb440		0		peri	0								
1953C		1953	8	liquid	SRR11115941	PRJNA607574	4		6	4	PBSC_unmodified	Hodgkin's Disease	64c2cf418c5ba6114eb440		0		peri	0								
1953D		1953	23	semi-formed	SRR11115764	PRJNA607574	19		6	4	PBSC_unmodified	Hodgkin's Disease	64c2cf418c5ba6114eb440		0		post	2								
1953E		1953	77	semi-formed	SRR11115762	PRJNA607574	73		6	4	PBSC_unmodified	Hodgkin's Disease	64c2cf418c5ba6114eb440		0		post	6								
1953F		1953	78	semi-formed	SRR11115761	PRJNA607574	74		6	4	PBSC_unmodified	Hodgkin's Disease	64c2cf418c5ba6114eb440		0		post	6								
1954A		1954	0	semi-formed	SRR11397064	PRJNA607574			3																	
1954B		1954	30	formed	SRR11397063	PRJNA607574			3																	
1954C		1954	114	formed	SRR11397062	PRJNA607574			3																	
1955A		1955	0	semi-formed	SRR11397060	PRJNA607574			4																	
1955B		1955	14	semi-formed	SRR11397059	PRJNA607574			4																	
1955C		1955	48	semi-formed	SRR11397058	PRJNA607574			4																	
1955D		1955	148	semi-formed	SRR11397057	PRJNA607574			4																	
1957A		1957	0	formed	SRR11115760	PRJNA607574	-9		13	9	TCD	Leukemia	eada1e78c77ce18dc88eec		0		pre	-2								
1957B		1957	1	formed	SRR11115759	PRJNA607574	-8		13	9	TCD	Leukemia	eada1e78c77ce18dc88eec		0		pre	-2								
1957C		1957	2	formed	SRR11115758	PRJNA607574	-7		13	9	TCD	Leukemia	eada1e78c77ce18dc88eec		0		pre	-2								
1957D		1957	5	semi-formed	SRR11115757	PRJNA607574	-4		13	9	TCD	Leukemia	eada1e78c77ce18dc88eec		0		pre	-1								
1957E		1957	6	semi-formed	SRR11115756	PRJNA607574	-3		13	9	TCD	Leukemia	eada1e78c77ce18dc88eec		0		pre	-1								
1957F		1957	7	liquid	SRR11115755	PRJNA607574	-2		13	9	TCD	Leukemia	eada1e78c77ce18dc88eec		0		pre	-1								
1957G		1957	8	liquid	SRR11115754	PRJNA607574	-1		13	9	TCD	Leukemia	eada1e78c77ce18dc88eec		0		pre	-1								
1957H		1957	9	liquid	SRR11115753	PRJNA607574	0		13	9	TCD	Leukemia	eada1e78c77ce18dc88eec		0		peri	-1								
1957I		1957	10	liquid	SRR11115751	PRJNA607574	1		13	9	TCD	Leukemia	eada1e78c77ce18dc88eec		0		peri	0								
1957L		1957	16	liquid	SRR11115750	PRJNA607574	7		13	9	TCD	Leukemia	eada1e78c77ce18dc88eec		0		post	0								
1957O		1957	49	formed	SRR11115749	PRJNA607574	40		13	9	TCD	Leukemia	eada1e78c77ce18dc88eec		0		post	5								
1957P		1957	83	formed	SRR11115748	PRJNA607574	74		13	9	TCD	Leukemia	eada1e78c77ce18dc88eec		0		post	6								
1957Q		1957	96	formed	SRR11115747	PRJNA607574	87		13	9	TCD	Leukemia	eada1e78c77ce18dc88eec		0		post	6								
1959A		1959	0	formed	SRR11115746	PRJNA607574	-7		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		pre	-2								
1959B		1959	3	formed	SRR11115745	PRJNA607574	-4		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		pre	-1								
1959C		1959	4	formed	SRR11115744	PRJNA607574	-3		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		pre	-1								
1959D		1959	5	formed	SRR11115743	PRJNA607574	-2		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		pre	-1								
1959E		1959	6	formed	SRR11115742	PRJNA607574	-1		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		pre	-1								
1959F		1959	10	formed	SRR11115740	PRJNA607574	3		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		peri	0								
1959G		1959	11	formed	SRR11115739	PRJNA607574	4		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		peri	0								
1959H		1959	12	semi-formed	SRR11115738	PRJNA607574	5		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		peri	0								
1959I		1959	13	formed	SRR11115737	PRJNA607574	6		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		post	0								
1959J		1959	14	formed	SRR11115736	PRJNA607574	7		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		post	0								
1959K		1959	17	formed	SRR11115735	PRJNA607574	10		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		post	1								
1959L		1959	18	formed	SRR11115734	PRJNA607574	11		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		post	1								
1959M		1959	19	semi-formed	SRR11115733	PRJNA607574	12		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		post	1								
1959N		1959	24	semi-formed	SRR11115732	PRJNA607574	17		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		post	2								
1959P		1959	27	semi-formed	SRR11115731	PRJNA607574	20		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		post	2								
1959Q		1959	28	semi-formed	SRR11115729	PRJNA607574	21		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		post	2								
1959R		1959	31	formed	SRR11115728	PRJNA607574	24		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		post	3								
1959S		1959	32	formed	SRR11115727	PRJNA607574	25		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		post	3								
1959T		1959	33	formed	SRR11115726	PRJNA607574	26		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		post	3								
1959U		1959	34	semi-formed	SRR11115725	PRJNA607574	27		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		post	3								
1959V		1959	35	semi-formed	SRR11115724	PRJNA607574	28		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		post	3								
1959W		1959	36	formed	SRR11115723	PRJNA607574	29		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		post	4								
1959X		1959	39	formed	SRR11115722	PRJNA607574	32		23	7	TCD	Leukemia	e2e0c9b3af25db7f477b6e		0		post	4								
195A		195	0	semi-formed	SRR11420679	PRJNA545312	-2		5	2	TCD	Myelodysplastic Syndromes	b94ca1ba5615e5b044304a	257	1		pre	-1								
195B		195	7	semi-formed	SRR11421353	PRJNA545312	5		5	2	TCD	Myelodysplastic Syndromes	b94ca1ba5615e5b044304a	257	1		peri	0								
195C		195	12	semi-formed	SRR11421352	PRJNA545312	10		5	2	TCD	Myelodysplastic Syndromes	b94ca1ba5615e5b044304a	257	1		post	1								
195D		195	14	semi-formed	SRR11419598	PRJNA545312	12		5	2	TCD	Myelodysplastic Syndromes	b94ca1ba5615e5b044304a	257	1		post	1								
195E		195	99	formed	SRR11419587	PRJNA545312	97		5	2	TCD	Myelodysplastic Syndromes	b94ca1ba5615e5b044304a	257	1		post	6								
1960A		1960	0	semi-formed	SRR11397056	PRJNA607574			5																	
1960B		1960	4	liquid	SRR11397055	PRJNA607574			5																	
1960C		1960	5	semi-formed	SRR11397054	PRJNA607574			5																	
1960D		1960	10	formed	SRR11397053	PRJNA607574			5																	
1960E		1960	48	semi-formed	SRR11397052	PRJNA607574			5																	
1964A		1964	0	formed	SRR11397051	PRJNA607574			6																	
1964B		1964	5		SRR11397049	PRJNA607574			6																	
1964C		1964	6	semi-formed	SRR11397048	PRJNA607574			6																	
1964D		1964	7	semi-formed	SRR11397047	PRJNA607574			6																	
1964E		1964	17	formed	SRR11397046	PRJNA607574			6																	
1964F		1964	32	formed	SRR11397045	PRJNA607574			6																	
1965A		1965	0	semi-formed	SRR11115721	PRJNA607574	-3		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		pre	-1								
1965B		1965	1	semi-formed	SRR11115720	PRJNA607574	-2		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		pre	-1								
1965C		1965	3	semi-formed	SRR11115718	PRJNA607574	0		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		peri	-1								
1965D		1965	6	semi-formed	SRR11115717	PRJNA607574	3		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		peri	0								
1965E		1965	7	liquid	SRR11115716	PRJNA607574	4		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		peri	0								
1965F		1965	8	semi-formed	SRR11115715	PRJNA607574	5		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		peri	0								
1965G		1965	11	semi-formed	SRR11115714	PRJNA607574	8		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		post	1								
1965H		1965	13	semi-formed	SRR11115713	PRJNA607574	10		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		post	1								
1965I		1965	14	liquid	SRR11115712	PRJNA607574	11		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		post	1								
1965J		1965	15	semi-formed	SRR11115711	PRJNA607574	12		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		post	1								
1965K		1965	20	semi-formed	SRR11115710	PRJNA607574	17		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		post	2								
1965L		1965	21	liquid	SRR11115709	PRJNA607574	18		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		post	2								
1965M		1965	28	semi-formed	SRR11115707	PRJNA607574	25		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		post	3								
1965N		1965	29	semi-formed	SRR11115706	PRJNA607574	26		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		post	3								
1965O		1965	30	semi-formed	SRR11115705	PRJNA607574	27		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		post	3								
1965P		1965	31	semi-formed	SRR11115704	PRJNA607574	28		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		post	3								
1965Q		1965	35	semi-formed	SRR11115703	PRJNA607574	32		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		post	4								
1965R		1965	37	liquid	SRR11115702	PRJNA607574	34		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		post	4								
1965S		1965	41	formed	SRR11115701	PRJNA607574	38		19	3	cord	Leukemia	ffe9f50b4d9ae12e3ae671		0		post	5								
1966A		1966	0	semi-formed	SRR11115700	PRJNA607574	-10		9	10	TCD	Myeloproliferative Disorder	22c2c616ce6666d0e34fcd		0		pre	-2								
1966B		1966	2	formed	SRR11115699	PRJNA607574	-8		9	10	TCD	Myeloproliferative Disorder	22c2c616ce6666d0e34fcd		0		pre	-2								
1966C		1966	3	formed	SRR11115698	PRJNA607574	-7		9	10	TCD	Myeloproliferative Disorder	22c2c616ce6666d0e34fcd		0		pre	-2								
1966D		1966	8	semi-formed	SRR11115696	PRJNA607574	-2		9	10	TCD	Myeloproliferative Disorder	22c2c616ce6666d0e34fcd		0		pre	-1								
1966E		1966	14	liquid	SRR11115695	PRJNA607574	4		9	10	TCD	Myeloproliferative Disorder	22c2c616ce6666d0e34fcd		0		peri	0								
1966F		1966	15	liquid	SRR11115694	PRJNA607574	5		9	10	TCD	Myeloproliferative Disorder	22c2c616ce6666d0e34fcd		0		peri	0								
1966H		1966	23	formed	SRR11115693	PRJNA607574	13		9	10	TCD	Myeloproliferative Disorder	22c2c616ce6666d0e34fcd		0		post	1								
1966I		1966	29	semi-formed	SRR11115692	PRJNA607574	19		9	10	TCD	Myeloproliferative Disorder	22c2c616ce6666d0e34fcd		0		post	2								
1966J		1966	30	semi-formed	SRR11115691	PRJNA607574	20		9	10	TCD	Myeloproliferative Disorder	22c2c616ce6666d0e34fcd		0		post	2								
196A		196	0	formed	SRR11419548	PRJNA545312	-6		4	6	TCD	Myelodysplastic Syndromes	38ff87198e6497bae6a02f	171	1		pre	-1								
196B		196	4	semi-formed	SRR11419537	PRJNA545312	-2		4	6	TCD	Myelodysplastic Syndromes	38ff87198e6497bae6a02f	171	1		pre	-1								
196C		196	19	liquid	SRR11419525	PRJNA545312	13		4	6	TCD	Myelodysplastic Syndromes	38ff87198e6497bae6a02f	171	1		post	1								
196D		196	28	semi-formed	SRR11419784	PRJNA545312	22		4	6	TCD	Myelodysplastic Syndromes	38ff87198e6497bae6a02f	171	1		post	3								
1973A		1973	0	semi-formed	SRR11397044	PRJNA607574			4																	
1973B		1973	15	semi-formed	SRR11397043	PRJNA607574			4																	
1973C		1973	49	semi-formed	SRR11397042	PRJNA607574			4																	
1973D		1973	133	formed	SRR11397041	PRJNA607574			4																	
1974A		1974	0	semi-formed	SRR11397040	PRJNA607574			4																	
1974B		1974	19	semi-formed	SRR11397037	PRJNA607574			4																	
1974C		1974	49	semi-formed	SRR11397036	PRJNA607574			4																	
1974D		1974	133	semi-formed	SRR11397035	PRJNA607574			4																	
1975B		1975	0	liquid	SRR11397034	PRJNA607574	11		5	-11	PBSC_unmodified	Leukemia	bee0109281dca839b8a80d		0		post	1								
1975C		1975	1	liquid	SRR11115689	PRJNA607574	12		5	-11	PBSC_unmodified	Leukemia	bee0109281dca839b8a80d		0		post	1								
1975D		1975	2	liquid	SRR11115688	PRJNA607574	13		5	-11	PBSC_unmodified	Leukemia	bee0109281dca839b8a80d		0		post	1								
1975E		1975	3	liquid	SRR11115687	PRJNA607574	14		5	-11	PBSC_unmodified	Leukemia	bee0109281dca839b8a80d		0		post	1								
1975F		1975	13	liquid	SRR11115685	PRJNA607574	24		5	-11	PBSC_unmodified	Leukemia	bee0109281dca839b8a80d		0		post	3								
1976A		1976	0	formed	SRR11115684	PRJNA607574	-4		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	f80d95b92eec78b4adda70		0		pre	-1								
1976B		1976	6	formed	SRR11115683	PRJNA607574	2		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	f80d95b92eec78b4adda70		0		peri	0								
1976C		1976	7	liquid	SRR11115682	PRJNA607574	3		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	f80d95b92eec78b4adda70		0		peri	0								
1976D		1976	8	liquid	SRR11115681	PRJNA607574	4		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	f80d95b92eec78b4adda70		0		peri	0								
1976E		1976	15	formed	SRR11115680	PRJNA607574	11		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	f80d95b92eec78b4adda70		0		post	1								
1976F		1976	23	semi-formed	SRR11115679	PRJNA607574	19		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	f80d95b92eec78b4adda70		0		post	2								
1976G		1976	44	formed	SRR11115678	PRJNA607574	40		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	f80d95b92eec78b4adda70		0		post	5								
1976H		1976	55	semi-formed	SRR11115677	PRJNA607574	51		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	f80d95b92eec78b4adda70		0		post	6								
1976I		1976	56	formed	SRR11126654	PRJNA607574	52		9	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	f80d95b92eec78b4adda70		0		post	6								
1977A		1977	0	formed	SRR11397033	PRJNA607574			1																	
1978A		1978	0	semi-formed	SRR11397032	PRJNA607574			1																	
1979A		1979	0		SRR11397031	PRJNA607574			4																	
1979B		1979	8	semi-formed	SRR11397030	PRJNA607574			4																	
1979C		1979	52	semi-formed	SRR11397029	PRJNA607574			4																	
1979D		1979	127	formed	SRR11397028	PRJNA607574			4																	
197C		197	10	liquid	SRR11419773	PRJNA545312	5		4	5	cord	Non-Hodgkin's Lymphoma	83621fda12b1668c68bdd6		1		peri	0								
197D		197	12	liquid	SRR11419436	PRJNA545312	7		4	5	cord	Non-Hodgkin's Lymphoma	83621fda12b1668c68bdd6		1		post	0								
197E		197	18	liquid	SRR11419425	PRJNA545312	13		4	5	cord	Non-Hodgkin's Lymphoma	83621fda12b1668c68bdd6		1		post	1								
197F		197	24	semi-formed	SRR11419414	PRJNA545312	19		4	5	cord	Non-Hodgkin's Lymphoma	83621fda12b1668c68bdd6		1		post	2								
1980A		1980	0	semi-formed	SRR11397026	PRJNA607574			1																	
1981A		1981	0	semi-formed	SRR11116653	PRJNA607574	-6		12	6	TCD	Multiple Myeloma	b58ba077c38b5ba80996ea		0		pre	-1								
1981B		1981	4	formed	SRR11116652	PRJNA607574	-2		12	6	TCD	Multiple Myeloma	b58ba077c38b5ba80996ea		0		pre	-1								
1981C		1981	5	formed	SRR11116764	PRJNA607574	-1		12	6	TCD	Multiple Myeloma	b58ba077c38b5ba80996ea		0		pre	-1								
1981D		1981	6	formed	SRR11117130	PRJNA607574	0		12	6	TCD	Multiple Myeloma	b58ba077c38b5ba80996ea		0		peri	-1								
1981E		1981	10	liquid	SRR11116991	PRJNA607574	4		12	6	TCD	Multiple Myeloma	b58ba077c38b5ba80996ea		0		peri	0								
1981F		1981	12	formed	SRR11116494	PRJNA607574	6		12	6	TCD	Multiple Myeloma	b58ba077c38b5ba80996ea		0		post	0								
1981G		1981	13	formed	SRR11116915	PRJNA607574	7		12	6	TCD	Multiple Myeloma	b58ba077c38b5ba80996ea		0		post	0								
1981H		1981	14	formed	SRR11117117	PRJNA607574	8		12	6	TCD	Multiple Myeloma	b58ba077c38b5ba80996ea		0		post	1								
1981I		1981	15	formed	SRR11116385	PRJNA607574	9		12	6	TCD	Multiple Myeloma	b58ba077c38b5ba80996ea		0		post	1								
1981K		1981	18	formed	SRR11116370	PRJNA607574	12		12	6	TCD	Multiple Myeloma	b58ba077c38b5ba80996ea		0		post	1								
1981L		1981	19	formed	SRR11116651	PRJNA607574	13		12	6	TCD	Multiple Myeloma	b58ba077c38b5ba80996ea		0		post	1								
1981M		1981	20	formed	SRR11116640	PRJNA607574	14		12	6	TCD	Multiple Myeloma	b58ba077c38b5ba80996ea		0		post	1								
1982A		1982	0	semi-formed	SRR11397025	PRJNA607574			3																	
1982B		1982	8	semi-formed	SRR11397024	PRJNA607574			3																	
1982C		1982	50	semi-formed	SRR11397023	PRJNA607574			3																	
1986A		1986	0	semi-formed	SRR11116629	PRJNA607574	-3		15	3	PBSC_unmodified	Leukemia	917f9f387fe40ee82e0145		0		pre	-1								
1986B		1986	1	semi-formed	SRR11116841	PRJNA607574	-2		15	3	PBSC_unmodified	Leukemia	917f9f387fe40ee82e0145		0		pre	-1								
1986C		1986	3	semi-formed	SRR11116830	PRJNA607574	0		15	3	PBSC_unmodified	Leukemia	917f9f387fe40ee82e0145		0		peri	-1								
1986D		1986	4	liquid	SRR11116819	PRJNA607574	1		15	3	PBSC_unmodified	Leukemia	917f9f387fe40ee82e0145		0		peri	0								
1986E		1986	5	liquid	SRR11116808	PRJNA607574	2		15	3	PBSC_unmodified	Leukemia	917f9f387fe40ee82e0145		0		peri	0								
1986F		1986	7	liquid	SRR11116797	PRJNA607574	4		15	3	PBSC_unmodified	Leukemia	917f9f387fe40ee82e0145		0		peri	0								
1986G		1986	9	liquid	SRR11116786	PRJNA607574	6		15	3	PBSC_unmodified	Leukemia	917f9f387fe40ee82e0145		0		post	0								
1986J		1986	15	liquid	SRR11116775	PRJNA607574	12		15	3	PBSC_unmodified	Leukemia	917f9f387fe40ee82e0145		0		post	1								
1986O		1986	32	liquid	SRR11116763	PRJNA607574	29		15	3	PBSC_unmodified	Leukemia	917f9f387fe40ee82e0145		0		post	4								
1986P		1986	39	liquid	SRR11116752	PRJNA607574	36		15	3	PBSC_unmodified	Leukemia	917f9f387fe40ee82e0145		0		post	5								
1986S		1986	43	semi-formed	SRR11116741	PRJNA607574	40		15	3	PBSC_unmodified	Leukemia	917f9f387fe40ee82e0145		0		post	5								
1986U		1986	45	liquid	SRR11397022	PRJNA607574	42		15	3	PBSC_unmodified	Leukemia	917f9f387fe40ee82e0145		0		post	5								
1986V		1986	46	semi-formed	SRR11116719	PRJNA607574	43		15	3	PBSC_unmodified	Leukemia	917f9f387fe40ee82e0145		0		post	6								
1986W		1986	53	semi-formed	SRR11116680	PRJNA607574	50		15	3	PBSC_unmodified	Leukemia	917f9f387fe40ee82e0145		0		post	6								
1986X		1986	57	semi-formed	SRR11116669	PRJNA607574	54		15	3	PBSC_unmodified	Leukemia	917f9f387fe40ee82e0145		0		post	6								
1987A		1987	0	formed	SRR11116658	PRJNA607574	-3		16	3	cord	Leukemia	833bd600fc6bd568ad000a		0		pre	-1								
1987B		1987	6	liquid	SRR11117152	PRJNA607574	3		16	3	cord	Leukemia	833bd600fc6bd568ad000a		0		peri	0								
1987C		1987	9	liquid	SRR11117141	PRJNA607574	6		16	3	cord	Leukemia	833bd600fc6bd568ad000a		0		post	0								
1987D		1987	10	liquid	SRR11117101	PRJNA607574	7		16	3	cord	Leukemia	833bd600fc6bd568ad000a		0		post	0								
1987E		1987	14	liquid	SRR11117090	PRJNA607574	11		16	3	cord	Leukemia	833bd600fc6bd568ad000a		0		post	1								
1987F		1987	20	liquid	SRR11117079	PRJNA607574	17		16	3	cord	Leukemia	833bd600fc6bd568ad000a		0		post	2								
1987H		1987	30	liquid	SRR11117068	PRJNA607574	27		16	3	cord	Leukemia	833bd600fc6bd568ad000a		0		post	3								
1987I		1987	31	liquid	SRR11117057	PRJNA607574	28		16	3	cord	Leukemia	833bd600fc6bd568ad000a		0		post	3								
1987J		1987	36	liquid	SRR11117046	PRJNA607574	33		16	3	cord	Leukemia	833bd600fc6bd568ad000a		0		post	4								
1987K		1987	37	liquid	SRR11117035	PRJNA607574	34		16	3	cord	Leukemia	833bd600fc6bd568ad000a		0		post	4								
1987L		1987	42	liquid	SRR11117024	PRJNA607574	39		16	3	cord	Leukemia	833bd600fc6bd568ad000a		0		post	5								
1987M		1987	48	semi-formed	SRR11117013	PRJNA607574	45		16	3	cord	Leukemia	833bd600fc6bd568ad000a		0		post	6								
1987N		1987	49	semi-formed	SRR11117002	PRJNA607574	46		16	3	cord	Leukemia	833bd600fc6bd568ad000a		0		post	6								
1987O		1987	52	semi-formed	SRR11116990	PRJNA607574	49		16	3	cord	Leukemia	833bd600fc6bd568ad000a		0		post	6								
1987P		1987	55	semi-formed	SRR11116622	PRJNA607574	52		16	3	cord	Leukemia	833bd600fc6bd568ad000a		0		post	6								
1987Q		1987	64	liquid	SRR11116610	PRJNA607574	61		16	3	cord	Leukemia	833bd600fc6bd568ad000a		0		post	6								
198A		198	0	formed	SRR11419375	PRJNA545312	-9		8	9	TCD	Multiple Myeloma	9117a008f2f307c9cf9459	79	1		pre	-2								
198B		198	15	semi-formed	SRR11419364	PRJNA545312	6		8	9	TCD	Multiple Myeloma	9117a008f2f307c9cf9459	79	1		post	0								
198C		198	22	semi-formed	SRR11419717	PRJNA545312	13		8	9	TCD	Multiple Myeloma	9117a008f2f307c9cf9459	79	1		post	1								
198D		198	53	liquid	SRR11419706	PRJNA545312	44		8	9	TCD	Multiple Myeloma	9117a008f2f307c9cf9459	79	1		post	6								
198E		198	56	semi-formed	SRR11419694	PRJNA545312	47		8	9	TCD	Multiple Myeloma	9117a008f2f307c9cf9459	79	1		post	6								
198F		198	78	formed	SRR11419515	PRJNA545312	69		8	9	TCD	Multiple Myeloma	9117a008f2f307c9cf9459	79	1		post	6								
198G		198	290	semi-formed	SRR11419504	PRJNA545312	281		8	9	TCD	Multiple Myeloma	9117a008f2f307c9cf9459	79	1		post	6								
198H		198	315	liquid	SRR11419493	PRJNA545312	306		8	9	TCD	Multiple Myeloma	9117a008f2f307c9cf9459	79	1		post	6								
1993A		pt_with_samples_1933_1993	0	semi-formed	SRR11116599	PRJNA607574	-8		8	8	TCD	Leukemia	72f9552bb5050162b12b1b		0		pre	-2								
1993B		pt_with_samples_1933_1993	6	semi-formed	SRR11116588	PRJNA607574	-2		8	8	TCD	Leukemia	72f9552bb5050162b12b1b		0		pre	-1								
1993C		pt_with_samples_1933_1993	7	semi-formed	SRR11116577	PRJNA607574	-1		8	8	TCD	Leukemia	72f9552bb5050162b12b1b		0		pre	-1								
1993D		pt_with_samples_1933_1993	10	formed	SRR11116566	PRJNA607574	2		8	8	TCD	Leukemia	72f9552bb5050162b12b1b		0		peri	0								
1993E		pt_with_samples_1933_1993	11	semi-formed	SRR11116555	PRJNA607574	3		8	8	TCD	Leukemia	72f9552bb5050162b12b1b		0		peri	0								
1993F		pt_with_samples_1933_1993	13	formed	SRR11116544	PRJNA607574	5		8	8	TCD	Leukemia	72f9552bb5050162b12b1b		0		peri	0								
1993G		pt_with_samples_1933_1993	14	semi-formed	SRR11116505	PRJNA607574	6		8	8	TCD	Leukemia	72f9552bb5050162b12b1b		0		post	0								
1993H		pt_with_samples_1933_1993	17	semi-formed	SRR11116493	PRJNA607574	9		8	8	TCD	Leukemia	72f9552bb5050162b12b1b		0		post	1								
1994A		1994	0	semi-formed	SRR11397021	PRJNA607574			5																	
1994B		1994	5	semi-formed	SRR11397020	PRJNA607574			5																	
1994C		1994	12	semi-formed	SRR11397019	PRJNA607574			5																	
1994D		1994	46	semi-formed	SRR11397018	PRJNA607574			5																	
1994E		1994	131	semi-formed	SRR11397017	PRJNA607574			5																	
1995A		1995	0	formed	SRR11116482	PRJNA607574	4		2	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	f347d681e09d53916f5cac		0		peri	0								
1995B		1995	3	liquid	SRR11116471	PRJNA607574	7		2	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	f347d681e09d53916f5cac		0		post	0								
1996A		1996	0	semi-formed	SRR11397008	PRJNA607574			4																	
1996D		1996	57	semi-formed	SRR11397007	PRJNA607574			4																	
1996E		1996	59	semi-formed	SRR11397006	PRJNA607574			4																	
1996F		1996	73	semi-formed	SRR11397005	PRJNA607574			4																	
1998A		1998	0	liquid	SRR11116421	PRJNA607574	4		9	-4	PBSC_unmodified	Myeloproliferative Disorder	3b3d1934330269ef9f02ab		0		peri	0								
1998C		1998	1	liquid	SRR11116410	PRJNA607574	5		9	-4	PBSC_unmodified	Myeloproliferative Disorder	3b3d1934330269ef9f02ab		0		peri	0								
1998D		1998	2	liquid	SRR11116399	PRJNA607574	6		9	-4	PBSC_unmodified	Myeloproliferative Disorder	3b3d1934330269ef9f02ab		0		post	0								
1998E		1998	3	semi-formed	SRR11116948	PRJNA607574	7		9	-4	PBSC_unmodified	Myeloproliferative Disorder	3b3d1934330269ef9f02ab		0		post	0								
1998F		1998	6	liquid	SRR11116937	PRJNA607574	10		9	-4	PBSC_unmodified	Myeloproliferative Disorder	3b3d1934330269ef9f02ab		0		post	1								
1998K		1998	16	liquid	SRR11116926	PRJNA607574	20		9	-4	PBSC_unmodified	Myeloproliferative Disorder	3b3d1934330269ef9f02ab		0		post	2								
1998N		1998	23	liquid	SRR11396999	PRJNA607574	27		9	-4	PBSC_unmodified	Myeloproliferative Disorder	3b3d1934330269ef9f02ab		0		post	3								
1998O		1998	24	semi-formed	SRR11116903	PRJNA607574	28		9	-4	PBSC_unmodified	Myeloproliferative Disorder	3b3d1934330269ef9f02ab		0		post	3								
1998P		1998	25	semi-formed	SRR11116892	PRJNA607574	29		9	-4	PBSC_unmodified	Myeloproliferative Disorder	3b3d1934330269ef9f02ab		0		post	4								
1999A		1999	0	formed	SRR11396998	PRJNA607574			4																	
1999B		1999	13	semi-formed	SRR11396997	PRJNA607574			4																	
1999C		1999	67	semi-formed	SRR11396996	PRJNA607574			4																	
1999D		1999	133	semi-formed	SRR11396995	PRJNA607574			4																	
199A		199	0	liquid	SRR11419482	PRJNA545312	3		3	-3	TCD	Leukemia	3894532c72d6a97c478688	267	1		peri	0								
199B		199	6	liquid	SRR11419471	PRJNA545312	9		3	-3	TCD	Leukemia	3894532c72d6a97c478688	267	1		post	1								
199C		199	7	liquid	SRR11419999	PRJNA545312	10		3	-3	TCD	Leukemia	3894532c72d6a97c478688	267	1		post	1								
2000A		2000	0	formed	SRR11419988	PRJNA545312	-128		4	128	TCD	Leukemia	4e29a84b2770d3c2f45181		0		pre	-3								
2000B		2000	8	semi-formed	SRR11420323	PRJNA545312	-120		4	128	TCD	Leukemia	4e29a84b2770d3c2f45181		0		pre	-3								
2000C		2000	14	liquid	SRR11420312	PRJNA545312	-114		4	128	TCD	Leukemia	4e29a84b2770d3c2f45181		0		pre	-3								
2000D		2000	64	formed	SRR11420300	PRJNA545312	-64		4	128	TCD	Leukemia	4e29a84b2770d3c2f45181		0		pre	-3								
2002A		2002	0	formed	SRR11396994	PRJNA607574			6																	
2002B		2002	9	formed	SRR11396993	PRJNA607574			6																	
2002C		2002	22	formed	SRR11396992	PRJNA607574			6																	
2002D		2002	28	formed	SRR11396991	PRJNA607574			6																	
2002E		2002	38	formed	SRR11396989	PRJNA607574			6																	
2002F		2002	50	formed	SRR11396988	PRJNA607574			6																	
2003A		pt_with_samples_2003_759	0	formed	SRR11420289	PRJNA545312	-247		7	247	PBSC_unmodified	Leukemia	9e0a047aec2c41fbe0b7c1	547	1		pre	-3								
2003B		pt_with_samples_2003_759	10	formed	SRR11420278	PRJNA545312	-237		7	247	PBSC_unmodified	Leukemia	9e0a047aec2c41fbe0b7c1	547	1		pre	-3								
2003D		pt_with_samples_2003_759	15	formed	SRR11420211	PRJNA545312	-232		7	247	PBSC_unmodified	Leukemia	9e0a047aec2c41fbe0b7c1	547	1		pre	-3								
2003E		pt_with_samples_2003_759	25	formed	SRR11420200	PRJNA545312	-222		7	247	PBSC_unmodified	Leukemia	9e0a047aec2c41fbe0b7c1	547	1		pre	-3								
2003F		pt_with_samples_2003_759	57	liquid	SRR11421351	PRJNA545312	-190		7	247	PBSC_unmodified	Leukemia	9e0a047aec2c41fbe0b7c1	547	1		pre	-3								
2004A		pt_with_samples_2004_699	0	formed	SRR11421350	PRJNA545312	-105		9	105	TCD	Leukemia	9033c7cd70cd7d396cba9b	234	1		pre	-3								
2004B		pt_with_samples_2004_699	11	formed	SRR11421349	PRJNA545312	-94		9	105	TCD	Leukemia	9033c7cd70cd7d396cba9b	234	1		pre	-3								
2004C		pt_with_samples_2004_699	23	formed	SRR11421348	PRJNA545312	-82		9	105	TCD	Leukemia	9033c7cd70cd7d396cba9b	234	1		pre	-3								
2004D		pt_with_samples_2004_699	47	liquid	SRR11421347	PRJNA545312	-58		9	105	TCD	Leukemia	9033c7cd70cd7d396cba9b	234	1		pre	-3								
2005A		2005	0	formed	SRR11396987	PRJNA607574			3																	
2005B		2005	6	semi-formed	SRR11396986	PRJNA607574			3																	
2005C		2005	22	semi-formed	SRR11396985	PRJNA607574			3																	
2006A		2006	0	formed	SRR11396984	PRJNA607574			2																	
2006B		2006	7		SRR11396983	PRJNA607574			2																	
2007A		2007	0	semi-formed	SRR11396982	PRJNA607574			3																	
2007B		2007	11	formed	SRR11396981	PRJNA607574			3																	
2007C		2007	26	formed	SRR11396980	PRJNA607574			3																	
2008A		pt_with_samples_2008_748	0	formed	SRR11421346	PRJNA545312	-156		5	156	TCD	Leukemia	418820a546187e47878824	554	1		pre	-3								
2008D		pt_with_samples_2008_748	21	liquid	SRR11421344	PRJNA545312	-135		5	156	TCD	Leukemia	418820a546187e47878824	554	1		pre	-3								
2009A		2009	0	semi-formed	SRR11396978	PRJNA607574			6																	
2009B		2009	14	formed	SRR11396977	PRJNA607574			6																	
2009C		2009	9	formed	SRR11396976	PRJNA607574			6																	
2009D		2009	16	formed	SRR11396975	PRJNA607574			6																	
2009E		2009	21	formed	SRR11396974	PRJNA607574			6																	
2009F		2009	27	semi-formed	SRR11396973	PRJNA607574			6																	
200A		200	0	semi-formed	SRR11421342	PRJNA545312	-6		12	6	cord	Non-Hodgkin's Lymphoma	6068947ac0a529413d7d76	85	1		pre	-1								
200B		200	3	semi-formed	SRR11421341	PRJNA545312	-3		12	6	cord	Non-Hodgkin's Lymphoma	6068947ac0a529413d7d76	85	1		pre	-1								
200C		200	17	semi-formed	SRR11421340	PRJNA545312	11		12	6	cord	Non-Hodgkin's Lymphoma	6068947ac0a529413d7d76	85	1		post	1								
200D		200	19	semi-formed	SRR11421339	PRJNA545312	13		12	6	cord	Non-Hodgkin's Lymphoma	6068947ac0a529413d7d76	85	1		post	1								
200E		200	28	liquid	SRR11421338	PRJNA545312	22		12	6	cord	Non-Hodgkin's Lymphoma	6068947ac0a529413d7d76	85	1		post	3								
200F		200	31	formed	SRR11421337	PRJNA545312	25		12	6	cord	Non-Hodgkin's Lymphoma	6068947ac0a529413d7d76	85	1		post	3								
200I		200	80	semi-formed	SRR11421336	PRJNA545312	74		12	6	cord	Non-Hodgkin's Lymphoma	6068947ac0a529413d7d76	85	1		post	6								
200J		200	83	semi-formed	SRR11421335	PRJNA545312	77		12	6	cord	Non-Hodgkin's Lymphoma	6068947ac0a529413d7d76	85	1		post	6								
200K		200	89	semi-formed	SRR11421334	PRJNA545312	83		12	6	cord	Non-Hodgkin's Lymphoma	6068947ac0a529413d7d76	85	1		post	6								
200L		200	101	liquid	SRR11421333	PRJNA545312	95		12	6	cord	Non-Hodgkin's Lymphoma	6068947ac0a529413d7d76	85	1		post	6								
200M		200	109	liquid	SRR11421331	PRJNA545312	103		12	6	cord	Non-Hodgkin's Lymphoma	6068947ac0a529413d7d76	85	1		post	6								
200O		200	151	semi-formed	SRR11116881	PRJNA607574	145		12	6	cord	Non-Hodgkin's Lymphoma	6068947ac0a529413d7d76	85	1		post	6								
2010A		2010	0	liquid	SRR11396972	PRJNA607574			2																	
2010B		2010	23	formed	SRR11396971	PRJNA607574			2																	
2011A		pt_with_samples_2011_737	0	semi-formed	SRR11421329	PRJNA545312	-100		9	100	PBSC_unmodified	Leukemia	c9357549047f75c9059642	512	1		pre	-3								
2011B		pt_with_samples_2011_737	10	formed	SRR11421328	PRJNA545312	-90		9	100	PBSC_unmodified	Leukemia	c9357549047f75c9059642	512	1		pre	-3								
2013A		2013	0	semi-formed	SRR11396970	PRJNA607574			5																	
2013B		2013	12	semi-formed	SRR11396969	PRJNA607574			5																	
2013C		2013	18	semi-formed	SRR11396967	PRJNA607574			5																	
2013D		2013	27	formed	SRR11396966	PRJNA607574			5																	
2013E		2013	54	liquid	SRR11396965	PRJNA607574			5																	
2014A		2014	0	formed	SRR11396964	PRJNA607574			2																	
2014B		2014	13	formed	SRR11396963	PRJNA607574			2																	
2015A		2015	0	formed	SRR11396962	PRJNA607574			8																	
2015B		2015	2	formed	SRR11396961	PRJNA607574			8																	
2015C		2015	7	formed	SRR11396960	PRJNA607574			8																	
2015D		2015	14	formed	SRR11396959	PRJNA607574			8																	
2015E		2015	18	semi-formed	SRR11396958	PRJNA607574			8																	
2015F		2015	21	formed	SRR11396956	PRJNA607574			8																	
2015G		2015	675	semi-formed	SRR11396955	PRJNA607574			8																	
2015H		2015	686	formed	SRR11396954	PRJNA607574			8																	
2016B		2016	8	semi-formed	SRR11396953	PRJNA607574			6																	
2016C		2016	12	semi-formed	SRR11396952	PRJNA607574			6																	
2016D		2016	22	semi-formed	SRR11396951	PRJNA607574			6																	
2016E		2016	0	formed	SRR11396950	PRJNA607574			6																	
2016F		2016	34	formed	SRR11396949	PRJNA607574			6																	
2016G		2016	114	formed	SRR11396948	PRJNA607574			6																	
2017A		2017	0	formed	SRR11396947	PRJNA607574			4																	
2017B		2017	2	formed	SRR11396945	PRJNA607574			4																	
2017D		2017	17	formed	SRR11396944	PRJNA607574			4																	
2017E		2017	21	formed	SRR11396943	PRJNA607574			4																	
2018A		pt_with_samples_2018_796	0	semi-formed	SRR11421327	PRJNA545312	-107		3	107	TCD	Leukemia	9218d8ce8b558a176a12e4	589	1		pre	-3								
2018B		pt_with_samples_2018_796	2	semi-formed	SRR11421298	PRJNA545312	-105		3	107	TCD	Leukemia	9218d8ce8b558a176a12e4	589	1		pre	-3								
2019A		pt_with_samples_2019_760	0	semi-formed	SRR11421297	PRJNA545312	-57		5	57	TCD	Leukemia	cf7566327c93ce1dca4b4a	541	1		pre	-3								
2019C		pt_with_samples_2019_760	14	semi-formed	SRR11421295	PRJNA545312	-43		5	57	TCD	Leukemia	cf7566327c93ce1dca4b4a	541	1		pre	-3								
201A		201	0	formed	SRR11421294	PRJNA545312	-52		7	52	PBSC_unmodified	Leukemia	8d92107aad67796975f551	207	1		pre	-3								
201B		201	48	formed	SRR11421292	PRJNA545312	-4		7	52	PBSC_unmodified	Leukemia	8d92107aad67796975f551	207	1		pre	-1								
201C		201	55	liquid	SRR11421291	PRJNA545312	3		7	52	PBSC_unmodified	Leukemia	8d92107aad67796975f551	207	1		peri	0								
201D		201	63	liquid	SRR11421290	PRJNA545312	11		7	52	PBSC_unmodified	Leukemia	8d92107aad67796975f551	207	1		post	1								
201E		201	69	liquid	SRR11421289	PRJNA545312	17		7	52	PBSC_unmodified	Leukemia	8d92107aad67796975f551	207	1		post	2								
201F		201	76	liquid	SRR11421288	PRJNA545312	24		7	52	PBSC_unmodified	Leukemia	8d92107aad67796975f551	207	1		post	3								
201G		201	83	liquid	SRR11421287	PRJNA545312	31		7	52	PBSC_unmodified	Leukemia	8d92107aad67796975f551	207	1		post	4								
2020B		pt_with_samples_2020_831	15	formed	SRR11421286	PRJNA545312	-36		3	51	PBSC_unmodified	Leukemia	26bb5924f9ec724ef37ebf	598	1		pre	-3								
2021A		pt_with_samples_2021_897	0	liquid	SRR11421285	PRJNA545312	-134		3	134	BM_unmodified	Leukemia	c8d8ec8ce947b7436a9561	596	1		pre	-3								
2022A		2022	0	liquid	SRR11396942	PRJNA607574			2																	
2022B		2022	11	semi-formed	SRR11396941	PRJNA607574			2																	
2023A		2023	0		SRR11421284	PRJNA545312	-71		5	71	PBSC_unmodified	Leukemia	f087d8c9eb0081a6c8b79e	702	1		pre	-3								
2023B		2023	7	liquid	SRR11421283	PRJNA545312	-64		5	71	PBSC_unmodified	Leukemia	f087d8c9eb0081a6c8b79e	702	1		pre	-3								
2023C		2023	15	semi-formed	SRR11421281	PRJNA545312	-56		5	71	PBSC_unmodified	Leukemia	f087d8c9eb0081a6c8b79e	702	1		pre	-3								
2023E		2023	64	formed	SRR11421280	PRJNA545312	-7		5	71	PBSC_unmodified	Leukemia	f087d8c9eb0081a6c8b79e	702	1		pre	-2								
2023F		2023	67	semi-formed	SRR11421279	PRJNA545312	-4		5	71	PBSC_unmodified	Leukemia	f087d8c9eb0081a6c8b79e	702	1		pre	-1								
2024B		pt_with_samples_1006_2024	6	semi-formed	SRR11396940	PRJNA607574			4																	
2024C		pt_with_samples_1006_2024	14	liquid	SRR11396939	PRJNA607574			4																	
2024D		pt_with_samples_1006_2024	20	semi-formed	SRR11396938	PRJNA607574			4																	
2025A		2025	0	formed	SRR11421278	PRJNA545312	-55		1	55	PBSC_unmodified	Leukemia	8929b8bc115eb87813830e		0		pre	-3								
2026A		2026	0	formed	SRR11396937	PRJNA607574			2																	
2026B		2026	14	semi-formed	SRR11396936	PRJNA607574			2																	
2029A		2029	0	liquid	SRR11116870	PRJNA607574	-1		4	1	PBSC_unmodified	Myelodysplastic Syndromes	2d0c9992f7f3853b8d3a3f		0		pre	-1								
2029B		2029	1	liquid	SRR11116859	PRJNA607574	0		4	1	PBSC_unmodified	Myelodysplastic Syndromes	2d0c9992f7f3853b8d3a3f		0		peri	-1								
2029C		2029	2	liquid	SRR11116848	PRJNA607574	1		4	1	PBSC_unmodified	Myelodysplastic Syndromes	2d0c9992f7f3853b8d3a3f		0		peri	0								
2029G		2029	17	semi-formed	SRR11116709	PRJNA607574	16		4	1	PBSC_unmodified	Myelodysplastic Syndromes	2d0c9992f7f3853b8d3a3f		0		post	2								
202A		202	0	formed	SRR11421277	PRJNA545312	-4		5	4	PBSC_unmodified	Leukemia	e0ac0234dff29770efe771	276	1		pre	-1								
202B		202	7	semi-formed	SRR11421276	PRJNA545312	3		5	4	PBSC_unmodified	Leukemia	e0ac0234dff29770efe771	276	1		peri	0								
202C		202	15	semi-formed	SRR11421275	PRJNA545312	11		5	4	PBSC_unmodified	Leukemia	e0ac0234dff29770efe771	276	1		post	1								
202D		202	22	liquid	SRR11421274	PRJNA545312	18		5	4	PBSC_unmodified	Leukemia	e0ac0234dff29770efe771	276	1		post	2								
202E		202	30	semi-formed	SRR11421273	PRJNA545312	26		5	4	PBSC_unmodified	Leukemia	e0ac0234dff29770efe771	276	1		post	3								
2031A		2031	0	formed	SRR11396931	PRJNA607574			12																	
2031B		2031	4	formed	SRR11396930	PRJNA607574			12																	
2031C		2031	5	formed	SRR11396929	PRJNA607574			12																	
2031D		2031	13	liquid	SRR11396928	PRJNA607574			12																	
2031E		2031	22	semi-formed	SRR11396927	PRJNA607574			12																	
2031F		2031	25	semi-formed	SRR11396926	PRJNA607574			12																	
2031G		2031	26	semi-formed	SRR11396925	PRJNA607574			12																	
2031H		2031	28	semi-formed	SRR11396922	PRJNA607574			12																	
2031I		2031	35	formed	SRR11396921	PRJNA607574			12																	
2031J		2031	39	semi-formed	SRR11396920	PRJNA607574			12																	
2031K		2031	42	formed	SRR11396919	PRJNA607574			12																	
2031N		2031	47	semi-formed	SRR11396918	PRJNA607574			12																	
2033A		2033	0	semi-formed	SRR11396917	PRJNA607574			1																	
2035A		2035	0	liquid	SRR11116698	PRJNA607574	7		5	-7	PBSC_unmodified	Leukemia	2d9e440c7dbc2351b4764c		0		post	0								
2035B		2035	1	liquid	SRR11117128	PRJNA607574	8		5	-7	PBSC_unmodified	Leukemia	2d9e440c7dbc2351b4764c		0		post	1								
2035C		2035	4	semi-formed	SRR11117116	PRJNA607574	11		5	-7	PBSC_unmodified	Leukemia	2d9e440c7dbc2351b4764c		0		post	1								
2035D		2035	5	semi-formed	SRR11117105	PRJNA607574	12		5	-7	PBSC_unmodified	Leukemia	2d9e440c7dbc2351b4764c		0		post	1								
2035E		2035	39	semi-formed	SRR11116972	PRJNA607574	46		5	-7	PBSC_unmodified	Leukemia	2d9e440c7dbc2351b4764c		0		post	6								
2039A		2039	0	semi-formed	SRR11396916	PRJNA607574			1																	
203A		203	0	formed	SRR11421272	PRJNA545312	-5		7	5	cord	Leukemia	98bd2a703a0ab3dfea4c47	284	1		pre	-1								
203B		203	3	semi-formed	SRR11421242	PRJNA545312	-2		7	5	cord	Leukemia	98bd2a703a0ab3dfea4c47	284	1		pre	-1								
203D		203	17	liquid	SRR11421241	PRJNA545312	12		7	5	cord	Leukemia	98bd2a703a0ab3dfea4c47	284	1		post	1								
203E		203	24	semi-formed	SRR11421240	PRJNA545312	19		7	5	cord	Leukemia	98bd2a703a0ab3dfea4c47	284	1		post	2								
203F		203	31	liquid	SRR11421239	PRJNA545312	26		7	5	cord	Leukemia	98bd2a703a0ab3dfea4c47	284	1		post	3								
203G		203	40	liquid	SRR11421238	PRJNA545312	35		7	5	cord	Leukemia	98bd2a703a0ab3dfea4c47	284	1		post	4								
203H		203	45	semi-formed	SRR11421237	PRJNA545312	40		7	5	cord	Leukemia	98bd2a703a0ab3dfea4c47	284	1		post	5								
2040A		2040	0	semi-formed	SRR11396915	PRJNA607574			2																	
2040B		2040	133	formed	SRR11396914	PRJNA607574			2																	
2042A		2042	0	liquid	SRR11116961	PRJNA607574	12		5	-12	PBSC_unmodified	Myelodysplastic Syndromes	fce9962ce0bda72e9a71fa		0		post	1								
2042B		2042	2	liquid	SRR11116536	PRJNA607574	14		5	-12	PBSC_unmodified	Myelodysplastic Syndromes	fce9962ce0bda72e9a71fa		0		post	1								
2042C		2042	7	liquid	SRR11116525	PRJNA607574	19		5	-12	PBSC_unmodified	Myelodysplastic Syndromes	fce9962ce0bda72e9a71fa		0		post	2								
2042D		2042	8	liquid	SRR11116514	PRJNA607574	20		5	-12	PBSC_unmodified	Myelodysplastic Syndromes	fce9962ce0bda72e9a71fa		0		post	2								
2042E		2042	23	liquid	SRR11116446	PRJNA607574	35		5	-12	PBSC_unmodified	Myelodysplastic Syndromes	fce9962ce0bda72e9a71fa		0		post	4								
2044A		2044	0	semi-formed	SRR11116435	PRJNA607574	8		7	-8	PBSC_unmodified	Leukemia	31830ac2205c96b88c158b		0		post	1								
2044B		2044	1	semi-formed	SRR11116397	PRJNA607574	9		7	-8	PBSC_unmodified	Leukemia	31830ac2205c96b88c158b		0		post	1								
2044C		2044	6	semi-formed	SRR11116384	PRJNA607574	14		7	-8	PBSC_unmodified	Leukemia	31830ac2205c96b88c158b		0		post	1								
2044D		2044	7	semi-formed	SRR11116379	PRJNA607574	15		7	-8	PBSC_unmodified	Leukemia	31830ac2205c96b88c158b		0		post	2								
2044E		2044	8	semi-formed	SRR11116378	PRJNA607574	16		7	-8	PBSC_unmodified	Leukemia	31830ac2205c96b88c158b		0		post	2								
2044F		2044	11	semi-formed	SRR11116377	PRJNA607574	19		7	-8	PBSC_unmodified	Leukemia	31830ac2205c96b88c158b		0		post	2								
2044G		2044	12	semi-formed	SRR11116376	PRJNA607574	20		7	-8	PBSC_unmodified	Leukemia	31830ac2205c96b88c158b		0		post	2								
2045A		2045	0	semi-formed	SRR11116375	PRJNA607574	-1		1	141	PBSC_unmodified		ca2c8fbc9e81e396a437bc		0		pre	-1								
2048A		2048	0	semi-formed	SRR11396913	PRJNA607574			1																	
204A		204	0	formed	SRR11421236	PRJNA545312	-5		3	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	91923bf05ff7eef11d162f	70	1		pre	-1								
204B		204	3	liquid	SRR11421235	PRJNA545312	-2		3	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	91923bf05ff7eef11d162f	70	1		pre	-1								
204C		204	10	liquid	SRR11421234	PRJNA545312	5		3	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	91923bf05ff7eef11d162f	70	1		peri	0								
2050A		2050	0	formed	SRR11396911	PRJNA607574			3																	
2050B		2050	14	semi-formed	SRR11396910	PRJNA607574			3																	
2050C		2050	20	formed	SRR11396909	PRJNA607574			3																	
2052A		2052	0	semi-formed	SRR11396908	PRJNA607574			4																	
2052B		2052	1	semi-formed	SRR11396907	PRJNA607574			4																	
2052D		2052	90	semi-formed	SRR11396906	PRJNA607574			4																	
2052E		2052	95	semi-formed	SRR11396905	PRJNA607574			4																	
2054A		2054	0	liquid	SRR11116374	PRJNA607574	18		5	-18	cord	Leukemia	fa99900d00948f3646a0ba		0		post	2								
2054B		2054	7	liquid	SRR11116373	PRJNA607574	25		5	-18	cord	Leukemia	fa99900d00948f3646a0ba		0		post	3								
2054C		2054	8	semi-formed	SRR11116372	PRJNA607574	26		5	-18	cord	Leukemia	fa99900d00948f3646a0ba		0		post	3								
2054D		2054	11	semi-formed	SRR11116371	PRJNA607574	29		5	-18	cord	Leukemia	fa99900d00948f3646a0ba		0		post	4								
2054E		2054	15	liquid	SRR11116369	PRJNA607574	33		5	-18	cord	Leukemia	fa99900d00948f3646a0ba		0		post	4								
2057A		2057	0	semi-formed	SRR11116368	PRJNA607574	-1		4	1	PBSC_unmodified	Leukemia	65839bccf23735b9e9b72a		0		pre	-1								
2057E		2057	11	formed	SRR11116367	PRJNA607574	10		4	1	PBSC_unmodified	Leukemia	65839bccf23735b9e9b72a		0		post	1								
2057F		2057	12	formed	SRR11116366	PRJNA607574	11		4	1	PBSC_unmodified	Leukemia	65839bccf23735b9e9b72a		0		post	1								
2057G		2057	13	formed	SRR11116365	PRJNA607574	12		4	1	PBSC_unmodified	Leukemia	65839bccf23735b9e9b72a		0		post	1								
2058A		2058	0	semi-formed	SRR11396904	PRJNA607574			2																	
2058B		2058	8	semi-formed	SRR11396903	PRJNA607574			2																	
205A		205	0	formed	SRR11421233	PRJNA545312	-7		5	7	TCD	Leukemia	0fdd60351d8536e57cc5b3	88	1		pre	-2								
205B		205	5	semi-formed	SRR11421231	PRJNA545312	-2		5	7	TCD	Leukemia	0fdd60351d8536e57cc5b3	88	1		pre	-1								
205C		205	10	liquid	SRR11421230	PRJNA545312	3		5	7	TCD	Leukemia	0fdd60351d8536e57cc5b3	88	1		peri	0								
205D		205	25	liquid	SRR11421229	PRJNA545312	18		5	7	TCD	Leukemia	0fdd60351d8536e57cc5b3	88	1		post	2								
205E		205	31	formed	SRR11421228	PRJNA545312	24		5	7	TCD	Leukemia	0fdd60351d8536e57cc5b3	88	1		post	3								
2060A		2060	0	liquid	SRR11396902	PRJNA607574			5																	
2060B		2060	1	liquid	SRR11396900	PRJNA607574			5																	
2060C		2060	3	liquid	SRR11396899	PRJNA607574			5																	
2060D		2060	4	liquid	SRR11396898	PRJNA607574			5																	
2060E		2060	7	formed	SRR11396897	PRJNA607574			5																	
2063A		2063	0	formed	SRR11396896	PRJNA607574			8																	
2063B		2063	2	liquid	SRR11396895	PRJNA607574			8																	
2063C		2063	7	liquid	SRR11396894	PRJNA607574			8																	
2063D		2063	8	liquid	SRR11396893	PRJNA607574			8																	
2063E		2063	9	liquid	SRR11396892	PRJNA607574			8																	
2063F		2063	10	semi-formed	SRR11396891	PRJNA607574			8																	
2063G		2063	13	semi-formed	SRR11396889	PRJNA607574			8																	
2063H		2063	14	semi-formed	SRR11396888	PRJNA607574			8																	
2064A		2064	0	liquid	SRR11116364	PRJNA607574	-1		5	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	4b20e5ef73480c1c2c7a91		0		pre	-1								
2064B		2064	1	liquid	SRR11116363	PRJNA607574	0		5	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	4b20e5ef73480c1c2c7a91		0		peri	-1								
2064D		2064	7	semi-formed	SRR11116362	PRJNA607574	6		5	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	4b20e5ef73480c1c2c7a91		0		post	0								
2064E		2064	8	semi-formed	SRR11116361	PRJNA607574	7		5	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	4b20e5ef73480c1c2c7a91		0		post	0								
2064F		2064	14	semi-formed	SRR11116360	PRJNA607574	13		5	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	4b20e5ef73480c1c2c7a91		0		post	1								
2065A		2065	0	formed	SRR11116650	PRJNA607574	-3	SRR13697183	7	3	PBSC_unmodified	Leukemia	4289b901509e6052754eeb		0		pre	-1								
2065B		2065	3	semi-formed	SRR11116649	PRJNA607574	0	SRR13697182	7	3	PBSC_unmodified	Leukemia	4289b901509e6052754eeb		0		peri	-1								
2065C		2065	7	semi-formed	SRR11116648	PRJNA607574	4	SRR13697181	7	3	PBSC_unmodified	Leukemia	4289b901509e6052754eeb		0		peri	0								
2065D		2065	8	semi-formed	SRR11116647	PRJNA607574	5	SRR13697180	7	3	PBSC_unmodified	Leukemia	4289b901509e6052754eeb		0		peri	0								
2065E		2065	9	semi-formed	SRR11116646	PRJNA607574	6	SRR14092336	7	3	PBSC_unmodified	Leukemia	4289b901509e6052754eeb		0		post	0								
2065F		2065	15	semi-formed	SRR11116645	PRJNA607574	12	SRR14092334	7	3	PBSC_unmodified	Leukemia	4289b901509e6052754eeb		0		post	1								
2065G		2065	16	formed	SRR11116644	PRJNA607574	13	SRR13697179	7	3	PBSC_unmodified	Leukemia	4289b901509e6052754eeb		0		post	1								
2066A		2066	0	formed	SRR11116643	PRJNA607574	-3		4	3	PBSC_unmodified	Leukemia	5b6053d277ef7273a825fb		0		pre	-1								
2066B		2066	13	semi-formed	SRR11116642	PRJNA607574	10		4	3	PBSC_unmodified	Leukemia	5b6053d277ef7273a825fb		0		post	1								
2066C		2066	14	semi-formed	SRR11116641	PRJNA607574	11		4	3	PBSC_unmodified	Leukemia	5b6053d277ef7273a825fb		0		post	1								
2066D		2066	16	semi-formed	SRR11116639	PRJNA607574	13		4	3	PBSC_unmodified	Leukemia	5b6053d277ef7273a825fb		0		post	1								
206A		206	0	formed	SRR11421227	PRJNA545312	-9		2	9	TCD	Multiple Myeloma	6ba9cf3b9239438076db3e	71	1		pre	-2								
206B		206	9	liquid	SRR11421226	PRJNA545312	0		2	9	TCD	Multiple Myeloma	6ba9cf3b9239438076db3e	71	1		peri	-1								
2070A		2070	0	semi-formed	SRR11116638	PRJNA607574	1		8	-1	BM_unmodified	Myelodysplastic Syndromes	afb44399448e6f800c397f		0		peri	0								
2070B		2070	1	semi-formed	SRR11116637	PRJNA607574	2		8	-1	BM_unmodified	Myelodysplastic Syndromes	afb44399448e6f800c397f		0		peri	0								
2070D		2070	4	formed	SRR11116636	PRJNA607574	5		8	-1	BM_unmodified	Myelodysplastic Syndromes	afb44399448e6f800c397f		0		peri	0								
2070E		2070	5	formed	SRR11116635	PRJNA607574	6		8	-1	BM_unmodified	Myelodysplastic Syndromes	afb44399448e6f800c397f		0		post	0								
2070F		2070	6	semi-formed	SRR11116634	PRJNA607574	7		8	-1	BM_unmodified	Myelodysplastic Syndromes	afb44399448e6f800c397f		0		post	0								
2070G		2070	13	liquid	SRR11116633	PRJNA607574	14		8	-1	BM_unmodified	Myelodysplastic Syndromes	afb44399448e6f800c397f		0		post	1								
2070H		2070	14	semi-formed	SRR11116632	PRJNA607574	15		8	-1	BM_unmodified	Myelodysplastic Syndromes	afb44399448e6f800c397f		0		post	2								
2070I		2070	21	liquid	SRR11116631	PRJNA607574	22		8	-1	BM_unmodified	Myelodysplastic Syndromes	afb44399448e6f800c397f		0		post	3								
2071A		2071	0	liquid	SRR11396887	PRJNA607574			3																	
2071B		2071	1	liquid	SRR11396886	PRJNA607574			3																	
2071C		2071	13	semi-formed	SRR11396885	PRJNA607574			3																	
2072A		2072	0	semi-formed	SRR11396884	PRJNA607574			4																	
2072B		2072	3	formed	SRR11396883	PRJNA607574			4																	
2072C		2072	6	semi-formed	SRR11396882	PRJNA607574			4																	
2072D		2072	13	formed	SRR11396881	PRJNA607574			4																	
2075A		2075	0	formed	SRR11396880	PRJNA607574			2																	
2075B		2075	3	liquid	SRR11396878	PRJNA607574			2																	
2077A		2077	0	liquid	SRR11116630	PRJNA607574	7		5	-7	TCD	Leukemia	75c7b570e0a20b7a371b81		0		post	0								
2077B		2077	1	liquid	SRR11116628	PRJNA607574	8		5	-7	TCD	Leukemia	75c7b570e0a20b7a371b81		0		post	1								
2077C		2077	4	liquid	SRR11116627	PRJNA607574	11		5	-7	TCD	Leukemia	75c7b570e0a20b7a371b81		0		post	1								
2077D		2077	5	liquid	SRR11116626	PRJNA607574	12		5	-7	TCD	Leukemia	75c7b570e0a20b7a371b81		0		post	1								
2077E		2077	7	semi-formed	SRR11116625	PRJNA607574	14		5	-7	TCD	Leukemia	75c7b570e0a20b7a371b81		0		post	1								
207A		207	0	liquid	SRR11421225	PRJNA545312	-2		3	2	PBSC_unmodified	Leukemia	027533316bfa65dee227f5	283	1		pre	-1								
207B		207	6	liquid	SRR11421224	PRJNA545312	4		3	2	PBSC_unmodified	Leukemia	027533316bfa65dee227f5	283	1		peri	0								
207C		207	7	liquid	SRR11421223	PRJNA545312	5		3	2	PBSC_unmodified	Leukemia	027533316bfa65dee227f5	283	1		peri	0								
2080B		2080	0	liquid	SRR11396877	PRJNA607574			3																	
2080C		2080	1	liquid	SRR11396876	PRJNA607574			3																	
2080D		2080	2	liquid	SRR11396875	PRJNA607574			3																	
2081A		2081	0	semi-formed	SRR11116624	PRJNA607574	-2		7	2	cord	Leukemia	a39ffefa0fa44efb21f7e0		0		pre	-1								
2081B		2081	3	liquid	SRR11116623	PRJNA607574	1		7	2	cord	Leukemia	a39ffefa0fa44efb21f7e0		0		peri	0								
2081C		2081	6	liquid	SRR11116621	PRJNA607574	4		7	2	cord	Leukemia	a39ffefa0fa44efb21f7e0		0		peri	0								
2081D		2081	8	liquid	SRR11116844	PRJNA607574	6		7	2	cord	Leukemia	a39ffefa0fa44efb21f7e0		0		post	0								
2081E		2081	9	liquid	SRR11116843	PRJNA607574	7		7	2	cord	Leukemia	a39ffefa0fa44efb21f7e0		0		post	0								
2081F		2081	14	semi-formed	SRR11116842	PRJNA607574	12		7	2	cord	Leukemia	a39ffefa0fa44efb21f7e0		0		post	1								
2081G		2081	16	semi-formed	SRR11116840	PRJNA607574	14		7	2	cord	Leukemia	a39ffefa0fa44efb21f7e0		0		post	1								
2083A		2083	0	formed	SRR11396874	PRJNA607574			2																	
2083B		2083	5	formed	SRR11396873	PRJNA607574			2																	
2090A		2090	0	formed	SRR11116839	PRJNA607574	-3		4	3	BM_unmodified	Myelodysplastic Syndromes	8c2f8ac3d490d072009c91		0		pre	-1								
2090B		2090	1	formed	SRR11116838	PRJNA607574	-2		4	3	BM_unmodified	Myelodysplastic Syndromes	8c2f8ac3d490d072009c91		0		pre	-1								
2090C		2090	5	liquid	SRR11116837	PRJNA607574	2		4	3	BM_unmodified	Myelodysplastic Syndromes	8c2f8ac3d490d072009c91		0		peri	0								
2090D		2090	6	liquid	SRR11116836	PRJNA607574	3		4	3	BM_unmodified	Myelodysplastic Syndromes	8c2f8ac3d490d072009c91		0		peri	0								
2092A		2092	0	semi-formed	SRR11396872	PRJNA607574			1																	
2093A		2093	0	semi-formed	SRR11396871	PRJNA607574			1																	
2099A		2099	0	semi-formed	SRR11396870	PRJNA607574			5																	
2099B		2099	7	liquid	SRR11396869	PRJNA607574			5																	
2099C		2099	12	liquid	SRR11396867	PRJNA607574			5																	
2099D		2099	42	formed	SRR11396866	PRJNA607574			5																	
2099E		2099	91	formed	SRR11396865	PRJNA607574			5																	
209A		209	0	formed	SRR11421222	PRJNA545312	-5		4	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	8e16d6e3d0f68465f36688	141	1		pre	-1								
209B		209	3	semi-formed	SRR11421219	PRJNA545312	-2		4	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	8e16d6e3d0f68465f36688	141	1		pre	-1								
209C		209	15	liquid	SRR11421218	PRJNA545312	10		4	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	8e16d6e3d0f68465f36688	141	1		post	1								
209D		209	20	semi-formed	SRR11421217	PRJNA545312	15		4	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	8e16d6e3d0f68465f36688	141	1		post	2								
2101B		2101	2	formed	SRR11116835	PRJNA607574	0		3	2	PBSC_unmodified	Myelodysplastic Syndromes	09ce0b14964478ea1df12d		0		peri	-1								
2101C		2101	6	liquid	SRR11116834	PRJNA607574	4		3	2	PBSC_unmodified	Myelodysplastic Syndromes	09ce0b14964478ea1df12d		0		peri	0								
2101D		2101	7	liquid	SRR11116833	PRJNA607574	5		3	2	PBSC_unmodified	Myelodysplastic Syndromes	09ce0b14964478ea1df12d		0		peri	0								
2104A		2104	0	formed	SRR11116832	PRJNA607574	-1		11	1	PBSC_unmodified	Leukemia	939c2e7047521877160905		0		pre	-1								
2104B		2104	1	formed	SRR11116831	PRJNA607574	0		11	1	PBSC_unmodified	Leukemia	939c2e7047521877160905		0		peri	-1								
2104C		2104	4	semi-formed	SRR11116829	PRJNA607574	3		11	1	PBSC_unmodified	Leukemia	939c2e7047521877160905		0		peri	0								
2104D		2104	5	formed	SRR11116828	PRJNA607574	4		11	1	PBSC_unmodified	Leukemia	939c2e7047521877160905		0		peri	0								
2104E		2104	6	semi-formed	SRR11116827	PRJNA607574	5		11	1	PBSC_unmodified	Leukemia	939c2e7047521877160905		0		peri	0								
2104G		2104	12	semi-formed	SRR11116826	PRJNA607574	11		11	1	PBSC_unmodified	Leukemia	939c2e7047521877160905		0		post	1								
2104H		2104	13	liquid	SRR11116825	PRJNA607574	12		11	1	PBSC_unmodified	Leukemia	939c2e7047521877160905		0		post	1								
2104I		2104	14	semi-formed	SRR11116824	PRJNA607574	13		11	1	PBSC_unmodified	Leukemia	939c2e7047521877160905		0		post	1								
2104J		2104	15	liquid	SRR11116823	PRJNA607574	14		11	1	PBSC_unmodified	Leukemia	939c2e7047521877160905		0		post	1								
2104K		2104	16	semi-formed	SRR11116822	PRJNA607574	15		11	1	PBSC_unmodified	Leukemia	939c2e7047521877160905		0		post	2								
2104L		2104	43	liquid	SRR11116821	PRJNA607574	42		11	1	PBSC_unmodified	Leukemia	939c2e7047521877160905		0		post	5								
2105A		2105	347	formed	SRR11116820	PRJNA607574	-8	SRR14092333	8	355	PBSC_unmodified		9b132684087672908effb9		0		pre	-2								
2105B		2105	348	formed	SRR11116818	PRJNA607574	-7	SRR14092332	8	355	PBSC_unmodified		9b132684087672908effb9		0		pre	-2								
2105C		2105	351	liquid	SRR11116817	PRJNA607574	-4	SRR14092331	8	355	PBSC_unmodified		9b132684087672908effb9		0		pre	-1								
2105D		2105	352	liquid	SRR11116816	PRJNA607574	-3	SRR14092330	8	355	PBSC_unmodified		9b132684087672908effb9		0		pre	-1								
2105E		2105	354	liquid	SRR11116815	PRJNA607574	-1	SRR14092329	8	355	PBSC_unmodified		9b132684087672908effb9		0		pre	-1								
2105F		2105	355	liquid	SRR11116814	PRJNA607574	0	SRR14092328	8	355	PBSC_unmodified		9b132684087672908effb9		0		peri	-1								
2105P		2105	368	semi-formed	SRR11116813	PRJNA607574	13		8	355	PBSC_unmodified		9b132684087672908effb9		0		post	1								
2105Q		2105	369	semi-formed	SRR11116812	PRJNA607574	14		8	355	PBSC_unmodified		9b132684087672908effb9		0		post	1								
2106A		2106	0	semi-formed	SRR11396864	PRJNA607574			3																	
2106B		2106	13	semi-formed	SRR11396863	PRJNA607574			3																	
2106C		2106	20	semi-formed	SRR11396862	PRJNA607574			3																	
2109A		2109	0	semi-formed	SRR11396861	PRJNA607574			3																	
2109B		2109	11		SRR11396860	PRJNA607574			3																	
2109C		2109	48	semi-formed	SRR11396859	PRJNA607574			3																	
210A		210	0	formed	SRR11421216	PRJNA545312	-6		12	6	cord	Leukemia	349a471f876506c2a0bb4a	311	1		pre	-1								
210B		210	4	liquid	SRR11421215	PRJNA545312	-2		12	6	cord	Leukemia	349a471f876506c2a0bb4a	311	1		pre	-1								
210C		210	14	liquid	SRR11421158	PRJNA545312	8		12	6	cord	Leukemia	349a471f876506c2a0bb4a	311	1		post	1								
210D		210	19	semi-formed	SRR11421157	PRJNA545312	13		12	6	cord	Leukemia	349a471f876506c2a0bb4a	311	1		post	1								
210E		210	27	semi-formed	SRR11421156	PRJNA545312	21		12	6	cord	Leukemia	349a471f876506c2a0bb4a	311	1		post	2								
210F		210	33	liquid	SRR11421155	PRJNA545312	27		12	6	cord	Leukemia	349a471f876506c2a0bb4a	311	1		post	3								
210G		210	41	semi-formed	SRR11421154	PRJNA545312	35		12	6	cord	Leukemia	349a471f876506c2a0bb4a	311	1		post	4								
210H		210	47	semi-formed	SRR11421152	PRJNA545312	41		12	6	cord	Leukemia	349a471f876506c2a0bb4a	311	1		post	5								
210I		210	53	semi-formed	SRR11421151	PRJNA545312	47		12	6	cord	Leukemia	349a471f876506c2a0bb4a	311	1		post	6								
210J		210	60	semi-formed	SRR11421150	PRJNA545312	54		12	6	cord	Leukemia	349a471f876506c2a0bb4a	311	1		post	6								
210K		210	103	liquid	SRR11421149	PRJNA545312	97		12	6	cord	Leukemia	349a471f876506c2a0bb4a	311	1		post	6								
210L		210	117	liquid	SRR11421148	PRJNA545312	111		12	6	cord	Leukemia	349a471f876506c2a0bb4a	311	1		post	6								
2111A		2111	0	formed	SRR11116811	PRJNA607574	-2		10	2	BM_unmodified		5e3fd7bfc304d864a2f121		0		pre	-1								
2111B		2111	7	liquid	SRR11116810	PRJNA607574	5		10	2	BM_unmodified		5e3fd7bfc304d864a2f121		0		peri	0								
2111C		2111	10	liquid	SRR11116809	PRJNA607574	8		10	2	BM_unmodified		5e3fd7bfc304d864a2f121		0		post	1								
2111D		2111	14	liquid	SRR11116807	PRJNA607574	12		10	2	BM_unmodified		5e3fd7bfc304d864a2f121		0		post	1								
2111E		2111	16	liquid	SRR11116806	PRJNA607574	14		10	2	BM_unmodified		5e3fd7bfc304d864a2f121		0		post	1								
2111F		2111	20	semi-formed	SRR11116805	PRJNA607574	18		10	2	BM_unmodified		5e3fd7bfc304d864a2f121		0		post	2								
2111G		2111	21	semi-formed	SRR11116804	PRJNA607574	19		10	2	BM_unmodified		5e3fd7bfc304d864a2f121		0		post	2								
2111H		2111	23	semi-formed	SRR11116803	PRJNA607574	21		10	2	BM_unmodified		5e3fd7bfc304d864a2f121		0		post	2								
2111I		2111	24	semi-formed	SRR11116802	PRJNA607574	22		10	2	BM_unmodified		5e3fd7bfc304d864a2f121		0		post	3								
2111J		2111	31	liquid	SRR11116801	PRJNA607574	29		10	2	BM_unmodified		5e3fd7bfc304d864a2f121		0		post	4								
2112A		2112	0	semi-formed	SRR11396858	PRJNA607574			2																	
2112C		2112	50	semi-formed	SRR11396856	PRJNA607574			2																	
2117A		2117	0	semi-formed	SRR11116800	PRJNA607574	0		6	0	cord		e7d60160755f5724f518d2		0		peri	-1								
2117B		2117	2	semi-formed	SRR11116799	PRJNA607574	2		6	0	cord		e7d60160755f5724f518d2		0		peri	0								
2117C		2117	6	semi-formed	SRR11116798	PRJNA607574	6		6	0	cord		e7d60160755f5724f518d2		0		post	0								
2117D		2117	11	liquid	SRR11116796	PRJNA607574	11		6	0	cord		e7d60160755f5724f518d2		0		post	1								
2117E		2117	12	liquid	SRR11116795	PRJNA607574	12		6	0	cord		e7d60160755f5724f518d2		0		post	1								
2117F		2117	20	semi-formed	SRR11116794	PRJNA607574	20		6	0	cord		e7d60160755f5724f518d2		0		post	2								
2119A		2119	0	formed	SRR11116793	PRJNA607574	-4		5	4	PBSC_unmodified		9e7321d43c36b08fdbdf93		0		pre	-1								
2119B		2119	1	formed	SRR11116792	PRJNA607574	-3		5	4	PBSC_unmodified		9e7321d43c36b08fdbdf93		0		pre	-1								
2119C		2119	2	formed	SRR11116791	PRJNA607574	-2		5	4	PBSC_unmodified		9e7321d43c36b08fdbdf93		0		pre	-1								
2119G		2119	16	semi-formed	SRR11116790	PRJNA607574	12		5	4	PBSC_unmodified		9e7321d43c36b08fdbdf93		0		post	1								
2119H		2119	44	semi-formed	SRR11116789	PRJNA607574	40		5	4	PBSC_unmodified		9e7321d43c36b08fdbdf93		0		post	5								
211A		211	0	formed	SRR11421147	PRJNA545312	-8		6	8	TCD	Multiple Myeloma	40769f8339edf272825e20	161	1		pre	-2								
211B		211	4	liquid	SRR11421146	PRJNA545312	-4		6	8	TCD	Multiple Myeloma	40769f8339edf272825e20	161	1		pre	-1								
211C		211	14	liquid	SRR11421145	PRJNA545312	6		6	8	TCD	Multiple Myeloma	40769f8339edf272825e20	161	1		post	0								
211D		211	19	liquid	SRR11421144	PRJNA545312	11		6	8	TCD	Multiple Myeloma	40769f8339edf272825e20	161	1		post	1								
211E		211	25	liquid	SRR11421143	PRJNA545312	17		6	8	TCD	Multiple Myeloma	40769f8339edf272825e20	161	1		post	2								
211G		211	425	liquid	SRR11421141	PRJNA545312	417		6	8	TCD	Multiple Myeloma	40769f8339edf272825e20	161	1		post	6								
2120D		2120	7	semi-formed	SRR11116788	PRJNA607574	6		9	1	PBSC_unmodified		59d121b7893e98c5bcdc2d		0		post	0								
2120E		2120	19	liquid	SRR11116787	PRJNA607574	18		9	1	PBSC_unmodified		59d121b7893e98c5bcdc2d		0		post	2								
2120G		2120	35	semi-formed	SRR11116785	PRJNA607574	34		9	1	PBSC_unmodified		59d121b7893e98c5bcdc2d		0		post	4								
2120H		2120	36	semi-formed	SRR11116784	PRJNA607574	35		9	1	PBSC_unmodified		59d121b7893e98c5bcdc2d		0		post	4								
2120I		2120	70	liquid	SRR11116783	PRJNA607574	69		9	1	PBSC_unmodified		59d121b7893e98c5bcdc2d		0		post	6								
2120J		2120	76	liquid	SRR11116782	PRJNA607574	75		9	1	PBSC_unmodified		59d121b7893e98c5bcdc2d		0		post	6								
2120K		2120	79	liquid	SRR11116781	PRJNA607574	78		9	1	PBSC_unmodified		59d121b7893e98c5bcdc2d		0		post	6								
2120L		2120	90	liquid	SRR11116780	PRJNA607574	89		9	1	PBSC_unmodified		59d121b7893e98c5bcdc2d		0		post	6								
2120M		2120	99	liquid	SRR11116779	PRJNA607574	98		9	1	PBSC_unmodified		59d121b7893e98c5bcdc2d		0		post	6								
2121A		2121	0	semi-formed	SRR11116778	PRJNA607574	-9		9	9	PBSC_unmodified		0db268b53cb2b0b4624f5e		0		pre	-2								
2121B		2121	1	semi-formed	SRR11116777	PRJNA607574	-8		9	9	PBSC_unmodified		0db268b53cb2b0b4624f5e		0		pre	-2								
2121C		2121	4	liquid	SRR11116776	PRJNA607574	-5		9	9	PBSC_unmodified		0db268b53cb2b0b4624f5e		0		pre	-1								
2121D		2121	7	liquid	SRR11116774	PRJNA607574	-2		9	9	PBSC_unmodified		0db268b53cb2b0b4624f5e		0		pre	-1								
2121E		2121	8	semi-formed	SRR11116773	PRJNA607574	-1		9	9	PBSC_unmodified		0db268b53cb2b0b4624f5e		0		pre	-1								
2121F		2121	12	liquid	SRR11116772	PRJNA607574	3		9	9	PBSC_unmodified		0db268b53cb2b0b4624f5e		0		peri	0								
2121G		2121	19	liquid	SRR11116771	PRJNA607574	10		9	9	PBSC_unmodified		0db268b53cb2b0b4624f5e		0		post	1								
2121H		2121	20	semi-formed	SRR11116770	PRJNA607574	11		9	9	PBSC_unmodified		0db268b53cb2b0b4624f5e		0		post	1								
2121I		2121	26	liquid	SRR11116769	PRJNA607574	17		9	9	PBSC_unmodified		0db268b53cb2b0b4624f5e		0		post	2								
2122A		2122	0	formed	SRR11396855	PRJNA607574			2																	
2122B		2122	7	formed	SRR11396854	PRJNA607574			2																	
2125A		2125	0	semi-formed	SRR11396853	PRJNA607574			1																	
2126A		2126	0	formed	SRR11116768	PRJNA607574	-8		7	8	PBSC_unmodified		68829d446fa5473651729f		0		pre	-2								
2126B		2126	1	formed	SRR11116767	PRJNA607574	-7		7	8	PBSC_unmodified		68829d446fa5473651729f		0		pre	-2								
2126C		2126	2	formed	SRR11116766	PRJNA607574	-6		7	8	PBSC_unmodified		68829d446fa5473651729f		0		pre	-1								
2126D		2126	7	liquid	SRR11116765	PRJNA607574	-1		7	8	PBSC_unmodified		68829d446fa5473651729f		0		pre	-1								
2126E		2126	9	liquid	SRR11116762	PRJNA607574	1		7	8	PBSC_unmodified		68829d446fa5473651729f		0		peri	0								
2126F		2126	15	liquid	SRR11116761	PRJNA607574	7		7	8	PBSC_unmodified		68829d446fa5473651729f		0		post	0								
2126G		2126	16	liquid	SRR11116760	PRJNA607574	8		7	8	PBSC_unmodified		68829d446fa5473651729f		0		post	1								
2127A		2127	0	liquid	SRR11116759	PRJNA607574	-3		5	3	cord		da652e4874d0e075c02ee8		0		pre	-1								
2127B		2127	9	liquid	SRR11116758	PRJNA607574	6		5	3	cord		da652e4874d0e075c02ee8		0		post	0								
2127C		2127	12	liquid	SRR11116757	PRJNA607574	9		5	3	cord		da652e4874d0e075c02ee8		0		post	1								
2127D		2127	13	liquid	SRR11116756	PRJNA607574	10		5	3	cord		da652e4874d0e075c02ee8		0		post	1								
2127F		2127	27	semi-formed	SRR11116755	PRJNA607574	24		5	3	cord		da652e4874d0e075c02ee8		0		post	3								
2130A		2130	0	semi-formed	SRR11396852	PRJNA607574			4																	
2130B		2130	7	semi-formed	SRR11396819	PRJNA607574			4																	
2130C		2130	15	semi-formed	SRR11396818	PRJNA607574			4																	
2130D		2130	49	semi-formed	SRR11396817	PRJNA607574			4																	
2131A		2131	0	liquid	SRR11116754	PRJNA607574	7		1	-7	cord		8686f8ff23f1119518b699		0		post	0								
2133A		2133	0	formed	SRR11116753	PRJNA607574	-3		7	3	PBSC_unmodified		fa217db3172cd5b30d7031		0		pre	-1								
2133B		2133	2	formed	SRR11116751	PRJNA607574	-1		7	3	PBSC_unmodified		fa217db3172cd5b30d7031		0		pre	-1								
2133C		2133	9	formed	SRR11116750	PRJNA607574	6		7	3	PBSC_unmodified		fa217db3172cd5b30d7031		0		post	0								
2133D		2133	16	semi-formed	SRR11116749	PRJNA607574	13		7	3	PBSC_unmodified		fa217db3172cd5b30d7031		0		post	1								
2133E		2133	17	semi-formed	SRR11116748	PRJNA607574	14		7	3	PBSC_unmodified		fa217db3172cd5b30d7031		0		post	1								
2133F		2133	21	formed	SRR11116747	PRJNA607574	18		7	3	PBSC_unmodified		fa217db3172cd5b30d7031		0		post	2								
2133G		2133	23	formed	SRR11116746	PRJNA607574	20		7	3	PBSC_unmodified		fa217db3172cd5b30d7031		0		post	2								
2136A		2136	0	semi-formed	SRR11396816	PRJNA607574			2																	
2136B		2136	6	semi-formed	SRR11396815	PRJNA607574			2																	
213A		213	0	semi-formed	SRR11421140	PRJNA545312	237		1	-237	TCD	Leukemia	7ba07dd7a1165af4bb235f		1		post	6								
2140A		2140	0	semi-formed	SRR11396813	PRJNA607574			2																	
2140B		2140	7	semi-formed	SRR11396812	PRJNA607574			2																	
2141A		2141	0	formed	SRR11396811	PRJNA607574			2																	
2141B		2141	7	semi-formed	SRR11396810	PRJNA607574			2																	
2142A		2142	0	formed	SRR11116745	PRJNA607574	-8	SRR14092327	6	8	PBSC_unmodified		1c49958649082ee829da94		0		pre	-2								
2142C		2142	1	formed	SRR11116744	PRJNA607574	-7	SRR14092326	6	8	PBSC_unmodified		1c49958649082ee829da94		0		pre	-2								
2142J		2142	19	liquid	SRR11116743	PRJNA607574	11	SRR13697178	6	8	PBSC_unmodified		1c49958649082ee829da94		0		post	1								
2142K		2142	20	liquid	SRR11116742	PRJNA607574	12	SRR14092325	6	8	PBSC_unmodified		1c49958649082ee829da94		0		post	1								
2142L		2142	21	semi-formed	SRR11116740	PRJNA607574	13	SRR14092323	6	8	PBSC_unmodified		1c49958649082ee829da94		0		post	1								
2142M		2142	22	liquid	SRR11116739	PRJNA607574	14	SRR14092322	6	8	PBSC_unmodified		1c49958649082ee829da94		0		post	1								
2144A		2144	0	formed	SRR11116738	PRJNA607574	-3		5	3	cord		0bbb4557be492def141882		0		pre	-1								
2144B		2144	15	liquid	SRR11116737	PRJNA607574	12		5	3	cord		0bbb4557be492def141882		0		post	1								
2144C		2144	17	liquid	SRR11116736	PRJNA607574	14		5	3	cord		0bbb4557be492def141882		0		post	1								
2144D		2144	21	formed	SRR11116735	PRJNA607574	18		5	3	cord		0bbb4557be492def141882		0		post	2								
2144E		2144	22	semi-formed	SRR11116734	PRJNA607574	19		5	3	cord		0bbb4557be492def141882		0		post	2								
2145A		2145	0	liquid	SRR11116733	PRJNA607574	-3		1	3	PBSC_unmodified		d3a407cfcfc0c30741fd14		0		pre	-1								
2146A		2146	0	semi-formed	SRR11396809	PRJNA607574			2																	
2146B		2146	14	semi-formed	SRR11396808	PRJNA607574			2																	
2147A		2147	0	semi-formed	SRR11116732	PRJNA607574	-3		10	3	cord		9ed384ff65d36c185adc5e		0		pre	-1								
2147B		2147	6	liquid	SRR11116731	PRJNA607574	3		10	3	cord		9ed384ff65d36c185adc5e		0		peri	0								
2147C		2147	8	semi-formed	SRR11116729	PRJNA607574	5		10	3	cord		9ed384ff65d36c185adc5e		0		peri	0								
2147D		2147	12	liquid	SRR11116728	PRJNA607574	9		10	3	cord		9ed384ff65d36c185adc5e		0		post	1								
2147E		2147	17	liquid	SRR11116727	PRJNA607574	14		10	3	cord		9ed384ff65d36c185adc5e		0		post	1								
2147F		2147	26	semi-formed	SRR11116726	PRJNA607574	23		10	3	cord		9ed384ff65d36c185adc5e		0		post	3								
2147G		2147	28	semi-formed	SRR11116725	PRJNA607574	25		10	3	cord		9ed384ff65d36c185adc5e		0		post	3								
2147H		2147	30	semi-formed	SRR11116724	PRJNA607574	27		10	3	cord		9ed384ff65d36c185adc5e		0		post	3								
2147I		2147	37	formed	SRR11116723	PRJNA607574	34		10	3	cord		9ed384ff65d36c185adc5e		0		post	4								
2147J		2147	65	formed	SRR11116722	PRJNA607574	62		10	3	cord		9ed384ff65d36c185adc5e		0		post	6								
2149A		2149	0	formed	SRR11116721	PRJNA607574	-6		7	6	cord		934fe1acdae174b049486e		0		pre	-1								
2149B		2149	3	formed	SRR11116720	PRJNA607574	-3		7	6	cord		934fe1acdae174b049486e		0		pre	-1								
2149C		2149	5	formed	SRR11116718	PRJNA607574	-1		7	6	cord		934fe1acdae174b049486e		0		pre	-1								
2149D		2149	7	semi-formed	SRR11116717	PRJNA607574	1		7	6	cord		934fe1acdae174b049486e		0		peri	0								
2149E		2149	10	formed	SRR11116688	PRJNA607574	4		7	6	cord		934fe1acdae174b049486e		0		peri	0								
2149F		2149	15	formed	SRR11116687	PRJNA607574	9		7	6	cord		934fe1acdae174b049486e		0		post	1								
2149G		2149	18	formed	SRR11116686	PRJNA607574	12		7	6	cord		934fe1acdae174b049486e		0		post	1								
214A		214	0	formed	SRR11421139	PRJNA545312	-5		6	5	PBSC_unmodified	Leukemia	8f0f154dc60fbb70ac72be	59	0		pre	-1								
214B		214	2	liquid	SRR11421138	PRJNA545312	-3		6	5	PBSC_unmodified	Leukemia	8f0f154dc60fbb70ac72be	59	0		pre	-1								
214C		214	9	semi-formed	SRR11421137	PRJNA545312	4		6	5	PBSC_unmodified	Leukemia	8f0f154dc60fbb70ac72be	59	0		peri	0								
214D		214	17	semi-formed	SRR11421136	PRJNA545312	12		6	5	PBSC_unmodified	Leukemia	8f0f154dc60fbb70ac72be	59	0		post	1								
214E		214	23	semi-formed	SRR11421135	PRJNA545312	18		6	5	PBSC_unmodified	Leukemia	8f0f154dc60fbb70ac72be	59	0		post	2								
214F		214	24	liquid	SRR11421134	PRJNA545312	19		6	5	PBSC_unmodified	Leukemia	8f0f154dc60fbb70ac72be	59	0		post	2								
2150A		2150	0	formed	SRR11116685	PRJNA607574	-8		10	8	PBSC_unmodified		27f2558b2d900d4a9d26e5		0		pre	-2								
2150B		2150	4	semi-formed	SRR11116684	PRJNA607574	-4		10	8	PBSC_unmodified		27f2558b2d900d4a9d26e5		0		pre	-1								
2150C		2150	6	liquid	SRR11116683	PRJNA607574	-2		10	8	PBSC_unmodified		27f2558b2d900d4a9d26e5		0		pre	-1								
2150D		2150	14	formed	SRR11116682	PRJNA607574	6		10	8	PBSC_unmodified		27f2558b2d900d4a9d26e5		0		post	0								
2150E		2150	17	formed	SRR11116681	PRJNA607574	9		10	8	PBSC_unmodified		27f2558b2d900d4a9d26e5		0		post	1								
2150F		2150	21	semi-formed	SRR11116679	PRJNA607574	13		10	8	PBSC_unmodified		27f2558b2d900d4a9d26e5		0		post	1								
2150G		2150	24	formed	SRR11116678	PRJNA607574	16		10	8	PBSC_unmodified		27f2558b2d900d4a9d26e5		0		post	2								
2150H		2150	49	formed	SRR11116677	PRJNA607574	41		10	8	PBSC_unmodified		27f2558b2d900d4a9d26e5		0		post	5								
2150I		2150	66	formed	SRR11116676	PRJNA607574	58		10	8	PBSC_unmodified		27f2558b2d900d4a9d26e5		0		post	6								
2150J		2150	67	semi-formed	SRR11116675	PRJNA607574	59		10	8	PBSC_unmodified		27f2558b2d900d4a9d26e5		0		post	6								
2151C		2151	5	semi-formed	SRR11116674	PRJNA607574	6		2	-1	PBSC_unmodified		82005c8ff387df270a09e3		0		post	0								
2151E		2151	12	semi-formed	SRR11116673	PRJNA607574	13		2	-1	PBSC_unmodified		82005c8ff387df270a09e3		0		post	1								
2156A		2156	0	semi-formed	SRR11396807	PRJNA607574			2																	
2156B		2156	8	semi-formed	SRR11396806	PRJNA607574			2																	
2157A		2157	0	formed	SRR11396805	PRJNA607574			1																	
2159A		2159	0	semi-formed	SRR11396804	PRJNA607574			2																	
2159B		2159	6	semi-formed	SRR11396802	PRJNA607574			2																	
215A		215	0	semi-formed	SRR11421133	PRJNA545312	5		1	-5	PBSC_unmodified	Non-Hodgkin's Lymphoma	73566e734169b57b69c548	14	1		peri	0								
2160A		2160	0	formed	SRR11396801	PRJNA607574			3																	
2160B		2160	5	formed	SRR11396800	PRJNA607574			3																	
2160C		2160	13	semi-formed	SRR11396799	PRJNA607574			3																	
2162A		2162	0	semi-formed	SRR11116672	PRJNA607574	1		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		peri	0								
2162B		2162	4	liquid	SRR11116671	PRJNA607574	5		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		peri	0								
2162C		2162	7	liquid	SRR11116670	PRJNA607574	8		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		post	1								
2162D		2162	11	liquid	SRR11116668	PRJNA607574	12		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		post	1								
2162E		2162	13	liquid	SRR11116667	PRJNA607574	14		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		post	1								
2162F		2162	24	liquid	SRR11116666	PRJNA607574	25		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		post	3								
2162G		2162	25	semi-formed	SRR11116665	PRJNA607574	26		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		post	3								
2162H		2162	26	semi-formed	SRR11116664	PRJNA607574	27		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		post	3								
2162I		2162	27	liquid	SRR11116663	PRJNA607574	28		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		post	3								
2162J		2162	31	liquid	SRR11116662	PRJNA607574	32		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		post	4								
2162K		2162	33	liquid	SRR11116661	PRJNA607574	34		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		post	4								
2162L		2162	34	liquid	SRR11116660	PRJNA607574	35		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		post	4								
2162M		2162	35	liquid	SRR11116659	PRJNA607574	36		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		post	5								
2162N		2162	40	liquid	SRR11116657	PRJNA607574	41		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		post	5								
2162O		2162	41	liquid	SRR11116656	PRJNA607574	42		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		post	5								
2162P		2162	42	semi-formed	SRR11116655	PRJNA607574	43		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		post	6								
2162Q		2162	45	formed	SRR11116654	PRJNA607574	46		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		post	6								
2162R		2162	53	semi-formed	SRR11116951	PRJNA607574	54		18	-1	PBSC_unmodified		bf8a70efecd47606c9032a		0		post	6								
2163A		2163	0	semi-formed	SRR11117157	PRJNA607574	-3		14	3	PBSC_unmodified		c108398ad35294e0eb1f16		0		pre	-1								
2163B		2163	1	semi-formed	SRR11117156	PRJNA607574	-2		14	3	PBSC_unmodified		c108398ad35294e0eb1f16		0		pre	-1								
2163C		2163	2	liquid	SRR11117155	PRJNA607574	-1		14	3	PBSC_unmodified		c108398ad35294e0eb1f16		0		pre	-1								
2163D		2163	3	liquid	SRR11117154	PRJNA607574	0		14	3	PBSC_unmodified		c108398ad35294e0eb1f16		0		peri	-1								
2163E		2163	4	liquid	SRR11117153	PRJNA607574	1		14	3	PBSC_unmodified		c108398ad35294e0eb1f16		0		peri	0								
2163F		2163	8	liquid	SRR11117151	PRJNA607574	5		14	3	PBSC_unmodified		c108398ad35294e0eb1f16		0		peri	0								
2163G		2163	9	liquid	SRR11117150	PRJNA607574	6		14	3	PBSC_unmodified		c108398ad35294e0eb1f16		0		post	0								
2163H		2163	10	liquid	SRR11117149	PRJNA607574	7		14	3	PBSC_unmodified		c108398ad35294e0eb1f16		0		post	0								
2163I		2163	11	liquid	SRR11117148	PRJNA607574	8		14	3	PBSC_unmodified		c108398ad35294e0eb1f16		0		post	1								
2163J		2163	15	liquid	SRR11117147	PRJNA607574	12		14	3	PBSC_unmodified		c108398ad35294e0eb1f16		0		post	1								
2163K		2163	18	liquid	SRR11117146	PRJNA607574	15		14	3	PBSC_unmodified		c108398ad35294e0eb1f16		0		post	2								
2163L		2163	21	liquid	SRR11117145	PRJNA607574	18		14	3	PBSC_unmodified		c108398ad35294e0eb1f16		0		post	2								
2163M		2163	22	semi-formed	SRR11117144	PRJNA607574	19		14	3	PBSC_unmodified		c108398ad35294e0eb1f16		0		post	2								
2163N		2163	36	semi-formed	SRR11117143	PRJNA607574	33		14	3	PBSC_unmodified		c108398ad35294e0eb1f16		0		post	4								
2168A		2168	0	semi-formed	SRR11396798	PRJNA607574			2																	
2168B		2168	7	semi-formed	SRR11396797	PRJNA607574			2																	
216A		216	0	semi-formed	SRR11396796	PRJNA607574			1																	
2173A		2173	0	semi-formed	SRR11396795	PRJNA607574			2																	
2173B		2173	8	semi-formed	SRR11396794	PRJNA607574			2																	
2175A		2175	0	formed	SRR11117142	PRJNA607574	-1		6	1	PBSC_unmodified		3f50cf403b16522b88635c		0		pre	-1								
2175B		2175	1	semi-formed	SRR11117140	PRJNA607574	0		6	1	PBSC_unmodified		3f50cf403b16522b88635c		0		peri	-1								
2175C		2175	3	formed	SRR11117139	PRJNA607574	2		6	1	PBSC_unmodified		3f50cf403b16522b88635c		0		peri	0								
2175D		2175	8	liquid	SRR11117138	PRJNA607574	7		6	1	PBSC_unmodified		3f50cf403b16522b88635c		0		post	0								
2175E		2175	12	formed	SRR11117137	PRJNA607574	11		6	1	PBSC_unmodified		3f50cf403b16522b88635c		0		post	1								
2175F		2175	41	liquid	SRR11117136	PRJNA607574	40		6	1	PBSC_unmodified		3f50cf403b16522b88635c		0		post	5								
217A		217	0	formed	SRR11421132	PRJNA545312	-7		5	7	TCD	Leukemia	c143197bf7816736ae6165	69	0		pre	-2								
217B		217	7	semi-formed	SRR11421102	PRJNA545312	0		5	7	TCD	Leukemia	c143197bf7816736ae6165	69	0		peri	-1								
217C		217	11	liquid	SRR11421101	PRJNA545312	4		5	7	TCD	Leukemia	c143197bf7816736ae6165	69	0		peri	0								
217D		217	12	liquid	SRR11421100	PRJNA545312	5		5	7	TCD	Leukemia	c143197bf7816736ae6165	69	0		peri	0								
217E		217	19	liquid	SRR11421099	PRJNA545312	12		5	7	TCD	Leukemia	c143197bf7816736ae6165	69	0		post	1								
2180A		2180	0	liquid	SRR11117135	PRJNA607574	3		7	-3	cord		ce47bd1832891848432d92		0		peri	0								
2180B		2180	3	liquid	SRR11117134	PRJNA607574	6		7	-3	cord		ce47bd1832891848432d92		0		post	0								
2180C		2180	4	liquid	SRR11117133	PRJNA607574	7		7	-3	cord		ce47bd1832891848432d92		0		post	0								
2180D		2180	10	liquid	SRR11117132	PRJNA607574	13		7	-3	cord		ce47bd1832891848432d92		0		post	1								
2180E		2180	16	semi-formed	SRR11117131	PRJNA607574	19		7	-3	cord		ce47bd1832891848432d92		0		post	2								
2180F		2180	23	semi-formed	SRR11117100	PRJNA607574	26		7	-3	cord		ce47bd1832891848432d92		0		post	3								
2180G		2180	25	liquid	SRR11117099	PRJNA607574	28		7	-3	cord		ce47bd1832891848432d92		0		post	3								
2181A		2181	0	formed	SRR11117098	PRJNA607574	-4		16	4	PBSC_unmodified		2579dace9b00a8315e57c5		0		pre	-1								
2181B		2181	3	liquid	SRR11117097	PRJNA607574	-1		16	4	PBSC_unmodified		2579dace9b00a8315e57c5		0		pre	-1								
2181C		2181	4	semi-formed	SRR11117096	PRJNA607574	0		16	4	PBSC_unmodified		2579dace9b00a8315e57c5		0		peri	-1								
2181D		2181	8	semi-formed	SRR11117095	PRJNA607574	4		16	4	PBSC_unmodified		2579dace9b00a8315e57c5		0		peri	0								
2181E		2181	10	formed	SRR11117094	PRJNA607574	6		16	4	PBSC_unmodified		2579dace9b00a8315e57c5		0		post	0								
2181F		2181	11	semi-formed	SRR11117093	PRJNA607574	7		16	4	PBSC_unmodified		2579dace9b00a8315e57c5		0		post	0								
2181G		2181	15	liquid	SRR11117092	PRJNA607574	11		16	4	PBSC_unmodified		2579dace9b00a8315e57c5		0		post	1								
2181H		2181	18	liquid	SRR11117091	PRJNA607574	14		16	4	PBSC_unmodified		2579dace9b00a8315e57c5		0		post	1								
2181J		2181	21	liquid	SRR11117088	PRJNA607574	17		16	4	PBSC_unmodified		2579dace9b00a8315e57c5		0		post	2								
2181K		2181	22	liquid	SRR11396793	PRJNA607574	18		16	4	PBSC_unmodified		2579dace9b00a8315e57c5		0		post	2								
2181L		2181	23	liquid	SRR11117087	PRJNA607574	19		16	4	PBSC_unmodified		2579dace9b00a8315e57c5		0		post	2								
2181M		2181	24	liquid	SRR11117086	PRJNA607574	20		16	4	PBSC_unmodified		2579dace9b00a8315e57c5		0		post	2								
2181N		2181	26	liquid	SRR11117085	PRJNA607574	22		16	4	PBSC_unmodified		2579dace9b00a8315e57c5		0		post	3								
2181O		2181	28	semi-formed	SRR11117084	PRJNA607574	24		16	4	PBSC_unmodified		2579dace9b00a8315e57c5		0		post	3								
2181P		2181	30	semi-formed	SRR11117083	PRJNA607574	26		16	4	PBSC_unmodified		2579dace9b00a8315e57c5		0		post	3								
2181Q		2181	31	formed	SRR11117082	PRJNA607574	27		16	4	PBSC_unmodified		2579dace9b00a8315e57c5		0		post	3								
2182A		2182	0	semi-formed	SRR11117081	PRJNA607574	4		9	-4	PBSC_unmodified		ba224fd004297b9f4ec573		0		peri	0								
2182B		2182	1	formed	SRR11117080	PRJNA607574	5		9	-4	PBSC_unmodified		ba224fd004297b9f4ec573		0		peri	0								
2182C		2182	3	semi-formed	SRR11117078	PRJNA607574	7		9	-4	PBSC_unmodified		ba224fd004297b9f4ec573		0		post	0								
2182D		2182	4	semi-formed	SRR11117077	PRJNA607574	8		9	-4	PBSC_unmodified		ba224fd004297b9f4ec573		0		post	1								
2182E		2182	7	semi-formed	SRR11117076	PRJNA607574	11		9	-4	PBSC_unmodified		ba224fd004297b9f4ec573		0		post	1								
2182F		2182	8	formed	SRR11117075	PRJNA607574	12		9	-4	PBSC_unmodified		ba224fd004297b9f4ec573		0		post	1								
2182G		2182	9	formed	SRR11117074	PRJNA607574	13		9	-4	PBSC_unmodified		ba224fd004297b9f4ec573		0		post	1								
2182H		2182	16	liquid	SRR11117073	PRJNA607574	20		9	-4	PBSC_unmodified		ba224fd004297b9f4ec573		0		post	2								
2182I		2182	18	semi-formed	SRR11117072	PRJNA607574	22		9	-4	PBSC_unmodified		ba224fd004297b9f4ec573		0		post	3								
218A		218	0	formed	SRR11421098	PRJNA545312	-9		11	1245	PBSC_unmodified	Leukemia	a390e649d2cb814cf73c23	281	1		pre	-2								
218B		218	7	semi-formed	SRR11421097	PRJNA545312	-2		11	1245	PBSC_unmodified	Leukemia	a390e649d2cb814cf73c23	281	1		pre	-1								
218C		218	8	liquid	SRR11421096	PRJNA545312	-1		11	1245	PBSC_unmodified	Leukemia	a390e649d2cb814cf73c23	281	1		pre	-1								
218D		218	19	liquid	SRR11421095	PRJNA545312	10		11	1245	PBSC_unmodified	Leukemia	a390e649d2cb814cf73c23	281	1		post	1								
218F		218	301	semi-formed	SRR11421094	PRJNA545312	292		11	1245	PBSC_unmodified	Leukemia	a390e649d2cb814cf73c23	281	1		post	6								
218G		218	327	semi-formed	SRR11421093	PRJNA545312	318		11	1245	PBSC_unmodified	Leukemia	a390e649d2cb814cf73c23	281	1		post	6								
218H		218	330	semi-formed	SRR11421091	PRJNA545312	321		11	1245	PBSC_unmodified	Leukemia	a390e649d2cb814cf73c23	281	1		post	6								
218I		218	1240	formed	SRR11421090	PRJNA545312	-5		11	1245	PBSC_unmodified	Leukemia	a390e649d2cb814cf73c23	281	1		pre	-1								
218J		218	1247	liquid	SRR11421089	PRJNA545312	2		11	1245	PBSC_unmodified	Leukemia	a390e649d2cb814cf73c23	281	1		peri	0								
218K		218	1264	liquid	SRR11421088	PRJNA545312	19		11	1245	PBSC_unmodified	Leukemia	a390e649d2cb814cf73c23	281	1		post	2								
218L		218	1272	liquid	SRR11421087	PRJNA545312	27		11	1245	PBSC_unmodified	Leukemia	a390e649d2cb814cf73c23	281	1		post	3								
2196A		2196	0	semi-formed	SRR11117071	PRJNA607574	-1		9	1	PBSC_unmodified		dcc623a0b541e44c3dcc9a		0		pre	-1								
2196B		2196	5	liquid	SRR11117070	PRJNA607574	4		9	1	PBSC_unmodified		dcc623a0b541e44c3dcc9a		0		peri	0								
2196C		2196	6	liquid	SRR11117069	PRJNA607574	5		9	1	PBSC_unmodified		dcc623a0b541e44c3dcc9a		0		peri	0								
2196D		2196	7	liquid	SRR11117067	PRJNA607574	6		9	1	PBSC_unmodified		dcc623a0b541e44c3dcc9a		0		post	0								
2196E		2196	10	liquid	SRR11117066	PRJNA607574	9		9	1	PBSC_unmodified		dcc623a0b541e44c3dcc9a		0		post	1								
2196F		2196	11	liquid	SRR11117065	PRJNA607574	10		9	1	PBSC_unmodified		dcc623a0b541e44c3dcc9a		0		post	1								
2196G		2196	12	liquid	SRR11117064	PRJNA607574	11		9	1	PBSC_unmodified		dcc623a0b541e44c3dcc9a		0		post	1								
2196H		2196	13	liquid	SRR11117063	PRJNA607574	12		9	1	PBSC_unmodified		dcc623a0b541e44c3dcc9a		0		post	1								
2196I		2196	14	semi-formed	SRR11117062	PRJNA607574	13		9	1	PBSC_unmodified		dcc623a0b541e44c3dcc9a		0		post	1								
2199A		2199	0	liquid	SRR11117061	PRJNA607574	-1		6	1	PBSC_unmodified		ae28ab8a55eb6307c766bd		0		pre	-1								
2199B		2199	2	liquid	SRR11117060	PRJNA607574	1		6	1	PBSC_unmodified		ae28ab8a55eb6307c766bd		0		peri	0								
2199C		2199	3	liquid	SRR11117059	PRJNA607574	2		6	1	PBSC_unmodified		ae28ab8a55eb6307c766bd		0		peri	0								
2199D		2199	6	liquid	SRR11117058	PRJNA607574	5		6	1	PBSC_unmodified		ae28ab8a55eb6307c766bd		0		peri	0								
2199E		2199	7	liquid	SRR11117056	PRJNA607574	6		6	1	PBSC_unmodified		ae28ab8a55eb6307c766bd		0		post	0								
2199F		2199	8	liquid	SRR11117055	PRJNA607574	7		6	1	PBSC_unmodified		ae28ab8a55eb6307c766bd		0		post	0								
2206A		2206	0	formed	SRR11117054	PRJNA607574	-8		5	8	PBSC_unmodified		f39b0a501992f284783b11		0		pre	-2								
2206B		2206	5	semi-formed	SRR11117053	PRJNA607574	-3		5	8	PBSC_unmodified		f39b0a501992f284783b11		0		pre	-1								
2206C		2206	6	liquid	SRR11117052	PRJNA607574	-2		5	8	PBSC_unmodified		f39b0a501992f284783b11		0		pre	-1								
2206D		2206	7	liquid	SRR11117051	PRJNA607574	-1		5	8	PBSC_unmodified		f39b0a501992f284783b11		0		pre	-1								
2206E		2206	8	liquid	SRR11117050	PRJNA607574	0		5	8	PBSC_unmodified		f39b0a501992f284783b11		0		peri	-1								
220A		220	0	formed	SRR11421086	PRJNA545312	-7		5	7	PBSC_unmodified	Hodgkin's Disease	623776f290cae6476599f0	231	1		pre	-2								
220B		220	6	semi-formed	SRR11421085	PRJNA545312	-1		5	7	PBSC_unmodified	Hodgkin's Disease	623776f290cae6476599f0	231	1		pre	-1								
220C		220	11	semi-formed	SRR11421084	PRJNA545312	4		5	7	PBSC_unmodified	Hodgkin's Disease	623776f290cae6476599f0	231	1		peri	0								
220D		220	18	semi-formed	SRR11421083	PRJNA545312	11		5	7	PBSC_unmodified	Hodgkin's Disease	623776f290cae6476599f0	231	1		post	1								
220E		220	26	semi-formed	SRR11421082	PRJNA545312	19		5	7	PBSC_unmodified	Hodgkin's Disease	623776f290cae6476599f0	231	1		post	2								
221A		221	0	formed	SRR11421080	PRJNA545312	-9		5	9	TCD	Myelodysplastic Syndromes	1d0ce9738a86946f0f6aa6	269	1		pre	-2								
221B		221	7	liquid	SRR11421079	PRJNA545312	-2		5	9	TCD	Myelodysplastic Syndromes	1d0ce9738a86946f0f6aa6	269	1		pre	-1								
221C		221	13	liquid	SRR11421078	PRJNA545312	4		5	9	TCD	Myelodysplastic Syndromes	1d0ce9738a86946f0f6aa6	269	1		peri	0								
221D		221	20	semi-formed	SRR11421077	PRJNA545312	11		5	9	TCD	Myelodysplastic Syndromes	1d0ce9738a86946f0f6aa6	269	1		post	1								
221F		221	35	formed	SRR11421076	PRJNA545312	26		5	9	TCD	Myelodysplastic Syndromes	1d0ce9738a86946f0f6aa6	269	1		post	3								
222A		222	0	formed	SRR11421075	PRJNA545312	-6		7	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	6f72785a3ab4689867c78d	68	1		pre	-1								
222B		222	5	formed	SRR11421612	PRJNA545312	-1		7	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	6f72785a3ab4689867c78d	68	1		pre	-1								
222C		222	6	formed	SRR11421611	PRJNA545312	0		7	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	6f72785a3ab4689867c78d	68	1		peri	-1								
222D		222	12	semi-formed	SRR11421610	PRJNA545312	6		7	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	6f72785a3ab4689867c78d	68	1		post	0								
222E		222	19	formed	SRR11421609	PRJNA545312	13		7	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	6f72785a3ab4689867c78d	68	1		post	1								
222F		222	26	formed	SRR11421607	PRJNA545312	20		7	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	6f72785a3ab4689867c78d	68	1		post	2								
222G		222	350	formed	SRR11421606	PRJNA545312	344		7	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	6f72785a3ab4689867c78d	68	1		post	6								
223A		223	0	formed	SRR11421605	PRJNA545312	-5		6	5	PBSC_unmodified	Leukemia	1d203a8ac18e871756346e	261	1		pre	-1								
223C		223	11	semi-formed	SRR11421604	PRJNA545312	6		6	5	PBSC_unmodified	Leukemia	1d203a8ac18e871756346e	261	1		post	0								
223D		223	18	formed	SRR11421603	PRJNA545312	13		6	5	PBSC_unmodified	Leukemia	1d203a8ac18e871756346e	261	1		post	1								
223E		223	25	formed	SRR11421602	PRJNA545312	20		6	5	PBSC_unmodified	Leukemia	1d203a8ac18e871756346e	261	1		post	2								
223F		223	31	semi-formed	SRR11421601	PRJNA545312	26		6	5	PBSC_unmodified	Leukemia	1d203a8ac18e871756346e	261	1		post	3								
223G		223	33	semi-formed	SRR11421600	PRJNA545312	28		6	5	PBSC_unmodified	Leukemia	1d203a8ac18e871756346e	261	1		post	3								
224A		224	0	formed	SRR11421599	PRJNA545312	-8		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		pre	-2								
224B		224	7	liquid	SRR11421598	PRJNA545312	-1		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		pre	-1								
224C		224	12	liquid	SRR11421596	PRJNA545312	4		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		peri	0								
224D		224	19	liquid	SRR11421595	PRJNA545312	11		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		post	1								
224E		224	33	liquid	SRR11421594	PRJNA545312	25		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		post	3								
224F		224	41	formed	SRR11421593	PRJNA545312	33		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		post	4								
224G		224	72	liquid	SRR11421592	PRJNA545312	-63		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		pre	-3								
224H		224	75	liquid	SRR11421591	PRJNA545312	-60		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		pre	-3								
224I		224	96	semi-formed	SRR11421590	PRJNA545312	-39		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		pre	-3								
224J		224	111	semi-formed	SRR11421589	PRJNA545312	-24		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		pre	-3								
224K		224	132	semi-formed	SRR11421588	PRJNA545312	-3		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		pre	-1								
224L		224	138	semi-formed	SRR11421587	PRJNA545312	3		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		peri	0								
224M		224	146	semi-formed	SRR11421585	PRJNA545312	11		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		post	1								
224N		224	160	semi-formed	SRR11421472	PRJNA545312	25		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		post	3								
224O		224	166	formed	SRR11421471	PRJNA545312	31		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		post	4								
224P		224	269	formed	SRR11421470	PRJNA545312	134		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		post	6								
224Q		224	273	formed	SRR11421469	PRJNA545312	138		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		post	6								
224R		224	364	formed	SRR11421468	PRJNA545312	229		18	135	TCD	Non-Malignant Hemat Disorders	5a8fe6a8423fe2076c6822	242	1		post	6								
225A		225	0	formed	SRR11421467	PRJNA545312	-6		2	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	eec07cf3c8831138082ac8	271	1		pre	-1								
225B		225	4	liquid	SRR11421466	PRJNA545312	-2		2	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	eec07cf3c8831138082ac8	271	1		pre	-1								
226A		226	0	formed	SRR11421465	PRJNA545312	-9		7	9	PBSC_unmodified	Leukemia	8c60ac00b2a58333844a2e	297	1		pre	-2								
226B		226	6	formed	SRR11421464	PRJNA545312	-3		7	9	PBSC_unmodified	Leukemia	8c60ac00b2a58333844a2e	297	1		pre	-1								
226C		226	14	semi-formed	SRR11421462	PRJNA545312	5		7	9	PBSC_unmodified	Leukemia	8c60ac00b2a58333844a2e	297	1		peri	0								
226E		226	27	semi-formed	SRR11421461	PRJNA545312	18		7	9	PBSC_unmodified	Leukemia	8c60ac00b2a58333844a2e	297	1		post	2								
226H		226	104	formed	SRR11421460	PRJNA545312	95		7	9	PBSC_unmodified	Leukemia	8c60ac00b2a58333844a2e	297	1		post	6								
226I		226	111	semi-formed	SRR11421459	PRJNA545312	102		7	9	PBSC_unmodified	Leukemia	8c60ac00b2a58333844a2e	297	1		post	6								
226J		226	319	semi-formed	SRR11421458	PRJNA545312	310		7	9	PBSC_unmodified	Leukemia	8c60ac00b2a58333844a2e	297	1		post	6								
227A		227	0	liquid	SRR11421457	PRJNA545312	-3		3	3	TCD	Leukemia	1024939d6c0a92b4662658	216	1		pre	-1								
227B		227	7	semi-formed	SRR11421456	PRJNA545312	4		3	3	TCD	Leukemia	1024939d6c0a92b4662658	216	1		peri	0								
227C		227	18	liquid	SRR11421455	PRJNA545312	15		3	3	TCD	Leukemia	1024939d6c0a92b4662658	216	1		post	2								
228A		228	0	formed	SRR11421454	PRJNA545312	-9		4	9	TCD	Myelodysplastic Syndromes	4e0e1523598f87c7525c32	3	1		pre	-2								
228B		228	7	liquid	SRR11421453	PRJNA545312	-2		4	9	TCD	Myelodysplastic Syndromes	4e0e1523598f87c7525c32	3	1		pre	-1								
228C		228	13	liquid	SRR11421450	PRJNA545312	4		4	9	TCD	Myelodysplastic Syndromes	4e0e1523598f87c7525c32	3	1		peri	0								
228D		228	27	liquid	SRR11421449	PRJNA545312	18		4	9	TCD	Myelodysplastic Syndromes	4e0e1523598f87c7525c32	3	1		post	2								
229A		229	0	semi-formed	SRR11421448	PRJNA545312	-9		3	9	TCD	Leukemia	03dc9a2a2a61c20cba659f	309	1		pre	-2								
229B		229	13	liquid	SRR11421447	PRJNA545312	4		3	9	TCD	Leukemia	03dc9a2a2a61c20cba659f	309	1		peri	0								
229D		229	27	semi-formed	SRR11421446	PRJNA545312	18		3	9	TCD	Leukemia	03dc9a2a2a61c20cba659f	309	1		post	2								
230A		230	0	formed	SRR11421445	PRJNA545312	-10		4	10	TCD	Myelodysplastic Syndromes	a6f57483194b65c388e8ca	266	1		pre	-2								
230B		230	9	formed	SRR11421388	PRJNA545312	-1		4	10	TCD	Myelodysplastic Syndromes	a6f57483194b65c388e8ca	266	1		pre	-1								
230C		230	13	liquid	SRR11421387	PRJNA545312	3		4	10	TCD	Myelodysplastic Syndromes	a6f57483194b65c388e8ca	266	1		peri	0								
230D		230	21	semi-formed	SRR11421386	PRJNA545312	11		4	10	TCD	Myelodysplastic Syndromes	a6f57483194b65c388e8ca	266	1		post	1								
232A		232	0	formed	SRR11421385	PRJNA545312	-5		12	5	cord	Leukemia	efe404f8baa4bcffc3243d	315	1		pre	-1								
232B		232	4	semi-formed	SRR11421383	PRJNA545312	-1		12	5	cord	Leukemia	efe404f8baa4bcffc3243d	315	1		pre	-1								
232C		232	9	semi-formed	SRR11421382	PRJNA545312	4		12	5	cord	Leukemia	efe404f8baa4bcffc3243d	315	1		peri	0								
232D		232	17	formed	SRR11421381	PRJNA545312	12		12	5	cord	Leukemia	efe404f8baa4bcffc3243d	315	1		post	1								
232F		232	29	formed	SRR11421380	PRJNA545312	24		12	5	cord	Leukemia	efe404f8baa4bcffc3243d	315	1		post	3								
232G		232	31	semi-formed	SRR11421379	PRJNA545312	26		12	5	cord	Leukemia	efe404f8baa4bcffc3243d	315	1		post	3								
232H		232	37	semi-formed	SRR11421378	PRJNA545312	32		12	5	cord	Leukemia	efe404f8baa4bcffc3243d	315	1		post	4								
232I		232	46	formed	SRR11421377	PRJNA545312	41		12	5	cord	Leukemia	efe404f8baa4bcffc3243d	315	1		post	5								
232J		232	55	formed	SRR11421376	PRJNA545312	50		12	5	cord	Leukemia	efe404f8baa4bcffc3243d	315	1		post	6								
232K		232	59	semi-formed	SRR11421375	PRJNA545312	54		12	5	cord	Leukemia	efe404f8baa4bcffc3243d	315	1		post	6								
232M		232	72	formed	SRR11421374	PRJNA545312	67		12	5	cord	Leukemia	efe404f8baa4bcffc3243d	315	1		post	6								
232N		232	264	formed	SRR11421372	PRJNA545312	259		12	5	cord	Leukemia	efe404f8baa4bcffc3243d	315	1		post	6								
233A		233	0	formed	SRR11421371	PRJNA545312	-10		3	10	TCD	Myelodysplastic Syndromes	f592dc5d1c1d8f2359795d	300	1		pre	-2								
233B		233	17	semi-formed	SRR11421370	PRJNA545312	7		3	10	TCD	Myelodysplastic Syndromes	f592dc5d1c1d8f2359795d	300	1		post	0								
233C		233	20	liquid	SRR11421369	PRJNA545312	10		3	10	TCD	Myelodysplastic Syndromes	f592dc5d1c1d8f2359795d	300	1		post	1								
234A		234	0	semi-formed	SRR11421368	PRJNA545312	-6		6	6	PBSC_unmodified	Leukemia	e1aa11eb2ecba8b78ee7b3	75	0		pre	-1								
234B		234	4	liquid	SRR11420963	PRJNA545312	-2		6	6	PBSC_unmodified	Leukemia	e1aa11eb2ecba8b78ee7b3	75	0		pre	-1								
234C		234	6	liquid	SRR11421069	PRJNA545312	0		6	6	PBSC_unmodified	Leukemia	e1aa11eb2ecba8b78ee7b3	75	0		peri	-1								
234D		234	11	liquid	SRR11421068	PRJNA545312	5		6	6	PBSC_unmodified	Leukemia	e1aa11eb2ecba8b78ee7b3	75	0		peri	0								
234E		234	18	liquid	SRR11421067	PRJNA545312	12		6	6	PBSC_unmodified	Leukemia	e1aa11eb2ecba8b78ee7b3	75	0		post	1								
234F		234	20	liquid	SRR11421066	PRJNA545312	14		6	6	PBSC_unmodified	Leukemia	e1aa11eb2ecba8b78ee7b3	75	0		post	1								
235A		235	0	formed	SRR11421064	PRJNA545312	0		8	0	BM_unmodified	Leukemia	1c5a0a5c1578caf6ff9ec1	210	1		peri	-1								
235B		235	8	semi-formed	SRR11421007	PRJNA545312	8		8	0	BM_unmodified	Leukemia	1c5a0a5c1578caf6ff9ec1	210	1		post	1								
235C		235	11	formed	SRR11421006	PRJNA545312	11		8	0	BM_unmodified	Leukemia	1c5a0a5c1578caf6ff9ec1	210	1		post	1								
235D		235	19	formed	SRR11420189	PRJNA545312	19		8	0	BM_unmodified	Leukemia	1c5a0a5c1578caf6ff9ec1	210	1		post	2								
235E		235	37	formed	SRR11420150	PRJNA545312	37		8	0	BM_unmodified	Leukemia	1c5a0a5c1578caf6ff9ec1	210	1		post	5								
235F		235	47	formed	SRR11420139	PRJNA545312	47		8	0	BM_unmodified	Leukemia	1c5a0a5c1578caf6ff9ec1	210	1		post	6								
235G		235	69	formed	SRR11420128	PRJNA545312	69		8	0	BM_unmodified	Leukemia	1c5a0a5c1578caf6ff9ec1	210	1		post	6								
235H		235	74	formed	SRR11420051	PRJNA545312	74		8	0	BM_unmodified	Leukemia	1c5a0a5c1578caf6ff9ec1	210	1		post	6								
236A		236	0	formed	SRR11420039	PRJNA545312	5		2	-5	cord	Leukemia	b5410a51f44a413faf0b48	323	1		peri	0								
236C		236	21	formed	SRR11419972	PRJNA545312	26		2	-5	cord	Leukemia	b5410a51f44a413faf0b48	323	1		post	3								
237A		237	0	formed	SRR11419961	PRJNA545312	-2		3	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	f92f25592ed1296f0d1e88	101	1		pre	-1								
237B		237	8	formed	SRR11419950	PRJNA545312	6		3	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	f92f25592ed1296f0d1e88	101	1		post	0								
237C		237	14	liquid	SRR11419939	PRJNA545312	12		3	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	f92f25592ed1296f0d1e88	101	1		post	1								
238A		238	0	formed	SRR11419928	PRJNA545312	-9		4	9	PBSC_unmodified	Leukemia	76d7347de07521c5715797	212	1		pre	-2								
238B		238	6	semi-formed	SRR11420263	PRJNA545312	-3		4	9	PBSC_unmodified	Leukemia	76d7347de07521c5715797	212	1		pre	-1								
238C		238	22	liquid	SRR11420252	PRJNA545312	13		4	9	PBSC_unmodified	Leukemia	76d7347de07521c5715797	212	1		post	1								
238D		238	28	semi-formed	SRR11420241	PRJNA545312	19		4	9	PBSC_unmodified	Leukemia	76d7347de07521c5715797	212	1		post	2								
239A		239	0	semi-formed	SRR11420230	PRJNA545312	-10		7	10	TCD	Leukemia	16fda86a35a070a668d3df	290	1		pre	-2								
239B		239	6	formed	SRR11420218	PRJNA545312	-4		7	10	TCD	Leukemia	16fda86a35a070a668d3df	290	1		pre	-1								
239C		239	14	liquid	SRR11420179	PRJNA545312	4		7	10	TCD	Leukemia	16fda86a35a070a668d3df	290	1		peri	0								
239D		239	20	liquid	SRR11420168	PRJNA545312	10		7	10	TCD	Leukemia	16fda86a35a070a668d3df	290	1		post	1								
239E		239	85	semi-formed	SRR11420157	PRJNA545312	75		7	10	TCD	Leukemia	16fda86a35a070a668d3df	290	1		post	6								
239F		239	111	liquid	SRR11420118	PRJNA545312	101		7	10	TCD	Leukemia	16fda86a35a070a668d3df	290	1		post	6								
239G		239	119	liquid	SRR11420107	PRJNA545312	109		7	10	TCD	Leukemia	16fda86a35a070a668d3df	290	1		post	6								
240A		240	0	formed	SRR11420030	PRJNA545312	-7		7	7	TCD	Myelodysplastic Syndromes	5b79d6fff276ee613ff85e	306	1		pre	-2								
240B		240	4	semi-formed	SRR11420019	PRJNA545312	-3		7	7	TCD	Myelodysplastic Syndromes	5b79d6fff276ee613ff85e	306	1		pre	-1								
240C		240	10	liquid	SRR11420008	PRJNA545312	3		7	7	TCD	Myelodysplastic Syndromes	5b79d6fff276ee613ff85e	306	1		peri	0								
240D		240	23	liquid	SRR11419913	PRJNA545312	16		7	7	TCD	Myelodysplastic Syndromes	5b79d6fff276ee613ff85e	306	1		post	2								
240E		240	89	formed	SRR11419901	PRJNA545312	82		7	7	TCD	Myelodysplastic Syndromes	5b79d6fff276ee613ff85e	306	1		post	6								
240F		240	94	formed	SRR11419890	PRJNA545312	87		7	7	TCD	Myelodysplastic Syndromes	5b79d6fff276ee613ff85e	306	1		post	6								
240G		240	187	formed	SRR11419879	PRJNA545312	180		7	7	TCD	Myelodysplastic Syndromes	5b79d6fff276ee613ff85e	306	1		post	6								
242A		242	0	semi-formed	SRR11419868	PRJNA545312	-1		4	1	TCD	Myelodysplastic Syndromes	06262364915f4156c1ce88	302	1		pre	-1								
242B		242	5	liquid	SRR11421005	PRJNA545312	4		4	1	TCD	Myelodysplastic Syndromes	06262364915f4156c1ce88	302	1		peri	0								
242C		242	12	semi-formed	SRR11421004	PRJNA545312	11		4	1	TCD	Myelodysplastic Syndromes	06262364915f4156c1ce88	302	1		post	1								
242D		242	40	liquid	SRR11421003	PRJNA545312	39		4	1	TCD	Myelodysplastic Syndromes	06262364915f4156c1ce88	302	1		post	5								
243A		243	0	formed	SRR11421002	PRJNA545312	-6		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4ae6e8698b705d8e480906	115	1		pre	-1								
243B		243	4	semi-formed	SRR11421001	PRJNA545312	-2		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4ae6e8698b705d8e480906	115	1		pre	-1								
243C		243	11	semi-formed	SRR11421000	PRJNA545312	5		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4ae6e8698b705d8e480906	115	1		peri	0								
243D		243	18	formed	SRR11420999	PRJNA545312	12		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4ae6e8698b705d8e480906	115	1		post	1								
244A		244	0	formed	SRR11420997	PRJNA545312	-6		3	6	cord	Leukemia	d6ed2456c0533041010152	332	1		pre	-1								
244B		244	10	liquid	SRR11420996	PRJNA545312	4		3	6	cord	Leukemia	d6ed2456c0533041010152	332	1		peri	0								
244C		244	37	semi-formed	SRR11420995	PRJNA545312	31		3	6	cord	Leukemia	d6ed2456c0533041010152	332	1		post	4								
245A		245	0	formed	SRR11420994	PRJNA545312	-10		3	10	TCD	Multiple Myeloma	b6ecd3c5279e586ce03257	107	1		pre	-2								
245B		245	8	semi-formed	SRR11420993	PRJNA545312	-2		3	10	TCD	Multiple Myeloma	b6ecd3c5279e586ce03257	107	1		pre	-1								
245C		245	15	semi-formed	SRR11420992	PRJNA545312	5		3	10	TCD	Multiple Myeloma	b6ecd3c5279e586ce03257	107	1		peri	0								
246A		246	0	formed	SRR11420991	PRJNA545312	-5		3	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	90d9b130ae8365b8359ce0	173	1		pre	-1								
246B		246	9	semi-formed	SRR11420990	PRJNA545312	4		3	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	90d9b130ae8365b8359ce0	173	1		peri	0								
246C		246	16	semi-formed	SRR11420989	PRJNA545312	11		3	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	90d9b130ae8365b8359ce0	173	1		post	1								
247A		247	0	formed	SRR11420988	PRJNA545312	-6		7	6	PBSC_unmodified	Leukemia	c850eb9fe4c24a02a64327	11	1		pre	-1								
247B		247	4	formed	SRR11420986	PRJNA545312	-2		7	6	PBSC_unmodified	Leukemia	c850eb9fe4c24a02a64327	11	1		pre	-1								
247D		247	17	liquid	SRR11420985	PRJNA545312	11		7	6	PBSC_unmodified	Leukemia	c850eb9fe4c24a02a64327	11	1		post	1								
247E		247	24	semi-formed	SRR11420984	PRJNA545312	18		7	6	PBSC_unmodified	Leukemia	c850eb9fe4c24a02a64327	11	1		post	2								
247F		247	47	liquid	SRR11420983	PRJNA545312	41		7	6	PBSC_unmodified	Leukemia	c850eb9fe4c24a02a64327	11	1		post	5								
247G		247	101	liquid	SRR11420982	PRJNA545312	95		7	6	PBSC_unmodified	Leukemia	c850eb9fe4c24a02a64327	11	1		post	6								
247H		247	144	semi-formed	SRR11420981	PRJNA545312	138		7	6	PBSC_unmodified	Leukemia	c850eb9fe4c24a02a64327	11	1		post	6								
248A		248	0	formed	SRR11420980	PRJNA545312	-8		5	8	TCD	Multiple Myeloma	2b5747ce4d77745686d5ab	116	1		pre	-2								
248B		248	7	formed	SRR11420678	PRJNA545312	-1		5	8	TCD	Multiple Myeloma	2b5747ce4d77745686d5ab	116	1		pre	-1								
248D		248	13	liquid	SRR11420677	PRJNA545312	5		5	8	TCD	Multiple Myeloma	2b5747ce4d77745686d5ab	116	1		peri	0								
248E		248	20	liquid	SRR11420676	PRJNA545312	12		5	8	TCD	Multiple Myeloma	2b5747ce4d77745686d5ab	116	1		post	1								
248F		248	95	formed	SRR11420674	PRJNA545312	87		5	8	TCD	Multiple Myeloma	2b5747ce4d77745686d5ab	116	1		post	6								
249A		249	0	formed	SRR11420673	PRJNA545312	-5		4	5	TCD	Leukemia	bddb81ebee8e475abcdd5c	305	1		pre	-1								
249B		249	2	formed	SRR11420672	PRJNA545312	-3		4	5	TCD	Leukemia	bddb81ebee8e475abcdd5c	305	1		pre	-1								
249C		249	9	liquid	SRR11420671	PRJNA545312	4		4	5	TCD	Leukemia	bddb81ebee8e475abcdd5c	305	1		peri	0								
249D		249	16	liquid	SRR11420670	PRJNA545312	11		4	5	TCD	Leukemia	bddb81ebee8e475abcdd5c	305	1		post	1								
251A		251	0	liquid	SRR11420669	PRJNA545312	5		9	-5	PBSC_unmodified	Leukemia	a3b5b62892bac845473675	312	1		peri	0								
251B		251	15	semi-formed	SRR11420668	PRJNA545312	20		9	-5	PBSC_unmodified	Leukemia	a3b5b62892bac845473675	312	1		post	2								
251D		251	42	semi-formed	SRR11420667	PRJNA545312	47		9	-5	PBSC_unmodified	Leukemia	a3b5b62892bac845473675	312	1		post	6								
251E		251	50	liquid	SRR11420666	PRJNA545312	55		9	-5	PBSC_unmodified	Leukemia	a3b5b62892bac845473675	312	1		post	6								
251F		251	57	semi-formed	SRR11420665	PRJNA545312	62		9	-5	PBSC_unmodified	Leukemia	a3b5b62892bac845473675	312	1		post	6								
251G		251	63	semi-formed	SRR11421367	PRJNA545312	68		9	-5	PBSC_unmodified	Leukemia	a3b5b62892bac845473675	312	1		post	6								
251H		251	70	semi-formed	SRR11421366	PRJNA545312	75		9	-5	PBSC_unmodified	Leukemia	a3b5b62892bac845473675	312	1		post	6								
251I		251	77	semi-formed	SRR11421365	PRJNA545312	82		9	-5	PBSC_unmodified	Leukemia	a3b5b62892bac845473675	312	1		post	6								
251J		251	91	semi-formed	SRR11421364	PRJNA545312	96		9	-5	PBSC_unmodified	Leukemia	a3b5b62892bac845473675	312	1		post	6								
254A		254	0	formed	SRR11421363	PRJNA545312	-8		4	8	TCD	Myelodysplastic Syndromes	194fc8c3ee86dc83e2e512	326	1		pre	-2								
254B		254	4	formed	SRR11421362	PRJNA545312	-4		4	8	TCD	Myelodysplastic Syndromes	194fc8c3ee86dc83e2e512	326	1		pre	-1								
254D		254	18	liquid	SRR11421361	PRJNA545312	10		4	8	TCD	Myelodysplastic Syndromes	194fc8c3ee86dc83e2e512	326	1		post	1								
254E		254	25	semi-formed	SRR11421360	PRJNA545312	17		4	8	TCD	Myelodysplastic Syndromes	194fc8c3ee86dc83e2e512	326	1		post	2								
255A		255	0	formed	SRR11421359	PRJNA545312	-8		3	8	TCD	Myelodysplastic Syndromes	de0d94443c69b56757adfa	191	1		pre	-2								
255B		255	7	semi-formed	SRR11421358	PRJNA545312	-1		3	8	TCD	Myelodysplastic Syndromes	de0d94443c69b56757adfa	191	1		pre	-1								
255C		255	20	semi-formed	SRR11421356	PRJNA545312	12		3	8	TCD	Myelodysplastic Syndromes	de0d94443c69b56757adfa	191	1		post	1								
256A		256	0	semi-formed	SRR11421355	PRJNA545312	-10		4	10	TCD	Leukemia	d7d7c1fe5d8dbdcb034780	296	1		pre	-2								
256B		256	6	liquid	SRR11421326	PRJNA545312	-4		4	10	TCD	Leukemia	d7d7c1fe5d8dbdcb034780	296	1		pre	-1								
256C		256	20	liquid	SRR11421325	PRJNA545312	10		4	10	TCD	Leukemia	d7d7c1fe5d8dbdcb034780	296	1		post	1								
256D		256	27	semi-formed	SRR11421324	PRJNA545312	17		4	10	TCD	Leukemia	d7d7c1fe5d8dbdcb034780	296	1		post	2								
257A		257	0	semi-formed	SRR11421323	PRJNA545312	-3		3	3	PBSC_unmodified	Leukemia	2984c88bc8a3dfc3a1e94d	291	1		pre	-1								
257B		257	6	semi-formed	SRR11421322	PRJNA545312	3		3	3	PBSC_unmodified	Leukemia	2984c88bc8a3dfc3a1e94d	291	1		peri	0								
257C		257	15	liquid	SRR11421321	PRJNA545312	12		3	3	PBSC_unmodified	Leukemia	2984c88bc8a3dfc3a1e94d	291	1		post	1								
258A		258	0	formed	SRR11421320	PRJNA545312	-7		3	7	TCD	Leukemia	4fab9360010458838487d3	316	1		pre	-2								
258B		258	11	liquid	SRR11421319	PRJNA545312	4		3	7	TCD	Leukemia	4fab9360010458838487d3	316	1		peri	0								
258C		258	18	semi-formed	SRR11421317	PRJNA545312	11		3	7	TCD	Leukemia	4fab9360010458838487d3	316	1		post	1								
259E		259	62	formed	SRR11421316	PRJNA545312	84		1	-22	cord	Hodgkin's Disease	5a1ce3452c16fcce0d5e83	199	1		post	6								
260A		260	0	semi-formed	SRR11421315	PRJNA545312	0		2	0	TCD	Myelodysplastic Syndromes	f8d71212664531ffa166cc	298	1		peri	-1								
260B		260	5	semi-formed	SRR11421314	PRJNA545312	5		2	0	TCD	Myelodysplastic Syndromes	f8d71212664531ffa166cc	298	1		peri	0								
261A		261	0	formed	SRR11421313	PRJNA545312	-2		3	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	fcf20bff0215be9f66a710	184	1		pre	-1								
261B		261	7	semi-formed	SRR11421312	PRJNA545312	5		3	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	fcf20bff0215be9f66a710	184	1		peri	0								
261C		261	2	liquid	SRR11421311	PRJNA545312	0		3	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	fcf20bff0215be9f66a710	184	1		peri	-1								
262A		262	0	liquid	SRR11421310	PRJNA545312	-4		15	4	cord	Leukemia	ac8c630385f262b666bd9e	235	1		pre	-1								
262B		262	2	formed	SRR11421309	PRJNA545312	-2		15	4	cord	Leukemia	ac8c630385f262b666bd9e	235	1		pre	-1								
262C		262	9	liquid	SRR11421308	PRJNA545312	5		15	4	cord	Leukemia	ac8c630385f262b666bd9e	235	1		peri	0								
262D		262	22	semi-formed	SRR11421305	PRJNA545312	18		15	4	cord	Leukemia	ac8c630385f262b666bd9e	235	1		post	2								
262E		262	24	semi-formed	SRR11421304	PRJNA545312	20		15	4	cord	Leukemia	ac8c630385f262b666bd9e	235	1		post	2								
262F		262	30	formed	SRR11421303	PRJNA545312	26		15	4	cord	Leukemia	ac8c630385f262b666bd9e	235	1		post	3								
262G		262	38	liquid	SRR11421302	PRJNA545312	34		15	4	cord	Leukemia	ac8c630385f262b666bd9e	235	1		post	4								
262H		262	44	liquid	SRR11421301	PRJNA545312	40		15	4	cord	Leukemia	ac8c630385f262b666bd9e	235	1		post	5								
262I		262	45	liquid	SRR11421300	PRJNA545312	41		15	4	cord	Leukemia	ac8c630385f262b666bd9e	235	1		post	5								
262J		262	100	formed	SRR11421299	PRJNA545312	96		15	4	cord	Leukemia	ac8c630385f262b666bd9e	235	1		post	6								
262K		262	430	liquid	SRR11421270	PRJNA545312	426		15	4	cord	Leukemia	ac8c630385f262b666bd9e	235	1		post	6								
262L		262	431	liquid	SRR11421269	PRJNA545312	427		15	4	cord	Leukemia	ac8c630385f262b666bd9e	235	1		post	6								
262M		262	667	semi-formed	SRR11421268	PRJNA545312	663		15	4	cord	Leukemia	ac8c630385f262b666bd9e	235	1		post	6								
262N		262	682	semi-formed	SRR11421266	PRJNA545312	678		15	4	cord	Leukemia	ac8c630385f262b666bd9e	235	1		post	6								
262O		262	842	semi-formed	SRR11421265	PRJNA545312	838		15	4	cord	Leukemia	ac8c630385f262b666bd9e	235	1		post	6								
264A		264	0	formed	SRR11421264	PRJNA545312	-9		4	9	TCD	Leukemia	ca87478766cecad2719e1d	301	1		pre	-2								
264B		264	7	liquid	SRR11421263	PRJNA545312	-2		4	9	TCD	Leukemia	ca87478766cecad2719e1d	301	1		pre	-1								
264C		264	13	liquid	SRR11421262	PRJNA545312	4		4	9	TCD	Leukemia	ca87478766cecad2719e1d	301	1		peri	0								
264D		264	34	formed	SRR11421261	PRJNA545312	25		4	9	TCD	Leukemia	ca87478766cecad2719e1d	301	1		post	3								
265A		265	0	formed	SRR11421260	PRJNA545312	-8		4	8	TCD	Leukemia	8e6945bd58f0a4af8a8bd8	148	1		pre	-2								
265B		265	6	semi-formed	SRR11421259	PRJNA545312	-2		4	8	TCD	Leukemia	8e6945bd58f0a4af8a8bd8	148	1		pre	-1								
265C		265	12	semi-formed	SRR11421258	PRJNA545312	4		4	8	TCD	Leukemia	8e6945bd58f0a4af8a8bd8	148	1		peri	0								
265D		265	19	liquid	SRR11421257	PRJNA545312	11		4	8	TCD	Leukemia	8e6945bd58f0a4af8a8bd8	148	1		post	1								
266A		266	0	formed	SRR11421255	PRJNA545312	-3		8	3	cord	Non-Hodgkin's Lymphoma	a947d6176a66582d4ced44	17	1		pre	-1								
266B		266	1	semi-formed	SRR11421254	PRJNA545312	-2		8	3	cord	Non-Hodgkin's Lymphoma	a947d6176a66582d4ced44	17	1		pre	-1								
266C		266	12	liquid	SRR11421253	PRJNA545312	9		8	3	cord	Non-Hodgkin's Lymphoma	a947d6176a66582d4ced44	17	1		post	1								
266D		266	18	liquid	SRR11421252	PRJNA545312	15		8	3	cord	Non-Hodgkin's Lymphoma	a947d6176a66582d4ced44	17	1		post	2								
266E		266	76	liquid	SRR11421251	PRJNA545312	73		8	3	cord	Non-Hodgkin's Lymphoma	a947d6176a66582d4ced44	17	1		post	6								
266F		266	106	liquid	SRR11421250	PRJNA545312	103		8	3	cord	Non-Hodgkin's Lymphoma	a947d6176a66582d4ced44	17	1		post	6								
266G		266	113	liquid	SRR11421249	PRJNA545312	110		8	3	cord	Non-Hodgkin's Lymphoma	a947d6176a66582d4ced44	17	1		post	6								
266H		266	190	liquid	SRR11421248	PRJNA545312	187		8	3	cord	Non-Hodgkin's Lymphoma	a947d6176a66582d4ced44	17	1		post	6								
267A		267	0	formed	SRR11421247	PRJNA545312	-3		5	3	cord	Hodgkin's Disease	c5db188207cf41ee9040cf	307	1		pre	-1								
267B		267	11	liquid	SRR11421246	PRJNA545312	8		5	3	cord	Hodgkin's Disease	c5db188207cf41ee9040cf	307	1		post	1								
267D		267	21	formed	SRR11421244	PRJNA545312	18		5	3	cord	Hodgkin's Disease	c5db188207cf41ee9040cf	307	1		post	2								
267E		267	28	formed	SRR11421243	PRJNA545312	25		5	3	cord	Hodgkin's Disease	c5db188207cf41ee9040cf	307	1		post	3								
267F		267	35	formed	SRR11421214	PRJNA545312	32		5	3	cord	Hodgkin's Disease	c5db188207cf41ee9040cf	307	1		post	4								
268A		268	0	formed	SRR11421213	PRJNA545312	-7		4	7	TCD	Myelodysplastic Syndromes	5511efd139dc1bc33c6100	304	1		pre	-2								
268B		268	5	formed	SRR11421212	PRJNA545312	-2		4	7	TCD	Myelodysplastic Syndromes	5511efd139dc1bc33c6100	304	1		pre	-1								
268C		268	12	liquid	SRR11421211	PRJNA545312	5		4	7	TCD	Myelodysplastic Syndromes	5511efd139dc1bc33c6100	304	1		peri	0								
268D		268	26	semi-formed	SRR11421210	PRJNA545312	19		4	7	TCD	Myelodysplastic Syndromes	5511efd139dc1bc33c6100	304	1		post	2								
269A		269	0	formed	SRR11421209	PRJNA545312	-5		3	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	e7a96c634de42fde836ce8	189	1		pre	-1								
269C		269	10	semi-formed	SRR11421208	PRJNA545312	5		3	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	e7a96c634de42fde836ce8	189	1		peri	0								
269D		269	528	liquid	SRR11421207	PRJNA545312	523		3	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	e7a96c634de42fde836ce8	189	1		post	6								
270A		270	0	formed	SRR11421205	PRJNA545312	-1		4	1	TCD	Myelodysplastic Syndromes	9c95baf6612bcef699d983	279	1		pre	-1								
270B		270	8	liquid	SRR11421204	PRJNA545312	7		4	1	TCD	Myelodysplastic Syndromes	9c95baf6612bcef699d983	279	1		post	0								
270C		270	11	liquid	SRR11421203	PRJNA545312	10		4	1	TCD	Myelodysplastic Syndromes	9c95baf6612bcef699d983	279	1		post	1								
270D		270	640	liquid	SRR11421202	PRJNA545312	639		4	1	TCD	Myelodysplastic Syndromes	9c95baf6612bcef699d983	279	1		post	6								
271A		271	0	formed	SRR11421201	PRJNA545312	-9		4	9	PBSC_unmodified	Leukemia	28574633c15ce62c44408a	340	0		pre	-2								
271C		271	21	liquid	SRR11421200	PRJNA545312	12		4	9	PBSC_unmodified	Leukemia	28574633c15ce62c44408a	340	0		post	1								
271D		271	28	liquid	SRR11421199	PRJNA545312	19		4	9	PBSC_unmodified	Leukemia	28574633c15ce62c44408a	340	0		post	2								
271E		271	31	liquid	SRR11421198	PRJNA545312	22		4	9	PBSC_unmodified	Leukemia	28574633c15ce62c44408a	340	0		post	3								
272A		272	0	formed	SRR11421197	PRJNA545312	-4		3	4	TCD	Multiple Myeloma	cbdc04927ae407161b2c94	143	1		pre	-1								
272B		272	3	liquid	SRR11421196	PRJNA545312	-1		3	4	TCD	Multiple Myeloma	cbdc04927ae407161b2c94	143	1		pre	-1								
272E		272	22	liquid	SRR11421194	PRJNA545312	18		3	4	TCD	Multiple Myeloma	cbdc04927ae407161b2c94	143	1		post	2								
273A		273	0	formed	SRR11421193	PRJNA545312	-7		4	7	TCD	Myelodysplastic Syndromes	b443b624a77000020ef9a7	322	1		pre	-2								
273B		273	6	semi-formed	SRR11421192	PRJNA545312	-1		4	7	TCD	Myelodysplastic Syndromes	b443b624a77000020ef9a7	322	1		pre	-1								
273E		273	25	semi-formed	SRR11421191	PRJNA545312	18		4	7	TCD	Myelodysplastic Syndromes	b443b624a77000020ef9a7	322	1		post	2								
273F		273	31	formed	SRR11421190	PRJNA545312	24		4	7	TCD	Myelodysplastic Syndromes	b443b624a77000020ef9a7	322	1		post	3								
274A		274	0	formed	SRR11421189	PRJNA545312	-6		9	6	cord	Leukemia	619f1fa47df4d0dcd2cfb2	221	1		pre	-1								
274B		274	1	liquid	SRR11421188	PRJNA545312	-5		9	6	cord	Leukemia	619f1fa47df4d0dcd2cfb2	221	1		pre	-1								
274C		274	13	liquid	SRR11421187	PRJNA545312	7		9	6	cord	Leukemia	619f1fa47df4d0dcd2cfb2	221	1		post	0								
274D		274	17	liquid	SRR11421074	PRJNA545312	11		9	6	cord	Leukemia	619f1fa47df4d0dcd2cfb2	221	1		post	1								
274E		274	29	semi-formed	SRR11421073	PRJNA545312	23		9	6	cord	Leukemia	619f1fa47df4d0dcd2cfb2	221	1		post	3								
274F		274	45	semi-formed	SRR11421070	PRJNA545312	39		9	6	cord	Leukemia	619f1fa47df4d0dcd2cfb2	221	1		post	5								
274G		274	51	formed	SRR11421664	PRJNA545312	45		9	6	cord	Leukemia	619f1fa47df4d0dcd2cfb2	221	1		post	6								
274H		274	59	formed	SRR11421663	PRJNA545312	53		9	6	cord	Leukemia	619f1fa47df4d0dcd2cfb2	221	1		post	6								
274I		274	87	semi-formed	SRR11421662	PRJNA545312	81		9	6	cord	Leukemia	619f1fa47df4d0dcd2cfb2	221	1		post	6								
275A		275	0	semi-formed	SRR11421661	PRJNA545312	-6		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	da4f201b8f7370fb97ec56	310	1		pre	-1								
275C		275	10	liquid	SRR11421660	PRJNA545312	4		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	da4f201b8f7370fb97ec56	310	1		peri	0								
275D		275	17	liquid	SRR11421659	PRJNA545312	11		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	da4f201b8f7370fb97ec56	310	1		post	1								
275E		275	18	formed	SRR11421658	PRJNA545312	12		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	da4f201b8f7370fb97ec56	310	1		post	1								
275F		275	25	liquid	SRR11421657	PRJNA545312	19		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	da4f201b8f7370fb97ec56	310	1		post	2								
276A		276	0	formed	SRR11421656	PRJNA545312	-2		6	2	BM_unmodified	Leukemia	087072b18b141eeaeddeb3		1		pre	-1								
276B		276	1	formed	SRR11421654	PRJNA545312	-1		6	2	BM_unmodified	Leukemia	087072b18b141eeaeddeb3		1		pre	-1								
276C		276	7	formed	SRR11421653	PRJNA545312	5		6	2	BM_unmodified	Leukemia	087072b18b141eeaeddeb3		1		peri	0								
276D		276	16	formed	SRR11421652	PRJNA545312	14		6	2	BM_unmodified	Leukemia	087072b18b141eeaeddeb3		1		post	1								
276E		276	586	formed	SRR11421651	PRJNA545312	584		6	2	BM_unmodified	Leukemia	087072b18b141eeaeddeb3		1		post	6								
276F		276	616	semi-formed	SRR11421650	PRJNA545312	614		6	2	BM_unmodified	Leukemia	087072b18b141eeaeddeb3		1		post	6								
277A		277	0	formed	SRR11421649	PRJNA545312	-9		3	9	TCD	Leukemia	195d7164ea65b9d416b2ac	325	1		pre	-2								
277B		277	7	liquid	SRR11421648	PRJNA545312	-2		3	9	TCD	Leukemia	195d7164ea65b9d416b2ac	325	1		pre	-1								
277D		277	21	liquid	SRR11421647	PRJNA545312	12		3	9	TCD	Leukemia	195d7164ea65b9d416b2ac	325	1		post	1								
278A		278	0	formed	SRR11421646	PRJNA545312	-8		6	8	TCD	Myelodysplastic Syndromes	0a7c7b1e45a30332a5241f	294	1		pre	-2								
278B		278	4	semi-formed	SRR11421645	PRJNA545312	-4		6	8	TCD	Myelodysplastic Syndromes	0a7c7b1e45a30332a5241f	294	1		pre	-1								
278C		278	11	liquid	SRR11421643	PRJNA545312	3		6	8	TCD	Myelodysplastic Syndromes	0a7c7b1e45a30332a5241f	294	1		peri	0								
278D		278	16	semi-formed	SRR11421642	PRJNA545312	8		6	8	TCD	Myelodysplastic Syndromes	0a7c7b1e45a30332a5241f	294	1		post	1								
278E		278	18	semi-formed	SRR11421641	PRJNA545312	10		6	8	TCD	Myelodysplastic Syndromes	0a7c7b1e45a30332a5241f	294	1		post	1								
278G		278	229	semi-formed	SRR11421583	PRJNA545312	221		6	8	TCD	Myelodysplastic Syndromes	0a7c7b1e45a30332a5241f	294	1		post	6								
279B		279	10	semi-formed	SRR11421582	PRJNA545312	21		1	-11	TCD	Myelodysplastic Syndromes	83dabf94f234cc19e70762	256	1		post	2								
280A		280	0	formed	SRR11421581	PRJNA545312	-9		6	9	TCD	Myelodysplastic Syndromes	22a71b2ef86b278d31313f	331	1		pre	-2								
280B		280	6	formed	SRR11421580	PRJNA545312	-3		6	9	TCD	Myelodysplastic Syndromes	22a71b2ef86b278d31313f	331	1		pre	-1								
280C		280	13	liquid	SRR11421579	PRJNA545312	4		6	9	TCD	Myelodysplastic Syndromes	22a71b2ef86b278d31313f	331	1		peri	0								
280D		280	21	liquid	SRR11421578	PRJNA545312	12		6	9	TCD	Myelodysplastic Syndromes	22a71b2ef86b278d31313f	331	1		post	1								
280E		280	27	formed	SRR11421576	PRJNA545312	18		6	9	TCD	Myelodysplastic Syndromes	22a71b2ef86b278d31313f	331	1		post	2								
280F		280	34	semi-formed	SRR11421575	PRJNA545312	25		6	9	TCD	Myelodysplastic Syndromes	22a71b2ef86b278d31313f	331	1		post	3								
281A		281	0	formed	SRR11421574	PRJNA545312	-1		4	1	cord	Leukemia	a8d599228abe6504c66b08	330	1		pre	-1								
281B		281	6	semi-formed	SRR11421573	PRJNA545312	5		4	1	cord	Leukemia	a8d599228abe6504c66b08	330	1		peri	0								
281C		281	15	semi-formed	SRR11421572	PRJNA545312	14		4	1	cord	Leukemia	a8d599228abe6504c66b08	330	1		post	1								
281D		281	20	formed	SRR11421571	PRJNA545312	19		4	1	cord	Leukemia	a8d599228abe6504c66b08	330	1		post	2								
282A		282	0	formed	SRR11421570	PRJNA545312	-9		5	9	TCD	Leukemia	2e246308735efc412a8c87	1	1		pre	-2								
282B		282	5	formed	SRR11421569	PRJNA545312	-4		5	9	TCD	Leukemia	2e246308735efc412a8c87	1	1		pre	-1								
282C		282	12	semi-formed	SRR11421568	PRJNA545312	3		5	9	TCD	Leukemia	2e246308735efc412a8c87	1	1		peri	0								
282E		282	215	formed	SRR11421567	PRJNA545312	206		5	9	TCD	Leukemia	2e246308735efc412a8c87	1	1		post	6								
282F		282	224	semi-formed	SRR11421564	PRJNA545312	215		5	9	TCD	Leukemia	2e246308735efc412a8c87	1	1		post	6								
283A		283	0	semi-formed	SRR11421563	PRJNA545312	-4		5	4	TCD	Leukemia	b2093cf2172f414887e375	329	1		pre	-1								
283B		283	2	liquid	SRR11421562	PRJNA545312	-2		5	4	TCD	Leukemia	b2093cf2172f414887e375	329	1		pre	-1								
283C		283	9	liquid	SRR11421561	PRJNA545312	5		5	4	TCD	Leukemia	b2093cf2172f414887e375	329	1		peri	0								
283D		283	16		SRR11421560	PRJNA545312	12		5	4	TCD	Leukemia	b2093cf2172f414887e375	329	1		post	1								
283E		283	23	liquid	SRR11421559	PRJNA545312	19		5	4	TCD	Leukemia	b2093cf2172f414887e375	329	1		post	2								
284A		284	0	semi-formed	SRR11421558	PRJNA545312	-7		4	7	PBSC_unmodified	Leukemia	402d79a720ecf52716b119	286	1		pre	-2								
284B		284	3	semi-formed	SRR11421557	PRJNA545312	-4		4	7	PBSC_unmodified	Leukemia	402d79a720ecf52716b119	286	1		pre	-1								
284C		284	10	liquid	SRR11421528	PRJNA545312	3		4	7	PBSC_unmodified	Leukemia	402d79a720ecf52716b119	286	1		peri	0								
284D		284	24	liquid	SRR11421527	PRJNA545312	17		4	7	PBSC_unmodified	Leukemia	402d79a720ecf52716b119	286	1		post	2								
285A		285	0	formed	SRR11421525	PRJNA545312	-8		7	8	TCD	Non-Hodgkin's Lymphoma	5403de7ba3eac1a54822e4	320	1		pre	-2								
285B		285	5	liquid	SRR11421524	PRJNA545312	-3		7	8	TCD	Non-Hodgkin's Lymphoma	5403de7ba3eac1a54822e4	320	1		pre	-1								
285D		285	20	liquid	SRR11421523	PRJNA545312	12		7	8	TCD	Non-Hodgkin's Lymphoma	5403de7ba3eac1a54822e4	320	1		post	1								
285E		285	28	formed	SRR11416303	PRJNA545312	20		7	8	TCD	Non-Hodgkin's Lymphoma	5403de7ba3eac1a54822e4	320	1		post	2								
285F		285	33	formed	SRR11416302	PRJNA545312	25		7	8	TCD	Non-Hodgkin's Lymphoma	5403de7ba3eac1a54822e4	320	1		post	3								
285H		285	40	formed	SRR11415812	PRJNA545312	32		7	8	TCD	Non-Hodgkin's Lymphoma	5403de7ba3eac1a54822e4	320	1		post	4								
285I		285	82	formed	SRR11417577	PRJNA545312	74		7	8	TCD	Non-Hodgkin's Lymphoma	5403de7ba3eac1a54822e4	320	1		post	6								
286A		286	0	formed	SRR11415606	PRJNA545312	-2		2	2	PBSC_unmodified	Leukemia	91e2e83dc15a85c0062c5e	198	1		pre	-1								
286C		286	14	formed	SRR11415859	PRJNA545312	12		2	2	PBSC_unmodified	Leukemia	91e2e83dc15a85c0062c5e	198	1		post	1								
287C		287	18	semi-formed	SRR11416223	PRJNA545312	19		2	-1	PBSC_unmodified	Non-Hodgkin's Lymphoma	8762035f6a53fa83b547e8	183	1		post	2								
287D		287	25	semi-formed	SRR11415732	PRJNA545312	26		2	-1	PBSC_unmodified	Non-Hodgkin's Lymphoma	8762035f6a53fa83b547e8	183	1		post	3								
288A		288	0	formed	SRR11415666	PRJNA545312	-2		3	2	TCD	Leukemia	2a49dc15e321f5eb4eebcc	317	1		pre	-1								
288B		288	7	liquid	SRR11416030	PRJNA545312	5		3	2	TCD	Leukemia	2a49dc15e321f5eb4eebcc	317	1		peri	0								
288C		288	14	semi-formed	SRR11416301	PRJNA545312	12		3	2	TCD	Leukemia	2a49dc15e321f5eb4eebcc	317	1		post	1								
289A		289	0	formed	SRR11415798	PRJNA545312	-9		3	9	TCD	Leukemia	ec8ac998a27508cb7bb58a	350	1		pre	-2								
289B		289	8	formed	SRR11415787	PRJNA545312	-1		3	9	TCD	Leukemia	ec8ac998a27508cb7bb58a	350	1		pre	-1								
289C		289	14	semi-formed	SRR11415585	PRJNA545312	5		3	9	TCD	Leukemia	ec8ac998a27508cb7bb58a	350	1		peri	0								
290A		290	0	formed	SRR11415574	PRJNA545312	-8		3	8	TCD	Multiple Myeloma	8d383d5c037ab8934fca91	292	1		pre	-2								
290B		290	5	liquid	SRR11415563	PRJNA545312	-3		3	8	TCD	Multiple Myeloma	8d383d5c037ab8934fca91	292	1		pre	-1								
290E		290	27	formed	SRR11415552	PRJNA545312	19		3	8	TCD	Multiple Myeloma	8d383d5c037ab8934fca91	292	1		post	2								
291A		291	0	semi-formed	SRR11415541	PRJNA545312	-10		4	10	TCD	Multiple Myeloma	06dd96df4ea1289208bbca	114	1		pre	-2								
291B		291	7	formed	SRR11415962	PRJNA545312	-3		4	10	TCD	Multiple Myeloma	06dd96df4ea1289208bbca	114	1		pre	-1								
291C		291	17	liquid	SRR11415951	PRJNA545312	7		4	10	TCD	Multiple Myeloma	06dd96df4ea1289208bbca	114	1		post	0								
291E		291	31	semi-formed	SRR11415939	PRJNA545312	21		4	10	TCD	Multiple Myeloma	06dd96df4ea1289208bbca	114	1		post	2								
292A		292	0	formed	SRR11415468	PRJNA545312	-7		3	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	0e8ffbd41abded35917f27	353	1		pre	-2								
292C		292	11	liquid	SRR11415457	PRJNA545312	4		3	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	0e8ffbd41abded35917f27	353	1		peri	0								
292D		292	18	liquid	SRR11416269	PRJNA545312	11		3	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	0e8ffbd41abded35917f27	353	1		post	1								
294A		294	0	formed	SRR11396791	PRJNA607574			2																	
294B		294	63	formed	SRR11396790	PRJNA607574			2																	
295A		295	0	formed	SRR11416258	PRJNA545312	-8		7	8	PBSC_unmodified	Leukemia	7992cd300041a48de7df6a	354	1		pre	-2								
295B		295	2	formed	SRR11416247	PRJNA545312	-6		7	8	PBSC_unmodified	Leukemia	7992cd300041a48de7df6a	354	1		pre	-1								
295C		295	5	semi-formed	SRR11415441	PRJNA545312	-3		7	8	PBSC_unmodified	Leukemia	7992cd300041a48de7df6a	354	1		pre	-1								
295E		295	11	semi-formed	SRR11415430	PRJNA545312	3		7	8	PBSC_unmodified	Leukemia	7992cd300041a48de7df6a	354	1		peri	0								
295F		295	19	liquid	SRR11415834	PRJNA545312	11		7	8	PBSC_unmodified	Leukemia	7992cd300041a48de7df6a	354	1		post	1								
295G		295	30	semi-formed	SRR11415823	PRJNA545312	22		7	8	PBSC_unmodified	Leukemia	7992cd300041a48de7df6a	354	1		post	3								
295H		295	33	liquid	SRR11415811	PRJNA545312	25		7	8	PBSC_unmodified	Leukemia	7992cd300041a48de7df6a	354	1		post	3								
296A		296	0	liquid	SRR11415901	PRJNA545312	-2		6	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	631e0dccd2e3f38bd8ca99	170	1		pre	-1								
296C		296	3	semi-formed	SRR11417576	PRJNA545312	1		6	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	631e0dccd2e3f38bd8ca99	170	1		peri	0								
296D		296	6	liquid	SRR11417575	PRJNA545312	4		6	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	631e0dccd2e3f38bd8ca99	170	1		peri	0								
296E		296	13	liquid	SRR11417574	PRJNA545312	11		6	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	631e0dccd2e3f38bd8ca99	170	1		post	1								
296G		296	69	formed	SRR11417572	PRJNA545312	67		6	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	631e0dccd2e3f38bd8ca99	170	1		post	6								
296H		296	90	semi-formed	SRR11417571	PRJNA545312	88		6	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	631e0dccd2e3f38bd8ca99	170	1		post	6								
297A		297	0	formed	SRR11417570	PRJNA545312	-9		10	490	PBSC_unmodified	Leukemia	6927a6331ac337663ebe53	357	1		pre	-2								
297B		297	6	liquid	SRR11417569	PRJNA545312	-3		10	490	PBSC_unmodified	Leukemia	6927a6331ac337663ebe53	357	1		pre	-1								
297C		297	7	semi-formed	SRR11415890	PRJNA545312	-2		10	490	PBSC_unmodified	Leukemia	6927a6331ac337663ebe53	357	1		pre	-1								
297E		297	17	liquid	SRR11415531	PRJNA545312	8		10	490	PBSC_unmodified	Leukemia	6927a6331ac337663ebe53	357	1		post	1								
297F		297	23	formed	SRR11415520	PRJNA545312	14		10	490	PBSC_unmodified	Leukemia	6927a6331ac337663ebe53	357	1		post	1								
297G		297	27	formed	SRR11415509	PRJNA545312	18		10	490	PBSC_unmodified	Leukemia	6927a6331ac337663ebe53	357	1		post	2								
297H		297	47	formed	SRR11415358	PRJNA545312	38		10	490	PBSC_unmodified	Leukemia	6927a6331ac337663ebe53	357	1		post	5								
297I		297	366	formed	SRR11415347	PRJNA545312	-14		10	490	PBSC_unmodified	Leukemia	6927a6331ac337663ebe53	357	1		pre	-3								
297J		297	516	formed	SRR11415628	PRJNA545312	26		10	490	PBSC_unmodified	Leukemia	6927a6331ac337663ebe53	357	1		post	3								
297K		297	525	formed	SRR11415617	PRJNA545312	35		10	490	PBSC_unmodified	Leukemia	6927a6331ac337663ebe53	357	1		post	4								
298A		298	0	formed	SRR11415605	PRJNA545312	-6		7	6	cord	Leukemia	259f0c0689754a0d5033bc	244	1		pre	-1								
298B		298	4	semi-formed	SRR11416125	PRJNA545312	-2		7	6	cord	Leukemia	259f0c0689754a0d5033bc	244	1		pre	-1								
298C		298	17	semi-formed	SRR11416114	PRJNA545312	11		7	6	cord	Leukemia	259f0c0689754a0d5033bc	244	1		post	1								
298D		298	24	semi-formed	SRR11416103	PRJNA545312	18		7	6	cord	Leukemia	259f0c0689754a0d5033bc	244	1		post	2								
298E		298	31	semi-formed	SRR11416092	PRJNA545312	25		7	6	cord	Leukemia	259f0c0689754a0d5033bc	244	1		post	3								
298F		298	39	semi-formed	SRR11416081	PRJNA545312	33		7	6	cord	Leukemia	259f0c0689754a0d5033bc	244	1		post	4								
298G		298	58	semi-formed	SRR11415707	PRJNA545312	52		7	6	cord	Leukemia	259f0c0689754a0d5033bc	244	1		post	6								
299A		299	0	liquid	SRR11415696	PRJNA545312	-2		2	2	TCD	Leukemia	8a5beb2619c388b11fb16c	360	1		pre	-1								
299B		299	13	liquid	SRR11415881	PRJNA545312	11		2	2	TCD	Leukemia	8a5beb2619c388b11fb16c	360	1		post	1								
400A		400	0	formed	SRR11415870	PRJNA545312	-1		6	1	PBSC_unmodified	Leukemia	bbc933049d0bef2c18030c	314	1		pre	-1								
400C		400	6	liquid	SRR11415858	PRJNA545312	5		6	1	PBSC_unmodified	Leukemia	bbc933049d0bef2c18030c	314	1		peri	0								
400D		400	13	liquid	SRR11415415	PRJNA545312	12		6	1	PBSC_unmodified	Leukemia	bbc933049d0bef2c18030c	314	1		post	1								
400E		400	218	formed	SRR11415404	PRJNA545312	217		6	1	PBSC_unmodified	Leukemia	bbc933049d0bef2c18030c	314	1		post	6								
400F		400	223	semi-formed	SRR11415780	PRJNA545312	222		6	1	PBSC_unmodified	Leukemia	bbc933049d0bef2c18030c	314	1		post	6								
400G		400	596	formed	SRR11415769	PRJNA545312	595		6	1	PBSC_unmodified	Leukemia	bbc933049d0bef2c18030c	314	1		post	6								
401A		401	0	liquid	SRR11415758	PRJNA545312	-3		4	3	TCD	Leukemia	d5e7b2f1acd77795a7f8f7	349	1		pre	-1								
401B		401	7	semi-formed	SRR11416183	PRJNA545312	4		4	3	TCD	Leukemia	d5e7b2f1acd77795a7f8f7	349	1		peri	0								
401C		401	14	semi-formed	SRR11416172	PRJNA545312	11		4	3	TCD	Leukemia	d5e7b2f1acd77795a7f8f7	349	1		post	1								
401D		401	21	semi-formed	SRR11416161	PRJNA545312	18		4	3	TCD	Leukemia	d5e7b2f1acd77795a7f8f7	349	1		post	2								
402A		402	0	semi-formed	SRR11416234	PRJNA545312	-9		5	9	TCD	Leukemia	ade7050aa8b8b5eb9e9f18	366	1		pre	-2								
402B		402	6	semi-formed	SRR11416222	PRJNA545312	-3		5	9	TCD	Leukemia	ade7050aa8b8b5eb9e9f18	366	1		pre	-1								
402C		402	13	semi-formed	SRR11416071	PRJNA545312	4		5	9	TCD	Leukemia	ade7050aa8b8b5eb9e9f18	366	1		peri	0								
402D		402	20	semi-formed	SRR11416060	PRJNA545312	11		5	9	TCD	Leukemia	ade7050aa8b8b5eb9e9f18	366	1		post	1								
402E		402	24	semi-formed	SRR11416049	PRJNA545312	15		5	9	TCD	Leukemia	ade7050aa8b8b5eb9e9f18	366	1		post	2								
403A		403	0	formed	SRR11415983	PRJNA545312	-6		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		pre	-1								
403AA		403	558	formed	SRR11415972	PRJNA545312	552		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403B		403	4	semi-formed	SRR11416156	PRJNA545312	-2		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		pre	-1								
403BB		403	964	liquid	SRR11416145	PRJNA545312	958		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403C		403	11	liquid	SRR11416134	PRJNA545312	5		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		peri	0								
403D		403	22	formed	SRR11415743	PRJNA545312	16		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	2								
403E		403	26	semi-formed	SRR11415731	PRJNA545312	20		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	2								
403F		403	32	semi-formed	SRR11416212	PRJNA545312	26		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	3								
403G		403	39	formed	SRR11416201	PRJNA545312	33		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	4								
403H		403	47	formed	SRR11416190	PRJNA545312	41		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	5								
403I		403	75	semi-formed	SRR11415384	PRJNA545312	69		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403K		403	371	semi-formed	SRR11415373	PRJNA545312	365		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403L		403	383	semi-formed	SRR11415334	PRJNA545312	377		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403M		403	390	semi-formed	SRR11415323	PRJNA545312	384		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403N		403	411	semi-formed	SRR11415312	PRJNA545312	405		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403O		403	432	formed	SRR11415677	PRJNA545312	426		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403P		403	459	formed	SRR11415665	PRJNA545312	453		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403Q		403	466	formed	SRR11416297	PRJNA545312	460		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403R		403	480	formed	SRR11416286	PRJNA545312	474		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403S		403	481	formed	SRR11416275	PRJNA545312	475		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403T		403	494	formed	SRR11415649	PRJNA545312	488		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403U		403	515	semi-formed	SRR11415638	PRJNA545312	509		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403V		403	520	formed	SRR11416018	PRJNA545312	514		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403W		403	525	semi-formed	SRR11416007	PRJNA545312	519		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403X		403	541	formed	SRR11415997	PRJNA545312	535		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403Y		403	544	formed	SRR11416041	PRJNA545312	538		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
403Z		403	552	formed	SRR11416029	PRJNA545312	546		27	6	cord	Leukemia	34d24c5b1cb8d610c23a0d	383	1		post	6								
404A		404	0	semi-formed	SRR11415503	PRJNA545312			6																	
404B		404	9	semi-formed	SRR11415492	PRJNA545312			6																	
404C		404	22	semi-formed	SRR11415481	PRJNA545312			6																	
404D		404	28	semi-formed	SRR11415930	PRJNA545312			6																	
404E		404	70	formed	SRR11415919	PRJNA545312			6																	
404F		404	196	semi-formed	SRR11415723	PRJNA545312			6																	
405B		405	4	semi-formed	SRR11415712	PRJNA545312	-2		2	6	PBSC_unmodified	Leukemia	1e58dcab9d38b149011774	293	1		pre	-1								
405E		405	26		SRR11415594	PRJNA545312	20		2	6	PBSC_unmodified	Leukemia	1e58dcab9d38b149011774	293	1		post	2								
406A		406	0	formed	SRR11415847	PRJNA545312	-97		6	97	PBSC_unmodified	Non-Hodgkin's Lymphoma	c05b8ee2fa4235559925e7	86	1		pre	-3								
406B		406	4	formed	SRR11415808	PRJNA545312	-93		6	97	PBSC_unmodified	Non-Hodgkin's Lymphoma	c05b8ee2fa4235559925e7	86	1		pre	-3								
406C		406	31	semi-formed	SRR11415807	PRJNA545312	-66		6	97	PBSC_unmodified	Non-Hodgkin's Lymphoma	c05b8ee2fa4235559925e7	86	1		pre	-3								
406D		406	71	semi-formed	SRR11415806	PRJNA545312	-26		6	97	PBSC_unmodified	Non-Hodgkin's Lymphoma	c05b8ee2fa4235559925e7	86	1		pre	-3								
406E		406	91	formed	SRR11415805	PRJNA545312	-6		6	97	PBSC_unmodified	Non-Hodgkin's Lymphoma	c05b8ee2fa4235559925e7	86	1		pre	-1								
406H		406	129	formed	SRR11415804	PRJNA545312	32		6	97	PBSC_unmodified	Non-Hodgkin's Lymphoma	c05b8ee2fa4235559925e7	86	1		post	4								
407A		407	0	formed	SRR11415803	PRJNA545312	-2		4	2	cord	Non-Hodgkin's Lymphoma	76b657dc96745f9bdc3056	128	1		pre	-1								
407C		407	30	formed	SRR11415802	PRJNA545312	28		4	2	cord	Non-Hodgkin's Lymphoma	76b657dc96745f9bdc3056	128	1		post	3								
407D		407	38	formed	SRR11415801	PRJNA545312	36		4	2	cord	Non-Hodgkin's Lymphoma	76b657dc96745f9bdc3056	128	1		post	5								
407E		407	203	liquid	SRR11415800	PRJNA545312	201		4	2	cord	Non-Hodgkin's Lymphoma	76b657dc96745f9bdc3056	128	1		post	6								
408A		408	0	formed	SRR11415799	PRJNA545312	-10		5	10	TCD	Leukemia	1aedc0179a7b0d195c933f	324	1		pre	-2								
408B		408	7	formed	SRR11415797	PRJNA545312	-3		5	10	TCD	Leukemia	1aedc0179a7b0d195c933f	324	1		pre	-1								
408D		408	28	liquid	SRR11415796	PRJNA545312	18		5	10	TCD	Leukemia	1aedc0179a7b0d195c933f	324	1		post	2								
408E		408	143	formed	SRR11415795	PRJNA545312	133		5	10	TCD	Leukemia	1aedc0179a7b0d195c933f	324	1		post	6								
408F		408	147	semi-formed	SRR11415794	PRJNA545312	137		5	10	TCD	Leukemia	1aedc0179a7b0d195c933f	324	1		post	6								
409A		409	0	liquid	SRR11415793	PRJNA545312	-4		5	4	TCD	Multiple Myeloma	53a6cfdfa069aeed7bdb08	172	1		pre	-1								
409B		409	6	semi-formed	SRR11415792	PRJNA545312	2		5	4	TCD	Multiple Myeloma	53a6cfdfa069aeed7bdb08	172	1		peri	0								
409C		409	11	semi-formed	SRR11415791	PRJNA545312	7		5	4	TCD	Multiple Myeloma	53a6cfdfa069aeed7bdb08	172	1		post	0								
409D		409	16	semi-formed	SRR11415790	PRJNA545312	12		5	4	TCD	Multiple Myeloma	53a6cfdfa069aeed7bdb08	172	1		post	1								
409E		409	24	formed	SRR11415789	PRJNA545312	20		5	4	TCD	Multiple Myeloma	53a6cfdfa069aeed7bdb08	172	1		post	2								
410A		410	0	formed	SRR11415788	PRJNA545312	-6		5	6	cord	Non-Hodgkin's Lymphoma	9856fbde7c3e4d0158a93f	373	1		pre	-1								
410B		410	9	semi-formed	SRR11415786	PRJNA545312	3		5	6	cord	Non-Hodgkin's Lymphoma	9856fbde7c3e4d0158a93f	373	1		peri	0								
410C		410	15	liquid	SRR11415785	PRJNA545312	9		5	6	cord	Non-Hodgkin's Lymphoma	9856fbde7c3e4d0158a93f	373	1		post	1								
410D		410	20	semi-formed	SRR11415784	PRJNA545312	14		5	6	cord	Non-Hodgkin's Lymphoma	9856fbde7c3e4d0158a93f	373	1		post	1								
410E		410	25	semi-formed	SRR11415783	PRJNA545312	19		5	6	cord	Non-Hodgkin's Lymphoma	9856fbde7c3e4d0158a93f	373	1		post	2								
411A		411	0	semi-formed	SRR11415782	PRJNA545312	-9		5	9	TCD	Multiple Myeloma	ccd7d535748f77cb74fc12	263	1		pre	-2								
411B		411	6	liquid	SRR11415781	PRJNA545312	-3		5	9	TCD	Multiple Myeloma	ccd7d535748f77cb74fc12	263	1		pre	-1								
411C		411	12	liquid	SRR11415589	PRJNA545312	3		5	9	TCD	Multiple Myeloma	ccd7d535748f77cb74fc12	263	1		peri	0								
411E		411	26	liquid	SRR11415588	PRJNA545312	17		5	9	TCD	Multiple Myeloma	ccd7d535748f77cb74fc12	263	1		post	2								
411F		411	77	formed	SRR11415587	PRJNA545312	68		5	9	TCD	Multiple Myeloma	ccd7d535748f77cb74fc12	263	1		post	6								
412A		412	0	formed	SRR11415586	PRJNA545312	-5		2	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	5caffde29d2b3456517880	225	1		pre	-1								
412B		412	3	liquid	SRR11415584	PRJNA545312	-2		2	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	5caffde29d2b3456517880	225	1		pre	-1								
413A		413	0	formed	SRR11415583	PRJNA545312	-9		1	9	TCD	Leukemia	9893bb814282260d5517f1	346	1		pre	-2								
414A		414	0	formed	SRR11415582	PRJNA545312	618		1	-618	PBSC_unmodified	Hodgkin's Disease	023579ce57c66235ac7dc6		1		post	6								
415A		415	0	formed	SRR11415581	PRJNA545312	-3		6	3	cord	Leukemia	a03738c62407f1503d0859	382	1		pre	-1								
415B		415	7	semi-formed	SRR11415580	PRJNA545312	4		6	3	cord	Leukemia	a03738c62407f1503d0859	382	1		peri	0								
415C		415	14	liquid	SRR11415579	PRJNA545312	11		6	3	cord	Leukemia	a03738c62407f1503d0859	382	1		post	1								
415D		415	23	formed	SRR11415578	PRJNA545312	20		6	3	cord	Leukemia	a03738c62407f1503d0859	382	1		post	2								
415E		415	28	formed	SRR11415577	PRJNA545312	25		6	3	cord	Leukemia	a03738c62407f1503d0859	382	1		post	3								
415F		415	39	formed	SRR11415576	PRJNA545312	36		6	3	cord	Leukemia	a03738c62407f1503d0859	382	1		post	5								
416A		416	0	formed	SRR11415575	PRJNA545312	-11		4	11	BM_unmodified	Leukemia	f3ba9db9122ee6f33f508a	356	1		pre	-2								
416B		416	9	liquid	SRR11415573	PRJNA545312	-2		4	11	BM_unmodified	Leukemia	f3ba9db9122ee6f33f508a	356	1		pre	-1								
416C		416	15	liquid	SRR11415572	PRJNA545312	4		4	11	BM_unmodified	Leukemia	f3ba9db9122ee6f33f508a	356	1		peri	0								
416D		416	25	liquid	SRR11415571	PRJNA545312	14		4	11	BM_unmodified	Leukemia	f3ba9db9122ee6f33f508a	356	1		post	1								
417A		417	0	formed	SRR11415570	PRJNA545312	-4		5	4	TCD	Myelodysplastic Syndromes	43e2747f7567e5cde67ddb	333	1		pre	-1								
417B		417	8	liquid	SRR11415569	PRJNA545312	4		5	4	TCD	Myelodysplastic Syndromes	43e2747f7567e5cde67ddb	333	1		peri	0								
417C		417	9	liquid	SRR11415568	PRJNA545312	5		5	4	TCD	Myelodysplastic Syndromes	43e2747f7567e5cde67ddb	333	1		peri	0								
417D		417	15	liquid	SRR11415567	PRJNA545312	11		5	4	TCD	Myelodysplastic Syndromes	43e2747f7567e5cde67ddb	333	1		post	1								
417E		417	21	formed	SRR11415566	PRJNA545312	17		5	4	TCD	Myelodysplastic Syndromes	43e2747f7567e5cde67ddb	333	1		post	2								
418A		418	0	semi-formed	SRR11415565	PRJNA545312	-6		8	6	TCD	Leukemia	b0fe10c6468a244264ae93	378	1		pre	-1								
418B		418	3	liquid	SRR11415564	PRJNA545312	-3		8	6	TCD	Leukemia	b0fe10c6468a244264ae93	378	1		pre	-1								
418C		418	10	semi-formed	SRR11415562	PRJNA545312	4		8	6	TCD	Leukemia	b0fe10c6468a244264ae93	378	1		peri	0								
418E		418	55	formed	SRR11415561	PRJNA545312	49		8	6	TCD	Leukemia	b0fe10c6468a244264ae93	378	1		post	6								
418F		418	66	formed	SRR11415560	PRJNA545312	60		8	6	TCD	Leukemia	b0fe10c6468a244264ae93	378	1		post	6								
418G		418	217	formed	SRR11415559	PRJNA545312	211		8	6	TCD	Leukemia	b0fe10c6468a244264ae93	378	1		post	6								
418H		418	272	semi-formed	SRR11415558	PRJNA545312	266		8	6	TCD	Leukemia	b0fe10c6468a244264ae93	378	1		post	6								
418I		418	392	semi-formed	SRR11415557	PRJNA545312	386		8	6	TCD	Leukemia	b0fe10c6468a244264ae93	378	1		post	6								
420A		420	0	formed	SRR11415556	PRJNA545312	-6		8	6	cord	Non-Hodgkin's Lymphoma	00d7a5d77e1a5f7a9d3f3c	218	1		pre	-1								
420B		420	4	formed	SRR11415555	PRJNA545312	-2		8	6	cord	Non-Hodgkin's Lymphoma	00d7a5d77e1a5f7a9d3f3c	218	1		pre	-1								
420C		420	6	formed	SRR11415554	PRJNA545312	0		8	6	cord	Non-Hodgkin's Lymphoma	00d7a5d77e1a5f7a9d3f3c	218	1		peri	-1								
420D		420	11	formed	SRR11415553	PRJNA545312	5		8	6	cord	Non-Hodgkin's Lymphoma	00d7a5d77e1a5f7a9d3f3c	218	1		peri	0								
420E		420	18	formed	SRR11415551	PRJNA545312	12		8	6	cord	Non-Hodgkin's Lymphoma	00d7a5d77e1a5f7a9d3f3c	218	1		post	1								
420F		420	25	formed	SRR11415550	PRJNA545312	19		8	6	cord	Non-Hodgkin's Lymphoma	00d7a5d77e1a5f7a9d3f3c	218	1		post	2								
420G		420	32	formed	SRR11415549	PRJNA545312	26		8	6	cord	Non-Hodgkin's Lymphoma	00d7a5d77e1a5f7a9d3f3c	218	1		post	3								
420H		420	308	liquid	SRR11415548	PRJNA545312	302		8	6	cord	Non-Hodgkin's Lymphoma	00d7a5d77e1a5f7a9d3f3c	218	1		post	6								
421A		421	0	semi-formed	SRR11415547	PRJNA545312	-7		4	7	PBSC_unmodified	Leukemia	9a78f7cae92a61d330f54d	299	1		pre	-2								
421B		421	5	semi-formed	SRR11415546	PRJNA545312	-2		4	7	PBSC_unmodified	Leukemia	9a78f7cae92a61d330f54d	299	1		pre	-1								
421D		421	20	semi-formed	SRR11415545	PRJNA545312	13		4	7	PBSC_unmodified	Leukemia	9a78f7cae92a61d330f54d	299	1		post	1								
421E		421	29	liquid	SRR11415544	PRJNA545312	22		4	7	PBSC_unmodified	Leukemia	9a78f7cae92a61d330f54d	299	1		post	3								
422A		422	0	formed	SRR11415543	PRJNA545312	-9		5	9	TCD	Leukemia	67631139e3ab9ffc22a3b8	370	1		pre	-2								
422B		422	6	formed	SRR11415542	PRJNA545312	-3		5	9	TCD	Leukemia	67631139e3ab9ffc22a3b8	370	1		pre	-1								
422C		422	14	liquid	SRR11415540	PRJNA545312	5		5	9	TCD	Leukemia	67631139e3ab9ffc22a3b8	370	1		peri	0								
422D		422	20	liquid	SRR11415539	PRJNA545312	11		5	9	TCD	Leukemia	67631139e3ab9ffc22a3b8	370	1		post	1								
422E		422	27	liquid	SRR11415538	PRJNA545312	18		5	9	TCD	Leukemia	67631139e3ab9ffc22a3b8	370	1		post	2								
423B		423	3	formed	SRR11415537	PRJNA545312	6		3	-3	PBSC_unmodified	Leukemia	83798bc885c9b2b352ce1e	352	1		post	0								
423C		423	10	semi-formed	SRR11415536	PRJNA545312	13		3	-3	PBSC_unmodified	Leukemia	83798bc885c9b2b352ce1e	352	1		post	1								
423D		423	38	liquid	SRR11415535	PRJNA545312	41		3	-3	PBSC_unmodified	Leukemia	83798bc885c9b2b352ce1e	352	1		post	5								
424A		424	0	formed	SRR11415534	PRJNA545312	-7		4	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	11a94263de6bcfe0c951f3	50	1		pre	-2								
424B		424	6	liquid	SRR11415965	PRJNA545312	-1		4	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	11a94263de6bcfe0c951f3	50	1		pre	-1								
424F		424	24	formed	SRR11415964	PRJNA545312	17		4	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	11a94263de6bcfe0c951f3	50	1		post	2								
424G		424	76	formed	SRR11415963	PRJNA545312	69		4	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	11a94263de6bcfe0c951f3	50	1		post	6								
426A		426	0	formed	SRR11415961	PRJNA545312	-9		4	9	TCD	Myelodysplastic Syndromes	24758a8ab9613ec0ce933b	343	1		pre	-2								
426B		426	5	liquid	SRR11415960	PRJNA545312	-4		4	9	TCD	Myelodysplastic Syndromes	24758a8ab9613ec0ce933b	343	1		pre	-1								
426D		426	19	liquid	SRR11415959	PRJNA545312	10		4	9	TCD	Myelodysplastic Syndromes	24758a8ab9613ec0ce933b	343	1		post	1								
426F		426	127	semi-formed	SRR11415958	PRJNA545312	118		4	9	TCD	Myelodysplastic Syndromes	24758a8ab9613ec0ce933b	343	1		post	6								
427D		427	13	semi-formed	SRR11415957	PRJNA545312	14		2	-1	PBSC_unmodified	Hodgkin's Disease	bd75518dd19212a0c76ecf	152	1		post	1								
427E		427	16	formed	SRR11415956	PRJNA545312	17		2	-1	PBSC_unmodified	Hodgkin's Disease	bd75518dd19212a0c76ecf	152	1		post	2								
428A		428	0	formed	SRR11415955	PRJNA545312	-6		10	6	cord	Hodgkin's Disease	e42f375ec004a7e0fb465b	336	1		pre	-1								
428B		428	6	formed	SRR11415954	PRJNA545312	0		10	6	cord	Hodgkin's Disease	e42f375ec004a7e0fb465b	336	1		peri	-1								
428C		428	15	liquid	SRR11415953	PRJNA545312	9		10	6	cord	Hodgkin's Disease	e42f375ec004a7e0fb465b	336	1		post	1								
428D		428	19	semi-formed	SRR11415952	PRJNA545312	13		10	6	cord	Hodgkin's Disease	e42f375ec004a7e0fb465b	336	1		post	1								
428E		428	26	formed	SRR11415950	PRJNA545312	20		10	6	cord	Hodgkin's Disease	e42f375ec004a7e0fb465b	336	1		post	2								
428F		428	33	semi-formed	SRR11415949	PRJNA545312	27		10	6	cord	Hodgkin's Disease	e42f375ec004a7e0fb465b	336	1		post	3								
428G		428	47	formed	SRR11415948	PRJNA545312	41		10	6	cord	Hodgkin's Disease	e42f375ec004a7e0fb465b	336	1		post	5								
428H		428	404	semi-formed	SRR11415947	PRJNA545312	398		10	6	cord	Hodgkin's Disease	e42f375ec004a7e0fb465b	336	1		post	6								
428I		428	405	semi-formed	SRR11415946	PRJNA545312	399		10	6	cord	Hodgkin's Disease	e42f375ec004a7e0fb465b	336	1		post	6								
428J		428	416	semi-formed	SRR11415945	PRJNA545312	410		10	6	cord	Hodgkin's Disease	e42f375ec004a7e0fb465b	336	1		post	6								
429A		429	0	formed	SRR11415944	PRJNA545312	-7		3	7	TCD	Myelodysplastic Syndromes	dba92ffb554049ad49062a	243	1		pre	-2								
429B		429	3	semi-formed	SRR11415943	PRJNA545312	-4		3	7	TCD	Myelodysplastic Syndromes	dba92ffb554049ad49062a	243	1		pre	-1								
429C		429	10	semi-formed	SRR11415942	PRJNA545312	3		3	7	TCD	Myelodysplastic Syndromes	dba92ffb554049ad49062a	243	1		peri	0								
430A		430	0	formed	SRR11415941	PRJNA545312	-3		16	3	cord	Leukemia	44d2d4fef564af826437e2	54	1		pre	-1								
430B		430	1	formed	SRR11415938	PRJNA545312	-2		16	3	cord	Leukemia	44d2d4fef564af826437e2	54	1		pre	-1								
430C		430	8	formed	SRR11415477	PRJNA545312	5		16	3	cord	Leukemia	44d2d4fef564af826437e2	54	1		peri	0								
430D		430	17	semi-formed	SRR11415476	PRJNA545312	14		16	3	cord	Leukemia	44d2d4fef564af826437e2	54	1		post	1								
430E		430	25	semi-formed	SRR11415475	PRJNA545312	22		16	3	cord	Leukemia	44d2d4fef564af826437e2	54	1		post	3								
430F		430	29	formed	SRR11415474	PRJNA545312	26		16	3	cord	Leukemia	44d2d4fef564af826437e2	54	1		post	3								
430G		430	37	formed	SRR11415473	PRJNA545312	34		16	3	cord	Leukemia	44d2d4fef564af826437e2	54	1		post	4								
430H		430	43	semi-formed	SRR11415472	PRJNA545312	40		16	3	cord	Leukemia	44d2d4fef564af826437e2	54	1		post	5								
430I		430	57	formed	SRR11415471	PRJNA545312	54		16	3	cord	Leukemia	44d2d4fef564af826437e2	54	1		post	6								
430J		430	71	semi-formed	SRR11415470	PRJNA545312	68		16	3	cord	Leukemia	44d2d4fef564af826437e2	54	1		post	6								
430K		430	78	liquid	SRR11415469	PRJNA545312	75		16	3	cord	Leukemia	44d2d4fef564af826437e2	54	1		post	6								
430M		430	93	liquid	SRR11415467	PRJNA545312	90		16	3	cord	Leukemia	44d2d4fef564af826437e2	54	1		post	6								
430N		430	95	liquid	SRR11415466	PRJNA545312	92		16	3	cord	Leukemia	44d2d4fef564af826437e2	54	1		post	6								
430O		430	102	liquid	SRR11415465	PRJNA545312	99		16	3	cord	Leukemia	44d2d4fef564af826437e2	54	1		post	6								
430P		430	107	liquid	SRR11415464	PRJNA545312	104		16	3	cord	Leukemia	44d2d4fef564af826437e2	54	1		post	6								
430R		430	121	liquid	SRR11415463	PRJNA545312	118		16	3	cord	Leukemia	44d2d4fef564af826437e2	54	1		post	6								
431A		431	0	formed	SRR11415462	PRJNA545312	-9		4	9	TCD	Myelodysplastic Syndromes	e0c765ca0c0ce08d200f53	328	1		pre	-2								
431B		431	7	liquid	SRR11415461	PRJNA545312	-2		4	9	TCD	Myelodysplastic Syndromes	e0c765ca0c0ce08d200f53	328	1		pre	-1								
431D		431	28	semi-formed	SRR11415460	PRJNA545312	19		4	9	TCD	Myelodysplastic Syndromes	e0c765ca0c0ce08d200f53	328	1		post	2								
431E		431	141	formed	SRR11415459	PRJNA545312	132		4	9	TCD	Myelodysplastic Syndromes	e0c765ca0c0ce08d200f53	328	1		post	6								
432A		432	0	liquid	SRR11415458	PRJNA545312	-3		3	3	TCD	Myelodysplastic Syndromes	8c98eaf8652994c4427629	213	1		pre	-1								
432B		432	8	liquid	SRR11415456	PRJNA545312	5		3	3	TCD	Myelodysplastic Syndromes	8c98eaf8652994c4427629	213	1		peri	0								
432C		432	14	liquid	SRR11415455	PRJNA545312	11		3	3	TCD	Myelodysplastic Syndromes	8c98eaf8652994c4427629	213	1		post	1								
434A		434	0	formed	SRR11415454	PRJNA545312	-10		3	10	TCD	Leukemia	34760ea0a0dcb7c3bb0a63	159	1		pre	-2								
434B		434	5	semi-formed	SRR11415453	PRJNA545312	-5		3	10	TCD	Leukemia	34760ea0a0dcb7c3bb0a63	159	1		pre	-1								
434C		434	17	liquid	SRR11415452	PRJNA545312	7		3	10	TCD	Leukemia	34760ea0a0dcb7c3bb0a63	159	1		post	0								
435A		435	0	liquid	SRR11415451	PRJNA545312	1		2	-1	TCD	Myelodysplastic Syndromes	69cbd564bd361c1fb73222	318	1		peri	0								
435C		435	4	liquid	SRR11415450	PRJNA545312	5		2	-1	TCD	Myelodysplastic Syndromes	69cbd564bd361c1fb73222	318	1		peri	0								
436A		436	0	liquid	SRR11416272	PRJNA545312	-2		2	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	31f988d4d9f81f6c5aa1a8	358	1		pre	-1								
436B		436	1	liquid	SRR11416271	PRJNA545312	-1		2	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	31f988d4d9f81f6c5aa1a8	358	1		pre	-1								
437A		437	0	formed	SRR11416270	PRJNA545312	-6		2	6	PBSC_unmodified	Leukemia	b6cc59ec0cfdf95c98dcd3	376	1		pre	-1								
437B		437	5	semi-formed	SRR11416268	PRJNA545312	-1		2	6	PBSC_unmodified	Leukemia	b6cc59ec0cfdf95c98dcd3	376	1		pre	-1								
438B		438	78	formed	SRR11416267	PRJNA545312	82		1	-4	cord	Myelodysplastic Syndromes	76eb1794d7179fc6f9b2e4	58	1		post	6								
439A		439	0	formed	SRR11416266	PRJNA545312	-8		2	8	PBSC_unmodified	Leukemia	9f06c3c163e7a4a6c7ed28	390	1		pre	-2								
439B		439	6	semi-formed	SRR11416265	PRJNA545312	-2		2	8	PBSC_unmodified	Leukemia	9f06c3c163e7a4a6c7ed28	390	1		pre	-1								
440A		440	0	semi-formed	SRR11416264	PRJNA545312	-1		3	1	TCD	Myelodysplastic Syndromes	94895899f2c53579299258	10	1		pre	-1								
440B		440	7	liquid	SRR11416263	PRJNA545312	6		3	1	TCD	Myelodysplastic Syndromes	94895899f2c53579299258	10	1		post	0								
440C		440	12	liquid	SRR11416262	PRJNA545312	11		3	1	TCD	Myelodysplastic Syndromes	94895899f2c53579299258	10	1		post	1								
441A		441	0	formed	SRR11416261	PRJNA545312	-2		1	2	PBSC_unmodified	Leukemia	929c6d05a4e84753a2cd13	363	1		pre	-1								
443B		443	2	formed	SRR11416260	PRJNA545312	-7		3	9	PBSC_unmodified	Leukemia	4c9b44fcfa947b986bb688	375	1		pre	-2								
443C		443	5	semi-formed	SRR11416259	PRJNA545312	-4		3	9	PBSC_unmodified	Leukemia	4c9b44fcfa947b986bb688	375	1		pre	-1								
443I		443	188	formed	SRR11416257	PRJNA545312	179		3	9	PBSC_unmodified	Leukemia	4c9b44fcfa947b986bb688	375	1		post	6								
444A		444	0	formed	SRR11416256	PRJNA545312	-5		2	5	PBSC_unmodified	Leukemia	21caca2fa07eeedf2df994	337	1		pre	-1								
444B		444	3	semi-formed	SRR11416255	PRJNA545312	-2		2	5	PBSC_unmodified	Leukemia	21caca2fa07eeedf2df994	337	1		pre	-1								
445A		445	0	formed	SRR11416254	PRJNA545312	-4		1	4	PBSC_unmodified	Leukemia	b8a5e682aa9762db504359		1		pre	-1								
446A		446	0	semi-formed	SRR11416253	PRJNA545312	-3		17	1661	PBSC_unmodified	Myelodysplastic Syndromes	bbf3712d9d70fae1c0c8a2	400	1		pre	-1								
446B		446	7	liquid	SRR11416252	PRJNA545312	4		17	1661	PBSC_unmodified	Myelodysplastic Syndromes	bbf3712d9d70fae1c0c8a2	400	1		peri	0								
446C		446	73	semi-formed	SRR11416251	PRJNA545312	70		17	1661	PBSC_unmodified	Myelodysplastic Syndromes	bbf3712d9d70fae1c0c8a2	400	1		post	6								
446D		446	1659	formed	SRR11416250	PRJNA545312	-2		17	1661	PBSC_unmodified	Myelodysplastic Syndromes	bbf3712d9d70fae1c0c8a2	400	1		pre	-1								
446E		446	1661	semi-formed	SRR11416249	PRJNA545312	0		17	1661	PBSC_unmodified	Myelodysplastic Syndromes	bbf3712d9d70fae1c0c8a2	400	1		peri	-1								
446F		446	1663	semi-formed	SRR11416248	PRJNA545312	2		17	1661	PBSC_unmodified	Myelodysplastic Syndromes	bbf3712d9d70fae1c0c8a2	400	1		peri	0								
446G		446	1666	semi-formed	SRR11416246	PRJNA545312	5		17	1661	PBSC_unmodified	Myelodysplastic Syndromes	bbf3712d9d70fae1c0c8a2	400	1		peri	0								
446H		446	1667	liquid	SRR11416245	PRJNA545312	6		17	1661	PBSC_unmodified	Myelodysplastic Syndromes	bbf3712d9d70fae1c0c8a2	400	1		post	0								
446I		446	1669	liquid	SRR11415449	PRJNA545312	8		17	1661	PBSC_unmodified	Myelodysplastic Syndromes	bbf3712d9d70fae1c0c8a2	400	1		post	1								
446J		446	1670	semi-formed	SRR11415448	PRJNA545312	9		17	1661	PBSC_unmodified	Myelodysplastic Syndromes	bbf3712d9d70fae1c0c8a2	400	1		post	1								
446K		446	1674	formed	SRR11415447	PRJNA545312	13		17	1661	PBSC_unmodified	Myelodysplastic Syndromes	bbf3712d9d70fae1c0c8a2	400	1		post	1								
446L		446	1675	semi-formed	SRR11415446	PRJNA545312	14		17	1661	PBSC_unmodified	Myelodysplastic Syndromes	bbf3712d9d70fae1c0c8a2	400	1		post	1								
446M		446	1676	formed	SRR11415445	PRJNA545312	15		17	1661	PBSC_unmodified	Myelodysplastic Syndromes	bbf3712d9d70fae1c0c8a2	400	1		post	2								
446N		446	1693	semi-formed	SRR11415444	PRJNA545312	32		17	1661	PBSC_unmodified	Myelodysplastic Syndromes	bbf3712d9d70fae1c0c8a2	400	1		post	4								
446O		446	1738	formed	SRR11415443	PRJNA545312	77		17	1661	PBSC_unmodified	Myelodysplastic Syndromes	bbf3712d9d70fae1c0c8a2	400	1		post	6								
446P		446	1885	semi-formed	SRR11117049	PRJNA607574	224		17	1661	PBSC_unmodified	Myelodysplastic Syndromes	bbf3712d9d70fae1c0c8a2	400	1		post	6								
446Q		446	2010	semi-formed	SRR11117048	PRJNA607574	349		17	1661	PBSC_unmodified	Myelodysplastic Syndromes	bbf3712d9d70fae1c0c8a2	400	1		post	6								
447A		447	0	liquid	SRR11415442	PRJNA545312	-4		3	4	TCD	Myelodysplastic Syndromes	bbc3667037b4e3f3ea8076	384	1		pre	-1								
447E		447	23	formed	SRR11415440	PRJNA545312	19		3	4	TCD	Myelodysplastic Syndromes	bbc3667037b4e3f3ea8076	384	1		post	2								
447F		447	26	formed	SRR11415439	PRJNA545312	22		3	4	TCD	Myelodysplastic Syndromes	bbc3667037b4e3f3ea8076	384	1		post	3								
448A		448	0	formed	SRR11415438	PRJNA545312	-7		10	7	PBSC_unmodified	Leukemia	ea18eb8beb1d559503b5a0	377	1		pre	-2								
448C		448	13	liquid	SRR11415437	PRJNA545312	6		10	7	PBSC_unmodified	Leukemia	ea18eb8beb1d559503b5a0	377	1		post	0								
448D		448	21	liquid	SRR11415436	PRJNA545312	14		10	7	PBSC_unmodified	Leukemia	ea18eb8beb1d559503b5a0	377	1		post	1								
448E		448	31	liquid	SRR11415435	PRJNA545312	24		10	7	PBSC_unmodified	Leukemia	ea18eb8beb1d559503b5a0	377	1		post	3								
448F		448	36	liquid	SRR11415434	PRJNA545312	29		10	7	PBSC_unmodified	Leukemia	ea18eb8beb1d559503b5a0	377	1		post	4								
448G		448	43	semi-formed	SRR11415433	PRJNA545312	36		10	7	PBSC_unmodified	Leukemia	ea18eb8beb1d559503b5a0	377	1		post	5								
448H		448	49	semi-formed	SRR11415432	PRJNA545312	42		10	7	PBSC_unmodified	Leukemia	ea18eb8beb1d559503b5a0	377	1		post	5								
448I		448	56	liquid	SRR11415431	PRJNA545312	49		10	7	PBSC_unmodified	Leukemia	ea18eb8beb1d559503b5a0	377	1		post	6								
448J		448	62	liquid	SRR11415429	PRJNA545312	55		10	7	PBSC_unmodified	Leukemia	ea18eb8beb1d559503b5a0	377	1		post	6								
448K		448	70	liquid	SRR11415428	PRJNA545312	63		10	7	PBSC_unmodified	Leukemia	ea18eb8beb1d559503b5a0	377	1		post	6								
449A		449	0	liquid	SRR11415427	PRJNA545312	-1		2	1	PBSC_unmodified	Hodgkin's Disease	5ad94b2a5e20eb70533929	204	1		pre	-1								
449C		449	18	liquid	SRR11415426	PRJNA545312	17		2	1	PBSC_unmodified	Hodgkin's Disease	5ad94b2a5e20eb70533929	204	1		post	2								
450A		450	0	formed	SRR11415425	PRJNA545312	-4		1	4	TCD	Multiple Myeloma	e36682aefba9db3c7e85d0	133	1		pre	-1								
451A		451	0	liquid	SRR11415424	PRJNA545312	0		5	0	cord	Leukemia	fbe5b8b082750b91724e1e	403	1		peri	-1								
451B		451	6	liquid	SRR11415423	PRJNA545312	6		5	0	cord	Leukemia	fbe5b8b082750b91724e1e	403	1		post	0								
451E		451	29	formed	SRR11415422	PRJNA545312	29		5	0	cord	Leukemia	fbe5b8b082750b91724e1e	403	1		post	4								
451F		451	94	semi-formed	SRR11415837	PRJNA545312	94		5	0	cord	Leukemia	fbe5b8b082750b91724e1e	403	1		post	6								
451G		451	409	formed	SRR11415835	PRJNA545312	409		5	0	cord	Leukemia	fbe5b8b082750b91724e1e	403	1		post	6								
452A		452	0	formed	SRR11415833	PRJNA545312	-8		4	8	TCD	Leukemia	77c187148f962243b7ce6a	389	1		pre	-2								
452B		452	6	formed	SRR11415832	PRJNA545312	-2		4	8	TCD	Leukemia	77c187148f962243b7ce6a	389	1		pre	-1								
452C		452	12	liquid	SRR11415831	PRJNA545312	4		4	8	TCD	Leukemia	77c187148f962243b7ce6a	389	1		peri	0								
452D		452	18	liquid	SRR11415830	PRJNA545312	10		4	8	TCD	Leukemia	77c187148f962243b7ce6a	389	1		post	1								
453A		453	0	formed	SRR11415829	PRJNA545312	-5		11	5	cord	Non-Hodgkin's Lymphoma	c4064beb16abb2e72e5512	25	1		pre	-1								
453B		453	5	formed	SRR11415828	PRJNA545312	0		11	5	cord	Non-Hodgkin's Lymphoma	c4064beb16abb2e72e5512	25	1		peri	-1								
453C		453	9	semi-formed	SRR11415827	PRJNA545312	4		11	5	cord	Non-Hodgkin's Lymphoma	c4064beb16abb2e72e5512	25	1		peri	0								
453D		453	10	formed	SRR11415826	PRJNA545312	5		11	5	cord	Non-Hodgkin's Lymphoma	c4064beb16abb2e72e5512	25	1		peri	0								
453E		453	25	formed	SRR11415825	PRJNA545312	20		11	5	cord	Non-Hodgkin's Lymphoma	c4064beb16abb2e72e5512	25	1		post	2								
453F		453	31	semi-formed	SRR11415824	PRJNA545312	26		11	5	cord	Non-Hodgkin's Lymphoma	c4064beb16abb2e72e5512	25	1		post	3								
453G		453	38	formed	SRR11415822	PRJNA545312	33		11	5	cord	Non-Hodgkin's Lymphoma	c4064beb16abb2e72e5512	25	1		post	4								
453H		453	45	formed	SRR11415821	PRJNA545312	40		11	5	cord	Non-Hodgkin's Lymphoma	c4064beb16abb2e72e5512	25	1		post	5								
453I		453	52	semi-formed	SRR11415820	PRJNA545312	47		11	5	cord	Non-Hodgkin's Lymphoma	c4064beb16abb2e72e5512	25	1		post	6								
453J		453	59	semi-formed	SRR11415819	PRJNA545312	54		11	5	cord	Non-Hodgkin's Lymphoma	c4064beb16abb2e72e5512	25	1		post	6								
453K		453	66	formed	SRR11415818	PRJNA545312	61		11	5	cord	Non-Hodgkin's Lymphoma	c4064beb16abb2e72e5512	25	1		post	6								
454A		454	0	formed	SRR11415817	PRJNA545312	-8		2	8	TCD	Leukemia	ab0fa27bbea611f10fa819	391	1		pre	-2								
454B		454	6	liquid	SRR11415816	PRJNA545312	-2		2	8	TCD	Leukemia	ab0fa27bbea611f10fa819	391	1		pre	-1								
455A		455	0	semi-formed	SRR11415815	PRJNA545312	-8		1	8	TCD	Leukemia	324e8a395e4d4b46dbaaf9	399	1		pre	-2								
457B		457	37	formed	SRR11415814	PRJNA545312	39		2	-2	PBSC_unmodified	Non-Hodgkin's Lymphoma	861f8d0b56a8c5b20c08ef	209	1		post	5								
457C		457	44	formed	SRR11415813	PRJNA545312	46		2	-2	PBSC_unmodified	Non-Hodgkin's Lymphoma	861f8d0b56a8c5b20c08ef	209	1		post	6								
458A		458	0	semi-formed	SRR11415810	PRJNA545312	-5		1	5	PBSC_unmodified	Leukemia	809391d113d5bf71141ae5	334	1		pre	-1								
459A		459	0	formed	SRR11140006	PRJNA606262			1																	
460A		460	0	formed	SRR11415809	PRJNA545312	-1		5	1	cord	Leukemia	92f33f547b7dbe096b3ce9	345	1		pre	-1								
460B		460	17	semi-formed	SRR11415909	PRJNA545312	16		5	1	cord	Leukemia	92f33f547b7dbe096b3ce9	345	1		post	2								
460C		460	18	semi-formed	SRR11415908	PRJNA545312	17		5	1	cord	Leukemia	92f33f547b7dbe096b3ce9	345	1		post	2								
460D		460	19	formed	SRR11415907	PRJNA545312	18		5	1	cord	Leukemia	92f33f547b7dbe096b3ce9	345	1		post	2								
460E		460	25	semi-formed	SRR11415906	PRJNA545312	24		5	1	cord	Leukemia	92f33f547b7dbe096b3ce9	345	1		post	3								
461A		461	0	semi-formed	SRR11415905	PRJNA545312	-10		6	10	TCD	Leukemia	900af2a78395242a486551	364	1		pre	-2								
461B		461	7	semi-formed	SRR11415904	PRJNA545312	-3		6	10	TCD	Leukemia	900af2a78395242a486551	364	1		pre	-1								
461C		461	8	semi-formed	SRR11415903	PRJNA545312	-2		6	10	TCD	Leukemia	900af2a78395242a486551	364	1		pre	-1								
461D		461	20	liquid	SRR11415902	PRJNA545312	10		6	10	TCD	Leukemia	900af2a78395242a486551	364	1		post	1								
461E		461	35	liquid	SRR11415900	PRJNA545312	25		6	10	TCD	Leukemia	900af2a78395242a486551	364	1		post	3								
461F		461	111	semi-formed	SRR11415899	PRJNA545312	101		6	10	TCD	Leukemia	900af2a78395242a486551	364	1		post	6								
462A		462	0	formed	SRR11415898	PRJNA545312	-4		2	4	PBSC_unmodified	Leukemia	cafba3b94d61c199a6003d	289	1		pre	-1								
462C		462	14	semi-formed	SRR11415897	PRJNA545312	10		2	4	PBSC_unmodified	Leukemia	cafba3b94d61c199a6003d	289	1		post	1								
463A		463	0	formed	SRR11415896	PRJNA545312	-8		2	8	TCD	Myeloproliferative Disorder	6cb0e31a6ceec7459b0a78	388	1		pre	-2								
463B		463	6	formed	SRR11415895	PRJNA545312	-2		2	8	TCD	Myeloproliferative Disorder	6cb0e31a6ceec7459b0a78	388	1		pre	-1								
464A		464	0	formed	SRR11415894	PRJNA545312	-8		4	8	BM_unmodified	Leukemia	00a7221374f597b954d09f	342	1		pre	-2								
464D		464	19	semi-formed	SRR11415893	PRJNA545312	11		4	8	BM_unmodified	Leukemia	00a7221374f597b954d09f	342	1		post	1								
464E		464	25	formed	SRR11415892	PRJNA545312	17		4	8	BM_unmodified	Leukemia	00a7221374f597b954d09f	342	1		post	2								
464F		464	26	semi-formed	SRR11415891	PRJNA545312	18		4	8	BM_unmodified	Leukemia	00a7221374f597b954d09f	342	1		post	2								
465A		465	0	formed	SRR11396787	PRJNA607574			1																	
466A		466	0	formed	SRR11415889	PRJNA545312	-7		2	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	77dcef2bbdb154c4c627cf	401	1		pre	-2								
466C		466	364	liquid	SRR11417567	PRJNA545312	357		2	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	77dcef2bbdb154c4c627cf	401	1		post	6								
467A		467	0	formed	SRR11417566	PRJNA545312	-5		5	5	cord	Leukemia	bb2dfad9d928c2bab18baa	407	1		pre	-1								
467B		467	6	formed	SRR11417565	PRJNA545312	1		5	5	cord	Leukemia	bb2dfad9d928c2bab18baa	407	1		peri	0								
467C		467	10	liquid	SRR11417508	PRJNA545312	5		5	5	cord	Leukemia	bb2dfad9d928c2bab18baa	407	1		peri	0								
467D		467	20	semi-formed	SRR11417507	PRJNA545312	15		5	5	cord	Leukemia	bb2dfad9d928c2bab18baa	407	1		post	2								
467E		467	31	semi-formed	SRR11417506	PRJNA545312	26		5	5	cord	Leukemia	bb2dfad9d928c2bab18baa	407	1		post	3								
468B		468	7	liquid	SRR11417505	PRJNA545312	6		3	1	TCD	Myelodysplastic Syndromes	fa0498a2aa1e8f8c355b94	344	1		post	0								
468C		468	23	formed	SRR11417504	PRJNA545312	22		3	1	TCD	Myelodysplastic Syndromes	fa0498a2aa1e8f8c355b94	344	1		post	3								
468D		468	300	formed	SRR11417503	PRJNA545312	299		3	1	TCD	Myelodysplastic Syndromes	fa0498a2aa1e8f8c355b94	344	1		post	6								
469A		469	0	formed	SRR11417502	PRJNA545312			2																	
469B		469	10	semi-formed	SRR11417500	PRJNA545312			2																	
470A		470	0	formed	SRR11417499	PRJNA545312	-8		5	8	TCD	Leukemia	ba1833211be7ca24147089	367	1		pre	-2								
470B		470	6	semi-formed	SRR11417498	PRJNA545312	-2		5	8	TCD	Leukemia	ba1833211be7ca24147089	367	1		pre	-1								
470C		470	12	liquid	SRR11417497	PRJNA545312	4		5	8	TCD	Leukemia	ba1833211be7ca24147089	367	1		peri	0								
470D		470	20	liquid	SRR11417496	PRJNA545312	12		5	8	TCD	Leukemia	ba1833211be7ca24147089	367	1		post	1								
470E		470	26	liquid	SRR11417495	PRJNA545312	18		5	8	TCD	Leukemia	ba1833211be7ca24147089	367	1		post	2								
471A		471	0	formed	SRR11417494	PRJNA545312	14		1	-14	BM_unmodified	Myelodysplastic Syndromes	622dfc7b8981e6ccf288c6	313	1		post	1								
472A		472	0	formed	SRR11417493	PRJNA545312	-5		7	5	cord	Non-Hodgkin's Lymphoma	b7ba7b5e608c78beb7598f	338	1		pre	-1								
472B		472	5	liquid	SRR11417492	PRJNA545312	0		7	5	cord	Non-Hodgkin's Lymphoma	b7ba7b5e608c78beb7598f	338	1		peri	-1								
472C		472	18	liquid	SRR11417491	PRJNA545312	13		7	5	cord	Non-Hodgkin's Lymphoma	b7ba7b5e608c78beb7598f	338	1		post	1								
472D		472	26	semi-formed	SRR11417489	PRJNA545312	21		7	5	cord	Non-Hodgkin's Lymphoma	b7ba7b5e608c78beb7598f	338	1		post	2								
472F		472	32	formed	SRR11417487	PRJNA545312	27		7	5	cord	Non-Hodgkin's Lymphoma	b7ba7b5e608c78beb7598f	338	1		post	3								
472G		472	39	semi-formed	SRR11417486	PRJNA545312	34		7	5	cord	Non-Hodgkin's Lymphoma	b7ba7b5e608c78beb7598f	338	1		post	4								
472H		472	88	semi-formed	SRR11417485	PRJNA545312	83		7	5	cord	Non-Hodgkin's Lymphoma	b7ba7b5e608c78beb7598f	338	1		post	6								
474A		474	0	formed	SRR11417484	PRJNA545312	-10		3	10	TCD	Leukemia	6f31b2fad5990e6f2fdefb	405	1		pre	-2								
474B		474	8	semi-formed	SRR11417483	PRJNA545312	-2		3	10	TCD	Leukemia	6f31b2fad5990e6f2fdefb	405	1		pre	-1								
474C		474	14	semi-formed	SRR11417482	PRJNA545312	4		3	10	TCD	Leukemia	6f31b2fad5990e6f2fdefb	405	1		peri	0								
475C		475	18	formed	SRR11417481	PRJNA545312	12		1	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	5ce2c19ecca3c1a0d1248f	109	1		post	1								
476A		476	0	formed	SRR11417935	PRJNA545312	-10		4	10	TCD	Leukemia	60c326ed4a9824cf43d3b1	404	1		pre	-2								
476B		476	6	semi-formed	SRR11417933	PRJNA545312	-4		4	10	TCD	Leukemia	60c326ed4a9824cf43d3b1	404	1		pre	-1								
476C		476	14	liquid	SRR11417932	PRJNA545312	4		4	10	TCD	Leukemia	60c326ed4a9824cf43d3b1	404	1		peri	0								
476D		476	20	semi-formed	SRR11417931	PRJNA545312	10		4	10	TCD	Leukemia	60c326ed4a9824cf43d3b1	404	1		post	1								
477A		477	0	liquid	SRR11417930	PRJNA545312	-1		4	1	TCD	Leukemia	7521c93ead5ddce06e6b06	397	1		pre	-1								
477B		477	6	liquid	SRR11417929	PRJNA545312	5		4	1	TCD	Leukemia	7521c93ead5ddce06e6b06	397	1		peri	0								
477C		477	15	semi-formed	SRR11417928	PRJNA545312	14		4	1	TCD	Leukemia	7521c93ead5ddce06e6b06	397	1		post	1								
477D		477	300	formed	SRR11417927	PRJNA545312	299		4	1	TCD	Leukemia	7521c93ead5ddce06e6b06	397	1		post	6								
478B		478	0	formed	SRR11417926	PRJNA545312	-7		2	7	TCD	Myeloproliferative Disorder	406fc762ee3c5818071974	368	1		pre	-2								
478C		478	6	formed	SRR11417925	PRJNA545312	-1		2	7	TCD	Myeloproliferative Disorder	406fc762ee3c5818071974	368	1		pre	-1								
479A		479	0	formed	SRR11417924	PRJNA545312	-5		4	5	PBSC_unmodified	Leukemia	f1ec1149761ad13003eba5	430	1		pre	-1								
479B		479	3	semi-formed	SRR11417922	PRJNA545312	-2		4	5	PBSC_unmodified	Leukemia	f1ec1149761ad13003eba5	430	1		pre	-1								
479D		479	26	liquid	SRR11417921	PRJNA545312	21		4	5	PBSC_unmodified	Leukemia	f1ec1149761ad13003eba5	430	1		post	2								
479E		479	30	semi-formed	SRR11417920	PRJNA545312	25		4	5	PBSC_unmodified	Leukemia	f1ec1149761ad13003eba5	430	1		post	3								
480A		480	0	formed	SRR11417919	PRJNA545312	-6		2	6	PBSC_unmodified	Leukemia	e7d155a83cef55d002625d	394	1		pre	-1								
480B		480	2	semi-formed	SRR11417918	PRJNA545312	-4		2	6	PBSC_unmodified	Leukemia	e7d155a83cef55d002625d	394	1		pre	-1								
481A		481	0	formed	SRR11417917	PRJNA545312	-3		3	3	TCD	Leukemia	9f7c713f6b58327984a1f7	413	1		pre	-1								
481B		481	7	liquid	SRR11417916	PRJNA545312	4		3	3	TCD	Leukemia	9f7c713f6b58327984a1f7	413	1		peri	0								
481C		481	11	liquid	SRR11417915	PRJNA545312	8		3	3	TCD	Leukemia	9f7c713f6b58327984a1f7	413	1		post	1								
482A		482	0	formed	SRR11417914	PRJNA545312	-9		2	9	TCD	Leukemia	69e9e282ce49ec5400f653	392	1		pre	-2								
482C		482	116	semi-formed	SRR11417913	PRJNA545312	107		2	9	TCD	Leukemia	69e9e282ce49ec5400f653	392	1		post	6								
483A		483	0	formed	SRR11417911	PRJNA545312	-9		2	9	PBSC_unmodified	Myelodysplastic Syndromes	82689c1473e3c2051e36ae	417	1		pre	-2								
483E		483	28	liquid	SRR11417910	PRJNA545312	19		2	9	PBSC_unmodified	Myelodysplastic Syndromes	82689c1473e3c2051e36ae	417	1		post	2								
484A		484	0	formed	SRR11417909	PRJNA545312	-9		4	9	TCD	Leukemia	95cf5cbc5036fbc203c3c0	427	1		pre	-2								
484B		484	15	liquid	SRR11417908	PRJNA545312	6		4	9	TCD	Leukemia	95cf5cbc5036fbc203c3c0	427	1		post	0								
484C		484	20	semi-formed	SRR11417823	PRJNA545312	11		4	9	TCD	Leukemia	95cf5cbc5036fbc203c3c0	427	1		post	1								
484D		484	27	semi-formed	SRR11417822	PRJNA545312	18		4	9	TCD	Leukemia	95cf5cbc5036fbc203c3c0	427	1		post	2								
486A		486	0	formed	SRR11417821	PRJNA545312	-6		2	6	PBSC_unmodified	Leukemia	cfe8e65a6985ed0fdf5c50	414	1		pre	-1								
486C		486	18	semi-formed	SRR11417820	PRJNA545312	12		2	6	PBSC_unmodified	Leukemia	cfe8e65a6985ed0fdf5c50	414	1		post	1								
488A		488	0	formed	SRR11417819	PRJNA545312	-8		6	8	TCD	Leukemia	d63219f1d6782229f84497	321	1		pre	-2								
488B		488	8	liquid	SRR11417818	PRJNA545312	0		6	8	TCD	Leukemia	d63219f1d6782229f84497	321	1		peri	-1								
488C		488	11	liquid	SRR11417816	PRJNA545312	3		6	8	TCD	Leukemia	d63219f1d6782229f84497	321	1		peri	0								
488D		488	23	semi-formed	SRR11417815	PRJNA545312	15		6	8	TCD	Leukemia	d63219f1d6782229f84497	321	1		post	2								
488E		488	26	liquid	SRR11417814	PRJNA545312	18		6	8	TCD	Leukemia	d63219f1d6782229f84497	321	1		post	2								
488F		488	69	formed	SRR11417813	PRJNA545312	61		6	8	TCD	Leukemia	d63219f1d6782229f84497	321	1		post	6								
489B		489	4	formed	SRR11417812	PRJNA545312	-3		2	7	PBSC_unmodified	Leukemia	b3e214f0952ba3d7994f3d	425	1		pre	-1								
489E		489	29	liquid	SRR11417811	PRJNA545312	22		2	7	PBSC_unmodified	Leukemia	b3e214f0952ba3d7994f3d	425	1		post	3								
490A		490	0	liquid	SRR11417810	PRJNA545312	3		1	-3	TCD	Leukemia	3272d8e903cc3296ccdcbf	412	1		peri	0								
491A		491	0	liquid	SRR11417809	PRJNA545312	-5		2	5	TCD	Multiple Myeloma	6141c215455852f5b53318	55	0		pre	-1								
491C		491	23	liquid	SRR11417808	PRJNA545312	18		2	5	TCD	Multiple Myeloma	6141c215455852f5b53318	55	0		post	2								
492A		492	0	liquid	SRR11417806	PRJNA545312	-16		5	16	TCD	Leukemia	70040ad69fc238a16a0035	433	1		pre	-3								
492B		492	6	formed	SRR11415888	PRJNA545312	-10		5	16	TCD	Leukemia	70040ad69fc238a16a0035	433	1		pre	-2								
492C		492	14	formed	SRR11415887	PRJNA545312	-2		5	16	TCD	Leukemia	70040ad69fc238a16a0035	433	1		pre	-1								
492D		492	26	liquid	SRR11415886	PRJNA545312	10		5	16	TCD	Leukemia	70040ad69fc238a16a0035	433	1		post	1								
492E		492	97	semi-formed	SRR11415885	PRJNA545312	81		5	16	TCD	Leukemia	70040ad69fc238a16a0035	433	1		post	6								
493A		493	0	semi-formed	SRR11415884	PRJNA545312	1208		1	-1208	cord	Leukemia	e59efb85b8ade0465fe156		1											
494A		494	0	formed	SRR11415883	PRJNA545312	-6		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	cf750dbeb584ebe59b419c	29	1		pre	-1								
494C		494	13	semi-formed	SRR11415882	PRJNA545312	7		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	cf750dbeb584ebe59b419c	29	1		post	0								
494D		494	18	semi-formed	SRR11415533	PRJNA545312	12		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	cf750dbeb584ebe59b419c	29	1		post	1								
495A		495	0	semi-formed	SRR11140499	PRJNA606262			1																	
496A		496	0	formed	SRR11415532	PRJNA545312	-8		2	8	PBSC_unmodified	Leukemia	9a5b19071ef4d45b99f876	393	1		pre	-2								
496B		496	9	semi-formed	SRR11415530	PRJNA545312	1		2	8	PBSC_unmodified	Leukemia	9a5b19071ef4d45b99f876	393	1		peri	0								
497A		497	0	formed	SRR11415529	PRJNA545312	0		1	0	TCD	Myelodysplastic Syndromes	03e6e09744d1dcb6a2f72d	319	1		peri	-1								
498A		498	0	formed	SRR11415528	PRJNA545312	-969		4	969	TCD	Multiple Myeloma	816f8b8b0f7a6c45431e0b	424	1		pre	-3								
498B		498	960	formed	SRR11415527	PRJNA545312	-9		4	969	TCD	Multiple Myeloma	816f8b8b0f7a6c45431e0b	424	1		pre	-2								
498C		498	971	semi-formed	SRR11415526	PRJNA545312	2		4	969	TCD	Multiple Myeloma	816f8b8b0f7a6c45431e0b	424	1		peri	0								
498D		498	973	liquid	SRR11415525	PRJNA545312	4		4	969	TCD	Multiple Myeloma	816f8b8b0f7a6c45431e0b	424	1		peri	0								
502A		502	0	formed	SRR11415524	PRJNA545312	-8		1	8	TCD	Multiple Myeloma	3867a5f87f98feff0ef0c2	409	1		pre	-2								
503A		503	0	formed	SRR11415523	PRJNA545312	-2		7	2	cord	Leukemia	7452379924142e2e5947d4	443	1		pre	-1								
503B		503	7	liquid	SRR11415522	PRJNA545312	5		7	2	cord	Leukemia	7452379924142e2e5947d4	443	1		peri	0								
503C		503	18	semi-formed	SRR11415521	PRJNA545312	16		7	2	cord	Leukemia	7452379924142e2e5947d4	443	1		post	2								
503D		503	21	semi-formed	SRR11415519	PRJNA545312	19		7	2	cord	Leukemia	7452379924142e2e5947d4	443	1		post	2								
503F		503	39	semi-formed	SRR11415518	PRJNA545312	37		7	2	cord	Leukemia	7452379924142e2e5947d4	443	1		post	5								
503G		503	64	formed	SRR11415517	PRJNA545312	62		7	2	cord	Leukemia	7452379924142e2e5947d4	443	1		post	6								
503H		503	175	formed	SRR11415516	PRJNA545312	173		7	2	cord	Leukemia	7452379924142e2e5947d4	443	1		post	6								
505A		505	0	semi-formed	SRR11415515	PRJNA545312	-6		3	6	TCD	Leukemia	25cfec7e5cb2b02e385240	421	1		pre	-1								
505B		505	18	semi-formed	SRR11415514	PRJNA545312	12		3	6	TCD	Leukemia	25cfec7e5cb2b02e385240	421	1		post	1								
505C		505	23	semi-formed	SRR11415513	PRJNA545312	17		3	6	TCD	Leukemia	25cfec7e5cb2b02e385240	421	1		post	2								
506A		506	0	formed	SRR11415512	PRJNA545312	-9		3	9	TCD	Myelodysplastic Syndromes	d4d22823be6c1a806cd961	408	1		pre	-2								
506B		506	3	liquid	SRR11415511	PRJNA545312	-6		3	9	TCD	Myelodysplastic Syndromes	d4d22823be6c1a806cd961	408	1		pre	-1								
506C		506	13	liquid	SRR11415510	PRJNA545312	4		3	9	TCD	Myelodysplastic Syndromes	d4d22823be6c1a806cd961	408	1		peri	0								
507A		507	0	semi-formed	SRR11415508	PRJNA545312	-16		2	16	cord	Leukemia	9e50380af155c3fb373ff5		1		pre	-3								
507B		507	11	formed	SRR11415507	PRJNA545312	-5		2	16	cord	Leukemia	9e50380af155c3fb373ff5		1		pre	-1								
508A		508	0	semi-formed	SRR11415506	PRJNA545312	4		2	-4	TCD	Leukemia	8c94fd3a302cfe56d3fe87	451	1		peri	0								
508B		508	14	formed	SRR11415365	PRJNA545312	18		2	-4	TCD	Leukemia	8c94fd3a302cfe56d3fe87	451	1		post	2								
509A		509	0	liquid	SRR11415364	PRJNA545312	3		2	-3	TCD	Leukemia	5681677892693ed8957cc0	435	1		peri	0								
509B		509	270	formed	SRR11415363	PRJNA545312	273		2	-3	TCD	Leukemia	5681677892693ed8957cc0	435	1		post	6								
510B		510	7	formed	SRR11415362	PRJNA545312	11		2	-4	PBSC_unmodified	Leukemia	0382b8a382cabcd7d7333f	419	1		post	1								
510C		510	14	semi-formed	SRR11415361	PRJNA545312	18		2	-4	PBSC_unmodified	Leukemia	0382b8a382cabcd7d7333f	419	1		post	2								
511A		511	0	formed	SRR11415360	PRJNA545312	-6		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fb392a4dc6ca3cf114286c	422	1		pre	-1								
511B		511	4	formed	SRR11415359	PRJNA545312	-2		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fb392a4dc6ca3cf114286c	422	1		pre	-1								
511D		511	23	formed	SRR11415357	PRJNA545312	17		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fb392a4dc6ca3cf114286c	422	1		post	2								
512A		512	0	formed	SRR11415356	PRJNA545312	-6		2	6	PBSC_unmodified	Leukemia	7dd6ad34a3f8cb34c83ce8	223	1		pre	-1								
512C		512	12	semi-formed	SRR11415355	PRJNA545312	6		2	6	PBSC_unmodified	Leukemia	7dd6ad34a3f8cb34c83ce8	223	1		post	0								
513A		513	0	semi-formed	SRR11415354	PRJNA545312	-6		1	6	PBSC_unmodified	Leukemia	853bfb79bb2e956c818f9c	418	1		pre	-1								
514B		514	13	semi-formed	SRR11415353	PRJNA545312	17		3	-4	BM_unmodified	Leukemia	e1dca9eea960e3db11dc1c	442	1		post	2								
514C		514	20	formed	SRR11415352	PRJNA545312	24		3	-4	BM_unmodified	Leukemia	e1dca9eea960e3db11dc1c	442	1		post	3								
514D		514	35	formed	SRR11415351	PRJNA545312	39		3	-4	BM_unmodified	Leukemia	e1dca9eea960e3db11dc1c	442	1		post	5								
515A		515	0	semi-formed	SRR11415350	PRJNA545312	-8		3	8	TCD	Leukemia	d1d74c468001c10005413c	438	1		pre	-2								
515B		515	61	liquid	SRR11415349	PRJNA545312	53		3	8	TCD	Leukemia	d1d74c468001c10005413c	438	1		post	6								
515C		515	74	semi-formed	SRR11415348	PRJNA545312	66		3	8	TCD	Leukemia	d1d74c468001c10005413c	438	1		post	6								
516B		516	10	semi-formed	SRR11415346	PRJNA545312	1		2	9	TCD	Myelodysplastic Syndromes	976b74c62bb767f7b7f274	359	1		peri	0								
516C		516	13	liquid	SRR11415345	PRJNA545312	4		2	9	TCD	Myelodysplastic Syndromes	976b74c62bb767f7b7f274	359	1		peri	0								
517A		517	0	semi-formed	SRR11415344	PRJNA545312	0		3	0	TCD	Myelodysplastic Syndromes	171fca9544676e4e04fd04	30	1		peri	-1								
517B		517	5	liquid	SRR11415343	PRJNA545312	5		3	0	TCD	Myelodysplastic Syndromes	171fca9544676e4e04fd04	30	1		peri	0								
517C		517	13	semi-formed	SRR11415342	PRJNA545312	13		3	0	TCD	Myelodysplastic Syndromes	171fca9544676e4e04fd04	30	1		post	1								
518A		518	0	formed	SRR11396784	PRJNA607574			1																	
519A		519	0	formed	SRR11415341	PRJNA545312	-9		2	9	PBSC_unmodified	Leukemia	c8cc77452fec019d8ce809	432	1		pre	-2								
519B		519	6	semi-formed	SRR11415340	PRJNA545312	-3		2	9	PBSC_unmodified	Leukemia	c8cc77452fec019d8ce809	432	1		pre	-1								
520A		520	0	formed	SRR11415339	PRJNA545312	-5		8	746	PBSC_unmodified	Myelodysplastic Syndromes	02a1205fe4c6be1ae0ebae	423	1		pre	-1								
520B		520	3	formed	SRR11415338	PRJNA545312	-2		8	746	PBSC_unmodified	Myelodysplastic Syndromes	02a1205fe4c6be1ae0ebae	423	1		pre	-1								
520C		520	10	liquid	SRR11415629	PRJNA545312	5		8	746	PBSC_unmodified	Myelodysplastic Syndromes	02a1205fe4c6be1ae0ebae	423	1		peri	0								
520D		520	741	formed	SRR11415627	PRJNA545312	-5		8	746	PBSC_unmodified	Myelodysplastic Syndromes	02a1205fe4c6be1ae0ebae	423	1		pre	-1								
520E		520	744	formed	SRR11415626	PRJNA545312	-2		8	746	PBSC_unmodified	Myelodysplastic Syndromes	02a1205fe4c6be1ae0ebae	423	1		pre	-1								
520F		520	751	formed	SRR11415625	PRJNA545312	5		8	746	PBSC_unmodified	Myelodysplastic Syndromes	02a1205fe4c6be1ae0ebae	423	1		peri	0								
520G		520	752	liquid	SRR11415624	PRJNA545312	6		8	746	PBSC_unmodified	Myelodysplastic Syndromes	02a1205fe4c6be1ae0ebae	423	1		post	0								
520I		520	767	semi-formed	SRR11415623	PRJNA545312	21		8	746	PBSC_unmodified	Myelodysplastic Syndromes	02a1205fe4c6be1ae0ebae	423	1		post	2								
521A		521	0	semi-formed	SRR11415622	PRJNA545312	-3		5	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	3519b28405bb93f644321c	229	1		pre	-1								
521B		521	2	liquid	SRR11415621	PRJNA545312	-1		5	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	3519b28405bb93f644321c	229	1		pre	-1								
521D		521	36	semi-formed	SRR11415620	PRJNA545312	33		5	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	3519b28405bb93f644321c	229	1		post	4								
521E		521	46	formed	SRR11415619	PRJNA545312	43		5	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	3519b28405bb93f644321c	229	1		post	6								
521F		521	51	semi-formed	SRR11415618	PRJNA545312	48		5	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	3519b28405bb93f644321c	229	1		post	6								
522A		522	0	liquid	SRR11415616	PRJNA545312	-2		3	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	846e6d0f6d536cd8beef51	362	1		pre	-1								
522B		522	6	liquid	SRR11415615	PRJNA545312	4		3	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	846e6d0f6d536cd8beef51	362	1		peri	0								
522C		522	13	semi-formed	SRR11415614	PRJNA545312	11		3	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	846e6d0f6d536cd8beef51	362	1		post	1								
523B		523	4	liquid	SRR11415613	PRJNA545312	6		4	-2	cord	Hodgkin's Disease	90d59436cb43aee264ce22	103	1		post	0								
523D		523	24	semi-formed	SRR11415612	PRJNA545312	26		4	-2	cord	Hodgkin's Disease	90d59436cb43aee264ce22	103	1		post	3								
523E		523	32	formed	SRR11415611	PRJNA545312	34		4	-2	cord	Hodgkin's Disease	90d59436cb43aee264ce22	103	1		post	4								
523F		523	84	semi-formed	SRR11415610	PRJNA545312	86		4	-2	cord	Hodgkin's Disease	90d59436cb43aee264ce22	103	1		post	6								
524A		524	0	formed	SRR11415609	PRJNA545312	-3		1	3	PBSC_unmodified	Leukemia	92f15e5233d1916e9aa871	445	1		pre	-1								
525A		525	0	formed	SRR11415608	PRJNA545312	-2		2	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	4935a2fee9089868066f6e	120	1		pre	-1								
525C		525	10	formed	SRR11415607	PRJNA545312	8		2	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	4935a2fee9089868066f6e	120	1		post	1								
526A		526	0	semi-formed	SRR11415604	PRJNA545312	5		3	227	PBSC_unmodified	Leukemia	d3736badc201a696e3ce8e	441	1		peri	0								
526B		526	6	semi-formed	SRR11415603	PRJNA545312	11		3	227	PBSC_unmodified	Leukemia	d3736badc201a696e3ce8e	441	1		post	1								
526C		526	244	formed	SRR11415602	PRJNA545312	17		3	227	PBSC_unmodified	Leukemia	d3736badc201a696e3ce8e	441	1		post	2								
527A		527	0	formed	SRR11416132	PRJNA545312	-6		2	6	TCD	Myelodysplastic Syndromes	f0974975420e8d7178282c	439	1		pre	-1								
527B		527	5	formed	SRR11416131	PRJNA545312	-1		2	6	TCD	Myelodysplastic Syndromes	f0974975420e8d7178282c	439	1		pre	-1								
528A		528	0	formed	SRR11416130	PRJNA545312	-1		6	1	cord	Leukemia	8af7893240f7b05a7cec67	268	1		pre	-1								
528B		528	14	semi-formed	SRR11416129	PRJNA545312	13		6	1	cord	Leukemia	8af7893240f7b05a7cec67	268	1		post	1								
528C		528	20	semi-formed	SRR11416128	PRJNA545312	19		6	1	cord	Leukemia	8af7893240f7b05a7cec67	268	1		post	2								
528D		528	31	formed	SRR11416127	PRJNA545312	30		6	1	cord	Leukemia	8af7893240f7b05a7cec67	268	1		post	4								
528E		528	261	formed	SRR11416126	PRJNA545312	260		6	1	cord	Leukemia	8af7893240f7b05a7cec67	268	1		post	6								
528F		528	265	formed	SRR11416124	PRJNA545312	264		6	1	cord	Leukemia	8af7893240f7b05a7cec67	268	1		post	6								
530A		530	0	formed	SRR11416123	PRJNA545312	-6		12	6	TCD	Leukemia	8c6d7d8826a2b8b1c31ade	436	1		pre	-1								
530B		530	4	semi-formed	SRR11416122	PRJNA545312	-2		12	6	TCD	Leukemia	8c6d7d8826a2b8b1c31ade	436	1		pre	-1								
530C		530	6	liquid	SRR11416121	PRJNA545312	0		12	6	TCD	Leukemia	8c6d7d8826a2b8b1c31ade	436	1		peri	-1								
530D		530	10	liquid	SRR11416120	PRJNA545312	4		12	6	TCD	Leukemia	8c6d7d8826a2b8b1c31ade	436	1		peri	0								
530E		530	17	semi-formed	SRR11416119	PRJNA545312	11		12	6	TCD	Leukemia	8c6d7d8826a2b8b1c31ade	436	1		post	1								
530F		530	25	semi-formed	SRR11416118	PRJNA545312	19		12	6	TCD	Leukemia	8c6d7d8826a2b8b1c31ade	436	1		post	2								
530G		530	24	semi-formed	SRR11416117	PRJNA545312	18		12	6	TCD	Leukemia	8c6d7d8826a2b8b1c31ade	436	1		post	2								
530H		530	31	liquid	SRR11416116	PRJNA545312	25		12	6	TCD	Leukemia	8c6d7d8826a2b8b1c31ade	436	1		post	3								
530I		530	38	liquid	SRR11416115	PRJNA545312	32		12	6	TCD	Leukemia	8c6d7d8826a2b8b1c31ade	436	1		post	4								
530J		530	45	liquid	SRR11416113	PRJNA545312	39		12	6	TCD	Leukemia	8c6d7d8826a2b8b1c31ade	436	1		post	5								
530K		530	52	liquid	SRR11416112	PRJNA545312	46		12	6	TCD	Leukemia	8c6d7d8826a2b8b1c31ade	436	1		post	6								
530L		530	66	liquid	SRR11416111	PRJNA545312	60		12	6	TCD	Leukemia	8c6d7d8826a2b8b1c31ade	436	1		post	6								
531A		531	0	formed	SRR11416110	PRJNA545312	-6		6	6	cord	Leukemia	a436fadea0598886ec5010	437	1		pre	-1								
531B		531	4	liquid	SRR11416109	PRJNA545312	-2		6	6	cord	Leukemia	a436fadea0598886ec5010	437	1		pre	-1								
531C		531	14	liquid	SRR11416108	PRJNA545312	8		6	6	cord	Leukemia	a436fadea0598886ec5010	437	1		post	1								
531E		531	19	semi-formed	SRR11416107	PRJNA545312	13		6	6	cord	Leukemia	a436fadea0598886ec5010	437	1		post	1								
531G		531	36	semi-formed	SRR11416106	PRJNA545312	30		6	6	cord	Leukemia	a436fadea0598886ec5010	437	1		post	4								
531H		531	46	semi-formed	SRR11416105	PRJNA545312	40		6	6	cord	Leukemia	a436fadea0598886ec5010	437	1		post	5								
532A		532	0	formed	SRR11416104	PRJNA545312	-9		3	9	TCD	Myelodysplastic Syndromes	8ac88d7f269f25fa1fcd8d	119	1		pre	-2								
532B		532	7	formed	SRR11416102	PRJNA545312	-2		3	9	TCD	Myelodysplastic Syndromes	8ac88d7f269f25fa1fcd8d	119	1		pre	-1								
532D		532	21		SRR11416100	PRJNA545312	12		3	9	TCD	Myelodysplastic Syndromes	8ac88d7f269f25fa1fcd8d	119	1		post	1								
533A		533	0	formed	SRR11416099	PRJNA545312	-5		4	5	cord	Leukemia	e74a8736058380cc0aab3f	456	1		pre	-1								
533B		533	3	formed	SRR11416098	PRJNA545312	-2		4	5	cord	Leukemia	e74a8736058380cc0aab3f	456	1		pre	-1								
533C		533	20	formed	SRR11416097	PRJNA545312	15		4	5	cord	Leukemia	e74a8736058380cc0aab3f	456	1		post	2								
533D		533	25	formed	SRR11416096	PRJNA545312	20		4	5	cord	Leukemia	e74a8736058380cc0aab3f	456	1		post	2								
534A		534	0	formed	SRR11416095	PRJNA545312	4		8	-4	cord	Leukemia	f675db368a937bafc29fb6	374	1		peri	0								
534B		534	1	liquid	SRR11416094	PRJNA545312	5		8	-4	cord	Leukemia	f675db368a937bafc29fb6	374	1		peri	0								
534C		534	13	semi-formed	SRR11416093	PRJNA545312	17		8	-4	cord	Leukemia	f675db368a937bafc29fb6	374	1		post	2								
534D		534	17	semi-formed	SRR11416091	PRJNA545312	21		8	-4	cord	Leukemia	f675db368a937bafc29fb6	374	1		post	2								
534E		534	21	semi-formed	SRR11416090	PRJNA545312	25		8	-4	cord	Leukemia	f675db368a937bafc29fb6	374	1		post	3								
534F		534	26	semi-formed	SRR11416089	PRJNA545312	30		8	-4	cord	Leukemia	f675db368a937bafc29fb6	374	1		post	4								
534G		534	29	semi-formed	SRR11416088	PRJNA545312	33		8	-4	cord	Leukemia	f675db368a937bafc29fb6	374	1		post	4								
534H		534	49	semi-formed	SRR11416087	PRJNA545312	53		8	-4	cord	Leukemia	f675db368a937bafc29fb6	374	1		post	6								
535A		535	0	formed	SRR11416086	PRJNA545312	-11		2	11	TCD	Leukemia	c525197308805b41a4cc57	455	1		pre	-2								
535B		535	13	semi-formed	SRR11416085	PRJNA545312	2		2	11	TCD	Leukemia	c525197308805b41a4cc57	455	1		peri	0								
537A		537	0	formed	SRR11416084	PRJNA545312	-9		13	9	TCD	Leukemia	5c3a4b9b06a112a57145c8	448	1		pre	-2								
537B		537	4	formed	SRR11416083	PRJNA545312	-5		13	9	TCD	Leukemia	5c3a4b9b06a112a57145c8	448	1		pre	-1								
537C		537	12	liquid	SRR11416082	PRJNA545312	3		13	9	TCD	Leukemia	5c3a4b9b06a112a57145c8	448	1		peri	0								
537D		537	26	liquid	SRR11416080	PRJNA545312	17		13	9	TCD	Leukemia	5c3a4b9b06a112a57145c8	448	1		post	2								
537E		537	54	liquid	SRR11416079	PRJNA545312	45		13	9	TCD	Leukemia	5c3a4b9b06a112a57145c8	448	1		post	6								
537F		537	61	liquid	SRR11416078	PRJNA545312	52		13	9	TCD	Leukemia	5c3a4b9b06a112a57145c8	448	1		post	6								
537G		537	214	liquid	SRR11416077	PRJNA545312	205		13	9	TCD	Leukemia	5c3a4b9b06a112a57145c8	448	1		post	6								
537H		537	219	formed	SRR11415309	PRJNA545312	210		13	9	TCD	Leukemia	5c3a4b9b06a112a57145c8	448	1		post	6								
537I		537	229	semi-formed	SRR11415308	PRJNA545312	220		13	9	TCD	Leukemia	5c3a4b9b06a112a57145c8	448	1		post	6								
537J		537	242	liquid	SRR11415307	PRJNA545312	233		13	9	TCD	Leukemia	5c3a4b9b06a112a57145c8	448	1		post	6								
537K		537	260	semi-formed	SRR11415306	PRJNA545312	251		13	9	TCD	Leukemia	5c3a4b9b06a112a57145c8	448	1		post	6								
537L		537	310	liquid	SRR11415304	PRJNA545312	301		13	9	TCD	Leukemia	5c3a4b9b06a112a57145c8	448	1		post	6								
537M		537	327	liquid	SRR11415708	PRJNA545312	318		13	9	TCD	Leukemia	5c3a4b9b06a112a57145c8	448	1		post	6								
538A		538	0	semi-formed	SRR11415706	PRJNA545312	6		3	-6	PBSC_unmodified	Leukemia	2e880252b39c9b38e0136b	23	1		post	0								
538B		538	7	formed	SRR11415705	PRJNA545312	13		3	-6	PBSC_unmodified	Leukemia	2e880252b39c9b38e0136b	23	1		post	1								
538C		538	205	liquid	SRR11415704	PRJNA545312	211		3	-6	PBSC_unmodified	Leukemia	2e880252b39c9b38e0136b	23	1		post	6								
539A		539	0	formed	SRR11415703	PRJNA545312	-2		3	2	PBSC_unmodified	Myelodysplastic Syndromes	ddd14c25c733edba162b3e	98	1		pre	-1								
539B		539	4	semi-formed	SRR11415702	PRJNA545312	2		3	2	PBSC_unmodified	Myelodysplastic Syndromes	ddd14c25c733edba162b3e	98	1		peri	0								
539D		539	17	formed	SRR11415701	PRJNA545312	15		3	2	PBSC_unmodified	Myelodysplastic Syndromes	ddd14c25c733edba162b3e	98	1		post	2								
540B		540	7	semi-formed	SRR11415700	PRJNA545312	-2		2	9	TCD	Leukemia	1b2ccf74d916d34cad6c4b	89	1		pre	-1								
540C		540	22	formed	SRR11415699	PRJNA545312	13		2	9	TCD	Leukemia	1b2ccf74d916d34cad6c4b	89	1		post	1								
541B		541	3	semi-formed	SRR11415698	PRJNA545312	-3		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	f9279de7beb9998164b347	361	1		pre	-1								
541C		541	9	liquid	SRR11415697	PRJNA545312	3		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	f9279de7beb9998164b347	361	1		peri	0								
541D		541	10	liquid	SRR11415695	PRJNA545312	4		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	f9279de7beb9998164b347	361	1		peri	0								
541E		541	16	semi-formed	SRR11415694	PRJNA545312	10		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	f9279de7beb9998164b347	361	1		post	1								
542A		542	0	formed	SRR11423228	PRJNA545312	-1		3	1	TCD	Myelodysplastic Syndromes	358065b071f81ab6aceae5	402	1		pre	-1								
542B		542	5	semi-formed	SRR11415693	PRJNA545312	4		3	1	TCD	Myelodysplastic Syndromes	358065b071f81ab6aceae5	402	1		peri	0								
542C		542	12	semi-formed	SRR11415692	PRJNA545312	11		3	1	TCD	Myelodysplastic Syndromes	358065b071f81ab6aceae5	402	1		post	1								
543A		543	0	formed	SRR11415691	PRJNA545312	-7		2	7	TCD	Myeloproliferative Disorder	e1159b463f8bf022fcd2c9	454	1		pre	-2								
543B		543	6	formed	SRR11415690	PRJNA545312	-1		2	7	TCD	Myeloproliferative Disorder	e1159b463f8bf022fcd2c9	454	1		pre	-1								
544A		544	0	formed	SRR11415689	PRJNA545312	-5		9	5	cord	Leukemia	b19c0928dd2f525df99d39	45	1		pre	-1								
544B		544	5	liquid	SRR11415688	PRJNA545312	0		9	5	cord	Leukemia	b19c0928dd2f525df99d39	45	1		peri	-1								
544C		544	13	liquid	SRR11415687	PRJNA545312	8		9	5	cord	Leukemia	b19c0928dd2f525df99d39	45	1		post	1								
544D		544	17	semi-formed	SRR11415686	PRJNA545312	12		9	5	cord	Leukemia	b19c0928dd2f525df99d39	45	1		post	1								
544E		544	25	liquid	SRR11415880	PRJNA545312	20		9	5	cord	Leukemia	b19c0928dd2f525df99d39	45	1		post	2								
544F		544	38	semi-formed	SRR11415879	PRJNA545312	33		9	5	cord	Leukemia	b19c0928dd2f525df99d39	45	1		post	4								
544G		544	45	liquid	SRR11415878	PRJNA545312	40		9	5	cord	Leukemia	b19c0928dd2f525df99d39	45	1		post	5								
544H		544	187	formed	SRR11415877	PRJNA545312	182		9	5	cord	Leukemia	b19c0928dd2f525df99d39	45	1		post	6								
544I		544	193	formed	SRR11415876	PRJNA545312	188		9	5	cord	Leukemia	b19c0928dd2f525df99d39	45	1		post	6								
545A		545	0	formed	SRR11415875	PRJNA545312	-7		7	7	TCD	Leukemia	2daf1df3e11ed74a730c24	468	1		pre	-2								
545B		545	4	liquid	SRR11415874	PRJNA545312	-3		7	7	TCD	Leukemia	2daf1df3e11ed74a730c24	468	1		pre	-1								
545C		545	11	liquid	SRR11415873	PRJNA545312	4		7	7	TCD	Leukemia	2daf1df3e11ed74a730c24	468	1		peri	0								
545D		545	19	liquid	SRR11415872	PRJNA545312	12		7	7	TCD	Leukemia	2daf1df3e11ed74a730c24	468	1		post	1								
545E		545	26	liquid	SRR11415871	PRJNA545312	19		7	7	TCD	Leukemia	2daf1df3e11ed74a730c24	468	1		post	2								
545F		545	33	formed	SRR11415869	PRJNA545312	26		7	7	TCD	Leukemia	2daf1df3e11ed74a730c24	468	1		post	3								
545G		545	35	liquid	SRR11415868	PRJNA545312	28		7	7	TCD	Leukemia	2daf1df3e11ed74a730c24	468	1		post	3								
546A		546	0	semi-formed	SRR11415867	PRJNA545312	-2		8	2	cord	Non-Hodgkin's Lymphoma	94f2d1ede5134df8e8c482	4	1		pre	-1								
546B		546	10	semi-formed	SRR11415866	PRJNA545312	8		8	2	cord	Non-Hodgkin's Lymphoma	94f2d1ede5134df8e8c482	4	1		post	1								
546C		546	21	semi-formed	SRR11415865	PRJNA545312	19		8	2	cord	Non-Hodgkin's Lymphoma	94f2d1ede5134df8e8c482	4	1		post	2								
546D		546	29	semi-formed	SRR11415864	PRJNA545312	27		8	2	cord	Non-Hodgkin's Lymphoma	94f2d1ede5134df8e8c482	4	1		post	3								
546E		546	49	semi-formed	SRR11415863	PRJNA545312	47		8	2	cord	Non-Hodgkin's Lymphoma	94f2d1ede5134df8e8c482	4	1		post	6								
546F		546	56	semi-formed	SRR11415862	PRJNA545312	54		8	2	cord	Non-Hodgkin's Lymphoma	94f2d1ede5134df8e8c482	4	1		post	6								
546G		546	63	semi-formed	SRR11415861	PRJNA545312	61		8	2	cord	Non-Hodgkin's Lymphoma	94f2d1ede5134df8e8c482	4	1		post	6								
546H		546	73	liquid	SRR11415860	PRJNA545312	71		8	2	cord	Non-Hodgkin's Lymphoma	94f2d1ede5134df8e8c482	4	1		post	6								
547B		547	4	formed	SRR11415857	PRJNA545312	-3		2	7	cord	Leukemia	faca3fc44c29be9404d488		1		pre	-1								
547D		547	19	semi-formed	SRR11423189	PRJNA545312	12		2	7	cord	Leukemia	faca3fc44c29be9404d488		1		post	1								
548A		548	0	semi-formed	SRR11415856	PRJNA545312			5																	
548B		548	1	semi-formed	SRR11415855	PRJNA545312			5																	
548C		548	17	formed	SRR11415854	PRJNA545312			5																	
548D		548	58	semi-formed	SRR11415421	PRJNA545312			5																	
548E		548	64	semi-formed	SRR11415420	PRJNA545312			5																	
549A		549	0	formed	SRR11415419	PRJNA545312	-5		3	5	PBSC_unmodified	Myelodysplastic Syndromes	013f51d44476079d04c831	80	1		pre	-1								
549B		549	10	formed	SRR11415418	PRJNA545312	5		3	5	PBSC_unmodified	Myelodysplastic Syndromes	013f51d44476079d04c831	80	1		peri	0								
549C		549	20	semi-formed	SRR11415417	PRJNA545312	15		3	5	PBSC_unmodified	Myelodysplastic Syndromes	013f51d44476079d04c831	80	1		post	2								
550A		550	0	formed	SRR11415416	PRJNA545312	0		1	0	PBSC_unmodified	Leukemia	b40d10558bd4df126120f4	84	1		peri	-1								
551A		551	0	formed	SRR11415414	PRJNA545312	-4		2	4	TCD	Multiple Myeloma	380065b4be7229cb30028d	440	1		pre	-1								
551B		551	3	semi-formed	SRR11415413	PRJNA545312	-1		2	4	TCD	Multiple Myeloma	380065b4be7229cb30028d	440	1		pre	-1								
552A		552	0	formed	SRR11415412	PRJNA545312	-8		2	8	TCD	Multiple Myeloma	94038b5b8a4094c925a745	469	1		pre	-2								
552B		552	11	liquid	SRR11415411	PRJNA545312	3		2	8	TCD	Multiple Myeloma	94038b5b8a4094c925a745	469	1		peri	0								
553A		553	0	semi-formed	SRR11139997	PRJNA606262			1																	
554A		554	0	formed	SRR11415410	PRJNA545312	-8		2	8	TCD	Leukemia	dee83e570368b5ddc79aac	477	1		pre	-2								
554B		554	12	liquid	SRR11415409	PRJNA545312	4		2	8	TCD	Leukemia	dee83e570368b5ddc79aac	477	1		peri	0								
555A		555	0	semi-formed	SRR11415408	PRJNA545312	-9		5	9	TCD	Multiple Myeloma	a8e9c4c40f845aa77c2ff9	33	1		pre	-2								
555B		555	6	formed	SRR11415407	PRJNA545312	-3		5	9	TCD	Multiple Myeloma	a8e9c4c40f845aa77c2ff9	33	1		pre	-1								
555D		555	19	formed	SRR11415406	PRJNA545312	10		5	9	TCD	Multiple Myeloma	a8e9c4c40f845aa77c2ff9	33	1		post	1								
555E		555	162	formed	SRR11415405	PRJNA545312	153		5	9	TCD	Multiple Myeloma	a8e9c4c40f845aa77c2ff9	33	1		post	6								
555F		555	191	semi-formed	SRR11415403	PRJNA545312	182		5	9	TCD	Multiple Myeloma	a8e9c4c40f845aa77c2ff9	33	1		post	6								
556B		556	7	semi-formed	SRR11415402	PRJNA545312	14		5	-7	cord	Non-Hodgkin's Lymphoma	7d5b54fb7d5b18eb891653	178	1		post	1								
556C		556	25	semi-formed	SRR11415401	PRJNA545312	32		5	-7	cord	Non-Hodgkin's Lymphoma	7d5b54fb7d5b18eb891653	178	1		post	4								
556E		556	39	liquid	SRR11415400	PRJNA545312	46		5	-7	cord	Non-Hodgkin's Lymphoma	7d5b54fb7d5b18eb891653	178	1		post	6								
556F		556	47	liquid	SRR11415399	PRJNA545312	54		5	-7	cord	Non-Hodgkin's Lymphoma	7d5b54fb7d5b18eb891653	178	1		post	6								
556G		556	62	formed	SRR11415398	PRJNA545312	69		5	-7	cord	Non-Hodgkin's Lymphoma	7d5b54fb7d5b18eb891653	178	1		post	6								
557A		557	0	liquid	SRR11415397	PRJNA545312	-2		4	2	TCD	Leukemia	391c20b1eedfa3c65ee14a	462	1		pre	-1								
557B		557	7	semi-formed	SRR11415396	PRJNA545312	5		4	2	TCD	Leukemia	391c20b1eedfa3c65ee14a	462	1		peri	0								
557C		557	10	semi-formed	SRR11415395	PRJNA545312	8		4	2	TCD	Leukemia	391c20b1eedfa3c65ee14a	462	1		post	1								
557D		557	14	semi-formed	SRR11117047	PRJNA607574	12		4	2	TCD	Leukemia	391c20b1eedfa3c65ee14a	462	1		post	1								
558A		558	0	formed	SRR11415394	PRJNA545312	-1		4	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	cf9d7d9a76f2fac3b9c615	369	1		pre	-1								
558B		558	7	formed	SRR11415779	PRJNA545312	6		4	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	cf9d7d9a76f2fac3b9c615	369	1		post	0								
558C		558	11	formed	SRR11415778	PRJNA545312	10		4	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	cf9d7d9a76f2fac3b9c615	369	1		post	1								
558D		558	18	semi-formed	SRR11415777	PRJNA545312	17		4	1	PBSC_unmodified	Non-Hodgkin's Lymphoma	cf9d7d9a76f2fac3b9c615	369	1		post	2								
559A		559	0	liquid	SRR11415776	PRJNA545312	5		2	-5	TCD	Leukemia	ffcf59d52566ac7729521f	458	1		peri	0								
559B		559	6	formed	SRR11415775	PRJNA545312	11		2	-5	TCD	Leukemia	ffcf59d52566ac7729521f	458	1		post	1								
560A		560	0	formed	SRR11415774	PRJNA545312	-8		1	8	TCD	Multiple Myeloma	2fa08605789f3206342cb5	452	1		pre	-2								
561A		561	0	formed	SRR11415773	PRJNA545312	174		1	-174	PBSC_unmodified	Non-Hodgkin's Lymphoma	027dd508d6e511b9647f49		1		post	6								
562A		562	0	semi-formed	SRR11415772	PRJNA545312	-3		3	3	TCD	Leukemia	059fb1b9a81053cbd1674b	476	1		pre	-1								
562B		562	7	liquid	SRR11415771	PRJNA545312	4		3	3	TCD	Leukemia	059fb1b9a81053cbd1674b	476	1		peri	0								
562C		562	19	semi-formed	SRR11415770	PRJNA545312	16		3	3	TCD	Leukemia	059fb1b9a81053cbd1674b	476	1		post	2								
563A		563	0	formed	SRR11415768	PRJNA545312	-2		6	930	PBSC_unmodified	Leukemia	a5ed94b395e0acb830a5a8		1		pre	-1								
563B		563	5	liquid	SRR11415767	PRJNA545312	3		6	930	PBSC_unmodified	Leukemia	a5ed94b395e0acb830a5a8		1		peri	0								
563C		563	12	semi-formed	SRR11415766	PRJNA545312	10		6	930	PBSC_unmodified	Leukemia	a5ed94b395e0acb830a5a8		1		post	1								
563D		563	22	liquid	SRR11415765	PRJNA545312	20		6	930	PBSC_unmodified	Leukemia	a5ed94b395e0acb830a5a8		1		post	2								
563E		563	26	semi-formed	SRR11415764	PRJNA545312	24		6	930	PBSC_unmodified	Leukemia	a5ed94b395e0acb830a5a8		1		post	3								
563F		563	925	formed	SRR11117045	PRJNA607574	-5		6	930	PBSC_unmodified	Leukemia	a5ed94b395e0acb830a5a8		1		pre	-1								
564A		564	0	formed	SRR11415763	PRJNA545312	11		2	-11	PBSC_unmodified	Non-Hodgkin's Lymphoma	18b985974f04cdd1e04e4f	57	1		post	1								
564B		564	233	semi-formed	SRR11415762	PRJNA545312	244		2	-11	PBSC_unmodified	Non-Hodgkin's Lymphoma	18b985974f04cdd1e04e4f	57	1		post	6								
566A		566	0	semi-formed	SRR11415761	PRJNA545312	3		4	-3	PBSC_unmodified	Myeloproliferative Disorder	9a381ef436ddbab010195b	466	1		peri	0								
566B		566	4	liquid	SRR11415760	PRJNA545312	7		4	-3	PBSC_unmodified	Myeloproliferative Disorder	9a381ef436ddbab010195b	466	1		post	0								
566C		566	7	liquid	SRR11415759	PRJNA545312	10		4	-3	PBSC_unmodified	Myeloproliferative Disorder	9a381ef436ddbab010195b	466	1		post	1								
566D		566	14	semi-formed	SRR11415757	PRJNA545312	17		4	-3	PBSC_unmodified	Myeloproliferative Disorder	9a381ef436ddbab010195b	466	1		post	2								
568A		568	0	formed	SRR11140416	PRJNA606262			1																	
569A		569	0	formed	SRR11415756	PRJNA545312	-10		4	10	TCD	Leukemia	b2179fff6a71f2d6373f58	380	1		pre	-2								
569B		569	8	liquid	SRR11415755	PRJNA545312	-2		4	10	TCD	Leukemia	b2179fff6a71f2d6373f58	380	1		pre	-1								
569C		569	14	liquid	SRR11415754	PRJNA545312	4		4	10	TCD	Leukemia	b2179fff6a71f2d6373f58	380	1		peri	0								
569D		569	21	liquid	SRR11415753	PRJNA545312	11		4	10	TCD	Leukemia	b2179fff6a71f2d6373f58	380	1		post	1								
570A		570	0	semi-formed	SRR11416188	PRJNA545312	5		3	-5	BM_unmodified	Leukemia	13c2f153fade4b99265b10	453	1		peri	0								
570B		570	2	semi-formed	SRR11416187	PRJNA545312	7		3	-5	BM_unmodified	Leukemia	13c2f153fade4b99265b10	453	1		post	0								
570C		570	40	liquid	SRR11416186	PRJNA545312	45		3	-5	BM_unmodified	Leukemia	13c2f153fade4b99265b10	453	1		post	6								
571A		571	0	semi-formed	SRR11416185	PRJNA545312	0		7	0	cord	Leukemia	0b94d9806548a7fabf0f6b	386	1		peri	-1								
571B		571	6	liquid	SRR11416184	PRJNA545312	6		7	0	cord	Leukemia	0b94d9806548a7fabf0f6b	386	1		post	0								
571C		571	12	liquid	SRR11416182	PRJNA545312	12		7	0	cord	Leukemia	0b94d9806548a7fabf0f6b	386	1		post	1								
571D		571	31	semi-formed	SRR11416181	PRJNA545312	31		7	0	cord	Leukemia	0b94d9806548a7fabf0f6b	386	1		post	4								
571E		571	36	semi-formed	SRR11416180	PRJNA545312	36		7	0	cord	Leukemia	0b94d9806548a7fabf0f6b	386	1		post	5								
571F		571	40	liquid	SRR11416179	PRJNA545312	40		7	0	cord	Leukemia	0b94d9806548a7fabf0f6b	386	1		post	5								
571G		571	138	formed	SRR11416178	PRJNA545312	138		7	0	cord	Leukemia	0b94d9806548a7fabf0f6b	386	1		post	6								
572A		572	0	formed	SRR11416177	PRJNA545312	-9		5	266	PBSC_unmodified		4da9d9fdedfddf6b80f015	465	1		pre	-2								
572B		572	14	liquid	SRR11416176	PRJNA545312	5		5	266	PBSC_unmodified		4da9d9fdedfddf6b80f015	465	1		peri	0								
572C		572	21	liquid	SRR11416175	PRJNA545312	12		5	266	PBSC_unmodified		4da9d9fdedfddf6b80f015	465	1		post	1								
572D		572	29	semi-formed	SRR11416174	PRJNA545312	20		5	266	PBSC_unmodified		4da9d9fdedfddf6b80f015	465	1		post	2								
572E		572	399	semi-formed	SRR11416173	PRJNA545312	133		5	266	PBSC_unmodified		4da9d9fdedfddf6b80f015	465	1		post	6								
573A		573	0	formed	SRR11416171	PRJNA545312	-5		11	5	cord	Non-Hodgkin's Lymphoma	b2cb585e81218793742558	415	1		pre	-1								
573B		573	4	formed	SRR11416170	PRJNA545312	-1		11	5	cord	Non-Hodgkin's Lymphoma	b2cb585e81218793742558	415	1		pre	-1								
573C		573	14	formed	SRR11416169	PRJNA545312	9		11	5	cord	Non-Hodgkin's Lymphoma	b2cb585e81218793742558	415	1		post	1								
573D		573	21	formed	SRR11416168	PRJNA545312	16		11	5	cord	Non-Hodgkin's Lymphoma	b2cb585e81218793742558	415	1		post	2								
573E		573	25	formed	SRR11416167	PRJNA545312	20		11	5	cord	Non-Hodgkin's Lymphoma	b2cb585e81218793742558	415	1		post	2								
573F		573	31	formed	SRR11416166	PRJNA545312	26		11	5	cord	Non-Hodgkin's Lymphoma	b2cb585e81218793742558	415	1		post	3								
573G		573	38	semi-formed	SRR11416165	PRJNA545312	33		11	5	cord	Non-Hodgkin's Lymphoma	b2cb585e81218793742558	415	1		post	4								
573H		573	45	semi-formed	SRR11416164	PRJNA545312	40		11	5	cord	Non-Hodgkin's Lymphoma	b2cb585e81218793742558	415	1		post	5								
573I		573	50	semi-formed	SRR11416163	PRJNA545312	45		11	5	cord	Non-Hodgkin's Lymphoma	b2cb585e81218793742558	415	1		post	6								
573J		573	52	semi-formed	SRR11416162	PRJNA545312	47		11	5	cord	Non-Hodgkin's Lymphoma	b2cb585e81218793742558	415	1		post	6								
573K		573	70	formed	SRR11416244	PRJNA545312	65		11	5	cord	Non-Hodgkin's Lymphoma	b2cb585e81218793742558	415	1		post	6								
574A		574	0	liquid	SRR11416243	PRJNA545312	-2		3	2	TCD	Leukemia	7c9465234d7c2c33b37132	474	1		pre	-1								
574B		574	13	liquid	SRR11416242	PRJNA545312	11		3	2	TCD	Leukemia	7c9465234d7c2c33b37132	474	1		post	1								
574C		574	20	semi-formed	SRR11416241	PRJNA545312	18		3	2	TCD	Leukemia	7c9465234d7c2c33b37132	474	1		post	2								
575A		FMT.0184	0	formed	SRR11416240	PRJNA545312	-5		6	5	PBSC_unmodified	Leukemia	a73ff42b25ed31a0f0abe1	489	1		pre	-1								
575B		FMT.0184	3	formed	SRR11416239	PRJNA545312	-2		6	5	PBSC_unmodified	Leukemia	a73ff42b25ed31a0f0abe1	489	1		pre	-1								
575C		FMT.0184	12	liquid	SRR11416238	PRJNA545312	7		6	5	PBSC_unmodified	Leukemia	a73ff42b25ed31a0f0abe1	489	1		post	0								
575D		FMT.0184	19	liquid	SRR11416237	PRJNA545312	14		6	5	PBSC_unmodified	Leukemia	a73ff42b25ed31a0f0abe1	489	1		post	1								
575E		FMT.0184	28	semi-formed	SRR11416236	PRJNA545312	23		6	5	PBSC_unmodified	Leukemia	a73ff42b25ed31a0f0abe1	489	1		post	3								
576A		576	0	semi-formed	SRR11416235	PRJNA545312	-6		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	b8e19cbdf1bf196f639f6e	67	1		pre	-1								
576B		576	17	liquid	SRR11416233	PRJNA545312	11		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	b8e19cbdf1bf196f639f6e	67	1		post	1								
576C		576	88	liquid	SRR11416232	PRJNA545312	82		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	b8e19cbdf1bf196f639f6e	67	1		post	6								
576D		576	122	liquid	SRR11416231	PRJNA545312	116		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	b8e19cbdf1bf196f639f6e	67	1		post	6								
576E		576	134	liquid	SRR11416230	PRJNA545312	128		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	b8e19cbdf1bf196f639f6e	67	1		post	6								
577A		577	0	formed	SRR11140420	PRJNA606262			3																	
577B		577	2	semi-formed	SRR11140409	PRJNA606262			3																	
577C		577	14	semi-formed	SRR11140398	PRJNA606262			3																	
578A		578	0	formed	SRR11416229	PRJNA545312	18		2	-18	cord	Non-Hodgkin's Lymphoma	83e2d4264a07e6c34f1f35	34	1		post	2								
578B		578	7	semi-formed	SRR11416228	PRJNA545312	25		2	-18	cord	Non-Hodgkin's Lymphoma	83e2d4264a07e6c34f1f35	34	1		post	3								
579A		579	0	liquid	SRR11416227	PRJNA545312	-2		2	2	cord	Leukemia	f0124941d8b75b31a30471	483	1		pre	-1								
579B		579	13	liquid	SRR11416226	PRJNA545312	11		2	2	cord	Leukemia	f0124941d8b75b31a30471	483	1		post	1								
580A		580	0	liquid	SRR11416225	PRJNA545312	-4		2	4	TCD	Leukemia	2ec9cee1e94f093db60c83	473	1		pre	-1								
580B		580	8	liquid	SRR11416224	PRJNA545312	4		2	4	TCD	Leukemia	2ec9cee1e94f093db60c83	473	1		peri	0								
582A		582	0	liquid	SRR11140417	PRJNA606262			1																	
583A		583	0	semi-formed	SRR11140400	PRJNA606262			1																	
584A		584	0	formed	SRR11416221	PRJNA545312	18		3	-18	cord	Leukemia	ddeb8f57e1255983c91a3c	478	1		post	2								
584B		584	2	formed	SRR11416220	PRJNA545312	20		3	-18	cord	Leukemia	ddeb8f57e1255983c91a3c	478	1		post	2								
584C		584	8	semi-formed	SRR11416219	PRJNA545312	26		3	-18	cord	Leukemia	ddeb8f57e1255983c91a3c	478	1		post	3								
585A		585	0	semi-formed	SRR11416218	PRJNA545312	-2		2	2	PBSC_unmodified	Hodgkin's Disease	96a51cdf5d223ecf876530	457	1		pre	-1								
585B		585	5	liquid	SRR11416217	PRJNA545312	3		2	2	PBSC_unmodified	Hodgkin's Disease	96a51cdf5d223ecf876530	457	1		peri	0								
586A		586	0	semi-formed	SRR11416076	PRJNA545312	1		2	-1	cord	Leukemia	e7a7e36e301ccb4d5364ac	135	1		peri	0								
586B		586	18	liquid	SRR11416075	PRJNA545312	19		2	-1	cord	Leukemia	e7a7e36e301ccb4d5364ac	135	1		post	2								
587A		587	0	formed	SRR11416074	PRJNA545312	-9		8	9	TCD	Multiple Myeloma	232447fee20043c2e11345	180	1		pre	-2								
587B		587	16	liquid	SRR11416073	PRJNA545312	7		8	9	TCD	Multiple Myeloma	232447fee20043c2e11345	180	1		post	0								
587C		587	21	semi-formed	SRR11416072	PRJNA545312	12		8	9	TCD	Multiple Myeloma	232447fee20043c2e11345	180	1		post	1								
587D		587	26	semi-formed	SRR11416070	PRJNA545312	17		8	9	TCD	Multiple Myeloma	232447fee20043c2e11345	180	1		post	2								
587E		587	145	formed	SRR11416069	PRJNA545312	136		8	9	TCD	Multiple Myeloma	232447fee20043c2e11345	180	1		post	6								
587G		587	243	semi-formed	SRR11416068	PRJNA545312	234		8	9	TCD	Multiple Myeloma	232447fee20043c2e11345	180	1		post	6								
587H		587	251	formed	SRR11416067	PRJNA545312	242		8	9	TCD	Multiple Myeloma	232447fee20043c2e11345	180	1		post	6								
587I		587	257	formed	SRR11416066	PRJNA545312	248		8	9	TCD	Multiple Myeloma	232447fee20043c2e11345	180	1		post	6								
588A		588	0	liquid	SRR11416065	PRJNA545312	-2		4	2	cord	Leukemia	51dc1c88790b9073ad222c	513	1		pre	-1								
588C		588	14	liquid	SRR11416064	PRJNA545312	12		4	2	cord	Leukemia	51dc1c88790b9073ad222c	513	1		post	1								
588D		588	24	semi-formed	SRR11416063	PRJNA545312	22		4	2	cord	Leukemia	51dc1c88790b9073ad222c	513	1		post	3								
588F		588	31	formed	SRR11416061	PRJNA545312	29		4	2	cord	Leukemia	51dc1c88790b9073ad222c	513	1		post	4								
589A		589	0	formed	SRR11416059	PRJNA545312	-6		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	e4cd0566f7d6e764f462fa	92	1		pre	-1								
589B		589	6	formed	SRR11416058	PRJNA545312	0		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	e4cd0566f7d6e764f462fa	92	1		peri	-1								
589C		589	19	formed	SRR11416057	PRJNA545312	13		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	e4cd0566f7d6e764f462fa	92	1		post	1								
590A		FMT.0026	0	formed	SRR11416056	PRJNA545312	-8		10	973	PBSC_unmodified	Leukemia	2fe521798f2a170866740c	486	1		pre	-2								
590B		FMT.0026	5	liquid	SRR11416055	PRJNA545312	-3		10	973	PBSC_unmodified	Leukemia	2fe521798f2a170866740c	486	1		pre	-1								
590C		FMT.0026	13	liquid	SRR11416054	PRJNA545312	5		10	973	PBSC_unmodified	Leukemia	2fe521798f2a170866740c	486	1		peri	0								
590D		FMT.0026	19	liquid	SRR11416053	PRJNA545312	11		10	973	PBSC_unmodified	Leukemia	2fe521798f2a170866740c	486	1		post	1								
591A		591	0	formed	SRR11416052	PRJNA545312	-5		6	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	b592ba51d2f4be968f8c32	459	1		pre	-1								
591B		591	8	formed	SRR11416051	PRJNA545312	3		6	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	b592ba51d2f4be968f8c32	459	1		peri	0								
591C		591	17	formed	SRR11416050	PRJNA545312	12		6	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	b592ba51d2f4be968f8c32	459	1		post	1								
591D		591	458	semi-formed	SRR11415993	PRJNA545312	453		6	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	b592ba51d2f4be968f8c32	459	1		post	6								
591E		591	487	formed	SRR11415992	PRJNA545312	482		6	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	b592ba51d2f4be968f8c32	459	1		post	6								
591F		591	514	semi-formed	SRR11415991	PRJNA545312	509		6	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	b592ba51d2f4be968f8c32	459	1		post	6								
592A		592	0	formed	SRR11415990	PRJNA545312	-11		3	11	TCD	Leukemia	2f4546e775f8d1505aaf53	484	1		pre	-2								
592B		592	19	liquid	SRR11415989	PRJNA545312	8		3	11	TCD	Leukemia	2f4546e775f8d1505aaf53	484	1		post	1								
592C		592	22	semi-formed	SRR11415988	PRJNA545312	11		3	11	TCD	Leukemia	2f4546e775f8d1505aaf53	484	1		post	1								
593A		593	0	formed	SRR11415987	PRJNA545312	-9		5	9	TCD	Myelodysplastic Syndromes	2b9fdfb969213855bbff7f	64	1		pre	-2								
593B		593	2	formed	SRR11415986	PRJNA545312	-7		5	9	TCD	Myelodysplastic Syndromes	2b9fdfb969213855bbff7f	64	1		pre	-2								
593C		593	6	liquid	SRR11415985	PRJNA545312	-3		5	9	TCD	Myelodysplastic Syndromes	2b9fdfb969213855bbff7f	64	1		pre	-1								
593E		593	20	semi-formed	SRR11415984	PRJNA545312	11		5	9	TCD	Myelodysplastic Syndromes	2b9fdfb969213855bbff7f	64	1		post	1								
593F		593	27	liquid	SRR11415982	PRJNA545312	18		5	9	TCD	Myelodysplastic Syndromes	2b9fdfb969213855bbff7f	64	1		post	2								
594A		594	0	formed	SRR11415981	PRJNA545312	4		2	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	a19d4ddaf71e789a122ad8	479	1		peri	0								
594B		594	6	formed	SRR11415980	PRJNA545312	10		2	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	a19d4ddaf71e789a122ad8	479	1		post	1								
595B		595	5	formed	SRR11415979	PRJNA545312	-3		3	8	TCD	Myeloproliferative Disorder	1f16fa1c085bb2bdacd5ec	475	1		pre	-1								
595C		595	13	semi-formed	SRR11415978	PRJNA545312	5		3	8	TCD	Myeloproliferative Disorder	1f16fa1c085bb2bdacd5ec	475	1		peri	0								
595D		595	18	semi-formed	SRR11415977	PRJNA545312	10		3	8	TCD	Myeloproliferative Disorder	1f16fa1c085bb2bdacd5ec	475	1		post	1								
596A		596	0	liquid	SRR11415976	PRJNA545312	3		2	-3	TCD	Leukemia	58bf74a2e9bcb5f6ca3d9e	485	1		peri	0								
596C		596	17	liquid	SRR11415975	PRJNA545312	20		2	-3	TCD	Leukemia	58bf74a2e9bcb5f6ca3d9e	485	1		post	2								
597A		597	0	formed	SRR11415974	PRJNA545312	-4		2	4	PBSC_unmodified	Myelodysplastic Syndromes	98ce277693fafcaf6638aa	285	1		pre	-1								
597C		597	17	semi-formed	SRR11415973	PRJNA545312	13		2	4	PBSC_unmodified	Myelodysplastic Syndromes	98ce277693fafcaf6638aa	285	1		post	1								
598A		598	0	semi-formed	SRR11415971	PRJNA545312	-6		4	6	cord	Leukemia	c8831de31bb8c776f02fe7	487	1		pre	-1								
598B		598	5	liquid	SRR11415970	PRJNA545312	-1		4	6	cord	Leukemia	c8831de31bb8c776f02fe7	487	1		pre	-1								
598D		598	18	liquid	SRR11415969	PRJNA545312	12		4	6	cord	Leukemia	c8831de31bb8c776f02fe7	487	1		post	1								
598E		598	33	semi-formed	SRR11415968	PRJNA545312	27		4	6	cord	Leukemia	c8831de31bb8c776f02fe7	487	1		post	3								
599A		599	0	formed	SRR11415967	PRJNA545312	-2		3	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	9e08248bd2674ed94d7e40	157	1		pre	-1								
599B		599	14	semi-formed	SRR11415966	PRJNA545312	12		3	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	9e08248bd2674ed94d7e40	157	1		post	1								
599C		599	29	semi-formed	SRR11416160	PRJNA545312	27		3	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	9e08248bd2674ed94d7e40	157	1		post	3								
600A		600	0	formed	SRR11396774	PRJNA607574			1																	
601A		601	0	liquid	SRR11416159	PRJNA545312	-2		2	2	TCD	Multiple Myeloma	a454a2d8b933057aa03238	387	1		pre	-1								
601C		601	14	semi-formed	SRR11416158	PRJNA545312	12		2	2	TCD	Multiple Myeloma	a454a2d8b933057aa03238	387	1		post	1								
602A		602	0	liquid	SRR11140419	PRJNA606262			2																	
602B		602	11	liquid	SRR11140418	PRJNA606262			2																	
603A		603	0	formed	SRR11416157	PRJNA545312	-10		3	10	TCD	Myelodysplastic Syndromes	62a9dc7b123a62d98698d3	471	1		pre	-2								
603B		603	16	liquid	SRR11416155	PRJNA545312	6		3	10	TCD	Myelodysplastic Syndromes	62a9dc7b123a62d98698d3	471	1		post	0								
603C		603	19	liquid	SRR11416154	PRJNA545312	9		3	10	TCD	Myelodysplastic Syndromes	62a9dc7b123a62d98698d3	471	1		post	1								
604A		604	0	liquid	SRR11416153	PRJNA545312	4		2	-4	TCD	Leukemia	ef590ede856d6f597d61a0	492	1		peri	0								
604B		604	7	liquid	SRR11416152	PRJNA545312	11		2	-4	TCD	Leukemia	ef590ede856d6f597d61a0	492	1		post	1								
605A		605	0	formed	SRR11416151	PRJNA545312	-5		4	5	cord	Non-Hodgkin's Lymphoma	b3a23726dd0e4806830ce4	177	1		pre	-1								
605B		605	5	formed	SRR11416150	PRJNA545312	0		4	5	cord	Non-Hodgkin's Lymphoma	b3a23726dd0e4806830ce4	177	1		peri	-1								
605C		605	9	formed	SRR11416149	PRJNA545312	4		4	5	cord	Non-Hodgkin's Lymphoma	b3a23726dd0e4806830ce4	177	1		peri	0								
605D		605	21	formed	SRR11416148	PRJNA545312	16		4	5	cord	Non-Hodgkin's Lymphoma	b3a23726dd0e4806830ce4	177	1		post	2								
606A		606	0	formed	SRR11416147	PRJNA545312	-5		4	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	3bc8f1e72631eb02a1bcb9	467	1		pre	-1								
606B		606	3	liquid	SRR11416146	PRJNA545312	-2		4	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	3bc8f1e72631eb02a1bcb9	467	1		pre	-1								
606C		606	10	liquid	SRR11416144	PRJNA545312	5		4	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	3bc8f1e72631eb02a1bcb9	467	1		peri	0								
606D		606	17	liquid	SRR11416143	PRJNA545312	12		4	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	3bc8f1e72631eb02a1bcb9	467	1		post	1								
607A		607	0	formed	SRR11416142	PRJNA545312	-6		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	0f91286b9e6f49880d8904	265	1		pre	-1								
607B		607	3	formed	SRR11416141	PRJNA545312	-3		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	0f91286b9e6f49880d8904	265	1		pre	-1								
607C		607	77	formed	SRR11416140	PRJNA545312	71		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	0f91286b9e6f49880d8904	265	1		post	6								
607D		607	130	semi-formed	SRR11416139	PRJNA545312	124		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	0f91286b9e6f49880d8904	265	1		post	6								
608A		608	0	formed	SRR11416138	PRJNA545312	-8		2	8	TCD	Multiple Myeloma	56dbe0b814a4f5a7ea1d57	154	1		pre	-2								
608B		608	5	formed	SRR11416137	PRJNA545312	-3		2	8	TCD	Multiple Myeloma	56dbe0b814a4f5a7ea1d57	154	1		pre	-1								
609A		609	0	formed	SRR11140404	PRJNA606262			2																	
609B		609	7	semi-formed	SRR11140403	PRJNA606262			2																	
610A		610	0	formed	SRR9259292	PRJNA548153	-5		10	5	cord	Leukemia	2ea508ac288e88e2d6ad2b	523	1		pre	-1								
610B		610	7	semi-formed	SRR11416136	PRJNA545312	2		10	5	cord	Leukemia	2ea508ac288e88e2d6ad2b	523	1		peri	0								
610C		610	9	liquid	SRR11416135	PRJNA545312	4		10	5	cord	Leukemia	2ea508ac288e88e2d6ad2b	523	1		peri	0								
610D		610	10	liquid	SRR11416133	PRJNA545312	5		10	5	cord	Leukemia	2ea508ac288e88e2d6ad2b	523	1		peri	0								
610E		610	11	liquid	SRR11415752	PRJNA545312	6		10	5	cord	Leukemia	2ea508ac288e88e2d6ad2b	523	1		post	0								
610F		610	15	liquid	SRR11415751	PRJNA545312	10		10	5	cord	Leukemia	2ea508ac288e88e2d6ad2b	523	1		post	1								
610G		610	17	liquid	SRR11415750	PRJNA545312	12		10	5	cord	Leukemia	2ea508ac288e88e2d6ad2b	523	1		post	1								
610H		610	24	semi-formed	SRR11415749	PRJNA545312	19		10	5	cord	Leukemia	2ea508ac288e88e2d6ad2b	523	1		post	2								
610I		610	32	formed	SRR11415748	PRJNA545312	27		10	5	cord	Leukemia	2ea508ac288e88e2d6ad2b	523	1		post	3								
610J		610	34	semi-formed	SRR11415747	PRJNA545312	29		10	5	cord	Leukemia	2ea508ac288e88e2d6ad2b	523	1		post	4								
611A		611	0	liquid	SRR11140519	PRJNA606262			1																	
612A		612	0	formed	SRR11415746	PRJNA545312	-9		4	9	TCD	Myelodysplastic Syndromes	434648c8fb3ed8e00b2141	461	1		pre	-2								
612B		612	9	semi-formed	SRR11415745	PRJNA545312	0		4	9	TCD	Myelodysplastic Syndromes	434648c8fb3ed8e00b2141	461	1		peri	-1								
612C		612	13	liquid	SRR11415744	PRJNA545312	4		4	9	TCD	Myelodysplastic Syndromes	434648c8fb3ed8e00b2141	461	1		peri	0								
612D		612	20	formed	SRR11415742	PRJNA545312	11		4	9	TCD	Myelodysplastic Syndromes	434648c8fb3ed8e00b2141	461	1		post	1								
613A		613	0	formed	SRR11415741	PRJNA545312	-6		14	6	cord	Non-Hodgkin's Lymphoma	2c8a3fd3aa3b373d3fe636	463	1		pre	-1								
613B		613	1	formed	SRR11415740	PRJNA545312	-5		14	6	cord	Non-Hodgkin's Lymphoma	2c8a3fd3aa3b373d3fe636	463	1		pre	-1								
613C		613	3	formed	SRR11415739	PRJNA545312	-3		14	6	cord	Non-Hodgkin's Lymphoma	2c8a3fd3aa3b373d3fe636	463	1		pre	-1								
613D		613	6	formed	SRR11415738	PRJNA545312	0		14	6	cord	Non-Hodgkin's Lymphoma	2c8a3fd3aa3b373d3fe636	463	1		peri	-1								
613E		613	7	formed	SRR11415737	PRJNA545312	1		14	6	cord	Non-Hodgkin's Lymphoma	2c8a3fd3aa3b373d3fe636	463	1		peri	0								
613F		613	8	liquid	SRR11415736	PRJNA545312	2		14	6	cord	Non-Hodgkin's Lymphoma	2c8a3fd3aa3b373d3fe636	463	1		peri	0								
613G		613	9	semi-formed	SRR11415735	PRJNA545312	3		14	6	cord	Non-Hodgkin's Lymphoma	2c8a3fd3aa3b373d3fe636	463	1		peri	0								
613H		613	11	liquid	SRR11415734	PRJNA545312	5		14	6	cord	Non-Hodgkin's Lymphoma	2c8a3fd3aa3b373d3fe636	463	1		peri	0								
613I		613	12	liquid	SRR11415733	PRJNA545312	6		14	6	cord	Non-Hodgkin's Lymphoma	2c8a3fd3aa3b373d3fe636	463	1		post	0								
613J		613	13	formed	SRR11415730	PRJNA545312	7		14	6	cord	Non-Hodgkin's Lymphoma	2c8a3fd3aa3b373d3fe636	463	1		post	0								
613K		613	14	liquid	SRR11415729	PRJNA545312	8		14	6	cord	Non-Hodgkin's Lymphoma	2c8a3fd3aa3b373d3fe636	463	1		post	1								
613L		613	17	semi-formed	SRR11415728	PRJNA545312	11		14	6	cord	Non-Hodgkin's Lymphoma	2c8a3fd3aa3b373d3fe636	463	1		post	1								
613S		613	30	semi-formed	SRR11415727	PRJNA545312	24		14	6	cord	Non-Hodgkin's Lymphoma	2c8a3fd3aa3b373d3fe636	463	1		post	3								
613T		613	32	liquid	SRR11415726	PRJNA545312	26		14	6	cord	Non-Hodgkin's Lymphoma	2c8a3fd3aa3b373d3fe636	463	1		post	3								
614A		614	0	formed	SRR11415725	PRJNA545312	-174		4	174	TCD	Multiple Myeloma	b933ea160c6170c487464d	498	1		pre	-3								
614B		614	172	semi-formed	SRR11416216	PRJNA545312	-2		4	174	TCD	Multiple Myeloma	b933ea160c6170c487464d	498	1		pre	-1								
614C		614	175	semi-formed	SRR11416215	PRJNA545312	1		4	174	TCD	Multiple Myeloma	b933ea160c6170c487464d	498	1		peri	0								
614D		614	179	semi-formed	SRR11416214	PRJNA545312	5		4	174	TCD	Multiple Myeloma	b933ea160c6170c487464d	498	1		peri	0								
615A		615	0	formed	SRR9260717	PRJNA548153	-9		12	9	TCD	Leukemia	71c9c0e1b7f2ab9611a9ab	93	1		pre	-2								
615B		615	2	formed	SRR9260718	PRJNA548153	-7		12	9	TCD	Leukemia	71c9c0e1b7f2ab9611a9ab	93	1		pre	-2								
615C		615	3	formed	SRR9260719	PRJNA548153	-6		12	9	TCD	Leukemia	71c9c0e1b7f2ab9611a9ab	93	1		pre	-1								
615D		615	4	formed	SRR9260720	PRJNA548153	-5		12	9	TCD	Leukemia	71c9c0e1b7f2ab9611a9ab	93	1		pre	-1								
615E		615	6	formed	SRR9260721	PRJNA548153	-3		12	9	TCD	Leukemia	71c9c0e1b7f2ab9611a9ab	93	1		pre	-1								
615F		615	8	semi-formed	SRR9260722	PRJNA548153	-1		12	9	TCD	Leukemia	71c9c0e1b7f2ab9611a9ab	93	1		pre	-1								
615G		615	9	formed	SRR11416213	PRJNA545312	0		12	9	TCD	Leukemia	71c9c0e1b7f2ab9611a9ab	93	1		peri	-1								
615H		615	10	liquid	SRR11416211	PRJNA545312	1		12	9	TCD	Leukemia	71c9c0e1b7f2ab9611a9ab	93	1		peri	0								
615I		615	11	semi-formed	SRR11416210	PRJNA545312	2		12	9	TCD	Leukemia	71c9c0e1b7f2ab9611a9ab	93	1		peri	0								
615J		615	12	liquid	SRR11416209	PRJNA545312	3		12	9	TCD	Leukemia	71c9c0e1b7f2ab9611a9ab	93	1		peri	0								
615K		615	13	liquid	SRR11416208	PRJNA545312	4		12	9	TCD	Leukemia	71c9c0e1b7f2ab9611a9ab	93	1		peri	0								
615L		615	15	liquid	SRR11416207	PRJNA545312	6		12	9	TCD	Leukemia	71c9c0e1b7f2ab9611a9ab	93	1		post	0								
616A		616	0	formed	SRR9260770	PRJNA548153	-9		14	9	TCD	Leukemia	2e5583b4d5f75e91f25586	504	1		pre	-2								
616B		616	2	formed	SRR9260771	PRJNA548153	-7		14	9	TCD	Leukemia	2e5583b4d5f75e91f25586	504	1		pre	-2								
616C		616	3	formed	SRR9260772	PRJNA548153	-6		14	9	TCD	Leukemia	2e5583b4d5f75e91f25586	504	1		pre	-1								
616D		616	4	formed	SRR9260777	PRJNA548153	-5		14	9	TCD	Leukemia	2e5583b4d5f75e91f25586	504	1		pre	-1								
616E		616	6	formed	SRR9260778	PRJNA548153	-3		14	9	TCD	Leukemia	2e5583b4d5f75e91f25586	504	1		pre	-1								
616F		616	7	semi-formed	SRR9260805	PRJNA548153	-2		14	9	TCD	Leukemia	2e5583b4d5f75e91f25586	504	1		pre	-1								
616G		616	8	semi-formed	SRR9260804	PRJNA548153	-1		14	9	TCD	Leukemia	2e5583b4d5f75e91f25586	504	1		pre	-1								
616H		616	9	liquid	SRR11416206	PRJNA545312	0		14	9	TCD	Leukemia	2e5583b4d5f75e91f25586	504	1		peri	-1								
616I		616	11	semi-formed	SRR11416205	PRJNA545312	2		14	9	TCD	Leukemia	2e5583b4d5f75e91f25586	504	1		peri	0								
616J		616	13	semi-formed	SRR11416204	PRJNA545312	4		14	9	TCD	Leukemia	2e5583b4d5f75e91f25586	504	1		peri	0								
616K		616	15	semi-formed	SRR11416203	PRJNA545312	6		14	9	TCD	Leukemia	2e5583b4d5f75e91f25586	504	1		post	0								
616L		616	16	formed	SRR11416202	PRJNA545312	7		14	9	TCD	Leukemia	2e5583b4d5f75e91f25586	504	1		post	0								
616M		616	17	formed	SRR11416200	PRJNA545312	8		14	9	TCD	Leukemia	2e5583b4d5f75e91f25586	504	1		post	1								
616N		616	18	formed	SRR11416199	PRJNA545312	9		14	9	TCD	Leukemia	2e5583b4d5f75e91f25586	504	1		post	1								
617A		617	0	formed	SRR9260812	PRJNA548153	-8		10	8	TCD	Leukemia	c127a7befa2982756a3d6e	501	1		pre	-2								
617B		617	1	formed	SRR9260849	PRJNA548153	-7		10	8	TCD	Leukemia	c127a7befa2982756a3d6e	501	1		pre	-2								
617C		617	6	semi-formed	SRR9260850	PRJNA548153	-2		10	8	TCD	Leukemia	c127a7befa2982756a3d6e	501	1		pre	-1								
617D		617	7	formed	SRR9260847	PRJNA548153	-1		10	8	TCD	Leukemia	c127a7befa2982756a3d6e	501	1		pre	-1								
617E		617	8	semi-formed	SRR11416198	PRJNA545312	0		10	8	TCD	Leukemia	c127a7befa2982756a3d6e	501	1		peri	-1								
617F		617	9	semi-formed	SRR11416197	PRJNA545312	1		10	8	TCD	Leukemia	c127a7befa2982756a3d6e	501	1		peri	0								
617G		617	10	liquid	SRR11416196	PRJNA545312	2		10	8	TCD	Leukemia	c127a7befa2982756a3d6e	501	1		peri	0								
617H		617	11	formed	SRR11416195	PRJNA545312	3		10	8	TCD	Leukemia	c127a7befa2982756a3d6e	501	1		peri	0								
617I		617	12	semi-formed	SRR11416194	PRJNA545312	4		10	8	TCD	Leukemia	c127a7befa2982756a3d6e	501	1		peri	0								
617J		617	18	formed	SRR11416193	PRJNA545312	10		10	8	TCD	Leukemia	c127a7befa2982756a3d6e	501	1		post	1								
618A		618	0	formed	SRR11416192	PRJNA545312	-3		3	3	cord	Non-Hodgkin's Lymphoma	6cbe65682f23dd101ac789	535	1		pre	-1								
618B		618	29	liquid	SRR11416191	PRJNA545312	26		3	3	cord	Non-Hodgkin's Lymphoma	6cbe65682f23dd101ac789	535	1		post	3								
618C		618	36	liquid	SRR11416189	PRJNA545312	33		3	3	cord	Non-Hodgkin's Lymphoma	6cbe65682f23dd101ac789	535	1		post	4								
619A		619	0	formed	SRR11415393	PRJNA545312	-156		6	156	PBSC_unmodified	Non-Hodgkin's Lymphoma	b284969f9a39c3bbfad6ef	494	1		pre	-3								
619B		619	7	semi-formed	SRR11415392	PRJNA545312	-149		6	156	PBSC_unmodified	Non-Hodgkin's Lymphoma	b284969f9a39c3bbfad6ef	494	1		pre	-3								
619C		619	150	formed	SRR11415391	PRJNA545312	-6		6	156	PBSC_unmodified	Non-Hodgkin's Lymphoma	b284969f9a39c3bbfad6ef	494	1		pre	-1								
619D		619	154	liquid	SRR11415390	PRJNA545312	-2		6	156	PBSC_unmodified	Non-Hodgkin's Lymphoma	b284969f9a39c3bbfad6ef	494	1		pre	-1								
619E		619	167	formed	SRR11415389	PRJNA545312	11		6	156	PBSC_unmodified	Non-Hodgkin's Lymphoma	b284969f9a39c3bbfad6ef	494	1		post	1								
619F		619	177	formed	SRR11415388	PRJNA545312	21		6	156	PBSC_unmodified	Non-Hodgkin's Lymphoma	b284969f9a39c3bbfad6ef	494	1		post	2								
621A		621	0	formed	SRR11415387	PRJNA545312	-9		2	9	TCD	Leukemia	985481932644e877ea047c	510	1		pre	-2								
621B		621	19	semi-formed	SRR11415386	PRJNA545312	10		2	9	TCD	Leukemia	985481932644e877ea047c	510	1		post	1								
622A		622	0	formed	SRR11140396	PRJNA606262			1																	
623A		623	0	liquid	SRR11415385	PRJNA545312	-5		4	5	TCD	Leukemia	85dbb79ff35c2f7cc44d39	500	1		pre	-1								
623B		623	3	liquid	SRR11415383	PRJNA545312	-2		4	5	TCD	Leukemia	85dbb79ff35c2f7cc44d39	500	1		pre	-1								
623C		623	10	liquid	SRR11415382	PRJNA545312	5		4	5	TCD	Leukemia	85dbb79ff35c2f7cc44d39	500	1		peri	0								
623D		623	17	semi-formed	SRR11415381	PRJNA545312	12		4	5	TCD	Leukemia	85dbb79ff35c2f7cc44d39	500	1		post	1								
624A		624	0	formed	SRR11415380	PRJNA545312	-9		7	226	cord	Leukemia	e25f8c23eb8f49e336489b	524	1		pre	-2								
624B		624	11	liquid	SRR11415379	PRJNA545312	2		7	226	cord	Leukemia	e25f8c23eb8f49e336489b	524	1		peri	0								
624C		624	14	liquid	SRR11415378	PRJNA545312	5		7	226	cord	Leukemia	e25f8c23eb8f49e336489b	524	1		peri	0								
624D		624	21	semi-formed	SRR11415377	PRJNA545312	12		7	226	cord	Leukemia	e25f8c23eb8f49e336489b	524	1		post	1								
624E		624	220	semi-formed	SRR11117044	PRJNA607574	-6		7	226	cord	Leukemia	e25f8c23eb8f49e336489b	524	1		pre	-1								
624F		624	238	liquid	SRR11415376	PRJNA545312	12		7	226	cord	Leukemia	e25f8c23eb8f49e336489b	524	1		post	1								
624G		624	245	semi-formed	SRR11415375	PRJNA545312	19		7	226	cord	Leukemia	e25f8c23eb8f49e336489b	524	1		post	2								
625A		625	0	formed	SRR11415374	PRJNA545312	-7		5	756	PBSC_unmodified	Leukemia	02872b52ea6a685694f92a		1		pre	-2								
625B		625	11	liquid	SRR11415372	PRJNA545312	4		5	756	PBSC_unmodified	Leukemia	02872b52ea6a685694f92a		1		peri	0								
625C		625	39	liquid	SRR11415371	PRJNA545312	32		5	756	PBSC_unmodified	Leukemia	02872b52ea6a685694f92a		1		post	4								
625D		625	45	semi-formed	SRR11415370	PRJNA545312	38		5	756	PBSC_unmodified	Leukemia	02872b52ea6a685694f92a		1		post	5								
625E		625	752	formed	SRR11117043	PRJNA607574	-4		5	756	PBSC_unmodified	Leukemia	02872b52ea6a685694f92a		1		pre	-1								
626A		626	0	formed	SRR11415369	PRJNA545312	-7		6	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	15c419ad8dced9e15f7f4a	508	1		pre	-2								
626B		626	5	formed	SRR11415368	PRJNA545312	-2		6	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	15c419ad8dced9e15f7f4a	508	1		pre	-1								
626C		626	10	liquid	SRR11415367	PRJNA545312	3		6	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	15c419ad8dced9e15f7f4a	508	1		peri	0								
626E		626	26	liquid	SRR11415366	PRJNA545312	19		6	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	15c419ad8dced9e15f7f4a	508	1		post	2								
626F		626	35	semi-formed	SRR11415337	PRJNA545312	28		6	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	15c419ad8dced9e15f7f4a	508	1		post	3								
626G		626	62	semi-formed	SRR11415336	PRJNA545312	55		6	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	15c419ad8dced9e15f7f4a	508	1		post	6								
627A		627	0	formed	SRR11415335	PRJNA545312	-9		2	9	TCD	Leukemia	acbb76ae719e546b502612	527	1		pre	-2								
627B		627	12	liquid	SRR11415333	PRJNA545312	3		2	9	TCD	Leukemia	acbb76ae719e546b502612	527	1		peri	0								
628A		628	0	semi-formed	SRR11415332	PRJNA545312	-1627		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1											
628B		628	1622	formed	SRR11415331	PRJNA545312	-5		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		pre	-1								
628C		628	1623	formed	SRR11415330	PRJNA545312	-4		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		pre	-1								
628D		628	1624	formed	SRR11415329	PRJNA545312	-3		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		pre	-1								
628E		628	1625	formed	SRR11415328	PRJNA545312	-2		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		pre	-1								
628F		628	1626	formed	SRR11415327	PRJNA545312	-1		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		pre	-1								
628G		628	1627	semi-formed	SRR11415326	PRJNA545312	0		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		peri	-1								
628H		628	1629	semi-formed	SRR11415325	PRJNA545312	2		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		peri	0								
628I		628	1630	semi-formed	SRR11415324	PRJNA545312	3		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		peri	0								
628J		628	1631	formed	SRR11415322	PRJNA545312	4		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		peri	0								
628K		628	1632	formed	SRR11415321	PRJNA545312	5		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		peri	0								
628L		628	1634	semi-formed	SRR11415320	PRJNA545312	7		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		post	0								
628M		628	1637	semi-formed	SRR11415319	PRJNA545312	10		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		post	1								
628N		628	1638	semi-formed	SRR11415318	PRJNA545312	11		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		post	1								
628O		628	1639	semi-formed	SRR11415317	PRJNA545312	12		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		post	1								
628P		628	1640	semi-formed	SRR11415316	PRJNA545312	13		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		post	1								
628Q		628	1657	semi-formed	SRR11415315	PRJNA545312	30		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		post	4								
628R		628	1678	semi-formed	SRR11117042	PRJNA607574	51		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		post	6								
628S		628	1680	formed	SRR11117041	PRJNA607574	53		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		post	6								
628T		628	1681	formed	SRR11117040	PRJNA607574	54		20	1627	PBSC_unmodified	Non-Hodgkin's Lymphoma	cd99a08d64239bc1f88670		1		post	6								
629A		629	0	formed	SRR11140386	PRJNA606262			2																	
629B		629	7	semi-formed	SRR11140385	PRJNA606262			2																	
630A		630	0	liquid	SRR11415314	PRJNA545312	5		6	-5	TCD	Myelodysplastic Syndromes	8a3388998aea665eca2cf2	308	1		peri	0								
630B		630	83	formed	SRR11415313	PRJNA545312	88		6	-5	TCD	Myelodysplastic Syndromes	8a3388998aea665eca2cf2	308	1		post	6								
630C		630	135	formed	SRR11415311	PRJNA545312	140		6	-5	TCD	Myelodysplastic Syndromes	8a3388998aea665eca2cf2	308	1		post	6								
630D		630	145	semi-formed	SRR11415310	PRJNA545312	150		6	-5	TCD	Myelodysplastic Syndromes	8a3388998aea665eca2cf2	308	1		post	6								
630E		630	148	formed	SRR11415685	PRJNA545312	153		6	-5	TCD	Myelodysplastic Syndromes	8a3388998aea665eca2cf2	308	1		post	6								
630F		630	154	formed	SRR11415684	PRJNA545312	159		6	-5	TCD	Myelodysplastic Syndromes	8a3388998aea665eca2cf2	308	1		post	6								
631A		631	0	formed	SRR11140394	PRJNA606262			1																	
632A		632	0	formed	SRR11415683	PRJNA545312	-2		1	2	PBSC_unmodified	Myeloproliferative Disorder	6cf11b6856c563332a6a66	496	1		pre	-1								
633A		633	0	formed	SRR11415682	PRJNA545312	-2		7	2	cord	Non-Hodgkin's Lymphoma	585fe250d9357db96f17e1	410	1		pre	-1								
633B		633	6	formed	SRR11415681	PRJNA545312	4		7	2	cord	Non-Hodgkin's Lymphoma	585fe250d9357db96f17e1	410	1		peri	0								
633C		633	16	formed	SRR11415680	PRJNA545312	14		7	2	cord	Non-Hodgkin's Lymphoma	585fe250d9357db96f17e1	410	1		post	1								
633D		633	17	formed	SRR11415679	PRJNA545312	15		7	2	cord	Non-Hodgkin's Lymphoma	585fe250d9357db96f17e1	410	1		post	2								
633E		633	21	formed	SRR11415678	PRJNA545312	19		7	2	cord	Non-Hodgkin's Lymphoma	585fe250d9357db96f17e1	410	1		post	2								
633F		633	31	liquid	SRR11415676	PRJNA545312	29		7	2	cord	Non-Hodgkin's Lymphoma	585fe250d9357db96f17e1	410	1		post	4								
633G		633	35	formed	SRR11415675	PRJNA545312	33		7	2	cord	Non-Hodgkin's Lymphoma	585fe250d9357db96f17e1	410	1		post	4								
634A		634	0	formed	SRR11415674	PRJNA545312	-5		3	5	PBSC_unmodified	Leukemia	889445ff6882bf07f34ab8	542	1		pre	-1								
634C		634	8	semi-formed	SRR11415672	PRJNA545312	3		3	5	PBSC_unmodified	Leukemia	889445ff6882bf07f34ab8	542	1		peri	0								
634F		634	36	semi-formed	SRR11415671	PRJNA545312	31		3	5	PBSC_unmodified	Leukemia	889445ff6882bf07f34ab8	542	1		post	4								
635A		635	0	liquid	SRR11415670	PRJNA545312	-6		3	6	TCD	Leukemia	2c3d8db96430623c146924	490	1		pre	-1								
635B		635	3	semi-formed	SRR11415669	PRJNA545312	-3		3	6	TCD	Leukemia	2c3d8db96430623c146924	490	1		pre	-1								
635C		635	19	semi-formed	SRR11415668	PRJNA545312	13		3	6	TCD	Leukemia	2c3d8db96430623c146924	490	1		post	1								
636A		636	0	formed	SRR11140504	PRJNA606262			1																	
637A		637	0	liquid	SRR11415667	PRJNA545312	0		6	0	cord	Leukemia	1a1a3c29f71d9d99987fb7	536	1		peri	-1								
637B		637	1	liquid	SRR11415664	PRJNA545312	1		6	0	cord	Leukemia	1a1a3c29f71d9d99987fb7	536	1		peri	0								
637C		637	4	liquid	SRR11415663	PRJNA545312	4		6	0	cord	Leukemia	1a1a3c29f71d9d99987fb7	536	1		peri	0								
637D		637	17	formed	SRR11415662	PRJNA545312	17		6	0	cord	Leukemia	1a1a3c29f71d9d99987fb7	536	1		post	2								
637E		637	19	formed	SRR11415661	PRJNA545312	19		6	0	cord	Leukemia	1a1a3c29f71d9d99987fb7	536	1		post	2								
637F		637	67	semi-formed	SRR11415660	PRJNA545312	67		6	0	cord	Leukemia	1a1a3c29f71d9d99987fb7	536	1		post	6								
639A		639	0	formed	SRR11415659	PRJNA545312	-6		2	6	PBSC_unmodified	Leukemia	428d997bc1fa1c7f706e30	208	1		pre	-1								
639B		639	4	formed	SRR11415658	PRJNA545312	-2		2	6	PBSC_unmodified	Leukemia	428d997bc1fa1c7f706e30	208	1		pre	-1								
640A		640	0	formed	SRR11416300	PRJNA545312	-458		11	458	BM_unmodified	Non-Hodgkin's Lymphoma	aa3c6a51d21f92e46dc421	126	1		pre	-3								
640B		640	9	formed	SRR11416299	PRJNA545312	-449		11	458	BM_unmodified	Non-Hodgkin's Lymphoma	aa3c6a51d21f92e46dc421	126	1		pre	-3								
640C		640	17	formed	SRR11416298	PRJNA545312	-441		11	458	BM_unmodified	Non-Hodgkin's Lymphoma	aa3c6a51d21f92e46dc421	126	1		pre	-3								
640D		640	454	formed	SRR11416296	PRJNA545312	-4		11	458	BM_unmodified	Non-Hodgkin's Lymphoma	aa3c6a51d21f92e46dc421	126	1		pre	-1								
640E		640	459	formed	SRR11416295	PRJNA545312	1		11	458	BM_unmodified	Non-Hodgkin's Lymphoma	aa3c6a51d21f92e46dc421	126	1		peri	0								
640F		640	464	liquid	SRR11416294	PRJNA545312	6		11	458	BM_unmodified	Non-Hodgkin's Lymphoma	aa3c6a51d21f92e46dc421	126	1		post	0								
640G		640	472	formed	SRR11416293	PRJNA545312	14		11	458	BM_unmodified	Non-Hodgkin's Lymphoma	aa3c6a51d21f92e46dc421	126	1		post	1								
640H		640	476	formed	SRR11416292	PRJNA545312	18		11	458	BM_unmodified	Non-Hodgkin's Lymphoma	aa3c6a51d21f92e46dc421	126	1		post	2								
640I		640	490	formed	SRR11416291	PRJNA545312	32		11	458	BM_unmodified	Non-Hodgkin's Lymphoma	aa3c6a51d21f92e46dc421	126	1		post	4								
640J		640	495	semi-formed	SRR11416290	PRJNA545312	37		11	458	BM_unmodified	Non-Hodgkin's Lymphoma	aa3c6a51d21f92e46dc421	126	1		post	5								
640K		640	514	liquid	SRR11416289	PRJNA545312	56		11	458	BM_unmodified	Non-Hodgkin's Lymphoma	aa3c6a51d21f92e46dc421	126	1		post	6								
641A		641	0	formed	SRR11416288	PRJNA545312	-4		6	4	PBSC_unmodified	Leukemia	1208cf93b6a19ac8021707	495	1		pre	-1								
641B		641	6	formed	SRR11416287	PRJNA545312	2		6	4	PBSC_unmodified	Leukemia	1208cf93b6a19ac8021707	495	1		peri	0								
641C		641	7	formed	SRR11416285	PRJNA545312	3		6	4	PBSC_unmodified	Leukemia	1208cf93b6a19ac8021707	495	1		peri	0								
641D		641	12	liquid	SRR11416284	PRJNA545312	8		6	4	PBSC_unmodified	Leukemia	1208cf93b6a19ac8021707	495	1		post	1								
641E		641	15	liquid	SRR11416283	PRJNA545312	11		6	4	PBSC_unmodified	Leukemia	1208cf93b6a19ac8021707	495	1		post	1								
641F		641	22	semi-formed	SRR11416282	PRJNA545312	18		6	4	PBSC_unmodified	Leukemia	1208cf93b6a19ac8021707	495	1		post	2								
642A		pt_with_samples_642_643	0	formed	SRR11416281	PRJNA545312	40		3	-40	TCD	Myeloproliferative Disorder	0b19b66b8728ecf787d7ba	528	1		post	5								
642B		pt_with_samples_642_643	18	semi-formed	SRR11416280	PRJNA545312	58		3	-40	TCD	Myeloproliferative Disorder	0b19b66b8728ecf787d7ba	528	1		post	6								
642D		pt_with_samples_642_643	58	semi-formed	SRR11416279	PRJNA545312	98		3	-40	TCD	Myeloproliferative Disorder	0b19b66b8728ecf787d7ba	528	1		post	6								
643A		643	0	semi-formed	SRR11140406	PRJNA606262			1																	
644A		644	0	formed	SRR11416278	PRJNA545312	-9		2	9	TCD	Multiple Myeloma	402dfc94233ce71c52812a	499	1		pre	-2								
644B		644	9	semi-formed	SRR11416277	PRJNA545312	0		2	9	TCD	Multiple Myeloma	402dfc94233ce71c52812a	499	1		peri	-1								
645A		645	0	formed	SRR11140392	PRJNA606262			1																	
646A		646	0	liquid	SRR11416276	PRJNA545312	-4		3	4	TCD	Multiple Myeloma	2ce83f43a78792e8113d76	532	1		pre	-1								
646B		646	7	semi-formed	SRR11416274	PRJNA545312	3		3	4	TCD	Multiple Myeloma	2ce83f43a78792e8113d76	532	1		peri	0								
646C		646	14	semi-formed	SRR11416273	PRJNA545312	10		3	4	TCD	Multiple Myeloma	2ce83f43a78792e8113d76	532	1		post	1								
647B		647	0	liquid	SRR11415656	PRJNA545312	-1		3	1	PBSC_unmodified	Leukemia	a8a54a2b7d42cfa76d925c	543	1		pre	-1								
647C		647	7	formed	SRR11415655	PRJNA545312	6		3	1	PBSC_unmodified	Leukemia	a8a54a2b7d42cfa76d925c	543	1		post	0								
647D		647	13	formed	SRR11415654	PRJNA545312	12		3	1	PBSC_unmodified	Leukemia	a8a54a2b7d42cfa76d925c	543	1		post	1								
648A		648	0	semi-formed	SRR11415653	PRJNA545312	-2		4	2	TCD	Leukemia	893cc39729893ff3192722	505	1		pre	-1								
648B		648	1	semi-formed	SRR11415652	PRJNA545312	-1		4	2	TCD	Leukemia	893cc39729893ff3192722	505	1		pre	-1								
648C		648	6	liquid	SRR11415651	PRJNA545312	4		4	2	TCD	Leukemia	893cc39729893ff3192722	505	1		peri	0								
648D		648	13	liquid	SRR11415650	PRJNA545312	11		4	2	TCD	Leukemia	893cc39729893ff3192722	505	1		post	1								
649A		649	0	formed	SRR11140401	PRJNA606262			1																	
650A		650	0	formed	SRR11140393	PRJNA606262			1																	
651A		pt_with_samples_651_652	0	formed	SRR11140399	PRJNA606262			2																	
652A		652	0	semi-formed	SRR11139955	PRJNA606262			1																	
652B		pt_with_samples_651_652	17	semi-formed	SRR11140397	PRJNA606262			2																	
653A		653	0	formed	SRR11415648	PRJNA545312	-6	SRR13697177	11	6	cord	Hodgkin's Disease	32e829c798b538b9fb745c	480	1		pre	-1								
653B		653	3	formed	SRR11415647	PRJNA545312	-3		11	6	cord	Hodgkin's Disease	32e829c798b538b9fb745c	480	1		pre	-1								
653C		653	11	liquid	SRR11415646	PRJNA545312	5		11	6	cord	Hodgkin's Disease	32e829c798b538b9fb745c	480	1		peri	0								
653D		653	13	liquid	SRR11415645	PRJNA545312	7		11	6	cord	Hodgkin's Disease	32e829c798b538b9fb745c	480	1		post	0								
653E		653	18	semi-formed	SRR11415644	PRJNA545312	12		11	6	cord	Hodgkin's Disease	32e829c798b538b9fb745c	480	1		post	1								
653F		653	24	semi-formed	SRR11415643	PRJNA545312	18	SRR13697176	11	6	cord	Hodgkin's Disease	32e829c798b538b9fb745c	480	1		post	2								
653G		653	28	formed	SRR11415642	PRJNA545312	22	SRR13697174	11	6	cord	Hodgkin's Disease	32e829c798b538b9fb745c	480	1		post	3								
653H		653	32	semi-formed	SRR11415641	PRJNA545312	26	SRR13697173	11	6	cord	Hodgkin's Disease	32e829c798b538b9fb745c	480	1		post	3								
653I		653	42	formed	SRR11415640	PRJNA545312	36		11	6	cord	Hodgkin's Disease	32e829c798b538b9fb745c	480	1		post	5								
653J		653	45	semi-formed	SRR11415639	PRJNA545312	39		11	6	cord	Hodgkin's Disease	32e829c798b538b9fb745c	480	1		post	5								
653K		653	326	semi-formed	SRR11415637	PRJNA545312	320		11	6	cord	Hodgkin's Disease	32e829c798b538b9fb745c	480	1		post	6								
654A		654	0	formed	SRR11415636	PRJNA545312	-3		3	3	TCD	Leukemia	c1a745928f6df3f0f55ca7	517	1		pre	-1								
654B		654	8	liquid	SRR11415635	PRJNA545312	5		3	3	TCD	Leukemia	c1a745928f6df3f0f55ca7	517	1		peri	0								
654C		654	15	liquid	SRR11415634	PRJNA545312	12		3	3	TCD	Leukemia	c1a745928f6df3f0f55ca7	517	1		post	1								
655A		655	0	formed	SRR11397378	PRJNA607574			1																	
657A		657	0	liquid	SRR11140390	PRJNA606262			3																	
657B		657	10	semi-formed	SRR11140389	PRJNA606262			3																	
657C		657	13	semi-formed	SRR11140388	PRJNA606262			3																	
658A		658	0	liquid	SRR11140424	PRJNA606262			2																	
658C		658	12	semi-formed	SRR11140422	PRJNA606262			2																	
659A		659	0	formed	SRR11415633	PRJNA545312	-4		1	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	0aeef0efbbda1958b1d3b0	339	1		pre	-1								
660A		660	0	semi-formed	SRR11415632	PRJNA545312	-1		1	1	TCD	Myelodysplastic Syndromes	f1f27f67473e789ad303b7	365	1		pre	-1								
661A		661	0	semi-formed	SRR11415631	PRJNA545312	-98		4	98	PBSC_unmodified	Leukemia	3de6f9bd89014b57704b9f	162	1		pre	-3								
661B		661	99	semi-formed	SRR11415630	PRJNA545312	1		4	98	PBSC_unmodified	Leukemia	3de6f9bd89014b57704b9f	162	1		peri	0								
661C		661	103	semi-formed	SRR11416020	PRJNA545312	5		4	98	PBSC_unmodified	Leukemia	3de6f9bd89014b57704b9f	162	1		peri	0								
661D		661	113	semi-formed	SRR11416019	PRJNA545312	15		4	98	PBSC_unmodified	Leukemia	3de6f9bd89014b57704b9f	162	1		post	2								
662A		662	0	semi-formed	SRR11416017	PRJNA545312	-7		4	7	TCD	Leukemia	62b8cd0da921d5aec1ff4a	13	1		pre	-2								
662B		662	7	liquid	SRR11416016	PRJNA545312	0		4	7	TCD	Leukemia	62b8cd0da921d5aec1ff4a	13	1		peri	-1								
662D		662	10	liquid	SRR11416015	PRJNA545312	3		4	7	TCD	Leukemia	62b8cd0da921d5aec1ff4a	13	1		peri	0								
662F		662	54	semi-formed	SRR11416014	PRJNA545312	47		4	7	TCD	Leukemia	62b8cd0da921d5aec1ff4a	13	1		post	6								
663A		663	0	liquid	SRR11416013	PRJNA545312	-475		4	475	PBSC_unmodified	Non-Hodgkin's Lymphoma	b34aac732f3a845d3c979a	62	1		pre	-3								
663B		663	469	formed	SRR11416012	PRJNA545312	-6		4	475	PBSC_unmodified	Non-Hodgkin's Lymphoma	b34aac732f3a845d3c979a	62	1		pre	-1								
663C		663	474	semi-formed	SRR11416011	PRJNA545312	-1		4	475	PBSC_unmodified	Non-Hodgkin's Lymphoma	b34aac732f3a845d3c979a	62	1		pre	-1								
663D		663	487	semi-formed	SRR11416010	PRJNA545312	12		4	475	PBSC_unmodified	Non-Hodgkin's Lymphoma	b34aac732f3a845d3c979a	62	1		post	1								
664A		664	0	formed	SRR11140002	PRJNA606262			3																	
664B		664	9	semi-formed	SRR11140001	PRJNA606262			3																	
664C		664	13	semi-formed	SRR11140000	PRJNA606262			3																	
665A		665	0	formed	SRR11416009	PRJNA545312	-8		9	737	PBSC_unmodified	Leukemia	3fe4475a02d83846a37076	44	1		pre	-2								
665B		665	7	semi-formed	SRR11416008	PRJNA545312	-1		9	737	PBSC_unmodified	Leukemia	3fe4475a02d83846a37076	44	1		pre	-1								
665C		665	10	semi-formed	SRR11415709	PRJNA545312	2		9	737	PBSC_unmodified	Leukemia	3fe4475a02d83846a37076	44	1		peri	0								
665D		665	13	liquid	SRR11416006	PRJNA545312	5		9	737	PBSC_unmodified	Leukemia	3fe4475a02d83846a37076	44	1		peri	0								
665F		665	38	semi-formed	SRR11416005	PRJNA545312	30		9	737	PBSC_unmodified	Leukemia	3fe4475a02d83846a37076	44	1		post	4								
665G		665	666	formed	SRR11416004	PRJNA545312	-71		9	737	PBSC_unmodified	Leukemia	3fe4475a02d83846a37076	44	1		pre	-3								
665H		665	737	formed	SRR11416003	PRJNA545312	0		9	737	PBSC_unmodified	Leukemia	3fe4475a02d83846a37076	44	1		peri	-1								
665I		665	744	formed	SRR11416002	PRJNA545312	7		9	737	PBSC_unmodified	Leukemia	3fe4475a02d83846a37076	44	1		post	0								
665J		665	749	formed	SRR11416001	PRJNA545312	12		9	737	PBSC_unmodified	Leukemia	3fe4475a02d83846a37076	44	1		post	1								
666A		666	0	formed	SRR11416000	PRJNA545312	-7		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		pre	-2								
666B		666	1	formed	SRR11415999	PRJNA545312	-6		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		pre	-1								
666C		666	3	formed	SRR11415998	PRJNA545312	-4		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		pre	-1								
666D		666	4	formed	SRR11415996	PRJNA545312	-3		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		pre	-1								
666E		666	5	formed	SRR11415995	PRJNA545312	-2		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		pre	-1								
666F		666	6	semi-formed	SRR11415994	PRJNA545312	-1		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		pre	-1								
666G		666	7	semi-formed	SRR11416048	PRJNA545312	0		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		peri	-1								
666H		666	9	semi-formed	SRR11416047	PRJNA545312	2		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		peri	0								
666I		666	10	formed	SRR11416046	PRJNA545312	3		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		peri	0								
666J		666	11	formed	SRR11416045	PRJNA545312	4		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		peri	0								
666K		666	12	semi-formed	SRR11416044	PRJNA545312	5		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		peri	0								
666L		666	13	formed	SRR11416043	PRJNA545312	6		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		post	0								
666M		666	14	formed	SRR11416042	PRJNA545312	7		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		post	0								
666N		666	15	liquid	SRR11416040	PRJNA545312	8		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		post	1								
666O		666	16	semi-formed	SRR11416039	PRJNA545312	9		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		post	1								
666P		666	17	semi-formed	SRR11416038	PRJNA545312	10		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		post	1								
666R		666	19	formed	SRR11416037	PRJNA545312	12		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		post	1								
666T		666	21	semi-formed	SRR11416036	PRJNA545312	14		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		post	1								
666U		666	27	formed	SRR11416035	PRJNA545312	20		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		post	2								
666V		666	28	formed	SRR11416034	PRJNA545312	21		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		post	2								
666W		666	22	formed	SRR11416033	PRJNA545312	15		21	7	PBSC_unmodified	Hodgkin's Disease	de732d277cece166296156	515	1		post	2								
667A		667	0	formed	SRR11416032	PRJNA545312	-8		4	8	PBSC_unmodified	Leukemia	001f938eeec58c18a4604a	491	1		pre	-2								
667B		667	5	semi-formed	SRR11416031	PRJNA545312	-3		4	8	PBSC_unmodified	Leukemia	001f938eeec58c18a4604a	491	1		pre	-1								
667C		667	11	semi-formed	SRR11416028	PRJNA545312	3		4	8	PBSC_unmodified	Leukemia	001f938eeec58c18a4604a	491	1		peri	0								
667D		667	15	liquid	SRR11416027	PRJNA545312	7		4	8	PBSC_unmodified	Leukemia	001f938eeec58c18a4604a	491	1		post	0								
668A		668	0	formed	SRR11416026	PRJNA545312	-862	SRR13697172	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		pre	-3								
668B		668	5	formed	SRR11416024	PRJNA545312	-857	SRR13697171	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		pre	-3								
668BB		668	911	liquid	SRR11416023	PRJNA545312	49	SRR13697170	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	6								
668C		668	10	liquid	SRR11416022	PRJNA545312	-852		39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		pre	-3								
668CC		668	912	semi-formed	SRR11416021	PRJNA545312	50	SRR13697169	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	6								
668D		668	12	liquid	SRR11415505	PRJNA545312	-850	SRR13697168	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		pre	-3								
668DD		668	913	liquid	SRR11415504	PRJNA545312	51	SRR13697167	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	6								
668E		668	15	semi-formed	SRR11415502	PRJNA545312	-847		39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		pre	-3								
668EE		668	914	liquid	SRR11415501	PRJNA545312	52	SRR13697166	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	6								
668F		668	859	formed	SRR11415500	PRJNA545312	-3	SRR13697165	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		pre	-1								
668FF		668	915	liquid	SRR11415499	PRJNA545312	53	SRR13697206	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	6								
668G		668	860	formed	SRR11415498	PRJNA545312	-2	SRR13697205	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		pre	-1								
668GG		668	916	liquid	SRR11415497	PRJNA545312	54	SRR13697204	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	6								
668H		668	861	formed	SRR11415496	PRJNA545312	-1		39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		pre	-1								
668HH		668	917	semi-formed	SRR11415495	PRJNA545312	55	SRR13697203	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	6								
668I		668	862	formed	SRR11415494	PRJNA545312	0		39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		peri	-1								
668II		668	919	semi-formed	SRR11419247	PRJNA545312	57	SRR13697202	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	6								
668J		668	864	formed	SRR11419246	PRJNA545312	2		39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		peri	0								
668JJ		668	924	liquid	SRR11418995	PRJNA545312	62	SRR13697201	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	6								
668K		668	865	liquid	SRR11418830	PRJNA545312	3	SRR13697200	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		peri	0								
668KK		668	926	semi-formed	SRR11415493	PRJNA545312	64	SRR13697199	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	6								
668L		668	867	semi-formed	SRR11419109	PRJNA545312	5	SRR13697198	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		peri	0								
668LL		668	928	liquid	SRR11419309	PRJNA545312	66	SRR13697197	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	6								
668M		668	868	semi-formed	SRR11418534	PRJNA545312	6	SRR13697065	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	0								
668MM		668	929	liquid	SRR11418750	PRJNA545312	67	SRR13697239	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	6								
668N		668	869	semi-formed	SRR11418508	PRJNA545312	7	SRR13697238	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	0								
668NN		668	933	semi-formed	SRR11419257	PRJNA545312	71	SRR13697237	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	6								
668O		668	872	formed	SRR11419245	PRJNA545312	10	SRR13697236	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	1								
668P		668	874	formed	SRR11418676	PRJNA545312	12	SRR13697235	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	1								
668Q		668	875	formed	SRR11418665	PRJNA545312	13	SRR13697234	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	1								
668R		668	876	semi-formed	SRR11419240	PRJNA545312	14	SRR13697233	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	1								
668S		668	884	formed	SRR11419229	PRJNA545312	22	SRR13697232	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	3								
668T		668	890	liquid	SRR11419218	PRJNA545312	28	SRR14092321	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	3								
668U		668	891	liquid	SRR11419179	PRJNA545312	29	SRR13697231	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	4								
668V		668	893	liquid	SRR11419168	PRJNA545312	31	SRR13697229	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	4								
668W		668	906	liquid	SRR11419017	PRJNA545312	44	SRR13697228	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	6								
668X		668	907	liquid	SRR11423178	PRJNA545312	45	SRR13697227	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	6								
668Y		668	908	liquid	SRR11419006	PRJNA545312	46	SRR14092320	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	6								
668Z		668	909	liquid	SRR11418994	PRJNA545312	47	SRR14092319	39	862	PBSC_unmodified	Multiple Myeloma	e79d84eae0b4a108703649	530	1		post	6								
669A		669	0	formed	SRR11418955	PRJNA545312	-6		4	6	cord	Leukemia	6a027ff4388633f0be9682	385	1		pre	-1								
669C		669	9	formed	SRR11418647	PRJNA545312	3		4	6	cord	Leukemia	6a027ff4388633f0be9682	385	1		peri	0								
669D		669	19	semi-formed	SRR11418496	PRJNA545312	13		4	6	cord	Leukemia	6a027ff4388633f0be9682	385	1		post	1								
669E		669	23	semi-formed	SRR11418485	PRJNA545312	17		4	6	cord	Leukemia	6a027ff4388633f0be9682	385	1		post	2								
670A		670	0	formed	SRR11418474	PRJNA545312	-6		6	6	PBSC_unmodified	Myeloproliferative Disorder	01479a8497cdea38317448	347	1		pre	-1								
670B		670	4	semi-formed	SRR11418390	PRJNA545312	-2		6	6	PBSC_unmodified	Myeloproliferative Disorder	01479a8497cdea38317448	347	1		pre	-1								
670C		670	11	formed	SRR11418379	PRJNA545312	5		6	6	PBSC_unmodified	Myeloproliferative Disorder	01479a8497cdea38317448	347	1		peri	0								
670D		670	23	formed	SRR11418852	PRJNA545312	17		6	6	PBSC_unmodified	Myeloproliferative Disorder	01479a8497cdea38317448	347	1		post	2								
670E		670	26	formed	SRR11418841	PRJNA545312	20		6	6	PBSC_unmodified	Myeloproliferative Disorder	01479a8497cdea38317448	347	1		post	2								
670F		670	218	semi-formed	SRR11418829	PRJNA545312	212		6	6	PBSC_unmodified	Myeloproliferative Disorder	01479a8497cdea38317448	347	1		post	6								
671A		671	0	formed	SRR11418790	PRJNA545312	-5		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		pre	-1								
671AA		671	53	liquid	SRR11418779	PRJNA545312	48		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	6								
671B		671	5	semi-formed	SRR11418712	PRJNA545312	0		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		peri	-1								
671BB		671	55	liquid	SRR11415491	PRJNA545312	50		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	6								
671C		671	6	liquid	SRR11415490	PRJNA545312	1		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		peri	0								
671CC		671	56	liquid	SRR11415489	PRJNA545312	51		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	6								
671DD		671	57	liquid	SRR11415487	PRJNA545312	52		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	6								
671E		671	9	liquid	SRR11415486	PRJNA545312	4		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		peri	0								
671F		671	13	semi-formed	SRR11415485	PRJNA545312	8		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	1								
671G		671	14	liquid	SRR11418701	PRJNA545312	9		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	1								
671H		671	15	liquid	SRR11418690	PRJNA545312	10		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	1								
671I		671	17	liquid	SRR11419352	PRJNA545312	12		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	1								
671J		671	18	liquid	SRR11419341	PRJNA545312	13		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	1								
671K		671	19	liquid	SRR11419131	PRJNA545312	14		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	1								
671L		671	21	semi-formed	SRR11419120	PRJNA545312	16		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	2								
671M		671	23	liquid	SRR11419108	PRJNA545312	18		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	2								
671N		671	30	formed	SRR11419041	PRJNA545312	25		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	3								
671O		671	36	formed	SRR11419030	PRJNA545312	31		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	4								
671P		671	38	semi-formed	SRR11418937	PRJNA545312	33		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	4								
671Q		671	39	semi-formed	SRR11418926	PRJNA545312	34		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	4								
671R		671	40	liquid	SRR11418915	PRJNA545312	35		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	4								
671S		671	41	semi-formed	SRR11418820	PRJNA545312	36		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	5								
671T		671	42	semi-formed	SRR11418809	PRJNA545312	37		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	5								
671U		671	44	semi-formed	SRR11419331	PRJNA545312	39		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	5								
671V		671	46	semi-formed	SRR11419320	PRJNA545312	41		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	5								
671W		671	47	semi-formed	SRR11419308	PRJNA545312	42		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	5								
671X		671	48	semi-formed	SRR11419297	PRJNA545312	43		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	6								
671Y		671	49	semi-formed	SRR11419286	PRJNA545312	44		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	6								
671Z		671	52	semi-formed	SRR11419160	PRJNA545312	47		29	5	cord	Leukemia	ff0027e7de97671e2a4218	531	1		post	6								
672A		FMT.0043	0	formed	SRR11419149	PRJNA545312	-946		13	946	BM_unmodified	Non-Hodgkin's Lymphoma	84c65590f5f94d1e4afee4		1		pre	-3								
672B		FMT.0043	5	semi-formed	SRR11419138	PRJNA545312	-941		13	946	BM_unmodified	Non-Hodgkin's Lymphoma	84c65590f5f94d1e4afee4		1		pre	-3								
672C		FMT.0043	10	semi-formed	SRR11418634	PRJNA545312	-936		13	946	BM_unmodified	Non-Hodgkin's Lymphoma	84c65590f5f94d1e4afee4		1		pre	-3								
672D		FMT.0043	13	liquid	SRR11418623	PRJNA545312	-933		13	946	BM_unmodified	Non-Hodgkin's Lymphoma	84c65590f5f94d1e4afee4		1		pre	-3								
673A		673	0	liquid	SRR11140379	PRJNA606262			2																	
673B		673	5	semi-formed	SRR11140378	PRJNA606262			2																	
674A		674	0	semi-formed	SRR11418612	PRJNA545312	-6		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	a33e55fb9388cb058f44aa	203	1		pre	-1								
674B		674	45	semi-formed	SRR11418545	PRJNA545312	39		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	a33e55fb9388cb058f44aa	203	1		post	5								
674C		674	47	semi-formed	SRR11418533	PRJNA545312	41		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	a33e55fb9388cb058f44aa	203	1		post	5								
675A		675	0	semi-formed	SRR11418421	PRJNA545312	11		1	-11	TCD	Leukemia	97af0e71545e2cb863c681	420	1		post	1								
676A		676	0	formed	SRR11418410	PRJNA545312	-10		4	10	TCD	Myeloproliferative Disorder	6c8d6db3769ef88371964f	52	1		pre	-2								
676B		676	6	semi-formed	SRR11418399	PRJNA545312	-4		4	10	TCD	Myeloproliferative Disorder	6c8d6db3769ef88371964f	52	1		pre	-1								
676C		676	13	semi-formed	SRR11418360	PRJNA545312	3		4	10	TCD	Myeloproliferative Disorder	6c8d6db3769ef88371964f	52	1		peri	0								
676D		676	21	formed	SRR11418945	PRJNA545312	11		4	10	TCD	Myeloproliferative Disorder	6c8d6db3769ef88371964f	52	1		post	1								
677A		677	0	formed	SRR11418906	PRJNA545312	-1		3	1	cord	Leukemia	c14a29539b25a382403632	522	1		pre	-1								
677B		677	13	liquid	SRR11418895	PRJNA545312	12		3	1	cord	Leukemia	c14a29539b25a382403632	522	1		post	1								
677C		677	29	semi-formed	SRR11418884	PRJNA545312	28		3	1	cord	Leukemia	c14a29539b25a382403632	522	1		post	3								
678A		678	0	formed	SRR11418761	PRJNA545312	-7		4	7	PBSC_unmodified	Hodgkin's Disease	59223d427d2bb39f80c3a7	464	1		pre	-2								
678B		678	4	liquid	SRR11418749	PRJNA545312	-3		4	7	PBSC_unmodified	Hodgkin's Disease	59223d427d2bb39f80c3a7	464	1		pre	-1								
678E		678	22	semi-formed	SRR11419212	PRJNA545312	15		4	7	PBSC_unmodified	Hodgkin's Disease	59223d427d2bb39f80c3a7	464	1		post	2								
678F		678	27	semi-formed	SRR11419201	PRJNA545312	20		4	7	PBSC_unmodified	Hodgkin's Disease	59223d427d2bb39f80c3a7	464	1		post	2								
679A		679	0	formed	SRR11419190	PRJNA545312	-8		1	8	TCD	Multiple Myeloma	014aa3b13c087d258eca40	472	1		pre	-2								
680A		680	0	formed	SRR11419067	PRJNA545312	-9		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		pre	-2								
680B		680	1	semi-formed	SRR11419056	PRJNA545312	-8		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		pre	-2								
680C		680	2	formed	SRR11418608	PRJNA545312	-7		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		pre	-2								
680D		680	3	formed	SRR11423167	PRJNA545312	-6		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		pre	-1								
680E		680	4	semi-formed	SRR11418597	PRJNA545312	-5		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		pre	-1								
680F		680	5	formed	SRR11418586	PRJNA545312	-4		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		pre	-1								
680G		680	6	semi-formed	SRR11418519	PRJNA545312	-3		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		pre	-1								
680H		680	7	liquid	SRR11418507	PRJNA545312	-2		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		pre	-1								
680I		680	8	liquid	SRR11418468	PRJNA545312	-1		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		pre	-1								
680J		680	9	semi-formed	SRR11418457	PRJNA545312	0		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		peri	-1								
680K		680	11	liquid	SRR11418446	PRJNA545312	2		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		peri	0								
680L		680	12	liquid	SRR11418874	PRJNA545312	3		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		peri	0								
680M		680	13	liquid	SRR11418863	PRJNA545312	4		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		peri	0								
680N		680	14	liquid	SRR11418740	PRJNA545312	5		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		peri	0								
680O		680	15	liquid	SRR11418729	PRJNA545312	6		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		post	0								
680P		680	16	liquid	SRR11418718	PRJNA545312	7		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		post	0								
680Q		680	18	liquid	SRR11419268	PRJNA545312	9		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		post	1								
680R		680	19	semi-formed	SRR11419256	PRJNA545312	10		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		post	1								
680S		680	20	semi-formed	SRR11419102	PRJNA545312	11		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		post	1								
680T		680	21	semi-formed	SRR11419091	PRJNA545312	12		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		post	1								
680U		680	22	formed	SRR11419080	PRJNA545312	13		21	9	TCD	Multiple Myeloma	b98bd4632e269b2017be08	447	1		post	1								
681A		681	0	formed	SRR11139999	PRJNA606262			2																	
681B		681	7	formed	SRR11139998	PRJNA606262			2																	
682A		682	0	formed	SRR11418985	PRJNA545312	1		17	-1	PBSC_unmodified	Leukemia	43c08d30584796cdbc9118	537	1		peri	0								
682B		682	1	formed	SRR11418974	PRJNA545312	2		17	-1	PBSC_unmodified	Leukemia	43c08d30584796cdbc9118	537	1		peri	0								
682C		682	2	formed	SRR11418582	PRJNA545312	3		17	-1	PBSC_unmodified	Leukemia	43c08d30584796cdbc9118	537	1		peri	0								
682D		682	3	semi-formed	SRR11418571	PRJNA545312	4		17	-1	PBSC_unmodified	Leukemia	43c08d30584796cdbc9118	537	1		peri	0								
682E		682	6	formed	SRR11418560	PRJNA545312	7		17	-1	PBSC_unmodified	Leukemia	43c08d30584796cdbc9118	537	1		post	0								
682F		682	7	semi-formed	SRR11418437	PRJNA545312	8		17	-1	PBSC_unmodified	Leukemia	43c08d30584796cdbc9118	537	1		post	1								
682G		682	9	formed	SRR11418686	PRJNA545312	10		17	-1	PBSC_unmodified	Leukemia	43c08d30584796cdbc9118	537	1		post	1								
682H		682	11	formed	SRR11418685	PRJNA545312	12		17	-1	PBSC_unmodified	Leukemia	43c08d30584796cdbc9118	537	1		post	1								
682I		682	12	semi-formed	SRR11418684	PRJNA545312	13		17	-1	PBSC_unmodified	Leukemia	43c08d30584796cdbc9118	537	1		post	1								
682J		682	15	semi-formed	SRR11418683	PRJNA545312	16		17	-1	PBSC_unmodified	Leukemia	43c08d30584796cdbc9118	537	1		post	2								
682K		682	16	semi-formed	SRR11418682	PRJNA545312	17		17	-1	PBSC_unmodified	Leukemia	43c08d30584796cdbc9118	537	1		post	2								
682L		682	17	formed	SRR11418681	PRJNA545312	18		17	-1	PBSC_unmodified	Leukemia	43c08d30584796cdbc9118	537	1		post	2								
682M		682	19	formed	SRR11418680	PRJNA545312	20		17	-1	PBSC_unmodified	Leukemia	43c08d30584796cdbc9118	537	1		post	2								
682N		682	20	formed	SRR11418679	PRJNA545312	21		17	-1	PBSC_unmodified	Leukemia	43c08d30584796cdbc9118	537	1		post	2								
682O		682	24	formed	SRR11418678	PRJNA545312	25		17	-1	PBSC_unmodified	Leukemia	43c08d30584796cdbc9118	537	1		post	3								
682P		682	26	semi-formed	SRR11418677	PRJNA545312	27		17	-1	PBSC_unmodified	Leukemia	43c08d30584796cdbc9118	537	1		post	3								
682Q		682	27	semi-formed	SRR11418675	PRJNA545312	28		17	-1	PBSC_unmodified	Leukemia	43c08d30584796cdbc9118	537	1		post	3								
684A		684	0	formed	SRR11418674	PRJNA545312	-7		6	706	PBSC_unmodified	Leukemia	2946a2ccc81549233e6af6		1		pre	-2								
684B		684	1	formed	SRR11418673	PRJNA545312	-6		6	706	PBSC_unmodified	Leukemia	2946a2ccc81549233e6af6		1		pre	-1								
684C		684	2	formed	SRR11418672	PRJNA545312	-5		6	706	PBSC_unmodified	Leukemia	2946a2ccc81549233e6af6		1		pre	-1								
684D		684	4	liquid	SRR11418671	PRJNA545312	-3		6	706	PBSC_unmodified	Leukemia	2946a2ccc81549233e6af6		1		pre	-1								
684E		684	25	semi-formed	SRR11418670	PRJNA545312	18		6	706	PBSC_unmodified	Leukemia	2946a2ccc81549233e6af6		1		post	2								
684F		684	26	formed	SRR11418669	PRJNA545312	19		6	706	PBSC_unmodified	Leukemia	2946a2ccc81549233e6af6		1		post	2								
685A		685	0	formed	SRR11140383	PRJNA606262			1																	
686A		686	0	formed	SRR11418668	PRJNA545312	-5		2	5	PBSC_unmodified	Leukemia	1135ca1001dea147d1e3de	179	1		pre	-1								
686D		686	25	semi-formed	SRR11418667	PRJNA545312	20		2	5	PBSC_unmodified	Leukemia	1135ca1001dea147d1e3de	179	1		post	2								
687A		687	0	formed	SRR11418666	PRJNA545312	-8		4	8	TCD	Multiple Myeloma	1b4518abe768d9c5073d83	113	1		pre	-2								
687B		687	3	formed	SRR11418664	PRJNA545312	-5		4	8	TCD	Multiple Myeloma	1b4518abe768d9c5073d83	113	1		pre	-1								
687C		687	9	liquid	SRR11418663	PRJNA545312	1		4	8	TCD	Multiple Myeloma	1b4518abe768d9c5073d83	113	1		peri	0								
687D		687	13	liquid	SRR11418662	PRJNA545312	5		4	8	TCD	Multiple Myeloma	1b4518abe768d9c5073d83	113	1		peri	0								
688A		688	0	formed	SRR11418661	PRJNA545312	-8		5	8	TCD	Multiple Myeloma	fa884843a743ceed3e4101	481	1		pre	-2								
688B		688	4	formed	SRR11418660	PRJNA545312	-4		5	8	TCD	Multiple Myeloma	fa884843a743ceed3e4101	481	1		pre	-1								
688C		688	11	semi-formed	SRR11418659	PRJNA545312	3		5	8	TCD	Multiple Myeloma	fa884843a743ceed3e4101	481	1		peri	0								
688D		688	20	formed	SRR11419244	PRJNA545312	12		5	8	TCD	Multiple Myeloma	fa884843a743ceed3e4101	481	1		post	1								
688E		688	34	formed	SRR11419243	PRJNA545312	26		5	8	TCD	Multiple Myeloma	fa884843a743ceed3e4101	481	1		post	3								
689A		689	0	formed	SRR11419242	PRJNA545312	-17		5	17	PBSC_unmodified	Non-Malignant Hemat Disorders	26f818d70f269b36812fd3	518	1		pre	-3								
689D		689	22	semi-formed	SRR11419241	PRJNA545312	5		5	17	PBSC_unmodified	Non-Malignant Hemat Disorders	26f818d70f269b36812fd3	518	1		peri	0								
689E		689	25	liquid	SRR11419239	PRJNA545312	8		5	17	PBSC_unmodified	Non-Malignant Hemat Disorders	26f818d70f269b36812fd3	518	1		post	1								
689F		689	33	formed	SRR11419238	PRJNA545312	16		5	17	PBSC_unmodified	Non-Malignant Hemat Disorders	26f818d70f269b36812fd3	518	1		post	2								
689I		689	72	semi-formed	SRR11419237	PRJNA545312	55		5	17	PBSC_unmodified	Non-Malignant Hemat Disorders	26f818d70f269b36812fd3	518	1		post	6								
690A		690	0	semi-formed	SRR11419236	PRJNA545312	-7		4	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	c99d5513594bd8f1a8af5b	511	1		pre	-2								
690B		690	12	liquid	SRR11419235	PRJNA545312	5		4	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	c99d5513594bd8f1a8af5b	511	1		peri	0								
690C		690	13	semi-formed	SRR11419234	PRJNA545312	6		4	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	c99d5513594bd8f1a8af5b	511	1		post	0								
690D		690	19	semi-formed	SRR11419233	PRJNA545312	12		4	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	c99d5513594bd8f1a8af5b	511	1		post	1								
691A		691	0	formed	SRR11419232	PRJNA545312	-5		4	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	db417327169b788184d8d5	327	1		pre	-1								
691B		691	4	formed	SRR11419231	PRJNA545312	-1		4	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	db417327169b788184d8d5	327	1		pre	-1								
691C		691	13	formed	SRR11419230	PRJNA545312	8		4	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	db417327169b788184d8d5	327	1		post	1								
691D		691	17	formed	SRR11419228	PRJNA545312	12		4	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	db417327169b788184d8d5	327	1		post	1								
692A		692	0	liquid	SRR11140377	PRJNA606262			1																	
694A		694	0	formed	SRR11419227	PRJNA545312	-7		4	7	TCD	Multiple Myeloma	95cfa14ea6bf022cd8bafa	428	1		pre	-2								
694B		694	7	liquid	SRR11419226	PRJNA545312	0		4	7	TCD	Multiple Myeloma	95cfa14ea6bf022cd8bafa	428	1		peri	-1								
694E		694	61	semi-formed	SRR11419225	PRJNA545312	54		4	7	TCD	Multiple Myeloma	95cfa14ea6bf022cd8bafa	428	1		post	6								
694F		694	68	formed	SRR11419224	PRJNA545312	61		4	7	TCD	Multiple Myeloma	95cfa14ea6bf022cd8bafa	428	1		post	6								
695A		695	0	formed	SRR11419223	PRJNA545312	-6		1	6	TCD	Leukemia	a0bc153a9471646c21d8e6	355	1		pre	-1								
696A		696	0	formed	SRR11419222	PRJNA545312	-7		5	7	TCD	Leukemia	48bb049d514b4daf2b2997	516	1		pre	-2								
696B		696	4	semi-formed	SRR11419221	PRJNA545312	-3		5	7	TCD	Leukemia	48bb049d514b4daf2b2997	516	1		pre	-1								
696C		696	9	semi-formed	SRR11419220	PRJNA545312	2		5	7	TCD	Leukemia	48bb049d514b4daf2b2997	516	1		peri	0								
696D		696	17	liquid	SRR11419219	PRJNA545312	10		5	7	TCD	Leukemia	48bb049d514b4daf2b2997	516	1		post	1								
696E		696	91	formed	SRR11419217	PRJNA545312	84		5	7	TCD	Leukemia	48bb049d514b4daf2b2997	516	1		post	6								
697A		697	0	formed	SRR11419188	PRJNA545312	-5		4	5	PBSC_unmodified	Leukemia	e6fe7c93ff21d5ded7c50b	540	1		pre	-1								
697B		697	4	formed	SRR11419187	PRJNA545312	-1		4	5	PBSC_unmodified	Leukemia	e6fe7c93ff21d5ded7c50b	540	1		pre	-1								
697C		697	11	formed	SRR11419186	PRJNA545312	6		4	5	PBSC_unmodified	Leukemia	e6fe7c93ff21d5ded7c50b	540	1		post	0								
697D		697	19	semi-formed	SRR11419185	PRJNA545312	14		4	5	PBSC_unmodified	Leukemia	e6fe7c93ff21d5ded7c50b	540	1		post	1								
698B		698	6	liquid	SRR11419184	PRJNA545312	0		10	1712	TCD	Multiple Myeloma	6d3b95f29974bec975cff2	460	1		peri	-1								
698C		698	9	liquid	SRR11419183	PRJNA545312	3		10	1712	TCD	Multiple Myeloma	6d3b95f29974bec975cff2	460	1		peri	0								
698D		698	11	liquid	SRR11419182	PRJNA545312	5		10	1712	TCD	Multiple Myeloma	6d3b95f29974bec975cff2	460	1		peri	0								
698E		698	14	liquid	SRR11419181	PRJNA545312	8		10	1712	TCD	Multiple Myeloma	6d3b95f29974bec975cff2	460	1		post	1								
698F		698	16	liquid	SRR11419180	PRJNA545312	10		10	1712	TCD	Multiple Myeloma	6d3b95f29974bec975cff2	460	1		post	1								
698G		698	1716	liquid	SRR11117039	PRJNA607574	4		10	1712	TCD	Multiple Myeloma	6d3b95f29974bec975cff2	460	1		peri	0								
698H		698	1717	liquid	SRR11117038	PRJNA607574	5		10	1712	TCD	Multiple Myeloma	6d3b95f29974bec975cff2	460	1		peri	0								
698I		698	1718	formed	SRR11117037	PRJNA607574	6		10	1712	TCD	Multiple Myeloma	6d3b95f29974bec975cff2	460	1		post	0								
698J		698	1719	semi-formed	SRR11117036	PRJNA607574	7		10	1712	TCD	Multiple Myeloma	6d3b95f29974bec975cff2	460	1		post	0								
698K		698	1724	semi-formed	SRR11117034	PRJNA607574	12		10	1712	TCD	Multiple Myeloma	6d3b95f29974bec975cff2	460	1		post	1								
699A		pt_with_samples_2004_699	102	liquid	SRR11419178	PRJNA545312	-3		9	105	TCD	Leukemia	9033c7cd70cd7d396cba9b	234	1		pre	-1								
699B		pt_with_samples_2004_699	109	semi-formed	SRR11419177	PRJNA545312	4		9	105	TCD	Leukemia	9033c7cd70cd7d396cba9b	234	1		peri	0								
699C		pt_with_samples_2004_699	115	semi-formed	SRR11419176	PRJNA545312	10		9	105	TCD	Leukemia	9033c7cd70cd7d396cba9b	234	1		post	1								
699D		pt_with_samples_2004_699	118	semi-formed	SRR11419175	PRJNA545312	13		9	105	TCD	Leukemia	9033c7cd70cd7d396cba9b	234	1		post	1								
699E		pt_with_samples_2004_699	774	semi-formed	SRR11419174	PRJNA545312	669		9	105	TCD	Leukemia	9033c7cd70cd7d396cba9b	234	1		post	6								
700A		FMT.0030	0	formed	SRR11419173	PRJNA545312	-8		6	839	PBSC_unmodified	Multiple Myeloma	5d052527e62335a86fcbf3	224	1		pre	-2								
700B		FMT.0030	8	semi-formed	SRR11419172	PRJNA545312	0		6	839	PBSC_unmodified	Multiple Myeloma	5d052527e62335a86fcbf3	224	1		peri	-1								
700E		FMT.0030	36	liquid	SRR11419171	PRJNA545312	28		6	839	PBSC_unmodified	Multiple Myeloma	5d052527e62335a86fcbf3	224	1		post	3								
701A		701	0	formed	SRR11419170	PRJNA545312	-6		17	6	PBSC_unmodified	Leukemia	1173dfad6eceedd566ad60	544	1		pre	-1								
701G		701	40	liquid	SRR11419169	PRJNA545312	34		17	6	PBSC_unmodified	Leukemia	1173dfad6eceedd566ad60	544	1		post	4								
701H		701	54	liquid	SRR11419167	PRJNA545312	48		17	6	PBSC_unmodified	Leukemia	1173dfad6eceedd566ad60	544	1		post	6								
701J		701	82	liquid	SRR11419166	PRJNA545312	76		17	6	PBSC_unmodified	Leukemia	1173dfad6eceedd566ad60	544	1		post	6								
701K		701	86	liquid	SRR11419165	PRJNA545312	80		17	6	PBSC_unmodified	Leukemia	1173dfad6eceedd566ad60	544	1		post	6								
701L		701	89	liquid	SRR11419164	PRJNA545312	83		17	6	PBSC_unmodified	Leukemia	1173dfad6eceedd566ad60	544	1		post	6								
701M		701	104	liquid	SRR11419163	PRJNA545312	98		17	6	PBSC_unmodified	Leukemia	1173dfad6eceedd566ad60	544	1		post	6								
701N		701	113	liquid	SRR11419162	PRJNA545312	107		17	6	PBSC_unmodified	Leukemia	1173dfad6eceedd566ad60	544	1		post	6								
701O		701	117	liquid	SRR11419161	PRJNA545312	111		17	6	PBSC_unmodified	Leukemia	1173dfad6eceedd566ad60	544	1		post	6								
701P		701	125	liquid	SRR11419020	PRJNA545312	119		17	6	PBSC_unmodified	Leukemia	1173dfad6eceedd566ad60	544	1		post	6								
701Q		701	135	liquid	SRR11419019	PRJNA545312	129		17	6	PBSC_unmodified	Leukemia	1173dfad6eceedd566ad60	544	1		post	6								
701R		701	145	liquid	SRR11419018	PRJNA545312	139		17	6	PBSC_unmodified	Leukemia	1173dfad6eceedd566ad60	544	1		post	6								
701S		701	191	liquid	SRR11419016	PRJNA545312	185		17	6	PBSC_unmodified	Leukemia	1173dfad6eceedd566ad60	544	1		post	6								
701T		701	201	semi-formed	SRR11419015	PRJNA545312	195		17	6	PBSC_unmodified	Leukemia	1173dfad6eceedd566ad60	544	1		post	6								
701U		701	211	liquid	SRR11419014	PRJNA545312	205		17	6	PBSC_unmodified	Leukemia	1173dfad6eceedd566ad60	544	1		post	6								
701V		701	213	liquid	SRR11419013	PRJNA545312	207		17	6	PBSC_unmodified	Leukemia	1173dfad6eceedd566ad60	544	1		post	6								
701W		701	242	semi-formed	SRR11419012	PRJNA545312	236		17	6	PBSC_unmodified	Leukemia	1173dfad6eceedd566ad60	544	1		post	6								
702A		702	0	semi-formed	SRR11419011	PRJNA545312	-2		4	2	TCD	Myelodysplastic Syndromes	2b6ff983b8ee2f6eee3e13	549	1		pre	-1								
702B		702	6	liquid	SRR11419010	PRJNA545312	4		4	2	TCD	Myelodysplastic Syndromes	2b6ff983b8ee2f6eee3e13	549	1		peri	0								
702C		702	13	semi-formed	SRR11419009	PRJNA545312	11		4	2	TCD	Myelodysplastic Syndromes	2b6ff983b8ee2f6eee3e13	549	1		post	1								
702D		702	20	semi-formed	SRR11419008	PRJNA545312	18		4	2	TCD	Myelodysplastic Syndromes	2b6ff983b8ee2f6eee3e13	549	1		post	2								
703A		703	0	formed	SRR11419007	PRJNA545312	-4		5	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	b46588762181e6373be3d6	507	1		pre	-1								
703B		703	4	formed	SRR11419005	PRJNA545312	0		5	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	b46588762181e6373be3d6	507	1		peri	-1								
703C		703	8	formed	SRR11419004	PRJNA545312	4		5	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	b46588762181e6373be3d6	507	1		peri	0								
703D		703	10	formed	SRR11419003	PRJNA545312	6		5	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	b46588762181e6373be3d6	507	1		post	0								
703E		703	328	formed	SRR11419002	PRJNA545312	324		5	4	PBSC_unmodified	Non-Hodgkin's Lymphoma	b46588762181e6373be3d6	507	1		post	6								
704A		704	0	formed	SRR11419001	PRJNA545312	-9		4	9	TCD	Multiple Myeloma	86c62874b5670db0d3e051	548	1		pre	-2								
704B		704	7	liquid	SRR11419000	PRJNA545312	-2		4	9	TCD	Multiple Myeloma	86c62874b5670db0d3e051	548	1		pre	-1								
704C		704	13	liquid	SRR11418999	PRJNA545312	4		4	9	TCD	Multiple Myeloma	86c62874b5670db0d3e051	548	1		peri	0								
704D		704	21	liquid	SRR11418998	PRJNA545312	12		4	9	TCD	Multiple Myeloma	86c62874b5670db0d3e051	548	1		post	1								
705A		705	0	formed	SRR11418997	PRJNA545312	-4		4	4	TCD	Multiple Myeloma	f2eaae25db57a329b763f1	166	1		pre	-1								
705B		705	1	formed	SRR11418996	PRJNA545312	-3		4	4	TCD	Multiple Myeloma	f2eaae25db57a329b763f1	166	1		pre	-1								
705C		705	8	formed	SRR11418993	PRJNA545312	4		4	4	TCD	Multiple Myeloma	f2eaae25db57a329b763f1	166	1		peri	0								
705D		705	15	formed	SRR11418964	PRJNA545312	11		4	4	TCD	Multiple Myeloma	f2eaae25db57a329b763f1	166	1		post	1								
706A		706	0	formed	SRR11140380	PRJNA606262			1																	
707D		707	17	formed	SRR11418963	PRJNA545312	17		1	0	TCD	Multiple Myeloma	e3072e63d76d3907b066ea	125	1		post	2								
708A		708	0	formed	SRR11418962	PRJNA545312	-10		3	10	TCD	Myelodysplastic Syndromes	b684cc474eb07b3f830fa5	90	1		pre	-2								
708B		708	6	semi-formed	SRR11418961	PRJNA545312	-4		3	10	TCD	Myelodysplastic Syndromes	b684cc474eb07b3f830fa5	90	1		pre	-1								
708D		708	20	formed	SRR11418960	PRJNA545312	10		3	10	TCD	Myelodysplastic Syndromes	b684cc474eb07b3f830fa5	90	1		post	1								
709B		709	3	semi-formed	SRR11140501	PRJNA606262			2																	
709C		709	17	liquid	SRR11140500	PRJNA606262			2																	
710A		710	0	liquid	SRR11418959	PRJNA545312	-42		3	42	TCD	Myeloproliferative Disorder	8519493331f1ce5744fe59	493	1		pre	-3								
710B		710	34	semi-formed	SRR11418958	PRJNA545312	-8		3	42	TCD	Myeloproliferative Disorder	8519493331f1ce5744fe59	493	1		pre	-2								
710C		710	38	formed	SRR11418957	PRJNA545312	-4		3	42	TCD	Myeloproliferative Disorder	8519493331f1ce5744fe59	493	1		pre	-1								
711A		711	0	formed	SRR11418956	PRJNA545312	-8		2	8	TCD	Leukemia	c66ab320534348518b5a3c	550	1		pre	-2								
711B		711	12	liquid	SRR11418954	PRJNA545312	4		2	8	TCD	Leukemia	c66ab320534348518b5a3c	550	1		peri	0								
712A		FMT.0156	0	formed	SRR11418953	PRJNA545312	-1179		10	1179	PBSC_unmodified	Non-Hodgkin's Lymphoma	526aebc43dfbdf54276c6f		1											
712B		FMT.0156	8	semi-formed	SRR11423128	PRJNA545312	-1171		10	1179	PBSC_unmodified	Non-Hodgkin's Lymphoma	526aebc43dfbdf54276c6f		1											
712C		FMT.0156	91	semi-formed	SRR11418952	PRJNA545312	-1088		10	1179	PBSC_unmodified	Non-Hodgkin's Lymphoma	526aebc43dfbdf54276c6f		1											
713C		713	12	semi-formed	SRR11418951	PRJNA545312	5		2	7	cord	Leukemia	fc156b3669a573971cdef6	7	1		peri	0								
713E		713	25	formed	SRR11418355	PRJNA545312	18		2	7	cord	Leukemia	fc156b3669a573971cdef6	7	1		post	2								
714A		714	0	liquid	SRR11418652	PRJNA545312	-7		4	7	TCD	Leukemia	52b82a54f3e9c98d20c70e	529	1		pre	-2								
714B		714	9	liquid	SRR11418651	PRJNA545312	2		4	7	TCD	Leukemia	52b82a54f3e9c98d20c70e	529	1		peri	0								
714C		714	11	liquid	SRR11418650	PRJNA545312	4		4	7	TCD	Leukemia	52b82a54f3e9c98d20c70e	529	1		peri	0								
714D		714	18	semi-formed	SRR11418649	PRJNA545312	11		4	7	TCD	Leukemia	52b82a54f3e9c98d20c70e	529	1		post	1								
715A		715	0	semi-formed	SRR11140374	PRJNA606262			1																	
716A		716	0	formed	SRR11418648	PRJNA545312	-2		3	2	PBSC_unmodified	Myelodysplastic Syndromes	2f68a3fae9d8f5f838436d	19	1		pre	-1								
716B		716	8	semi-formed	SRR11418646	PRJNA545312	6		3	2	PBSC_unmodified	Myelodysplastic Syndromes	2f68a3fae9d8f5f838436d	19	1		post	0								
716C		716	309	formed	SRR11418645	PRJNA545312	307		3	2	PBSC_unmodified	Myelodysplastic Syndromes	2f68a3fae9d8f5f838436d	19	1		post	6								
717A		717	0	formed	SRR11418644	PRJNA545312	-9		1	9	TCD	Myelodysplastic Syndromes	14f66d11df5eca834e4355	553	1		pre	-2								
718A		718	0	formed	SRR11140319	PRJNA606262			3																	
718B		718	6	formed	SRR11140308	PRJNA606262			3																	
718C		718	13	liquid	SRR11140296	PRJNA606262			3																	
719A		719	0	formed	SRR11418643	PRJNA545312	-5		9	5	PBSC_unmodified	Leukemia	9ab4cbfdcf60cbe25d0900	502	1		pre	-1								
719B		719	3	semi-formed	SRR11418642	PRJNA545312	-2		9	5	PBSC_unmodified	Leukemia	9ab4cbfdcf60cbe25d0900	502	1		pre	-1								
719C		719	10	liquid	SRR11418641	PRJNA545312	5		9	5	PBSC_unmodified	Leukemia	9ab4cbfdcf60cbe25d0900	502	1		peri	0								
719D		719	12	liquid	SRR11418640	PRJNA545312	7		9	5	PBSC_unmodified	Leukemia	9ab4cbfdcf60cbe25d0900	502	1		post	0								
719E		719	15	liquid	SRR11418499	PRJNA545312	10		9	5	PBSC_unmodified	Leukemia	9ab4cbfdcf60cbe25d0900	502	1		post	1								
719F		719	22	semi-formed	SRR11418498	PRJNA545312	17		9	5	PBSC_unmodified	Leukemia	9ab4cbfdcf60cbe25d0900	502	1		post	2								
719G		719	498	formed	SRR11418497	PRJNA545312	493		9	5	PBSC_unmodified	Leukemia	9ab4cbfdcf60cbe25d0900	502	1		post	6								
719H		719	512	semi-formed	SRR11418495	PRJNA545312	507		9	5	PBSC_unmodified	Leukemia	9ab4cbfdcf60cbe25d0900	502	1		post	6								
719I		719	533	semi-formed	SRR11418494	PRJNA545312	528		9	5	PBSC_unmodified	Leukemia	9ab4cbfdcf60cbe25d0900	502	1		post	6								
720A		720	0	liquid	SRR11418493	PRJNA545312	-1		3	1	TCD	Myelodysplastic Syndromes	7e97881d5d01856bdaad30	546	1		pre	-1								
720B		720	1	liquid	SRR11418492	PRJNA545312	0		3	1	TCD	Myelodysplastic Syndromes	7e97881d5d01856bdaad30	546	1		peri	-1								
720C		720	6	liquid	SRR11418491	PRJNA545312	5		3	1	TCD	Myelodysplastic Syndromes	7e97881d5d01856bdaad30	546	1		peri	0								
721A		721	0	formed	SRR11418490	PRJNA545312	-8		3	8	TCD	Leukemia	d6538fcbfa44cac7582c38	562	1		pre	-2								
721B		721	19	liquid	SRR11418489	PRJNA545312	11		3	8	TCD	Leukemia	d6538fcbfa44cac7582c38	562	1		post	1								
721C		721	20	liquid	SRR11418488	PRJNA545312	12		3	8	TCD	Leukemia	d6538fcbfa44cac7582c38	562	1		post	1								
722A		722	0	formed	SRR11418487	PRJNA545312	-9		2	9	TCD	Myelodysplastic Syndromes	425228cf1cdfcdb37ef880	434	1		pre	-2								
722B		722	23	liquid	SRR11418486	PRJNA545312	14		2	9	TCD	Myelodysplastic Syndromes	425228cf1cdfcdb37ef880	434	1		post	1								
723A		723	0	formed	SRR11418484	PRJNA545312	-4		4	385	PBSC_unmodified	Myeloproliferative Disorder	45e79823a8eea955b9818f	94	1		pre	-1								
723E		723	31	liquid	SRR11418483	PRJNA545312	27		4	385	PBSC_unmodified	Myeloproliferative Disorder	45e79823a8eea955b9818f	94	1		post	3								
723G		723	381	formed	SRR11418482	PRJNA545312	-4		4	385	PBSC_unmodified	Myeloproliferative Disorder	45e79823a8eea955b9818f	94	1		pre	-1								
723H		723	395	liquid	SRR11418481	PRJNA545312	10		4	385	PBSC_unmodified	Myeloproliferative Disorder	45e79823a8eea955b9818f	94	1		post	1								
724A		724	0	formed	SRR11418480	PRJNA545312	-10		1	10	TCD	Leukemia	66daa587ce765ae0f5571b	9	1		pre	-2								
725A		725	0	liquid	SRR11418479	PRJNA545312	0		9	0	cord	Leukemia	b0b69f83d67b2617fd1cd4	566	1		peri	-1								
725B		725	2	semi-formed	SRR11418478	PRJNA545312	2		9	0	cord	Leukemia	b0b69f83d67b2617fd1cd4	566	1		peri	0								
725C		725	5	liquid	SRR11418477	PRJNA545312	5		9	0	cord	Leukemia	b0b69f83d67b2617fd1cd4	566	1		peri	0								
725D		725	12	formed	SRR11418476	PRJNA545312	12		9	0	cord	Leukemia	b0b69f83d67b2617fd1cd4	566	1		post	1								
725E		725	20	semi-formed	SRR11418475	PRJNA545312	20		9	0	cord	Leukemia	b0b69f83d67b2617fd1cd4	566	1		post	2								
725F		725	28	liquid	SRR11418473	PRJNA545312	28		9	0	cord	Leukemia	b0b69f83d67b2617fd1cd4	566	1		post	3								
725G		725	33	semi-formed	SRR11418472	PRJNA545312	33		9	0	cord	Leukemia	b0b69f83d67b2617fd1cd4	566	1		post	4								
725H		725	51	formed	SRR11418398	PRJNA545312	51		9	0	cord	Leukemia	b0b69f83d67b2617fd1cd4	566	1		post	6								
725I		725	68	formed	SRR11418397	PRJNA545312	68		9	0	cord	Leukemia	b0b69f83d67b2617fd1cd4	566	1		post	6								
726A		726	0	formed	SRR11418396	PRJNA545312	-9		4	9	BM_unmodified	Leukemia	87cce83356765a5017d109	15	1		pre	-2								
726B		726	5	semi-formed	SRR11418395	PRJNA545312	-4		4	9	BM_unmodified	Leukemia	87cce83356765a5017d109	15	1		pre	-1								
726C		726	12	liquid	SRR11418394	PRJNA545312	3		4	9	BM_unmodified	Leukemia	87cce83356765a5017d109	15	1		peri	0								
726D		726	19	semi-formed	SRR11418393	PRJNA545312	10		4	9	BM_unmodified	Leukemia	87cce83356765a5017d109	15	1		post	1								
727A		727	0	formed	SRR11418392	PRJNA545312	-196		6	196	TCD	Multiple Myeloma	d33c51b6d12f87a17ae779	83	1		pre	-3								
727B		727	187	formed	SRR11418391	PRJNA545312	-9		6	196	TCD	Multiple Myeloma	d33c51b6d12f87a17ae779	83	1		pre	-2								
727C		727	195	semi-formed	SRR11418389	PRJNA545312	-1		6	196	TCD	Multiple Myeloma	d33c51b6d12f87a17ae779	83	1		pre	-1								
727D		727	201	liquid	SRR11418388	PRJNA545312	5		6	196	TCD	Multiple Myeloma	d33c51b6d12f87a17ae779	83	1		peri	0								
727E		727	207	semi-formed	SRR11418387	PRJNA545312	11		6	196	TCD	Multiple Myeloma	d33c51b6d12f87a17ae779	83	1		post	1								
727F		727	467	liquid	SRR11418386	PRJNA545312	271		6	196	TCD	Multiple Myeloma	d33c51b6d12f87a17ae779	83	1		post	6								
728A		728	0	formed	SRR11418385	PRJNA545312	3		6	-3	PBSC_unmodified	Leukemia	672cd93857580164aa4b77	539	1		peri	0								
728B		728	5	semi-formed	SRR11418384	PRJNA545312	8		6	-3	PBSC_unmodified	Leukemia	672cd93857580164aa4b77	539	1		post	1								
728C		728	12	formed	SRR11418383	PRJNA545312	15		6	-3	PBSC_unmodified	Leukemia	672cd93857580164aa4b77	539	1		post	2								
728D		728	502	formed	SRR11418382	PRJNA545312	505		6	-3	PBSC_unmodified	Leukemia	672cd93857580164aa4b77	539	1		post	6								
728E		728	794	semi-formed	SRR11418381	PRJNA545312	797		6	-3	PBSC_unmodified	Leukemia	672cd93857580164aa4b77	539	1		post	6								
728F		728	868	semi-formed	SRR11418380	PRJNA545312	871		6	-3	PBSC_unmodified	Leukemia	672cd93857580164aa4b77	539	1		post	6								
729A		729	0	formed	SRR11418378	PRJNA545312	-7		9	381	PBSC_unmodified	Myeloproliferative Disorder	c50f3af03bfb6690ceb125	559	1		pre	-2								
729B		729	3	formed	SRR11418377	PRJNA545312	-4		9	381	PBSC_unmodified	Myeloproliferative Disorder	c50f3af03bfb6690ceb125	559	1		pre	-1								
729E		729	24	formed	SRR11418376	PRJNA545312	17		9	381	PBSC_unmodified	Myeloproliferative Disorder	c50f3af03bfb6690ceb125	559	1		post	2								
729F		729	31	formed	SRR11418375	PRJNA545312	24		9	381	PBSC_unmodified	Myeloproliferative Disorder	c50f3af03bfb6690ceb125	559	1		post	3								
729G		729	45	semi-formed	SRR11418374	PRJNA545312	38		9	381	PBSC_unmodified	Myeloproliferative Disorder	c50f3af03bfb6690ceb125	559	1		post	5								
729I		729	150	formed	SRR11418373	PRJNA545312	143		9	381	PBSC_unmodified	Myeloproliferative Disorder	c50f3af03bfb6690ceb125	559	1		post	6								
729J		729	376	formed	SRR11418372	PRJNA545312	-5		9	381	PBSC_unmodified	Myeloproliferative Disorder	c50f3af03bfb6690ceb125	559	1		pre	-1								
729K		729	385	semi-formed	SRR11418371	PRJNA545312	4		9	381	PBSC_unmodified	Myeloproliferative Disorder	c50f3af03bfb6690ceb125	559	1		peri	0								
729L		729	388	semi-formed	SRR11418854	PRJNA545312	7		9	381	PBSC_unmodified	Myeloproliferative Disorder	c50f3af03bfb6690ceb125	559	1		post	0								
730A		730	0	semi-formed	SRR11418853	PRJNA545312	-4		3	4	TCD	Multiple Myeloma	80486a19e07d98d3d2b9fb	497	1		pre	-1								
730B		730	1	formed	SRR11418851	PRJNA545312	-3		3	4	TCD	Multiple Myeloma	80486a19e07d98d3d2b9fb	497	1		pre	-1								
730C		730	8	semi-formed	SRR11418850	PRJNA545312	4		3	4	TCD	Multiple Myeloma	80486a19e07d98d3d2b9fb	497	1		peri	0								
731A		731	0	semi-formed	SRR11418849	PRJNA545312	4		2	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	644a7bb18bfa31897eaec6	396	1		peri	0								
731B		731	1	semi-formed	SRR11418848	PRJNA545312	5		2	-4	PBSC_unmodified	Non-Hodgkin's Lymphoma	644a7bb18bfa31897eaec6	396	1		peri	0								
732A		732	0	liquid	SRR11418847	PRJNA545312	1		1	-1	TCD	Aplastic Anemia	c415fabbb8b86e3d4bf1f6	470	1		peri	0								
733A		733	0	formed	SRR11418846	PRJNA545312	-9		3	9	TCD	Leukemia	18ca41b91519988a5913f3	564	1		pre	-2								
733B		733	5	liquid	SRR11418845	PRJNA545312	-4		3	9	TCD	Leukemia	18ca41b91519988a5913f3	564	1		pre	-1								
733D		733	15	semi-formed	SRR11418844	PRJNA545312	6		3	9	TCD	Leukemia	18ca41b91519988a5913f3	564	1		post	0								
734A		734	0	formed	SRR11418843	PRJNA545312	-6		5	6	TCD	Leukemia	92837ff4a34231ed9489a5	22	1		pre	-1								
734B		734	90	formed	SRR11418842	PRJNA545312	84		5	6	TCD	Leukemia	92837ff4a34231ed9489a5	22	1		post	6								
734C		734	95	formed	SRR11418840	PRJNA545312	89		5	6	TCD	Leukemia	92837ff4a34231ed9489a5	22	1		post	6								
734D		734	104	formed	SRR11418839	PRJNA545312	98		5	6	TCD	Leukemia	92837ff4a34231ed9489a5	22	1		post	6								
734E		734	109	formed	SRR11418838	PRJNA545312	103		5	6	TCD	Leukemia	92837ff4a34231ed9489a5	22	1		post	6								
735A		735	0	formed	SRR11418837	PRJNA545312	-6		4	6	cord	Leukemia	d9352d5bfcfe3a40abfd6a	560	1		pre	-1								
735B		735	8	semi-formed	SRR11418836	PRJNA545312	2		4	6	cord	Leukemia	d9352d5bfcfe3a40abfd6a	560	1		peri	0								
735C		735	19	semi-formed	SRR11418835	PRJNA545312	13		4	6	cord	Leukemia	d9352d5bfcfe3a40abfd6a	560	1		post	1								
735D		735	45	formed	SRR11418834	PRJNA545312	39		4	6	cord	Leukemia	d9352d5bfcfe3a40abfd6a	560	1		post	5								
736A		736	0	formed	SRR11418833	PRJNA545312	-3		6	3	TCD	Leukemia	581d62c13e0d03e6c2824e	557	1		pre	-1								
736B		736	10	liquid	SRR11418832	PRJNA545312	7		6	3	TCD	Leukemia	581d62c13e0d03e6c2824e	557	1		post	0								
736C		736	14	liquid	SRR11418831	PRJNA545312	11		6	3	TCD	Leukemia	581d62c13e0d03e6c2824e	557	1		post	1								
736D		736	25	semi-formed	SRR11418828	PRJNA545312	22		6	3	TCD	Leukemia	581d62c13e0d03e6c2824e	557	1		post	3								
736E		736	87	semi-formed	SRR11418827	PRJNA545312	84		6	3	TCD	Leukemia	581d62c13e0d03e6c2824e	557	1		post	6								
736F		736	91	formed	SRR11418798	PRJNA545312	88		6	3	TCD	Leukemia	581d62c13e0d03e6c2824e	557	1		post	6								
737A		pt_with_samples_2011_737	95	formed	SRR11418797	PRJNA545312	-5		9	100	PBSC_unmodified	Leukemia	c9357549047f75c9059642	512	1		pre	-1								
737B		pt_with_samples_2011_737	99	liquid	SRR11418796	PRJNA545312	-1		9	100	PBSC_unmodified	Leukemia	c9357549047f75c9059642	512	1		pre	-1								
737C		pt_with_samples_2011_737	105	liquid	SRR11418795	PRJNA545312	5		9	100	PBSC_unmodified	Leukemia	c9357549047f75c9059642	512	1		peri	0								
737D		pt_with_samples_2011_737	129	liquid	SRR11418794	PRJNA545312	29		9	100	PBSC_unmodified	Leukemia	c9357549047f75c9059642	512	1		post	4								
737E		pt_with_samples_2011_737	211	semi-formed	SRR11418793	PRJNA545312	111		9	100	PBSC_unmodified	Leukemia	c9357549047f75c9059642	512	1		post	6								
737F		pt_with_samples_2011_737	218	liquid	SRR11418792	PRJNA545312	118		9	100	PBSC_unmodified	Leukemia	c9357549047f75c9059642	512	1		post	6								
737G		pt_with_samples_2011_737	238	semi-formed	SRR11418791	PRJNA545312	138		9	100	PBSC_unmodified	Leukemia	c9357549047f75c9059642	512	1		post	6								
738A		738	0	semi-formed	SRR11418789	PRJNA545312	-8		3	8	TCD	Myelodysplastic Syndromes	81c9394244bd8e323b0835	295	1		pre	-2								
738B		738	5	semi-formed	SRR11418788	PRJNA545312	-3		3	8	TCD	Myelodysplastic Syndromes	81c9394244bd8e323b0835	295	1		pre	-1								
738C		738	8	semi-formed	SRR11418787	PRJNA545312	0		3	8	TCD	Myelodysplastic Syndromes	81c9394244bd8e323b0835	295	1		peri	-1								
739A		739	0	formed	SRR11418786	PRJNA545312			10																	
739B		739	5	formed	SRR11418785	PRJNA545312			10																	
739E		739	28	formed	SRR11418784	PRJNA545312			10																	
739F		739	32	formed	SRR11418783	PRJNA545312			10																	
739G		739	42	formed	SRR11418782	PRJNA545312			10																	
739H		739	46	semi-formed	SRR11418781	PRJNA545312			10																	
739I		739	55	semi-formed	SRR11418780	PRJNA545312			10																	
739J		739	63	liquid	SRR11418778	PRJNA545312			10																	
739K		739	81	formed	SRR11418777	PRJNA545312			10																	
739M		739	271	liquid	SRR11418776	PRJNA545312			10																	
740A		740	0	formed	SRR11418775	PRJNA545312	-8		3	8	TCD	Multiple Myeloma	c7281bd3a5911e0c9d10a0	121	1		pre	-2								
740B		740	4	liquid	SRR11418774	PRJNA545312	-4		3	8	TCD	Multiple Myeloma	c7281bd3a5911e0c9d10a0	121	1		pre	-1								
740C		740	11	liquid	SRR11418773	PRJNA545312	3		3	8	TCD	Multiple Myeloma	c7281bd3a5911e0c9d10a0	121	1		peri	0								
741A		741	0	liquid	SRR11418772	PRJNA545312	1		3	-1	TCD	Myelodysplastic Syndromes	0c75f87cd5183b38b2074f	545	1		peri	0								
741B		741	7	semi-formed	SRR11418771	PRJNA545312	8		3	-1	TCD	Myelodysplastic Syndromes	0c75f87cd5183b38b2074f	545	1		post	1								
741C		741	12	formed	SRR11418714	PRJNA545312	13		3	-1	TCD	Myelodysplastic Syndromes	0c75f87cd5183b38b2074f	545	1		post	1								
742A		742	0	formed	SRR11418713	PRJNA545312	-6		3	6	TCD	Myeloproliferative Disorder	61f494490393a838fa739e	108	1		pre	-1								
742C		742	23	semi-formed	SRR11418711	PRJNA545312	17		3	6	TCD	Myeloproliferative Disorder	61f494490393a838fa739e	108	1		post	2								
742E		742	82	formed	SRR11418710	PRJNA545312	76		3	6	TCD	Myeloproliferative Disorder	61f494490393a838fa739e	108	1		post	6								
743A		743	0	semi-formed	SRR11418709	PRJNA545312	-9		3	9	TCD	Multiple Myeloma	ca85db5e2f5f9cf3199699	558	1		pre	-2								
743B		743	8	liquid	SRR11418708	PRJNA545312	-1		3	9	TCD	Multiple Myeloma	ca85db5e2f5f9cf3199699	558	1		pre	-1								
743E		743	209	formed	SRR11418707	PRJNA545312	200		3	9	TCD	Multiple Myeloma	ca85db5e2f5f9cf3199699	558	1		post	6								
744A		744	0	formed	SRR11418706	PRJNA545312	-9		4	9	TCD	Leukemia	9df1ba1c0643919a34f123	568	1		pre	-2								
744B		744	5	semi-formed	SRR11418705	PRJNA545312	-4		4	9	TCD	Leukemia	9df1ba1c0643919a34f123	568	1		pre	-1								
744C		744	21	semi-formed	SRR11418704	PRJNA545312	12		4	9	TCD	Leukemia	9df1ba1c0643919a34f123	568	1		post	1								
744D		744	419	formed	SRR11418703	PRJNA545312	410		4	9	TCD	Leukemia	9df1ba1c0643919a34f123	568	1		post	6								
745A		745	0	semi-formed	SRR11140110	PRJNA606262			1																	
746B		746	4	liquid	SRR11418700	PRJNA545312	9		2	-5	TCD	Leukemia	e9de0a372632652230dc13	572	1		post	1								
746C		746	8	semi-formed	SRR11418699	PRJNA545312	13		2	-5	TCD	Leukemia	e9de0a372632652230dc13	572	1		post	1								
747A		747	0	formed	SRR11418698	PRJNA545312	-4		2	4	TCD	Leukemia	f42732993302412072f060	381	1		pre	-1								
747B		747	1	formed	SRR11418697	PRJNA545312	-3		2	4	TCD	Leukemia	f42732993302412072f060	381	1		pre	-1								
748A		pt_with_samples_2008_748	154	semi-formed	SRR11418696	PRJNA545312	-2		5	156	TCD	Leukemia	418820a546187e47878824	554	1		pre	-1								
748B		pt_with_samples_2008_748	158	liquid	SRR11418695	PRJNA545312	2		5	156	TCD	Leukemia	418820a546187e47878824	554	1		peri	0								
748C		pt_with_samples_2008_748	167	liquid	SRR11415484	PRJNA545312	11		5	156	TCD	Leukemia	418820a546187e47878824	554	1		post	1								
749B		749	9	semi-formed	SRR11415483	PRJNA545312	-5		6	14	cord	Myelodysplastic Syndromes	c8856bbb17648144364e4e	46	1		pre	-1								
749C		749	18	liquid	SRR11415482	PRJNA545312	4		6	14	cord	Myelodysplastic Syndromes	c8856bbb17648144364e4e	46	1		peri	0								
749D		749	31	liquid	SRR11415480	PRJNA545312	17		6	14	cord	Myelodysplastic Syndromes	c8856bbb17648144364e4e	46	1		post	2								
749E		749	34	semi-formed	SRR11415479	PRJNA545312	20		6	14	cord	Myelodysplastic Syndromes	c8856bbb17648144364e4e	46	1		post	2								
749F		749	38	liquid	SRR11415478	PRJNA545312	24		6	14	cord	Myelodysplastic Syndromes	c8856bbb17648144364e4e	46	1		post	3								
749G		749	39	liquid	SRR11415937	PRJNA545312	25		6	14	cord	Myelodysplastic Syndromes	c8856bbb17648144364e4e	46	1		post	3								
750A		750	0	formed	SRR11415936	PRJNA545312	-6		2	6	PBSC_unmodified	Leukemia	b460b77e4dd56944161cfa		1		pre	-1								
750B		750	13	semi-formed	SRR11415935	PRJNA545312	7		2	6	PBSC_unmodified	Leukemia	b460b77e4dd56944161cfa		1		post	0								
751A		751	0	formed	SRR11415934	PRJNA545312	-8		4	8	TCD	Myelodysplastic Syndromes	55dd110dd199a8271cf331	147	1		pre	-2								
751B		751	9	formed	SRR11415933	PRJNA545312	1		4	8	TCD	Myelodysplastic Syndromes	55dd110dd199a8271cf331	147	1		peri	0								
751C		751	14	formed	SRR11415932	PRJNA545312	6		4	8	TCD	Myelodysplastic Syndromes	55dd110dd199a8271cf331	147	1		post	0								
751D		751	20	liquid	SRR11415931	PRJNA545312	12		4	8	TCD	Myelodysplastic Syndromes	55dd110dd199a8271cf331	147	1		post	1								
752A		752	0	semi-formed	SRR11415929	PRJNA545312	-7		9	425	cord	Leukemia	64b4087289eafa9eaf57ae	577	1		pre	-2								
752B		752	5	liquid	SRR11415928	PRJNA545312	-2		9	425	cord	Leukemia	64b4087289eafa9eaf57ae	577	1		pre	-1								
752D		752	17	liquid	SRR11415927	PRJNA545312	10		9	425	cord	Leukemia	64b4087289eafa9eaf57ae	577	1		post	1								
752E		752	22	semi-formed	SRR11415926	PRJNA545312	15		9	425	cord	Leukemia	64b4087289eafa9eaf57ae	577	1		post	2								
752F		752	422	formed	SRR11415925	PRJNA545312	-3		9	425	cord	Leukemia	64b4087289eafa9eaf57ae	577	1		pre	-1								
752G		752	427	liquid	SRR11415924	PRJNA545312	2		9	425	cord	Leukemia	64b4087289eafa9eaf57ae	577	1		peri	0								
752H		752	433	liquid	SRR11415923	PRJNA545312	8		9	425	cord	Leukemia	64b4087289eafa9eaf57ae	577	1		post	1								
752I		752	439	semi-formed	SRR11415922	PRJNA545312	14		9	425	cord	Leukemia	64b4087289eafa9eaf57ae	577	1		post	1								
752J		752	458	formed	SRR11415921	PRJNA545312	33		9	425	cord	Leukemia	64b4087289eafa9eaf57ae	577	1		post	4								
753A		753	0	formed	SRR11415920	PRJNA545312	-8		2	8	TCD	Myelodysplastic Syndromes	543380a92ebb339e64a114	556	1		pre	-2								
753D		753	28	formed	SRR11415918	PRJNA545312	20		2	8	TCD	Myelodysplastic Syndromes	543380a92ebb339e64a114	556	1		post	2								
754A		754	0	semi-formed	SRR11415917	PRJNA545312	-2		3	2	TCD	Multiple Myeloma	93a7cbe6e365801b2f359f	575	1		pre	-1								
754B		754	7	liquid	SRR11415916	PRJNA545312	5		3	2	TCD	Multiple Myeloma	93a7cbe6e365801b2f359f	575	1		peri	0								
754D		754	967	semi-formed	SRR11415915	PRJNA545312	965		3	2	TCD	Multiple Myeloma	93a7cbe6e365801b2f359f	575	1		post	6								
755A		755	0	formed	SRR11415914	PRJNA545312	-6		4	6	PBSC_unmodified	Leukemia	b5f7f8aaf7d79c7a76c362	444	1		pre	-1								
755B		755	6	liquid	SRR11415913	PRJNA545312	0		4	6	PBSC_unmodified	Leukemia	b5f7f8aaf7d79c7a76c362	444	1		peri	-1								
755C		755	9	liquid	SRR11415912	PRJNA545312	3		4	6	PBSC_unmodified	Leukemia	b5f7f8aaf7d79c7a76c362	444	1		peri	0								
755D		755	23	liquid	SRR11415911	PRJNA545312	17		4	6	PBSC_unmodified	Leukemia	b5f7f8aaf7d79c7a76c362	444	1		post	2								
756A		756	0	liquid	SRR11140116	PRJNA606262			1																	
757A		757	0	formed	SRR11415910	PRJNA545312	-9		3	9	TCD	Multiple Myeloma	9c0b0989fb38cfdca88908	100	0		pre	-2								
757B		757	7	semi-formed	SRR11415724	PRJNA545312	-2		3	9	TCD	Multiple Myeloma	9c0b0989fb38cfdca88908	100	0		pre	-1								
757C		757	20	semi-formed	SRR11415722	PRJNA545312	11		3	9	TCD	Multiple Myeloma	9c0b0989fb38cfdca88908	100	0		post	1								
758A		758	0	formed	SRR11415721	PRJNA545312	-10		1	10	TCD	Multiple Myeloma	380f3f1cfa1b252c1071da	371	1		pre	-2								
759A		pt_with_samples_2003_759	250	formed	SRR11415720	PRJNA545312	3		7	247	PBSC_unmodified	Leukemia	9e0a047aec2c41fbe0b7c1	547	1		peri	0								
759B		pt_with_samples_2003_759	266	semi-formed	SRR11415719	PRJNA545312	19		7	247	PBSC_unmodified	Leukemia	9e0a047aec2c41fbe0b7c1	547	1		post	2								
760A		pt_with_samples_2019_760	54	semi-formed	SRR11415718	PRJNA545312	-3		5	57	TCD	Leukemia	cf7566327c93ce1dca4b4a	541	1		pre	-1								
760B		pt_with_samples_2019_760	62	liquid	SRR11415717	PRJNA545312	5		5	57	TCD	Leukemia	cf7566327c93ce1dca4b4a	541	1		peri	0								
760C		pt_with_samples_2019_760	69	liquid	SRR11415716	PRJNA545312	12		5	57	TCD	Leukemia	cf7566327c93ce1dca4b4a	541	1		post	1								
761A		761	0	formed	SRR11415715	PRJNA545312	-3		2	3	BM_unmodified	Leukemia	f522d632906af2a1e513c3	335	1		pre	-1								
761B		761	16	formed	SRR11415714	PRJNA545312	13		2	3	BM_unmodified	Leukemia	f522d632906af2a1e513c3	335	1		post	1								
762A		762	0	liquid	SRR11415713	PRJNA545312	-3		8	3	TCD	Leukemia	959150ebac091e45545f7a	580	1		pre	-1								
762B		762	7	liquid	SRR11415711	PRJNA545312	4		8	3	TCD	Leukemia	959150ebac091e45545f7a	580	1		peri	0								
762C		762	14	semi-formed	SRR11415710	PRJNA545312	11		8	3	TCD	Leukemia	959150ebac091e45545f7a	580	1		post	1								
762D		762	23	liquid	SRR11415305	PRJNA545312	20		8	3	TCD	Leukemia	959150ebac091e45545f7a	580	1		post	2								
762E		762	25	semi-formed	SRR11415601	PRJNA545312	22		8	3	TCD	Leukemia	959150ebac091e45545f7a	580	1		post	3								
762F		762	37	semi-formed	SRR11415600	PRJNA545312	34		8	3	TCD	Leukemia	959150ebac091e45545f7a	580	1		post	4								
762G		762	40	formed	SRR11415599	PRJNA545312	37		8	3	TCD	Leukemia	959150ebac091e45545f7a	580	1		post	5								
762H		762	42	semi-formed	SRR11415598	PRJNA545312	39		8	3	TCD	Leukemia	959150ebac091e45545f7a	580	1		post	5								
763A		763	0	formed	SRR11140421	PRJNA606262			1																	
764A		764	0	liquid	SRR11415597	PRJNA545312	-1		3	1	cord	Non-Hodgkin's Lymphoma	934c007e8cadb880175933	122	1		pre	-1								
764B		764	5	semi-formed	SRR11415596	PRJNA545312	4		3	1	cord	Non-Hodgkin's Lymphoma	934c007e8cadb880175933	122	1		peri	0								
764C		764	19	formed	SRR11415595	PRJNA545312	18		3	1	cord	Non-Hodgkin's Lymphoma	934c007e8cadb880175933	122	1		post	2								
765A		765	0	formed	SRR11415593	PRJNA545312	-2		3	2	TCD	Leukemia	bcc02db27c0f4daf97f57a	585	1		pre	-1								
765B		765	7	liquid	SRR11415592	PRJNA545312	5		3	2	TCD	Leukemia	bcc02db27c0f4daf97f57a	585	1		peri	0								
765C		765	46	semi-formed	SRR11415591	PRJNA545312	44		3	2	TCD	Leukemia	bcc02db27c0f4daf97f57a	585	1		post	6								
766A		766	0	formed	SRR11415590	PRJNA545312	-6		3	6	TCD	Myelodysplastic Syndromes	226ae80381e4140b8d4ce2	127	1		pre	-1								
766B		766	2	formed	SRR11415853	PRJNA545312	-4		3	6	TCD	Myelodysplastic Syndromes	226ae80381e4140b8d4ce2	127	1		pre	-1								
766C		766	21	semi-formed	SRR11415852	PRJNA545312	15		3	6	TCD	Myelodysplastic Syndromes	226ae80381e4140b8d4ce2	127	1		post	2								
767A		767	0	liquid	SRR11140120	PRJNA606262			3																	
767B		767	3	liquid	SRR11140119	PRJNA606262			3																	
767E		767	20	liquid	SRR11140118	PRJNA606262			3																	
768A		768	0	liquid	SRR11415851	PRJNA545312	-5		5	5	TCD	Multiple Myeloma	ec6ba6b8380065ac3545a3	341	1		pre	-1								
768B		768	5	semi-formed	SRR11415850	PRJNA545312	0		5	5	TCD	Multiple Myeloma	ec6ba6b8380065ac3545a3	341	1		peri	-1								
768C		768	9	liquid	SRR11415849	PRJNA545312	4		5	5	TCD	Multiple Myeloma	ec6ba6b8380065ac3545a3	341	1		peri	0								
768E		768	58	semi-formed	SRR11415848	PRJNA545312	53		5	5	TCD	Multiple Myeloma	ec6ba6b8380065ac3545a3	341	1		post	6								
768F		768	78	formed	SRR11415846	PRJNA545312	73		5	5	TCD	Multiple Myeloma	ec6ba6b8380065ac3545a3	341	1		post	6								
769A		769	0	semi-formed	SRR11415845	PRJNA545312	-1		5	1	TCD	Myeloproliferative Disorder	71e9ada8189bc696a8c641	600	1		pre	-1								
769B		769	4	semi-formed	SRR11415844	PRJNA545312	3		5	1	TCD	Myeloproliferative Disorder	71e9ada8189bc696a8c641	600	1		peri	0								
769C		769	7	formed	SRR11415843	PRJNA545312	6		5	1	TCD	Myeloproliferative Disorder	71e9ada8189bc696a8c641	600	1		post	0								
769D		769	13	liquid	SRR11415842	PRJNA545312	12		5	1	TCD	Myeloproliferative Disorder	71e9ada8189bc696a8c641	600	1		post	1								
769E		769	1768	semi-formed	SRR11117033	PRJNA607574	1767		5	1	TCD	Myeloproliferative Disorder	71e9ada8189bc696a8c641	600	1											
770A		770	0	semi-formed	SRR11415841	PRJNA545312	-4		9	4	cord	Leukemia	7bc3fc8aa51eacc1b2bf47	574	1		pre	-1								
770B		770	14	semi-formed	SRR11415840	PRJNA545312	10		9	4	cord	Leukemia	7bc3fc8aa51eacc1b2bf47	574	1		post	1								
770C		770	16	liquid	SRR11415839	PRJNA545312	12		9	4	cord	Leukemia	7bc3fc8aa51eacc1b2bf47	574	1		post	1								
770D		770	28	semi-formed	SRR11415838	PRJNA545312	24		9	4	cord	Leukemia	7bc3fc8aa51eacc1b2bf47	574	1		post	3								
770E		770	30	semi-formed	SRR11415836	PRJNA545312	26		9	4	cord	Leukemia	7bc3fc8aa51eacc1b2bf47	574	1		post	3								
770F		770	87	liquid	SRR11418694	PRJNA545312	83		9	4	cord	Leukemia	7bc3fc8aa51eacc1b2bf47	574	1		post	6								
770G		770	106	formed	SRR11418693	PRJNA545312	102		9	4	cord	Leukemia	7bc3fc8aa51eacc1b2bf47	574	1		post	6								
770H		770	241	semi-formed	SRR11418692	PRJNA545312	237		9	4	cord	Leukemia	7bc3fc8aa51eacc1b2bf47	574	1		post	6								
770I		770	247	formed	SRR11418691	PRJNA545312	243		9	4	cord	Leukemia	7bc3fc8aa51eacc1b2bf47	574	1		post	6								
771A		771	0	formed	SRR11418689	PRJNA545312	-8		7	8	TCD	Multiple Myeloma	444f55be78342b08e2b71b	35	1		pre	-2								
771B		771	7	liquid	SRR11418688	PRJNA545312	-1		7	8	TCD	Multiple Myeloma	444f55be78342b08e2b71b	35	1		pre	-1								
771C		771	11	liquid	SRR11418687	PRJNA545312	3		7	8	TCD	Multiple Myeloma	444f55be78342b08e2b71b	35	1		peri	0								
771D		771	21	semi-formed	SRR11418658	PRJNA545312	13		7	8	TCD	Multiple Myeloma	444f55be78342b08e2b71b	35	1		post	1								
771E		771	27	liquid	SRR11418657	PRJNA545312	19		7	8	TCD	Multiple Myeloma	444f55be78342b08e2b71b	35	1		post	2								
771F		771	34	semi-formed	SRR11418656	PRJNA545312	26		7	8	TCD	Multiple Myeloma	444f55be78342b08e2b71b	35	1		post	3								
771G		771	41	semi-formed	SRR11418655	PRJNA545312	33		7	8	TCD	Multiple Myeloma	444f55be78342b08e2b71b	35	1		post	4								
772A		772	0	liquid	SRR11418653	PRJNA545312	-791		8	791	PBSC_unmodified	Non-Hodgkin's Lymphoma	b477b3dc7343e3616fe4da	582	1		pre	-3								
772B		772	786	formed	SRR11419354	PRJNA545312	-5		8	791	PBSC_unmodified	Non-Hodgkin's Lymphoma	b477b3dc7343e3616fe4da	582	1		pre	-1								
772C		772	790	formed	SRR11419353	PRJNA545312	-1		8	791	PBSC_unmodified	Non-Hodgkin's Lymphoma	b477b3dc7343e3616fe4da	582	1		pre	-1								
772D		772	797	liquid	SRR11419351	PRJNA545312	6		8	791	PBSC_unmodified	Non-Hodgkin's Lymphoma	b477b3dc7343e3616fe4da	582	1		post	0								
772E		772	832	liquid	SRR11419350	PRJNA545312	41		8	791	PBSC_unmodified	Non-Hodgkin's Lymphoma	b477b3dc7343e3616fe4da	582	1		post	5								
772F		772	835	liquid	SRR11419349	PRJNA545312	44		8	791	PBSC_unmodified	Non-Hodgkin's Lymphoma	b477b3dc7343e3616fe4da	582	1		post	6								
772G		772	839	liquid	SRR11419348	PRJNA545312	48		8	791	PBSC_unmodified	Non-Hodgkin's Lymphoma	b477b3dc7343e3616fe4da	582	1		post	6								
772H		772	871	semi-formed	SRR11419347	PRJNA545312	80		8	791	PBSC_unmodified	Non-Hodgkin's Lymphoma	b477b3dc7343e3616fe4da	582	1		post	6								
773B		773	7	semi-formed	SRR11419346	PRJNA545312	-1		1	8	TCD	Leukemia	b5eff09bb721d508fcf6fa	591	1		pre	-1								
774A		774	0	formed	SRR11419345	PRJNA545312	-5		5	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	ca2bd0b317a3cb1cbcee4c	76	1		pre	-1								
774B		774	2	semi-formed	SRR11419344	PRJNA545312	-3		5	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	ca2bd0b317a3cb1cbcee4c	76	1		pre	-1								
774C		774	12	semi-formed	SRR11419343	PRJNA545312	7		5	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	ca2bd0b317a3cb1cbcee4c	76	1		post	0								
774F		774	92	semi-formed	SRR11419342	PRJNA545312	87		5	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	ca2bd0b317a3cb1cbcee4c	76	1		post	6								
774G		774	96	semi-formed	SRR11419340	PRJNA545312	91		5	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	ca2bd0b317a3cb1cbcee4c	76	1		post	6								
775A		775	0	formed	SRR11419339	PRJNA545312	-8		5	8	TCD	Leukemia	1bc543e94bd914274f1e12	482	1		pre	-2								
775B		775	5	liquid	SRR11419338	PRJNA545312	-3		5	8	TCD	Leukemia	1bc543e94bd914274f1e12	482	1		pre	-1								
775D		775	26	semi-formed	SRR11419337	PRJNA545312	18		5	8	TCD	Leukemia	1bc543e94bd914274f1e12	482	1		post	2								
775E		775	282	formed	SRR11419336	PRJNA545312	274		5	8	TCD	Leukemia	1bc543e94bd914274f1e12	482	1		post	6								
775F		775	341	semi-formed	SRR11419335	PRJNA545312	333		5	8	TCD	Leukemia	1bc543e94bd914274f1e12	482	1		post	6								
777A		777	0	formed	SRR11419334	PRJNA545312	-3		4	3	PBSC_unmodified	Myelodysplastic Syndromes	2dcd6617886c808a97a3a6	20	1		pre	-1								
777B		777	5	formed	SRR11419333	PRJNA545312	2		4	3	PBSC_unmodified	Myelodysplastic Syndromes	2dcd6617886c808a97a3a6	20	1		peri	0								
777C		777	10	formed	SRR11419332	PRJNA545312	7		4	3	PBSC_unmodified	Myelodysplastic Syndromes	2dcd6617886c808a97a3a6	20	1		post	0								
777D		777	18	semi-formed	SRR11419132	PRJNA545312	15		4	3	PBSC_unmodified	Myelodysplastic Syndromes	2dcd6617886c808a97a3a6	20	1		post	2								
778A		778	0	formed	SRR11419130	PRJNA545312	-5		4	5	cord	Leukemia	b77a02064eacc008606dc6	599	1		pre	-1								
778B		778	10	liquid	SRR11419129	PRJNA545312	5		4	5	cord	Leukemia	b77a02064eacc008606dc6	599	1		peri	0								
778C		778	16	liquid	SRR11419128	PRJNA545312	11		4	5	cord	Leukemia	b77a02064eacc008606dc6	599	1		post	1								
778D		778	47	liquid	SRR11419127	PRJNA545312	42		4	5	cord	Leukemia	b77a02064eacc008606dc6	599	1		post	5								
779A		779	0	formed	SRR11419126	PRJNA545312	-6		5	6	TCD	Multiple Myeloma	ace7f302244ef82c914d12	96	1		pre	-1								
779B		779	5	formed	SRR11419125	PRJNA545312	-1		5	6	TCD	Multiple Myeloma	ace7f302244ef82c914d12	96	1		pre	-1								
779C		779	15	liquid	SRR11419124	PRJNA545312	9		5	6	TCD	Multiple Myeloma	ace7f302244ef82c914d12	96	1		post	1								
779D		779	17	liquid	SRR11419123	PRJNA545312	11		5	6	TCD	Multiple Myeloma	ace7f302244ef82c914d12	96	1		post	1								
779E		779	24	formed	SRR11419122	PRJNA545312	18		5	6	TCD	Multiple Myeloma	ace7f302244ef82c914d12	96	1		post	2								
780A		780	0	semi-formed	SRR11419121	PRJNA545312	0		9	0	PBSC_unmodified	Leukemia	9e644d2d69ca67ad859a4e	594	1		peri	-1								
780B		780	9	liquid	SRR11419119	PRJNA545312	9		9	0	PBSC_unmodified	Leukemia	9e644d2d69ca67ad859a4e	594	1		post	1								
780C		780	13	liquid	SRR11419118	PRJNA545312	13		9	0	PBSC_unmodified	Leukemia	9e644d2d69ca67ad859a4e	594	1		post	1								
780D		780	24	formed	SRR11419117	PRJNA545312	24		9	0	PBSC_unmodified	Leukemia	9e644d2d69ca67ad859a4e	594	1		post	3								
780E		780	27	semi-formed	SRR11419116	PRJNA545312	27		9	0	PBSC_unmodified	Leukemia	9e644d2d69ca67ad859a4e	594	1		post	3								
780F		780	38	semi-formed	SRR11419115	PRJNA545312	38		9	0	PBSC_unmodified	Leukemia	9e644d2d69ca67ad859a4e	594	1		post	5								
780G		780	66	semi-formed	SRR11419114	PRJNA545312	66		9	0	PBSC_unmodified	Leukemia	9e644d2d69ca67ad859a4e	594	1		post	6								
780H		780	143	semi-formed	SRR11419113	PRJNA545312	143		9	0	PBSC_unmodified	Leukemia	9e644d2d69ca67ad859a4e	594	1		post	6								
780I		780	146	semi-formed	SRR11419112	PRJNA545312	146		9	0	PBSC_unmodified	Leukemia	9e644d2d69ca67ad859a4e	594	1		post	6								
781A		781	0	formed	SRR11140402	PRJNA606262			1																	
782A		782	0	liquid	SRR11419111	PRJNA545312	-4		3	4	TCD	Myelodysplastic Syndromes	be9d7820d544c39eee46b2	270	1		pre	-1								
782B		782	1	liquid	SRR11419110	PRJNA545312	-3		3	4	TCD	Myelodysplastic Syndromes	be9d7820d544c39eee46b2	270	1		pre	-1								
782C		782	6	liquid	SRR11419107	PRJNA545312	2		3	4	TCD	Myelodysplastic Syndromes	be9d7820d544c39eee46b2	270	1		peri	0								
783A		783	0	formed	SRR11419106	PRJNA545312	2		1	-2	TCD	Myelodysplastic Syndromes	f0b91399bd1e438b0c97a5	592	1		peri	0								
784A		784	0	semi-formed	SRR11419105	PRJNA545312	6		2	-6	PBSC_unmodified	Leukemia	07d5ef2bc20c7b851a0c54	586	1		post	0								
784B		784	7	semi-formed	SRR11419048	PRJNA545312	13		2	-6	PBSC_unmodified	Leukemia	07d5ef2bc20c7b851a0c54	586	1		post	1								
786A		786	0	semi-formed	SRR11419047	PRJNA545312	-3		2	3	PBSC_unmodified	Leukemia	306e9ca377530985becc6d	578	1		pre	-1								
786B		786	9	semi-formed	SRR11419046	PRJNA545312	6		2	3	PBSC_unmodified	Leukemia	306e9ca377530985becc6d	578	1		post	0								
787A		787	0	formed	SRR11140103	PRJNA606262			1																	
788A		788	0	semi-formed	SRR11419045	PRJNA545312	3		2	-3	BM_unmodified	Leukemia	7d5779192c07eb45343559	379	1		peri	0								
788B		788	21	semi-formed	SRR11419044	PRJNA545312	24		2	-3	BM_unmodified	Leukemia	7d5779192c07eb45343559	379	1		post	3								
789A		789	0	liquid	SRR11419043	PRJNA545312	9		2	-9	BM_unmodified	Myelodysplastic Syndromes	a102d79e52a731de49f680	533	1		post	1								
789B		789	1	semi-formed	SRR11419042	PRJNA545312	10		2	-9	BM_unmodified	Myelodysplastic Syndromes	a102d79e52a731de49f680	533	1		post	1								
790A		790	0	liquid	SRR11419040	PRJNA545312	3		2	-3	TCD	Leukemia	88f7a556036609472d6e5c	579	1		peri	0								
790B		790	372	formed	SRR11419039	PRJNA545312	375		2	-3	TCD	Leukemia	88f7a556036609472d6e5c	579	1		post	6								
791A		791	0	formed	SRR11419038	PRJNA545312	-9		5	9	TCD	Myelodysplastic Syndromes	52820817dd063f401473ee	8	1		pre	-2								
791B		791	15	liquid	SRR11419037	PRJNA545312	6		5	9	TCD	Myelodysplastic Syndromes	52820817dd063f401473ee	8	1		post	0								
791C		791	109	formed	SRR11419036	PRJNA545312	100		5	9	TCD	Myelodysplastic Syndromes	52820817dd063f401473ee	8	1		post	6								
791D		791	377	formed	SRR11419035	PRJNA545312	368		5	9	TCD	Myelodysplastic Syndromes	52820817dd063f401473ee	8	1		post	6								
791E		791	413	semi-formed	SRR11419034	PRJNA545312	404		5	9	TCD	Myelodysplastic Syndromes	52820817dd063f401473ee	8	1		post	6								
792A		792	0	semi-formed	SRR11419033	PRJNA545312	-4		5	4	TCD	Myeloproliferative Disorder	0b6ff50ba2147bf607b8f4	552	1		pre	-1								
792B		792	7	semi-formed	SRR11419032	PRJNA545312	3		5	4	TCD	Myeloproliferative Disorder	0b6ff50ba2147bf607b8f4	552	1		peri	0								
792C		792	9	liquid	SRR11419031	PRJNA545312	5		5	4	TCD	Myeloproliferative Disorder	0b6ff50ba2147bf607b8f4	552	1		peri	0								
792D		792	16	semi-formed	SRR11419029	PRJNA545312	12		5	4	TCD	Myeloproliferative Disorder	0b6ff50ba2147bf607b8f4	552	1		post	1								
792E		792	163	semi-formed	SRR11419028	PRJNA545312	159		5	4	TCD	Myeloproliferative Disorder	0b6ff50ba2147bf607b8f4	552	1		post	6								
793A		pt_with_samples_2012_793	203	formed	SRR11419027	PRJNA545312	-1		4	204	cord	Leukemia	e6ef9354a2638f2045a4b8	567	1		pre	-1								
793B		pt_with_samples_2012_793	214	liquid	SRR11419026	PRJNA545312	10		4	204	cord	Leukemia	e6ef9354a2638f2045a4b8	567	1		post	1								
793C		pt_with_samples_2012_793	217	semi-formed	SRR11419025	PRJNA545312	13		4	204	cord	Leukemia	e6ef9354a2638f2045a4b8	567	1		post	1								
793D		pt_with_samples_2012_793	229	semi-formed	SRR11419024	PRJNA545312	25		4	204	cord	Leukemia	e6ef9354a2638f2045a4b8	567	1		post	3								
794A		794	0	semi-formed	SRR11419023	PRJNA545312	-11		4	11	TCD	Multiple Myeloma	49c063a9d9f53423523710	520	1		pre	-2								
794B		794	5	formed	SRR11419022	PRJNA545312	-6		4	11	TCD	Multiple Myeloma	49c063a9d9f53423523710	520	1		pre	-1								
794C		794	18	liquid	SRR11419021	PRJNA545312	7		4	11	TCD	Multiple Myeloma	49c063a9d9f53423523710	520	1		post	0								
794E		794	26	semi-formed	SRR11418938	PRJNA545312	15		4	11	TCD	Multiple Myeloma	49c063a9d9f53423523710	520	1		post	2								
795A		795	0	liquid	SRR11140405	PRJNA606262			1																	
796A		pt_with_samples_2018_796	110	liquid	SRR11418936	PRJNA545312	3		3	107	TCD	Leukemia	9218d8ce8b558a176a12e4	589	1		peri	0								
797A		797	0	semi-formed	SRR11140044	PRJNA606262			1																	
798A		798	0	formed	SRR11418935	PRJNA545312	-6		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	54d29709220e61732efa59	587	1		pre	-1								
798B		798	9	formed	SRR11418934	PRJNA545312	3		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	54d29709220e61732efa59	587	1		peri	0								
798C		798	14	formed	SRR11418933	PRJNA545312	8		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	54d29709220e61732efa59	587	1		post	1								
798E		798	26	formed	SRR11418932	PRJNA545312	20		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	54d29709220e61732efa59	587	1		post	2								
799A		799	0	formed	SRR11418931	PRJNA545312	-5		2	5	BM_unmodified	Leukemia	d2bcb67956986275b1619f	597	1		pre	-1								
799B		799	7	semi-formed	SRR11418930	PRJNA545312	2		2	5	BM_unmodified	Leukemia	d2bcb67956986275b1619f	597	1		peri	0								
800A		800	0	semi-formed	SRR11140350	PRJNA606262			1																	
801A		801	0	semi-formed	SRR11418929	PRJNA545312	-2		2	2	PBSC_unmodified	Leukemia	5f242c5f813b0bdae665e0	601	1		pre	-1								
801B		801	13	semi-formed	SRR11418928	PRJNA545312	11		2	2	PBSC_unmodified	Leukemia	5f242c5f813b0bdae665e0	601	1		post	1								
802A		802	0	liquid	SRR11418927	PRJNA545312	-1		6	1	cord	Myelodysplastic Syndromes	51db2531c80fef5d138c5c	110	1		pre	-1								
802B		802	6	liquid	SRR11418925	PRJNA545312	5		6	1	cord	Myelodysplastic Syndromes	51db2531c80fef5d138c5c	110	1		peri	0								
802C		802	13	semi-formed	SRR11418924	PRJNA545312	12		6	1	cord	Myelodysplastic Syndromes	51db2531c80fef5d138c5c	110	1		post	1								
802D		802	21	liquid	SRR11418923	PRJNA545312	20		6	1	cord	Myelodysplastic Syndromes	51db2531c80fef5d138c5c	110	1		post	2								
802E		802	35	semi-formed	SRR11418922	PRJNA545312	34		6	1	cord	Myelodysplastic Syndromes	51db2531c80fef5d138c5c	110	1		post	4								
802G		802	233	liquid	SRR11418921	PRJNA545312	232		6	1	cord	Myelodysplastic Syndromes	51db2531c80fef5d138c5c	110	1		post	6								
803B		803	7	semi-formed	SRR11418920	PRJNA545312	3		4	4	BM_unmodified	Myelodysplastic Syndromes	c944ad81c84a8bb5fc52f7	118	1		peri	0								
803C		803	8	semi-formed	SRR11418919	PRJNA545312	4		4	4	BM_unmodified	Myelodysplastic Syndromes	c944ad81c84a8bb5fc52f7	118	1		peri	0								
803D		803	22	semi-formed	SRR11418918	PRJNA545312	18		4	4	BM_unmodified	Myelodysplastic Syndromes	c944ad81c84a8bb5fc52f7	118	1		post	2								
803E		803	56	formed	SRR11418917	PRJNA545312	52		4	4	BM_unmodified	Myelodysplastic Syndromes	c944ad81c84a8bb5fc52f7	118	1		post	6								
804A		804	0	formed	SRR11418916	PRJNA545312	-6		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	f012a3edb5e33fb80c541e	519	1		pre	-1								
804B		804	5	formed	SRR11418914	PRJNA545312	-1		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	f012a3edb5e33fb80c541e	519	1		pre	-1								
804C		804	13	formed	SRR11418913	PRJNA545312	7		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	f012a3edb5e33fb80c541e	519	1		post	0								
804D		804	17	semi-formed	SRR11418912	PRJNA545312	11		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	f012a3edb5e33fb80c541e	519	1		post	1								
804E		804	25	liquid	SRR11418911	PRJNA545312	19		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	f012a3edb5e33fb80c541e	519	1		post	2								
805A		805	0	formed	SRR11140097	PRJNA606262			1																	
806A		806	0	semi-formed	SRR11140101	PRJNA606262			1																	
807A		807	0	semi-formed	SRR11140102	PRJNA606262			1																	
808A		808	0	semi-formed	SRR11418826	PRJNA545312	-1		1	1	TCD	Leukemia	e8fe8b547214e2ef044385	595	1		pre	-1								
809A		809	0	semi-formed	SRR11418825	PRJNA545312	-8		4	8	TCD	Leukemia	4b3a141a96904ee77012df	584	1		pre	-2								
809B		809	4	semi-formed	SRR11418824	PRJNA545312	-4		4	8	TCD	Leukemia	4b3a141a96904ee77012df	584	1		pre	-1								
809C		809	19	semi-formed	SRR11418823	PRJNA545312	11		4	8	TCD	Leukemia	4b3a141a96904ee77012df	584	1		post	1								
809D		809	27	semi-formed	SRR11418822	PRJNA545312	19		4	8	TCD	Leukemia	4b3a141a96904ee77012df	584	1		post	2								
810A		810	0	liquid	SRR11418821	PRJNA545312	5		2	-5	cord	Leukemia	1a392f6013e1af68b99349	611	1		peri	0								
810B		810	16	liquid	SRR11418819	PRJNA545312	21		2	-5	cord	Leukemia	1a392f6013e1af68b99349	611	1		post	2								
811A		811	0	formed	SRR11418818	PRJNA545312	-9		2	9	TCD	Leukemia	8f1b126c0d89dba62867ce	395	1		pre	-2								
811B		811	27	liquid	SRR11418817	PRJNA545312	18		2	9	TCD	Leukemia	8f1b126c0d89dba62867ce	395	1		post	2								
812A		812	0	formed	SRR11397302	PRJNA607574			2																	
812B		812	44	formed	SRR11140094	PRJNA606262			2																	
813A		813	0	liquid	SRR11140384	PRJNA606262			1																	
814A		814	0	formed	SRR11418816	PRJNA545312	-5		7	5	PBSC_unmodified	Leukemia	3d39d6a2a9a5f0fb3ef7ed	606	1		pre	-1								
814B		814	3	formed	SRR11418815	PRJNA545312	-2		7	5	PBSC_unmodified	Leukemia	3d39d6a2a9a5f0fb3ef7ed	606	1		pre	-1								
814C		814	6	formed	SRR11418814	PRJNA545312	1		7	5	PBSC_unmodified	Leukemia	3d39d6a2a9a5f0fb3ef7ed	606	1		peri	0								
814D		814	10	formed	SRR11418813	PRJNA545312	5		7	5	PBSC_unmodified	Leukemia	3d39d6a2a9a5f0fb3ef7ed	606	1		peri	0								
814E		814	18	semi-formed	SRR11418812	PRJNA545312	13		7	5	PBSC_unmodified	Leukemia	3d39d6a2a9a5f0fb3ef7ed	606	1		post	1								
814F		814	682	semi-formed	SRR11418811	PRJNA545312	677		7	5	PBSC_unmodified	Leukemia	3d39d6a2a9a5f0fb3ef7ed	606	1		post	6								
814G		814	724	semi-formed	SRR11418810	PRJNA545312	719		7	5	PBSC_unmodified	Leukemia	3d39d6a2a9a5f0fb3ef7ed	606	1		post	6								
815A		815	0	semi-formed	SRR11140337	PRJNA606262			2																	
815B		815	2	semi-formed	SRR11140336	PRJNA606262			2																	
816A		816	0	formed	SRR11418808	PRJNA545312	-5		2	5	PBSC_unmodified	Hodgkin's Disease	6d3e8b86996a928898cf03	488	1		pre	-1								
816B		816	20	semi-formed	SRR11418807	PRJNA545312	15		2	5	PBSC_unmodified	Hodgkin's Disease	6d3e8b86996a928898cf03	488	1		post	2								
817A		817	0	semi-formed	SRR11418806	PRJNA545312	4		9	-4	BM_unmodified	Leukemia	ace2e7a358bef0f6664e31	565	1		peri	0								
817B		817	3	semi-formed	SRR11418805	PRJNA545312	7		9	-4	BM_unmodified	Leukemia	ace2e7a358bef0f6664e31	565	1		post	0								
817C		817	10	liquid	SRR11418804	PRJNA545312	14		9	-4	BM_unmodified	Leukemia	ace2e7a358bef0f6664e31	565	1		post	1								
817D		817	16	semi-formed	SRR11418803	PRJNA545312	20		9	-4	BM_unmodified	Leukemia	ace2e7a358bef0f6664e31	565	1		post	2								
817E		817	40	semi-formed	SRR11418802	PRJNA545312	44		9	-4	BM_unmodified	Leukemia	ace2e7a358bef0f6664e31	565	1		post	6								
817F		817	51	semi-formed	SRR11418801	PRJNA545312	55		9	-4	BM_unmodified	Leukemia	ace2e7a358bef0f6664e31	565	1		post	6								
817G		817	56	liquid	SRR11418800	PRJNA545312	60		9	-4	BM_unmodified	Leukemia	ace2e7a358bef0f6664e31	565	1		post	6								
817H		817	57	liquid	SRR11418799	PRJNA545312	61		9	-4	BM_unmodified	Leukemia	ace2e7a358bef0f6664e31	565	1		post	6								
817I		817	78	liquid	SRR11419330	PRJNA545312	82		9	-4	BM_unmodified	Leukemia	ace2e7a358bef0f6664e31	565	1		post	6								
818A		818	0	semi-formed	SRR11419329	PRJNA545312			11																	
818B		818	9	liquid	SRR11419328	PRJNA545312			11																	
818C		818	10	liquid	SRR11419327	PRJNA545312			11																	
818D		818	17	liquid	SRR11419326	PRJNA545312			11																	
818F		818	30	semi-formed	SRR11419325	PRJNA545312			11																	
818G		818	56	formed	SRR11419324	PRJNA545312			11																	
818J		818	109	semi-formed	SRR11419323	PRJNA545312			11																	
818K		818	110	semi-formed	SRR11419322	PRJNA545312			11																	
818L		818	117	formed	SRR11419321	PRJNA545312			11																	
818M		818	124	liquid	SRR11419319	PRJNA545312			11																	
818N		818	160	formed	SRR11419318	PRJNA545312			11																	
819A		819	0	semi-formed	SRR11419317	PRJNA545312	-2		1	2	TCD	Leukemia	d59c4baaa9bbd2afa0656c	450	1		pre	-1								
820A		820	0	liquid	SRR11140100	PRJNA606262			1																	
821A		821	0	formed	SRR11140112	PRJNA606262			2																	
821B		821	1	formed	SRR11140111	PRJNA606262			2																	
822A		822	0	liquid	SRR11397293	PRJNA607574			1																	
823A		823	0	liquid	SRR11419316	PRJNA545312	1		1	-1	TCD	Leukemia	02194f18fe78fd8ce6b9ed	214	0		peri	0								
824A		824	0	semi-formed	SRR11419315	PRJNA545312	4		3	-4	cord	Leukemia	4d55670033fdaa8ad7c697	190	1		peri	0								
824B		824	1	semi-formed	SRR11419314	PRJNA545312	5		3	-4	cord	Leukemia	4d55670033fdaa8ad7c697	190	1		peri	0								
824C		824	15	semi-formed	SRR11419313	PRJNA545312	19		3	-4	cord	Leukemia	4d55670033fdaa8ad7c697	190	1		post	2								
825A		825	0	liquid	SRR11140145	PRJNA606262			1																	
826A		826	0	formed	SRR11419312	PRJNA545312	-9		4	9	TCD	Myelodysplastic Syndromes	ff3800c6f18651feb4a133	60	1		pre	-2								
826B		826	17	liquid	SRR11419311	PRJNA545312	8		4	9	TCD	Myelodysplastic Syndromes	ff3800c6f18651feb4a133	60	1		post	1								
826C		826	18	liquid	SRR11419310	PRJNA545312	9		4	9	TCD	Myelodysplastic Syndromes	ff3800c6f18651feb4a133	60	1		post	1								
826D		826	329	formed	SRR11419307	PRJNA545312	320		4	9	TCD	Myelodysplastic Syndromes	ff3800c6f18651feb4a133	60	1		post	6								
827A		827	0	formed	SRR11139970	PRJNA606262			2																	
827B		827	6	semi-formed	SRR11140055	PRJNA606262			2																	
828A		828	0	formed	SRR11419306	PRJNA545312	-3		12	3	cord	Non-Hodgkin's Lymphoma	96ee6dd9fa512791b9b4f5	602	1		pre	-1								
828B		828	11	semi-formed	SRR11419305	PRJNA545312	8		12	3	cord	Non-Hodgkin's Lymphoma	96ee6dd9fa512791b9b4f5	602	1		post	1								
828C		828	9	semi-formed	SRR11419304	PRJNA545312	6		12	3	cord	Non-Hodgkin's Lymphoma	96ee6dd9fa512791b9b4f5	602	1		post	0								
828D		828	15	formed	SRR11419303	PRJNA545312	12		12	3	cord	Non-Hodgkin's Lymphoma	96ee6dd9fa512791b9b4f5	602	1		post	1								
828E		828	21	formed	SRR11419302	PRJNA545312	18		12	3	cord	Non-Hodgkin's Lymphoma	96ee6dd9fa512791b9b4f5	602	1		post	2								
828F		828	44	liquid	SRR11419301	PRJNA545312	41		12	3	cord	Non-Hodgkin's Lymphoma	96ee6dd9fa512791b9b4f5	602	1		post	5								
828G		828	53	liquid	SRR11419300	PRJNA545312	50		12	3	cord	Non-Hodgkin's Lymphoma	96ee6dd9fa512791b9b4f5	602	1		post	6								
828H		828	54	formed	SRR11419299	PRJNA545312	51		12	3	cord	Non-Hodgkin's Lymphoma	96ee6dd9fa512791b9b4f5	602	1		post	6								
828I		828	56	liquid	SRR11419298	PRJNA545312	53		12	3	cord	Non-Hodgkin's Lymphoma	96ee6dd9fa512791b9b4f5	602	1		post	6								
828J		828	59	formed	SRR11419296	PRJNA545312	56		12	3	cord	Non-Hodgkin's Lymphoma	96ee6dd9fa512791b9b4f5	602	1		post	6								
828K		828	65	formed	SRR11419295	PRJNA545312	62		12	3	cord	Non-Hodgkin's Lymphoma	96ee6dd9fa512791b9b4f5	602	1		post	6								
828L		828	105	formed	SRR11419294	PRJNA545312	102		12	3	cord	Non-Hodgkin's Lymphoma	96ee6dd9fa512791b9b4f5	602	1		post	6								
829A		829	0	formed	SRR11419293	PRJNA545312	-2		2	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	8f8bab14a2e41784a458d9	538	1		pre	-1								
829B		829	7	semi-formed	SRR11419292	PRJNA545312	5		2	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	8f8bab14a2e41784a458d9	538	1		peri	0								
830A		830	0	liquid	SRR11140229	PRJNA606262			1																	
831A		pt_with_samples_2020_831	49	formed	SRR11419291	PRJNA545312	-2		3	51	PBSC_unmodified	Leukemia	26bb5924f9ec724ef37ebf	598	1		pre	-1								
831B		pt_with_samples_2020_831	56	semi-formed	SRR11419290	PRJNA545312	5		3	51	PBSC_unmodified	Leukemia	26bb5924f9ec724ef37ebf	598	1		peri	0								
832A		832	0	formed	SRR11419289	PRJNA545312	-4		5	4	PBSC_unmodified	Leukemia	75a59fb47b0c07fb07ed18	137	1		pre	-1								
832B		832	6	formed	SRR11419288	PRJNA545312	2		5	4	PBSC_unmodified	Leukemia	75a59fb47b0c07fb07ed18	137	1		peri	0								
832C		832	9	formed	SRR11419287	PRJNA545312	5		5	4	PBSC_unmodified	Leukemia	75a59fb47b0c07fb07ed18	137	1		peri	0								
832D		832	16	semi-formed	SRR11419285	PRJNA545312	12		5	4	PBSC_unmodified	Leukemia	75a59fb47b0c07fb07ed18	137	1		post	1								
832E		832	79	liquid	SRR11419284	PRJNA545312	75		5	4	PBSC_unmodified	Leukemia	75a59fb47b0c07fb07ed18	137	1		post	6								
833B		833	40	formed	SRR11419283	PRJNA545312	51		5	-11	TCD	Multiple Myeloma	8146b0fa27e1cb8759a614	398	1		post	6								
833D		833	58	formed	SRR11419282	PRJNA545312	69		5	-11	TCD	Multiple Myeloma	8146b0fa27e1cb8759a614	398	1		post	6								
833E		833	70	semi-formed	SRR11419281	PRJNA545312	81		5	-11	TCD	Multiple Myeloma	8146b0fa27e1cb8759a614	398	1		post	6								
833F		833	114	formed	SRR11419280	PRJNA545312	125		5	-11	TCD	Multiple Myeloma	8146b0fa27e1cb8759a614	398	1		post	6								
833G		833	123	liquid	SRR11419279	PRJNA545312	134		5	-11	TCD	Multiple Myeloma	8146b0fa27e1cb8759a614	398	1		post	6								
834B		834	6	semi-formed	SRR11140263	PRJNA606262			1																	
835A		835	0	semi-formed	SRR11419278	PRJNA545312	-79		9	79	TCD	Multiple Myeloma	fc140805c82997f90c2e01	449	1		pre	-3								
835C		835	63	formed	SRR11419276	PRJNA545312	-16		9	79	TCD	Multiple Myeloma	fc140805c82997f90c2e01	449	1		pre	-3								
835D		835	71	formed	SRR11419159	PRJNA545312	-8		9	79	TCD	Multiple Myeloma	fc140805c82997f90c2e01	449	1		pre	-2								
835E		835	72	semi-formed	SRR11419158	PRJNA545312	-7		9	79	TCD	Multiple Myeloma	fc140805c82997f90c2e01	449	1		pre	-2								
835F		835	77	semi-formed	SRR11419157	PRJNA545312	-2		9	79	TCD	Multiple Myeloma	fc140805c82997f90c2e01	449	1		pre	-1								
835I		835	90	liquid	SRR11419156	PRJNA545312	11		9	79	TCD	Multiple Myeloma	fc140805c82997f90c2e01	449	1		post	1								
835J		835	139	formed	SRR11419155	PRJNA545312	60		9	79	TCD	Multiple Myeloma	fc140805c82997f90c2e01	449	1		post	6								
835K		835	146	semi-formed	SRR11419154	PRJNA545312	67		9	79	TCD	Multiple Myeloma	fc140805c82997f90c2e01	449	1		post	6								
835L		835	153	formed	SRR11419153	PRJNA545312	74		9	79	TCD	Multiple Myeloma	fc140805c82997f90c2e01	449	1		post	6								
836A		836	0	semi-formed	SRR11419152	PRJNA545312	1		7	-1	PBSC_unmodified	Non-Hodgkin's Lymphoma	6f3df2c91f50b16a78949e	503	1		peri	0								
836B		836	4	liquid	SRR11419151	PRJNA545312	5		7	-1	PBSC_unmodified	Non-Hodgkin's Lymphoma	6f3df2c91f50b16a78949e	503	1		peri	0								
836C		836	5	liquid	SRR11419150	PRJNA545312	6		7	-1	PBSC_unmodified	Non-Hodgkin's Lymphoma	6f3df2c91f50b16a78949e	503	1		post	0								
836D		836	10	liquid	SRR11419148	PRJNA545312	11		7	-1	PBSC_unmodified	Non-Hodgkin's Lymphoma	6f3df2c91f50b16a78949e	503	1		post	1								
836F		836	690	semi-formed	SRR11419147	PRJNA545312	691		7	-1	PBSC_unmodified	Non-Hodgkin's Lymphoma	6f3df2c91f50b16a78949e	503	1		post	6								
836G		836	721	formed	SRR11419146	PRJNA545312	722		7	-1	PBSC_unmodified	Non-Hodgkin's Lymphoma	6f3df2c91f50b16a78949e	503	1		post	6								
836H		836	727	liquid	SRR11419145	PRJNA545312	728		7	-1	PBSC_unmodified	Non-Hodgkin's Lymphoma	6f3df2c91f50b16a78949e	503	1		post	6								
837A		837	0	semi-formed	SRR11419144	PRJNA545312	1		3	-1	TCD	Multiple Myeloma	1745582ffda8650725064e	348	1		peri	0								
837B		837	3	liquid	SRR11419143	PRJNA545312	4		3	-1	TCD	Multiple Myeloma	1745582ffda8650725064e	348	1		peri	0								
837C		837	9	liquid	SRR11419142	PRJNA545312	10		3	-1	TCD	Multiple Myeloma	1745582ffda8650725064e	348	1		post	1								
838A		838	0	semi-formed	SRR11419141	PRJNA545312	-9		2	9	TCD	Leukemia	8545bb419ffc8bc8c5c7d4	613	1		pre	-2								
838B		838	7	formed	SRR11419140	PRJNA545312	-2		2	9	TCD	Leukemia	8545bb419ffc8bc8c5c7d4	613	1		pre	-1								
839A		839	0	formed	SRR11419139	PRJNA545312	-10		5	10	TCD	Multiple Myeloma	b5ad18b54a08c056bc25e5	282	1		pre	-2								
839B		839	7	formed	SRR11419137	PRJNA545312	-3		5	10	TCD	Multiple Myeloma	b5ad18b54a08c056bc25e5	282	1		pre	-1								
839C		839	14	semi-formed	SRR11419136	PRJNA545312	4		5	10	TCD	Multiple Myeloma	b5ad18b54a08c056bc25e5	282	1		peri	0								
839D		839	21	liquid	SRR11419135	PRJNA545312	11		5	10	TCD	Multiple Myeloma	b5ad18b54a08c056bc25e5	282	1		post	1								
839E		839	28	formed	SRR11419134	PRJNA545312	18		5	10	TCD	Multiple Myeloma	b5ad18b54a08c056bc25e5	282	1		post	2								
840A		840	0	formed	SRR11419133	PRJNA545312	-9		7	997	PBSC_unmodified	Leukemia	fa58f4e9583d00c161428a		1		pre	-2								
840B		840	5	semi-formed	SRR11418639	PRJNA545312	-4		7	997	PBSC_unmodified	Leukemia	fa58f4e9583d00c161428a		1		pre	-1								
840C		840	7	liquid	SRR11418638	PRJNA545312	-2		7	997	PBSC_unmodified	Leukemia	fa58f4e9583d00c161428a		1		pre	-1								
840D		840	13	semi-formed	SRR11418637	PRJNA545312	4		7	997	PBSC_unmodified	Leukemia	fa58f4e9583d00c161428a		1		peri	0								
840E		840	1013	liquid	SRR11418636	PRJNA545312	16		7	997	PBSC_unmodified	Leukemia	fa58f4e9583d00c161428a		1		post	2								
840F		840	1015	liquid	SRR11418635	PRJNA545312	18		7	997	PBSC_unmodified	Leukemia	fa58f4e9583d00c161428a		1		post	2								
840G		840	1016	liquid	SRR11418633	PRJNA545312	19		7	997	PBSC_unmodified	Leukemia	fa58f4e9583d00c161428a		1		post	2								
841A		841	0	formed	SRR11418632	PRJNA545312	-2		6	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	7de947fa7e1aaad5cf5910	406	1		pre	-1								
841B		841	7	semi-formed	SRR11418631	PRJNA545312	5		6	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	7de947fa7e1aaad5cf5910	406	1		peri	0								
841C		841	52	formed	SRR11418630	PRJNA545312	50		6	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	7de947fa7e1aaad5cf5910	406	1		post	6								
841D		841	56	liquid	SRR11418629	PRJNA545312	54		6	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	7de947fa7e1aaad5cf5910	406	1		post	6								
841E		841	70	formed	SRR11418628	PRJNA545312	68		6	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	7de947fa7e1aaad5cf5910	406	1		post	6								
841F		841	77	semi-formed	SRR11418627	PRJNA545312	75		6	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	7de947fa7e1aaad5cf5910	406	1		post	6								
842A		842	0	formed	SRR11418626	PRJNA545312	-2		5	2	TCD	Leukemia	51a877e5891e6445bbe128	608	1		pre	-1								
842B		842	4	liquid	SRR11418625	PRJNA545312	2		5	2	TCD	Leukemia	51a877e5891e6445bbe128	608	1		peri	0								
842C		842	6	liquid	SRR11418624	PRJNA545312	4		5	2	TCD	Leukemia	51a877e5891e6445bbe128	608	1		peri	0								
842E		842	49	semi-formed	SRR11418622	PRJNA545312	47		5	2	TCD	Leukemia	51a877e5891e6445bbe128	608	1		post	6								
842F		842	55	formed	SRR11418621	PRJNA545312	53		5	2	TCD	Leukemia	51a877e5891e6445bbe128	608	1		post	6								
843A		843	0	formed	SRR11418620	PRJNA545312	-7		5	7	TCD	Leukemia	c19896033d08963781018f	426	1		pre	-2								
843B		843	3	semi-formed	SRR11418619	PRJNA545312	-4		5	7	TCD	Leukemia	c19896033d08963781018f	426	1		pre	-1								
843C		843	11	semi-formed	SRR11418618	PRJNA545312	4		5	7	TCD	Leukemia	c19896033d08963781018f	426	1		peri	0								
843D		843	19	liquid	SRR11418617	PRJNA545312	12		5	7	TCD	Leukemia	c19896033d08963781018f	426	1		post	1								
843E		843	28	semi-formed	SRR11418616	PRJNA545312	21		5	7	TCD	Leukemia	c19896033d08963781018f	426	1		post	2								
844A		844	0	formed	SRR11418615	PRJNA545312	-8		5	8	TCD	Myelodysplastic Syndromes	93bc22335adae39d23dd33	129	0		pre	-2								
844B		844	6	liquid	SRR11418614	PRJNA545312	-2		5	8	TCD	Myelodysplastic Syndromes	93bc22335adae39d23dd33	129	0		pre	-1								
844C		844	25	liquid	SRR11418613	PRJNA545312	17		5	8	TCD	Myelodysplastic Syndromes	93bc22335adae39d23dd33	129	0		post	2								
844D		844	26	liquid	SRR11418555	PRJNA545312	18		5	8	TCD	Myelodysplastic Syndromes	93bc22335adae39d23dd33	129	0		post	2								
844E		844	47	semi-formed	SRR11418554	PRJNA545312	39		5	8	TCD	Myelodysplastic Syndromes	93bc22335adae39d23dd33	129	0		post	5								
845A		845	0	formed	SRR11418553	PRJNA545312	0		3	0	TCD	Multiple Myeloma	39c22c7c08d652d2b64842	66	1		peri	-1								
845B		845	8	formed	SRR11418552	PRJNA545312	8		3	0	TCD	Multiple Myeloma	39c22c7c08d652d2b64842	66	1		post	1								
845C		845	11	formed	SRR11418551	PRJNA545312	11		3	0	TCD	Multiple Myeloma	39c22c7c08d652d2b64842	66	1		post	1								
846A		846	0	formed	SRR11418550	PRJNA545312	3		3	-3	PBSC_unmodified	Hodgkin's Disease	52955ec3d96b772cb3bd92	160	1		peri	0								
846B		846	7	formed	SRR11418549	PRJNA545312	10		3	-3	PBSC_unmodified	Hodgkin's Disease	52955ec3d96b772cb3bd92	160	1		post	1								
846C		846	949	formed	SRR11418548	PRJNA545312	952		3	-3	PBSC_unmodified	Hodgkin's Disease	52955ec3d96b772cb3bd92	160	1		post	6								
847A		847	0	formed	SRR11418547	PRJNA545312	-4		5	4	PBSC_unmodified	Leukemia	9ea6db02dee6321b70cfcb	12	1		pre	-1								
847B		847	3	formed	SRR11418546	PRJNA545312	-1		5	4	PBSC_unmodified	Leukemia	9ea6db02dee6321b70cfcb	12	1		pre	-1								
847C		847	10	formed	SRR11418544	PRJNA545312	6		5	4	PBSC_unmodified	Leukemia	9ea6db02dee6321b70cfcb	12	1		post	0								
847D		847	14	semi-formed	SRR11418543	PRJNA545312	10		5	4	PBSC_unmodified	Leukemia	9ea6db02dee6321b70cfcb	12	1		post	1								
847E		847	19	semi-formed	SRR11418542	PRJNA545312	15		5	4	PBSC_unmodified	Leukemia	9ea6db02dee6321b70cfcb	12	1		post	2								
848C		848	9	liquid	SRR11418541	PRJNA545312	12		2	-3	TCD	Myelodysplastic Syndromes	0fff2825a2138ae414442d	588	1		post	1								
848D		848	44	formed	SRR11418540	PRJNA545312	47		2	-3	TCD	Myelodysplastic Syndromes	0fff2825a2138ae414442d	588	1		post	6								
849A		849	0	semi-formed	SRR11418539	PRJNA545312	5		2	-5	TCD	Myelodysplastic Syndromes	92ac5ced99581e4ab5b686	603	1		peri	0								
849B		849	8	semi-formed	SRR11418538	PRJNA545312	13		2	-5	TCD	Myelodysplastic Syndromes	92ac5ced99581e4ab5b686	603	1		post	1								
850A		850	0	formed	SRR11140328	PRJNA606262			1																	
851A		851	0	formed	SRR11418537	PRJNA545312	-9		3	9	TCD	Multiple Myeloma	26d1e88622e8b7d294fd81	570	1		pre	-2								
851B		851	7	semi-formed	SRR11418536	PRJNA545312	-2		3	9	TCD	Multiple Myeloma	26d1e88622e8b7d294fd81	570	1		pre	-1								
851C		851	15	liquid	SRR11418535	PRJNA545312	6		3	9	TCD	Multiple Myeloma	26d1e88622e8b7d294fd81	570	1		post	0								
852A		852	0	formed	SRR11418532	PRJNA545312	1		6	-1	cord	Leukemia	b930f93148bfc4f8cc9afd	610	1		peri	0								
852B		852	8	semi-formed	SRR11418531	PRJNA545312	9		6	-1	cord	Leukemia	b930f93148bfc4f8cc9afd	610	1		post	1								
852C		852	16	liquid	SRR11418530	PRJNA545312	17		6	-1	cord	Leukemia	b930f93148bfc4f8cc9afd	610	1		post	2								
852D		852	18	semi-formed	SRR11418529	PRJNA545312	19		6	-1	cord	Leukemia	b930f93148bfc4f8cc9afd	610	1		post	2								
852E		852	26	semi-formed	SRR11418528	PRJNA545312	27		6	-1	cord	Leukemia	b930f93148bfc4f8cc9afd	610	1		post	3								
852F		852	40	formed	SRR11418427	PRJNA545312	41		6	-1	cord	Leukemia	b930f93148bfc4f8cc9afd	610	1		post	5								
853A		853	0	formed	SRR11418425	PRJNA545312	10		2	-10	PBSC_unmodified	Leukemia	d9627ffe0e329e7f508b0d	431	1		post	1								
853B		853	2	formed	SRR11418424	PRJNA545312	12		2	-10	PBSC_unmodified	Leukemia	d9627ffe0e329e7f508b0d	431	1		post	1								
854A		854	0	formed	SRR11418423	PRJNA545312	-2		4	2	PBSC_unmodified	Leukemia	fdcfcbda56373c7f0b71b5	561	1		pre	-1								
854B		854	7	formed	SRR11418422	PRJNA545312	5		4	2	PBSC_unmodified	Leukemia	fdcfcbda56373c7f0b71b5	561	1		peri	0								
854C		854	14	liquid	SRR11418420	PRJNA545312	12		4	2	PBSC_unmodified	Leukemia	fdcfcbda56373c7f0b71b5	561	1		post	1								
854D		854	189	semi-formed	SRR11418419	PRJNA545312	187		4	2	PBSC_unmodified	Leukemia	fdcfcbda56373c7f0b71b5	561	1		post	6								
855A		855	0	liquid	SRR11140334	PRJNA606262			1																	
857A		857	0	formed	SRR11418418	PRJNA545312	-9		2	9	TCD	Leukemia	20fd8dc2b8f15a5e7790e0	277	1		pre	-2								
857D		857	22	liquid	SRR11418417	PRJNA545312	13		2	9	TCD	Leukemia	20fd8dc2b8f15a5e7790e0	277	1		post	1								
858A		858	0	formed	SRR11418416	PRJNA545312	-10		3	10	TCD	Myelodysplastic Syndromes	881168f09ceaabc7d9f3f9	303	1		pre	-2								
858B		858	11	liquid	SRR11418415	PRJNA545312	1		3	10	TCD	Myelodysplastic Syndromes	881168f09ceaabc7d9f3f9	303	1		peri	0								
858C		858	13	liquid	SRR11418414	PRJNA545312	3		3	10	TCD	Myelodysplastic Syndromes	881168f09ceaabc7d9f3f9	303	1		peri	0								
860A		860	0	formed	SRR11418413	PRJNA545312	-4		3	4	PBSC_unmodified	Leukemia	777226b73ec592c5608e55	616	1		pre	-1								
860B		860	27	formed	SRR11418412	PRJNA545312	23		3	4	PBSC_unmodified	Leukemia	777226b73ec592c5608e55	616	1		post	3								
860C		860	77	formed	SRR11418411	PRJNA545312	73		3	4	PBSC_unmodified	Leukemia	777226b73ec592c5608e55	616	1		post	6								
861A		861	0	formed	SRR11418409	PRJNA545312	-6		4	6	TCD	Myelodysplastic Syndromes	faa08083ff511c29a4aca8	53	1		pre	-1								
861B		861	3	liquid	SRR11418408	PRJNA545312	-3		4	6	TCD	Myelodysplastic Syndromes	faa08083ff511c29a4aca8	53	1		pre	-1								
861C		861	10	semi-formed	SRR11418407	PRJNA545312	4		4	6	TCD	Myelodysplastic Syndromes	faa08083ff511c29a4aca8	53	1		peri	0								
861D		861	16	semi-formed	SRR11418406	PRJNA545312	10		4	6	TCD	Myelodysplastic Syndromes	faa08083ff511c29a4aca8	53	1		post	1								
862A		862	0	formed	SRR11418405	PRJNA545312	-6		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	d0fa661039ea4fda876fe6	124	1		pre	-1								
862B		862	5	semi-formed	SRR11418404	PRJNA545312	-1		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	d0fa661039ea4fda876fe6	124	1		pre	-1								
862D		862	19	formed	SRR11418403	PRJNA545312	13		3	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	d0fa661039ea4fda876fe6	124	1		post	1								
863A		863	0	formed	SRR11418402	PRJNA545312	-6		7	6	cord	Myelodysplastic Syndromes	e81e9df94310ffcac1475e	605	1		pre	-1								
863B		863	7	liquid	SRR11418401	PRJNA545312	1		7	6	cord	Myelodysplastic Syndromes	e81e9df94310ffcac1475e	605	1		peri	0								
863C		863	10	semi-formed	SRR11418400	PRJNA545312	4		7	6	cord	Myelodysplastic Syndromes	e81e9df94310ffcac1475e	605	1		peri	0								
863D		863	18	formed	SRR11418370	PRJNA545312	12		7	6	cord	Myelodysplastic Syndromes	e81e9df94310ffcac1475e	605	1		post	1								
863E		863	19	semi-formed	SRR11418369	PRJNA545312	13		7	6	cord	Myelodysplastic Syndromes	e81e9df94310ffcac1475e	605	1		post	1								
863F		863	25	formed	SRR11418368	PRJNA545312	19		7	6	cord	Myelodysplastic Syndromes	e81e9df94310ffcac1475e	605	1		post	2								
863G		863	34	semi-formed	SRR11418367	PRJNA545312	28		7	6	cord	Myelodysplastic Syndromes	e81e9df94310ffcac1475e	605	1		post	3								
864B		864	7	formed	SRR11418366	PRJNA545312	0		2	7	TCD	Leukemia	f71ca0eb3337606a6a9729	621	1		peri	-1								
864D		864	16	semi-formed	SRR11418365	PRJNA545312	9		2	7	TCD	Leukemia	f71ca0eb3337606a6a9729	621	1		post	1								
865A		865	0	formed	SRR11418364	PRJNA545312	-6		3	6	cord	Leukemia	ae1e5efff437f9c14f8084	28	1		pre	-1								
865B		865	6	semi-formed	SRR11418363	PRJNA545312	0		3	6	cord	Leukemia	ae1e5efff437f9c14f8084	28	1		peri	-1								
865C		865	32	semi-formed	SRR11418362	PRJNA545312	26		3	6	cord	Leukemia	ae1e5efff437f9c14f8084	28	1		post	3								
866A		866	0	formed	SRR11418361	PRJNA545312	-6		4	6	cord	Leukemia	446cf73204b56381ad6869	641	1		pre	-1								
866B		866	3	semi-formed	SRR11418359	PRJNA545312	-3		4	6	cord	Leukemia	446cf73204b56381ad6869	641	1		pre	-1								
866C		866	10	liquid	SRR11418358	PRJNA545312	4		4	6	cord	Leukemia	446cf73204b56381ad6869	641	1		peri	0								
866D		866	29	semi-formed	SRR11418357	PRJNA545312	23		4	6	cord	Leukemia	446cf73204b56381ad6869	641	1		post	3								
868A		868	0	liquid	SRR11418356	PRJNA545312	-172		9	172	TCD	Multiple Myeloma	a173c086f55d348d15e9ed	18	1		pre	-3								
868B		868	163	formed	SRR11418654	PRJNA545312	-9		9	172	TCD	Multiple Myeloma	a173c086f55d348d15e9ed	18	1		pre	-2								
868C		868	168	liquid	SRR11418950	PRJNA545312	-4		9	172	TCD	Multiple Myeloma	a173c086f55d348d15e9ed	18	1		pre	-1								
868D		868	175	liquid	SRR11418949	PRJNA545312	3		9	172	TCD	Multiple Myeloma	a173c086f55d348d15e9ed	18	1		peri	0								
868E		868	182	liquid	SRR11418948	PRJNA545312	10		9	172	TCD	Multiple Myeloma	a173c086f55d348d15e9ed	18	1		post	1								
868G		868	198	formed	SRR11418947	PRJNA545312	26		9	172	TCD	Multiple Myeloma	a173c086f55d348d15e9ed	18	1		post	3								
868H		868	224	semi-formed	SRR11418946	PRJNA545312	52		9	172	TCD	Multiple Myeloma	a173c086f55d348d15e9ed	18	1		post	6								
868I		868	232	semi-formed	SRR11418944	PRJNA545312	60		9	172	TCD	Multiple Myeloma	a173c086f55d348d15e9ed	18	1		post	6								
868J		868	238	semi-formed	SRR11418943	PRJNA545312	66		9	172	TCD	Multiple Myeloma	a173c086f55d348d15e9ed	18	1		post	6								
869A		869	0	formed	SRR11140020	PRJNA606262			2																	
869B		869	13	liquid	SRR11140019	PRJNA606262			2																	
870A		870	0	formed	SRR11418942	PRJNA545312	-9		6	9	TCD	Leukemia	eec184b965d5c55b7604bd	624	1		pre	-2								
870B		870	1	formed	SRR11418941	PRJNA545312	-8		6	9	TCD	Leukemia	eec184b965d5c55b7604bd	624	1		pre	-2								
870C		870	11	semi-formed	SRR11418940	PRJNA545312	2		6	9	TCD	Leukemia	eec184b965d5c55b7604bd	624	1		peri	0								
870D		870	13	liquid	SRR11418939	PRJNA545312	4		6	9	TCD	Leukemia	eec184b965d5c55b7604bd	624	1		peri	0								
870E		870	20	liquid	SRR11418910	PRJNA545312	11		6	9	TCD	Leukemia	eec184b965d5c55b7604bd	624	1		post	1								
870F		870	55	liquid	SRR11418909	PRJNA545312	46		6	9	TCD	Leukemia	eec184b965d5c55b7604bd	624	1		post	6								
871A		871	0	formed	SRR11140345	PRJNA606262			1																	
872A		872	0	formed	SRR11418908	PRJNA545312	-7		6	573	PBSC_unmodified	Leukemia	45f7fa4fa0ff6e5d4b5ca0	617	1		pre	-2								
872B		872	6	liquid	SRR11418907	PRJNA545312	-1		6	573	PBSC_unmodified	Leukemia	45f7fa4fa0ff6e5d4b5ca0	617	1		pre	-1								
872C		872	10	liquid	SRR11418905	PRJNA545312	3		6	573	PBSC_unmodified	Leukemia	45f7fa4fa0ff6e5d4b5ca0	617	1		peri	0								
872D		872	11	liquid	SRR11418904	PRJNA545312	4		6	573	PBSC_unmodified	Leukemia	45f7fa4fa0ff6e5d4b5ca0	617	1		peri	0								
872E		872	18	liquid	SRR11418903	PRJNA545312	11		6	573	PBSC_unmodified	Leukemia	45f7fa4fa0ff6e5d4b5ca0	617	1		post	1								
872F		872	576	formed	SRR11418902	PRJNA545312	3		6	573	PBSC_unmodified	Leukemia	45f7fa4fa0ff6e5d4b5ca0	617	1		peri	0								
873A		873	0	formed	SRR11418901	PRJNA545312	-9		7	9	TCD	Multiple Myeloma	7defd39b698f8e579e56d4	416	1		pre	-2								
873B		873	3	formed	SRR11418900	PRJNA545312	-6		7	9	TCD	Multiple Myeloma	7defd39b698f8e579e56d4	416	1		pre	-1								
873C		873	7	liquid	SRR11418899	PRJNA545312	-2		7	9	TCD	Multiple Myeloma	7defd39b698f8e579e56d4	416	1		pre	-1								
873E		873	21	liquid	SRR11418898	PRJNA545312	12		7	9	TCD	Multiple Myeloma	7defd39b698f8e579e56d4	416	1		post	1								
873F		873	28	liquid	SRR11418897	PRJNA545312	19		7	9	TCD	Multiple Myeloma	7defd39b698f8e579e56d4	416	1		post	2								
873G		873	162	semi-formed	SRR11418896	PRJNA545312	153		7	9	TCD	Multiple Myeloma	7defd39b698f8e579e56d4	416	1		post	6								
873H		873	204	semi-formed	SRR11418894	PRJNA545312	195		7	9	TCD	Multiple Myeloma	7defd39b698f8e579e56d4	416	1		post	6								
875A		875	0	formed	SRR11418893	PRJNA545312	-7		5	7	TCD	Multiple Myeloma	2a39dd16c45536332000aa	620	1		pre	-2								
875B		875	2	semi-formed	SRR11418892	PRJNA545312	-5		5	7	TCD	Multiple Myeloma	2a39dd16c45536332000aa	620	1		pre	-1								
875C		875	9	formed	SRR11418891	PRJNA545312	2		5	7	TCD	Multiple Myeloma	2a39dd16c45536332000aa	620	1		peri	0								
875D		875	10	liquid	SRR11418890	PRJNA545312	3		5	7	TCD	Multiple Myeloma	2a39dd16c45536332000aa	620	1		peri	0								
875E		875	19	liquid	SRR11418889	PRJNA545312	12		5	7	TCD	Multiple Myeloma	2a39dd16c45536332000aa	620	1		post	1								
876A		876	0	formed	SRR11418888	PRJNA545312	-13		6	13	TCD	Multiple Myeloma	af958f63e8f8bdb573370c	607	1		pre	-2								
876B		876	11	semi-formed	SRR11418887	PRJNA545312	-2		6	13	TCD	Multiple Myeloma	af958f63e8f8bdb573370c	607	1		pre	-1								
876C		876	14	liquid	SRR11418886	PRJNA545312	1		6	13	TCD	Multiple Myeloma	af958f63e8f8bdb573370c	607	1		peri	0								
876D		876	27	semi-formed	SRR11418885	PRJNA545312	14		6	13	TCD	Multiple Myeloma	af958f63e8f8bdb573370c	607	1		post	1								
876E		876	28	semi-formed	SRR11418883	PRJNA545312	15		6	13	TCD	Multiple Myeloma	af958f63e8f8bdb573370c	607	1		post	2								
876F		876	35	semi-formed	SRR11418770	PRJNA545312	22		6	13	TCD	Multiple Myeloma	af958f63e8f8bdb573370c	607	1		post	3								
877B		877	1	liquid	SRR11418769	PRJNA545312	-2		3	3	PBSC_unmodified	Leukemia	e96001a7ebf88f3270aba3	629	1		pre	-1								
877D		877	9	liquid	SRR11418768	PRJNA545312	6		3	3	PBSC_unmodified	Leukemia	e96001a7ebf88f3270aba3	629	1		post	0								
877E		877	36	liquid	SRR11418767	PRJNA545312	33		3	3	PBSC_unmodified	Leukemia	e96001a7ebf88f3270aba3	629	1		post	4								
878A		878	0	formed	SRR11418766	PRJNA545312	-5		4	5	BM_unmodified	Non-Hodgkin's Lymphoma	2b36f1b0be2543aa6ec011	509	1		pre	-1								
878B		878	3	semi-formed	SRR11418765	PRJNA545312	-2		4	5	BM_unmodified	Non-Hodgkin's Lymphoma	2b36f1b0be2543aa6ec011	509	1		pre	-1								
878D		878	17	liquid	SRR11418764	PRJNA545312	12		4	5	BM_unmodified	Non-Hodgkin's Lymphoma	2b36f1b0be2543aa6ec011	509	1		post	1								
878E		878	24	semi-formed	SRR11418763	PRJNA545312	19		4	5	BM_unmodified	Non-Hodgkin's Lymphoma	2b36f1b0be2543aa6ec011	509	1		post	2								
879A		879	0	formed	SRR11140093	PRJNA606262			4																	
879B		879	5	formed	SRR11140360	PRJNA606262			4																	
879C		879	8	formed	SRR11140359	PRJNA606262			4																	
879D		879	13	liquid	SRR11140358	PRJNA606262			4																	
880A		FMT.0169	0	formed	SRR11418762	PRJNA545312	-928		17	928	PBSC_unmodified	Non-Hodgkin's Lymphoma	02ccfb467aa6a4a92122d8		1		pre	-3								
880B		FMT.0169	7	semi-formed	SRR11418760	PRJNA545312	-921		17	928	PBSC_unmodified	Non-Hodgkin's Lymphoma	02ccfb467aa6a4a92122d8		1		pre	-3								
881A		881	0	semi-formed	SRR11140096	PRJNA606262			1																	
882A		882	0	formed	SRR11418759	PRJNA545312	-5		7	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	4645996bc10cb5945b1bf7	155	1		pre	-1								
882B		882	9	semi-formed	SRR11418758	PRJNA545312	4		7	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	4645996bc10cb5945b1bf7	155	1		peri	0								
882C		882	10	semi-formed	SRR11418757	PRJNA545312	5		7	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	4645996bc10cb5945b1bf7	155	1		peri	0								
882D		882	17	semi-formed	SRR11418756	PRJNA545312	12		7	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	4645996bc10cb5945b1bf7	155	1		post	1								
882E		882	18	semi-formed	SRR11418755	PRJNA545312	13		7	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	4645996bc10cb5945b1bf7	155	1		post	1								
882F		882	52	semi-formed	SRR11418754	PRJNA545312	47		7	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	4645996bc10cb5945b1bf7	155	1		post	6								
882G		882	80	formed	SRR11418753	PRJNA545312	75		7	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	4645996bc10cb5945b1bf7	155	1		post	6								
883A		pt_with_samples_833_883	0	formed	SRR11418752	PRJNA545312	-203		8	203	cord	Non-Hodgkin's Lymphoma	53b0574a249bc507a42e80	615	1		pre	-3								
883B		pt_with_samples_833_883	5	formed	SRR11418751	PRJNA545312	-198		8	203	cord	Non-Hodgkin's Lymphoma	53b0574a249bc507a42e80	615	1		pre	-3								
883D		pt_with_samples_833_883	25	formed	SRR11418748	PRJNA545312	-178		8	203	cord	Non-Hodgkin's Lymphoma	53b0574a249bc507a42e80	615	1		pre	-3								
883E		pt_with_samples_833_883	198	formed	SRR11418747	PRJNA545312	-5		8	203	cord	Non-Hodgkin's Lymphoma	53b0574a249bc507a42e80	615	1		pre	-1								
883F		pt_with_samples_833_883	204	semi-formed	SRR11418746	PRJNA545312	1		8	203	cord	Non-Hodgkin's Lymphoma	53b0574a249bc507a42e80	615	1		peri	0								
883G		pt_with_samples_833_883	209	formed	SRR11418745	PRJNA545312	6		8	203	cord	Non-Hodgkin's Lymphoma	53b0574a249bc507a42e80	615	1		post	0								
883H		pt_with_samples_833_883	219	semi-formed	SRR11418744	PRJNA545312	16		8	203	cord	Non-Hodgkin's Lymphoma	53b0574a249bc507a42e80	615	1		post	2								
883I		pt_with_samples_833_883	544	liquid	SRR11418743	PRJNA545312	341		8	203	cord	Non-Hodgkin's Lymphoma	53b0574a249bc507a42e80	615	1		post	6								
884A		884	0	formed	SRR11419216	PRJNA545312	-9		5	9	TCD	Leukemia	4d8b756242a078cbf2f293	638	1		pre	-2								
884B		884	8	liquid	SRR11419215	PRJNA545312	-1		5	9	TCD	Leukemia	4d8b756242a078cbf2f293	638	1		pre	-1								
884C		884	14	semi-formed	SRR11419214	PRJNA545312	5		5	9	TCD	Leukemia	4d8b756242a078cbf2f293	638	1		peri	0								
884D		884	24	semi-formed	SRR11419213	PRJNA545312	15		5	9	TCD	Leukemia	4d8b756242a078cbf2f293	638	1		post	2								
884E		884	29	semi-formed	SRR11419211	PRJNA545312	20		5	9	TCD	Leukemia	4d8b756242a078cbf2f293	638	1		post	2								
885A		885	0	formed	SRR11419210	PRJNA545312	0		5	0	BM_unmodified	Myelodysplastic Syndromes	c3b65300b7dad4f6be2113	622	1		peri	-1								
885B		885	1	formed	SRR11419209	PRJNA545312	1		5	0	BM_unmodified	Myelodysplastic Syndromes	c3b65300b7dad4f6be2113	622	1		peri	0								
885C		885	6	semi-formed	SRR11419208	PRJNA545312	6		5	0	BM_unmodified	Myelodysplastic Syndromes	c3b65300b7dad4f6be2113	622	1		post	0								
885D		885	12	semi-formed	SRR11419207	PRJNA545312	12		5	0	BM_unmodified	Myelodysplastic Syndromes	c3b65300b7dad4f6be2113	622	1		post	1								
885E		885	19	semi-formed	SRR11419206	PRJNA545312	19		5	0	BM_unmodified	Myelodysplastic Syndromes	c3b65300b7dad4f6be2113	622	1		post	2								
886A		886	0	formed	SRR11419205	PRJNA545312	-9		2	9	TCD	Non-Malignant Hemat Disorders	e08965d8561b6cd69454fc	581	1		pre	-2								
886B		886	8	formed	SRR11419204	PRJNA545312	-1		2	9	TCD	Non-Malignant Hemat Disorders	e08965d8561b6cd69454fc	581	1		pre	-1								
887A		887	0	formed	SRR11419203	PRJNA545312	-7		5	7	TCD	Myelodysplastic Syndromes	6cc0c278abf1f04b2d508b	635	1		pre	-2								
887B		887	2	formed	SRR11419202	PRJNA545312	-5		5	7	TCD	Myelodysplastic Syndromes	6cc0c278abf1f04b2d508b	635	1		pre	-1								
887C		887	3	semi-formed	SRR11419200	PRJNA545312	-4		5	7	TCD	Myelodysplastic Syndromes	6cc0c278abf1f04b2d508b	635	1		pre	-1								
887E		887	17	liquid	SRR11419199	PRJNA545312	10		5	7	TCD	Myelodysplastic Syndromes	6cc0c278abf1f04b2d508b	635	1		post	1								
887F		887	24	semi-formed	SRR11419198	PRJNA545312	17		5	7	TCD	Myelodysplastic Syndromes	6cc0c278abf1f04b2d508b	635	1		post	2								
888A		888	0	formed	SRR11419197	PRJNA545312	-8		4	8	TCD	Multiple Myeloma	52276452580c5166671475	627	1		pre	-2								
888B		888	6	semi-formed	SRR11419196	PRJNA545312	-2		4	8	TCD	Multiple Myeloma	52276452580c5166671475	627	1		pre	-1								
888C		888	13	liquid	SRR11419195	PRJNA545312	5		4	8	TCD	Multiple Myeloma	52276452580c5166671475	627	1		peri	0								
888D		888	20	formed	SRR11419194	PRJNA545312	12		4	8	TCD	Multiple Myeloma	52276452580c5166671475	627	1		post	1								
889A		889	0	liquid	SRR11419193	PRJNA545312	4		3	-4	BM_unmodified	Leukemia	a108f3504bdb8e73f75af3	646	1		peri	0								
889B		889	2	semi-formed	SRR11419192	PRJNA545312	6		3	-4	BM_unmodified	Leukemia	a108f3504bdb8e73f75af3	646	1		post	0								
889C		889	17	semi-formed	SRR11419191	PRJNA545312	21		3	-4	BM_unmodified	Leukemia	a108f3504bdb8e73f75af3	646	1		post	2								
890A		890	0	semi-formed	SRR11419189	PRJNA545312	-5		3	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	914fd9173a9bd7f2e41535	573	1		pre	-1								
890B		890	2	semi-formed	SRR11419076	PRJNA545312	-3		3	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	914fd9173a9bd7f2e41535	573	1		pre	-1								
890C		890	16	semi-formed	SRR11419075	PRJNA545312	11		3	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	914fd9173a9bd7f2e41535	573	1		post	1								
891A		891	0	formed	SRR11140333	PRJNA606262			1																	
892A		892	0	formed	SRR11419074	PRJNA545312	-2		6	2	cord	Non-Hodgkin's Lymphoma	6f4904474ae52a6c21eee6	51	1		pre	-1								
892B		892	6	semi-formed	SRR11419073	PRJNA545312	4		6	2	cord	Non-Hodgkin's Lymphoma	6f4904474ae52a6c21eee6	51	1		peri	0								
892C		892	14	semi-formed	SRR11419072	PRJNA545312	12		6	2	cord	Non-Hodgkin's Lymphoma	6f4904474ae52a6c21eee6	51	1		post	1								
892D		892	20	formed	SRR11419071	PRJNA545312	18		6	2	cord	Non-Hodgkin's Lymphoma	6f4904474ae52a6c21eee6	51	1		post	2								
892E		892	27	liquid	SRR11419070	PRJNA545312	25		6	2	cord	Non-Hodgkin's Lymphoma	6f4904474ae52a6c21eee6	51	1		post	3								
892F		892	36	formed	SRR11419069	PRJNA545312	34		6	2	cord	Non-Hodgkin's Lymphoma	6f4904474ae52a6c21eee6	51	1		post	4								
893A		893	0	liquid	SRR11419068	PRJNA545312	10		1	-10	PBSC_unmodified	Myelodysplastic Syndromes	f50a9c77c2cfc833ca7718	609	1		post	1								
894A		894	0	semi-formed	SRR11419066	PRJNA545312	0		3	0	BM_unmodified	Leukemia	fbd71013cda7e36c63fe68	628	1		peri	-1								
894B		894	7	formed	SRR11419065	PRJNA545312	7		3	0	BM_unmodified	Leukemia	fbd71013cda7e36c63fe68	628	1		post	0								
894C		894	14	semi-formed	SRR11419064	PRJNA545312	14		3	0	BM_unmodified	Leukemia	fbd71013cda7e36c63fe68	628	1		post	1								
895A		895	0	formed	SRR11419063	PRJNA545312	1686		1	-1686	TCD	Leukemia	f821a13262bf72f7449e71		1											
896A		896	0	formed	SRR11419062	PRJNA545312	-5		8	5	cord	Non-Hodgkin's Lymphoma	a13d11f37be6ac5d5f2eb9	525	1		pre	-1								
896B		896	2	formed	SRR11419061	PRJNA545312	-3		8	5	cord	Non-Hodgkin's Lymphoma	a13d11f37be6ac5d5f2eb9	525	1		pre	-1								
896D		896	16	semi-formed	SRR11419060	PRJNA545312	11		8	5	cord	Non-Hodgkin's Lymphoma	a13d11f37be6ac5d5f2eb9	525	1		post	1								
896E		896	23	semi-formed	SRR11419059	PRJNA545312	18		8	5	cord	Non-Hodgkin's Lymphoma	a13d11f37be6ac5d5f2eb9	525	1		post	2								
896F		896	30	formed	SRR11419058	PRJNA545312	25		8	5	cord	Non-Hodgkin's Lymphoma	a13d11f37be6ac5d5f2eb9	525	1		post	3								
896G		896	32	formed	SRR11419057	PRJNA545312	27		8	5	cord	Non-Hodgkin's Lymphoma	a13d11f37be6ac5d5f2eb9	525	1		post	3								
896I		896	129	liquid	SRR11419055	PRJNA545312	124		8	5	cord	Non-Hodgkin's Lymphoma	a13d11f37be6ac5d5f2eb9	525	1		post	6								
896J		896	154	liquid	SRR11419054	PRJNA545312	149		8	5	cord	Non-Hodgkin's Lymphoma	a13d11f37be6ac5d5f2eb9	525	1		post	6								
897A		pt_with_samples_2021_897	132	formed	SRR11419053	PRJNA545312	-2		3	134	BM_unmodified	Leukemia	c8d8ec8ce947b7436a9561	596	1		pre	-1								
897B		pt_with_samples_2021_897	139	formed	SRR11419052	PRJNA545312	5		3	134	BM_unmodified	Leukemia	c8d8ec8ce947b7436a9561	596	1		peri	0								
898A		898	0	semi-formed	SRR11419051	PRJNA545312	-7		1	7	TCD	Leukemia	1ffaaff038cfded84a28d5	648	1		pre	-2								
899A		899	0	formed	SRR11419050	PRJNA545312	-5		4	441	cord	Leukemia	8fc58809e777d1ff8ad319		1		pre	-1								
899B		899	6	semi-formed	SRR11419049	PRJNA545312	1		4	441	cord	Leukemia	8fc58809e777d1ff8ad319		1		peri	0								
899C		899	15	formed	SRR11418611	PRJNA545312	10		4	441	cord	Leukemia	8fc58809e777d1ff8ad319		1		post	1								
899F		899	698	formed	SRR11418610	PRJNA545312	257		4	441	cord	Leukemia	8fc58809e777d1ff8ad319		1		post	6								
900A		900	0	formed	SRR11418609	PRJNA545312	3		1	-3	PBSC_unmodified	Non-Hodgkin's Lymphoma	22e2d07ce76de8b1f34f2b	514	1		peri	0								
901A		901	0	formed	SRR11140344	PRJNA606262			1																	
902A		902	0	liquid	SRR11418607	PRJNA545312	-3		4	3	TCD	Multiple Myeloma	14574aa7babd417c928d0e	590	1		pre	-1								
902B		902	7	liquid	SRR11418606	PRJNA545312	4		4	3	TCD	Multiple Myeloma	14574aa7babd417c928d0e	590	1		peri	0								
902C		902	11	formed	SRR11418605	PRJNA545312	8		4	3	TCD	Multiple Myeloma	14574aa7babd417c928d0e	590	1		post	1								
902D		902	14	formed	SRR11418604	PRJNA545312	11		4	3	TCD	Multiple Myeloma	14574aa7babd417c928d0e	590	1		post	1								
903A		903	0	formed	SRR11418603	PRJNA545312	-8		1	8	TCD	Multiple Myeloma	6407a0de68419469f2f4f9	576	1		pre	-2								
904A		904	0	formed	SRR11418602	PRJNA545312	-9		3	9	TCD	Leukemia	266173497a45d8e5e02bc0	626	1		pre	-2								
904B		904	5	formed	SRR11418601	PRJNA545312	-4		3	9	TCD	Leukemia	266173497a45d8e5e02bc0	626	1		pre	-1								
904E		904	19	semi-formed	SRR11418600	PRJNA545312	10		3	9	TCD	Leukemia	266173497a45d8e5e02bc0	626	1		post	1								
905A		905	0	formed	SRR11418599	PRJNA545312	-5		2	5	cord	Leukemia	6eeb6bd19dba5d65981a00	521	1		pre	-1								
905B		905	11	liquid	SRR11418598	PRJNA545312	6		2	5	cord	Leukemia	6eeb6bd19dba5d65981a00	521	1		post	0								
906A		906	0	semi-formed	SRR11418596	PRJNA545312	-4		3	4	cord	Myelodysplastic Syndromes	80bafdc80969d20b175b97	571	1		pre	-1								
906B		906	9	liquid	SRR11418595	PRJNA545312	5		3	4	cord	Myelodysplastic Syndromes	80bafdc80969d20b175b97	571	1		peri	0								
906C		906	15	semi-formed	SRR11418594	PRJNA545312	11		3	4	cord	Myelodysplastic Syndromes	80bafdc80969d20b175b97	571	1		post	1								
907A		907	0	formed	SRR11418593	PRJNA545312	-6		3	6	PBSC_unmodified	Leukemia	a8f5f6a6dbdd5f2b5dfed3	634	1		pre	-1								
907B		907	5	liquid	SRR11418592	PRJNA545312	-1		3	6	PBSC_unmodified	Leukemia	a8f5f6a6dbdd5f2b5dfed3	634	1		pre	-1								
907C		907	19	semi-formed	SRR11418591	PRJNA545312	13		3	6	PBSC_unmodified	Leukemia	a8f5f6a6dbdd5f2b5dfed3	634	1		post	1								
908A		908	0	formed	SRR11418590	PRJNA545312	1		4	-1	cord	Leukemia	82eb9ed5af7f5305dc4a0c	664	1		peri	0								
908C		908	5	semi-formed	SRR11418588	PRJNA545312	6		4	-1	cord	Leukemia	82eb9ed5af7f5305dc4a0c	664	1		post	0								
908D		908	11	semi-formed	SRR11418587	PRJNA545312	12		4	-1	cord	Leukemia	82eb9ed5af7f5305dc4a0c	664	1		post	1								
908E		908	18	liquid	SRR11418585	PRJNA545312	19		4	-1	cord	Leukemia	82eb9ed5af7f5305dc4a0c	664	1		post	2								
909A		909	0	formed	SRR11418584	PRJNA545312	-9		4	9	TCD	Multiple Myeloma	b389dfa261297233a34ab1	132	1		pre	-2								
909B		909	6	semi-formed	SRR11418527	PRJNA545312	-3		4	9	TCD	Multiple Myeloma	b389dfa261297233a34ab1	132	1		pre	-1								
909C		909	13	liquid	SRR11418526	PRJNA545312	4		4	9	TCD	Multiple Myeloma	b389dfa261297233a34ab1	132	1		peri	0								
909D		909	19	semi-formed	SRR11418525	PRJNA545312	10		4	9	TCD	Multiple Myeloma	b389dfa261297233a34ab1	132	1		post	1								
910A		910	0	formed	SRR11418524	PRJNA545312	-7		3	7	TCD	Leukemia	ca2cb49b4a32d4cd31c072	612	1		pre	-2								
910B		910	13	liquid	SRR11418523	PRJNA545312	6		3	7	TCD	Leukemia	ca2cb49b4a32d4cd31c072	612	1		post	0								
910C		910	18	liquid	SRR11418522	PRJNA545312	11		3	7	TCD	Leukemia	ca2cb49b4a32d4cd31c072	612	1		post	1								
911A		911	0	formed	SRR11418521	PRJNA545312	-6		2	6	cord	Leukemia	9e152e0fadf83d2bfe93b3	652	1		pre	-1								
911B		911	3	formed	SRR11418520	PRJNA545312	-3		2	6	cord	Leukemia	9e152e0fadf83d2bfe93b3	652	1		pre	-1								
912A		912	0	formed	SRR11140004	PRJNA606262			1																	
913A		913	0	formed	SRR11418518	PRJNA545312	-9		2	9	TCD	Multiple Myeloma	e3ef49c3bae2f966301325	49	1		pre	-2								
913B		913	6	semi-formed	SRR11418517	PRJNA545312	-3		2	9	TCD	Multiple Myeloma	e3ef49c3bae2f966301325	49	1		pre	-1								
915A		915	0	semi-formed	SRR11418516	PRJNA545312	11		1	-11	cord	Aplastic Anemia	a7adc621a01de127ce3245	655	1		post	1								
916A		916	0	semi-formed	SRR11418515	PRJNA545312	-2		4	2	cord	Leukemia	ee7a7830827d25989e5d38	41	1		pre	-1								
916C		916	25	liquid	SRR11418514	PRJNA545312	23		4	2	cord	Leukemia	ee7a7830827d25989e5d38	41	1		post	3								
916D		916	32	liquid	SRR11418513	PRJNA545312	30		4	2	cord	Leukemia	ee7a7830827d25989e5d38	41	1		post	4								
916E		916	36	semi-formed	SRR11418512	PRJNA545312	34		4	2	cord	Leukemia	ee7a7830827d25989e5d38	41	1		post	4								
917A		917	0	formed	SRR11418511	PRJNA545312	-6		3	6	TCD	Leukemia	6af667d68c2875f2815626	660	1		pre	-1								
917C		917	12	formed	SRR11418510	PRJNA545312	6		3	6	TCD	Leukemia	6af667d68c2875f2815626	660	1		post	0								
917D		917	17	semi-formed	SRR11418509	PRJNA545312	11		3	6	TCD	Leukemia	6af667d68c2875f2815626	660	1		post	1								
918A		918	0	liquid	SRR11418506	PRJNA545312	4		1	-4	PBSC_unmodified	Leukemia	92ec3f08ae2b17c735baef	186	1		peri	0								
919A		919	0	formed	SRR11418505	PRJNA545312	-3		2	3	TCD	Multiple Myeloma	cbb34eb86177475e5630b0	614	1		pre	-1								
919B		919	4	liquid	SRR11418504	PRJNA545312	1		2	3	TCD	Multiple Myeloma	cbb34eb86177475e5630b0	614	1		peri	0								
91A		pt_with_samples_185_91	576	formed	SRR11418503	PRJNA545312	-1		9	577	cord	Non-Hodgkin's Lymphoma	528a13bfba5b2c8c3d0be8	250	1		pre	-1								
91C		pt_with_samples_185_91	582	formed	SRR11418502	PRJNA545312	5		9	577	cord	Non-Hodgkin's Lymphoma	528a13bfba5b2c8c3d0be8	250	1		peri	0								
91D		pt_with_samples_185_91	588	semi-formed	SRR11418501	PRJNA545312	11		9	577	cord	Non-Hodgkin's Lymphoma	528a13bfba5b2c8c3d0be8	250	1		post	1								
91E		pt_with_samples_185_91	595	formed	SRR11418500	PRJNA545312	18		9	577	cord	Non-Hodgkin's Lymphoma	528a13bfba5b2c8c3d0be8	250	1		post	2								
91F		pt_with_samples_185_91	609	formed	SRR11418471	PRJNA545312	32		9	577	cord	Non-Hodgkin's Lymphoma	528a13bfba5b2c8c3d0be8	250	1		post	4								
91G		pt_with_samples_185_91	648	liquid	SRR11418470	PRJNA545312	71		9	577	cord	Non-Hodgkin's Lymphoma	528a13bfba5b2c8c3d0be8	250	1		post	6								
91H		pt_with_samples_185_91	651	liquid	SRR11418469	PRJNA545312	74		9	577	cord	Non-Hodgkin's Lymphoma	528a13bfba5b2c8c3d0be8	250	1		post	6								
91I		pt_with_samples_185_91	672	semi-formed	SRR11418467	PRJNA545312	95		9	577	cord	Non-Hodgkin's Lymphoma	528a13bfba5b2c8c3d0be8	250	1		post	6								
920A		920	0	semi-formed	SRR11418466	PRJNA545312	-5		4	5	TCD	Multiple Myeloma	78e693ca15d61e3f6f81a3	631	1		pre	-1								
920B		920	4	liquid	SRR11418465	PRJNA545312	-1		4	5	TCD	Multiple Myeloma	78e693ca15d61e3f6f81a3	631	1		pre	-1								
920C		920	8	liquid	SRR11418464	PRJNA545312	3		4	5	TCD	Multiple Myeloma	78e693ca15d61e3f6f81a3	631	1		peri	0								
920D		920	51	liquid	SRR11418463	PRJNA545312	46		4	5	TCD	Multiple Myeloma	78e693ca15d61e3f6f81a3	631	1		post	6								
921A		921	0	formed	SRR11418462	PRJNA545312	-5		4	5	TCD	Leukemia	52ed4a61094de68341ffdf	640	1		pre	-1								
921B		921	3	liquid	SRR11418461	PRJNA545312	-2		4	5	TCD	Leukemia	52ed4a61094de68341ffdf	640	1		pre	-1								
921F		921	24	formed	SRR11418460	PRJNA545312	19		4	5	TCD	Leukemia	52ed4a61094de68341ffdf	640	1		post	2								
921G		921	52	formed	SRR11418459	PRJNA545312	47		4	5	TCD	Leukemia	52ed4a61094de68341ffdf	640	1		post	6								
922A		922	0	semi-formed	SRR11418458	PRJNA545312	-3		3	3	PBSC_unmodified	Leukemia	bcf0771451dbd779eff8e1	140	1		pre	-1								
922B		922	7	semi-formed	SRR11418456	PRJNA545312	4		3	3	PBSC_unmodified	Leukemia	bcf0771451dbd779eff8e1	140	1		peri	0								
922C		922	21	semi-formed	SRR11418455	PRJNA545312	18		3	3	PBSC_unmodified	Leukemia	bcf0771451dbd779eff8e1	140	1		post	2								
923A		923	0	formed	SRR11418454	PRJNA545312	-8		5	8	TCD	Leukemia	a32280c7e28a61b98bcee8	673	1		pre	-2								
923B		923	1	liquid	SRR11418453	PRJNA545312	-7		5	8	TCD	Leukemia	a32280c7e28a61b98bcee8	673	1		pre	-2								
923C		923	20	semi-formed	SRR11418452	PRJNA545312	12		5	8	TCD	Leukemia	a32280c7e28a61b98bcee8	673	1		post	1								
923E		923	91	formed	SRR11418451	PRJNA545312	83		5	8	TCD	Leukemia	a32280c7e28a61b98bcee8	673	1		post	6								
923F		923	104	semi-formed	SRR11418450	PRJNA545312	96		5	8	TCD	Leukemia	a32280c7e28a61b98bcee8	673	1		post	6								
924A		924	0	liquid	SRR11418449	PRJNA545312	2		5	-2	cord	Leukemia	588be6bf68d058e001d5e3	650	1		peri	0								
924B		924	2	liquid	SRR11418448	PRJNA545312	4		5	-2	cord	Leukemia	588be6bf68d058e001d5e3	650	1		peri	0								
924C		924	10	semi-formed	SRR11418447	PRJNA545312	12		5	-2	cord	Leukemia	588be6bf68d058e001d5e3	650	1		post	1								
924D		924	18	liquid	SRR11418445	PRJNA545312	20		5	-2	cord	Leukemia	588be6bf68d058e001d5e3	650	1		post	2								
924E		924	23	liquid	SRR11418444	PRJNA545312	25		5	-2	cord	Leukemia	588be6bf68d058e001d5e3	650	1		post	3								
925A		925	0	liquid	SRR11418882	PRJNA545312	1		5	-1	TCD	Leukemia	8681eda329c0289683009c	663	1		peri	0								
925B		925	4	liquid	SRR11418881	PRJNA545312	5		5	-1	TCD	Leukemia	8681eda329c0289683009c	663	1		peri	0								
925C		925	8	liquid	SRR11418880	PRJNA545312	9		5	-1	TCD	Leukemia	8681eda329c0289683009c	663	1		post	1								
925D		925	10	liquid	SRR11418879	PRJNA545312	11		5	-1	TCD	Leukemia	8681eda329c0289683009c	663	1		post	1								
925E		925	26	formed	SRR11418878	PRJNA545312	27		5	-1	TCD	Leukemia	8681eda329c0289683009c	663	1		post	3								
926A		926	0	semi-formed	SRR11418877	PRJNA545312	-5		7	5	TCD	Multiple Myeloma	59c9825a8fe4c94665753a	372	1		pre	-1								
926B		926	4	liquid	SRR11418876	PRJNA545312	-1		7	5	TCD	Multiple Myeloma	59c9825a8fe4c94665753a	372	1		pre	-1								
926C		926	7	liquid	SRR11418875	PRJNA545312	2		7	5	TCD	Multiple Myeloma	59c9825a8fe4c94665753a	372	1		peri	0								
926D		926	9	liquid	SRR11418873	PRJNA545312	4		7	5	TCD	Multiple Myeloma	59c9825a8fe4c94665753a	372	1		peri	0								
926E		926	16	semi-formed	SRR11418872	PRJNA545312	11		7	5	TCD	Multiple Myeloma	59c9825a8fe4c94665753a	372	1		post	1								
926F		926	173	liquid	SRR11418871	PRJNA545312	168		7	5	TCD	Multiple Myeloma	59c9825a8fe4c94665753a	372	1		post	6								
926G		926	858	semi-formed	SRR11418870	PRJNA545312	853		7	5	TCD	Multiple Myeloma	59c9825a8fe4c94665753a	372	1		post	6								
927A		927	0	formed	SRR11418869	PRJNA545312	-6		2	6	TCD	Myelodysplastic Syndromes	d5c68121c63178191417f0	618	1		pre	-1								
927B		927	9	liquid	SRR11418868	PRJNA545312	3		2	6	TCD	Myelodysplastic Syndromes	d5c68121c63178191417f0	618	1		peri	0								
928B		928	13	semi-formed	SRR11418866	PRJNA545312	8		1	5	PBSC_unmodified	Hodgkin's Disease	4509e8bcbfc6694b4001b6	555	1		post	1								
929A		929	0	formed	SRR11418865	PRJNA545312	-3		3	3	TCD	Leukemia	ec5d4bb4a445038b6e906b	647	1		pre	-1								
929B		929	7	semi-formed	SRR11418864	PRJNA545312	4		3	3	TCD	Leukemia	ec5d4bb4a445038b6e906b	647	1		peri	0								
929C		929	15	liquid	SRR11418862	PRJNA545312	12		3	3	TCD	Leukemia	ec5d4bb4a445038b6e906b	647	1		post	1								
930A		930	0	formed	SRR11418861	PRJNA545312	-8		9	8	TCD	Multiple Myeloma	9aef9dae8a446eacf1ed0b	74	1		pre	-2								
930B		930	4	liquid	SRR11418860	PRJNA545312	-4		9	8	TCD	Multiple Myeloma	9aef9dae8a446eacf1ed0b	74	1		pre	-1								
930C		930	8	liquid	SRR11418859	PRJNA545312	0		9	8	TCD	Multiple Myeloma	9aef9dae8a446eacf1ed0b	74	1		peri	-1								
930E		930	26	formed	SRR11418858	PRJNA545312	18		9	8	TCD	Multiple Myeloma	9aef9dae8a446eacf1ed0b	74	1		post	2								
930F		930	63	liquid	SRR11418857	PRJNA545312	55		9	8	TCD	Multiple Myeloma	9aef9dae8a446eacf1ed0b	74	1		post	6								
930G		930	71	liquid	SRR11418856	PRJNA545312	63		9	8	TCD	Multiple Myeloma	9aef9dae8a446eacf1ed0b	74	1		post	6								
930H		930	76	liquid	SRR11418855	PRJNA545312	68		9	8	TCD	Multiple Myeloma	9aef9dae8a446eacf1ed0b	74	1		post	6								
930I		930	91	semi-formed	SRR11418742	PRJNA545312	83		9	8	TCD	Multiple Myeloma	9aef9dae8a446eacf1ed0b	74	1		post	6								
930J		930	105	formed	SRR11418741	PRJNA545312	97		9	8	TCD	Multiple Myeloma	9aef9dae8a446eacf1ed0b	74	1		post	6								
931A		931	0	semi-formed	SRR11139594	PRJNA606262			1																	
932B		FMT.0017	0	liquid	SRR11418738	PRJNA545312	-4		14	308	PBSC_unmodified	Leukemia	61e3a931ca0188b382a796	654	1		pre	-1								
932C		FMT.0017	14	semi-formed	SRR11418737	PRJNA545312	10		14	308	PBSC_unmodified	Leukemia	61e3a931ca0188b382a796	654	1		post	1								
932D		FMT.0017	16	semi-formed	SRR11418736	PRJNA545312	12		14	308	PBSC_unmodified	Leukemia	61e3a931ca0188b382a796	654	1		post	1								
932F		FMT.0017	23	liquid	SRR11418734	PRJNA545312	19		14	308	PBSC_unmodified	Leukemia	61e3a931ca0188b382a796	654	1		post	2								
932G		FMT.0017	31	formed	SRR11418733	PRJNA545312	27		14	308	PBSC_unmodified	Leukemia	61e3a931ca0188b382a796	654	1		post	3								
932H		FMT.0017	257	semi-formed	SRR11418732	PRJNA545312	-51		14	308	PBSC_unmodified	Leukemia	61e3a931ca0188b382a796	654	1		pre	-3								
932I		FMT.0017	265	semi-formed	SRR11418731	PRJNA545312	-43		14	308	PBSC_unmodified	Leukemia	61e3a931ca0188b382a796	654	1		pre	-3								
932J		FMT.0017	269	formed	SRR11418730	PRJNA545312	-39		14	308	PBSC_unmodified	Leukemia	61e3a931ca0188b382a796	654	1		pre	-3								
933A		933	0	formed	SRR11418728	PRJNA545312	17		3	-17	cord	Leukemia	7ee3afeddc666009d93b29	637	1		post	2								
933B		933	22	semi-formed	SRR11418727	PRJNA545312	39		3	-17	cord	Leukemia	7ee3afeddc666009d93b29	637	1		post	5								
933C		933	126	semi-formed	SRR11418726	PRJNA545312	143		3	-17	cord	Leukemia	7ee3afeddc666009d93b29	637	1		post	6								
934A		FMT.0085	0	formed	SRR11418725	PRJNA545312	-8		12	603	PBSC_unmodified	Myeloproliferative Disorder	ad70c1155dcb39600174d5		1		pre	-2								
934B		FMT.0085	9	liquid	SRR11418724	PRJNA545312	1		12	603	PBSC_unmodified	Myeloproliferative Disorder	ad70c1155dcb39600174d5		1		peri	0								
934C		FMT.0085	15	semi-formed	SRR11418723	PRJNA545312	7		12	603	PBSC_unmodified	Myeloproliferative Disorder	ad70c1155dcb39600174d5		1		post	0								
934D		FMT.0085	22	formed	SRR11418722	PRJNA545312	14		12	603	PBSC_unmodified	Myeloproliferative Disorder	ad70c1155dcb39600174d5		1		post	1								
935A		935	0	semi-formed	SRR11140349	PRJNA606262			2																	
935B		935	8	liquid	SRR11140348	PRJNA606262			2																	
936A		936	0	liquid	SRR11418721	PRJNA545312	-2		4	2	TCD	Leukemia	02c090ef3457811a0d46ca	658	1		pre	-1								
936C		936	13	liquid	SRR11418720	PRJNA545312	11		4	2	TCD	Leukemia	02c090ef3457811a0d46ca	658	1		post	1								
936D		936	16	formed	SRR11418719	PRJNA545312	14		4	2	TCD	Leukemia	02c090ef3457811a0d46ca	658	1		post	1								
936E		936	20	formed	SRR11418717	PRJNA545312	18		4	2	TCD	Leukemia	02c090ef3457811a0d46ca	658	1		post	2								
937B		937	0	formed	SRR11418715	PRJNA545312	1		2	-1	PBSC_unmodified	Leukemia	01f11bdcbd4b0897d528d6	217	1		peri	0								
937C		937	10	liquid	SRR11419275	PRJNA545312	11		2	-1	PBSC_unmodified	Leukemia	01f11bdcbd4b0897d528d6	217	1		post	1								
938A		938	0	formed	SRR11419274	PRJNA545312	-2		2	2	TCD	Myelodysplastic Syndromes	d1b6973b7297b113542be3	639	1		pre	-1								
938B		938	7	semi-formed	SRR11419273	PRJNA545312	5		2	2	TCD	Myelodysplastic Syndromes	d1b6973b7297b113542be3	639	1		peri	0								
939A		939	0	liquid	SRR11419272	PRJNA545312	0		3	0	PBSC_unmodified	Leukemia	8e3c69d859c28a27d7a36f	674	1		peri	-1								
939B		939	7	liquid	SRR11419271	PRJNA545312	7		3	0	PBSC_unmodified	Leukemia	8e3c69d859c28a27d7a36f	674	1		post	0								
939C		939	17	liquid	SRR11419270	PRJNA545312	17		3	0	PBSC_unmodified	Leukemia	8e3c69d859c28a27d7a36f	674	1		post	2								
940A		940	0	formed	SRR11419269	PRJNA545312	0		3	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	28bab4b5126fa7cbb96e36	2	1		peri	-1								
940B		940	6	formed	SRR11419267	PRJNA545312	6		3	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	28bab4b5126fa7cbb96e36	2	1		post	0								
940C		940	12	formed	SRR11419266	PRJNA545312	12		3	0	PBSC_unmodified	Non-Hodgkin's Lymphoma	28bab4b5126fa7cbb96e36	2	1		post	1								
941A		941	0	formed	SRR11419265	PRJNA545312	-7		4	7	TCD	Myelodysplastic Syndromes	8b90bb2843183d2efcde0c	38	1		pre	-2								
941B		941	6	semi-formed	SRR11419264	PRJNA545312	-1		4	7	TCD	Myelodysplastic Syndromes	8b90bb2843183d2efcde0c	38	1		pre	-1								
941C		941	12	semi-formed	SRR11419263	PRJNA545312	5		4	7	TCD	Myelodysplastic Syndromes	8b90bb2843183d2efcde0c	38	1		peri	0								
941D		941	16	semi-formed	SRR11419262	PRJNA545312	9		4	7	TCD	Myelodysplastic Syndromes	8b90bb2843183d2efcde0c	38	1		post	1								
943A		943	0	semi-formed	SRR11419261	PRJNA545312	-9		6	9	TCD	Leukemia	542021af8537fc4c00507e	656	1		pre	-2								
943B		943	7	semi-formed	SRR11419260	PRJNA545312	-2		6	9	TCD	Leukemia	542021af8537fc4c00507e	656	1		pre	-1								
943C		943	12	liquid	SRR11419259	PRJNA545312	3		6	9	TCD	Leukemia	542021af8537fc4c00507e	656	1		peri	0								
943D		943	123	formed	SRR11419258	PRJNA545312	114		6	9	TCD	Leukemia	542021af8537fc4c00507e	656	1		post	6								
943E		943	138	formed	SRR11419255	PRJNA545312	129		6	9	TCD	Leukemia	542021af8537fc4c00507e	656	1		post	6								
943F		943	151	formed	SRR11419254	PRJNA545312	142		6	9	TCD	Leukemia	542021af8537fc4c00507e	656	1		post	6								
944A		944	0	semi-formed	SRR11140305	PRJNA606262			1																	
945A		945	0	liquid	SRR11140520	PRJNA606262			1																	
946A		946	0	formed	SRR11419253	PRJNA545312	-3		5	3	BM_unmodified	Leukemia	1193c9ff8adad5ad6add33	583	1		pre	-1								
946B		946	6	semi-formed	SRR11419252	PRJNA545312	3		5	3	BM_unmodified	Leukemia	1193c9ff8adad5ad6add33	583	1		peri	0								
946D		946	34	liquid	SRR11419251	PRJNA545312	31		5	3	BM_unmodified	Leukemia	1193c9ff8adad5ad6add33	583	1		post	4								
946E		946	48	liquid	SRR11419250	PRJNA545312	45		5	3	BM_unmodified	Leukemia	1193c9ff8adad5ad6add33	583	1		post	6								
946F		946	141	liquid	SRR11419249	PRJNA545312	138		5	3	BM_unmodified	Leukemia	1193c9ff8adad5ad6add33	583	1		post	6								
947A		947	0	formed	SRR11419248	PRJNA545312	-3		6	3	PBSC_unmodified	Leukemia	b42585d2b56a4007344cde	680	1		pre	-1								
947B		947	7	liquid	SRR11419104	PRJNA545312	4		6	3	PBSC_unmodified	Leukemia	b42585d2b56a4007344cde	680	1		peri	0								
947C		947	18	liquid	SRR11419103	PRJNA545312	15		6	3	PBSC_unmodified	Leukemia	b42585d2b56a4007344cde	680	1		post	2								
947D		947	23	liquid	SRR11419101	PRJNA545312	20		6	3	PBSC_unmodified	Leukemia	b42585d2b56a4007344cde	680	1		post	2								
947E		947	27	semi-formed	SRR11419100	PRJNA545312	24		6	3	PBSC_unmodified	Leukemia	b42585d2b56a4007344cde	680	1		post	3								
947F		947	69	liquid	SRR11419099	PRJNA545312	66		6	3	PBSC_unmodified	Leukemia	b42585d2b56a4007344cde	680	1		post	6								
948A		948	0	liquid	SRR11419098	PRJNA545312	-3		4	3	PBSC_unmodified	Leukemia	fc02ad78d0c63eff08b666	653	1		pre	-1								
948B		948	3	formed	SRR11419097	PRJNA545312	0		4	3	PBSC_unmodified	Leukemia	fc02ad78d0c63eff08b666	653	1		peri	-1								
948D		948	13	liquid	SRR11419096	PRJNA545312	10		4	3	PBSC_unmodified	Leukemia	fc02ad78d0c63eff08b666	653	1		post	1								
948E		948	22	semi-formed	SRR11419095	PRJNA545312	19		4	3	PBSC_unmodified	Leukemia	fc02ad78d0c63eff08b666	653	1		post	2								
949A		949	0	formed	SRR11419094	PRJNA545312	-6		6	6	cord	Myelodysplastic Syndromes	02aa183acb0417206586ec	657	1		pre	-1								
949B		949	9	semi-formed	SRR11419857	PRJNA545312	3		6	6	cord	Myelodysplastic Syndromes	02aa183acb0417206586ec	657	1		peri	0								
949C		949	11	formed	SRR11419846	PRJNA545312	5		6	6	cord	Myelodysplastic Syndromes	02aa183acb0417206586ec	657	1		peri	0								
949D		949	25	formed	SRR11419818	PRJNA545312	19		6	6	cord	Myelodysplastic Syndromes	02aa183acb0417206586ec	657	1		post	2								
949E		949	32	liquid	SRR11419807	PRJNA545312	26		6	6	cord	Myelodysplastic Syndromes	02aa183acb0417206586ec	657	1		post	3								
949F		949	95	semi-formed	SRR11419796	PRJNA545312	89		6	6	cord	Myelodysplastic Syndromes	02aa183acb0417206586ec	657	1		post	6								
950A		950	0	formed	SRR11419093	PRJNA545312	-9		4	1377	PBSC_unmodified	Myelodysplastic Syndromes	b933e14b6f06b036662c4e	43	1		pre	-2								
950B		950	8	semi-formed	SRR11420092	PRJNA545312	-1		4	1377	PBSC_unmodified	Myelodysplastic Syndromes	b933e14b6f06b036662c4e	43	1		pre	-1								
950C		950	13	liquid	SRR11420080	PRJNA545312	4		4	1377	PBSC_unmodified	Myelodysplastic Syndromes	b933e14b6f06b036662c4e	43	1		peri	0								
950D		950	22	liquid	SRR11419092	PRJNA545312	13		4	1377	PBSC_unmodified	Myelodysplastic Syndromes	b933e14b6f06b036662c4e	43	1		post	1								
951A		951	0	semi-formed	SRR11419090	PRJNA545312	-6		2	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	34d74267ed2a07301223af	625	1		pre	-1								
951B		951	25	semi-formed	SRR11420069	PRJNA545312	19		2	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	34d74267ed2a07301223af	625	1		post	2								
952A		952	0	liquid	SRR11420058	PRJNA545312			4																	
952B		952	11	liquid	SRR11419750	PRJNA545312			4																	
952D		952	21	liquid	SRR11419739	PRJNA545312			4																	
952E		952	28	liquid	SRR11419728	PRJNA545312			4																	
953A		953	0	liquid	SRR11419661	PRJNA545312	0		3	0	cord	Leukemia	89b935fe52371e9633f515	649	1		peri	-1								
953B		953	12	semi-formed	SRR11419650	PRJNA545312	12		3	0	cord	Leukemia	89b935fe52371e9633f515	649	1		post	1								
953C		953	27	formed	SRR11419639	PRJNA545312	27		3	0	cord	Leukemia	89b935fe52371e9633f515	649	1		post	3								
954A		954	0	formed	SRR11419831	PRJNA545312	-2		3	2	TCD	Myelodysplastic Syndromes	228f061101e35ef796eb31	651	1		pre	-1								
954D		954	20	liquid	SRR11419578	PRJNA545312	18		3	2	TCD	Myelodysplastic Syndromes	228f061101e35ef796eb31	651	1		post	2								
954E		954	26	liquid	SRR11419577	PRJNA545312	24		3	2	TCD	Myelodysplastic Syndromes	228f061101e35ef796eb31	651	1		post	3								
955A		955	0	formed	SRR11419576	PRJNA545312	-5		3	5	PBSC_unmodified	Leukemia	72b3c3970c16c4adfbbb80	604	1		pre	-1								
955B		955	1	formed	SRR11419575	PRJNA545312	-4		3	5	PBSC_unmodified	Leukemia	72b3c3970c16c4adfbbb80	604	1		pre	-1								
955C		955	2	formed	SRR11419574	PRJNA545312	-3		3	5	PBSC_unmodified	Leukemia	72b3c3970c16c4adfbbb80	604	1		pre	-1								
956A		956	0	formed	SRR11419573	PRJNA545312	-13		9	13	cord	Leukemia	35a874ec30e3a0b5a27594	645	1		pre	-2								
956B		956	7	semi-formed	SRR11419572	PRJNA545312	-6		9	13	cord	Leukemia	35a874ec30e3a0b5a27594	645	1		pre	-1								
956C		956	11	semi-formed	SRR11419571	PRJNA545312	-2		9	13	cord	Leukemia	35a874ec30e3a0b5a27594	645	1		pre	-1								
956D		956	18	liquid	SRR11419570	PRJNA545312	5		9	13	cord	Leukemia	35a874ec30e3a0b5a27594	645	1		peri	0								
956E		956	25	liquid	SRR11419569	PRJNA545312	12		9	13	cord	Leukemia	35a874ec30e3a0b5a27594	645	1		post	1								
956F		956	36	liquid	SRR11419567	PRJNA545312	23		9	13	cord	Leukemia	35a874ec30e3a0b5a27594	645	1		post	3								
956G		956	41	semi-formed	SRR11419566	PRJNA545312	28		9	13	cord	Leukemia	35a874ec30e3a0b5a27594	645	1		post	3								
956H		956	46	semi-formed	SRR11419565	PRJNA545312	33		9	13	cord	Leukemia	35a874ec30e3a0b5a27594	645	1		post	4								
956I		956	55	semi-formed	SRR11419089	PRJNA545312	42		9	13	cord	Leukemia	35a874ec30e3a0b5a27594	645	1		post	5								
957A		957	0	formed	SRR11419088	PRJNA545312	-5		4	5	cord	Leukemia	89a8821ca25a11f8f606d2	632	1		pre	-1								
957B		957	13	liquid	SRR11419087	PRJNA545312	8		4	5	cord	Leukemia	89a8821ca25a11f8f606d2	632	1		post	1								
957C		957	17	liquid	SRR11419564	PRJNA545312	12		4	5	cord	Leukemia	89a8821ca25a11f8f606d2	632	1		post	1								
957D		957	94	semi-formed	SRR11419563	PRJNA545312	89		4	5	cord	Leukemia	89a8821ca25a11f8f606d2	632	1		post	6								
958A		958	0	formed	SRR11140115	PRJNA606262			3																	
958B		958	7	formed	SRR11140114	PRJNA606262			3																	
958C		958	13	formed	SRR11140113	PRJNA606262			3																	
959B		959	8	liquid	SRR11419562	PRJNA545312	13		2	-5	PBSC_unmodified	Leukemia	7b3c7bbceaf231d8a03678	211	0		post	1								
959C		959	14	semi-formed	SRR11419561	PRJNA545312	19		2	-5	PBSC_unmodified	Leukemia	7b3c7bbceaf231d8a03678	211	0		post	2								
961A		961	0	formed	SRR11419560	PRJNA545312	-9		6	9	TCD	Myelodysplastic Syndromes	98a61f085e33cbd64d1dc5	662	1		pre	-2								
961B		961	4	semi-formed	SRR11419559	PRJNA545312	-5		6	9	TCD	Myelodysplastic Syndromes	98a61f085e33cbd64d1dc5	662	1		pre	-1								
961C		961	8	semi-formed	SRR11419558	PRJNA545312	-1		6	9	TCD	Myelodysplastic Syndromes	98a61f085e33cbd64d1dc5	662	1		pre	-1								
961D		961	13	liquid	SRR11419556	PRJNA545312	4		6	9	TCD	Myelodysplastic Syndromes	98a61f085e33cbd64d1dc5	662	1		peri	0								
961E		961	21	liquid	SRR11419555	PRJNA545312	12		6	9	TCD	Myelodysplastic Syndromes	98a61f085e33cbd64d1dc5	662	1		post	1								
961F		961	853	liquid	SRR11419554	PRJNA545312	844		6	9	TCD	Myelodysplastic Syndromes	98a61f085e33cbd64d1dc5	662	1		post	6								
963A		963	0	semi-formed	SRR11419553	PRJNA545312	-4		7	4	PBSC_unmodified	Myelodysplastic Syndromes	3379012da2667d3dd5c96a	666	1		pre	-1								
963B		963	7	semi-formed	SRR11419552	PRJNA545312	3		7	4	PBSC_unmodified	Myelodysplastic Syndromes	3379012da2667d3dd5c96a	666	1		peri	0								
963C		963	8	semi-formed	SRR11419551	PRJNA545312	4		7	4	PBSC_unmodified	Myelodysplastic Syndromes	3379012da2667d3dd5c96a	666	1		peri	0								
963D		963	13	liquid	SRR11419764	PRJNA545312	9		7	4	PBSC_unmodified	Myelodysplastic Syndromes	3379012da2667d3dd5c96a	666	1		post	1								
963E		963	15	liquid	SRR11419763	PRJNA545312	11		7	4	PBSC_unmodified	Myelodysplastic Syndromes	3379012da2667d3dd5c96a	666	1		post	1								
963F		963	21	liquid	SRR11419762	PRJNA545312	17		7	4	PBSC_unmodified	Myelodysplastic Syndromes	3379012da2667d3dd5c96a	666	1		post	2								
963G		963	28	semi-formed	SRR11419761	PRJNA545312	24		7	4	PBSC_unmodified	Myelodysplastic Syndromes	3379012da2667d3dd5c96a	666	1		post	3								
964A		964	0		SRR11419461	PRJNA545312	-5		2	5	cord	Myeloproliferative Disorder	0e8f1931e10059e0afe730	136	1		pre	-1								
964B		964	12	semi-formed	SRR11419460	PRJNA545312	7		2	5	cord	Myeloproliferative Disorder	0e8f1931e10059e0afe730	136	1		post	0								
965A		965	0	formed	SRR11140292	PRJNA606262			2																	
965B		965	20	liquid	SRR11140291	PRJNA606262			2																	
966A		966	0	formed	SRR11419459	PRJNA545312	0		7	0	cord	Leukemia	0dbf8f3b5c44831fa63cdb	678	1		peri	-1								
966B		966	5	liquid	SRR11419458	PRJNA545312	5		7	0	cord	Leukemia	0dbf8f3b5c44831fa63cdb	678	1		peri	0								
966C		966	17	semi-formed	SRR11419457	PRJNA545312	17		7	0	cord	Leukemia	0dbf8f3b5c44831fa63cdb	678	1		post	2								
966D		966	24	semi-formed	SRR11419456	PRJNA545312	24		7	0	cord	Leukemia	0dbf8f3b5c44831fa63cdb	678	1		post	3								
966E		966	33	formed	SRR11419455	PRJNA545312	33		7	0	cord	Leukemia	0dbf8f3b5c44831fa63cdb	678	1		post	4								
966F		966	41	formed	SRR11419454	PRJNA545312	41		7	0	cord	Leukemia	0dbf8f3b5c44831fa63cdb	678	1		post	5								
966G		966	501	liquid	SRR11419453	PRJNA545312	501		7	0	cord	Leukemia	0dbf8f3b5c44831fa63cdb	678	1		post	6								
967A		967	0	liquid	SRR11140331	PRJNA606262			2																	
967B		967	7	semi-formed	SRR11140329	PRJNA606262			2																	
968B		968	12	formed	SRR11140295	PRJNA606262			1																	
969A		969	0	formed	SRR11419452	PRJNA545312	-7		7	7	TCD	Leukemia	c886d44d9d964c206a2b46	677	1		pre	-2								
969B		969	10	liquid	SRR11419450	PRJNA545312	3		7	7	TCD	Leukemia	c886d44d9d964c206a2b46	677	1		peri	0								
969C		969	11	liquid	SRR11419449	PRJNA545312	4		7	7	TCD	Leukemia	c886d44d9d964c206a2b46	677	1		peri	0								
969D		969	20	liquid	SRR11419448	PRJNA545312	13		7	7	TCD	Leukemia	c886d44d9d964c206a2b46	677	1		post	1								
969E		969	28	semi-formed	SRR11419447	PRJNA545312	21		7	7	TCD	Leukemia	c886d44d9d964c206a2b46	677	1		post	2								
969F		969	60	liquid	SRR11419086	PRJNA545312	53		7	7	TCD	Leukemia	c886d44d9d964c206a2b46	677	1		post	6								
969G		969	102	liquid	SRR11419085	PRJNA545312	95		7	7	TCD	Leukemia	c886d44d9d964c206a2b46	677	1		post	6								
970A		970	0	semi-formed	SRR11419084	PRJNA545312	5		2	-5	PBSC_unmodified	Leukemia	173e4bd8dc9ad808c67ee3	681	1		peri	0								
970B		970	1	formed	SRR11419446	PRJNA545312	6		2	-5	PBSC_unmodified	Leukemia	173e4bd8dc9ad808c67ee3	681	1		post	0								
971A		971	0	formed	SRR11140303	PRJNA606262			1																	
972A		972	0	formed	SRR11140339	PRJNA606262	-1172		17	1172	PBSC_unmodified	Myelodysplastic Syndromes	93a7002b8d9f93d3bf59a1		0											
972B		972	21	liquid	SRR11140338	PRJNA606262	-1151		17	1172	PBSC_unmodified	Myelodysplastic Syndromes	93a7002b8d9f93d3bf59a1		0											
972C		972	1170	formed	SRR9270301	PRJNA548153	-2		17	1172	PBSC_unmodified	Myelodysplastic Syndromes	93a7002b8d9f93d3bf59a1		0		pre	-1								
972D		972	1171	semi-formed	SRR9270300	PRJNA548153	-1		17	1172	PBSC_unmodified	Myelodysplastic Syndromes	93a7002b8d9f93d3bf59a1		0		pre	-1								
972E		972	1172	semi-formed	SRR9270299	PRJNA548153	0		17	1172	PBSC_unmodified	Myelodysplastic Syndromes	93a7002b8d9f93d3bf59a1		0		peri	-1								
972F		972	1175	semi-formed	SRR9270306	PRJNA548153	3		17	1172	PBSC_unmodified	Myelodysplastic Syndromes	93a7002b8d9f93d3bf59a1		0		peri	0								
972G		972	1176	semi-formed	SRR9270305	PRJNA548153	4		17	1172	PBSC_unmodified	Myelodysplastic Syndromes	93a7002b8d9f93d3bf59a1		0		peri	0								
972H		972	1177	liquid	SRR9270375	PRJNA548153	5		17	1172	PBSC_unmodified	Myelodysplastic Syndromes	93a7002b8d9f93d3bf59a1		0		peri	0								
972I		972	1179	semi-formed	SRR9270376	PRJNA548153	7		17	1172	PBSC_unmodified	Myelodysplastic Syndromes	93a7002b8d9f93d3bf59a1		0		post	0								
972K		972	1182	semi-formed	SRR9270373	PRJNA548153	10		17	1172	PBSC_unmodified	Myelodysplastic Syndromes	93a7002b8d9f93d3bf59a1		0		post	1								
972L		972	1184	formed	SRR9270374	PRJNA548153	12		17	1172	PBSC_unmodified	Myelodysplastic Syndromes	93a7002b8d9f93d3bf59a1		0		post	1								
972M		972	1185	formed	SRR9270371	PRJNA548153	13		17	1172	PBSC_unmodified	Myelodysplastic Syndromes	93a7002b8d9f93d3bf59a1		0		post	1								
972N		972	1186	semi-formed	SRR9270372	PRJNA548153	14		17	1172	PBSC_unmodified	Myelodysplastic Syndromes	93a7002b8d9f93d3bf59a1		0		post	1								
972O		972	1189	semi-formed	SRR11117031	PRJNA607574	17		17	1172	PBSC_unmodified	Myelodysplastic Syndromes	93a7002b8d9f93d3bf59a1		0		post	2								
972P		972	1191	semi-formed	SRR11117030	PRJNA607574	19		17	1172	PBSC_unmodified	Myelodysplastic Syndromes	93a7002b8d9f93d3bf59a1		0		post	2								
972Q		972	1192	semi-formed	SRR11117029	PRJNA607574	20		17	1172	PBSC_unmodified	Myelodysplastic Syndromes	93a7002b8d9f93d3bf59a1		0		post	2								
972R		972	1193	semi-formed	SRR11117028	PRJNA607574	21		17	1172	PBSC_unmodified	Myelodysplastic Syndromes	93a7002b8d9f93d3bf59a1		0		post	2								
973A		973	0	formed	SRR11419445	PRJNA545312	-3		3	3	PBSC_unmodified	Leukemia	12474450f023d1c7919551	688	1		pre	-1								
973B		973	13	formed	SRR11419444	PRJNA545312	10		3	3	PBSC_unmodified	Leukemia	12474450f023d1c7919551	688	1		post	1								
973C		973	17	semi-formed	SRR11419443	PRJNA545312	14		3	3	PBSC_unmodified	Leukemia	12474450f023d1c7919551	688	1		post	1								
974A		974	0	liquid	SRR11419442	PRJNA545312	0		3	0	TCD	Leukemia	57927b098de9d8ba64adf2	669	1		peri	-1								
974B		974	12	liquid	SRR11419441	PRJNA545312	12		3	0	TCD	Leukemia	57927b098de9d8ba64adf2	669	1		post	1								
974C		974	24	semi-formed	SRR11419439	PRJNA545312	24		3	0	TCD	Leukemia	57927b098de9d8ba64adf2	669	1		post	3								
975A		975	0	formed	SRR11140099	PRJNA606262			2																	
975B		975	14	formed	SRR11140098	PRJNA606262			2																	
976A		976	0	liquid	SRR11140302	PRJNA606262			1																	
977A		977	0	liquid	SRR11419410	PRJNA545312	-416		3	416	PBSC_unmodified	Non-Hodgkin's Lymphoma	568d5919b9f0e23608e591		1		pre	-3								
977B		977	7	liquid	SRR11419409	PRJNA545312	-409		3	416	PBSC_unmodified	Non-Hodgkin's Lymphoma	568d5919b9f0e23608e591		1		pre	-3								
977C		977	633	formed	SRR11419408	PRJNA545312	217		3	416	PBSC_unmodified	Non-Hodgkin's Lymphoma	568d5919b9f0e23608e591		1		post	6								
978A		978	0	liquid	SRR11140283	PRJNA606262			1																	
979A		979	0	formed	SRR11419407	PRJNA545312	-3		5	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	3baf5161c545f4642900e4	272	1		pre	-1								
979B		979	2	formed	SRR11419406	PRJNA545312	-1		5	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	3baf5161c545f4642900e4	272	1		pre	-1								
979C		979	6	semi-formed	SRR11419405	PRJNA545312	3		5	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	3baf5161c545f4642900e4	272	1		peri	0								
979D		979	19	liquid	SRR11419404	PRJNA545312	16		5	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	3baf5161c545f4642900e4	272	1		post	2								
979E		979	27	semi-formed	SRR11419403	PRJNA545312	24		5	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	3baf5161c545f4642900e4	272	1		post	3								
980A		980	0	liquid	SRR11140306	PRJNA606262			1																	
981A		981	0	semi-formed	SRR11419402	PRJNA545312	0		3	0	TCD	Leukemia	d3ec68d2bdce39a52b1cb9	689	1		peri	-1								
981B		981	4	liquid	SRR11419400	PRJNA545312	4		3	0	TCD	Leukemia	d3ec68d2bdce39a52b1cb9	689	1		peri	0								
981C		981	11	semi-formed	SRR11419399	PRJNA545312	11		3	0	TCD	Leukemia	d3ec68d2bdce39a52b1cb9	689	1		post	1								
982A		982	0	formed	SRR11419398	PRJNA545312	-6		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe3fae4eb74de40c362512	665	1		pre	-1								
982B		982	8	formed	SRR11419397	PRJNA545312	2		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe3fae4eb74de40c362512	665	1		peri	0								
982C		982	14	liquid	SRR11419396	PRJNA545312	8		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe3fae4eb74de40c362512	665	1		post	1								
982D		982	21	liquid	SRR11419395	PRJNA545312	15		4	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	fe3fae4eb74de40c362512	665	1		post	2								
983A		983	0	formed	SRR11419394	PRJNA545312	-2		3	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	ec9e1bc0b0c89491bf63c7	39	1		pre	-1								
983C		983	15	semi-formed	SRR11419393	PRJNA545312	13		3	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	ec9e1bc0b0c89491bf63c7	39	1		post	1								
983D		983	20	semi-formed	SRR11419392	PRJNA545312	18		3	2	PBSC_unmodified	Non-Hodgkin's Lymphoma	ec9e1bc0b0c89491bf63c7	39	1		post	2								
984A		984	0	liquid	SRR11419391	PRJNA545312	2		4	-2	PBSC_unmodified	Leukemia	84ffb979a623f0dd24ea3f	623	1		peri	0								
984B		984	3	liquid	SRR11419389	PRJNA545312	5		4	-2	PBSC_unmodified	Leukemia	84ffb979a623f0dd24ea3f	623	1		peri	0								
984C		984	12	formed	SRR11419388	PRJNA545312	14		4	-2	PBSC_unmodified	Leukemia	84ffb979a623f0dd24ea3f	623	1		post	1								
984D		984	18	formed	SRR11419387	PRJNA545312	20		4	-2	PBSC_unmodified	Leukemia	84ffb979a623f0dd24ea3f	623	1		post	2								
985A		985	0	formed	SRR11419083	PRJNA545312	0		3	0	TCD	Multiple Myeloma	35d9ec68ce586136ba5515	675	1		peri	-1								
985B		985	4	liquid	SRR11419082	PRJNA545312	4		3	0	TCD	Multiple Myeloma	35d9ec68ce586136ba5515	675	1		peri	0								
985C		985	11	semi-formed	SRR11419081	PRJNA545312	11		3	0	TCD	Multiple Myeloma	35d9ec68ce586136ba5515	675	1		post	1								
986A		986	0	liquid	SRR11419079	PRJNA545312	3		2	-3	TCD	Leukemia	1bdc3e1612818cf42b81fd	659	1		peri	0								
986B		986	14	formed	SRR11419078	PRJNA545312	17		2	-3	TCD	Leukemia	1bdc3e1612818cf42b81fd	659	1		post	2								
987A		987	0	semi-formed	SRR11419077	PRJNA545312	-3		5	3	TCD	Leukemia	6a914b033932df19dde8b3	682	1		pre	-1								
987B		987	12	liquid	SRR11418992	PRJNA545312	9		5	3	TCD	Leukemia	6a914b033932df19dde8b3	682	1		post	1								
987C		987	15	formed	SRR11418991	PRJNA545312	12		5	3	TCD	Leukemia	6a914b033932df19dde8b3	682	1		post	1								
987D		987	36	formed	SRR11418990	PRJNA545312	33		5	3	TCD	Leukemia	6a914b033932df19dde8b3	682	1		post	4								
987E		987	357	formed	SRR11418989	PRJNA545312	354		5	3	TCD	Leukemia	6a914b033932df19dde8b3	682	1		post	6								
988A		988	0	formed	SRR11418988	PRJNA545312	-3		3	3	PBSC_unmodified	Leukemia	0114e2869efb5b85f4950b	687	1		pre	-1								
988B		988	9	semi-formed	SRR11418987	PRJNA545312	6		3	3	PBSC_unmodified	Leukemia	0114e2869efb5b85f4950b	687	1		post	0								
988C		988	14	semi-formed	SRR11419386	PRJNA545312	11		3	3	PBSC_unmodified	Leukemia	0114e2869efb5b85f4950b	687	1		post	1								
989A		989	0	formed	SRR11140294	PRJNA606262			2																	
989B		989	5		SRR11140293	PRJNA606262			2																	
990A		990	0	semi-formed	SRR11140299	PRJNA606262			2																	
990B		990	8	semi-formed	SRR11140298	PRJNA606262			2																	
991A		991	0	semi-formed	SRR11419385	PRJNA545312	-3		3	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	f17c25f02ff31f170a9ea8	446	1		pre	-1								
991B		991	22	liquid	SRR11419384	PRJNA545312	19		3	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	f17c25f02ff31f170a9ea8	446	1		post	2								
991D		991	36	semi-formed	SRR11419383	PRJNA545312	33		3	3	PBSC_unmodified	Non-Hodgkin's Lymphoma	f17c25f02ff31f170a9ea8	446	1		post	4								
992A	-14	FMT.0001	17	semi-formed	SRR11420351	PRJNA545312	12		15	5	BM_unmodified	Leukemia	f59248b285b757a9899418	T1	1	treatment	post	1	Treatment	26	26	FMT.0001A	FMT.0001C	FMT.0001D	-3	pre
992B	-12	FMT.0001	19	semi-formed	SRR11420350	PRJNA545312	14		15	5	BM_unmodified	Leukemia	f59248b285b757a9899418	T1	1	treatment	post	1	Treatment	26	26	FMT.0001A	FMT.0001C	FMT.0001D	-2	pre
992C	-7	FMT.0001	24	semi-formed	SRR11420349	PRJNA545312	19		15	5	BM_unmodified	Leukemia	f59248b285b757a9899418	T1	1	treatment	post	2	Treatment	26	26	FMT.0001A	FMT.0001C	FMT.0001D	-2	pre
993A		993	0	formed	SRR11140282	PRJNA606262			1																	
994A		994	0	formed	SRR11140286	PRJNA606262	-1331		6	1331	BM_unmodified	Multiple Myeloma	6049e3be92bfba11713bcc		0											
994B		994	1353	liquid	SRR11117027	PRJNA607574	22		6	1331	BM_unmodified	Multiple Myeloma	6049e3be92bfba11713bcc		0		post	3								
994C		994	1358	liquid	SRR11117026	PRJNA607574	27		6	1331	BM_unmodified	Multiple Myeloma	6049e3be92bfba11713bcc		0		post	3								
994D		994	1359	liquid	SRR11117025	PRJNA607574	28		6	1331	BM_unmodified	Multiple Myeloma	6049e3be92bfba11713bcc		0		post	3								
994F		994	1361	liquid	SRR11397132	PRJNA607574	30		6	1331	BM_unmodified	Multiple Myeloma	6049e3be92bfba11713bcc		0		post	4								
994G		994	1364	formed	SRR11117022	PRJNA607574	33		6	1331	BM_unmodified	Multiple Myeloma	6049e3be92bfba11713bcc		0		post	4								
995A		995	0	formed	SRR11420347	PRJNA545312	-10		4	10	TCD	Leukemia	8a2ba6e2dfc33d0e99ef08	693	1		pre	-2								
995B		995	7	liquid	SRR11420346	PRJNA545312	-3		4	10	TCD	Leukemia	8a2ba6e2dfc33d0e99ef08	693	1		pre	-1								
995C		995	14	formed	SRR11420345	PRJNA545312	4		4	10	TCD	Leukemia	8a2ba6e2dfc33d0e99ef08	693	1		peri	0								
995D		995	28	liquid	SRR11420344	PRJNA545312	18		4	10	TCD	Leukemia	8a2ba6e2dfc33d0e99ef08	693	1		post	2								
996A		996	0	semi-formed	SRR11420343	PRJNA545312	-8		3	8	TCD	Myeloproliferative Disorder	d6e36837565d3b50e675f6	506	1		pre	-2								
996B		996	10	liquid	SRR11420342	PRJNA545312	2		3	8	TCD	Myeloproliferative Disorder	d6e36837565d3b50e675f6	506	1		peri	0								
996D		996	20	liquid	SRR11420340	PRJNA545312	12		3	8	TCD	Myeloproliferative Disorder	d6e36837565d3b50e675f6	506	1		post	1								
997A		997	0	formed	SRR11397131	PRJNA607574			1																	
998A		998	0	formed	SRR11140280	PRJNA606262			1																	
FMT.0001A	-31	FMT.0001	0	liquid	SRR11420339	PRJNA545312	-5	SRR13221818	15	5	BM_unmodified	Leukemia	f59248b285b757a9899418	T1	1	treatment	pre	-1	Treatment	26	26	FMT.0001A	FMT.0001C	FMT.0001D	-3	pre
FMT.0001B	-28	FMT.0001	3	semi-formed	SRR11420338	PRJNA545312	-2		15	5	BM_unmodified	Leukemia	f59248b285b757a9899418	T1	1	treatment	pre	-1	Treatment	26	26	FMT.0001A	FMT.0001C	FMT.0001D	-3	pre
FMT.0001C	-5	FMT.0001	26	liquid	SRR11420336	PRJNA545312	21		15	5	BM_unmodified	Leukemia	f59248b285b757a9899418	T1	1	treatment	post	2	Treatment	26	26	FMT.0001A	FMT.0001C	FMT.0001D	-1	pre
FMT.0001D	4	FMT.0001	35	semi-formed	SRR10668377	PRJNA545312	30		15	5	BM_unmodified	Leukemia	f59248b285b757a9899418	T1	1	treatment	post	4	Treatment	26	26	FMT.0001A	FMT.0001C	FMT.0001D	0	peri
FMT.0001E	32	FMT.0001	63	formed	SRR11117021	PRJNA607574	58	SRR13221817	15	5	BM_unmodified	Leukemia	f59248b285b757a9899418	T1	1	treatment	post	6	Treatment	26	26	FMT.0001A	FMT.0001C	FMT.0001D	4	post
FMT.0001F	169	FMT.0001	200	formed	SRR11117020	PRJNA607574	195		15	5	BM_unmodified	Leukemia	f59248b285b757a9899418	T1	1	treatment	post	6	Treatment	26	26	FMT.0001A	FMT.0001C	FMT.0001D	6	post
FMT.0001G	190	FMT.0001	221	formed	SRR11117019	PRJNA607574	216		15	5	BM_unmodified	Leukemia	f59248b285b757a9899418	T1	1	treatment	post	6	Treatment	26	26	FMT.0001A	FMT.0001C	FMT.0001D	6	post
FMT.0001H	220	FMT.0001	251	semi-formed	SRR11117018	PRJNA607574	246		15	5	BM_unmodified	Leukemia	f59248b285b757a9899418	T1	1	treatment	post	6	Treatment	26	26	FMT.0001A	FMT.0001C	FMT.0001D	6	post
FMT.0001I	240	FMT.0001	271	semi-formed	SRR11117017	PRJNA607574	266		15	5	BM_unmodified	Leukemia	f59248b285b757a9899418	T1	1	treatment	post	6	Treatment	26	26	FMT.0001A	FMT.0001C	FMT.0001D	6	post
FMT.0001J	311	FMT.0001	342	semi-formed	SRR11117016	PRJNA607574	337		15	5	BM_unmodified	Leukemia	f59248b285b757a9899418	T1	1	treatment	post	6	Treatment	26	26	FMT.0001A	FMT.0001C	FMT.0001D	6	post
FMT.0001K	339	FMT.0001	370	formed	SRR11117015	PRJNA607574	365		15	5	BM_unmodified	Leukemia	f59248b285b757a9899418	T1	1	treatment	post	6	Treatment	26	26	FMT.0001A	FMT.0001C	FMT.0001D	6	post
FMT.0001L	353	FMT.0001	384	formed	SRR11117014	PRJNA607574	379		15	5	BM_unmodified	Leukemia	f59248b285b757a9899418	T1	1	treatment	post	6	Treatment	26	26	FMT.0001A	FMT.0001C	FMT.0001D	6	post
FMT.0002A		FMT.0002	0		SRR11420335	PRJNA545312	-11		6	11	TCD	Leukemia	444ae43d61a3ec1b7de52f		1		pre	-2								
FMT.0002B		FMT.0002	15	semi-formed	SRR11420334	PRJNA545312	4		6	11	TCD	Leukemia	444ae43d61a3ec1b7de52f		1		peri	0								
FMT.0002C		FMT.0002	21	semi-formed	SRR11420333	PRJNA545312	10		6	11	TCD	Leukemia	444ae43d61a3ec1b7de52f		1		post	1								
FMT.0002D		FMT.0002	23	semi-formed	SRR11420332	PRJNA545312	12		6	11	TCD	Leukemia	444ae43d61a3ec1b7de52f		1		post	1								
FMT.0003B		FMT.0003	29	formed	SRR11420330	PRJNA545312	-7		4	36	TCD	Leukemia	ea8209379f38be340324f8		1		pre	-2								
FMT.0003C		FMT.0003	32	liquid	SRR11420329	PRJNA545312	-4		4	36	TCD	Leukemia	ea8209379f38be340324f8		1		pre	-1								
FMT.0003D		FMT.0003	39	liquid	SRR11420328	PRJNA545312	3		4	36	TCD	Leukemia	ea8209379f38be340324f8		1		peri	0								
FMT.0003E		FMT.0003	52	semi-formed	SRR11420327	PRJNA545312	16		4	36	TCD	Leukemia	ea8209379f38be340324f8		1		post	2								
FMT.0004A		FMT.0004	0	formed	SRR11420324	PRJNA545312	-13		2	13	PBSC_unmodified	Myelodysplastic Syndromes	1c3441ea0a605b22ab4c06		1		pre	-2								
FMT.0004B		FMT.0004	35	liquid	SRR11419690	PRJNA545312	22		2	13	PBSC_unmodified	Myelodysplastic Syndromes	1c3441ea0a605b22ab4c06		1		post	3								
FMT.0005A		FMT.0005	0	formed	SRR11419689	PRJNA545312	-16		6	16	TCD	Leukemia	7c17f4d6a42dde7185606c		1		pre	-3								
FMT.0005B		FMT.0005	6	formed	SRR11419688	PRJNA545312	-10		6	16	TCD	Leukemia	7c17f4d6a42dde7185606c		1		pre	-2								
FMT.0005C		FMT.0005	10	semi-formed	SRR11419687	PRJNA545312	-6		6	16	TCD	Leukemia	7c17f4d6a42dde7185606c		1		pre	-1								
FMT.0005D		FMT.0005	18	liquid	SRR11419686	PRJNA545312	2		6	16	TCD	Leukemia	7c17f4d6a42dde7185606c		1		peri	0								
FMT.0005E		FMT.0005	28	formed	SRR11419685	PRJNA545312	12		6	16	TCD	Leukemia	7c17f4d6a42dde7185606c		1		post	1								
FMT.0005F		FMT.0005	36	formed	SRR11419684	PRJNA545312	20		6	16	TCD	Leukemia	7c17f4d6a42dde7185606c		1		post	2								
FMT.0006A		FMT.0006	0	formed	SRR11419683	PRJNA545312	-7		2	7	BM_unmodified	Non-Hodgkin's Lymphoma	60901f287a2ff5e77bca70		1		pre	-2								
FMT.0006B		FMT.0006	5	liquid	SRR11419682	PRJNA545312	-2		2	7	BM_unmodified	Non-Hodgkin's Lymphoma	60901f287a2ff5e77bca70		1		pre	-1								
FMT.0007A		FMT.0007	0	formed	SRR11419680	PRJNA545312	-12		4	12	PBSC_unmodified	Leukemia	01f8929eb7be600624dbab		1		pre	-2								
FMT.0007B		FMT.0007	18	semi-formed	SRR11419679	PRJNA545312	6		4	12	PBSC_unmodified	Leukemia	01f8929eb7be600624dbab		1		post	0								
FMT.0007C		FMT.0007	26	formed	SRR11419678	PRJNA545312	14		4	12	PBSC_unmodified	Leukemia	01f8929eb7be600624dbab		1		post	1								
FMT.0007D		FMT.0007	42	formed	SRR11419677	PRJNA545312	30		4	12	PBSC_unmodified	Leukemia	01f8929eb7be600624dbab		1		post	4								
FMT.0008B		FMT.0008	0	formed	SRR11419676	PRJNA545312	-10		1	10	TCD	Multiple Myeloma	4da746cabb1a9aafbc8c5e		1		pre	-2								
FMT.0009A	-41	FMT.0009	0	formed	SRR11419675	PRJNA545312	-6	SRR14092318	19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	pre	-1	Control	35					-3	pre
FMT.0009AA	112	FMT.0009	153	formed	SRR11419674	PRJNA545312	147	SRR13221824	19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	post	6	Control	35					6	post
FMT.0009BB	169	FMT.0009	210	formed	SRR11419672	PRJNA545312	204		19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	post	6	Control	35					6	post
FMT.0009C	-35	FMT.0009	6	semi-formed	SRR11419671	PRJNA545312	0		19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	peri	-1	Control	35					-3	pre
FMT.0009CC	203	FMT.0009	244	formed	SRR11419669	PRJNA545312	238		19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	post	6	Control	35					6	post
FMT.0009D	-34	FMT.0009	7	formed	SRR11419668	PRJNA545312	1		19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	peri	0	Control	35					-3	pre
FMT.0009DD	267	FMT.0009	308	formed	SRR11419667	PRJNA545312	302		19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	post	6	Control	35					6	post
FMT.0009E	-33	FMT.0009	8	formed	SRR11419666	PRJNA545312	2		19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	peri	0	Control	35					-3	pre
FMT.0009F	-31	FMT.0009	10	liquid	SRR11419665	PRJNA545312	4		19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	peri	0	Control	35					-3	pre
FMT.0009H	-29	FMT.0009	12	semi-formed	SRR11419663	PRJNA545312	6		19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	post	0	Control	35					-3	pre
FMT.0009I	-28	FMT.0009	13	semi-formed	SRR11419634	PRJNA545312	7		19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	post	0	Control	35					-3	pre
FMT.0009L	-25	FMT.0009	16	semi-formed	SRR11419632	PRJNA545312	10		19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	post	1	Control	35					-3	pre
FMT.0009P	-19	FMT.0009	22	semi-formed	SRR11419628	PRJNA545312	16		19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	post	2	Control	35					-3	pre
FMT.0009R	-17	FMT.0009	24	semi-formed	SRR11419626	PRJNA545312	18		19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	post	2	Control	35					-3	pre
FMT.0009U	-14	FMT.0009	27	liquid	SRR11419623	PRJNA545312	21		19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	post	2	Control	35					-3	pre
FMT.0009V	-13	FMT.0009	28	semi-formed	SRR11419622	PRJNA545312	22		19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	post	3	Control	35					-2	pre
FMT.0009W	-2	FMT.0009	39	formed	SRR11419621	PRJNA545312	33		19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	post	4	Control	35					-1	pre
FMT.0009X	2	FMT.0009	43	semi-formed	SRR11419619	PRJNA545312	37	SRR14092317	19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	post	5	Control	35					0	peri
FMT.0009Y	5	FMT.0009	46	semi-formed	SRR11419618	PRJNA545312	40	SRR13221823	19	6	PBSC_unmodified	Myelodysplastic Syndromes	fbd892ee98b7d398f1506e	C1	1	control	post	5	Control	35					0	peri
FMT.0010A	-45	FMT.0010	0	semi-formed	SRR11419616	PRJNA545312	-6	SRR14092316	13	6	cord	Leukemia	688524ef9180bc574f9a61	T2	1	treatment	pre	-1	Treatment	39	39	FMT.0010A	FMT.0010Q	FMT.0010S	-3	pre
FMT.0010B	-36	FMT.0010	9	semi-formed	SRR11419615	PRJNA545312	3		13	6	cord	Leukemia	688524ef9180bc574f9a61	T2	1	treatment	peri	0	Treatment	39	39	FMT.0010A	FMT.0010Q	FMT.0010S	-3	pre
FMT.0010C	-35	FMT.0010	10	liquid	SRR11419614	PRJNA545312	4		13	6	cord	Leukemia	688524ef9180bc574f9a61	T2	1	treatment	peri	0	Treatment	39	39	FMT.0010A	FMT.0010Q	FMT.0010S	-3	pre
FMT.0010E	-24	FMT.0010	21	liquid	SRR11419612	PRJNA545312	15		13	6	cord	Leukemia	688524ef9180bc574f9a61	T2	1	treatment	post	2	Treatment	39	39	FMT.0010A	FMT.0010Q	FMT.0010S	-3	pre
FMT.0010F	-22	FMT.0010	23	semi-formed	SRR11419611	PRJNA545312	17		13	6	cord	Leukemia	688524ef9180bc574f9a61	T2	1	treatment	post	2	Treatment	39	39	FMT.0010A	FMT.0010Q	FMT.0010S	-3	pre
FMT.0010M	-14	FMT.0010	31	liquid	SRR11419603	PRJNA545312	25		13	6	cord	Leukemia	688524ef9180bc574f9a61	T2	1	treatment	post	3	Treatment	39	39	FMT.0010A	FMT.0010Q	FMT.0010S	-3	pre
FMT.0010O	-12	FMT.0010	33	liquid	SRR11419601	PRJNA545312	27		13	6	cord	Leukemia	688524ef9180bc574f9a61	T2	1	treatment	post	3	Treatment	39	39	FMT.0010A	FMT.0010Q	FMT.0010S	-2	pre
FMT.0010Q	-6	FMT.0010	39	semi-formed	SRR11419599	PRJNA545312	33		13	6	cord	Leukemia	688524ef9180bc574f9a61	T2	1	treatment	post	4	Treatment	39	39	FMT.0010A	FMT.0010Q	FMT.0010S	-1	pre
FMT.0010S	1	FMT.0010	46	semi-formed	SRR11117012	PRJNA607574	40	SRR13221829	13	6	cord	Leukemia	688524ef9180bc574f9a61	T2	1	treatment	post	5	Treatment	39	39	FMT.0010A	FMT.0010Q	FMT.0010S	0	peri
FMT.0010T	46	FMT.0010	91	semi-formed	SRR11117011	PRJNA607574	85		13	6	cord	Leukemia	688524ef9180bc574f9a61	T2	1	treatment	post	6	Treatment	39	39	FMT.0010A	FMT.0010Q	FMT.0010S	6	post
FMT.0010U	77	FMT.0010	122	semi-formed	SRR11117010	PRJNA607574	116		13	6	cord	Leukemia	688524ef9180bc574f9a61	T2	1	treatment	post	6	Treatment	39	39	FMT.0010A	FMT.0010Q	FMT.0010S	6	post
FMT.0010V	190	FMT.0010	235	liquid	SRR11117009	PRJNA607574	229		13	6	cord	Leukemia	688524ef9180bc574f9a61	T2	1	treatment	post	6	Treatment	39	39	FMT.0010A	FMT.0010Q	FMT.0010S	6	post
FMT.0010W	253	FMT.0010	298	semi-formed	SRR11117008	PRJNA607574	292		13	6	cord	Leukemia	688524ef9180bc574f9a61	T2	1	treatment	post	6	Treatment	39	39	FMT.0010A	FMT.0010Q	FMT.0010S	6	post
FMT.0011A		FMT.0011	0	formed	SRR11419597	PRJNA545312	-6		3	6	PBSC_unmodified	Leukemia	0e8ea1c8ed5b2a0d879133		1		pre	-1								
FMT.0011C		FMT.0011	22	liquid	SRR11419595	PRJNA545312	16		3	6	PBSC_unmodified	Leukemia	0e8ea1c8ed5b2a0d879133		1		post	2								
FMT.0011D		FMT.0011	39	semi-formed	SRR11419594	PRJNA545312	33		3	6	PBSC_unmodified	Leukemia	0e8ea1c8ed5b2a0d879133		1		post	4								
FMT.0012A		FMT.0012	0	formed	SRR11419593	PRJNA545312	-10		14	10	cord	Leukemia	e3120f08e9acc7aac5701e		1		pre	-2								
FMT.0012B		FMT.0012	10	formed	SRR11419592	PRJNA545312	0		14	10	cord	Leukemia	e3120f08e9acc7aac5701e		1		peri	-1								
FMT.0012D		FMT.0012	15	semi-formed	SRR11419591	PRJNA545312	5		14	10	cord	Leukemia	e3120f08e9acc7aac5701e		1		peri	0								
FMT.0012E		FMT.0012	23	formed	SRR11419590	PRJNA545312	13		14	10	cord	Leukemia	e3120f08e9acc7aac5701e		1		post	1								
FMT.0012F		FMT.0012	28	semi-formed	SRR11419589	PRJNA545312	18		14	10	cord	Leukemia	e3120f08e9acc7aac5701e		1		post	2								
FMT.0012G		FMT.0012	31	semi-formed	SRR11419588	PRJNA545312	21		14	10	cord	Leukemia	e3120f08e9acc7aac5701e		1		post	2								
FMT.0012H		FMT.0012	38	semi-formed	SRR11419586	PRJNA545312	28		14	10	cord	Leukemia	e3120f08e9acc7aac5701e		1		post	3								
FMT.0012I		FMT.0012	42	liquid	SRR11419585	PRJNA545312	32		14	10	cord	Leukemia	e3120f08e9acc7aac5701e		1		post	4								
FMT.0012J		FMT.0012	59	semi-formed	SRR11419584	PRJNA545312	49		14	10	cord	Leukemia	e3120f08e9acc7aac5701e		1		post	6								
FMT.0012L		FMT.0012	109	semi-formed	SRR11419582	PRJNA545312	99		14	10	cord	Leukemia	e3120f08e9acc7aac5701e		1		post	6								
FMT.0012M		FMT.0012	168	semi-formed	SRR11419581	PRJNA545312	158		14	10	cord	Leukemia	e3120f08e9acc7aac5701e		1		post	6								
FMT.0012N		FMT.0012	177	semi-formed	SRR11419580	PRJNA545312	167		14	10	cord	Leukemia	e3120f08e9acc7aac5701e		1		post	6								
FMT.0012P		FMT.0012	224	semi-formed	SRR11419579	PRJNA545312	214		14	10	cord	Leukemia	e3120f08e9acc7aac5701e		1		post	6								
FMT.0012Q		FMT.0012	427	semi-formed	SRR11419550	PRJNA545312	417		14	10	cord	Leukemia	e3120f08e9acc7aac5701e		1		post	6								
FMT.0013A		FMT.0013	0	formed	SRR11419549	PRJNA545312	-21		15	21	PBSC_unmodified	Myeloproliferative Disorder	da09912abd48b928c6486c		1		pre	-3								
FMT.0013B		FMT.0013	16	formed	SRR11419547	PRJNA545312	-5		15	21	PBSC_unmodified	Myeloproliferative Disorder	da09912abd48b928c6486c		1		pre	-1								
FMT.0013C		FMT.0013	17	formed	SRR11419546	PRJNA545312	-4		15	21	PBSC_unmodified	Myeloproliferative Disorder	da09912abd48b928c6486c		1		pre	-1								
FMT.0013D		FMT.0013	20	formed	SRR11419545	PRJNA545312	-1		15	21	PBSC_unmodified	Myeloproliferative Disorder	da09912abd48b928c6486c		1		pre	-1								
FMT.0013F		FMT.0013	21	formed	SRR11419543	PRJNA545312	0		15	21	PBSC_unmodified	Myeloproliferative Disorder	da09912abd48b928c6486c		1		peri	-1								
FMT.0013G		FMT.0013	22	formed	SRR11419542	PRJNA545312	1		15	21	PBSC_unmodified	Myeloproliferative Disorder	da09912abd48b928c6486c		1		peri	0								
FMT.0013H		FMT.0013	23	formed	SRR11419541	PRJNA545312	2		15	21	PBSC_unmodified	Myeloproliferative Disorder	da09912abd48b928c6486c		1		peri	0								
FMT.0013I		FMT.0013	24	formed	SRR11419540	PRJNA545312	3		15	21	PBSC_unmodified	Myeloproliferative Disorder	da09912abd48b928c6486c		1		peri	0								
FMT.0013J		FMT.0013	27	formed	SRR11419539	PRJNA545312	6		15	21	PBSC_unmodified	Myeloproliferative Disorder	da09912abd48b928c6486c		1		post	0								
FMT.0013K		FMT.0013	28	semi-formed	SRR11419538	PRJNA545312	7		15	21	PBSC_unmodified	Myeloproliferative Disorder	da09912abd48b928c6486c		1		post	0								
FMT.0013L		FMT.0013	29	formed	SRR11419536	PRJNA545312	8		15	21	PBSC_unmodified	Myeloproliferative Disorder	da09912abd48b928c6486c		1		post	1								
FMT.0013M		FMT.0013	30	semi-formed	SRR11419535	PRJNA545312	9		15	21	PBSC_unmodified	Myeloproliferative Disorder	da09912abd48b928c6486c		1		post	1								
FMT.0013N		FMT.0013	32	formed	SRR11419534	PRJNA545312	11		15	21	PBSC_unmodified	Myeloproliferative Disorder	da09912abd48b928c6486c		1		post	1								
FMT.0013O		FMT.0013	37	semi-formed	SRR11419533	PRJNA545312	16		15	21	PBSC_unmodified	Myeloproliferative Disorder	da09912abd48b928c6486c		1		post	2								
FMT.0013P		FMT.0013	49	formed	SRR11419532	PRJNA545312	28		15	21	PBSC_unmodified	Myeloproliferative Disorder	da09912abd48b928c6486c		1		post	3								
FMT.0014A		FMT.0014	0	semi-formed	SRR11419531	PRJNA545312	-10		13	10	TCD	Leukemia	ccf4d5c648eda8a5371f20		1		pre	-2								
FMT.0014B		FMT.0014	2	semi-formed	SRR11419530	PRJNA545312	-8		13	10	TCD	Leukemia	ccf4d5c648eda8a5371f20		1		pre	-2								
FMT.0014C		FMT.0014	3	liquid	SRR11419529	PRJNA545312	-7		13	10	TCD	Leukemia	ccf4d5c648eda8a5371f20		1		pre	-2								
FMT.0014D		FMT.0014	4	liquid	SRR11419528	PRJNA545312	-6		13	10	TCD	Leukemia	ccf4d5c648eda8a5371f20		1		pre	-1								
FMT.0014E		FMT.0014	5	semi-formed	SRR11419527	PRJNA545312	-5		13	10	TCD	Leukemia	ccf4d5c648eda8a5371f20		1		pre	-1								
FMT.0014F		FMT.0014	6	liquid	SRR11419524	PRJNA545312	-4		13	10	TCD	Leukemia	ccf4d5c648eda8a5371f20		1		pre	-1								
FMT.0014G		FMT.0014	7	liquid	SRR11419523	PRJNA545312	-3		13	10	TCD	Leukemia	ccf4d5c648eda8a5371f20		1		pre	-1								
FMT.0014H		FMT.0014	8	liquid	SRR11419792	PRJNA545312	-2		13	10	TCD	Leukemia	ccf4d5c648eda8a5371f20		1		pre	-1								
FMT.0014J		FMT.0014	10	liquid	SRR11419791	PRJNA545312	0		13	10	TCD	Leukemia	ccf4d5c648eda8a5371f20		1		peri	-1								
FMT.0014K		FMT.0014	12	liquid	SRR11419790	PRJNA545312	2		13	10	TCD	Leukemia	ccf4d5c648eda8a5371f20		1		peri	0								
FMT.0014L		FMT.0014	13	liquid	SRR11419789	PRJNA545312	3		13	10	TCD	Leukemia	ccf4d5c648eda8a5371f20		1		peri	0								
FMT.0014M		FMT.0014	14	liquid	SRR11419788	PRJNA545312	4		13	10	TCD	Leukemia	ccf4d5c648eda8a5371f20		1		peri	0								
FMT.0014P		FMT.0014	31		SRR11419787	PRJNA545312	21		13	10	TCD	Leukemia	ccf4d5c648eda8a5371f20		1		post	2								
FMT.0016A		FMT.0016	0	semi-formed	SRR11419786	PRJNA545312	-14		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		pre	-3								
FMT.0016AA		FMT.0016	425	liquid	SRR11419785	PRJNA545312	22		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		post	3								
FMT.0016B		FMT.0016	18	semi-formed	SRR11419783	PRJNA545312	4		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		peri	0								
FMT.0016C		FMT.0016	19	liquid	SRR11419782	PRJNA545312	5		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		peri	0								
FMT.0016D		FMT.0016	41	formed	SRR11419781	PRJNA545312	27		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		post	3								
FMT.0016E		FMT.0016	187	formed	SRR11419780	PRJNA545312	173		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		post	6								
FMT.0016F		FMT.0016	281	formed	SRR11419779	PRJNA545312	-122		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		pre	-3								
FMT.0016G		FMT.0016	371	formed	SRR11419778	PRJNA545312	-32		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		pre	-3								
FMT.0016H		FMT.0016	391	liquid	SRR11419777	PRJNA545312	-12		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		pre	-2								
FMT.0016I		FMT.0016	392	liquid	SRR11419776	PRJNA545312	-11		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		pre	-2								
FMT.0016J		FMT.0016	395	semi-formed	SRR11419775	PRJNA545312	-8		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		pre	-2								
FMT.0016K		FMT.0016	396	semi-formed	SRR11419774	PRJNA545312	-7		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		pre	-2								
FMT.0016L		FMT.0016	398	semi-formed	SRR11419772	PRJNA545312	-5		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		pre	-1								
FMT.0016M		FMT.0016	399	semi-formed	SRR11419771	PRJNA545312	-4		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		pre	-1								
FMT.0016N		FMT.0016	400	semi-formed	SRR11419770	PRJNA545312	-3		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		pre	-1								
FMT.0016O		FMT.0016	402	liquid	SRR11419769	PRJNA545312	-1		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		pre	-1								
FMT.0016P		FMT.0016	404	semi-formed	SRR11419768	PRJNA545312	1		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		peri	0								
FMT.0016R		FMT.0016	405	formed	SRR11419766	PRJNA545312	2		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		peri	0								
FMT.0016S		FMT.0016	406	liquid	SRR11419765	PRJNA545312	3		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		peri	0								
FMT.0016U		FMT.0016	410	liquid	SRR11419438	PRJNA545312	7		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		post	0								
FMT.0016V		FMT.0016	411	liquid	SRR11419437	PRJNA545312	8		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		post	1								
FMT.0016W		FMT.0016	412	semi-formed	SRR11419435	PRJNA545312	9		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		post	1								
FMT.0016Y		FMT.0016	418	semi-formed	SRR11419434	PRJNA545312	15		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		post	2								
FMT.0016Z		FMT.0016	423	semi-formed	SRR11419433	PRJNA545312	20		24	403	PBSC_unmodified	Myelodysplastic Syndromes	4d9e44ac9019c110a71267		1		post	2								
FMT.0017A		FMT.0017	299	semi-formed	SRR11419432	PRJNA545312	-9		14	308	PBSC_unmodified	Leukemia	61e3a931ca0188b382a796	654	1		pre	-2								
FMT.0017B		FMT.0017	302	semi-formed	SRR11419431	PRJNA545312	-6		14	308	PBSC_unmodified	Leukemia	61e3a931ca0188b382a796	654	1		pre	-1								
FMT.0017C		FMT.0017	306	formed	SRR11419430	PRJNA545312	-2		14	308	PBSC_unmodified	Leukemia	61e3a931ca0188b382a796	654	1		pre	-1								
FMT.0017D		FMT.0017	310	semi-formed	SRR11419429	PRJNA545312	2		14	308	PBSC_unmodified	Leukemia	61e3a931ca0188b382a796	654	1		peri	0								
FMT.0017E		FMT.0017	320	liquid	SRR11419428	PRJNA545312	12		14	308	PBSC_unmodified	Leukemia	61e3a931ca0188b382a796	654	1		post	1								
FMT.0017F		FMT.0017	321	semi-formed	SRR11419427	PRJNA545312	13		14	308	PBSC_unmodified	Leukemia	61e3a931ca0188b382a796	654	1		post	1								
FMT.0018A		FMT.0018	0	semi-formed	SRR11419426	PRJNA545312	-6		6	6	PBSC_unmodified	Leukemia	95d54049b7c65ce7a2e221		1		pre	-1								
FMT.0018B		FMT.0018	1	formed	SRR11419424	PRJNA545312	-5		6	6	PBSC_unmodified	Leukemia	95d54049b7c65ce7a2e221		1		pre	-1								
FMT.0018C		FMT.0018	11	semi-formed	SRR11419423	PRJNA545312	5		6	6	PBSC_unmodified	Leukemia	95d54049b7c65ce7a2e221		1		peri	0								
FMT.0018D		FMT.0018	17	semi-formed	SRR11419422	PRJNA545312	11		6	6	PBSC_unmodified	Leukemia	95d54049b7c65ce7a2e221		1		post	1								
FMT.0018E		FMT.0018	41	semi-formed	SRR11419421	PRJNA545312	35		6	6	PBSC_unmodified	Leukemia	95d54049b7c65ce7a2e221		1		post	4								
FMT.0018F		FMT.0018	367	formed	SRR11419420	PRJNA545312	361		6	6	PBSC_unmodified	Leukemia	95d54049b7c65ce7a2e221		1		post	6								
FMT.0019A		FMT.0019	0	semi-formed	SRR11419419	PRJNA545312	-6		6	6	PBSC_unmodified	Leukemia	1de55016fed6ac6b92b6df		1		pre	-1								
FMT.0019B		FMT.0019	1	formed	SRR11419418	PRJNA545312	-5		6	6	PBSC_unmodified	Leukemia	1de55016fed6ac6b92b6df		1		pre	-1								
FMT.0019C		FMT.0019	3	formed	SRR11419417	PRJNA545312	-3		6	6	PBSC_unmodified	Leukemia	1de55016fed6ac6b92b6df		1		pre	-1								
FMT.0019D		FMT.0019	9	semi-formed	SRR11419416	PRJNA545312	3		6	6	PBSC_unmodified	Leukemia	1de55016fed6ac6b92b6df		1		peri	0								
FMT.0019E		FMT.0019	14	formed	SRR11419415	PRJNA545312	8		6	6	PBSC_unmodified	Leukemia	1de55016fed6ac6b92b6df		1		post	1								
FMT.0019F		FMT.0019	20	semi-formed	SRR11419413	PRJNA545312	14		6	6	PBSC_unmodified	Leukemia	1de55016fed6ac6b92b6df		1		post	1								
FMT.0020A	-43	FMT.0020	0	semi-formed	SRR11419412	PRJNA545312	-6	SRR14092314	11	6	cord	Leukemia	12850a83b2e9bc0105a96a	T3	1	treatment	pre	-1	Treatment	37	37	FMT.0020A	FMT.0020E	FMT.0020G	-3	pre
FMT.0020B	-39	FMT.0020	4	formed	SRR11419411	PRJNA545312	-2		11	6	cord	Leukemia	12850a83b2e9bc0105a96a	T3	1	treatment	pre	-1	Treatment	37	37	FMT.0020A	FMT.0020E	FMT.0020G	-3	pre
FMT.0020C	-32	FMT.0020	11	formed	SRR11419382	PRJNA545312	5		11	6	cord	Leukemia	12850a83b2e9bc0105a96a	T3	1	treatment	peri	0	Treatment	37	37	FMT.0020A	FMT.0020E	FMT.0020G	-3	pre
FMT.0020D	-25	FMT.0020	18	liquid	SRR11419381	PRJNA545312	12		11	6	cord	Leukemia	12850a83b2e9bc0105a96a	T3	1	treatment	post	1	Treatment	37	37	FMT.0020A	FMT.0020E	FMT.0020G	-3	pre
FMT.0020E	-18	FMT.0020	25	formed	SRR11419380	PRJNA545312	19		11	6	cord	Leukemia	12850a83b2e9bc0105a96a	T3	1	treatment	post	2	Treatment	37	37	FMT.0020A	FMT.0020E	FMT.0020G	-3	pre
FMT.0020G	3	FMT.0020	46	semi-formed	SRR11117007	PRJNA607574	40	SRR13221827	11	6	cord	Leukemia	12850a83b2e9bc0105a96a	T3	1	treatment	post	5	Treatment	37	37	FMT.0020A	FMT.0020E	FMT.0020G	0	peri
FMT.0020H	24	FMT.0020	67	semi-formed	SRR11117006	PRJNA607574	61		11	6	cord	Leukemia	12850a83b2e9bc0105a96a	T3	1	treatment	post	6	Treatment	37	37	FMT.0020A	FMT.0020E	FMT.0020G	3	post
FMT.0020J	81	FMT.0020	124	formed	SRR11117005	PRJNA607574	118		11	6	cord	Leukemia	12850a83b2e9bc0105a96a	T3	1	treatment	post	6	Treatment	37	37	FMT.0020A	FMT.0020E	FMT.0020G	6	post
FMT.0020K	109	FMT.0020	152	formed	SRR11117004	PRJNA607574	146		11	6	cord	Leukemia	12850a83b2e9bc0105a96a	T3	1	treatment	post	6	Treatment	37	37	FMT.0020A	FMT.0020E	FMT.0020G	6	post
FMT.0020L	146	FMT.0020	189	formed	SRR11117003	PRJNA607574	183		11	6	cord	Leukemia	12850a83b2e9bc0105a96a	T3	1	treatment	post	6	Treatment	37	37	FMT.0020A	FMT.0020E	FMT.0020G	6	post
FMT.0020M	180	FMT.0020	223	formed	SRR11117001	PRJNA607574	217		11	6	cord	Leukemia	12850a83b2e9bc0105a96a	T3	1	treatment	post	6	Treatment	37	37	FMT.0020A	FMT.0020E	FMT.0020G	6	post
FMT.0021A		FMT.0021	0	formed	SRR11419379	PRJNA545312	-9		5	9	TCD	Multiple Myeloma	f449a7d47b27e681a89bdc		1		pre	-2								
FMT.0021B		FMT.0021	9	formed	SRR11419378	PRJNA545312	0		5	9	TCD	Multiple Myeloma	f449a7d47b27e681a89bdc		1		peri	-1								
FMT.0021C		FMT.0021	12	liquid	SRR11419377	PRJNA545312	3		5	9	TCD	Multiple Myeloma	f449a7d47b27e681a89bdc		1		peri	0								
FMT.0021D		FMT.0021	19	semi-formed	SRR11419376	PRJNA545312	10		5	9	TCD	Multiple Myeloma	f449a7d47b27e681a89bdc		1		post	1								
FMT.0021E		FMT.0021	20	semi-formed	SRR11419374	PRJNA545312	11		5	9	TCD	Multiple Myeloma	f449a7d47b27e681a89bdc		1		post	1								
FMT.0022A		FMT.0022	0	semi-formed	SRR11419373	PRJNA545312	-10		10	10	cord	Non-Malignant Hemat Disorders	94b7601d33660a593135b6		1		pre	-2								
FMT.0022B		FMT.0022	4	formed	SRR11419372	PRJNA545312	-6		10	10	cord	Non-Malignant Hemat Disorders	94b7601d33660a593135b6		1		pre	-1								
FMT.0022D		FMT.0022	28	semi-formed	SRR11419370	PRJNA545312	18		10	10	cord	Non-Malignant Hemat Disorders	94b7601d33660a593135b6		1		post	2								
FMT.0022E		FMT.0022	40	semi-formed	SRR11419369	PRJNA545312	30		10	10	cord	Non-Malignant Hemat Disorders	94b7601d33660a593135b6		1		post	4								
FMT.0022F		FMT.0022	50	semi-formed	SRR11419368	PRJNA545312	40		10	10	cord	Non-Malignant Hemat Disorders	94b7601d33660a593135b6		1		post	5								
FMT.0022I		FMT.0022	168	semi-formed	SRR11419367	PRJNA545312	158		10	10	cord	Non-Malignant Hemat Disorders	94b7601d33660a593135b6		1		post	6								
FMT.0022J		FMT.0022	183	semi-formed	SRR11419366	PRJNA545312	173		10	10	cord	Non-Malignant Hemat Disorders	94b7601d33660a593135b6		1		post	6								
FMT.0022K		FMT.0022	491	semi-formed	SRR11419365	PRJNA545312	481		10	10	cord	Non-Malignant Hemat Disorders	94b7601d33660a593135b6		1		post	6								
FMT.0022L		FMT.0022	496	semi-formed	SRR11419363	PRJNA545312	486		10	10	cord	Non-Malignant Hemat Disorders	94b7601d33660a593135b6		1		post	6								
FMT.0022M		FMT.0022	549	semi-formed	SRR11419362	PRJNA545312	539		10	10	cord	Non-Malignant Hemat Disorders	94b7601d33660a593135b6		1		post	6								
FMT.0023A		FMT.0023	0	formed	SRR11419361	PRJNA545312	-5		15	5	PBSC_unmodified	Myelodysplastic Syndromes	43eeb2b61262448bead22b		1		pre	-1								
FMT.0023B		FMT.0023	3	formed	SRR11419360	PRJNA545312	-2		15	5	PBSC_unmodified	Myelodysplastic Syndromes	43eeb2b61262448bead22b		1		pre	-1								
FMT.0023C		FMT.0023	4	formed	SRR11419359	PRJNA545312	-1		15	5	PBSC_unmodified	Myelodysplastic Syndromes	43eeb2b61262448bead22b		1		pre	-1								
FMT.0023D		FMT.0023	6	formed	SRR11419358	PRJNA545312	1		15	5	PBSC_unmodified	Myelodysplastic Syndromes	43eeb2b61262448bead22b		1		peri	0								
FMT.0023E		FMT.0023	7	formed	SRR11419357	PRJNA545312	2		15	5	PBSC_unmodified	Myelodysplastic Syndromes	43eeb2b61262448bead22b		1		peri	0								
FMT.0023F		FMT.0023	8	formed	SRR11419356	PRJNA545312	3		15	5	PBSC_unmodified	Myelodysplastic Syndromes	43eeb2b61262448bead22b		1		peri	0								
FMT.0023G		FMT.0023	11	formed	SRR11419355	PRJNA545312	6		15	5	PBSC_unmodified	Myelodysplastic Syndromes	43eeb2b61262448bead22b		1		post	0								
FMT.0023H		FMT.0023	13	formed	SRR11419718	PRJNA545312	8		15	5	PBSC_unmodified	Myelodysplastic Syndromes	43eeb2b61262448bead22b		1		post	1								
FMT.0023I		FMT.0023	16	formed	SRR11419716	PRJNA545312	11		15	5	PBSC_unmodified	Myelodysplastic Syndromes	43eeb2b61262448bead22b		1		post	1								
FMT.0023J		FMT.0023	17	formed	SRR11419715	PRJNA545312	12		15	5	PBSC_unmodified	Myelodysplastic Syndromes	43eeb2b61262448bead22b		1		post	1								
FMT.0023K		FMT.0023	19	semi-formed	SRR11419714	PRJNA545312	14		15	5	PBSC_unmodified	Myelodysplastic Syndromes	43eeb2b61262448bead22b		1		post	1								
FMT.0023L		FMT.0023	23	formed	SRR11419713	PRJNA545312	18		15	5	PBSC_unmodified	Myelodysplastic Syndromes	43eeb2b61262448bead22b		1		post	2								
FMT.0023M		FMT.0023	67	semi-formed	SRR11419712	PRJNA545312	62		15	5	PBSC_unmodified	Myelodysplastic Syndromes	43eeb2b61262448bead22b		1		post	6								
FMT.0026A		FMT.0026	967	semi-formed	SRR11419711	PRJNA545312	-6		10	973	PBSC_unmodified	Leukemia	2fe521798f2a170866740c	486	1		pre	-1								
FMT.0026B		FMT.0026	971	formed	SRR11419710	PRJNA545312	-2		10	973	PBSC_unmodified	Leukemia	2fe521798f2a170866740c	486	1		pre	-1								
FMT.0026C		FMT.0026	978	semi-formed	SRR11419709	PRJNA545312	5		10	973	PBSC_unmodified	Leukemia	2fe521798f2a170866740c	486	1		peri	0								
FMT.0026D		FMT.0026	985	liquid	SRR11419708	PRJNA545312	12		10	973	PBSC_unmodified	Leukemia	2fe521798f2a170866740c	486	1		post	1								
FMT.0026E		FMT.0026	1006	liquid	SRR11419707	PRJNA545312	33		10	973	PBSC_unmodified	Leukemia	2fe521798f2a170866740c	486	1		post	4								
FMT.0026F		FMT.0026	1011	liquid	SRR11419705	PRJNA545312	38		10	973	PBSC_unmodified	Leukemia	2fe521798f2a170866740c	486	1		post	5								
FMT.0027A		FMT.0027	0	formed	SRR11419704	PRJNA545312	-7		6	7	cord	Non-Hodgkin's Lymphoma	92be77e8602e5c782f9f7c		1		pre	-2								
FMT.0027B		FMT.0027	5	formed	SRR11419703	PRJNA545312	-2		6	7	cord	Non-Hodgkin's Lymphoma	92be77e8602e5c782f9f7c		1		pre	-1								
FMT.0027C		FMT.0027	11	semi-formed	SRR11418986	PRJNA545312	4		6	7	cord	Non-Hodgkin's Lymphoma	92be77e8602e5c782f9f7c		1		peri	0								
FMT.0027D		FMT.0027	18	semi-formed	SRR11418984	PRJNA545312	11		6	7	cord	Non-Hodgkin's Lymphoma	92be77e8602e5c782f9f7c		1		post	1								
FMT.0027E		FMT.0027	25	semi-formed	SRR11418983	PRJNA545312	18		6	7	cord	Non-Hodgkin's Lymphoma	92be77e8602e5c782f9f7c		1		post	2								
FMT.0027F		FMT.0027	327	semi-formed	SRR11418982	PRJNA545312	320		6	7	cord	Non-Hodgkin's Lymphoma	92be77e8602e5c782f9f7c		1		post	6								
FMT.0028A	-34	FMT.0028	0	semi-formed	SRR11418981	PRJNA545312	-5		16	5	PBSC_unmodified	Leukemia	adc54714b4df020bdcfaf3	T4	1	treatment	pre	-1	Treatment	28	29	FMT.0028A	FMT.0028I	FMT.0028K	-3	pre
FMT.0028B	-30	FMT.0028	4	formed	SRR11418980	PRJNA545312	-1		16	5	PBSC_unmodified	Leukemia	adc54714b4df020bdcfaf3	T4	1	treatment	pre	-1	Treatment	28	29	FMT.0028A	FMT.0028I	FMT.0028K	-3	pre
FMT.0028C	-24	FMT.0028	10	liquid	SRR11418979	PRJNA545312	5		16	5	PBSC_unmodified	Leukemia	adc54714b4df020bdcfaf3	T4	1	treatment	peri	0	Treatment	28	29	FMT.0028A	FMT.0028I	FMT.0028K	-3	pre
FMT.0028E	-19	FMT.0028	15	liquid	SRR11418977	PRJNA545312	10		16	5	PBSC_unmodified	Leukemia	adc54714b4df020bdcfaf3	T4	1	treatment	post	1	Treatment	28	29	FMT.0028A	FMT.0028I	FMT.0028K	-3	pre
FMT.0028F	-10	FMT.0028	24	liquid	SRR11418976	PRJNA545312	19		16	5	PBSC_unmodified	Leukemia	adc54714b4df020bdcfaf3	T4	1	treatment	post	2	Treatment	28	29	FMT.0028A	FMT.0028I	FMT.0028K	-2	pre
FMT.0028G	-7	FMT.0028	27	liquid	SRR11418975	PRJNA545312	22		16	5	PBSC_unmodified	Leukemia	adc54714b4df020bdcfaf3	T4	1	treatment	post	3	Treatment	28	29	FMT.0028A	FMT.0028I	FMT.0028K	-2	pre
FMT.0028H	-4	FMT.0028	30	semi-formed	SRR11418973	PRJNA545312	25		16	5	PBSC_unmodified	Leukemia	adc54714b4df020bdcfaf3	T4	1	treatment	post	3	Treatment	28	29	FMT.0028A	FMT.0028I	FMT.0028K	-1	pre
FMT.0028I	-3	FMT.0028	31	semi-formed	SRR11418972	PRJNA545312	26		16	5	PBSC_unmodified	Leukemia	adc54714b4df020bdcfaf3	T4	1	treatment	post	3	Treatment	28	29	FMT.0028A	FMT.0028I	FMT.0028K	-1	pre
FMT.0028K	0	FMT.0028	34	liquid	SRR11117000	PRJNA607574	29		16	5	PBSC_unmodified	Leukemia	adc54714b4df020bdcfaf3	T4	1	treatment	post	4	Treatment	28	29	FMT.0028A	FMT.0028I	FMT.0028K	-1	peri
FMT.0028L	4	FMT.0028	38	semi-formed	SRR11116999	PRJNA607574	33		16	5	PBSC_unmodified	Leukemia	adc54714b4df020bdcfaf3	T4	1	treatment	post	4	Treatment	28	29	FMT.0028A	FMT.0028I	FMT.0028K	0	peri
FMT.0028M	7	FMT.0028	41	formed	SRR11116998	PRJNA607574	36		16	5	PBSC_unmodified	Leukemia	adc54714b4df020bdcfaf3	T4	1	treatment	post	5	Treatment	28	29	FMT.0028A	FMT.0028I	FMT.0028K	0	post
FMT.0028N	14	FMT.0028	48	semi-formed	SRR11116997	PRJNA607574	43		16	5	PBSC_unmodified	Leukemia	adc54714b4df020bdcfaf3	T4	1	treatment	post	6	Treatment	28	29	FMT.0028A	FMT.0028I	FMT.0028K	1	post
FMT.0028O	28	FMT.0028	62	semi-formed	SRR11116996	PRJNA607574	57		16	5	PBSC_unmodified	Leukemia	adc54714b4df020bdcfaf3	T4	1	treatment	post	6	Treatment	28	29	FMT.0028A	FMT.0028I	FMT.0028K	3	post
FMT.0028P	108	FMT.0028	142	formed	SRR11116995	PRJNA607574	137		16	5	PBSC_unmodified	Leukemia	adc54714b4df020bdcfaf3	T4	1	treatment	post	6	Treatment	28	29	FMT.0028A	FMT.0028I	FMT.0028K	6	post
FMT.0028Q	297	FMT.0028	331	formed	SRR11116994	PRJNA607574	326		16	5	PBSC_unmodified	Leukemia	adc54714b4df020bdcfaf3	T4	1	treatment	post	6	Treatment	28	29	FMT.0028A	FMT.0028I	FMT.0028K	6	post
FMT.0028R	332	FMT.0028	366	formed	SRR11116993	PRJNA607574	361		16	5	PBSC_unmodified	Leukemia	adc54714b4df020bdcfaf3	T4	1	treatment	post	6	Treatment	28	29	FMT.0028A	FMT.0028I	FMT.0028K	6	post
FMT.0030A		FMT.0030	817	semi-formed	SRR11418971	PRJNA545312	-22		6	839	PBSC_unmodified	Multiple Myeloma	5d052527e62335a86fcbf3	224	1		pre	-3								
FMT.0030B		FMT.0030	845	liquid	SRR11418970	PRJNA545312	6		6	839	PBSC_unmodified	Multiple Myeloma	5d052527e62335a86fcbf3	224	1		post	0								
FMT.0030C		FMT.0030	873	liquid	SRR11418969	PRJNA545312	34		6	839	PBSC_unmodified	Multiple Myeloma	5d052527e62335a86fcbf3	224	1		post	4								
FMT.0032A		FMT.0032	0	formed	SRR11397129	PRJNA607574			2																	
FMT.0032B		FMT.0032	26	formed	SRR11397128	PRJNA607574			2																	
FMT.0033A		FMT.0033	0	formed	SRR11418968	PRJNA545312	-14		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		pre	-3								
FMT.0033AA		FMT.0033	749	liquid	SRR11418967	PRJNA545312	15		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		post	2								
FMT.0033B		FMT.0033	6	formed	SRR11418966	PRJNA545312	-8		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		pre	-2								
FMT.0033CC		FMT.0033	754	liquid	SRR11418583	PRJNA545312	20		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		post	2								
FMT.0033D		FMT.0033	11	formed	SRR11418581	PRJNA545312	-3		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		pre	-1								
FMT.0033E		FMT.0033	12	formed	SRR11418580	PRJNA545312	-2		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		pre	-1								
FMT.0033F		FMT.0033	13	semi-formed	SRR11418579	PRJNA545312	-1		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		pre	-1								
FMT.0033G		FMT.0033	15	semi-formed	SRR11418578	PRJNA545312	1		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		peri	0								
FMT.0033I		FMT.0033	17	semi-formed	SRR11418577	PRJNA545312	3		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		peri	0								
FMT.0033J		FMT.0033	18	semi-formed	SRR11418576	PRJNA545312	4		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		peri	0								
FMT.0033K		FMT.0033	20	semi-formed	SRR11418575	PRJNA545312	6		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		post	0								
FMT.0033L		FMT.0033	21	semi-formed	SRR11418574	PRJNA545312	7		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		post	0								
FMT.0033M		FMT.0033	22	liquid	SRR11419702	PRJNA545312	8		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		post	1								
FMT.0033O		FMT.0033	25	liquid	SRR11419701	PRJNA545312	11		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		post	1								
FMT.0033P		FMT.0033	26	semi-formed	SRR11419700	PRJNA545312	12		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		post	1								
FMT.0033V		FMT.0033	735	semi-formed	SRR11419696	PRJNA545312	1		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		peri	0								
FMT.0033W		FMT.0033	740	liquid	SRR11419693	PRJNA545312	6		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		post	0								
FMT.0033X		FMT.0033	741	liquid	SRR11419692	PRJNA545312	7		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		post	0								
FMT.0033Y		FMT.0033	746	liquid	SRR11419691	PRJNA545312	12		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		post	1								
FMT.0033Z		FMT.0033	747	liquid	SRR11419522	PRJNA545312	13		20	734	TCD	Leukemia	8b13112c6ac5e832836b57		1		post	1								
FMT.0034A	-56	FMT.0034	0	semi-formed	SRR11419521	PRJNA545312	-28	SRR13697226	21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	pre	-3	Control	28					-3	pre
FMT.0034B	-36	FMT.0034	20	formed	SRR11419520	PRJNA545312	-8		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	pre	-2	Control	28					-3	pre
FMT.0034C	-27	FMT.0034	29	liquid	SRR11419519	PRJNA545312	1		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	peri	0	Control	28					-3	pre
FMT.0034D	-24	FMT.0034	32	liquid	SRR11419518	PRJNA545312	4		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	peri	0	Control	28					-3	pre
FMT.0034E	-17	FMT.0034	39	liquid	SRR11419517	PRJNA545312	11		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	post	1	Control	28					-3	pre
FMT.0034F	-15	FMT.0034	41	formed	SRR11419516	PRJNA545312	13		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	post	1	Control	28					-3	pre
FMT.0034G	-10	FMT.0034	46	formed	SRR11419514	PRJNA545312	18		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	post	2	Control	28					-2	pre
FMT.0034I	0	FMT.0034	56	semi-formed	SRR11419513	PRJNA545312	28	SRR13221831	21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	post	3	Control	28					-1	peri
FMT.0034J	12	FMT.0034	68	liquid	SRR11419512	PRJNA545312	40	SRR14092184	21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	post	5	Control	28					1	post
FMT.0034K	13	FMT.0034	69	liquid	SRR11419511	PRJNA545312	41		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	post	5	Control	28					1	post
FMT.0034L	18	FMT.0034	74	liquid	SRR11419510	PRJNA545312	46		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	post	6	Control	28					2	post
FMT.0034M	25	FMT.0034	81	liquid	SRR11419509	PRJNA545312	53		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	post	6	Control	28					3	post
FMT.0034N	27	FMT.0034	83	liquid	SRR11419508	PRJNA545312	55		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	post	6	Control	28					3	post
FMT.0034O	35	FMT.0034	91	liquid	SRR11419507	PRJNA545312	63		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	post	6	Control	28					4	post
FMT.0034P	40	FMT.0034	96	liquid	SRR11419506	PRJNA545312	68		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	post	6	Control	28					5	post
FMT.0034Q	48	FMT.0034	104	liquid	SRR11419505	PRJNA545312	76		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	post	6	Control	28					6	post
FMT.0034R	53	FMT.0034	109	liquid	SRR11419503	PRJNA545312	81		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	post	6	Control	28					6	post
FMT.0034S	63	FMT.0034	119	liquid	SRR11419502	PRJNA545312	91		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	post	6	Control	28					6	post
FMT.0034T	67	FMT.0034	123	liquid	SRR11419501	PRJNA545312	95		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	post	6	Control	28					6	post
FMT.0034U	75	FMT.0034	131	liquid	SRR11419500	PRJNA545312	103		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	post	6	Control	28					6	post
FMT.0034V	82	FMT.0034	138	liquid	SRR11419499	PRJNA545312	110		21	28	TCD	Multiple Myeloma	5f951107df9536a898501c	C4	1	control	post	6	Control	28					6	post
FMT.0035A	-70	FMT.0035	0	formed	SRR11419498	PRJNA545312	-21	SRR13221826	21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	pre	-3	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	-3	pre
FMT.0035B	-56	FMT.0035	14	formed	SRR11419497	PRJNA545312	-7		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	pre	-2	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	-3	pre
FMT.0035C	-52	FMT.0035	18	formed	SRR11419496	PRJNA545312	-3		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	pre	-1	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	-3	pre
FMT.0035D	-46	FMT.0035	24	liquid	SRR11419495	PRJNA545312	3		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	peri	0	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	-3	pre
FMT.0035E	-36	FMT.0035	34	liquid	SRR11419494	PRJNA545312	13		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	post	1	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	-3	pre
FMT.0035F	-28	FMT.0035	42	semi-formed	SRR11419492	PRJNA545312	21		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	post	2	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	-3	pre
FMT.0035G	-19	FMT.0035	51	semi-formed	SRR11419491	PRJNA545312	30		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	post	4	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	-3	pre
FMT.0035H	-10	FMT.0035	60	formed	SRR11419490	PRJNA545312	39		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	post	5	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	-2	pre
FMT.0035J	0	FMT.0035	70	liquid	SRR11116992	PRJNA607574	49		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	post	6	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	-1	peri
FMT.0035K	4	FMT.0035	74	formed	SRR11116989	PRJNA607574	53	SRR13221825	21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	post	6	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	0	peri
FMT.0035L	20	FMT.0035	90	semi-formed	SRR11116988	PRJNA607574	69		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	post	6	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	2	post
FMT.0035M	42	FMT.0035	112	semi-formed	SRR11116987	PRJNA607574	91		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	post	6	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	5	post
FMT.0035N	91	FMT.0035	161	formed	SRR11116986	PRJNA607574	140		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	post	6	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	6	post
FMT.0035O	92	FMT.0035	162		SRR11116985	PRJNA607574	141		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	post	6	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	6	post
FMT.0035P	94	FMT.0035	164		SRR11116984	PRJNA607574	143		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	post	6	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	6	post
FMT.0035Q	95	FMT.0035	165		SRR11116983	PRJNA607574	144		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	post	6	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	6	post
FMT.0035R	119	FMT.0035	189	formed	SRR11116982	PRJNA607574	168		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	post	6	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	6	post
FMT.0035S	121	FMT.0035	191	formed	SRR11116981	PRJNA607574	170		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	post	6	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	6	post
FMT.0035T	120	FMT.0035	190	semi-formed	SRR11116980	PRJNA607574	169		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	post	6	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	6	post
FMT.0035U	122	FMT.0035	192	semi-formed	SRR11116620	PRJNA607574	171		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	post	6	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	6	post
FMT.0035V	125	FMT.0035	195	semi-formed	SRR11116619	PRJNA607574	174		21	21	cord	Leukemia	d98075bf7fe4523e409606	T5	1	treatment	post	6	Treatment	49	49	FMT.0035A	FMT.0035H	FMT.0035J	6	post
FMT.0036A		FMT.0036	0	formed	SRR11397127	PRJNA607574			1																	
FMT.0039A	-40	FMT.0039	0	formed	SRR11419489	PRJNA545312	-6	SRR14092183	16	6	cord	Leukemia	f1c248cd1d9bbac6711114	C3	1	control	pre	-1	Control	34					-3	pre
FMT.0039B	-20	FMT.0039	20	liquid	SRR11419488	PRJNA545312	14		16	6	cord	Leukemia	f1c248cd1d9bbac6711114	C3	1	control	post	1	Control	34					-3	pre
FMT.0039C	-18	FMT.0039	22	liquid	SRR11419487	PRJNA545312	16		16	6	cord	Leukemia	f1c248cd1d9bbac6711114	C3	1	control	post	2	Control	34					-3	pre
FMT.0039D	-13	FMT.0039	27	semi-formed	SRR11419486	PRJNA545312	21		16	6	cord	Leukemia	f1c248cd1d9bbac6711114	C3	1	control	post	2	Control	34					-2	pre
FMT.0039E	4	FMT.0039	44	formed	SRR11419485	PRJNA545312	38	SRR14092182	16	6	cord	Leukemia	f1c248cd1d9bbac6711114	C3	1	control	post	5	Control	34					0	peri
FMT.0039F	18	FMT.0039	58	formed	SRR11419484	PRJNA545312	52	SRR13221821	16	6	cord	Leukemia	f1c248cd1d9bbac6711114	C3	1	control	post	6	Control	34					2	post
FMT.0039I	133	FMT.0039	173	liquid	SRR11419481	PRJNA545312	167		16	6	cord	Leukemia	f1c248cd1d9bbac6711114	C3	1	control	post	6	Control	34					6	post
FMT.0039J	135	FMT.0039	175	semi-formed	SRR11419480	PRJNA545312	169		16	6	cord	Leukemia	f1c248cd1d9bbac6711114	C3	1	control	post	6	Control	34					6	post
FMT.0039K	134	FMT.0039	174	liquid	SRR11419479	PRJNA545312	168		16	6	cord	Leukemia	f1c248cd1d9bbac6711114	C3	1	control	post	6	Control	34					6	post
FMT.0039L	136	FMT.0039	176	semi-formed	SRR11419478	PRJNA545312	170		16	6	cord	Leukemia	f1c248cd1d9bbac6711114	C3	1	control	post	6	Control	34					6	post
FMT.0039M	161	FMT.0039	201	formed	SRR11419477	PRJNA545312	195		16	6	cord	Leukemia	f1c248cd1d9bbac6711114	C3	1	control	post	6	Control	34					6	post
FMT.0039N	162	FMT.0039	202	semi-formed	SRR11419476	PRJNA545312	196		16	6	cord	Leukemia	f1c248cd1d9bbac6711114	C3	1	control	post	6	Control	34					6	post
FMT.0039O	163	FMT.0039	203	formed	SRR11419475	PRJNA545312	197		16	6	cord	Leukemia	f1c248cd1d9bbac6711114	C3	1	control	post	6	Control	34					6	post
FMT.0039P	176	FMT.0039	216	semi-formed	SRR11419474	PRJNA545312	210		16	6	cord	Leukemia	f1c248cd1d9bbac6711114	C3	1	control	post	6	Control	34					6	post
FMT.0039Q	177	FMT.0039	217	formed	SRR11419473	PRJNA545312	211		16	6	cord	Leukemia	f1c248cd1d9bbac6711114	C3	1	control	post	6	Control	34					6	post
FMT.0039R	178	FMT.0039	218	liquid	SRR11419472	PRJNA545312	212		16	6	cord	Leukemia	f1c248cd1d9bbac6711114	C3	1	control	post	6	Control	34					6	post
FMT.0041A		FMT.0041	0	semi-formed	SRR11419470	PRJNA545312	-14		8	14	PBSC_unmodified	Leukemia	1e96da99cfda9aafe35a90		1		pre	-3								
FMT.0041B		FMT.0041	13	formed	SRR11419469	PRJNA545312	-1		8	14	PBSC_unmodified	Leukemia	1e96da99cfda9aafe35a90		1		pre	-1								
FMT.0041C		FMT.0041	18	semi-formed	SRR11419468	PRJNA545312	4		8	14	PBSC_unmodified	Leukemia	1e96da99cfda9aafe35a90		1		peri	0								
FMT.0041D		FMT.0041	25	semi-formed	SRR11419467	PRJNA545312	11		8	14	PBSC_unmodified	Leukemia	1e96da99cfda9aafe35a90		1		post	1								
FMT.0041E		FMT.0041	33	semi-formed	SRR10668376	PRJNA545312	19		8	14	PBSC_unmodified	Leukemia	1e96da99cfda9aafe35a90		1		post	2								
FMT.0041F		FMT.0041	39	formed	SRR11420005	PRJNA545312	25		8	14	PBSC_unmodified	Leukemia	1e96da99cfda9aafe35a90		1		post	3								
FMT.0041G		FMT.0041	200	semi-formed	SRR11420004	PRJNA545312	186		8	14	PBSC_unmodified	Leukemia	1e96da99cfda9aafe35a90		1		post	6								
FMT.0041H		FMT.0041	341	formed	SRR11420003	PRJNA545312	327		8	14	PBSC_unmodified	Leukemia	1e96da99cfda9aafe35a90		1		post	6								
FMT.0042A		FMT.0042	0	formed	SRR11420002	PRJNA545312	-6		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	03f77e0e22362ac236451e		1		pre	-1								
FMT.0042B		FMT.0042	4	formed	SRR11420001	PRJNA545312	-2		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	03f77e0e22362ac236451e		1		pre	-1								
FMT.0042C		FMT.0042	9	formed	SRR11420000	PRJNA545312	3		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	03f77e0e22362ac236451e		1		peri	0								
FMT.0042D		FMT.0042	13	formed	SRR11419998	PRJNA545312	7		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	03f77e0e22362ac236451e		1		post	0								
FMT.0042E		FMT.0042	20	formed	SRR11419997	PRJNA545312	14		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	03f77e0e22362ac236451e		1		post	1								
FMT.0043A		FMT.0043	926	semi-formed	SRR11116618	PRJNA607574	-20		13	946	BM_unmodified	Non-Hodgkin's Lymphoma	84c65590f5f94d1e4afee4		1		pre	-3								
FMT.0043B		FMT.0043	941	semi-formed	SRR11419996	PRJNA545312	-5		13	946	BM_unmodified	Non-Hodgkin's Lymphoma	84c65590f5f94d1e4afee4		1		pre	-1								
FMT.0043C		FMT.0043	944	semi-formed	SRR11419995	PRJNA545312	-2		13	946	BM_unmodified	Non-Hodgkin's Lymphoma	84c65590f5f94d1e4afee4		1		pre	-1								
FMT.0043D		FMT.0043	950	liquid	SRR11419994	PRJNA545312	4		13	946	BM_unmodified	Non-Hodgkin's Lymphoma	84c65590f5f94d1e4afee4		1		peri	0								
FMT.0043E		FMT.0043	958	semi-formed	SRR11419993	PRJNA545312	12		13	946	BM_unmodified	Non-Hodgkin's Lymphoma	84c65590f5f94d1e4afee4		1		post	1								
FMT.0043F		FMT.0043	964	liquid	SRR11419992	PRJNA545312	18		13	946	BM_unmodified	Non-Hodgkin's Lymphoma	84c65590f5f94d1e4afee4		1		post	2								
FMT.0043G		FMT.0043	971	semi-formed	SRR11419991	PRJNA545312	25		13	946	BM_unmodified	Non-Hodgkin's Lymphoma	84c65590f5f94d1e4afee4		1		post	3								
FMT.0043H		FMT.0043	1162	formed	SRR11419990	PRJNA545312	216		13	946	BM_unmodified	Non-Hodgkin's Lymphoma	84c65590f5f94d1e4afee4		1		post	6								
FMT.0043I		FMT.0043	1281	formed	SRR11419989	PRJNA545312	335		13	946	BM_unmodified	Non-Hodgkin's Lymphoma	84c65590f5f94d1e4afee4		1		post	6								
FMT.0044A		FMT.0044	0	formed	SRR11419987	PRJNA545312	-10		9	10	TCD	Myelodysplastic Syndromes	785ed3de896aba93a68777		1		pre	-2								
FMT.0044B		FMT.0044	3	liquid	SRR11419986	PRJNA545312	-7		9	10	TCD	Myelodysplastic Syndromes	785ed3de896aba93a68777		1		pre	-2								
FMT.0044C		FMT.0044	6	liquid	SRR11419985	PRJNA545312	-4		9	10	TCD	Myelodysplastic Syndromes	785ed3de896aba93a68777		1		pre	-1								
FMT.0044D		FMT.0044	20	liquid	SRR11419984	PRJNA545312	10		9	10	TCD	Myelodysplastic Syndromes	785ed3de896aba93a68777		1		post	1								
FMT.0044E		FMT.0044	28	liquid	SRR11419983	PRJNA545312	18		9	10	TCD	Myelodysplastic Syndromes	785ed3de896aba93a68777		1		post	2								
FMT.0044F		FMT.0044	35	semi-formed	SRR11419982	PRJNA545312	25		9	10	TCD	Myelodysplastic Syndromes	785ed3de896aba93a68777		1		post	3								
FMT.0044G		FMT.0044	41	liquid	SRR11419981	PRJNA545312	31		9	10	TCD	Myelodysplastic Syndromes	785ed3de896aba93a68777		1		post	4								
FMT.0044H		FMT.0044	55	semi-formed	SRR11419980	PRJNA545312	45		9	10	TCD	Myelodysplastic Syndromes	785ed3de896aba93a68777		1		post	6								
FMT.0044I		FMT.0044	387	formed	SRR11419979	PRJNA545312	377		9	10	TCD	Myelodysplastic Syndromes	785ed3de896aba93a68777		1		post	6								
FMT.0045A		FMT.0045	0	semi-formed	SRR11419978	PRJNA545312	-10		2	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	4ff94cf79cfe83a0f3fc96	717	1		pre	-2								
FMT.0045B		FMT.0045	14	liquid	SRR11420322	PRJNA545312	4		2	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	4ff94cf79cfe83a0f3fc96	717	1		peri	0								
FMT.0046A		FMT.0046	0	formed	SRR11420320	PRJNA545312	-32		10	1222	BM_unmodified		beffa68c86657c5a4ba6fe		0		pre	-3								
FMT.0046F		FMT.0046	66	liquid	SRR10668375	PRJNA545312	34		10	1222	BM_unmodified		beffa68c86657c5a4ba6fe		0		post	4								
FMT.0046G		FMT.0046	69	semi-formed	SRR10668374	PRJNA545312	37		10	1222	BM_unmodified		beffa68c86657c5a4ba6fe		0		post	5								
FMT.0046H		FMT.0046	91	formed	SRR10668373	PRJNA545312	59		10	1222	BM_unmodified		beffa68c86657c5a4ba6fe		0		post	6								
FMT.0046I		FMT.0046	129	formed	SRR11116617	PRJNA607574	97		10	1222	BM_unmodified		beffa68c86657c5a4ba6fe		0		post	6								
FMT.0046J		FMT.0046	180	semi-formed	SRR11116616	PRJNA607574	148		10	1222	BM_unmodified		beffa68c86657c5a4ba6fe		0		post	6								
FMT.0046K		FMT.0046	207	formed	SRR11116615	PRJNA607574	175		10	1222	BM_unmodified		beffa68c86657c5a4ba6fe		0		post	6								
FMT.0046L		FMT.0046	260	semi-formed	SRR11116614	PRJNA607574	228		10	1222	BM_unmodified		beffa68c86657c5a4ba6fe		0		post	6								
FMT.0046M		FMT.0046	283	formed	SRR11116613	PRJNA607574	251		10	1222	BM_unmodified		beffa68c86657c5a4ba6fe		0		post	6								
FMT.0046N		FMT.0046	314	formed	SRR11116612	PRJNA607574	282		10	1222	BM_unmodified		beffa68c86657c5a4ba6fe		0		post	6								
FMT.0047A		FMT.0047	0	semi-formed	SRR11116611	PRJNA607574	-6		11	6	cord	Leukemia	cab9c999c365b723d167d1		1		pre	-1								
FMT.0047B		FMT.0047	5	semi-formed	SRR11420319	PRJNA545312	-1		11	6	cord	Leukemia	cab9c999c365b723d167d1		1		pre	-1								
FMT.0047C		FMT.0047	12	semi-formed	SRR11420318	PRJNA545312	6		11	6	cord	Leukemia	cab9c999c365b723d167d1		1		post	0								
FMT.0047D		FMT.0047	26	semi-formed	SRR11420317	PRJNA545312	20		11	6	cord	Leukemia	cab9c999c365b723d167d1		1		post	2								
FMT.0047E		FMT.0047	38	semi-formed	SRR11420316	PRJNA545312	32		11	6	cord	Leukemia	cab9c999c365b723d167d1		1		post	4								
FMT.0047F		FMT.0047	50	semi-formed	SRR11420315	PRJNA545312	44		11	6	cord	Leukemia	cab9c999c365b723d167d1		1		post	6								
FMT.0047G		FMT.0047	142	semi-formed	SRR11420314	PRJNA545312	136		11	6	cord	Leukemia	cab9c999c365b723d167d1		1		post	6								
FMT.0047H		FMT.0047	148	liquid	SRR11420313	PRJNA545312	142		11	6	cord	Leukemia	cab9c999c365b723d167d1		1		post	6								
FMT.0047I		FMT.0047	149	liquid	SRR11420311	PRJNA545312	143		11	6	cord	Leukemia	cab9c999c365b723d167d1		1		post	6								
FMT.0047J		FMT.0047	150	semi-formed	SRR11420310	PRJNA545312	144		11	6	cord	Leukemia	cab9c999c365b723d167d1		1		post	6								
FMT.0047K		FMT.0047	152	liquid	SRR11420309	PRJNA545312	146		11	6	cord	Leukemia	cab9c999c365b723d167d1		1		post	6								
FMT.0048A		FMT.0048	0	formed	SRR9260796	PRJNA548153	-8		10	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	8b2ff314447798556f0482		1		pre	-2								
FMT.0048B		FMT.0048	11	semi-formed	SRR11420308	PRJNA545312	3		10	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	8b2ff314447798556f0482		1		peri	0								
FMT.0048C		FMT.0048	12	semi-formed	SRR11420307	PRJNA545312	4		10	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	8b2ff314447798556f0482		1		peri	0								
FMT.0048D		FMT.0048	21	formed	SRR11420306	PRJNA545312	13		10	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	8b2ff314447798556f0482		1		post	1								
FMT.0048E		FMT.0048	49	semi-formed	SRR11420305	PRJNA545312	41		10	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	8b2ff314447798556f0482		1		post	5								
FMT.0048F		FMT.0048	64	formed	SRR11420304	PRJNA545312	56		10	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	8b2ff314447798556f0482		1		post	6								
FMT.0048G		FMT.0048	96	formed	SRR11420303	PRJNA545312	88		10	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	8b2ff314447798556f0482		1		post	6								
FMT.0048H		FMT.0048	188	semi-formed	SRR11420302	PRJNA545312	180		10	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	8b2ff314447798556f0482		1		post	6								
FMT.0048I		FMT.0048	279	semi-formed	SRR11420299	PRJNA545312	271		10	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	8b2ff314447798556f0482		1		post	6								
FMT.0048J		FMT.0048	384	formed	SRR11420298	PRJNA545312	376		10	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	8b2ff314447798556f0482		1		post	6								
FMT.0049A		FMT.0049	0	formed	SRR11420297	PRJNA545312	-7		11	7	PBSC_unmodified	Leukemia	ed169b0918c38e8de32f57		1		pre	-2								
FMT.0049B		FMT.0049	6	semi-formed	SRR11420296	PRJNA545312	-1		11	7	PBSC_unmodified	Leukemia	ed169b0918c38e8de32f57		1		pre	-1								
FMT.0049C		FMT.0049	13	semi-formed	SRR11420295	PRJNA545312	6		11	7	PBSC_unmodified	Leukemia	ed169b0918c38e8de32f57		1		post	0								
FMT.0049D		FMT.0049	17	semi-formed	SRR11420294	PRJNA545312	10		11	7	PBSC_unmodified	Leukemia	ed169b0918c38e8de32f57		1		post	1								
FMT.0049E		FMT.0049	25	formed	SRR11420293	PRJNA545312	18		11	7	PBSC_unmodified	Leukemia	ed169b0918c38e8de32f57		1		post	2								
FMT.0049F		FMT.0049	54	formed	SRR11420292	PRJNA545312	47		11	7	PBSC_unmodified	Leukemia	ed169b0918c38e8de32f57		1		post	6								
FMT.0049G		FMT.0049	68	formed	SRR11420291	PRJNA545312	61		11	7	PBSC_unmodified	Leukemia	ed169b0918c38e8de32f57		1		post	6								
FMT.0049H		FMT.0049	99	formed	SRR11420290	PRJNA545312	92		11	7	PBSC_unmodified	Leukemia	ed169b0918c38e8de32f57		1		post	6								
FMT.0049I		FMT.0049	195	formed	SRR11420288	PRJNA545312	188		11	7	PBSC_unmodified	Leukemia	ed169b0918c38e8de32f57		1		post	6								
FMT.0049J		FMT.0049	265	formed	SRR11420287	PRJNA545312	258		11	7	PBSC_unmodified	Leukemia	ed169b0918c38e8de32f57		1		post	6								
FMT.0049K		FMT.0049	376	semi-formed	SRR11420286	PRJNA545312	369		11	7	PBSC_unmodified	Leukemia	ed169b0918c38e8de32f57		1		post	6								
FMT.0050A	-44	FMT.0050	0	formed	SRR11420285	PRJNA545312	-10	SRR13221820	17	10	TCD	Leukemia	17391b8feccb550fe3f7dd	C5	1	control	pre	-2	Control	34					-3	pre
FMT.0050B	-40	FMT.0050	4	semi-formed	SRR11420284	PRJNA545312	-6		17	10	TCD	Leukemia	17391b8feccb550fe3f7dd	C5	1	control	pre	-1	Control	34					-3	pre
FMT.0050C	-38	FMT.0050	6	semi-formed	SRR11420283	PRJNA545312	-4		17	10	TCD	Leukemia	17391b8feccb550fe3f7dd	C5	1	control	pre	-1	Control	34					-3	pre
FMT.0050D	-28	FMT.0050	16	liquid	SRR11420282	PRJNA545312	6		17	10	TCD	Leukemia	17391b8feccb550fe3f7dd	C5	1	control	post	0	Control	34					-3	pre
FMT.0050E	-24	FMT.0050	20	liquid	SRR11420281	PRJNA545312	10		17	10	TCD	Leukemia	17391b8feccb550fe3f7dd	C5	1	control	post	1	Control	34					-3	pre
FMT.0050F	-23	FMT.0050	21	liquid	SRR11420280	PRJNA545312	11		17	10	TCD	Leukemia	17391b8feccb550fe3f7dd	C5	1	control	post	1	Control	34					-3	pre
FMT.0050G	-17	FMT.0050	27	liquid	SRR11420279	PRJNA545312	17		17	10	TCD	Leukemia	17391b8feccb550fe3f7dd	C5	1	control	post	2	Control	34					-3	pre
FMT.0050H	-16	FMT.0050	28	liquid	SRR11420277	PRJNA545312	18		17	10	TCD	Leukemia	17391b8feccb550fe3f7dd	C5	1	control	post	2	Control	34					-3	pre
FMT.0050I	-15	FMT.0050	29	liquid	SRR11420276	PRJNA545312	19		17	10	TCD	Leukemia	17391b8feccb550fe3f7dd	C5	1	control	post	2	Control	34					-3	pre
FMT.0050K	4	FMT.0050	48	formed	SRR11420275	PRJNA545312	38		17	10	TCD	Leukemia	17391b8feccb550fe3f7dd	C5	1	control	post	5	Control	34					0	peri
FMT.0050L	42	FMT.0050	86	formed	SRR11420274	PRJNA545312	76	SRR13221819	17	10	TCD	Leukemia	17391b8feccb550fe3f7dd	C5	1	control	post	6	Control	34					5	post
FMT.0050M	64	FMT.0050	108	formed	SRR11420273	PRJNA545312	98		17	10	TCD	Leukemia	17391b8feccb550fe3f7dd	C5	1	control	post	6	Control	34					6	post
FMT.0050N	95	FMT.0050	139	semi-formed	SRR11420272	PRJNA545312	129		17	10	TCD	Leukemia	17391b8feccb550fe3f7dd	C5	1	control	post	6	Control	34					6	post
FMT.0050O	138	FMT.0050	182	formed	SRR11420271	PRJNA545312	172		17	10	TCD	Leukemia	17391b8feccb550fe3f7dd	C5	1	control	post	6	Control	34					6	post
FMT.0050P	154	FMT.0050	198	formed	SRR11420270	PRJNA545312	188		17	10	TCD	Leukemia	17391b8feccb550fe3f7dd	C5	1	control	post	6	Control	34					6	post
FMT.0050Q	194	FMT.0050	238	formed	SRR11420269	PRJNA545312	228		17	10	TCD	Leukemia	17391b8feccb550fe3f7dd	C5	1	control	post	6	Control	34					6	post
FMT.0050R	327	FMT.0050	371	formed	SRR11420268	PRJNA545312	361		17	10	TCD	Leukemia	17391b8feccb550fe3f7dd	C5	1	control	post	6	Control	34					6	post
FMT.0052A		FMT.0052	0	formed	SRR11420210	PRJNA545312	-20		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		pre	-3								
FMT.0052B		FMT.0052	15	semi-formed	SRR11420209	PRJNA545312	-5		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		pre	-1								
FMT.0052C		FMT.0052	17	semi-formed	SRR11420208	PRJNA545312	-3		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		pre	-1								
FMT.0052D		FMT.0052	18	liquid	SRR11420207	PRJNA545312	-2		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		pre	-1								
FMT.0052E		FMT.0052	19	semi-formed	SRR11420206	PRJNA545312	-1		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		pre	-1								
FMT.0052F		FMT.0052	20	semi-formed	SRR11420205	PRJNA545312	0		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		peri	-1								
FMT.0052G		FMT.0052	21	semi-formed	SRR11420204	PRJNA545312	1		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		peri	0								
FMT.0052H		FMT.0052	22	semi-formed	SRR11420203	PRJNA545312	2		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		peri	0								
FMT.0052I		FMT.0052	23	semi-formed	SRR11420202	PRJNA545312	3		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		peri	0								
FMT.0052J		FMT.0052	24	semi-formed	SRR11420201	PRJNA545312	4		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		peri	0								
FMT.0052K		FMT.0052	28	formed	SRR11420199	PRJNA545312	8		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		post	1								
FMT.0052L		FMT.0052	30	formed	SRR11420198	PRJNA545312	10		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		post	1								
FMT.0052M		FMT.0052	32	formed	SRR11420197	PRJNA545312	12		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		post	1								
FMT.0052O		FMT.0052	36	formed	SRR11420195	PRJNA545312	16		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		post	2								
FMT.0052P		FMT.0052	37	semi-formed	SRR11420194	PRJNA545312	17		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		post	2								
FMT.0052Q		FMT.0052	38	liquid	SRR11420193	PRJNA545312	18		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		post	2								
FMT.0052R		FMT.0052	39	liquid	SRR11420192	PRJNA545312	19		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		post	2								
FMT.0052S		FMT.0052	42	semi-formed	SRR11420191	PRJNA545312	22		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		post	3								
FMT.0052T		FMT.0052	43	liquid	SRR11420190	PRJNA545312	23		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		post	3								
FMT.0052U		FMT.0052	44	liquid	SRR11420188	PRJNA545312	24		20	20	BM_unmodified	Myelodysplastic Syndromes	f6eefa4feaf0975772d863		1		post	3								
FMT.0053A		FMT.0053	0	formed	SRR11420187	PRJNA545312	-5		4	5	PBSC_unmodified	Hodgkin's Disease	0d9a7bd031166f0903a8d7		1		pre	-1								
FMT.0053B		FMT.0053	3	formed	SRR11420186	PRJNA545312	-2		4	5	PBSC_unmodified	Hodgkin's Disease	0d9a7bd031166f0903a8d7		1		pre	-1								
FMT.0053C		FMT.0053	14	liquid	SRR11420185	PRJNA545312	9		4	5	PBSC_unmodified	Hodgkin's Disease	0d9a7bd031166f0903a8d7		1		post	1								
FMT.0053D		FMT.0053	38	formed	SRR11420184	PRJNA545312	33		4	5	PBSC_unmodified	Hodgkin's Disease	0d9a7bd031166f0903a8d7		1		post	4								
FMT.0054A		FMT.0054	0	formed	SRR11420155	PRJNA545312	-10		8	10	PBSC_unmodified	Myelodysplastic Syndromes	aba877a42f584aaad6f786		1		pre	-2								
FMT.0054B		FMT.0054	5	formed	SRR11420154	PRJNA545312	-5		8	10	PBSC_unmodified	Myelodysplastic Syndromes	aba877a42f584aaad6f786		1		pre	-1								
FMT.0054C		FMT.0054	8	formed	SRR11420153	PRJNA545312	-2		8	10	PBSC_unmodified	Myelodysplastic Syndromes	aba877a42f584aaad6f786		1		pre	-1								
FMT.0054D		FMT.0054	15	liquid	SRR11420152	PRJNA545312	5		8	10	PBSC_unmodified	Myelodysplastic Syndromes	aba877a42f584aaad6f786		1		peri	0								
FMT.0054E		FMT.0054	16	liquid	SRR11420151	PRJNA545312	6		8	10	PBSC_unmodified	Myelodysplastic Syndromes	aba877a42f584aaad6f786		1		post	0								
FMT.0054F		FMT.0054	19	semi-formed	SRR11420149	PRJNA545312	9		8	10	PBSC_unmodified	Myelodysplastic Syndromes	aba877a42f584aaad6f786		1		post	1								
FMT.0054G		FMT.0054	22	liquid	SRR11420148	PRJNA545312	12		8	10	PBSC_unmodified	Myelodysplastic Syndromes	aba877a42f584aaad6f786		1		post	1								
FMT.0054H		FMT.0054	24	semi-formed	SRR11418573	PRJNA545312	14		8	10	PBSC_unmodified	Myelodysplastic Syndromes	aba877a42f584aaad6f786		1		post	1								
FMT.0055A		FMT.0055	0	formed	SRR11418572	PRJNA545312	-20		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		pre	-3								
FMT.0055C		FMT.0055	13	formed	SRR11418570	PRJNA545312	-7		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		pre	-2								
FMT.0055D		FMT.0055	14	formed	SRR11418569	PRJNA545312	-6		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		pre	-1								
FMT.0055E		FMT.0055	15	liquid	SRR11420147	PRJNA545312	-5		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		pre	-1								
FMT.0055F		FMT.0055	16	liquid	SRR11420146	PRJNA545312	-4		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		pre	-1								
FMT.0055G		FMT.0055	18	liquid	SRR11420145	PRJNA545312	-2		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		pre	-1								
FMT.0055H		FMT.0055	19	semi-formed	SRR11420144	PRJNA545312	-1		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		pre	-1								
FMT.0055I		FMT.0055	20	semi-formed	SRR11420143	PRJNA545312	0		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		peri	-1								
FMT.0055J		FMT.0055	21	semi-formed	SRR11420142	PRJNA545312	1		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		peri	0								
FMT.0055K		FMT.0055	22	liquid	SRR11420141	PRJNA545312	2		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		peri	0								
FMT.0055L		FMT.0055	23	liquid	SRR11420140	PRJNA545312	3		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		peri	0								
FMT.0055N		FMT.0055	24	liquid	SRR11420137	PRJNA545312	4		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		peri	0								
FMT.0055O		FMT.0055	25	liquid	SRR11420136	PRJNA545312	5		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		peri	0								
FMT.0055P		FMT.0055	26	semi-formed	SRR11420135	PRJNA545312	6		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		post	0								
FMT.0055Q		FMT.0055	28	semi-formed	SRR11420134	PRJNA545312	8		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		post	1								
FMT.0055R		FMT.0055	30	semi-formed	SRR11420133	PRJNA545312	10		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		post	1								
FMT.0055S		FMT.0055	31	formed	SRR11420132	PRJNA545312	11		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		post	1								
FMT.0055T		FMT.0055	34	semi-formed	SRR11420131	PRJNA545312	14		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		post	1								
FMT.0055U		FMT.0055	120	semi-formed	SRR11420130	PRJNA545312	100		19	20	TCD	Myelodysplastic Syndromes	c00834cd4562c651c9d868		1		post	6								
FMT.0056A		FMT.0056	0	semi-formed	SRR11396711	PRJNA607574			1																	
FMT.0057A		FMT.0057	0	formed	SRR11420129	PRJNA545312	-7		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		pre	-2								
FMT.0057C		FMT.0057	1	formed	SRR11419465	PRJNA545312	-6		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		pre	-1								
FMT.0057D		FMT.0057	6	semi-formed	SRR11419464	PRJNA545312	-1		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		pre	-1								
FMT.0057E		FMT.0057	11	liquid	SRR11419462	PRJNA545312	4		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		peri	0								
FMT.0057F		FMT.0057	16	semi-formed	SRR11420057	PRJNA545312	9		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		post	1								
FMT.0057G		FMT.0057	18	liquid	SRR11420056	PRJNA545312	11		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		post	1								
FMT.0057H		FMT.0057	29	formed	SRR11420055	PRJNA545312	22		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		post	3								
FMT.0057I		FMT.0057	36	formed	SRR11420054	PRJNA545312	29		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		post	4								
FMT.0057J		FMT.0057	32	formed	SRR11420053	PRJNA545312	25		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		post	3								
FMT.0057K		FMT.0057	37	formed	SRR11420052	PRJNA545312	30		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		post	4								
FMT.0057L		FMT.0057	38	formed	SRR11420050	PRJNA545312	31		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		post	4								
FMT.0057M		FMT.0057	40	formed	SRR11420049	PRJNA545312	33		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		post	4								
FMT.0057N		FMT.0057	39	formed	SRR11420048	PRJNA545312	32		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		post	4								
FMT.0057O		FMT.0057	68	formed	SRR11420047	PRJNA545312	61		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		post	6								
FMT.0057P		FMT.0057	88	formed	SRR11420046	PRJNA545312	81		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		post	6								
FMT.0057Q		FMT.0057	125	semi-formed	SRR11420045	PRJNA545312	118		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		post	6								
FMT.0057R		FMT.0057	187	formed	SRR11420044	PRJNA545312	180		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		post	6								
FMT.0057S		FMT.0057	286	formed	SRR11420043	PRJNA545312	279		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		post	6								
FMT.0057T		FMT.0057	384	formed	SRR11420042	PRJNA545312	377		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		post	6								
FMT.0057U		FMT.0057	496	formed	SRR11420041	PRJNA545312	489		20	7	cord	Leukemia	4ad67ea7ddd46b772fc3e3		1		post	6								
FMT.0059A		FMT.0059	56	formed	SRR11420038	PRJNA545312	-7		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		pre	-2								
FMT.0059AA		FMT.0059	86	formed	SRR11420037	PRJNA545312	23		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	3								
FMT.0059B		FMT.0059	57	formed	SRR11420036	PRJNA545312	-6		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		pre	-1								
FMT.0059BB		FMT.0059	87	formed	SRR11420035	PRJNA545312	24		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	3								
FMT.0059C		FMT.0059	58	formed	SRR11420034	PRJNA545312	-5		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		pre	-1								
FMT.0059CC		FMT.0059	183	semi-formed	SRR11419977	PRJNA545312	120		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	6								
FMT.0059D		FMT.0059	59	formed	SRR11419976	PRJNA545312	-4		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		pre	-1								
FMT.0059DD		FMT.0059	260	formed	SRR11419975	PRJNA545312	197		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	6								
FMT.0059E		FMT.0059	60	formed	SRR11419974	PRJNA545312	-3		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		pre	-1								
FMT.0059F		FMT.0059	62	formed	SRR11419973	PRJNA545312	-1		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		pre	-1								
FMT.0059FF		FMT.0059	376	semi-formed	SRR11419971	PRJNA545312	313		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	6								
FMT.0059G		FMT.0059	64	formed	SRR11419970	PRJNA545312	1		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		peri	0								
FMT.0059GG		FMT.0059	884	formed	SRR11116609	PRJNA607574	821		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	6								
FMT.0059H		FMT.0059	65	formed	SRR11419969	PRJNA545312	2		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		peri	0								
FMT.0059HH		FMT.0059	988	liquid	SRR11116608	PRJNA607574	925		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	6								
FMT.0059I		FMT.0059	66	formed	SRR11419968	PRJNA545312	3		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		peri	0								
FMT.0059J		FMT.0059	67	formed	SRR11419967	PRJNA545312	4		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		peri	0								
FMT.0059K		FMT.0059	68	formed	SRR11419966	PRJNA545312	5		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		peri	0								
FMT.0059L		FMT.0059	69	formed	SRR11419965	PRJNA545312	6		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	0								
FMT.0059M		FMT.0059	70	formed	SRR11419964	PRJNA545312	7		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	0								
FMT.0059N		FMT.0059	72	formed	SRR11419963	PRJNA545312	9		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	1								
FMT.0059O		FMT.0059	73	liquid	SRR11419962	PRJNA545312	10		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	1								
FMT.0059P		FMT.0059	74	semi-formed	SRR11419960	PRJNA545312	11		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	1								
FMT.0059Q		FMT.0059	75	semi-formed	SRR11419959	PRJNA545312	12		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	1								
FMT.0059R		FMT.0059	77	liquid	SRR11419958	PRJNA545312	14		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	1								
FMT.0059S		FMT.0059	78	formed	SRR11419957	PRJNA545312	15		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	2								
FMT.0059T		FMT.0059	79	formed	SRR11419956	PRJNA545312	16		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	2								
FMT.0059U		FMT.0059	80	formed	SRR11419955	PRJNA545312	17		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	2								
FMT.0059V		FMT.0059	81	formed	SRR11419954	PRJNA545312	18		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	2								
FMT.0059X		FMT.0059	82	formed	SRR11419952	PRJNA545312	19		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	2								
FMT.0059Y		FMT.0059	83	formed	SRR11419951	PRJNA545312	20		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	2								
FMT.0059Z		FMT.0059	84	semi-formed	SRR11419949	PRJNA545312	21		36	63	cord	Leukemia	92c1d6cbc5b53878122f48		1		post	2								
FMT.0060A		FMT.0060	0	formed	SRR11419948	PRJNA545312	-50		15	50	BM_unmodified	Myelodysplastic Syndromes	38420c6a5b7b8273d04ac2		1		pre	-3								
FMT.0060B		FMT.0060	46	formed	SRR11419947	PRJNA545312	-4		15	50	BM_unmodified	Myelodysplastic Syndromes	38420c6a5b7b8273d04ac2		1		pre	-1								
FMT.0060C		FMT.0060	47	formed	SRR11419946	PRJNA545312	-3		15	50	BM_unmodified	Myelodysplastic Syndromes	38420c6a5b7b8273d04ac2		1		pre	-1								
FMT.0060D		FMT.0060	48	formed	SRR11419945	PRJNA545312	-2		15	50	BM_unmodified	Myelodysplastic Syndromes	38420c6a5b7b8273d04ac2		1		pre	-1								
FMT.0060E		FMT.0060	50	formed	SRR11419944	PRJNA545312	0		15	50	BM_unmodified	Myelodysplastic Syndromes	38420c6a5b7b8273d04ac2		1		peri	-1								
FMT.0060F		FMT.0060	51	formed	SRR11419943	PRJNA545312	1		15	50	BM_unmodified	Myelodysplastic Syndromes	38420c6a5b7b8273d04ac2		1		peri	0								
FMT.0060G		FMT.0060	53	formed	SRR11419942	PRJNA545312	3		15	50	BM_unmodified	Myelodysplastic Syndromes	38420c6a5b7b8273d04ac2		1		peri	0								
FMT.0060H		FMT.0060	55	formed	SRR11419941	PRJNA545312	5		15	50	BM_unmodified	Myelodysplastic Syndromes	38420c6a5b7b8273d04ac2		1		peri	0								
FMT.0060I		FMT.0060	57	formed	SRR11419940	PRJNA545312	7		15	50	BM_unmodified	Myelodysplastic Syndromes	38420c6a5b7b8273d04ac2		1		post	0								
FMT.0060J		FMT.0060	63	formed	SRR11419938	PRJNA545312	13		15	50	BM_unmodified	Myelodysplastic Syndromes	38420c6a5b7b8273d04ac2		1		post	1								
FMT.0060K		FMT.0060	68	formed	SRR11419937	PRJNA545312	18		15	50	BM_unmodified	Myelodysplastic Syndromes	38420c6a5b7b8273d04ac2		1		post	2								
FMT.0060L		FMT.0060	69	formed	SRR11419936	PRJNA545312	19		15	50	BM_unmodified	Myelodysplastic Syndromes	38420c6a5b7b8273d04ac2		1		post	2								
FMT.0060M		FMT.0060	74	semi-formed	SRR11419935	PRJNA545312	24		15	50	BM_unmodified	Myelodysplastic Syndromes	38420c6a5b7b8273d04ac2		1		post	3								
FMT.0060N		FMT.0060	75	semi-formed	SRR11419934	PRJNA545312	25		15	50	BM_unmodified	Myelodysplastic Syndromes	38420c6a5b7b8273d04ac2		1		post	3								
FMT.0060O		FMT.0060	132	semi-formed	SRR11419933	PRJNA545312	82		15	50	BM_unmodified	Myelodysplastic Syndromes	38420c6a5b7b8273d04ac2		1		post	6								
FMT.0061A	-53	FMT.0061	0	formed	SRR11419932	PRJNA545312	-17	SRR14092181	26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	pre	-3	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-3	pre
FMT.0061AA	3	FMT.0061	56	formed	SRR11116607	PRJNA607574	39		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	post	5	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	0	peri
FMT.0061B	-45	FMT.0061	8	formed	SRR11419931	PRJNA545312	-9		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	pre	-2	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-3	pre
FMT.0061BB	26	FMT.0061	79	formed	SRR11116606	PRJNA607574	62		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	post	6	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	3	post
FMT.0061C	-44	FMT.0061	9	formed	SRR11419930	PRJNA545312	-8		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	pre	-2	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-3	pre
FMT.0061CC	58	FMT.0061	111	formed	SRR11116605	PRJNA607574	94		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	post	6	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	6	post
FMT.0061D	-42	FMT.0061	11	formed	SRR11419929	PRJNA545312	-6		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	pre	-1	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-3	pre
FMT.0061DD	94	FMT.0061	147	formed	SRR11116604	PRJNA607574	130		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	post	6	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	6	post
FMT.0061E	-41	FMT.0061	12	formed	SRR11419927	PRJNA545312	-5		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	pre	-1	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-3	pre
FMT.0061EE	143	FMT.0061	196	formed	SRR11116603	PRJNA607574	179		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	post	6	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	6	post
FMT.0061F	-40	FMT.0061	13	formed	SRR11419926	PRJNA545312	-4		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	pre	-1	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-3	pre
FMT.0061FF	175	FMT.0061	228	formed	SRR11116602	PRJNA607574	211		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	post	6	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	6	post
FMT.0061G	-39	FMT.0061	14	formed	SRR11419925	PRJNA545312	-3		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	pre	-1	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-3	pre
FMT.0061GG	235	FMT.0061	288	formed	SRR11116601	PRJNA607574	271		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	post	6	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	6	post
FMT.0061H	-38	FMT.0061	15	liquid	SRR11419924	PRJNA545312	-2		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	pre	-1	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-3	pre
FMT.0061HH	361	FMT.0061	414	semi-formed	SRR11116600	PRJNA607574	397		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	post	6	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	6	post
FMT.0061I	-37	FMT.0061	16	liquid	SRR11419923	PRJNA545312	-1		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	pre	-1	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-3	pre
FMT.0061J	-36	FMT.0061	17	liquid	SRR11419922	PRJNA545312	0		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	peri	-1	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-3	pre
FMT.0061K	-35	FMT.0061	18	semi-formed	SRR11420267	PRJNA545312	1		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	peri	0	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-3	pre
FMT.0061L	-34	FMT.0061	19	semi-formed	SRR11420266	PRJNA545312	2		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	peri	0	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-3	pre
FMT.0061R	-28	FMT.0061	25	liquid	SRR11420265	PRJNA545312	8		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	post	1	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-3	pre
FMT.0061S	-27	FMT.0061	26	semi-formed	SRR11420264	PRJNA545312	9		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	post	1	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-3	pre
FMT.0061U	-26	FMT.0061	27	liquid	SRR11420261	PRJNA545312	10		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	post	1	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-3	pre
FMT.0061V	-25	FMT.0061	28	liquid	SRR11420260	PRJNA545312	11		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	post	1	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-3	pre
FMT.0061X	-23	FMT.0061	30	semi-formed	SRR11420259	PRJNA545312	13		26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	post	1	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-3	pre
FMT.0061Z	0	FMT.0061	53	liquid	SRR11116598	PRJNA607574	36	SRR14092180	26	17	TCD	Myelodysplastic Syndromes	c989fa0e051492b49ac7ff	T7	1	treatment	post	5	Treatment	33	36	FMT.0061A	FMT.0061X	FMT.0061Z	-1	peri
FMT.0062A		FMT.0062	0	formed	SRR11420258	PRJNA545312	-112		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		pre	-3								
FMT.0062AA		FMT.0062	144	semi-formed	SRR11420257	PRJNA545312	32		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		post	4								
FMT.0062B		FMT.0062	106	formed	SRR11420256	PRJNA545312	-6		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		pre	-1								
FMT.0062BB		FMT.0062	145	formed	SRR11420255	PRJNA545312	33		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		post	4								
FMT.0062D		FMT.0062	108	formed	SRR11420254	PRJNA545312	-4		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		pre	-1								
FMT.0062E		FMT.0062	109	formed	SRR11420253	PRJNA545312	-3		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		pre	-1								
FMT.0062EE		FMT.0062	148	formed	SRR11420251	PRJNA545312	36		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		post	5								
FMT.0062F		FMT.0062	112	liquid	SRR11420250	PRJNA545312	0		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		peri	-1								
FMT.0062G		FMT.0062	113	semi-formed	SRR11420249	PRJNA545312	1		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		peri	0								
FMT.0062H		FMT.0062	114	semi-formed	SRR11420248	PRJNA545312	2		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		peri	0								
FMT.0062L		FMT.0062	119	formed	SRR11420247	PRJNA545312	7		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		post	0								
FMT.0062M		FMT.0062	121	semi-formed	SRR11420246	PRJNA545312	9		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		post	1								
FMT.0062O		FMT.0062	123	semi-formed	SRR11420245	PRJNA545312	11		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		post	1								
FMT.0062P		FMT.0062	124	semi-formed	SRR11420244	PRJNA545312	12		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		post	1								
FMT.0062Q		FMT.0062	125	liquid	SRR11420243	PRJNA545312	13		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		post	1								
FMT.0062R		FMT.0062	126	semi-formed	SRR11420242	PRJNA545312	14		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		post	1								
FMT.0062S		FMT.0062	128	formed	SRR11420240	PRJNA545312	16		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		post	2								
FMT.0062T		FMT.0062	129	semi-formed	SRR11420239	PRJNA545312	17		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		post	2								
FMT.0062V		FMT.0062	131	formed	SRR11420238	PRJNA545312	19		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		post	2								
FMT.0062W		FMT.0062	135	formed	SRR11420237	PRJNA545312	23		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		post	3								
FMT.0062X		FMT.0062	138	formed	SRR11420236	PRJNA545312	26		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		post	3								
FMT.0062Y		FMT.0062	140	formed	SRR11420235	PRJNA545312	28		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		post	3								
FMT.0062Z		FMT.0062	141	formed	SRR11420234	PRJNA545312	29		23	112	cord	Non-Hodgkin's Lymphoma	3d89559bb0801598211996	721	1		post	4								
FMT.0063A	-55	FMT.0063	0	formed	SRR11420233	PRJNA545312	-6	SRR14092179	46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	pre	-1	Control	49					-3	pre
FMT.0063AAA	19	FMT.0063	74	formed	SRR11420232	PRJNA545312	68		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					2	post
FMT.0063B	-53	FMT.0063	2	formed	SRR11420231	PRJNA545312	-4		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	pre	-1	Control	49					-3	pre
FMT.0063BBB	20	FMT.0063	75	formed	SRR11420229	PRJNA545312	69		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					2	post
FMT.0063C	-52	FMT.0063	3	semi-formed	SRR11420228	PRJNA545312	-3		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	pre	-1	Control	49					-3	pre
FMT.0063CC	-21	FMT.0063	34	liquid	SRR11420227	PRJNA545312	28		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	3	Control	49					-3	pre
FMT.0063CCC	21	FMT.0063	76	formed	SRR11420226	PRJNA545312	70		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					2	post
FMT.0063D	-51	FMT.0063	4	liquid	SRR11420225	PRJNA545312	-2		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	pre	-1	Control	49					-3	pre
FMT.0063E	-50	FMT.0063	5	liquid	SRR11420224	PRJNA545312	-1		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	pre	-1	Control	49					-3	pre
FMT.0063EE	-19	FMT.0063	36	semi-formed	SRR11420223	PRJNA545312	30		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	4	Control	49					-3	pre
FMT.0063EEE	23	FMT.0063	78	semi-formed	SRR11420222	PRJNA545312	72		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					3	post
FMT.0063F	-49	FMT.0063	6	liquid	SRR11420221	PRJNA545312	0		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	peri	-1	Control	49					-3	pre
FMT.0063FFF	28	FMT.0063	83	formed	SRR11420220	PRJNA545312	77		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					3	post
FMT.0063G	-48	FMT.0063	7	liquid	SRR11420217	PRJNA545312	1		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	peri	0	Control	49					-3	pre
FMT.0063GG	-18	FMT.0063	37	liquid	SRR11420216	PRJNA545312	31		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	4	Control	49					-3	pre
FMT.0063GGG	30	FMT.0063	85	formed	SRR11420215	PRJNA545312	79		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					4	post
FMT.0063HH	-15	FMT.0063	40	liquid	SRR11420213	PRJNA545312	34		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	4	Control	49					-3	pre
FMT.0063HHH	49	FMT.0063	104	semi-formed	SRR11420212	PRJNA545312	98		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					6	post
FMT.0063I	-47	FMT.0063	8	semi-formed	SRR11420183	PRJNA545312	2		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	peri	0	Control	49					-3	pre
FMT.0063II	-14	FMT.0063	41	liquid	SRR11418568	PRJNA545312	35		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	4	Control	49					-3	pre
FMT.0063III	93	FMT.0063	148	semi-formed	SRR11418567	PRJNA545312	142		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					6	post
FMT.0063JJ	-9	FMT.0063	46	semi-formed	SRR11418565	PRJNA545312	40		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	5	Control	49					-2	pre
FMT.0063JJJ	142	FMT.0063	197	semi-formed	SRR11418564	PRJNA545312	191		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					6	post
FMT.0063K	-46	FMT.0063	9	liquid	SRR11418563	PRJNA545312	3		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	peri	0	Control	49					-3	pre
FMT.0063KK	-4	FMT.0063	51	formed	SRR11418562	PRJNA545312	45		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					-1	pre
FMT.0063KKK	247	FMT.0063	302	formed	SRR11418561	PRJNA545312	296		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					6	post
FMT.0063L	-45	FMT.0063	10	liquid	SRR11418559	PRJNA545312	4		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	peri	0	Control	49					-3	pre
FMT.0063LL	-3	FMT.0063	52	semi-formed	SRR11418558	PRJNA545312	46		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					-1	pre
FMT.0063LLL	288	FMT.0063	343	liquid	SRR11418557	PRJNA545312	337		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					6	post
FMT.0063M	-44	FMT.0063	11	semi-formed	SRR11418556	PRJNA545312	5		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	peri	0	Control	49					-3	pre
FMT.0063MM	-1	FMT.0063	54	semi-formed	SRR11418443	PRJNA545312	48		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					-1	pre
FMT.0063MMM	338	FMT.0063	393	semi-formed	SRR11418442	PRJNA545312	387		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					6	post
FMT.0063N	-43	FMT.0063	12	liquid	SRR11418441	PRJNA545312	6		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	0	Control	49					-3	pre
FMT.0063NN	0	FMT.0063	55	semi-formed	SRR11418440	PRJNA545312	49		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					-1	peri
FMT.0063OO	2	FMT.0063	57	semi-formed	SRR11418439	PRJNA545312	51	SRR13697225	46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					0	peri
FMT.0063P	-36	FMT.0063	19	liquid	SRR11418438	PRJNA545312	13		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	1	Control	49					-3	pre
FMT.0063PP	4	FMT.0063	59	formed	SRR11418436	PRJNA545312	53		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					0	peri
FMT.0063QQ	6	FMT.0063	61	formed	SRR11418435	PRJNA545312	55		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					0	post
FMT.0063SS	8	FMT.0063	63	formed	SRR11418433	PRJNA545312	57		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					1	post
FMT.0063TT	9	FMT.0063	64	formed	SRR11418432	PRJNA545312	58		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					1	post
FMT.0063UU	10	FMT.0063	65	formed	SRR11418431	PRJNA545312	59		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					1	post
FMT.0063VV	11	FMT.0063	66	formed	SRR11418430	PRJNA545312	60		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					1	post
FMT.0063WW	12	FMT.0063	67		SRR11418429	PRJNA545312	61		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					1	post
FMT.0063XX	25	FMT.0063	80	formed	SRR11418428	PRJNA545312	74		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					3	post
FMT.0063YY	26	FMT.0063	81	formed	SRR11418426	PRJNA545312	75		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					3	post
FMT.0063ZZ	18	FMT.0063	73	formed	SRR11420182	PRJNA545312	67		46	6	PBSC_unmodified	Leukemia	2314663ceda58b12364a02	C6	1	control	post	6	Control	49					2	post
FMT.0064A	-49	FMT.0064	0	formed	SRR11420181	PRJNA545312	-10	SRR13697224	28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	pre	-2	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064AA	63	FMT.0064	112	semi-formed	SRR11116597	PRJNA607574	102		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	post	6	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	6	post
FMT.0064B	-48	FMT.0064	1	semi-formed	SRR11420180	PRJNA545312	-9	SRR14092178	28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	pre	-2	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064BB	77	FMT.0064	126	semi-formed	SRR11116596	PRJNA607574	116		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	post	6	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	6	post
FMT.0064C	-47	FMT.0064	2	formed	SRR11420178	PRJNA545312	-8	SRR14092177	28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	pre	-2	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064CC	92	FMT.0064	141	semi-formed	SRR11116595	PRJNA607574	131		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	post	6	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	6	post
FMT.0064D	-46	FMT.0064	3	semi-formed	SRR11420177	PRJNA545312	-7	SRR14092176	28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	pre	-2	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064DD	93	FMT.0064	142	liquid	SRR11116594	PRJNA607574	132		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	post	6	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	6	post
FMT.0064E	-45	FMT.0064	4	formed	SRR11420176	PRJNA545312	-6		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	pre	-1	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064EE	95	FMT.0064	144	semi-formed	SRR11116593	PRJNA607574	134		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	post	6	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	6	post
FMT.0064F	-43	FMT.0064	6	liquid	SRR11420175	PRJNA545312	-4	SRR14092175	28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	pre	-1	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064FF	133	FMT.0064	182	semi-formed	SRR11116592	PRJNA607574	172		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	post	6	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	6	post
FMT.0064G	-40	FMT.0064	9	formed	SRR11420174	PRJNA545312	-1	SRR13697223	28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	pre	-1	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064H	-38	FMT.0064	11	liquid	SRR11420173	PRJNA545312	1		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	peri	0	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064I	-37	FMT.0064	12	liquid	SRR11420172	PRJNA545312	2		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	peri	0	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064J	-36	FMT.0064	13	liquid	SRR11420171	PRJNA545312	3		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	peri	0	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064K	-35	FMT.0064	14	liquid	SRR11420170	PRJNA545312	4		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	peri	0	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064M	-34	FMT.0064	15	liquid	SRR11420167	PRJNA545312	5	SRR13697222	28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	peri	0	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064O	-33	FMT.0064	16	liquid	SRR11420166	PRJNA545312	6		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	post	0	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064P	-32	FMT.0064	17	liquid	SRR11420165	PRJNA545312	7		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	post	0	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064Q	-31	FMT.0064	18	liquid	SRR11420164	PRJNA545312	8		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	post	1	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064R	-30	FMT.0064	19	liquid	SRR11420163	PRJNA545312	9		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	post	1	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064S	-28	FMT.0064	21	liquid	SRR11420162	PRJNA545312	11		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	post	1	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064T	-27	FMT.0064	22	liquid	SRR11420161	PRJNA545312	12		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	post	1	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064V	-18	FMT.0064	31	liquid	SRR11420160	PRJNA545312	21		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	post	2	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-3	pre
FMT.0064X	0	FMT.0064	49	liquid	SRR11116591	PRJNA607574	39	SRR13697221	28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	post	5	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	-1	peri
FMT.0064Y	7	FMT.0064	56	semi-formed	SRR11116590	PRJNA607574	46		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	post	6	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	0	post
FMT.0064Z	21	FMT.0064	70	formed	SRR11116589	PRJNA607574	60		28	10	TCD	Multiple Myeloma	8ae11671e89fe36ab08a7b	T6	1	treatment	post	6	Treatment	38	39	FMT.0064A	FMT.0064V	FMT.0064X	2	post
FMT.0066A		FMT.0066	0	semi-formed	SRR11420159	PRJNA545312	-7		27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		pre	-2								
FMT.0066AA		FMT.0066	89	semi-formed	SRR11420158	PRJNA545312	82		27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	6								
FMT.0066B		FMT.0066	3	formed	SRR11420156	PRJNA545312	-4	SRR13697220	27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		pre	-1								
FMT.0066C		FMT.0066	4	formed	SRR11420127	PRJNA545312	-3		27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		pre	-1								
FMT.0066D		FMT.0066	5	formed	SRR11420126	PRJNA545312	-2	SRR14092173	27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		pre	-1								
FMT.0066E		FMT.0066	8	semi-formed	SRR11420125	PRJNA545312	1	SRR14092172	27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		peri	0								
FMT.0066F		FMT.0066	9	formed	SRR11420124	PRJNA545312	2		27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		peri	0								
FMT.0066G		FMT.0066	10	semi-formed	SRR11420123	PRJNA545312	3		27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		peri	0								
FMT.0066H		FMT.0066	11	semi-formed	SRR11420122	PRJNA545312	4		27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		peri	0								
FMT.0066I		FMT.0066	12	semi-formed	SRR11420121	PRJNA545312	5	SRR14092171	27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		peri	0								
FMT.0066J		FMT.0066	13	semi-formed	SRR11420120	PRJNA545312	6	SRR13697218	27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	0								
FMT.0066K		FMT.0066	14	semi-formed	SRR11420119	PRJNA545312	7		27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	0								
FMT.0066L		FMT.0066	16	semi-formed	SRR11420117	PRJNA545312	9		27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	1								
FMT.0066M		FMT.0066	17	formed	SRR11420116	PRJNA545312	10	SRR13697217	27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	1								
FMT.0066N		FMT.0066	18	semi-formed	SRR11420115	PRJNA545312	11	SRR13697216	27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	1								
FMT.0066O		FMT.0066	20	semi-formed	SRR11420114	PRJNA545312	13	SRR14092170	27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	1								
FMT.0066P		FMT.0066	21	semi-formed	SRR11420113	PRJNA545312	14	SRR13697215	27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	1								
FMT.0066Q		FMT.0066	22	formed	SRR11420112	PRJNA545312	15	SRR13697214	27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	2								
FMT.0066R		FMT.0066	23	formed	SRR11420111	PRJNA545312	16	SRR13697213	27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	2								
FMT.0066S		FMT.0066	24	formed	SRR11420110	PRJNA545312	17	SRR13697212	27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	2								
FMT.0066T		FMT.0066	26	semi-formed	SRR11420109	PRJNA545312	19	SRR13697211	27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	2								
FMT.0066U		FMT.0066	25	semi-formed	SRR11420108	PRJNA545312	18	SRR14092169	27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	2								
FMT.0066V		FMT.0066	27	semi-formed	SRR11420106	PRJNA545312	20	SRR14143412	27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	2								
FMT.0066W		FMT.0066	29	formed	SRR11420105	PRJNA545312	22	SRR13697210	27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	3								
FMT.0066X		FMT.0066	30	semi-formed	SRR11420104	PRJNA545312	23	SRR13697209	27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	3								
FMT.0066Y		FMT.0066	87	liquid	SRR11420103	PRJNA545312	80		27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	6								
FMT.0066Z		FMT.0066	88	semi-formed	SRR11420102	PRJNA545312	81		27	7	PBSC_unmodified	Leukemia	f871850139cd8c88db1aec		1		post	6								
FMT.0067A		FMT.0067	0	semi-formed	SRR11420101	PRJNA545312	-8		12	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	6763379601e382aed5660b		1		pre	-2								
FMT.0067B		FMT.0067	3	formed	SRR11420100	PRJNA545312	-5		12	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	6763379601e382aed5660b		1		pre	-1								
FMT.0067C		FMT.0067	4	semi-formed	SRR11420033	PRJNA545312	-4		12	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	6763379601e382aed5660b		1		pre	-1								
FMT.0067D		FMT.0067	5	liquid	SRR11420032	PRJNA545312	-3		12	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	6763379601e382aed5660b		1		pre	-1								
FMT.0067E		FMT.0067	9	semi-formed	SRR11420031	PRJNA545312	1		12	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	6763379601e382aed5660b		1		peri	0								
FMT.0067K		FMT.0067	25	liquid	SRR11420029	PRJNA545312	17		12	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	6763379601e382aed5660b		1		post	2								
FMT.0067N		FMT.0067	48	semi-formed	SRR11420028	PRJNA545312	40		12	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	6763379601e382aed5660b		1		post	5								
FMT.0067O		FMT.0067	49	semi-formed	SRR11420027	PRJNA545312	41		12	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	6763379601e382aed5660b		1		post	5								
FMT.0067R		FMT.0067	57	formed	SRR11420026	PRJNA545312	49		12	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	6763379601e382aed5660b		1		post	6								
FMT.0067S		FMT.0067	58	formed	SRR11420025	PRJNA545312	50		12	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	6763379601e382aed5660b		1		post	6								
FMT.0067T		FMT.0067	59	semi-formed	SRR11420024	PRJNA545312	51		12	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	6763379601e382aed5660b		1		post	6								
FMT.0067U		FMT.0067	260	semi-formed	SRR11420023	PRJNA545312	252		12	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	6763379601e382aed5660b		1		post	6								
FMT.0068A		FMT.0068	0	formed	SRR11420022	PRJNA545312	-10		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		pre	-2								
FMT.0068AA		FMT.0068	73	semi-formed	SRR11420021	PRJNA545312	63		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		post	6								
FMT.0068B		FMT.0068	4	formed	SRR11420020	PRJNA545312	-6		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		pre	-1								
FMT.0068C		FMT.0068	5	semi-formed	SRR11420018	PRJNA545312	-5		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		pre	-1								
FMT.0068D		FMT.0068	7	formed	SRR11420017	PRJNA545312	-3		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		pre	-1								
FMT.0068E		FMT.0068	8	formed	SRR11420016	PRJNA545312	-2		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		pre	-1								
FMT.0068F		FMT.0068	9	formed	SRR11420015	PRJNA545312	-1		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		pre	-1								
FMT.0068G		FMT.0068	10	semi-formed	SRR11420014	PRJNA545312	0		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		peri	-1								
FMT.0068H		FMT.0068	11	formed	SRR11420013	PRJNA545312	1		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		peri	0								
FMT.0068I		FMT.0068	13	formed	SRR11420012	PRJNA545312	3		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		peri	0								
FMT.0068J		FMT.0068	15	formed	SRR11420011	PRJNA545312	5		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		peri	0								
FMT.0068L		FMT.0068	18	semi-formed	SRR11420009	PRJNA545312	8		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		post	1								
FMT.0068M		FMT.0068	19	formed	SRR11420007	PRJNA545312	9		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		post	1								
FMT.0068N		FMT.0068	20	liquid	SRR11420006	PRJNA545312	10		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		post	1								
FMT.0068O		FMT.0068	21	liquid	SRR11419921	PRJNA545312	11		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		post	1								
FMT.0068Q		FMT.0068	23	liquid	SRR11419920	PRJNA545312	13		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		post	1								
FMT.0068R		FMT.0068	24	liquid	SRR11419919	PRJNA545312	14		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		post	1								
FMT.0068T		FMT.0068	25	semi-formed	SRR11419917	PRJNA545312	15		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		post	2								
FMT.0068U		FMT.0068	27	semi-formed	SRR11419916	PRJNA545312	17		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		post	2								
FMT.0068V		FMT.0068	30	semi-formed	SRR11419915	PRJNA545312	20		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		post	2								
FMT.0068W		FMT.0068	31	liquid	SRR11419914	PRJNA545312	21		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		post	2								
FMT.0068X		FMT.0068	35	formed	SRR11419912	PRJNA545312	25		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		post	3								
FMT.0068Y		FMT.0068	36	semi-formed	SRR11419911	PRJNA545312	26		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		post	3								
FMT.0068Z		FMT.0068	44	formed	SRR11419910	PRJNA545312	34		24	10	cord	Non-Hodgkin's Lymphoma	7941e4cae71c4b58c59331		1		post	4								
FMT.0069A		FMT.0069	0	formed	SRR11419909	PRJNA545312	-15		26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		pre	-3								
FMT.0069AA		FMT.0069	272	formed	SRR11419908	PRJNA545312	257		26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		post	6								
FMT.0069B		FMT.0069	10	formed	SRR11419907	PRJNA545312	-5		26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		pre	-1								
FMT.0069C		FMT.0069	11	formed	SRR11419906	PRJNA545312	-4	SRR14092168	26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		pre	-1								
FMT.0069D		FMT.0069	12	formed	SRR11419905	PRJNA545312	-3	SRR13697100	26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		pre	-1								
FMT.0069E		FMT.0069	13	formed	SRR11419904	PRJNA545312	-2	SRR13697099	26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		pre	-1								
FMT.0069F		FMT.0069	14	semi-formed	SRR11419903	PRJNA545312	-1	SRR14092167	26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		pre	-1								
FMT.0069G		FMT.0069	15	semi-formed	SRR11419900	PRJNA545312	0	SRR14092166	26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		peri	-1								
FMT.0069H		FMT.0069	16	semi-formed	SRR11419899	PRJNA545312	1	SRR13697098	26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		peri	0								
FMT.0069I		FMT.0069	17	semi-formed	SRR11419898	PRJNA545312	2	SRR14092165	26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		peri	0								
FMT.0069J		FMT.0069	19	formed	SRR11419897	PRJNA545312	4	SRR13697097	26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		peri	0								
FMT.0069L		FMT.0069	20	liquid	SRR11419895	PRJNA545312	5		26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		peri	0								
FMT.0069M		FMT.0069	22	liquid	SRR11419894	PRJNA545312	7		26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		post	0								
FMT.0069N		FMT.0069	23	liquid	SRR11419893	PRJNA545312	8		26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		post	1								
FMT.0069O		FMT.0069	24	liquid	SRR11419892	PRJNA545312	9	SRR14092164	26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		post	1								
FMT.0069P		FMT.0069	26	semi-formed	SRR11419891	PRJNA545312	11	SRR13697096	26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		post	1								
FMT.0069Q		FMT.0069	27	semi-formed	SRR11419889	PRJNA545312	12	SRR14092162	26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		post	1								
FMT.0069R		FMT.0069	28	liquid	SRR11419888	PRJNA545312	13	SRR13697095	26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		post	1								
FMT.0069S		FMT.0069	29	semi-formed	SRR11419887	PRJNA545312	14	SRR13697094	26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		post	1								
FMT.0069T		FMT.0069	70	semi-formed	SRR11419886	PRJNA545312	55		26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		post	6								
FMT.0069U		FMT.0069	98	semi-formed	SRR11419885	PRJNA545312	83		26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		post	6								
FMT.0069V		FMT.0069	129	formed	SRR11419884	PRJNA545312	114		26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		post	6								
FMT.0069W		FMT.0069	159	formed	SRR11419883	PRJNA545312	144		26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		post	6								
FMT.0069X		FMT.0069	189	semi-formed	SRR11419882	PRJNA545312	174		26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		post	6								
FMT.0069Y		FMT.0069	243	semi-formed	SRR11419881	PRJNA545312	228		26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		post	6								
FMT.0069Z		FMT.0069	267	formed	SRR11419880	PRJNA545312	252		26	15	PBSC_unmodified	Leukemia	266d2264d85ae8bfde60e6		1		post	6								
FMT.0070A		FMT.0070	0	formed	SRR11419878	PRJNA545312	-33		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		pre	-3								
FMT.0070B		FMT.0070	22	formed	SRR11419877	PRJNA545312	-11		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		pre	-2								
FMT.0070C		FMT.0070	29	formed	SRR11419876	PRJNA545312	-4		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		pre	-1								
FMT.0070D		FMT.0070	36	formed	SRR11419875	PRJNA545312	3		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		peri	0								
FMT.0070F		FMT.0070	37	semi-formed	SRR11419873	PRJNA545312	4		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		peri	0								
FMT.0070G		FMT.0070	38	liquid	SRR11419872	PRJNA545312	5		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		peri	0								
FMT.0070H		FMT.0070	39	semi-formed	SRR11419871	PRJNA545312	6		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		post	0								
FMT.0070J		FMT.0070	40	liquid	SRR11419869	PRJNA545312	7		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		post	0								
FMT.0070K		FMT.0070	41	liquid	SRR11419867	PRJNA545312	8		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		post	1								
FMT.0070M		FMT.0070	44	liquid	SRR11419865	PRJNA545312	11		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		post	1								
FMT.0070O		FMT.0070	45	liquid	SRR11419863	PRJNA545312	12		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		post	1								
FMT.0070P		FMT.0070	46	liquid	SRR11419862	PRJNA545312	13		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		post	1								
FMT.0070R		FMT.0070	47	liquid	SRR11419860	PRJNA545312	14		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		post	1								
FMT.0070S		FMT.0070	82	semi-formed	SRR11419859	PRJNA545312	49		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		post	6								
FMT.0070T		FMT.0070	91	semi-formed	SRR11419858	PRJNA545312	58		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		post	6								
FMT.0070U		FMT.0070	155	formed	SRR11419856	PRJNA545312	122		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		post	6								
FMT.0070V		FMT.0070	223	semi-formed	SRR11419855	PRJNA545312	190		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		post	6								
FMT.0070W		FMT.0070	355	formed	SRR11419854	PRJNA545312	322		18	33	PBSC_unmodified	Leukemia	ee8bf08f67564f39262821		1		post	6								
FMT.0072A		FMT.0072	0	semi-formed	SRR11419853	PRJNA545312	-16		9	16	TCD	Leukemia	6ee0fc511027700d9bba92		1		pre	-3								
FMT.0072B		FMT.0072	7	formed	SRR11419852	PRJNA545312	-9		9	16	TCD	Leukemia	6ee0fc511027700d9bba92		1		pre	-2								
FMT.0072D		FMT.0072	14	liquid	SRR11419850	PRJNA545312	-2		9	16	TCD	Leukemia	6ee0fc511027700d9bba92		1		pre	-1								
FMT.0072E		FMT.0072	16	liquid	SRR11419849	PRJNA545312	0		9	16	TCD	Leukemia	6ee0fc511027700d9bba92		1		peri	-1								
FMT.0072F		FMT.0072	17	semi-formed	SRR11419848	PRJNA545312	1		9	16	TCD	Leukemia	6ee0fc511027700d9bba92		1		peri	0								
FMT.0072G		FMT.0072	18	liquid	SRR11419847	PRJNA545312	2		9	16	TCD	Leukemia	6ee0fc511027700d9bba92		1		peri	0								
FMT.0072I		FMT.0072	20	liquid	SRR11419845	PRJNA545312	4		9	16	TCD	Leukemia	6ee0fc511027700d9bba92		1		peri	0								
FMT.0072J		FMT.0072	21	liquid	SRR11419844	PRJNA545312	5		9	16	TCD	Leukemia	6ee0fc511027700d9bba92		1		peri	0								
FMT.0072K		FMT.0072	26	semi-formed	SRR11419843	PRJNA545312	10		9	16	TCD	Leukemia	6ee0fc511027700d9bba92		1		post	1								
FMT.0073A		FMT.0073	0	formed	SRR11419842	PRJNA545312	-6		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		pre	-1								
FMT.0073B		FMT.0073	1	semi-formed	SRR11419841	PRJNA545312	-5		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		pre	-1								
FMT.0073C		FMT.0073	2	semi-formed	SRR11419840	PRJNA545312	-4		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		pre	-1								
FMT.0073D		FMT.0073	5	semi-formed	SRR11419839	PRJNA545312	-1		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		pre	-1								
FMT.0073F		FMT.0073	7	liquid	SRR11419821	PRJNA545312	1		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		peri	0								
FMT.0073G		FMT.0073	8	formed	SRR11419819	PRJNA545312	2		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		peri	0								
FMT.0073H		FMT.0073	6	liquid	SRR11419817	PRJNA545312	0		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		peri	-1								
FMT.0073I		FMT.0073	11	liquid	SRR11419816	PRJNA545312	5		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		peri	0								
FMT.0073J		FMT.0073	15	liquid	SRR11419815	PRJNA545312	9		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		post	1								
FMT.0073L		FMT.0073	17	liquid	SRR11419813	PRJNA545312	11		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		post	1								
FMT.0073M		FMT.0073	18	liquid	SRR11419812	PRJNA545312	12		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		post	1								
FMT.0073N		FMT.0073	19	liquid	SRR11419811	PRJNA545312	13		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		post	1								
FMT.0073O		FMT.0073	24	liquid	SRR11419810	PRJNA545312	18		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		post	2								
FMT.0073P		FMT.0073	27	semi-formed	SRR11419809	PRJNA545312	21		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		post	2								
FMT.0073Q		FMT.0073	31	semi-formed	SRR11419808	PRJNA545312	25		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		post	3								
FMT.0073R		FMT.0073	33	liquid	SRR11419806	PRJNA545312	27		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		post	3								
FMT.0073S		FMT.0073	42	semi-formed	SRR11419805	PRJNA545312	36		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		post	5								
FMT.0073T		FMT.0073	44	liquid	SRR11419804	PRJNA545312	38		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		post	5								
FMT.0073U		FMT.0073	45	liquid	SRR11419803	PRJNA545312	39		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		post	5								
FMT.0073V		FMT.0073	46	liquid	SRR11419802	PRJNA545312	40		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		post	5								
FMT.0073W		FMT.0073	48	liquid	SRR11419801	PRJNA545312	42		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		post	5								
FMT.0073X		FMT.0073	51	liquid	SRR11419800	PRJNA545312	45		22	6	cord	Non-Hodgkin's Lymphoma	32c8e9dac466f04b7098c5		1		post	6								
FMT.0074A		FMT.0074	0	semi-formed	SRR11419799	PRJNA545312	-6		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		pre	-1								
FMT.0074B		FMT.0074	1	semi-formed	SRR11419798	PRJNA545312	-5		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		pre	-1								
FMT.0074C		FMT.0074	2	formed	SRR11419797	PRJNA545312	-4		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		pre	-1								
FMT.0074D		FMT.0074	3	formed	SRR11419795	PRJNA545312	-3		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		pre	-1								
FMT.0074E		FMT.0074	4	formed	SRR11419794	PRJNA545312	-2		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		pre	-1								
FMT.0074F		FMT.0074	5	formed	SRR11419793	PRJNA545312	-1		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		pre	-1								
FMT.0074G		FMT.0074	6	semi-formed	SRR11420099	PRJNA545312	0		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		peri	-1								
FMT.0074H		FMT.0074	7	formed	SRR11420098	PRJNA545312	1		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		peri	0								
FMT.0074I		FMT.0074	8	formed	SRR11420097	PRJNA545312	2		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		peri	0								
FMT.0074J		FMT.0074	9	semi-formed	SRR11420096	PRJNA545312	3		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		peri	0								
FMT.0074L		FMT.0074	10	liquid	SRR11420094	PRJNA545312	4		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		peri	0								
FMT.0074M		FMT.0074	11	formed	SRR11420093	PRJNA545312	5		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		peri	0								
FMT.0074N		FMT.0074	12	formed	SRR11420091	PRJNA545312	6		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		post	0								
FMT.0074O		FMT.0074	13	semi-formed	SRR11420090	PRJNA545312	7		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		post	0								
FMT.0074P		FMT.0074	14	formed	SRR11420089	PRJNA545312	8		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		post	1								
FMT.0074Q		FMT.0074	16	semi-formed	SRR11420088	PRJNA545312	10		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		post	1								
FMT.0074R		FMT.0074	21	liquid	SRR11420087	PRJNA545312	15		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		post	2								
FMT.0074S		FMT.0074	24	semi-formed	SRR11420086	PRJNA545312	18		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		post	2								
FMT.0074T		FMT.0074	25	formed	SRR11420085	PRJNA545312	19		19	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	93d63e3d29804d9ec6c6ef		1		post	2								
FMT.0075A		FMT.0075	0	formed	SRR11420084	PRJNA545312	-8		14	8	PBSC_unmodified	Myelodysplastic Syndromes	48bc2dedde5706b563e1e4		0		pre	-2								
FMT.0075B		FMT.0075	3	formed	SRR11420083	PRJNA545312	-5		14	8	PBSC_unmodified	Myelodysplastic Syndromes	48bc2dedde5706b563e1e4		0		pre	-1								
FMT.0075C		FMT.0075	6	formed	SRR11420082	PRJNA545312	-2		14	8	PBSC_unmodified	Myelodysplastic Syndromes	48bc2dedde5706b563e1e4		0		pre	-1								
FMT.0075D		FMT.0075	7	formed	SRR11420079	PRJNA545312	-1		14	8	PBSC_unmodified	Myelodysplastic Syndromes	48bc2dedde5706b563e1e4		0		pre	-1								
FMT.0075E		FMT.0075	8	formed	SRR11420078	PRJNA545312	0		14	8	PBSC_unmodified	Myelodysplastic Syndromes	48bc2dedde5706b563e1e4		0		peri	-1								
FMT.0075F		FMT.0075	9	formed	SRR11420077	PRJNA545312	1		14	8	PBSC_unmodified	Myelodysplastic Syndromes	48bc2dedde5706b563e1e4		0		peri	0								
FMT.0075G		FMT.0075	10	formed	SRR11420076	PRJNA545312	2		14	8	PBSC_unmodified	Myelodysplastic Syndromes	48bc2dedde5706b563e1e4		0		peri	0								
FMT.0075H		FMT.0075	11	formed	SRR11420075	PRJNA545312	3		14	8	PBSC_unmodified	Myelodysplastic Syndromes	48bc2dedde5706b563e1e4		0		peri	0								
FMT.0075I		FMT.0075	15	formed	SRR11420074	PRJNA545312	7		14	8	PBSC_unmodified	Myelodysplastic Syndromes	48bc2dedde5706b563e1e4		0		post	0								
FMT.0075J		FMT.0075	18	formed	SRR11420073	PRJNA545312	10		14	8	PBSC_unmodified	Myelodysplastic Syndromes	48bc2dedde5706b563e1e4		0		post	1								
FMT.0075K		FMT.0075	19	semi-formed	SRR11420072	PRJNA545312	11		14	8	PBSC_unmodified	Myelodysplastic Syndromes	48bc2dedde5706b563e1e4		0		post	1								
FMT.0075L		FMT.0075	20	formed	SRR11420071	PRJNA545312	12		14	8	PBSC_unmodified	Myelodysplastic Syndromes	48bc2dedde5706b563e1e4		0		post	1								
FMT.0075M		FMT.0075	21	liquid	SRR11420070	PRJNA545312	13		14	8	PBSC_unmodified	Myelodysplastic Syndromes	48bc2dedde5706b563e1e4		0		post	1								
FMT.0075N		FMT.0075	222	semi-formed	SRR11420068	PRJNA545312	214		14	8	PBSC_unmodified	Myelodysplastic Syndromes	48bc2dedde5706b563e1e4		0		post	6								
FMT.0076A	-50	FMT.0076	0	formed	SRR11420067	PRJNA545312	-6		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	pre	-1	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	-3	pre
FMT.0076B	-30	FMT.0076	20	semi-formed	SRR11420066	PRJNA545312	14		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	1	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	-3	pre
FMT.0076C	-29	FMT.0076	21	formed	SRR11420065	PRJNA545312	15		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	2	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	-3	pre
FMT.0076D	-28	FMT.0076	22	semi-formed	SRR11420064	PRJNA545312	16		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	2	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	-3	pre
FMT.0076E	-27	FMT.0076	23	semi-formed	SRR11420063	PRJNA545312	17		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	2	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	-3	pre
FMT.0076F	-26	FMT.0076	24	semi-formed	SRR11420062	PRJNA545312	18		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	2	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	-3	pre
FMT.0076G	-25	FMT.0076	25	semi-formed	SRR11420061	PRJNA545312	19		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	2	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	-3	pre
FMT.0076H	-24	FMT.0076	26	semi-formed	SRR11420060	PRJNA545312	20		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	2	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	-3	pre
FMT.0076I	-23	FMT.0076	27	semi-formed	SRR11420059	PRJNA545312	21		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	2	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	-3	pre
FMT.0076J	-20	FMT.0076	30	semi-formed	SRR11419463	PRJNA545312	24		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	3	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	-3	pre
FMT.0076K	-18	FMT.0076	32	semi-formed	SRR11419759	PRJNA545312	26		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	3	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	-3	pre
FMT.0076M	-15	FMT.0076	35	semi-formed	SRR11419758	PRJNA545312	29		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	4	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	-3	pre
FMT.0076N	-14	FMT.0076	36	formed	SRR11419757	PRJNA545312	30		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	4	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	-3	pre
FMT.0076O	-13	FMT.0076	37	semi-formed	SRR11419756	PRJNA545312	31		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	4	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	-2	pre
FMT.0076Q	0	FMT.0076	50	liquid	SRR10668372	PRJNA545312	44		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	6	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	-1	peri
FMT.0076R	5	FMT.0076	55	semi-formed	SRR11116587	PRJNA607574	49		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	6	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	0	peri
FMT.0076S	38	FMT.0076	88	liquid	SRR11116586	PRJNA607574	82		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	6	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	5	post
FMT.0076T	39	FMT.0076	89	liquid	SRR11116585	PRJNA607574	83		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	6	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	5	post
FMT.0076U	42	FMT.0076	92	semi-formed	SRR11116584	PRJNA607574	86		19	6	cord	Leukemia	0732f69a60924b8f0152f7	T8	1	treatment	post	6	Treatment	43	44	FMT.0076A	FMT.0076O	FMT.0076Q	5	post
FMT.0077A		FMT.0077	0	semi-formed	SRR11419755	PRJNA545312	-15		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		pre	-3								
FMT.0077AA		FMT.0077	40	formed	SRR11419754	PRJNA545312	25		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	3								
FMT.0077B		FMT.0077	9	formed	SRR11419753	PRJNA545312	-6	SRR13697093	42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		pre	-1								
FMT.0077C		FMT.0077	10	formed	SRR11419752	PRJNA545312	-5		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		pre	-1								
FMT.0077CC		FMT.0077	43	formed	SRR11419751	PRJNA545312	28		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	3								
FMT.0077D		FMT.0077	13	semi-formed	SRR11419749	PRJNA545312	-2		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		pre	-1								
FMT.0077DD		FMT.0077	44	semi-formed	SRR11419748	PRJNA545312	29		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	4								
FMT.0077EE		FMT.0077	45	formed	SRR11419746	PRJNA545312	30		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	4								
FMT.0077F		FMT.0077	14	liquid	SRR11419745	PRJNA545312	-1		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		pre	-1								
FMT.0077FF		FMT.0077	49	formed	SRR11419744	PRJNA545312	34		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	4								
FMT.0077G		FMT.0077	15	liquid	SRR11419743	PRJNA545312	0		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		peri	-1								
FMT.0077GG		FMT.0077	51	semi-formed	SRR11419742	PRJNA545312	36		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	5								
FMT.0077H		FMT.0077	16	liquid	SRR11419741	PRJNA545312	1		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		peri	0								
FMT.0077HH		FMT.0077	56	semi-formed	SRR11419740	PRJNA545312	41		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	5								
FMT.0077I		FMT.0077	17	liquid	SRR11419738	PRJNA545312	2		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		peri	0								
FMT.0077II		FMT.0077	62	formed	SRR11419737	PRJNA545312	47		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	6								
FMT.0077J		FMT.0077	18	liquid	SRR11419736	PRJNA545312	3		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		peri	0								
FMT.0077JJ		FMT.0077	67	formed	SRR11419735	PRJNA545312	52		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	6								
FMT.0077K		FMT.0077	19	liquid	SRR11419734	PRJNA545312	4		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		peri	0								
FMT.0077KK		FMT.0077	69	formed	SRR11419733	PRJNA545312	54		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	6								
FMT.0077L		FMT.0077	20	liquid	SRR11419732	PRJNA545312	5		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		peri	0								
FMT.0077LL		FMT.0077	70	formed	SRR11419731	PRJNA545312	55		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	6								
FMT.0077M		FMT.0077	21	liquid	SRR11419730	PRJNA545312	6		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	0								
FMT.0077MM		FMT.0077	75	semi-formed	SRR11419729	PRJNA545312	60		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	6								
FMT.0077N		FMT.0077	22	liquid	SRR11419727	PRJNA545312	7		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	0								
FMT.0077NN		FMT.0077	277	formed	SRR11419726	PRJNA545312	-87		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		pre	-3								
FMT.0077O		FMT.0077	23	liquid	SRR11419725	PRJNA545312	8		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	1								
FMT.0077OO		FMT.0077	286	semi-formed	SRR11419724	PRJNA545312	-78		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		pre	-3								
FMT.0077P		FMT.0077	24	liquid	SRR11419723	PRJNA545312	9		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	1								
FMT.0077PP		FMT.0077	287	semi-formed	SRR11419722	PRJNA545312	-77		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		pre	-3								
FMT.0077Q		FMT.0077	26	formed	SRR11419721	PRJNA545312	11		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	1								
FMT.0077QQ		FMT.0077	301	semi-formed	SRR11419720	PRJNA545312	-63		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		pre	-3								
FMT.0077R		FMT.0077	27	formed	SRR11419719	PRJNA545312	12		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	1								
FMT.0077RR		FMT.0077	302	liquid	SRR11419662	PRJNA545312	-62		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		pre	-3								
FMT.0077S		FMT.0077	28	semi-formed	SRR11419660	PRJNA545312	13		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	1								
FMT.0077SS		FMT.0077	306	formed	SRR11419659	PRJNA545312	-58		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		pre	-3								
FMT.0077T		FMT.0077	32	formed	SRR11419658	PRJNA545312	17		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	2								
FMT.0077TT		FMT.0077	362	formed	SRR11419657	PRJNA545312	-2		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		pre	-1								
FMT.0077U		FMT.0077	34	formed	SRR11419656	PRJNA545312	19		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	2								
FMT.0077X		FMT.0077	37	formed	SRR11419655	PRJNA545312	22		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	3								
FMT.0077Y		FMT.0077	38	semi-formed	SRR11419654	PRJNA545312	23		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	3								
FMT.0077Z		FMT.0077	39	formed	SRR11419653	PRJNA545312	24		42	364	PBSC_unmodified		e730f79dd280af252193ee	723	1		post	3								
FMT.0078A		FMT.0078	0	semi-formed	SRR11419652	PRJNA545312	-140		15	140	PBSC_unmodified	Non-Hodgkin's Lymphoma	741bc316be4d56f6a66454		1		pre	-3								
FMT.0078B		FMT.0078	33	formed	SRR11419651	PRJNA545312	-107		15	140	PBSC_unmodified	Non-Hodgkin's Lymphoma	741bc316be4d56f6a66454		1		pre	-3								
FMT.0078C		FMT.0078	138	formed	SRR11419649	PRJNA545312	-2		15	140	PBSC_unmodified	Non-Hodgkin's Lymphoma	741bc316be4d56f6a66454		1		pre	-1								
FMT.0078D		FMT.0078	146	liquid	SRR11419648	PRJNA545312	6		15	140	PBSC_unmodified	Non-Hodgkin's Lymphoma	741bc316be4d56f6a66454		1		post	0								
FMT.0078F		FMT.0078	148	liquid	SRR11419647	PRJNA545312	8		15	140	PBSC_unmodified	Non-Hodgkin's Lymphoma	741bc316be4d56f6a66454		1		post	1								
FMT.0078H		FMT.0078	158	liquid	SRR11419646	PRJNA545312	18		15	140	PBSC_unmodified	Non-Hodgkin's Lymphoma	741bc316be4d56f6a66454		1		post	2								
FMT.0078J		FMT.0078	161	semi-formed	SRR11419645	PRJNA545312	21		15	140	PBSC_unmodified	Non-Hodgkin's Lymphoma	741bc316be4d56f6a66454		1		post	2								
FMT.0078K		FMT.0078	162	liquid	SRR11419644	PRJNA545312	22		15	140	PBSC_unmodified	Non-Hodgkin's Lymphoma	741bc316be4d56f6a66454		1		post	3								
FMT.0078L		FMT.0078	163	liquid	SRR11419643	PRJNA545312	23		15	140	PBSC_unmodified	Non-Hodgkin's Lymphoma	741bc316be4d56f6a66454		1		post	3								
FMT.0078M		FMT.0078	165	liquid	SRR11419642	PRJNA545312	25		15	140	PBSC_unmodified	Non-Hodgkin's Lymphoma	741bc316be4d56f6a66454		1		post	3								
FMT.0078N		FMT.0078	166	liquid	SRR11419641	PRJNA545312	26		15	140	PBSC_unmodified	Non-Hodgkin's Lymphoma	741bc316be4d56f6a66454		1		post	3								
FMT.0078O		FMT.0078	169	liquid	SRR11419640	PRJNA545312	29		15	140	PBSC_unmodified	Non-Hodgkin's Lymphoma	741bc316be4d56f6a66454		1		post	4								
FMT.0078P		FMT.0078	170	liquid	SRR11419638	PRJNA545312	30		15	140	PBSC_unmodified	Non-Hodgkin's Lymphoma	741bc316be4d56f6a66454		1		post	4								
FMT.0078Q		FMT.0078	172	semi-formed	SRR11419637	PRJNA545312	32		15	140	PBSC_unmodified	Non-Hodgkin's Lymphoma	741bc316be4d56f6a66454		1		post	4								
FMT.0078R		FMT.0078	173	semi-formed	SRR11419636	PRJNA545312	33		15	140	PBSC_unmodified	Non-Hodgkin's Lymphoma	741bc316be4d56f6a66454		1		post	4								
FMT.0079A		FMT.0079	0	formed	SRR11419635	PRJNA545312	-20		14	20	PBSC_unmodified	Leukemia	e01b8c4e252690d8537519	741	1		pre	-3								
FMT.0079B		FMT.0079	15	formed	SRR11419837	PRJNA545312	-5		14	20	PBSC_unmodified	Leukemia	e01b8c4e252690d8537519	741	1		pre	-1								
FMT.0079C		FMT.0079	22	formed	SRR11419836	PRJNA545312	2		14	20	PBSC_unmodified	Leukemia	e01b8c4e252690d8537519	741	1		peri	0								
FMT.0079D		FMT.0079	23	semi-formed	SRR11419835	PRJNA545312	3		14	20	PBSC_unmodified	Leukemia	e01b8c4e252690d8537519	741	1		peri	0								
FMT.0079E		FMT.0079	25	liquid	SRR11419834	PRJNA545312	5		14	20	PBSC_unmodified	Leukemia	e01b8c4e252690d8537519	741	1		peri	0								
FMT.0079F		FMT.0079	27	semi-formed	SRR11419833	PRJNA545312	7		14	20	PBSC_unmodified	Leukemia	e01b8c4e252690d8537519	741	1		post	0								
FMT.0079G		FMT.0079	28	liquid	SRR11419832	PRJNA545312	8		14	20	PBSC_unmodified	Leukemia	e01b8c4e252690d8537519	741	1		post	1								
FMT.0079H		FMT.0079	29	semi-formed	SRR11419830	PRJNA545312	9		14	20	PBSC_unmodified	Leukemia	e01b8c4e252690d8537519	741	1		post	1								
FMT.0079I		FMT.0079	30	semi-formed	SRR11419829	PRJNA545312	10		14	20	PBSC_unmodified	Leukemia	e01b8c4e252690d8537519	741	1		post	1								
FMT.0079K		FMT.0079	35	liquid	SRR11419827	PRJNA545312	15		14	20	PBSC_unmodified	Leukemia	e01b8c4e252690d8537519	741	1		post	2								
FMT.0079L		FMT.0079	39	semi-formed	SRR11419826	PRJNA545312	19		14	20	PBSC_unmodified	Leukemia	e01b8c4e252690d8537519	741	1		post	2								
FMT.0079M		FMT.0079	41	liquid	SRR11419825	PRJNA545312	21		14	20	PBSC_unmodified	Leukemia	e01b8c4e252690d8537519	741	1		post	2								
FMT.0079O		FMT.0079	62	semi-formed	SRR11419824	PRJNA545312	42		14	20	PBSC_unmodified	Leukemia	e01b8c4e252690d8537519	741	1		post	5								
FMT.0079P		FMT.0079	87	semi-formed	SRR11419823	PRJNA545312	67		14	20	PBSC_unmodified	Leukemia	e01b8c4e252690d8537519	741	1		post	6								
FMT.0080A	-38	FMT.0080	0	formed	SRR11419822	PRJNA545312	-5	SRR14143425	19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	pre	-1	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	-3	pre
FMT.0080B	-37	FMT.0080	1	formed	SRR11419820	PRJNA545312	-4		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	pre	-1	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	-3	pre
FMT.0080C	-31	FMT.0080	7	liquid	SRR11422260	PRJNA545312	2		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	peri	0	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	-3	pre
FMT.0080D	-30	FMT.0080	8	liquid	SRR11422259	PRJNA545312	3		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	peri	0	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	-3	pre
FMT.0080E	-29	FMT.0080	9	semi-formed	SRR11421673	PRJNA545312	4		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	peri	0	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	-3	pre
FMT.0080F	-28	FMT.0080	10	semi-formed	SRR11422205	PRJNA545312	5		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	peri	0	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	-3	pre
FMT.0080G	-25	FMT.0080	13	liquid	SRR11421871	PRJNA545312	8		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	post	1	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	-3	pre
FMT.0080H	-24	FMT.0080	14	formed	SRR11421816	PRJNA545312	9		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	post	1	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	-3	pre
FMT.0080I	-23	FMT.0080	15	liquid	SRR11421761	PRJNA545312	10		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	post	1	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	-3	pre
FMT.0080J	-22	FMT.0080	16	semi-formed	SRR11422408	PRJNA545312	11		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	post	1	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	-3	pre
FMT.0080K	-21	FMT.0080	17	semi-formed	SRR11422605	PRJNA545312	12		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	post	1	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	-3	pre
FMT.0080L	-19	FMT.0080	19	formed	SRR11422326	PRJNA545312	14		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	post	1	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	-3	pre
FMT.0080M	-18	FMT.0080	20	formed	SRR11422258	PRJNA545312	15		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	post	2	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	-3	pre
FMT.0080O	-15	FMT.0080	23	formed	SRR11422306	PRJNA545312	18		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	post	2	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	-3	pre
FMT.0080Q	0	FMT.0080	38	liquid	SRR10668371	PRJNA545312	33		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	post	4	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	-1	peri
FMT.0080R	7	FMT.0080	45	semi-formed	SRR11116583	PRJNA607574	40		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	post	5	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	0	post
FMT.0080S	59	FMT.0080	97	semi-formed	SRR11116582	PRJNA607574	92		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	post	6	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	6	post
FMT.0080T	119	FMT.0080	157	semi-formed	SRR11116581	PRJNA607574	152		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	post	6	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	6	post
FMT.0080U	287	FMT.0080	325	semi-formed	SRR11116580	PRJNA607574	320		19	5	PBSC_unmodified	Myelodysplastic Syndromes	c30ddb1f9cb76c2cc147f1	T9	1	treatment	post	6	Treatment	33	33	FMT.0080A	FMT.0080O	FMT.0080Q	6	post
FMT.0081A		FMT.0081	0	formed	SRR11422295	PRJNA545312	-6		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		pre	-1								
FMT.0081AA		FMT.0081	286	formed	SRR11422508	PRJNA545312	280		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	6								
FMT.0081B		FMT.0081	4	formed	SRR11422497	PRJNA545312	-2		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		pre	-1								
FMT.0081BB		FMT.0081	438	formed	SRR11422486	PRJNA545312	432		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	6								
FMT.0081C		FMT.0081	6	formed	SRR11421996	PRJNA545312	0		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		peri	-1								
FMT.0081G		FMT.0081	10	semi-formed	SRR11421985	PRJNA545312	4		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		peri	0								
FMT.0081I		FMT.0081	14	semi-formed	SRR11421695	PRJNA545312	8		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	1								
FMT.0081J		FMT.0081	15	semi-formed	SRR11421684	PRJNA545312	9		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	1								
FMT.0081K		FMT.0081	18	formed	SRR11421672	PRJNA545312	12		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	1								
FMT.0081L		FMT.0081	20	formed	SRR11422531	PRJNA545312	14		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	1								
FMT.0081M		FMT.0081	22	formed	SRR11422520	PRJNA545312	16		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	2								
FMT.0081N		FMT.0081	23	formed	SRR11422254	PRJNA545312	17		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	2								
FMT.0081O		FMT.0081	24	formed	SRR11422243	PRJNA545312	18		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	2								
FMT.0081P		FMT.0081	31	formed	SRR11422232	PRJNA545312	25		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	3								
FMT.0081Q		FMT.0081	33	formed	SRR11422448	PRJNA545312	27		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	3								
FMT.0081R		FMT.0081	35	formed	SRR11422437	PRJNA545312	29		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	4								
FMT.0081S		FMT.0081	36	formed	SRR11422227	PRJNA545312	30		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	4								
FMT.0081T		FMT.0081	38	formed	SRR11422216	PRJNA545312	32		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	4								
FMT.0081V		FMT.0081	40	semi-formed	SRR11422280	PRJNA545312	34		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	4								
FMT.0081W		FMT.0081	41	formed	SRR11422269	PRJNA545312	35		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	4								
FMT.0081X		FMT.0081	66	semi-formed	SRR11422482	PRJNA545312	60		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	6								
FMT.0081Y		FMT.0081	75	formed	SRR11422471	PRJNA545312	69		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	6								
FMT.0081Z		FMT.0081	94	semi-formed	SRR11422460	PRJNA545312	88		23	6	cord	Leukemia	fdd7818b9812973309d735	671	1		post	6								
FMT.0082A		FMT.0082	83	formed	SRR11422194	PRJNA545312	-9		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		pre	-2								
FMT.0082B		FMT.0082	84	formed	SRR11422183	PRJNA545312	-8		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		pre	-2								
FMT.0082C		FMT.0082	86	formed	SRR11421893	PRJNA545312	-6		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		pre	-1								
FMT.0082D		FMT.0082	87	formed	SRR11421882	PRJNA545312	-5		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		pre	-1								
FMT.0082E		FMT.0082	88	semi-formed	SRR11421870	PRJNA545312	-4		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		pre	-1								
FMT.0082F		FMT.0082	90	liquid	SRR11422138	PRJNA545312	-2		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		pre	-1								
FMT.0082J		FMT.0082	94	semi-formed	SRR11422127	PRJNA545312	2		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		peri	0								
FMT.0082K		FMT.0082	95	semi-formed	SRR11421865	PRJNA545312	3		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		peri	0								
FMT.0082L		FMT.0082	96	liquid	SRR11421854	PRJNA545312	4		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		peri	0								
FMT.0082M		FMT.0082	97	liquid	SRR11421843	PRJNA545312	5		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		peri	0								
FMT.0082N		FMT.0082	98	semi-formed	SRR11421971	PRJNA545312	6		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		post	0								
FMT.0082O		FMT.0082	99	semi-formed	SRR11422663	PRJNA545312	7		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		post	0								
FMT.0082Q		FMT.0082	101	liquid	SRR11421838	PRJNA545312	9		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		post	1								
FMT.0082R		FMT.0082	102	liquid	SRR11421827	PRJNA545312	10		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		post	1								
FMT.0082U		FMT.0082	105	semi-formed	SRR11421815	PRJNA545312	13		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		post	1								
FMT.0082V		FMT.0082	160	formed	SRR11422646	PRJNA545312	68		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		post	6								
FMT.0082W		FMT.0082	181	formed	SRR11422635	PRJNA545312	89		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		post	6								
FMT.0082X		FMT.0082	216	formed	SRR11421810	PRJNA545312	124		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		post	6								
FMT.0082Y		FMT.0082	258	semi-formed	SRR11421799	PRJNA545312	166		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		post	6								
FMT.0082Z		FMT.0082	390	semi-formed	SRR11421788	PRJNA545312	298		22	92	TCD	Leukemia	dafca5dbb7e43c72a712b9		1		post	6								
FMT.0083A		FMT.0083	0	semi-formed	SRR11422112	PRJNA545312	-13		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		pre	-2								
FMT.0083AA		FMT.0083	376	semi-formed	SRR11421522	PRJNA545312	-2		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		pre	-1								
FMT.0083B		FMT.0083	4	formed	SRR11421521	PRJNA545312	-9		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		pre	-2								
FMT.0083BB		FMT.0083	377	semi-formed	SRR11421520	PRJNA545312	-1		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		pre	-1								
FMT.0083C		FMT.0083	16	liquid	SRR11422101	PRJNA545312	3		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		peri	0								
FMT.0083CC		FMT.0083	378	semi-formed	SRR11422090	PRJNA545312	0		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		peri	-1								
FMT.0083DD		FMT.0083	379	liquid	SRR11421772	PRJNA545312	1		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		peri	0								
FMT.0083EE		FMT.0083	382	liquid	SRR11421760	PRJNA545312	4		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		peri	0								
FMT.0083F		FMT.0083	9	semi-formed	SRR11422084	PRJNA545312	-4		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		pre	-1								
FMT.0083FF		FMT.0083	399	liquid	SRR11422073	PRJNA545312	21		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		post	2								
FMT.0083G		FMT.0083	10	semi-formed	SRR11422062	PRJNA545312	-3		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		pre	-1								
FMT.0083GG		FMT.0083	403	semi-formed	SRR11421929	PRJNA545312	25		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		post	3								
FMT.0083H		FMT.0083	11	semi-formed	SRR11421918	PRJNA545312	-2		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		pre	-1								
FMT.0083I		FMT.0083	12	liquid	SRR11422057	PRJNA545312	-1		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		pre	-1								
FMT.0083J		FMT.0083	14	liquid	SRR11422046	PRJNA545312	1		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		peri	0								
FMT.0083K		FMT.0083	19	liquid	SRR11422035	PRJNA545312	6		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		post	0								
FMT.0083L		FMT.0083	20	liquid	SRR11422419	PRJNA545312	7		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		post	0								
FMT.0083M		FMT.0083	22	liquid	SRR11422407	PRJNA545312	9		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		post	1								
FMT.0083N		FMT.0083	23	liquid	SRR11422169	PRJNA545312	10		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		post	1								
FMT.0083O		FMT.0083	24	liquid	SRR11422158	PRJNA545312	11		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		post	1								
FMT.0083P		FMT.0083	27	semi-formed	SRR11422147	PRJNA545312	14		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		post	1								
FMT.0083Q		FMT.0083	29	semi-formed	SRR11421519	PRJNA545312	16		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		post	2								
FMT.0083R		FMT.0083	28	liquid	SRR11421518	PRJNA545312	15		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		post	2								
FMT.0083S		FMT.0083	31	semi-formed	SRR11421517	PRJNA545312	18		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		post	2								
FMT.0083T		FMT.0083	55	semi-formed	SRR11422391	PRJNA545312	42		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		post	5								
FMT.0083U		FMT.0083	70	formed	SRR11422380	PRJNA545312	57		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		post	6								
FMT.0083V		FMT.0083	105	semi-formed	SRR11421667	PRJNA545312	92		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		post	6								
FMT.0083W		FMT.0083	215	semi-formed	SRR11422358	PRJNA545312	-163		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		pre	-3								
FMT.0083X		FMT.0083	250	formed	SRR11422347	PRJNA545312	-128		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		pre	-3								
FMT.0083Y		FMT.0083	374	formed	SRR11422616	PRJNA545312	-4		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		pre	-1								
FMT.0083Z		FMT.0083	375	semi-formed	SRR11422604	PRJNA545312	-3		31	378	PBSC_unmodified	Leukemia	ebaa04cc8d02a01648a57b	761	1		pre	-1								
FMT.0085A		FMT.0085	597	formed	SRR11421751	PRJNA545312	-6		12	603	PBSC_unmodified	Myeloproliferative Disorder	ad70c1155dcb39600174d5		1		pre	-1								
FMT.0085B		FMT.0085	601	semi-formed	SRR11421740	PRJNA545312	-2		12	603	PBSC_unmodified	Myeloproliferative Disorder	ad70c1155dcb39600174d5		1		pre	-1								
FMT.0085C		FMT.0085	606	semi-formed	SRR11421729	PRJNA545312	3		12	603	PBSC_unmodified	Myeloproliferative Disorder	ad70c1155dcb39600174d5		1		peri	0								
FMT.0085D		FMT.0085	607	formed	SRR11422025	PRJNA545312	4		12	603	PBSC_unmodified	Myeloproliferative Disorder	ad70c1155dcb39600174d5		1		peri	0								
FMT.0085E		FMT.0085	610	semi-formed	SRR11422014	PRJNA545312	7		12	603	PBSC_unmodified	Myeloproliferative Disorder	ad70c1155dcb39600174d5		1		post	0								
FMT.0085F		FMT.0085	612	formed	SRR11422370	PRJNA545312	9		12	603	PBSC_unmodified	Myeloproliferative Disorder	ad70c1155dcb39600174d5		1		post	1								
FMT.0085G		FMT.0085	614	formed	SRR11421954	PRJNA545312	11		12	603	PBSC_unmodified	Myeloproliferative Disorder	ad70c1155dcb39600174d5		1		post	1								
FMT.0085H		FMT.0085	617	formed	SRR11421943	PRJNA545312	14		12	603	PBSC_unmodified	Myeloproliferative Disorder	ad70c1155dcb39600174d5		1		post	1								
FMT.0088A		FMT.0088	0	semi-formed	SRR11422337	PRJNA545312	2		8	-2	BM_unmodified	Leukemia	06567b73a88251a589bfd2		1		peri	0								
FMT.0088B		FMT.0088	2	formed	SRR11422325	PRJNA545312	4		8	-2	BM_unmodified	Leukemia	06567b73a88251a589bfd2		1		peri	0								
FMT.0088C		FMT.0088	4	semi-formed	SRR11421516	PRJNA545312	6		8	-2	BM_unmodified	Leukemia	06567b73a88251a589bfd2		1		post	0								
FMT.0088D		FMT.0088	5	semi-formed	SRR11421514	PRJNA545312	7		8	-2	BM_unmodified	Leukemia	06567b73a88251a589bfd2		1		post	0								
FMT.0088E		FMT.0088	10	semi-formed	SRR11422566	PRJNA545312	12		8	-2	BM_unmodified	Leukemia	06567b73a88251a589bfd2		1		post	1								
FMT.0088F		FMT.0088	12	formed	SRR11422555	PRJNA545312	14		8	-2	BM_unmodified	Leukemia	06567b73a88251a589bfd2		1		post	1								
FMT.0088G		FMT.0088	18	formed	SRR11422544	PRJNA545312	20		8	-2	BM_unmodified	Leukemia	06567b73a88251a589bfd2		1		post	2								
FMT.0088H		FMT.0088	20	formed	SRR11421719	PRJNA545312	22		8	-2	BM_unmodified	Leukemia	06567b73a88251a589bfd2		1		post	3								
FMT.0089A		FMT.0089	0	semi-formed	SRR11421708	PRJNA545312	-24		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		pre	-3								
FMT.0089B		FMT.0089	15	semi-formed	SRR11422595	PRJNA545312	-9		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		pre	-2								
FMT.0089C		FMT.0089	18	semi-formed	SRR11422584	PRJNA545312	-6		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		pre	-1								
FMT.0089D		FMT.0089	19	formed	SRR11422573	PRJNA545312	-5		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		pre	-1								
FMT.0089E		FMT.0089	23	semi-formed	SRR11421905	PRJNA545312	-1		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		pre	-1								
FMT.0089F		FMT.0089	24	semi-formed	SRR11422316	PRJNA545312	0		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		peri	-1								
FMT.0089G		FMT.0089	25	liquid	SRR11422315	PRJNA545312	1		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		peri	0								
FMT.0089H		FMT.0089	26	liquid	SRR11422314	PRJNA545312	2		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		peri	0								
FMT.0089I		FMT.0089	27	semi-formed	SRR11422313	PRJNA545312	3		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		peri	0								
FMT.0089J		FMT.0089	28	liquid	SRR11422312	PRJNA545312	4		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		peri	0								
FMT.0089K		FMT.0089	29	liquid	SRR11422311	PRJNA545312	5		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		peri	0								
FMT.0089L		FMT.0089	30	liquid	SRR11422310	PRJNA545312	6		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		post	0								
FMT.0089M		FMT.0089	31	semi-formed	SRR11422309	PRJNA545312	7		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		post	0								
FMT.0089N		FMT.0089	32	liquid	SRR11422308	PRJNA545312	8		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		post	1								
FMT.0089O		FMT.0089	33	liquid	SRR11422307	PRJNA545312	9		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		post	1								
FMT.0089P		FMT.0089	34	semi-formed	SRR11422305	PRJNA545312	10		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		post	1								
FMT.0089Q		FMT.0089	35	liquid	SRR11422304	PRJNA545312	11		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		post	1								
FMT.0089R		FMT.0089	36	liquid	SRR11422303	PRJNA545312	12		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		post	1								
FMT.0089S		FMT.0089	38	semi-formed	SRR11422302	PRJNA545312	14		19	24	TCD	Myelodysplastic Syndromes	8b54a045c87ce289d7e783		1		post	1								
FMT.0090A		FMT.0090	0	formed	SRR11422301	PRJNA545312	-43		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		pre	-3								
FMT.0090AA		FMT.0090	274	liquid	SRR11422300	PRJNA545312	231		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		post	6								
FMT.0090B		FMT.0090	36	formed	SRR11422299	PRJNA545312	-7		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		pre	-2								
FMT.0090C		FMT.0090	41	formed	SRR11422298	PRJNA545312	-2		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		pre	-1								
FMT.0090D		FMT.0090	45	semi-formed	SRR11422297	PRJNA545312	2		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		peri	0								
FMT.0090E		FMT.0090	46	liquid	SRR11422296	PRJNA545312	3		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		peri	0								
FMT.0090F		FMT.0090	47	liquid	SRR11422294	PRJNA545312	4		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		peri	0								
FMT.0090G		FMT.0090	48	semi-formed	SRR11422293	PRJNA545312	5		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		peri	0								
FMT.0090H		FMT.0090	49	liquid	SRR11422292	PRJNA545312	6		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		post	0								
FMT.0090K		FMT.0090	53	semi-formed	SRR11422291	PRJNA545312	10		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		post	1								
FMT.0090P		FMT.0090	60	liquid	SRR11422290	PRJNA545312	17		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		post	2								
FMT.0090Q		FMT.0090	62	semi-formed	SRR11422289	PRJNA545312	19		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		post	2								
FMT.0090R		FMT.0090	63	semi-formed	SRR11422512	PRJNA545312	20		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		post	2								
FMT.0090T		FMT.0090	70	semi-formed	SRR11422511	PRJNA545312	27		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		post	3								
FMT.0090U		FMT.0090	85	semi-formed	SRR11422510	PRJNA545312	42		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		post	5								
FMT.0090V		FMT.0090	99	formed	SRR11422509	PRJNA545312	56		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		post	6								
FMT.0090W		FMT.0090	133	liquid	SRR11422507	PRJNA545312	90		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		post	6								
FMT.0090X		FMT.0090	168	semi-formed	SRR11422506	PRJNA545312	125		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		post	6								
FMT.0090Y		FMT.0090	202	semi-formed	SRR11422505	PRJNA545312	159		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		post	6								
FMT.0090Z		FMT.0090	273	semi-formed	SRR11422504	PRJNA545312	230		20	43	BM_unmodified	Leukemia	a5ef7977287f66548a7f44		1		post	6								
FMT.0091AA	-25	FMT.0091	26	liquid	SRR11422502	PRJNA545312	19		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	2	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091B	-51	FMT.0091	0	formed	SRR11422501	PRJNA545312	-7		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	pre	-2	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091BB	-24	FMT.0091	27	liquid	SRR11422500	PRJNA545312	20		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	2	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091CC	-23	FMT.0091	28	liquid	SRR11422498	PRJNA545312	21		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	2	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091D	-49	FMT.0091	2	formed	SRR11422496	PRJNA545312	-5		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	pre	-1	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091DD	-22	FMT.0091	29	liquid	SRR11422495	PRJNA545312	22		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	3	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091E	-48	FMT.0091	3	formed	SRR11422494	PRJNA545312	-4	SRR13697092	36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	pre	-1	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091EE	-21	FMT.0091	30	liquid	SRR11422493	PRJNA545312	23		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	3	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091F	-45	FMT.0091	6	semi-formed	SRR11422492	PRJNA545312	-1		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	pre	-1	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091FF	-20	FMT.0091	31	liquid	SRR11422491	PRJNA545312	24		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	3	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091G	-46	FMT.0091	5	formed	SRR11422490	PRJNA545312	-2		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	pre	-1	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091GG	-18	FMT.0091	33	semi-formed	SRR11422489	PRJNA545312	26		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	3	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091H	-44	FMT.0091	7	liquid	SRR11422488	PRJNA545312	0		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	peri	-1	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091HH	-17	FMT.0091	34	liquid	SRR11422487	PRJNA545312	27		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	3	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091II	-14	FMT.0091	37	liquid	SRR11422005	PRJNA545312	30		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	4	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091J	-42	FMT.0091	9	liquid	SRR11422004	PRJNA545312	2		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	peri	0	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091K	-41	FMT.0091	10	liquid	SRR11422003	PRJNA545312	3		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	peri	0	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091KK	0	FMT.0091	51	liquid	SRR11116579	PRJNA607574	44		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	6	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-1	peri
FMT.0091LL	3	FMT.0091	54	semi-formed	SRR11116578	PRJNA607574	47		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	6	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	0	peri
FMT.0091MM	21	FMT.0091	72	semi-formed	SRR11116576	PRJNA607574	65		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	6	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	2	post
FMT.0091NN	47	FMT.0091	98	semi-formed	SRR11116575	PRJNA607574	91		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	6	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	6	post
FMT.0091O	-38	FMT.0091	13	liquid	SRR11422002	PRJNA545312	6		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	0	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091OO	62	FMT.0091	113	semi-formed	SRR11116574	PRJNA607574	106		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	6	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	6	post
FMT.0091PP	105	FMT.0091	156	semi-formed	SRR11116573	PRJNA607574	149		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	6	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	6	post
FMT.0091Q	-36	FMT.0091	15	liquid	SRR11422001	PRJNA545312	8		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	1	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091QQ	133	FMT.0091	184	semi-formed	SRR11116572	PRJNA607574	177		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	6	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	6	post
FMT.0091RR	160	FMT.0091	211		SRR11116571	PRJNA607574	204		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	6	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	6	post
FMT.0091S	-33	FMT.0091	18	liquid	SRR11422000	PRJNA545312	11		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	1	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091SS	217	FMT.0091	268	formed	SRR11116570	PRJNA607574	261		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	6	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	6	post
FMT.0091TT	252	FMT.0091	303	formed	SRR11116569	PRJNA607574	296		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	6	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	6	post
FMT.0091UU	279	FMT.0091	330	formed	SRR11116568	PRJNA607574	323		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	6	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	6	post
FMT.0091V	-30	FMT.0091	21	liquid	SRR11421999	PRJNA545312	14		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	1	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091W	-29	FMT.0091	22	liquid	SRR11421998	PRJNA545312	15		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	2	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091X	-28	FMT.0091	23	liquid	SRR11421997	PRJNA545312	16		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	2	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091Y	-27	FMT.0091	24	semi-formed	SRR11421995	PRJNA545312	17		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	2	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0091Z	-26	FMT.0091	25	liquid	SRR11421994	PRJNA545312	18		36	7	BM_unmodified	Myelodysplastic Syndromes	a9ccb3575b661fc75b1e51	T12	1	treatment	post	2	Treatment	44	44	FMT.0091A	FMT.0091II	FMT.0091KK	-3	pre
FMT.0092A	-38	FMT.0092	0	formed	SRR11421993	PRJNA545312	-9	SRR14092160	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	pre	-2	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092AA	-8	FMT.0092	30	semi-formed	SRR11421992	PRJNA545312	21		38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	2	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-2	pre
FMT.0092B	-34	FMT.0092	4	formed	SRR11421991	PRJNA545312	-5		38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	pre	-1	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092C	-33	FMT.0092	5	formed	SRR11421990	PRJNA545312	-4		38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	pre	-1	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092CC	0	FMT.0092	38	liquid	SRR10668370	PRJNA545312	29		38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	4	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-1	peri
FMT.0092D	-32	FMT.0092	6	formed	SRR11421989	PRJNA545312	-3	SRR14092159	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	pre	-1	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092DD	4	FMT.0092	42	semi-formed	SRR11116567	PRJNA607574	33		38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	4	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	0	peri
FMT.0092E	-31	FMT.0092	7	formed	SRR11421988	PRJNA545312	-2	SRR14143424	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	pre	-1	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092EE	33	FMT.0092	71	formed	SRR11116565	PRJNA607574	62	SRR13697091	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	6	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	4	post
FMT.0092F	-30	FMT.0092	8	formed	SRR11421987	PRJNA545312	-1		38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	pre	-1	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092FF	57	FMT.0092	95	semi-formed	SRR11116564	PRJNA607574	86	SRR14143423	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	6	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	6	post
FMT.0092G	-29	FMT.0092	9	formed	SRR11421986	PRJNA545312	0	SRR13697089	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	peri	-1	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092GG	61	FMT.0092	99	semi-formed	SRR11116563	PRJNA607574	90		38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	6	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	6	post
FMT.0092HH	96	FMT.0092	134	formed	SRR11116562	PRJNA607574	125	SRR14092158	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	6	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	6	post
FMT.0092I	-26	FMT.0092	12	semi-formed	SRR11421984	PRJNA545312	3	SRR13697088	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	peri	0	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092II	138	FMT.0092	176	semi-formed	SRR11116561	PRJNA607574	167	SRR13697087	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	6	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	6	post
FMT.0092J	-25	FMT.0092	13	semi-formed	SRR11421983	PRJNA545312	4	SRR13697086	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	peri	0	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092JJ	165	FMT.0092	203	semi-formed	SRR11116560	PRJNA607574	194	SRR13697085	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	6	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	6	post
FMT.0092K	-23	FMT.0092	15	semi-formed	SRR11421982	PRJNA545312	6		38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	0	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092KK	196	FMT.0092	234	formed	SRR11116559	PRJNA607574	225		38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	6	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	6	post
FMT.0092L	-22	FMT.0092	16	liquid	SRR11421981	PRJNA545312	7	SRR13697084	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	0	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092LL	237	FMT.0092	275	formed	SRR11116558	PRJNA607574	266	SRR14092157	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	6	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	6	post
FMT.0092M	-21	FMT.0092	17	liquid	SRR11421980	PRJNA545312	8	SRR14092156	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	1	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092MM	250	FMT.0092	288	formed	SRR11116557	PRJNA607574	279	SRR14092155	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	6	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	6	post
FMT.0092N	-20	FMT.0092	18	liquid	SRR11421979	PRJNA545312	9	SRR14092154	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	1	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092NN	292	FMT.0092	330	formed	SRR11116556	PRJNA607574	321		38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	6	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	6	post
FMT.0092O	-19	FMT.0092	19	liquid	SRR11421978	PRJNA545312	10		38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	1	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092OO	313	FMT.0092	351	formed	SRR11116554	PRJNA607574	342	SRR14092153	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	6	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	6	post
FMT.0092P	-18	FMT.0092	20	semi-formed	SRR11421698	PRJNA545312	11	SRR14092311	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	1	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092Q	-17	FMT.0092	21	liquid	SRR11421697	PRJNA545312	12	SRR14092310	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	1	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092S	-16	FMT.0092	22	semi-formed	SRR11421694	PRJNA545312	13		38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	1	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092T	-15	FMT.0092	23	liquid	SRR11421693	PRJNA545312	14	SRR13697083	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	1	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092U	-14	FMT.0092	24	semi-formed	SRR11421692	PRJNA545312	15	SRR13697082	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	2	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-3	pre
FMT.0092V	-13	FMT.0092	25	formed	SRR11421691	PRJNA545312	16	SRR14092309	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	2	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-2	pre
FMT.0092W	-12	FMT.0092	26	liquid	SRR11421690	PRJNA545312	17	SRR14092308	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	2	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-2	pre
FMT.0092X	-11	FMT.0092	27	liquid	SRR11421689	PRJNA545312	18	SRR13697081	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	2	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-2	pre
FMT.0092Y	-10	FMT.0092	28	semi-formed	SRR11421688	PRJNA545312	19	SRR14092307	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	2	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-2	pre
FMT.0092Z	-9	FMT.0092	29	formed	SRR11421687	PRJNA545312	20	SRR13697080	38	9	PBSC_unmodified	Leukemia	6fd7955698a9bde254481d	T11	1	treatment	post	2	Treatment	29	29	FMT.0092A	FMT.0092AA	FMT.0092CC	-2	pre
FMT.0093A	-43	FMT.0093	0	formed	SRR11421686	PRJNA545312	-9	SRR14143422	32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	pre	-2	Control	34					-3	pre
FMT.0093AA	33	FMT.0093	76	formed	SRR11421685	PRJNA545312	67		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	6	Control	34					4	post
FMT.0093B	-41	FMT.0093	2	formed	SRR11421683	PRJNA545312	-7		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	pre	-2	Control	34					-3	pre
FMT.0093BB	56	FMT.0093	99	semi-formed	SRR11421682	PRJNA545312	90		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	6	Control	34					6	post
FMT.0093C	-39	FMT.0093	4	liquid	SRR11421681	PRJNA545312	-5		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	pre	-1	Control	34					-3	pre
FMT.0093CC	57	FMT.0093	100	formed	SRR11421680	PRJNA545312	91		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	6	Control	34					6	post
FMT.0093D	-38	FMT.0093	5	liquid	SRR11421679	PRJNA545312	-4		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	pre	-1	Control	34					-3	pre
FMT.0093DD	59	FMT.0093	102	semi-formed	SRR11421678	PRJNA545312	93		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	6	Control	34					6	post
FMT.0093E	-36	FMT.0093	7	semi-formed	SRR11421677	PRJNA545312	-2		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	pre	-1	Control	34					-3	pre
FMT.0093EE	61	FMT.0093	104	semi-formed	SRR11421676	PRJNA545312	95		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	6	Control	34					6	post
FMT.0093F	-35	FMT.0093	8	semi-formed	SRR11421675	PRJNA545312	-1		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	pre	-1	Control	34					-3	pre
FMT.0093FF	64	FMT.0093	107	semi-formed	SRR11421674	PRJNA545312	98		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	6	Control	34					6	post
FMT.0093G	-32	FMT.0093	11	semi-formed	SRR11421671	PRJNA545312	2		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	peri	0	Control	34					-3	pre
FMT.0093GG	215	FMT.0093	258	semi-formed	SRR11422540	PRJNA545312	249		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	6	Control	34					6	post
FMT.0093H	-31	FMT.0093	12	semi-formed	SRR11422539	PRJNA545312	3		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	peri	0	Control	34					-3	pre
FMT.0093HH	244	FMT.0093	287	formed	SRR11422538	PRJNA545312	278		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	6	Control	34					6	post
FMT.0093I	-33	FMT.0093	10	semi-formed	SRR11422537	PRJNA545312	1		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	peri	0	Control	34					-3	pre
FMT.0093J	-34	FMT.0093	9	liquid	SRR11422536	PRJNA545312	0		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	peri	-1	Control	34					-3	pre
FMT.0093K	-30	FMT.0093	13	liquid	SRR11422535	PRJNA545312	4		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	peri	0	Control	34					-3	pre
FMT.0093L	-29	FMT.0093	14	liquid	SRR11422534	PRJNA545312	5		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	peri	0	Control	34					-3	pre
FMT.0093M	-28	FMT.0093	15	liquid	SRR11422533	PRJNA545312	6		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	0	Control	34					-3	pre
FMT.0093P	-25	FMT.0093	18	liquid	SRR11422532	PRJNA545312	9		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	1	Control	34					-3	pre
FMT.0093Q	-24	FMT.0093	19	liquid	SRR11422530	PRJNA545312	10		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	1	Control	34					-3	pre
FMT.0093R	-23	FMT.0093	20	liquid	SRR11422529	PRJNA545312	11		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	1	Control	34					-3	pre
FMT.0093S	-22	FMT.0093	21	liquid	SRR11422528	PRJNA545312	12		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	1	Control	34					-3	pre
FMT.0093T	-20	FMT.0093	23	semi-formed	SRR11422527	PRJNA545312	14		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	1	Control	34					-3	pre
FMT.0093U	-19	FMT.0093	24	semi-formed	SRR11422526	PRJNA545312	15		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	2	Control	34					-3	pre
FMT.0093V	-18	FMT.0093	25	formed	SRR11422525	PRJNA545312	16		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	2	Control	34					-3	pre
FMT.0093W	-16	FMT.0093	27	semi-formed	SRR11422524	PRJNA545312	18		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	2	Control	34					-3	pre
FMT.0093X	-14	FMT.0093	29	formed	SRR11422523	PRJNA545312	20		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	2	Control	34					-3	pre
FMT.0093Y	-13	FMT.0093	30	formed	SRR11422522	PRJNA545312	21		32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	2	Control	34					-2	pre
FMT.0093Z	5	FMT.0093	48	semi-formed	SRR11422521	PRJNA545312	39	SRR13697078	32	9	TCD	Multiple Myeloma	398756dc8f5513128ea0c5	C7	1	control	post	5	Control	34					0	peri
FMT.0094A	-41	FMT.0094	0	formed	SRR11422519	PRJNA545312	-13	SRR14092306	24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	pre	-2	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094B	-35	FMT.0094	6	formed	SRR11422518	PRJNA545312	-7		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	pre	-2	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094C	-33	FMT.0094	8	formed	SRR11422517	PRJNA545312	-5		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	pre	-1	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094D	-30	FMT.0094	11	liquid	SRR11422516	PRJNA545312	-2	SRR14092305	24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	pre	-1	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094E	-31	FMT.0094	10	formed	SRR11422515	PRJNA545312	-3	SRR13697077	24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	pre	-1	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094F	-29	FMT.0094	12	liquid	SRR11422514	PRJNA545312	-1		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	pre	-1	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094G	-28	FMT.0094	13	liquid	SRR11422513	PRJNA545312	0		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	peri	-1	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094H	-27	FMT.0094	14	liquid	SRR11422257	PRJNA545312	1		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	peri	0	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094I	-26	FMT.0094	15	liquid	SRR11422256	PRJNA545312	2		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	peri	0	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094J	-25	FMT.0094	16	liquid	SRR11422255	PRJNA545312	3		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	peri	0	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094K	-23	FMT.0094	18	liquid	SRR11422253	PRJNA545312	5		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	peri	0	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094L	-22	FMT.0094	19	semi-formed	SRR11422252	PRJNA545312	6		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	post	0	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094M	-21	FMT.0094	20	semi-formed	SRR11422251	PRJNA545312	7		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	post	0	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094N	-20	FMT.0094	21	liquid	SRR11422250	PRJNA545312	8		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	post	1	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094O	-19	FMT.0094	22	liquid	SRR11422249	PRJNA545312	9		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	post	1	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094P	-16	FMT.0094	25	semi-formed	SRR11422248	PRJNA545312	12		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	post	1	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094Q	-17	FMT.0094	24	liquid	SRR11422247	PRJNA545312	11		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	post	1	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094R	-15	FMT.0094	26	semi-formed	SRR11422246	PRJNA545312	13	SRR14092304	24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	post	1	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-3	pre
FMT.0094T	0	FMT.0094	41	liquid	SRR11116553	PRJNA607574	28		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	post	3	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	-1	peri
FMT.0094U	7	FMT.0094	48	formed	SRR11116552	PRJNA607574	35	SRR14092303	24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	post	4	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	0	post
FMT.0094V	31	FMT.0094	72	semi-formed	SRR11116551	PRJNA607574	59		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	post	6	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	4	post
FMT.0094W	70	FMT.0094	111	formed	SRR11116550	PRJNA607574	98		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	post	6	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	6	post
FMT.0094X	98	FMT.0094	139	formed	SRR11116549	PRJNA607574	126		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	post	6	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	6	post
FMT.0094Y	180	FMT.0094	221	formed	SRR11116548	PRJNA607574	208		24	13	TCD	Leukemia	ece90549698de0564a9f97	T10	1	treatment	post	6	Treatment	28	28	FMT.0094A	FMT.0094R	FMT.0094T	6	post
FMT.0097A		FMT.0097	0	semi-formed	SRR11422245	PRJNA545312	-12	SRR13697076	29	368	BM_unmodified		809a6a9627784e56b5f953		1		pre	-2								
FMT.0097AA		FMT.0097	544	liquid	SRR11116547	PRJNA607574	176		29	368	BM_unmodified		809a6a9627784e56b5f953		1		post	6								
FMT.0097B		FMT.0097	3	formed	SRR11422244	PRJNA545312	-9	SRR13697075	29	368	BM_unmodified		809a6a9627784e56b5f953		1		pre	-2								
FMT.0097BB		FMT.0097	545	semi-formed	SRR11116546	PRJNA607574	177		29	368	BM_unmodified		809a6a9627784e56b5f953		1		post	6								
FMT.0097C		FMT.0097	10	liquid	SRR11422242	PRJNA545312	-2	SRR13697074	29	368	BM_unmodified		809a6a9627784e56b5f953		1		pre	-1								
FMT.0097CC		FMT.0097	585	formed	SRR11116545	PRJNA607574	217		29	368	BM_unmodified		809a6a9627784e56b5f953		1		post	6								
FMT.0097D		FMT.0097	11	semi-formed	SRR11422241	PRJNA545312	-1	SRR14092302	29	368	BM_unmodified		809a6a9627784e56b5f953		1		pre	-1								
FMT.0097DD		FMT.0097	586	formed	SRR11116543	PRJNA607574	218		29	368	BM_unmodified		809a6a9627784e56b5f953		1		post	6								
FMT.0097E		FMT.0097	12	liquid	SRR11422240	PRJNA545312	0	SRR14092300	29	368	BM_unmodified		809a6a9627784e56b5f953		1		peri	-1								
FMT.0097F		FMT.0097	13	semi-formed	SRR11422239	PRJNA545312	1		29	368	BM_unmodified		809a6a9627784e56b5f953		1		peri	0								
FMT.0097G		FMT.0097	14	liquid	SRR11422238	PRJNA545312	2	SRR14143421	29	368	BM_unmodified		809a6a9627784e56b5f953		1		peri	0								
FMT.0097H		FMT.0097	16	liquid	SRR11422237	PRJNA545312	4	SRR13697073	29	368	BM_unmodified		809a6a9627784e56b5f953		1		peri	0								
FMT.0097I		FMT.0097	17	liquid	SRR11422236	PRJNA545312	5	SRR13697072	29	368	BM_unmodified		809a6a9627784e56b5f953		1		peri	0								
FMT.0097J		FMT.0097	18	liquid	SRR11422235	PRJNA545312	6	SRR13697071	29	368	BM_unmodified		809a6a9627784e56b5f953		1		post	0								
FMT.0097K		FMT.0097	19	liquid	SRR11422234	PRJNA545312	7	SRR14092299	29	368	BM_unmodified		809a6a9627784e56b5f953		1		post	0								
FMT.0097L		FMT.0097	20	liquid	SRR11422233	PRJNA545312	8		29	368	BM_unmodified		809a6a9627784e56b5f953		1		post	1								
FMT.0097M		FMT.0097	21	liquid	SRR11422231	PRJNA545312	9	SRR13697070	29	368	BM_unmodified		809a6a9627784e56b5f953		1		post	1								
FMT.0097N		FMT.0097	24	semi-formed	SRR11422230	PRJNA545312	12	SRR13697069	29	368	BM_unmodified		809a6a9627784e56b5f953		1		post	1								
FMT.0097O		FMT.0097	220	formed	SRR11422456	PRJNA545312	-148		29	368	BM_unmodified		809a6a9627784e56b5f953		1		pre	-3								
FMT.0097P		FMT.0097	257	semi-formed	SRR11422455	PRJNA545312	-111		29	368	BM_unmodified		809a6a9627784e56b5f953		1		pre	-3								
FMT.0097Q		FMT.0097	278	formed	SRR11422454	PRJNA545312	-90		29	368	BM_unmodified		809a6a9627784e56b5f953		1		pre	-3								
FMT.0097R		FMT.0097	451	liquid	SRR11116542	PRJNA607574	83		29	368	BM_unmodified		809a6a9627784e56b5f953		1		post	6								
FMT.0097S		FMT.0097	457	liquid	SRR11116541	PRJNA607574	89		29	368	BM_unmodified		809a6a9627784e56b5f953		1		post	6								
FMT.0097T		FMT.0097	483	formed	SRR11116540	PRJNA607574	115		29	368	BM_unmodified		809a6a9627784e56b5f953		1		post	6								
FMT.0097U		FMT.0097	485	semi-formed	SRR11116539	PRJNA607574	117		29	368	BM_unmodified		809a6a9627784e56b5f953		1		post	6								
FMT.0097V		FMT.0097	500	formed	SRR11116538	PRJNA607574	132		29	368	BM_unmodified		809a6a9627784e56b5f953		1		post	6								
FMT.0097W		FMT.0097	516	semi-formed	SRR11116509	PRJNA607574	148		29	368	BM_unmodified		809a6a9627784e56b5f953		1		post	6								
FMT.0097Y		FMT.0097	527	liquid	SRR11116508	PRJNA607574	159		29	368	BM_unmodified		809a6a9627784e56b5f953		1		post	6								
FMT.0097Z		FMT.0097	536	semi-formed	SRR11116507	PRJNA607574	168		29	368	BM_unmodified		809a6a9627784e56b5f953		1		post	6								
FMT.0098A		FMT.0098	0	formed	SRR11422453	PRJNA545312	-9		22	665	cord	Leukemia	723815e2006e133314a593		1		pre	-2								
FMT.0098B		FMT.0098	4	semi-formed	SRR11422452	PRJNA545312	-5		22	665	cord	Leukemia	723815e2006e133314a593		1		pre	-1								
FMT.0098C		FMT.0098	5	formed	SRR11422451	PRJNA545312	-4		22	665	cord	Leukemia	723815e2006e133314a593		1		pre	-1								
FMT.0098D		FMT.0098	6	formed	SRR11422450	PRJNA545312	-3		22	665	cord	Leukemia	723815e2006e133314a593		1		pre	-1								
FMT.0098E		FMT.0098	12	semi-formed	SRR11422449	PRJNA545312	3		22	665	cord	Leukemia	723815e2006e133314a593		1		peri	0								
FMT.0098F		FMT.0098	16	semi-formed	SRR11422447	PRJNA545312	7		22	665	cord	Leukemia	723815e2006e133314a593		1		post	0								
FMT.0098G		FMT.0098	17	liquid	SRR11422446	PRJNA545312	8		22	665	cord	Leukemia	723815e2006e133314a593		1		post	1								
FMT.0098H		FMT.0098	18	liquid	SRR11422445	PRJNA545312	9		22	665	cord	Leukemia	723815e2006e133314a593		1		post	1								
FMT.0098I		FMT.0098	23	semi-formed	SRR11422444	PRJNA545312	14		22	665	cord	Leukemia	723815e2006e133314a593		1		post	1								
FMT.0098J		FMT.0098	24	formed	SRR11422443	PRJNA545312	15		22	665	cord	Leukemia	723815e2006e133314a593		1		post	2								
FMT.0098K		FMT.0098	26	formed	SRR11422442	PRJNA545312	17		22	665	cord	Leukemia	723815e2006e133314a593		1		post	2								
FMT.0098L		FMT.0098	34	liquid	SRR11422441	PRJNA545312	25		22	665	cord	Leukemia	723815e2006e133314a593		1		post	3								
FMT.0098M		FMT.0098	36	formed	SRR11422440	PRJNA545312	27		22	665	cord	Leukemia	723815e2006e133314a593		1		post	3								
FMT.0098N		FMT.0098	44	formed	SRR11422439	PRJNA545312	35		22	665	cord	Leukemia	723815e2006e133314a593		1		post	4								
FMT.0098O		FMT.0098	113	formed	SRR11422438	PRJNA545312	104		22	665	cord	Leukemia	723815e2006e133314a593		1		post	6								
FMT.0098P		FMT.0098	246	formed	SRR11422436	PRJNA545312	237		22	665	cord	Leukemia	723815e2006e133314a593		1		post	6								
FMT.0098R		FMT.0098	539	semi-formed	SRR11116506	PRJNA607574	-126		22	665	cord	Leukemia	723815e2006e133314a593		1		pre	-3								
FMT.0098S		FMT.0098	658	formed	SRR9270328	PRJNA548153	-7		22	665	cord	Leukemia	723815e2006e133314a593		1		pre	-2								
FMT.0098T		FMT.0098	659	formed	SRR9270311	PRJNA548153	-6		22	665	cord	Leukemia	723815e2006e133314a593		1		pre	-1								
FMT.0098U		FMT.0098	665	liquid	SRR9270312	PRJNA548153	0		22	665	cord	Leukemia	723815e2006e133314a593		1		peri	-1								
FMT.0098V		FMT.0098	677	liquid	SRR9270178	PRJNA548153	12		22	665	cord	Leukemia	723815e2006e133314a593		1		post	1								
FMT.0098X		FMT.0098	685	liquid	SRR9270282	PRJNA548153	20		22	665	cord	Leukemia	723815e2006e133314a593		1		post	2								
FMT.0099A	-48	FMT.0099	0	formed	SRR11422435	PRJNA545312	-13	SRR14092298	18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	pre	-2	Control	35					-3	pre
FMT.0099B	-42	FMT.0099	6	formed	SRR11422434	PRJNA545312	-7		18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	pre	-2	Control	35					-3	pre
FMT.0099C	-38	FMT.0099	10	semi-formed	SRR11422433	PRJNA545312	-3		18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	pre	-1	Control	35					-3	pre
FMT.0099D	-37	FMT.0099	11	liquid	SRR11422432	PRJNA545312	-2		18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	pre	-1	Control	35					-3	pre
FMT.0099E	-35	FMT.0099	13	liquid	SRR11422431	PRJNA545312	0		18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	peri	-1	Control	35					-3	pre
FMT.0099F	-34	FMT.0099	14	semi-formed	SRR11422430	PRJNA545312	1		18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	peri	0	Control	35					-3	pre
FMT.0099G	-33	FMT.0099	15	liquid	SRR11422429	PRJNA545312	2		18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	peri	0	Control	35					-3	pre
FMT.0099H	-30	FMT.0099	18	liquid	SRR11422229	PRJNA545312	5		18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	peri	0	Control	35					-3	pre
FMT.0099I	-28	FMT.0099	20	liquid	SRR11422228	PRJNA545312	7		18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	post	0	Control	35					-3	pre
FMT.0099J	-27	FMT.0099	21	liquid	SRR11422226	PRJNA545312	8		18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	post	1	Control	35					-3	pre
FMT.0099K	-24	FMT.0099	24	liquid	SRR11422225	PRJNA545312	11		18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	post	1	Control	35					-3	pre
FMT.0099L	-23	FMT.0099	25	liquid	SRR11422224	PRJNA545312	12		18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	post	1	Control	35					-3	pre
FMT.0099M	-22	FMT.0099	26	semi-formed	SRR11422223	PRJNA545312	13		18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	post	1	Control	35					-3	pre
FMT.0099N	-21	FMT.0099	27	semi-formed	SRR11422222	PRJNA545312	14		18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	post	1	Control	35					-3	pre
FMT.0099O	14	FMT.0099	62	formed	SRR11422221	PRJNA545312	49	SRR14092297	18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	post	6	Control	35					1	post
FMT.0099P	43	FMT.0099	91	formed	SRR11422220	PRJNA545312	78		18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	post	6	Control	35					6	post
FMT.0099Q	280	FMT.0099	328	formed	SRR11422219	PRJNA545312	315		18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	post	6	Control	35					6	post
FMT.0099R	322	FMT.0099	370	semi-formed	SRR11422218	PRJNA545312	357		18	13	TCD	Leukemia	3bf14dbd427c9a2f06180e	C8	1	control	post	6	Control	35					6	post
FMT.0100A		FMT.0100	0	formed	SRR11422217	PRJNA545312	-173		15	173	TCD	Myelodysplastic Syndromes	d06b91be0e32acf7dfabc3		1		pre	-3								
FMT.0100B		FMT.0100	166	formed	SRR11422215	PRJNA545312	-7		15	173	TCD	Myelodysplastic Syndromes	d06b91be0e32acf7dfabc3		1		pre	-2								
FMT.0100C		FMT.0100	170	semi-formed	SRR11422214	PRJNA545312	-3		15	173	TCD	Myelodysplastic Syndromes	d06b91be0e32acf7dfabc3		1		pre	-1								
FMT.0100D		FMT.0100	171	semi-formed	SRR11422213	PRJNA545312	-2		15	173	TCD	Myelodysplastic Syndromes	d06b91be0e32acf7dfabc3		1		pre	-1								
FMT.0100E		FMT.0100	173	semi-formed	SRR11422212	PRJNA545312	0		15	173	TCD	Myelodysplastic Syndromes	d06b91be0e32acf7dfabc3		1		peri	-1								
FMT.0100F		FMT.0100	172	semi-formed	SRR11422211	PRJNA545312	-1		15	173	TCD	Myelodysplastic Syndromes	d06b91be0e32acf7dfabc3		1		pre	-1								
FMT.0100H		FMT.0100	177	semi-formed	SRR11422210	PRJNA545312	4		15	173	TCD	Myelodysplastic Syndromes	d06b91be0e32acf7dfabc3		1		peri	0								
FMT.0100I		FMT.0100	178	liquid	SRR11422209	PRJNA545312	5		15	173	TCD	Myelodysplastic Syndromes	d06b91be0e32acf7dfabc3		1		peri	0								
FMT.0100J		FMT.0100	179	semi-formed	SRR11422208	PRJNA545312	6		15	173	TCD	Myelodysplastic Syndromes	d06b91be0e32acf7dfabc3		1		post	0								
FMT.0100K		FMT.0100	183	formed	SRR11422207	PRJNA545312	10		15	173	TCD	Myelodysplastic Syndromes	d06b91be0e32acf7dfabc3		1		post	1								
FMT.0100L		FMT.0100	184	formed	SRR11422206	PRJNA545312	11		15	173	TCD	Myelodysplastic Syndromes	d06b91be0e32acf7dfabc3		1		post	1								
FMT.0100M		FMT.0100	186	liquid	SRR11422203	PRJNA545312	13		15	173	TCD	Myelodysplastic Syndromes	d06b91be0e32acf7dfabc3		1		post	1								
FMT.0100N		FMT.0100	188	semi-formed	SRR11422202	PRJNA545312	15		15	173	TCD	Myelodysplastic Syndromes	d06b91be0e32acf7dfabc3		1		post	2								
FMT.0100O		FMT.0100	190	formed	SRR11422288	PRJNA545312	17		15	173	TCD	Myelodysplastic Syndromes	d06b91be0e32acf7dfabc3		1		post	2								
FMT.0100P		FMT.0100	195	semi-formed	SRR11422287	PRJNA545312	22		15	173	TCD	Myelodysplastic Syndromes	d06b91be0e32acf7dfabc3		1		post	3								
FMT.0101A		FMT.0101	0	formed	SRR11422286	PRJNA545312	-13		12	13	PBSC_unmodified	Non-Hodgkin's Lymphoma	49eccc8dc737591cc235b3	111	1		pre	-2								
FMT.0101B		FMT.0101	12	liquid	SRR11422285	PRJNA545312	-1		12	13	PBSC_unmodified	Non-Hodgkin's Lymphoma	49eccc8dc737591cc235b3	111	1		pre	-1								
FMT.0101C		FMT.0101	13	formed	SRR11422284	PRJNA545312	0		12	13	PBSC_unmodified	Non-Hodgkin's Lymphoma	49eccc8dc737591cc235b3	111	1		peri	-1								
FMT.0101D		FMT.0101	16	liquid	SRR11422283	PRJNA545312	3		12	13	PBSC_unmodified	Non-Hodgkin's Lymphoma	49eccc8dc737591cc235b3	111	1		peri	0								
FMT.0101E		FMT.0101	17	liquid	SRR11422282	PRJNA545312	4		12	13	PBSC_unmodified	Non-Hodgkin's Lymphoma	49eccc8dc737591cc235b3	111	1		peri	0								
FMT.0101F		FMT.0101	18	semi-formed	SRR11422281	PRJNA545312	5		12	13	PBSC_unmodified	Non-Hodgkin's Lymphoma	49eccc8dc737591cc235b3	111	1		peri	0								
FMT.0101G		FMT.0101	19	liquid	SRR11422279	PRJNA545312	6		12	13	PBSC_unmodified	Non-Hodgkin's Lymphoma	49eccc8dc737591cc235b3	111	1		post	0								
FMT.0101H		FMT.0101	20	liquid	SRR11422278	PRJNA545312	7		12	13	PBSC_unmodified	Non-Hodgkin's Lymphoma	49eccc8dc737591cc235b3	111	1		post	0								
FMT.0101I		FMT.0101	21	liquid	SRR11422277	PRJNA545312	8		12	13	PBSC_unmodified	Non-Hodgkin's Lymphoma	49eccc8dc737591cc235b3	111	1		post	1								
FMT.0101J		FMT.0101	22	semi-formed	SRR11422276	PRJNA545312	9		12	13	PBSC_unmodified	Non-Hodgkin's Lymphoma	49eccc8dc737591cc235b3	111	1		post	1								
FMT.0101K		FMT.0101	25	liquid	SRR11422275	PRJNA545312	12		12	13	PBSC_unmodified	Non-Hodgkin's Lymphoma	49eccc8dc737591cc235b3	111	1		post	1								
FMT.0101L		FMT.0101	26	liquid	SRR5979353	PRJNA394877	13		12	13	PBSC_unmodified	Non-Hodgkin's Lymphoma	49eccc8dc737591cc235b3	111	1		post	1								
FMT.0102A		FMT.0102	0	semi-formed	SRR11422273	PRJNA545312	-18		11	18	PBSC_unmodified	Myeloproliferative Disorder	d755c92bf92d62936aeabc		1		pre	-3								
FMT.0102D		FMT.0102	21	semi-formed	SRR11422272	PRJNA545312	3		11	18	PBSC_unmodified	Myeloproliferative Disorder	d755c92bf92d62936aeabc		1		peri	0								
FMT.0102E		FMT.0102	24	liquid	SRR11422271	PRJNA545312	6		11	18	PBSC_unmodified	Myeloproliferative Disorder	d755c92bf92d62936aeabc		1		post	0								
FMT.0102F		FMT.0102	30	semi-formed	SRR11422270	PRJNA545312	12		11	18	PBSC_unmodified	Myeloproliferative Disorder	d755c92bf92d62936aeabc		1		post	1								
FMT.0102G		FMT.0102	33	formed	SRR11422268	PRJNA545312	15		11	18	PBSC_unmodified	Myeloproliferative Disorder	d755c92bf92d62936aeabc		1		post	2								
FMT.0102H		FMT.0102	35	semi-formed	SRR11422267	PRJNA545312	17		11	18	PBSC_unmodified	Myeloproliferative Disorder	d755c92bf92d62936aeabc		1		post	2								
FMT.0102I		FMT.0102	39	semi-formed	SRR11422266	PRJNA545312	21		11	18	PBSC_unmodified	Myeloproliferative Disorder	d755c92bf92d62936aeabc		1		post	2								
FMT.0102J		FMT.0102	98	semi-formed	SRR11422265	PRJNA545312	80		11	18	PBSC_unmodified	Myeloproliferative Disorder	d755c92bf92d62936aeabc		1		post	6								
FMT.0102K		FMT.0102	245	semi-formed	SRR11422264	PRJNA545312	227		11	18	PBSC_unmodified	Myeloproliferative Disorder	d755c92bf92d62936aeabc		1		post	6								
FMT.0102L		FMT.0102	329	semi-formed	SRR11422263	PRJNA545312	311		11	18	PBSC_unmodified	Myeloproliferative Disorder	d755c92bf92d62936aeabc		1		post	6								
FMT.0102M		FMT.0102	441	semi-formed	SRR11116504	PRJNA607574	423		11	18	PBSC_unmodified	Myeloproliferative Disorder	d755c92bf92d62936aeabc		1		post	6								
FMT.0103A	-60	FMT.0103	0	formed	SRR11422262	PRJNA545312	-13	SRR14092296	23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	pre	-2	Control	47					-3	pre
FMT.0103B	-53	FMT.0103	7	formed	SRR11422261	PRJNA545312	-6		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	pre	-1	Control	47					-3	pre
FMT.0103C	-51	FMT.0103	9	formed	SRR11422484	PRJNA545312	-4		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	pre	-1	Control	47					-3	pre
FMT.0103D	-50	FMT.0103	10	semi-formed	SRR11422483	PRJNA545312	-3		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	pre	-1	Control	47					-3	pre
FMT.0103E	-49	FMT.0103	11	semi-formed	SRR11422481	PRJNA545312	-2		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	pre	-1	Control	47					-3	pre
FMT.0103F	-48	FMT.0103	12	semi-formed	SRR11422480	PRJNA545312	-1		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	pre	-1	Control	47					-3	pre
FMT.0103G	-47	FMT.0103	13	semi-formed	SRR11422479	PRJNA545312	0		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	peri	-1	Control	47					-3	pre
FMT.0103H	-46	FMT.0103	14	semi-formed	SRR11422478	PRJNA545312	1		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	peri	0	Control	47					-3	pre
FMT.0103I	-42	FMT.0103	18	semi-formed	SRR11422477	PRJNA545312	5		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	peri	0	Control	47					-3	pre
FMT.0103J	-41	FMT.0103	19	semi-formed	SRR11422476	PRJNA545312	6		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	post	0	Control	47					-3	pre
FMT.0103K	-40	FMT.0103	20	liquid	SRR11422475	PRJNA545312	7		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	post	0	Control	47					-3	pre
FMT.0103M	-36	FMT.0103	24	semi-formed	SRR11422474	PRJNA545312	11		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	post	1	Control	47					-3	pre
FMT.0103N	-35	FMT.0103	25	semi-formed	SRR11422473	PRJNA545312	12		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	post	1	Control	47					-3	pre
FMT.0103O	-34	FMT.0103	26	liquid	SRR11422472	PRJNA545312	13		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	post	1	Control	47					-3	pre
FMT.0103R	-28	FMT.0103	32	semi-formed	SRR11422470	PRJNA545312	19		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	post	2	Control	47					-3	pre
FMT.0103S	-27	FMT.0103	33	semi-formed	SRR11422469	PRJNA545312	20		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	post	2	Control	47					-3	pre
FMT.0103T	-26	FMT.0103	34	semi-formed	SRR11422468	PRJNA545312	21		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	post	2	Control	47					-3	pre
FMT.0103U	-25	FMT.0103	35	liquid	SRR11422467	PRJNA545312	22		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	post	3	Control	47					-3	pre
FMT.0103V	-18	FMT.0103	42	semi-formed	SRR11422466	PRJNA545312	29		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	post	4	Control	47					-3	pre
FMT.0103W	-17	FMT.0103	43	semi-formed	SRR11422465	PRJNA545312	30		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	post	4	Control	47					-3	pre
FMT.0103X	-7	FMT.0103	53	formed	SRR11422464	PRJNA545312	40		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	post	5	Control	47					-2	pre
FMT.0103Y	6	FMT.0103	66	semi-formed	SRR11422463	PRJNA545312	53	SRR14092295	23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	post	6	Control	47					0	post
FMT.0103Z	59	FMT.0103	119	semi-formed	SRR11422462	PRJNA545312	106		23	13	BM_unmodified	Myelodysplastic Syndromes	d90e1b7f7d96d7133d7172	C10	1	control	post	6	Control	47					6	post
FMT.0104A		FMT.0104	0	formed	SRR11422461	PRJNA545312	-13		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		pre	-2								
FMT.0104B		FMT.0104	4	formed	SRR11422459	PRJNA545312	-9		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		pre	-2								
FMT.0104C		FMT.0104	5	formed	SRR11422458	PRJNA545312	-8		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		pre	-2								
FMT.0104D		FMT.0104	10	semi-formed	SRR11422457	PRJNA545312	-3		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		pre	-1								
FMT.0104E		FMT.0104	11	semi-formed	SRR11422201	PRJNA545312	-2		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		pre	-1								
FMT.0104H		FMT.0104	14	liquid	SRR11422200	PRJNA545312	1		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		peri	0								
FMT.0104I		FMT.0104	15	liquid	SRR11422199	PRJNA545312	2		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		peri	0								
FMT.0104J		FMT.0104	16	liquid	SRR11422198	PRJNA545312	3		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		peri	0								
FMT.0104K		FMT.0104	17	liquid	SRR11422197	PRJNA545312	4		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		peri	0								
FMT.0104L		FMT.0104	18	liquid	SRR11422196	PRJNA545312	5		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		peri	0								
FMT.0104M		FMT.0104	20	formed	SRR11422195	PRJNA545312	7		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		post	0								
FMT.0104N		FMT.0104	24	semi-formed	SRR11422193	PRJNA545312	11		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		post	1								
FMT.0104O		FMT.0104	25	semi-formed	SRR11422192	PRJNA545312	12		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		post	1								
FMT.0104P		FMT.0104	26	semi-formed	SRR11422191	PRJNA545312	13		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		post	1								
FMT.0104Q		FMT.0104	56	formed	SRR11422190	PRJNA545312	43		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		post	6								
FMT.0104R		FMT.0104	69	formed	SRR11422189	PRJNA545312	56		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		post	6								
FMT.0104S		FMT.0104	98	formed	SRR11422188	PRJNA545312	85		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		post	6								
FMT.0104T		FMT.0104	195	formed	SRR11422187	PRJNA545312	182		18	13	TCD	Leukemia	75a075f2b7e8fb6e8977fe		1		post	6								
FMT.0105A		FMT.0105	0	formed	SRR11422186	PRJNA545312	-20		16	20	TCD	Multiple Myeloma	0555bfe76317c3a99281d2		1		pre	-3								
FMT.0105B		FMT.0105	11	formed	SRR11422185	PRJNA545312	-9		16	20	TCD	Multiple Myeloma	0555bfe76317c3a99281d2		1		pre	-2								
FMT.0105C		FMT.0105	12	formed	SRR11422184	PRJNA545312	-8		16	20	TCD	Multiple Myeloma	0555bfe76317c3a99281d2		1		pre	-2								
FMT.0105D		FMT.0105	13	semi-formed	SRR11422182	PRJNA545312	-7		16	20	TCD	Multiple Myeloma	0555bfe76317c3a99281d2		1		pre	-2								
FMT.0105E		FMT.0105	15	semi-formed	SRR11422181	PRJNA545312	-5		16	20	TCD	Multiple Myeloma	0555bfe76317c3a99281d2		1		pre	-1								
FMT.0105F		FMT.0105	17	semi-formed	SRR11422180	PRJNA545312	-3		16	20	TCD	Multiple Myeloma	0555bfe76317c3a99281d2		1		pre	-1								
FMT.0105G		FMT.0105	19	semi-formed	SRR11422179	PRJNA545312	-1		16	20	TCD	Multiple Myeloma	0555bfe76317c3a99281d2		1		pre	-1								
FMT.0105H		FMT.0105	20	liquid	SRR11422178	PRJNA545312	0		16	20	TCD	Multiple Myeloma	0555bfe76317c3a99281d2		1		peri	-1								
FMT.0105I		FMT.0105	21	liquid	SRR11422177	PRJNA545312	1		16	20	TCD	Multiple Myeloma	0555bfe76317c3a99281d2		1		peri	0								
FMT.0105J		FMT.0105	24	liquid	SRR11422176	PRJNA545312	4		16	20	TCD	Multiple Myeloma	0555bfe76317c3a99281d2		1		peri	0								
FMT.0105K		FMT.0105	25	liquid	SRR11422175	PRJNA545312	5		16	20	TCD	Multiple Myeloma	0555bfe76317c3a99281d2		1		peri	0								
FMT.0105L		FMT.0105	26	liquid	SRR11422174	PRJNA545312	6		16	20	TCD	Multiple Myeloma	0555bfe76317c3a99281d2		1		post	0								
FMT.0105M		FMT.0105	27	liquid	SRR11421895	PRJNA545312	7		16	20	TCD	Multiple Myeloma	0555bfe76317c3a99281d2		1		post	0								
FMT.0105O		FMT.0105	31	semi-formed	SRR11421892	PRJNA545312	11		16	20	TCD	Multiple Myeloma	0555bfe76317c3a99281d2		1		post	1								
FMT.0105P		FMT.0105	32	liquid	SRR11421891	PRJNA545312	12		16	20	TCD	Multiple Myeloma	0555bfe76317c3a99281d2		1		post	1								
FMT.0105Q		FMT.0105	33	semi-formed	SRR11421890	PRJNA545312	13		16	20	TCD	Multiple Myeloma	0555bfe76317c3a99281d2		1		post	1								
FMT.0106A	-35	FMT.0106	0	formed	SRR11421889	PRJNA545312	-15	SRR14092294	29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	pre	-3	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	-3	pre
FMT.0106AA	60	FMT.0106	95	liquid	SRR11116503	PRJNA607574	80		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	6	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	6	post
FMT.0106B	-25	FMT.0106	10	formed	SRR11421888	PRJNA545312	-5		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	pre	-1	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	-3	pre
FMT.0106BB	61	FMT.0106	96	liquid	SRR11116502	PRJNA607574	81		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	6	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	6	post
FMT.0106C	-24	FMT.0106	11	formed	SRR11421887	PRJNA545312	-4		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	pre	-1	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	-3	pre
FMT.0106CC	64	FMT.0106	99	semi-formed	SRR11116501	PRJNA607574	84		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	6	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	6	post
FMT.0106D	-23	FMT.0106	12	formed	SRR11421886	PRJNA545312	-3		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	pre	-1	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	-3	pre
FMT.0106DD	66	FMT.0106	101	semi-formed	SRR11116500	PRJNA607574	86		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	6	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	6	post
FMT.0106E	-22	FMT.0106	13	formed	SRR11421885	PRJNA545312	-2		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	pre	-1	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	-3	pre
FMT.0106EE	67	FMT.0106	102	liquid	SRR11116499	PRJNA607574	87		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	6	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	6	post
FMT.0106F	-21	FMT.0106	14	semi-formed	SRR11421884	PRJNA545312	-1		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	pre	-1	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	-3	pre
FMT.0106G	-20	FMT.0106	15	liquid	SRR11421883	PRJNA545312	0		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	peri	-1	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	-3	pre
FMT.0106GG	123	FMT.0106	158	liquid	SRR11116498	PRJNA607574	143		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	6	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	6	post
FMT.0106H	-18	FMT.0106	17	liquid	SRR11421881	PRJNA545312	2		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	peri	0	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	-3	pre
FMT.0106HH	155	FMT.0106	190	liquid	SRR11116497	PRJNA607574	175		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	6	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	6	post
FMT.0106I	-13	FMT.0106	22	liquid	SRR11421880	PRJNA545312	7		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	0	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	-2	pre
FMT.0106K	-10	FMT.0106	25	liquid	SRR11421879	PRJNA545312	10		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	1	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	-2	pre
FMT.0106L	-9	FMT.0106	26	liquid	SRR11421878	PRJNA545312	11		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	1	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	-2	pre
FMT.0106M	-7	FMT.0106	28	liquid	SRR11421877	PRJNA545312	13		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	1	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	-2	pre
FMT.0106N	-3	FMT.0106	32	liquid	SRR11421876	PRJNA545312	17		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	2	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	-1	pre
FMT.0106R	0	FMT.0106	35	liquid	SRR10668367	PRJNA545312	20		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	2	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	-1	peri
FMT.0106S	5	FMT.0106	40	liquid	SRR11116496	PRJNA607574	25	SRR14092293	29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	3	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	0	peri
FMT.0106T	27	FMT.0106	62	semi-formed	SRR11116495	PRJNA607574	47		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	6	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	3	post
FMT.0106U	40	FMT.0106	75	semi-formed	SRR10668366	PRJNA545312	60		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	6	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	5	post
FMT.0106V	41	FMT.0106	76	liquid	SRR11116492	PRJNA607574	61		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	6	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	5	post
FMT.0106W	46	FMT.0106	81	liquid	SRR11116491	PRJNA607574	66		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	6	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	6	post
FMT.0106X	47	FMT.0106	82	liquid	SRR11116490	PRJNA607574	67		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	6	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	6	post
FMT.0106Y	48	FMT.0106	83	semi-formed	SRR11116489	PRJNA607574	68		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	6	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	6	post
FMT.0106Z	49	FMT.0106	84	liquid	SRR11116488	PRJNA607574	69		29	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	852d3a14316666c0bacfbb	T13	0	treatment	post	6	Treatment	20	20	FMT.0106A	FMT.0106N	FMT.0106R	6	post
FMT.0107A	-44	FMT.0107	0	formed	SRR11421875	PRJNA545312	-20	SRR14092292	23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	pre	-3	Control	24					-3	pre
FMT.0107B	-25	FMT.0107	19	liquid	SRR11421874	PRJNA545312	-1		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	pre	-1	Control	24					-3	pre
FMT.0107C	-24	FMT.0107	20	formed	SRR11421873	PRJNA545312	0		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	peri	-1	Control	24					-3	pre
FMT.0107D	-23	FMT.0107	21	semi-formed	SRR11421872	PRJNA545312	1		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	peri	0	Control	24					-3	pre
FMT.0107E	-22	FMT.0107	22	semi-formed	SRR11421869	PRJNA545312	2		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	peri	0	Control	24					-3	pre
FMT.0107F	-19	FMT.0107	25	liquid	SRR11421868	PRJNA545312	5		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	peri	0	Control	24					-3	pre
FMT.0107G	-15	FMT.0107	29	semi-formed	SRR11421867	PRJNA545312	9		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	post	1	Control	24					-3	pre
FMT.0107H	-14	FMT.0107	30	liquid	SRR11422145	PRJNA545312	10		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	post	1	Control	24					-3	pre
FMT.0107I	-12	FMT.0107	32	liquid	SRR11422144	PRJNA545312	12		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	post	1	Control	24					-2	pre
FMT.0107J	-11	FMT.0107	33	liquid	SRR11422143	PRJNA545312	13		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	post	1	Control	24					-2	pre
FMT.0107K	-9	FMT.0107	35	semi-formed	SRR11422142	PRJNA545312	15		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	post	2	Control	24					-2	pre
FMT.0107L	-8	FMT.0107	36	semi-formed	SRR11422141	PRJNA545312	16		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	post	2	Control	24					-2	pre
FMT.0107M	-7	FMT.0107	37	semi-formed	SRR11422140	PRJNA545312	17		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	post	2	Control	24					-2	pre
FMT.0107N	-5	FMT.0107	39	semi-formed	SRR11422139	PRJNA545312	19		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	post	2	Control	24					-1	pre
FMT.0107O	-4	FMT.0107	40	formed	SRR11422137	PRJNA545312	20		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	post	2	Control	24					-1	pre
FMT.0107P	-3	FMT.0107	41	semi-formed	SRR11422136	PRJNA545312	21		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	post	2	Control	24					-1	pre
FMT.0107Q	-1	FMT.0107	43	formed	SRR11422135	PRJNA545312	23		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	post	3	Control	24					-1	pre
FMT.0107R	4	FMT.0107	48	formed	SRR11422134	PRJNA545312	28		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	post	3	Control	24					0	peri
FMT.0107S	11	FMT.0107	55	formed	SRR11422133	PRJNA545312	35		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	post	4	Control	24					1	post
FMT.0107T	44	FMT.0107	88	semi-formed	SRR11422132	PRJNA545312	68		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	post	6	Control	24					6	post
FMT.0107U	93	FMT.0107	137	formed	SRR11422131	PRJNA545312	117		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	post	6	Control	24					6	post
FMT.0107V	135	FMT.0107	179		SRR11422130	PRJNA545312	159		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	post	6	Control	24					6	post
FMT.0107W	191	FMT.0107	235	formed	SRR11422129	PRJNA545312	215		23	20	PBSC_unmodified	Myelodysplastic Syndromes	03ac27da97dc05981f5766	C11	1	control	post	6	Control	24					6	post
FMT.0108A		FMT.0108	0	semi-formed	SRR11422128	PRJNA545312	-13		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		pre	-2								
FMT.0108B		FMT.0108	7	formed	SRR11422126	PRJNA545312	-6		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		pre	-1								
FMT.0108C		FMT.0108	11	formed	SRR11422125	PRJNA545312	-2		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		pre	-1								
FMT.0108D		FMT.0108	12	liquid	SRR11422124	PRJNA545312	-1		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		pre	-1								
FMT.0108E		FMT.0108	13	semi-formed	SRR11422123	PRJNA545312	0		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		peri	-1								
FMT.0108F		FMT.0108	14	semi-formed	SRR11422122	PRJNA545312	1		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		peri	0								
FMT.0108G		FMT.0108	15	formed	SRR11422121	PRJNA545312	2		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		peri	0								
FMT.0108H		FMT.0108	17	semi-formed	SRR11422120	PRJNA545312	4		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		peri	0								
FMT.0108I		FMT.0108	18	liquid	SRR11422119	PRJNA545312	5		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		peri	0								
FMT.0108J		FMT.0108	19	liquid	SRR11422118	PRJNA545312	6		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		post	0								
FMT.0108K		FMT.0108	20	semi-formed	SRR11421866	PRJNA545312	7		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		post	0								
FMT.0108L		FMT.0108	21	semi-formed	SRR11421864	PRJNA545312	8		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		post	1								
FMT.0108M		FMT.0108	22	semi-formed	SRR11421863	PRJNA545312	9		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		post	1								
FMT.0108N		FMT.0108	24	semi-formed	SRR11421862	PRJNA545312	11		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		post	1								
FMT.0108P		FMT.0108	29	semi-formed	SRR11421861	PRJNA545312	16		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		post	2								
FMT.0108Q		FMT.0108	31	semi-formed	SRR11421860	PRJNA545312	18		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		post	2								
FMT.0108R		FMT.0108	32	semi-formed	SRR11421859	PRJNA545312	19		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		post	2								
FMT.0108S		FMT.0108	33	liquid	SRR11421858	PRJNA545312	20		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		post	2								
FMT.0108T		FMT.0108	34	liquid	SRR11421857	PRJNA545312	21		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		post	2								
FMT.0108U		FMT.0108	35	semi-formed	SRR11421856	PRJNA545312	22		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		post	3								
FMT.0108V		FMT.0108	39	liquid	SRR11421855	PRJNA545312	26		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		post	3								
FMT.0108W		FMT.0108	40	liquid	SRR11421853	PRJNA545312	27		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		post	3								
FMT.0108X		FMT.0108	231	semi-formed	SRR11421852	PRJNA545312	218		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		post	6								
FMT.0108Y		FMT.0108	385	formed	SRR11421851	PRJNA545312	372		24	13	BM_unmodified	Leukemia	1dbea9394f467568071ef6	642	1		post	6								
FMT.0109A		FMT.0109	0	formed	SRR11421850	PRJNA545312	-17		13	17	BM_unmodified	Leukemia	0d683fcdb687ec3a6f1096		1		pre	-3								
FMT.0109B		FMT.0109	20	semi-formed	SRR11421849	PRJNA545312	3		13	17	BM_unmodified	Leukemia	0d683fcdb687ec3a6f1096		1		peri	0								
FMT.0109C		FMT.0109	21	liquid	SRR11421848	PRJNA545312	4		13	17	BM_unmodified	Leukemia	0d683fcdb687ec3a6f1096		1		peri	0								
FMT.0109D		FMT.0109	23	semi-formed	SRR11421847	PRJNA545312	6		13	17	BM_unmodified	Leukemia	0d683fcdb687ec3a6f1096		1		post	0								
FMT.0109F		FMT.0109	27	semi-formed	SRR11421846	PRJNA545312	10		13	17	BM_unmodified	Leukemia	0d683fcdb687ec3a6f1096		1		post	1								
FMT.0109G		FMT.0109	28	formed	SRR11421845	PRJNA545312	11		13	17	BM_unmodified	Leukemia	0d683fcdb687ec3a6f1096		1		post	1								
FMT.0109H		FMT.0109	31	semi-formed	SRR11421844	PRJNA545312	14		13	17	BM_unmodified	Leukemia	0d683fcdb687ec3a6f1096		1		post	1								
FMT.0109I		FMT.0109	35	liquid	SRR11421842	PRJNA545312	18		13	17	BM_unmodified	Leukemia	0d683fcdb687ec3a6f1096		1		post	2								
FMT.0109J		FMT.0109	37	liquid	SRR11421841	PRJNA545312	20		13	17	BM_unmodified	Leukemia	0d683fcdb687ec3a6f1096		1		post	2								
FMT.0109K		FMT.0109	43	semi-formed	SRR11421840	PRJNA545312	26		13	17	BM_unmodified	Leukemia	0d683fcdb687ec3a6f1096		1		post	3								
FMT.0109L		FMT.0109	45	semi-formed	SRR11421839	PRJNA545312	28		13	17	BM_unmodified	Leukemia	0d683fcdb687ec3a6f1096		1		post	3								
FMT.0109M		FMT.0109	265	semi-formed	SRR11421977	PRJNA545312	248		13	17	BM_unmodified	Leukemia	0d683fcdb687ec3a6f1096		1		post	6								
FMT.0109N		FMT.0109	343	liquid	SRR11421976	PRJNA545312	326		13	17	BM_unmodified	Leukemia	0d683fcdb687ec3a6f1096		1		post	6								
FMT.0110A		FMT.0110	0	formed	SRR11421975	PRJNA545312	-6		16	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e3b0fd2aa4aba04d72f8a	259	1		pre	-1								
FMT.0110B		FMT.0110	3	formed	SRR11421974	PRJNA545312	-3		16	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e3b0fd2aa4aba04d72f8a	259	1		pre	-1								
FMT.0110C		FMT.0110	4	formed	SRR11421973	PRJNA545312	-2		16	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e3b0fd2aa4aba04d72f8a	259	1		pre	-1								
FMT.0110D		FMT.0110	5	formed	SRR11421972	PRJNA545312	-1		16	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e3b0fd2aa4aba04d72f8a	259	1		pre	-1								
FMT.0110E		FMT.0110	6	formed	SRR11421970	PRJNA545312	0		16	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e3b0fd2aa4aba04d72f8a	259	1		peri	-1								
FMT.0110F		FMT.0110	7	semi-formed	SRR11421969	PRJNA545312	1		16	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e3b0fd2aa4aba04d72f8a	259	1		peri	0								
FMT.0110G		FMT.0110	10	semi-formed	SRR11421968	PRJNA545312	4		16	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e3b0fd2aa4aba04d72f8a	259	1		peri	0								
FMT.0110H		FMT.0110	11	semi-formed	SRR11421967	PRJNA545312	5		16	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e3b0fd2aa4aba04d72f8a	259	1		peri	0								
FMT.0110I		FMT.0110	12	formed	SRR11421966	PRJNA545312	6		16	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e3b0fd2aa4aba04d72f8a	259	1		post	0								
FMT.0110J		FMT.0110	13	semi-formed	SRR11421965	PRJNA545312	7		16	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e3b0fd2aa4aba04d72f8a	259	1		post	0								
FMT.0110K		FMT.0110	16	formed	SRR11421964	PRJNA545312	10		16	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e3b0fd2aa4aba04d72f8a	259	1		post	1								
FMT.0110L		FMT.0110	18	formed	SRR11422369	PRJNA545312	12		16	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e3b0fd2aa4aba04d72f8a	259	1		post	1								
FMT.0110M		FMT.0110	19	formed	SRR11422665	PRJNA545312	13		16	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e3b0fd2aa4aba04d72f8a	259	1		post	1								
FMT.0110N		FMT.0110	20	formed	SRR11422664	PRJNA545312	14		16	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e3b0fd2aa4aba04d72f8a	259	1		post	1								
FMT.0110O		FMT.0110	209	semi-formed	SRR11422662	PRJNA545312	203		16	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e3b0fd2aa4aba04d72f8a	259	1		post	6								
FMT.0110P		FMT.0110	354	semi-formed	SRR11422661	PRJNA545312	348		16	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	2e3b0fd2aa4aba04d72f8a	259	1		post	6								
FMT.0111A	-31	FMT.0111	0	formed	SRR11422660	PRJNA545312	-9		23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	pre	-2	Control	22					-3	pre
FMT.0111AA	248	FMT.0111	279	formed	SRR11422659	PRJNA545312	270		23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	post	6	Control	22					6	post
FMT.0111B	-30	FMT.0111	1	formed	SRR11422658	PRJNA545312	-8	SRR13697131	23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	pre	-2	Control	22					-3	pre
FMT.0111BB	339	FMT.0111	370	formed	SRR11422657	PRJNA545312	361		23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	post	6	Control	22					6	post
FMT.0111C	-29	FMT.0111	2	formed	SRR11422656	PRJNA545312	-7	SRR14092291	23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	pre	-2	Control	22					-3	pre
FMT.0111D	-28	FMT.0111	3	formed	SRR11422655	PRJNA545312	-6	SRR13697130	23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	pre	-1	Control	22					-3	pre
FMT.0111E	-25	FMT.0111	6	formed	SRR11422654	PRJNA545312	-3	SRR14092289	23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	pre	-1	Control	22					-3	pre
FMT.0111F	-24	FMT.0111	7	formed	SRR11422653	PRJNA545312	-2	SRR14092288	23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	pre	-1	Control	22					-3	pre
FMT.0111G	-23	FMT.0111	8	liquid	SRR11421837	PRJNA545312	-1	SRR13697129	23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	pre	-1	Control	22					-3	pre
FMT.0111I	-19	FMT.0111	12	liquid	SRR11421836	PRJNA545312	3		23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	peri	0	Control	22					-3	pre
FMT.0111J	-18	FMT.0111	13	semi-formed	SRR11421835	PRJNA545312	4		23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	peri	0	Control	22					-3	pre
FMT.0111L	-16	FMT.0111	15	liquid	SRR11421834	PRJNA545312	6		23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	post	0	Control	22					-3	pre
FMT.0111M	-15	FMT.0111	16	liquid	SRR11421833	PRJNA545312	7		23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	post	0	Control	22					-3	pre
FMT.0111N	-14	FMT.0111	17	liquid	SRR11421832	PRJNA545312	8		23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	post	1	Control	22					-3	pre
FMT.0111P	-11	FMT.0111	20	semi-formed	SRR11421830	PRJNA545312	11		23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	post	1	Control	22					-2	pre
FMT.0111S	-9	FMT.0111	22	liquid	SRR11421828	PRJNA545312	13		23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	post	1	Control	22					-2	pre
FMT.0111T	4	FMT.0111	35	formed	SRR11421826	PRJNA545312	26		23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	post	3	Control	22					0	peri
FMT.0111U	38	FMT.0111	69	formed	SRR11421825	PRJNA545312	60		23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	post	6	Control	22					5	post
FMT.0111V	73	FMT.0111	104	formed	SRR11421824	PRJNA545312	95		23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	post	6	Control	22					6	post
FMT.0111W	122	FMT.0111	153	formed	SRR11421823	PRJNA545312	144		23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	post	6	Control	22					6	post
FMT.0111X	152	FMT.0111	183	formed	SRR11421822	PRJNA545312	174		23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	post	6	Control	22					6	post
FMT.0111Y	192	FMT.0111	223	formed	SRR11421821	PRJNA545312	214		23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	post	6	Control	22					6	post
FMT.0111Z	220	FMT.0111	251	formed	SRR11421820	PRJNA545312	242		23	9	TCD	Leukemia	90dd721182743d0a7aa9a9	C9	1	control	post	6	Control	22					6	post
FMT.0112A		FMT.0112	0	semi-formed	SRR11421819	PRJNA545312	-15		27	15	cord	Leukemia	3307e0923dc561269cb334		1		pre	-3								
FMT.0112AA		FMT.0112	285	formed	SRR11421818	PRJNA545312	270		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	6								
FMT.0112B		FMT.0112	12	formed	SRR11421817	PRJNA545312	-3		27	15	cord	Leukemia	3307e0923dc561269cb334		1		pre	-1								
FMT.0112BB		FMT.0112	377	formed	SRR11421814	PRJNA545312	362		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	6								
FMT.0112D		FMT.0112	14	formed	SRR11421812	PRJNA545312	-1		27	15	cord	Leukemia	3307e0923dc561269cb334		1		pre	-1								
FMT.0112E		FMT.0112	15	semi-formed	SRR11421811	PRJNA545312	0		27	15	cord	Leukemia	3307e0923dc561269cb334		1		peri	-1								
FMT.0112F		FMT.0112	16	semi-formed	SRR11422652	PRJNA545312	1		27	15	cord	Leukemia	3307e0923dc561269cb334		1		peri	0								
FMT.0112G		FMT.0112	19	semi-formed	SRR11422651	PRJNA545312	4		27	15	cord	Leukemia	3307e0923dc561269cb334		1		peri	0								
FMT.0112H		FMT.0112	20	semi-formed	SRR11422650	PRJNA545312	5		27	15	cord	Leukemia	3307e0923dc561269cb334		1		peri	0								
FMT.0112I		FMT.0112	21	formed	SRR11422649	PRJNA545312	6		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	0								
FMT.0112J		FMT.0112	22	semi-formed	SRR11422648	PRJNA545312	7		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	0								
FMT.0112K		FMT.0112	25	semi-formed	SRR11422647	PRJNA545312	10		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	1								
FMT.0112L		FMT.0112	26	formed	SRR11422645	PRJNA545312	11		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	1								
FMT.0112M		FMT.0112	29	formed	SRR11422644	PRJNA545312	14		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	1								
FMT.0112N		FMT.0112	30	formed	SRR11422643	PRJNA545312	15		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	2								
FMT.0112O		FMT.0112	33	formed	SRR11422642	PRJNA545312	18		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	2								
FMT.0112P		FMT.0112	34	formed	SRR11422641	PRJNA545312	19		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	2								
FMT.0112Q		FMT.0112	35	formed	SRR11422640	PRJNA545312	20		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	2								
FMT.0112R		FMT.0112	36	formed	SRR11422639	PRJNA545312	21		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	2								
FMT.0112S		FMT.0112	39	formed	SRR11422638	PRJNA545312	24		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	3								
FMT.0112T		FMT.0112	41	formed	SRR11422637	PRJNA545312	26		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	3								
FMT.0112U		FMT.0112	42	formed	SRR11422636	PRJNA545312	27		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	3								
FMT.0112V		FMT.0112	43	formed	SRR11422634	PRJNA545312	28		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	3								
FMT.0112W		FMT.0112	62	semi-formed	SRR11422633	PRJNA545312	47		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	6								
FMT.0112X		FMT.0112	76	semi-formed	SRR11422632	PRJNA545312	61		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	6								
FMT.0112Y		FMT.0112	97	semi-formed	SRR11422631	PRJNA545312	82		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	6								
FMT.0112Z		FMT.0112	209	semi-formed	SRR11422630	PRJNA545312	194		27	15	cord	Leukemia	3307e0923dc561269cb334		1		post	6								
FMT.0113A		FMT.0113	0	formed	SRR11422629	PRJNA545312	-13		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		pre	-2								
FMT.0113AA		FMT.0113	531	formed	SRR9271418	PRJNA548153	8		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	1								
FMT.0113B		FMT.0113	10	formed	SRR11422628	PRJNA545312	-3	SRR13697128	40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		pre	-1								
FMT.0113BB		FMT.0113	537	semi-formed	SRR9271417	PRJNA548153	14		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	1								
FMT.0113C		FMT.0113	13	liquid	SRR11422627	PRJNA545312	0		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		peri	-1								
FMT.0113CC		FMT.0113	538	semi-formed	SRR11116487	PRJNA607574	15		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	2								
FMT.0113D		FMT.0113	15	semi-formed	SRR11422626	PRJNA545312	2		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		peri	0								
FMT.0113DD		FMT.0113	539	semi-formed	SRR9271416	PRJNA548153	16		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	2								
FMT.0113E		FMT.0113	16	semi-formed	SRR11422625	PRJNA545312	3		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		peri	0								
FMT.0113EE		FMT.0113	540	semi-formed	SRR9271415	PRJNA548153	17		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	2								
FMT.0113F		FMT.0113	19	liquid	SRR11421809	PRJNA545312	6		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	0								
FMT.0113FF		FMT.0113	543	liquid	SRR11116486	PRJNA607574	20		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	2								
FMT.0113G		FMT.0113	20	semi-formed	SRR11421808	PRJNA545312	7		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	0								
FMT.0113H		FMT.0113	21	semi-formed	SRR11421807	PRJNA545312	8		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	1								
FMT.0113HH		FMT.0113	544	liquid	SRR11116485	PRJNA607574	21		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	2								
FMT.0113I		FMT.0113	22	semi-formed	SRR11421806	PRJNA545312	9		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	1								
FMT.0113II		FMT.0113	546	liquid	SRR11116484	PRJNA607574	23		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	3								
FMT.0113J		FMT.0113	23	liquid	SRR11421805	PRJNA545312	10		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	1								
FMT.0113JJ		FMT.0113	547	liquid	SRR11116483	PRJNA607574	24		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	3								
FMT.0113K		FMT.0113	25	semi-formed	SRR11421804	PRJNA545312	12		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	1								
FMT.0113KK		FMT.0113	553	semi-formed	SRR11116481	PRJNA607574	30		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	4								
FMT.0113L		FMT.0113	26	formed	SRR11421803	PRJNA545312	13		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	1								
FMT.0113LL		FMT.0113	554	semi-formed	SRR11116480	PRJNA607574	31		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	4								
FMT.0113M		FMT.0113	27	formed	SRR11421802	PRJNA545312	14		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	1								
FMT.0113MM		FMT.0113	557	formed	SRR11116479	PRJNA607574	34		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	4								
FMT.0113N		FMT.0113	28	semi-formed	SRR11421801	PRJNA545312	15		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	2								
FMT.0113NN		FMT.0113	560	formed	SRR11116478	PRJNA607574	37		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	5								
FMT.0113O		FMT.0113	147	semi-formed	SRR11421800	PRJNA545312	134		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	6								
FMT.0113OO		FMT.0113	561	formed	SRR11116477	PRJNA607574	38		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		post	5								
FMT.0113P		FMT.0113	490	semi-formed	SRR11116476	PRJNA607574	-33		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		pre	-3								
FMT.0113Q		FMT.0113	516	formed	SRR11421798	PRJNA545312	-7		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		pre	-2								
FMT.0113R		FMT.0113	517	formed	SRR11421797	PRJNA545312	-6		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		pre	-1								
FMT.0113S		FMT.0113	518	formed	SRR11421796	PRJNA545312	-5		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		pre	-1								
FMT.0113T		FMT.0113	519	formed	SRR11421795	PRJNA545312	-4		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		pre	-1								
FMT.0113U		FMT.0113	522	semi-formed	SRR11421794	PRJNA545312	-1		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		pre	-1								
FMT.0113V		FMT.0113	523	formed	SRR9271414	PRJNA548153	0		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		peri	-1								
FMT.0113W		FMT.0113	524	formed	SRR9271413	PRJNA548153	1		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		peri	0								
FMT.0113X		FMT.0113	525	semi-formed	SRR9271520	PRJNA548153	2		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		peri	0								
FMT.0113Y		FMT.0113	526	liquid	SRR9271521	PRJNA548153	3		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		peri	0								
FMT.0113Z		FMT.0113	527	liquid	SRR9271518	PRJNA548153	4		40	523	PBSC_unmodified	Leukemia	d29572ba327976de7cdc0c		1		peri	0								
FMT.0114A		FMT.0114	0	formed	SRR11421793	PRJNA545312	-23	SRR14092287	31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		pre	-3								
FMT.0114AA		FMT.0114	241	liquid	SRR11421792	PRJNA545312	42		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		post	5								
FMT.0114B		FMT.0114	15	formed	SRR11421791	PRJNA545312	-8	SRR13697127	31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		pre	-2								
FMT.0114BB		FMT.0114	243	formed	SRR11421790	PRJNA545312	44		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		post	6								
FMT.0114C		FMT.0114	16	formed	SRR11421789	PRJNA545312	-7	SRR14143420	31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		pre	-2								
FMT.0114CC		FMT.0114	287	formed	SRR11421787	PRJNA545312	88		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		post	6								
FMT.0114D		FMT.0114	17	formed	SRR11421786	PRJNA545312	-6	SRR14092286	31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		pre	-1								
FMT.0114DD		FMT.0114	308	formed	SRR11421513	PRJNA545312	109		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		post	6								
FMT.0114E		FMT.0114	20	semi-formed	SRR11421512	PRJNA545312	-3	SRR13697126	31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		pre	-1								
FMT.0114EE		FMT.0114	310	liquid	SRR11421511	PRJNA545312	111		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		post	6								
FMT.0114F		FMT.0114	21	liquid	SRR11421510	PRJNA545312	-2		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		pre	-1								
FMT.0114FF		FMT.0114	311	semi-formed	SRR11421509	PRJNA545312	112		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		post	6								
FMT.0114G		FMT.0114	23	liquid	SRR11421508	PRJNA545312	0	SRR13697125	31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		peri	-1								
FMT.0114GG		FMT.0114	376	liquid	SRR11421507	PRJNA545312	177		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		post	6								
FMT.0114H		FMT.0114	24	liquid	SRR11421506	PRJNA545312	1	SRR13697124	31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		peri	0								
FMT.0114HH		FMT.0114	405	semi-formed	SRR11116475	PRJNA607574	206		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		post	6								
FMT.0114I		FMT.0114	26	liquid	SRR11421505	PRJNA545312	3	SRR14092285	31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		peri	0								
FMT.0114J		FMT.0114	27	liquid	SRR11421503	PRJNA545312	4	SRR14092284	31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		peri	0								
FMT.0114K		FMT.0114	29	liquid	SRR11421502	PRJNA545312	6	SRR13697123	31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		post	0								
FMT.0114O		FMT.0114	34	formed	SRR11421785	PRJNA545312	11		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		post	1								
FMT.0114P		FMT.0114	35	semi-formed	SRR11421784	PRJNA545312	12	SRR13697120	31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		post	1								
FMT.0114Q		FMT.0114	99	formed	SRR11421783	PRJNA545312	76		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		post	6								
FMT.0114R		FMT.0114	176	semi-formed	SRR11421501	PRJNA545312	-23		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		pre	-3								
FMT.0114S		FMT.0114	177	semi-formed	SRR11421444	PRJNA545312	-22		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		pre	-3								
FMT.0114T		FMT.0114	178	semi-formed	SRR11421443	PRJNA545312	-21		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		pre	-3								
FMT.0114U		FMT.0114	182	formed	SRR11421442	PRJNA545312	-17		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		pre	-3								
FMT.0114V		FMT.0114	183	semi-formed	SRR11421441	PRJNA545312	-16		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		pre	-3								
FMT.0114W		FMT.0114	184	formed	SRR11421440	PRJNA545312	-15		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		pre	-3								
FMT.0114X		FMT.0114	185	semi-formed	SRR11421439	PRJNA545312	-14		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		pre	-3								
FMT.0114Y		FMT.0114	187	formed	SRR11421438	PRJNA545312	-12		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		pre	-2								
FMT.0114Z		FMT.0114	240	liquid	SRR11421436	PRJNA545312	41		31	199	PBSC_unmodified		21ba20a7bec2237a748cac		1		post	5								
FMT.0115A		FMT.0115	0	formed	SRR11421435	PRJNA545312	-8		10	8	TCD	Leukemia	b8104be482d9306dbaf4e9		1		pre	-2								
FMT.0115B		FMT.0115	1	formed	SRR11421434	PRJNA545312	-7		10	8	TCD	Leukemia	b8104be482d9306dbaf4e9		1		pre	-2								
FMT.0115C		FMT.0115	4	formed	SRR11421433	PRJNA545312	-4		10	8	TCD	Leukemia	b8104be482d9306dbaf4e9		1		pre	-1								
FMT.0115D		FMT.0115	5	formed	SRR11421432	PRJNA545312	-3		10	8	TCD	Leukemia	b8104be482d9306dbaf4e9		1		pre	-1								
FMT.0115E		FMT.0115	7	liquid	SRR11421431	PRJNA545312	-1		10	8	TCD	Leukemia	b8104be482d9306dbaf4e9		1		pre	-1								
FMT.0115F		FMT.0115	12	liquid	SRR11421430	PRJNA545312	4		10	8	TCD	Leukemia	b8104be482d9306dbaf4e9		1		peri	0								
FMT.0115G		FMT.0115	13	liquid	SRR11421429	PRJNA545312	5		10	8	TCD	Leukemia	b8104be482d9306dbaf4e9		1		peri	0								
FMT.0115H		FMT.0115	14	liquid	SRR11421428	PRJNA545312	6		10	8	TCD	Leukemia	b8104be482d9306dbaf4e9		1		post	0								
FMT.0115I		FMT.0115	15	liquid	SRR11422117	PRJNA545312	7		10	8	TCD	Leukemia	b8104be482d9306dbaf4e9		1		post	0								
FMT.0115J		FMT.0115	16	liquid	SRR11422116	PRJNA545312	8		10	8	TCD	Leukemia	b8104be482d9306dbaf4e9		1		post	1								
FMT.0116A		FMT.0116	0	formed	SRR11422115	PRJNA545312	-7		16	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	ee58ad4844a5528cc51f76		1		pre	-2								
FMT.0116B		FMT.0116	8	formed	SRR11422114	PRJNA545312	1		16	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	ee58ad4844a5528cc51f76		1		peri	0								
FMT.0116C		FMT.0116	11	liquid	SRR11422113	PRJNA545312	4		16	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	ee58ad4844a5528cc51f76		1		peri	0								
FMT.0116D		FMT.0116	12	semi-formed	SRR11422111	PRJNA545312	5		16	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	ee58ad4844a5528cc51f76		1		peri	0								
FMT.0116E		FMT.0116	13	semi-formed	SRR11422110	PRJNA545312	6		16	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	ee58ad4844a5528cc51f76		1		post	0								
FMT.0116F		FMT.0116	14	formed	SRR11422109	PRJNA545312	7		16	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	ee58ad4844a5528cc51f76		1		post	0								
FMT.0116G		FMT.0116	18	formed	SRR11422108	PRJNA545312	11		16	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	ee58ad4844a5528cc51f76		1		post	1								
FMT.0116H		FMT.0116	24	formed	SRR11422107	PRJNA545312	17		16	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	ee58ad4844a5528cc51f76		1		post	2								
FMT.0116I		FMT.0116	25	formed	SRR11422106	PRJNA545312	18		16	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	ee58ad4844a5528cc51f76		1		post	2								
FMT.0116J		FMT.0116	26	formed	SRR11422105	PRJNA545312	19		16	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	ee58ad4844a5528cc51f76		1		post	2								
FMT.0116K		FMT.0116	27	formed	SRR11422104	PRJNA545312	20		16	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	ee58ad4844a5528cc51f76		1		post	2								
FMT.0116L		FMT.0116	28	formed	SRR11422103	PRJNA545312	21		16	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	ee58ad4844a5528cc51f76		1		post	2								
FMT.0116M		FMT.0116	29	formed	SRR11422102	PRJNA545312	22		16	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	ee58ad4844a5528cc51f76		1		post	3								
FMT.0116N		FMT.0116	556	formed	SRR11116474	PRJNA607574	549		16	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	ee58ad4844a5528cc51f76		1		post	6								
FMT.0116O		FMT.0116	557	semi-formed	SRR11116473	PRJNA607574	550		16	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	ee58ad4844a5528cc51f76		1		post	6								
FMT.0116P		FMT.0116	558	formed	SRR11116472	PRJNA607574	551		16	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	ee58ad4844a5528cc51f76		1		post	6								
FMT.0117A		FMT.0117	0	formed	SRR11422100	PRJNA545312	-23		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		pre	-3								
FMT.0117B		FMT.0117	17	formed	SRR11422099	PRJNA545312	-6		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		pre	-1								
FMT.0117C		FMT.0117	21	formed	SRR11422098	PRJNA545312	-2		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		pre	-1								
FMT.0117D		FMT.0117	22	formed	SRR11422097	PRJNA545312	-1		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		pre	-1								
FMT.0117E		FMT.0117	23	semi-formed	SRR11422096	PRJNA545312	0		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		peri	-1								
FMT.0117F		FMT.0117	24	liquid	SRR11422095	PRJNA545312	1		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		peri	0								
FMT.0117G		FMT.0117	30	semi-formed	SRR11422094	PRJNA545312	7		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		post	0								
FMT.0117H		FMT.0117	35	semi-formed	SRR11422093	PRJNA545312	12		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		post	1								
FMT.0117I		FMT.0117	36	formed	SRR11422092	PRJNA545312	13		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		post	1								
FMT.0117J		FMT.0117	61	formed	SRR11422091	PRJNA545312	38		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		post	5								
FMT.0117K		FMT.0117	97	formed	SRR11421782	PRJNA545312	74		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		post	6								
FMT.0117L		FMT.0117	139	formed	SRR11421781	PRJNA545312	116		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		post	6								
FMT.0117M		FMT.0117	227	semi-formed	SRR11421780	PRJNA545312	204		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		post	6								
FMT.0117N		FMT.0117	246	formed	SRR11421779	PRJNA545312	223		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		post	6								
FMT.0117O		FMT.0117	247	semi-formed	SRR11421778	PRJNA545312	224		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		post	6								
FMT.0117P		FMT.0117	248	formed	SRR11421777	PRJNA545312	225		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		post	6								
FMT.0117Q		FMT.0117	249	formed	SRR11421776	PRJNA545312	226		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		post	6								
FMT.0117R		FMT.0117	251	formed	SRR11421775	PRJNA545312	228		18	23	TCD	Leukemia	48c4f7863e337d20752856	775	1		post	6								
FMT.0118A		FMT.0118	0	formed	SRR11421774	PRJNA545312	-10		14	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	3e7180b1a35a66c53ba1c1		1		pre	-2								
FMT.0118B		FMT.0118	15	liquid	SRR11421773	PRJNA545312	5		14	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	3e7180b1a35a66c53ba1c1		1		peri	0								
FMT.0118C		FMT.0118	26	semi-formed	SRR11421771	PRJNA545312	16		14	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	3e7180b1a35a66c53ba1c1		1		post	2								
FMT.0118D		FMT.0118	27	liquid	SRR11421770	PRJNA545312	17		14	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	3e7180b1a35a66c53ba1c1		1		post	2								
FMT.0118E		FMT.0118	28	liquid	SRR11421769	PRJNA545312	18		14	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	3e7180b1a35a66c53ba1c1		1		post	2								
FMT.0118F		FMT.0118	30	semi-formed	SRR11421768	PRJNA545312	20		14	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	3e7180b1a35a66c53ba1c1		1		post	2								
FMT.0118H		FMT.0118	42	liquid	SRR10668365	PRJNA545312	32		14	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	3e7180b1a35a66c53ba1c1		1		post	4								
FMT.0118I		FMT.0118	58	semi-formed	SRR11116470	PRJNA607574	48		14	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	3e7180b1a35a66c53ba1c1		1		post	6								
FMT.0118J		FMT.0118	104	liquid	SRR11116469	PRJNA607574	94		14	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	3e7180b1a35a66c53ba1c1		1		post	6								
FMT.0118K		FMT.0118	128	liquid	SRR11116468	PRJNA607574	118		14	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	3e7180b1a35a66c53ba1c1		1		post	6								
FMT.0118L		FMT.0118	129	semi-formed	SRR11116467	PRJNA607574	119		14	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	3e7180b1a35a66c53ba1c1		1		post	6								
FMT.0118M		FMT.0118	131	formed	SRR11116466	PRJNA607574	121		14	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	3e7180b1a35a66c53ba1c1		1		post	6								
FMT.0118N		FMT.0118	132	liquid	SRR11116465	PRJNA607574	122		14	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	3e7180b1a35a66c53ba1c1		1		post	6								
FMT.0118O		FMT.0118	133	semi-formed	SRR11116464	PRJNA607574	123		14	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	3e7180b1a35a66c53ba1c1		1		post	6								
FMT.0119A		FMT.0119	0	formed	SRR11421767	PRJNA545312	-35		13	35	PBSC_unmodified	Myelodysplastic Syndromes	bc108ec29730fda866a949		1		pre	-3								
FMT.0119B		FMT.0119	33	semi-formed	SRR11421766	PRJNA545312	-2		13	35	PBSC_unmodified	Myelodysplastic Syndromes	bc108ec29730fda866a949		1		pre	-1								
FMT.0119C		FMT.0119	35	semi-formed	SRR11421765	PRJNA545312	0		13	35	PBSC_unmodified	Myelodysplastic Syndromes	bc108ec29730fda866a949		1		peri	-1								
FMT.0119D		FMT.0119	38	liquid	SRR11421764	PRJNA545312	3		13	35	PBSC_unmodified	Myelodysplastic Syndromes	bc108ec29730fda866a949		1		peri	0								
FMT.0119E		FMT.0119	40	semi-formed	SRR11421763	PRJNA545312	5		13	35	PBSC_unmodified	Myelodysplastic Syndromes	bc108ec29730fda866a949		1		peri	0								
FMT.0119F		FMT.0119	41	semi-formed	SRR11421762	PRJNA545312	6		13	35	PBSC_unmodified	Myelodysplastic Syndromes	bc108ec29730fda866a949		1		post	0								
FMT.0119G		FMT.0119	45	semi-formed	SRR11421759	PRJNA545312	10		13	35	PBSC_unmodified	Myelodysplastic Syndromes	bc108ec29730fda866a949		1		post	1								
FMT.0119H		FMT.0119	48	liquid	SRR11421758	PRJNA545312	13		13	35	PBSC_unmodified	Myelodysplastic Syndromes	bc108ec29730fda866a949		1		post	1								
FMT.0119I		FMT.0119	51	semi-formed	SRR11421757	PRJNA545312	16		13	35	PBSC_unmodified	Myelodysplastic Syndromes	bc108ec29730fda866a949		1		post	2								
FMT.0119J		FMT.0119	61	formed	SRR11421756	PRJNA545312	26		13	35	PBSC_unmodified	Myelodysplastic Syndromes	bc108ec29730fda866a949		1		post	3								
FMT.0119K		FMT.0119	126	semi-formed	SRR11421755	PRJNA545312	91		13	35	PBSC_unmodified	Myelodysplastic Syndromes	bc108ec29730fda866a949		1		post	6								
FMT.0119L		FMT.0119	131	semi-formed	SRR11422089	PRJNA545312	96		13	35	PBSC_unmodified	Myelodysplastic Syndromes	bc108ec29730fda866a949		1		post	6								
FMT.0119M		FMT.0119	136	semi-formed	SRR11422088	PRJNA545312	101		13	35	PBSC_unmodified	Myelodysplastic Syndromes	bc108ec29730fda866a949		1		post	6								
FMT.0120A	-40	FMT.0120	0	semi-formed	SRR11422087	PRJNA545312	-6	SRR14092283	23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	pre	-1	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	-3	pre
FMT.0120B	-32	FMT.0120	8	formed	SRR11422086	PRJNA545312	2		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	peri	0	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	-3	pre
FMT.0120C	-31	FMT.0120	9	semi-formed	SRR11422085	PRJNA545312	3		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	peri	0	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	-3	pre
FMT.0120D	-28	FMT.0120	12	formed	SRR11422083	PRJNA545312	6		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	0	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	-3	pre
FMT.0120E	-26	FMT.0120	14	semi-formed	SRR11422082	PRJNA545312	8		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	1	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	-3	pre
FMT.0120F	-25	FMT.0120	15	semi-formed	SRR11422081	PRJNA545312	9		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	1	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	-3	pre
FMT.0120G	-22	FMT.0120	18	semi-formed	SRR11422080	PRJNA545312	12		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	1	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	-3	pre
FMT.0120H	-21	FMT.0120	19	semi-formed	SRR11422079	PRJNA545312	13		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	1	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	-3	pre
FMT.0120I	-20	FMT.0120	20	semi-formed	SRR11422078	PRJNA545312	14		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	1	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	-3	pre
FMT.0120J	-14	FMT.0120	26	liquid	SRR11422077	PRJNA545312	20		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	2	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	-3	pre
FMT.0120K	-13	FMT.0120	27	liquid	SRR11422076	PRJNA545312	21		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	2	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	-2	pre
FMT.0120L	-12	FMT.0120	28	formed	SRR11422075	PRJNA545312	22		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	3	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	-2	pre
FMT.0120N	0	FMT.0120	40	liquid	SRR10668364	PRJNA545312	34		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	4	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	-1	peri
FMT.0120O	2	FMT.0120	42	semi-formed	SRR11116463	PRJNA607574	36	SRR14092282	23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	5	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	0	peri
FMT.0120P	49	FMT.0120	89	formed	SRR11116462	PRJNA607574	83		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	6	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	6	post
FMT.0120Q	85	FMT.0120	125	formed	SRR11116461	PRJNA607574	119		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	6	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	6	post
FMT.0120R	113	FMT.0120	153	formed	SRR11116459	PRJNA607574	147		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	6	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	6	post
FMT.0120S	143	FMT.0120	183	formed	SRR11116458	PRJNA607574	177		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	6	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	6	post
FMT.0120T	169	FMT.0120	209	formed	SRR11116457	PRJNA607574	203		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	6	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	6	post
FMT.0120U	225	FMT.0120	265	formed	SRR11116456	PRJNA607574	259		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	6	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	6	post
FMT.0120V	252	FMT.0120	292	semi-formed	SRR11116455	PRJNA607574	286		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	6	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	6	post
FMT.0120W	308	FMT.0120	348	formed	SRR11116454	PRJNA607574	342		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	6	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	6	post
FMT.0120X	353	FMT.0120	393	formed	SRR11116452	PRJNA607574	387		23	6	BM_unmodified	Leukemia	1ee58943a428b5dccad65a	T14	1	treatment	post	6	Treatment	34	34	FMT.0120A	FMT.0120L	FMT.0120N	6	post
FMT.0121B		FMT.0121	0	semi-formed	SRR11396706	PRJNA607574			1																	
FMT.0122A		FMT.0122	0	formed	SRR11422074	PRJNA545312	-12		9	12	PBSC_unmodified	Non-Hodgkin's Lymphoma	2db6c774db2bf0e6ff21f3		1		pre	-2								
FMT.0122B		FMT.0122	7	formed	SRR11422072	PRJNA545312	-5		9	12	PBSC_unmodified	Non-Hodgkin's Lymphoma	2db6c774db2bf0e6ff21f3		1		pre	-1								
FMT.0122C		FMT.0122	12	formed	SRR11422071	PRJNA545312	0		9	12	PBSC_unmodified	Non-Hodgkin's Lymphoma	2db6c774db2bf0e6ff21f3		1		peri	-1								
FMT.0122D		FMT.0122	13	liquid	SRR11422070	PRJNA545312	1		9	12	PBSC_unmodified	Non-Hodgkin's Lymphoma	2db6c774db2bf0e6ff21f3		1		peri	0								
FMT.0122E		FMT.0122	14	liquid	SRR11422069	PRJNA545312	2		9	12	PBSC_unmodified	Non-Hodgkin's Lymphoma	2db6c774db2bf0e6ff21f3		1		peri	0								
FMT.0122F		FMT.0122	15	liquid	SRR11422068	PRJNA545312	3		9	12	PBSC_unmodified	Non-Hodgkin's Lymphoma	2db6c774db2bf0e6ff21f3		1		peri	0								
FMT.0122G		FMT.0122	17	liquid	SRR11422067	PRJNA545312	5		9	12	PBSC_unmodified	Non-Hodgkin's Lymphoma	2db6c774db2bf0e6ff21f3		1		peri	0								
FMT.0122I		FMT.0122	20	semi-formed	SRR11422066	PRJNA545312	8		9	12	PBSC_unmodified	Non-Hodgkin's Lymphoma	2db6c774db2bf0e6ff21f3		1		post	1								
FMT.0122J		FMT.0122	21	semi-formed	SRR11422065	PRJNA545312	9		9	12	PBSC_unmodified	Non-Hodgkin's Lymphoma	2db6c774db2bf0e6ff21f3		1		post	1								
FMT.0124A		FMT.0124	0	formed	SRR11422064	PRJNA545312	-6		15	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4c510407ad322b6320ed68		1		pre	-1								
FMT.0124B		FMT.0124	4	formed	SRR11422063	PRJNA545312	-2		15	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4c510407ad322b6320ed68		1		pre	-1								
FMT.0124C		FMT.0124	5	formed	SRR11421939	PRJNA545312	-1		15	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4c510407ad322b6320ed68		1		pre	-1								
FMT.0124D		FMT.0124	6	formed	SRR11421938	PRJNA545312	0		15	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4c510407ad322b6320ed68		1		peri	-1								
FMT.0124E		FMT.0124	7	formed	SRR11421937	PRJNA545312	1		15	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4c510407ad322b6320ed68		1		peri	0								
FMT.0124F		FMT.0124	10	semi-formed	SRR11421936	PRJNA545312	4		15	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4c510407ad322b6320ed68		1		peri	0								
FMT.0124G		FMT.0124	11	formed	SRR11421935	PRJNA545312	5		15	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4c510407ad322b6320ed68		1		peri	0								
FMT.0124H		FMT.0124	15	formed	SRR11421934	PRJNA545312	9		15	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4c510407ad322b6320ed68		1		post	1								
FMT.0124I		FMT.0124	17	formed	SRR11421933	PRJNA545312	11		15	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4c510407ad322b6320ed68		1		post	1								
FMT.0124J		FMT.0124	18	formed	SRR11421932	PRJNA545312	12		15	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4c510407ad322b6320ed68		1		post	1								
FMT.0124K		FMT.0124	19	formed	SRR11421931	PRJNA545312	13		15	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4c510407ad322b6320ed68		1		post	1								
FMT.0124L		FMT.0124	21	formed	SRR11421930	PRJNA545312	15		15	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4c510407ad322b6320ed68		1		post	2								
FMT.0124M		FMT.0124	66	semi-formed	SRR11421928	PRJNA545312	60		15	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4c510407ad322b6320ed68		1		post	6								
FMT.0124N		FMT.0124	88	formed	SRR11421927	PRJNA545312	82		15	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4c510407ad322b6320ed68		1		post	6								
FMT.0124O		FMT.0124	298		SRR11116424	PRJNA607574	292		15	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	4c510407ad322b6320ed68		1		post	6								
FMT.0125A		FMT.0125	0	liquid	SRR11421926	PRJNA545312	-198		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		pre	-3								
FMT.0125AA		FMT.0125	237	semi-formed	SRR11421925	PRJNA545312	39		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	5								
FMT.0125B		FMT.0125	141	liquid	SRR11421924	PRJNA545312	-57		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		pre	-3								
FMT.0125BB		FMT.0125	238	formed	SRR11421923	PRJNA545312	40		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	5								
FMT.0125C		FMT.0125	148	liquid	SRR11421922	PRJNA545312	-50		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		pre	-3								
FMT.0125CC		FMT.0125	239	semi-formed	SRR11421921	PRJNA545312	41		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	5								
FMT.0125D		FMT.0125	152	semi-formed	SRR11421920	PRJNA545312	-46		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		pre	-3								
FMT.0125DD		FMT.0125	240	semi-formed	SRR11421919	PRJNA545312	42		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	5								
FMT.0125E		FMT.0125	154	semi-formed	SRR11421917	PRJNA545312	-44		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		pre	-3								
FMT.0125EE		FMT.0125	262		SRR11421916	PRJNA545312	64		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	6								
FMT.0125F		FMT.0125	194	formed	SRR11421915	PRJNA545312	-4		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		pre	-1								
FMT.0125FF		FMT.0125	275	formed	SRR11421914	PRJNA545312	77		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	6								
FMT.0125G		FMT.0125	196	formed	SRR11421913	PRJNA545312	-2		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		pre	-1								
FMT.0125GG		FMT.0125	296	semi-formed	SRR11421912	PRJNA545312	98		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	6								
FMT.0125H		FMT.0125	197	formed	SRR11422061	PRJNA545312	-1		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		pre	-1								
FMT.0125HH		FMT.0125	327		SRR11116423	PRJNA607574	129		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	6								
FMT.0125I		FMT.0125	202	formed	SRR11422060	PRJNA545312	4		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		peri	0								
FMT.0125II		FMT.0125	367	formed	SRR11422059	PRJNA545312	169		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	6								
FMT.0125JJ		FMT.0125	463	semi-formed	SRR11116422	PRJNA607574	265		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	6								
FMT.0125K		FMT.0125	204	liquid	SRR11422058	PRJNA545312	6		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	0								
FMT.0125L		FMT.0125	205	semi-formed	SRR11422056	PRJNA545312	7		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	0								
FMT.0125M		FMT.0125	208	liquid	SRR11422055	PRJNA545312	10		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	1								
FMT.0125N		FMT.0125	210	semi-formed	SRR11422054	PRJNA545312	12		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	1								
FMT.0125O		FMT.0125	211	liquid	SRR11422053	PRJNA545312	13		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	1								
FMT.0125P		FMT.0125	212	semi-formed	SRR11422052	PRJNA545312	14		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	1								
FMT.0125Q		FMT.0125	215	semi-formed	SRR11422051	PRJNA545312	17		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	2								
FMT.0125R		FMT.0125	217	liquid	SRR11422050	PRJNA545312	19		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	2								
FMT.0125S		FMT.0125	222	semi-formed	SRR11422049	PRJNA545312	24		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	3								
FMT.0125T		FMT.0125	225	liquid	SRR11422048	PRJNA545312	27		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	3								
FMT.0125U		FMT.0125	226	liquid	SRR11422047	PRJNA545312	28		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	3								
FMT.0125V		FMT.0125	227	liquid	SRR11422045	PRJNA545312	29		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	4								
FMT.0125W		FMT.0125	231	semi-formed	SRR11422044	PRJNA545312	33		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	4								
FMT.0125X		FMT.0125	232	semi-formed	SRR11422043	PRJNA545312	34		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	4								
FMT.0125Y		FMT.0125	233	semi-formed	SRR11422042	PRJNA545312	35		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	4								
FMT.0125Z		FMT.0125	234	formed	SRR11422041	PRJNA545312	36		35	198	BM_unmodified	Leukemia	f642a1078a7ab9ffe16158		1		post	5								
FMT.0126A		FMT.0126	0	formed	SRR11422040	PRJNA545312	-17		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		pre	-3								
FMT.0126AA		FMT.0126	149	formed	SRR11116420	PRJNA607574	132		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	6								
FMT.0126B		FMT.0126	8	formed	SRR11422039	PRJNA545312	-9		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		pre	-2								
FMT.0126BB		FMT.0126	169	formed	SRR11116419	PRJNA607574	152		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	6								
FMT.0126CC		FMT.0126	189	semi-formed	SRR11116418	PRJNA607574	172		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	6								
FMT.0126DD		FMT.0126	196	semi-formed	SRR11116417	PRJNA607574	179		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	6								
FMT.0126E		FMT.0126	12	formed	SRR11422038	PRJNA545312	-5		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		pre	-1								
FMT.0126F		FMT.0126	15	formed	SRR11422037	PRJNA545312	-2		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		pre	-1								
FMT.0126FF		FMT.0126	199	semi-formed	SRR11116416	PRJNA607574	182		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	6								
FMT.0126G		FMT.0126	16	liquid	SRR11422036	PRJNA545312	-1		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		pre	-1								
FMT.0126GG		FMT.0126	202	semi-formed	SRR11116415	PRJNA607574	185		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	6								
FMT.0126H		FMT.0126	17	semi-formed	SRR11422034	PRJNA545312	0		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		peri	-1								
FMT.0126HH		FMT.0126	203	semi-formed	SRR11116414	PRJNA607574	186		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	6								
FMT.0126I		FMT.0126	19	liquid	SRR11422428	PRJNA545312	2		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		peri	0								
FMT.0126II		FMT.0126	222	liquid	SRR11116413	PRJNA607574	205		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	6								
FMT.0126J		FMT.0126	20	liquid	SRR11422427	PRJNA545312	3		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		peri	0								
FMT.0126K		FMT.0126	21	liquid	SRR11422426	PRJNA545312	4		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		peri	0								
FMT.0126KK		FMT.0126	259	semi-formed	SRR11116412	PRJNA607574	242		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	6								
FMT.0126L		FMT.0126	22	liquid	SRR11422425	PRJNA545312	5		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		peri	0								
FMT.0126LL		FMT.0126	268	semi-formed	SRR11116411	PRJNA607574	251		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	6								
FMT.0126MM		FMT.0126	624	formed	SRR11116409	PRJNA607574	0		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		peri	-1								
FMT.0126N		FMT.0126	27	semi-formed	SRR11422424	PRJNA545312	10		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	1								
FMT.0126NN		FMT.0126	629	liquid	SRR11116408	PRJNA607574	5		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		peri	0								
FMT.0126O		FMT.0126	28	semi-formed	SRR11422423	PRJNA545312	11		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	1								
FMT.0126OO		FMT.0126	630	semi-formed	SRR11116407	PRJNA607574	6		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	0								
FMT.0126P		FMT.0126	29	liquid	SRR11422422	PRJNA545312	12		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	1								
FMT.0126PP		FMT.0126	631	liquid	SRR11116406	PRJNA607574	7		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	0								
FMT.0126Q		FMT.0126	30	semi-formed	SRR11422421	PRJNA545312	13		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	1								
FMT.0126QQ		FMT.0126	635	formed	SRR11116405	PRJNA607574	11		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	1								
FMT.0126R		FMT.0126	31	semi-formed	SRR11422420	PRJNA545312	14		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	1								
FMT.0126SS		FMT.0126	636	liquid	SRR11396705	PRJNA607574	12		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	1								
FMT.0126T		FMT.0126	35	semi-formed	SRR11422418	PRJNA545312	18		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	2								
FMT.0126TT		FMT.0126	638	semi-formed	SRR11116403	PRJNA607574	14		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	1								
FMT.0126U		FMT.0126	37	formed	SRR11422417	PRJNA545312	20		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	2								
FMT.0126UU		FMT.0126	639	semi-formed	SRR11116402	PRJNA607574	15		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	2								
FMT.0126V		FMT.0126	38	formed	SRR11422416	PRJNA545312	21		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	2								
FMT.0126VV		FMT.0126	640	semi-formed	SRR11116401	PRJNA607574	16		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	2								
FMT.0126X		FMT.0126	42	liquid	SRR10668363	PRJNA545312	25		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	3								
FMT.0126Y		FMT.0126	51	formed	SRR11116400	PRJNA607574	34		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	4								
FMT.0126Z		FMT.0126	121		SRR11116398	PRJNA607574	104		40	624	PBSC_unmodified	Multiple Myeloma	df557d369287506531c4ff		1		post	6								
FMT.0127A		FMT.0127	0	formed	SRR11422415	PRJNA545312	-11		10	11	TCD	Myelodysplastic Syndromes	8bd10e1815b554b7e59541		1		pre	-2								
FMT.0127B		FMT.0127	4	semi-formed	SRR11422414	PRJNA545312	-7		10	11	TCD	Myelodysplastic Syndromes	8bd10e1815b554b7e59541		1		pre	-2								
FMT.0127C		FMT.0127	10	semi-formed	SRR11422413	PRJNA545312	-1		10	11	TCD	Myelodysplastic Syndromes	8bd10e1815b554b7e59541		1		pre	-1								
FMT.0127D		FMT.0127	13	liquid	SRR11422412	PRJNA545312	2		10	11	TCD	Myelodysplastic Syndromes	8bd10e1815b554b7e59541		1		peri	0								
FMT.0127E		FMT.0127	17	semi-formed	SRR11422411	PRJNA545312	6		10	11	TCD	Myelodysplastic Syndromes	8bd10e1815b554b7e59541		1		post	0								
FMT.0127F		FMT.0127	18	semi-formed	SRR11422410	PRJNA545312	7		10	11	TCD	Myelodysplastic Syndromes	8bd10e1815b554b7e59541		1		post	0								
FMT.0127G		FMT.0127	20	semi-formed	SRR11422409	PRJNA545312	9		10	11	TCD	Myelodysplastic Syndromes	8bd10e1815b554b7e59541		1		post	1								
FMT.0127H		FMT.0127	21	semi-formed	SRR11422406	PRJNA545312	10		10	11	TCD	Myelodysplastic Syndromes	8bd10e1815b554b7e59541		1		post	1								
FMT.0127I		FMT.0127	22	semi-formed	SRR11422405	PRJNA545312	11		10	11	TCD	Myelodysplastic Syndromes	8bd10e1815b554b7e59541		1		post	1								
FMT.0127J		FMT.0127	24	semi-formed	SRR11422404	PRJNA545312	13		10	11	TCD	Myelodysplastic Syndromes	8bd10e1815b554b7e59541		1		post	1								
FMT.0128A		FMT.0128	0	formed	SRR11422403	PRJNA545312	-8		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		pre	-2								
FMT.0128B		FMT.0128	2	formed	SRR11422402	PRJNA545312	-6		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		pre	-1								
FMT.0128C		FMT.0128	6	formed	SRR11422401	PRJNA545312	-2		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		pre	-1								
FMT.0128D		FMT.0128	8	formed	SRR11422173	PRJNA545312	0		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		peri	-1								
FMT.0128E		FMT.0128	10	semi-formed	SRR11422172	PRJNA545312	2		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		peri	0								
FMT.0128F		FMT.0128	14	semi-formed	SRR11422171	PRJNA545312	6		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	0								
FMT.0128G		FMT.0128	16	liquid	SRR11422170	PRJNA545312	8		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	1								
FMT.0128H		FMT.0128	19	semi-formed	SRR11422168	PRJNA545312	11		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	1								
FMT.0128I		FMT.0128	21	liquid	SRR11422167	PRJNA545312	13		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	1								
FMT.0128J		FMT.0128	22	semi-formed	SRR11422166	PRJNA545312	14		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	1								
FMT.0128K		FMT.0128	23	semi-formed	SRR11422165	PRJNA545312	15		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	2								
FMT.0128L		FMT.0128	24	semi-formed	SRR11422164	PRJNA545312	16		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	2								
FMT.0128M		FMT.0128	27	formed	SRR11422163	PRJNA545312	19		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	2								
FMT.0128N		FMT.0128	28	semi-formed	SRR11422162	PRJNA545312	20		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	2								
FMT.0128O		FMT.0128	29	semi-formed	SRR11422161	PRJNA545312	21		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	2								
FMT.0128P		FMT.0128	34	semi-formed	SRR11422160	PRJNA545312	26		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	3								
FMT.0128Q		FMT.0128	37	formed	SRR11422159	PRJNA545312	29		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	4								
FMT.0128R		FMT.0128	38	formed	SRR11422157	PRJNA545312	30		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	4								
FMT.0128S		FMT.0128	40	formed	SRR11422156	PRJNA545312	32		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	4								
FMT.0128T		FMT.0128	42	formed	SRR11422155	PRJNA545312	34		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	4								
FMT.0128U		FMT.0128	43	formed	SRR11422154	PRJNA545312	35		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	4								
FMT.0128V		FMT.0128	44	formed	SRR11422153	PRJNA545312	36		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	5								
FMT.0128W		FMT.0128	45	formed	SRR11421427	PRJNA545312	37		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	5								
FMT.0128X		FMT.0128	20	semi-formed	SRR11421425	PRJNA545312	12		24	8	cord	Myelodysplastic Syndromes	2eb7aa207f3a4cce6be6a9		1		post	1								
FMT.0130A		FMT.0130	0	semi-formed	SRR11421424	PRJNA545312	-10		9	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	e28aa9c173e6b38fdc5c01		1		pre	-2								
FMT.0130B		FMT.0130	4	formed	SRR11421423	PRJNA545312	-6		9	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	e28aa9c173e6b38fdc5c01		1		pre	-1								
FMT.0130C		FMT.0130	7	formed	SRR11421422	PRJNA545312	-3		9	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	e28aa9c173e6b38fdc5c01		1		pre	-1								
FMT.0130D		FMT.0130	10	semi-formed	SRR11421421	PRJNA545312	0		9	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	e28aa9c173e6b38fdc5c01		1		peri	-1								
FMT.0130E		FMT.0130	11	liquid	SRR11421420	PRJNA545312	1		9	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	e28aa9c173e6b38fdc5c01		1		peri	0								
FMT.0130F		FMT.0130	15	semi-formed	SRR11421419	PRJNA545312	5		9	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	e28aa9c173e6b38fdc5c01		1		peri	0								
FMT.0130G		FMT.0130	22	liquid	SRR11421418	PRJNA545312	12		9	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	e28aa9c173e6b38fdc5c01		1		post	1								
FMT.0130H		FMT.0130	25	semi-formed	SRR11421417	PRJNA545312	15		9	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	e28aa9c173e6b38fdc5c01		1		post	2								
FMT.0130I		FMT.0130	57	semi-formed	SRR11421063	PRJNA545312	47		9	10	PBSC_unmodified	Non-Hodgkin's Lymphoma	e28aa9c173e6b38fdc5c01		1		post	6								
FMT.0131A		FMT.0131	0	formed	SRR11421061	PRJNA545312	-6		17	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	92be05e424153be4d951dc		1		pre	-1								
FMT.0131B		FMT.0131	3	formed	SRR11421060	PRJNA545312	-3		17	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	92be05e424153be4d951dc		1		pre	-1								
FMT.0131C		FMT.0131	4	formed	SRR11421059	PRJNA545312	-2		17	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	92be05e424153be4d951dc		1		pre	-1								
FMT.0131D		FMT.0131	7	formed	SRR11421058	PRJNA545312	1		17	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	92be05e424153be4d951dc		1		peri	0								
FMT.0131E		FMT.0131	8	semi-formed	SRR11421057	PRJNA545312	2		17	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	92be05e424153be4d951dc		1		peri	0								
FMT.0131F		FMT.0131	10	liquid	SRR11421056	PRJNA545312	4		17	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	92be05e424153be4d951dc		1		peri	0								
FMT.0131G		FMT.0131	11	formed	SRR11421055	PRJNA545312	5		17	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	92be05e424153be4d951dc		1		peri	0								
FMT.0131H		FMT.0131	12	formed	SRR11421054	PRJNA545312	6		17	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	92be05e424153be4d951dc		1		post	0								
FMT.0131I		FMT.0131	13	semi-formed	SRR11421053	PRJNA545312	7		17	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	92be05e424153be4d951dc		1		post	0								
FMT.0131J		FMT.0131	14	semi-formed	SRR11421052	PRJNA545312	8		17	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	92be05e424153be4d951dc		1		post	1								
FMT.0131K		FMT.0131	18	semi-formed	SRR11421050	PRJNA545312	12		17	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	92be05e424153be4d951dc		1		post	1								
FMT.0131L		FMT.0131	20	formed	SRR11421049	PRJNA545312	14		17	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	92be05e424153be4d951dc		1		post	1								
FMT.0131M		FMT.0131	21	formed	SRR11421048	PRJNA545312	15		17	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	92be05e424153be4d951dc		1		post	2								
FMT.0131N		FMT.0131	32	liquid	SRR11421047	PRJNA545312	26		17	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	92be05e424153be4d951dc		1		post	3								
FMT.0131O		FMT.0131	33	liquid	SRR11421046	PRJNA545312	27		17	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	92be05e424153be4d951dc		1		post	3								
FMT.0131P		FMT.0131	43	liquid	SRR11421045	PRJNA545312	37		17	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	92be05e424153be4d951dc		1		post	5								
FMT.0131Q		FMT.0131	127	formed	SRR11421044	PRJNA545312	121		17	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	92be05e424153be4d951dc		1		post	6								
FMT.0132A		FMT.0132	0	formed	SRR11421043	PRJNA545312	-70		4	70	TCD	Myelodysplastic Syndromes	915f9fabf22a3113936757		1		pre	-3								
FMT.0132B		FMT.0132	73	formed	SRR11422152	PRJNA545312	3		4	70	TCD	Myelodysplastic Syndromes	915f9fabf22a3113936757		1		peri	0								
FMT.0132C		FMT.0132	82	semi-formed	SRR11422151	PRJNA545312	12		4	70	TCD	Myelodysplastic Syndromes	915f9fabf22a3113936757		1		post	1								
FMT.0132D		FMT.0132	83	liquid	SRR11422150	PRJNA545312	13		4	70	TCD	Myelodysplastic Syndromes	915f9fabf22a3113936757		1		post	1								
FMT.0133A		FMT.0133	0	semi-formed	SRR11422149	PRJNA545312	-8		3	8	PBSC_unmodified	Leukemia	051bac3977c0dc96398749		1		pre	-2								
FMT.0133B		FMT.0133	10	formed	SRR11422148	PRJNA545312	2		3	8	PBSC_unmodified	Leukemia	051bac3977c0dc96398749		1		peri	0								
FMT.0133C		FMT.0133	25	semi-formed	SRR11422146	PRJNA545312	17		3	8	PBSC_unmodified	Leukemia	051bac3977c0dc96398749		1		post	2								
FMT.0134A		FMT.0134	0	formed	SRR11422400	PRJNA545312	-17		7	17	TCD	Multiple Myeloma	6a56511c66100e3206f1aa		1		pre	-3								
FMT.0134B		FMT.0134	8	formed	SRR11422399	PRJNA545312	-9		7	17	TCD	Multiple Myeloma	6a56511c66100e3206f1aa		1		pre	-2								
FMT.0134C		FMT.0134	15	formed	SRR11422398	PRJNA545312	-2		7	17	TCD	Multiple Myeloma	6a56511c66100e3206f1aa		1		pre	-1								
FMT.0134D		FMT.0134	16	liquid	SRR11422397	PRJNA545312	-1		7	17	TCD	Multiple Myeloma	6a56511c66100e3206f1aa		1		pre	-1								
FMT.0134E		FMT.0134	17	semi-formed	SRR11422396	PRJNA545312	0		7	17	TCD	Multiple Myeloma	6a56511c66100e3206f1aa		1		peri	-1								
FMT.0134F		FMT.0134	18	semi-formed	SRR11422395	PRJNA545312	1		7	17	TCD	Multiple Myeloma	6a56511c66100e3206f1aa		1		peri	0								
FMT.0134G		FMT.0134	28	formed	SRR11422394	PRJNA545312	11		7	17	TCD	Multiple Myeloma	6a56511c66100e3206f1aa		1		post	1								
FMT.0135A		FMT.0135	0	liquid	SRR11422393	PRJNA545312	5		9	-5	TCD	Multiple Myeloma	9f22c59338349574d5111f		0		peri	0								
FMT.0135B		FMT.0135	5	liquid	SRR11422392	PRJNA545312	10		9	-5	TCD	Multiple Myeloma	9f22c59338349574d5111f		0		post	1								
FMT.0135C		FMT.0135	7	liquid	SRR11422390	PRJNA545312	12		9	-5	TCD	Multiple Myeloma	9f22c59338349574d5111f		0		post	1								
FMT.0135D		FMT.0135	10	liquid	SRR11422389	PRJNA545312	15		9	-5	TCD	Multiple Myeloma	9f22c59338349574d5111f		0		post	2								
FMT.0135E		FMT.0135	16	liquid	SRR11422388	PRJNA545312	21		9	-5	TCD	Multiple Myeloma	9f22c59338349574d5111f		0		post	2								
FMT.0135F		FMT.0135	34	semi-formed	SRR11422387	PRJNA545312	39		9	-5	TCD	Multiple Myeloma	9f22c59338349574d5111f		0		post	5								
FMT.0135G		FMT.0135	35	semi-formed	SRR11422386	PRJNA545312	40		9	-5	TCD	Multiple Myeloma	9f22c59338349574d5111f		0		post	5								
FMT.0135H		FMT.0135	91	semi-formed	SRR11422385	PRJNA545312	96		9	-5	TCD	Multiple Myeloma	9f22c59338349574d5111f		0		post	6								
FMT.0135I		FMT.0135	197	formed	SRR11422384	PRJNA545312	202		9	-5	TCD	Multiple Myeloma	9f22c59338349574d5111f		0		post	6								
FMT.0136A		FMT.0136	0	formed	SRR11422383	PRJNA545312	-31		15	31	TCD	Myelodysplastic Syndromes	1fe50befa6a3ef8af80f8b		1		pre	-3								
FMT.0136B		FMT.0136	28	liquid	SRR11422382	PRJNA545312	-3	SRR14092281	15	31	TCD	Myelodysplastic Syndromes	1fe50befa6a3ef8af80f8b		1		pre	-1								
FMT.0136C		FMT.0136	31	formed	SRR11422381	PRJNA545312	0		15	31	TCD	Myelodysplastic Syndromes	1fe50befa6a3ef8af80f8b		1		peri	-1								
FMT.0136D		FMT.0136	33	liquid	SRR11422379	PRJNA545312	2		15	31	TCD	Myelodysplastic Syndromes	1fe50befa6a3ef8af80f8b		1		peri	0								
FMT.0136E		FMT.0136	36	liquid	SRR11422378	PRJNA545312	5		15	31	TCD	Myelodysplastic Syndromes	1fe50befa6a3ef8af80f8b		1		peri	0								
FMT.0136F		FMT.0136	40	liquid	SRR11422377	PRJNA545312	9		15	31	TCD	Myelodysplastic Syndromes	1fe50befa6a3ef8af80f8b		1		post	1								
FMT.0136G		FMT.0136	42	liquid	SRR11422376	PRJNA545312	11	SRR14092280	15	31	TCD	Myelodysplastic Syndromes	1fe50befa6a3ef8af80f8b		1		post	1								
FMT.0136I		FMT.0136	43	liquid	SRR11422374	PRJNA545312	12		15	31	TCD	Myelodysplastic Syndromes	1fe50befa6a3ef8af80f8b		1		post	1								
FMT.0136J		FMT.0136	44	semi-formed	SRR11422373	PRJNA545312	13		15	31	TCD	Myelodysplastic Syndromes	1fe50befa6a3ef8af80f8b		1		post	1								
FMT.0136K		FMT.0136	45	liquid	SRR11421670	PRJNA545312	14		15	31	TCD	Myelodysplastic Syndromes	1fe50befa6a3ef8af80f8b		1		post	1								
FMT.0136L		FMT.0136	47	liquid	SRR11421669	PRJNA545312	16		15	31	TCD	Myelodysplastic Syndromes	1fe50befa6a3ef8af80f8b		1		post	2								
FMT.0136M		FMT.0136	48	liquid	SRR11421668	PRJNA545312	17		15	31	TCD	Myelodysplastic Syndromes	1fe50befa6a3ef8af80f8b		1		post	2								
FMT.0136N		FMT.0136	51	liquid	SRR11421666	PRJNA545312	20		15	31	TCD	Myelodysplastic Syndromes	1fe50befa6a3ef8af80f8b		1		post	2								
FMT.0136O		FMT.0136	52	formed	SRR11422367	PRJNA545312	21		15	31	TCD	Myelodysplastic Syndromes	1fe50befa6a3ef8af80f8b		1		post	2								
FMT.0136P		FMT.0136	56	semi-formed	SRR11422366	PRJNA545312	25		15	31	TCD	Myelodysplastic Syndromes	1fe50befa6a3ef8af80f8b		1		post	3								
FMT.0137A		FMT.0137	156	formed	SRR11422365	PRJNA545312	-14		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		pre	-3								
FMT.0137B		FMT.0137	174	semi-formed	SRR11422364	PRJNA545312	4		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		peri	0								
FMT.0137C		FMT.0137	181	formed	SRR11422363	PRJNA545312	11		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		post	1								
FMT.0137D		FMT.0137	183	liquid	SRR11422362	PRJNA545312	13		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		post	1								
FMT.0137E		FMT.0137	185	semi-formed	SRR11422361	PRJNA545312	15		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		post	2								
FMT.0137F		FMT.0137	188	liquid	SRR11422360	PRJNA545312	18		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		post	2								
FMT.0137G		FMT.0137	189	semi-formed	SRR11422359	PRJNA545312	19		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		post	2								
FMT.0137H		FMT.0137	190	liquid	SRR11422357	PRJNA545312	20		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		post	2								
FMT.0137I		FMT.0137	195	semi-formed	SRR11422356	PRJNA545312	25		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		post	3								
FMT.0137J		FMT.0137	196	semi-formed	SRR11422355	PRJNA545312	26		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		post	3								
FMT.0137K		FMT.0137	198	semi-formed	SRR11422354	PRJNA545312	28		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		post	3								
FMT.0137L		FMT.0137	199	liquid	SRR11422353	PRJNA545312	29		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		post	4								
FMT.0137M		FMT.0137	249	formed	SRR11422352	PRJNA545312	79		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		post	6								
FMT.0137N		FMT.0137	346	semi-formed	SRR11422351	PRJNA545312	176		19	170	PBSC_unmodified	Leukemia	4eb14350975528e03709a6	766	1		post	6								
FMT.0138A		FMT.0138	0	semi-formed	SRR11422350	PRJNA545312	-17		10	17	TCD	Myeloproliferative Disorder	44796687aad06b40a7bf75		1		pre	-3								
FMT.0138B		FMT.0138	8	semi-formed	SRR11422349	PRJNA545312	-9		10	17	TCD	Myeloproliferative Disorder	44796687aad06b40a7bf75		1		pre	-2								
FMT.0138C		FMT.0138	10	formed	SRR11422348	PRJNA545312	-7		10	17	TCD	Myeloproliferative Disorder	44796687aad06b40a7bf75		1		pre	-2								
FMT.0138D		FMT.0138	13	semi-formed	SRR11422346	PRJNA545312	-4		10	17	TCD	Myeloproliferative Disorder	44796687aad06b40a7bf75		1		pre	-1								
FMT.0138E		FMT.0138	14	formed	SRR11422345	PRJNA545312	-3		10	17	TCD	Myeloproliferative Disorder	44796687aad06b40a7bf75		1		pre	-1								
FMT.0138F		FMT.0138	17	semi-formed	SRR11422624	PRJNA545312	0		10	17	TCD	Myeloproliferative Disorder	44796687aad06b40a7bf75		1		peri	-1								
FMT.0138G		FMT.0138	21	liquid	SRR11422623	PRJNA545312	4		10	17	TCD	Myeloproliferative Disorder	44796687aad06b40a7bf75		1		peri	0								
FMT.0138H		FMT.0138	28	semi-formed	SRR11422622	PRJNA545312	11		10	17	TCD	Myeloproliferative Disorder	44796687aad06b40a7bf75		1		post	1								
FMT.0138I		FMT.0138	95	formed	SRR11422621	PRJNA545312	78		10	17	TCD	Myeloproliferative Disorder	44796687aad06b40a7bf75		1		post	6								
FMT.0138J		FMT.0138	273	semi-formed	SRR11116396	PRJNA607574	256		10	17	TCD	Myeloproliferative Disorder	44796687aad06b40a7bf75		1		post	6								
FMT.0139A		FMT.0139	0	formed	SRR11422620	PRJNA545312	-10		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		pre	-2								
FMT.0139AA		FMT.0139	189	liquid	SRR11422619	PRJNA545312	179		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139B		FMT.0139	2	formed	SRR11422618	PRJNA545312	-8		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		pre	-2								
FMT.0139BB		FMT.0139	190	semi-formed	SRR11422617	PRJNA545312	180		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139C		FMT.0139	6	semi-formed	SRR11422615	PRJNA545312	-4		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		pre	-1								
FMT.0139CC		FMT.0139	194	liquid	SRR11422614	PRJNA545312	184		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139D		FMT.0139	7	liquid	SRR11422613	PRJNA545312	-3		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		pre	-1								
FMT.0139DD		FMT.0139	195	semi-formed	SRR11422612	PRJNA545312	185		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139E		FMT.0139	17	semi-formed	SRR11422611	PRJNA545312	7		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	0								
FMT.0139EE		FMT.0139	196	semi-formed	SRR11422610	PRJNA545312	186		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139F		FMT.0139	19	liquid	SRR11422609	PRJNA545312	9		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	1								
FMT.0139FF		FMT.0139	198	semi-formed	SRR11422608	PRJNA545312	188		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139G		FMT.0139	21	liquid	SRR11422607	PRJNA545312	11		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	1								
FMT.0139GG		FMT.0139	289	semi-formed	SRR11422606	PRJNA545312	279		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139H		FMT.0139	26	liquid	SRR11422603	PRJNA545312	16		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	2								
FMT.0139HH		FMT.0139	352	semi-formed	SRR11116359	PRJNA607574	342		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139I		FMT.0139	27	liquid	SRR11422602	PRJNA545312	17		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	2								
FMT.0139J		FMT.0139	28	liquid	SRR11422601	PRJNA545312	18		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	2								
FMT.0139JJ		FMT.0139	408	semi-formed	SRR11116358	PRJNA607574	398		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139K		FMT.0139	89		SRR11422600	PRJNA545312	79		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139KK		FMT.0139	439	semi-formed	SRR11422599	PRJNA545312	429		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139L		FMT.0139	140	semi-formed	SRR11422598	PRJNA545312	130		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139M		FMT.0139	167	semi-formed	SRR11421754	PRJNA545312	157		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139MM		FMT.0139	440	semi-formed	SRR11421753	PRJNA545312	430		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139N		FMT.0139	168	liquid	SRR11421752	PRJNA545312	158		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139NN		FMT.0139	441	formed	SRR11421750	PRJNA545312	431		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139O		FMT.0139	169	semi-formed	SRR11421749	PRJNA545312	159		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139OO		FMT.0139	447	formed	SRR11421748	PRJNA545312	437		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139P		FMT.0139	170	liquid	SRR11421747	PRJNA545312	160		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139Q		FMT.0139	171	liquid	SRR11421746	PRJNA545312	161		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139R		FMT.0139	173	liquid	SRR11421745	PRJNA545312	163		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139S		FMT.0139	174	liquid	SRR11421744	PRJNA545312	164		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139T		FMT.0139	175	semi-formed	SRR11421743	PRJNA545312	165		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139U		FMT.0139	176	semi-formed	SRR11421742	PRJNA545312	166		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139V		FMT.0139	177	semi-formed	SRR11421741	PRJNA545312	167		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139W		FMT.0139	180	semi-formed	SRR11421739	PRJNA545312	170		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139X		FMT.0139	183	semi-formed	SRR11421738	PRJNA545312	173		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139Y		FMT.0139	185	semi-formed	SRR11421737	PRJNA545312	175		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0139Z		FMT.0139	188	liquid	SRR11421736	PRJNA545312	178		39	10	TCD	Leukemia	696cea5815cbed245e7eeb		1		post	6								
FMT.0140A		FMT.0140	0	formed	SRR11421735	PRJNA545312	-294		3	294	TCD	Leukemia	95166d14a833d4341d74ae		1		pre	-3								
FMT.0140B		FMT.0140	282	formed	SRR11421734	PRJNA545312	-12		3	294	TCD	Leukemia	95166d14a833d4341d74ae		1		pre	-2								
FMT.0140C		FMT.0140	299	semi-formed	SRR11421733	PRJNA545312	5		3	294	TCD	Leukemia	95166d14a833d4341d74ae		1		peri	0								
FMT.0141A		FMT.0141	0	formed	SRR11421732	PRJNA545312	-5		15	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	7a5349b76df2ce4e8bcfe2		1		pre	-1								
FMT.0141B		FMT.0141	1	semi-formed	SRR11421731	PRJNA545312	-4		15	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	7a5349b76df2ce4e8bcfe2		1		pre	-1								
FMT.0141C		FMT.0141	4	semi-formed	SRR11421730	PRJNA545312	-1		15	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	7a5349b76df2ce4e8bcfe2		1		pre	-1								
FMT.0141D		FMT.0141	5	semi-formed	SRR11421728	PRJNA545312	0		15	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	7a5349b76df2ce4e8bcfe2		1		peri	-1								
FMT.0141E		FMT.0141	7	liquid	SRR11421727	PRJNA545312	2		15	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	7a5349b76df2ce4e8bcfe2		1		peri	0								
FMT.0141F		FMT.0141	8	semi-formed	SRR11422033	PRJNA545312	3		15	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	7a5349b76df2ce4e8bcfe2		1		peri	0								
FMT.0141G		FMT.0141	9	liquid	SRR11422032	PRJNA545312	4		15	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	7a5349b76df2ce4e8bcfe2		1		peri	0								
FMT.0141H		FMT.0141	11	semi-formed	SRR11422031	PRJNA545312	6		15	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	7a5349b76df2ce4e8bcfe2		1		post	0								
FMT.0141I		FMT.0141	14	formed	SRR11422030	PRJNA545312	9		15	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	7a5349b76df2ce4e8bcfe2		1		post	1								
FMT.0141J		FMT.0141	15	liquid	SRR11422029	PRJNA545312	10		15	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	7a5349b76df2ce4e8bcfe2		1		post	1								
FMT.0141K		FMT.0141	22	formed	SRR11422028	PRJNA545312	17		15	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	7a5349b76df2ce4e8bcfe2		1		post	2								
FMT.0141L		FMT.0141	25	semi-formed	SRR11422027	PRJNA545312	20		15	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	7a5349b76df2ce4e8bcfe2		1		post	2								
FMT.0141M		FMT.0141	28	liquid	SRR11422026	PRJNA545312	23		15	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	7a5349b76df2ce4e8bcfe2		1		post	3								
FMT.0141N		FMT.0141	29	formed	SRR11422024	PRJNA545312	24		15	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	7a5349b76df2ce4e8bcfe2		1		post	3								
FMT.0141O		FMT.0141	30	semi-formed	SRR11422023	PRJNA545312	25		15	5	PBSC_unmodified	Non-Hodgkin's Lymphoma	7a5349b76df2ce4e8bcfe2		1		post	3								
FMT.0142A		FMT.0142	0	semi-formed	SRR11422022	PRJNA545312	-7		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		pre	-2								
FMT.0142AA		FMT.0142	46	semi-formed	SRR11422021	PRJNA545312	39		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	5								
FMT.0142B		FMT.0142	4	formed	SRR11422020	PRJNA545312	-3		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		pre	-1								
FMT.0142BB		FMT.0142	47	semi-formed	SRR11422019	PRJNA545312	40		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	5								
FMT.0142C		FMT.0142	6	semi-formed	SRR11422018	PRJNA545312	-1		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		pre	-1								
FMT.0142D		FMT.0142	7	liquid	SRR11422017	PRJNA545312	0		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		peri	-1								
FMT.0142E		FMT.0142	8	liquid	SRR11422016	PRJNA545312	1		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		peri	0								
FMT.0142F		FMT.0142	10	liquid	SRR11422015	PRJNA545312	3		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		peri	0								
FMT.0142G		FMT.0142	12	semi-formed	SRR11422013	PRJNA545312	5		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		peri	0								
FMT.0142H		FMT.0142	13	semi-formed	SRR11422012	PRJNA545312	6		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	0								
FMT.0142I		FMT.0142	14	liquid	SRR11422011	PRJNA545312	7		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	0								
FMT.0142J		FMT.0142	15	liquid	SRR11422010	PRJNA545312	8		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	1								
FMT.0142K		FMT.0142	18	liquid	SRR11422009	PRJNA545312	11		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	1								
FMT.0142L		FMT.0142	19	semi-formed	SRR11422008	PRJNA545312	12		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	1								
FMT.0142M		FMT.0142	20	semi-formed	SRR11422007	PRJNA545312	13		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	1								
FMT.0142N		FMT.0142	21	liquid	SRR11422006	PRJNA545312	14		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	1								
FMT.0142O		FMT.0142	22	liquid	SRR11422372	PRJNA545312	15		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	2								
FMT.0142P		FMT.0142	25	liquid	SRR11422371	PRJNA545312	18		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	2								
FMT.0142Q		FMT.0142	26	formed	SRR11422368	PRJNA545312	19		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	2								
FMT.0142R		FMT.0142	28	semi-formed	SRR11421963	PRJNA545312	21		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	2								
FMT.0142S		FMT.0142	31	semi-formed	SRR11421962	PRJNA545312	24		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	3								
FMT.0142T		FMT.0142	33	semi-formed	SRR11421961	PRJNA545312	26		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	3								
FMT.0142U		FMT.0142	34	liquid	SRR11421960	PRJNA545312	27		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	3								
FMT.0142V		FMT.0142	38	liquid	SRR11421959	PRJNA545312	31		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	4								
FMT.0142W		FMT.0142	39	liquid	SRR11421958	PRJNA545312	32		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	4								
FMT.0142X		FMT.0142	40	liquid	SRR11421957	PRJNA545312	33		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	4								
FMT.0142Y		FMT.0142	42	semi-formed	SRR11421956	PRJNA545312	35		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	4								
FMT.0142Z		FMT.0142	43	formed	SRR11421955	PRJNA545312	36		28	7	cord	Leukemia	1707bc3cfd0dc87c135984	726	1		post	5								
FMT.0143A		FMT.0143	0	formed	SRR11421953	PRJNA545312	-22		14	22	TCD	Leukemia	1cf46f1af5b23fdebe4d77		1		pre	-3								
FMT.0143B		FMT.0143	16	formed	SRR11421952	PRJNA545312	-6		14	22	TCD	Leukemia	1cf46f1af5b23fdebe4d77		1		pre	-1								
FMT.0143C		FMT.0143	20	formed	SRR11421951	PRJNA545312	-2		14	22	TCD	Leukemia	1cf46f1af5b23fdebe4d77		1		pre	-1								
FMT.0143D		FMT.0143	21	formed	SRR11421950	PRJNA545312	-1		14	22	TCD	Leukemia	1cf46f1af5b23fdebe4d77		1		pre	-1								
FMT.0143E		FMT.0143	22	semi-formed	SRR11421949	PRJNA545312	0		14	22	TCD	Leukemia	1cf46f1af5b23fdebe4d77		1		peri	-1								
FMT.0143F		FMT.0143	23	liquid	SRR11421948	PRJNA545312	1		14	22	TCD	Leukemia	1cf46f1af5b23fdebe4d77		1		peri	0								
FMT.0143G		FMT.0143	24	liquid	SRR11421947	PRJNA545312	2		14	22	TCD	Leukemia	1cf46f1af5b23fdebe4d77		1		peri	0								
FMT.0143H		FMT.0143	26	semi-formed	SRR11421946	PRJNA545312	4		14	22	TCD	Leukemia	1cf46f1af5b23fdebe4d77		1		peri	0								
FMT.0143I		FMT.0143	27	semi-formed	SRR11421945	PRJNA545312	5		14	22	TCD	Leukemia	1cf46f1af5b23fdebe4d77		1		peri	0								
FMT.0143J		FMT.0143	29	formed	SRR11421944	PRJNA545312	7		14	22	TCD	Leukemia	1cf46f1af5b23fdebe4d77		1		post	0								
FMT.0143K		FMT.0143	33	liquid	SRR11421942	PRJNA545312	11		14	22	TCD	Leukemia	1cf46f1af5b23fdebe4d77		1		post	1								
FMT.0143L		FMT.0143	34	liquid	SRR11421941	PRJNA545312	12		14	22	TCD	Leukemia	1cf46f1af5b23fdebe4d77		1		post	1								
FMT.0143M		FMT.0143	35	semi-formed	SRR11421940	PRJNA545312	13		14	22	TCD	Leukemia	1cf46f1af5b23fdebe4d77		1		post	1								
FMT.0143N		FMT.0143	36	semi-formed	SRR11422344	PRJNA545312	14		14	22	TCD	Leukemia	1cf46f1af5b23fdebe4d77		1		post	1								
FMT.0144A		FMT.0144	0	formed	SRR11422343	PRJNA545312	-6		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	f0a9a0cb1ed83ed2644c5c		1		pre	-1								
FMT.0144B		FMT.0144	7	formed	SRR11422342	PRJNA545312	1		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	f0a9a0cb1ed83ed2644c5c		1		peri	0								
FMT.0144C		FMT.0144	12	liquid	SRR11422341	PRJNA545312	6		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	f0a9a0cb1ed83ed2644c5c		1		post	0								
FMT.0144D		FMT.0144	17	liquid	SRR11422340	PRJNA545312	11		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	f0a9a0cb1ed83ed2644c5c		1		post	1								
FMT.0144E		FMT.0144	81	formed	SRR11422339	PRJNA545312	75		5	6	PBSC_unmodified	Non-Hodgkin's Lymphoma	f0a9a0cb1ed83ed2644c5c		1		post	6								
FMT.0145A		FMT.0145	0	formed	SRR11422338	PRJNA545312	-10		4	10	TCD	Leukemia	5edc0c0476e732d62a4977		1		pre	-2								
FMT.0145B		FMT.0145	2	semi-formed	SRR11422336	PRJNA545312	-8		4	10	TCD	Leukemia	5edc0c0476e732d62a4977		1		pre	-2								
FMT.0145C		FMT.0145	4	formed	SRR11422335	PRJNA545312	-6		4	10	TCD	Leukemia	5edc0c0476e732d62a4977		1		pre	-1								
FMT.0145D		FMT.0145	37	semi-formed	SRR11422334	PRJNA545312	27		4	10	TCD	Leukemia	5edc0c0476e732d62a4977		1		post	3								
FMT.0146A		FMT.0146	0	formed	SRR11422333	PRJNA545312	-7		7	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	8b736b2e399a6f72cc47eb	274	1		pre	-2								
FMT.0146B		FMT.0146	1	formed	SRR11422332	PRJNA545312	-6		7	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	8b736b2e399a6f72cc47eb	274	1		pre	-1								
FMT.0146C		FMT.0146	14	liquid	SRR11422331	PRJNA545312	7		7	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	8b736b2e399a6f72cc47eb	274	1		post	0								
FMT.0146D		FMT.0146	15	liquid	SRR11422330	PRJNA545312	8		7	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	8b736b2e399a6f72cc47eb	274	1		post	1								
FMT.0146E		FMT.0146	41	formed	SRR11422329	PRJNA545312	34		7	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	8b736b2e399a6f72cc47eb	274	1		post	4								
FMT.0146F		FMT.0146	82	semi-formed	SRR11421042	PRJNA545312	75		7	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	8b736b2e399a6f72cc47eb	274	1		post	6								
FMT.0146G		FMT.0146	215	semi-formed	SRR11421041	PRJNA545312	208		7	7	PBSC_unmodified	Non-Hodgkin's Lymphoma	8b736b2e399a6f72cc47eb	274	1		post	6								
FMT.0147A		FMT.0147	0	formed	SRR11421039	PRJNA545312	-9		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		pre	-2								
FMT.0147AA		FMT.0147	105	liquid	SRR11421038	PRJNA545312	96		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147B		FMT.0147	3	formed	SRR11421037	PRJNA545312	-6		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		pre	-1								
FMT.0147BB		FMT.0147	120	liquid	SRR11421036	PRJNA545312	111		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147C		FMT.0147	4	semi-formed	SRR11420979	PRJNA545312	-5		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		pre	-1								
FMT.0147CC		FMT.0147	126	liquid	SRR11420978	PRJNA545312	117		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147D		FMT.0147	7	formed	SRR11420977	PRJNA545312	-2		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		pre	-1								
FMT.0147DD		FMT.0147	133	liquid	SRR11420976	PRJNA545312	124		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147E		FMT.0147	11	semi-formed	SRR11420975	PRJNA545312	2		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		peri	0								
FMT.0147EE		FMT.0147	135	liquid	SRR11420974	PRJNA545312	126		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147F		FMT.0147	20	liquid	SRR11420972	PRJNA545312	11		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	1								
FMT.0147FF		FMT.0147	136	liquid	SRR11420971	PRJNA545312	127		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147G		FMT.0147	21	semi-formed	SRR11420970	PRJNA545312	12		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	1								
FMT.0147GG		FMT.0147	140	liquid	SRR11420969	PRJNA545312	131		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147H		FMT.0147	22	semi-formed	SRR11420968	PRJNA545312	13		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	1								
FMT.0147HH		FMT.0147	150	liquid	SRR11420967	PRJNA545312	141		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147I		FMT.0147	27	semi-formed	SRR11420966	PRJNA545312	18		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	2								
FMT.0147J		FMT.0147	43	semi-formed	SRR11420964	PRJNA545312	34		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	4								
FMT.0147JJ		FMT.0147	169	semi-formed	SRR11420962	PRJNA545312	160		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147K		FMT.0147	47	semi-formed	SRR11422328	PRJNA545312	38		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	5								
FMT.0147KK		FMT.0147	170	liquid	SRR11422327	PRJNA545312	161		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147L		FMT.0147	52	formed	SRR11422324	PRJNA545312	43		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147LL		FMT.0147	174	liquid	SRR11422323	PRJNA545312	165		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147M		FMT.0147	67	liquid	SRR11422322	PRJNA545312	58		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147MM		FMT.0147	178	liquid	SRR11422321	PRJNA545312	169		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147N		FMT.0147	76	semi-formed	SRR11422320	PRJNA545312	67		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147O		FMT.0147	80	semi-formed	SRR11422319	PRJNA545312	71		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147P		FMT.0147	84	semi-formed	SRR11422318	PRJNA545312	75		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147Q		FMT.0147	85	liquid	SRR11422317	PRJNA545312	76		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147R		FMT.0147	86	semi-formed	SRR11422568	PRJNA545312	77		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147S		FMT.0147	87	liquid	SRR11422567	PRJNA545312	78		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147T		FMT.0147	88	liquid	SRR11422565	PRJNA545312	79		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147U		FMT.0147	93	liquid	SRR11422564	PRJNA545312	84		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147V		FMT.0147	95	semi-formed	SRR11422563	PRJNA545312	86		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147W		FMT.0147	97	liquid	SRR11423728	PRJNA545312	88		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147Y		FMT.0147	99	liquid	SRR11423697	PRJNA545312	90		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0147Z		FMT.0147	101	liquid	SRR11423685	PRJNA545312	92		37	9	cord	Leukemia	b8fa33cd5e19482a49d3c5		1		post	6								
FMT.0150A		FMT.0150	0	formed	SRR11423674	PRJNA545312	-1		9	1	PBSC_unmodified	Leukemia	db22bca04b9452b8986b2c		1		pre	-1								
FMT.0150B		FMT.0150	2	liquid	SRR11423663	PRJNA545312	1		9	1	PBSC_unmodified	Leukemia	db22bca04b9452b8986b2c		1		peri	0								
FMT.0150C		FMT.0150	5	formed	SRR11423652	PRJNA545312	4		9	1	PBSC_unmodified	Leukemia	db22bca04b9452b8986b2c		1		peri	0								
FMT.0150D		FMT.0150	6	semi-formed	SRR11423641	PRJNA545312	5		9	1	PBSC_unmodified	Leukemia	db22bca04b9452b8986b2c		1		peri	0								
FMT.0150E		FMT.0150	12	semi-formed	SRR11422562	PRJNA545312	11		9	1	PBSC_unmodified	Leukemia	db22bca04b9452b8986b2c		1		post	1								
FMT.0150F		FMT.0150	14	liquid	SRR11423630	PRJNA545312	13		9	1	PBSC_unmodified	Leukemia	db22bca04b9452b8986b2c		1		post	1								
FMT.0150G		FMT.0150	15	liquid	SRR11423619	PRJNA545312	14		9	1	PBSC_unmodified	Leukemia	db22bca04b9452b8986b2c		1		post	1								
FMT.0150H		FMT.0150	19	formed	SRR11423608	PRJNA545312	18		9	1	PBSC_unmodified	Leukemia	db22bca04b9452b8986b2c		1		post	2								
FMT.0150I		FMT.0150	20	formed	SRR11423597	PRJNA545312	19		9	1	PBSC_unmodified	Leukemia	db22bca04b9452b8986b2c		1		post	2								
FMT.0151A		FMT.0151	0	semi-formed	SRR11423586	PRJNA545312	-11		15	11	BM_unmodified	Leukemia	fc653b7381e2624c703935	197	1		pre	-2								
FMT.0151B		FMT.0151	14	liquid	SRR11423574	PRJNA545312	3		15	11	BM_unmodified	Leukemia	fc653b7381e2624c703935	197	1		peri	0								
FMT.0151C		FMT.0151	15	liquid	SRR11423563	PRJNA545312	4		15	11	BM_unmodified	Leukemia	fc653b7381e2624c703935	197	1		peri	0								
FMT.0151D		FMT.0151	17	liquid	SRR11423552	PRJNA545312	6		15	11	BM_unmodified	Leukemia	fc653b7381e2624c703935	197	1		post	0								
FMT.0151E		FMT.0151	21	liquid	SRR11423541	PRJNA545312	10		15	11	BM_unmodified	Leukemia	fc653b7381e2624c703935	197	1		post	1								
FMT.0151F		FMT.0151	24	liquid	SRR11423530	PRJNA545312	13		15	11	BM_unmodified	Leukemia	fc653b7381e2624c703935	197	1		post	1								
FMT.0151G		FMT.0151	28	semi-formed	SRR11423519	PRJNA545312	17		15	11	BM_unmodified	Leukemia	fc653b7381e2624c703935	197	1		post	2								
FMT.0151H		FMT.0151	27	liquid	SRR11423508	PRJNA545312	16		15	11	BM_unmodified	Leukemia	fc653b7381e2624c703935	197	1		post	2								
FMT.0151I		FMT.0151	30	liquid	SRR11423497	PRJNA545312	19		15	11	BM_unmodified	Leukemia	fc653b7381e2624c703935	197	1		post	2								
FMT.0151J		FMT.0151	43	liquid	SRR11423486	PRJNA545312	32		15	11	BM_unmodified	Leukemia	fc653b7381e2624c703935	197	1		post	4								
FMT.0151K		FMT.0151	48	liquid	SRR11423475	PRJNA545312	37		15	11	BM_unmodified	Leukemia	fc653b7381e2624c703935	197	1		post	5								
FMT.0151L		FMT.0151	49	liquid	SRR11423463	PRJNA545312	38		15	11	BM_unmodified	Leukemia	fc653b7381e2624c703935	197	1		post	5								
FMT.0151M		FMT.0151	50	liquid	SRR11423452	PRJNA545312	39		15	11	BM_unmodified	Leukemia	fc653b7381e2624c703935	197	1		post	5								
FMT.0151N		FMT.0151	51	liquid	SRR11423441	PRJNA545312	40		15	11	BM_unmodified	Leukemia	fc653b7381e2624c703935	197	1		post	5								
FMT.0151O		FMT.0151	56	semi-formed	SRR11423118	PRJNA545312	45		15	11	BM_unmodified	Leukemia	fc653b7381e2624c703935	197	1		post	6								
FMT.0152A		FMT.0152	0	semi-formed	SRR5979560	PRJNA394877			1																	
FMT.0153A		FMT.0153	0	formed	SRR11423107	PRJNA545312	-7		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		pre	-2								
FMT.0153B		FMT.0153	4	liquid	SRR11423096	PRJNA545312	-3		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		pre	-1								
FMT.0153C		FMT.0153	6	liquid	SRR11423085	PRJNA545312	-1		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		pre	-1								
FMT.0153D		FMT.0153	10	semi-formed	SRR11423074	PRJNA545312	3		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		peri	0								
FMT.0153E		FMT.0153	19	liquid	SRR11423063	PRJNA545312	12		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		post	1								
FMT.0153F		FMT.0153	20	liquid	SRR11423024	PRJNA545312	13		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		post	1								
FMT.0153G		FMT.0153	21	liquid	SRR11423012	PRJNA545312	14		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		post	1								
FMT.0153H		FMT.0153	25	semi-formed	SRR11422973	PRJNA545312	18		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		post	2								
FMT.0153I		FMT.0153	26	liquid	SRR9298260	PRJNA548153	19		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		post	2								
FMT.0153J		FMT.0153	30	formed	SRR11422962	PRJNA545312	23		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		post	3								
FMT.0153K		FMT.0153	31	liquid	SRR11422951	PRJNA545312	24		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		post	3								
FMT.0153L		FMT.0153	32	liquid	SRR11422884	PRJNA545312	25		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		post	3								
FMT.0153M		FMT.0153	38	formed	SRR11422873	PRJNA545312	31		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		post	4								
FMT.0153N		FMT.0153	42	formed	SRR11422834	PRJNA545312	35		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		post	4								
FMT.0153O		FMT.0153	67	semi-formed	SRR11423432	PRJNA545312	60		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		post	6								
FMT.0153P		FMT.0153	41	semi-formed	SRR11423421	PRJNA545312	34		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		post	4								
FMT.0153Q		FMT.0153	102	semi-formed	SRR11423379	PRJNA545312	95		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		post	6								
FMT.0153R		FMT.0153	131		SRR11423367	PRJNA545312	124		18	7	cord	Leukemia	c34b41661c3c4b89c19376		1		post	6								
FMT.0154A		FMT.0154	0	formed	SRR11423328	PRJNA545312	-5		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		pre	-1								
FMT.0154B		FMT.0154	6	liquid	SRR11423317	PRJNA545312	1		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		peri	0								
FMT.0154C		FMT.0154	9	liquid	SRR11423306	PRJNA545312	4		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		peri	0								
FMT.0154D		FMT.0154	10	liquid	SRR11423267	PRJNA545312	5		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		peri	0								
FMT.0154E		FMT.0154	17	liquid	SRR11423256	PRJNA545312	12		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	1								
FMT.0154F		FMT.0154	20	liquid	SRR11116357	PRJNA607574	15		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	2								
FMT.0154G		FMT.0154	23	liquid	SRR11423217	PRJNA545312	18		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	2								
FMT.0154H		FMT.0154	24	semi-formed	SRR11423206	PRJNA545312	19		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	2								
FMT.0154J		FMT.0154	33	liquid	SRR10668362	PRJNA545312	28		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	3								
FMT.0154K		FMT.0154	34	liquid	SRR10668361	PRJNA545312	29		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	4								
FMT.0154L		FMT.0154	50	liquid	SRR10668360	PRJNA545312	45		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	6								
FMT.0154M		FMT.0154	51	liquid	SRR10668359	PRJNA545312	46		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	6								
FMT.0154N		FMT.0154	53	liquid	SRR10668358	PRJNA545312	48		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	6								
FMT.0154P		FMT.0154	57	liquid	SRR10668356	PRJNA545312	52		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	6								
FMT.0154Q		FMT.0154	68	liquid	SRR10668355	PRJNA545312	63		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	6								
FMT.0154R		FMT.0154	87	semi-formed	SRR11116356	PRJNA607574	82		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	6								
FMT.0154S		FMT.0154	118	semi-formed	SRR11116355	PRJNA607574	113		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	6								
FMT.0154T		FMT.0154	162	semi-formed	SRR11116354	PRJNA607574	157		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	6								
FMT.0154U		FMT.0154	194	formed	SRR11116950	PRJNA607574	189		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	6								
FMT.0154V		FMT.0154	208	semi-formed	SRR11116949	PRJNA607574	203		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	6								
FMT.0154W		FMT.0154	253	formed	SRR11116947	PRJNA607574	248		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	6								
FMT.0154X		FMT.0154	303	formed	SRR11116946	PRJNA607574	298		22	5	BM_unmodified	Non-Hodgkin's Lymphoma	49cd8f998facfe3d0f40d3		1		post	6								
FMT.0155A		FMT.0155	10	formed	SRR11423195	PRJNA545312	-15		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		pre	-3								
FMT.0155B		FMT.0155	21	formed	SRR11423156	PRJNA545312	-4		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		pre	-1								
FMT.0155C		FMT.0155	23	liquid	SRR11423144	PRJNA545312	-2		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		pre	-1								
FMT.0155D		FMT.0155	28	semi-formed	SRR11423718	PRJNA545312	3		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		peri	0								
FMT.0155E		FMT.0155	34	liquid	SRR11423717	PRJNA545312	9		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		post	1								
FMT.0155F		FMT.0155	37	liquid	SRR11423716	PRJNA545312	12		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		post	1								
FMT.0155G		FMT.0155	39	liquid	SRR11423715	PRJNA545312	14		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		post	1								
FMT.0155H		FMT.0155	45	liquid	SRR11423714	PRJNA545312	20		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		post	2								
FMT.0155I		FMT.0155	46	liquid	SRR11423713	PRJNA545312	21		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		post	2								
FMT.0155J		FMT.0155	50	semi-formed	SRR11423712	PRJNA545312	25		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		post	3								
FMT.0155K		FMT.0155	51	semi-formed	SRR11423711	PRJNA545312	26		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		post	3								
FMT.0155L		FMT.0155	63	formed	SRR11423709	PRJNA545312	38		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		post	5								
FMT.0155M		FMT.0155	64	semi-formed	SRR11423061	PRJNA545312	39		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		post	5								
FMT.0155N		FMT.0155	65	liquid	SRR11423060	PRJNA545312	40		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		post	5								
FMT.0155O		FMT.0155	88	semi-formed	SRR11423059	PRJNA545312	63		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		post	6								
FMT.0155P		FMT.0155	176	semi-formed	SRR11423058	PRJNA545312	151		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		post	6								
FMT.0155Q		FMT.0155	360	formed	SRR11116945	PRJNA607574	335		19	25	cord	Non-Hodgkin's Lymphoma	2a69a16014fd659516e11f	771	1		post	6								
FMT.0156A		FMT.0156	1172	formed	SRR11423057	PRJNA545312	-7		10	1179	PBSC_unmodified	Non-Hodgkin's Lymphoma	526aebc43dfbdf54276c6f		1		pre	-2								
FMT.0156B		FMT.0156	1176	semi-formed	SRR11423056	PRJNA545312	-3		10	1179	PBSC_unmodified	Non-Hodgkin's Lymphoma	526aebc43dfbdf54276c6f		1		pre	-1								
FMT.0156C		FMT.0156	1180	semi-formed	SRR11423055	PRJNA545312	1		10	1179	PBSC_unmodified	Non-Hodgkin's Lymphoma	526aebc43dfbdf54276c6f		1		peri	0								
FMT.0156D		FMT.0156	1185	semi-formed	SRR11423054	PRJNA545312	6		10	1179	PBSC_unmodified	Non-Hodgkin's Lymphoma	526aebc43dfbdf54276c6f		1		post	0								
FMT.0156E		FMT.0156	1191	formed	SRR11423053	PRJNA545312	12		10	1179	PBSC_unmodified	Non-Hodgkin's Lymphoma	526aebc43dfbdf54276c6f		1		post	1								
FMT.0156F		FMT.0156	1222	semi-formed	SRR11423052	PRJNA545312	43		10	1179	PBSC_unmodified	Non-Hodgkin's Lymphoma	526aebc43dfbdf54276c6f		1		post	6								
FMT.0156G		FMT.0156	1309	semi-formed	SRR11423050	PRJNA545312	130		10	1179	PBSC_unmodified	Non-Hodgkin's Lymphoma	526aebc43dfbdf54276c6f		1		post	6								
FMT.0157A		FMT.0157	0	semi-formed	SRR11423049	PRJNA545312	-19		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		pre	-3								
FMT.0157B		FMT.0157	13	semi-formed	SRR11423048	PRJNA545312	-6		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		pre	-1								
FMT.0157C		FMT.0157	14	semi-formed	SRR11422561	PRJNA545312	-5		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		pre	-1								
FMT.0157D		FMT.0157	17	semi-formed	SRR11422560	PRJNA545312	-2		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		pre	-1								
FMT.0157E		FMT.0157	20	liquid	SRR11422559	PRJNA545312	1		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		peri	0								
FMT.0157F		FMT.0157	21	formed	SRR11422558	PRJNA545312	2		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		peri	0								
FMT.0157G		FMT.0157	23	liquid	SRR11422557	PRJNA545312	4		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		peri	0								
FMT.0157H		FMT.0157	24	liquid	SRR11422556	PRJNA545312	5		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		peri	0								
FMT.0157I		FMT.0157	25	liquid	SRR11422554	PRJNA545312	6		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		post	0								
FMT.0157J		FMT.0157	26	liquid	SRR11423047	PRJNA545312	7		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		post	0								
FMT.0157K		FMT.0157	27	liquid	SRR11423046	PRJNA545312	8		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		post	1								
FMT.0157L		FMT.0157	32	liquid	SRR11423045	PRJNA545312	13		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		post	1								
FMT.0157M		FMT.0157	31	semi-formed	SRR11423044	PRJNA545312	12		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		post	1								
FMT.0157N		FMT.0157	33	liquid	SRR11423043	PRJNA545312	14		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		post	1								
FMT.0157O		FMT.0157	35	liquid	SRR11116944	PRJNA607574	16		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		post	2								
FMT.0157P		FMT.0157	76	semi-formed	SRR11423042	PRJNA545312	57		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		post	6								
FMT.0157Q		FMT.0157	97	semi-formed	SRR11423041	PRJNA545312	78		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		post	6								
FMT.0157R		FMT.0157	208	semi-formed	SRR11423039	PRJNA545312	189		18	19	PBSC_unmodified	Non-Hodgkin's Lymphoma	1c6f6f960b693dacd0ef95		1		post	6								
FMT.0158A		FMT.0158	0	semi-formed	SRR11423038	PRJNA545312	-23		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		pre	-3								
FMT.0158AA		FMT.0158	180	liquid	SRR11423037	PRJNA545312	2		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		peri	0								
FMT.0158B		FMT.0158	14	liquid	SRR11423036	PRJNA545312	-9		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		pre	-2								
FMT.0158BB		FMT.0158	182	semi-formed	SRR11423035	PRJNA545312	4		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		peri	0								
FMT.0158C		FMT.0158	15	formed	SRR11423034	PRJNA545312	-8		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		pre	-2								
FMT.0158CC		FMT.0158	183	formed	SRR11423005	PRJNA545312	5		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		peri	0								
FMT.0158D		FMT.0158	17	formed	SRR11423004	PRJNA545312	-6		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		pre	-1								
FMT.0158DD		FMT.0158	184	formed	SRR11423003	PRJNA545312	6		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	0								
FMT.0158E		FMT.0158	21	semi-formed	SRR11423002	PRJNA545312	-2		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		pre	-1								
FMT.0158EE		FMT.0158	185	semi-formed	SRR11423000	PRJNA545312	7		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	0								
FMT.0158F		FMT.0158	22	liquid	SRR11422999	PRJNA545312	-1		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		pre	-1								
FMT.0158FF		FMT.0158	187	semi-formed	SRR11422998	PRJNA545312	9		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	1								
FMT.0158G		FMT.0158	23	liquid	SRR11422997	PRJNA545312	0		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		peri	-1								
FMT.0158GG		FMT.0158	188	semi-formed	SRR11422996	PRJNA545312	10		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	1								
FMT.0158H		FMT.0158	24	liquid	SRR11422995	PRJNA545312	1		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		peri	0								
FMT.0158HH		FMT.0158	266	formed	SRR11116943	PRJNA607574	88		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	6								
FMT.0158I		FMT.0158	27	semi-formed	SRR11422994	PRJNA545312	4		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		peri	0								
FMT.0158II		FMT.0158	267	semi-formed	SRR11116942	PRJNA607574	89		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	6								
FMT.0158J		FMT.0158	28		SRR11422993	PRJNA545312	5		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		peri	0								
FMT.0158JJ		FMT.0158	268	semi-formed	SRR11116941	PRJNA607574	90		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	6								
FMT.0158K		FMT.0158	29	liquid	SRR11422992	PRJNA545312	6		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	0								
FMT.0158KK		FMT.0158	269	liquid	SRR11116940	PRJNA607574	91		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	6								
FMT.0158L		FMT.0158	30	semi-formed	SRR11422991	PRJNA545312	7		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	0								
FMT.0158LL		FMT.0158	296	formed	SRR11116939	PRJNA607574	118		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	6								
FMT.0158M		FMT.0158	31	semi-formed	SRR11422989	PRJNA545312	8		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	1								
FMT.0158MM		FMT.0158	321	semi-formed	SRR11116938	PRJNA607574	143		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	6								
FMT.0158N		FMT.0158	33	liquid	SRR11422988	PRJNA545312	10		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	1								
FMT.0158O		FMT.0158	34	liquid	SRR11422987	PRJNA545312	11		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	1								
FMT.0158P		FMT.0158	35	formed	SRR11422986	PRJNA545312	12		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	1								
FMT.0158Q		FMT.0158	36	formed	SRR11422985	PRJNA545312	13		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	1								
FMT.0158R		FMT.0158	51	semi-formed	SRR11422984	PRJNA545312	28		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	3								
FMT.0158S		FMT.0158	90	semi-formed	SRR11422983	PRJNA545312	67		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		post	6								
FMT.0158T		FMT.0158	126	formed	SRR11422982	PRJNA545312	-52		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		pre	-3								
FMT.0158U		FMT.0158	127	formed	SRR11422981	PRJNA545312	-51		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		pre	-3								
FMT.0158V		FMT.0158	133	formed	SRR11422980	PRJNA545312	-45		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		pre	-3								
FMT.0158W		FMT.0158	155	formed	SRR11422978	PRJNA545312	-23		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		pre	-3								
FMT.0158X		FMT.0158	169	formed	SRR11422949	PRJNA545312	-9		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		pre	-2								
FMT.0158Y		FMT.0158	170	formed	SRR11422948	PRJNA545312	-8		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		pre	-2								
FMT.0158Z		FMT.0158	171	formed	SRR11422947	PRJNA545312	-7		39	178	PBSC_unmodified	Leukemia	f9d0d0ce191445b9763199	776	1		pre	-2								
FMT.0159A		FMT.0159	0	formed	SRR11422946	PRJNA545312	-10		15	10	TCD	Leukemia	8ceaa6900c5287a3d21660		1		pre	-2								
FMT.0159B		FMT.0159	7	formed	SRR11422945	PRJNA545312	-3		15	10	TCD	Leukemia	8ceaa6900c5287a3d21660		1		pre	-1								
FMT.0159E		FMT.0159	17	liquid	SRR11422944	PRJNA545312	7		15	10	TCD	Leukemia	8ceaa6900c5287a3d21660		1		post	0								
FMT.0159G		FMT.0159	23	liquid	SRR11422943	PRJNA545312	13		15	10	TCD	Leukemia	8ceaa6900c5287a3d21660		1		post	1								
FMT.0159H		FMT.0159	153	liquid	SRR11422942	PRJNA545312	143		15	10	TCD	Leukemia	8ceaa6900c5287a3d21660		1		post	6								
FMT.0159I		FMT.0159	162	liquid	SRR11422941	PRJNA545312	152		15	10	TCD	Leukemia	8ceaa6900c5287a3d21660		1		post	6								
FMT.0159J		FMT.0159	168	liquid	SRR11422939	PRJNA545312	158		15	10	TCD	Leukemia	8ceaa6900c5287a3d21660		1		post	6								
FMT.0159K		FMT.0159	170	liquid	SRR11422938	PRJNA545312	160		15	10	TCD	Leukemia	8ceaa6900c5287a3d21660		1		post	6								
FMT.0159L		FMT.0159	182	liquid	SRR11422937	PRJNA545312	172		15	10	TCD	Leukemia	8ceaa6900c5287a3d21660		1		post	6								
FMT.0159M		FMT.0159	196	liquid	SRR11422936	PRJNA545312	186		15	10	TCD	Leukemia	8ceaa6900c5287a3d21660		1		post	6								
FMT.0159N		FMT.0159	197	liquid	SRR11422935	PRJNA545312	187		15	10	TCD	Leukemia	8ceaa6900c5287a3d21660		1		post	6								
FMT.0159O		FMT.0159	198	liquid	SRR11422934	PRJNA545312	188		15	10	TCD	Leukemia	8ceaa6900c5287a3d21660		1		post	6								
FMT.0159P		FMT.0159	205	liquid	SRR11422933	PRJNA545312	195		15	10	TCD	Leukemia	8ceaa6900c5287a3d21660		1		post	6								
FMT.0159Q		FMT.0159	206	liquid	SRR11422932	PRJNA545312	196		15	10	TCD	Leukemia	8ceaa6900c5287a3d21660		1		post	6								
FMT.0159R		FMT.0159	274	semi-formed	SRR11116936	PRJNA607574	264		15	10	TCD	Leukemia	8ceaa6900c5287a3d21660		1		post	6								
FMT.0160A		FMT.0160	0	formed	SRR11422931	PRJNA545312	-16		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		pre	-3								
FMT.0160B		FMT.0160	13	semi-formed	SRR11422930	PRJNA545312	-3		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		pre	-1								
FMT.0160C		FMT.0160	15	liquid	SRR11422928	PRJNA545312	-1		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		pre	-1								
FMT.0160D		FMT.0160	16	liquid	SRR11422927	PRJNA545312	0		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		peri	-1								
FMT.0160E		FMT.0160	17	liquid	SRR11422926	PRJNA545312	1		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		peri	0								
FMT.0160F		FMT.0160	18	liquid	SRR11422925	PRJNA545312	2		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		peri	0								
FMT.0160G		FMT.0160	20	semi-formed	SRR11422924	PRJNA545312	4		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		peri	0								
FMT.0160H		FMT.0160	21	liquid	SRR11422923	PRJNA545312	5		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		peri	0								
FMT.0160I		FMT.0160	22	liquid	SRR11422922	PRJNA545312	6		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		post	0								
FMT.0160J		FMT.0160	23	liquid	SRR11422921	PRJNA545312	7		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		post	0								
FMT.0160K		FMT.0160	24	liquid	SRR11422920	PRJNA545312	8		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		post	1								
FMT.0160L		FMT.0160	25	liquid	SRR11422919	PRJNA545312	9		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		post	1								
FMT.0160M		FMT.0160	28	semi-formed	SRR11422917	PRJNA545312	12		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		post	1								
FMT.0160N		FMT.0160	30	semi-formed	SRR11422916	PRJNA545312	14		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		post	1								
FMT.0160O		FMT.0160	31	semi-formed	SRR11422915	PRJNA545312	15		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		post	2								
FMT.0160Q		FMT.0160	42	liquid	SRR10668354	PRJNA545312	26		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		post	3								
FMT.0160R		FMT.0160	49	liquid	SRR10668353	PRJNA545312	33		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		post	4								
FMT.0160S		FMT.0160	66	liquid	SRR10668352	PRJNA545312	50		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		post	6								
FMT.0160T		FMT.0160	70	formed	SRR10668351	PRJNA545312	54		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		post	6								
FMT.0160U		FMT.0160	123	semi-formed	SRR11116935	PRJNA607574	107		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		post	6								
FMT.0160V		FMT.0160	130	formed	SRR11116934	PRJNA607574	114		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		post	6								
FMT.0160W		FMT.0160	154	semi-formed	SRR11116933	PRJNA607574	138		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		post	6								
FMT.0160X		FMT.0160	254	semi-formed	SRR11116932	PRJNA607574	238		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		post	6								
FMT.0160Y		FMT.0160	268	liquid	SRR11116931	PRJNA607574	252		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		post	6								
FMT.0160Z		FMT.0160	314	semi-formed	SRR11116930	PRJNA607574	298		25	16	TCD	Leukemia	71bf18f3080f840f66f5b3		1		post	6								
FMT.0161A		FMT.0161	0	semi-formed	SRR11422914	PRJNA545312	-30		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		pre	-3								
FMT.0161B		FMT.0161	21	semi-formed	SRR11422913	PRJNA545312	-9		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		pre	-2								
FMT.0161C		FMT.0161	25	semi-formed	SRR11422912	PRJNA545312	-5		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		pre	-1								
FMT.0161D		FMT.0161	26	liquid	SRR11422911	PRJNA545312	-4		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		pre	-1								
FMT.0161E		FMT.0161	29	liquid	SRR11422910	PRJNA545312	-1		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		pre	-1								
FMT.0161F		FMT.0161	32	liquid	SRR11422909	PRJNA545312	2		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		peri	0								
FMT.0161H		FMT.0161	33	liquid	SRR11422906	PRJNA545312	3		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		peri	0								
FMT.0161I		FMT.0161	35	liquid	SRR11422905	PRJNA545312	5		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		peri	0								
FMT.0161K		FMT.0161	36	liquid	SRR11422904	PRJNA545312	6		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		post	0								
FMT.0161L		FMT.0161	37	liquid	SRR11422903	PRJNA545312	7		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		post	0								
FMT.0161M		FMT.0161	40	liquid	SRR11422902	PRJNA545312	10		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		post	1								
FMT.0161N		FMT.0161	41	liquid	SRR11422901	PRJNA545312	11		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		post	1								
FMT.0161O		FMT.0161	42	liquid	SRR11422900	PRJNA545312	12		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		post	1								
FMT.0161P		FMT.0161	44	liquid	SRR11422899	PRJNA545312	14		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		post	1								
FMT.0161Q		FMT.0161	46	liquid	SRR11422898	PRJNA545312	16		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		post	2								
FMT.0161R		FMT.0161	47	liquid	SRR11422897	PRJNA545312	17		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		post	2								
FMT.0161S		FMT.0161	48	liquid	SRR11422894	PRJNA545312	18		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		post	2								
FMT.0161T		FMT.0161	53	liquid	SRR11422865	PRJNA545312	23		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		post	3								
FMT.0161U		FMT.0161	58	semi-formed	SRR11422864	PRJNA545312	28		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		post	3								
FMT.0161V		FMT.0161	61	liquid	SRR11422863	PRJNA545312	31		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		post	4								
FMT.0161W		FMT.0161	84	semi-formed	SRR11422862	PRJNA545312	54		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		post	6								
FMT.0161X		FMT.0161	89	liquid	SRR11422861	PRJNA545312	59		22	30	TCD	Multiple Myeloma	000f9b9617d476abf1f143		1		post	6								
FMT.0162A		FMT.0162	0	formed	SRR11422860	PRJNA545312	-23		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		pre	-3								
FMT.0162B		FMT.0162	10	formed	SRR11422859	PRJNA545312	-13		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		pre	-2								
FMT.0162C		FMT.0162	18	formed	SRR11422858	PRJNA545312	-5		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		pre	-1								
FMT.0162D		FMT.0162	20	formed	SRR11422857	PRJNA545312	-3		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		pre	-1								
FMT.0162E		FMT.0162	21	formed	SRR11422855	PRJNA545312	-2		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		pre	-1								
FMT.0162F		FMT.0162	22	formed	SRR11422854	PRJNA545312	-1		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		pre	-1								
FMT.0162G		FMT.0162	23	formed	SRR11422853	PRJNA545312	0		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		peri	-1								
FMT.0162H		FMT.0162	25	formed	SRR11422852	PRJNA545312	2		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		peri	0								
FMT.0162I		FMT.0162	28	formed	SRR11422851	PRJNA545312	5		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		peri	0								
FMT.0162J		FMT.0162	30	formed	SRR11422850	PRJNA545312	7		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		post	0								
FMT.0162K		FMT.0162	31	semi-formed	SRR11422849	PRJNA545312	8		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		post	1								
FMT.0162L		FMT.0162	32	semi-formed	SRR11422848	PRJNA545312	9		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		post	1								
FMT.0162M		FMT.0162	34	formed	SRR11422847	PRJNA545312	11		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		post	1								
FMT.0162N		FMT.0162	35	formed	SRR11422846	PRJNA545312	12		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		post	1								
FMT.0162O		FMT.0162	36	formed	SRR11422844	PRJNA545312	13		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		post	1								
FMT.0162P		FMT.0162	37	semi-formed	SRR11422843	PRJNA545312	14		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		post	1								
FMT.0162Q		FMT.0162	38	semi-formed	SRR11422842	PRJNA545312	15		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		post	2								
FMT.0162R		FMT.0162	42	formed	SRR11422841	PRJNA545312	19		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		post	2								
FMT.0162S		FMT.0162	44	formed	SRR11422840	PRJNA545312	21		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		post	2								
FMT.0162T		FMT.0162	49	formed	SRR11422839	PRJNA545312	26		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		post	3								
FMT.0162U		FMT.0162	52	formed	SRR11422838	PRJNA545312	29		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		post	4								
FMT.0162V		FMT.0162	56	formed	SRR11423415	PRJNA545312	33		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		post	4								
FMT.0162W		FMT.0162	58	formed	SRR11423414	PRJNA545312	35		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		post	4								
FMT.0162X		FMT.0162	63	liquid	SRR11423413	PRJNA545312	40		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		post	5								
FMT.0162Y		FMT.0162	86	formed	SRR11423411	PRJNA545312	63		25	23	PBSC_unmodified	Myelodysplastic Syndromes	79223cc9f81f402013249e		1		post	6								
FMT.0163A		FMT.0163	0	semi-formed	SRR11423410	PRJNA545312	-7		9	7	BM_unmodified	Leukemia	06e0058065121cc42bc8c3		1		pre	-2								
FMT.0163B		FMT.0163	5	formed	SRR11423409	PRJNA545312	-2		9	7	BM_unmodified	Leukemia	06e0058065121cc42bc8c3		1		pre	-1								
FMT.0163C		FMT.0163	17	semi-formed	SRR11423408	PRJNA545312	10		9	7	BM_unmodified	Leukemia	06e0058065121cc42bc8c3		1		post	1								
FMT.0163D		FMT.0163	18	semi-formed	SRR11423407	PRJNA545312	11		9	7	BM_unmodified	Leukemia	06e0058065121cc42bc8c3		1		post	1								
FMT.0163E		FMT.0163	23	formed	SRR11423406	PRJNA545312	16		9	7	BM_unmodified	Leukemia	06e0058065121cc42bc8c3		1		post	2								
FMT.0163F		FMT.0163	25	formed	SRR11423405	PRJNA545312	18		9	7	BM_unmodified	Leukemia	06e0058065121cc42bc8c3		1		post	2								
FMT.0163G		FMT.0163	28	formed	SRR11423404	PRJNA545312	21		9	7	BM_unmodified	Leukemia	06e0058065121cc42bc8c3		1		post	2								
FMT.0163H		FMT.0163	31	formed	SRR11423403	PRJNA545312	24		9	7	BM_unmodified	Leukemia	06e0058065121cc42bc8c3		1		post	3								
FMT.0163I		FMT.0163	32	formed	SRR11423402	PRJNA545312	25		9	7	BM_unmodified	Leukemia	06e0058065121cc42bc8c3		1		post	3								
FMT.0164A		FMT.0164	0	semi-formed	SRR11423400	PRJNA545312	-8		14	8	TCD	Leukemia	32ca4242871519ff3b84b1		1		pre	-2								
FMT.0164B		FMT.0164	8	semi-formed	SRR11423399	PRJNA545312	0		14	8	TCD	Leukemia	32ca4242871519ff3b84b1		1		peri	-1								
FMT.0164C		FMT.0164	7	liquid	SRR11423398	PRJNA545312	-1		14	8	TCD	Leukemia	32ca4242871519ff3b84b1		1		pre	-1								
FMT.0164D		FMT.0164	9	formed	SRR11423397	PRJNA545312	1		14	8	TCD	Leukemia	32ca4242871519ff3b84b1		1		peri	0								
FMT.0164E		FMT.0164	12	semi-formed	SRR11423396	PRJNA545312	4		14	8	TCD	Leukemia	32ca4242871519ff3b84b1		1		peri	0								
FMT.0164F		FMT.0164	13	liquid	SRR11423395	PRJNA545312	5		14	8	TCD	Leukemia	32ca4242871519ff3b84b1		1		peri	0								
FMT.0164G		FMT.0164	14	semi-formed	SRR11423394	PRJNA545312	6		14	8	TCD	Leukemia	32ca4242871519ff3b84b1		1		post	0								
FMT.0164H		FMT.0164	15	semi-formed	SRR11423393	PRJNA545312	7		14	8	TCD	Leukemia	32ca4242871519ff3b84b1		1		post	0								
FMT.0164I		FMT.0164	16	semi-formed	SRR11423392	PRJNA545312	8		14	8	TCD	Leukemia	32ca4242871519ff3b84b1		1		post	1								
FMT.0164J		FMT.0164	18	semi-formed	SRR11423391	PRJNA545312	10		14	8	TCD	Leukemia	32ca4242871519ff3b84b1		1		post	1								
FMT.0164K		FMT.0164	21	semi-formed	SRR11423389	PRJNA545312	13		14	8	TCD	Leukemia	32ca4242871519ff3b84b1		1		post	1								
FMT.0164L		FMT.0164	22	semi-formed	SRR11423388	PRJNA545312	14		14	8	TCD	Leukemia	32ca4242871519ff3b84b1		1		post	1								
FMT.0164M		FMT.0164	23	semi-formed	SRR11423359	PRJNA545312	15		14	8	TCD	Leukemia	32ca4242871519ff3b84b1		1		post	2								
FMT.0164N		FMT.0164	50	semi-formed	SRR11423358	PRJNA545312	42		14	8	TCD	Leukemia	32ca4242871519ff3b84b1		1		post	5								
FMT.0165A		FMT.0165	0	formed	SRR11423357	PRJNA545312	-20		16	20	TCD	Leukemia	4a6ceb4457d72d090b23e6	777	1		pre	-3								
FMT.0165B		FMT.0165	16	formed	SRR11423356	PRJNA545312	-4		16	20	TCD	Leukemia	4a6ceb4457d72d090b23e6	777	1		pre	-1								
FMT.0165C		FMT.0165	18	liquid	SRR11423355	PRJNA545312	-2		16	20	TCD	Leukemia	4a6ceb4457d72d090b23e6	777	1		pre	-1								
FMT.0165G		FMT.0165	26	liquid	SRR11423353	PRJNA545312	6		16	20	TCD	Leukemia	4a6ceb4457d72d090b23e6	777	1		post	0								
FMT.0165H		FMT.0165	27	liquid	SRR11423352	PRJNA545312	7		16	20	TCD	Leukemia	4a6ceb4457d72d090b23e6	777	1		post	0								
FMT.0165I		FMT.0165	31	semi-formed	SRR11423350	PRJNA545312	11		16	20	TCD	Leukemia	4a6ceb4457d72d090b23e6	777	1		post	1								
FMT.0165J		FMT.0165	33	semi-formed	SRR11423349	PRJNA545312	13		16	20	TCD	Leukemia	4a6ceb4457d72d090b23e6	777	1		post	1								
FMT.0165K		FMT.0165	37	semi-formed	SRR11423348	PRJNA545312	17		16	20	TCD	Leukemia	4a6ceb4457d72d090b23e6	777	1		post	2								
FMT.0165L		FMT.0165	46	semi-formed	SRR11423347	PRJNA545312	26		16	20	TCD	Leukemia	4a6ceb4457d72d090b23e6	777	1		post	3								
FMT.0165M		FMT.0165	67	formed	SRR11423346	PRJNA545312	47		16	20	TCD	Leukemia	4a6ceb4457d72d090b23e6	777	1		post	6								
FMT.0165N		FMT.0165	130	semi-formed	SRR11423345	PRJNA545312	110		16	20	TCD	Leukemia	4a6ceb4457d72d090b23e6	777	1		post	6								
FMT.0165O		FMT.0165	137	semi-formed	SRR11423344	PRJNA545312	117		16	20	TCD	Leukemia	4a6ceb4457d72d090b23e6	777	1		post	6								
FMT.0165P		FMT.0165	161	semi-formed	SRR11423343	PRJNA545312	141		16	20	TCD	Leukemia	4a6ceb4457d72d090b23e6	777	1		post	6								
FMT.0165Q		FMT.0165	200	formed	SRR11423342	PRJNA545312	180		16	20	TCD	Leukemia	4a6ceb4457d72d090b23e6	777	1		post	6								
FMT.0165R		FMT.0165	252	semi-formed	SRR11116929	PRJNA607574	232		16	20	TCD	Leukemia	4a6ceb4457d72d090b23e6	777	1		post	6								
FMT.0165S		FMT.0165	284	formed	SRR11116928	PRJNA607574	264		16	20	TCD	Leukemia	4a6ceb4457d72d090b23e6	777	1		post	6								
FMT.0166A		FMT.0166	0	formed	SRR11423341	PRJNA545312	-28	SRR13697119	8	28	TCD	Leukemia	b29b4224f69df33317e7be		1		pre	-3								
FMT.0166B		FMT.0166	21	semi-formed	SRR11423339	PRJNA545312	-7		8	28	TCD	Leukemia	b29b4224f69df33317e7be		1		pre	-2								
FMT.0166C		FMT.0166	23	semi-formed	SRR11423338	PRJNA545312	-5		8	28	TCD	Leukemia	b29b4224f69df33317e7be		1		pre	-1								
FMT.0166D		FMT.0166	24	semi-formed	SRR11423337	PRJNA545312	-4		8	28	TCD	Leukemia	b29b4224f69df33317e7be		1		pre	-1								
FMT.0166E		FMT.0166	26	liquid	SRR11423336	PRJNA545312	-2	SRR13697118	8	28	TCD	Leukemia	b29b4224f69df33317e7be		1		pre	-1								
FMT.0166F		FMT.0166	31	liquid	SRR11423335	PRJNA545312	3		8	28	TCD	Leukemia	b29b4224f69df33317e7be		1		peri	0								
FMT.0166G		FMT.0166	38	semi-formed	SRR11423334	PRJNA545312	10		8	28	TCD	Leukemia	b29b4224f69df33317e7be		1		post	1								
FMT.0166H		FMT.0166	41	liquid	SRR11423333	PRJNA545312	13		8	28	TCD	Leukemia	b29b4224f69df33317e7be		1		post	1								
FMT.0167A		FMT.0167	0	formed	SRR11423332	PRJNA545312	-5		10	535	PBSC_unmodified	Leukemia	98b48ad9357704990efd66		1		pre	-1								
FMT.0167B		FMT.0167	26	liquid	SRR11423303	PRJNA545312	21		10	535	PBSC_unmodified	Leukemia	98b48ad9357704990efd66		1		post	2								
FMT.0167C		FMT.0167	533	semi-formed	SRR9270549	PRJNA548153	-2		10	535	PBSC_unmodified	Leukemia	98b48ad9357704990efd66		1		pre	-1								
FMT.0167D		FMT.0167	536	formed	SRR9270550	PRJNA548153	1		10	535	PBSC_unmodified	Leukemia	98b48ad9357704990efd66		1		peri	0								
FMT.0167E		FMT.0167	540	liquid	SRR9270547	PRJNA548153	5		10	535	PBSC_unmodified	Leukemia	98b48ad9357704990efd66		1		peri	0								
FMT.0167F		FMT.0167	541	formed	SRR9270548	PRJNA548153	6		10	535	PBSC_unmodified	Leukemia	98b48ad9357704990efd66		1		post	0								
FMT.0167G		FMT.0167	542	semi-formed	SRR9270553	PRJNA548153	7		10	535	PBSC_unmodified	Leukemia	98b48ad9357704990efd66		1		post	0								
FMT.0167H		FMT.0167	543	semi-formed	SRR9270554	PRJNA548153	8		10	535	PBSC_unmodified	Leukemia	98b48ad9357704990efd66		1		post	1								
FMT.0167I		FMT.0167	547	semi-formed	SRR9270551	PRJNA548153	12		10	535	PBSC_unmodified	Leukemia	98b48ad9357704990efd66		1		post	1								
FMT.0167J		FMT.0167	548	semi-formed	SRR11116927	PRJNA607574	13		10	535	PBSC_unmodified	Leukemia	98b48ad9357704990efd66		1		post	1								
FMT.0168A		FMT.0168	0	semi-formed	SRR11423302	PRJNA545312	-7		10	7	cord	Myelodysplastic Syndromes	5b42bf8bc086d009c6218f	778	1		pre	-2								
FMT.0168B		FMT.0168	3	formed	SRR11423300	PRJNA545312	-4		10	7	cord	Myelodysplastic Syndromes	5b42bf8bc086d009c6218f	778	1		pre	-1								
FMT.0168C		FMT.0168	4	semi-formed	SRR11423299	PRJNA545312	-3		10	7	cord	Myelodysplastic Syndromes	5b42bf8bc086d009c6218f	778	1		pre	-1								
FMT.0168D		FMT.0168	12	formed	SRR11423298	PRJNA545312	5		10	7	cord	Myelodysplastic Syndromes	5b42bf8bc086d009c6218f	778	1		peri	0								
FMT.0168E		FMT.0168	17	semi-formed	SRR11423297	PRJNA545312	10		10	7	cord	Myelodysplastic Syndromes	5b42bf8bc086d009c6218f	778	1		post	1								
FMT.0168F		FMT.0168	20	formed	SRR11423296	PRJNA545312	13		10	7	cord	Myelodysplastic Syndromes	5b42bf8bc086d009c6218f	778	1		post	1								
FMT.0168G		FMT.0168	21	formed	SRR11423295	PRJNA545312	14		10	7	cord	Myelodysplastic Syndromes	5b42bf8bc086d009c6218f	778	1		post	1								
FMT.0168H		FMT.0168	33	formed	SRR11423294	PRJNA545312	26		10	7	cord	Myelodysplastic Syndromes	5b42bf8bc086d009c6218f	778	1		post	3								
FMT.0168I		FMT.0168	34	semi-formed	SRR11423293	PRJNA545312	27		10	7	cord	Myelodysplastic Syndromes	5b42bf8bc086d009c6218f	778	1		post	3								
FMT.0168J		FMT.0168	159	formed	SRR11423292	PRJNA545312	152		10	7	cord	Myelodysplastic Syndromes	5b42bf8bc086d009c6218f	778	1		post	6								
FMT.0169A		FMT.0169	911	formed	SRR11423291	PRJNA545312	-17		17	928	PBSC_unmodified	Non-Hodgkin's Lymphoma	02ccfb467aa6a4a92122d8		1		pre	-3								
FMT.0169B		FMT.0169	927	semi-formed	SRR11423289	PRJNA545312	-1		17	928	PBSC_unmodified	Non-Hodgkin's Lymphoma	02ccfb467aa6a4a92122d8		1		pre	-1								
FMT.0169C		FMT.0169	928	semi-formed	SRR11423288	PRJNA545312	0		17	928	PBSC_unmodified	Non-Hodgkin's Lymphoma	02ccfb467aa6a4a92122d8		1		peri	-1								
FMT.0169D		FMT.0169	930	formed	SRR11423287	PRJNA545312	2		17	928	PBSC_unmodified	Non-Hodgkin's Lymphoma	02ccfb467aa6a4a92122d8		1		peri	0								
FMT.0169E		FMT.0169	931	formed	SRR11423286	PRJNA545312	3		17	928	PBSC_unmodified	Non-Hodgkin's Lymphoma	02ccfb467aa6a4a92122d8		1		peri	0								
FMT.0169F		FMT.0169	932	semi-formed	SRR11423285	PRJNA545312	4		17	928	PBSC_unmodified	Non-Hodgkin's Lymphoma	02ccfb467aa6a4a92122d8		1		peri	0								
FMT.0169G		FMT.0169	933	semi-formed	SRR11423284	PRJNA545312	5		17	928	PBSC_unmodified	Non-Hodgkin's Lymphoma	02ccfb467aa6a4a92122d8		1		peri	0								
FMT.0169H		FMT.0169	934	semi-formed	SRR11423283	PRJNA545312	6		17	928	PBSC_unmodified	Non-Hodgkin's Lymphoma	02ccfb467aa6a4a92122d8		1		post	0								
FMT.0169I		FMT.0169	935	liquid	SRR11423282	PRJNA545312	7		17	928	PBSC_unmodified	Non-Hodgkin's Lymphoma	02ccfb467aa6a4a92122d8		1		post	0								
FMT.0169J		FMT.0169	937	semi-formed	SRR11423281	PRJNA545312	9		17	928	PBSC_unmodified	Non-Hodgkin's Lymphoma	02ccfb467aa6a4a92122d8		1		post	1								
FMT.0169K		FMT.0169	938	semi-formed	SRR11423280	PRJNA545312	10		17	928	PBSC_unmodified	Non-Hodgkin's Lymphoma	02ccfb467aa6a4a92122d8		1		post	1								
FMT.0169L		FMT.0169	939	semi-formed	SRR11423277	PRJNA545312	11		17	928	PBSC_unmodified	Non-Hodgkin's Lymphoma	02ccfb467aa6a4a92122d8		1		post	1								
FMT.0169M		FMT.0169	940	formed	SRR11423276	PRJNA545312	12		17	928	PBSC_unmodified	Non-Hodgkin's Lymphoma	02ccfb467aa6a4a92122d8		1		post	1								
FMT.0169O		FMT.0169	942	formed	SRR11423247	PRJNA545312	14		17	928	PBSC_unmodified	Non-Hodgkin's Lymphoma	02ccfb467aa6a4a92122d8		1		post	1								
FMT.0169P		FMT.0169	945	formed	SRR11423246	PRJNA545312	17		17	928	PBSC_unmodified	Non-Hodgkin's Lymphoma	02ccfb467aa6a4a92122d8		1		post	2								
FMT.0171A		FMT.0171	0	formed	SRR11423245	PRJNA545312	-16		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		pre	-3								
FMT.0171AA		FMT.0171	193	formed	SRR11116925	PRJNA607574	177		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		post	6								
FMT.0171B		FMT.0171	10	formed	SRR11423244	PRJNA545312	-6		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		pre	-1								
FMT.0171BB		FMT.0171	280	formed	SRR11116924	PRJNA607574	264		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		post	6								
FMT.0171C		FMT.0171	13	semi-formed	SRR11423243	PRJNA545312	-3		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		pre	-1								
FMT.0171D		FMT.0171	14	semi-formed	SRR11423242	PRJNA545312	-2		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		pre	-1								
FMT.0171F		FMT.0171	15	liquid	SRR11423240	PRJNA545312	-1		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		pre	-1								
FMT.0171G		FMT.0171	16	liquid	SRR11423238	PRJNA545312	0		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		peri	-1								
FMT.0171H		FMT.0171	17	semi-formed	SRR11423237	PRJNA545312	1		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		peri	0								
FMT.0171I		FMT.0171	18	semi-formed	SRR11423236	PRJNA545312	2		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		peri	0								
FMT.0171J		FMT.0171	20	liquid	SRR11423235	PRJNA545312	4		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		peri	0								
FMT.0171L		FMT.0171	22	semi-formed	SRR11423234	PRJNA545312	6		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		post	0								
FMT.0171M		FMT.0171	23	semi-formed	SRR11423233	PRJNA545312	7		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		post	0								
FMT.0171N		FMT.0171	24	semi-formed	SRR11423232	PRJNA545312	8		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		post	1								
FMT.0171P		FMT.0171	28	semi-formed	SRR11423231	PRJNA545312	12		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		post	1								
FMT.0171Q		FMT.0171	29	liquid	SRR11423230	PRJNA545312	13		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		post	1								
FMT.0171R		FMT.0171	30	formed	SRR11423229	PRJNA545312	14		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		post	1								
FMT.0171S		FMT.0171	31	formed	SRR11423227	PRJNA545312	15		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		post	2								
FMT.0171U		FMT.0171	49	liquid	SRR10668350	PRJNA545312	33		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		post	4								
FMT.0171V		FMT.0171	56	formed	SRR10668349	PRJNA545312	40		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		post	5								
FMT.0171W		FMT.0171	93	formed	SRR10668348	PRJNA545312	77		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		post	6								
FMT.0171Y		FMT.0171	147	formed	SRR11116923	PRJNA607574	131		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		post	6								
FMT.0171Z		FMT.0171	168	semi-formed	SRR11116922	PRJNA607574	152		23	16	TCD	Leukemia	01bb0c3eb95ae6b4f10004		1		post	6								
FMT.0172A		FMT.0172	0	semi-formed	SRR11423226	PRJNA545312	-11		13	11	PBSC_unmodified	Leukemia	c2a7132b7e9b270b9c5bdc		1		pre	-2								
FMT.0172B		FMT.0172	6	formed	SRR11423225	PRJNA545312	-5		13	11	PBSC_unmodified	Leukemia	c2a7132b7e9b270b9c5bdc		1		pre	-1								
FMT.0172C		FMT.0172	8	semi-formed	SRR11423224	PRJNA545312	-3		13	11	PBSC_unmodified	Leukemia	c2a7132b7e9b270b9c5bdc		1		pre	-1								
FMT.0172D		FMT.0172	10	formed	SRR11423223	PRJNA545312	-1		13	11	PBSC_unmodified	Leukemia	c2a7132b7e9b270b9c5bdc		1		pre	-1								
FMT.0172E		FMT.0172	11	semi-formed	SRR11423222	PRJNA545312	0		13	11	PBSC_unmodified	Leukemia	c2a7132b7e9b270b9c5bdc		1		peri	-1								
FMT.0172F		FMT.0172	13	liquid	SRR11423221	PRJNA545312	2		13	11	PBSC_unmodified	Leukemia	c2a7132b7e9b270b9c5bdc		1		peri	0								
FMT.0172G		FMT.0172	14	formed	SRR11423220	PRJNA545312	3		13	11	PBSC_unmodified	Leukemia	c2a7132b7e9b270b9c5bdc		1		peri	0								
FMT.0172H		FMT.0172	16	formed	SRR11423191	PRJNA545312	5		13	11	PBSC_unmodified	Leukemia	c2a7132b7e9b270b9c5bdc		1		peri	0								
FMT.0172I		FMT.0172	17	liquid	SRR11423190	PRJNA545312	6		13	11	PBSC_unmodified	Leukemia	c2a7132b7e9b270b9c5bdc		1		post	0								
FMT.0172J		FMT.0172	18	semi-formed	SRR11423188	PRJNA545312	7		13	11	PBSC_unmodified	Leukemia	c2a7132b7e9b270b9c5bdc		1		post	0								
FMT.0172K		FMT.0172	20	liquid	SRR11423187	PRJNA545312	9		13	11	PBSC_unmodified	Leukemia	c2a7132b7e9b270b9c5bdc		1		post	1								
FMT.0172L		FMT.0172	23	formed	SRR11423186	PRJNA545312	12		13	11	PBSC_unmodified	Leukemia	c2a7132b7e9b270b9c5bdc		1		post	1								
FMT.0172M		FMT.0172	24	formed	SRR11423185	PRJNA545312	13		13	11	PBSC_unmodified	Leukemia	c2a7132b7e9b270b9c5bdc		1		post	1								
FMT.0173A		FMT.0173	0	formed	SRR11423184	PRJNA545312	-108		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		pre	-3								
FMT.0173B		FMT.0173	103	formed	SRR11423183	PRJNA545312	-5		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		pre	-1								
FMT.0173C		FMT.0173	104	formed	SRR11423182	PRJNA545312	-4		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		pre	-1								
FMT.0173D		FMT.0173	105	formed	SRR11423181	PRJNA545312	-3		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		pre	-1								
FMT.0173E		FMT.0173	106	semi-formed	SRR11423180	PRJNA545312	-2		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		pre	-1								
FMT.0173F		FMT.0173	111	semi-formed	SRR11423179	PRJNA545312	3		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		peri	0								
FMT.0173G		FMT.0173	114	semi-formed	SRR11423177	PRJNA545312	6		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		post	0								
FMT.0173H		FMT.0173	116	formed	SRR11423176	PRJNA545312	8		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		post	1								
FMT.0173I		FMT.0173	117	formed	SRR11423175	PRJNA545312	9		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		post	1								
FMT.0173J		FMT.0173	118	formed	SRR11423174	PRJNA545312	10		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		post	1								
FMT.0173K		FMT.0173	119	formed	SRR11423173	PRJNA545312	11		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		post	1								
FMT.0173L		FMT.0173	120	semi-formed	SRR11423172	PRJNA545312	12		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		post	1								
FMT.0173M		FMT.0173	121	semi-formed	SRR11423171	PRJNA545312	13		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		post	1								
FMT.0173N		FMT.0173	123	semi-formed	SRR11423170	PRJNA545312	15		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		post	2								
FMT.0173P		FMT.0173	127	liquid	SRR10668345	PRJNA545312	19		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		post	2								
FMT.0173Q		FMT.0173	133	semi-formed	SRR10668344	PRJNA545312	25		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		post	3								
FMT.0173R		FMT.0173	147	formed	SRR10668343	PRJNA545312	39		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		post	5								
FMT.0173S		FMT.0173	196	formed	SRR11116921	PRJNA607574	88		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		post	6								
FMT.0173T		FMT.0173	201	formed	SRR11116920	PRJNA607574	93		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		post	6								
FMT.0173U		FMT.0173	210	formed	SRR11116919	PRJNA607574	102		20	108	TCD	Multiple Myeloma	a38a19063534f7018afddb		1		post	6								
FMT.0174A		FMT.0174	0	semi-formed	SRR11423169	PRJNA545312	-14		10	14	TCD	Leukemia	06d549076893fd5edc70ce		1		pre	-3								
FMT.0174B		FMT.0174	8	formed	SRR11423168	PRJNA545312	-6		10	14	TCD	Leukemia	06d549076893fd5edc70ce		1		pre	-1								
FMT.0174C		FMT.0174	12	semi-formed	SRR11423166	PRJNA545312	-2		10	14	TCD	Leukemia	06d549076893fd5edc70ce		1		pre	-1								
FMT.0174D		FMT.0174	14	liquid	SRR11422553	PRJNA545312	0		10	14	TCD	Leukemia	06d549076893fd5edc70ce		1		peri	-1								
FMT.0174E		FMT.0174	17	liquid	SRR11422552	PRJNA545312	3		10	14	TCD	Leukemia	06d549076893fd5edc70ce		1		peri	0								
FMT.0174F		FMT.0174	24	semi-formed	SRR11422551	PRJNA545312	10		10	14	TCD	Leukemia	06d549076893fd5edc70ce		1		post	1								
FMT.0174G		FMT.0174	28	semi-formed	SRR11422550	PRJNA545312	14		10	14	TCD	Leukemia	06d549076893fd5edc70ce		1		post	1								
FMT.0174H		FMT.0174	34	semi-formed	SRR11422549	PRJNA545312	20		10	14	TCD	Leukemia	06d549076893fd5edc70ce		1		post	2								
FMT.0174I		FMT.0174	35	formed	SRR11422548	PRJNA545312	21		10	14	TCD	Leukemia	06d549076893fd5edc70ce		1		post	2								
FMT.0174J		FMT.0174	200	formed	SRR11422547	PRJNA545312	186		10	14	TCD	Leukemia	06d549076893fd5edc70ce		1		post	6								
FMT.0175A		FMT.0175	0	formed	SRR11423165	PRJNA545312			17																	
FMT.0175B		FMT.0175	2	formed	SRR11423164	PRJNA545312			17																	
FMT.0175C		FMT.0175	3	formed	SRR11423135	PRJNA545312			17																	
FMT.0175D		FMT.0175	4	formed	SRR11423134	PRJNA545312			17																	
FMT.0175E		FMT.0175	9	formed	SRR11423133	PRJNA545312			17																	
FMT.0175F		FMT.0175	10	semi-formed	SRR11423132	PRJNA545312			17																	
FMT.0175G		FMT.0175	13	liquid	SRR11423131	PRJNA545312			17																	
FMT.0175I		FMT.0175	16	liquid	SRR11423129	PRJNA545312			17																	
FMT.0175J		FMT.0175	17	formed	SRR11423127	PRJNA545312			17																	
FMT.0175K		FMT.0175	22	formed	SRR11423126	PRJNA545312			17																	
FMT.0175L		FMT.0175	24	semi-formed	SRR11423125	PRJNA545312			17																	
FMT.0175M		FMT.0175	25	formed	SRR11423124	PRJNA545312			17																	
FMT.0175N		FMT.0175	27	formed	SRR11423123	PRJNA545312			17																	
FMT.0175O		FMT.0175	97	formed	SRR11423122	PRJNA545312			17																	
FMT.0175P		FMT.0175	98	formed	SRR11423434	PRJNA545312			17																	
FMT.0175Q		FMT.0175	106	formed	SRR11423731	PRJNA545312			17																	
FMT.0175R		FMT.0175	108	semi-formed	SRR11423730	PRJNA545312			17																	
FMT.0176A		FMT.0176	0	formed	SRR11423729	PRJNA545312	-6		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		pre	-1								
FMT.0176AA		FMT.0176	126	formed	SRR11116918	PRJNA607574	120		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	6								
FMT.0176BB		FMT.0176	157	formed	SRR11116917	PRJNA607574	151		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	6								
FMT.0176C		FMT.0176	5	semi-formed	SRR11423726	PRJNA545312	-1		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		pre	-1								
FMT.0176CC		FMT.0176	158	formed	SRR11116916	PRJNA607574	152		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	6								
FMT.0176D		FMT.0176	6	liquid	SRR11423725	PRJNA545312	0		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		peri	-1								
FMT.0176DD		FMT.0176	179	semi-formed	SRR11116913	PRJNA607574	173		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	6								
FMT.0176E		FMT.0176	7	liquid	SRR11423724	PRJNA545312	1		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		peri	0								
FMT.0176EE		FMT.0176	193	semi-formed	SRR11116912	PRJNA607574	187		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	6								
FMT.0176F		FMT.0176	10	semi-formed	SRR11423723	PRJNA545312	4		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		peri	0								
FMT.0176FF		FMT.0176	195	formed	SRR11116911	PRJNA607574	189		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	6								
FMT.0176G		FMT.0176	11	semi-formed	SRR11423722	PRJNA545312	5		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		peri	0								
FMT.0176GG		FMT.0176	235	formed	SRR11116910	PRJNA607574	229		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	6								
FMT.0176H		FMT.0176	14	semi-formed	SRR11423721	PRJNA545312	8		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	1								
FMT.0176HH		FMT.0176	277	semi-formed	SRR11116909	PRJNA607574	271		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	6								
FMT.0176I		FMT.0176	15	semi-formed	SRR11423720	PRJNA545312	9		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	1								
FMT.0176II		FMT.0176	278	semi-formed	SRR11116908	PRJNA607574	272		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	6								
FMT.0176J		FMT.0176	19	semi-formed	SRR11423719	PRJNA545312	13		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	1								
FMT.0176JJ		FMT.0176	284	semi-formed	SRR11116907	PRJNA607574	278		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	6								
FMT.0176K		FMT.0176	22	semi-formed	SRR11423710	PRJNA545312	16		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	2								
FMT.0176KK		FMT.0176	287	formed	SRR11116906	PRJNA607574	281		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	6								
FMT.0176L		FMT.0176	24	semi-formed	SRR11423707	PRJNA545312	18		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	2								
FMT.0176LL		FMT.0176	302	semi-formed	SRR11116905	PRJNA607574	296		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	6								
FMT.0176M		FMT.0176	25	formed	SRR11423706	PRJNA545312	19		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	2								
FMT.0176N		FMT.0176	26	formed	SRR11423705	PRJNA545312	20		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	2								
FMT.0176P		FMT.0176	29	semi-formed	SRR11423704	PRJNA545312	23		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	3								
FMT.0176Q		FMT.0176	34	semi-formed	SRR11423703	PRJNA545312	28		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	3								
FMT.0176S		FMT.0176	35	liquid	SRR10668342	PRJNA545312	29		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	4								
FMT.0176T		FMT.0176	39	semi-formed	SRR10668341	PRJNA545312	33		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	4								
FMT.0176U		FMT.0176	43	semi-formed	SRR10668340	PRJNA545312	37		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	5								
FMT.0176V		FMT.0176	47	formed	SRR10668339	PRJNA545312	41		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	5								
FMT.0176W		FMT.0176	50	semi-formed	SRR10668338	PRJNA545312	44		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	6								
FMT.0176X		FMT.0176	73	semi-formed	SRR10668337	PRJNA545312	67		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	6								
FMT.0176Y		FMT.0176	90	formed	SRR11116904	PRJNA607574	84		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	6								
FMT.0176Z		FMT.0176	105	formed	SRR11116902	PRJNA607574	99		35	6	cord	Leukemia	38ea84bb99bae205f6b2a8		1		post	6								
FMT.0177A		FMT.0177	0		SRR11423702	PRJNA545312	-30		14	30	TCD	Multiple Myeloma	8d8fb389ccd82755f79698		1		pre	-3								
FMT.0177B		FMT.0177	29	semi-formed	SRR11423701	PRJNA545312	-1		14	30	TCD	Multiple Myeloma	8d8fb389ccd82755f79698		1		pre	-1								
FMT.0177C		FMT.0177	30	liquid	SRR11423700	PRJNA545312	0		14	30	TCD	Multiple Myeloma	8d8fb389ccd82755f79698		1		peri	-1								
FMT.0177D		FMT.0177	32	formed	SRR11423699	PRJNA545312	2		14	30	TCD	Multiple Myeloma	8d8fb389ccd82755f79698		1		peri	0								
FMT.0177E		FMT.0177	35	liquid	SRR11423698	PRJNA545312	5		14	30	TCD	Multiple Myeloma	8d8fb389ccd82755f79698		1		peri	0								
FMT.0177J		FMT.0177	60	semi-formed	SRR11423696	PRJNA545312	30		14	30	TCD	Multiple Myeloma	8d8fb389ccd82755f79698		1		post	4								
FMT.0177K		FMT.0177	77	semi-formed	SRR11423695	PRJNA545312	47		14	30	TCD	Multiple Myeloma	8d8fb389ccd82755f79698		1		post	6								
FMT.0177L		FMT.0177	93	semi-formed	SRR11116901	PRJNA607574	63		14	30	TCD	Multiple Myeloma	8d8fb389ccd82755f79698		1		post	6								
FMT.0177M		FMT.0177	112	semi-formed	SRR11116900	PRJNA607574	82		14	30	TCD	Multiple Myeloma	8d8fb389ccd82755f79698		1		post	6								
FMT.0177N		FMT.0177	127	formed	SRR11116899	PRJNA607574	97		14	30	TCD	Multiple Myeloma	8d8fb389ccd82755f79698		1		post	6								
FMT.0177O		FMT.0177	190	formed	SRR11116898	PRJNA607574	160		14	30	TCD	Multiple Myeloma	8d8fb389ccd82755f79698		1		post	6								
FMT.0177P		FMT.0177	205	formed	SRR11116897	PRJNA607574	175		14	30	TCD	Multiple Myeloma	8d8fb389ccd82755f79698		1		post	6								
FMT.0177R		FMT.0177	247	semi-formed	SRR11116896	PRJNA607574	217		14	30	TCD	Multiple Myeloma	8d8fb389ccd82755f79698		1		post	6								
FMT.0177S		FMT.0177	281	formed	SRR11116895	PRJNA607574	251		14	30	TCD	Multiple Myeloma	8d8fb389ccd82755f79698		1		post	6								
FMT.0178A		FMT.0178	0	semi-formed	SRR11423694	PRJNA545312	-100		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		pre	-3								
FMT.0178AA		FMT.0178	152	semi-formed	SRR10668336	PRJNA545312	52		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178AAA		FMT.0178	489	semi-formed	SRR11116894	PRJNA607574	389		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178B		FMT.0178	94	formed	SRR11423693	PRJNA545312	-6		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		pre	-1								
FMT.0178BB		FMT.0178	180	liquid	SRR11116893	PRJNA607574	80		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178C		FMT.0178	98	semi-formed	SRR11423692	PRJNA545312	-2		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		pre	-1								
FMT.0178CC		FMT.0178	190	liquid	SRR11116891	PRJNA607574	90		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178D		FMT.0178	99	semi-formed	SRR11423691	PRJNA545312	-1		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		pre	-1								
FMT.0178DD		FMT.0178	197	liquid	SRR11116890	PRJNA607574	97		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178E		FMT.0178	101	semi-formed	SRR11423690	PRJNA545312	1		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		peri	0								
FMT.0178F		FMT.0178	103	semi-formed	SRR11423689	PRJNA545312	3		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		peri	0								
FMT.0178FF		FMT.0178	198	liquid	SRR11116889	PRJNA607574	98		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178G		FMT.0178	104	semi-formed	SRR11423688	PRJNA545312	4		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		peri	0								
FMT.0178GG		FMT.0178	205	semi-formed	SRR11116888	PRJNA607574	105		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178H		FMT.0178	106	liquid	SRR11423687	PRJNA545312	6		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	0								
FMT.0178HH		FMT.0178	208	semi-formed	SRR11116887	PRJNA607574	108		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178I		FMT.0178	107	liquid	SRR11423684	PRJNA545312	7		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	0								
FMT.0178II		FMT.0178	209		SRR11116886	PRJNA607574	109		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178J		FMT.0178	108	liquid	SRR11423683	PRJNA545312	8		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	1								
FMT.0178JJ		FMT.0178	210	semi-formed	SRR11116885	PRJNA607574	110		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178K		FMT.0178	110	liquid	SRR11423682	PRJNA545312	10		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	1								
FMT.0178KK		FMT.0178	220	semi-formed	SRR11116884	PRJNA607574	120		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178L		FMT.0178	111	liquid	SRR11423681	PRJNA545312	11		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	1								
FMT.0178LL		FMT.0178	223	semi-formed	SRR11116883	PRJNA607574	123		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178M		FMT.0178	113	semi-formed	SRR11423680	PRJNA545312	13		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	1								
FMT.0178MM		FMT.0178	225	liquid	SRR11116882	PRJNA607574	125		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178N		FMT.0178	115	semi-formed	SRR11423679	PRJNA545312	15		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	2								
FMT.0178NN		FMT.0178	229	liquid	SRR11116880	PRJNA607574	129		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178O		FMT.0178	117	liquid	SRR11423678	PRJNA545312	17		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	2								
FMT.0178OO		FMT.0178	236	semi-formed	SRR11116879	PRJNA607574	136		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178P		FMT.0178	118	semi-formed	SRR11423677	PRJNA545312	18		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	2								
FMT.0178PP		FMT.0178	253	semi-formed	SRR11116878	PRJNA607574	153		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178Q		FMT.0178	122	formed	SRR11423676	PRJNA545312	22		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	3								
FMT.0178QQ		FMT.0178	255	semi-formed	SRR11116877	PRJNA607574	155		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178R		FMT.0178	124	formed	SRR11423675	PRJNA545312	24		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	3								
FMT.0178RR		FMT.0178	257	formed	SRR11116876	PRJNA607574	157		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178S		FMT.0178	125	formed	SRR11423673	PRJNA545312	25		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	3								
FMT.0178SS		FMT.0178	258	semi-formed	SRR11116875	PRJNA607574	158		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178T		FMT.0178	126	liquid	SRR11423672	PRJNA545312	26		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	3								
FMT.0178TT		FMT.0178	259	formed	SRR11116874	PRJNA607574	159		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178U		FMT.0178	127	formed	SRR11423671	PRJNA545312	27		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	3								
FMT.0178UU		FMT.0178	266	semi-formed	SRR11116873	PRJNA607574	166		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178V		FMT.0178	128	semi-formed	SRR11423670	PRJNA545312	28		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	3								
FMT.0178VV		FMT.0178	267	semi-formed	SRR11116872	PRJNA607574	167		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178W		FMT.0178	129	formed	SRR11423669	PRJNA545312	29		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	4								
FMT.0178WW		FMT.0178	302	semi-formed	SRR11116871	PRJNA607574	202		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178XX		FMT.0178	331	semi-formed	SRR11116869	PRJNA607574	231		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178Y		FMT.0178	134	liquid	SRR10668333	PRJNA545312	34		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	4								
FMT.0178YY		FMT.0178	362		SRR11116868	PRJNA607574	262		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0178Z		FMT.0178	136	formed	SRR10668332	PRJNA545312	36		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	5								
FMT.0178ZZ		FMT.0178	485	formed	SRR11116867	PRJNA607574	385		51	100	cord	Leukemia	1b233edd66974c45c12d68		1		post	6								
FMT.0179A		FMT.0179	0	semi-formed	SRR11423668	PRJNA545312	-13		12	13	TCD	Leukemia	fc07a208f5a95e47a3724b		1		pre	-2								
FMT.0179B		FMT.0179	3	formed	SRR11423667	PRJNA545312	-10		12	13	TCD	Leukemia	fc07a208f5a95e47a3724b		1		pre	-2								
FMT.0179C		FMT.0179	11	formed	SRR11423666	PRJNA545312	-2		12	13	TCD	Leukemia	fc07a208f5a95e47a3724b		1		pre	-1								
FMT.0179D		FMT.0179	12	liquid	SRR11423665	PRJNA545312	-1		12	13	TCD	Leukemia	fc07a208f5a95e47a3724b		1		pre	-1								
FMT.0179E		FMT.0179	13	liquid	SRR11423664	PRJNA545312	0		12	13	TCD	Leukemia	fc07a208f5a95e47a3724b		1		peri	-1								
FMT.0179F		FMT.0179	14	liquid	SRR11423662	PRJNA545312	1		12	13	TCD	Leukemia	fc07a208f5a95e47a3724b		1		peri	0								
FMT.0179G		FMT.0179	16	formed	SRR11423661	PRJNA545312	3		12	13	TCD	Leukemia	fc07a208f5a95e47a3724b		1		peri	0								
FMT.0179H		FMT.0179	18	formed	SRR11423660	PRJNA545312	5		12	13	TCD	Leukemia	fc07a208f5a95e47a3724b		1		peri	0								
FMT.0179I		FMT.0179	19	semi-formed	SRR11423659	PRJNA545312	6		12	13	TCD	Leukemia	fc07a208f5a95e47a3724b		1		post	0								
FMT.0179J		FMT.0179	20	formed	SRR11423658	PRJNA545312	7		12	13	TCD	Leukemia	fc07a208f5a95e47a3724b		1		post	0								
FMT.0179K		FMT.0179	21	semi-formed	SRR11423657	PRJNA545312	8		12	13	TCD	Leukemia	fc07a208f5a95e47a3724b		1		post	1								
FMT.0179L		FMT.0179	25	formed	SRR11423656	PRJNA545312	12		12	13	TCD	Leukemia	fc07a208f5a95e47a3724b		1		post	1								
FMT.0180A		FMT.0180	0	semi-formed	SRR11423655	PRJNA545312	-7		14	7	PBSC_unmodified	Hodgkin's Disease	dfcd65577149f3a88d568f		1		pre	-2								
FMT.0180B		FMT.0180	6	formed	SRR11423654	PRJNA545312	-1		14	7	PBSC_unmodified	Hodgkin's Disease	dfcd65577149f3a88d568f		1		pre	-1								
FMT.0180C		FMT.0180	10	liquid	SRR11423653	PRJNA545312	3		14	7	PBSC_unmodified	Hodgkin's Disease	dfcd65577149f3a88d568f		1		peri	0								
FMT.0180D		FMT.0180	12	liquid	SRR11423651	PRJNA545312	5		14	7	PBSC_unmodified	Hodgkin's Disease	dfcd65577149f3a88d568f		1		peri	0								
FMT.0180E		FMT.0180	14	liquid	SRR11423650	PRJNA545312	7		14	7	PBSC_unmodified	Hodgkin's Disease	dfcd65577149f3a88d568f		1		post	0								
FMT.0180F		FMT.0180	16	liquid	SRR11423649	PRJNA545312	9		14	7	PBSC_unmodified	Hodgkin's Disease	dfcd65577149f3a88d568f		1		post	1								
FMT.0180G		FMT.0180	17	liquid	SRR11423648	PRJNA545312	10		14	7	PBSC_unmodified	Hodgkin's Disease	dfcd65577149f3a88d568f		1		post	1								
FMT.0180H		FMT.0180	21	liquid	SRR11423647	PRJNA545312	14		14	7	PBSC_unmodified	Hodgkin's Disease	dfcd65577149f3a88d568f		1		post	1								
FMT.0180I		FMT.0180	22	liquid	SRR11423646	PRJNA545312	15		14	7	PBSC_unmodified	Hodgkin's Disease	dfcd65577149f3a88d568f		1		post	2								
FMT.0180J		FMT.0180	27	liquid	SRR11423645	PRJNA545312	20		14	7	PBSC_unmodified	Hodgkin's Disease	dfcd65577149f3a88d568f		1		post	2								
FMT.0180K		FMT.0180	28	semi-formed	SRR11423644	PRJNA545312	21		14	7	PBSC_unmodified	Hodgkin's Disease	dfcd65577149f3a88d568f		1		post	2								
FMT.0180L		FMT.0180	30	formed	SRR11423643	PRJNA545312	23		14	7	PBSC_unmodified	Hodgkin's Disease	dfcd65577149f3a88d568f		1		post	3								
FMT.0180M		FMT.0180	83	formed	SRR11423642	PRJNA545312	76		14	7	PBSC_unmodified	Hodgkin's Disease	dfcd65577149f3a88d568f		1		post	6								
FMT.0180N		FMT.0180	133	formed	SRR11423640	PRJNA545312	126		14	7	PBSC_unmodified	Hodgkin's Disease	dfcd65577149f3a88d568f		1		post	6								
FMT.0181A		FMT.0181	0	formed	SRR11423639	PRJNA545312	-24		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		pre	-3								
FMT.0181AA		FMT.0181	496	formed	SRR11116866	PRJNA607574	472		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	6								
FMT.0181B		FMT.0181	16	formed	SRR11423638	PRJNA545312	-8		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		pre	-2								
FMT.0181BB		FMT.0181	498	formed	SRR11116865	PRJNA607574	474		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	6								
FMT.0181C		FMT.0181	17	formed	SRR11423637	PRJNA545312	-7		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		pre	-2								
FMT.0181D		FMT.0181	18	formed	SRR11423636	PRJNA545312	-6		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		pre	-1								
FMT.0181E		FMT.0181	20	liquid	SRR11423635	PRJNA545312	-4		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		pre	-1								
FMT.0181F		FMT.0181	28	semi-formed	SRR11423634	PRJNA545312	4		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		peri	0								
FMT.0181G		FMT.0181	29	liquid	SRR11423633	PRJNA545312	5		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		peri	0								
FMT.0181H		FMT.0181	30	semi-formed	SRR11423632	PRJNA545312	6		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	0								
FMT.0181I		FMT.0181	31	liquid	SRR11423631	PRJNA545312	7		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	0								
FMT.0181J		FMT.0181	32	liquid	SRR11423629	PRJNA545312	8		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	1								
FMT.0181K		FMT.0181	34	semi-formed	SRR11423628	PRJNA545312	10		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	1								
FMT.0181L		FMT.0181	35	liquid	SRR11423627	PRJNA545312	11		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	1								
FMT.0181M		FMT.0181	38	semi-formed	SRR11423626	PRJNA545312	14		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	1								
FMT.0181N		FMT.0181	41	formed	SRR11423625	PRJNA545312	17		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	2								
FMT.0181O		FMT.0181	51	formed	SRR11423624	PRJNA545312	27		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	3								
FMT.0181P		FMT.0181	60	semi-formed	SRR11423623	PRJNA545312	36		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	5								
FMT.0181Q		FMT.0181	91	semi-formed	SRR11423622	PRJNA545312	67		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	6								
FMT.0181R		FMT.0181	105		SRR11423621	PRJNA545312	81		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	6								
FMT.0181S		FMT.0181	154	formed	SRR11116864	PRJNA607574	130		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	6								
FMT.0181T		FMT.0181	203	formed	SRR11116863	PRJNA607574	179		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	6								
FMT.0181U		FMT.0181	280	formed	SRR11116862	PRJNA607574	256		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	6								
FMT.0181V		FMT.0181	311	formed	SRR11116861	PRJNA607574	287		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	6								
FMT.0181W		FMT.0181	475	semi-formed	SRR11116860	PRJNA607574	451		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	6								
FMT.0181X		FMT.0181	476	semi-formed	SRR11116858	PRJNA607574	452		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	6								
FMT.0181Y		FMT.0181	483	formed	SRR11116857	PRJNA607574	459		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	6								
FMT.0181Z		FMT.0181	485	liquid	SRR11116856	PRJNA607574	461		28	24	TCD	Myelodysplastic Syndromes	b3bf4d77d87908e868485c		1		post	6								
FMT.0182A		FMT.0182	0	semi-formed	SRR11423620	PRJNA545312	-17		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		pre	-3								
FMT.0182B		FMT.0182	9	semi-formed	SRR11423618	PRJNA545312	-8		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		pre	-2								
FMT.0182C		FMT.0182	14	liquid	SRR11423617	PRJNA545312	-3		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		pre	-1								
FMT.0182D		FMT.0182	17	liquid	SRR11423616	PRJNA545312	0		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		peri	-1								
FMT.0182E		FMT.0182	21	liquid	SRR11423615	PRJNA545312	4		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		peri	0								
FMT.0182F		FMT.0182	22	liquid	SRR11423614	PRJNA545312	5		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		peri	0								
FMT.0182G		FMT.0182	25	liquid	SRR11423613	PRJNA545312	8		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		post	1								
FMT.0182H		FMT.0182	27	liquid	SRR11423612	PRJNA545312	10		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		post	1								
FMT.0182I		FMT.0182	28	semi-formed	SRR11423611	PRJNA545312	11		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		post	1								
FMT.0182K		FMT.0182	35	liquid	SRR10668330	PRJNA545312	18		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		post	2								
FMT.0182L		FMT.0182	38	formed	SRR10668329	PRJNA545312	21		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		post	2								
FMT.0182N		FMT.0182	77	liquid	SRR11116855	PRJNA607574	60		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		post	6								
FMT.0182O		FMT.0182	105	semi-formed	SRR11116854	PRJNA607574	88		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		post	6								
FMT.0182P		FMT.0182	136	semi-formed	SRR11116853	PRJNA607574	119		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		post	6								
FMT.0182Q		FMT.0182	162	semi-formed	SRR11116852	PRJNA607574	145		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		post	6								
FMT.0182R		FMT.0182	168	semi-formed	SRR11116851	PRJNA607574	151		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		post	6								
FMT.0182S		FMT.0182	169	semi-formed	SRR11116850	PRJNA607574	152		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		post	6								
FMT.0182T		FMT.0182	217	semi-formed	SRR11116849	PRJNA607574	200		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		post	6								
FMT.0182U		FMT.0182	266	liquid	SRR11116847	PRJNA607574	249		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		post	6								
FMT.0182V		FMT.0182	330	formed	SRR11116846	PRJNA607574	313		20	17	TCD	Myelodysplastic Syndromes	71d266646e47f1b0db2745		1		post	6								
FMT.0183A		FMT.0183	0	formed	SRR11423610	PRJNA545312	-45		12	45	TCD	Myelodysplastic Syndromes	b15b305696c54ccb18bcdd		1		pre	-3								
FMT.0183B		FMT.0183	44	liquid	SRR11423609	PRJNA545312	-1		12	45	TCD	Myelodysplastic Syndromes	b15b305696c54ccb18bcdd		1		pre	-1								
FMT.0183C		FMT.0183	45	liquid	SRR11423607	PRJNA545312	0		12	45	TCD	Myelodysplastic Syndromes	b15b305696c54ccb18bcdd		1		peri	-1								
FMT.0183D		FMT.0183	46	liquid	SRR11423606	PRJNA545312	1		12	45	TCD	Myelodysplastic Syndromes	b15b305696c54ccb18bcdd		1		peri	0								
FMT.0183E		FMT.0183	48	semi-formed	SRR11423605	PRJNA545312	3		12	45	TCD	Myelodysplastic Syndromes	b15b305696c54ccb18bcdd		1		peri	0								
FMT.0183F		FMT.0183	49	liquid	SRR11423604	PRJNA545312	4		12	45	TCD	Myelodysplastic Syndromes	b15b305696c54ccb18bcdd		1		peri	0								
FMT.0183G		FMT.0183	51	liquid	SRR11423603	PRJNA545312	6		12	45	TCD	Myelodysplastic Syndromes	b15b305696c54ccb18bcdd		1		post	0								
FMT.0183I		FMT.0183	52	liquid	SRR11423601	PRJNA545312	7		12	45	TCD	Myelodysplastic Syndromes	b15b305696c54ccb18bcdd		1		post	0								
FMT.0183J		FMT.0183	56	semi-formed	SRR11423600	PRJNA545312	11		12	45	TCD	Myelodysplastic Syndromes	b15b305696c54ccb18bcdd		1		post	1								
FMT.0183K		FMT.0183	57	semi-formed	SRR11423599	PRJNA545312	12		12	45	TCD	Myelodysplastic Syndromes	b15b305696c54ccb18bcdd		1		post	1								
FMT.0183M		FMT.0183	65	formed	SRR11423598	PRJNA545312	20		12	45	TCD	Myelodysplastic Syndromes	b15b305696c54ccb18bcdd		1		post	2								
FMT.0183N		FMT.0183	66	formed	SRR11423596	PRJNA545312	21		12	45	TCD	Myelodysplastic Syndromes	b15b305696c54ccb18bcdd		1		post	2								
FMT.0184A		FMT.0184	1514	formed	SRR11423595	PRJNA545312	1509		6	5	PBSC_unmodified	Leukemia	a73ff42b25ed31a0f0abe1	489	1											
FMT.0185A		FMT.0185	0	formed	SRR11423594	PRJNA545312	-66		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		pre	-3								
FMT.0185B		FMT.0185	59	formed	SRR11423593	PRJNA545312	-7		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		pre	-2								
FMT.0185C		FMT.0185	63	formed	SRR11423592	PRJNA545312	-3		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		pre	-1								
FMT.0185D		FMT.0185	64	semi-formed	SRR11423591	PRJNA545312	-2		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		pre	-1								
FMT.0185E		FMT.0185	65	semi-formed	SRR11423590	PRJNA545312	-1		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		pre	-1								
FMT.0185F		FMT.0185	66	formed	SRR11423589	PRJNA545312	0		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		peri	-1								
FMT.0185G		FMT.0185	67	semi-formed	SRR11423588	PRJNA545312	1		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		peri	0								
FMT.0185H		FMT.0185	69	formed	SRR11423587	PRJNA545312	3		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		peri	0								
FMT.0185I		FMT.0185	70	formed	SRR11423585	PRJNA545312	4		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		peri	0								
FMT.0185J		FMT.0185	71	semi-formed	SRR11423584	PRJNA545312	5		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		peri	0								
FMT.0185K		FMT.0185	72	formed	SRR11423583	PRJNA545312	6		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		post	0								
FMT.0185L		FMT.0185	73	formed	SRR11423582	PRJNA545312	7		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		post	0								
FMT.0185M		FMT.0185	74	formed	SRR11423581	PRJNA545312	8		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		post	1								
FMT.0185N		FMT.0185	77	formed	SRR11423580	PRJNA545312	11		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		post	1								
FMT.0185O		FMT.0185	78	semi-formed	SRR11423579	PRJNA545312	12		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		post	1								
FMT.0185P		FMT.0185	79	formed	SRR11423578	PRJNA545312	13		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		post	1								
FMT.0185Q		FMT.0185	80	formed	SRR11423577	PRJNA545312	14		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		post	1								
FMT.0185R		FMT.0185	81	formed	SRR11423576	PRJNA545312	15		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		post	2								
FMT.0185S		FMT.0185	83	formed	SRR11423573	PRJNA545312	17		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		post	2								
FMT.0185T		FMT.0185	84	formed	SRR11423572	PRJNA545312	18		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		post	2								
FMT.0185U		FMT.0185	85	formed	SRR11423571	PRJNA545312	19		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		post	2								
FMT.0185V		FMT.0185	88	semi-formed	SRR11423570	PRJNA545312	22		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		post	3								
FMT.0185W		FMT.0185	90	formed	SRR11423569	PRJNA545312	24		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		post	3								
FMT.0185X		FMT.0185	91	semi-formed	SRR11423568	PRJNA545312	25		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		post	3								
FMT.0185Y		FMT.0185	92	formed	SRR11423567	PRJNA545312	26		25	66	BM_unmodified	Myeloproliferative Disorder	a22a8351a4f4aa8fa1eccb		1		post	3								
FMT.0186A		FMT.0186	75	semi-formed	SRR11423566	PRJNA545312	-27		17	102	TCD	Leukemia	d80b7783edd2eb82c5253b		1		pre	-3								
FMT.0186B		FMT.0186	93	formed	SRR11423565	PRJNA545312	-9		17	102	TCD	Leukemia	d80b7783edd2eb82c5253b		1		pre	-2								
FMT.0186C		FMT.0186	94	formed	SRR11423564	PRJNA545312	-8		17	102	TCD	Leukemia	d80b7783edd2eb82c5253b		1		pre	-2								
FMT.0186D		FMT.0186	98	formed	SRR11423562	PRJNA545312	-4		17	102	TCD	Leukemia	d80b7783edd2eb82c5253b		1		pre	-1								
FMT.0186E		FMT.0186	100	formed	SRR11423561	PRJNA545312	-2		17	102	TCD	Leukemia	d80b7783edd2eb82c5253b		1		pre	-1								
FMT.0186F		FMT.0186	101	semi-formed	SRR11423560	PRJNA545312	-1		17	102	TCD	Leukemia	d80b7783edd2eb82c5253b		1		pre	-1								
FMT.0186G		FMT.0186	102	semi-formed	SRR11423559	PRJNA545312	0		17	102	TCD	Leukemia	d80b7783edd2eb82c5253b		1		peri	-1								
FMT.0186H		FMT.0186	103	liquid	SRR11423558	PRJNA545312	1		17	102	TCD	Leukemia	d80b7783edd2eb82c5253b		1		peri	0								
FMT.0186I		FMT.0186	105	semi-formed	SRR11423557	PRJNA545312	3		17	102	TCD	Leukemia	d80b7783edd2eb82c5253b		1		peri	0								
FMT.0186J		FMT.0186	106	semi-formed	SRR11423556	PRJNA545312	4		17	102	TCD	Leukemia	d80b7783edd2eb82c5253b		1		peri	0								
FMT.0186K		FMT.0186	107	semi-formed	SRR11423555	PRJNA545312	5		17	102	TCD	Leukemia	d80b7783edd2eb82c5253b		1		peri	0								
FMT.0186L		FMT.0186	108	semi-formed	SRR11423554	PRJNA545312	6		17	102	TCD	Leukemia	d80b7783edd2eb82c5253b		1		post	0								
FMT.0186M		FMT.0186	109	semi-formed	SRR11423553	PRJNA545312	7		17	102	TCD	Leukemia	d80b7783edd2eb82c5253b		1		post	0								
FMT.0186N		FMT.0186	113	semi-formed	SRR11423551	PRJNA545312	11		17	102	TCD	Leukemia	d80b7783edd2eb82c5253b		1		post	1								
FMT.0186O		FMT.0186	115	semi-formed	SRR11423550	PRJNA545312	13		17	102	TCD	Leukemia	d80b7783edd2eb82c5253b		1		post	1								
FMT.0186P		FMT.0186	148	semi-formed	SRR11423549	PRJNA545312	46		17	102	TCD	Leukemia	d80b7783edd2eb82c5253b		1		post	6								
FMT.0186Q		FMT.0186	164	semi-formed	SRR11423548	PRJNA545312	62		17	102	TCD	Leukemia	d80b7783edd2eb82c5253b		1		post	6								
FMT.0187A		FMT.0187	0	semi-formed	SRR11423547	PRJNA545312	-14	SRR13697117	16	14	BM_unmodified	Leukemia	3ce9282f72dd815f18e6ad		1		pre	-3								
FMT.0187B		FMT.0187	9	formed	SRR11423546	PRJNA545312	-5	SRR14092278	16	14	BM_unmodified	Leukemia	3ce9282f72dd815f18e6ad		1		pre	-1								
FMT.0187C		FMT.0187	12	semi-formed	SRR11423545	PRJNA545312	-2	SRR14092277	16	14	BM_unmodified	Leukemia	3ce9282f72dd815f18e6ad		1		pre	-1								
FMT.0187D		FMT.0187	13	formed	SRR11423544	PRJNA545312	-1		16	14	BM_unmodified	Leukemia	3ce9282f72dd815f18e6ad		1		pre	-1								
FMT.0187E		FMT.0187	14	liquid	SRR11423543	PRJNA545312	0	SRR13697116	16	14	BM_unmodified	Leukemia	3ce9282f72dd815f18e6ad		1		peri	-1								
FMT.0187F		FMT.0187	16	liquid	SRR11423542	PRJNA545312	2		16	14	BM_unmodified	Leukemia	3ce9282f72dd815f18e6ad		1		peri	0								
FMT.0187G		FMT.0187	17	semi-formed	SRR11423540	PRJNA545312	3		16	14	BM_unmodified	Leukemia	3ce9282f72dd815f18e6ad		1		peri	0								
FMT.0187H		FMT.0187	19	liquid	SRR11423539	PRJNA545312	5		16	14	BM_unmodified	Leukemia	3ce9282f72dd815f18e6ad		1		peri	0								
FMT.0187J		FMT.0187	20	liquid	SRR11423537	PRJNA545312	6		16	14	BM_unmodified	Leukemia	3ce9282f72dd815f18e6ad		1		post	0								
FMT.0187K		FMT.0187	21	semi-formed	SRR11423536	PRJNA545312	7		16	14	BM_unmodified	Leukemia	3ce9282f72dd815f18e6ad		1		post	0								
FMT.0187L		FMT.0187	22	semi-formed	SRR11423535	PRJNA545312	8		16	14	BM_unmodified	Leukemia	3ce9282f72dd815f18e6ad		1		post	1								
FMT.0187M		FMT.0187	27	semi-formed	SRR11423534	PRJNA545312	13	SRR14092276	16	14	BM_unmodified	Leukemia	3ce9282f72dd815f18e6ad		1		post	1								
FMT.0187O		FMT.0187	28	semi-formed	SRR11423532	PRJNA545312	14	SRR14092275	16	14	BM_unmodified	Leukemia	3ce9282f72dd815f18e6ad		1		post	1								
FMT.0187P		FMT.0187	29	liquid	SRR11423531	PRJNA545312	15	SRR14092274	16	14	BM_unmodified	Leukemia	3ce9282f72dd815f18e6ad		1		post	2								
FMT.0187Q		FMT.0187	30	liquid	SRR11423529	PRJNA545312	16	SRR14092273	16	14	BM_unmodified	Leukemia	3ce9282f72dd815f18e6ad		1		post	2								
FMT.0187R		FMT.0187	146	formed	SRR11423528	PRJNA545312	132		16	14	BM_unmodified	Leukemia	3ce9282f72dd815f18e6ad		1		post	6								
FMT.0188A		FMT.0188	0	formed	SRR11423527	PRJNA545312	-98		2	98	PBSC_unmodified	Non-Hodgkin's Lymphoma	5256409ca7234721f704b6		1		pre	-3								
FMT.0188C		FMT.0188	123		SRR11423526	PRJNA545312	25		2	98	PBSC_unmodified	Non-Hodgkin's Lymphoma	5256409ca7234721f704b6		1		post	3								
FMT.0189A		FMT.0189	0	formed	SRR11423525	PRJNA545312	-29		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		pre	-3								
FMT.0189B		FMT.0189	14	formed	SRR11423524	PRJNA545312	-15		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		pre	-3								
FMT.0189C		FMT.0189	24	formed	SRR11423523	PRJNA545312	-5		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		pre	-1								
FMT.0189D		FMT.0189	25	semi-formed	SRR11423522	PRJNA545312	-4		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		pre	-1								
FMT.0189E		FMT.0189	30	liquid	SRR11423521	PRJNA545312	1		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		peri	0								
FMT.0189F		FMT.0189	35	liquid	SRR11423520	PRJNA545312	6		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		post	0								
FMT.0189G		FMT.0189	36	liquid	SRR11423518	PRJNA545312	7		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		post	0								
FMT.0189H		FMT.0189	37	semi-formed	SRR11423517	PRJNA545312	8		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		post	1								
FMT.0189I		FMT.0189	38	liquid	SRR11423516	PRJNA545312	9		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		post	1								
FMT.0189J		FMT.0189	39	liquid	SRR11423515	PRJNA545312	10		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		post	1								
FMT.0189K		FMT.0189	41	semi-formed	SRR11423514	PRJNA545312	12		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		post	1								
FMT.0189L		FMT.0189	43	semi-formed	SRR11423513	PRJNA545312	14		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		post	1								
FMT.0189M		FMT.0189	44	semi-formed	SRR11423512	PRJNA545312	15		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		post	2								
FMT.0189N		FMT.0189	45	liquid	SRR11423511	PRJNA545312	16		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		post	2								
FMT.0189O		FMT.0189	46	liquid	SRR11423510	PRJNA545312	17		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		post	2								
FMT.0189P		FMT.0189	49	semi-formed	SRR11423509	PRJNA545312	20		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		post	2								
FMT.0189S		FMT.0189	52	formed	SRR11423507	PRJNA545312	23		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		post	3								
FMT.0189T		FMT.0189	92	liquid	SRR11423506	PRJNA545312	63		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		post	6								
FMT.0189U		FMT.0189	93	semi-formed	SRR11423505	PRJNA545312	64		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		post	6								
FMT.0189V		FMT.0189	98	liquid	SRR11423504	PRJNA545312	69		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		post	6								
FMT.0189W		FMT.0189	99	formed	SRR11423503	PRJNA545312	70		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		post	6								
FMT.0189X		FMT.0189	100	semi-formed	SRR11423502	PRJNA545312	71		22	29	BM_unmodified	Leukemia	40383fed69fd3a912d6aa1		1		post	6								
FMT.0190A		FMT.0190	0	formed	SRR11423501	PRJNA545312	-6		3	6	PBSC_unmodified	Leukemia	9dc94d6a50abe83ffbe167		1		pre	-1								
FMT.0190B		FMT.0190	1	formed	SRR11423500	PRJNA545312	-5		3	6	PBSC_unmodified	Leukemia	9dc94d6a50abe83ffbe167		1		pre	-1								
FMT.0190C		FMT.0190	11	formed	SRR11423499	PRJNA545312	5		3	6	PBSC_unmodified	Leukemia	9dc94d6a50abe83ffbe167		1		peri	0								
FMT.0191A		FMT.0191	0	formed	SRR11423498	PRJNA545312	-21		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		pre	-3								
FMT.0191B		FMT.0191	14	formed	SRR11423496	PRJNA545312	-7		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		pre	-2								
FMT.0191C		FMT.0191	22	semi-formed	SRR11423495	PRJNA545312	1		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		peri	0								
FMT.0191D		FMT.0191	26	semi-formed	SRR11423494	PRJNA545312	5		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		peri	0								
FMT.0191E		FMT.0191	27	liquid	SRR11423493	PRJNA545312	6		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	0								
FMT.0191F		FMT.0191	29	liquid	SRR11423492	PRJNA545312	8		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	1								
FMT.0191G		FMT.0191	34	semi-formed	SRR11423491	PRJNA545312	13		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	1								
FMT.0191H		FMT.0191	36	semi-formed	SRR11423490	PRJNA545312	15		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	2								
FMT.0191I		FMT.0191	39	formed	SRR11423489	PRJNA545312	18		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	2								
FMT.0191J		FMT.0191	40	liquid	SRR11423488	PRJNA545312	19		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	2								
FMT.0191K		FMT.0191	43	semi-formed	SRR11423487	PRJNA545312	22		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	3								
FMT.0191L		FMT.0191	46	formed	SRR11423485	PRJNA545312	25		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	3								
FMT.0191O		FMT.0191	55	semi-formed	SRR10668328	PRJNA545312	34		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	4								
FMT.0191P		FMT.0191	72	semi-formed	SRR10668327	PRJNA545312	51		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	6								
FMT.0191Q		FMT.0191	90	semi-formed	SRR10668326	PRJNA545312	69		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	6								
FMT.0191R		FMT.0191	111	semi-formed	SRR11116845	PRJNA607574	90		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	6								
FMT.0191S		FMT.0191	120	semi-formed	SRR11116716	PRJNA607574	99		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	6								
FMT.0191T		FMT.0191	148	liquid	SRR11116715	PRJNA607574	127		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	6								
FMT.0191U		FMT.0191	149	liquid	SRR11116714	PRJNA607574	128		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	6								
FMT.0191V		FMT.0191	156	liquid	SRR11116713	PRJNA607574	135		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	6								
FMT.0191W		FMT.0191	155	liquid	SRR11116712	PRJNA607574	134		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	6								
FMT.0191X		FMT.0191	158	liquid	SRR11116711	PRJNA607574	137		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	6								
FMT.0191Y		FMT.0191	159	liquid	SRR11116710	PRJNA607574	138		23	21	BM_unmodified	Myelodysplastic Syndromes	9fb0c9ff3579a4db2e5f2e		1		post	6								
FMT.0192A		FMT.0192	0	semi-formed	SRR11423484	PRJNA545312	-15		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		pre	-3								
FMT.0192B		FMT.0192	9	formed	SRR11423483	PRJNA545312	-6		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		pre	-1								
FMT.0192C		FMT.0192	10	formed	SRR11423482	PRJNA545312	-5		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		pre	-1								
FMT.0192D		FMT.0192	12	formed	SRR11423481	PRJNA545312	-3		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		pre	-1								
FMT.0192E		FMT.0192	13	formed	SRR11423480	PRJNA545312	-2		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		pre	-1								
FMT.0192F		FMT.0192	15	formed	SRR11423479	PRJNA545312	0		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		peri	-1								
FMT.0192G		FMT.0192	14	formed	SRR11423478	PRJNA545312	-1		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		pre	-1								
FMT.0192H		FMT.0192	16	formed	SRR11423477	PRJNA545312	1		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		peri	0								
FMT.0192I		FMT.0192	17	formed	SRR11423476	PRJNA545312	2		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		peri	0								
FMT.0192J		FMT.0192	19	formed	SRR11423474	PRJNA545312	4		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		peri	0								
FMT.0192K		FMT.0192	20	formed	SRR11423473	PRJNA545312	5		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		peri	0								
FMT.0192L		FMT.0192	21	formed	SRR11423472	PRJNA545312	6		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		post	0								
FMT.0192M		FMT.0192	22	formed	SRR11423471	PRJNA545312	7		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		post	0								
FMT.0192N		FMT.0192	23	formed	SRR11423470	PRJNA545312	8		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		post	1								
FMT.0192O		FMT.0192	27	liquid	SRR11423469	PRJNA545312	12		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		post	1								
FMT.0192P		FMT.0192	28	liquid	SRR11423468	PRJNA545312	13		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		post	1								
FMT.0192Q		FMT.0192	29	formed	SRR11423467	PRJNA545312	14		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		post	1								
FMT.0192R		FMT.0192	30	formed	SRR11423466	PRJNA545312	15		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		post	2								
FMT.0192S		FMT.0192	31	semi-formed	SRR11423465	PRJNA545312	16		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		post	2								
FMT.0192T		FMT.0192	33	semi-formed	SRR11423462	PRJNA545312	18		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		post	2								
FMT.0192U		FMT.0192	175	formed	SRR11116708	PRJNA607574	160		21	15	PBSC_unmodified	Non-Hodgkin's Lymphoma	32d4d277a5649b2b3c75e1		1		post	6								
FMT.0193A		FMT.0193	0	semi-formed	SRR11423461	PRJNA545312	-7		6	7	cord	Myelodysplastic Syndromes	d0e8e515877fbcf09ea536		1		pre	-2								
FMT.0193B		FMT.0193	8	liquid	SRR11423460	PRJNA545312	1		6	7	cord	Myelodysplastic Syndromes	d0e8e515877fbcf09ea536		1		peri	0								
FMT.0193C		FMT.0193	11	liquid	SRR11423459	PRJNA545312	4		6	7	cord	Myelodysplastic Syndromes	d0e8e515877fbcf09ea536		1		peri	0								
FMT.0193D		FMT.0193	12	semi-formed	SRR11423458	PRJNA545312	5		6	7	cord	Myelodysplastic Syndromes	d0e8e515877fbcf09ea536		1		peri	0								
FMT.0193E		FMT.0193	18	liquid	SRR11423457	PRJNA545312	11		6	7	cord	Myelodysplastic Syndromes	d0e8e515877fbcf09ea536		1		post	1								
FMT.0193F		FMT.0193	23	liquid	SRR11423456	PRJNA545312	16		6	7	cord	Myelodysplastic Syndromes	d0e8e515877fbcf09ea536		1		post	2								
FMT.0194A		FMT.0194	0	formed	SRR11423455	PRJNA545312	-19		17	19	BM_unmodified	Leukemia	a4af57c5da6a08920f2775		1		pre	-3								
FMT.0194B		FMT.0194	17	semi-formed	SRR11423454	PRJNA545312	-2		17	19	BM_unmodified	Leukemia	a4af57c5da6a08920f2775		1		pre	-1								
FMT.0194C		FMT.0194	18	semi-formed	SRR11423453	PRJNA545312	-1		17	19	BM_unmodified	Leukemia	a4af57c5da6a08920f2775		1		pre	-1								
FMT.0194D		FMT.0194	21	semi-formed	SRR11423451	PRJNA545312	2		17	19	BM_unmodified	Leukemia	a4af57c5da6a08920f2775		1		peri	0								
FMT.0194E		FMT.0194	23	liquid	SRR11423450	PRJNA545312	4		17	19	BM_unmodified	Leukemia	a4af57c5da6a08920f2775		1		peri	0								
FMT.0194F		FMT.0194	24	semi-formed	SRR11423449	PRJNA545312	5		17	19	BM_unmodified	Leukemia	a4af57c5da6a08920f2775		1		peri	0								
FMT.0194G		FMT.0194	25	liquid	SRR11423448	PRJNA545312	6		17	19	BM_unmodified	Leukemia	a4af57c5da6a08920f2775		1		post	0								
FMT.0194H		FMT.0194	26	semi-formed	SRR11423447	PRJNA545312	7		17	19	BM_unmodified	Leukemia	a4af57c5da6a08920f2775		1		post	0								
FMT.0194I		FMT.0194	27	semi-formed	SRR11423446	PRJNA545312	8		17	19	BM_unmodified	Leukemia	a4af57c5da6a08920f2775		1		post	1								
FMT.0194J		FMT.0194	28	semi-formed	SRR11423445	PRJNA545312	9		17	19	BM_unmodified	Leukemia	a4af57c5da6a08920f2775		1		post	1								
FMT.0194K		FMT.0194	30	semi-formed	SRR11423444	PRJNA545312	11		17	19	BM_unmodified	Leukemia	a4af57c5da6a08920f2775		1		post	1								
FMT.0194L		FMT.0194	31	semi-formed	SRR11423443	PRJNA545312	12		17	19	BM_unmodified	Leukemia	a4af57c5da6a08920f2775		1		post	1								
FMT.0194N		FMT.0194	35	semi-formed	SRR11423442	PRJNA545312	16		17	19	BM_unmodified	Leukemia	a4af57c5da6a08920f2775		1		post	2								
FMT.0194O		FMT.0194	37	semi-formed	SRR11423440	PRJNA545312	18		17	19	BM_unmodified	Leukemia	a4af57c5da6a08920f2775		1		post	2								
FMT.0194P		FMT.0194	38	semi-formed	SRR11423439	PRJNA545312	19		17	19	BM_unmodified	Leukemia	a4af57c5da6a08920f2775		1		post	2								
FMT.0194Q		FMT.0194	39	semi-formed	SRR11423438	PRJNA545312	20		17	19	BM_unmodified	Leukemia	a4af57c5da6a08920f2775		1		post	2								
FMT.0194R		FMT.0194	40	formed	SRR11423437	PRJNA545312	21		17	19	BM_unmodified	Leukemia	a4af57c5da6a08920f2775		1		post	2								
FMT.0195A		FMT.0195	0	formed	SRR11423436	PRJNA545312	-28		9	28	TCD	Leukemia	4c1b06025f6e540e71cca1		1		pre	-3								
FMT.0195B		FMT.0195	19	formed	SRR11423435	PRJNA545312	-9		9	28	TCD	Leukemia	4c1b06025f6e540e71cca1		1		pre	-2								
FMT.0195C		FMT.0195	20	semi-formed	SRR11422825	PRJNA545312	-8		9	28	TCD	Leukemia	4c1b06025f6e540e71cca1		1		pre	-2								
FMT.0195D		FMT.0195	26	semi-formed	SRR11423121	PRJNA545312	-2		9	28	TCD	Leukemia	4c1b06025f6e540e71cca1		1		pre	-1								
FMT.0195E		FMT.0195	29	liquid	SRR11423120	PRJNA545312	1		9	28	TCD	Leukemia	4c1b06025f6e540e71cca1		1		peri	0								
FMT.0195F		FMT.0195	34	liquid	SRR11423119	PRJNA545312	6		9	28	TCD	Leukemia	4c1b06025f6e540e71cca1		1		post	0								
FMT.0195G		FMT.0195	38	liquid	SRR11423117	PRJNA545312	10		9	28	TCD	Leukemia	4c1b06025f6e540e71cca1		1		post	1								
FMT.0195H		FMT.0195	39	semi-formed	SRR11423116	PRJNA545312	11		9	28	TCD	Leukemia	4c1b06025f6e540e71cca1		1		post	1								
FMT.0195I		FMT.0195	40	semi-formed	SRR11423115	PRJNA545312	12		9	28	TCD	Leukemia	4c1b06025f6e540e71cca1		1		post	1								
FMT.0196A		FMT.0196	0	semi-formed	SRR11423114	PRJNA545312	-7		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		pre	-2								
FMT.0196B		FMT.0196	2	formed	SRR11423113	PRJNA545312	-5		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		pre	-1								
FMT.0196C		FMT.0196	7	semi-formed	SRR11423112	PRJNA545312	0		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		peri	-1								
FMT.0196D		FMT.0196	11	semi-formed	SRR11423111	PRJNA545312	4		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		peri	0								
FMT.0196E		FMT.0196	12	liquid	SRR11423110	PRJNA545312	5		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		peri	0								
FMT.0196F		FMT.0196	19	semi-formed	SRR11423109	PRJNA545312	12		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	1								
FMT.0196G		FMT.0196	20	formed	SRR11423108	PRJNA545312	13		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	1								
FMT.0196H		FMT.0196	21	liquid	SRR11423106	PRJNA545312	14		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	1								
FMT.0196I		FMT.0196	22	semi-formed	SRR11423105	PRJNA545312	15		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	2								
FMT.0196J		FMT.0196	23	semi-formed	SRR11423104	PRJNA545312	16		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	2								
FMT.0196K		FMT.0196	29	semi-formed	SRR11423103	PRJNA545312	22		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	3								
FMT.0196L		FMT.0196	30	semi-formed	SRR11423102	PRJNA545312	23		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	3								
FMT.0196M		FMT.0196	32	semi-formed	SRR11423101	PRJNA545312	25		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	3								
FMT.0196N		FMT.0196	35	semi-formed	SRR11423100	PRJNA545312	28		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	3								
FMT.0196O		FMT.0196	36	semi-formed	SRR11423099	PRJNA545312	29		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	4								
FMT.0196P		FMT.0196	51	formed	SRR11423098	PRJNA545312	44		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	6								
FMT.0196Q		FMT.0196	64	semi-formed	SRR11423097	PRJNA545312	57		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	6								
FMT.0196R		FMT.0196	96	liquid	SRR11423095	PRJNA545312	89		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	6								
FMT.0196S		FMT.0196	97	liquid	SRR11423094	PRJNA545312	90		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	6								
FMT.0196T		FMT.0196	105	semi-formed	SRR11423093	PRJNA545312	98		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	6								
FMT.0196U		FMT.0196	162	semi-formed	SRR11116707	PRJNA607574	155		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	6								
FMT.0196V		FMT.0196	176	liquid	SRR11116706	PRJNA607574	169		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	6								
FMT.0196W		FMT.0196	193	formed	SRR11116705	PRJNA607574	186		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	6								
FMT.0196X		FMT.0196	194	formed	SRR11116704	PRJNA607574	187		24	7	cord	Leukemia	7646b301b8b77aab87e5d5		1		post	6								
FMT.0197A		FMT.0197	0	semi-formed	SRR11423092	PRJNA545312	-16		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		pre	-3								
FMT.0197B		FMT.0197	11	formed	SRR11423091	PRJNA545312	-5		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		pre	-1								
FMT.0197C		FMT.0197	13	formed	SRR11423090	PRJNA545312	-3		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		pre	-1								
FMT.0197D		FMT.0197	15	formed	SRR11423089	PRJNA545312	-1		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		pre	-1								
FMT.0197E		FMT.0197	16	semi-formed	SRR11423088	PRJNA545312	0		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		peri	-1								
FMT.0197F		FMT.0197	17	formed	SRR11423087	PRJNA545312	1		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		peri	0								
FMT.0197G		FMT.0197	18	formed	SRR11423086	PRJNA545312	2		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		peri	0								
FMT.0197H		FMT.0197	20	formed	SRR11423084	PRJNA545312	4		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		peri	0								
FMT.0197I		FMT.0197	22	formed	SRR11423083	PRJNA545312	6		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		post	0								
FMT.0197J		FMT.0197	27	semi-formed	SRR11423082	PRJNA545312	11		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		post	1								
FMT.0197K		FMT.0197	29	formed	SRR11423081	PRJNA545312	13		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		post	1								
FMT.0197L		FMT.0197	30	formed	SRR11423080	PRJNA545312	14		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		post	1								
FMT.0197M		FMT.0197	35	formed	SRR11423079	PRJNA545312	19		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		post	2								
FMT.0197N		FMT.0197	36	formed	SRR11423078	PRJNA545312	20		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		post	2								
FMT.0197O		FMT.0197	37	semi-formed	SRR11423077	PRJNA545312	21		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		post	2								
FMT.0197P		FMT.0197	38	semi-formed	SRR11423076	PRJNA545312	22		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		post	3								
FMT.0197Q		FMT.0197	41	formed	SRR11423075	PRJNA545312	25		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		post	3								
FMT.0197R		FMT.0197	42	formed	SRR11423073	PRJNA545312	26		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		post	3								
FMT.0197S		FMT.0197	43	formed	SRR11423072	PRJNA545312	27		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		post	3								
FMT.0197T		FMT.0197	44	formed	SRR11423071	PRJNA545312	28		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		post	3								
FMT.0197U		FMT.0197	45	semi-formed	SRR11423070	PRJNA545312	29		21	16	PBSC_unmodified	Myeloproliferative Disorder	b6e7d2321d3fef695130aa		1		post	4								
FMT.0198A		FMT.0198	0	semi-formed	SRR11423069	PRJNA545312	-3		8	3	TCD	Leukemia	06a6a2425dd77703905123		1		pre	-1								
FMT.0198B		FMT.0198	6	liquid	SRR11423068	PRJNA545312	3		8	3	TCD	Leukemia	06a6a2425dd77703905123		1		peri	0								
FMT.0198C		FMT.0198	7	liquid	SRR11423067	PRJNA545312	4		8	3	TCD	Leukemia	06a6a2425dd77703905123		1		peri	0								
FMT.0198E		FMT.0198	10	liquid	SRR11423065	PRJNA545312	7		8	3	TCD	Leukemia	06a6a2425dd77703905123		1		post	0								
FMT.0198G		FMT.0198	13	liquid	SRR11423064	PRJNA545312	10		8	3	TCD	Leukemia	06a6a2425dd77703905123		1		post	1								
FMT.0198H		FMT.0198	14	semi-formed	SRR11423062	PRJNA545312	11		8	3	TCD	Leukemia	06a6a2425dd77703905123		1		post	1								
FMT.0198I		FMT.0198	15	semi-formed	SRR11423033	PRJNA545312	12		8	3	TCD	Leukemia	06a6a2425dd77703905123		1		post	1								
FMT.0198J		FMT.0198	17	semi-formed	SRR11423032	PRJNA545312	14		8	3	TCD	Leukemia	06a6a2425dd77703905123		1		post	1								
FMT.0199A		FMT.0199	0	formed	SRR11423031	PRJNA545312	-8		3	8	PBSC_unmodified	Myelodysplastic Syndromes	d06f057f85396bbbd4d9e8		1		pre	-2								
FMT.0199B		FMT.0199	17	semi-formed	SRR11423030	PRJNA545312	9		3	8	PBSC_unmodified	Myelodysplastic Syndromes	d06f057f85396bbbd4d9e8		1		post	1								
FMT.0199C		FMT.0199	19	liquid	SRR11423029	PRJNA545312	11		3	8	PBSC_unmodified	Myelodysplastic Syndromes	d06f057f85396bbbd4d9e8		1		post	1								
FMT.0200A		FMT.0200	0	semi-formed	SRR11423028	PRJNA545312	-8		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		pre	-2								
FMT.0200B		FMT.0200	7	formed	SRR11423027	PRJNA545312	-1		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		pre	-1								
FMT.0200C		FMT.0200	8	semi-formed	SRR11423026	PRJNA545312	0		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		peri	-1								
FMT.0200D		FMT.0200	13	semi-formed	SRR11423025	PRJNA545312	5		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		peri	0								
FMT.0200E		FMT.0200	16	liquid	SRR11423023	PRJNA545312	8		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		post	1								
FMT.0200F		FMT.0200	17	liquid	SRR11423022	PRJNA545312	9		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		post	1								
FMT.0200G		FMT.0200	20	liquid	SRR11423021	PRJNA545312	12		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		post	1								
FMT.0200H		FMT.0200	22	semi-formed	SRR11423020	PRJNA545312	14		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		post	1								
FMT.0200I		FMT.0200	23	liquid	SRR11423019	PRJNA545312	15		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		post	2								
FMT.0200J		FMT.0200	33	formed	SRR11423018	PRJNA545312	25		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		post	3								
FMT.0200K		FMT.0200	47	liquid	SRR11423017	PRJNA545312	39		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		post	5								
FMT.0200L		FMT.0200	50	liquid	SRR11423016	PRJNA545312	42		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		post	5								
FMT.0200M		FMT.0200	51	liquid	SRR11423015	PRJNA545312	43		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		post	6								
FMT.0200N		FMT.0200	57	liquid	SRR11423014	PRJNA545312	49		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		post	6								
FMT.0200O		FMT.0200	58	semi-formed	SRR11423011	PRJNA545312	50		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		post	6								
FMT.0200P		FMT.0200	92	liquid	SRR11423010	PRJNA545312	84		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		post	6								
FMT.0200Q		FMT.0200	93	liquid	SRR11423009	PRJNA545312	85		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		post	6								
FMT.0200R		FMT.0200	94	liquid	SRR11423008	PRJNA545312	86		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		post	6								
FMT.0200S		FMT.0200	104	liquid	SRR11423007	PRJNA545312	96		19	8	PBSC_unmodified	Non-Hodgkin's Lymphoma	477934bcebfdecf6548f51		1		post	6								
FMT.0201A		FMT.0201	0	formed	SRR11423006	PRJNA545312	-10		9	10	TCD	Leukemia	32e44c7bd322f980b3e865		1		pre	-2								
FMT.0201B		FMT.0201	14	liquid	SRR11422977	PRJNA545312	4		9	10	TCD	Leukemia	32e44c7bd322f980b3e865		1		peri	0								
FMT.0201C		FMT.0201	20	semi-formed	SRR11422976	PRJNA545312	10		9	10	TCD	Leukemia	32e44c7bd322f980b3e865		1		post	1								
FMT.0201D		FMT.0201	21	semi-formed	SRR11422975	PRJNA545312	11		9	10	TCD	Leukemia	32e44c7bd322f980b3e865		1		post	1								
FMT.0201E		FMT.0201	30	formed	SRR11422974	PRJNA545312	20		9	10	TCD	Leukemia	32e44c7bd322f980b3e865		1		post	2								
FMT.0201F		FMT.0201	56	formed	SRR11422972	PRJNA545312	46		9	10	TCD	Leukemia	32e44c7bd322f980b3e865		1		post	6								
FMT.0201G		FMT.0201	141	formed	SRR11116703	PRJNA607574	131		9	10	TCD	Leukemia	32e44c7bd322f980b3e865		1		post	6								
FMT.0201H		FMT.0201	310	formed	SRR11116702	PRJNA607574	300		9	10	TCD	Leukemia	32e44c7bd322f980b3e865		1		post	6								
FMT.0201I		FMT.0201	366	formed	SRR11116701	PRJNA607574	356		9	10	TCD	Leukemia	32e44c7bd322f980b3e865		1		post	6								
FMT.0202A		FMT.0202	0	semi-formed	SRR11422971	PRJNA545312	-7		8	7	PBSC_unmodified	Leukemia	36ff6a29e68af8a8d06528		1		pre	-2								
FMT.0202B		FMT.0202	2	formed	SRR11422970	PRJNA545312	-5		8	7	PBSC_unmodified	Leukemia	36ff6a29e68af8a8d06528		1		pre	-1								
FMT.0202C		FMT.0202	4	formed	SRR11422969	PRJNA545312	-3		8	7	PBSC_unmodified	Leukemia	36ff6a29e68af8a8d06528		1		pre	-1								
FMT.0202D		FMT.0202	5	semi-formed	SRR11422968	PRJNA545312	-2		8	7	PBSC_unmodified	Leukemia	36ff6a29e68af8a8d06528		1		pre	-1								
FMT.0202E		FMT.0202	11	semi-formed	SRR11422967	PRJNA545312	4		8	7	PBSC_unmodified	Leukemia	36ff6a29e68af8a8d06528		1		peri	0								
FMT.0202F		FMT.0202	19	formed	SRR11422966	PRJNA545312	12		8	7	PBSC_unmodified	Leukemia	36ff6a29e68af8a8d06528		1		post	1								
FMT.0202G		FMT.0202	32	semi-formed	SRR11422965	PRJNA545312	25		8	7	PBSC_unmodified	Leukemia	36ff6a29e68af8a8d06528		1		post	3								
FMT.0202H		FMT.0202	73	formed	SRR11422964	PRJNA545312	66		8	7	PBSC_unmodified	Leukemia	36ff6a29e68af8a8d06528		1		post	6								
FMT.0203A		FMT.0203	0	formed	SRR11422963	PRJNA545312	-6		8	6	cord	Leukemia	53100d39190194384f0f22		1		pre	-1								
FMT.0203B		FMT.0203	14	semi-formed	SRR11422961	PRJNA545312	8		8	6	cord	Leukemia	53100d39190194384f0f22		1		post	1								
FMT.0203C		FMT.0203	16	semi-formed	SRR11422960	PRJNA545312	10		8	6	cord	Leukemia	53100d39190194384f0f22		1		post	1								
FMT.0203D		FMT.0203	17	semi-formed	SRR11422959	PRJNA545312	11		8	6	cord	Leukemia	53100d39190194384f0f22		1		post	1								
FMT.0203E		FMT.0203	18	liquid	SRR11422958	PRJNA545312	12		8	6	cord	Leukemia	53100d39190194384f0f22		1		post	1								
FMT.0203F		FMT.0203	25	semi-formed	SRR11422957	PRJNA545312	19		8	6	cord	Leukemia	53100d39190194384f0f22		1		post	2								
FMT.0203G		FMT.0203	31	semi-formed	SRR11422956	PRJNA545312	25		8	6	cord	Leukemia	53100d39190194384f0f22		1		post	3								
FMT.0203H		FMT.0203	34	semi-formed	SRR11422955	PRJNA545312	28		8	6	cord	Leukemia	53100d39190194384f0f22		1		post	3								
FMT.0204A		FMT.0204	0	formed	SRR11422954	PRJNA545312	-15		14	15	TCD	Leukemia	697807b5e8eaa5aecdb01b		1		pre	-3								
FMT.0204B		FMT.0204	6	formed	SRR11422953	PRJNA545312	-9		14	15	TCD	Leukemia	697807b5e8eaa5aecdb01b		1		pre	-2								
FMT.0204C		FMT.0204	7	formed	SRR11422952	PRJNA545312	-8		14	15	TCD	Leukemia	697807b5e8eaa5aecdb01b		1		pre	-2								
FMT.0204D		FMT.0204	8	formed	SRR11422950	PRJNA545312	-7		14	15	TCD	Leukemia	697807b5e8eaa5aecdb01b		1		pre	-2								
FMT.0204E		FMT.0204	14	formed	SRR11422893	PRJNA545312	-1		14	15	TCD	Leukemia	697807b5e8eaa5aecdb01b		1		pre	-1								
FMT.0204F		FMT.0204	15	formed	SRR11422892	PRJNA545312	0		14	15	TCD	Leukemia	697807b5e8eaa5aecdb01b		1		peri	-1								
FMT.0204G		FMT.0204	17	liquid	SRR11422891	PRJNA545312	2		14	15	TCD	Leukemia	697807b5e8eaa5aecdb01b		1		peri	0								
FMT.0204H		FMT.0204	18	liquid	SRR11422890	PRJNA545312	3		14	15	TCD	Leukemia	697807b5e8eaa5aecdb01b		1		peri	0								
FMT.0204I		FMT.0204	20	semi-formed	SRR11422889	PRJNA545312	5		14	15	TCD	Leukemia	697807b5e8eaa5aecdb01b		1		peri	0								
FMT.0204J		FMT.0204	22	semi-formed	SRR11422888	PRJNA545312	7		14	15	TCD	Leukemia	697807b5e8eaa5aecdb01b		1		post	0								
FMT.0204K		FMT.0204	25	semi-formed	SRR11422887	PRJNA545312	10		14	15	TCD	Leukemia	697807b5e8eaa5aecdb01b		1		post	1								
FMT.0204L		FMT.0204	26	liquid	SRR11422886	PRJNA545312	11		14	15	TCD	Leukemia	697807b5e8eaa5aecdb01b		1		post	1								
FMT.0204M		FMT.0204	27	semi-formed	SRR11422885	PRJNA545312	12		14	15	TCD	Leukemia	697807b5e8eaa5aecdb01b		1		post	1								
FMT.0204N		FMT.0204	28	semi-formed	SRR11422883	PRJNA545312	13		14	15	TCD	Leukemia	697807b5e8eaa5aecdb01b		1		post	1								
FMT.0205A		FMT.0205	0	formed	SRR11422882	PRJNA545312	-9		11	9	PBSC_unmodified	Hodgkin's Disease	f2e0cd17f4d16361dcd65a		1		pre	-2								
FMT.0205B		FMT.0205	6	formed	SRR11422881	PRJNA545312	-3		11	9	PBSC_unmodified	Hodgkin's Disease	f2e0cd17f4d16361dcd65a		1		pre	-1								
FMT.0205C		FMT.0205	7	formed	SRR11422880	PRJNA545312	-2		11	9	PBSC_unmodified	Hodgkin's Disease	f2e0cd17f4d16361dcd65a		1		pre	-1								
FMT.0205D		FMT.0205	9	formed	SRR11422879	PRJNA545312	0		11	9	PBSC_unmodified	Hodgkin's Disease	f2e0cd17f4d16361dcd65a		1		peri	-1								
FMT.0205E		FMT.0205	10	semi-formed	SRR11422878	PRJNA545312	1		11	9	PBSC_unmodified	Hodgkin's Disease	f2e0cd17f4d16361dcd65a		1		peri	0								
FMT.0205F		FMT.0205	11	semi-formed	SRR11422877	PRJNA545312	2		11	9	PBSC_unmodified	Hodgkin's Disease	f2e0cd17f4d16361dcd65a		1		peri	0								
FMT.0205G		FMT.0205	13	semi-formed	SRR11422876	PRJNA545312	4		11	9	PBSC_unmodified	Hodgkin's Disease	f2e0cd17f4d16361dcd65a		1		peri	0								
FMT.0205H		FMT.0205	17	semi-formed	SRR11422875	PRJNA545312	8		11	9	PBSC_unmodified	Hodgkin's Disease	f2e0cd17f4d16361dcd65a		1		post	1								
FMT.0205I		FMT.0205	22	formed	SRR11422874	PRJNA545312	13		11	9	PBSC_unmodified	Hodgkin's Disease	f2e0cd17f4d16361dcd65a		1		post	1								
FMT.0205J		FMT.0205	24	semi-formed	SRR11422872	PRJNA545312	15		11	9	PBSC_unmodified	Hodgkin's Disease	f2e0cd17f4d16361dcd65a		1		post	2								
FMT.0205K		FMT.0205	25	liquid	SRR11422871	PRJNA545312	16		11	9	PBSC_unmodified	Hodgkin's Disease	f2e0cd17f4d16361dcd65a		1		post	2								
FMT.0206A		FMT.0206	0	semi-formed	SRR11422870	PRJNA545312	-34		17	34	BM_unmodified	Leukemia	438217fec2f2b07e73ced4		1		pre	-3								
FMT.0206B		FMT.0206	29	formed	SRR11422869	PRJNA545312	-5		17	34	BM_unmodified	Leukemia	438217fec2f2b07e73ced4		1		pre	-1								
FMT.0206C		FMT.0206	31	formed	SRR11422868	PRJNA545312	-3		17	34	BM_unmodified	Leukemia	438217fec2f2b07e73ced4		1		pre	-1								
FMT.0206E		FMT.0206	35	formed	SRR11422867	PRJNA545312	1		17	34	BM_unmodified	Leukemia	438217fec2f2b07e73ced4		1		peri	0								
FMT.0206F		FMT.0206	36	formed	SRR11422866	PRJNA545312	2		17	34	BM_unmodified	Leukemia	438217fec2f2b07e73ced4		1		peri	0								
FMT.0206G		FMT.0206	38	formed	SRR11422837	PRJNA545312	4		17	34	BM_unmodified	Leukemia	438217fec2f2b07e73ced4		1		peri	0								
FMT.0206H		FMT.0206	39	formed	SRR11422836	PRJNA545312	5		17	34	BM_unmodified	Leukemia	438217fec2f2b07e73ced4		1		peri	0								
FMT.0206I		FMT.0206	40	formed	SRR11422835	PRJNA545312	6		17	34	BM_unmodified	Leukemia	438217fec2f2b07e73ced4		1		post	0								
FMT.0206J		FMT.0206	41	formed	SRR11422833	PRJNA545312	7		17	34	BM_unmodified	Leukemia	438217fec2f2b07e73ced4		1		post	0								
FMT.0206K		FMT.0206	42	formed	SRR11422832	PRJNA545312	8		17	34	BM_unmodified	Leukemia	438217fec2f2b07e73ced4		1		post	1								
FMT.0206L		FMT.0206	43	formed	SRR11422831	PRJNA545312	9		17	34	BM_unmodified	Leukemia	438217fec2f2b07e73ced4		1		post	1								
FMT.0206M		FMT.0206	47	formed	SRR11422830	PRJNA545312	13		17	34	BM_unmodified	Leukemia	438217fec2f2b07e73ced4		1		post	1								
FMT.0206N		FMT.0206	49	formed	SRR11422829	PRJNA545312	15		17	34	BM_unmodified	Leukemia	438217fec2f2b07e73ced4		1		post	2								
FMT.0206O		FMT.0206	50	formed	SRR11422828	PRJNA545312	16		17	34	BM_unmodified	Leukemia	438217fec2f2b07e73ced4		1		post	2								
FMT.0206P		FMT.0206	52	formed	SRR11422827	PRJNA545312	18		17	34	BM_unmodified	Leukemia	438217fec2f2b07e73ced4		1		post	2								
FMT.0206Q		FMT.0206	53	formed	SRR11422826	PRJNA545312	19		17	34	BM_unmodified	Leukemia	438217fec2f2b07e73ced4		1		post	2								
FMT.0206R		FMT.0206	105	semi-formed	SRR11116700	PRJNA607574	71		17	34	BM_unmodified	Leukemia	438217fec2f2b07e73ced4		1		post	6								
FMT.0207A		FMT.0207	0	formed	SRR11422824	PRJNA545312	-27		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		pre	-3								
FMT.0207AA		FMT.0207	375	formed	SRR11116699	PRJNA607574	348		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	6								
FMT.0207B		FMT.0207	18	formed	SRR11423433	PRJNA545312	-9		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		pre	-2								
FMT.0207C		FMT.0207	20	formed	SRR11423431	PRJNA545312	-7		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		pre	-2								
FMT.0207D		FMT.0207	21	formed	SRR11423430	PRJNA545312	-6		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		pre	-1								
FMT.0207E		FMT.0207	24	formed	SRR11423429	PRJNA545312	-3		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		pre	-1								
FMT.0207F		FMT.0207	25	liquid	SRR11423428	PRJNA545312	-2		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		pre	-1								
FMT.0207G		FMT.0207	26	liquid	SRR11423427	PRJNA545312	-1		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		pre	-1								
FMT.0207H		FMT.0207	27	liquid	SRR11423426	PRJNA545312	0		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		peri	-1								
FMT.0207I		FMT.0207	35	semi-formed	SRR11423425	PRJNA545312	8		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	1								
FMT.0207J		FMT.0207	37	formed	SRR11423424	PRJNA545312	10		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	1								
FMT.0207K		FMT.0207	40	semi-formed	SRR11423423	PRJNA545312	13		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	1								
FMT.0207L		FMT.0207	41	semi-formed	SRR11423422	PRJNA545312	14		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	1								
FMT.0207M		FMT.0207	42	semi-formed	SRR11423420	PRJNA545312	15		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	2								
FMT.0207O		FMT.0207	54	liquid	SRR10668322	PRJNA545312	27		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	3								
FMT.0207P		FMT.0207	61	formed	SRR10668321	PRJNA545312	34		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	4								
FMT.0207Q		FMT.0207	75	formed	SRR10668320	PRJNA545312	48		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	6								
FMT.0207R		FMT.0207	89	semi-formed	SRR10668319	PRJNA545312	62		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	6								
FMT.0207S		FMT.0207	110	formed	SRR11116697	PRJNA607574	83		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	6								
FMT.0207T		FMT.0207	173	semi-formed	SRR11116696	PRJNA607574	146		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	6								
FMT.0207U		FMT.0207	207	formed	SRR11116695	PRJNA607574	180		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	6								
FMT.0207V		FMT.0207	223	formed	SRR11116694	PRJNA607574	196		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	6								
FMT.0207W		FMT.0207	251	formed	SRR11116693	PRJNA607574	224		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	6								
FMT.0207X		FMT.0207	277	formed	SRR11116692	PRJNA607574	250		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	6								
FMT.0207Y		FMT.0207	312	formed	SRR11116691	PRJNA607574	285		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	6								
FMT.0207Z		FMT.0207	342	formed	SRR11116690	PRJNA607574	315		26	27	TCD	Leukemia	77a939ef53c23d2756c1b6		1		post	6								
FMT.0208A		FMT.0208	0		SRR11423419	PRJNA545312	-12		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		pre	-2								
FMT.0208AA		FMT.0208	123	liquid	SRR11116689	PRJNA607574	111		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	6								
FMT.0208B		FMT.0208	13	formed	SRR11423387	PRJNA545312	1		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		peri	0								
FMT.0208BB		FMT.0208	130	liquid	SRR11117129	PRJNA607574	118		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	6								
FMT.0208C		FMT.0208	16	formed	SRR11422546	PRJNA545312	4		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		peri	0								
FMT.0208CC		FMT.0208	131	semi-formed	SRR11117127	PRJNA607574	119		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	6								
FMT.0208D		FMT.0208	17	liquid	SRR11422545	PRJNA545312	5		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		peri	0								
FMT.0208DD		FMT.0208	167	liquid	SRR11117126	PRJNA607574	155		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	6								
FMT.0208E		FMT.0208	18	liquid	SRR11422543	PRJNA545312	6		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	0								
FMT.0208EE		FMT.0208	185	liquid	SRR11117125	PRJNA607574	173		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	6								
FMT.0208F		FMT.0208	19	liquid	SRR11422542	PRJNA545312	7		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	0								
FMT.0208G		FMT.0208	20	liquid	SRR11422541	PRJNA545312	8		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	1								
FMT.0208H		FMT.0208	24	liquid	SRR11421726	PRJNA545312	12		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	1								
FMT.0208I		FMT.0208	25	liquid	SRR11421725	PRJNA545312	13		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	1								
FMT.0208J		FMT.0208	26	liquid	SRR11421724	PRJNA545312	14		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	1								
FMT.0208K		FMT.0208	27	liquid	SRR11421723	PRJNA545312	15		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	2								
FMT.0208L		FMT.0208	28	semi-formed	SRR11421722	PRJNA545312	16		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	2								
FMT.0208M		FMT.0208	34	liquid	SRR11421721	PRJNA545312	22		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	3								
FMT.0208N		FMT.0208	35	liquid	SRR11421720	PRJNA545312	23		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	3								
FMT.0208O		FMT.0208	37	liquid	SRR11421718	PRJNA545312	25		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	3								
FMT.0208P		FMT.0208	38	liquid	SRR11421717	PRJNA545312	26		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	3								
FMT.0208Q		FMT.0208	39	liquid	SRR11421716	PRJNA545312	27		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	3								
FMT.0208R		FMT.0208	59	semi-formed	SRR11421715	PRJNA545312	47		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	6								
FMT.0208S		FMT.0208	60	liquid	SRR11421714	PRJNA545312	48		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	6								
FMT.0208T		FMT.0208	62	liquid	SRR11421713	PRJNA545312	50		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	6								
FMT.0208U		FMT.0208	66	liquid	SRR11421712	PRJNA545312	54		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	6								
FMT.0208V		FMT.0208	87	semi-formed	SRR11421711	PRJNA545312	75		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	6								
FMT.0208W		FMT.0208	88	semi-formed	SRR11421710	PRJNA545312	76		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	6								
FMT.0208X		FMT.0208	96	liquid	SRR11421709	PRJNA545312	84		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	6								
FMT.0208Y		FMT.0208	107	liquid	SRR11421707	PRJNA545312	95		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	6								
FMT.0208Z		FMT.0208	108	liquid	SRR11421706	PRJNA545312	96		31	12	BM_unmodified	Leukemia	6ee0dd85e063131e77bb33		1		post	6								
FMT.0209A		FMT.0209	0	semi-formed	SRR11396699	PRJNA607574			1																	
FMT.0210A		FMT.0210	0	semi-formed	SRR11421705	PRJNA545312	4		2	-4	cord	Leukemia	c076b62b20f563ae586643		1		peri	0								
FMT.0210B		FMT.0210	12	semi-formed	SRR11421704	PRJNA545312	16		2	-4	cord	Leukemia	c076b62b20f563ae586643		1		post	2								
FMT.0211A		FMT.0211	0	formed	SRR11421703	PRJNA545312	-14		14	536	cord	Leukemia	bc7e7fe17dd8786aa1f36e		1		pre	-3								
FMT.0211B		FMT.0211	6	formed	SRR9271262	PRJNA548153	-8		14	536	cord	Leukemia	bc7e7fe17dd8786aa1f36e		1		pre	-2								
FMT.0211C		FMT.0211	12	formed	SRR9271255	PRJNA548153	-2		14	536	cord	Leukemia	bc7e7fe17dd8786aa1f36e		1		pre	-1								
FMT.0211D		FMT.0211	14	liquid	SRR9271254	PRJNA548153	0		14	536	cord	Leukemia	bc7e7fe17dd8786aa1f36e		1		peri	-1								
FMT.0211E		FMT.0211	13	liquid	SRR9271193	PRJNA548153	-1		14	536	cord	Leukemia	bc7e7fe17dd8786aa1f36e		1		pre	-1								
FMT.0211F		FMT.0211	18	liquid	SRR9271194	PRJNA548153	4		14	536	cord	Leukemia	bc7e7fe17dd8786aa1f36e		1		peri	0								
FMT.0211G		FMT.0211	19	liquid	SRR9271191	PRJNA548153	5		14	536	cord	Leukemia	bc7e7fe17dd8786aa1f36e		1		peri	0								
FMT.0211K		FMT.0211	25	liquid	SRR11117124	PRJNA607574	11		14	536	cord	Leukemia	bc7e7fe17dd8786aa1f36e		1		post	1								
FMT.0211O		FMT.0211	110	liquid	SRR11117123	PRJNA607574	96		14	536	cord	Leukemia	bc7e7fe17dd8786aa1f36e		1		post	6								
FMT.0211Q		FMT.0211	543	liquid	SRR11117121	PRJNA607574	7		14	536	cord	Leukemia	bc7e7fe17dd8786aa1f36e		1		post	0								
FMT.0211R		FMT.0211	546	liquid	SRR11117120	PRJNA607574	10		14	536	cord	Leukemia	bc7e7fe17dd8786aa1f36e		1		post	1								
FMT.0211S		FMT.0211	551	liquid	SRR11117119	PRJNA607574	15		14	536	cord	Leukemia	bc7e7fe17dd8786aa1f36e		1		post	2								
FMT.0211W		FMT.0211	560	liquid	SRR11117115	PRJNA607574	24		14	536	cord	Leukemia	bc7e7fe17dd8786aa1f36e		1		post	3								
FMT.0211X		FMT.0211	564	liquid	SRR11117114	PRJNA607574	28		14	536	cord	Leukemia	bc7e7fe17dd8786aa1f36e		1		post	3								
FMT.0212A		FMT.0212	0	semi-formed	SRR11421702	PRJNA545312	-8		15	8	cord	Leukemia	19d8c1ce8c541dee744a8d		1		pre	-2								
FMT.0212B		FMT.0212	20	liquid	SRR11421701	PRJNA545312	12		15	8	cord	Leukemia	19d8c1ce8c541dee744a8d		1		post	1								
FMT.0212C		FMT.0212	21	liquid	SRR11421700	PRJNA545312	13		15	8	cord	Leukemia	19d8c1ce8c541dee744a8d		1		post	1								
FMT.0212D		FMT.0212	30	liquid	SRR11421699	PRJNA545312	22		15	8	cord	Leukemia	19d8c1ce8c541dee744a8d		1		post	3								
FMT.0212E		FMT.0212	32	liquid	SRR11422596	PRJNA545312	24		15	8	cord	Leukemia	19d8c1ce8c541dee744a8d		1		post	3								
FMT.0212F		FMT.0212	33	semi-formed	SRR11422594	PRJNA545312	25		15	8	cord	Leukemia	19d8c1ce8c541dee744a8d		1		post	3								
FMT.0212G		FMT.0212	36	liquid	SRR11422593	PRJNA545312	28		15	8	cord	Leukemia	19d8c1ce8c541dee744a8d		1		post	3								
FMT.0212H		FMT.0212	51	semi-formed	SRR11117113	PRJNA607574	43		15	8	cord	Leukemia	19d8c1ce8c541dee744a8d		1		post	6								
FMT.0212I		FMT.0212	71	liquid	SRR11422592	PRJNA545312	63		15	8	cord	Leukemia	19d8c1ce8c541dee744a8d		1		post	6								
FMT.0212J		FMT.0212	91	semi-formed	SRR11117112	PRJNA607574	83		15	8	cord	Leukemia	19d8c1ce8c541dee744a8d		1		post	6								
FMT.0212K		FMT.0212	118	semi-formed	SRR11117111	PRJNA607574	110		15	8	cord	Leukemia	19d8c1ce8c541dee744a8d		1		post	6								
FMT.0212L		FMT.0212	160	semi-formed	SRR11117110	PRJNA607574	152		15	8	cord	Leukemia	19d8c1ce8c541dee744a8d		1		post	6								
FMT.0212M		FMT.0212	215	liquid	SRR11117109	PRJNA607574	207		15	8	cord	Leukemia	19d8c1ce8c541dee744a8d		1		post	6								
FMT.0212N		FMT.0212	239	liquid	SRR11117108	PRJNA607574	231		15	8	cord	Leukemia	19d8c1ce8c541dee744a8d		1		post	6								
FMT.0212O		FMT.0212	293	liquid	SRR11117107	PRJNA607574	285		15	8	cord	Leukemia	19d8c1ce8c541dee744a8d		1		post	6								
FMT.0213A		FMT.0213	0	formed	SRR11396695	PRJNA607574			4																	
FMT.0213B		FMT.0213	112	liquid	SRR11140365	PRJNA606262			4																	
FMT.0213C		FMT.0213	119	liquid	SRR11140363	PRJNA606262			4																	
FMT.0213D		FMT.0213	121	liquid	SRR11140362	PRJNA606262			4																	
FMT.0214A		FMT.0214	0	semi-formed	SRR11422591	PRJNA545312	-24		6	24	TCD	Multiple Myeloma	71d8e28b77b6d147defe3f		1		pre	-3								
FMT.0214B		FMT.0214	21	liquid	SRR11422590	PRJNA545312	-3		6	24	TCD	Multiple Myeloma	71d8e28b77b6d147defe3f		1		pre	-1								
FMT.0214C		FMT.0214	22	liquid	SRR11422589	PRJNA545312	-2		6	24	TCD	Multiple Myeloma	71d8e28b77b6d147defe3f		1		pre	-1								
FMT.0214D		FMT.0214	23	liquid	SRR11422588	PRJNA545312	-1		6	24	TCD	Multiple Myeloma	71d8e28b77b6d147defe3f		1		pre	-1								
FMT.0214E		FMT.0214	34	formed	SRR11422587	PRJNA545312	10		6	24	TCD	Multiple Myeloma	71d8e28b77b6d147defe3f		1		post	1								
FMT.0214F		FMT.0214	35	semi-formed	SRR11422586	PRJNA545312	11		6	24	TCD	Multiple Myeloma	71d8e28b77b6d147defe3f		1		post	1								
FMT.0215A		FMT.0215	0	formed	SRR11422585	PRJNA545312	-7		9	7	TCD	Myelodysplastic Syndromes	f263a1718311c287478243		1		pre	-2								
FMT.0215B		FMT.0215	4	semi-formed	SRR11422583	PRJNA545312	-3		9	7	TCD	Myelodysplastic Syndromes	f263a1718311c287478243		1		pre	-1								
FMT.0215C		FMT.0215	7	semi-formed	SRR11422582	PRJNA545312	0		9	7	TCD	Myelodysplastic Syndromes	f263a1718311c287478243		1		peri	-1								
FMT.0215D		FMT.0215	8	liquid	SRR11422581	PRJNA545312	1		9	7	TCD	Myelodysplastic Syndromes	f263a1718311c287478243		1		peri	0								
FMT.0215E		FMT.0215	10	liquid	SRR11422580	PRJNA545312	3		9	7	TCD	Myelodysplastic Syndromes	f263a1718311c287478243		1		peri	0								
FMT.0215G		FMT.0215	13	liquid	SRR11422579	PRJNA545312	6		9	7	TCD	Myelodysplastic Syndromes	f263a1718311c287478243		1		post	0								
FMT.0215H		FMT.0215	21	liquid	SRR11422578	PRJNA545312	14		9	7	TCD	Myelodysplastic Syndromes	f263a1718311c287478243		1		post	1								
FMT.0215I		FMT.0215	24	semi-formed	SRR11422577	PRJNA545312	17		9	7	TCD	Myelodysplastic Syndromes	f263a1718311c287478243		1		post	2								
FMT.0215J		FMT.0215	25	liquid	SRR11422576	PRJNA545312	18		9	7	TCD	Myelodysplastic Syndromes	f263a1718311c287478243		1		post	2								
FMT.0216A		FMT.0216	178	semi-formed	SRR11422575	PRJNA545312	-7		15	185	PBSC_unmodified	Non-Hodgkin's Lymphoma	0108dfb76b3943dc8934a8		1		pre	-2								
FMT.0216B		FMT.0216	179	semi-formed	SRR11422574	PRJNA545312	-6		15	185	PBSC_unmodified	Non-Hodgkin's Lymphoma	0108dfb76b3943dc8934a8		1		pre	-1								
FMT.0216C		FMT.0216	180	formed	SRR11422572	PRJNA545312	-5		15	185	PBSC_unmodified	Non-Hodgkin's Lymphoma	0108dfb76b3943dc8934a8		1		pre	-1								
FMT.0216D		FMT.0216	193	semi-formed	SRR11422571	PRJNA545312	8		15	185	PBSC_unmodified	Non-Hodgkin's Lymphoma	0108dfb76b3943dc8934a8		1		post	1								
FMT.0216E		FMT.0216	198	semi-formed	SRR11422570	PRJNA545312	13		15	185	PBSC_unmodified	Non-Hodgkin's Lymphoma	0108dfb76b3943dc8934a8		1		post	1								
FMT.0216F		FMT.0216	199	liquid	SRR11422569	PRJNA545312	14		15	185	PBSC_unmodified	Non-Hodgkin's Lymphoma	0108dfb76b3943dc8934a8		1		post	1								
FMT.0216G		FMT.0216	222	formed	SRR11421911	PRJNA545312	37		15	185	PBSC_unmodified	Non-Hodgkin's Lymphoma	0108dfb76b3943dc8934a8		1		post	5								
FMT.0216H		FMT.0216	248	formed	SRR11117106	PRJNA607574	63		15	185	PBSC_unmodified	Non-Hodgkin's Lymphoma	0108dfb76b3943dc8934a8		1		post	6								
FMT.0216I		FMT.0216	305	formed	SRR11117104	PRJNA607574	120		15	185	PBSC_unmodified	Non-Hodgkin's Lymphoma	0108dfb76b3943dc8934a8		1		post	6								
FMT.0217A		FMT.0217	0	formed	SRR11117103	PRJNA607574	-23		12	23	TCD	Myeloproliferative Disorder	cf25f4050a56f7147e00a8		1		pre	-3								
FMT.0217B		FMT.0217	14	formed	SRR11421910	PRJNA545312	-9		12	23	TCD	Myeloproliferative Disorder	cf25f4050a56f7147e00a8		1		pre	-2								
FMT.0217C		FMT.0217	18	formed	SRR11421909	PRJNA545312	-5		12	23	TCD	Myeloproliferative Disorder	cf25f4050a56f7147e00a8		1		pre	-1								
FMT.0217D		FMT.0217	19	liquid	SRR11421908	PRJNA545312	-4		12	23	TCD	Myeloproliferative Disorder	cf25f4050a56f7147e00a8		1		pre	-1								
FMT.0217E		FMT.0217	22	liquid	SRR11421907	PRJNA545312	-1		12	23	TCD	Myeloproliferative Disorder	cf25f4050a56f7147e00a8		1		pre	-1								
FMT.0217F		FMT.0217	26	liquid	SRR11421906	PRJNA545312	3		12	23	TCD	Myeloproliferative Disorder	cf25f4050a56f7147e00a8		1		peri	0								
FMT.0217G		FMT.0217	27	semi-formed	SRR11421904	PRJNA545312	4		12	23	TCD	Myeloproliferative Disorder	cf25f4050a56f7147e00a8		1		peri	0								
FMT.0217H		FMT.0217	32	semi-formed	SRR11421903	PRJNA545312	9		12	23	TCD	Myeloproliferative Disorder	cf25f4050a56f7147e00a8		1		post	1								
FMT.0217I		FMT.0217	35	formed	SRR11421902	PRJNA545312	12		12	23	TCD	Myeloproliferative Disorder	cf25f4050a56f7147e00a8		1		post	1								
FMT.0217J		FMT.0217	37	formed	SRR11421901	PRJNA545312	14		12	23	TCD	Myeloproliferative Disorder	cf25f4050a56f7147e00a8		1		post	1								
FMT.0217K		FMT.0217	40	formed	SRR11421900	PRJNA545312	17		12	23	TCD	Myeloproliferative Disorder	cf25f4050a56f7147e00a8		1		post	2								
FMT.0217L		FMT.0217	79	semi-formed	SRR11117102	PRJNA607574	56		12	23	TCD	Myeloproliferative Disorder	cf25f4050a56f7147e00a8		1		post	6								
FMT.0218A		FMT.0218	0	semi-formed	SRR11116979	PRJNA607574	0		6	0	PBSC_unmodified	Leukemia	07c5a3683913a883ba2d06		0		peri	-1								
FMT.0218B		FMT.0218	1	formed	SRR11116978	PRJNA607574	1		6	0	PBSC_unmodified	Leukemia	07c5a3683913a883ba2d06		0		peri	0								
FMT.0218C		FMT.0218	4	semi-formed	SRR11116977	PRJNA607574	4		6	0	PBSC_unmodified	Leukemia	07c5a3683913a883ba2d06		0		peri	0								
FMT.0218D		FMT.0218	8	semi-formed	SRR11116976	PRJNA607574	8		6	0	PBSC_unmodified	Leukemia	07c5a3683913a883ba2d06		0		post	1								
FMT.0218E		FMT.0218	11	formed	SRR11116975	PRJNA607574	11		6	0	PBSC_unmodified	Leukemia	07c5a3683913a883ba2d06		0		post	1								
FMT.0218F		FMT.0218	12	semi-formed	SRR11116974	PRJNA607574	12		6	0	PBSC_unmodified	Leukemia	07c5a3683913a883ba2d06		0		post	1								
FMT.0219A		FMT.0219	0	formed	SRR11421899	PRJNA545312	-10		10	10	TCD	Myeloproliferative Disorder	814378a8b905a036e3c5d4		1		pre	-2								
FMT.0219B		FMT.0219	1	formed	SRR11116973	PRJNA607574	-9		10	10	TCD	Myeloproliferative Disorder	814378a8b905a036e3c5d4		1		pre	-2								
FMT.0219C		FMT.0219	2	formed	SRR11421898	PRJNA545312	-8		10	10	TCD	Myeloproliferative Disorder	814378a8b905a036e3c5d4		1		pre	-2								
FMT.0219D		FMT.0219	5	semi-formed	SRR11421897	PRJNA545312	-5		10	10	TCD	Myeloproliferative Disorder	814378a8b905a036e3c5d4		1		pre	-1								
FMT.0219E		FMT.0219	8	formed	SRR11421896	PRJNA545312	-2		10	10	TCD	Myeloproliferative Disorder	814378a8b905a036e3c5d4		1		pre	-1								
FMT.0219F		FMT.0219	9	formed	SRR11421894	PRJNA545312	-1		10	10	TCD	Myeloproliferative Disorder	814378a8b905a036e3c5d4		1		pre	-1								
FMT.0219G		FMT.0219	15	semi-formed	SRR11423386	PRJNA545312	5		10	10	TCD	Myeloproliferative Disorder	814378a8b905a036e3c5d4		1		peri	0								
FMT.0219H		FMT.0219	16	semi-formed	SRR11423385	PRJNA545312	6		10	10	TCD	Myeloproliferative Disorder	814378a8b905a036e3c5d4		1		post	0								
FMT.0219I		FMT.0219	20	formed	SRR11423384	PRJNA545312	10		10	10	TCD	Myeloproliferative Disorder	814378a8b905a036e3c5d4		1		post	1								
FMT.0219J		FMT.0219	19	formed	SRR11423383	PRJNA545312	9		10	10	TCD	Myeloproliferative Disorder	814378a8b905a036e3c5d4		1		post	1								
FMT.0220A		FMT.0220	0	formed	SRR11423382	PRJNA545312	-6		5	6	BM_unmodified	Aplastic Anemia	11ca42800b08b28762b481		1		pre	-1								
FMT.0220B		FMT.0220	5	formed	SRR11423381	PRJNA545312	-1		5	6	BM_unmodified	Aplastic Anemia	11ca42800b08b28762b481		1		pre	-1								
FMT.0220C		FMT.0220	12	formed	SRR11423380	PRJNA545312	6		5	6	BM_unmodified	Aplastic Anemia	11ca42800b08b28762b481		1		post	0								
FMT.0220D		FMT.0220	16	formed	SRR11423378	PRJNA545312	10		5	6	BM_unmodified	Aplastic Anemia	11ca42800b08b28762b481		1		post	1								
FMT.0220E		FMT.0220	33		SRR11423377	PRJNA545312	27		5	6	BM_unmodified	Aplastic Anemia	11ca42800b08b28762b481		1		post	3								
FMT.0221B		FMT.0221	6	formed	SRR11423376	PRJNA545312	-3		6	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	e814ffc003abf35f95a32b		1		pre	-1								
FMT.0221C		FMT.0221	14	semi-formed	SRR11423375	PRJNA545312	5		6	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	e814ffc003abf35f95a32b		1		peri	0								
FMT.0221D		FMT.0221	15	semi-formed	SRR11423374	PRJNA545312	6		6	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	e814ffc003abf35f95a32b		1		post	0								
FMT.0221E		FMT.0221	16	formed	SRR11423373	PRJNA545312	7		6	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	e814ffc003abf35f95a32b		1		post	0								
FMT.0221F		FMT.0221	19	formed	SRR11423372	PRJNA545312	10		6	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	e814ffc003abf35f95a32b		1		post	1								
FMT.0221G		FMT.0221	20	semi-formed	SRR11423371	PRJNA545312	11		6	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	e814ffc003abf35f95a32b		1		post	1								
FMT.0222A		FMT.0222	0	formed	SRR11423370	PRJNA545312	-9		13	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	7abb0818ee2bf20d33eee7		1		pre	-2								
FMT.0222B		FMT.0222	5	formed	SRR11423369	PRJNA545312	-4		13	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	7abb0818ee2bf20d33eee7		1		pre	-1								
FMT.0222C		FMT.0222	6	formed	SRR11423366	PRJNA545312	-3		13	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	7abb0818ee2bf20d33eee7		1		pre	-1								
FMT.0222D		FMT.0222	8	formed	SRR11423365	PRJNA545312	-1		13	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	7abb0818ee2bf20d33eee7		1		pre	-1								
FMT.0222E		FMT.0222	9	formed	SRR11423364	PRJNA545312	0		13	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	7abb0818ee2bf20d33eee7		1		peri	-1								
FMT.0222F		FMT.0222	12	liquid	SRR11423363	PRJNA545312	3		13	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	7abb0818ee2bf20d33eee7		1		peri	0								
FMT.0222H		FMT.0222	15	semi-formed	SRR11423362	PRJNA545312	6		13	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	7abb0818ee2bf20d33eee7		1		post	0								
FMT.0222K		FMT.0222	19	semi-formed	SRR11423361	PRJNA545312	10		13	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	7abb0818ee2bf20d33eee7		1		post	1								
FMT.0222L		FMT.0222	20	liquid	SRR11423360	PRJNA545312	11		13	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	7abb0818ee2bf20d33eee7		1		post	1								
FMT.0222R		FMT.0222	29	formed	SRR11423331	PRJNA545312	20		13	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	7abb0818ee2bf20d33eee7		1		post	2								
FMT.0222S		FMT.0222	30	semi-formed	SRR11423330	PRJNA545312	21		13	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	7abb0818ee2bf20d33eee7		1		post	2								
FMT.0222T		FMT.0222	31	formed	SRR11423329	PRJNA545312	22		13	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	7abb0818ee2bf20d33eee7		1		post	3								
FMT.0222U		FMT.0222	66	semi-formed	SRR11116971	PRJNA607574	57		13	9	PBSC_unmodified	Non-Hodgkin's Lymphoma	7abb0818ee2bf20d33eee7		1		post	6								
FMT.0223A		FMT.0223	0	formed	SRR11423327	PRJNA545312	-10		12	10	TCD	Multiple Myeloma	fe5d59743a68305ac5cf35		1		pre	-2								
FMT.0223B		FMT.0223	3	formed	SRR11423326	PRJNA545312	-7		12	10	TCD	Multiple Myeloma	fe5d59743a68305ac5cf35		1		pre	-2								
FMT.0223C		FMT.0223	4	formed	SRR11423325	PRJNA545312	-6		12	10	TCD	Multiple Myeloma	fe5d59743a68305ac5cf35		1		pre	-1								
FMT.0223D		FMT.0223	24	semi-formed	SRR11423324	PRJNA545312	14		12	10	TCD	Multiple Myeloma	fe5d59743a68305ac5cf35		1		post	1								
FMT.0223E		FMT.0223	46		SRR11116970	PRJNA607574	36		12	10	TCD	Multiple Myeloma	fe5d59743a68305ac5cf35		1		post	5								
FMT.0223F		FMT.0223	65	formed	SRR11116969	PRJNA607574	55		12	10	TCD	Multiple Myeloma	fe5d59743a68305ac5cf35		1		post	6								
FMT.0223G		FMT.0223	231	semi-formed	SRR11116968	PRJNA607574	221		12	10	TCD	Multiple Myeloma	fe5d59743a68305ac5cf35		1		post	6								
FMT.0223H		FMT.0223	232	semi-formed	SRR11116967	PRJNA607574	222		12	10	TCD	Multiple Myeloma	fe5d59743a68305ac5cf35		1		post	6								
FMT.0224A		FMT.0224	0	formed	SRR11423323	PRJNA545312	-55		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		pre	-3								
FMT.0224B		FMT.0224	48	formed	SRR11423322	PRJNA545312	-7		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		pre	-2								
FMT.0224C		FMT.0224	53	semi-formed	SRR11423321	PRJNA545312	-2		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		pre	-1								
FMT.0224D		FMT.0224	54	semi-formed	SRR11423320	PRJNA545312	-1		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		pre	-1								
FMT.0224E		FMT.0224	56	liquid	SRR11423319	PRJNA545312	1		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		peri	0								
FMT.0224F		FMT.0224	58	liquid	SRR11423318	PRJNA545312	3		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		peri	0								
FMT.0224G		FMT.0224	59	liquid	SRR11423316	PRJNA545312	4		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		peri	0								
FMT.0224H		FMT.0224	61	liquid	SRR11423315	PRJNA545312	6		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		post	0								
FMT.0224I		FMT.0224	62	liquid	SRR11423314	PRJNA545312	7		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		post	0								
FMT.0224J		FMT.0224	63	liquid	SRR11423313	PRJNA545312	8		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		post	1								
FMT.0224K		FMT.0224	65	semi-formed	SRR11423312	PRJNA545312	10		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		post	1								
FMT.0224L		FMT.0224	66	liquid	SRR11423311	PRJNA545312	11		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		post	1								
FMT.0224M		FMT.0224	68	liquid	SRR11423310	PRJNA545312	13		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		post	1								
FMT.0224N		FMT.0224	70	formed	SRR11423309	PRJNA545312	15		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		post	2								
FMT.0224O		FMT.0224	80	liquid	SRR10668318	PRJNA545312	25		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		post	3								
FMT.0224P		FMT.0224	81	liquid	SRR10668317	PRJNA545312	26		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		post	3								
FMT.0224Q		FMT.0224	82	semi-formed	SRR10668316	PRJNA545312	27		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		post	3								
FMT.0224R		FMT.0224	98	formed	SRR10668315	PRJNA545312	43		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		post	6								
FMT.0224S		FMT.0224	112	semi-formed	SRR10668314	PRJNA545312	57		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		post	6								
FMT.0224T		FMT.0224	132	formed	SRR11116966	PRJNA607574	77		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		post	6								
FMT.0224U		FMT.0224	168	semi-formed	SRR11116965	PRJNA607574	113		21	55	TCD	Myeloproliferative Disorder	a97d8d87ddebfdcdd396fe		1		post	6								
FMT.0225A		FMT.0225	0	formed	SRR11423308	PRJNA545312	-33		7	33	PBSC_unmodified	Non-Hodgkin's Lymphoma	1017b67510ed386a9863f8		1		pre	-3								
FMT.0225B		FMT.0225	42		SRR10668313	PRJNA545312	9		7	33	PBSC_unmodified	Non-Hodgkin's Lymphoma	1017b67510ed386a9863f8		1		post	1								
FMT.0225C		FMT.0225	49		SRR11423307	PRJNA545312	16		7	33	PBSC_unmodified	Non-Hodgkin's Lymphoma	1017b67510ed386a9863f8		1		post	2								
FMT.0225D		FMT.0225	61	formed	SRR11116964	PRJNA607574	28		7	33	PBSC_unmodified	Non-Hodgkin's Lymphoma	1017b67510ed386a9863f8		1		post	3								
FMT.0225E		FMT.0225	87	liquid	SRR11116963	PRJNA607574	54		7	33	PBSC_unmodified	Non-Hodgkin's Lymphoma	1017b67510ed386a9863f8		1		post	6								
FMT.0225F		FMT.0225	137	liquid	SRR11116962	PRJNA607574	104		7	33	PBSC_unmodified	Non-Hodgkin's Lymphoma	1017b67510ed386a9863f8		1		post	6								
FMT.0225G		FMT.0225	200	semi-formed	SRR11116960	PRJNA607574	167		7	33	PBSC_unmodified	Non-Hodgkin's Lymphoma	1017b67510ed386a9863f8		1		post	6								
FMT.0226A		FMT.0226	0	semi-formed	SRR11423305	PRJNA545312	-49		5	49	PBSC_unmodified	Non-Hodgkin's Lymphoma	ba207d0be64915b5df0036		0		pre	-3								
FMT.0226B		FMT.0226	46	formed	SRR11116959	PRJNA607574	-3		5	49	PBSC_unmodified	Non-Hodgkin's Lymphoma	ba207d0be64915b5df0036		0		pre	-1								
FMT.0226C		FMT.0226	49	liquid	SRR10668311	PRJNA545312	0		5	49	PBSC_unmodified	Non-Hodgkin's Lymphoma	ba207d0be64915b5df0036		0		peri	-1								
FMT.0226D		FMT.0226	52	liquid	SRR10668310	PRJNA545312	3		5	49	PBSC_unmodified	Non-Hodgkin's Lymphoma	ba207d0be64915b5df0036		0		peri	0								
FMT.0226E		FMT.0226	53	liquid	SRR10668309	PRJNA545312	4		5	49	PBSC_unmodified	Non-Hodgkin's Lymphoma	ba207d0be64915b5df0036		0		peri	0								
FMT.0227A		FMT.0227	0	semi-formed	SRR11423304	PRJNA545312	-13		8	13	TCD	Leukemia	add27d027c19c8566651c0		1		pre	-2								
FMT.0227B		FMT.0227	12	liquid	SRR11116958	PRJNA607574	-1		8	13	TCD	Leukemia	add27d027c19c8566651c0		1		pre	-1								
FMT.0227D		FMT.0227	17	liquid	SRR11116957	PRJNA607574	4		8	13	TCD	Leukemia	add27d027c19c8566651c0		1		peri	0								
FMT.0227F		FMT.0227	20	semi-formed	SRR11116956	PRJNA607574	7		8	13	TCD	Leukemia	add27d027c19c8566651c0		1		post	0								
FMT.0227G		FMT.0227	21	liquid	SRR11116955	PRJNA607574	8		8	13	TCD	Leukemia	add27d027c19c8566651c0		1		post	1								
FMT.0227H		FMT.0227	23	formed	SRR11423275	PRJNA545312	10		8	13	TCD	Leukemia	add27d027c19c8566651c0		1		post	1								
FMT.0227I		FMT.0227	25	formed	SRR11116954	PRJNA607574	12		8	13	TCD	Leukemia	add27d027c19c8566651c0		1		post	1								
FMT.0227J		FMT.0227	26	semi-formed	SRR11116953	PRJNA607574	13		8	13	TCD	Leukemia	add27d027c19c8566651c0		1		post	1								
FMT.0228A		FMT.0228	0	formed	SRR11423274	PRJNA545312	-6		9	6	PBSC_unmodified	Leukemia	3d3d05a7109c78a14934d4		1		pre	-1								
FMT.0228B		FMT.0228	8	semi-formed	SRR10668308	PRJNA545312	2		9	6	PBSC_unmodified	Leukemia	3d3d05a7109c78a14934d4		1		peri	0								
FMT.0228C		FMT.0228	21	liquid	SRR10668307	PRJNA545312	15		9	6	PBSC_unmodified	Leukemia	3d3d05a7109c78a14934d4		1		post	2								
FMT.0228D		FMT.0228	50	semi-formed	SRR11116952	PRJNA607574	44		9	6	PBSC_unmodified	Leukemia	3d3d05a7109c78a14934d4		1		post	6								
FMT.0228F		FMT.0228	53	semi-formed	SRR11116537	PRJNA607574	47		9	6	PBSC_unmodified	Leukemia	3d3d05a7109c78a14934d4		1		post	6								
FMT.0228G		FMT.0228	58	formed	SRR11116535	PRJNA607574	52		9	6	PBSC_unmodified	Leukemia	3d3d05a7109c78a14934d4		1		post	6								
FMT.0228H		FMT.0228	59	formed	SRR11116534	PRJNA607574	53		9	6	PBSC_unmodified	Leukemia	3d3d05a7109c78a14934d4		1		post	6								
FMT.0228I		FMT.0228	65	formed	SRR11116533	PRJNA607574	59		9	6	PBSC_unmodified	Leukemia	3d3d05a7109c78a14934d4		1		post	6								
FMT.0228J		FMT.0228	79	formed	SRR11116532	PRJNA607574	73		9	6	PBSC_unmodified	Leukemia	3d3d05a7109c78a14934d4		1		post	6								
FMT.0229A		FMT.0229	0	formed	SRR11423273	PRJNA545312	-22		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		pre	-3								
FMT.0229B		FMT.0229	15	formed	SRR11423272	PRJNA545312	-7		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		pre	-2								
FMT.0229C		FMT.0229	19	semi-formed	SRR11423271	PRJNA545312	-3		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		pre	-1								
FMT.0229D		FMT.0229	23	formed	SRR11423270	PRJNA545312	1		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		peri	0								
FMT.0229E		FMT.0229	24	semi-formed	SRR11423269	PRJNA545312	2		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		peri	0								
FMT.0229F		FMT.0229	35	semi-formed	SRR11423268	PRJNA545312	13		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		post	1								
FMT.0229G		FMT.0229	37	semi-formed	SRR11423266	PRJNA545312	15		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		post	2								
FMT.0229H		FMT.0229	41	formed	SRR11423265	PRJNA545312	19		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		post	2								
FMT.0229I		FMT.0229	42	semi-formed	SRR11423264	PRJNA545312	20		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		post	2								
FMT.0229J		FMT.0229	43	semi-formed	SRR11423263	PRJNA545312	21		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		post	2								
FMT.0229K		FMT.0229	44	semi-formed	SRR11423262	PRJNA545312	22		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		post	3								
FMT.0229L		FMT.0229	65		SRR11423261	PRJNA545312	43		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		post	6								
FMT.0229M		FMT.0229	72	semi-formed	SRR11116531	PRJNA607574	50		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		post	6								
FMT.0229N		FMT.0229	104	formed	SRR11116530	PRJNA607574	82		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		post	6								
FMT.0229O		FMT.0229	120	formed	SRR11116529	PRJNA607574	98		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		post	6								
FMT.0229P		FMT.0229	145	formed	SRR11116528	PRJNA607574	123		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		post	6								
FMT.0229Q		FMT.0229	160	formed	SRR11116527	PRJNA607574	138		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		post	6								
FMT.0229R		FMT.0229	184	formed	SRR11116526	PRJNA607574	162		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		post	6								
FMT.0229S		FMT.0229	202	formed	SRR11116524	PRJNA607574	180		19	22	BM_unmodified	Aplastic Anemia	87361dc7b53bb65f569e51		1		post	6								
FMT.0230A		FMT.0230	0	semi-formed	SRR11423260	PRJNA545312	-22		4	22	PBSC_unmodified	Non-Hodgkin's Lymphoma	d42d28d406f5ccbe98e70c		1		pre	-3								
FMT.0230B		FMT.0230	20	formed	SRR11116523	PRJNA607574	-2		4	22	PBSC_unmodified	Non-Hodgkin's Lymphoma	d42d28d406f5ccbe98e70c		1		pre	-1								
FMT.0230C		FMT.0230	26	formed	SRR10668306	PRJNA545312	4		4	22	PBSC_unmodified	Non-Hodgkin's Lymphoma	d42d28d406f5ccbe98e70c		1		peri	0								
FMT.0230D		FMT.0230	40	formed	SRR10668305	PRJNA545312	18		4	22	PBSC_unmodified	Non-Hodgkin's Lymphoma	d42d28d406f5ccbe98e70c		1		post	2								
FMT.0231A		FMT.0231	0	formed	SRR11423259	PRJNA545312	-11		6	11	TCD	Leukemia	64f37a2d32442e5d85d944		1		pre	-2								
FMT.0231C		FMT.0231	10	formed	SRR11423258	PRJNA545312	-1		6	11	TCD	Leukemia	64f37a2d32442e5d85d944		1		pre	-1								
FMT.0231D		FMT.0231	23	formed	SRR11423257	PRJNA545312	12		6	11	TCD	Leukemia	64f37a2d32442e5d85d944		1		post	1								
FMT.0231F		FMT.0231	27	formed	SRR11423255	PRJNA545312	16		6	11	TCD	Leukemia	64f37a2d32442e5d85d944		1		post	2								
FMT.0231G		FMT.0231	28	formed	SRR11423254	PRJNA545312	17		6	11	TCD	Leukemia	64f37a2d32442e5d85d944		1		post	2								
FMT.0231H		FMT.0231	29	formed	SRR11423253	PRJNA545312	18		6	11	TCD	Leukemia	64f37a2d32442e5d85d944		1		post	2								
FMT.0232A		FMT.0232	0	formed	SRR11423252	PRJNA545312	-24		15	24	cord	Leukemia	620846f35ee1efd0fa2bd6		1		pre	-3								
FMT.0232B		FMT.0232	23	semi-formed	SRR11116522	PRJNA607574	-1		15	24	cord	Leukemia	620846f35ee1efd0fa2bd6		1		pre	-1								
FMT.0232C		FMT.0232	27	formed	SRR10668304	PRJNA545312	3		15	24	cord	Leukemia	620846f35ee1efd0fa2bd6		1		peri	0								
FMT.0232E		FMT.0232	30	formed	SRR10668303	PRJNA545312	6		15	24	cord	Leukemia	620846f35ee1efd0fa2bd6		1		post	0								
FMT.0232F		FMT.0232	31	formed	SRR10668302	PRJNA545312	7		15	24	cord	Leukemia	620846f35ee1efd0fa2bd6		1		post	0								
FMT.0232G		FMT.0232	33	semi-formed	SRR10668300	PRJNA545312	9		15	24	cord	Leukemia	620846f35ee1efd0fa2bd6		1		post	1								
FMT.0232H		FMT.0232	35	semi-formed	SRR10668299	PRJNA545312	11		15	24	cord	Leukemia	620846f35ee1efd0fa2bd6		1		post	1								
FMT.0232I		FMT.0232	37	semi-formed	SRR10668298	PRJNA545312	13		15	24	cord	Leukemia	620846f35ee1efd0fa2bd6		1		post	1								
FMT.0232J		FMT.0232	42	semi-formed	SRR10668297	PRJNA545312	18		15	24	cord	Leukemia	620846f35ee1efd0fa2bd6		1		post	2								
FMT.0232K		FMT.0232	49	liquid	SRR11116521	PRJNA607574	25		15	24	cord	Leukemia	620846f35ee1efd0fa2bd6		1		post	3								
FMT.0232L		FMT.0232	50	semi-formed	SRR11116520	PRJNA607574	26		15	24	cord	Leukemia	620846f35ee1efd0fa2bd6		1		post	3								
FMT.0232M		FMT.0232	56	liquid	SRR11116519	PRJNA607574	32		15	24	cord	Leukemia	620846f35ee1efd0fa2bd6		1		post	4								
FMT.0232N		FMT.0232	61	liquid	SRR11116518	PRJNA607574	37		15	24	cord	Leukemia	620846f35ee1efd0fa2bd6		1		post	5								
FMT.0232O		FMT.0232	83	formed	SRR11116517	PRJNA607574	59		15	24	cord	Leukemia	620846f35ee1efd0fa2bd6		1		post	6								
FMT.0232Q		FMT.0232	128	formed	SRR11116516	PRJNA607574	104		15	24	cord	Leukemia	620846f35ee1efd0fa2bd6		1		post	6								
FMT.0233I		FMT.0223	237	liquid	SRR11116515	PRJNA607574	227		12	10	TCD	Multiple Myeloma	fe5d59743a68305ac5cf35		1		post	6								
FMT.0233J		FMT.0223	238	formed	SRR11116513	PRJNA607574	228		12	10	TCD	Multiple Myeloma	fe5d59743a68305ac5cf35		1		post	6								
FMT.0233K		FMT.0223	239	liquid	SRR11116512	PRJNA607574	229		12	10	TCD	Multiple Myeloma	fe5d59743a68305ac5cf35		1		post	6								
FMT.0233L		FMT.0223	244	formed	SRR11116511	PRJNA607574	234		12	10	TCD	Multiple Myeloma	fe5d59743a68305ac5cf35		1		post	6								
FMT.0234A		FMT.0234	0	semi-formed	SRR11423251	PRJNA545312	-6		1	6	PBSC_unmodified	Leukemia	0ef4e7dfaa9ba6c107c6d2		1		pre	-1								
FMT.0236A		FMT.0236	0	semi-formed	SRR11423250	PRJNA545312	-15		13	15	PBSC_unmodified	Myelodysplastic Syndromes	fee849ce466637098d4a4a		1		pre	-3								
FMT.0236B		FMT.0236	12	formed	SRR9271198	PRJNA548153	-3		13	15	PBSC_unmodified	Myelodysplastic Syndromes	fee849ce466637098d4a4a		1		pre	-1								
FMT.0236C		FMT.0236	13	formed	SRR9271195	PRJNA548153	-2		13	15	PBSC_unmodified	Myelodysplastic Syndromes	fee849ce466637098d4a4a		1		pre	-1								
FMT.0236D		FMT.0236	14	formed	SRR9271196	PRJNA548153	-1		13	15	PBSC_unmodified	Myelodysplastic Syndromes	fee849ce466637098d4a4a		1		pre	-1								
FMT.0236E		FMT.0236	15	liquid	SRR9271185	PRJNA548153	0		13	15	PBSC_unmodified	Myelodysplastic Syndromes	fee849ce466637098d4a4a		1		peri	-1								
FMT.0236F		FMT.0236	20	liquid	SRR9271186	PRJNA548153	5		13	15	PBSC_unmodified	Myelodysplastic Syndromes	fee849ce466637098d4a4a		1		peri	0								
FMT.0236G		FMT.0236	21	liquid	SRR9271168	PRJNA548153	6		13	15	PBSC_unmodified	Myelodysplastic Syndromes	fee849ce466637098d4a4a		1		post	0								
FMT.0236H		FMT.0236	22	liquid	SRR9271167	PRJNA548153	7		13	15	PBSC_unmodified	Myelodysplastic Syndromes	fee849ce466637098d4a4a		1		post	0								
FMT.0236I		FMT.0236	24	formed	SRR9271166	PRJNA548153	9		13	15	PBSC_unmodified	Myelodysplastic Syndromes	fee849ce466637098d4a4a		1		post	1								
FMT.0236L		FMT.0236	28	semi-formed	SRR10668296	PRJNA545312	13		13	15	PBSC_unmodified	Myelodysplastic Syndromes	fee849ce466637098d4a4a		1		post	1								
FMT.0236M		FMT.0236	29	semi-formed	SRR10668295	PRJNA545312	14		13	15	PBSC_unmodified	Myelodysplastic Syndromes	fee849ce466637098d4a4a		1		post	1								
FMT.0236N		FMT.0236	30	semi-formed	SRR10668294	PRJNA545312	15		13	15	PBSC_unmodified	Myelodysplastic Syndromes	fee849ce466637098d4a4a		1		post	2								
FMT.0236O		FMT.0236	35	formed	SRR10668293	PRJNA545312	20		13	15	PBSC_unmodified	Myelodysplastic Syndromes	fee849ce466637098d4a4a		1		post	2								
FMT.0237B		FMT.0237	7	liquid	SRR11116510	PRJNA607574	-1		9	8	PBSC_unmodified	Leukemia	185c2a823dd816c460c995		1		pre	-1								
FMT.0237C		FMT.0237	8	liquid	SRR10668292	PRJNA545312	0		9	8	PBSC_unmodified	Leukemia	185c2a823dd816c460c995		1		peri	-1								
FMT.0237D		FMT.0237	13	liquid	SRR10668291	PRJNA545312	5		9	8	PBSC_unmodified	Leukemia	185c2a823dd816c460c995		1		peri	0								
FMT.0237E		FMT.0237	17	semi-formed	SRR10668289	PRJNA545312	9		9	8	PBSC_unmodified	Leukemia	185c2a823dd816c460c995		1		post	1								
FMT.0237F		FMT.0237	20	semi-formed	SRR11423249	PRJNA545312	12		9	8	PBSC_unmodified	Leukemia	185c2a823dd816c460c995		1		post	1								
FMT.0237G		FMT.0237	21	semi-formed	SRR10668288	PRJNA545312	13		9	8	PBSC_unmodified	Leukemia	185c2a823dd816c460c995		1		post	1								
FMT.0237H		FMT.0237	24	semi-formed	SRR10668287	PRJNA545312	16		9	8	PBSC_unmodified	Leukemia	185c2a823dd816c460c995		1		post	2								
FMT.0237I		FMT.0237	28	formed	SRR10668286	PRJNA545312	20		9	8	PBSC_unmodified	Leukemia	185c2a823dd816c460c995		1		post	2								
FMT.0237J		FMT.0237	29	formed	SRR11116453	PRJNA607574	21		9	8	PBSC_unmodified	Leukemia	185c2a823dd816c460c995		1		post	2								
FMT.0238A		FMT.0238	0	formed	SRR11423248	PRJNA545312	-13		7	13	TCD	Leukemia	3c1bb589148e491e468578		1		pre	-2								
FMT.0238B		FMT.0238	13	liquid	SRR11116451	PRJNA607574	0		7	13	TCD	Leukemia	3c1bb589148e491e468578		1		peri	-1								
FMT.0238C		FMT.0238	27	formed	SRR11116450	PRJNA607574	14		7	13	TCD	Leukemia	3c1bb589148e491e468578		1		post	1								
FMT.0238D		FMT.0238	28	formed	SRR11116449	PRJNA607574	15		7	13	TCD	Leukemia	3c1bb589148e491e468578		1		post	2								
FMT.0238E		FMT.0238	39	liquid	SRR11116448	PRJNA607574	26		7	13	TCD	Leukemia	3c1bb589148e491e468578		1		post	3								
FMT.0238G		FMT.0238	49	semi-formed	SRR11116447	PRJNA607574	36		7	13	TCD	Leukemia	3c1bb589148e491e468578		1		post	5								
FMT.0238H		FMT.0238	165	formed	SRR11116445	PRJNA607574	152		7	13	TCD	Leukemia	3c1bb589148e491e468578		1		post	6								
FMT.0239A		FMT.0239	0	formed	SRR11423219	PRJNA545312	-15		11	15	PBSC_unmodified	Leukemia	f01d45ee68f260f9f5727a		1		pre	-3								
FMT.0239B		FMT.0239	9	formed	SRR11423218	PRJNA545312	-6		11	15	PBSC_unmodified	Leukemia	f01d45ee68f260f9f5727a		1		pre	-1								
FMT.0239C		FMT.0239	21	formed	SRR11423216	PRJNA545312	6		11	15	PBSC_unmodified	Leukemia	f01d45ee68f260f9f5727a		1		post	0								
FMT.0239D		FMT.0239	23	formed	SRR11423215	PRJNA545312	8		11	15	PBSC_unmodified	Leukemia	f01d45ee68f260f9f5727a		1		post	1								
FMT.0239E		FMT.0239	26	formed	SRR11423214	PRJNA545312	11		11	15	PBSC_unmodified	Leukemia	f01d45ee68f260f9f5727a		1		post	1								
FMT.0239F		FMT.0239	27	formed	SRR11423213	PRJNA545312	12		11	15	PBSC_unmodified	Leukemia	f01d45ee68f260f9f5727a		1		post	1								
FMT.0239G		FMT.0239	28	formed	SRR11423212	PRJNA545312	13		11	15	PBSC_unmodified	Leukemia	f01d45ee68f260f9f5727a		1		post	1								
FMT.0239H		FMT.0239	52	semi-formed	SRR11116444	PRJNA607574	37		11	15	PBSC_unmodified	Leukemia	f01d45ee68f260f9f5727a		1		post	5								
FMT.0239I		FMT.0239	77	formed	SRR11116443	PRJNA607574	62		11	15	PBSC_unmodified	Leukemia	f01d45ee68f260f9f5727a		1		post	6								
FMT.0239J		FMT.0239	160	semi-formed	SRR11116442	PRJNA607574	145		11	15	PBSC_unmodified	Leukemia	f01d45ee68f260f9f5727a		1		post	6								
FMT.0239K		FMT.0239	232	formed	SRR11116441	PRJNA607574	217		11	15	PBSC_unmodified	Leukemia	f01d45ee68f260f9f5727a		1		post	6								
FMT.0240A		FMT.0240	0	semi-formed	SRR11423211	PRJNA545312	-6		12	6	PBSC_unmodified	Myelodysplastic Syndromes	1bb5eab3ffe3867c0b0d68		1		pre	-1								
FMT.0240B		FMT.0240	4	semi-formed	SRR9271220	PRJNA548153	-2		12	6	PBSC_unmodified	Myelodysplastic Syndromes	1bb5eab3ffe3867c0b0d68		1		pre	-1								
FMT.0240C		FMT.0240	5	formed	SRR9271221	PRJNA548153	-1		12	6	PBSC_unmodified	Myelodysplastic Syndromes	1bb5eab3ffe3867c0b0d68		1		pre	-1								
FMT.0240D		FMT.0240	6	formed	SRR9271083	PRJNA548153	0		12	6	PBSC_unmodified	Myelodysplastic Syndromes	1bb5eab3ffe3867c0b0d68		1		peri	-1								
FMT.0240E		FMT.0240	7	semi-formed	SRR9271237	PRJNA548153	1		12	6	PBSC_unmodified	Myelodysplastic Syndromes	1bb5eab3ffe3867c0b0d68		1		peri	0								
FMT.0240G		FMT.0240	8	semi-formed	SRR9271085	PRJNA548153	2		12	6	PBSC_unmodified	Myelodysplastic Syndromes	1bb5eab3ffe3867c0b0d68		1		peri	0								
FMT.0240I		FMT.0240	11	formed	SRR11116440	PRJNA607574	5		12	6	PBSC_unmodified	Myelodysplastic Syndromes	1bb5eab3ffe3867c0b0d68		1		peri	0								
FMT.0240K		FMT.0240	12	formed	SRR9271234	PRJNA548153	6		12	6	PBSC_unmodified	Myelodysplastic Syndromes	1bb5eab3ffe3867c0b0d68		1		post	0								
FMT.0240L		FMT.0240	13	formed	SRR9271233	PRJNA548153	7		12	6	PBSC_unmodified	Myelodysplastic Syndromes	1bb5eab3ffe3867c0b0d68		1		post	0								
FMT.0240M		FMT.0240	14	formed	SRR9271236	PRJNA548153	8		12	6	PBSC_unmodified	Myelodysplastic Syndromes	1bb5eab3ffe3867c0b0d68		1		post	1								
FMT.0240N		FMT.0240	19	formed	SRR11116438	PRJNA607574	13		12	6	PBSC_unmodified	Myelodysplastic Syndromes	1bb5eab3ffe3867c0b0d68		1		post	1								
FMT.0240O		FMT.0240	20	semi-formed	SRR11116437	PRJNA607574	14		12	6	PBSC_unmodified	Myelodysplastic Syndromes	1bb5eab3ffe3867c0b0d68		1		post	1								
FMT.0241A		FMT.0241	0	liquid	SRR11423210	PRJNA545312	-9		7	9	BM_unmodified	Non-Malignant Hemat Disorders	b4323dc60594ff9a0c81bc		1		pre	-2								
FMT.0241B		FMT.0241	7	formed	SRR11423209	PRJNA545312	-2		7	9	BM_unmodified	Non-Malignant Hemat Disorders	b4323dc60594ff9a0c81bc		1		pre	-1								
FMT.0241C		FMT.0241	14	semi-formed	SRR11423208	PRJNA545312	5		7	9	BM_unmodified	Non-Malignant Hemat Disorders	b4323dc60594ff9a0c81bc		1		peri	0								
FMT.0241D		FMT.0241	16	formed	SRR11423207	PRJNA545312	7		7	9	BM_unmodified	Non-Malignant Hemat Disorders	b4323dc60594ff9a0c81bc		1		post	0								
FMT.0241E		FMT.0241	21	semi-formed	SRR11423205	PRJNA545312	12		7	9	BM_unmodified	Non-Malignant Hemat Disorders	b4323dc60594ff9a0c81bc		1		post	1								
FMT.0241F		FMT.0241	30	semi-formed	SRR11423204	PRJNA545312	21		7	9	BM_unmodified	Non-Malignant Hemat Disorders	b4323dc60594ff9a0c81bc		1		post	2								
FMT.0241G		FMT.0241	33	semi-formed	SRR11423203	PRJNA545312	24		7	9	BM_unmodified	Non-Malignant Hemat Disorders	b4323dc60594ff9a0c81bc		1		post	3								
FMT.0242A		FMT.0242	0	formed	SRR9271192	PRJNA548153	-6		9	6	PBSC_unmodified	Leukemia	6eb9df295af8b4c883a08d		1		pre	-1								
FMT.0242B		FMT.0242	4	formed	SRR11423202	PRJNA545312	-2		9	6	PBSC_unmodified	Leukemia	6eb9df295af8b4c883a08d		1		pre	-1								
FMT.0242C		FMT.0242	6	liquid	SRR11423201	PRJNA545312	0		9	6	PBSC_unmodified	Leukemia	6eb9df295af8b4c883a08d		1		peri	-1								
FMT.0242D		FMT.0242	9	formed	SRR11423200	PRJNA545312	3		9	6	PBSC_unmodified	Leukemia	6eb9df295af8b4c883a08d		1		peri	0								
FMT.0242E		FMT.0242	11	formed	SRR11423199	PRJNA545312	5		9	6	PBSC_unmodified	Leukemia	6eb9df295af8b4c883a08d		1		peri	0								
FMT.0242F		FMT.0242	12	formed	SRR11423198	PRJNA545312	6		9	6	PBSC_unmodified	Leukemia	6eb9df295af8b4c883a08d		1		post	0								
FMT.0242G		FMT.0242	13	semi-formed	SRR11423197	PRJNA545312	7		9	6	PBSC_unmodified	Leukemia	6eb9df295af8b4c883a08d		1		post	0								
FMT.0242H		FMT.0242	17	formed	SRR11423196	PRJNA545312	11		9	6	PBSC_unmodified	Leukemia	6eb9df295af8b4c883a08d		1		post	1								
FMT.0242I		FMT.0242	18	formed	SRR11423194	PRJNA545312	12		9	6	PBSC_unmodified	Leukemia	6eb9df295af8b4c883a08d		1		post	1								
FMT.0243A		FMT.0243	0	formed	SRR11423193	PRJNA545312	-6		9	6	PBSC_unmodified	Myeloproliferative Disorder	7d1ebbc2a93151760f243e		1		pre	-1								
FMT.0243B		FMT.0243	4	semi-formed	SRR11423192	PRJNA545312	-2		9	6	PBSC_unmodified	Myeloproliferative Disorder	7d1ebbc2a93151760f243e		1		pre	-1								
FMT.0243C		FMT.0243	5	formed	SRR11423163	PRJNA545312	-1		9	6	PBSC_unmodified	Myeloproliferative Disorder	7d1ebbc2a93151760f243e		1		pre	-1								
FMT.0243D		FMT.0243	12	semi-formed	SRR11423162	PRJNA545312	6		9	6	PBSC_unmodified	Myeloproliferative Disorder	7d1ebbc2a93151760f243e		1		post	0								
FMT.0243H		FMT.0243	25	liquid	SRR11423161	PRJNA545312	19		9	6	PBSC_unmodified	Myeloproliferative Disorder	7d1ebbc2a93151760f243e		1		post	2								
FMT.0243I		FMT.0243	31	semi-formed	SRR11423160	PRJNA545312	25		9	6	PBSC_unmodified	Myeloproliferative Disorder	7d1ebbc2a93151760f243e		1		post	3								
FMT.0243J		FMT.0243	33	liquid	SRR11423159	PRJNA545312	27		9	6	PBSC_unmodified	Myeloproliferative Disorder	7d1ebbc2a93151760f243e		1		post	3								
FMT.0243K		FMT.0243	35	semi-formed	SRR11116436	PRJNA607574	29		9	6	PBSC_unmodified	Myeloproliferative Disorder	7d1ebbc2a93151760f243e		1		post	4								
FMT.0243L		FMT.0243	42	semi-formed	SRR11116434	PRJNA607574	36		9	6	PBSC_unmodified	Myeloproliferative Disorder	7d1ebbc2a93151760f243e		1		post	5								
FMT.0244A		FMT.0244	0	semi-formed	SRR9271235	PRJNA548153	-6		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		pre	-1								
FMT.0244B		FMT.0244	1	formed	SRR11423158	PRJNA545312	-5		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		pre	-1								
FMT.0244C		FMT.0244	4	semi-formed	SRR11423157	PRJNA545312	-2		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		pre	-1								
FMT.0244D		FMT.0244	5	formed	SRR11423155	PRJNA545312	-1		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		pre	-1								
FMT.0244E		FMT.0244	6	liquid	SRR11423154	PRJNA545312	0		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		peri	-1								
FMT.0244F		FMT.0244	7	formed	SRR11423153	PRJNA545312	1		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		peri	0								
FMT.0244G		FMT.0244	8	formed	SRR11423152	PRJNA545312	2		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		peri	0								
FMT.0244H		FMT.0244	9	formed	SRR11423151	PRJNA545312	3		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		peri	0								
FMT.0244I		FMT.0244	11	semi-formed	SRR11423150	PRJNA545312	5		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		peri	0								
FMT.0244J		FMT.0244	12	formed	SRR11423149	PRJNA545312	6		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		post	0								
FMT.0244K		FMT.0244	13	liquid	SRR9271516	PRJNA548153	7		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		post	0								
FMT.0244L		FMT.0244	14	formed	SRR9271517	PRJNA548153	8		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		post	1								
FMT.0244M		FMT.0244	15	semi-formed	SRR9271514	PRJNA548153	9		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		post	1								
FMT.0244N		FMT.0244	16	semi-formed	SRR9271515	PRJNA548153	10		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		post	1								
FMT.0244O		FMT.0244	18	formed	SRR11116433	PRJNA607574	12		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		post	1								
FMT.0244P		FMT.0244	19	semi-formed	SRR11423148	PRJNA545312	13		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		post	1								
FMT.0244Q		FMT.0244	21	formed	SRR11116432	PRJNA607574	15		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		post	2								
FMT.0244R		FMT.0244	22	formed	SRR11116431	PRJNA607574	16		18	6	PBSC_unmodified	Leukemia	64f565e338eb2431ac365f		1		post	2								
FMT.0245A		FMT.0245	0	semi-formed	SRR11423147	PRJNA545312	-28		16	28	cord	Leukemia	8967f73958c863550cfc3e		1		pre	-3								
FMT.0245B		FMT.0245	31	liquid	SRR10668285	PRJNA545312	3		16	28	cord	Leukemia	8967f73958c863550cfc3e		1		peri	0								
FMT.0245D		FMT.0245	33	semi-formed	SRR10668284	PRJNA545312	5		16	28	cord	Leukemia	8967f73958c863550cfc3e		1		peri	0								
FMT.0245E		FMT.0245	35	liquid	SRR10668283	PRJNA545312	7		16	28	cord	Leukemia	8967f73958c863550cfc3e		1		post	0								
FMT.0245F		FMT.0245	40	liquid	SRR11423146	PRJNA545312	12		16	28	cord	Leukemia	8967f73958c863550cfc3e		1		post	1								
FMT.0245G		FMT.0245	41	semi-formed	SRR10668282	PRJNA545312	13		16	28	cord	Leukemia	8967f73958c863550cfc3e		1		post	1								
FMT.0245H		FMT.0245	46	liquid	SRR10668281	PRJNA545312	18		16	28	cord	Leukemia	8967f73958c863550cfc3e		1		post	2								
FMT.0245I		FMT.0245	47	semi-formed	SRR10668280	PRJNA545312	19		16	28	cord	Leukemia	8967f73958c863550cfc3e		1		post	2								
FMT.0245J		FMT.0245	48	liquid	SRR10668278	PRJNA545312	20		16	28	cord	Leukemia	8967f73958c863550cfc3e		1		post	2								
FMT.0245K		FMT.0245	49	liquid	SRR10668277	PRJNA545312	21		16	28	cord	Leukemia	8967f73958c863550cfc3e		1		post	2								
FMT.0245L		FMT.0245	52	semi-formed	SRR11116430	PRJNA607574	24		16	28	cord	Leukemia	8967f73958c863550cfc3e		1		post	3								
FMT.0245M		FMT.0245	57	liquid	SRR11116429	PRJNA607574	29		16	28	cord	Leukemia	8967f73958c863550cfc3e		1		post	4								
FMT.0245N		FMT.0245	77	semi-formed	SRR11116428	PRJNA607574	49		16	28	cord	Leukemia	8967f73958c863550cfc3e		1		post	6								
FMT.0245O		FMT.0245	110	formed	SRR11116427	PRJNA607574	82		16	28	cord	Leukemia	8967f73958c863550cfc3e		1		post	6								
FMT.0245P		FMT.0245	124	semi-formed	SRR11116426	PRJNA607574	96		16	28	cord	Leukemia	8967f73958c863550cfc3e		1		post	6								
FMT.0245Q		FMT.0245	141	semi-formed	SRR11116425	PRJNA607574	113		16	28	cord	Leukemia	8967f73958c863550cfc3e		1		post	6								
FMT.0248A		FMT.0248	0	formed	SRR9271197	PRJNA548153	-10		9	10	TCD	Leukemia	ed9f94fb240d230eb4633c		1		pre	-2								
FMT.0248B		FMT.0248	8	liquid	SRR11423143	PRJNA545312	-2		9	10	TCD	Leukemia	ed9f94fb240d230eb4633c		1		pre	-1								
FMT.0248C		FMT.0248	9	liquid	SRR11423142	PRJNA545312	-1		9	10	TCD	Leukemia	ed9f94fb240d230eb4633c		1		pre	-1								
FMT.0248D		FMT.0248	12	liquid	SRR11423141	PRJNA545312	2		9	10	TCD	Leukemia	ed9f94fb240d230eb4633c		1		peri	0								
FMT.0248E		FMT.0248	13	liquid	SRR11423140	PRJNA545312	3		9	10	TCD	Leukemia	ed9f94fb240d230eb4633c		1		peri	0								
FMT.0248F		FMT.0248	14	liquid	SRR11423139	PRJNA545312	4		9	10	TCD	Leukemia	ed9f94fb240d230eb4633c		1		peri	0								
FMT.0248G		FMT.0248	15	liquid	SRR11423138	PRJNA545312	5		9	10	TCD	Leukemia	ed9f94fb240d230eb4633c		1		peri	0								
FMT.0248H		FMT.0248	16	liquid	SRR11423137	PRJNA545312	6		9	10	TCD	Leukemia	ed9f94fb240d230eb4633c		1		post	0								
FMT.0248I		FMT.0248	17	liquid	SRR11423136	PRJNA545312	7		9	10	TCD	Leukemia	ed9f94fb240d230eb4633c		1		post	0								
FMT.0249A		FMT.0249	0	liquid	SRR11116395	PRJNA607574	0		5	0	TCD	Leukemia	717afcc7fdcc8bfedc6668		0		peri	-1								
FMT.0249B		FMT.0249	28	formed	SRR11116394	PRJNA607574	28		5	0	TCD	Leukemia	717afcc7fdcc8bfedc6668		0		post	3								
FMT.0249C		FMT.0249	70	semi-formed	SRR11116393	PRJNA607574	70		5	0	TCD	Leukemia	717afcc7fdcc8bfedc6668		0		post	6								
FMT.0249D		FMT.0249	95		SRR11116392	PRJNA607574	95		5	0	TCD	Leukemia	717afcc7fdcc8bfedc6668		0		post	6								
FMT.0249E		FMT.0249	187	formed	SRR11116391	PRJNA607574	187		5	0	TCD	Leukemia	717afcc7fdcc8bfedc6668		0		post	6								
FMT.0250A		FMT.0250	0	semi-formed	SRR11116390	PRJNA607574	-16		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		pre	-3								
FMT.0250AA		FMT.0250	252	formed	SRR11116389	PRJNA607574	236		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		post	6								
FMT.0250B		FMT.0250	11	formed	SRR9271560	PRJNA548153	-5		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		pre	-1								
FMT.0250C		FMT.0250	14	formed	SRR9271559	PRJNA548153	-2		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		pre	-1								
FMT.0250D		FMT.0250	15	semi-formed	SRR9271558	PRJNA548153	-1		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		pre	-1								
FMT.0250E		FMT.0250	16	semi-formed	SRR9271565	PRJNA548153	0		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		peri	-1								
FMT.0250F		FMT.0250	17	semi-formed	SRR9271564	PRJNA548153	1		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		peri	0								
FMT.0250G		FMT.0250	18	formed	SRR9271563	PRJNA548153	2		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		peri	0								
FMT.0250H		FMT.0250	21	semi-formed	SRR9271562	PRJNA548153	5		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		peri	0								
FMT.0250I		FMT.0250	22	liquid	SRR9271557	PRJNA548153	6		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		post	0								
FMT.0250J		FMT.0250	23	semi-formed	SRR9271556	PRJNA548153	7		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		post	0								
FMT.0250K		FMT.0250	24	semi-formed	SRR9271383	PRJNA548153	8		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		post	1								
FMT.0250L		FMT.0250	25	liquid	SRR9271384	PRJNA548153	9		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		post	1								
FMT.0250M		FMT.0250	28		SRR9271381	PRJNA548153	12		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		post	1								
FMT.0250P		FMT.0250	31	liquid	SRR9271382	PRJNA548153	15		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		post	2								
FMT.0250R		FMT.0250	35	semi-formed	SRR11116388	PRJNA607574	19		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		post	2								
FMT.0250U		FMT.0250	38	semi-formed	SRR11116387	PRJNA607574	22		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		post	3								
FMT.0250V		FMT.0250	39	formed	SRR11116386	PRJNA607574	23		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		post	3								
FMT.0250W		FMT.0250	44	formed	SRR11116383	PRJNA607574	28		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		post	3								
FMT.0250X		FMT.0250	59	semi-formed	SRR11116382	PRJNA607574	43		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		post	6								
FMT.0250Y		FMT.0250	94	formed	SRR11116381	PRJNA607574	78		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		post	6								
FMT.0250Z		FMT.0250	164	semi-formed	SRR11116380	PRJNA607574	148		22	16	BM_unmodified	Myelodysplastic Syndromes	8a6abaffc11bf51c265600		0		post	6								
FMT.0251A		FMT.0251	0	semi-formed	SRR9270315	PRJNA548153	-1		10	1	PBSC_unmodified	Myelodysplastic Syndromes	183aa8c63b28813c8b5475		0		pre	-1								
FMT.0251B		FMT.0251	1	formed	SRR9270316	PRJNA548153	0		10	1	PBSC_unmodified	Myelodysplastic Syndromes	183aa8c63b28813c8b5475		0		peri	-1								
FMT.0251C		FMT.0251	4	semi-formed	SRR9270317	PRJNA548153	3		10	1	PBSC_unmodified	Myelodysplastic Syndromes	183aa8c63b28813c8b5475		0		peri	0								
FMT.0251D		FMT.0251	5	liquid	SRR9270318	PRJNA548153	4		10	1	PBSC_unmodified	Myelodysplastic Syndromes	183aa8c63b28813c8b5475		0		peri	0								
FMT.0251E		FMT.0251	6	semi-formed	SRR9270216	PRJNA548153	5		10	1	PBSC_unmodified	Myelodysplastic Syndromes	183aa8c63b28813c8b5475		0		peri	0								
FMT.0251G		FMT.0251	8	semi-formed	SRR9270380	PRJNA548153	7		10	1	PBSC_unmodified	Myelodysplastic Syndromes	183aa8c63b28813c8b5475		0		post	0								
FMT.0251H		FMT.0251	7	semi-formed	SRR11396690	PRJNA607574	6		10	1	PBSC_unmodified	Myelodysplastic Syndromes	183aa8c63b28813c8b5475		0		post	0								
FMT.0251I		FMT.0251	12	semi-formed	SRR9270379	PRJNA548153	11		10	1	PBSC_unmodified	Myelodysplastic Syndromes	183aa8c63b28813c8b5475		0		post	1								
FMT.0251J		FMT.0251	13	semi-formed	SRR9270382	PRJNA548153	12		10	1	PBSC_unmodified	Myelodysplastic Syndromes	183aa8c63b28813c8b5475		0		post	1								
FMT.0251L		FMT.0251	15	semi-formed	SRR9270381	PRJNA548153	14		10	1	PBSC_unmodified	Myelodysplastic Syndromes	183aa8c63b28813c8b5475		0		post	1								
